<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />


<meta name="author" content="William Muir" />

<meta name="date" content="2020-03-30" />

<title>Health Care Procedure Coding System</title>

<script>/*! jQuery v1.11.3 | (c) 2005, 2015 jQuery Foundation, Inc. | jquery.org/license */
!function(a,b){"object"==typeof module&&"object"==typeof module.exports?module.exports=a.document?b(a,!0):function(a){if(!a.document)throw new Error("jQuery requires a window with a document");return b(a)}:b(a)}("undefined"!=typeof window?window:this,function(a,b){var c=[],d=c.slice,e=c.concat,f=c.push,g=c.indexOf,h={},i=h.toString,j=h.hasOwnProperty,k={},l="1.11.3",m=function(a,b){return new m.fn.init(a,b)},n=/^[\s\uFEFF\xA0]+|[\s\uFEFF\xA0]+$/g,o=/^-ms-/,p=/-([\da-z])/gi,q=function(a,b){return b.toUpperCase()};m.fn=m.prototype={jquery:l,constructor:m,selector:"",length:0,toArray:function(){return d.call(this)},get:function(a){return null!=a?0>a?this[a+this.length]:this[a]:d.call(this)},pushStack:function(a){var b=m.merge(this.constructor(),a);return b.prevObject=this,b.context=this.context,b},each:function(a,b){return m.each(this,a,b)},map:function(a){return this.pushStack(m.map(this,function(b,c){return a.call(b,c,b)}))},slice:function(){return this.pushStack(d.apply(this,arguments))},first:function(){return this.eq(0)},last:function(){return this.eq(-1)},eq:function(a){var b=this.length,c=+a+(0>a?b:0);return this.pushStack(c>=0&&b>c?[this[c]]:[])},end:function(){return this.prevObject||this.constructor(null)},push:f,sort:c.sort,splice:c.splice},m.extend=m.fn.extend=function(){var a,b,c,d,e,f,g=arguments[0]||{},h=1,i=arguments.length,j=!1;for("boolean"==typeof g&&(j=g,g=arguments[h]||{},h++),"object"==typeof g||m.isFunction(g)||(g={}),h===i&&(g=this,h--);i>h;h++)if(null!=(e=arguments[h]))for(d in e)a=g[d],c=e[d],g!==c&&(j&&c&&(m.isPlainObject(c)||(b=m.isArray(c)))?(b?(b=!1,f=a&&m.isArray(a)?a:[]):f=a&&m.isPlainObject(a)?a:{},g[d]=m.extend(j,f,c)):void 0!==c&&(g[d]=c));return g},m.extend({expando:"jQuery"+(l+Math.random()).replace(/\D/g,""),isReady:!0,error:function(a){throw new Error(a)},noop:function(){},isFunction:function(a){return"function"===m.type(a)},isArray:Array.isArray||function(a){return"array"===m.type(a)},isWindow:function(a){return null!=a&&a==a.window},isNumeric:function(a){return!m.isArray(a)&&a-parseFloat(a)+1>=0},isEmptyObject:function(a){var b;for(b in a)return!1;return!0},isPlainObject:function(a){var b;if(!a||"object"!==m.type(a)||a.nodeType||m.isWindow(a))return!1;try{if(a.constructor&&!j.call(a,"constructor")&&!j.call(a.constructor.prototype,"isPrototypeOf"))return!1}catch(c){return!1}if(k.ownLast)for(b in a)return j.call(a,b);for(b in a);return void 0===b||j.call(a,b)},type:function(a){return null==a?a+"":"object"==typeof a||"function"==typeof a?h[i.call(a)]||"object":typeof a},globalEval:function(b){b&&m.trim(b)&&(a.execScript||function(b){a.eval.call(a,b)})(b)},camelCase:function(a){return a.replace(o,"ms-").replace(p,q)},nodeName:function(a,b){return a.nodeName&&a.nodeName.toLowerCase()===b.toLowerCase()},each:function(a,b,c){var d,e=0,f=a.length,g=r(a);if(c){if(g){for(;f>e;e++)if(d=b.apply(a[e],c),d===!1)break}else for(e in a)if(d=b.apply(a[e],c),d===!1)break}else if(g){for(;f>e;e++)if(d=b.call(a[e],e,a[e]),d===!1)break}else for(e in a)if(d=b.call(a[e],e,a[e]),d===!1)break;return a},trim:function(a){return null==a?"":(a+"").replace(n,"")},makeArray:function(a,b){var c=b||[];return null!=a&&(r(Object(a))?m.merge(c,"string"==typeof a?[a]:a):f.call(c,a)),c},inArray:function(a,b,c){var d;if(b){if(g)return g.call(b,a,c);for(d=b.length,c=c?0>c?Math.max(0,d+c):c:0;d>c;c++)if(c in b&&b[c]===a)return c}return-1},merge:function(a,b){var c=+b.length,d=0,e=a.length;while(c>d)a[e++]=b[d++];if(c!==c)while(void 0!==b[d])a[e++]=b[d++];return a.length=e,a},grep:function(a,b,c){for(var d,e=[],f=0,g=a.length,h=!c;g>f;f++)d=!b(a[f],f),d!==h&&e.push(a[f]);return e},map:function(a,b,c){var d,f=0,g=a.length,h=r(a),i=[];if(h)for(;g>f;f++)d=b(a[f],f,c),null!=d&&i.push(d);else for(f in a)d=b(a[f],f,c),null!=d&&i.push(d);return e.apply([],i)},guid:1,proxy:function(a,b){var c,e,f;return"string"==typeof b&&(f=a[b],b=a,a=f),m.isFunction(a)?(c=d.call(arguments,2),e=function(){return a.apply(b||this,c.concat(d.call(arguments)))},e.guid=a.guid=a.guid||m.guid++,e):void 0},now:function(){return+new Date},support:k}),m.each("Boolean Number String Function Array Date RegExp Object Error".split(" "),function(a,b){h["[object "+b+"]"]=b.toLowerCase()});function r(a){var b="length"in a&&a.length,c=m.type(a);return"function"===c||m.isWindow(a)?!1:1===a.nodeType&&b?!0:"array"===c||0===b||"number"==typeof b&&b>0&&b-1 in a}var s=function(a){var b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u="sizzle"+1*new Date,v=a.document,w=0,x=0,y=ha(),z=ha(),A=ha(),B=function(a,b){return a===b&&(l=!0),0},C=1<<31,D={}.hasOwnProperty,E=[],F=E.pop,G=E.push,H=E.push,I=E.slice,J=function(a,b){for(var c=0,d=a.length;d>c;c++)if(a[c]===b)return c;return-1},K="checked|selected|async|autofocus|autoplay|controls|defer|disabled|hidden|ismap|loop|multiple|open|readonly|required|scoped",L="[\\x20\\t\\r\\n\\f]",M="(?:\\\\.|[\\w-]|[^\\x00-\\xa0])+",N=M.replace("w","w#"),O="\\["+L+"*("+M+")(?:"+L+"*([*^$|!~]?=)"+L+"*(?:'((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\"|("+N+"))|)"+L+"*\\]",P=":("+M+")(?:\\((('((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\")|((?:\\\\.|[^\\\\()[\\]]|"+O+")*)|.*)\\)|)",Q=new RegExp(L+"+","g"),R=new RegExp("^"+L+"+|((?:^|[^\\\\])(?:\\\\.)*)"+L+"+$","g"),S=new RegExp("^"+L+"*,"+L+"*"),T=new RegExp("^"+L+"*([>+~]|"+L+")"+L+"*"),U=new RegExp("="+L+"*([^\\]'\"]*?)"+L+"*\\]","g"),V=new RegExp(P),W=new RegExp("^"+N+"$"),X={ID:new RegExp("^#("+M+")"),CLASS:new RegExp("^\\.("+M+")"),TAG:new RegExp("^("+M.replace("w","w*")+")"),ATTR:new RegExp("^"+O),PSEUDO:new RegExp("^"+P),CHILD:new RegExp("^:(only|first|last|nth|nth-last)-(child|of-type)(?:\\("+L+"*(even|odd|(([+-]|)(\\d*)n|)"+L+"*(?:([+-]|)"+L+"*(\\d+)|))"+L+"*\\)|)","i"),bool:new RegExp("^(?:"+K+")$","i"),needsContext:new RegExp("^"+L+"*[>+~]|:(even|odd|eq|gt|lt|nth|first|last)(?:\\("+L+"*((?:-\\d)?\\d*)"+L+"*\\)|)(?=[^-]|$)","i")},Y=/^(?:input|select|textarea|button)$/i,Z=/^h\d$/i,$=/^[^{]+\{\s*\[native \w/,_=/^(?:#([\w-]+)|(\w+)|\.([\w-]+))$/,aa=/[+~]/,ba=/'|\\/g,ca=new RegExp("\\\\([\\da-f]{1,6}"+L+"?|("+L+")|.)","ig"),da=function(a,b,c){var d="0x"+b-65536;return d!==d||c?b:0>d?String.fromCharCode(d+65536):String.fromCharCode(d>>10|55296,1023&d|56320)},ea=function(){m()};try{H.apply(E=I.call(v.childNodes),v.childNodes),E[v.childNodes.length].nodeType}catch(fa){H={apply:E.length?function(a,b){G.apply(a,I.call(b))}:function(a,b){var c=a.length,d=0;while(a[c++]=b[d++]);a.length=c-1}}}function ga(a,b,d,e){var f,h,j,k,l,o,r,s,w,x;if((b?b.ownerDocument||b:v)!==n&&m(b),b=b||n,d=d||[],k=b.nodeType,"string"!=typeof a||!a||1!==k&&9!==k&&11!==k)return d;if(!e&&p){if(11!==k&&(f=_.exec(a)))if(j=f[1]){if(9===k){if(h=b.getElementById(j),!h||!h.parentNode)return d;if(h.id===j)return d.push(h),d}else if(b.ownerDocument&&(h=b.ownerDocument.getElementById(j))&&t(b,h)&&h.id===j)return d.push(h),d}else{if(f[2])return H.apply(d,b.getElementsByTagName(a)),d;if((j=f[3])&&c.getElementsByClassName)return H.apply(d,b.getElementsByClassName(j)),d}if(c.qsa&&(!q||!q.test(a))){if(s=r=u,w=b,x=1!==k&&a,1===k&&"object"!==b.nodeName.toLowerCase()){o=g(a),(r=b.getAttribute("id"))?s=r.replace(ba,"\\$&"):b.setAttribute("id",s),s="[id='"+s+"'] ",l=o.length;while(l--)o[l]=s+ra(o[l]);w=aa.test(a)&&pa(b.parentNode)||b,x=o.join(",")}if(x)try{return H.apply(d,w.querySelectorAll(x)),d}catch(y){}finally{r||b.removeAttribute("id")}}}return i(a.replace(R,"$1"),b,d,e)}function ha(){var a=[];function b(c,e){return a.push(c+" ")>d.cacheLength&&delete b[a.shift()],b[c+" "]=e}return b}function ia(a){return a[u]=!0,a}function ja(a){var b=n.createElement("div");try{return!!a(b)}catch(c){return!1}finally{b.parentNode&&b.parentNode.removeChild(b),b=null}}function ka(a,b){var c=a.split("|"),e=a.length;while(e--)d.attrHandle[c[e]]=b}function la(a,b){var c=b&&a,d=c&&1===a.nodeType&&1===b.nodeType&&(~b.sourceIndex||C)-(~a.sourceIndex||C);if(d)return d;if(c)while(c=c.nextSibling)if(c===b)return-1;return a?1:-1}function ma(a){return function(b){var c=b.nodeName.toLowerCase();return"input"===c&&b.type===a}}function na(a){return function(b){var c=b.nodeName.toLowerCase();return("input"===c||"button"===c)&&b.type===a}}function oa(a){return ia(function(b){return b=+b,ia(function(c,d){var e,f=a([],c.length,b),g=f.length;while(g--)c[e=f[g]]&&(c[e]=!(d[e]=c[e]))})})}function pa(a){return a&&"undefined"!=typeof a.getElementsByTagName&&a}c=ga.support={},f=ga.isXML=function(a){var b=a&&(a.ownerDocument||a).documentElement;return b?"HTML"!==b.nodeName:!1},m=ga.setDocument=function(a){var b,e,g=a?a.ownerDocument||a:v;return g!==n&&9===g.nodeType&&g.documentElement?(n=g,o=g.documentElement,e=g.defaultView,e&&e!==e.top&&(e.addEventListener?e.addEventListener("unload",ea,!1):e.attachEvent&&e.attachEvent("onunload",ea)),p=!f(g),c.attributes=ja(function(a){return a.className="i",!a.getAttribute("className")}),c.getElementsByTagName=ja(function(a){return a.appendChild(g.createComment("")),!a.getElementsByTagName("*").length}),c.getElementsByClassName=$.test(g.getElementsByClassName),c.getById=ja(function(a){return o.appendChild(a).id=u,!g.getElementsByName||!g.getElementsByName(u).length}),c.getById?(d.find.ID=function(a,b){if("undefined"!=typeof b.getElementById&&p){var c=b.getElementById(a);return c&&c.parentNode?[c]:[]}},d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){return a.getAttribute("id")===b}}):(delete d.find.ID,d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){var c="undefined"!=typeof a.getAttributeNode&&a.getAttributeNode("id");return c&&c.value===b}}),d.find.TAG=c.getElementsByTagName?function(a,b){return"undefined"!=typeof b.getElementsByTagName?b.getElementsByTagName(a):c.qsa?b.querySelectorAll(a):void 0}:function(a,b){var c,d=[],e=0,f=b.getElementsByTagName(a);if("*"===a){while(c=f[e++])1===c.nodeType&&d.push(c);return d}return f},d.find.CLASS=c.getElementsByClassName&&function(a,b){return p?b.getElementsByClassName(a):void 0},r=[],q=[],(c.qsa=$.test(g.querySelectorAll))&&(ja(function(a){o.appendChild(a).innerHTML="<a id='"+u+"'></a><select id='"+u+"-\f]' msallowcapture=''><option selected=''></option></select>",a.querySelectorAll("[msallowcapture^='']").length&&q.push("[*^$]="+L+"*(?:''|\"\")"),a.querySelectorAll("[selected]").length||q.push("\\["+L+"*(?:value|"+K+")"),a.querySelectorAll("[id~="+u+"-]").length||q.push("~="),a.querySelectorAll(":checked").length||q.push(":checked"),a.querySelectorAll("a#"+u+"+*").length||q.push(".#.+[+~]")}),ja(function(a){var b=g.createElement("input");b.setAttribute("type","hidden"),a.appendChild(b).setAttribute("name","D"),a.querySelectorAll("[name=d]").length&&q.push("name"+L+"*[*^$|!~]?="),a.querySelectorAll(":enabled").length||q.push(":enabled",":disabled"),a.querySelectorAll("*,:x"),q.push(",.*:")})),(c.matchesSelector=$.test(s=o.matches||o.webkitMatchesSelector||o.mozMatchesSelector||o.oMatchesSelector||o.msMatchesSelector))&&ja(function(a){c.disconnectedMatch=s.call(a,"div"),s.call(a,"[s!='']:x"),r.push("!=",P)}),q=q.length&&new RegExp(q.join("|")),r=r.length&&new RegExp(r.join("|")),b=$.test(o.compareDocumentPosition),t=b||$.test(o.contains)?function(a,b){var c=9===a.nodeType?a.documentElement:a,d=b&&b.parentNode;return a===d||!(!d||1!==d.nodeType||!(c.contains?c.contains(d):a.compareDocumentPosition&&16&a.compareDocumentPosition(d)))}:function(a,b){if(b)while(b=b.parentNode)if(b===a)return!0;return!1},B=b?function(a,b){if(a===b)return l=!0,0;var d=!a.compareDocumentPosition-!b.compareDocumentPosition;return d?d:(d=(a.ownerDocument||a)===(b.ownerDocument||b)?a.compareDocumentPosition(b):1,1&d||!c.sortDetached&&b.compareDocumentPosition(a)===d?a===g||a.ownerDocument===v&&t(v,a)?-1:b===g||b.ownerDocument===v&&t(v,b)?1:k?J(k,a)-J(k,b):0:4&d?-1:1)}:function(a,b){if(a===b)return l=!0,0;var c,d=0,e=a.parentNode,f=b.parentNode,h=[a],i=[b];if(!e||!f)return a===g?-1:b===g?1:e?-1:f?1:k?J(k,a)-J(k,b):0;if(e===f)return la(a,b);c=a;while(c=c.parentNode)h.unshift(c);c=b;while(c=c.parentNode)i.unshift(c);while(h[d]===i[d])d++;return d?la(h[d],i[d]):h[d]===v?-1:i[d]===v?1:0},g):n},ga.matches=function(a,b){return ga(a,null,null,b)},ga.matchesSelector=function(a,b){if((a.ownerDocument||a)!==n&&m(a),b=b.replace(U,"='$1']"),!(!c.matchesSelector||!p||r&&r.test(b)||q&&q.test(b)))try{var d=s.call(a,b);if(d||c.disconnectedMatch||a.document&&11!==a.document.nodeType)return d}catch(e){}return ga(b,n,null,[a]).length>0},ga.contains=function(a,b){return(a.ownerDocument||a)!==n&&m(a),t(a,b)},ga.attr=function(a,b){(a.ownerDocument||a)!==n&&m(a);var e=d.attrHandle[b.toLowerCase()],f=e&&D.call(d.attrHandle,b.toLowerCase())?e(a,b,!p):void 0;return void 0!==f?f:c.attributes||!p?a.getAttribute(b):(f=a.getAttributeNode(b))&&f.specified?f.value:null},ga.error=function(a){throw new Error("Syntax error, unrecognized expression: "+a)},ga.uniqueSort=function(a){var b,d=[],e=0,f=0;if(l=!c.detectDuplicates,k=!c.sortStable&&a.slice(0),a.sort(B),l){while(b=a[f++])b===a[f]&&(e=d.push(f));while(e--)a.splice(d[e],1)}return k=null,a},e=ga.getText=function(a){var b,c="",d=0,f=a.nodeType;if(f){if(1===f||9===f||11===f){if("string"==typeof a.textContent)return a.textContent;for(a=a.firstChild;a;a=a.nextSibling)c+=e(a)}else if(3===f||4===f)return a.nodeValue}else while(b=a[d++])c+=e(b);return c},d=ga.selectors={cacheLength:50,createPseudo:ia,match:X,attrHandle:{},find:{},relative:{">":{dir:"parentNode",first:!0}," ":{dir:"parentNode"},"+":{dir:"previousSibling",first:!0},"~":{dir:"previousSibling"}},preFilter:{ATTR:function(a){return a[1]=a[1].replace(ca,da),a[3]=(a[3]||a[4]||a[5]||"").replace(ca,da),"~="===a[2]&&(a[3]=" "+a[3]+" "),a.slice(0,4)},CHILD:function(a){return a[1]=a[1].toLowerCase(),"nth"===a[1].slice(0,3)?(a[3]||ga.error(a[0]),a[4]=+(a[4]?a[5]+(a[6]||1):2*("even"===a[3]||"odd"===a[3])),a[5]=+(a[7]+a[8]||"odd"===a[3])):a[3]&&ga.error(a[0]),a},PSEUDO:function(a){var b,c=!a[6]&&a[2];return X.CHILD.test(a[0])?null:(a[3]?a[2]=a[4]||a[5]||"":c&&V.test(c)&&(b=g(c,!0))&&(b=c.indexOf(")",c.length-b)-c.length)&&(a[0]=a[0].slice(0,b),a[2]=c.slice(0,b)),a.slice(0,3))}},filter:{TAG:function(a){var b=a.replace(ca,da).toLowerCase();return"*"===a?function(){return!0}:function(a){return a.nodeName&&a.nodeName.toLowerCase()===b}},CLASS:function(a){var b=y[a+" "];return b||(b=new RegExp("(^|"+L+")"+a+"("+L+"|$)"))&&y(a,function(a){return b.test("string"==typeof a.className&&a.className||"undefined"!=typeof a.getAttribute&&a.getAttribute("class")||"")})},ATTR:function(a,b,c){return function(d){var e=ga.attr(d,a);return null==e?"!="===b:b?(e+="","="===b?e===c:"!="===b?e!==c:"^="===b?c&&0===e.indexOf(c):"*="===b?c&&e.indexOf(c)>-1:"$="===b?c&&e.slice(-c.length)===c:"~="===b?(" "+e.replace(Q," ")+" ").indexOf(c)>-1:"|="===b?e===c||e.slice(0,c.length+1)===c+"-":!1):!0}},CHILD:function(a,b,c,d,e){var f="nth"!==a.slice(0,3),g="last"!==a.slice(-4),h="of-type"===b;return 1===d&&0===e?function(a){return!!a.parentNode}:function(b,c,i){var j,k,l,m,n,o,p=f!==g?"nextSibling":"previousSibling",q=b.parentNode,r=h&&b.nodeName.toLowerCase(),s=!i&&!h;if(q){if(f){while(p){l=b;while(l=l[p])if(h?l.nodeName.toLowerCase()===r:1===l.nodeType)return!1;o=p="only"===a&&!o&&"nextSibling"}return!0}if(o=[g?q.firstChild:q.lastChild],g&&s){k=q[u]||(q[u]={}),j=k[a]||[],n=j[0]===w&&j[1],m=j[0]===w&&j[2],l=n&&q.childNodes[n];while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if(1===l.nodeType&&++m&&l===b){k[a]=[w,n,m];break}}else if(s&&(j=(b[u]||(b[u]={}))[a])&&j[0]===w)m=j[1];else while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if((h?l.nodeName.toLowerCase()===r:1===l.nodeType)&&++m&&(s&&((l[u]||(l[u]={}))[a]=[w,m]),l===b))break;return m-=e,m===d||m%d===0&&m/d>=0}}},PSEUDO:function(a,b){var c,e=d.pseudos[a]||d.setFilters[a.toLowerCase()]||ga.error("unsupported pseudo: "+a);return e[u]?e(b):e.length>1?(c=[a,a,"",b],d.setFilters.hasOwnProperty(a.toLowerCase())?ia(function(a,c){var d,f=e(a,b),g=f.length;while(g--)d=J(a,f[g]),a[d]=!(c[d]=f[g])}):function(a){return e(a,0,c)}):e}},pseudos:{not:ia(function(a){var b=[],c=[],d=h(a.replace(R,"$1"));return d[u]?ia(function(a,b,c,e){var f,g=d(a,null,e,[]),h=a.length;while(h--)(f=g[h])&&(a[h]=!(b[h]=f))}):function(a,e,f){return b[0]=a,d(b,null,f,c),b[0]=null,!c.pop()}}),has:ia(function(a){return function(b){return ga(a,b).length>0}}),contains:ia(function(a){return a=a.replace(ca,da),function(b){return(b.textContent||b.innerText||e(b)).indexOf(a)>-1}}),lang:ia(function(a){return W.test(a||"")||ga.error("unsupported lang: "+a),a=a.replace(ca,da).toLowerCase(),function(b){var c;do if(c=p?b.lang:b.getAttribute("xml:lang")||b.getAttribute("lang"))return c=c.toLowerCase(),c===a||0===c.indexOf(a+"-");while((b=b.parentNode)&&1===b.nodeType);return!1}}),target:function(b){var c=a.location&&a.location.hash;return c&&c.slice(1)===b.id},root:function(a){return a===o},focus:function(a){return a===n.activeElement&&(!n.hasFocus||n.hasFocus())&&!!(a.type||a.href||~a.tabIndex)},enabled:function(a){return a.disabled===!1},disabled:function(a){return a.disabled===!0},checked:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&!!a.checked||"option"===b&&!!a.selected},selected:function(a){return a.parentNode&&a.parentNode.selectedIndex,a.selected===!0},empty:function(a){for(a=a.firstChild;a;a=a.nextSibling)if(a.nodeType<6)return!1;return!0},parent:function(a){return!d.pseudos.empty(a)},header:function(a){return Z.test(a.nodeName)},input:function(a){return Y.test(a.nodeName)},button:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&"button"===a.type||"button"===b},text:function(a){var b;return"input"===a.nodeName.toLowerCase()&&"text"===a.type&&(null==(b=a.getAttribute("type"))||"text"===b.toLowerCase())},first:oa(function(){return[0]}),last:oa(function(a,b){return[b-1]}),eq:oa(function(a,b,c){return[0>c?c+b:c]}),even:oa(function(a,b){for(var c=0;b>c;c+=2)a.push(c);return a}),odd:oa(function(a,b){for(var c=1;b>c;c+=2)a.push(c);return a}),lt:oa(function(a,b,c){for(var d=0>c?c+b:c;--d>=0;)a.push(d);return a}),gt:oa(function(a,b,c){for(var d=0>c?c+b:c;++d<b;)a.push(d);return a})}},d.pseudos.nth=d.pseudos.eq;for(b in{radio:!0,checkbox:!0,file:!0,password:!0,image:!0})d.pseudos[b]=ma(b);for(b in{submit:!0,reset:!0})d.pseudos[b]=na(b);function qa(){}qa.prototype=d.filters=d.pseudos,d.setFilters=new qa,g=ga.tokenize=function(a,b){var c,e,f,g,h,i,j,k=z[a+" "];if(k)return b?0:k.slice(0);h=a,i=[],j=d.preFilter;while(h){(!c||(e=S.exec(h)))&&(e&&(h=h.slice(e[0].length)||h),i.push(f=[])),c=!1,(e=T.exec(h))&&(c=e.shift(),f.push({value:c,type:e[0].replace(R," ")}),h=h.slice(c.length));for(g in d.filter)!(e=X[g].exec(h))||j[g]&&!(e=j[g](e))||(c=e.shift(),f.push({value:c,type:g,matches:e}),h=h.slice(c.length));if(!c)break}return b?h.length:h?ga.error(a):z(a,i).slice(0)};function ra(a){for(var b=0,c=a.length,d="";c>b;b++)d+=a[b].value;return d}function sa(a,b,c){var d=b.dir,e=c&&"parentNode"===d,f=x++;return b.first?function(b,c,f){while(b=b[d])if(1===b.nodeType||e)return a(b,c,f)}:function(b,c,g){var h,i,j=[w,f];if(g){while(b=b[d])if((1===b.nodeType||e)&&a(b,c,g))return!0}else while(b=b[d])if(1===b.nodeType||e){if(i=b[u]||(b[u]={}),(h=i[d])&&h[0]===w&&h[1]===f)return j[2]=h[2];if(i[d]=j,j[2]=a(b,c,g))return!0}}}function ta(a){return a.length>1?function(b,c,d){var e=a.length;while(e--)if(!a[e](b,c,d))return!1;return!0}:a[0]}function ua(a,b,c){for(var d=0,e=b.length;e>d;d++)ga(a,b[d],c);return c}function va(a,b,c,d,e){for(var f,g=[],h=0,i=a.length,j=null!=b;i>h;h++)(f=a[h])&&(!c||c(f,d,e))&&(g.push(f),j&&b.push(h));return g}function wa(a,b,c,d,e,f){return d&&!d[u]&&(d=wa(d)),e&&!e[u]&&(e=wa(e,f)),ia(function(f,g,h,i){var j,k,l,m=[],n=[],o=g.length,p=f||ua(b||"*",h.nodeType?[h]:h,[]),q=!a||!f&&b?p:va(p,m,a,h,i),r=c?e||(f?a:o||d)?[]:g:q;if(c&&c(q,r,h,i),d){j=va(r,n),d(j,[],h,i),k=j.length;while(k--)(l=j[k])&&(r[n[k]]=!(q[n[k]]=l))}if(f){if(e||a){if(e){j=[],k=r.length;while(k--)(l=r[k])&&j.push(q[k]=l);e(null,r=[],j,i)}k=r.length;while(k--)(l=r[k])&&(j=e?J(f,l):m[k])>-1&&(f[j]=!(g[j]=l))}}else r=va(r===g?r.splice(o,r.length):r),e?e(null,g,r,i):H.apply(g,r)})}function xa(a){for(var b,c,e,f=a.length,g=d.relative[a[0].type],h=g||d.relative[" "],i=g?1:0,k=sa(function(a){return a===b},h,!0),l=sa(function(a){return J(b,a)>-1},h,!0),m=[function(a,c,d){var e=!g&&(d||c!==j)||((b=c).nodeType?k(a,c,d):l(a,c,d));return b=null,e}];f>i;i++)if(c=d.relative[a[i].type])m=[sa(ta(m),c)];else{if(c=d.filter[a[i].type].apply(null,a[i].matches),c[u]){for(e=++i;f>e;e++)if(d.relative[a[e].type])break;return wa(i>1&&ta(m),i>1&&ra(a.slice(0,i-1).concat({value:" "===a[i-2].type?"*":""})).replace(R,"$1"),c,e>i&&xa(a.slice(i,e)),f>e&&xa(a=a.slice(e)),f>e&&ra(a))}m.push(c)}return ta(m)}function ya(a,b){var c=b.length>0,e=a.length>0,f=function(f,g,h,i,k){var l,m,o,p=0,q="0",r=f&&[],s=[],t=j,u=f||e&&d.find.TAG("*",k),v=w+=null==t?1:Math.random()||.1,x=u.length;for(k&&(j=g!==n&&g);q!==x&&null!=(l=u[q]);q++){if(e&&l){m=0;while(o=a[m++])if(o(l,g,h)){i.push(l);break}k&&(w=v)}c&&((l=!o&&l)&&p--,f&&r.push(l))}if(p+=q,c&&q!==p){m=0;while(o=b[m++])o(r,s,g,h);if(f){if(p>0)while(q--)r[q]||s[q]||(s[q]=F.call(i));s=va(s)}H.apply(i,s),k&&!f&&s.length>0&&p+b.length>1&&ga.uniqueSort(i)}return k&&(w=v,j=t),r};return c?ia(f):f}return h=ga.compile=function(a,b){var c,d=[],e=[],f=A[a+" "];if(!f){b||(b=g(a)),c=b.length;while(c--)f=xa(b[c]),f[u]?d.push(f):e.push(f);f=A(a,ya(e,d)),f.selector=a}return f},i=ga.select=function(a,b,e,f){var i,j,k,l,m,n="function"==typeof a&&a,o=!f&&g(a=n.selector||a);if(e=e||[],1===o.length){if(j=o[0]=o[0].slice(0),j.length>2&&"ID"===(k=j[0]).type&&c.getById&&9===b.nodeType&&p&&d.relative[j[1].type]){if(b=(d.find.ID(k.matches[0].replace(ca,da),b)||[])[0],!b)return e;n&&(b=b.parentNode),a=a.slice(j.shift().value.length)}i=X.needsContext.test(a)?0:j.length;while(i--){if(k=j[i],d.relative[l=k.type])break;if((m=d.find[l])&&(f=m(k.matches[0].replace(ca,da),aa.test(j[0].type)&&pa(b.parentNode)||b))){if(j.splice(i,1),a=f.length&&ra(j),!a)return H.apply(e,f),e;break}}}return(n||h(a,o))(f,b,!p,e,aa.test(a)&&pa(b.parentNode)||b),e},c.sortStable=u.split("").sort(B).join("")===u,c.detectDuplicates=!!l,m(),c.sortDetached=ja(function(a){return 1&a.compareDocumentPosition(n.createElement("div"))}),ja(function(a){return a.innerHTML="<a href='#'></a>","#"===a.firstChild.getAttribute("href")})||ka("type|href|height|width",function(a,b,c){return c?void 0:a.getAttribute(b,"type"===b.toLowerCase()?1:2)}),c.attributes&&ja(function(a){return a.innerHTML="<input/>",a.firstChild.setAttribute("value",""),""===a.firstChild.getAttribute("value")})||ka("value",function(a,b,c){return c||"input"!==a.nodeName.toLowerCase()?void 0:a.defaultValue}),ja(function(a){return null==a.getAttribute("disabled")})||ka(K,function(a,b,c){var d;return c?void 0:a[b]===!0?b.toLowerCase():(d=a.getAttributeNode(b))&&d.specified?d.value:null}),ga}(a);m.find=s,m.expr=s.selectors,m.expr[":"]=m.expr.pseudos,m.unique=s.uniqueSort,m.text=s.getText,m.isXMLDoc=s.isXML,m.contains=s.contains;var t=m.expr.match.needsContext,u=/^<(\w+)\s*\/?>(?:<\/\1>|)$/,v=/^.[^:#\[\.,]*$/;function w(a,b,c){if(m.isFunction(b))return m.grep(a,function(a,d){return!!b.call(a,d,a)!==c});if(b.nodeType)return m.grep(a,function(a){return a===b!==c});if("string"==typeof b){if(v.test(b))return m.filter(b,a,c);b=m.filter(b,a)}return m.grep(a,function(a){return m.inArray(a,b)>=0!==c})}m.filter=function(a,b,c){var d=b[0];return c&&(a=":not("+a+")"),1===b.length&&1===d.nodeType?m.find.matchesSelector(d,a)?[d]:[]:m.find.matches(a,m.grep(b,function(a){return 1===a.nodeType}))},m.fn.extend({find:function(a){var b,c=[],d=this,e=d.length;if("string"!=typeof a)return this.pushStack(m(a).filter(function(){for(b=0;e>b;b++)if(m.contains(d[b],this))return!0}));for(b=0;e>b;b++)m.find(a,d[b],c);return c=this.pushStack(e>1?m.unique(c):c),c.selector=this.selector?this.selector+" "+a:a,c},filter:function(a){return this.pushStack(w(this,a||[],!1))},not:function(a){return this.pushStack(w(this,a||[],!0))},is:function(a){return!!w(this,"string"==typeof a&&t.test(a)?m(a):a||[],!1).length}});var x,y=a.document,z=/^(?:\s*(<[\w\W]+>)[^>]*|#([\w-]*))$/,A=m.fn.init=function(a,b){var c,d;if(!a)return this;if("string"==typeof a){if(c="<"===a.charAt(0)&&">"===a.charAt(a.length-1)&&a.length>=3?[null,a,null]:z.exec(a),!c||!c[1]&&b)return!b||b.jquery?(b||x).find(a):this.constructor(b).find(a);if(c[1]){if(b=b instanceof m?b[0]:b,m.merge(this,m.parseHTML(c[1],b&&b.nodeType?b.ownerDocument||b:y,!0)),u.test(c[1])&&m.isPlainObject(b))for(c in b)m.isFunction(this[c])?this[c](b[c]):this.attr(c,b[c]);return this}if(d=y.getElementById(c[2]),d&&d.parentNode){if(d.id!==c[2])return x.find(a);this.length=1,this[0]=d}return this.context=y,this.selector=a,this}return a.nodeType?(this.context=this[0]=a,this.length=1,this):m.isFunction(a)?"undefined"!=typeof x.ready?x.ready(a):a(m):(void 0!==a.selector&&(this.selector=a.selector,this.context=a.context),m.makeArray(a,this))};A.prototype=m.fn,x=m(y);var B=/^(?:parents|prev(?:Until|All))/,C={children:!0,contents:!0,next:!0,prev:!0};m.extend({dir:function(a,b,c){var d=[],e=a[b];while(e&&9!==e.nodeType&&(void 0===c||1!==e.nodeType||!m(e).is(c)))1===e.nodeType&&d.push(e),e=e[b];return d},sibling:function(a,b){for(var c=[];a;a=a.nextSibling)1===a.nodeType&&a!==b&&c.push(a);return c}}),m.fn.extend({has:function(a){var b,c=m(a,this),d=c.length;return this.filter(function(){for(b=0;d>b;b++)if(m.contains(this,c[b]))return!0})},closest:function(a,b){for(var c,d=0,e=this.length,f=[],g=t.test(a)||"string"!=typeof a?m(a,b||this.context):0;e>d;d++)for(c=this[d];c&&c!==b;c=c.parentNode)if(c.nodeType<11&&(g?g.index(c)>-1:1===c.nodeType&&m.find.matchesSelector(c,a))){f.push(c);break}return this.pushStack(f.length>1?m.unique(f):f)},index:function(a){return a?"string"==typeof a?m.inArray(this[0],m(a)):m.inArray(a.jquery?a[0]:a,this):this[0]&&this[0].parentNode?this.first().prevAll().length:-1},add:function(a,b){return this.pushStack(m.unique(m.merge(this.get(),m(a,b))))},addBack:function(a){return this.add(null==a?this.prevObject:this.prevObject.filter(a))}});function D(a,b){do a=a[b];while(a&&1!==a.nodeType);return a}m.each({parent:function(a){var b=a.parentNode;return b&&11!==b.nodeType?b:null},parents:function(a){return m.dir(a,"parentNode")},parentsUntil:function(a,b,c){return m.dir(a,"parentNode",c)},next:function(a){return D(a,"nextSibling")},prev:function(a){return D(a,"previousSibling")},nextAll:function(a){return m.dir(a,"nextSibling")},prevAll:function(a){return m.dir(a,"previousSibling")},nextUntil:function(a,b,c){return m.dir(a,"nextSibling",c)},prevUntil:function(a,b,c){return m.dir(a,"previousSibling",c)},siblings:function(a){return m.sibling((a.parentNode||{}).firstChild,a)},children:function(a){return m.sibling(a.firstChild)},contents:function(a){return m.nodeName(a,"iframe")?a.contentDocument||a.contentWindow.document:m.merge([],a.childNodes)}},function(a,b){m.fn[a]=function(c,d){var e=m.map(this,b,c);return"Until"!==a.slice(-5)&&(d=c),d&&"string"==typeof d&&(e=m.filter(d,e)),this.length>1&&(C[a]||(e=m.unique(e)),B.test(a)&&(e=e.reverse())),this.pushStack(e)}});var E=/\S+/g,F={};function G(a){var b=F[a]={};return m.each(a.match(E)||[],function(a,c){b[c]=!0}),b}m.Callbacks=function(a){a="string"==typeof a?F[a]||G(a):m.extend({},a);var b,c,d,e,f,g,h=[],i=!a.once&&[],j=function(l){for(c=a.memory&&l,d=!0,f=g||0,g=0,e=h.length,b=!0;h&&e>f;f++)if(h[f].apply(l[0],l[1])===!1&&a.stopOnFalse){c=!1;break}b=!1,h&&(i?i.length&&j(i.shift()):c?h=[]:k.disable())},k={add:function(){if(h){var d=h.length;!function f(b){m.each(b,function(b,c){var d=m.type(c);"function"===d?a.unique&&k.has(c)||h.push(c):c&&c.length&&"string"!==d&&f(c)})}(arguments),b?e=h.length:c&&(g=d,j(c))}return this},remove:function(){return h&&m.each(arguments,function(a,c){var d;while((d=m.inArray(c,h,d))>-1)h.splice(d,1),b&&(e>=d&&e--,f>=d&&f--)}),this},has:function(a){return a?m.inArray(a,h)>-1:!(!h||!h.length)},empty:function(){return h=[],e=0,this},disable:function(){return h=i=c=void 0,this},disabled:function(){return!h},lock:function(){return i=void 0,c||k.disable(),this},locked:function(){return!i},fireWith:function(a,c){return!h||d&&!i||(c=c||[],c=[a,c.slice?c.slice():c],b?i.push(c):j(c)),this},fire:function(){return k.fireWith(this,arguments),this},fired:function(){return!!d}};return k},m.extend({Deferred:function(a){var b=[["resolve","done",m.Callbacks("once memory"),"resolved"],["reject","fail",m.Callbacks("once memory"),"rejected"],["notify","progress",m.Callbacks("memory")]],c="pending",d={state:function(){return c},always:function(){return e.done(arguments).fail(arguments),this},then:function(){var a=arguments;return m.Deferred(function(c){m.each(b,function(b,f){var g=m.isFunction(a[b])&&a[b];e[f[1]](function(){var a=g&&g.apply(this,arguments);a&&m.isFunction(a.promise)?a.promise().done(c.resolve).fail(c.reject).progress(c.notify):c[f[0]+"With"](this===d?c.promise():this,g?[a]:arguments)})}),a=null}).promise()},promise:function(a){return null!=a?m.extend(a,d):d}},e={};return d.pipe=d.then,m.each(b,function(a,f){var g=f[2],h=f[3];d[f[1]]=g.add,h&&g.add(function(){c=h},b[1^a][2].disable,b[2][2].lock),e[f[0]]=function(){return e[f[0]+"With"](this===e?d:this,arguments),this},e[f[0]+"With"]=g.fireWith}),d.promise(e),a&&a.call(e,e),e},when:function(a){var b=0,c=d.call(arguments),e=c.length,f=1!==e||a&&m.isFunction(a.promise)?e:0,g=1===f?a:m.Deferred(),h=function(a,b,c){return function(e){b[a]=this,c[a]=arguments.length>1?d.call(arguments):e,c===i?g.notifyWith(b,c):--f||g.resolveWith(b,c)}},i,j,k;if(e>1)for(i=new Array(e),j=new Array(e),k=new Array(e);e>b;b++)c[b]&&m.isFunction(c[b].promise)?c[b].promise().done(h(b,k,c)).fail(g.reject).progress(h(b,j,i)):--f;return f||g.resolveWith(k,c),g.promise()}});var H;m.fn.ready=function(a){return m.ready.promise().done(a),this},m.extend({isReady:!1,readyWait:1,holdReady:function(a){a?m.readyWait++:m.ready(!0)},ready:function(a){if(a===!0?!--m.readyWait:!m.isReady){if(!y.body)return setTimeout(m.ready);m.isReady=!0,a!==!0&&--m.readyWait>0||(H.resolveWith(y,[m]),m.fn.triggerHandler&&(m(y).triggerHandler("ready"),m(y).off("ready")))}}});function I(){y.addEventListener?(y.removeEventListener("DOMContentLoaded",J,!1),a.removeEventListener("load",J,!1)):(y.detachEvent("onreadystatechange",J),a.detachEvent("onload",J))}function J(){(y.addEventListener||"load"===event.type||"complete"===y.readyState)&&(I(),m.ready())}m.ready.promise=function(b){if(!H)if(H=m.Deferred(),"complete"===y.readyState)setTimeout(m.ready);else if(y.addEventListener)y.addEventListener("DOMContentLoaded",J,!1),a.addEventListener("load",J,!1);else{y.attachEvent("onreadystatechange",J),a.attachEvent("onload",J);var c=!1;try{c=null==a.frameElement&&y.documentElement}catch(d){}c&&c.doScroll&&!function e(){if(!m.isReady){try{c.doScroll("left")}catch(a){return setTimeout(e,50)}I(),m.ready()}}()}return H.promise(b)};var K="undefined",L;for(L in m(k))break;k.ownLast="0"!==L,k.inlineBlockNeedsLayout=!1,m(function(){var a,b,c,d;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="display:inline;margin:0;border:0;padding:1px;width:1px;zoom:1",k.inlineBlockNeedsLayout=a=3===b.offsetWidth,a&&(c.style.zoom=1)),c.removeChild(d))}),function(){var a=y.createElement("div");if(null==k.deleteExpando){k.deleteExpando=!0;try{delete a.test}catch(b){k.deleteExpando=!1}}a=null}(),m.acceptData=function(a){var b=m.noData[(a.nodeName+" ").toLowerCase()],c=+a.nodeType||1;return 1!==c&&9!==c?!1:!b||b!==!0&&a.getAttribute("classid")===b};var M=/^(?:\{[\w\W]*\}|\[[\w\W]*\])$/,N=/([A-Z])/g;function O(a,b,c){if(void 0===c&&1===a.nodeType){var d="data-"+b.replace(N,"-$1").toLowerCase();if(c=a.getAttribute(d),"string"==typeof c){try{c="true"===c?!0:"false"===c?!1:"null"===c?null:+c+""===c?+c:M.test(c)?m.parseJSON(c):c}catch(e){}m.data(a,b,c)}else c=void 0}return c}function P(a){var b;for(b in a)if(("data"!==b||!m.isEmptyObject(a[b]))&&"toJSON"!==b)return!1;

return!0}function Q(a,b,d,e){if(m.acceptData(a)){var f,g,h=m.expando,i=a.nodeType,j=i?m.cache:a,k=i?a[h]:a[h]&&h;if(k&&j[k]&&(e||j[k].data)||void 0!==d||"string"!=typeof b)return k||(k=i?a[h]=c.pop()||m.guid++:h),j[k]||(j[k]=i?{}:{toJSON:m.noop}),("object"==typeof b||"function"==typeof b)&&(e?j[k]=m.extend(j[k],b):j[k].data=m.extend(j[k].data,b)),g=j[k],e||(g.data||(g.data={}),g=g.data),void 0!==d&&(g[m.camelCase(b)]=d),"string"==typeof b?(f=g[b],null==f&&(f=g[m.camelCase(b)])):f=g,f}}function R(a,b,c){if(m.acceptData(a)){var d,e,f=a.nodeType,g=f?m.cache:a,h=f?a[m.expando]:m.expando;if(g[h]){if(b&&(d=c?g[h]:g[h].data)){m.isArray(b)?b=b.concat(m.map(b,m.camelCase)):b in d?b=[b]:(b=m.camelCase(b),b=b in d?[b]:b.split(" ")),e=b.length;while(e--)delete d[b[e]];if(c?!P(d):!m.isEmptyObject(d))return}(c||(delete g[h].data,P(g[h])))&&(f?m.cleanData([a],!0):k.deleteExpando||g!=g.window?delete g[h]:g[h]=null)}}}m.extend({cache:{},noData:{"applet ":!0,"embed ":!0,"object ":"clsid:D27CDB6E-AE6D-11cf-96B8-444553540000"},hasData:function(a){return a=a.nodeType?m.cache[a[m.expando]]:a[m.expando],!!a&&!P(a)},data:function(a,b,c){return Q(a,b,c)},removeData:function(a,b){return R(a,b)},_data:function(a,b,c){return Q(a,b,c,!0)},_removeData:function(a,b){return R(a,b,!0)}}),m.fn.extend({data:function(a,b){var c,d,e,f=this[0],g=f&&f.attributes;if(void 0===a){if(this.length&&(e=m.data(f),1===f.nodeType&&!m._data(f,"parsedAttrs"))){c=g.length;while(c--)g[c]&&(d=g[c].name,0===d.indexOf("data-")&&(d=m.camelCase(d.slice(5)),O(f,d,e[d])));m._data(f,"parsedAttrs",!0)}return e}return"object"==typeof a?this.each(function(){m.data(this,a)}):arguments.length>1?this.each(function(){m.data(this,a,b)}):f?O(f,a,m.data(f,a)):void 0},removeData:function(a){return this.each(function(){m.removeData(this,a)})}}),m.extend({queue:function(a,b,c){var d;return a?(b=(b||"fx")+"queue",d=m._data(a,b),c&&(!d||m.isArray(c)?d=m._data(a,b,m.makeArray(c)):d.push(c)),d||[]):void 0},dequeue:function(a,b){b=b||"fx";var c=m.queue(a,b),d=c.length,e=c.shift(),f=m._queueHooks(a,b),g=function(){m.dequeue(a,b)};"inprogress"===e&&(e=c.shift(),d--),e&&("fx"===b&&c.unshift("inprogress"),delete f.stop,e.call(a,g,f)),!d&&f&&f.empty.fire()},_queueHooks:function(a,b){var c=b+"queueHooks";return m._data(a,c)||m._data(a,c,{empty:m.Callbacks("once memory").add(function(){m._removeData(a,b+"queue"),m._removeData(a,c)})})}}),m.fn.extend({queue:function(a,b){var c=2;return"string"!=typeof a&&(b=a,a="fx",c--),arguments.length<c?m.queue(this[0],a):void 0===b?this:this.each(function(){var c=m.queue(this,a,b);m._queueHooks(this,a),"fx"===a&&"inprogress"!==c[0]&&m.dequeue(this,a)})},dequeue:function(a){return this.each(function(){m.dequeue(this,a)})},clearQueue:function(a){return this.queue(a||"fx",[])},promise:function(a,b){var c,d=1,e=m.Deferred(),f=this,g=this.length,h=function(){--d||e.resolveWith(f,[f])};"string"!=typeof a&&(b=a,a=void 0),a=a||"fx";while(g--)c=m._data(f[g],a+"queueHooks"),c&&c.empty&&(d++,c.empty.add(h));return h(),e.promise(b)}});var S=/[+-]?(?:\d*\.|)\d+(?:[eE][+-]?\d+|)/.source,T=["Top","Right","Bottom","Left"],U=function(a,b){return a=b||a,"none"===m.css(a,"display")||!m.contains(a.ownerDocument,a)},V=m.access=function(a,b,c,d,e,f,g){var h=0,i=a.length,j=null==c;if("object"===m.type(c)){e=!0;for(h in c)m.access(a,b,h,c[h],!0,f,g)}else if(void 0!==d&&(e=!0,m.isFunction(d)||(g=!0),j&&(g?(b.call(a,d),b=null):(j=b,b=function(a,b,c){return j.call(m(a),c)})),b))for(;i>h;h++)b(a[h],c,g?d:d.call(a[h],h,b(a[h],c)));return e?a:j?b.call(a):i?b(a[0],c):f},W=/^(?:checkbox|radio)$/i;!function(){var a=y.createElement("input"),b=y.createElement("div"),c=y.createDocumentFragment();if(b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",k.leadingWhitespace=3===b.firstChild.nodeType,k.tbody=!b.getElementsByTagName("tbody").length,k.htmlSerialize=!!b.getElementsByTagName("link").length,k.html5Clone="<:nav></:nav>"!==y.createElement("nav").cloneNode(!0).outerHTML,a.type="checkbox",a.checked=!0,c.appendChild(a),k.appendChecked=a.checked,b.innerHTML="<textarea>x</textarea>",k.noCloneChecked=!!b.cloneNode(!0).lastChild.defaultValue,c.appendChild(b),b.innerHTML="<input type='radio' checked='checked' name='t'/>",k.checkClone=b.cloneNode(!0).cloneNode(!0).lastChild.checked,k.noCloneEvent=!0,b.attachEvent&&(b.attachEvent("onclick",function(){k.noCloneEvent=!1}),b.cloneNode(!0).click()),null==k.deleteExpando){k.deleteExpando=!0;try{delete b.test}catch(d){k.deleteExpando=!1}}}(),function(){var b,c,d=y.createElement("div");for(b in{submit:!0,change:!0,focusin:!0})c="on"+b,(k[b+"Bubbles"]=c in a)||(d.setAttribute(c,"t"),k[b+"Bubbles"]=d.attributes[c].expando===!1);d=null}();var X=/^(?:input|select|textarea)$/i,Y=/^key/,Z=/^(?:mouse|pointer|contextmenu)|click/,$=/^(?:focusinfocus|focusoutblur)$/,_=/^([^.]*)(?:\.(.+)|)$/;function aa(){return!0}function ba(){return!1}function ca(){try{return y.activeElement}catch(a){}}m.event={global:{},add:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m._data(a);if(r){c.handler&&(i=c,c=i.handler,e=i.selector),c.guid||(c.guid=m.guid++),(g=r.events)||(g=r.events={}),(k=r.handle)||(k=r.handle=function(a){return typeof m===K||a&&m.event.triggered===a.type?void 0:m.event.dispatch.apply(k.elem,arguments)},k.elem=a),b=(b||"").match(E)||[""],h=b.length;while(h--)f=_.exec(b[h])||[],o=q=f[1],p=(f[2]||"").split(".").sort(),o&&(j=m.event.special[o]||{},o=(e?j.delegateType:j.bindType)||o,j=m.event.special[o]||{},l=m.extend({type:o,origType:q,data:d,handler:c,guid:c.guid,selector:e,needsContext:e&&m.expr.match.needsContext.test(e),namespace:p.join(".")},i),(n=g[o])||(n=g[o]=[],n.delegateCount=0,j.setup&&j.setup.call(a,d,p,k)!==!1||(a.addEventListener?a.addEventListener(o,k,!1):a.attachEvent&&a.attachEvent("on"+o,k))),j.add&&(j.add.call(a,l),l.handler.guid||(l.handler.guid=c.guid)),e?n.splice(n.delegateCount++,0,l):n.push(l),m.event.global[o]=!0);a=null}},remove:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m.hasData(a)&&m._data(a);if(r&&(k=r.events)){b=(b||"").match(E)||[""],j=b.length;while(j--)if(h=_.exec(b[j])||[],o=q=h[1],p=(h[2]||"").split(".").sort(),o){l=m.event.special[o]||{},o=(d?l.delegateType:l.bindType)||o,n=k[o]||[],h=h[2]&&new RegExp("(^|\\.)"+p.join("\\.(?:.*\\.|)")+"(\\.|$)"),i=f=n.length;while(f--)g=n[f],!e&&q!==g.origType||c&&c.guid!==g.guid||h&&!h.test(g.namespace)||d&&d!==g.selector&&("**"!==d||!g.selector)||(n.splice(f,1),g.selector&&n.delegateCount--,l.remove&&l.remove.call(a,g));i&&!n.length&&(l.teardown&&l.teardown.call(a,p,r.handle)!==!1||m.removeEvent(a,o,r.handle),delete k[o])}else for(o in k)m.event.remove(a,o+b[j],c,d,!0);m.isEmptyObject(k)&&(delete r.handle,m._removeData(a,"events"))}},trigger:function(b,c,d,e){var f,g,h,i,k,l,n,o=[d||y],p=j.call(b,"type")?b.type:b,q=j.call(b,"namespace")?b.namespace.split("."):[];if(h=l=d=d||y,3!==d.nodeType&&8!==d.nodeType&&!$.test(p+m.event.triggered)&&(p.indexOf(".")>=0&&(q=p.split("."),p=q.shift(),q.sort()),g=p.indexOf(":")<0&&"on"+p,b=b[m.expando]?b:new m.Event(p,"object"==typeof b&&b),b.isTrigger=e?2:3,b.namespace=q.join("."),b.namespace_re=b.namespace?new RegExp("(^|\\.)"+q.join("\\.(?:.*\\.|)")+"(\\.|$)"):null,b.result=void 0,b.target||(b.target=d),c=null==c?[b]:m.makeArray(c,[b]),k=m.event.special[p]||{},e||!k.trigger||k.trigger.apply(d,c)!==!1)){if(!e&&!k.noBubble&&!m.isWindow(d)){for(i=k.delegateType||p,$.test(i+p)||(h=h.parentNode);h;h=h.parentNode)o.push(h),l=h;l===(d.ownerDocument||y)&&o.push(l.defaultView||l.parentWindow||a)}n=0;while((h=o[n++])&&!b.isPropagationStopped())b.type=n>1?i:k.bindType||p,f=(m._data(h,"events")||{})[b.type]&&m._data(h,"handle"),f&&f.apply(h,c),f=g&&h[g],f&&f.apply&&m.acceptData(h)&&(b.result=f.apply(h,c),b.result===!1&&b.preventDefault());if(b.type=p,!e&&!b.isDefaultPrevented()&&(!k._default||k._default.apply(o.pop(),c)===!1)&&m.acceptData(d)&&g&&d[p]&&!m.isWindow(d)){l=d[g],l&&(d[g]=null),m.event.triggered=p;try{d[p]()}catch(r){}m.event.triggered=void 0,l&&(d[g]=l)}return b.result}},dispatch:function(a){a=m.event.fix(a);var b,c,e,f,g,h=[],i=d.call(arguments),j=(m._data(this,"events")||{})[a.type]||[],k=m.event.special[a.type]||{};if(i[0]=a,a.delegateTarget=this,!k.preDispatch||k.preDispatch.call(this,a)!==!1){h=m.event.handlers.call(this,a,j),b=0;while((f=h[b++])&&!a.isPropagationStopped()){a.currentTarget=f.elem,g=0;while((e=f.handlers[g++])&&!a.isImmediatePropagationStopped())(!a.namespace_re||a.namespace_re.test(e.namespace))&&(a.handleObj=e,a.data=e.data,c=((m.event.special[e.origType]||{}).handle||e.handler).apply(f.elem,i),void 0!==c&&(a.result=c)===!1&&(a.preventDefault(),a.stopPropagation()))}return k.postDispatch&&k.postDispatch.call(this,a),a.result}},handlers:function(a,b){var c,d,e,f,g=[],h=b.delegateCount,i=a.target;if(h&&i.nodeType&&(!a.button||"click"!==a.type))for(;i!=this;i=i.parentNode||this)if(1===i.nodeType&&(i.disabled!==!0||"click"!==a.type)){for(e=[],f=0;h>f;f++)d=b[f],c=d.selector+" ",void 0===e[c]&&(e[c]=d.needsContext?m(c,this).index(i)>=0:m.find(c,this,null,[i]).length),e[c]&&e.push(d);e.length&&g.push({elem:i,handlers:e})}return h<b.length&&g.push({elem:this,handlers:b.slice(h)}),g},fix:function(a){if(a[m.expando])return a;var b,c,d,e=a.type,f=a,g=this.fixHooks[e];g||(this.fixHooks[e]=g=Z.test(e)?this.mouseHooks:Y.test(e)?this.keyHooks:{}),d=g.props?this.props.concat(g.props):this.props,a=new m.Event(f),b=d.length;while(b--)c=d[b],a[c]=f[c];return a.target||(a.target=f.srcElement||y),3===a.target.nodeType&&(a.target=a.target.parentNode),a.metaKey=!!a.metaKey,g.filter?g.filter(a,f):a},props:"altKey bubbles cancelable ctrlKey currentTarget eventPhase metaKey relatedTarget shiftKey target timeStamp view which".split(" "),fixHooks:{},keyHooks:{props:"char charCode key keyCode".split(" "),filter:function(a,b){return null==a.which&&(a.which=null!=b.charCode?b.charCode:b.keyCode),a}},mouseHooks:{props:"button buttons clientX clientY fromElement offsetX offsetY pageX pageY screenX screenY toElement".split(" "),filter:function(a,b){var c,d,e,f=b.button,g=b.fromElement;return null==a.pageX&&null!=b.clientX&&(d=a.target.ownerDocument||y,e=d.documentElement,c=d.body,a.pageX=b.clientX+(e&&e.scrollLeft||c&&c.scrollLeft||0)-(e&&e.clientLeft||c&&c.clientLeft||0),a.pageY=b.clientY+(e&&e.scrollTop||c&&c.scrollTop||0)-(e&&e.clientTop||c&&c.clientTop||0)),!a.relatedTarget&&g&&(a.relatedTarget=g===a.target?b.toElement:g),a.which||void 0===f||(a.which=1&f?1:2&f?3:4&f?2:0),a}},special:{load:{noBubble:!0},focus:{trigger:function(){if(this!==ca()&&this.focus)try{return this.focus(),!1}catch(a){}},delegateType:"focusin"},blur:{trigger:function(){return this===ca()&&this.blur?(this.blur(),!1):void 0},delegateType:"focusout"},click:{trigger:function(){return m.nodeName(this,"input")&&"checkbox"===this.type&&this.click?(this.click(),!1):void 0},_default:function(a){return m.nodeName(a.target,"a")}},beforeunload:{postDispatch:function(a){void 0!==a.result&&a.originalEvent&&(a.originalEvent.returnValue=a.result)}}},simulate:function(a,b,c,d){var e=m.extend(new m.Event,c,{type:a,isSimulated:!0,originalEvent:{}});d?m.event.trigger(e,null,b):m.event.dispatch.call(b,e),e.isDefaultPrevented()&&c.preventDefault()}},m.removeEvent=y.removeEventListener?function(a,b,c){a.removeEventListener&&a.removeEventListener(b,c,!1)}:function(a,b,c){var d="on"+b;a.detachEvent&&(typeof a[d]===K&&(a[d]=null),a.detachEvent(d,c))},m.Event=function(a,b){return this instanceof m.Event?(a&&a.type?(this.originalEvent=a,this.type=a.type,this.isDefaultPrevented=a.defaultPrevented||void 0===a.defaultPrevented&&a.returnValue===!1?aa:ba):this.type=a,b&&m.extend(this,b),this.timeStamp=a&&a.timeStamp||m.now(),void(this[m.expando]=!0)):new m.Event(a,b)},m.Event.prototype={isDefaultPrevented:ba,isPropagationStopped:ba,isImmediatePropagationStopped:ba,preventDefault:function(){var a=this.originalEvent;this.isDefaultPrevented=aa,a&&(a.preventDefault?a.preventDefault():a.returnValue=!1)},stopPropagation:function(){var a=this.originalEvent;this.isPropagationStopped=aa,a&&(a.stopPropagation&&a.stopPropagation(),a.cancelBubble=!0)},stopImmediatePropagation:function(){var a=this.originalEvent;this.isImmediatePropagationStopped=aa,a&&a.stopImmediatePropagation&&a.stopImmediatePropagation(),this.stopPropagation()}},m.each({mouseenter:"mouseover",mouseleave:"mouseout",pointerenter:"pointerover",pointerleave:"pointerout"},function(a,b){m.event.special[a]={delegateType:b,bindType:b,handle:function(a){var c,d=this,e=a.relatedTarget,f=a.handleObj;return(!e||e!==d&&!m.contains(d,e))&&(a.type=f.origType,c=f.handler.apply(this,arguments),a.type=b),c}}}),k.submitBubbles||(m.event.special.submit={setup:function(){return m.nodeName(this,"form")?!1:void m.event.add(this,"click._submit keypress._submit",function(a){var b=a.target,c=m.nodeName(b,"input")||m.nodeName(b,"button")?b.form:void 0;c&&!m._data(c,"submitBubbles")&&(m.event.add(c,"submit._submit",function(a){a._submit_bubble=!0}),m._data(c,"submitBubbles",!0))})},postDispatch:function(a){a._submit_bubble&&(delete a._submit_bubble,this.parentNode&&!a.isTrigger&&m.event.simulate("submit",this.parentNode,a,!0))},teardown:function(){return m.nodeName(this,"form")?!1:void m.event.remove(this,"._submit")}}),k.changeBubbles||(m.event.special.change={setup:function(){return X.test(this.nodeName)?(("checkbox"===this.type||"radio"===this.type)&&(m.event.add(this,"propertychange._change",function(a){"checked"===a.originalEvent.propertyName&&(this._just_changed=!0)}),m.event.add(this,"click._change",function(a){this._just_changed&&!a.isTrigger&&(this._just_changed=!1),m.event.simulate("change",this,a,!0)})),!1):void m.event.add(this,"beforeactivate._change",function(a){var b=a.target;X.test(b.nodeName)&&!m._data(b,"changeBubbles")&&(m.event.add(b,"change._change",function(a){!this.parentNode||a.isSimulated||a.isTrigger||m.event.simulate("change",this.parentNode,a,!0)}),m._data(b,"changeBubbles",!0))})},handle:function(a){var b=a.target;return this!==b||a.isSimulated||a.isTrigger||"radio"!==b.type&&"checkbox"!==b.type?a.handleObj.handler.apply(this,arguments):void 0},teardown:function(){return m.event.remove(this,"._change"),!X.test(this.nodeName)}}),k.focusinBubbles||m.each({focus:"focusin",blur:"focusout"},function(a,b){var c=function(a){m.event.simulate(b,a.target,m.event.fix(a),!0)};m.event.special[b]={setup:function(){var d=this.ownerDocument||this,e=m._data(d,b);e||d.addEventListener(a,c,!0),m._data(d,b,(e||0)+1)},teardown:function(){var d=this.ownerDocument||this,e=m._data(d,b)-1;e?m._data(d,b,e):(d.removeEventListener(a,c,!0),m._removeData(d,b))}}}),m.fn.extend({on:function(a,b,c,d,e){var f,g;if("object"==typeof a){"string"!=typeof b&&(c=c||b,b=void 0);for(f in a)this.on(f,b,c,a[f],e);return this}if(null==c&&null==d?(d=b,c=b=void 0):null==d&&("string"==typeof b?(d=c,c=void 0):(d=c,c=b,b=void 0)),d===!1)d=ba;else if(!d)return this;return 1===e&&(g=d,d=function(a){return m().off(a),g.apply(this,arguments)},d.guid=g.guid||(g.guid=m.guid++)),this.each(function(){m.event.add(this,a,d,c,b)})},one:function(a,b,c,d){return this.on(a,b,c,d,1)},off:function(a,b,c){var d,e;if(a&&a.preventDefault&&a.handleObj)return d=a.handleObj,m(a.delegateTarget).off(d.namespace?d.origType+"."+d.namespace:d.origType,d.selector,d.handler),this;if("object"==typeof a){for(e in a)this.off(e,b,a[e]);return this}return(b===!1||"function"==typeof b)&&(c=b,b=void 0),c===!1&&(c=ba),this.each(function(){m.event.remove(this,a,c,b)})},trigger:function(a,b){return this.each(function(){m.event.trigger(a,b,this)})},triggerHandler:function(a,b){var c=this[0];return c?m.event.trigger(a,b,c,!0):void 0}});function da(a){var b=ea.split("|"),c=a.createDocumentFragment();if(c.createElement)while(b.length)c.createElement(b.pop());return c}var ea="abbr|article|aside|audio|bdi|canvas|data|datalist|details|figcaption|figure|footer|header|hgroup|mark|meter|nav|output|progress|section|summary|time|video",fa=/ jQuery\d+="(?:null|\d+)"/g,ga=new RegExp("<(?:"+ea+")[\\s/>]","i"),ha=/^\s+/,ia=/<(?!area|br|col|embed|hr|img|input|link|meta|param)(([\w:]+)[^>]*)\/>/gi,ja=/<([\w:]+)/,ka=/<tbody/i,la=/<|&#?\w+;/,ma=/<(?:script|style|link)/i,na=/checked\s*(?:[^=]|=\s*.checked.)/i,oa=/^$|\/(?:java|ecma)script/i,pa=/^true\/(.*)/,qa=/^\s*<!(?:\[CDATA\[|--)|(?:\]\]|--)>\s*$/g,ra={option:[1,"<select multiple='multiple'>","</select>"],legend:[1,"<fieldset>","</fieldset>"],area:[1,"<map>","</map>"],param:[1,"<object>","</object>"],thead:[1,"<table>","</table>"],tr:[2,"<table><tbody>","</tbody></table>"],col:[2,"<table><tbody></tbody><colgroup>","</colgroup></table>"],td:[3,"<table><tbody><tr>","</tr></tbody></table>"],_default:k.htmlSerialize?[0,"",""]:[1,"X<div>","</div>"]},sa=da(y),ta=sa.appendChild(y.createElement("div"));ra.optgroup=ra.option,ra.tbody=ra.tfoot=ra.colgroup=ra.caption=ra.thead,ra.th=ra.td;function ua(a,b){var c,d,e=0,f=typeof a.getElementsByTagName!==K?a.getElementsByTagName(b||"*"):typeof a.querySelectorAll!==K?a.querySelectorAll(b||"*"):void 0;if(!f)for(f=[],c=a.childNodes||a;null!=(d=c[e]);e++)!b||m.nodeName(d,b)?f.push(d):m.merge(f,ua(d,b));return void 0===b||b&&m.nodeName(a,b)?m.merge([a],f):f}function va(a){W.test(a.type)&&(a.defaultChecked=a.checked)}function wa(a,b){return m.nodeName(a,"table")&&m.nodeName(11!==b.nodeType?b:b.firstChild,"tr")?a.getElementsByTagName("tbody")[0]||a.appendChild(a.ownerDocument.createElement("tbody")):a}function xa(a){return a.type=(null!==m.find.attr(a,"type"))+"/"+a.type,a}function ya(a){var b=pa.exec(a.type);return b?a.type=b[1]:a.removeAttribute("type"),a}function za(a,b){for(var c,d=0;null!=(c=a[d]);d++)m._data(c,"globalEval",!b||m._data(b[d],"globalEval"))}function Aa(a,b){if(1===b.nodeType&&m.hasData(a)){var c,d,e,f=m._data(a),g=m._data(b,f),h=f.events;if(h){delete g.handle,g.events={};for(c in h)for(d=0,e=h[c].length;e>d;d++)m.event.add(b,c,h[c][d])}g.data&&(g.data=m.extend({},g.data))}}function Ba(a,b){var c,d,e;if(1===b.nodeType){if(c=b.nodeName.toLowerCase(),!k.noCloneEvent&&b[m.expando]){e=m._data(b);for(d in e.events)m.removeEvent(b,d,e.handle);b.removeAttribute(m.expando)}"script"===c&&b.text!==a.text?(xa(b).text=a.text,ya(b)):"object"===c?(b.parentNode&&(b.outerHTML=a.outerHTML),k.html5Clone&&a.innerHTML&&!m.trim(b.innerHTML)&&(b.innerHTML=a.innerHTML)):"input"===c&&W.test(a.type)?(b.defaultChecked=b.checked=a.checked,b.value!==a.value&&(b.value=a.value)):"option"===c?b.defaultSelected=b.selected=a.defaultSelected:("input"===c||"textarea"===c)&&(b.defaultValue=a.defaultValue)}}m.extend({clone:function(a,b,c){var d,e,f,g,h,i=m.contains(a.ownerDocument,a);if(k.html5Clone||m.isXMLDoc(a)||!ga.test("<"+a.nodeName+">")?f=a.cloneNode(!0):(ta.innerHTML=a.outerHTML,ta.removeChild(f=ta.firstChild)),!(k.noCloneEvent&&k.noCloneChecked||1!==a.nodeType&&11!==a.nodeType||m.isXMLDoc(a)))for(d=ua(f),h=ua(a),g=0;null!=(e=h[g]);++g)d[g]&&Ba(e,d[g]);if(b)if(c)for(h=h||ua(a),d=d||ua(f),g=0;null!=(e=h[g]);g++)Aa(e,d[g]);else Aa(a,f);return d=ua(f,"script"),d.length>0&&za(d,!i&&ua(a,"script")),d=h=e=null,f},buildFragment:function(a,b,c,d){for(var e,f,g,h,i,j,l,n=a.length,o=da(b),p=[],q=0;n>q;q++)if(f=a[q],f||0===f)if("object"===m.type(f))m.merge(p,f.nodeType?[f]:f);else if(la.test(f)){h=h||o.appendChild(b.createElement("div")),i=(ja.exec(f)||["",""])[1].toLowerCase(),l=ra[i]||ra._default,h.innerHTML=l[1]+f.replace(ia,"<$1></$2>")+l[2],e=l[0];while(e--)h=h.lastChild;if(!k.leadingWhitespace&&ha.test(f)&&p.push(b.createTextNode(ha.exec(f)[0])),!k.tbody){f="table"!==i||ka.test(f)?"<table>"!==l[1]||ka.test(f)?0:h:h.firstChild,e=f&&f.childNodes.length;while(e--)m.nodeName(j=f.childNodes[e],"tbody")&&!j.childNodes.length&&f.removeChild(j)}m.merge(p,h.childNodes),h.textContent="";while(h.firstChild)h.removeChild(h.firstChild);h=o.lastChild}else p.push(b.createTextNode(f));h&&o.removeChild(h),k.appendChecked||m.grep(ua(p,"input"),va),q=0;while(f=p[q++])if((!d||-1===m.inArray(f,d))&&(g=m.contains(f.ownerDocument,f),h=ua(o.appendChild(f),"script"),g&&za(h),c)){e=0;while(f=h[e++])oa.test(f.type||"")&&c.push(f)}return h=null,o},cleanData:function(a,b){for(var d,e,f,g,h=0,i=m.expando,j=m.cache,l=k.deleteExpando,n=m.event.special;null!=(d=a[h]);h++)if((b||m.acceptData(d))&&(f=d[i],g=f&&j[f])){if(g.events)for(e in g.events)n[e]?m.event.remove(d,e):m.removeEvent(d,e,g.handle);j[f]&&(delete j[f],l?delete d[i]:typeof d.removeAttribute!==K?d.removeAttribute(i):d[i]=null,c.push(f))}}}),m.fn.extend({text:function(a){return V(this,function(a){return void 0===a?m.text(this):this.empty().append((this[0]&&this[0].ownerDocument||y).createTextNode(a))},null,a,arguments.length)},append:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.appendChild(a)}})},prepend:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.insertBefore(a,b.firstChild)}})},before:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this)})},after:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this.nextSibling)})},remove:function(a,b){for(var c,d=a?m.filter(a,this):this,e=0;null!=(c=d[e]);e++)b||1!==c.nodeType||m.cleanData(ua(c)),c.parentNode&&(b&&m.contains(c.ownerDocument,c)&&za(ua(c,"script")),c.parentNode.removeChild(c));return this},empty:function(){for(var a,b=0;null!=(a=this[b]);b++){1===a.nodeType&&m.cleanData(ua(a,!1));while(a.firstChild)a.removeChild(a.firstChild);a.options&&m.nodeName(a,"select")&&(a.options.length=0)}return this},clone:function(a,b){return a=null==a?!1:a,b=null==b?a:b,this.map(function(){return m.clone(this,a,b)})},html:function(a){return V(this,function(a){var b=this[0]||{},c=0,d=this.length;if(void 0===a)return 1===b.nodeType?b.innerHTML.replace(fa,""):void 0;if(!("string"!=typeof a||ma.test(a)||!k.htmlSerialize&&ga.test(a)||!k.leadingWhitespace&&ha.test(a)||ra[(ja.exec(a)||["",""])[1].toLowerCase()])){a=a.replace(ia,"<$1></$2>");try{for(;d>c;c++)b=this[c]||{},1===b.nodeType&&(m.cleanData(ua(b,!1)),b.innerHTML=a);b=0}catch(e){}}b&&this.empty().append(a)},null,a,arguments.length)},replaceWith:function(){var a=arguments[0];return this.domManip(arguments,function(b){a=this.parentNode,m.cleanData(ua(this)),a&&a.replaceChild(b,this)}),a&&(a.length||a.nodeType)?this:this.remove()},detach:function(a){return this.remove(a,!0)},domManip:function(a,b){a=e.apply([],a);var c,d,f,g,h,i,j=0,l=this.length,n=this,o=l-1,p=a[0],q=m.isFunction(p);if(q||l>1&&"string"==typeof p&&!k.checkClone&&na.test(p))return this.each(function(c){var d=n.eq(c);q&&(a[0]=p.call(this,c,d.html())),d.domManip(a,b)});if(l&&(i=m.buildFragment(a,this[0].ownerDocument,!1,this),c=i.firstChild,1===i.childNodes.length&&(i=c),c)){for(g=m.map(ua(i,"script"),xa),f=g.length;l>j;j++)d=i,j!==o&&(d=m.clone(d,!0,!0),f&&m.merge(g,ua(d,"script"))),b.call(this[j],d,j);if(f)for(h=g[g.length-1].ownerDocument,m.map(g,ya),j=0;f>j;j++)d=g[j],oa.test(d.type||"")&&!m._data(d,"globalEval")&&m.contains(h,d)&&(d.src?m._evalUrl&&m._evalUrl(d.src):m.globalEval((d.text||d.textContent||d.innerHTML||"").replace(qa,"")));i=c=null}return this}}),m.each({appendTo:"append",prependTo:"prepend",insertBefore:"before",insertAfter:"after",replaceAll:"replaceWith"},function(a,b){m.fn[a]=function(a){for(var c,d=0,e=[],g=m(a),h=g.length-1;h>=d;d++)c=d===h?this:this.clone(!0),m(g[d])[b](c),f.apply(e,c.get());return this.pushStack(e)}});var Ca,Da={};function Ea(b,c){var d,e=m(c.createElement(b)).appendTo(c.body),f=a.getDefaultComputedStyle&&(d=a.getDefaultComputedStyle(e[0]))?d.display:m.css(e[0],"display");return e.detach(),f}function Fa(a){var b=y,c=Da[a];return c||(c=Ea(a,b),"none"!==c&&c||(Ca=(Ca||m("<iframe frameborder='0' width='0' height='0'/>")).appendTo(b.documentElement),b=(Ca[0].contentWindow||Ca[0].contentDocument).document,b.write(),b.close(),c=Ea(a,b),Ca.detach()),Da[a]=c),c}!function(){var a;k.shrinkWrapBlocks=function(){if(null!=a)return a;a=!1;var b,c,d;return c=y.getElementsByTagName("body")[0],c&&c.style?(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:1px;width:1px;zoom:1",b.appendChild(y.createElement("div")).style.width="5px",a=3!==b.offsetWidth),c.removeChild(d),a):void 0}}();var Ga=/^margin/,Ha=new RegExp("^("+S+")(?!px)[a-z%]+$","i"),Ia,Ja,Ka=/^(top|right|bottom|left)$/;a.getComputedStyle?(Ia=function(b){return b.ownerDocument.defaultView.opener?b.ownerDocument.defaultView.getComputedStyle(b,null):a.getComputedStyle(b,null)},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c.getPropertyValue(b)||c[b]:void 0,c&&(""!==g||m.contains(a.ownerDocument,a)||(g=m.style(a,b)),Ha.test(g)&&Ga.test(b)&&(d=h.width,e=h.minWidth,f=h.maxWidth,h.minWidth=h.maxWidth=h.width=g,g=c.width,h.width=d,h.minWidth=e,h.maxWidth=f)),void 0===g?g:g+""}):y.documentElement.currentStyle&&(Ia=function(a){return a.currentStyle},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c[b]:void 0,null==g&&h&&h[b]&&(g=h[b]),Ha.test(g)&&!Ka.test(b)&&(d=h.left,e=a.runtimeStyle,f=e&&e.left,f&&(e.left=a.currentStyle.left),h.left="fontSize"===b?"1em":g,g=h.pixelLeft+"px",h.left=d,f&&(e.left=f)),void 0===g?g:g+""||"auto"});function La(a,b){return{get:function(){var c=a();if(null!=c)return c?void delete this.get:(this.get=b).apply(this,arguments)}}}!function(){var b,c,d,e,f,g,h;if(b=y.createElement("div"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=d&&d.style){c.cssText="float:left;opacity:.5",k.opacity="0.5"===c.opacity,k.cssFloat=!!c.cssFloat,b.style.backgroundClip="content-box",b.cloneNode(!0).style.backgroundClip="",k.clearCloneStyle="content-box"===b.style.backgroundClip,k.boxSizing=""===c.boxSizing||""===c.MozBoxSizing||""===c.WebkitBoxSizing,m.extend(k,{reliableHiddenOffsets:function(){return null==g&&i(),g},boxSizingReliable:function(){return null==f&&i(),f},pixelPosition:function(){return null==e&&i(),e},reliableMarginRight:function(){return null==h&&i(),h}});function i(){var b,c,d,i;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),b.style.cssText="-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;display:block;margin-top:1%;top:1%;border:1px;padding:1px;width:4px;position:absolute",e=f=!1,h=!0,a.getComputedStyle&&(e="1%"!==(a.getComputedStyle(b,null)||{}).top,f="4px"===(a.getComputedStyle(b,null)||{width:"4px"}).width,i=b.appendChild(y.createElement("div")),i.style.cssText=b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:0",i.style.marginRight=i.style.width="0",b.style.width="1px",h=!parseFloat((a.getComputedStyle(i,null)||{}).marginRight),b.removeChild(i)),b.innerHTML="<table><tr><td></td><td>t</td></tr></table>",i=b.getElementsByTagName("td"),i[0].style.cssText="margin:0;border:0;padding:0;display:none",g=0===i[0].offsetHeight,g&&(i[0].style.display="",i[1].style.display="none",g=0===i[0].offsetHeight),c.removeChild(d))}}}(),m.swap=function(a,b,c,d){var e,f,g={};for(f in b)g[f]=a.style[f],a.style[f]=b[f];e=c.apply(a,d||[]);for(f in b)a.style[f]=g[f];return e};var Ma=/alpha\([^)]*\)/i,Na=/opacity\s*=\s*([^)]*)/,Oa=/^(none|table(?!-c[ea]).+)/,Pa=new RegExp("^("+S+")(.*)$","i"),Qa=new RegExp("^([+-])=("+S+")","i"),Ra={position:"absolute",visibility:"hidden",display:"block"},Sa={letterSpacing:"0",fontWeight:"400"},Ta=["Webkit","O","Moz","ms"];function Ua(a,b){if(b in a)return b;var c=b.charAt(0).toUpperCase()+b.slice(1),d=b,e=Ta.length;while(e--)if(b=Ta[e]+c,b in a)return b;return d}function Va(a,b){for(var c,d,e,f=[],g=0,h=a.length;h>g;g++)d=a[g],d.style&&(f[g]=m._data(d,"olddisplay"),c=d.style.display,b?(f[g]||"none"!==c||(d.style.display=""),""===d.style.display&&U(d)&&(f[g]=m._data(d,"olddisplay",Fa(d.nodeName)))):(e=U(d),(c&&"none"!==c||!e)&&m._data(d,"olddisplay",e?c:m.css(d,"display"))));for(g=0;h>g;g++)d=a[g],d.style&&(b&&"none"!==d.style.display&&""!==d.style.display||(d.style.display=b?f[g]||"":"none"));return a}function Wa(a,b,c){var d=Pa.exec(b);return d?Math.max(0,d[1]-(c||0))+(d[2]||"px"):b}function Xa(a,b,c,d,e){for(var f=c===(d?"border":"content")?4:"width"===b?1:0,g=0;4>f;f+=2)"margin"===c&&(g+=m.css(a,c+T[f],!0,e)),d?("content"===c&&(g-=m.css(a,"padding"+T[f],!0,e)),"margin"!==c&&(g-=m.css(a,"border"+T[f]+"Width",!0,e))):(g+=m.css(a,"padding"+T[f],!0,e),"padding"!==c&&(g+=m.css(a,"border"+T[f]+"Width",!0,e)));return g}function Ya(a,b,c){var d=!0,e="width"===b?a.offsetWidth:a.offsetHeight,f=Ia(a),g=k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,f);if(0>=e||null==e){if(e=Ja(a,b,f),(0>e||null==e)&&(e=a.style[b]),Ha.test(e))return e;d=g&&(k.boxSizingReliable()||e===a.style[b]),e=parseFloat(e)||0}return e+Xa(a,b,c||(g?"border":"content"),d,f)+"px"}m.extend({cssHooks:{opacity:{get:function(a,b){if(b){var c=Ja(a,"opacity");return""===c?"1":c}}}},cssNumber:{columnCount:!0,fillOpacity:!0,flexGrow:!0,flexShrink:!0,fontWeight:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,widows:!0,zIndex:!0,zoom:!0},cssProps:{"float":k.cssFloat?"cssFloat":"styleFloat"},style:function(a,b,c,d){if(a&&3!==a.nodeType&&8!==a.nodeType&&a.style){var e,f,g,h=m.camelCase(b),i=a.style;if(b=m.cssProps[h]||(m.cssProps[h]=Ua(i,h)),g=m.cssHooks[b]||m.cssHooks[h],void 0===c)return g&&"get"in g&&void 0!==(e=g.get(a,!1,d))?e:i[b];if(f=typeof c,"string"===f&&(e=Qa.exec(c))&&(c=(e[1]+1)*e[2]+parseFloat(m.css(a,b)),f="number"),null!=c&&c===c&&("number"!==f||m.cssNumber[h]||(c+="px"),k.clearCloneStyle||""!==c||0!==b.indexOf("background")||(i[b]="inherit"),!(g&&"set"in g&&void 0===(c=g.set(a,c,d)))))try{i[b]=c}catch(j){}}},css:function(a,b,c,d){var e,f,g,h=m.camelCase(b);return b=m.cssProps[h]||(m.cssProps[h]=Ua(a.style,h)),g=m.cssHooks[b]||m.cssHooks[h],g&&"get"in g&&(f=g.get(a,!0,c)),void 0===f&&(f=Ja(a,b,d)),"normal"===f&&b in Sa&&(f=Sa[b]),""===c||c?(e=parseFloat(f),c===!0||m.isNumeric(e)?e||0:f):f}}),m.each(["height","width"],function(a,b){m.cssHooks[b]={get:function(a,c,d){return c?Oa.test(m.css(a,"display"))&&0===a.offsetWidth?m.swap(a,Ra,function(){return Ya(a,b,d)}):Ya(a,b,d):void 0},set:function(a,c,d){var e=d&&Ia(a);return Wa(a,c,d?Xa(a,b,d,k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,e),e):0)}}}),k.opacity||(m.cssHooks.opacity={get:function(a,b){return Na.test((b&&a.currentStyle?a.currentStyle.filter:a.style.filter)||"")?.01*parseFloat(RegExp.$1)+"":b?"1":""},set:function(a,b){var c=a.style,d=a.currentStyle,e=m.isNumeric(b)?"alpha(opacity="+100*b+")":"",f=d&&d.filter||c.filter||"";c.zoom=1,(b>=1||""===b)&&""===m.trim(f.replace(Ma,""))&&c.removeAttribute&&(c.removeAttribute("filter"),""===b||d&&!d.filter)||(c.filter=Ma.test(f)?f.replace(Ma,e):f+" "+e)}}),m.cssHooks.marginRight=La(k.reliableMarginRight,function(a,b){return b?m.swap(a,{display:"inline-block"},Ja,[a,"marginRight"]):void 0}),m.each({margin:"",padding:"",border:"Width"},function(a,b){m.cssHooks[a+b]={expand:function(c){for(var d=0,e={},f="string"==typeof c?c.split(" "):[c];4>d;d++)e[a+T[d]+b]=f[d]||f[d-2]||f[0];return e}},Ga.test(a)||(m.cssHooks[a+b].set=Wa)}),m.fn.extend({css:function(a,b){return V(this,function(a,b,c){var d,e,f={},g=0;if(m.isArray(b)){for(d=Ia(a),e=b.length;e>g;g++)f[b[g]]=m.css(a,b[g],!1,d);return f}return void 0!==c?m.style(a,b,c):m.css(a,b)},a,b,arguments.length>1)},show:function(){return Va(this,!0)},hide:function(){return Va(this)},toggle:function(a){return"boolean"==typeof a?a?this.show():this.hide():this.each(function(){U(this)?m(this).show():m(this).hide()})}});function Za(a,b,c,d,e){
return new Za.prototype.init(a,b,c,d,e)}m.Tween=Za,Za.prototype={constructor:Za,init:function(a,b,c,d,e,f){this.elem=a,this.prop=c,this.easing=e||"swing",this.options=b,this.start=this.now=this.cur(),this.end=d,this.unit=f||(m.cssNumber[c]?"":"px")},cur:function(){var a=Za.propHooks[this.prop];return a&&a.get?a.get(this):Za.propHooks._default.get(this)},run:function(a){var b,c=Za.propHooks[this.prop];return this.options.duration?this.pos=b=m.easing[this.easing](a,this.options.duration*a,0,1,this.options.duration):this.pos=b=a,this.now=(this.end-this.start)*b+this.start,this.options.step&&this.options.step.call(this.elem,this.now,this),c&&c.set?c.set(this):Za.propHooks._default.set(this),this}},Za.prototype.init.prototype=Za.prototype,Za.propHooks={_default:{get:function(a){var b;return null==a.elem[a.prop]||a.elem.style&&null!=a.elem.style[a.prop]?(b=m.css(a.elem,a.prop,""),b&&"auto"!==b?b:0):a.elem[a.prop]},set:function(a){m.fx.step[a.prop]?m.fx.step[a.prop](a):a.elem.style&&(null!=a.elem.style[m.cssProps[a.prop]]||m.cssHooks[a.prop])?m.style(a.elem,a.prop,a.now+a.unit):a.elem[a.prop]=a.now}}},Za.propHooks.scrollTop=Za.propHooks.scrollLeft={set:function(a){a.elem.nodeType&&a.elem.parentNode&&(a.elem[a.prop]=a.now)}},m.easing={linear:function(a){return a},swing:function(a){return.5-Math.cos(a*Math.PI)/2}},m.fx=Za.prototype.init,m.fx.step={};var $a,_a,ab=/^(?:toggle|show|hide)$/,bb=new RegExp("^(?:([+-])=|)("+S+")([a-z%]*)$","i"),cb=/queueHooks$/,db=[ib],eb={"*":[function(a,b){var c=this.createTween(a,b),d=c.cur(),e=bb.exec(b),f=e&&e[3]||(m.cssNumber[a]?"":"px"),g=(m.cssNumber[a]||"px"!==f&&+d)&&bb.exec(m.css(c.elem,a)),h=1,i=20;if(g&&g[3]!==f){f=f||g[3],e=e||[],g=+d||1;do h=h||".5",g/=h,m.style(c.elem,a,g+f);while(h!==(h=c.cur()/d)&&1!==h&&--i)}return e&&(g=c.start=+g||+d||0,c.unit=f,c.end=e[1]?g+(e[1]+1)*e[2]:+e[2]),c}]};function fb(){return setTimeout(function(){$a=void 0}),$a=m.now()}function gb(a,b){var c,d={height:a},e=0;for(b=b?1:0;4>e;e+=2-b)c=T[e],d["margin"+c]=d["padding"+c]=a;return b&&(d.opacity=d.width=a),d}function hb(a,b,c){for(var d,e=(eb[b]||[]).concat(eb["*"]),f=0,g=e.length;g>f;f++)if(d=e[f].call(c,b,a))return d}function ib(a,b,c){var d,e,f,g,h,i,j,l,n=this,o={},p=a.style,q=a.nodeType&&U(a),r=m._data(a,"fxshow");c.queue||(h=m._queueHooks(a,"fx"),null==h.unqueued&&(h.unqueued=0,i=h.empty.fire,h.empty.fire=function(){h.unqueued||i()}),h.unqueued++,n.always(function(){n.always(function(){h.unqueued--,m.queue(a,"fx").length||h.empty.fire()})})),1===a.nodeType&&("height"in b||"width"in b)&&(c.overflow=[p.overflow,p.overflowX,p.overflowY],j=m.css(a,"display"),l="none"===j?m._data(a,"olddisplay")||Fa(a.nodeName):j,"inline"===l&&"none"===m.css(a,"float")&&(k.inlineBlockNeedsLayout&&"inline"!==Fa(a.nodeName)?p.zoom=1:p.display="inline-block")),c.overflow&&(p.overflow="hidden",k.shrinkWrapBlocks()||n.always(function(){p.overflow=c.overflow[0],p.overflowX=c.overflow[1],p.overflowY=c.overflow[2]}));for(d in b)if(e=b[d],ab.exec(e)){if(delete b[d],f=f||"toggle"===e,e===(q?"hide":"show")){if("show"!==e||!r||void 0===r[d])continue;q=!0}o[d]=r&&r[d]||m.style(a,d)}else j=void 0;if(m.isEmptyObject(o))"inline"===("none"===j?Fa(a.nodeName):j)&&(p.display=j);else{r?"hidden"in r&&(q=r.hidden):r=m._data(a,"fxshow",{}),f&&(r.hidden=!q),q?m(a).show():n.done(function(){m(a).hide()}),n.done(function(){var b;m._removeData(a,"fxshow");for(b in o)m.style(a,b,o[b])});for(d in o)g=hb(q?r[d]:0,d,n),d in r||(r[d]=g.start,q&&(g.end=g.start,g.start="width"===d||"height"===d?1:0))}}function jb(a,b){var c,d,e,f,g;for(c in a)if(d=m.camelCase(c),e=b[d],f=a[c],m.isArray(f)&&(e=f[1],f=a[c]=f[0]),c!==d&&(a[d]=f,delete a[c]),g=m.cssHooks[d],g&&"expand"in g){f=g.expand(f),delete a[d];for(c in f)c in a||(a[c]=f[c],b[c]=e)}else b[d]=e}function kb(a,b,c){var d,e,f=0,g=db.length,h=m.Deferred().always(function(){delete i.elem}),i=function(){if(e)return!1;for(var b=$a||fb(),c=Math.max(0,j.startTime+j.duration-b),d=c/j.duration||0,f=1-d,g=0,i=j.tweens.length;i>g;g++)j.tweens[g].run(f);return h.notifyWith(a,[j,f,c]),1>f&&i?c:(h.resolveWith(a,[j]),!1)},j=h.promise({elem:a,props:m.extend({},b),opts:m.extend(!0,{specialEasing:{}},c),originalProperties:b,originalOptions:c,startTime:$a||fb(),duration:c.duration,tweens:[],createTween:function(b,c){var d=m.Tween(a,j.opts,b,c,j.opts.specialEasing[b]||j.opts.easing);return j.tweens.push(d),d},stop:function(b){var c=0,d=b?j.tweens.length:0;if(e)return this;for(e=!0;d>c;c++)j.tweens[c].run(1);return b?h.resolveWith(a,[j,b]):h.rejectWith(a,[j,b]),this}}),k=j.props;for(jb(k,j.opts.specialEasing);g>f;f++)if(d=db[f].call(j,a,k,j.opts))return d;return m.map(k,hb,j),m.isFunction(j.opts.start)&&j.opts.start.call(a,j),m.fx.timer(m.extend(i,{elem:a,anim:j,queue:j.opts.queue})),j.progress(j.opts.progress).done(j.opts.done,j.opts.complete).fail(j.opts.fail).always(j.opts.always)}m.Animation=m.extend(kb,{tweener:function(a,b){m.isFunction(a)?(b=a,a=["*"]):a=a.split(" ");for(var c,d=0,e=a.length;e>d;d++)c=a[d],eb[c]=eb[c]||[],eb[c].unshift(b)},prefilter:function(a,b){b?db.unshift(a):db.push(a)}}),m.speed=function(a,b,c){var d=a&&"object"==typeof a?m.extend({},a):{complete:c||!c&&b||m.isFunction(a)&&a,duration:a,easing:c&&b||b&&!m.isFunction(b)&&b};return d.duration=m.fx.off?0:"number"==typeof d.duration?d.duration:d.duration in m.fx.speeds?m.fx.speeds[d.duration]:m.fx.speeds._default,(null==d.queue||d.queue===!0)&&(d.queue="fx"),d.old=d.complete,d.complete=function(){m.isFunction(d.old)&&d.old.call(this),d.queue&&m.dequeue(this,d.queue)},d},m.fn.extend({fadeTo:function(a,b,c,d){return this.filter(U).css("opacity",0).show().end().animate({opacity:b},a,c,d)},animate:function(a,b,c,d){var e=m.isEmptyObject(a),f=m.speed(b,c,d),g=function(){var b=kb(this,m.extend({},a),f);(e||m._data(this,"finish"))&&b.stop(!0)};return g.finish=g,e||f.queue===!1?this.each(g):this.queue(f.queue,g)},stop:function(a,b,c){var d=function(a){var b=a.stop;delete a.stop,b(c)};return"string"!=typeof a&&(c=b,b=a,a=void 0),b&&a!==!1&&this.queue(a||"fx",[]),this.each(function(){var b=!0,e=null!=a&&a+"queueHooks",f=m.timers,g=m._data(this);if(e)g[e]&&g[e].stop&&d(g[e]);else for(e in g)g[e]&&g[e].stop&&cb.test(e)&&d(g[e]);for(e=f.length;e--;)f[e].elem!==this||null!=a&&f[e].queue!==a||(f[e].anim.stop(c),b=!1,f.splice(e,1));(b||!c)&&m.dequeue(this,a)})},finish:function(a){return a!==!1&&(a=a||"fx"),this.each(function(){var b,c=m._data(this),d=c[a+"queue"],e=c[a+"queueHooks"],f=m.timers,g=d?d.length:0;for(c.finish=!0,m.queue(this,a,[]),e&&e.stop&&e.stop.call(this,!0),b=f.length;b--;)f[b].elem===this&&f[b].queue===a&&(f[b].anim.stop(!0),f.splice(b,1));for(b=0;g>b;b++)d[b]&&d[b].finish&&d[b].finish.call(this);delete c.finish})}}),m.each(["toggle","show","hide"],function(a,b){var c=m.fn[b];m.fn[b]=function(a,d,e){return null==a||"boolean"==typeof a?c.apply(this,arguments):this.animate(gb(b,!0),a,d,e)}}),m.each({slideDown:gb("show"),slideUp:gb("hide"),slideToggle:gb("toggle"),fadeIn:{opacity:"show"},fadeOut:{opacity:"hide"},fadeToggle:{opacity:"toggle"}},function(a,b){m.fn[a]=function(a,c,d){return this.animate(b,a,c,d)}}),m.timers=[],m.fx.tick=function(){var a,b=m.timers,c=0;for($a=m.now();c<b.length;c++)a=b[c],a()||b[c]!==a||b.splice(c--,1);b.length||m.fx.stop(),$a=void 0},m.fx.timer=function(a){m.timers.push(a),a()?m.fx.start():m.timers.pop()},m.fx.interval=13,m.fx.start=function(){_a||(_a=setInterval(m.fx.tick,m.fx.interval))},m.fx.stop=function(){clearInterval(_a),_a=null},m.fx.speeds={slow:600,fast:200,_default:400},m.fn.delay=function(a,b){return a=m.fx?m.fx.speeds[a]||a:a,b=b||"fx",this.queue(b,function(b,c){var d=setTimeout(b,a);c.stop=function(){clearTimeout(d)}})},function(){var a,b,c,d,e;b=y.createElement("div"),b.setAttribute("className","t"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=y.createElement("select"),e=c.appendChild(y.createElement("option")),a=b.getElementsByTagName("input")[0],d.style.cssText="top:1px",k.getSetAttribute="t"!==b.className,k.style=/top/.test(d.getAttribute("style")),k.hrefNormalized="/a"===d.getAttribute("href"),k.checkOn=!!a.value,k.optSelected=e.selected,k.enctype=!!y.createElement("form").enctype,c.disabled=!0,k.optDisabled=!e.disabled,a=y.createElement("input"),a.setAttribute("value",""),k.input=""===a.getAttribute("value"),a.value="t",a.setAttribute("type","radio"),k.radioValue="t"===a.value}();var lb=/\r/g;m.fn.extend({val:function(a){var b,c,d,e=this[0];{if(arguments.length)return d=m.isFunction(a),this.each(function(c){var e;1===this.nodeType&&(e=d?a.call(this,c,m(this).val()):a,null==e?e="":"number"==typeof e?e+="":m.isArray(e)&&(e=m.map(e,function(a){return null==a?"":a+""})),b=m.valHooks[this.type]||m.valHooks[this.nodeName.toLowerCase()],b&&"set"in b&&void 0!==b.set(this,e,"value")||(this.value=e))});if(e)return b=m.valHooks[e.type]||m.valHooks[e.nodeName.toLowerCase()],b&&"get"in b&&void 0!==(c=b.get(e,"value"))?c:(c=e.value,"string"==typeof c?c.replace(lb,""):null==c?"":c)}}}),m.extend({valHooks:{option:{get:function(a){var b=m.find.attr(a,"value");return null!=b?b:m.trim(m.text(a))}},select:{get:function(a){for(var b,c,d=a.options,e=a.selectedIndex,f="select-one"===a.type||0>e,g=f?null:[],h=f?e+1:d.length,i=0>e?h:f?e:0;h>i;i++)if(c=d[i],!(!c.selected&&i!==e||(k.optDisabled?c.disabled:null!==c.getAttribute("disabled"))||c.parentNode.disabled&&m.nodeName(c.parentNode,"optgroup"))){if(b=m(c).val(),f)return b;g.push(b)}return g},set:function(a,b){var c,d,e=a.options,f=m.makeArray(b),g=e.length;while(g--)if(d=e[g],m.inArray(m.valHooks.option.get(d),f)>=0)try{d.selected=c=!0}catch(h){d.scrollHeight}else d.selected=!1;return c||(a.selectedIndex=-1),e}}}}),m.each(["radio","checkbox"],function(){m.valHooks[this]={set:function(a,b){return m.isArray(b)?a.checked=m.inArray(m(a).val(),b)>=0:void 0}},k.checkOn||(m.valHooks[this].get=function(a){return null===a.getAttribute("value")?"on":a.value})});var mb,nb,ob=m.expr.attrHandle,pb=/^(?:checked|selected)$/i,qb=k.getSetAttribute,rb=k.input;m.fn.extend({attr:function(a,b){return V(this,m.attr,a,b,arguments.length>1)},removeAttr:function(a){return this.each(function(){m.removeAttr(this,a)})}}),m.extend({attr:function(a,b,c){var d,e,f=a.nodeType;if(a&&3!==f&&8!==f&&2!==f)return typeof a.getAttribute===K?m.prop(a,b,c):(1===f&&m.isXMLDoc(a)||(b=b.toLowerCase(),d=m.attrHooks[b]||(m.expr.match.bool.test(b)?nb:mb)),void 0===c?d&&"get"in d&&null!==(e=d.get(a,b))?e:(e=m.find.attr(a,b),null==e?void 0:e):null!==c?d&&"set"in d&&void 0!==(e=d.set(a,c,b))?e:(a.setAttribute(b,c+""),c):void m.removeAttr(a,b))},removeAttr:function(a,b){var c,d,e=0,f=b&&b.match(E);if(f&&1===a.nodeType)while(c=f[e++])d=m.propFix[c]||c,m.expr.match.bool.test(c)?rb&&qb||!pb.test(c)?a[d]=!1:a[m.camelCase("default-"+c)]=a[d]=!1:m.attr(a,c,""),a.removeAttribute(qb?c:d)},attrHooks:{type:{set:function(a,b){if(!k.radioValue&&"radio"===b&&m.nodeName(a,"input")){var c=a.value;return a.setAttribute("type",b),c&&(a.value=c),b}}}}}),nb={set:function(a,b,c){return b===!1?m.removeAttr(a,c):rb&&qb||!pb.test(c)?a.setAttribute(!qb&&m.propFix[c]||c,c):a[m.camelCase("default-"+c)]=a[c]=!0,c}},m.each(m.expr.match.bool.source.match(/\w+/g),function(a,b){var c=ob[b]||m.find.attr;ob[b]=rb&&qb||!pb.test(b)?function(a,b,d){var e,f;return d||(f=ob[b],ob[b]=e,e=null!=c(a,b,d)?b.toLowerCase():null,ob[b]=f),e}:function(a,b,c){return c?void 0:a[m.camelCase("default-"+b)]?b.toLowerCase():null}}),rb&&qb||(m.attrHooks.value={set:function(a,b,c){return m.nodeName(a,"input")?void(a.defaultValue=b):mb&&mb.set(a,b,c)}}),qb||(mb={set:function(a,b,c){var d=a.getAttributeNode(c);return d||a.setAttributeNode(d=a.ownerDocument.createAttribute(c)),d.value=b+="","value"===c||b===a.getAttribute(c)?b:void 0}},ob.id=ob.name=ob.coords=function(a,b,c){var d;return c?void 0:(d=a.getAttributeNode(b))&&""!==d.value?d.value:null},m.valHooks.button={get:function(a,b){var c=a.getAttributeNode(b);return c&&c.specified?c.value:void 0},set:mb.set},m.attrHooks.contenteditable={set:function(a,b,c){mb.set(a,""===b?!1:b,c)}},m.each(["width","height"],function(a,b){m.attrHooks[b]={set:function(a,c){return""===c?(a.setAttribute(b,"auto"),c):void 0}}})),k.style||(m.attrHooks.style={get:function(a){return a.style.cssText||void 0},set:function(a,b){return a.style.cssText=b+""}});var sb=/^(?:input|select|textarea|button|object)$/i,tb=/^(?:a|area)$/i;m.fn.extend({prop:function(a,b){return V(this,m.prop,a,b,arguments.length>1)},removeProp:function(a){return a=m.propFix[a]||a,this.each(function(){try{this[a]=void 0,delete this[a]}catch(b){}})}}),m.extend({propFix:{"for":"htmlFor","class":"className"},prop:function(a,b,c){var d,e,f,g=a.nodeType;if(a&&3!==g&&8!==g&&2!==g)return f=1!==g||!m.isXMLDoc(a),f&&(b=m.propFix[b]||b,e=m.propHooks[b]),void 0!==c?e&&"set"in e&&void 0!==(d=e.set(a,c,b))?d:a[b]=c:e&&"get"in e&&null!==(d=e.get(a,b))?d:a[b]},propHooks:{tabIndex:{get:function(a){var b=m.find.attr(a,"tabindex");return b?parseInt(b,10):sb.test(a.nodeName)||tb.test(a.nodeName)&&a.href?0:-1}}}}),k.hrefNormalized||m.each(["href","src"],function(a,b){m.propHooks[b]={get:function(a){return a.getAttribute(b,4)}}}),k.optSelected||(m.propHooks.selected={get:function(a){var b=a.parentNode;return b&&(b.selectedIndex,b.parentNode&&b.parentNode.selectedIndex),null}}),m.each(["tabIndex","readOnly","maxLength","cellSpacing","cellPadding","rowSpan","colSpan","useMap","frameBorder","contentEditable"],function(){m.propFix[this.toLowerCase()]=this}),k.enctype||(m.propFix.enctype="encoding");var ub=/[\t\r\n\f]/g;m.fn.extend({addClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j="string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).addClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):" ")){f=0;while(e=b[f++])d.indexOf(" "+e+" ")<0&&(d+=e+" ");g=m.trim(d),c.className!==g&&(c.className=g)}return this},removeClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j=0===arguments.length||"string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).removeClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):"")){f=0;while(e=b[f++])while(d.indexOf(" "+e+" ")>=0)d=d.replace(" "+e+" "," ");g=a?m.trim(d):"",c.className!==g&&(c.className=g)}return this},toggleClass:function(a,b){var c=typeof a;return"boolean"==typeof b&&"string"===c?b?this.addClass(a):this.removeClass(a):this.each(m.isFunction(a)?function(c){m(this).toggleClass(a.call(this,c,this.className,b),b)}:function(){if("string"===c){var b,d=0,e=m(this),f=a.match(E)||[];while(b=f[d++])e.hasClass(b)?e.removeClass(b):e.addClass(b)}else(c===K||"boolean"===c)&&(this.className&&m._data(this,"__className__",this.className),this.className=this.className||a===!1?"":m._data(this,"__className__")||"")})},hasClass:function(a){for(var b=" "+a+" ",c=0,d=this.length;d>c;c++)if(1===this[c].nodeType&&(" "+this[c].className+" ").replace(ub," ").indexOf(b)>=0)return!0;return!1}}),m.each("blur focus focusin focusout load resize scroll unload click dblclick mousedown mouseup mousemove mouseover mouseout mouseenter mouseleave change select submit keydown keypress keyup error contextmenu".split(" "),function(a,b){m.fn[b]=function(a,c){return arguments.length>0?this.on(b,null,a,c):this.trigger(b)}}),m.fn.extend({hover:function(a,b){return this.mouseenter(a).mouseleave(b||a)},bind:function(a,b,c){return this.on(a,null,b,c)},unbind:function(a,b){return this.off(a,null,b)},delegate:function(a,b,c,d){return this.on(b,a,c,d)},undelegate:function(a,b,c){return 1===arguments.length?this.off(a,"**"):this.off(b,a||"**",c)}});var vb=m.now(),wb=/\?/,xb=/(,)|(\[|{)|(}|])|"(?:[^"\\\r\n]|\\["\\\/bfnrt]|\\u[\da-fA-F]{4})*"\s*:?|true|false|null|-?(?!0\d)\d+(?:\.\d+|)(?:[eE][+-]?\d+|)/g;m.parseJSON=function(b){if(a.JSON&&a.JSON.parse)return a.JSON.parse(b+"");var c,d=null,e=m.trim(b+"");return e&&!m.trim(e.replace(xb,function(a,b,e,f){return c&&b&&(d=0),0===d?a:(c=e||b,d+=!f-!e,"")}))?Function("return "+e)():m.error("Invalid JSON: "+b)},m.parseXML=function(b){var c,d;if(!b||"string"!=typeof b)return null;try{a.DOMParser?(d=new DOMParser,c=d.parseFromString(b,"text/xml")):(c=new ActiveXObject("Microsoft.XMLDOM"),c.async="false",c.loadXML(b))}catch(e){c=void 0}return c&&c.documentElement&&!c.getElementsByTagName("parsererror").length||m.error("Invalid XML: "+b),c};var yb,zb,Ab=/#.*$/,Bb=/([?&])_=[^&]*/,Cb=/^(.*?):[ \t]*([^\r\n]*)\r?$/gm,Db=/^(?:about|app|app-storage|.+-extension|file|res|widget):$/,Eb=/^(?:GET|HEAD)$/,Fb=/^\/\//,Gb=/^([\w.+-]+:)(?:\/\/(?:[^\/?#]*@|)([^\/?#:]*)(?::(\d+)|)|)/,Hb={},Ib={},Jb="*/".concat("*");try{zb=location.href}catch(Kb){zb=y.createElement("a"),zb.href="",zb=zb.href}yb=Gb.exec(zb.toLowerCase())||[];function Lb(a){return function(b,c){"string"!=typeof b&&(c=b,b="*");var d,e=0,f=b.toLowerCase().match(E)||[];if(m.isFunction(c))while(d=f[e++])"+"===d.charAt(0)?(d=d.slice(1)||"*",(a[d]=a[d]||[]).unshift(c)):(a[d]=a[d]||[]).push(c)}}function Mb(a,b,c,d){var e={},f=a===Ib;function g(h){var i;return e[h]=!0,m.each(a[h]||[],function(a,h){var j=h(b,c,d);return"string"!=typeof j||f||e[j]?f?!(i=j):void 0:(b.dataTypes.unshift(j),g(j),!1)}),i}return g(b.dataTypes[0])||!e["*"]&&g("*")}function Nb(a,b){var c,d,e=m.ajaxSettings.flatOptions||{};for(d in b)void 0!==b[d]&&((e[d]?a:c||(c={}))[d]=b[d]);return c&&m.extend(!0,a,c),a}function Ob(a,b,c){var d,e,f,g,h=a.contents,i=a.dataTypes;while("*"===i[0])i.shift(),void 0===e&&(e=a.mimeType||b.getResponseHeader("Content-Type"));if(e)for(g in h)if(h[g]&&h[g].test(e)){i.unshift(g);break}if(i[0]in c)f=i[0];else{for(g in c){if(!i[0]||a.converters[g+" "+i[0]]){f=g;break}d||(d=g)}f=f||d}return f?(f!==i[0]&&i.unshift(f),c[f]):void 0}function Pb(a,b,c,d){var e,f,g,h,i,j={},k=a.dataTypes.slice();if(k[1])for(g in a.converters)j[g.toLowerCase()]=a.converters[g];f=k.shift();while(f)if(a.responseFields[f]&&(c[a.responseFields[f]]=b),!i&&d&&a.dataFilter&&(b=a.dataFilter(b,a.dataType)),i=f,f=k.shift())if("*"===f)f=i;else if("*"!==i&&i!==f){if(g=j[i+" "+f]||j["* "+f],!g)for(e in j)if(h=e.split(" "),h[1]===f&&(g=j[i+" "+h[0]]||j["* "+h[0]])){g===!0?g=j[e]:j[e]!==!0&&(f=h[0],k.unshift(h[1]));break}if(g!==!0)if(g&&a["throws"])b=g(b);else try{b=g(b)}catch(l){return{state:"parsererror",error:g?l:"No conversion from "+i+" to "+f}}}return{state:"success",data:b}}m.extend({active:0,lastModified:{},etag:{},ajaxSettings:{url:zb,type:"GET",isLocal:Db.test(yb[1]),global:!0,processData:!0,async:!0,contentType:"application/x-www-form-urlencoded; charset=UTF-8",accepts:{"*":Jb,text:"text/plain",html:"text/html",xml:"application/xml, text/xml",json:"application/json, text/javascript"},contents:{xml:/xml/,html:/html/,json:/json/},responseFields:{xml:"responseXML",text:"responseText",json:"responseJSON"},converters:{"* text":String,"text html":!0,"text json":m.parseJSON,"text xml":m.parseXML},flatOptions:{url:!0,context:!0}},ajaxSetup:function(a,b){return b?Nb(Nb(a,m.ajaxSettings),b):Nb(m.ajaxSettings,a)},ajaxPrefilter:Lb(Hb),ajaxTransport:Lb(Ib),ajax:function(a,b){"object"==typeof a&&(b=a,a=void 0),b=b||{};var c,d,e,f,g,h,i,j,k=m.ajaxSetup({},b),l=k.context||k,n=k.context&&(l.nodeType||l.jquery)?m(l):m.event,o=m.Deferred(),p=m.Callbacks("once memory"),q=k.statusCode||{},r={},s={},t=0,u="canceled",v={readyState:0,getResponseHeader:function(a){var b;if(2===t){if(!j){j={};while(b=Cb.exec(f))j[b[1].toLowerCase()]=b[2]}b=j[a.toLowerCase()]}return null==b?null:b},getAllResponseHeaders:function(){return 2===t?f:null},setRequestHeader:function(a,b){var c=a.toLowerCase();return t||(a=s[c]=s[c]||a,r[a]=b),this},overrideMimeType:function(a){return t||(k.mimeType=a),this},statusCode:function(a){var b;if(a)if(2>t)for(b in a)q[b]=[q[b],a[b]];else v.always(a[v.status]);return this},abort:function(a){var b=a||u;return i&&i.abort(b),x(0,b),this}};if(o.promise(v).complete=p.add,v.success=v.done,v.error=v.fail,k.url=((a||k.url||zb)+"").replace(Ab,"").replace(Fb,yb[1]+"//"),k.type=b.method||b.type||k.method||k.type,k.dataTypes=m.trim(k.dataType||"*").toLowerCase().match(E)||[""],null==k.crossDomain&&(c=Gb.exec(k.url.toLowerCase()),k.crossDomain=!(!c||c[1]===yb[1]&&c[2]===yb[2]&&(c[3]||("http:"===c[1]?"80":"443"))===(yb[3]||("http:"===yb[1]?"80":"443")))),k.data&&k.processData&&"string"!=typeof k.data&&(k.data=m.param(k.data,k.traditional)),Mb(Hb,k,b,v),2===t)return v;h=m.event&&k.global,h&&0===m.active++&&m.event.trigger("ajaxStart"),k.type=k.type.toUpperCase(),k.hasContent=!Eb.test(k.type),e=k.url,k.hasContent||(k.data&&(e=k.url+=(wb.test(e)?"&":"?")+k.data,delete k.data),k.cache===!1&&(k.url=Bb.test(e)?e.replace(Bb,"$1_="+vb++):e+(wb.test(e)?"&":"?")+"_="+vb++)),k.ifModified&&(m.lastModified[e]&&v.setRequestHeader("If-Modified-Since",m.lastModified[e]),m.etag[e]&&v.setRequestHeader("If-None-Match",m.etag[e])),(k.data&&k.hasContent&&k.contentType!==!1||b.contentType)&&v.setRequestHeader("Content-Type",k.contentType),v.setRequestHeader("Accept",k.dataTypes[0]&&k.accepts[k.dataTypes[0]]?k.accepts[k.dataTypes[0]]+("*"!==k.dataTypes[0]?", "+Jb+"; q=0.01":""):k.accepts["*"]);for(d in k.headers)v.setRequestHeader(d,k.headers[d]);if(k.beforeSend&&(k.beforeSend.call(l,v,k)===!1||2===t))return v.abort();u="abort";for(d in{success:1,error:1,complete:1})v[d](k[d]);if(i=Mb(Ib,k,b,v)){v.readyState=1,h&&n.trigger("ajaxSend",[v,k]),k.async&&k.timeout>0&&(g=setTimeout(function(){v.abort("timeout")},k.timeout));try{t=1,i.send(r,x)}catch(w){if(!(2>t))throw w;x(-1,w)}}else x(-1,"No Transport");function x(a,b,c,d){var j,r,s,u,w,x=b;2!==t&&(t=2,g&&clearTimeout(g),i=void 0,f=d||"",v.readyState=a>0?4:0,j=a>=200&&300>a||304===a,c&&(u=Ob(k,v,c)),u=Pb(k,u,v,j),j?(k.ifModified&&(w=v.getResponseHeader("Last-Modified"),w&&(m.lastModified[e]=w),w=v.getResponseHeader("etag"),w&&(m.etag[e]=w)),204===a||"HEAD"===k.type?x="nocontent":304===a?x="notmodified":(x=u.state,r=u.data,s=u.error,j=!s)):(s=x,(a||!x)&&(x="error",0>a&&(a=0))),v.status=a,v.statusText=(b||x)+"",j?o.resolveWith(l,[r,x,v]):o.rejectWith(l,[v,x,s]),v.statusCode(q),q=void 0,h&&n.trigger(j?"ajaxSuccess":"ajaxError",[v,k,j?r:s]),p.fireWith(l,[v,x]),h&&(n.trigger("ajaxComplete",[v,k]),--m.active||m.event.trigger("ajaxStop")))}return v},getJSON:function(a,b,c){return m.get(a,b,c,"json")},getScript:function(a,b){return m.get(a,void 0,b,"script")}}),m.each(["get","post"],function(a,b){m[b]=function(a,c,d,e){return m.isFunction(c)&&(e=e||d,d=c,c=void 0),m.ajax({url:a,type:b,dataType:e,data:c,success:d})}}),m._evalUrl=function(a){return m.ajax({url:a,type:"GET",dataType:"script",async:!1,global:!1,"throws":!0})},m.fn.extend({wrapAll:function(a){if(m.isFunction(a))return this.each(function(b){m(this).wrapAll(a.call(this,b))});if(this[0]){var b=m(a,this[0].ownerDocument).eq(0).clone(!0);this[0].parentNode&&b.insertBefore(this[0]),b.map(function(){var a=this;while(a.firstChild&&1===a.firstChild.nodeType)a=a.firstChild;return a}).append(this)}return this},wrapInner:function(a){return this.each(m.isFunction(a)?function(b){m(this).wrapInner(a.call(this,b))}:function(){var b=m(this),c=b.contents();c.length?c.wrapAll(a):b.append(a)})},wrap:function(a){var b=m.isFunction(a);return this.each(function(c){m(this).wrapAll(b?a.call(this,c):a)})},unwrap:function(){return this.parent().each(function(){m.nodeName(this,"body")||m(this).replaceWith(this.childNodes)}).end()}}),m.expr.filters.hidden=function(a){return a.offsetWidth<=0&&a.offsetHeight<=0||!k.reliableHiddenOffsets()&&"none"===(a.style&&a.style.display||m.css(a,"display"))},m.expr.filters.visible=function(a){return!m.expr.filters.hidden(a)};var Qb=/%20/g,Rb=/\[\]$/,Sb=/\r?\n/g,Tb=/^(?:submit|button|image|reset|file)$/i,Ub=/^(?:input|select|textarea|keygen)/i;function Vb(a,b,c,d){var e;if(m.isArray(b))m.each(b,function(b,e){c||Rb.test(a)?d(a,e):Vb(a+"["+("object"==typeof e?b:"")+"]",e,c,d)});else if(c||"object"!==m.type(b))d(a,b);else for(e in b)Vb(a+"["+e+"]",b[e],c,d)}m.param=function(a,b){var c,d=[],e=function(a,b){b=m.isFunction(b)?b():null==b?"":b,d[d.length]=encodeURIComponent(a)+"="+encodeURIComponent(b)};if(void 0===b&&(b=m.ajaxSettings&&m.ajaxSettings.traditional),m.isArray(a)||a.jquery&&!m.isPlainObject(a))m.each(a,function(){e(this.name,this.value)});else for(c in a)Vb(c,a[c],b,e);return d.join("&").replace(Qb,"+")},m.fn.extend({serialize:function(){return m.param(this.serializeArray())},serializeArray:function(){return this.map(function(){var a=m.prop(this,"elements");return a?m.makeArray(a):this}).filter(function(){var a=this.type;return this.name&&!m(this).is(":disabled")&&Ub.test(this.nodeName)&&!Tb.test(a)&&(this.checked||!W.test(a))}).map(function(a,b){var c=m(this).val();return null==c?null:m.isArray(c)?m.map(c,function(a){return{name:b.name,value:a.replace(Sb,"\r\n")}}):{name:b.name,value:c.replace(Sb,"\r\n")}}).get()}}),m.ajaxSettings.xhr=void 0!==a.ActiveXObject?function(){return!this.isLocal&&/^(get|post|head|put|delete|options)$/i.test(this.type)&&Zb()||$b()}:Zb;var Wb=0,Xb={},Yb=m.ajaxSettings.xhr();a.attachEvent&&a.attachEvent("onunload",function(){for(var a in Xb)Xb[a](void 0,!0)}),k.cors=!!Yb&&"withCredentials"in Yb,Yb=k.ajax=!!Yb,Yb&&m.ajaxTransport(function(a){if(!a.crossDomain||k.cors){var b;return{send:function(c,d){var e,f=a.xhr(),g=++Wb;if(f.open(a.type,a.url,a.async,a.username,a.password),a.xhrFields)for(e in a.xhrFields)f[e]=a.xhrFields[e];a.mimeType&&f.overrideMimeType&&f.overrideMimeType(a.mimeType),a.crossDomain||c["X-Requested-With"]||(c["X-Requested-With"]="XMLHttpRequest");for(e in c)void 0!==c[e]&&f.setRequestHeader(e,c[e]+"");f.send(a.hasContent&&a.data||null),b=function(c,e){var h,i,j;if(b&&(e||4===f.readyState))if(delete Xb[g],b=void 0,f.onreadystatechange=m.noop,e)4!==f.readyState&&f.abort();else{j={},h=f.status,"string"==typeof f.responseText&&(j.text=f.responseText);try{i=f.statusText}catch(k){i=""}h||!a.isLocal||a.crossDomain?1223===h&&(h=204):h=j.text?200:404}j&&d(h,i,j,f.getAllResponseHeaders())},a.async?4===f.readyState?setTimeout(b):f.onreadystatechange=Xb[g]=b:b()},abort:function(){b&&b(void 0,!0)}}}});function Zb(){try{return new a.XMLHttpRequest}catch(b){}}function $b(){try{return new a.ActiveXObject("Microsoft.XMLHTTP")}catch(b){}}m.ajaxSetup({accepts:{script:"text/javascript, application/javascript, application/ecmascript, application/x-ecmascript"},contents:{script:/(?:java|ecma)script/},converters:{"text script":function(a){return m.globalEval(a),a}}}),m.ajaxPrefilter("script",function(a){void 0===a.cache&&(a.cache=!1),a.crossDomain&&(a.type="GET",a.global=!1)}),m.ajaxTransport("script",function(a){if(a.crossDomain){var b,c=y.head||m("head")[0]||y.documentElement;return{send:function(d,e){b=y.createElement("script"),b.async=!0,a.scriptCharset&&(b.charset=a.scriptCharset),b.src=a.url,b.onload=b.onreadystatechange=function(a,c){(c||!b.readyState||/loaded|complete/.test(b.readyState))&&(b.onload=b.onreadystatechange=null,b.parentNode&&b.parentNode.removeChild(b),b=null,c||e(200,"success"))},c.insertBefore(b,c.firstChild)},abort:function(){b&&b.onload(void 0,!0)}}}});var _b=[],ac=/(=)\?(?=&|$)|\?\?/;m.ajaxSetup({jsonp:"callback",jsonpCallback:function(){var a=_b.pop()||m.expando+"_"+vb++;return this[a]=!0,a}}),m.ajaxPrefilter("json jsonp",function(b,c,d){var e,f,g,h=b.jsonp!==!1&&(ac.test(b.url)?"url":"string"==typeof b.data&&!(b.contentType||"").indexOf("application/x-www-form-urlencoded")&&ac.test(b.data)&&"data");return h||"jsonp"===b.dataTypes[0]?(e=b.jsonpCallback=m.isFunction(b.jsonpCallback)?b.jsonpCallback():b.jsonpCallback,h?b[h]=b[h].replace(ac,"$1"+e):b.jsonp!==!1&&(b.url+=(wb.test(b.url)?"&":"?")+b.jsonp+"="+e),b.converters["script json"]=function(){return g||m.error(e+" was not called"),g[0]},b.dataTypes[0]="json",f=a[e],a[e]=function(){g=arguments},d.always(function(){a[e]=f,b[e]&&(b.jsonpCallback=c.jsonpCallback,_b.push(e)),g&&m.isFunction(f)&&f(g[0]),g=f=void 0}),"script"):void 0}),m.parseHTML=function(a,b,c){if(!a||"string"!=typeof a)return null;"boolean"==typeof b&&(c=b,b=!1),b=b||y;var d=u.exec(a),e=!c&&[];return d?[b.createElement(d[1])]:(d=m.buildFragment([a],b,e),e&&e.length&&m(e).remove(),m.merge([],d.childNodes))};var bc=m.fn.load;m.fn.load=function(a,b,c){if("string"!=typeof a&&bc)return bc.apply(this,arguments);var d,e,f,g=this,h=a.indexOf(" ");return h>=0&&(d=m.trim(a.slice(h,a.length)),a=a.slice(0,h)),m.isFunction(b)?(c=b,b=void 0):b&&"object"==typeof b&&(f="POST"),g.length>0&&m.ajax({url:a,type:f,dataType:"html",data:b}).done(function(a){e=arguments,g.html(d?m("<div>").append(m.parseHTML(a)).find(d):a)}).complete(c&&function(a,b){g.each(c,e||[a.responseText,b,a])}),this},m.each(["ajaxStart","ajaxStop","ajaxComplete","ajaxError","ajaxSuccess","ajaxSend"],function(a,b){m.fn[b]=function(a){return this.on(b,a)}}),m.expr.filters.animated=function(a){return m.grep(m.timers,function(b){return a===b.elem}).length};var cc=a.document.documentElement;function dc(a){return m.isWindow(a)?a:9===a.nodeType?a.defaultView||a.parentWindow:!1}m.offset={setOffset:function(a,b,c){var d,e,f,g,h,i,j,k=m.css(a,"position"),l=m(a),n={};"static"===k&&(a.style.position="relative"),h=l.offset(),f=m.css(a,"top"),i=m.css(a,"left"),j=("absolute"===k||"fixed"===k)&&m.inArray("auto",[f,i])>-1,j?(d=l.position(),g=d.top,e=d.left):(g=parseFloat(f)||0,e=parseFloat(i)||0),m.isFunction(b)&&(b=b.call(a,c,h)),null!=b.top&&(n.top=b.top-h.top+g),null!=b.left&&(n.left=b.left-h.left+e),"using"in b?b.using.call(a,n):l.css(n)}},m.fn.extend({offset:function(a){if(arguments.length)return void 0===a?this:this.each(function(b){m.offset.setOffset(this,a,b)});var b,c,d={top:0,left:0},e=this[0],f=e&&e.ownerDocument;if(f)return b=f.documentElement,m.contains(b,e)?(typeof e.getBoundingClientRect!==K&&(d=e.getBoundingClientRect()),c=dc(f),{top:d.top+(c.pageYOffset||b.scrollTop)-(b.clientTop||0),left:d.left+(c.pageXOffset||b.scrollLeft)-(b.clientLeft||0)}):d},position:function(){if(this[0]){var a,b,c={top:0,left:0},d=this[0];return"fixed"===m.css(d,"position")?b=d.getBoundingClientRect():(a=this.offsetParent(),b=this.offset(),m.nodeName(a[0],"html")||(c=a.offset()),c.top+=m.css(a[0],"borderTopWidth",!0),c.left+=m.css(a[0],"borderLeftWidth",!0)),{top:b.top-c.top-m.css(d,"marginTop",!0),left:b.left-c.left-m.css(d,"marginLeft",!0)}}},offsetParent:function(){return this.map(function(){var a=this.offsetParent||cc;while(a&&!m.nodeName(a,"html")&&"static"===m.css(a,"position"))a=a.offsetParent;return a||cc})}}),m.each({scrollLeft:"pageXOffset",scrollTop:"pageYOffset"},function(a,b){var c=/Y/.test(b);m.fn[a]=function(d){return V(this,function(a,d,e){var f=dc(a);return void 0===e?f?b in f?f[b]:f.document.documentElement[d]:a[d]:void(f?f.scrollTo(c?m(f).scrollLeft():e,c?e:m(f).scrollTop()):a[d]=e)},a,d,arguments.length,null)}}),m.each(["top","left"],function(a,b){m.cssHooks[b]=La(k.pixelPosition,function(a,c){return c?(c=Ja(a,b),Ha.test(c)?m(a).position()[b]+"px":c):void 0})}),m.each({Height:"height",Width:"width"},function(a,b){m.each({padding:"inner"+a,content:b,"":"outer"+a},function(c,d){m.fn[d]=function(d,e){var f=arguments.length&&(c||"boolean"!=typeof d),g=c||(d===!0||e===!0?"margin":"border");return V(this,function(b,c,d){var e;return m.isWindow(b)?b.document.documentElement["client"+a]:9===b.nodeType?(e=b.documentElement,Math.max(b.body["scroll"+a],e["scroll"+a],b.body["offset"+a],e["offset"+a],e["client"+a])):void 0===d?m.css(b,c,g):m.style(b,c,d,g)},b,f?d:void 0,f,null)}})}),m.fn.size=function(){return this.length},m.fn.andSelf=m.fn.addBack,"function"==typeof define&&define.amd&&define("jquery",[],function(){return m});var ec=a.jQuery,fc=a.$;return m.noConflict=function(b){return a.$===m&&(a.$=fc),b&&a.jQuery===m&&(a.jQuery=ec),m},typeof b===K&&(a.jQuery=a.$=m),m});
</script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<style type="text/css">
@font-face {
font-family: 'Open Sans';
font-style: normal;
font-weight: 300;
src: url(data:application/x-font-truetype;base64,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) format('truetype');
}
@font-face {
font-family: 'Open Sans';
font-style: normal;
font-weight: 400;
src: url(data:application/x-font-truetype;base64,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) format('truetype');
}
@font-face {
font-family: 'Open Sans';
font-style: normal;
font-weight: 700;
src: url(data:application/x-font-truetype;base64,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) format('truetype');
}
@font-face {
font-family: 'Open Sans';
font-style: italic;
font-weight: 300;
src: url(data:application/x-font-truetype;base64,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) format('truetype');
}
@font-face {
font-family: 'Open Sans';
font-style: italic;
font-weight: 400;
src: url(data:application/x-font-truetype;base64,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) format('truetype');
}
@font-face {
font-family: 'Open Sans';
font-style: italic;
font-weight: 700;
src: url(data:application/x-font-truetype;base64,AAEAAAASAQAABAAgR0RFRgAQANwAAICQAAAAFkdQT1MAFQAKAACAqAAAAAxHU1VC3cremgAAgLQAAAB0T1MvMqJ5mMsAAFOEAAAAYGNtYXDPgnIkAABT5AAAAMRjdnQgE2cZaQAAXYwAAACsZnBnbbtzpHUAAFSoAAAH4Gdhc3AACAAbAACAhAAAAAxnbHlmNvWK3QAAASwAAEy2aGVhZPio+LsAAE/AAAAANmhoZWEQgA5XAABTYAAAACRobXR4sZosgAAAT/gAAANoa2VybqPrpOMAAF44AAAekGxvY2Hta9jnAABOBAAAAbptYXhwAm4BrwAATeQAAAAgbmFtZR7GN8QAAHzIAAABknBvc3Rqt5auAAB+XAAAAiZwcmVw4q8TBQAAXIgAAAEBAAIAwQAABAoFtgADAAcADLMEAwcAAC8yLzMxMBMhESE3IREhwQNJ/LdoAnn9hwW2+kpoBOYAAAIAGf/lAocFtgADAA8AIkASDwEfAQIJAwEBDQIDDQdUWQ0WAD8rABg/EjkvX15dMTABIxMhATQ2MzIWFRQGIyImAYfxnQFU/ZJrYURSbllJUgHlA9H6vVpsTEVXbEsAAAIAyQOmA7oFtgADAAcADbQGAgcDAwA/M80yMTABAyMTIQMjEwIlmMRHAqqXx0oFtv3wAhD98AIQAAACACkAAAU1BbYAGwAfADtAHggECwscAQ4fAA8PGRUSMBJAEgIOEg4SChcTAwYKEgA/Mz8zEjk5Ly9dETMzMxEzMxEzMzMRMzMxMAEHIQchAyMTIwMjEyM3ITcjNyETMwMzEzMDMwcFMzcjBAxFAQIT/td03HXCc9dx7hIBFUb8EgEhd9l1x3TXdO8S/QbFRcQDTujO/mgBmP5oAZjO6NEBl/5pAZf+adHo6AAAAwAz/4kEYAYUAB4AJQArAENAJSsbDCUEBhUmGhUaT1kSFR8LBgtQWQVAEBRIBQYDBhUGFQYsFAAAPxI5OS8vETMQzSsrEQAzETMrEQAzERIXOTEwARQGBwcjNyYnERYXEyYmNTQ2NzczBxYXByYnAx4CATY2NTQmJwMGBhUUFwQK+/InjCzRksbOR6Oc/t8jiyGmgWqEbj+DgEL+SD9OMSMSPkVQAfC41xHHyQxKAQprCgFCPbR8rdUPl5cWROhBCf7VM2GB/v0JSD4uOw4CPQdEPE8gAAUAc//uBo8FywAJABcAGwAnADUALUAYHDAzATMzGwU/DgEODhobBhoYABUHIiwZAD8zPzM/PxI5L10zETkvXTMxMAEiAhUUMzISNTQXFAIGIyImNTQSNjMyFiUBIwETIgYGFRQzMjY2NTQXFAIGIyImNTQSNjMyFgIGP184QV72cL56i49vunuJlQLd+8XwBEA5J0guNylIL/VsvHmQkWq+fImVBPr+/5VgAQaQYG2m/uCSp5mpAR2QoIv6SgW2/PxwxGFhbsdhYGSn/tuUnZCxASOUnQADAET/7AWWBc0AGwAkADAAN0AdAhsEJBUiGCUcChQEBBgPARIPK01ZDwQEIkxZBBMAPysAGD8rABg/EjkRFzkREjk5Ejk5MTAhIScGIyImNTQ2NyY1NDYzMhYVEAUTNjY3IQIHAQYGFRQWMzI3AzY2NTQmIyIGFRQWBS3+okiv5NHfncNM68epwv6TwyxJKgEshbH9vVhGW0dzamhxVTwoQkkYYnbDt5HPYYKAw+Gljv7okv75OYFt/se4AVAza05BVjsCcTtoPDkzXUkuXAAAAQDJA6YCJQW2AAMACbICAwMAP80xMAEDIxMCJZjERwW2/fACEAABAEr+vANIBbYACwAKswMDCicAPz8xMBMQEgEhAgIREBMjAkr1AQMBBv/1deqVARkBUwI/AQv+6v2x/r3+zP7iAQoAAAH/bf68AmoFtgAKAAqzCAMEJwA/PzEwARACAyEAERADMxICavj//voB83TplQNa/qr9v/75AiEChwEzAR/++AABAKwCQgSHBiUADgAJsgYOAAA/zTEwAQMlByUTBwMDJyUlNwUTA3VxAYMS/q6g9lrFzwET/rpWAVIhBfL+nx3+K/6wSQFR/uqk+FztrgFxAAEAbQD4BCUEsAALACVAGAsJAAYEDwMfAz8DAy8DnwO/A98D7wMFAwAvXXEzMzMyMjEwASE1IREzESEVIREjAdv+kgFu2wFv/pHbAmTbAXH+j9v+lAAAAf+a/vgBgQDuAAYACrIEgAAALxrNMTAlFwYHIzYTAXkIdpDhSnjuF//gpwFPAAEAKQGoAmoCogADAAixAAEALzMxMBM3IQcpNQIMNQGo+voAAAEAGf/lAXsBOQALAAy1CQNUWQkWAD8rMTA3NDYzMhYVFAYjIiYZa2FEUm5ZSVJzWmxMRVdsSwAAAf+mAAAD9gW2AAMACrMDAwISAD8/MTABASEBA/b81/7ZAykFtvpKBbYAAgBC/+wEVgXNAAsAGQAXQAwKDE9ZCgcDE09ZAxkAPysAGD8rMTABEAAhIiY1EBIkMyAFIgYCFRQWMzI2EjU0JgRW/q/+0MbNqAEgvQGP/lZQi2A3RlGLXT0D9P4q/c708wEpAeDx+tD+dKpzddQBhr9vZgABALYAAAPlBbYACgAQtgQHAQkGARgAPz8SOTkxMCEhEzY3BgYHJwEzArD+z7QjKQlp0oUCNvkDPZiHCE6D1wFcAAAB/88AAARKBcsAGgAeQA8CARkQCU5ZEAcBGU5ZARgAPysAGD8rERIAOTEwISE3ATY2NTQmIyIGByc2NjMyFhUUBgYHBRUhA5H8PisB3bSJUkVCi2aShPCCvt5So7n+8wI41QGon79US09DVctwX8Sha7y8l94KAAABAA7/7ARQBcsAJwA1QBwDFxgYF1FZDBgBDQMYGAshJR9PWSUHCxFPWQsZAD8rABg/KxESADkYL19eXSsREgA5MTABFAYHFRYWFRQGBCMiJxEWFjMyNjU0ISM3MzI2NTQmIyIHJzY2MzIWBFC9p4OHlP7sve+UVMRdnqr+/oouSafAVk6GmX982Yq+2AR9nNQdBBqheYXSdU8BCzIzf3Gs3XxuQ0pkzFFBtQAAAv/nAAAEUAW2AAoAEwAlQBIQAwcBBRMFUFkGCRMTAwcGAxgAPz8SOS8zMysRADMREjkxMAEjAyETITcBIQMzITc2NjcjBgcBBASqP/7bP/2yMAMCATfDqv4xOgw4DgYjYf7HAS/+0QEv6gOd/Gn4OtQjP3b+jAAAAQAb/+wEaAW2ABwAJkAUABNQWQAABxcXGk5ZFwYHDU9ZBxkAPysAGD8rERIAORgvKzEwATIWFRQGBCMiJicRFjMyNjU0JiMiBycTIQMhAzYCb7fUj/7uwXXLPa6ymq5zbWZvaM8C8zf+F1hIA5rOuKf6hy4jAQ1jjnteXiFOAt3++v7bDwACAFj/7ASBBc0AGQAmAC1AFw0XEBAgUFkQEBcFBQpPWQUHFxpPWRcZAD8rABg/KxESADkYLysREgA5MTATNBISJDMyFwcmIyIGBzM2MzIWFRQCBiMiJgUyNjU0JiMiBgYVFBZYetUBLM99YjNUa8LvQgRzxJ2rju+e1NgBumN9Q0U8bUJQAdXKAYMBG5Ab9hnY7abCsKn+347+B7yOR1VHeGRbaAAAAQBOAAAEwQW2AAYAEbcAGAMCTlkDBgA/KwAYPzEwMwEhEyEHAU4C4f2LOAPPKf0QBLIBBML7DAADADf/7ARmBc0AFwAjAC0AIEAQGCkNAAAkUVkABw0eUVkNGQA/KwAYPysREgA5OTEwATIWFhUUBgcWFRQGBiMiJjUQJSY1NDY2EwYGFRQWMzI2NTQmEyIGFRQXNjU0JgLRe7lhoZbZf+uc1vUBXKV03Ah0cmRVXW1JHExae7lPBc1UmGKGxzSN4HrBasiqASqAhKd3u2j8ti18W1Ffa1VJdQKfXUmERUiVRE4AAgBW/+wERAXNABkAJwAtQBcNFxAQIVBZEBAEFxcaT1kXBwQJT1kEGQA/KwAYPysREgA5GC8rERIAOTEwARACBCMiJxEWMzI2NjcjBiMiJjU0EjYzMhYFIgYGFRQWMzI2NjU0JgRExv627oBwb3R5rXMqBG+4o7OS9qPL0/5BQWU3S0Q8Zz1HA+n+6P4G6yABAClis6iez7amAReJ9gJUkFFXWUl/X1RqAAACABn/5QIxBHMACwAXABdADAMJVFkDEBUPVFkVFgA/KwAYPysxMBM0NjMyFhUUBiMiJgM0NjMyFhUUBiMiJs9vXkRRbVpIU7ZrYURSbllJUgOsXGtNRVZsSf0LWmxMRVdsSwAAAv+a/vgCMQRzAAYAEgAVQAkDgAUKEFRZChAAPysAGC8azjEwJQYHIzYTIQM0NjMyFhUUBiMiJgGBdpDhSngBHapvXkRRbVpIU9f/4KcBTwK+XGtNRVZsSQAAAQBtAMsEJQUAAAYAFbcEAwMGAAIBBQA9LzMzMzIzETMxMCUBNQEVAQEEJfxIA7j9fQKDywG2jwHw8P7D/ucAAAIAbQGiBCUEAAADAAcAG0AQAAEEHwUBLwV/Bd8F7wUEBQAvXXEzxjIxMBM1IRUBNSEVbQO4/EgDuAMn2dn+e9vbAAEAbQDLBCUFAAAGABpACgAGBgECAwMFBAEAPS8zMzMRMxEzETMxMBMBATUBFQFtAoP9fQO4/EgBugEZAT3w/hCP/koAAgCm/+UD7gXLABoAJgAkQBMPAB8AAgkDAAAkCQ8EJB5UWSQWAD8rABg/MxI5L19eXTEwATc2Njc2NjU0IyIGByc2MzIWFRQGBgcOAgcBNDYzMhYVFAYjIiYBBA4TbXZ8Q4UycZFc5texzjlsiEBBKBL+oG5fRFFuWEpSAeVOZ5RRVFY1dyBE3X2vnVOFcVsrPEVK/o5ba0xFV2xMAAACAFz/RgbFBbYAOABEADJAGQgLORLvEAEaQARAC/ALARILEgsoITYDKC4ALzM/MxI5OS8vXREzMxEzXREzEjkxMAEUAgYjIiYnIwYGIyImNTQSNjMyFwMGBhUUMzI2NjU0JiMiBAIVFAAzMjY3FQYjIiQCNRASJCEgAAUiBgYVFBYzMhM3JgbFgOONWHEQBjJ+VH+Oh/CUuY5qCxA6QnRF9+zL/rm3AQzydc135uvZ/r6q8QG9ARMBPgFq/R5Sf0kxLY1IOSQDSK3+2KZNRk1Gn5aTAQOXN/5cLEEgRIDWa9XhvP6o3PP+7SguulqrATjLARcBtPf+ufZnq1lBSgEO3goAAAL/hQAABIsFvAAHAA8AH0APDAMEDwFMWQ8PBAcDEgQDAD8/MxI5LysREgA5MTABIQMhASETIQMDJjU1BgcDA0r+J6z+wAL+AXWT/tcnGgosQbwBXP6kBbz6RAJgAV6DeiR4hv5/AAMANQAABOMFtgAPABcAHwA1QBwGHxAQH01ZDBABDQMQEA4PDxdMWQ8DDhhMWQ4SAD8rABg/KxESADkYL19eXSsREgA5MTABMhYVFAYHFRYWFRQEISEBEzMyNjU0IyMDMzI2NTQjIwMU5eqmmWR3/s7+8v32ATW3lXl5qpjKtHWFt6UFtqOilsMgBhqNbuX4Bbb9vWFbifxIdGeiAAEAe//sBTcFzQAZABdADBMATFkTBAwHTFkMEwA/KwAYPysxMAEiBgIVFBYzMjcRBiMiABEQEiQzMhYXByYmA4mE04CJlpLAx8n+/ubQAVzifcJvdmqKBMui/sW1p6JN/vxNASsBEgEGAbnlLTz6OyYAAAIANQAABSsFtgAJABMAF0AMBhJMWQYDBRNMWQUSAD8rABg/KzEwARACBCMhASEgAAEyNhI1NCYjIwMFK8T+jfz+PQE1AYwBDgEn/NuU3HyRiHPKA43+6P5j2AW2/uL8aJgBJ76aofxIAAABADUAAAScBbYACwAuQBkGCUxZDAYBDQMGBgECAgVMWQIDAQpMWQESAD8rABg/KxESADkYL19eXSsxMCEhASEHIQMhByEDIQNm/M8BNQMyNv4AQwHdN/4jUAIABbb+/r/+/ocAAQA1AAAEmAW2AAkAHUAPBglMWQYGAgESAgVMWQIDAD8rABg/EjkvKzEwISEBIQchAyEHIQFm/s8BNQMuNv4ETwHZOP4nBbb+/of9AAEAe//sBW0FzQAdACZAFAAdTFkAAAUMDBJMWQwEBRlMWQUTAD8rABg/KxESADkYLysxMAEhAwYGIyAAERASJDMyFwcmJiMiBgIVFBYzMjcTIQLyAjOihuWA/v3+5tYBhP7awHNKlFeZ8YmRlkxeQv71AzX9Bi4hASYBEwEMAbHrY/soMKb+zbGsoRgBKwABADUAAAWkBbYACwAeQBAIA0xZTAgBCAgFCgYDAQUSAD8zPzMSOS9dKzEwISETIQMhASEDIRMhBG/+zob+KYb+zwE1ATJ5Add5ATECd/2JBbb9wwI9AAH+vv5SArIFtgANABG3CQMABUxZACMAPysAGD8xMAMiJzUWMzI2NwEhAQYGh15dWExjexwBJQEx/tE09/5SG/0UeYMFZPpx9eAAAQA1AAAFpAW2AAwAI0AQDAICAwsLBgMICAUGAwEFEgA/Mz8SOREzETMREjkRMzEwISEDBwMhASEDNwEhAQR1/q7TfW3+zwE1ATKYngGZAWn9rgJQRv32Bbb9Qs0B8f1EAAABADUAAAOcBbYABQARtwEDAANMWQASAD8rABg/MTAzASEBIQM1ATUBMv8AAgA2Bbb7Sv8AAAABADUAAAcUBbYAEwAZQAwLCBMDEAERAwoEEBIAPzMzPzMSFzkxMAEBIQEhEzY3IwEhAyMGAgMhASETA0YCJwGn/sv+6JE1NAX9x/7nPQQLNqD+7QE1AZREAXEERfpKArT3wvuTBG1Y/uL9CQW2+7sAAQA1AAAGFAW2ABAAFUAJAwsIDwkDAQgSAD8zPzMSOTkxMCEhASMHBgcDIQEhATM2EhMhBN/+qv6cBgQgIpH+7QE1AWUBVAQMNpkBEgRSINiq/VAFtvvLTAEaAs8AAAIAe//sBZgFzQANABsAF0AMCw5MWQsEBBVMWQQTAD8rABg/KzEwARACBCMgABEQEiQzMgAlIgYCFRQWMzI2EjU0JgWYxv6o4P8A/uHGAVzk/wEY/dB5ynOFeXnHcIIDqv7l/kHkAScBBgEJAb3u/uAet/7Au5OWrgE+xo6bAAIANQAABKYFtgAHABIAHUAPDABMWQwMDw4SDwdMWQ8DAD8rABg/EjkvKzEwATMyNjU0IyMFFAAhIwMhASEyFgIKOI6jw0oCQP6t/tZWbf7PATUBUvL4AwaKdLSs8f7t/fgFttUAAAIAe/6kBZgFzQAQAB4AIUAQBQcOEUxZDgQDBwcYTFkHEwA/KxEAMxg/KwAYEMYxMAEQAgcTIQMjIAAREBIkMzIAJSIGAhUUFjMyNhI1NCYFmPXU/v6Zshr/AP7hxgFc5P8BGP3QecpzhXl5x3CCA6r+xP4hYv53AUgBJwEGAQkBve7+4B63/sC7k5auAT7GjpsAAgA1AAAErAW2AAgAFgAmQBMTCQwACU1ZAAAMFQsSDAhMWQwDAD8rABg/MxI5LysREgA5MTABMzI2NTQmIyMDAyEBITIWFRQGBwEhAwISToOSX2ZKiXf+zwE1AWft7qacAQX+tM8DLXJ1UlL9ef3PBbbMxZ7jN/2TAjEAAAEAKf/sBFYFywAjACBAEAseAxYWG0xZFgQDCExZAxMAPysAGD8rERIAOTkxMAEUBCMiJxEWMzI2NTQmJicmJjU0NjYzMhcHJiMiBhUUFhcWFgOy/tj93YfBpXB+GzJjinB85ZXZtG2chFNqQnN5eAGw0fNaARJsVUorQThKY8JwgctxY+lKWko9W0tQwQABAKgAAATRBbYABwAWQAoBEgcDBANMWQQDAD8rEQAzGD8xMCEhEyETIQMhAjv+z/7+oDcD8jf+nwS0AQL+/gAAAQCN/+wFmgW2ABQAFEAJFAoDBBBMWQQTAD8rABg/MzEwAQMCACEiJjU0NxMhAwYVFDMyNjcTBZrJOf6+/v7U8w/EATHCEb17kCDCBbb8Tv72/vLjwkhCA5v8aUozspmYA5UAAAEAuAAABXEFtgANABC2DQYDBwMGEgA/PzMSOTEwATY3ASEBIQMhExYVBgcCF04gAbABPP0U/rJ/ASczBAIEASvdPgNw+koFtvyQLVhnLwAAAQC4AAAH5wW2AB4AGUAMCh4TAwQXDwUDGgQSAD8zPzMzEhc5MTABBgcBIQMhExQGBzM2NjcBIRMUBzM2NwEhASEDJzQ3A+4uRf68/q4tAR8GCAYGFloPAXEBDhUJBitYAUoBNf15/qYWAgQD+pKZ/TEFtvziNPI1QOkdAzP8l5J+gdwDHPpKAtGLWEYAAAH/iwAABXkFtgALABhADAgLBQIEBAkGAwEEEgA/Mz8zEhc5MTAhIQMBIQEDIRMBIQEEZP61rP50/qoCQO4BQJkBawFY/d8CH/3hAvwCuv36Agb9KwAAAQC6AAAFPwW2AAgAF0AKAwYAAAUBBwMFEgA/PzMSOREzMzEwAQEhAQMhEwMhAnMBdgFW/ZZ3/tF37AE4A2YCUPx5/dECLwOHAAAB/8MAAASwBbYACQAkQBIHBAUFBExZBQMCCAEBCExZARIAPysREgA5GD8rERIAOTEwISE3ASETIQcBIQOY/CsmAwn94TUDqCn88gJUyQPtAQDK/BQAAAH/2/68AzEFtgAHAA61BQIDBgEnAD8zPzMxMAEhASEHIwEzAbT+JwF9Adkt1/7d1/68BvrT+qwAAQDdAAACwQW2AAMACrMDAwISAD8/MTABEyEDAeHg/vXZBbb6SgW2AAH/d/68AssFtgAHAA61AwQDAAcnAD8zPzMxMAczASM3IQEhXNUBI9ctAdn+g/4pcQVU0/kGAAEAFAIIBCcFvgAGAA20BQAEAgMAP80yOTEwEwEzASMDARQCa5MBFd+u/m4CCAO2/EoCef2HAAH/Rv68Apr/SAADAAy0AgABAQEAL10zMTABITchAnv8yx4DNv68jAABAfwE2QOmBiEACAAKsgaAAQAvGs0xMAEjJiYnNSEWFwOmuEeHJAE3JE8E2UWpRRWUmwAAAgBa/+wEngRzABIAIAAlQBMLEQ8MDwcaR1kHEAATR1kAFg8VAD8/KwAYPysAGD8SOTkxMAUiJjU0EjYzMhYXMzczAyM3IwYnMjY2NTQmIyIGBhUUFgGWk6mQ6oxhjScIOeju5Q4EhkNFgE5NP0R7SUMU1cDGAWfFVFCP+6KRpfOG5ZFHXZDsdFhYAAACACX/7ARoBhQAFAAhACtAFgoRChEHAA0ADBUAFUdZABAHHEdZBxYAPysAGD8rABg/PxESOTkvLzEwATIWFRQCBiMiJyMHIwEhAwYHMzY2ByIGBhUUFjMyNjY1NAMtkqmI7pDCUgg65wFKAS0+KSsIToEtRHxQSkFDeksEc9i+vv6d0KOPBhT+4LZ1Ykj0gueHUGCK8XWwAAEAWv/sA/IEcwAZABdADAcNR1kHEAAUR1kAFgA/KwAYPysxMAUiJjU0EiQzMhcHJiYjIgYGFRQWMzI2NxUGAfrJ15UBDq22klw2aEJViU1bUUyCRZgU18TUAVu9SOUXIoDfgGBhLyP2TwACAFr/7AT6BhQAFgAjACdAFAsUAAcPAAceR1kHEAAXR1kAFhIVAD8/KwAYPysAGD8REjk5MTAFIiY1NBI2MzIWFzM3NjcTIQEjNyMGBjcyNjY1NCYjIgYGFRQBlpOpj+qNUnc1CAIGE0wBLf625Q4ER5shQn1MS0FEe0kU1sHEAWXHSlocblUBZvnskVdO84nkg1BgkOx0sAAAAgBa/+wEQgRzAAgAIQAuQBkDF0tZDwMBDAYDAwkQEABKWRAQCRxGWQkWAD8rABg/KxESADkYL19eXSsxMAEiBgczMjY1NAEiJjU0EiQzMhYVFAQhIwcVFBYzMjY3FQYCuFicGC2brf7z0uilARqyscb+sv7KMwJnYFeOZawDmqBzYVNf/FLizs8BVbOjjrvLFRRbaSYw41YAAAH/Jf4UA9sGHwAeACpAFgwKHBkQFUdZEAAZHEZZGQ8ABUdZABsAPysAGD8rABg/KxESADk5MTADIic1FjMyNjcTIz8CNjYzMhcHJiMiBgcHMwcjAwItaEY9Nj1cE8yjHrcSKcOwg2hQRUA5RgwM2zHc103+FBnyFVBaA8WRVFS+rzHgH1BBPuX8Dv6NAAAD/43+FASiBHMAKAA0AD4ANEAcBzpLWQcHKA4bKSY1S1kmECgCSlkoDxUuS1kVGwA/KwAYPysAGD8rABgvMzMSOS8rMTABBwcWFRQGIyInBhUUFhcXFhYVFAQhIiY1NDY3JjU0NjcmJjU0NjMyFwEGBhUUMzI2NTQmJxMiBhUUMzI2NTQEoiOuEPLQOyhUPDuJo5X+yP7e0OmJkkpZZkE++9hTU/5Wam3Cl5pBaYdNX2dLXQRcpik0QsPjChszIh4IEhV/eNPgl4RmkzAvVkdnLzF+WsfpF/ueDlZCc1pSJyoOA8iZc3eZdXUAAAEAJQAABG0GFAAZABxADhALFBQGR1kUEAwAAQsVAD8zPz8rERIAOTEwISETNjU0IyIGBwMhASEGBgczNjYzMhYVFAcD0f7TiRBsXJYrYv7TAUoBLScqQQg+mGSKlxcCjUQze+TM/jEGFLXC1E1dp5tJawAAAgAlAAACjQYUAAoADgATQAoDCUlZAwANDwwVAD8/PysxMAE0NjMyFhUUBiMiEyETIQFCX1dJTFhclxD+0+0BLQVkV1k+OlBj+xcEXgAAAv74/hQCjwYUAAsAFgAaQA4PFUlZDwAIDwAFR1kAGwA/KwAYPz8rMTADIic1FjMyNxMhAQITNDYzMhYVFAYjIlpoRj01iST9AS7+901YX1dJTFhcl/4UGfIVqgSq+yn+jQdQV1k+OlBjAAEAJQAABPAGFAAPABlADQ4GBQIECAkAAA8ECBUAPzM/PxEXOTEwASEBASEDBwMhASEDBgcHMwOYAVj+DgEd/rC3eEr+0wFKAS2UCBUcBARe/gj9mgGkSP6kBhT9SilMZgAAAQAlAAACnAYUAAMACrMCAAEVAD8/MTAhIQEhAVL+0wFKAS0GFAABACUAAAbVBHMAJgAlQBIlAwAXDSEVEhwAHEdZBgAQIg8APz8yKxEAMxg/MzMSOTkxMAEyFzM2NjMyFhUUBwMhEzY1NCMiBgcDIRM2NTQjIgYHAyETMwczNgNM2ysGRLlpiI8Xhf7TihBiXJUsYP7TiRBiXJYrYv7T7eYVBpIEc+RudqqYTGj9gwKNRDN74M7+LwKNRDN75Mz+MQRez+QAAQAlAAAEbQRzABYAHEAODgsREQZHWREQDA8BCxUAPzM/PysREgA5MTAhIRM2NTQjIgYHAyETMwczNjMyFhUUBwPR/tOJEGxcliti/tPt5hUGktGKlxcCjUQze+TM/jEEXs/kp5tJawACAFr/7ARUBHMACwAZABdADBcCR1kXEBAIR1kQFgA/KwAYPysxMAE0IyIGBhUUMzI2NiUUAgQjIiY1NBIkMzIWAyWPS3dLlkt4QwEvjf72t8PpjwEOtcTkArjFeux9uXvbgdP+urPrw9UBTbfsAAL/vP4UBGgEcwAUACEAJ0AUEA8PGwoSBwAHHEdZBxYAFUdZABAAPysAGD8rERIAOTkYPz8xMAEyFhUUAgYjIiYnIwYHAyEBMwczNhciBgYVFBYzMjY2NTQDLZKpie6PU3gzCAwfSP7TAVbmEQmKOkR/TUpBQ3pLBHPXwb/+n89KWZ+I/qwGSqq/9IfhiFBgivF1sAACAFr+FASeBHMAFgAkACdAFAsUAAgNDxAbCB5HWQgQABdHWQAWAD8rABg/KwAYPz8REjk5MTAFIiYmNTQSNjMyFhczNzMBITY2NyMGBjcyNjY1NCYjIgYGFRQWAYdYiE2Q6oxWhToIOej+qv7TLzQ6CEiOPUB/SUtBRHtJSRRftoDGAWfFS1mP+bba77leTPOM3oZQYJDsdFhYAAABACUAAAOqBHMADwAUQAkNCgUAEAoVCw8APz8/MhE5MTABMhcDJiMiBgcDIRMzBzM2A0o7JUItN3SvJWr+0+3mFQaTBHML/t4Qt6v+DARez+QAAQAX/+wDoARzACIAIEAQDB0DFRUaRlkVEAMJRlkDFgA/KwAYPysREgA5OTEwARQGIyImJzUWMzI2NTQmJyYmNTQ2MzIXByYjIgYVFBYXFhYDPfnea59FnaJQZkpeeWDdzcmiY4x2OUZAWHtuAXG8yR4j+FpBOCtENESHXKq7X9dUMysnOy0/lAAAAQBe/+wDbwVMABgAJ0ATDxFACxQOEREURlkRDwUAR1kFFgA/KwAYPysRADMRMxoYEM0xMCUyNxUGIyImNTQ3EyM/AjMHIQchAwYVFAICQWFvm5aNDHOYHcSEwjEBGzL+5nMG3yPhNX6EMj4CG5NU7O7l/eUeF0oAAQBv/+wEsgReABYAG0ANDxEKAA8RBkdZERYNFQA/PysAGD8zEjkxMAEhAwYVFDMyNjcTIQMjNyMGIyImNTQ3AQYBLYkQbFyWK2IBLe3mFQaR0oqSGARe/XNEM3vkzAHP+6LP46WcXXgAAAEAZgAABI8EXgALABC2CwYDBw8GFQA/PzMSOTEwATY3ASEBIQMhExYVAcc3JQEpAUP9pP69igEnLQcBLZlGAlL7ogRe/baFYgAAAQB9AAAGtgReAB4AGUAMABMJAwUbBBUYDwUPAD8zMz8zEhc5MTABBgcDIQMhEwcHMz4CNxMhERQHMzc2NxMhASEDNDcDWD496f68MwEZBAQHBAYQVgPnAUgKBhxJFtsBM/3u/rYGCgNcso394wRe/hGnqxQr5gQCGP3ojptQ0DIB7/uiAgibuQAAAf+cAAAEpAReAAsAGEAMCQYAAwQLBAEPCAsVAD8zPzMSFzkxMAEDIRMTIQETIQMBIQF74QFBc/QBYv4t9P66ff74/qICPQIh/rIBTv3P/dMBVv6qAAAB/3P+FASRBF4AFgAYQAsEFgkADw0SR1kNGwA/KwAYPzMvMzEwEyETFhUzNjY3ASEBAiEiJzUWMzI2NzdmASc4DgYUMCkBBAFH/Vix/s5aOUQwVH82GgRe/fp6qzOJVQIa+wL+tBPwDWBlMQAB/9EAAAPHBF4ACQAkQBIHBAUFBEZZBQ8CCAEBCEZZARUAPysREgA5GD8rERIAOTEwISE3ASE3IQcBIQLs/OUjAj/+czMC7iv9ygG3tALB6cj9UwAB//j+vANkBbYAJwAbQAwCAxMTHwwMCgMeHycAPzM/MxESOREzMzEwEzQjNzI2NxM2NjMzBwYGBwMGBxUWFhUUBwcGFRQWMxUjIiY1NDc3NsnRLXqNFj0murFUMVpRD0It51VTDyQHQzo1p60OJw8BP4zlU2EBHaqL4QJBSv7Xzx0IGnFOLEWyHBc2KOJ/eTlEuEUAAQHH/i8CogYOAAMACbIDAAAAP80xMAEzESMBx9vbBg74IQAAAf+c/rwC4QW2ACYAG0AMCgkbGxIlJgMTExInAD8RMz8zEjkRMzMxMAEgFRQHBwYVFDMHIgYHAwYGIyM1NjY3EzY2NzUmNTQ3NzY1NCYjNwEAAVQOJw/RLXqNFT4lu7EtXVgPQhmMb6gPJQZJSSkFtvg4RLlFEYvlVGH+5KqM4gNBSQEpb24OCTOmK0WzHhU2KOEAAAEAbQInBCUDfQAXAChAGQMMEhIPAB8GAQ8GHwY/Bl8GfwaPBq8GBwYAL11xMzMzfS8zMzEwASIGBzU2MzIWFxYWMzI2NxUGIyImJyYmAVY2fTZlm0BqVkBeMDN6PWeZO2RhWUwCoEI3520cJBscPTznbRcoJhIAAAL/tv6NAiUEXgADAA8AIUARAAAQAAIJAwAADQMNB1RZDQ8APysAGC8SOS9fXl0xMBMzAyEBFAYjIiY1NDYzMha28p7+rAJvb15EUWxaSVMCXvwvBURca0xGVW1KAAABAKT/7AQ7BcsAHgAqQA8MElBZCQxACgceGE9ZAh64/8C1EBNIHgEZAD/NKzIrABg/Gs0yKzEwBSM3JiY1NBI2NzczBxYXByYmIyICFRQWMzI2NxUGBwI/vDGGin3nmCG8I3ZrXDVoQoWmWlJLgkWIoxTSJMiewQFEyReeng4z5hci/uLBYGAvI/ZHCQAAAf/0AAAE2QXNABwALUAXDBcYF1FZCRgYEgAABU9ZAAcSD05ZEhgAPysAGD8rERIAORgvMysRADMxMAEyFwcmIyIGBwchByEHBgchAyE3Njc3IzczNzY2A2jDrnGNYEtgFC8BKy3+1RIqpwKPN/wfMcQwFsAtwDEp8gXNVuhET13l3FTDS/789jDYaNz3xc8AAgBzAP4EIwSqABsAJwAuQCAXExAaAgwJBQgHFRUfBw8lHyU/JV8lfyWvJc8l7yUIJQAvXTPGMhESFzkxMBM0Nyc3FzYzMhc3FwcWFRQHFwcnBiMiJwcnNyY3FBYzMjY1NCYjIga+NoGTf1tqaVt/loE1NX2Sf19lc1R9kX82z21QUW9xT05vAtNmX3+TfzU3gY+BWW5rXH2RfTMze5F9XWhNb25OUG5wAAABAFgAAAUKBbYAFgA+QCAGEhMSUlkAAwEDDxMBCQMTDwoODw5SWQcPDwwBFQYMGAA/PzMSOS8zKxEAMxgQxF9eXTIREjkrEQAzMTABASEBMwcjBzMHIwchNyM3MzcjNzMDIQJgAXMBN/4Gyyf8HPwl/C/+3S/8Jfwd/CfEwAEpA2gCTv0Vsoqy3d2yirIC6wACAcf+LwKiBg4AAwAHABG2AwQDBAcAAAA/Lzk5Ly8xMAEzESMRMxEjAcfb29vbBg780f5//NEAAAIAFP/sBAQGKQAqADUAGkAOMSsTFzEoBh0OCQEiHRYAPzM/MxIXOTEwEzQ2NyYmNTQ2MzIXByYjIhUUFhcWFRQHFhYVFAYjIic1FjMyNjU0JicmJgEGBhUUFhc2NjU0ll9rKjjqxKysUpOHkFFX8sEmNPzbzISsrWNbQl51gAFkMz5XZDE1AvhZlEQiZTmVq1jBVGorQidqxbxzI2U6oblL4GlGOSdDLjmUATUZWzY2VS4fXzBtAAACAY0E+ARGBgQACQAUAA60DQMDEwgALzMzETMxMAE0NjMyFRQGIyIlNDYzMhYVFAYjIgGNVU2FTlKHAZJUTkFET1GHBWZOUGxJV25OUDg0SVcAAwB9/+wGXAXLABYAJgA2AEdAMgAAEgEAEhAScBKAEpAS4BLwEgcSEhsGDwwBDwwfDH8MjwyfDO8M/wwHDAwjMxsEKyMTAD8zPzMSOS9dcTMROS9dcTMxMAEiBhUUFjMyNjcVBiMiJjU0NjMyFwcmATQSJDMyBBIVFAIEIyIkAjcUEgQzMiQSNTQCJCMiBAIDpG9ob2grgzuDg8Te69COjkty/H7IAV7KxwFdy8X+pM7P/qLDjaMBHaOnARqhof7lpqT+46ID8pKNhoofHL859dbh/EiuOv7pyAFeysb+n8nH/qTMzwFaxqT+5qSmARmjowEZpqX+5gACAJgC8ANtBccAEQAcABhACgoPBw4SAAsYBx8APzPE1DLEEjk5MTABIiY1NDY2MzIXMzczAyM3IwYnMjY2NTQjIgYVFAFxZ3JcmmR4PAYnmp6aCAJQMS1ONVhJZQLwjIB13nhnWv1CXGiXU51MasB3bwACAEgAWgR/BAgABgANAD1AHg0GBgMHAAAKAwMCCwQEDDAFAQUFAQ4JAgIIIAEBAQAvXTMzETMREjkvXTMzETMSOREzMxEzETMRMzEwEwEXARMHAyUBFwETBwNIAZG//umH9soB5wGSvv7piPbLAjkBz5v+sv6iZwHNEgHPm/6y/qJnAc0AAAEAbQD4BCUDPwAFAB9AFQEDDwQfBD8EAy8EnwS/BN8E7wQFBAAvXXEzxDEwJSMRITUhBCXb/SMDuPgBbNv//wApAagCagKiAgYAEAAAAAQAff/sBlwFywANABYAJgA2ADlAHwMHBw4OCgUJDwkfCQIWCgAKEAoCCQoJCiMzGwQrIxMAPzM/MxI5OS8vXREzXREzEjkvMxEzMTABFAYHEyMDIxEjESEyFgEzMjY1NCYjIwE0EiQzMgQSFRQCBCMiJAI3FBIEMzIkEjU0AiQjIgQCBNVYVsX+ikPmATStuf5MM0hSR1E1/VzIAV7KxwFdy8X+pM7P/qLDjaMBHaOnARqhof7lpqT+46IDg1Z/If6YASn+1wNqh/7uPj07O/70yAFeysb+n8nH/qTMzwFaxqT+5qSmARmjowEZpqX+5gAAAf/6BhQEMwbdAAMAGUARAg8BLwE/AW8BfwGvAe8BBwEAL10zMTABITchBAb79C0EDAYUyQAAAgCkAxkDWAXLAA8AGwAWQAsTcAwBXwwBDBkEBwA/M8RdXTIxMBM0NjYzMhYWFRQGBiMiJiY3FBYzMjY1NCYjIgakXaJbXaFcXKBeXaBdvltBQlpbQUFbBHFdoVxeoFxdoFtaoF4/W1w+P15fAAACAG0AAAQlBO4ACwAPABdACQ0MCwkBAQYEAgAvMzMzETMzLzMxMAEhNSERMxEhFSERIwE1IRUB2/6SAW7bAW/+kdv+kgO4AqLbAXH+j9v+k/7L29sAAAEAOwJKAysFywAZABVACQIYAQoQHxgBIAA/Mz8zERI5MTABITclPgI1NCYjIgcnNjYzMhYVFAYGBwchAsP9eCMBEW88HTMjVmZkSqRue5MsYI2BAVsCSqbbWz44HCooUp45PH5hRmplZl8AAAEAXAI5Ay0FyQAlACdAFwMWFg8XHxe/F88X3xcFFxcJHiMfDwkhAD8zPzMSOS9dMxI5MTABFAYHFRYVFAYjIiYnNRYzMjY1NCYjIzczMjY1NCYjIgcnNjMyFgMtZnOa1rJLjTJ9gUxiND5/IlpUYTQtVmZSjquCmQT2V3UeBCGPg5wfGcBIPTolM6A4OSgoQpZcbwABAeME2QQQBiEACAAKsgOACAAvGs0xMAE2NyEVBgYHIwHjT48BTy7YVtEE8ljXETjBPgAAAf+8/hQEvgReABoAIEAQEgwOBxcPFhsOA0dZDhYKFQA/PysAGD8/MxI5OTEwARQWMzI2NxMhAyM3IwYjIiYnIwYGAyEBIQMGAag/MFqRLWIBLe3lEgZ1lTNNFAYIG0X+0AFWAS2HEAFcPEHV1QHV+6KwxCccQpL+uQZK/XtGAAABAJP+/ASyBhQADwATtwgIDgUBAw4AAD8zLzMSOS8xMAEjESMRIxEGIyImNRASMyEEsqKmoT5U2MzX7AJc/vwGUPmwAzMS+vsBAAECAP//AIMCKQHlA30ABwARAGoCRAAB/zH+FAEGAAAAEQAbQAsQEA0NCQ4GCQkDGwA/MxEzLxI5Ejl8LzEwBRQGIyInNRYzMjU0Jic3MwcWAQaml1ZCPz5mPk9guSeN+nR+F6gXUiItCZpIMQAAAQCBAkoC3wW2AAoAELYGCQMAHgMgAD8/ETk5MTABMwMjEzY3BgcHJwIQz7r2VBgfEECDZgW2/JQBjW1iDy1RpQAAAgCiAvADKQXHAAwAFgANtBIEDQofAD8zxDIxMAEUBgYjIiY1NDYzMhYFIgYVFDMyNjU0AylhqHCGiNCtgYn+4UBXUD9UBKqA0WmWiMX0kxGzbm+remsAAAIAAABIBDcD9gAGAA0ARUAnDQYGAwcAAAoDAwQJAgIIAQEFDgsEBAwPBU8FbwWPBa8FzwXvBQcFAC9dMzMRMxESOS8zMxEzEjkRMzMRMxEzETMxMAEBJwEDNxMFAScBAzcTBDf+b78BF4f2yv4Z/m6+AReI9ssCF/4xmwFOAV5n/jMS/jGbAU4BXmf+M///AGEAAAZKBbYAJwDOAsUAAAAmAHrgAAEHANMDHf23AAmzAwISEgA/NTUA//8AYQAABpwFtgAnAHMDcf23ACYAeuAAAQcAzgLFAAAAB7IAARIAPzUA//8AhQAABocFyQAnAM4DSgAAACcA0wNa/bcBBgB0KQAACbMCAQcSAD81NQAAAv+8/nkDBAReABoAJgAmQBQAGhAaAgkDGhoPJCQeVFkkDwkPIgA/Mz8rERIAORgvX15dMTABBwYGBwYGFRQzMjY3FwYjIiY1NDY2NzY2NzcBFAYjIiY1NDYzMhYCpg4Tc3B6RYUycZFc3eCxzjluhl1GEAgBYG9eRFFtWUlTAl5OaZZMU1Y3diBE3X2vnVKFc1k+WT4hAXNca0xGVmxK////hQAABIsHcwImACQAAAEHAEIAHwFSAAizAhEFJgArNf///4UAAAUMB3MCJgAkAAABBwB1APwBUgAIswIYBSYAKzX///+FAAAE0wdzAiYAJAAAAQcAwABzAVIACLMCFgUmACs1////hQAABQYHYAImACQAAAEHAMIAhQFSAAizAhkFJgArNf///4UAAAS9B1YCJgAkAAABBwBpAHcBUgAKtAMCIwUmACs1Nf///4UAAASLBwoCJgAkAAABBgDBNVgACbMDAiUDAD81NQAAAv+FAAAHbwW2AA8AEwBIQCcKDUxZDAoBDQMKCgEGEwNMWQoTChMBBgUSCRIGEkxZBgMBDkxZARIAPysAGD8rEQAzGD8REjk5Ly8rERIAORgvX15dKzEwISETIQMhASEHIQMhByEDIQETIwEGOfzPSv5W2/64A5oEUDb+AEMB3Tf+Ik8CAP0af1D+lAFc/qQFtv7+v/7+hwFgAlj9qP//AHv+FAU3Bc0CJgAmAAAABwB5AjMAAP//ADUAAAScB3MCJgAoAAABBwBC/+QBUgAIswENBSYAKzX//wA1AAAEnAdzAiYAKAAAAQcAdQB9AVIACLMBFAUmACs1//8ANQAABJwHcwImACgAAAEHAMAAOQFSAAizARIFJgArNf//ADUAAAScB1YCJgAoAAABBwBpACkBUgAKtAIBHwUmACs1NQACACUAAAUrBbYADQAbAC1AFxoHCAdMWRcICAUKChZMWQoDBRtMWQUSAD8rABg/KxESADkYLzMrEQAzMTABEAIEIyETIzczEyEgAAEyNhI1NCYjIwMzByMDBSvE/o38/j19jTeLgwGMAQ4BJ/zblNx8kYhzS+037kcDjf7o/mPYAlT+AmT+4vxomAEnvpqh/pr+/qz//wA1AAAGFAdgAiYAMAAAAQcAwgD4AVIACLMBGgUmACs1//8Ae//sBZgHcwImADEAAAEHAEIAdwFSAAizAh0FJgArNf//AHv/7AWYB3MCJgAxAAABBwB1AQ4BUgAIswIkBSYAKzX//wB7/+wFmAdzAiYAMQAAAQcAwAC8AVIACLMCIgUmACs1//8Ae//sBZgHYAImADEAAAEHAMIAzQFSAAizAiUFJgArNf//AHv/7AWYB1YCJgAxAAABBwBpALwBUgAKtAMCLwUmACs1NQABAIEBDAQQBJoACwASQAovAF8AfwDfAAQAABkvXTEwAQE3AQEXAQEHAQEnAaz+1ZgBLQExmf7PAS2V/s/+05YC0wEtmv7VASuW/s/+0ZgBLf7VmAADAGT/qgWyBgQAFQAeACYAIEAQHCAjFg8WTVkPBAQjTFkEEwA/KwAYPysREgA5OTEwARACBCMiJwcnNyY1EBIkMzIXNxcHFiUiBgIVFBcBJhMnARYzMjYSBZjG/qjgtHxsmnlixgFc5LZ7aZd1W/3Ofs5yCAJURa4F/bM7XnzMcQOq/uX+QeRHiXOXitsBCQG97kyDdZGGWbf+vr8gRQLyK/7RUP0cJbIBPQD//wCN/+wFmgdzAiYANwAAAQcAQgBEAVIACLMBFgUmACs1//8Ajf/sBZoHcwImADcAAAEHAHUBEgFSAAizAR0FJgArNf//AI3/7AWaB3MCJgA3AAABBwDAAKQBUgAIswEbBSYAKzX//wCN/+wFmgdWAiYANwAAAQcAaQCoAVIACrQCASgFJgArNTX//wC6AAAFPwdzAiYAOwAAAQcAdQB7AVIACLMBEQUmACs1AAIANQAABHcFtgAMABQAH0ARBA1MWQkUTFkECQQJBgcDBhIAPz8SOTkvLysrMTABFAAhIwMhASEHMzIWATMyNjU0IyMEd/6r/thWPv7PATUBMjIj8vj9ZDeLp8NKAyfz/vH+2wW25dX+J4V3tAAAAf78/hQFFAYfADoALEAYJgkaAxcpAClHWQAAEhdGWRIWMDVHWTAbAD8rABg/KwAYPysREgAXOTEwATIWFRQGBwYGFRQWFxYWFRQGIyInNRYzMjY1NCYnJiY1NDY3NjY1NCYjIgYHAwYGIyInNRYzMjcTNiQDTtD2YoFJLiw5a0v31rtugIJlXjVSXkZadUJNT1VgeBn+K9CtWkY9NoUl/i8BDgYftJZynEoqNRwXNStTh1OqyD3wTkI1KEY+SHREVHpCJU45PklnePs9xrUZ8hWyBLfgzAD//wBa/+wEngYhAiYAQwAAAQYAQr8AAAizAiIRJgArNf//AFr/7ASeBiECJgBDAAABBgB1cwAACLMCKREmACs1//8AWv/sBJ4GIAImAEMAAAEGAMAA/wAIswInESYAKzX//wBa/+wEngYOAiYAQwAAAQYAwhIAAAizAioRJgArNf//AFr/7ASeBgQCJgBDAAABBgBpAAAACrQDAjQRJgArNTX//wBa/+wEngayAiYAQwAAAQYAwfUAAAq0AwIkESYAKzU1AAMAWv/sBscEcwAsADoAQwBUQDAUGAMGBAoRPiJLWQ8+AQwGPj4AGxYPGztKWRsQETRHWREQACdGWQAKCi1HWQoWBRUAPz8rEQAzKwAYPysAGD8rABg/ERI5L19eXSsREgAXOTEwBSImJwcjNyMGBiMiJjU0EjYzMhYXMzczBzY2MzIWFRQEISMHFRQWMzI2NxUGJTI2NjU0JiMiBgYVFBYBIgYHMzI2NTQEtm2NLxC8DgZHl1ySo4npjmCBMgY5vBIsmVyds/6y/ss0Am9oQqxMs/yaSHxKQkVEeEZBA3FYnBgtm60UNjxekVhN2rvIAV/LTVePWjE+p4q7yxMTYGcuKONW84jpf1Bgiul9VFwCu6BzYVNfAP//AFr+FAPyBHMCJgBFAAAABwB5AYcAAP//AFr/7ARCBiECJgBHAAABBgBCqwAACLMCIxEmACs1//8AWv/sBEIGIQImAEcAAAEGAHUtAAAIswIqESYAKzX//wBa/+wETQYhAiYARwAAAQYAwO0AAAizAigRJgArNf//AFr/7ARCBgQCJgBHAAABBgBp4AAACrQDAjURJgArNTX//wAlAAACQwYhAiYAvQAAAQcAQv6dAAAACLMBBREmACs1//8AJQAAA1AGIQImAL0AAAEHAHX/QAAAAAizAQwRJgArNf//ACQAAANNBiECJgC9AAABBwDA/u0AAAAIswEKESYAKzX//wAlAAADNwYEAiYAvQAAAQcAaf7xAAAACrQCARcRJgArNTUAAgBI/+wEhQYnAB4ALAA3QB4eABwFCAcGHR0GGg8WFiZGWRYWDwIDBgEPH0ZZDxYAPysAGD/GMhE5LysREgA5EjkRFzkxMAEmJzcWFzcXBxYSFRQCBCMiJjU0EjYzMhYXMyYnBycTMjY2NTQmIyIGBhUUFgJqIlp2hmLtTMBRQIv+9L3Y4oHolVOJLgYUYedYbkJxQU1GSXI/TgUdIi66PU6DmGpr/wCX+f6Rx9zOpQEQmD4/1WGDk/whb7pkTVtqtGtRWwD//wAlAAAErAYOAiYAUAAAAQYAwisAAAizASARJgArNf//AFr/7ARUBiECJgBRAAABBgBCpwAACLMCGxEmACs1//8AWv/sBGgGIQImAFEAAAEGAHVYAAAIswIiESYAKzX//wBa/+wEVQYhAiYAUQAAAQYAwPUAAAizAiARJgArNf//AFr/7ASABg4CJgBRAAABBgDC/wAACLMCIxEmACs1//8AWv/sBFQGBAImAFEAAAEGAGn1AAAKtAMCLREmACs1NQADAG0A3QQlBMcAAwAPABsAM0AkGZ8TARMNAAdQB2AHcAcEBwAPAR8BPwEDLwGfAb8B3wHvAQUBAC9dcTPEXTLEXTIxMBM1IRUFNDYzMhYVFAYjIiYRNDYzMhYVFAYjIiZtA7j9l0pCQklKQUFLSkJDSEpBQUsCZNvb70xLTklGUk4DBEtNUUdGUU4AAAMAK/+aBGYEkwAVAB0AJQAgQBAaIh4WDxZGWQ8QBB5GWQQWAD8rABg/KxESADk5MTABFAIEIyInByc3JjU0EiQzMhc3FwcWJSIGBhUVASYDMhI1NQEWFgRUjf72t3tmbY13SI8BDrWDYEaRVEL+QlF/RQFtI6xynv6aCzECuNP+urM1h2yUa5XVAU23OFhuaWs2fdZ+DAHFGP1QAQq5EP5ECA///wBv/+wEsgYhAiYAVwAAAQYAQqcAAAizARgRJgArNf//AG//7ASyBiECJgBXAAABBgB1fwAACLMBHxEmACs1//8Ab//sBLIGIQImAFcAAAEGAMAXAAAIswEdESYAKzX//wBv/+wEsgYEAiYAVwAAAQYAaQ4AAAq0AgEqESYAKzU1////c/4UBJEGIQImAFsAAAEGAHUOAAAIswEfESYAKzUAAv+8/hQEaAYUABUAIwAnQBQKEwcADwAOGwAWR1kAEAcdR1kHFgA/KwAYPysAGD8/ERI5OTEwATIWFRQCBiMiJyMGBwMhASEDBgczNhciBgYVFBYzMjY2NTQmAy2WpYriibJdCAwfSP7TAbMBLUIdMwiDFUd2SUNIRXhLSwRz1cPH/pS8o5+I/qwIAP7Ng5Wq9ILvf1Bggu2BWFj///9z/hQEkQYEAiYAWwAAAQYAaakAAAq0AgEqESYAKzU1AAEAJQAAAj8EXgADAAqzAg8BFQA/PzEwISETIQFS/tPtAS0EXgAAAgB7/+wHewXNABUAIQBCQCUQE0xZDBABDQMQEAEMARRMWQESDA9MWQwDChtMWQoEAxZMWQMTAD8rABg/KwAYPysAGD8rERIAORgvX15dKzEwISEGIyAAERASJDMyFyEHIQMhByEDIQUyNxMmIyIGAhUUFgZG/QhdV/8A/uHGAVzkjEUDKTX+AEQB3Tf+I1ACAPw1WEbCPmp5ynOFFAEnAQYBCQG97hf+/r/+/ocQIAOUJ7f+wLuTlgAAAwBa/+wG2wRzACMAMAA5AEtAKQ8DAA00GEtZDzQBDAY0NAANETFKWREQDSRHWQ0QBitHWQYWAB1GWQAWAD8rABg/KwAYPysAGD8rERIAORgvX15dKxESADk5MTAFIiYnBgYjIiY1NBIkMzIXNjMyFhUUBCEjBxUUFjMyNjcVBgYBIgYGFRQWMzISNTQmJSIGBzMyNjU0BK50uC4/qHu73YoBBrLRaJr1scb+sv7LMwJmYFeOZV25/WhHcEVJSW2MSgKIWJsZLZusFE1ERE3qyNgBSbSgoKOOu8sVFFtpJjDjLigDkXnofltiAQ3KYGUdnXZhU18AAQE3BNkEYAYhAA4ADrQDC4AGAQAvMxrNMjEwASMmJwYHIzU2NjchFhYXBGDGP2Npf9k/tDQBUhZoMgTZNXNYUBk5tEI2sUgAAgIUBNcECgayAAsAFwATQAkPDwkfCQIJFQMALzPMXTIxMAEUBiMiJjU0NjMyFgc0JiMiBhUUFjMyNgQKjHJuiolvbpCdNyoqNjAwKjcFx2uFf29tgIJrLTMzLS00NAAAAQE7BNcEgQYOABUAIUAQEAAFCwALAAtvFH8UAhSACQAvGsxdOTkvLxEzETMxMAEiLgIjIgYHIxIzMh4CMzI2NzMCA2IxS0A7IR8xDrE73jFNQjofIjAWrEIE2SEnITgzATUhJyAzN/7LAAEAKQG0A64CmgADAAixAAEALzMxMBM3IQcpMQNUMQG05uYAAAEAKQG0B4UCmgADAAixAAEALzMxMBM3IQcpMQcrMQG05uYAAAEAcwPBAloFtgAGAAuzAIADAwA/Gs0xMBMnNjczBgN7CGef4VtnA8EW4/zV/uAAAAEAagPBAlIFtgAGAAuzBIAGAwA/Gs4xMAEXBgcjNhMCSghnn+JZagW2FuP8zgEnAAH/mv74AYEA7gAGAAqyBIAAAC8azTEwJRcGByM2EwF5CGef4Vhq7hfj/M8BJwACAHMDwQQZBbYABgANAA+1AAeAAwoDAD8zGs0yMTABJzY3MwYDISc2NzMGAwI5CGef4mFi/SUIZ5/hW2cDwRbj/OP+7hbj/NX+4AAAAgBqA8EEEAW2AAYADgAPtQsEgA4GAwA/MxrOMjEwARcGByM2EyEXBgcjNjYTAkoIZ5/iWWoC2whnn+EXL30Fthbj/M4BJxbj/DV0AUwAAv+a/vgDQgDuAAYADgAOtAsEgA4AAC8yGs0yMTAlFwYHIzYTIRcGAyM2NhMBeQhnn+FYagLdCWSj4Rgyee4X4/zPAScX3f7+OXsBQgAAAQBoAa4CtgQpAAwAEUAJCj8EfwSfBAMEAC9dzTEwEzQ2NjMyFhUUBiMiJmhVm2l4fbeddYUCrmqwYYZ8sciGAAEASABaApgECAAGABlADAQwBQEFBQcCIAEBAQAvXTMSOS9dMzEwEwEXARMHA0gBkb/+6Yf2ygI5Ac+b/rL+omcBzQAAAQAAAEgCUAP2AAYALUAbBgADAwQCAgEBBwQPBU8FbwWPBa8FzwXvBQcFAC9dMxI5LzMREjkRMzMxMAEBJwEDNxMCUP5uvgEXiPbLAhf+MZsBTgFeZ/4zAAH97AAAAxcFtgADAAqzAwMCEgA/PzEwAQEjAQMX+8TvBD8FtvpKBbYAAAEAKf/sBN0FzQAmAEpAKAYbHBtSWQMPHB8cAgkDHBdACxYXFlJZCBcXEyAgAE9ZIAcTDk5ZExkAPysAGD8rERIAORgvMysRADMaGBDMX15dMisRADMxMAEiBgchByEGByEHIRQWMzI3EQYjIBEjNzM2NyM3MzYAMzIWFwcmJgODYZ44AVwn/pgLDgErJf7oWWeFln7M/kKYJX8JDX0nh1cBR9NknlZ9V1gE1ZWKsCJRsnh7P/7+PwH1skMwsPwBGy453zEdAAEAbQJkBCUDPwADAB1AFAAPAR8BPwEDLwGfAb8B3wHvAQUBAC9dcTMxMBM1IRVtA7gCZNvb////Jf4UBXQGHwAmAEgAAAAHAEsC5wAA////Jf4UBYMGHwAmAEgAAAAHAE4C5wAAAAIALwJKAy0FvAAKABAAIUARAQUFCQ8QHxACEBAHAyANBx4APzM/EjkvXTMzETMxMAEjByM3ITcBIQMzITc3BgYHAwh3IO4h/osfAdsBBHl3/pw6Fg08tQLhl5euAi39zedKFEzRAAP/Jf4UCC0GHwA4ADwARwBGQCdARklZQAA6FSMVEBVHWR4QAAkqNhk2Rlk7JwwDGQ8yBQAFR1ktABsAPzIrEQAzGD8XMysRADMzGD8zKxEAMxg/PysxMAMiJzUWMzI2NxMjPwI2NjMyFwcmIyIGBwchNzY2MzIXByYjIgYHBzMHIwMCISInNRYzMjcTIQMCASETIQM0NjMyFhUUBiMiLWhGPTY9XBPMox63EinDsINoUEVAOUYMDAGLEinDsINoT0VBOUUNDNsx29dN/rloRj02iCTN/nTXTQXZ/tPtAS3+YFdJTFhcmP4UGfIVUFoDxZFUVL6vMeAfUEE+VL6vMeAfUEE+5fwO/o0Z8hWqA8X8Dv6NAewEXgEGV1k+OlBjAAL/Jf4UCDsGHwA4ADwAP0AhOwA6FSMVEBVHWR4QAAkqNhk2RlkMJxkPMgUABUdZLQAbAD8yKxEAMxg/MzMrEQAzMxg/MysRADMYPz8xMAMiJzUWMzI2NxMjPwI2NjMyFwcmIyIGBwchNzY2MzIXByYjIgYHBzMHIwMCISInNRYzMjcTIQMCASEBIS1oRj02PVwTzKMetxIpw7CDaFBFQDlGDAwBixIpw7CDaE9FQTlFDQzbMdvXTf65aEY9Nogkzf50100F2f7TAUkBLf4UGfIVUFoDxZFUVL6vMeAfUEE+VL6vMeAfUEE+5fwO/o0Z8hWqA8X8Dv6NAewGFAAAAf8l/hQGkwYfADgAOEAdIxUQFUdZHhAACSo2GTZGWQwnGQ8yBQAFR1ktABsAPzIrEQAzGD8zMysRADMzGD8zKxEAMzEwAyInNRYzMjY3EyM/AjY2MzIXByYjIgYHByE3NjYzMhcHJiMiBgcHMwcjAwIhIic1FjMyNxMhAwItaEY9Nj1cE8yjHrcSKcOwg2hQRUA5RgwMAYsSKcOwg2hPRUE5RQ0M2zHb103+uWhGPTaIJM3+dNdN/hQZ8hVQWgPFkVRUvq8x4B9QQT5Uvq8x4B9QQT7l/A7+jRnyFaoDxfwO/o0AAQA1AAACngW2AAMACrMBAwASAD8/MTAzASEBNQE4ATH+yAW2+koA//8ANQAAAp4HcwImANcAAAEHAEL+9QFSAAizAQUFJgArNf//ADUAAAPLB3MCJgDXAAABBwB1/7sBUgAIswEMBSYAKzX//wA1AAADqQdzAiYA1wAAAQcAwP9JAVIACLMBCgUmACs1//8ANQAAA5cHVgImANcAAAEHAGn/UQFSAAq0AgEXBSYAKzU1AAAAAQAAANwAigAWAFcABQACABAALwBcAAABBwCcAAMAAQAAABsAGwAbABsASwBoAL4BKQGUAfwCDwIxAlECeQKkArsCzQLpAv4DOANZA5UD6wQnBGoEvQTZBS8FhAW2BeMGAwYkBkYGlQcXB0oHmAfRCAYIOAheCKUI0Aj1CSYJQQl5CagJ5woaCmMKoQroCwgLOgtiC6kL1Av5DCQMQAxUDG8MigyeDLgM/g1KDX8NzA4ZDmAO1g8QDzcPbA+dD7AQABA0EGsQtREDESwRcRGtEeISBxJMEncSrRLXEyETMxN9E7kTuRPoFC8UdxTMFRQVMBWMFbUWMRZqFq0WzBbUF00XaBefF8oYABhKGGQYpBjLGNQZABkhGU0ZlBmqGb8Z1RolGjYaRxpYGmkaexqMGtsa5xr4GwkbGhssG3YbhxuYG6kbuhvLG90cBxxdHG4cfxyQHKIcsxzqHVYdZh12HYYdlh2nHbgeRB5QHmAecB6AHpEeoh6zHsQe1h85H0kfWR9pH3kfiR+aH+AgMiBCIFIgYiBzIIMg0SDiIPUhUiHNIfEiISJWImgieiKSIqoiwSLnIw4jNSNVI3cjoyO4JBskNiRCJE4kgSURJZAmAiYWJicmOCZJJlsAAAABAAAAARmaoYzqXl8PPPUACQgAAAAAAMljSR4AAAAAyehK0Pvl/agKWAiNAAMACQACAAAAAAAABM0AwQAAAAAEFAAAAhQAAAJKABkDoADJBSsAKQRoADMG2QBzBaoARAIKAMkCtgBKArb/bQRcAKwEaABtAjn/mgKTACkCSAAZA17/pgRoAEIEaAC2BGj/zwRoAA4EaP/nBGgAGwRoAFgEaABOBGgANwRoAFYCSAAZAkj/mgRoAG0EaABtBGgAbQOsAKYG2QBcBQb/hQT2ADUE5QB7BWoANQRWADUEPwA1BYUAewWaADUCpv6+BOcANQQlADUHCgA1BgoANQXXAHsEpAA1BdcAewTfADUEPQApBD8AqAWHAI0EuAC4BycAuATZ/4sEgwC6BEr/wwKm/9sDXgDdAqb/dwQ5ABQDM/9GBG8B/ATBAFoEwwAlA90AWgTBAFoEdQBaAvz/JQRU/40E1QAlAmAAJQJg/vgEiwAlAmAAJQc9ACUE1QAlBK4AWgTD/7wEwQBaA14AJQPJABcDSABeBNUAbwQZAGYGTgB9BD//nAQn/3MDpP/RAtf/+ARoAccC1/+cBGgAbQIUAAACSv+2BGgApARo//QEaABzBGgAWARoAccD4wAUBG8BjQaoAH0DBACYBH8ASARoAG0CkwApBqgAfQQA//oDbQCkBGgAbQMIADsDCABcBG8B4wTh/7wFPQCTAkgAgwGk/zEDCACBAvIAogR/AAAHDABhBwwAYQcMAIUDrP+8BQb/hQUG/4UFBv+FBQb/hQUG/4UFBv+FByn/hQTlAHsEVgA1BFYANQRWADUEVgA1BWoAJQYKADUF1wB7BdcAewXXAHsF1wB7BdcAewRoAIEF1wBkBYcAjQWHAI0FhwCNBYcAjQSDALoEpAA1BUb+/ATBAFoEwQBaBMEAWgTBAFoEwQBaBMEAWgb6AFoD3QBaBHUAWgR1AFoEdQBaBHUAWgJgACUCYAAlAmAAJAJgACUEngBIBNUAJQSuAFoErgBaBK4AWgSuAFoErgBaBGgAbQSuACsE1QBvBNUAbwTVAG8E1QBvBCf/cwTD/7wEJ/9zAmAAJQc1AHsHDgBaBG8BNwSeAhQEbwE7A9cAKQeuACkBuABzAbgAagI5/5oDdwBzA3cAagP6/5oC4wBoApgASAKYAAABAP3sBGgAKQRoAG0FSP8lBUj/JQMIAC8IAP8lCAD/JQW0/yUCkwA1ADUANQA1ADUAAQAACI39qAAACe775f3pClgIAAGzAAAAAAAAAAAAAAAAANgAAwTDArwABQAIBZoFMwAAAR8FmgUzAAAD0QBmAgAAAAILCAYDBQQCAgTgAALvQAAgWwAAACgAAAAAMUFTQwAhACD//QYf/hQAhAiNAlggAAGfAAAAAAReBbYAAAAgAAMAAAABAAMAAQAAAAwABAC4AAAAKgAgAAQACgBIAEkAfgDLAM8A/wExAVMCxgLaAtwgFCAaIB4gIiA6IEQgdCCsIhL//wAAACAASQBKAKAAzADQATEBUgLGAtoC3CATIBggHCAiIDkgRCB0IKwiEv///+MAjv/i/8EADP+9/4z/bP36/ef95uCw4K3grOCp4JPgiuBf4CPevgABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAQEdbWllYVVRTUlFQT05NTEtKSUhHRkVEQ0JBQD8+PTw7Ojk4NzY1MTAvLi0sKCcmJSQjIiEfGBQREA8ODQsKCQgHBgUEAwIBACwgsAFgRbADJSARRmEjRSNhSC0sIEUYaEQtLEUjRmCwIGEgsEZgsAQmI0hILSxFI0YjYbAgYCCwJmGwIGGwBCYjSEgtLEUjRmCwQGEgsGZgsAQmI0hILSxFI0YjYbBAYCCwJmGwQGGwBCYjSEgtLAEQIDwAPC0sIEUjILDNRCMguAFaUVgjILCNRCNZILDtUVgjILBNRCNZILAEJlFYIyCwDUQjWSEhLSwgIEUYaEQgsAFgIEWwRnZoikVgRC0sAbELCkMjQ2UKLSwAsQoLQyNDCy0sALAoI3CxASg+AbAoI3CxAihFOrECAAgNLSwgRbADJUVhZLBQUVhFRBshIVktLEmwDiNELSwgRbAAQ2BELSwBsAZDsAdDZQotLCBpsEBhsACLILEswIqMuBAAYmArDGQjZGFcWLADYVktLIoDRYqKh7ARK7ApI0SwKXrkGC0sRWWwLCNERbArI0QtLEtSWEVEGyEhWS0sS1FYRUQbISFZLSwBsAUlECMgivUAsAFgI+3sLSwBsAUlECMgivUAsAFhI+3sLSwBsAYlEPUA7ewtLLACQ7ABUlghISEhIRtGI0ZgiopGIyBGimCKYbj/gGIjIBAjirEMDIpwRWAgsABQWLABYbj/uosbsEaMWbAQYGgBOlktLCBFsAMlRlJLsBNRW1iwAiVGIGhhsAMlsAMlPyMhOBshEVktLCBFsAMlRlBYsAIlRiBoYbADJbADJT8jITgbIRFZLSwAsAdDsAZDCy0sISEMZCNki7hAAGItLCGwgFFYDGQjZIu4IABiG7IAQC8rWbACYC0sIbDAUVgMZCNki7gVVWIbsgCALytZsAJgLSwMZCNki7hAAGJgIyEtLEtTWIqwBCVJZCNFabBAi2GwgGKwIGFqsA4jRCMQsA72GyEjihIRIDkvWS0sS1NYILADJUlkaSCwBSawBiVJZCNhsIBisCBharAOI0SwBCYQsA72ihCwDiNEsA72sA4jRLAO7RuKsAQmERIgOSMgOS8vWS0sRSNFYCNFYCNFYCN2aBiwgGIgLSywSCstLCBFsABUWLBARCBFsEBhRBshIVktLEWxMC9FI0VhYLABYGlELSxLUViwLyNwsBQjQhshIVktLEtRWCCwAyVFaVNYRBshIVkbISFZLSxFsBRDsABgY7ABYGlELSywL0VELSxFIyBFimBELSxGI0ZgiopGIyBGimCKYbj/gGIjIBAjirEMDIpwRWAgsABQWLABYbj/gIsbsIGMWWg6LSxLI1FYuQAz/+CxNCAbszMANABZREQtLLAWQ1iwAyZFilhkZrAfYBtksCBgZiBYGyGwQFmwAWFZI1hlWbApI0QjELAp4BshISEhIVktLLACQ1RYS1MjS1FaWDgbISFZGyEhISFZLSywFkNYsAQlRWSwIGBmIFgbIbBAWbABYSNYG2VZsCkjRLAFJbAIJQggWAIbA1mwBCUQsAUlIEawBCUjQjywBCWwByUIsAclELAGJSBGsAQlsAFgI0I8IFgBGwBZsAQlELAFJbAp4LApIEVlRLAHJRCwBiWwKeCwBSWwCCUIIFgCGwNZsAUlsAMlQ0iwBCWwByUIsAYlsAMlsAFgQ0gbIVkhISEhISEhLSwCsAQlICBGsAQlI0KwBSUIsAMlRUghISEhLSwCsAMlILAEJQiwAiVDSCEhIS0sRSMgRRggsABQIFgjZSNZI2ggsEBQWCGwQFkjWGVZimBELSxLUyNLUVpYIEWKYEQbISFZLSxLVFggRYpgRBshIVktLEtTI0tRWlg4GyEhWS0ssAAhS1RYOBshIVktLLACQ1RYsEYrGyEhISFZLSywAkNUWLBHKxshISFZLSywAkNUWLBIKxshISEhWS0ssAJDVFiwSSsbISEhWS0sIIoII0tTiktRWlgjOBshIVktLACwAiVJsABTWCCwQDgRGyFZLSwBRiNGYCNGYSMgECBGimG4/4BiirFAQIpwRWBoOi0sIIojSWSKI1NYPBshWS0sS1JYfRt6WS0ssBIASwFLVEItLLECAEKxIwGIUbFAAYhTWli5EAAAIIhUWLICAQJDYEJZsSQBiFFYuSAAAECIVFiyAgICQ2BCsSQBiFRYsgIgAkNgQgBLAUtSWLICCAJDYEJZG7lAAACAiFRYsgIEAkNgQlm5QAAAgGO4AQCIVFiyAggCQ2BCWblAAAEAY7gCAIhUWLICEAJDYEJZsSYBiFFYuUAAAgBjuAQAiFRYsgJAAkNgQlm5QAAEAGO4CACIVFiyAoACQ2BCWVlZWVlZsQACQ1RYQAoFQAhACUAMAg0CG7EBAkNUWLIFQAi6AQAACQEAswwBDQEbsYACQ1JYsgVACLgBgLEJQBuyBUAIugGAAAkBQFm5QAAAgIhVuUAAAgBjuAQAiFVaWLMMAA0BG7MMAA0BWVlZQkJCQkItLEUYaCNLUVgjIEUgZLBAUFh8WWiKYFlELSywABawAiWwAiUBsAEjPgCwAiM+sQECBgywCiNlQrALI0IBsAEjPwCwAiM/sQECBgywBiNlQrAHI0KwARYBLSywgLACQ1CwAbACQ1RbWCEjELAgGskbihDtWS0ssFkrLSyKEOUtQJIJIUggVSABA1UfSANVHgP/H1BMFh9PTWQfTkxkHyY0EFUlMyRVGRP/HwcE/x8GA/8fTUweH2RMAUxGDR8TMxJVBQEDVQQzA1UfAwEPAz8DrwMDBktGy0bbRgMjMyJVTyIBHDMbVRYzFVURAQ9VEDMPVa8Pzw8CMA8BAgEAVQEzAFVvAH8ArwDvAAQQAAGAFgEFAbgBkLFUUysrS7gH/1JLsAlQW7ABiLAlU7ABiLBAUVqwBoiwAFVaW1ixAQGOWYWNjQBCHUuwMlNYsCAdWUuwZFNYsBAdsRYAQllzcysrc3MrKysrcytzXnN0KysrK3QrKysrKysrKysrKysrGF4AAAAGFAAXAE4FtgAXAHUFtgXNAAAAAAAAAAAAAAAAAAAEXgAVAHsAAP/sAAAAAP/sAAAAAP/sAAD+FP/sAAAFtgAV/JT/6/5v/+f+v//pABz+vAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAgAAAAAAADlAPYBAAErANMAxwECAPYBAgD2AO0A3wCyAAABVP5WAAAAAQAAHowAAQUVGAAACgZ+AAUAJP9xAAUANgApAAUAOAApAAUAOQApAAUAOwAUAAUAQ/+uAAUARf+FAAUARv+FAAUAR/+FAAUASf/DAAUAT//DAAUAUP/DAAUAUf+FAAUAUv/DAAUAU/+FAAUAVP/DAAUAVf/DAAUAV//DAAUAgf9xAAUAgv9xAAUAg/9xAAUAhP9xAAUAhf9xAAUAhv9xAAUAmgAUAAUAnf+FAAUAnv+uAAUAn/+uAAUAoP+uAAUAof+uAAUAov+uAAUAo/+uAAUApP+FAAUApf+FAAUApv+FAAUAp/+FAAUAqP+FAAUAr/+FAAUAsP+FAAUAsf+FAAUAsv+FAAUAs/+FAAUAtf+FAAUAtv/DAAUAt//DAAUAuP/DAAUAuf/DAAUAv/+FAAoAJP9xAAoANgApAAoAOAApAAoAOQApAAoAOwAUAAoAQ/+uAAoARf+FAAoARv+FAAoAR/+FAAoASf/DAAoAT//DAAoAUP/DAAoAUf+FAAoAUv/DAAoAU/+FAAoAVP/DAAoAVf/DAAoAV//DAAoAgf9xAAoAgv9xAAoAg/9xAAoAhP9xAAoAhf9xAAoAhv9xAAoAmgAUAAoAnf+FAAoAnv+uAAoAn/+uAAoAoP+uAAoAof+uAAoAov+uAAoAo/+uAAoApP+FAAoApf+FAAoApv+FAAoAp/+FAAoAqP+FAAoAr/+FAAoAsP+FAAoAsf+FAAoAsv+FAAoAs/+FAAoAtf+FAAoAtv/DAAoAt//DAAoAuP/DAAoAuf/DAAoAv/+FAAsALAC4AA8AJv+aAA8AKv+aAA8AMf+aAA8AM/+aAA8ANv9xAA8AN//XAA8AOP+FAA8AOf+FAA8AO/+FAA8AiP+aAA8Aj/+aAA8AkP+aAA8Akf+aAA8Akv+aAA8Ak/+aAA8Alf+aAA8Alv/XAA8Al//XAA8AmP/XAA8Amf/XAA8Amv+FAA8Avv+aABAANv+uABEAJv+aABEAKv+aABEAMf+aABEAM/+aABEANv9xABEAN//XABEAOP+FABEAOf+FABEAO/+FABEAiP+aABEAj/+aABEAkP+aABEAkf+aABEAkv+aABEAk/+aABEAlf+aABEAlv/XABEAl//XABEAmP/XABEAmf/XABEAmv+FABEAvv+aACQABf9xACQACv9xACQAJv/XACQAKv/XACQALAEKACQAMf/XACQAM//XACQANv9xACQAOP+uACQAOf+uACQAO/+FACQAiP/XACQAj//XACQAkP/XACQAkf/XACQAkv/XACQAk//XACQAlf/XACQAmv+FACQAvv/XACQAxv9xACQAyf9xACUAD/+uACUAEf+uACUAJP/XACUANv/DACUAOP/sACUAOf/sACUAOv/XACUAO//sACUAPP/sACUAgf/XACUAgv/XACUAg//XACUAhP/XACUAhf/XACUAhv/XACUAmv/sACUAx/+uACUAyv+uACYAJv/XACYAKv/XACYAMf/XACYAM//XACYAiP/XACYAj//XACYAkP/XACYAkf/XACYAkv/XACYAk//XACYAlf/XACYAvv/XACcAD/+uACcAEf+uACcAJP/XACcANv/DACcAOP/sACcAOf/sACcAOv/XACcAO//sACcAPP/sACcAgf/XACcAgv/XACcAg//XACcAhP/XACcAhf/XACcAhv/XACcAmv/sACcAx/+uACcAyv+uACgALAB7ACkAD/+FACkAEf+FACkAIgApACkAJP/XACkAgf/XACkAgv/XACkAg//XACkAhP/XACkAhf/XACkAhv/XACkAx/+FACkAyv+FAC0AJv/XAC0AKv/XAC0AMf/XAC0AM//XAC0AiP/XAC0Aj//XAC0AkP/XAC0Akf/XAC0Akv/XAC0Ak//XAC0Alf/XAC0Avv/XAC4ABf9cAC4ACv9cAC4AJv/XAC4AKv/XAC4AMf/XAC4AM//XAC4ANv/XAC4AN//sAC4AOP/XAC4AOf/XAC4AO//DAC4AiP/XAC4Aj//XAC4AkP/XAC4Akf/XAC4Akv/XAC4Ak//XAC4Alf/XAC4Alv/sAC4Al//sAC4AmP/sAC4Amf/sAC4Amv/DAC4Avv/XAC4Axv9cAC4Ayf9cADEAD/+uADEAEf+uADEAJP/XADEANv/DADEAOP/sADEAOf/sADEAOv/XADEAO//sADEAPP/sADEAgf/XADEAgv/XADEAg//XADEAhP/XADEAhf/XADEAhv/XADEAmv/sADEAx/+uADEAyv+uADIAD/72ADIAEf72ADIAJP+aADIAOv/XADIAPP/sADIAgf+aADIAgv+aADIAg/+aADIAhP+aADIAhf+aADIAhv+aADIAx/72ADIAyv72ADMAD/+uADMAEf+uADMAJP/XADMANv/DADMAOP/sADMAOf/sADMAOv/XADMAO//sADMAPP/sADMAgf/XADMAgv/XADMAg//XADMAhP/XADMAhf/XADMAhv/XADMAmv/sADMAx/+uADMAyv+uADYAD/+FADYAEP+uADYAEf+FADYAIgApADYAJP9xADYAJv/XADYAKv/XADYAMf/XADYAM//XADYANgApADYAQ/9cADYARf9xADYARv9xADYAR/9xADYASf9xADYAT/+aADYAUP+aADYAUf9xADYAUv+aADYAU/9xADYAVP+aADYAVf+FADYAV/+aADYAWP/XADYAWf/XADYAWv/XADYAW//XADYAXP+uADYAgf9xADYAgv9xADYAg/9xADYAhP9xADYAhf9xADYAhv9xADYAiP/XADYAj//XADYAkP/XADYAkf/XADYAkv/XADYAk//XADYAlf/XADYAnf9xADYAnv9cADYAn/9cADYAoP9cADYAof9cADYAov9cADYAo/9cADYApP9xADYApf9xADYApv9xADYAp/9xADYAqP9xADYAr/9xADYAsP9xADYAsf9xADYAsv9xADYAs/9xADYAtf9xADYAtv+aADYAt/+aADYAuP+aADYAuf+aADYAuv/XADYAvv/XADYAv/9xADYAw/+uADYAxP+uADYAx/+FADYAyv+FADcAD//XADcAEf/XADcAJP/sADcAgf/sADcAgv/sADcAg//sADcAhP/sADcAhf/sADcAhv/sADcAx//XADcAyv/XADgAD/+aADgAEf+aADgAIgApADgAJP+uADgAJv/sADgAKv/sADgAMf/sADgAM//sADgAQ//XADgARf/XADgARv/XADgAR//XADgASf/sADgAT//sADgAUP/sADgAUf/XADgAUv/sADgAU//XADgAVP/sADgAVf/sADgAV//sADgAgf+uADgAgv+uADgAg/+uADgAhP+uADgAhf+uADgAhv+uADgAiP/sADgAj//sADgAkP/sADgAkf/sADgAkv/sADgAk//sADgAlf/sADgAnf/XADgAnv/XADgAn//XADgAoP/XADgAof/XADgAov/XADgAo//XADgApP/XADgApf/XADgApv/XADgAp//XADgAqP/XADgAr//XADgAsP/XADgAsf/XADgAsv/XADgAs//XADgAtf/XADgAtv/sADgAt//sADgAuP/sADgAuf/sADgAvv/sADgAv//XADgAx/+aADgAyv+aADkAD/+aADkAEf+aADkAIgApADkAJP+uADkAJv/sADkAKv/sADkAMf/sADkAM//sADkAQ//XADkARf/XADkARv/XADkAR//XADkASf/sADkAT//sADkAUP/sADkAUf/XADkAUv/sADkAU//XADkAVP/sADkAVf/sADkAV//sADkAgf+uADkAgv+uADkAg/+uADkAhP+uADkAhf+uADkAhv+uADkAiP/sADkAj//sADkAkP/sADkAkf/sADkAkv/sADkAk//sADkAlf/sADkAnf/XADkAnv/XADkAn//XADkAoP/XADkAof/XADkAov/XADkAo//XADkApP/XADkApf/XADkApv/XADkAp//XADkAqP/XADkAr//XADkAsP/XADkAsf/XADkAsv/XADkAs//XADkAtf/XADkAtv/sADkAt//sADkAuP/sADkAuf/sADkAvv/sADkAv//XADkAx/+aADkAyv+aADoAJv/XADoAKv/XADoAMf/XADoAM//XADoAiP/XADoAj//XADoAkP/XADoAkf/XADoAkv/XADoAk//XADoAlf/XADoAvv/XADsAD/+FADsAEf+FADsAIgApADsAJP+FADsAJv/XADsAKv/XADsAMf/XADsAM//XADsAQ/+aADsARf+aADsARv+aADsAR/+aADsASf/XADsAT//DADsAUP/DADsAUf+aADsAUv/DADsAU/+aADsAVP/DADsAVf+uADsAV//DADsAXP/XADsAgf+FADsAgv+FADsAg/+FADsAhP+FADsAhf+FADsAhv+FADsAiP/XADsAj//XADsAkP/XADsAkf/XADsAkv/XADsAk//XADsAlf/XADsAnf+aADsAnv+aADsAn/+aADsAoP+aADsAof+aADsAov+aADsAo/+aADsApP+aADsApf+aADsApv+aADsAp/+aADsAqP+aADsAr/+aADsAsP+aADsAsf+aADsAsv+aADsAs/+aADsAtf+aADsAtv/DADsAt//DADsAuP/DADsAuf/DADsAvv/XADsAv/+aADsAx/+FADsAyv+FADwAJv/sADwAKv/sADwAMf/sADwAM//sADwAiP/sADwAj//sADwAkP/sADwAkf/sADwAkv/sADwAk//sADwAlf/sADwAvv/sAD0ALAC4AEMABf/sAEMACv/sAEMAxv/sAEMAyf/sAEQABf/sAEQACv/sAEQAWP/XAEQAWf/XAEQAWv/XAEQAW//XAEQAXP/sAEQAuv/XAEQAxv/sAEQAyf/sAEUABQApAEUACgApAEUAxgApAEUAyQApAEcABf/sAEcACv/sAEcAWP/XAEcAWf/XAEcAWv/XAEcAW//XAEcAXP/sAEcAuv/XAEcAxv/sAEcAyf/sAEgABQB7AEgACgB7AEgAxgB7AEgAyQB7AEoABf/sAEoACv/sAEoAxv/sAEoAyf/sAE0ARf/XAE0ARv/XAE0AR//XAE0AUf/XAE0AU//XAE0Anf/XAE0ApP/XAE0Apf/XAE0Apv/XAE0Ap//XAE0AqP/XAE0Ar//XAE0AsP/XAE0Asf/XAE0Asv/XAE0As//XAE0Atf/XAE0Av//XAE8ABf/sAE8ACv/sAE8Axv/sAE8Ayf/sAFAABf/sAFAACv/sAFAAxv/sAFAAyf/sAFEABf/sAFEACv/sAFEAWP/XAFEAWf/XAFEAWv/XAFEAW//XAFEAXP/sAFEAuv/XAFEAxv/sAFEAyf/sAFIABf/sAFIACv/sAFIAWP/XAFIAWf/XAFIAWv/XAFIAW//XAFIAXP/sAFIAuv/XAFIAxv/sAFIAyf/sAFQABQBSAFQACgBSAFQAQ//XAFQARf/XAFQARv/XAFQAR//XAFQASf/sAFQAUf/XAFQAU//XAFQAnf/XAFQAnv/XAFQAn//XAFQAoP/XAFQAof/XAFQAov/XAFQAo//XAFQApP/XAFQApf/XAFQApv/XAFQAp//XAFQAqP/XAFQAr//XAFQAsP/XAFQAsf/XAFQAsv/XAFQAs//XAFQAtf/XAFQAv//XAFQAxgBSAFQAyQBSAFYABQApAFYACgApAFYAxgApAFYAyQApAFgABQBSAFgACgBSAFgAD/+uAFgAEf+uAFgAIgApAFgAxgBSAFgAx/+uAFgAyQBSAFgAyv+uAFkABQBSAFkACgBSAFkAD/+uAFkAEf+uAFkAIgApAFkAxgBSAFkAx/+uAFkAyQBSAFkAyv+uAFoARf/XAFoARv/XAFoAR//XAFoAUf/XAFoAU//XAFoAnf/XAFoApP/XAFoApf/XAFoApv/XAFoAp//XAFoAqP/XAFoAr//XAFoAsP/XAFoAsf/XAFoAsv/XAFoAs//XAFoAtf/XAFoAv//XAFsABQBSAFsACgBSAFsAD/+uAFsAEf+uAFsAIgApAFsAxgBSAFsAx/+uAFsAyQBSAFsAyv+uAF0ALAC4AIEABf9xAIEACv9xAIEAJv/XAIEAKv/XAIEALAEKAIEAMf/XAIEAM//XAIEANv9xAIEAOP+uAIEAOf+uAIEAO/+FAIEAiP/XAIEAj//XAIEAkP/XAIEAkf/XAIEAkv/XAIEAk//XAIEAlf/XAIEAmv+FAIEAvv/XAIEAxv9xAIEAyf9xAIIABf9xAIIACv9xAIIAJv/XAIIAKv/XAIIALAEKAIIAMf/XAIIAM//XAIIANv9xAIIAOP+uAIIAOf+uAIIAO/+FAIIAiP/XAIIAj//XAIIAkP/XAIIAkf/XAIIAkv/XAIIAk//XAIIAlf/XAIIAmv+FAIIAvv/XAIIAxv9xAIIAyf9xAIMABf9xAIMACv9xAIMAJv/XAIMAKv/XAIMALAEKAIMAMf/XAIMAM//XAIMANv9xAIMAOP+uAIMAOf+uAIMAO/+FAIMAiP/XAIMAj//XAIMAkP/XAIMAkf/XAIMAkv/XAIMAk//XAIMAlf/XAIMAmv+FAIMAvv/XAIMAxv9xAIMAyf9xAIQABf9xAIQACv9xAIQAJv/XAIQAKv/XAIQALAEKAIQAMf/XAIQAM//XAIQANv9xAIQAOP+uAIQAOf+uAIQAO/+FAIQAiP/XAIQAj//XAIQAkP/XAIQAkf/XAIQAkv/XAIQAk//XAIQAlf/XAIQAmv+FAIQAvv/XAIQAxv9xAIQAyf9xAIUABf9xAIUACv9xAIUAJv/XAIUAKv/XAIUALAEKAIUAMf/XAIUAM//XAIUANv9xAIUAOP+uAIUAOf+uAIUAO/+FAIUAiP/XAIUAj//XAIUAkP/XAIUAkf/XAIUAkv/XAIUAk//XAIUAlf/XAIUAmv+FAIUAvv/XAIUAxv9xAIUAyf9xAIYABf9xAIYACv9xAIYAJv/XAIYAKv/XAIYALAEKAIYAMf/XAIYAM//XAIYANv9xAIYAOP+uAIYAOf+uAIYAO/+FAIYAiP/XAIYAj//XAIYAkP/XAIYAkf/XAIYAkv/XAIYAk//XAIYAlf/XAIYAmv+FAIYAvv/XAIYAxv9xAIYAyf9xAIcALAB7AIgAJv/XAIgAKv/XAIgAMf/XAIgAM//XAIgAiP/XAIgAj//XAIgAkP/XAIgAkf/XAIgAkv/XAIgAk//XAIgAlf/XAIgAvv/XAIkALAB7AIoALAB7AIsALAB7AIwALAB7AI0AD/+uAI0AEf+uAI0AJP/XAI0ANv/DAI0AOP/sAI0AOf/sAI0AOv/XAI0AO//sAI0APP/sAI0Agf/XAI0Agv/XAI0Ag//XAI0AhP/XAI0Ahf/XAI0Ahv/XAI0Amv/sAI0Ax/+uAI0Ayv+uAI8AD/+uAI8AEf+uAI8AJP/XAI8ANv/DAI8AOP/sAI8AOf/sAI8AOv/XAI8AO//sAI8APP/sAI8Agf/XAI8Agv/XAI8Ag//XAI8AhP/XAI8Ahf/XAI8Ahv/XAI8Amv/sAI8Ax/+uAI8Ayv+uAJAAD/+uAJAAEf+uAJAAJP/XAJAANv/DAJAAOP/sAJAAOf/sAJAAOv/XAJAAO//sAJAAPP/sAJAAgf/XAJAAgv/XAJAAg//XAJAAhP/XAJAAhf/XAJAAhv/XAJAAmv/sAJAAx/+uAJAAyv+uAJEAD/+uAJEAEf+uAJEAJP/XAJEANv/DAJEAOP/sAJEAOf/sAJEAOv/XAJEAO//sAJEAPP/sAJEAgf/XAJEAgv/XAJEAg//XAJEAhP/XAJEAhf/XAJEAhv/XAJEAmv/sAJEAx/+uAJEAyv+uAJIAD/+uAJIAEf+uAJIAJP/XAJIANv/DAJIAOP/sAJIAOf/sAJIAOv/XAJIAO//sAJIAPP/sAJIAgf/XAJIAgv/XAJIAg//XAJIAhP/XAJIAhf/XAJIAhv/XAJIAmv/sAJIAx/+uAJIAyv+uAJMAD/+uAJMAEf+uAJMAJP/XAJMANv/DAJMAOP/sAJMAOf/sAJMAOv/XAJMAO//sAJMAPP/sAJMAgf/XAJMAgv/XAJMAg//XAJMAhP/XAJMAhf/XAJMAhv/XAJMAmv/sAJMAx/+uAJMAyv+uAJUAD/+uAJUAEf+uAJUAJP/XAJUANv/DAJUAOP/sAJUAOf/sAJUAOv/XAJUAO//sAJUAPP/sAJUAgf/XAJUAgv/XAJUAg//XAJUAhP/XAJUAhf/XAJUAhv/XAJUAmv/sAJUAx/+uAJUAyv+uAJYAD//XAJYAEf/XAJYAJP/sAJYAgf/sAJYAgv/sAJYAg//sAJYAhP/sAJYAhf/sAJYAhv/sAJYAx//XAJYAyv/XAJcAD//XAJcAEf/XAJcAJP/sAJcAgf/sAJcAgv/sAJcAg//sAJcAhP/sAJcAhf/sAJcAhv/sAJcAx//XAJcAyv/XAJgAD//XAJgAEf/XAJgAJP/sAJgAgf/sAJgAgv/sAJgAg//sAJgAhP/sAJgAhf/sAJgAhv/sAJgAx//XAJgAyv/XAJkAD//XAJkAEf/XAJkAJP/sAJkAgf/sAJkAgv/sAJkAg//sAJkAhP/sAJkAhf/sAJkAhv/sAJkAx//XAJkAyv/XAJoAD/+FAJoAEf+FAJoAIgApAJoAJP+FAJoAJv/XAJoAKv/XAJoAMf/XAJoAM//XAJoAQ/+aAJoARf+aAJoARv+aAJoAR/+aAJoASf/XAJoAT//DAJoAUP/DAJoAUf+aAJoAUv/DAJoAU/+aAJoAVP/DAJoAVf+uAJoAV//DAJoAXP/XAJoAgf+FAJoAgv+FAJoAg/+FAJoAhP+FAJoAhf+FAJoAhv+FAJoAiP/XAJoAj//XAJoAkP/XAJoAkf/XAJoAkv/XAJoAk//XAJoAlf/XAJoAnf+aAJoAnv+aAJoAn/+aAJoAoP+aAJoAof+aAJoAov+aAJoAo/+aAJoApP+aAJoApf+aAJoApv+aAJoAp/+aAJoAqP+aAJoAr/+aAJoAsP+aAJoAsf+aAJoAsv+aAJoAs/+aAJoAtf+aAJoAtv/DAJoAt//DAJoAuP/DAJoAuf/DAJoAvv/XAJoAv/+aAJoAx/+FAJoAyv+FAJsAD/72AJsAEf72AJsAJP+aAJsAOv/XAJsAPP/sAJsAgf+aAJsAgv+aAJsAg/+aAJsAhP+aAJsAhf+aAJsAhv+aAJsAx/72AJsAyv72AJ0ABf/sAJ0ACv/sAJ0Axv/sAJ0Ayf/sAJ4ABf/sAJ4ACv/sAJ4Axv/sAJ4Ayf/sAJ8ABf/sAJ8ACv/sAJ8Axv/sAJ8Ayf/sAKAABf/sAKAACv/sAKAAxv/sAKAAyf/sAKEABf/sAKEACv/sAKEAxv/sAKEAyf/sAKIABf/sAKIACv/sAKIAxv/sAKIAyf/sAKUABf/sAKUACv/sAKUAWP/XAKUAWf/XAKUAWv/XAKUAW//XAKUAXP/sAKUAuv/XAKUAxv/sAKUAyf/sAKYABf/sAKYACv/sAKYAWP/XAKYAWf/XAKYAWv/XAKYAW//XAKYAXP/sAKYAuv/XAKYAxv/sAKYAyf/sAKcABf/sAKcACv/sAKcAWP/XAKcAWf/XAKcAWv/XAKcAW//XAKcAXP/sAKcAuv/XAKcAxv/sAKcAyf/sAKgABf/sAKgACv/sAKgAWP/XAKgAWf/XAKgAWv/XAKgAW//XAKgAXP/sAKgAuv/XAKgAxv/sAKgAyf/sAK0ABf/sAK0ACv/sAK0AWP/XAK0AWf/XAK0AWv/XAK0AW//XAK0AXP/sAK0Auv/XAK0Axv/sAK0Ayf/sAK8ABf/sAK8ACv/sAK8AWP/XAK8AWf/XAK8AWv/XAK8AW//XAK8AXP/sAK8Auv/XAK8Axv/sAK8Ayf/sALAABf/sALAACv/sALAAWP/XALAAWf/XALAAWv/XALAAW//XALAAXP/sALAAuv/XALAAxv/sALAAyf/sALEABf/sALEACv/sALEAWP/XALEAWf/XALEAWv/XALEAW//XALEAXP/sALEAuv/XALEAxv/sALEAyf/sALMABf/XALMACv/XALMAxv/XALMAyf/XALUABf/sALUACv/sALUAWP/XALUAWf/XALUAWv/XALUAW//XALUAXP/sALUAuv/XALUAxv/sALUAyf/sALoABQBSALoACgBSALoAD/+uALoAEf+uALoAIgApALoAxgBSALoAx/+uALoAyQBSALoAyv+uALsABf/sALsACv/sALsAWP/XALsAWf/XALsAWv/XALsAW//XALsAXP/sALsAuv/XALsAxv/sALsAyf/sALwABQBSALwACgBSALwAD/+uALwAEf+uALwAIgApALwAxgBSALwAx/+uALwAyQBSALwAyv+uAL4ALAB7AAAABwBaAAMAAQQJAAEAEgAAAAMAAQQJAAIAFgASAAMAAQQJAAMAVAAoAAMAAQQJAAQAKgB8AAMAAQQJAAUAGACmAAMAAQQJAAYAJgC+AAMAAQQJAA4AVADkAE8AcABlAG4AIABTAGEAbgBzAEIAbwBsAGQAIABJAHQAYQBsAGkAYwBBAHMAYwBlAG4AZABlAHIAIAAtACAATwBwAGUAbgAgAFMAYQBuAHMAIABCAG8AbABkACAASQB0AGEAbABpAGMAIABCAHUAaQBsAGQAIAAxADAAMABPAHAAZQBuACAAUwBhAG4AcwAgAEIAbwBsAGQAIABJAHQAYQBsAGkAYwBWAGUAcgBzAGkAbwBuACAAMQAuADEAMABPAHAAZQBuAFMAYQBuAHMALQBCAG8AbABkAEkAdABhAGwAaQBjAGgAdAB0AHAAOgAvAC8AdwB3AHcALgBhAHAAYQBjAGgAZQAuAG8AcgBnAC8AbABpAGMAZQBuAHMAZQBzAC8ATABJAEMARQBOAFMARQAtADIALgAwAAAAAgAA//QAAP9mAGYAAAAAAAAAAAAAAAAAAAAAAAAAAADcAAABAgACAAMABAAFAAYABwAIAAkACgALAAwADQAOAA8AEAARABIAEwAUABUAFgAXABgAGQAaABsAHAAdAB4AHwAgACEAIgAjACQAJQAmACcAKAApACoAKwAtAC4ALwAwADEAMgAzADQANQA2ADcAOAA5ADoAOwA8AD0APgA/AEAAQQBCAEMARABFAEYARwBIAEkASgBLAEwATQBOAE8AUABRAFIAUwBUAFUAVgBXAFgAWQBaAFsAXABdAF4AXwBgAGEArACjAIQAhQC9AJYA6ACGAI4AiwCdAKkApAEDAIoBBACDAJMA8gDzAI0AlwCIAMMA3gDxAJ4AqgD1APQA9gCiAK0AyQDHAK4AYgBjAJAAZADLAGUAyADKAOkAZgDTANAA0QCvAGcA8ACRANYA1ADVAGgA6wDtAIkAagBpAGsAbQBsAG4AoABvAHEAcAByAHMAdQB0AHYAdwDqAHgAegB5AHsAfQB8ALgAoQB/AH4AgACBAOwA7gC6ANcAsACxANgA3QDZALIAswC2ALcAxAC0ALUAxQCHAL4AvwC8AQUA7wEGAQcBCAEJAQoBCwAsAM8AzADNAM4EbnVsbAd1bmkwMEFECW92ZXJzY29yZQRFdXJvB3VuaUZCMDEHdW5pRkIwMgxmb3Vyc3VwZXJpb3IHdW5pRkIwMwd1bmlGQjA0AmZmAAAAAQACAAgACv//AA8AAQAAAAwAAAAAAAAAAgABAAAA2wABAAAAAQAAAAoACgAKAAAAAQAAAAoAHgAsAAFsYXRuAAgABAAAAAD//wABAAAAAWxpZ2EACAAAAAEAAAABAAQABAAAAAEACAABADYAAQAIAAUADAAUABwAIgAoANUAAwBIAE4A1AADAEgASwDWAAIASADSAAIATgDRAAIASwABAAEASA==) format('truetype');
}
html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}article,aside,details,figcaption,figure,footer,header,hgroup,main,menu,nav,section,summary{display:block}audio,canvas,progress,video{display:inline-block;vertical-align:baseline}audio:not([controls]){display:none;height:0}[hidden],template{display:none}a{background-color:transparent}a:active,a:hover{outline:0}abbr[title]{border-bottom:1px dotted}b,strong{font-weight:bold}dfn{font-style:italic}h1{font-size:2em;margin:0.67em 0}mark{background:#ff0;color:#000}small{font-size:80%}sub,sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sup{top:-0.5em}sub{bottom:-0.25em}img{border:0}svg:not(:root){overflow:hidden}figure{margin:1em 40px}hr{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;height:0}pre{overflow:auto}code,kbd,pre,samp{font-family:monospace, monospace;font-size:1em}button,input,optgroup,select,textarea{color:inherit;font:inherit;margin:0}button{overflow:visible}button,select{text-transform:none}button,html input[type="button"],input[type="reset"],input[type="submit"]{-webkit-appearance:button;cursor:pointer}button[disabled],html input[disabled]{cursor:default}button::-moz-focus-inner,input::-moz-focus-inner{border:0;padding:0}input{line-height:normal}input[type="checkbox"],input[type="radio"]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;padding:0}input[type="number"]::-webkit-inner-spin-button,input[type="number"]::-webkit-outer-spin-button{height:auto}input[type="search"]{-webkit-appearance:textfield;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}input[type="search"]::-webkit-search-cancel-button,input[type="search"]::-webkit-search-decoration{-webkit-appearance:none}fieldset{border:1px solid #c0c0c0;margin:0 2px;padding:0.35em 0.625em 0.75em}legend{border:0;padding:0}textarea{overflow:auto}optgroup{font-weight:bold}table{border-collapse:collapse;border-spacing:0}td,th{padding:0}@media print{*,*:before,*:after{background:transparent !important;color:#000 !important;-webkit-box-shadow:none !important;box-shadow:none !important;text-shadow:none !important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}abbr[title]:after{content:" (" attr(title) ")"}a[href^="#"]:after,a[href^="javascript:"]:after{content:""}pre,blockquote{border:1px solid #999;page-break-inside:avoid}thead{display:table-header-group}tr,img{page-break-inside:avoid}img{max-width:100% !important}p,h2,h3{orphans:3;widows:3}h2,h3{page-break-after:avoid}.navbar{display:none}.btn>.caret,.dropup>.btn>.caret{border-top-color:#000 !important}.label{border:1px solid #000}.table{border-collapse:collapse !important}.table td,.table th{background-color:#fff !important}.table-bordered th,.table-bordered td{border:1px solid #ddd !important}}@font-face{font-family:'Glyphicons Halflings';src:url(data:application/vnd.ms-fontobject;base64,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);src:url(data:application/vnd.ms-fontobject;base64,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) format('embedded-opentype'),url(data:application/font-woff;base64,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) format('woff'),url(data:application/x-font-truetype;base64,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) format('truetype'),url(data:image/svg+xml;base64,<?xml version="1.0" standalone="no"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd" >
<svg xmlns="http://www.w3.org/2000/svg">
<metadata></metadata>
<defs>
<font id="glyphicons_halflingsregular" horiz-adv-x="1200" >
<font-face units-per-em="1200" ascent="960" descent="-240" />
<missing-glyph horiz-adv-x="500" />
<glyph horiz-adv-x="0" />
<glyph horiz-adv-x="400" />
<glyph unicode=" " />
<glyph unicode="*" d="M600 1100q15 0 34 -1.5t30 -3.5l11 -1q10 -2 17.5 -10.5t7.5 -18.5v-224l158 158q7 7 18 8t19 -6l106 -106q7 -8 6 -19t-8 -18l-158 -158h224q10 0 18.5 -7.5t10.5 -17.5q6 -41 6 -75q0 -15 -1.5 -34t-3.5 -30l-1 -11q-2 -10 -10.5 -17.5t-18.5 -7.5h-224l158 -158 q7 -7 8 -18t-6 -19l-106 -106q-8 -7 -19 -6t-18 8l-158 158v-224q0 -10 -7.5 -18.5t-17.5 -10.5q-41 -6 -75 -6q-15 0 -34 1.5t-30 3.5l-11 1q-10 2 -17.5 10.5t-7.5 18.5v224l-158 -158q-7 -7 -18 -8t-19 6l-106 106q-7 8 -6 19t8 18l158 158h-224q-10 0 -18.5 7.5 t-10.5 17.5q-6 41 -6 75q0 15 1.5 34t3.5 30l1 11q2 10 10.5 17.5t18.5 7.5h224l-158 158q-7 7 -8 18t6 19l106 106q8 7 19 6t18 -8l158 -158v224q0 10 7.5 18.5t17.5 10.5q41 6 75 6z" />
<glyph unicode="+" d="M450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-350h350q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-350v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v350h-350q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5 h350v350q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xa0;" />
<glyph unicode="&#xa5;" d="M825 1100h250q10 0 12.5 -5t-5.5 -13l-364 -364q-6 -6 -11 -18h268q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-100h275q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-174q0 -11 -7.5 -18.5t-18.5 -7.5h-148q-11 0 -18.5 7.5t-7.5 18.5v174 h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h125v100h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h118q-5 12 -11 18l-364 364q-8 8 -5.5 13t12.5 5h250q25 0 43 -18l164 -164q8 -8 18 -8t18 8l164 164q18 18 43 18z" />
<glyph unicode="&#x2000;" horiz-adv-x="650" />
<glyph unicode="&#x2001;" horiz-adv-x="1300" />
<glyph unicode="&#x2002;" horiz-adv-x="650" />
<glyph unicode="&#x2003;" horiz-adv-x="1300" />
<glyph unicode="&#x2004;" horiz-adv-x="433" />
<glyph unicode="&#x2005;" horiz-adv-x="325" />
<glyph unicode="&#x2006;" horiz-adv-x="216" />
<glyph unicode="&#x2007;" horiz-adv-x="216" />
<glyph unicode="&#x2008;" horiz-adv-x="162" />
<glyph unicode="&#x2009;" horiz-adv-x="260" />
<glyph unicode="&#x200a;" horiz-adv-x="72" />
<glyph unicode="&#x202f;" horiz-adv-x="260" />
<glyph unicode="&#x205f;" horiz-adv-x="325" />
<glyph unicode="&#x20ac;" d="M744 1198q242 0 354 -189q60 -104 66 -209h-181q0 45 -17.5 82.5t-43.5 61.5t-58 40.5t-60.5 24t-51.5 7.5q-19 0 -40.5 -5.5t-49.5 -20.5t-53 -38t-49 -62.5t-39 -89.5h379l-100 -100h-300q-6 -50 -6 -100h406l-100 -100h-300q9 -74 33 -132t52.5 -91t61.5 -54.5t59 -29 t47 -7.5q22 0 50.5 7.5t60.5 24.5t58 41t43.5 61t17.5 80h174q-30 -171 -128 -278q-107 -117 -274 -117q-206 0 -324 158q-36 48 -69 133t-45 204h-217l100 100h112q1 47 6 100h-218l100 100h134q20 87 51 153.5t62 103.5q117 141 297 141z" />
<glyph unicode="&#x20bd;" d="M428 1200h350q67 0 120 -13t86 -31t57 -49.5t35 -56.5t17 -64.5t6.5 -60.5t0.5 -57v-16.5v-16.5q0 -36 -0.5 -57t-6.5 -61t-17 -65t-35 -57t-57 -50.5t-86 -31.5t-120 -13h-178l-2 -100h288q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-138v-175q0 -11 -5.5 -18 t-15.5 -7h-149q-10 0 -17.5 7.5t-7.5 17.5v175h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v100h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v475q0 10 7.5 17.5t17.5 7.5zM600 1000v-300h203q64 0 86.5 33t22.5 119q0 84 -22.5 116t-86.5 32h-203z" />
<glyph unicode="&#x2212;" d="M250 700h800q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#x231b;" d="M1000 1200v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-50v-100q0 -91 -49.5 -165.5t-130.5 -109.5q81 -35 130.5 -109.5t49.5 -165.5v-150h50q21 0 35.5 -14.5t14.5 -35.5v-150h-800v150q0 21 14.5 35.5t35.5 14.5h50v150q0 91 49.5 165.5t130.5 109.5q-81 35 -130.5 109.5 t-49.5 165.5v100h-50q-21 0 -35.5 14.5t-14.5 35.5v150h800zM400 1000v-100q0 -60 32.5 -109.5t87.5 -73.5q28 -12 44 -37t16 -55t-16 -55t-44 -37q-55 -24 -87.5 -73.5t-32.5 -109.5v-150h400v150q0 60 -32.5 109.5t-87.5 73.5q-28 12 -44 37t-16 55t16 55t44 37 q55 24 87.5 73.5t32.5 109.5v100h-400z" />
<glyph unicode="&#x25fc;" horiz-adv-x="500" d="M0 0z" />
<glyph unicode="&#x2601;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -206.5q0 -121 -85 -207.5t-205 -86.5h-750q-79 0 -135.5 57t-56.5 137q0 69 42.5 122.5t108.5 67.5q-2 12 -2 37q0 153 108 260.5t260 107.5z" />
<glyph unicode="&#x26fa;" d="M774 1193.5q16 -9.5 20.5 -27t-5.5 -33.5l-136 -187l467 -746h30q20 0 35 -18.5t15 -39.5v-42h-1200v42q0 21 15 39.5t35 18.5h30l468 746l-135 183q-10 16 -5.5 34t20.5 28t34 5.5t28 -20.5l111 -148l112 150q9 16 27 20.5t34 -5zM600 200h377l-182 112l-195 534v-646z " />
<glyph unicode="&#x2709;" d="M25 1100h1150q10 0 12.5 -5t-5.5 -13l-564 -567q-8 -8 -18 -8t-18 8l-564 567q-8 8 -5.5 13t12.5 5zM18 882l264 -264q8 -8 8 -18t-8 -18l-264 -264q-8 -8 -13 -5.5t-5 12.5v550q0 10 5 12.5t13 -5.5zM918 618l264 264q8 8 13 5.5t5 -12.5v-550q0 -10 -5 -12.5t-13 5.5 l-264 264q-8 8 -8 18t8 18zM818 482l364 -364q8 -8 5.5 -13t-12.5 -5h-1150q-10 0 -12.5 5t5.5 13l364 364q8 8 18 8t18 -8l164 -164q8 -8 18 -8t18 8l164 164q8 8 18 8t18 -8z" />
<glyph unicode="&#x270f;" d="M1011 1210q19 0 33 -13l153 -153q13 -14 13 -33t-13 -33l-99 -92l-214 214l95 96q13 14 32 14zM1013 800l-615 -614l-214 214l614 614zM317 96l-333 -112l110 335z" />
<glyph unicode="&#xe001;" d="M700 650v-550h250q21 0 35.5 -14.5t14.5 -35.5v-50h-800v50q0 21 14.5 35.5t35.5 14.5h250v550l-500 550h1200z" />
<glyph unicode="&#xe002;" d="M368 1017l645 163q39 15 63 0t24 -49v-831q0 -55 -41.5 -95.5t-111.5 -63.5q-79 -25 -147 -4.5t-86 75t25.5 111.5t122.5 82q72 24 138 8v521l-600 -155v-606q0 -42 -44 -90t-109 -69q-79 -26 -147 -5.5t-86 75.5t25.5 111.5t122.5 82.5q72 24 138 7v639q0 38 14.5 59 t53.5 34z" />
<glyph unicode="&#xe003;" d="M500 1191q100 0 191 -39t156.5 -104.5t104.5 -156.5t39 -191l-1 -2l1 -5q0 -141 -78 -262l275 -274q23 -26 22.5 -44.5t-22.5 -42.5l-59 -58q-26 -20 -46.5 -20t-39.5 20l-275 274q-119 -77 -261 -77l-5 1l-2 -1q-100 0 -191 39t-156.5 104.5t-104.5 156.5t-39 191 t39 191t104.5 156.5t156.5 104.5t191 39zM500 1022q-88 0 -162 -43t-117 -117t-43 -162t43 -162t117 -117t162 -43t162 43t117 117t43 162t-43 162t-117 117t-162 43z" />
<glyph unicode="&#xe005;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104z" />
<glyph unicode="&#xe006;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429z" />
<glyph unicode="&#xe007;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429zM477 700h-240l197 -142l-74 -226 l193 139l195 -140l-74 229l192 140h-234l-78 211z" />
<glyph unicode="&#xe008;" d="M600 1200q124 0 212 -88t88 -212v-250q0 -46 -31 -98t-69 -52v-75q0 -10 6 -21.5t15 -17.5l358 -230q9 -5 15 -16.5t6 -21.5v-93q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v93q0 10 6 21.5t15 16.5l358 230q9 6 15 17.5t6 21.5v75q-38 0 -69 52 t-31 98v250q0 124 88 212t212 88z" />
<glyph unicode="&#xe009;" d="M25 1100h1150q10 0 17.5 -7.5t7.5 -17.5v-1050q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v1050q0 10 7.5 17.5t17.5 7.5zM100 1000v-100h100v100h-100zM875 1000h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5t17.5 -7.5h550 q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM1000 1000v-100h100v100h-100zM100 800v-100h100v100h-100zM1000 800v-100h100v100h-100zM100 600v-100h100v100h-100zM1000 600v-100h100v100h-100zM875 500h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5 t17.5 -7.5h550q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM100 400v-100h100v100h-100zM1000 400v-100h100v100h-100zM100 200v-100h100v100h-100zM1000 200v-100h100v100h-100z" />
<glyph unicode="&#xe010;" d="M50 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM50 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe011;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM850 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 700h200q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h200 q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5 t35.5 14.5z" />
<glyph unicode="&#xe012;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h700q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe013;" d="M465 477l571 571q8 8 18 8t17 -8l177 -177q8 -7 8 -17t-8 -18l-783 -784q-7 -8 -17.5 -8t-17.5 8l-384 384q-8 8 -8 18t8 17l177 177q7 8 17 8t18 -8l171 -171q7 -7 18 -7t18 7z" />
<glyph unicode="&#xe014;" d="M904 1083l178 -179q8 -8 8 -18.5t-8 -17.5l-267 -268l267 -268q8 -7 8 -17.5t-8 -18.5l-178 -178q-8 -8 -18.5 -8t-17.5 8l-268 267l-268 -267q-7 -8 -17.5 -8t-18.5 8l-178 178q-8 8 -8 18.5t8 17.5l267 268l-267 268q-8 7 -8 17.5t8 18.5l178 178q8 8 18.5 8t17.5 -8 l268 -267l268 268q7 7 17.5 7t18.5 -7z" />
<glyph unicode="&#xe015;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM425 900h150q10 0 17.5 -7.5t7.5 -17.5v-75h75q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5 t-17.5 -7.5h-75v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-75q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v75q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe016;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM325 800h350q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-350q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe017;" d="M550 1200h100q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM800 975v166q167 -62 272 -209.5t105 -331.5q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5 t-184.5 123t-123 184.5t-45.5 224q0 184 105 331.5t272 209.5v-166q-103 -55 -165 -155t-62 -220q0 -116 57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5q0 120 -62 220t-165 155z" />
<glyph unicode="&#xe018;" d="M1025 1200h150q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM725 800h150q10 0 17.5 -7.5t7.5 -17.5v-750q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v750 q0 10 7.5 17.5t17.5 7.5zM425 500h150q10 0 17.5 -7.5t7.5 -17.5v-450q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v450q0 10 7.5 17.5t17.5 7.5zM125 300h150q10 0 17.5 -7.5t7.5 -17.5v-250q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5 v250q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe019;" d="M600 1174q33 0 74 -5l38 -152l5 -1q49 -14 94 -39l5 -2l134 80q61 -48 104 -105l-80 -134l3 -5q25 -44 39 -93l1 -6l152 -38q5 -43 5 -73q0 -34 -5 -74l-152 -38l-1 -6q-15 -49 -39 -93l-3 -5l80 -134q-48 -61 -104 -105l-134 81l-5 -3q-44 -25 -94 -39l-5 -2l-38 -151 q-43 -5 -74 -5q-33 0 -74 5l-38 151l-5 2q-49 14 -94 39l-5 3l-134 -81q-60 48 -104 105l80 134l-3 5q-25 45 -38 93l-2 6l-151 38q-6 42 -6 74q0 33 6 73l151 38l2 6q13 48 38 93l3 5l-80 134q47 61 105 105l133 -80l5 2q45 25 94 39l5 1l38 152q43 5 74 5zM600 815 q-89 0 -152 -63t-63 -151.5t63 -151.5t152 -63t152 63t63 151.5t-63 151.5t-152 63z" />
<glyph unicode="&#xe020;" d="M500 1300h300q41 0 70.5 -29.5t29.5 -70.5v-100h275q10 0 17.5 -7.5t7.5 -17.5v-75h-1100v75q0 10 7.5 17.5t17.5 7.5h275v100q0 41 29.5 70.5t70.5 29.5zM500 1200v-100h300v100h-300zM1100 900v-800q0 -41 -29.5 -70.5t-70.5 -29.5h-700q-41 0 -70.5 29.5t-29.5 70.5 v800h900zM300 800v-700h100v700h-100zM500 800v-700h100v700h-100zM700 800v-700h100v700h-100zM900 800v-700h100v700h-100z" />
<glyph unicode="&#xe021;" d="M18 618l620 608q8 7 18.5 7t17.5 -7l608 -608q8 -8 5.5 -13t-12.5 -5h-175v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v375h-300v-375q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v575h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe022;" d="M600 1200v-400q0 -41 29.5 -70.5t70.5 -29.5h300v-650q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5h450zM1000 800h-250q-21 0 -35.5 14.5t-14.5 35.5v250z" />
<glyph unicode="&#xe023;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h50q10 0 17.5 -7.5t7.5 -17.5v-275h175q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe024;" d="M1300 0h-538l-41 400h-242l-41 -400h-538l431 1200h209l-21 -300h162l-20 300h208zM515 800l-27 -300h224l-27 300h-170z" />
<glyph unicode="&#xe025;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-450h191q20 0 25.5 -11.5t-7.5 -27.5l-327 -400q-13 -16 -32 -16t-32 16l-327 400q-13 16 -7.5 27.5t25.5 11.5h191v450q0 21 14.5 35.5t35.5 14.5zM1125 400h50q10 0 17.5 -7.5t7.5 -17.5v-350q0 -10 -7.5 -17.5t-17.5 -7.5 h-1050q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h50q10 0 17.5 -7.5t7.5 -17.5v-175h900v175q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe026;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -275q-13 -16 -32 -16t-32 16l-223 275q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z " />
<glyph unicode="&#xe027;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM632 914l223 -275q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5l223 275q13 16 32 16 t32 -16z" />
<glyph unicode="&#xe028;" d="M225 1200h750q10 0 19.5 -7t12.5 -17l186 -652q7 -24 7 -49v-425q0 -12 -4 -27t-9 -17q-12 -6 -37 -6h-1100q-12 0 -27 4t-17 8q-6 13 -6 38l1 425q0 25 7 49l185 652q3 10 12.5 17t19.5 7zM878 1000h-556q-10 0 -19 -7t-11 -18l-87 -450q-2 -11 4 -18t16 -7h150 q10 0 19.5 -7t11.5 -17l38 -152q2 -10 11.5 -17t19.5 -7h250q10 0 19.5 7t11.5 17l38 152q2 10 11.5 17t19.5 7h150q10 0 16 7t4 18l-87 450q-2 11 -11 18t-19 7z" />
<glyph unicode="&#xe029;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM540 820l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe030;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-362q0 -10 -7.5 -17.5t-17.5 -7.5h-362q-11 0 -13 5.5t5 12.5l133 133q-109 76 -238 76q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5h150q0 -117 -45.5 -224 t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117z" />
<glyph unicode="&#xe031;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-361q0 -11 -7.5 -18.5t-18.5 -7.5h-361q-11 0 -13 5.5t5 12.5l134 134q-110 75 -239 75q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5h-150q0 117 45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117zM1027 600h150 q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5q-192 0 -348 118l-134 -134q-7 -8 -12.5 -5.5t-5.5 12.5v360q0 11 7.5 18.5t18.5 7.5h360q10 0 12.5 -5.5t-5.5 -12.5l-133 -133q110 -76 240 -76q116 0 214.5 57t155.5 155.5t57 214.5z" />
<glyph unicode="&#xe032;" d="M125 1200h1050q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-1050q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM1075 1000h-850q-10 0 -17.5 -7.5t-7.5 -17.5v-850q0 -10 7.5 -17.5t17.5 -7.5h850q10 0 17.5 7.5t7.5 17.5v850 q0 10 -7.5 17.5t-17.5 7.5zM325 900h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 900h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 700h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 700h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 500h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 500h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 300h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 300h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe033;" d="M900 800v200q0 83 -58.5 141.5t-141.5 58.5h-300q-82 0 -141 -59t-59 -141v-200h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h900q41 0 70.5 29.5t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5h-100zM400 800v150q0 21 15 35.5t35 14.5h200 q20 0 35 -14.5t15 -35.5v-150h-300z" />
<glyph unicode="&#xe034;" d="M125 1100h50q10 0 17.5 -7.5t7.5 -17.5v-1075h-100v1075q0 10 7.5 17.5t17.5 7.5zM1075 1052q4 0 9 -2q16 -6 16 -23v-421q0 -6 -3 -12q-33 -59 -66.5 -99t-65.5 -58t-56.5 -24.5t-52.5 -6.5q-26 0 -57.5 6.5t-52.5 13.5t-60 21q-41 15 -63 22.5t-57.5 15t-65.5 7.5 q-85 0 -160 -57q-7 -5 -15 -5q-6 0 -11 3q-14 7 -14 22v438q22 55 82 98.5t119 46.5q23 2 43 0.5t43 -7t32.5 -8.5t38 -13t32.5 -11q41 -14 63.5 -21t57 -14t63.5 -7q103 0 183 87q7 8 18 8z" />
<glyph unicode="&#xe035;" d="M600 1175q116 0 227 -49.5t192.5 -131t131 -192.5t49.5 -227v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v300q0 127 -70.5 231.5t-184.5 161.5t-245 57t-245 -57t-184.5 -161.5t-70.5 -231.5v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50 q-10 0 -17.5 7.5t-7.5 17.5v300q0 116 49.5 227t131 192.5t192.5 131t227 49.5zM220 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460q0 8 6 14t14 6zM820 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460 q0 8 6 14t14 6z" />
<glyph unicode="&#xe036;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM900 668l120 120q7 7 17 7t17 -7l34 -34q7 -7 7 -17t-7 -17l-120 -120l120 -120q7 -7 7 -17 t-7 -17l-34 -34q-7 -7 -17 -7t-17 7l-120 119l-120 -119q-7 -7 -17 -7t-17 7l-34 34q-7 7 -7 17t7 17l119 120l-119 120q-7 7 -7 17t7 17l34 34q7 8 17 8t17 -8z" />
<glyph unicode="&#xe037;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6 l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238q-6 8 -4.5 18t9.5 17l29 22q7 5 15 5z" />
<glyph unicode="&#xe038;" d="M967 1004h3q11 -1 17 -10q135 -179 135 -396q0 -105 -34 -206.5t-98 -185.5q-7 -9 -17 -10h-3q-9 0 -16 6l-42 34q-8 6 -9 16t5 18q111 150 111 328q0 90 -29.5 176t-84.5 157q-6 9 -5 19t10 16l42 33q7 5 15 5zM321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5 t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238 q-6 8 -4.5 18.5t9.5 16.5l29 22q7 5 15 5z" />
<glyph unicode="&#xe039;" d="M500 900h100v-100h-100v-100h-400v-100h-100v600h500v-300zM1200 700h-200v-100h200v-200h-300v300h-200v300h-100v200h600v-500zM100 1100v-300h300v300h-300zM800 1100v-300h300v300h-300zM300 900h-100v100h100v-100zM1000 900h-100v100h100v-100zM300 500h200v-500 h-500v500h200v100h100v-100zM800 300h200v-100h-100v-100h-200v100h-100v100h100v200h-200v100h300v-300zM100 400v-300h300v300h-300zM300 200h-100v100h100v-100zM1200 200h-100v100h100v-100zM700 0h-100v100h100v-100zM1200 0h-300v100h300v-100z" />
<glyph unicode="&#xe040;" d="M100 200h-100v1000h100v-1000zM300 200h-100v1000h100v-1000zM700 200h-200v1000h200v-1000zM900 200h-100v1000h100v-1000zM1200 200h-200v1000h200v-1000zM400 0h-300v100h300v-100zM600 0h-100v91h100v-91zM800 0h-100v91h100v-91zM1100 0h-200v91h200v-91z" />
<glyph unicode="&#xe041;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe042;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM800 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-56 56l424 426l-700 700h150zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5 t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe043;" d="M300 1200h825q75 0 75 -75v-900q0 -25 -18 -43l-64 -64q-8 -8 -13 -5.5t-5 12.5v950q0 10 -7.5 17.5t-17.5 7.5h-700q-25 0 -43 -18l-64 -64q-8 -8 -5.5 -13t12.5 -5h700q10 0 17.5 -7.5t7.5 -17.5v-950q0 -10 -7.5 -17.5t-17.5 -7.5h-850q-10 0 -17.5 7.5t-7.5 17.5v975 q0 25 18 43l139 139q18 18 43 18z" />
<glyph unicode="&#xe044;" d="M250 1200h800q21 0 35.5 -14.5t14.5 -35.5v-1150l-450 444l-450 -445v1151q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe045;" d="M822 1200h-444q-11 0 -19 -7.5t-9 -17.5l-78 -301q-7 -24 7 -45l57 -108q6 -9 17.5 -15t21.5 -6h450q10 0 21.5 6t17.5 15l62 108q14 21 7 45l-83 301q-1 10 -9 17.5t-19 7.5zM1175 800h-150q-10 0 -21 -6.5t-15 -15.5l-78 -156q-4 -9 -15 -15.5t-21 -6.5h-550 q-10 0 -21 6.5t-15 15.5l-78 156q-4 9 -15 15.5t-21 6.5h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-650q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h750q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5 t7.5 17.5v650q0 10 -7.5 17.5t-17.5 7.5zM850 200h-500q-10 0 -19.5 -7t-11.5 -17l-38 -152q-2 -10 3.5 -17t15.5 -7h600q10 0 15.5 7t3.5 17l-38 152q-2 10 -11.5 17t-19.5 7z" />
<glyph unicode="&#xe046;" d="M500 1100h200q56 0 102.5 -20.5t72.5 -50t44 -59t25 -50.5l6 -20h150q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5h150q2 8 6.5 21.5t24 48t45 61t72 48t102.5 21.5zM900 800v-100 h100v100h-100zM600 730q-95 0 -162.5 -67.5t-67.5 -162.5t67.5 -162.5t162.5 -67.5t162.5 67.5t67.5 162.5t-67.5 162.5t-162.5 67.5zM600 603q43 0 73 -30t30 -73t-30 -73t-73 -30t-73 30t-30 73t30 73t73 30z" />
<glyph unicode="&#xe047;" d="M681 1199l385 -998q20 -50 60 -92q18 -19 36.5 -29.5t27.5 -11.5l10 -2v-66h-417v66q53 0 75 43.5t5 88.5l-82 222h-391q-58 -145 -92 -234q-11 -34 -6.5 -57t25.5 -37t46 -20t55 -6v-66h-365v66q56 24 84 52q12 12 25 30.5t20 31.5l7 13l399 1006h93zM416 521h340 l-162 457z" />
<glyph unicode="&#xe048;" d="M753 641q5 -1 14.5 -4.5t36 -15.5t50.5 -26.5t53.5 -40t50.5 -54.5t35.5 -70t14.5 -87q0 -67 -27.5 -125.5t-71.5 -97.5t-98.5 -66.5t-108.5 -40.5t-102 -13h-500v89q41 7 70.5 32.5t29.5 65.5v827q0 24 -0.5 34t-3.5 24t-8.5 19.5t-17 13.5t-28 12.5t-42.5 11.5v71 l471 -1q57 0 115.5 -20.5t108 -57t80.5 -94t31 -124.5q0 -51 -15.5 -96.5t-38 -74.5t-45 -50.5t-38.5 -30.5zM400 700h139q78 0 130.5 48.5t52.5 122.5q0 41 -8.5 70.5t-29.5 55.5t-62.5 39.5t-103.5 13.5h-118v-350zM400 200h216q80 0 121 50.5t41 130.5q0 90 -62.5 154.5 t-156.5 64.5h-159v-400z" />
<glyph unicode="&#xe049;" d="M877 1200l2 -57q-83 -19 -116 -45.5t-40 -66.5l-132 -839q-9 -49 13 -69t96 -26v-97h-500v97q186 16 200 98l173 832q3 17 3 30t-1.5 22.5t-9 17.5t-13.5 12.5t-21.5 10t-26 8.5t-33.5 10q-13 3 -19 5v57h425z" />
<glyph unicode="&#xe050;" d="M1300 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM175 1000h-75v-800h75l-125 -167l-125 167h75v800h-75l125 167z" />
<glyph unicode="&#xe051;" d="M1100 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-650q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v650h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM1167 50l-167 -125v75h-800v-75l-167 125l167 125v-75h800v75z" />
<glyph unicode="&#xe052;" d="M50 1100h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe053;" d="M250 1100h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM250 500h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe054;" d="M500 950v100q0 21 14.5 35.5t35.5 14.5h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5zM100 650v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000 q-21 0 -35.5 14.5t-14.5 35.5zM300 350v100q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5zM0 50v100q0 21 14.5 35.5t35.5 14.5h1100q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5z" />
<glyph unicode="&#xe055;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe056;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 1100h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 800h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 500h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 500h800q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 200h800 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe057;" d="M400 0h-100v1100h100v-1100zM550 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM267 550l-167 -125v75h-200v100h200v75zM550 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe058;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM900 0h-100v1100h100v-1100zM50 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM1100 600h200v-100h-200v-75l-167 125l167 125v-75zM50 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe059;" d="M75 1000h750q31 0 53 -22t22 -53v-650q0 -31 -22 -53t-53 -22h-750q-31 0 -53 22t-22 53v650q0 31 22 53t53 22zM1200 300l-300 300l300 300v-600z" />
<glyph unicode="&#xe060;" d="M44 1100h1112q18 0 31 -13t13 -31v-1012q0 -18 -13 -31t-31 -13h-1112q-18 0 -31 13t-13 31v1012q0 18 13 31t31 13zM100 1000v-737l247 182l298 -131l-74 156l293 318l236 -288v500h-1000zM342 884q56 0 95 -39t39 -94.5t-39 -95t-95 -39.5t-95 39.5t-39 95t39 94.5 t95 39z" />
<glyph unicode="&#xe062;" d="M648 1169q117 0 216 -60t156.5 -161t57.5 -218q0 -115 -70 -258q-69 -109 -158 -225.5t-143 -179.5l-54 -62q-9 8 -25.5 24.5t-63.5 67.5t-91 103t-98.5 128t-95.5 148q-60 132 -60 249q0 88 34 169.5t91.5 142t137 96.5t166.5 36zM652.5 974q-91.5 0 -156.5 -65 t-65 -157t65 -156.5t156.5 -64.5t156.5 64.5t65 156.5t-65 157t-156.5 65z" />
<glyph unicode="&#xe063;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 173v854q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57z" />
<glyph unicode="&#xe064;" d="M554 1295q21 -72 57.5 -143.5t76 -130t83 -118t82.5 -117t70 -116t49.5 -126t18.5 -136.5q0 -71 -25.5 -135t-68.5 -111t-99 -82t-118.5 -54t-125.5 -23q-84 5 -161.5 34t-139.5 78.5t-99 125t-37 164.5q0 69 18 136.5t49.5 126.5t69.5 116.5t81.5 117.5t83.5 119 t76.5 131t58.5 143zM344 710q-23 -33 -43.5 -70.5t-40.5 -102.5t-17 -123q1 -37 14.5 -69.5t30 -52t41 -37t38.5 -24.5t33 -15q21 -7 32 -1t13 22l6 34q2 10 -2.5 22t-13.5 19q-5 4 -14 12t-29.5 40.5t-32.5 73.5q-26 89 6 271q2 11 -6 11q-8 1 -15 -10z" />
<glyph unicode="&#xe065;" d="M1000 1013l108 115q2 1 5 2t13 2t20.5 -1t25 -9.5t28.5 -21.5q22 -22 27 -43t0 -32l-6 -10l-108 -115zM350 1100h400q50 0 105 -13l-187 -187h-368q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v182l200 200v-332 q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM1009 803l-362 -362l-161 -50l55 170l355 355z" />
<glyph unicode="&#xe066;" d="M350 1100h361q-164 -146 -216 -200h-195q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5l200 153v-103q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M824 1073l339 -301q8 -7 8 -17.5t-8 -17.5l-340 -306q-7 -6 -12.5 -4t-6.5 11v203q-26 1 -54.5 0t-78.5 -7.5t-92 -17.5t-86 -35t-70 -57q10 59 33 108t51.5 81.5t65 58.5t68.5 40.5t67 24.5t56 13.5t40 4.5v210q1 10 6.5 12.5t13.5 -4.5z" />
<glyph unicode="&#xe067;" d="M350 1100h350q60 0 127 -23l-178 -177h-349q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v69l200 200v-219q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M643 639l395 395q7 7 17.5 7t17.5 -7l101 -101q7 -7 7 -17.5t-7 -17.5l-531 -532q-7 -7 -17.5 -7t-17.5 7l-248 248q-7 7 -7 17.5t7 17.5l101 101q7 7 17.5 7t17.5 -7l111 -111q8 -7 18 -7t18 7z" />
<glyph unicode="&#xe068;" d="M318 918l264 264q8 8 18 8t18 -8l260 -264q7 -8 4.5 -13t-12.5 -5h-170v-200h200v173q0 10 5 12t13 -5l264 -260q8 -7 8 -17.5t-8 -17.5l-264 -265q-8 -7 -13 -5t-5 12v173h-200v-200h170q10 0 12.5 -5t-4.5 -13l-260 -264q-8 -8 -18 -8t-18 8l-264 264q-8 8 -5.5 13 t12.5 5h175v200h-200v-173q0 -10 -5 -12t-13 5l-264 265q-8 7 -8 17.5t8 17.5l264 260q8 7 13 5t5 -12v-173h200v200h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe069;" d="M250 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe070;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5 t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe071;" d="M1200 1050v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-492 480q-15 14 -15 35t15 35l492 480q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25z" />
<glyph unicode="&#xe072;" d="M243 1074l814 -498q18 -11 18 -26t-18 -26l-814 -498q-18 -11 -30.5 -4t-12.5 28v1000q0 21 12.5 28t30.5 -4z" />
<glyph unicode="&#xe073;" d="M250 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM650 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe074;" d="M1100 950v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe075;" d="M500 612v438q0 21 10.5 25t25.5 -10l492 -480q15 -14 15 -35t-15 -35l-492 -480q-15 -14 -25.5 -10t-10.5 25v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10z" />
<glyph unicode="&#xe076;" d="M1048 1102l100 1q20 0 35 -14.5t15 -35.5l5 -1000q0 -21 -14.5 -35.5t-35.5 -14.5l-100 -1q-21 0 -35.5 14.5t-14.5 35.5l-2 437l-463 -454q-14 -15 -24.5 -10.5t-10.5 25.5l-2 437l-462 -455q-15 -14 -25.5 -9.5t-10.5 24.5l-5 1000q0 21 10.5 25.5t25.5 -10.5l466 -450 l-2 438q0 20 10.5 24.5t25.5 -9.5l466 -451l-2 438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe077;" d="M850 1100h100q21 0 35.5 -14.5t14.5 -35.5v-1000q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10l464 -453v438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe078;" d="M686 1081l501 -540q15 -15 10.5 -26t-26.5 -11h-1042q-22 0 -26.5 11t10.5 26l501 540q15 15 36 15t36 -15zM150 400h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe079;" d="M885 900l-352 -353l352 -353l-197 -198l-552 552l552 550z" />
<glyph unicode="&#xe080;" d="M1064 547l-551 -551l-198 198l353 353l-353 353l198 198z" />
<glyph unicode="&#xe081;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM650 900h-100q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-150 q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5h150v-150q0 -21 14.5 -35.5t35.5 -14.5h100q21 0 35.5 14.5t14.5 35.5v150h150q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-150v150q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe082;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM850 700h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5 t35.5 -14.5h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe083;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM741.5 913q-12.5 0 -21.5 -9l-120 -120l-120 120q-9 9 -21.5 9 t-21.5 -9l-141 -141q-9 -9 -9 -21.5t9 -21.5l120 -120l-120 -120q-9 -9 -9 -21.5t9 -21.5l141 -141q9 -9 21.5 -9t21.5 9l120 120l120 -120q9 -9 21.5 -9t21.5 9l141 141q9 9 9 21.5t-9 21.5l-120 120l120 120q9 9 9 21.5t-9 21.5l-141 141q-9 9 -21.5 9z" />
<glyph unicode="&#xe084;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM546 623l-84 85q-7 7 -17.5 7t-18.5 -7l-139 -139q-7 -8 -7 -18t7 -18 l242 -241q7 -8 17.5 -8t17.5 8l375 375q7 7 7 17.5t-7 18.5l-139 139q-7 7 -17.5 7t-17.5 -7z" />
<glyph unicode="&#xe085;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM588 941q-29 0 -59 -5.5t-63 -20.5t-58 -38.5t-41.5 -63t-16.5 -89.5 q0 -25 20 -25h131q30 -5 35 11q6 20 20.5 28t45.5 8q20 0 31.5 -10.5t11.5 -28.5q0 -23 -7 -34t-26 -18q-1 0 -13.5 -4t-19.5 -7.5t-20 -10.5t-22 -17t-18.5 -24t-15.5 -35t-8 -46q-1 -8 5.5 -16.5t20.5 -8.5h173q7 0 22 8t35 28t37.5 48t29.5 74t12 100q0 47 -17 83 t-42.5 57t-59.5 34.5t-64 18t-59 4.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe086;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM675 1000h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5 t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5zM675 700h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h75v-200h-75q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h350q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5 t-17.5 7.5h-75v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe087;" d="M525 1200h150q10 0 17.5 -7.5t7.5 -17.5v-194q103 -27 178.5 -102.5t102.5 -178.5h194q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-194q-27 -103 -102.5 -178.5t-178.5 -102.5v-194q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v194 q-103 27 -178.5 102.5t-102.5 178.5h-194q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h194q27 103 102.5 178.5t178.5 102.5v194q0 10 7.5 17.5t17.5 7.5zM700 893v-168q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v168q-68 -23 -119 -74 t-74 -119h168q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-168q23 -68 74 -119t119 -74v168q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-168q68 23 119 74t74 119h-168q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h168 q-23 68 -74 119t-119 74z" />
<glyph unicode="&#xe088;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM759 823l64 -64q7 -7 7 -17.5t-7 -17.5l-124 -124l124 -124q7 -7 7 -17.5t-7 -17.5l-64 -64q-7 -7 -17.5 -7t-17.5 7l-124 124l-124 -124q-7 -7 -17.5 -7t-17.5 7l-64 64 q-7 7 -7 17.5t7 17.5l124 124l-124 124q-7 7 -7 17.5t7 17.5l64 64q7 7 17.5 7t17.5 -7l124 -124l124 124q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe089;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM782 788l106 -106q7 -7 7 -17.5t-7 -17.5l-320 -321q-8 -7 -18 -7t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l197 197q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe090;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5q0 -120 65 -225 l587 587q-105 65 -225 65zM965 819l-584 -584q104 -62 219 -62q116 0 214.5 57t155.5 155.5t57 214.5q0 115 -62 219z" />
<glyph unicode="&#xe091;" d="M39 582l522 427q16 13 27.5 8t11.5 -26v-291h550q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-550v-291q0 -21 -11.5 -26t-27.5 8l-522 427q-16 13 -16 32t16 32z" />
<glyph unicode="&#xe092;" d="M639 1009l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291h-550q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h550v291q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe093;" d="M682 1161l427 -522q13 -16 8 -27.5t-26 -11.5h-291v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v550h-291q-21 0 -26 11.5t8 27.5l427 522q13 16 32 16t32 -16z" />
<glyph unicode="&#xe094;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-550h291q21 0 26 -11.5t-8 -27.5l-427 -522q-13 -16 -32 -16t-32 16l-427 522q-13 16 -8 27.5t26 11.5h291v550q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe095;" d="M639 1109l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291q-94 -2 -182 -20t-170.5 -52t-147 -92.5t-100.5 -135.5q5 105 27 193.5t67.5 167t113 135t167 91.5t225.5 42v262q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe096;" d="M850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5zM350 0h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249 q8 7 18 7t18 -7l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5z" />
<glyph unicode="&#xe097;" d="M1014 1120l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249q8 7 18 7t18 -7zM250 600h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5z" />
<glyph unicode="&#xe101;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM704 900h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5 t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe102;" d="M260 1200q9 0 19 -2t15 -4l5 -2q22 -10 44 -23l196 -118q21 -13 36 -24q29 -21 37 -12q11 13 49 35l196 118q22 13 45 23q17 7 38 7q23 0 47 -16.5t37 -33.5l13 -16q14 -21 18 -45l25 -123l8 -44q1 -9 8.5 -14.5t17.5 -5.5h61q10 0 17.5 -7.5t7.5 -17.5v-50 q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 -7.5t-7.5 -17.5v-175h-400v300h-200v-300h-400v175q0 10 -7.5 17.5t-17.5 7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5h61q11 0 18 3t7 8q0 4 9 52l25 128q5 25 19 45q2 3 5 7t13.5 15t21.5 19.5t26.5 15.5 t29.5 7zM915 1079l-166 -162q-7 -7 -5 -12t12 -5h219q10 0 15 7t2 17l-51 149q-3 10 -11 12t-15 -6zM463 917l-177 157q-8 7 -16 5t-11 -12l-51 -143q-3 -10 2 -17t15 -7h231q11 0 12.5 5t-5.5 12zM500 0h-375q-10 0 -17.5 7.5t-7.5 17.5v375h400v-400zM1100 400v-375 q0 -10 -7.5 -17.5t-17.5 -7.5h-375v400h400z" />
<glyph unicode="&#xe103;" d="M1165 1190q8 3 21 -6.5t13 -17.5q-2 -178 -24.5 -323.5t-55.5 -245.5t-87 -174.5t-102.5 -118.5t-118 -68.5t-118.5 -33t-120 -4.5t-105 9.5t-90 16.5q-61 12 -78 11q-4 1 -12.5 0t-34 -14.5t-52.5 -40.5l-153 -153q-26 -24 -37 -14.5t-11 43.5q0 64 42 102q8 8 50.5 45 t66.5 58q19 17 35 47t13 61q-9 55 -10 102.5t7 111t37 130t78 129.5q39 51 80 88t89.5 63.5t94.5 45t113.5 36t129 31t157.5 37t182 47.5zM1116 1098q-8 9 -22.5 -3t-45.5 -50q-38 -47 -119 -103.5t-142 -89.5l-62 -33q-56 -30 -102 -57t-104 -68t-102.5 -80.5t-85.5 -91 t-64 -104.5q-24 -56 -31 -86t2 -32t31.5 17.5t55.5 59.5q25 30 94 75.5t125.5 77.5t147.5 81q70 37 118.5 69t102 79.5t99 111t86.5 148.5q22 50 24 60t-6 19z" />
<glyph unicode="&#xe104;" d="M653 1231q-39 -67 -54.5 -131t-10.5 -114.5t24.5 -96.5t47.5 -80t63.5 -62.5t68.5 -46.5t65 -30q-4 7 -17.5 35t-18.5 39.5t-17 39.5t-17 43t-13 42t-9.5 44.5t-2 42t4 43t13.5 39t23 38.5q96 -42 165 -107.5t105 -138t52 -156t13 -159t-19 -149.5q-13 -55 -44 -106.5 t-68 -87t-78.5 -64.5t-72.5 -45t-53 -22q-72 -22 -127 -11q-31 6 -13 19q6 3 17 7q13 5 32.5 21t41 44t38.5 63.5t21.5 81.5t-6.5 94.5t-50 107t-104 115.5q10 -104 -0.5 -189t-37 -140.5t-65 -93t-84 -52t-93.5 -11t-95 24.5q-80 36 -131.5 114t-53.5 171q-2 23 0 49.5 t4.5 52.5t13.5 56t27.5 60t46 64.5t69.5 68.5q-8 -53 -5 -102.5t17.5 -90t34 -68.5t44.5 -39t49 -2q31 13 38.5 36t-4.5 55t-29 64.5t-36 75t-26 75.5q-15 85 2 161.5t53.5 128.5t85.5 92.5t93.5 61t81.5 25.5z" />
<glyph unicode="&#xe105;" d="M600 1094q82 0 160.5 -22.5t140 -59t116.5 -82.5t94.5 -95t68 -95t42.5 -82.5t14 -57.5t-14 -57.5t-43 -82.5t-68.5 -95t-94.5 -95t-116.5 -82.5t-140 -59t-159.5 -22.5t-159.5 22.5t-140 59t-116.5 82.5t-94.5 95t-68.5 95t-43 82.5t-14 57.5t14 57.5t42.5 82.5t68 95 t94.5 95t116.5 82.5t140 59t160.5 22.5zM888 829q-15 15 -18 12t5 -22q25 -57 25 -119q0 -124 -88 -212t-212 -88t-212 88t-88 212q0 59 23 114q8 19 4.5 22t-17.5 -12q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q22 -36 47 -71t70 -82t92.5 -81t113 -58.5t133.5 -24.5 t133.5 24t113 58.5t92.5 81.5t70 81.5t47 70.5q11 18 9 42.5t-14 41.5q-90 117 -163 189zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l35 34q14 15 12.5 33.5t-16.5 33.5q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe106;" d="M592 0h-148l31 120q-91 20 -175.5 68.5t-143.5 106.5t-103.5 119t-66.5 110t-22 76q0 21 14 57.5t42.5 82.5t68 95t94.5 95t116.5 82.5t140 59t160.5 22.5q61 0 126 -15l32 121h148zM944 770l47 181q108 -85 176.5 -192t68.5 -159q0 -26 -19.5 -71t-59.5 -102t-93 -112 t-129 -104.5t-158 -75.5l46 173q77 49 136 117t97 131q11 18 9 42.5t-14 41.5q-54 70 -107 130zM310 824q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q18 -30 39 -60t57 -70.5t74 -73t90 -61t105 -41.5l41 154q-107 18 -178.5 101.5t-71.5 193.5q0 59 23 114q8 19 4.5 22 t-17.5 -12zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l12 11l22 86l-3 4q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe107;" d="M-90 100l642 1066q20 31 48 28.5t48 -35.5l642 -1056q21 -32 7.5 -67.5t-50.5 -35.5h-1294q-37 0 -50.5 34t7.5 66zM155 200h345v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h345l-445 723zM496 700h208q20 0 32 -14.5t8 -34.5l-58 -252 q-4 -20 -21.5 -34.5t-37.5 -14.5h-54q-20 0 -37.5 14.5t-21.5 34.5l-58 252q-4 20 8 34.5t32 14.5z" />
<glyph unicode="&#xe108;" d="M650 1200q62 0 106 -44t44 -106v-339l363 -325q15 -14 26 -38.5t11 -44.5v-41q0 -20 -12 -26.5t-29 5.5l-359 249v-263q100 -93 100 -113v-64q0 -21 -13 -29t-32 1l-205 128l-205 -128q-19 -9 -32 -1t-13 29v64q0 20 100 113v263l-359 -249q-17 -12 -29 -5.5t-12 26.5v41 q0 20 11 44.5t26 38.5l363 325v339q0 62 44 106t106 44z" />
<glyph unicode="&#xe109;" d="M850 1200h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-150h-1100v150q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5h100q21 0 35.5 -14.5t14.5 -35.5v-50h500v50q0 21 14.5 35.5t35.5 14.5zM1100 800v-750q0 -21 -14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v750h1100zM100 600v-100h100v100h-100zM300 600v-100h100v100h-100zM500 600v-100h100v100h-100zM700 600v-100h100v100h-100zM900 600v-100h100v100h-100zM100 400v-100h100v100h-100zM300 400v-100h100v100h-100zM500 400 v-100h100v100h-100zM700 400v-100h100v100h-100zM900 400v-100h100v100h-100zM100 200v-100h100v100h-100zM300 200v-100h100v100h-100zM500 200v-100h100v100h-100zM700 200v-100h100v100h-100zM900 200v-100h100v100h-100z" />
<glyph unicode="&#xe110;" d="M1135 1165l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-159l-600 -600h-291q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h209l600 600h241v150q0 21 10.5 25t24.5 -10zM522 819l-141 -141l-122 122h-209q-21 0 -35.5 14.5 t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h291zM1135 565l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-241l-181 181l141 141l122 -122h159v150q0 21 10.5 25t24.5 -10z" />
<glyph unicode="&#xe111;" d="M100 1100h1000q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-596l-304 -300v300h-100q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5z" />
<glyph unicode="&#xe112;" d="M150 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM850 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM1100 800v-300q0 -41 -3 -77.5t-15 -89.5t-32 -96t-58 -89t-89 -77t-129 -51t-174 -20t-174 20 t-129 51t-89 77t-58 89t-32 96t-15 89.5t-3 77.5v300h300v-250v-27v-42.5t1.5 -41t5 -38t10 -35t16.5 -30t25.5 -24.5t35 -19t46.5 -12t60 -4t60 4.5t46.5 12.5t35 19.5t25 25.5t17 30.5t10 35t5 38t2 40.5t-0.5 42v25v250h300z" />
<glyph unicode="&#xe113;" d="M1100 411l-198 -199l-353 353l-353 -353l-197 199l551 551z" />
<glyph unicode="&#xe114;" d="M1101 789l-550 -551l-551 551l198 199l353 -353l353 353z" />
<glyph unicode="&#xe115;" d="M404 1000h746q21 0 35.5 -14.5t14.5 -35.5v-551h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v401h-381zM135 984l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-400h385l215 -200h-750q-21 0 -35.5 14.5 t-14.5 35.5v550h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe116;" d="M56 1200h94q17 0 31 -11t18 -27l38 -162h896q24 0 39 -18.5t10 -42.5l-100 -475q-5 -21 -27 -42.5t-55 -21.5h-633l48 -200h535q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-50q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-300v-50 q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-31q-18 0 -32.5 10t-20.5 19l-5 10l-201 961h-54q-20 0 -35 14.5t-15 35.5t15 35.5t35 14.5z" />
<glyph unicode="&#xe117;" d="M1200 1000v-100h-1200v100h200q0 41 29.5 70.5t70.5 29.5h300q41 0 70.5 -29.5t29.5 -70.5h500zM0 800h1200v-800h-1200v800z" />
<glyph unicode="&#xe118;" d="M200 800l-200 -400v600h200q0 41 29.5 70.5t70.5 29.5h300q42 0 71 -29.5t29 -70.5h500v-200h-1000zM1500 700l-300 -700h-1200l300 700h1200z" />
<glyph unicode="&#xe119;" d="M635 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-601h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v601h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe120;" d="M936 864l249 -229q14 -15 14 -35.5t-14 -35.5l-249 -229q-15 -15 -25.5 -10.5t-10.5 24.5v151h-600v-151q0 -20 -10.5 -24.5t-25.5 10.5l-249 229q-14 15 -14 35.5t14 35.5l249 229q15 15 25.5 10.5t10.5 -25.5v-149h600v149q0 21 10.5 25.5t25.5 -10.5z" />
<glyph unicode="&#xe121;" d="M1169 400l-172 732q-5 23 -23 45.5t-38 22.5h-672q-20 0 -38 -20t-23 -41l-172 -739h1138zM1100 300h-1000q-41 0 -70.5 -29.5t-29.5 -70.5v-100q0 -41 29.5 -70.5t70.5 -29.5h1000q41 0 70.5 29.5t29.5 70.5v100q0 41 -29.5 70.5t-70.5 29.5zM800 100v100h100v-100h-100 zM1000 100v100h100v-100h-100z" />
<glyph unicode="&#xe122;" d="M1150 1100q21 0 35.5 -14.5t14.5 -35.5v-850q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v850q0 21 14.5 35.5t35.5 14.5zM1000 200l-675 200h-38l47 -276q3 -16 -5.5 -20t-29.5 -4h-7h-84q-20 0 -34.5 14t-18.5 35q-55 337 -55 351v250v6q0 16 1 23.5t6.5 14 t17.5 6.5h200l675 250v-850zM0 750v-250q-4 0 -11 0.5t-24 6t-30 15t-24 30t-11 48.5v50q0 26 10.5 46t25 30t29 16t25.5 7z" />
<glyph unicode="&#xe123;" d="M553 1200h94q20 0 29 -10.5t3 -29.5l-18 -37q83 -19 144 -82.5t76 -140.5l63 -327l118 -173h17q19 0 33 -14.5t14 -35t-13 -40.5t-31 -27q-8 -4 -23 -9.5t-65 -19.5t-103 -25t-132.5 -20t-158.5 -9q-57 0 -115 5t-104 12t-88.5 15.5t-73.5 17.5t-54.5 16t-35.5 12l-11 4 q-18 8 -31 28t-13 40.5t14 35t33 14.5h17l118 173l63 327q15 77 76 140t144 83l-18 32q-6 19 3.5 32t28.5 13zM498 110q50 -6 102 -6q53 0 102 6q-12 -49 -39.5 -79.5t-62.5 -30.5t-63 30.5t-39 79.5z" />
<glyph unicode="&#xe124;" d="M800 946l224 78l-78 -224l234 -45l-180 -155l180 -155l-234 -45l78 -224l-224 78l-45 -234l-155 180l-155 -180l-45 234l-224 -78l78 224l-234 45l180 155l-180 155l234 45l-78 224l224 -78l45 234l155 -180l155 180z" />
<glyph unicode="&#xe125;" d="M650 1200h50q40 0 70 -40.5t30 -84.5v-150l-28 -125h328q40 0 70 -40.5t30 -84.5v-100q0 -45 -29 -74l-238 -344q-16 -24 -38 -40.5t-45 -16.5h-250q-7 0 -42 25t-66 50l-31 25h-61q-45 0 -72.5 18t-27.5 57v400q0 36 20 63l145 196l96 198q13 28 37.5 48t51.5 20z M650 1100l-100 -212l-150 -213v-375h100l136 -100h214l250 375v125h-450l50 225v175h-50zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe126;" d="M600 1100h250q23 0 45 -16.5t38 -40.5l238 -344q29 -29 29 -74v-100q0 -44 -30 -84.5t-70 -40.5h-328q28 -118 28 -125v-150q0 -44 -30 -84.5t-70 -40.5h-50q-27 0 -51.5 20t-37.5 48l-96 198l-145 196q-20 27 -20 63v400q0 39 27.5 57t72.5 18h61q124 100 139 100z M50 1000h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM636 1000l-136 -100h-100v-375l150 -213l100 -212h50v175l-50 225h450v125l-250 375h-214z" />
<glyph unicode="&#xe127;" d="M356 873l363 230q31 16 53 -6l110 -112q13 -13 13.5 -32t-11.5 -34l-84 -121h302q84 0 138 -38t54 -110t-55 -111t-139 -39h-106l-131 -339q-6 -21 -19.5 -41t-28.5 -20h-342q-7 0 -90 81t-83 94v525q0 17 14 35.5t28 28.5zM400 792v-503l100 -89h293l131 339 q6 21 19.5 41t28.5 20h203q21 0 30.5 25t0.5 50t-31 25h-456h-7h-6h-5.5t-6 0.5t-5 1.5t-5 2t-4 2.5t-4 4t-2.5 4.5q-12 25 5 47l146 183l-86 83zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe128;" d="M475 1103l366 -230q2 -1 6 -3.5t14 -10.5t18 -16.5t14.5 -20t6.5 -22.5v-525q0 -13 -86 -94t-93 -81h-342q-15 0 -28.5 20t-19.5 41l-131 339h-106q-85 0 -139.5 39t-54.5 111t54 110t138 38h302l-85 121q-11 15 -10.5 34t13.5 32l110 112q22 22 53 6zM370 945l146 -183 q17 -22 5 -47q-2 -2 -3.5 -4.5t-4 -4t-4 -2.5t-5 -2t-5 -1.5t-6 -0.5h-6h-6.5h-6h-475v-100h221q15 0 29 -20t20 -41l130 -339h294l106 89v503l-342 236zM1050 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5 v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe129;" d="M550 1294q72 0 111 -55t39 -139v-106l339 -131q21 -6 41 -19.5t20 -28.5v-342q0 -7 -81 -90t-94 -83h-525q-17 0 -35.5 14t-28.5 28l-9 14l-230 363q-16 31 6 53l112 110q13 13 32 13.5t34 -11.5l121 -84v302q0 84 38 138t110 54zM600 972v203q0 21 -25 30.5t-50 0.5 t-25 -31v-456v-7v-6v-5.5t-0.5 -6t-1.5 -5t-2 -5t-2.5 -4t-4 -4t-4.5 -2.5q-25 -12 -47 5l-183 146l-83 -86l236 -339h503l89 100v293l-339 131q-21 6 -41 19.5t-20 28.5zM450 200h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe130;" d="M350 1100h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5zM600 306v-106q0 -84 -39 -139t-111 -55t-110 54t-38 138v302l-121 -84q-15 -12 -34 -11.5t-32 13.5l-112 110 q-22 22 -6 53l230 363q1 2 3.5 6t10.5 13.5t16.5 17t20 13.5t22.5 6h525q13 0 94 -83t81 -90v-342q0 -15 -20 -28.5t-41 -19.5zM308 900l-236 -339l83 -86l183 146q22 17 47 5q2 -1 4.5 -2.5t4 -4t2.5 -4t2 -5t1.5 -5t0.5 -6v-5.5v-6v-7v-456q0 -22 25 -31t50 0.5t25 30.5 v203q0 15 20 28.5t41 19.5l339 131v293l-89 100h-503z" />
<glyph unicode="&#xe131;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM914 632l-275 223q-16 13 -27.5 8t-11.5 -26v-137h-275 q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h275v-137q0 -21 11.5 -26t27.5 8l275 223q16 13 16 32t-16 32z" />
<glyph unicode="&#xe132;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM561 855l-275 -223q-16 -13 -16 -32t16 -32l275 -223q16 -13 27.5 -8 t11.5 26v137h275q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5h-275v137q0 21 -11.5 26t-27.5 -8z" />
<glyph unicode="&#xe133;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM855 639l-223 275q-13 16 -32 16t-32 -16l-223 -275q-13 -16 -8 -27.5 t26 -11.5h137v-275q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v275h137q21 0 26 11.5t-8 27.5z" />
<glyph unicode="&#xe134;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM675 900h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-275h-137q-21 0 -26 -11.5 t8 -27.5l223 -275q13 -16 32 -16t32 16l223 275q13 16 8 27.5t-26 11.5h-137v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe135;" d="M600 1176q116 0 222.5 -46t184 -123.5t123.5 -184t46 -222.5t-46 -222.5t-123.5 -184t-184 -123.5t-222.5 -46t-222.5 46t-184 123.5t-123.5 184t-46 222.5t46 222.5t123.5 184t184 123.5t222.5 46zM627 1101q-15 -12 -36.5 -20.5t-35.5 -12t-43 -8t-39 -6.5 q-15 -3 -45.5 0t-45.5 -2q-20 -7 -51.5 -26.5t-34.5 -34.5q-3 -11 6.5 -22.5t8.5 -18.5q-3 -34 -27.5 -91t-29.5 -79q-9 -34 5 -93t8 -87q0 -9 17 -44.5t16 -59.5q12 0 23 -5t23.5 -15t19.5 -14q16 -8 33 -15t40.5 -15t34.5 -12q21 -9 52.5 -32t60 -38t57.5 -11 q7 -15 -3 -34t-22.5 -40t-9.5 -38q13 -21 23 -34.5t27.5 -27.5t36.5 -18q0 -7 -3.5 -16t-3.5 -14t5 -17q104 -2 221 112q30 29 46.5 47t34.5 49t21 63q-13 8 -37 8.5t-36 7.5q-15 7 -49.5 15t-51.5 19q-18 0 -41 -0.5t-43 -1.5t-42 -6.5t-38 -16.5q-51 -35 -66 -12 q-4 1 -3.5 25.5t0.5 25.5q-6 13 -26.5 17.5t-24.5 6.5q1 15 -0.5 30.5t-7 28t-18.5 11.5t-31 -21q-23 -25 -42 4q-19 28 -8 58q6 16 22 22q6 -1 26 -1.5t33.5 -4t19.5 -13.5q7 -12 18 -24t21.5 -20.5t20 -15t15.5 -10.5l5 -3q2 12 7.5 30.5t8 34.5t-0.5 32q-3 18 3.5 29 t18 22.5t15.5 24.5q6 14 10.5 35t8 31t15.5 22.5t34 22.5q-6 18 10 36q8 0 24 -1.5t24.5 -1.5t20 4.5t20.5 15.5q-10 23 -31 42.5t-37.5 29.5t-49 27t-43.5 23q0 1 2 8t3 11.5t1.5 10.5t-1 9.5t-4.5 4.5q31 -13 58.5 -14.5t38.5 2.5l12 5q5 28 -9.5 46t-36.5 24t-50 15 t-41 20q-18 -4 -37 0zM613 994q0 -17 8 -42t17 -45t9 -23q-8 1 -39.5 5.5t-52.5 10t-37 16.5q3 11 16 29.5t16 25.5q10 -10 19 -10t14 6t13.5 14.5t16.5 12.5z" />
<glyph unicode="&#xe136;" d="M756 1157q164 92 306 -9l-259 -138l145 -232l251 126q6 -89 -34 -156.5t-117 -110.5q-60 -34 -127 -39.5t-126 16.5l-596 -596q-15 -16 -36.5 -16t-36.5 16l-111 110q-15 15 -15 36.5t15 37.5l600 599q-34 101 5.5 201.5t135.5 154.5z" />
<glyph unicode="&#xe137;" horiz-adv-x="1220" d="M100 1196h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 1096h-200v-100h200v100zM100 796h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 696h-500v-100h500v100zM100 396h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 296h-300v-100h300v100z " />
<glyph unicode="&#xe138;" d="M150 1200h900q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM700 500v-300l-200 -200v500l-350 500h900z" />
<glyph unicode="&#xe139;" d="M500 1200h200q41 0 70.5 -29.5t29.5 -70.5v-100h300q41 0 70.5 -29.5t29.5 -70.5v-400h-500v100h-200v-100h-500v400q0 41 29.5 70.5t70.5 29.5h300v100q0 41 29.5 70.5t70.5 29.5zM500 1100v-100h200v100h-200zM1200 400v-200q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v200h1200z" />
<glyph unicode="&#xe140;" d="M50 1200h300q21 0 25 -10.5t-10 -24.5l-94 -94l199 -199q7 -8 7 -18t-7 -18l-106 -106q-8 -7 -18 -7t-18 7l-199 199l-94 -94q-14 -14 -24.5 -10t-10.5 25v300q0 21 14.5 35.5t35.5 14.5zM850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-199 -199q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l199 199l-94 94q-14 14 -10 24.5t25 10.5zM364 470l106 -106q7 -8 7 -18t-7 -18l-199 -199l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l199 199 q8 7 18 7t18 -7zM1071 271l94 94q14 14 24.5 10t10.5 -25v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -25 10.5t10 24.5l94 94l-199 199q-7 8 -7 18t7 18l106 106q8 7 18 7t18 -7z" />
<glyph unicode="&#xe141;" d="M596 1192q121 0 231.5 -47.5t190 -127t127 -190t47.5 -231.5t-47.5 -231.5t-127 -190.5t-190 -127t-231.5 -47t-231.5 47t-190.5 127t-127 190.5t-47 231.5t47 231.5t127 190t190.5 127t231.5 47.5zM596 1010q-112 0 -207.5 -55.5t-151 -151t-55.5 -207.5t55.5 -207.5 t151 -151t207.5 -55.5t207.5 55.5t151 151t55.5 207.5t-55.5 207.5t-151 151t-207.5 55.5zM454.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38.5 -16.5t-38.5 16.5t-16 39t16 38.5t38.5 16zM754.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38 -16.5q-14 0 -29 10l-55 -145 q17 -23 17 -51q0 -36 -25.5 -61.5t-61.5 -25.5t-61.5 25.5t-25.5 61.5q0 32 20.5 56.5t51.5 29.5l122 126l1 1q-9 14 -9 28q0 23 16 39t38.5 16zM345.5 709q22.5 0 38.5 -16t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16zM854.5 709q22.5 0 38.5 -16 t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16z" />
<glyph unicode="&#xe142;" d="M546 173l469 470q91 91 99 192q7 98 -52 175.5t-154 94.5q-22 4 -47 4q-34 0 -66.5 -10t-56.5 -23t-55.5 -38t-48 -41.5t-48.5 -47.5q-376 -375 -391 -390q-30 -27 -45 -41.5t-37.5 -41t-32 -46.5t-16 -47.5t-1.5 -56.5q9 -62 53.5 -95t99.5 -33q74 0 125 51l548 548 q36 36 20 75q-7 16 -21.5 26t-32.5 10q-26 0 -50 -23q-13 -12 -39 -38l-341 -338q-15 -15 -35.5 -15.5t-34.5 13.5t-14 34.5t14 34.5q327 333 361 367q35 35 67.5 51.5t78.5 16.5q14 0 29 -1q44 -8 74.5 -35.5t43.5 -68.5q14 -47 2 -96.5t-47 -84.5q-12 -11 -32 -32 t-79.5 -81t-114.5 -115t-124.5 -123.5t-123 -119.5t-96.5 -89t-57 -45q-56 -27 -120 -27q-70 0 -129 32t-93 89q-48 78 -35 173t81 163l511 511q71 72 111 96q91 55 198 55q80 0 152 -33q78 -36 129.5 -103t66.5 -154q17 -93 -11 -183.5t-94 -156.5l-482 -476 q-15 -15 -36 -16t-37 14t-17.5 34t14.5 35z" />
<glyph unicode="&#xe143;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104zM896 972q-33 0 -64.5 -19t-56.5 -46t-47.5 -53.5t-43.5 -45.5t-37.5 -19t-36 19t-40 45.5t-43 53.5t-54 46t-65.5 19q-67 0 -122.5 -55.5t-55.5 -132.5q0 -23 13.5 -51t46 -65t57.5 -63t76 -75l22 -22q15 -14 44 -44t50.5 -51t46 -44t41 -35t23 -12 t23.5 12t42.5 36t46 44t52.5 52t44 43q4 4 12 13q43 41 63.5 62t52 55t46 55t26 46t11.5 44q0 79 -53 133.5t-120 54.5z" />
<glyph unicode="&#xe144;" d="M776.5 1214q93.5 0 159.5 -66l141 -141q66 -66 66 -160q0 -42 -28 -95.5t-62 -87.5l-29 -29q-31 53 -77 99l-18 18l95 95l-247 248l-389 -389l212 -212l-105 -106l-19 18l-141 141q-66 66 -66 159t66 159l283 283q65 66 158.5 66zM600 706l105 105q10 -8 19 -17l141 -141 q66 -66 66 -159t-66 -159l-283 -283q-66 -66 -159 -66t-159 66l-141 141q-66 66 -66 159.5t66 159.5l55 55q29 -55 75 -102l18 -17l-95 -95l247 -248l389 389z" />
<glyph unicode="&#xe145;" d="M603 1200q85 0 162 -15t127 -38t79 -48t29 -46v-953q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-41 0 -70.5 29.5t-29.5 70.5v953q0 21 30 46.5t81 48t129 37.5t163 15zM300 1000v-700h600v700h-600zM600 254q-43 0 -73.5 -30.5t-30.5 -73.5t30.5 -73.5t73.5 -30.5t73.5 30.5 t30.5 73.5t-30.5 73.5t-73.5 30.5z" />
<glyph unicode="&#xe146;" d="M902 1185l283 -282q15 -15 15 -36t-14.5 -35.5t-35.5 -14.5t-35 15l-36 35l-279 -267v-300l-212 210l-308 -307l-280 -203l203 280l307 308l-210 212h300l267 279l-35 36q-15 14 -15 35t14.5 35.5t35.5 14.5t35 -15z" />
<glyph unicode="&#xe148;" d="M700 1248v-78q38 -5 72.5 -14.5t75.5 -31.5t71 -53.5t52 -84t24 -118.5h-159q-4 36 -10.5 59t-21 45t-40 35.5t-64.5 20.5v-307l64 -13q34 -7 64 -16.5t70 -32t67.5 -52.5t47.5 -80t20 -112q0 -139 -89 -224t-244 -97v-77h-100v79q-150 16 -237 103q-40 40 -52.5 93.5 t-15.5 139.5h139q5 -77 48.5 -126t117.5 -65v335l-27 8q-46 14 -79 26.5t-72 36t-63 52t-40 72.5t-16 98q0 70 25 126t67.5 92t94.5 57t110 27v77h100zM600 754v274q-29 -4 -50 -11t-42 -21.5t-31.5 -41.5t-10.5 -65q0 -29 7 -50.5t16.5 -34t28.5 -22.5t31.5 -14t37.5 -10 q9 -3 13 -4zM700 547v-310q22 2 42.5 6.5t45 15.5t41.5 27t29 42t12 59.5t-12.5 59.5t-38 44.5t-53 31t-66.5 24.5z" />
<glyph unicode="&#xe149;" d="M561 1197q84 0 160.5 -40t123.5 -109.5t47 -147.5h-153q0 40 -19.5 71.5t-49.5 48.5t-59.5 26t-55.5 9q-37 0 -79 -14.5t-62 -35.5q-41 -44 -41 -101q0 -26 13.5 -63t26.5 -61t37 -66q6 -9 9 -14h241v-100h-197q8 -50 -2.5 -115t-31.5 -95q-45 -62 -99 -112 q34 10 83 17.5t71 7.5q32 1 102 -16t104 -17q83 0 136 30l50 -147q-31 -19 -58 -30.5t-55 -15.5t-42 -4.5t-46 -0.5q-23 0 -76 17t-111 32.5t-96 11.5q-39 -3 -82 -16t-67 -25l-23 -11l-55 145q4 3 16 11t15.5 10.5t13 9t15.5 12t14.5 14t17.5 18.5q48 55 54 126.5 t-30 142.5h-221v100h166q-23 47 -44 104q-7 20 -12 41.5t-6 55.5t6 66.5t29.5 70.5t58.5 71q97 88 263 88z" />
<glyph unicode="&#xe150;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM935 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-900h-200v900h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe151;" d="M1000 700h-100v100h-100v-100h-100v500h300v-500zM400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM801 1100v-200h100v200h-100zM1000 350l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150z " />
<glyph unicode="&#xe152;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 1050l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150zM1000 0h-100v100h-100v-100h-100v500h300v-500zM801 400v-200h100v200h-100z " />
<glyph unicode="&#xe153;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 700h-100v400h-100v100h200v-500zM1100 0h-100v100h-200v400h300v-500zM901 400v-200h100v200h-100z" />
<glyph unicode="&#xe154;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1100 700h-100v100h-200v400h300v-500zM901 1100v-200h100v200h-100zM1000 0h-100v400h-100v100h200v-500z" />
<glyph unicode="&#xe155;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM900 1000h-200v200h200v-200zM1000 700h-300v200h300v-200zM1100 400h-400v200h400v-200zM1200 100h-500v200h500v-200z" />
<glyph unicode="&#xe156;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1200 1000h-500v200h500v-200zM1100 700h-400v200h400v-200zM1000 400h-300v200h300v-200zM900 100h-200v200h200v-200z" />
<glyph unicode="&#xe157;" d="M350 1100h400q162 0 256 -93.5t94 -256.5v-400q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5z" />
<glyph unicode="&#xe158;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-163 0 -256.5 92.5t-93.5 257.5v400q0 163 94 256.5t256 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM440 770l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe159;" d="M350 1100h400q163 0 256.5 -94t93.5 -256v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 163 92.5 256.5t257.5 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM350 700h400q21 0 26.5 -12t-6.5 -28l-190 -253q-12 -17 -30 -17t-30 17l-190 253q-12 16 -6.5 28t26.5 12z" />
<glyph unicode="&#xe160;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -163 -92.5 -256.5t-257.5 -93.5h-400q-163 0 -256.5 94t-93.5 256v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM580 693l190 -253q12 -16 6.5 -28t-26.5 -12h-400q-21 0 -26.5 12t6.5 28l190 253q12 17 30 17t30 -17z" />
<glyph unicode="&#xe161;" d="M550 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h450q41 0 70.5 29.5t29.5 70.5v500q0 41 -29.5 70.5t-70.5 29.5h-450q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM338 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe162;" d="M793 1182l9 -9q8 -10 5 -27q-3 -11 -79 -225.5t-78 -221.5l300 1q24 0 32.5 -17.5t-5.5 -35.5q-1 0 -133.5 -155t-267 -312.5t-138.5 -162.5q-12 -15 -26 -15h-9l-9 8q-9 11 -4 32q2 9 42 123.5t79 224.5l39 110h-302q-23 0 -31 19q-10 21 6 41q75 86 209.5 237.5 t228 257t98.5 111.5q9 16 25 16h9z" />
<glyph unicode="&#xe163;" d="M350 1100h400q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-450q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h450q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400 q0 165 92.5 257.5t257.5 92.5zM938 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe164;" d="M750 1200h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -10.5 -25t-24.5 10l-109 109l-312 -312q-15 -15 -35.5 -15t-35.5 15l-141 141q-15 15 -15 35.5t15 35.5l312 312l-109 109q-14 14 -10 24.5t25 10.5zM456 900h-156q-41 0 -70.5 -29.5t-29.5 -70.5v-500 q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v148l200 200v-298q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5h300z" />
<glyph unicode="&#xe165;" d="M600 1186q119 0 227.5 -46.5t187 -125t125 -187t46.5 -227.5t-46.5 -227.5t-125 -187t-187 -125t-227.5 -46.5t-227.5 46.5t-187 125t-125 187t-46.5 227.5t46.5 227.5t125 187t187 125t227.5 46.5zM600 1022q-115 0 -212 -56.5t-153.5 -153.5t-56.5 -212t56.5 -212 t153.5 -153.5t212 -56.5t212 56.5t153.5 153.5t56.5 212t-56.5 212t-153.5 153.5t-212 56.5zM600 794q80 0 137 -57t57 -137t-57 -137t-137 -57t-137 57t-57 137t57 137t137 57z" />
<glyph unicode="&#xe166;" d="M450 1200h200q21 0 35.5 -14.5t14.5 -35.5v-350h245q20 0 25 -11t-9 -26l-383 -426q-14 -15 -33.5 -15t-32.5 15l-379 426q-13 15 -8.5 26t25.5 11h250v350q0 21 14.5 35.5t35.5 14.5zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe167;" d="M583 1182l378 -435q14 -15 9 -31t-26 -16h-244v-250q0 -20 -17 -35t-39 -15h-200q-20 0 -32 14.5t-12 35.5v250h-250q-20 0 -25.5 16.5t8.5 31.5l383 431q14 16 33.5 17t33.5 -14zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe168;" d="M396 723l369 369q7 7 17.5 7t17.5 -7l139 -139q7 -8 7 -18.5t-7 -17.5l-525 -525q-7 -8 -17.5 -8t-17.5 8l-292 291q-7 8 -7 18t7 18l139 139q8 7 18.5 7t17.5 -7zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50 h-100z" />
<glyph unicode="&#xe169;" d="M135 1023l142 142q14 14 35 14t35 -14l77 -77l-212 -212l-77 76q-14 15 -14 36t14 35zM655 855l210 210q14 14 24.5 10t10.5 -25l-2 -599q-1 -20 -15.5 -35t-35.5 -15l-597 -1q-21 0 -25 10.5t10 24.5l208 208l-154 155l212 212zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5 v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe170;" d="M350 1200l599 -2q20 -1 35 -15.5t15 -35.5l1 -597q0 -21 -10.5 -25t-24.5 10l-208 208l-155 -154l-212 212l155 154l-210 210q-14 14 -10 24.5t25 10.5zM524 512l-76 -77q-15 -14 -36 -14t-35 14l-142 142q-14 14 -14 35t14 35l77 77zM50 300h1000q21 0 35.5 -14.5 t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe171;" d="M1200 103l-483 276l-314 -399v423h-399l1196 796v-1096zM483 424v-230l683 953z" />
<glyph unicode="&#xe172;" d="M1100 1000v-850q0 -21 -14.5 -35.5t-35.5 -14.5h-150v400h-700v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200z" />
<glyph unicode="&#xe173;" d="M1100 1000l-2 -149l-299 -299l-95 95q-9 9 -21.5 9t-21.5 -9l-149 -147h-312v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1132 638l106 -106q7 -7 7 -17.5t-7 -17.5l-420 -421q-8 -7 -18 -7 t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l297 297q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe174;" d="M1100 1000v-269l-103 -103l-134 134q-15 15 -33.5 16.5t-34.5 -12.5l-266 -266h-329v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1202 572l70 -70q15 -15 15 -35.5t-15 -35.5l-131 -131 l131 -131q15 -15 15 -35.5t-15 -35.5l-70 -70q-15 -15 -35.5 -15t-35.5 15l-131 131l-131 -131q-15 -15 -35.5 -15t-35.5 15l-70 70q-15 15 -15 35.5t15 35.5l131 131l-131 131q-15 15 -15 35.5t15 35.5l70 70q15 15 35.5 15t35.5 -15l131 -131l131 131q15 15 35.5 15 t35.5 -15z" />
<glyph unicode="&#xe175;" d="M1100 1000v-300h-350q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-500v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM850 600h100q21 0 35.5 -14.5t14.5 -35.5v-250h150q21 0 25 -10.5t-10 -24.5 l-230 -230q-14 -14 -35 -14t-35 14l-230 230q-14 14 -10 24.5t25 10.5h150v250q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe176;" d="M1100 1000v-400l-165 165q-14 15 -35 15t-35 -15l-263 -265h-402v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM935 565l230 -229q14 -15 10 -25.5t-25 -10.5h-150v-250q0 -20 -14.5 -35 t-35.5 -15h-100q-21 0 -35.5 15t-14.5 35v250h-150q-21 0 -25 10.5t10 25.5l230 229q14 15 35 15t35 -15z" />
<glyph unicode="&#xe177;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-150h-1200v150q0 21 14.5 35.5t35.5 14.5zM1200 800v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v550h1200zM100 500v-200h400v200h-400z" />
<glyph unicode="&#xe178;" d="M935 1165l248 -230q14 -14 14 -35t-14 -35l-248 -230q-14 -14 -24.5 -10t-10.5 25v150h-400v200h400v150q0 21 10.5 25t24.5 -10zM200 800h-50q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v-200zM400 800h-100v200h100v-200zM18 435l247 230 q14 14 24.5 10t10.5 -25v-150h400v-200h-400v-150q0 -21 -10.5 -25t-24.5 10l-247 230q-15 14 -15 35t15 35zM900 300h-100v200h100v-200zM1000 500h51q20 0 34.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-34.5 -14.5h-51v200z" />
<glyph unicode="&#xe179;" d="M862 1073l276 116q25 18 43.5 8t18.5 -41v-1106q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v397q-4 1 -11 5t-24 17.5t-30 29t-24 42t-11 56.5v359q0 31 18.5 65t43.5 52zM550 1200q22 0 34.5 -12.5t14.5 -24.5l1 -13v-450q0 -28 -10.5 -59.5 t-25 -56t-29 -45t-25.5 -31.5l-10 -11v-447q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v447q-4 4 -11 11.5t-24 30.5t-30 46t-24 55t-11 60v450q0 2 0.5 5.5t4 12t8.5 15t14.5 12t22.5 5.5q20 0 32.5 -12.5t14.5 -24.5l3 -13v-350h100v350v5.5t2.5 12 t7 15t15 12t25.5 5.5q23 0 35.5 -12.5t13.5 -24.5l1 -13v-350h100v350q0 2 0.5 5.5t3 12t7 15t15 12t24.5 5.5z" />
<glyph unicode="&#xe180;" d="M1200 1100v-56q-4 0 -11 -0.5t-24 -3t-30 -7.5t-24 -15t-11 -24v-888q0 -22 25 -34.5t50 -13.5l25 -2v-56h-400v56q75 0 87.5 6.5t12.5 43.5v394h-500v-394q0 -37 12.5 -43.5t87.5 -6.5v-56h-400v56q4 0 11 0.5t24 3t30 7.5t24 15t11 24v888q0 22 -25 34.5t-50 13.5 l-25 2v56h400v-56q-75 0 -87.5 -6.5t-12.5 -43.5v-394h500v394q0 37 -12.5 43.5t-87.5 6.5v56h400z" />
<glyph unicode="&#xe181;" d="M675 1000h375q21 0 35.5 -14.5t14.5 -35.5v-150h-105l-295 -98v98l-200 200h-400l100 100h375zM100 900h300q41 0 70.5 -29.5t29.5 -70.5v-500q0 -41 -29.5 -70.5t-70.5 -29.5h-300q-41 0 -70.5 29.5t-29.5 70.5v500q0 41 29.5 70.5t70.5 29.5zM100 800v-200h300v200 h-300zM1100 535l-400 -133v163l400 133v-163zM100 500v-200h300v200h-300zM1100 398v-248q0 -21 -14.5 -35.5t-35.5 -14.5h-375l-100 -100h-375l-100 100h400l200 200h105z" />
<glyph unicode="&#xe182;" d="M17 1007l162 162q17 17 40 14t37 -22l139 -194q14 -20 11 -44.5t-20 -41.5l-119 -118q102 -142 228 -268t267 -227l119 118q17 17 42.5 19t44.5 -12l192 -136q19 -14 22.5 -37.5t-13.5 -40.5l-163 -162q-3 -1 -9.5 -1t-29.5 2t-47.5 6t-62.5 14.5t-77.5 26.5t-90 42.5 t-101.5 60t-111 83t-119 108.5q-74 74 -133.5 150.5t-94.5 138.5t-60 119.5t-34.5 100t-15 74.5t-4.5 48z" />
<glyph unicode="&#xe183;" d="M600 1100q92 0 175 -10.5t141.5 -27t108.5 -36.5t81.5 -40t53.5 -37t31 -27l9 -10v-200q0 -21 -14.5 -33t-34.5 -9l-202 34q-20 3 -34.5 20t-14.5 38v146q-141 24 -300 24t-300 -24v-146q0 -21 -14.5 -38t-34.5 -20l-202 -34q-20 -3 -34.5 9t-14.5 33v200q3 4 9.5 10.5 t31 26t54 37.5t80.5 39.5t109 37.5t141 26.5t175 10.5zM600 795q56 0 97 -9.5t60 -23.5t30 -28t12 -24l1 -10v-50l365 -303q14 -15 24.5 -40t10.5 -45v-212q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v212q0 20 10.5 45t24.5 40l365 303v50 q0 4 1 10.5t12 23t30 29t60 22.5t97 10z" />
<glyph unicode="&#xe184;" d="M1100 700l-200 -200h-600l-200 200v500h200v-200h200v200h200v-200h200v200h200v-500zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5 t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe185;" d="M700 1100h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-1000h300v1000q0 41 -29.5 70.5t-70.5 29.5zM1100 800h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-700h300v700q0 41 -29.5 70.5t-70.5 29.5zM400 0h-300v400q0 41 29.5 70.5t70.5 29.5h100q41 0 70.5 -29.5t29.5 -70.5v-400z " />
<glyph unicode="&#xe186;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe187;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 300h-100v200h-100v-200h-100v500h100v-200h100v200h100v-500zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe188;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-300h200v-100h-300v500h300v-100zM900 700h-200v-300h200v-100h-300v500h300v-100z" />
<glyph unicode="&#xe189;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 400l-300 150l300 150v-300zM900 550l-300 -150v300z" />
<glyph unicode="&#xe190;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM900 300h-700v500h700v-500zM800 700h-130q-38 0 -66.5 -43t-28.5 -108t27 -107t68 -42h130v300zM300 700v-300 h130q41 0 68 42t27 107t-28.5 108t-66.5 43h-130z" />
<glyph unicode="&#xe191;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 300h-100v400h-100v100h200v-500z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe192;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM300 700h200v-400h-300v500h100v-100zM900 300h-100v400h-100v100h200v-500zM300 600v-200h100v200h-100z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe193;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 500l-199 -200h-100v50l199 200v150h-200v100h300v-300zM900 300h-100v400h-100v100h200v-500zM701 300h-100 v100h100v-100z" />
<glyph unicode="&#xe194;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700h-300v-200h300v-100h-300l-100 100v200l100 100h300v-100z" />
<glyph unicode="&#xe195;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700v-100l-50 -50l100 -100v-50h-100l-100 100h-150v-100h-100v400h300zM500 700v-100h200v100h-200z" />
<glyph unicode="&#xe197;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -207t-85 -207t-205 -86.5h-128v250q0 21 -14.5 35.5t-35.5 14.5h-300q-21 0 -35.5 -14.5t-14.5 -35.5v-250h-222q-80 0 -136 57.5t-56 136.5q0 69 43 122.5t108 67.5q-2 19 -2 37q0 100 49 185 t134 134t185 49zM525 500h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -244q-13 -16 -32 -16t-32 16l-223 244q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe198;" d="M502 1089q110 0 201 -59.5t135 -156.5q43 15 89 15q121 0 206 -86.5t86 -206.5q0 -99 -60 -181t-150 -110l-378 360q-13 16 -31.5 16t-31.5 -16l-381 -365h-9q-79 0 -135.5 57.5t-56.5 136.5q0 69 43 122.5t108 67.5q-2 19 -2 38q0 100 49 184.5t133.5 134t184.5 49.5z M632 467l223 -228q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5q199 204 223 228q19 19 31.5 19t32.5 -19z" />
<glyph unicode="&#xe199;" d="M700 100v100h400l-270 300h170l-270 300h170l-300 333l-300 -333h170l-270 -300h170l-270 -300h400v-100h-50q-21 0 -35.5 -14.5t-14.5 -35.5v-50h400v50q0 21 -14.5 35.5t-35.5 14.5h-50z" />
<glyph unicode="&#xe200;" d="M600 1179q94 0 167.5 -56.5t99.5 -145.5q89 -6 150.5 -71.5t61.5 -155.5q0 -61 -29.5 -112.5t-79.5 -82.5q9 -29 9 -55q0 -74 -52.5 -126.5t-126.5 -52.5q-55 0 -100 30v-251q21 0 35.5 -14.5t14.5 -35.5v-50h-300v50q0 21 14.5 35.5t35.5 14.5v251q-45 -30 -100 -30 q-74 0 -126.5 52.5t-52.5 126.5q0 18 4 38q-47 21 -75.5 65t-28.5 97q0 74 52.5 126.5t126.5 52.5q5 0 23 -2q0 2 -1 10t-1 13q0 116 81.5 197.5t197.5 81.5z" />
<glyph unicode="&#xe201;" d="M1010 1010q111 -111 150.5 -260.5t0 -299t-150.5 -260.5q-83 -83 -191.5 -126.5t-218.5 -43.5t-218.5 43.5t-191.5 126.5q-111 111 -150.5 260.5t0 299t150.5 260.5q83 83 191.5 126.5t218.5 43.5t218.5 -43.5t191.5 -126.5zM476 1065q-4 0 -8 -1q-121 -34 -209.5 -122.5 t-122.5 -209.5q-4 -12 2.5 -23t18.5 -14l36 -9q3 -1 7 -1q23 0 29 22q27 96 98 166q70 71 166 98q11 3 17.5 13.5t3.5 22.5l-9 35q-3 13 -14 19q-7 4 -15 4zM512 920q-4 0 -9 -2q-80 -24 -138.5 -82.5t-82.5 -138.5q-4 -13 2 -24t19 -14l34 -9q4 -1 8 -1q22 0 28 21 q18 58 58.5 98.5t97.5 58.5q12 3 18 13.5t3 21.5l-9 35q-3 12 -14 19q-7 4 -15 4zM719.5 719.5q-49.5 49.5 -119.5 49.5t-119.5 -49.5t-49.5 -119.5t49.5 -119.5t119.5 -49.5t119.5 49.5t49.5 119.5t-49.5 119.5zM855 551q-22 0 -28 -21q-18 -58 -58.5 -98.5t-98.5 -57.5 q-11 -4 -17 -14.5t-3 -21.5l9 -35q3 -12 14 -19q7 -4 15 -4q4 0 9 2q80 24 138.5 82.5t82.5 138.5q4 13 -2.5 24t-18.5 14l-34 9q-4 1 -8 1zM1000 515q-23 0 -29 -22q-27 -96 -98 -166q-70 -71 -166 -98q-11 -3 -17.5 -13.5t-3.5 -22.5l9 -35q3 -13 14 -19q7 -4 15 -4 q4 0 8 1q121 34 209.5 122.5t122.5 209.5q4 12 -2.5 23t-18.5 14l-36 9q-3 1 -7 1z" />
<glyph unicode="&#xe202;" d="M700 800h300v-380h-180v200h-340v-200h-380v755q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM700 300h162l-212 -212l-212 212h162v200h100v-200zM520 0h-395q-10 0 -17.5 7.5t-7.5 17.5v395zM1000 220v-195q0 -10 -7.5 -17.5t-17.5 -7.5h-195z" />
<glyph unicode="&#xe203;" d="M700 800h300v-520l-350 350l-550 -550v1095q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM862 200h-162v-200h-100v200h-162l212 212zM480 0h-355q-10 0 -17.5 7.5t-7.5 17.5v55h380v-80zM1000 80v-55q0 -10 -7.5 -17.5t-17.5 -7.5h-155v80h180z" />
<glyph unicode="&#xe204;" d="M1162 800h-162v-200h100l100 -100h-300v300h-162l212 212zM200 800h200q27 0 40 -2t29.5 -10.5t23.5 -30t7 -57.5h300v-100h-600l-200 -350v450h100q0 36 7 57.5t23.5 30t29.5 10.5t40 2zM800 400h240l-240 -400h-800l300 500h500v-100z" />
<glyph unicode="&#xe205;" d="M650 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM1000 850v150q41 0 70.5 -29.5t29.5 -70.5v-800 q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-1 0 -20 4l246 246l-326 326v324q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM412 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe206;" d="M450 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM800 850v150q41 0 70.5 -29.5t29.5 -70.5v-500 h-200v-300h200q0 -36 -7 -57.5t-23.5 -30t-29.5 -10.5t-40 -2h-600q-41 0 -70.5 29.5t-29.5 70.5v800q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM1212 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe209;" d="M658 1197l637 -1104q23 -38 7 -65.5t-60 -27.5h-1276q-44 0 -60 27.5t7 65.5l637 1104q22 39 54 39t54 -39zM704 800h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM500 300v-100h200 v100h-200z" />
<glyph unicode="&#xe210;" d="M425 1100h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM825 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM25 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5zM425 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5 v150q0 10 7.5 17.5t17.5 7.5zM25 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe211;" d="M700 1200h100v-200h-100v-100h350q62 0 86.5 -39.5t-3.5 -94.5l-66 -132q-41 -83 -81 -134h-772q-40 51 -81 134l-66 132q-28 55 -3.5 94.5t86.5 39.5h350v100h-100v200h100v100h200v-100zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100 h-950l138 100h-13q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe212;" d="M600 1300q40 0 68.5 -29.5t28.5 -70.5h-194q0 41 28.5 70.5t68.5 29.5zM443 1100h314q18 -37 18 -75q0 -8 -3 -25h328q41 0 44.5 -16.5t-30.5 -38.5l-175 -145h-678l-178 145q-34 22 -29 38.5t46 16.5h328q-3 17 -3 25q0 38 18 75zM250 700h700q21 0 35.5 -14.5 t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-150v-200l275 -200h-950l275 200v200h-150q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe213;" d="M600 1181q75 0 128 -53t53 -128t-53 -128t-128 -53t-128 53t-53 128t53 128t128 53zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13 l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe214;" d="M600 1300q47 0 92.5 -53.5t71 -123t25.5 -123.5q0 -78 -55.5 -133.5t-133.5 -55.5t-133.5 55.5t-55.5 133.5q0 62 34 143l144 -143l111 111l-163 163q34 26 63 26zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45 zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe215;" d="M600 1200l300 -161v-139h-300q0 -57 18.5 -108t50 -91.5t63 -72t70 -67.5t57.5 -61h-530q-60 83 -90.5 177.5t-30.5 178.5t33 164.5t87.5 139.5t126 96.5t145.5 41.5v-98zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100 h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe216;" d="M600 1300q41 0 70.5 -29.5t29.5 -70.5v-78q46 -26 73 -72t27 -100v-50h-400v50q0 54 27 100t73 72v78q0 41 29.5 70.5t70.5 29.5zM400 800h400q54 0 100 -27t72 -73h-172v-100h200v-100h-200v-100h200v-100h-200v-100h200q0 -83 -58.5 -141.5t-141.5 -58.5h-400 q-83 0 -141.5 58.5t-58.5 141.5v400q0 83 58.5 141.5t141.5 58.5z" />
<glyph unicode="&#xe218;" d="M150 1100h900q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM125 400h950q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-283l224 -224q13 -13 13 -31.5t-13 -32 t-31.5 -13.5t-31.5 13l-88 88h-524l-87 -88q-13 -13 -32 -13t-32 13.5t-13 32t13 31.5l224 224h-289q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM541 300l-100 -100h324l-100 100h-124z" />
<glyph unicode="&#xe219;" d="M200 1100h800q83 0 141.5 -58.5t58.5 -141.5v-200h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100v200q0 83 58.5 141.5t141.5 58.5zM100 600h1000q41 0 70.5 -29.5 t29.5 -70.5v-300h-1200v300q0 41 29.5 70.5t70.5 29.5zM300 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200zM1100 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200z" />
<glyph unicode="&#xe221;" d="M480 1165l682 -683q31 -31 31 -75.5t-31 -75.5l-131 -131h-481l-517 518q-32 31 -32 75.5t32 75.5l295 296q31 31 75.5 31t76.5 -31zM108 794l342 -342l303 304l-341 341zM250 100h800q21 0 35.5 -14.5t14.5 -35.5v-50h-900v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe223;" d="M1057 647l-189 506q-8 19 -27.5 33t-40.5 14h-400q-21 0 -40.5 -14t-27.5 -33l-189 -506q-8 -19 1.5 -33t30.5 -14h625v-150q0 -21 14.5 -35.5t35.5 -14.5t35.5 14.5t14.5 35.5v150h125q21 0 30.5 14t1.5 33zM897 0h-595v50q0 21 14.5 35.5t35.5 14.5h50v50 q0 21 14.5 35.5t35.5 14.5h48v300h200v-300h47q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-50z" />
<glyph unicode="&#xe224;" d="M900 800h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-375v591l-300 300v84q0 10 7.5 17.5t17.5 7.5h375v-400zM1200 900h-200v200zM400 600h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-650q-10 0 -17.5 7.5t-7.5 17.5v950q0 10 7.5 17.5t17.5 7.5h375v-400zM700 700h-200v200z " />
<glyph unicode="&#xe225;" d="M484 1095h195q75 0 146 -32.5t124 -86t89.5 -122.5t48.5 -142q18 -14 35 -20q31 -10 64.5 6.5t43.5 48.5q10 34 -15 71q-19 27 -9 43q5 8 12.5 11t19 -1t23.5 -16q41 -44 39 -105q-3 -63 -46 -106.5t-104 -43.5h-62q-7 -55 -35 -117t-56 -100l-39 -234q-3 -20 -20 -34.5 t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l12 70q-49 -14 -91 -14h-195q-24 0 -65 8l-11 -64q-3 -20 -20 -34.5t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l26 157q-84 74 -128 175l-159 53q-19 7 -33 26t-14 40v50q0 21 14.5 35.5t35.5 14.5h124q11 87 56 166l-111 95 q-16 14 -12.5 23.5t24.5 9.5h203q116 101 250 101zM675 1000h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h250q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe226;" d="M641 900l423 247q19 8 42 2.5t37 -21.5l32 -38q14 -15 12.5 -36t-17.5 -34l-139 -120h-390zM50 1100h106q67 0 103 -17t66 -71l102 -212h823q21 0 35.5 -14.5t14.5 -35.5v-50q0 -21 -14 -40t-33 -26l-737 -132q-23 -4 -40 6t-26 25q-42 67 -100 67h-300q-62 0 -106 44 t-44 106v200q0 62 44 106t106 44zM173 928h-80q-19 0 -28 -14t-9 -35v-56q0 -51 42 -51h134q16 0 21.5 8t5.5 24q0 11 -16 45t-27 51q-18 28 -43 28zM550 727q-32 0 -54.5 -22.5t-22.5 -54.5t22.5 -54.5t54.5 -22.5t54.5 22.5t22.5 54.5t-22.5 54.5t-54.5 22.5zM130 389 l152 130q18 19 34 24t31 -3.5t24.5 -17.5t25.5 -28q28 -35 50.5 -51t48.5 -13l63 5l48 -179q13 -61 -3.5 -97.5t-67.5 -79.5l-80 -69q-47 -40 -109 -35.5t-103 51.5l-130 151q-40 47 -35.5 109.5t51.5 102.5zM380 377l-102 -88q-31 -27 2 -65l37 -43q13 -15 27.5 -19.5 t31.5 6.5l61 53q19 16 14 49q-2 20 -12 56t-17 45q-11 12 -19 14t-23 -8z" />
<glyph unicode="&#xe227;" d="M625 1200h150q10 0 17.5 -7.5t7.5 -17.5v-109q79 -33 131 -87.5t53 -128.5q1 -46 -15 -84.5t-39 -61t-46 -38t-39 -21.5l-17 -6q6 0 15 -1.5t35 -9t50 -17.5t53 -30t50 -45t35.5 -64t14.5 -84q0 -59 -11.5 -105.5t-28.5 -76.5t-44 -51t-49.5 -31.5t-54.5 -16t-49.5 -6.5 t-43.5 -1v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-100v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-175q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v600h-75q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5h175v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h100v75q0 10 7.5 17.5t17.5 7.5zM400 900v-200h263q28 0 48.5 10.5t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-263zM400 500v-200h363q28 0 48.5 10.5 t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-363z" />
<glyph unicode="&#xe230;" d="M212 1198h780q86 0 147 -61t61 -147v-416q0 -51 -18 -142.5t-36 -157.5l-18 -66q-29 -87 -93.5 -146.5t-146.5 -59.5h-572q-82 0 -147 59t-93 147q-8 28 -20 73t-32 143.5t-20 149.5v416q0 86 61 147t147 61zM600 1045q-70 0 -132.5 -11.5t-105.5 -30.5t-78.5 -41.5 t-57 -45t-36 -41t-20.5 -30.5l-6 -12l156 -243h560l156 243q-2 5 -6 12.5t-20 29.5t-36.5 42t-57 44.5t-79 42t-105 29.5t-132.5 12zM762 703h-157l195 261z" />
<glyph unicode="&#xe231;" d="M475 1300h150q103 0 189 -86t86 -189v-500q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe232;" d="M475 1300h96q0 -150 89.5 -239.5t239.5 -89.5v-446q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe233;" d="M1294 767l-638 -283l-378 170l-78 -60v-224l100 -150v-199l-150 148l-150 -149v200l100 150v250q0 4 -0.5 10.5t0 9.5t1 8t3 8t6.5 6l47 40l-147 65l642 283zM1000 380l-350 -166l-350 166v147l350 -165l350 165v-147z" />
<glyph unicode="&#xe234;" d="M250 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM650 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM1050 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe235;" d="M550 1100q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 700q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 300q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe236;" d="M125 1100h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM125 700h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM125 300h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe237;" d="M350 1200h500q162 0 256 -93.5t94 -256.5v-500q0 -165 -93.5 -257.5t-256.5 -92.5h-500q-165 0 -257.5 92.5t-92.5 257.5v500q0 165 92.5 257.5t257.5 92.5zM900 1000h-600q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h600q41 0 70.5 29.5 t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5zM350 900h500q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-500q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 14.5 35.5t35.5 14.5zM400 800v-200h400v200h-400z" />
<glyph unicode="&#xe238;" d="M150 1100h1000q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe239;" d="M650 1187q87 -67 118.5 -156t0 -178t-118.5 -155q-87 66 -118.5 155t0 178t118.5 156zM300 800q124 0 212 -88t88 -212q-124 0 -212 88t-88 212zM1000 800q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM300 500q124 0 212 -88t88 -212q-124 0 -212 88t-88 212z M1000 500q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM700 199v-144q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v142q40 -4 43 -4q17 0 57 6z" />
<glyph unicode="&#xe240;" d="M745 878l69 19q25 6 45 -12l298 -295q11 -11 15 -26.5t-2 -30.5q-5 -14 -18 -23.5t-28 -9.5h-8q1 0 1 -13q0 -29 -2 -56t-8.5 -62t-20 -63t-33 -53t-51 -39t-72.5 -14h-146q-184 0 -184 288q0 24 10 47q-20 4 -62 4t-63 -4q11 -24 11 -47q0 -288 -184 -288h-142 q-48 0 -84.5 21t-56 51t-32 71.5t-16 75t-3.5 68.5q0 13 2 13h-7q-15 0 -27.5 9.5t-18.5 23.5q-6 15 -2 30.5t15 25.5l298 296q20 18 46 11l76 -19q20 -5 30.5 -22.5t5.5 -37.5t-22.5 -31t-37.5 -5l-51 12l-182 -193h891l-182 193l-44 -12q-20 -5 -37.5 6t-22.5 31t6 37.5 t31 22.5z" />
<glyph unicode="&#xe241;" d="M1200 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM500 450h-25q0 15 -4 24.5t-9 14.5t-17 7.5t-20 3t-25 0.5h-100v-425q0 -11 12.5 -17.5t25.5 -7.5h12v-50h-200v50q50 0 50 25v425h-100q-17 0 -25 -0.5t-20 -3t-17 -7.5t-9 -14.5t-4 -24.5h-25v150h500v-150z" />
<glyph unicode="&#xe242;" d="M1000 300v50q-25 0 -55 32q-14 14 -25 31t-16 27l-4 11l-289 747h-69l-300 -754q-18 -35 -39 -56q-9 -9 -24.5 -18.5t-26.5 -14.5l-11 -5v-50h273v50q-49 0 -78.5 21.5t-11.5 67.5l69 176h293l61 -166q13 -34 -3.5 -66.5t-55.5 -32.5v-50h312zM412 691l134 342l121 -342 h-255zM1100 150v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe243;" d="M50 1200h1100q21 0 35.5 -14.5t14.5 -35.5v-1100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5zM611 1118h-70q-13 0 -18 -12l-299 -753q-17 -32 -35 -51q-18 -18 -56 -34q-12 -5 -12 -18v-50q0 -8 5.5 -14t14.5 -6 h273q8 0 14 6t6 14v50q0 8 -6 14t-14 6q-55 0 -71 23q-10 14 0 39l63 163h266l57 -153q11 -31 -6 -55q-12 -17 -36 -17q-8 0 -14 -6t-6 -14v-50q0 -8 6 -14t14 -6h313q8 0 14 6t6 14v50q0 7 -5.5 13t-13.5 7q-17 0 -42 25q-25 27 -40 63h-1l-288 748q-5 12 -19 12zM639 611 h-197l103 264z" />
<glyph unicode="&#xe244;" d="M1200 1100h-1200v100h1200v-100zM50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 1000h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM700 900v-300h300v300h-300z" />
<glyph unicode="&#xe245;" d="M50 1200h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 700h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM700 600v-300h300v300h-300zM1200 0h-1200v100h1200v-100z" />
<glyph unicode="&#xe246;" d="M50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-350h100v150q0 21 14.5 35.5t35.5 14.5h400q21 0 35.5 -14.5t14.5 -35.5v-150h100v-100h-100v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v150h-100v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM700 700v-300h300v300h-300z" />
<glyph unicode="&#xe247;" d="M100 0h-100v1200h100v-1200zM250 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM300 1000v-300h300v300h-300zM250 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe248;" d="M600 1100h150q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-100h450q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h350v100h-150q-21 0 -35.5 14.5 t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h150v100h100v-100zM400 1000v-300h300v300h-300z" />
<glyph unicode="&#xe249;" d="M1200 0h-100v1200h100v-1200zM550 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM600 1000v-300h300v300h-300zM50 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe250;" d="M865 565l-494 -494q-23 -23 -41 -23q-14 0 -22 13.5t-8 38.5v1000q0 25 8 38.5t22 13.5q18 0 41 -23l494 -494q14 -14 14 -35t-14 -35z" />
<glyph unicode="&#xe251;" d="M335 635l494 494q29 29 50 20.5t21 -49.5v-1000q0 -41 -21 -49.5t-50 20.5l-494 494q-14 14 -14 35t14 35z" />
<glyph unicode="&#xe252;" d="M100 900h1000q41 0 49.5 -21t-20.5 -50l-494 -494q-14 -14 -35 -14t-35 14l-494 494q-29 29 -20.5 50t49.5 21z" />
<glyph unicode="&#xe253;" d="M635 865l494 -494q29 -29 20.5 -50t-49.5 -21h-1000q-41 0 -49.5 21t20.5 50l494 494q14 14 35 14t35 -14z" />
<glyph unicode="&#xe254;" d="M700 741v-182l-692 -323v221l413 193l-413 193v221zM1200 0h-800v200h800v-200z" />
<glyph unicode="&#xe255;" d="M1200 900h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300zM0 700h50q0 21 4 37t9.5 26.5t18 17.5t22 11t28.5 5.5t31 2t37 0.5h100v-550q0 -22 -25 -34.5t-50 -13.5l-25 -2v-100h400v100q-4 0 -11 0.5t-24 3t-30 7t-24 15t-11 24.5v550h100q25 0 37 -0.5t31 -2 t28.5 -5.5t22 -11t18 -17.5t9.5 -26.5t4 -37h50v300h-800v-300z" />
<glyph unicode="&#xe256;" d="M800 700h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-100v-550q0 -22 25 -34.5t50 -14.5l25 -1v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v550h-100q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h800v-300zM1100 200h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300z" />
<glyph unicode="&#xe257;" d="M701 1098h160q16 0 21 -11t-7 -23l-464 -464l464 -464q12 -12 7 -23t-21 -11h-160q-13 0 -23 9l-471 471q-7 8 -7 18t7 18l471 471q10 9 23 9z" />
<glyph unicode="&#xe258;" d="M339 1098h160q13 0 23 -9l471 -471q7 -8 7 -18t-7 -18l-471 -471q-10 -9 -23 -9h-160q-16 0 -21 11t7 23l464 464l-464 464q-12 12 -7 23t21 11z" />
<glyph unicode="&#xe259;" d="M1087 882q11 -5 11 -21v-160q0 -13 -9 -23l-471 -471q-8 -7 -18 -7t-18 7l-471 471q-9 10 -9 23v160q0 16 11 21t23 -7l464 -464l464 464q12 12 23 7z" />
<glyph unicode="&#xe260;" d="M618 993l471 -471q9 -10 9 -23v-160q0 -16 -11 -21t-23 7l-464 464l-464 -464q-12 -12 -23 -7t-11 21v160q0 13 9 23l471 471q8 7 18 7t18 -7z" />
<glyph unicode="&#xf8ff;" d="M1000 1200q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM450 1000h100q21 0 40 -14t26 -33l79 -194q5 1 16 3q34 6 54 9.5t60 7t65.5 1t61 -10t56.5 -23t42.5 -42t29 -64t5 -92t-19.5 -121.5q-1 -7 -3 -19.5t-11 -50t-20.5 -73t-32.5 -81.5t-46.5 -83t-64 -70 t-82.5 -50q-13 -5 -42 -5t-65.5 2.5t-47.5 2.5q-14 0 -49.5 -3.5t-63 -3.5t-43.5 7q-57 25 -104.5 78.5t-75 111.5t-46.5 112t-26 90l-7 35q-15 63 -18 115t4.5 88.5t26 64t39.5 43.5t52 25.5t58.5 13t62.5 2t59.5 -4.5t55.5 -8l-147 192q-12 18 -5.5 30t27.5 12z" />
<glyph unicode="&#x1f511;" d="M250 1200h600q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-500l-255 -178q-19 -9 -32 -1t-13 29v650h-150q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM400 1100v-100h300v100h-300z" />
<glyph unicode="&#x1f6aa;" d="M250 1200h750q39 0 69.5 -40.5t30.5 -84.5v-933l-700 -117v950l600 125h-700v-1000h-100v1025q0 23 15.5 49t34.5 26zM500 525v-100l100 20v100z" />
</font>
</defs></svg> ) format('svg')}.glyphicon{position:relative;top:1px;display:inline-block;font-family:'Glyphicons Halflings';font-style:normal;font-weight:normal;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.glyphicon-asterisk:before{content:"\002a"}.glyphicon-plus:before{content:"\002b"}.glyphicon-euro:before,.glyphicon-eur:before{content:"\20ac"}.glyphicon-minus:before{content:"\2212"}.glyphicon-cloud:before{content:"\2601"}.glyphicon-envelope:before{content:"\2709"}.glyphicon-pencil:before{content:"\270f"}.glyphicon-glass:before{content:"\e001"}.glyphicon-music:before{content:"\e002"}.glyphicon-search:before{content:"\e003"}.glyphicon-heart:before{content:"\e005"}.glyphicon-star:before{content:"\e006"}.glyphicon-star-empty:before{content:"\e007"}.glyphicon-user:before{content:"\e008"}.glyphicon-film:before{content:"\e009"}.glyphicon-th-large:before{content:"\e010"}.glyphicon-th:before{content:"\e011"}.glyphicon-th-list:before{content:"\e012"}.glyphicon-ok:before{content:"\e013"}.glyphicon-remove:before{content:"\e014"}.glyphicon-zoom-in:before{content:"\e015"}.glyphicon-zoom-out:before{content:"\e016"}.glyphicon-off:before{content:"\e017"}.glyphicon-signal:before{content:"\e018"}.glyphicon-cog:before{content:"\e019"}.glyphicon-trash:before{content:"\e020"}.glyphicon-home:before{content:"\e021"}.glyphicon-file:before{content:"\e022"}.glyphicon-time:before{content:"\e023"}.glyphicon-road:before{content:"\e024"}.glyphicon-download-alt:before{content:"\e025"}.glyphicon-download:before{content:"\e026"}.glyphicon-upload:before{content:"\e027"}.glyphicon-inbox:before{content:"\e028"}.glyphicon-play-circle:before{content:"\e029"}.glyphicon-repeat:before{content:"\e030"}.glyphicon-refresh:before{content:"\e031"}.glyphicon-list-alt:before{content:"\e032"}.glyphicon-lock:before{content:"\e033"}.glyphicon-flag:before{content:"\e034"}.glyphicon-headphones:before{content:"\e035"}.glyphicon-volume-off:before{content:"\e036"}.glyphicon-volume-down:before{content:"\e037"}.glyphicon-volume-up:before{content:"\e038"}.glyphicon-qrcode:before{content:"\e039"}.glyphicon-barcode:before{content:"\e040"}.glyphicon-tag:before{content:"\e041"}.glyphicon-tags:before{content:"\e042"}.glyphicon-book:before{content:"\e043"}.glyphicon-bookmark:before{content:"\e044"}.glyphicon-print:before{content:"\e045"}.glyphicon-camera:before{content:"\e046"}.glyphicon-font:before{content:"\e047"}.glyphicon-bold:before{content:"\e048"}.glyphicon-italic:before{content:"\e049"}.glyphicon-text-height:before{content:"\e050"}.glyphicon-text-width:before{content:"\e051"}.glyphicon-align-left:before{content:"\e052"}.glyphicon-align-center:before{content:"\e053"}.glyphicon-align-right:before{content:"\e054"}.glyphicon-align-justify:before{content:"\e055"}.glyphicon-list:before{content:"\e056"}.glyphicon-indent-left:before{content:"\e057"}.glyphicon-indent-right:before{content:"\e058"}.glyphicon-facetime-video:before{content:"\e059"}.glyphicon-picture:before{content:"\e060"}.glyphicon-map-marker:before{content:"\e062"}.glyphicon-adjust:before{content:"\e063"}.glyphicon-tint:before{content:"\e064"}.glyphicon-edit:before{content:"\e065"}.glyphicon-share:before{content:"\e066"}.glyphicon-check:before{content:"\e067"}.glyphicon-move:before{content:"\e068"}.glyphicon-step-backward:before{content:"\e069"}.glyphicon-fast-backward:before{content:"\e070"}.glyphicon-backward:before{content:"\e071"}.glyphicon-play:before{content:"\e072"}.glyphicon-pause:before{content:"\e073"}.glyphicon-stop:before{content:"\e074"}.glyphicon-forward:before{content:"\e075"}.glyphicon-fast-forward:before{content:"\e076"}.glyphicon-step-forward:before{content:"\e077"}.glyphicon-eject:before{content:"\e078"}.glyphicon-chevron-left:before{content:"\e079"}.glyphicon-chevron-right:before{content:"\e080"}.glyphicon-plus-sign:before{content:"\e081"}.glyphicon-minus-sign:before{content:"\e082"}.glyphicon-remove-sign:before{content:"\e083"}.glyphicon-ok-sign:before{content:"\e084"}.glyphicon-question-sign:before{content:"\e085"}.glyphicon-info-sign:before{content:"\e086"}.glyphicon-screenshot:before{content:"\e087"}.glyphicon-remove-circle:before{content:"\e088"}.glyphicon-ok-circle:before{content:"\e089"}.glyphicon-ban-circle:before{content:"\e090"}.glyphicon-arrow-left:before{content:"\e091"}.glyphicon-arrow-right:before{content:"\e092"}.glyphicon-arrow-up:before{content:"\e093"}.glyphicon-arrow-down:before{content:"\e094"}.glyphicon-share-alt:before{content:"\e095"}.glyphicon-resize-full:before{content:"\e096"}.glyphicon-resize-small:before{content:"\e097"}.glyphicon-exclamation-sign:before{content:"\e101"}.glyphicon-gift:before{content:"\e102"}.glyphicon-leaf:before{content:"\e103"}.glyphicon-fire:before{content:"\e104"}.glyphicon-eye-open:before{content:"\e105"}.glyphicon-eye-close:before{content:"\e106"}.glyphicon-warning-sign:before{content:"\e107"}.glyphicon-plane:before{content:"\e108"}.glyphicon-calendar:before{content:"\e109"}.glyphicon-random:before{content:"\e110"}.glyphicon-comment:before{content:"\e111"}.glyphicon-magnet:before{content:"\e112"}.glyphicon-chevron-up:before{content:"\e113"}.glyphicon-chevron-down:before{content:"\e114"}.glyphicon-retweet:before{content:"\e115"}.glyphicon-shopping-cart:before{content:"\e116"}.glyphicon-folder-close:before{content:"\e117"}.glyphicon-folder-open:before{content:"\e118"}.glyphicon-resize-vertical:before{content:"\e119"}.glyphicon-resize-horizontal:before{content:"\e120"}.glyphicon-hdd:before{content:"\e121"}.glyphicon-bullhorn:before{content:"\e122"}.glyphicon-bell:before{content:"\e123"}.glyphicon-certificate:before{content:"\e124"}.glyphicon-thumbs-up:before{content:"\e125"}.glyphicon-thumbs-down:before{content:"\e126"}.glyphicon-hand-right:before{content:"\e127"}.glyphicon-hand-left:before{content:"\e128"}.glyphicon-hand-up:before{content:"\e129"}.glyphicon-hand-down:before{content:"\e130"}.glyphicon-circle-arrow-right:before{content:"\e131"}.glyphicon-circle-arrow-left:before{content:"\e132"}.glyphicon-circle-arrow-up:before{content:"\e133"}.glyphicon-circle-arrow-down:before{content:"\e134"}.glyphicon-globe:before{content:"\e135"}.glyphicon-wrench:before{content:"\e136"}.glyphicon-tasks:before{content:"\e137"}.glyphicon-filter:before{content:"\e138"}.glyphicon-briefcase:before{content:"\e139"}.glyphicon-fullscreen:before{content:"\e140"}.glyphicon-dashboard:before{content:"\e141"}.glyphicon-paperclip:before{content:"\e142"}.glyphicon-heart-empty:before{content:"\e143"}.glyphicon-link:before{content:"\e144"}.glyphicon-phone:before{content:"\e145"}.glyphicon-pushpin:before{content:"\e146"}.glyphicon-usd:before{content:"\e148"}.glyphicon-gbp:before{content:"\e149"}.glyphicon-sort:before{content:"\e150"}.glyphicon-sort-by-alphabet:before{content:"\e151"}.glyphicon-sort-by-alphabet-alt:before{content:"\e152"}.glyphicon-sort-by-order:before{content:"\e153"}.glyphicon-sort-by-order-alt:before{content:"\e154"}.glyphicon-sort-by-attributes:before{content:"\e155"}.glyphicon-sort-by-attributes-alt:before{content:"\e156"}.glyphicon-unchecked:before{content:"\e157"}.glyphicon-expand:before{content:"\e158"}.glyphicon-collapse-down:before{content:"\e159"}.glyphicon-collapse-up:before{content:"\e160"}.glyphicon-log-in:before{content:"\e161"}.glyphicon-flash:before{content:"\e162"}.glyphicon-log-out:before{content:"\e163"}.glyphicon-new-window:before{content:"\e164"}.glyphicon-record:before{content:"\e165"}.glyphicon-save:before{content:"\e166"}.glyphicon-open:before{content:"\e167"}.glyphicon-saved:before{content:"\e168"}.glyphicon-import:before{content:"\e169"}.glyphicon-export:before{content:"\e170"}.glyphicon-send:before{content:"\e171"}.glyphicon-floppy-disk:before{content:"\e172"}.glyphicon-floppy-saved:before{content:"\e173"}.glyphicon-floppy-remove:before{content:"\e174"}.glyphicon-floppy-save:before{content:"\e175"}.glyphicon-floppy-open:before{content:"\e176"}.glyphicon-credit-card:before{content:"\e177"}.glyphicon-transfer:before{content:"\e178"}.glyphicon-cutlery:before{content:"\e179"}.glyphicon-header:before{content:"\e180"}.glyphicon-compressed:before{content:"\e181"}.glyphicon-earphone:before{content:"\e182"}.glyphicon-phone-alt:before{content:"\e183"}.glyphicon-tower:before{content:"\e184"}.glyphicon-stats:before{content:"\e185"}.glyphicon-sd-video:before{content:"\e186"}.glyphicon-hd-video:before{content:"\e187"}.glyphicon-subtitles:before{content:"\e188"}.glyphicon-sound-stereo:before{content:"\e189"}.glyphicon-sound-dolby:before{content:"\e190"}.glyphicon-sound-5-1:before{content:"\e191"}.glyphicon-sound-6-1:before{content:"\e192"}.glyphicon-sound-7-1:before{content:"\e193"}.glyphicon-copyright-mark:before{content:"\e194"}.glyphicon-registration-mark:before{content:"\e195"}.glyphicon-cloud-download:before{content:"\e197"}.glyphicon-cloud-upload:before{content:"\e198"}.glyphicon-tree-conifer:before{content:"\e199"}.glyphicon-tree-deciduous:before{content:"\e200"}.glyphicon-cd:before{content:"\e201"}.glyphicon-save-file:before{content:"\e202"}.glyphicon-open-file:before{content:"\e203"}.glyphicon-level-up:before{content:"\e204"}.glyphicon-copy:before{content:"\e205"}.glyphicon-paste:before{content:"\e206"}.glyphicon-alert:before{content:"\e209"}.glyphicon-equalizer:before{content:"\e210"}.glyphicon-king:before{content:"\e211"}.glyphicon-queen:before{content:"\e212"}.glyphicon-pawn:before{content:"\e213"}.glyphicon-bishop:before{content:"\e214"}.glyphicon-knight:before{content:"\e215"}.glyphicon-baby-formula:before{content:"\e216"}.glyphicon-tent:before{content:"\26fa"}.glyphicon-blackboard:before{content:"\e218"}.glyphicon-bed:before{content:"\e219"}.glyphicon-apple:before{content:"\f8ff"}.glyphicon-erase:before{content:"\e221"}.glyphicon-hourglass:before{content:"\231b"}.glyphicon-lamp:before{content:"\e223"}.glyphicon-duplicate:before{content:"\e224"}.glyphicon-piggy-bank:before{content:"\e225"}.glyphicon-scissors:before{content:"\e226"}.glyphicon-bitcoin:before{content:"\e227"}.glyphicon-btc:before{content:"\e227"}.glyphicon-xbt:before{content:"\e227"}.glyphicon-yen:before{content:"\00a5"}.glyphicon-jpy:before{content:"\00a5"}.glyphicon-ruble:before{content:"\20bd"}.glyphicon-rub:before{content:"\20bd"}.glyphicon-scale:before{content:"\e230"}.glyphicon-ice-lolly:before{content:"\e231"}.glyphicon-ice-lolly-tasted:before{content:"\e232"}.glyphicon-education:before{content:"\e233"}.glyphicon-option-horizontal:before{content:"\e234"}.glyphicon-option-vertical:before{content:"\e235"}.glyphicon-menu-hamburger:before{content:"\e236"}.glyphicon-modal-window:before{content:"\e237"}.glyphicon-oil:before{content:"\e238"}.glyphicon-grain:before{content:"\e239"}.glyphicon-sunglasses:before{content:"\e240"}.glyphicon-text-size:before{content:"\e241"}.glyphicon-text-color:before{content:"\e242"}.glyphicon-text-background:before{content:"\e243"}.glyphicon-object-align-top:before{content:"\e244"}.glyphicon-object-align-bottom:before{content:"\e245"}.glyphicon-object-align-horizontal:before{content:"\e246"}.glyphicon-object-align-left:before{content:"\e247"}.glyphicon-object-align-vertical:before{content:"\e248"}.glyphicon-object-align-right:before{content:"\e249"}.glyphicon-triangle-right:before{content:"\e250"}.glyphicon-triangle-left:before{content:"\e251"}.glyphicon-triangle-bottom:before{content:"\e252"}.glyphicon-triangle-top:before{content:"\e253"}.glyphicon-console:before{content:"\e254"}.glyphicon-superscript:before{content:"\e255"}.glyphicon-subscript:before{content:"\e256"}.glyphicon-menu-left:before{content:"\e257"}.glyphicon-menu-right:before{content:"\e258"}.glyphicon-menu-down:before{content:"\e259"}.glyphicon-menu-up:before{content:"\e260"}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}*:before,*:after{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:rgba(0,0,0,0)}body{font-family:"Open Sans","Helvetica Neue",Helvetica,Arial,sans-serif;font-size:15px;line-height:1.4;color:#222222;background-color:#ffffff}input,button,select,textarea{font-family:inherit;font-size:inherit;line-height:inherit}a{color:#008cba;text-decoration:none}a:hover,a:focus{color:#008cba;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}figure{margin:0}img{vertical-align:middle}.img-responsive,.thumbnail>img,.thumbnail a>img,.carousel-inner>.item>img,.carousel-inner>.item>a>img{display:block;max-width:100%;height:auto}.img-rounded{border-radius:0}.img-thumbnail{padding:4px;line-height:1.4;background-color:#ffffff;border:1px solid #dddddd;border-radius:0;-webkit-transition:all .2s ease-in-out;-o-transition:all .2s ease-in-out;transition:all .2s ease-in-out;display:inline-block;max-width:100%;height:auto}.img-circle{border-radius:50%}hr{margin-top:21px;margin-bottom:21px;border:0;border-top:1px solid #dddddd}.sr-only{position:absolute;width:1px;height:1px;margin:-1px;padding:0;overflow:hidden;clip:rect(0, 0, 0, 0);border:0}.sr-only-focusable:active,.sr-only-focusable:focus{position:static;width:auto;height:auto;margin:0;overflow:visible;clip:auto}[role="button"]{cursor:pointer}h1,h2,h3,h4,h5,h6,.h1,.h2,.h3,.h4,.h5,.h6{font-family:"Open Sans","Helvetica Neue",Helvetica,Arial,sans-serif;font-weight:300;line-height:1.1;color:inherit}h1 small,h2 small,h3 small,h4 small,h5 small,h6 small,.h1 small,.h2 small,.h3 small,.h4 small,.h5 small,.h6 small,h1 .small,h2 .small,h3 .small,h4 .small,h5 .small,h6 .small,.h1 .small,.h2 .small,.h3 .small,.h4 .small,.h5 .small,.h6 .small{font-weight:normal;line-height:1;color:#999999}h1,.h1,h2,.h2,h3,.h3{margin-top:21px;margin-bottom:10.5px}h1 small,.h1 small,h2 small,.h2 small,h3 small,.h3 small,h1 .small,.h1 .small,h2 .small,.h2 .small,h3 .small,.h3 .small{font-size:65%}h4,.h4,h5,.h5,h6,.h6{margin-top:10.5px;margin-bottom:10.5px}h4 small,.h4 small,h5 small,.h5 small,h6 small,.h6 small,h4 .small,.h4 .small,h5 .small,.h5 .small,h6 .small,.h6 .small{font-size:75%}h1,.h1{font-size:39px}h2,.h2{font-size:32px}h3,.h3{font-size:26px}h4,.h4{font-size:19px}h5,.h5{font-size:15px}h6,.h6{font-size:13px}p{margin:0 0 10.5px}.lead{margin-bottom:21px;font-size:17px;font-weight:300;line-height:1.4}@media (min-width:768px){.lead{font-size:22.5px}}small,.small{font-size:80%}mark,.mark{background-color:#fcf8e3;padding:.2em}.text-left{text-align:left}.text-right{text-align:right}.text-center{text-align:center}.text-justify{text-align:justify}.text-nowrap{white-space:nowrap}.text-lowercase{text-transform:lowercase}.text-uppercase{text-transform:uppercase}.text-capitalize{text-transform:capitalize}.text-muted{color:#999999}.text-primary{color:#008cba}a.text-primary:hover,a.text-primary:focus{color:#006687}.text-success{color:#43ac6a}a.text-success:hover,a.text-success:focus{color:#358753}.text-info{color:#5bc0de}a.text-info:hover,a.text-info:focus{color:#31b0d5}.text-warning{color:#e99002}a.text-warning:hover,a.text-warning:focus{color:#b67102}.text-danger{color:#f04124}a.text-danger:hover,a.text-danger:focus{color:#d32a0e}.bg-primary{color:#fff;background-color:#008cba}a.bg-primary:hover,a.bg-primary:focus{background-color:#006687}.bg-success{background-color:#dff0d8}a.bg-success:hover,a.bg-success:focus{background-color:#c1e2b3}.bg-info{background-color:#d9edf7}a.bg-info:hover,a.bg-info:focus{background-color:#afd9ee}.bg-warning{background-color:#fcf8e3}a.bg-warning:hover,a.bg-warning:focus{background-color:#f7ecb5}.bg-danger{background-color:#f2dede}a.bg-danger:hover,a.bg-danger:focus{background-color:#e4b9b9}.page-header{padding-bottom:9.5px;margin:42px 0 21px;border-bottom:1px solid #dddddd}ul,ol{margin-top:0;margin-bottom:10.5px}ul ul,ol ul,ul ol,ol ol{margin-bottom:0}.list-unstyled{padding-left:0;list-style:none}.list-inline{padding-left:0;list-style:none;margin-left:-5px}.list-inline>li{display:inline-block;padding-left:5px;padding-right:5px}dl{margin-top:0;margin-bottom:21px}dt,dd{line-height:1.4}dt{font-weight:bold}dd{margin-left:0}@media (min-width:768px){.dl-horizontal dt{float:left;width:160px;clear:left;text-align:right;overflow:hidden;text-overflow:ellipsis;white-space:nowrap}.dl-horizontal dd{margin-left:180px}}abbr[title],abbr[data-original-title]{cursor:help;border-bottom:1px dotted #999999}.initialism{font-size:90%;text-transform:uppercase}blockquote{padding:10.5px 21px;margin:0 0 21px;font-size:18.75px;border-left:5px solid #dddddd}blockquote p:last-child,blockquote ul:last-child,blockquote ol:last-child{margin-bottom:0}blockquote footer,blockquote small,blockquote .small{display:block;font-size:80%;line-height:1.4;color:#6f6f6f}blockquote footer:before,blockquote small:before,blockquote .small:before{content:'\2014 \00A0'}.blockquote-reverse,blockquote.pull-right{padding-right:15px;padding-left:0;border-right:5px solid #dddddd;border-left:0;text-align:right}.blockquote-reverse footer:before,blockquote.pull-right footer:before,.blockquote-reverse small:before,blockquote.pull-right small:before,.blockquote-reverse .small:before,blockquote.pull-right .small:before{content:''}.blockquote-reverse footer:after,blockquote.pull-right footer:after,.blockquote-reverse small:after,blockquote.pull-right small:after,.blockquote-reverse .small:after,blockquote.pull-right .small:after{content:'\00A0 \2014'}address{margin-bottom:21px;font-style:normal;line-height:1.4}code,kbd,pre,samp{font-family:monospace}code{padding:2px 4px;font-size:90%;color:#c7254e;background-color:#f9f2f4;border-radius:0}kbd{padding:2px 4px;font-size:90%;color:#ffffff;background-color:#333333;border-radius:0;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,0.25);box-shadow:inset 0 -1px 0 rgba(0,0,0,0.25)}kbd kbd{padding:0;font-size:100%;font-weight:bold;-webkit-box-shadow:none;box-shadow:none}pre{display:block;padding:10px;margin:0 0 10.5px;font-size:14px;line-height:1.4;word-break:break-all;word-wrap:break-word;color:#333333;background-color:#f5f5f5;border:1px solid #cccccc;border-radius:0}pre code{padding:0;font-size:inherit;color:inherit;white-space:pre-wrap;background-color:transparent;border-radius:0}.pre-scrollable{max-height:340px;overflow-y:scroll}.container{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}.row{margin-left:-15px;margin-right:-15px}.col-xs-1,.col-sm-1,.col-md-1,.col-lg-1,.col-xs-2,.col-sm-2,.col-md-2,.col-lg-2,.col-xs-3,.col-sm-3,.col-md-3,.col-lg-3,.col-xs-4,.col-sm-4,.col-md-4,.col-lg-4,.col-xs-5,.col-sm-5,.col-md-5,.col-lg-5,.col-xs-6,.col-sm-6,.col-md-6,.col-lg-6,.col-xs-7,.col-sm-7,.col-md-7,.col-lg-7,.col-xs-8,.col-sm-8,.col-md-8,.col-lg-8,.col-xs-9,.col-sm-9,.col-md-9,.col-lg-9,.col-xs-10,.col-sm-10,.col-md-10,.col-lg-10,.col-xs-11,.col-sm-11,.col-md-11,.col-lg-11,.col-xs-12,.col-sm-12,.col-md-12,.col-lg-12{position:relative;min-height:1px;padding-left:15px;padding-right:15px}.col-xs-1,.col-xs-2,.col-xs-3,.col-xs-4,.col-xs-5,.col-xs-6,.col-xs-7,.col-xs-8,.col-xs-9,.col-xs-10,.col-xs-11,.col-xs-12{float:left}.col-xs-12{width:100%}.col-xs-11{width:91.66666667%}.col-xs-10{width:83.33333333%}.col-xs-9{width:75%}.col-xs-8{width:66.66666667%}.col-xs-7{width:58.33333333%}.col-xs-6{width:50%}.col-xs-5{width:41.66666667%}.col-xs-4{width:33.33333333%}.col-xs-3{width:25%}.col-xs-2{width:16.66666667%}.col-xs-1{width:8.33333333%}.col-xs-pull-12{right:100%}.col-xs-pull-11{right:91.66666667%}.col-xs-pull-10{right:83.33333333%}.col-xs-pull-9{right:75%}.col-xs-pull-8{right:66.66666667%}.col-xs-pull-7{right:58.33333333%}.col-xs-pull-6{right:50%}.col-xs-pull-5{right:41.66666667%}.col-xs-pull-4{right:33.33333333%}.col-xs-pull-3{right:25%}.col-xs-pull-2{right:16.66666667%}.col-xs-pull-1{right:8.33333333%}.col-xs-pull-0{right:auto}.col-xs-push-12{left:100%}.col-xs-push-11{left:91.66666667%}.col-xs-push-10{left:83.33333333%}.col-xs-push-9{left:75%}.col-xs-push-8{left:66.66666667%}.col-xs-push-7{left:58.33333333%}.col-xs-push-6{left:50%}.col-xs-push-5{left:41.66666667%}.col-xs-push-4{left:33.33333333%}.col-xs-push-3{left:25%}.col-xs-push-2{left:16.66666667%}.col-xs-push-1{left:8.33333333%}.col-xs-push-0{left:auto}.col-xs-offset-12{margin-left:100%}.col-xs-offset-11{margin-left:91.66666667%}.col-xs-offset-10{margin-left:83.33333333%}.col-xs-offset-9{margin-left:75%}.col-xs-offset-8{margin-left:66.66666667%}.col-xs-offset-7{margin-left:58.33333333%}.col-xs-offset-6{margin-left:50%}.col-xs-offset-5{margin-left:41.66666667%}.col-xs-offset-4{margin-left:33.33333333%}.col-xs-offset-3{margin-left:25%}.col-xs-offset-2{margin-left:16.66666667%}.col-xs-offset-1{margin-left:8.33333333%}.col-xs-offset-0{margin-left:0%}@media (min-width:768px){.col-sm-1,.col-sm-2,.col-sm-3,.col-sm-4,.col-sm-5,.col-sm-6,.col-sm-7,.col-sm-8,.col-sm-9,.col-sm-10,.col-sm-11,.col-sm-12{float:left}.col-sm-12{width:100%}.col-sm-11{width:91.66666667%}.col-sm-10{width:83.33333333%}.col-sm-9{width:75%}.col-sm-8{width:66.66666667%}.col-sm-7{width:58.33333333%}.col-sm-6{width:50%}.col-sm-5{width:41.66666667%}.col-sm-4{width:33.33333333%}.col-sm-3{width:25%}.col-sm-2{width:16.66666667%}.col-sm-1{width:8.33333333%}.col-sm-pull-12{right:100%}.col-sm-pull-11{right:91.66666667%}.col-sm-pull-10{right:83.33333333%}.col-sm-pull-9{right:75%}.col-sm-pull-8{right:66.66666667%}.col-sm-pull-7{right:58.33333333%}.col-sm-pull-6{right:50%}.col-sm-pull-5{right:41.66666667%}.col-sm-pull-4{right:33.33333333%}.col-sm-pull-3{right:25%}.col-sm-pull-2{right:16.66666667%}.col-sm-pull-1{right:8.33333333%}.col-sm-pull-0{right:auto}.col-sm-push-12{left:100%}.col-sm-push-11{left:91.66666667%}.col-sm-push-10{left:83.33333333%}.col-sm-push-9{left:75%}.col-sm-push-8{left:66.66666667%}.col-sm-push-7{left:58.33333333%}.col-sm-push-6{left:50%}.col-sm-push-5{left:41.66666667%}.col-sm-push-4{left:33.33333333%}.col-sm-push-3{left:25%}.col-sm-push-2{left:16.66666667%}.col-sm-push-1{left:8.33333333%}.col-sm-push-0{left:auto}.col-sm-offset-12{margin-left:100%}.col-sm-offset-11{margin-left:91.66666667%}.col-sm-offset-10{margin-left:83.33333333%}.col-sm-offset-9{margin-left:75%}.col-sm-offset-8{margin-left:66.66666667%}.col-sm-offset-7{margin-left:58.33333333%}.col-sm-offset-6{margin-left:50%}.col-sm-offset-5{margin-left:41.66666667%}.col-sm-offset-4{margin-left:33.33333333%}.col-sm-offset-3{margin-left:25%}.col-sm-offset-2{margin-left:16.66666667%}.col-sm-offset-1{margin-left:8.33333333%}.col-sm-offset-0{margin-left:0%}}@media (min-width:992px){.col-md-1,.col-md-2,.col-md-3,.col-md-4,.col-md-5,.col-md-6,.col-md-7,.col-md-8,.col-md-9,.col-md-10,.col-md-11,.col-md-12{float:left}.col-md-12{width:100%}.col-md-11{width:91.66666667%}.col-md-10{width:83.33333333%}.col-md-9{width:75%}.col-md-8{width:66.66666667%}.col-md-7{width:58.33333333%}.col-md-6{width:50%}.col-md-5{width:41.66666667%}.col-md-4{width:33.33333333%}.col-md-3{width:25%}.col-md-2{width:16.66666667%}.col-md-1{width:8.33333333%}.col-md-pull-12{right:100%}.col-md-pull-11{right:91.66666667%}.col-md-pull-10{right:83.33333333%}.col-md-pull-9{right:75%}.col-md-pull-8{right:66.66666667%}.col-md-pull-7{right:58.33333333%}.col-md-pull-6{right:50%}.col-md-pull-5{right:41.66666667%}.col-md-pull-4{right:33.33333333%}.col-md-pull-3{right:25%}.col-md-pull-2{right:16.66666667%}.col-md-pull-1{right:8.33333333%}.col-md-pull-0{right:auto}.col-md-push-12{left:100%}.col-md-push-11{left:91.66666667%}.col-md-push-10{left:83.33333333%}.col-md-push-9{left:75%}.col-md-push-8{left:66.66666667%}.col-md-push-7{left:58.33333333%}.col-md-push-6{left:50%}.col-md-push-5{left:41.66666667%}.col-md-push-4{left:33.33333333%}.col-md-push-3{left:25%}.col-md-push-2{left:16.66666667%}.col-md-push-1{left:8.33333333%}.col-md-push-0{left:auto}.col-md-offset-12{margin-left:100%}.col-md-offset-11{margin-left:91.66666667%}.col-md-offset-10{margin-left:83.33333333%}.col-md-offset-9{margin-left:75%}.col-md-offset-8{margin-left:66.66666667%}.col-md-offset-7{margin-left:58.33333333%}.col-md-offset-6{margin-left:50%}.col-md-offset-5{margin-left:41.66666667%}.col-md-offset-4{margin-left:33.33333333%}.col-md-offset-3{margin-left:25%}.col-md-offset-2{margin-left:16.66666667%}.col-md-offset-1{margin-left:8.33333333%}.col-md-offset-0{margin-left:0%}}@media (min-width:1200px){.col-lg-1,.col-lg-2,.col-lg-3,.col-lg-4,.col-lg-5,.col-lg-6,.col-lg-7,.col-lg-8,.col-lg-9,.col-lg-10,.col-lg-11,.col-lg-12{float:left}.col-lg-12{width:100%}.col-lg-11{width:91.66666667%}.col-lg-10{width:83.33333333%}.col-lg-9{width:75%}.col-lg-8{width:66.66666667%}.col-lg-7{width:58.33333333%}.col-lg-6{width:50%}.col-lg-5{width:41.66666667%}.col-lg-4{width:33.33333333%}.col-lg-3{width:25%}.col-lg-2{width:16.66666667%}.col-lg-1{width:8.33333333%}.col-lg-pull-12{right:100%}.col-lg-pull-11{right:91.66666667%}.col-lg-pull-10{right:83.33333333%}.col-lg-pull-9{right:75%}.col-lg-pull-8{right:66.66666667%}.col-lg-pull-7{right:58.33333333%}.col-lg-pull-6{right:50%}.col-lg-pull-5{right:41.66666667%}.col-lg-pull-4{right:33.33333333%}.col-lg-pull-3{right:25%}.col-lg-pull-2{right:16.66666667%}.col-lg-pull-1{right:8.33333333%}.col-lg-pull-0{right:auto}.col-lg-push-12{left:100%}.col-lg-push-11{left:91.66666667%}.col-lg-push-10{left:83.33333333%}.col-lg-push-9{left:75%}.col-lg-push-8{left:66.66666667%}.col-lg-push-7{left:58.33333333%}.col-lg-push-6{left:50%}.col-lg-push-5{left:41.66666667%}.col-lg-push-4{left:33.33333333%}.col-lg-push-3{left:25%}.col-lg-push-2{left:16.66666667%}.col-lg-push-1{left:8.33333333%}.col-lg-push-0{left:auto}.col-lg-offset-12{margin-left:100%}.col-lg-offset-11{margin-left:91.66666667%}.col-lg-offset-10{margin-left:83.33333333%}.col-lg-offset-9{margin-left:75%}.col-lg-offset-8{margin-left:66.66666667%}.col-lg-offset-7{margin-left:58.33333333%}.col-lg-offset-6{margin-left:50%}.col-lg-offset-5{margin-left:41.66666667%}.col-lg-offset-4{margin-left:33.33333333%}.col-lg-offset-3{margin-left:25%}.col-lg-offset-2{margin-left:16.66666667%}.col-lg-offset-1{margin-left:8.33333333%}.col-lg-offset-0{margin-left:0%}}table{background-color:transparent}caption{padding-top:8px;padding-bottom:8px;color:#999999;text-align:left}th{}.table{width:100%;max-width:100%;margin-bottom:21px}.table>thead>tr>th,.table>tbody>tr>th,.table>tfoot>tr>th,.table>thead>tr>td,.table>tbody>tr>td,.table>tfoot>tr>td{padding:8px;line-height:1.4;vertical-align:top;border-top:1px solid #dddddd}.table>thead>tr>th{vertical-align:bottom;border-bottom:2px solid #dddddd}.table>caption+thead>tr:first-child>th,.table>colgroup+thead>tr:first-child>th,.table>thead:first-child>tr:first-child>th,.table>caption+thead>tr:first-child>td,.table>colgroup+thead>tr:first-child>td,.table>thead:first-child>tr:first-child>td{border-top:0}.table>tbody+tbody{border-top:2px solid #dddddd}.table .table{background-color:#ffffff}.table-condensed>thead>tr>th,.table-condensed>tbody>tr>th,.table-condensed>tfoot>tr>th,.table-condensed>thead>tr>td,.table-condensed>tbody>tr>td,.table-condensed>tfoot>tr>td{padding:5px}.table-bordered{border:1px solid #dddddd}.table-bordered>thead>tr>th,.table-bordered>tbody>tr>th,.table-bordered>tfoot>tr>th,.table-bordered>thead>tr>td,.table-bordered>tbody>tr>td,.table-bordered>tfoot>tr>td{border:1px solid #dddddd}.table-bordered>thead>tr>th,.table-bordered>thead>tr>td{border-bottom-width:2px}.table-striped>tbody>tr:nth-of-type(odd){background-color:#f9f9f9}.table-hover>tbody>tr:hover{background-color:#f5f5f5}table col[class*="col-"]{position:static;float:none;display:table-column}table td[class*="col-"],table th[class*="col-"]{position:static;float:none;display:table-cell}.table>thead>tr>td.active,.table>tbody>tr>td.active,.table>tfoot>tr>td.active,.table>thead>tr>th.active,.table>tbody>tr>th.active,.table>tfoot>tr>th.active,.table>thead>tr.active>td,.table>tbody>tr.active>td,.table>tfoot>tr.active>td,.table>thead>tr.active>th,.table>tbody>tr.active>th,.table>tfoot>tr.active>th{background-color:#f5f5f5}.table-hover>tbody>tr>td.active:hover,.table-hover>tbody>tr>th.active:hover,.table-hover>tbody>tr.active:hover>td,.table-hover>tbody>tr:hover>.active,.table-hover>tbody>tr.active:hover>th{background-color:#e8e8e8}.table>thead>tr>td.success,.table>tbody>tr>td.success,.table>tfoot>tr>td.success,.table>thead>tr>th.success,.table>tbody>tr>th.success,.table>tfoot>tr>th.success,.table>thead>tr.success>td,.table>tbody>tr.success>td,.table>tfoot>tr.success>td,.table>thead>tr.success>th,.table>tbody>tr.success>th,.table>tfoot>tr.success>th{background-color:#dff0d8}.table-hover>tbody>tr>td.success:hover,.table-hover>tbody>tr>th.success:hover,.table-hover>tbody>tr.success:hover>td,.table-hover>tbody>tr:hover>.success,.table-hover>tbody>tr.success:hover>th{background-color:#d0e9c6}.table>thead>tr>td.info,.table>tbody>tr>td.info,.table>tfoot>tr>td.info,.table>thead>tr>th.info,.table>tbody>tr>th.info,.table>tfoot>tr>th.info,.table>thead>tr.info>td,.table>tbody>tr.info>td,.table>tfoot>tr.info>td,.table>thead>tr.info>th,.table>tbody>tr.info>th,.table>tfoot>tr.info>th{background-color:#d9edf7}.table-hover>tbody>tr>td.info:hover,.table-hover>tbody>tr>th.info:hover,.table-hover>tbody>tr.info:hover>td,.table-hover>tbody>tr:hover>.info,.table-hover>tbody>tr.info:hover>th{background-color:#c4e3f3}.table>thead>tr>td.warning,.table>tbody>tr>td.warning,.table>tfoot>tr>td.warning,.table>thead>tr>th.warning,.table>tbody>tr>th.warning,.table>tfoot>tr>th.warning,.table>thead>tr.warning>td,.table>tbody>tr.warning>td,.table>tfoot>tr.warning>td,.table>thead>tr.warning>th,.table>tbody>tr.warning>th,.table>tfoot>tr.warning>th{background-color:#fcf8e3}.table-hover>tbody>tr>td.warning:hover,.table-hover>tbody>tr>th.warning:hover,.table-hover>tbody>tr.warning:hover>td,.table-hover>tbody>tr:hover>.warning,.table-hover>tbody>tr.warning:hover>th{background-color:#faf2cc}.table>thead>tr>td.danger,.table>tbody>tr>td.danger,.table>tfoot>tr>td.danger,.table>thead>tr>th.danger,.table>tbody>tr>th.danger,.table>tfoot>tr>th.danger,.table>thead>tr.danger>td,.table>tbody>tr.danger>td,.table>tfoot>tr.danger>td,.table>thead>tr.danger>th,.table>tbody>tr.danger>th,.table>tfoot>tr.danger>th{background-color:#f2dede}.table-hover>tbody>tr>td.danger:hover,.table-hover>tbody>tr>th.danger:hover,.table-hover>tbody>tr.danger:hover>td,.table-hover>tbody>tr:hover>.danger,.table-hover>tbody>tr.danger:hover>th{background-color:#ebcccc}.table-responsive{overflow-x:auto;min-height:0.01%}@media screen and (max-width:767px){.table-responsive{width:100%;margin-bottom:15.75px;overflow-y:hidden;-ms-overflow-style:-ms-autohiding-scrollbar;border:1px solid #dddddd}.table-responsive>.table{margin-bottom:0}.table-responsive>.table>thead>tr>th,.table-responsive>.table>tbody>tr>th,.table-responsive>.table>tfoot>tr>th,.table-responsive>.table>thead>tr>td,.table-responsive>.table>tbody>tr>td,.table-responsive>.table>tfoot>tr>td{white-space:nowrap}.table-responsive>.table-bordered{border:0}.table-responsive>.table-bordered>thead>tr>th:first-child,.table-responsive>.table-bordered>tbody>tr>th:first-child,.table-responsive>.table-bordered>tfoot>tr>th:first-child,.table-responsive>.table-bordered>thead>tr>td:first-child,.table-responsive>.table-bordered>tbody>tr>td:first-child,.table-responsive>.table-bordered>tfoot>tr>td:first-child{border-left:0}.table-responsive>.table-bordered>thead>tr>th:last-child,.table-responsive>.table-bordered>tbody>tr>th:last-child,.table-responsive>.table-bordered>tfoot>tr>th:last-child,.table-responsive>.table-bordered>thead>tr>td:last-child,.table-responsive>.table-bordered>tbody>tr>td:last-child,.table-responsive>.table-bordered>tfoot>tr>td:last-child{border-right:0}.table-responsive>.table-bordered>tbody>tr:last-child>th,.table-responsive>.table-bordered>tfoot>tr:last-child>th,.table-responsive>.table-bordered>tbody>tr:last-child>td,.table-responsive>.table-bordered>tfoot>tr:last-child>td{border-bottom:0}}fieldset{padding:0;margin:0;border:0;min-width:0}legend{display:block;width:100%;padding:0;margin-bottom:21px;font-size:22.5px;line-height:inherit;color:#333333;border:0;border-bottom:1px solid #e5e5e5}label{display:inline-block;max-width:100%;margin-bottom:5px;font-weight:bold}input[type="search"]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}input[type="radio"],input[type="checkbox"]{margin:4px 0 0;margin-top:1px \9;line-height:normal}input[type="file"]{display:block}input[type="range"]{display:block;width:100%}select[multiple],select[size]{height:auto}input[type="file"]:focus,input[type="radio"]:focus,input[type="checkbox"]:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}output{display:block;padding-top:9px;font-size:15px;line-height:1.4;color:#6f6f6f}.form-control{display:block;width:100%;height:39px;padding:8px 12px;font-size:15px;line-height:1.4;color:#6f6f6f;background-color:#ffffff;background-image:none;border:1px solid #cccccc;border-radius:0;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);-webkit-transition:border-color ease-in-out .15s,-webkit-box-shadow ease-in-out .15s;-o-transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s;transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s}.form-control:focus{border-color:#66afe9;outline:0;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 8px rgba(102,175,233,0.6);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 8px rgba(102,175,233,0.6)}.form-control::-moz-placeholder{color:#999999;opacity:1}.form-control:-ms-input-placeholder{color:#999999}.form-control::-webkit-input-placeholder{color:#999999}.form-control::-ms-expand{border:0;background-color:transparent}.form-control[disabled],.form-control[readonly],fieldset[disabled] .form-control{background-color:#eeeeee;opacity:1}.form-control[disabled],fieldset[disabled] .form-control{cursor:not-allowed}textarea.form-control{height:auto}input[type="search"]{-webkit-appearance:none}@media screen and (-webkit-min-device-pixel-ratio:0){input[type="date"].form-control,input[type="time"].form-control,input[type="datetime-local"].form-control,input[type="month"].form-control{line-height:39px}input[type="date"].input-sm,input[type="time"].input-sm,input[type="datetime-local"].input-sm,input[type="month"].input-sm,.input-group-sm input[type="date"],.input-group-sm input[type="time"],.input-group-sm input[type="datetime-local"],.input-group-sm input[type="month"]{line-height:36px}input[type="date"].input-lg,input[type="time"].input-lg,input[type="datetime-local"].input-lg,input[type="month"].input-lg,.input-group-lg input[type="date"],.input-group-lg input[type="time"],.input-group-lg input[type="datetime-local"],.input-group-lg input[type="month"]{line-height:60px}}.form-group{margin-bottom:15px}.radio,.checkbox{position:relative;display:block;margin-top:10px;margin-bottom:10px}.radio label,.checkbox label{min-height:21px;padding-left:20px;margin-bottom:0;font-weight:normal;cursor:pointer}.radio input[type="radio"],.radio-inline input[type="radio"],.checkbox input[type="checkbox"],.checkbox-inline input[type="checkbox"]{position:absolute;margin-left:-20px;margin-top:4px \9}.radio+.radio,.checkbox+.checkbox{margin-top:-5px}.radio-inline,.checkbox-inline{position:relative;display:inline-block;padding-left:20px;margin-bottom:0;vertical-align:middle;font-weight:normal;cursor:pointer}.radio-inline+.radio-inline,.checkbox-inline+.checkbox-inline{margin-top:0;margin-left:10px}input[type="radio"][disabled],input[type="checkbox"][disabled],input[type="radio"].disabled,input[type="checkbox"].disabled,fieldset[disabled] input[type="radio"],fieldset[disabled] input[type="checkbox"]{cursor:not-allowed}.radio-inline.disabled,.checkbox-inline.disabled,fieldset[disabled] .radio-inline,fieldset[disabled] .checkbox-inline{cursor:not-allowed}.radio.disabled label,.checkbox.disabled label,fieldset[disabled] .radio label,fieldset[disabled] .checkbox label{cursor:not-allowed}.form-control-static{padding-top:9px;padding-bottom:9px;margin-bottom:0;min-height:36px}.form-control-static.input-lg,.form-control-static.input-sm{padding-left:0;padding-right:0}.input-sm{height:36px;padding:8px 12px;font-size:12px;line-height:1.5;border-radius:0}select.input-sm{height:36px;line-height:36px}textarea.input-sm,select[multiple].input-sm{height:auto}.form-group-sm .form-control{height:36px;padding:8px 12px;font-size:12px;line-height:1.5;border-radius:0}.form-group-sm select.form-control{height:36px;line-height:36px}.form-group-sm textarea.form-control,.form-group-sm select[multiple].form-control{height:auto}.form-group-sm .form-control-static{height:36px;min-height:33px;padding:9px 12px;font-size:12px;line-height:1.5}.input-lg{height:60px;padding:16px 20px;font-size:19px;line-height:1.3333333;border-radius:0}select.input-lg{height:60px;line-height:60px}textarea.input-lg,select[multiple].input-lg{height:auto}.form-group-lg .form-control{height:60px;padding:16px 20px;font-size:19px;line-height:1.3333333;border-radius:0}.form-group-lg select.form-control{height:60px;line-height:60px}.form-group-lg textarea.form-control,.form-group-lg select[multiple].form-control{height:auto}.form-group-lg .form-control-static{height:60px;min-height:40px;padding:17px 20px;font-size:19px;line-height:1.3333333}.has-feedback{position:relative}.has-feedback .form-control{padding-right:48.75px}.form-control-feedback{position:absolute;top:0;right:0;z-index:2;display:block;width:39px;height:39px;line-height:39px;text-align:center;pointer-events:none}.input-lg+.form-control-feedback,.input-group-lg+.form-control-feedback,.form-group-lg .form-control+.form-control-feedback{width:60px;height:60px;line-height:60px}.input-sm+.form-control-feedback,.input-group-sm+.form-control-feedback,.form-group-sm .form-control+.form-control-feedback{width:36px;height:36px;line-height:36px}.has-success .help-block,.has-success .control-label,.has-success .radio,.has-success .checkbox,.has-success .radio-inline,.has-success .checkbox-inline,.has-success.radio label,.has-success.checkbox label,.has-success.radio-inline label,.has-success.checkbox-inline label{color:#43ac6a}.has-success .form-control{border-color:#43ac6a;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075)}.has-success .form-control:focus{border-color:#358753;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #85d0a1;box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #85d0a1}.has-success .input-group-addon{color:#43ac6a;border-color:#43ac6a;background-color:#dff0d8}.has-success .form-control-feedback{color:#43ac6a}.has-warning .help-block,.has-warning .control-label,.has-warning .radio,.has-warning .checkbox,.has-warning .radio-inline,.has-warning .checkbox-inline,.has-warning.radio label,.has-warning.checkbox label,.has-warning.radio-inline label,.has-warning.checkbox-inline label{color:#e99002}.has-warning .form-control{border-color:#e99002;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075)}.has-warning .form-control:focus{border-color:#b67102;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #febc53;box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #febc53}.has-warning .input-group-addon{color:#e99002;border-color:#e99002;background-color:#fcf8e3}.has-warning .form-control-feedback{color:#e99002}.has-error .help-block,.has-error .control-label,.has-error .radio,.has-error .checkbox,.has-error .radio-inline,.has-error .checkbox-inline,.has-error.radio label,.has-error.checkbox label,.has-error.radio-inline label,.has-error.checkbox-inline label{color:#f04124}.has-error .form-control{border-color:#f04124;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075);box-shadow:inset 0 1px 1px rgba(0,0,0,0.075)}.has-error .form-control:focus{border-color:#d32a0e;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #f79483;box-shadow:inset 0 1px 1px rgba(0,0,0,0.075),0 0 6px #f79483}.has-error .input-group-addon{color:#f04124;border-color:#f04124;background-color:#f2dede}.has-error .form-control-feedback{color:#f04124}.has-feedback label~.form-control-feedback{top:26px}.has-feedback label.sr-only~.form-control-feedback{top:0}.help-block{display:block;margin-top:5px;margin-bottom:10px;color:#626262}@media (min-width:768px){.form-inline .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.form-inline .form-control{display:inline-block;width:auto;vertical-align:middle}.form-inline .form-control-static{display:inline-block}.form-inline .input-group{display:inline-table;vertical-align:middle}.form-inline .input-group .input-group-addon,.form-inline .input-group .input-group-btn,.form-inline .input-group .form-control{width:auto}.form-inline .input-group>.form-control{width:100%}.form-inline .control-label{margin-bottom:0;vertical-align:middle}.form-inline .radio,.form-inline .checkbox{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.form-inline .radio label,.form-inline .checkbox label{padding-left:0}.form-inline .radio input[type="radio"],.form-inline .checkbox input[type="checkbox"]{position:relative;margin-left:0}.form-inline .has-feedback .form-control-feedback{top:0}}.form-horizontal .radio,.form-horizontal .checkbox,.form-horizontal .radio-inline,.form-horizontal .checkbox-inline{margin-top:0;margin-bottom:0;padding-top:9px}.form-horizontal .radio,.form-horizontal .checkbox{min-height:30px}.form-horizontal .form-group{margin-left:-15px;margin-right:-15px}@media (min-width:768px){.form-horizontal .control-label{text-align:right;margin-bottom:0;padding-top:9px}}.form-horizontal .has-feedback .form-control-feedback{right:15px}@media (min-width:768px){.form-horizontal .form-group-lg .control-label{padding-top:17px;font-size:19px}}@media (min-width:768px){.form-horizontal .form-group-sm .control-label{padding-top:9px;font-size:12px}}.btn{display:inline-block;margin-bottom:0;font-weight:normal;text-align:center;vertical-align:middle;-ms-touch-action:manipulation;touch-action:manipulation;cursor:pointer;background-image:none;border:1px solid transparent;white-space:nowrap;padding:8px 12px;font-size:15px;line-height:1.4;border-radius:0;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none}.btn:focus,.btn:active:focus,.btn.active:focus,.btn.focus,.btn:active.focus,.btn.active.focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}.btn:hover,.btn:focus,.btn.focus{color:#333333;text-decoration:none}.btn:active,.btn.active{outline:0;background-image:none;-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,0.125);box-shadow:inset 0 3px 5px rgba(0,0,0,0.125)}.btn.disabled,.btn[disabled],fieldset[disabled] .btn{cursor:not-allowed;opacity:0.65;filter:alpha(opacity=65);-webkit-box-shadow:none;box-shadow:none}a.btn.disabled,fieldset[disabled] a.btn{pointer-events:none}.btn-default{color:#333333;background-color:#e7e7e7;border-color:#cccccc}.btn-default:focus,.btn-default.focus{color:#333333;background-color:#cecece;border-color:#8c8c8c}.btn-default:hover{color:#333333;background-color:#cecece;border-color:#adadad}.btn-default:active,.btn-default.active,.open>.dropdown-toggle.btn-default{color:#333333;background-color:#cecece;border-color:#adadad}.btn-default:active:hover,.btn-default.active:hover,.open>.dropdown-toggle.btn-default:hover,.btn-default:active:focus,.btn-default.active:focus,.open>.dropdown-toggle.btn-default:focus,.btn-default:active.focus,.btn-default.active.focus,.open>.dropdown-toggle.btn-default.focus{color:#333333;background-color:#bcbcbc;border-color:#8c8c8c}.btn-default:active,.btn-default.active,.open>.dropdown-toggle.btn-default{background-image:none}.btn-default.disabled:hover,.btn-default[disabled]:hover,fieldset[disabled] .btn-default:hover,.btn-default.disabled:focus,.btn-default[disabled]:focus,fieldset[disabled] .btn-default:focus,.btn-default.disabled.focus,.btn-default[disabled].focus,fieldset[disabled] .btn-default.focus{background-color:#e7e7e7;border-color:#cccccc}.btn-default .badge{color:#e7e7e7;background-color:#333333}.btn-primary{color:#ffffff;background-color:#008cba;border-color:#0079a1}.btn-primary:focus,.btn-primary.focus{color:#ffffff;background-color:#006687;border-color:#001921}.btn-primary:hover{color:#ffffff;background-color:#006687;border-color:#004b63}.btn-primary:active,.btn-primary.active,.open>.dropdown-toggle.btn-primary{color:#ffffff;background-color:#006687;border-color:#004b63}.btn-primary:active:hover,.btn-primary.active:hover,.open>.dropdown-toggle.btn-primary:hover,.btn-primary:active:focus,.btn-primary.active:focus,.open>.dropdown-toggle.btn-primary:focus,.btn-primary:active.focus,.btn-primary.active.focus,.open>.dropdown-toggle.btn-primary.focus{color:#ffffff;background-color:#004b63;border-color:#001921}.btn-primary:active,.btn-primary.active,.open>.dropdown-toggle.btn-primary{background-image:none}.btn-primary.disabled:hover,.btn-primary[disabled]:hover,fieldset[disabled] .btn-primary:hover,.btn-primary.disabled:focus,.btn-primary[disabled]:focus,fieldset[disabled] .btn-primary:focus,.btn-primary.disabled.focus,.btn-primary[disabled].focus,fieldset[disabled] .btn-primary.focus{background-color:#008cba;border-color:#0079a1}.btn-primary .badge{color:#008cba;background-color:#ffffff}.btn-success{color:#ffffff;background-color:#43ac6a;border-color:#3c9a5f}.btn-success:focus,.btn-success.focus{color:#ffffff;background-color:#358753;border-color:#183e26}.btn-success:hover{color:#ffffff;background-color:#358753;border-color:#2b6e44}.btn-success:active,.btn-success.active,.open>.dropdown-toggle.btn-success{color:#ffffff;background-color:#358753;border-color:#2b6e44}.btn-success:active:hover,.btn-success.active:hover,.open>.dropdown-toggle.btn-success:hover,.btn-success:active:focus,.btn-success.active:focus,.open>.dropdown-toggle.btn-success:focus,.btn-success:active.focus,.btn-success.active.focus,.open>.dropdown-toggle.btn-success.focus{color:#ffffff;background-color:#2b6e44;border-color:#183e26}.btn-success:active,.btn-success.active,.open>.dropdown-toggle.btn-success{background-image:none}.btn-success.disabled:hover,.btn-success[disabled]:hover,fieldset[disabled] .btn-success:hover,.btn-success.disabled:focus,.btn-success[disabled]:focus,fieldset[disabled] .btn-success:focus,.btn-success.disabled.focus,.btn-success[disabled].focus,fieldset[disabled] .btn-success.focus{background-color:#43ac6a;border-color:#3c9a5f}.btn-success .badge{color:#43ac6a;background-color:#ffffff}.btn-info{color:#ffffff;background-color:#5bc0de;border-color:#46b8da}.btn-info:focus,.btn-info.focus{color:#ffffff;background-color:#31b0d5;border-color:#1b6d85}.btn-info:hover{color:#ffffff;background-color:#31b0d5;border-color:#269abc}.btn-info:active,.btn-info.active,.open>.dropdown-toggle.btn-info{color:#ffffff;background-color:#31b0d5;border-color:#269abc}.btn-info:active:hover,.btn-info.active:hover,.open>.dropdown-toggle.btn-info:hover,.btn-info:active:focus,.btn-info.active:focus,.open>.dropdown-toggle.btn-info:focus,.btn-info:active.focus,.btn-info.active.focus,.open>.dropdown-toggle.btn-info.focus{color:#ffffff;background-color:#269abc;border-color:#1b6d85}.btn-info:active,.btn-info.active,.open>.dropdown-toggle.btn-info{background-image:none}.btn-info.disabled:hover,.btn-info[disabled]:hover,fieldset[disabled] .btn-info:hover,.btn-info.disabled:focus,.btn-info[disabled]:focus,fieldset[disabled] .btn-info:focus,.btn-info.disabled.focus,.btn-info[disabled].focus,fieldset[disabled] .btn-info.focus{background-color:#5bc0de;border-color:#46b8da}.btn-info .badge{color:#5bc0de;background-color:#ffffff}.btn-warning{color:#ffffff;background-color:#e99002;border-color:#d08002}.btn-warning:focus,.btn-warning.focus{color:#ffffff;background-color:#b67102;border-color:#513201}.btn-warning:hover{color:#ffffff;background-color:#b67102;border-color:#935b01}.btn-warning:active,.btn-warning.active,.open>.dropdown-toggle.btn-warning{color:#ffffff;background-color:#b67102;border-color:#935b01}.btn-warning:active:hover,.btn-warning.active:hover,.open>.dropdown-toggle.btn-warning:hover,.btn-warning:active:focus,.btn-warning.active:focus,.open>.dropdown-toggle.btn-warning:focus,.btn-warning:active.focus,.btn-warning.active.focus,.open>.dropdown-toggle.btn-warning.focus{color:#ffffff;background-color:#935b01;border-color:#513201}.btn-warning:active,.btn-warning.active,.open>.dropdown-toggle.btn-warning{background-image:none}.btn-warning.disabled:hover,.btn-warning[disabled]:hover,fieldset[disabled] .btn-warning:hover,.btn-warning.disabled:focus,.btn-warning[disabled]:focus,fieldset[disabled] .btn-warning:focus,.btn-warning.disabled.focus,.btn-warning[disabled].focus,fieldset[disabled] .btn-warning.focus{background-color:#e99002;border-color:#d08002}.btn-warning .badge{color:#e99002;background-color:#ffffff}.btn-danger{color:#ffffff;background-color:#f04124;border-color:#ea2f10}.btn-danger:focus,.btn-danger.focus{color:#ffffff;background-color:#d32a0e;border-color:#731708}.btn-danger:hover{color:#ffffff;background-color:#d32a0e;border-color:#b1240c}.btn-danger:active,.btn-danger.active,.open>.dropdown-toggle.btn-danger{color:#ffffff;background-color:#d32a0e;border-color:#b1240c}.btn-danger:active:hover,.btn-danger.active:hover,.open>.dropdown-toggle.btn-danger:hover,.btn-danger:active:focus,.btn-danger.active:focus,.open>.dropdown-toggle.btn-danger:focus,.btn-danger:active.focus,.btn-danger.active.focus,.open>.dropdown-toggle.btn-danger.focus{color:#ffffff;background-color:#b1240c;border-color:#731708}.btn-danger:active,.btn-danger.active,.open>.dropdown-toggle.btn-danger{background-image:none}.btn-danger.disabled:hover,.btn-danger[disabled]:hover,fieldset[disabled] .btn-danger:hover,.btn-danger.disabled:focus,.btn-danger[disabled]:focus,fieldset[disabled] .btn-danger:focus,.btn-danger.disabled.focus,.btn-danger[disabled].focus,fieldset[disabled] .btn-danger.focus{background-color:#f04124;border-color:#ea2f10}.btn-danger .badge{color:#f04124;background-color:#ffffff}.btn-link{color:#008cba;font-weight:normal;border-radius:0}.btn-link,.btn-link:active,.btn-link.active,.btn-link[disabled],fieldset[disabled] .btn-link{background-color:transparent;-webkit-box-shadow:none;box-shadow:none}.btn-link,.btn-link:hover,.btn-link:focus,.btn-link:active{border-color:transparent}.btn-link:hover,.btn-link:focus{color:#008cba;text-decoration:underline;background-color:transparent}.btn-link[disabled]:hover,fieldset[disabled] .btn-link:hover,.btn-link[disabled]:focus,fieldset[disabled] .btn-link:focus{color:#999999;text-decoration:none}.btn-lg,.btn-group-lg>.btn{padding:16px 20px;font-size:19px;line-height:1.3333333;border-radius:0}.btn-sm,.btn-group-sm>.btn{padding:8px 12px;font-size:12px;line-height:1.5;border-radius:0}.btn-xs,.btn-group-xs>.btn{padding:4px 6px;font-size:12px;line-height:1.5;border-radius:0}.btn-block{display:block;width:100%}.btn-block+.btn-block{margin-top:5px}input[type="submit"].btn-block,input[type="reset"].btn-block,input[type="button"].btn-block{width:100%}.fade{opacity:0;-webkit-transition:opacity 0.15s linear;-o-transition:opacity 0.15s linear;transition:opacity 0.15s linear}.fade.in{opacity:1}.collapse{display:none}.collapse.in{display:block}tr.collapse.in{display:table-row}tbody.collapse.in{display:table-row-group}.collapsing{position:relative;height:0;overflow:hidden;-webkit-transition-property:height, visibility;-o-transition-property:height, visibility;transition-property:height, visibility;-webkit-transition-duration:0.35s;-o-transition-duration:0.35s;transition-duration:0.35s;-webkit-transition-timing-function:ease;-o-transition-timing-function:ease;transition-timing-function:ease}.caret{display:inline-block;width:0;height:0;margin-left:2px;vertical-align:middle;border-top:4px dashed;border-top:4px solid \9;border-right:4px solid transparent;border-left:4px solid transparent}.dropup,.dropdown{position:relative}.dropdown-toggle:focus{outline:0}.dropdown-menu{position:absolute;top:100%;left:0;z-index:1000;display:none;float:left;min-width:160px;padding:5px 0;margin:2px 0 0;list-style:none;font-size:15px;text-align:left;background-color:#ffffff;border:1px solid #cccccc;border:1px solid rgba(0,0,0,0.15);border-radius:0;-webkit-box-shadow:0 6px 12px rgba(0,0,0,0.175);box-shadow:0 6px 12px rgba(0,0,0,0.175);-webkit-background-clip:padding-box;background-clip:padding-box}.dropdown-menu.pull-right{right:0;left:auto}.dropdown-menu .divider{height:1px;margin:9.5px 0;overflow:hidden;background-color:rgba(0,0,0,0.2)}.dropdown-menu>li>a{display:block;padding:3px 20px;clear:both;font-weight:normal;line-height:1.4;color:#555555;white-space:nowrap}.dropdown-menu>li>a:hover,.dropdown-menu>li>a:focus{text-decoration:none;color:#262626;background-color:#eeeeee}.dropdown-menu>.active>a,.dropdown-menu>.active>a:hover,.dropdown-menu>.active>a:focus{color:#ffffff;text-decoration:none;outline:0;background-color:#008cba}.dropdown-menu>.disabled>a,.dropdown-menu>.disabled>a:hover,.dropdown-menu>.disabled>a:focus{color:#999999}.dropdown-menu>.disabled>a:hover,.dropdown-menu>.disabled>a:focus{text-decoration:none;background-color:transparent;background-image:none;filter:progid:DXImageTransform.Microsoft.gradient(enabled=false);cursor:not-allowed}.open>.dropdown-menu{display:block}.open>a{outline:0}.dropdown-menu-right{left:auto;right:0}.dropdown-menu-left{left:0;right:auto}.dropdown-header{display:block;padding:3px 20px;font-size:12px;line-height:1.4;color:#999999;white-space:nowrap}.dropdown-backdrop{position:fixed;left:0;right:0;bottom:0;top:0;z-index:990}.pull-right>.dropdown-menu{right:0;left:auto}.dropup .caret,.navbar-fixed-bottom .dropdown .caret{border-top:0;border-bottom:4px dashed;border-bottom:4px solid \9;content:""}.dropup .dropdown-menu,.navbar-fixed-bottom .dropdown .dropdown-menu{top:auto;bottom:100%;margin-bottom:2px}@media (min-width:768px){.navbar-right .dropdown-menu{left:auto;right:0}.navbar-right .dropdown-menu-left{left:0;right:auto}}.btn-group,.btn-group-vertical{position:relative;display:inline-block;vertical-align:middle}.btn-group>.btn,.btn-group-vertical>.btn{position:relative;float:left}.btn-group>.btn:hover,.btn-group-vertical>.btn:hover,.btn-group>.btn:focus,.btn-group-vertical>.btn:focus,.btn-group>.btn:active,.btn-group-vertical>.btn:active,.btn-group>.btn.active,.btn-group-vertical>.btn.active{z-index:2}.btn-group .btn+.btn,.btn-group .btn+.btn-group,.btn-group .btn-group+.btn,.btn-group .btn-group+.btn-group{margin-left:-1px}.btn-toolbar{margin-left:-5px}.btn-toolbar .btn,.btn-toolbar .btn-group,.btn-toolbar .input-group{float:left}.btn-toolbar>.btn,.btn-toolbar>.btn-group,.btn-toolbar>.input-group{margin-left:5px}.btn-group>.btn:not(:first-child):not(:last-child):not(.dropdown-toggle){border-radius:0}.btn-group>.btn:first-child{margin-left:0}.btn-group>.btn:first-child:not(:last-child):not(.dropdown-toggle){border-bottom-right-radius:0;border-top-right-radius:0}.btn-group>.btn:last-child:not(:first-child),.btn-group>.dropdown-toggle:not(:first-child){border-bottom-left-radius:0;border-top-left-radius:0}.btn-group>.btn-group{float:left}.btn-group>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-bottom-right-radius:0;border-top-right-radius:0}.btn-group>.btn-group:last-child:not(:first-child)>.btn:first-child{border-bottom-left-radius:0;border-top-left-radius:0}.btn-group .dropdown-toggle:active,.btn-group.open .dropdown-toggle{outline:0}.btn-group>.btn+.dropdown-toggle{padding-left:8px;padding-right:8px}.btn-group>.btn-lg+.dropdown-toggle{padding-left:12px;padding-right:12px}.btn-group.open .dropdown-toggle{-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,0.125);box-shadow:inset 0 3px 5px rgba(0,0,0,0.125)}.btn-group.open .dropdown-toggle.btn-link{-webkit-box-shadow:none;box-shadow:none}.btn .caret{margin-left:0}.btn-lg .caret{border-width:5px 5px 0;border-bottom-width:0}.dropup .btn-lg .caret{border-width:0 5px 5px}.btn-group-vertical>.btn,.btn-group-vertical>.btn-group,.btn-group-vertical>.btn-group>.btn{display:block;float:none;width:100%;max-width:100%}.btn-group-vertical>.btn-group>.btn{float:none}.btn-group-vertical>.btn+.btn,.btn-group-vertical>.btn+.btn-group,.btn-group-vertical>.btn-group+.btn,.btn-group-vertical>.btn-group+.btn-group{margin-top:-1px;margin-left:0}.btn-group-vertical>.btn:not(:first-child):not(:last-child){border-radius:0}.btn-group-vertical>.btn:first-child:not(:last-child){border-top-right-radius:0;border-top-left-radius:0;border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn:last-child:not(:first-child){border-top-right-radius:0;border-top-left-radius:0;border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group-vertical>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group-vertical>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn-group:last-child:not(:first-child)>.btn:first-child{border-top-right-radius:0;border-top-left-radius:0}.btn-group-justified{display:table;width:100%;table-layout:fixed;border-collapse:separate}.btn-group-justified>.btn,.btn-group-justified>.btn-group{float:none;display:table-cell;width:1%}.btn-group-justified>.btn-group .btn{width:100%}.btn-group-justified>.btn-group .dropdown-menu{left:auto}[data-toggle="buttons"]>.btn input[type="radio"],[data-toggle="buttons"]>.btn-group>.btn input[type="radio"],[data-toggle="buttons"]>.btn input[type="checkbox"],[data-toggle="buttons"]>.btn-group>.btn input[type="checkbox"]{position:absolute;clip:rect(0, 0, 0, 0);pointer-events:none}.input-group{position:relative;display:table;border-collapse:separate}.input-group[class*="col-"]{float:none;padding-left:0;padding-right:0}.input-group .form-control{position:relative;z-index:2;float:left;width:100%;margin-bottom:0}.input-group .form-control:focus{z-index:3}.input-group-lg>.form-control,.input-group-lg>.input-group-addon,.input-group-lg>.input-group-btn>.btn{height:60px;padding:16px 20px;font-size:19px;line-height:1.3333333;border-radius:0}select.input-group-lg>.form-control,select.input-group-lg>.input-group-addon,select.input-group-lg>.input-group-btn>.btn{height:60px;line-height:60px}textarea.input-group-lg>.form-control,textarea.input-group-lg>.input-group-addon,textarea.input-group-lg>.input-group-btn>.btn,select[multiple].input-group-lg>.form-control,select[multiple].input-group-lg>.input-group-addon,select[multiple].input-group-lg>.input-group-btn>.btn{height:auto}.input-group-sm>.form-control,.input-group-sm>.input-group-addon,.input-group-sm>.input-group-btn>.btn{height:36px;padding:8px 12px;font-size:12px;line-height:1.5;border-radius:0}select.input-group-sm>.form-control,select.input-group-sm>.input-group-addon,select.input-group-sm>.input-group-btn>.btn{height:36px;line-height:36px}textarea.input-group-sm>.form-control,textarea.input-group-sm>.input-group-addon,textarea.input-group-sm>.input-group-btn>.btn,select[multiple].input-group-sm>.form-control,select[multiple].input-group-sm>.input-group-addon,select[multiple].input-group-sm>.input-group-btn>.btn{height:auto}.input-group-addon,.input-group-btn,.input-group .form-control{display:table-cell}.input-group-addon:not(:first-child):not(:last-child),.input-group-btn:not(:first-child):not(:last-child),.input-group .form-control:not(:first-child):not(:last-child){border-radius:0}.input-group-addon,.input-group-btn{width:1%;white-space:nowrap;vertical-align:middle}.input-group-addon{padding:8px 12px;font-size:15px;font-weight:normal;line-height:1;color:#6f6f6f;text-align:center;background-color:#eeeeee;border:1px solid #cccccc;border-radius:0}.input-group-addon.input-sm{padding:8px 12px;font-size:12px;border-radius:0}.input-group-addon.input-lg{padding:16px 20px;font-size:19px;border-radius:0}.input-group-addon input[type="radio"],.input-group-addon input[type="checkbox"]{margin-top:0}.input-group .form-control:first-child,.input-group-addon:first-child,.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group>.btn,.input-group-btn:first-child>.dropdown-toggle,.input-group-btn:last-child>.btn:not(:last-child):not(.dropdown-toggle),.input-group-btn:last-child>.btn-group:not(:last-child)>.btn{border-bottom-right-radius:0;border-top-right-radius:0}.input-group-addon:first-child{border-right:0}.input-group .form-control:last-child,.input-group-addon:last-child,.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group>.btn,.input-group-btn:last-child>.dropdown-toggle,.input-group-btn:first-child>.btn:not(:first-child),.input-group-btn:first-child>.btn-group:not(:first-child)>.btn{border-bottom-left-radius:0;border-top-left-radius:0}.input-group-addon:last-child{border-left:0}.input-group-btn{position:relative;font-size:0;white-space:nowrap}.input-group-btn>.btn{position:relative}.input-group-btn>.btn+.btn{margin-left:-1px}.input-group-btn>.btn:hover,.input-group-btn>.btn:focus,.input-group-btn>.btn:active{z-index:2}.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group{margin-right:-1px}.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group{z-index:2;margin-left:-1px}.nav{margin-bottom:0;padding-left:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:hover,.nav>li>a:focus{text-decoration:none;background-color:#eeeeee}.nav>li.disabled>a{color:#999999}.nav>li.disabled>a:hover,.nav>li.disabled>a:focus{color:#999999;text-decoration:none;background-color:transparent;cursor:not-allowed}.nav .open>a,.nav .open>a:hover,.nav .open>a:focus{background-color:#eeeeee;border-color:#008cba}.nav .nav-divider{height:1px;margin:9.5px 0;overflow:hidden;background-color:#e5e5e5}.nav>li>a>img{max-width:none}.nav-tabs{border-bottom:1px solid #dddddd}.nav-tabs>li{float:left;margin-bottom:-1px}.nav-tabs>li>a{margin-right:2px;line-height:1.4;border:1px solid transparent;border-radius:0 0 0 0}.nav-tabs>li>a:hover{border-color:#eeeeee #eeeeee #dddddd}.nav-tabs>li.active>a,.nav-tabs>li.active>a:hover,.nav-tabs>li.active>a:focus{color:#6f6f6f;background-color:#ffffff;border:1px solid #dddddd;border-bottom-color:transparent;cursor:default}.nav-tabs.nav-justified{width:100%;border-bottom:0}.nav-tabs.nav-justified>li{float:none}.nav-tabs.nav-justified>li>a{text-align:center;margin-bottom:5px}.nav-tabs.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-tabs.nav-justified>li{display:table-cell;width:1%}.nav-tabs.nav-justified>li>a{margin-bottom:0}}.nav-tabs.nav-justified>li>a{margin-right:0;border-radius:0}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:hover,.nav-tabs.nav-justified>.active>a:focus{border:1px solid #dddddd}@media (min-width:768px){.nav-tabs.nav-justified>li>a{border-bottom:1px solid #dddddd;border-radius:0 0 0 0}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:hover,.nav-tabs.nav-justified>.active>a:focus{border-bottom-color:#ffffff}}.nav-pills>li{float:left}.nav-pills>li>a{border-radius:0}.nav-pills>li+li{margin-left:2px}.nav-pills>li.active>a,.nav-pills>li.active>a:hover,.nav-pills>li.active>a:focus{color:#ffffff;background-color:#008cba}.nav-stacked>li{float:none}.nav-stacked>li+li{margin-top:2px;margin-left:0}.nav-justified{width:100%}.nav-justified>li{float:none}.nav-justified>li>a{text-align:center;margin-bottom:5px}.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-justified>li{display:table-cell;width:1%}.nav-justified>li>a{margin-bottom:0}}.nav-tabs-justified{border-bottom:0}.nav-tabs-justified>li>a{margin-right:0;border-radius:0}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:hover,.nav-tabs-justified>.active>a:focus{border:1px solid #dddddd}@media (min-width:768px){.nav-tabs-justified>li>a{border-bottom:1px solid #dddddd;border-radius:0 0 0 0}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:hover,.nav-tabs-justified>.active>a:focus{border-bottom-color:#ffffff}}.tab-content>.tab-pane{display:none}.tab-content>.active{display:block}.nav-tabs .dropdown-menu{margin-top:-1px;border-top-right-radius:0;border-top-left-radius:0}.navbar{position:relative;min-height:45px;margin-bottom:21px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:0}}@media (min-width:768px){.navbar-header{float:left}}.navbar-collapse{overflow-x:visible;padding-right:15px;padding-left:15px;border-top:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,0.1);box-shadow:inset 0 1px 0 rgba(255,255,255,0.1);-webkit-overflow-scrolling:touch}.navbar-collapse.in{overflow-y:auto}@media (min-width:768px){.navbar-collapse{width:auto;border-top:0;-webkit-box-shadow:none;box-shadow:none}.navbar-collapse.collapse{display:block !important;height:auto !important;padding-bottom:0;overflow:visible !important}.navbar-collapse.in{overflow-y:visible}.navbar-fixed-top .navbar-collapse,.navbar-static-top .navbar-collapse,.navbar-fixed-bottom .navbar-collapse{padding-left:0;padding-right:0}}.navbar-fixed-top .navbar-collapse,.navbar-fixed-bottom .navbar-collapse{max-height:340px}@media (max-device-width:480px) and (orientation:landscape){.navbar-fixed-top .navbar-collapse,.navbar-fixed-bottom .navbar-collapse{max-height:200px}}.container>.navbar-header,.container-fluid>.navbar-header,.container>.navbar-collapse,.container-fluid>.navbar-collapse{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container>.navbar-header,.container-fluid>.navbar-header,.container>.navbar-collapse,.container-fluid>.navbar-collapse{margin-right:0;margin-left:0}}.navbar-static-top{z-index:1000;border-width:0 0 1px}@media (min-width:768px){.navbar-static-top{border-radius:0}}.navbar-fixed-top,.navbar-fixed-bottom{position:fixed;right:0;left:0;z-index:1030}@media (min-width:768px){.navbar-fixed-top,.navbar-fixed-bottom{border-radius:0}}.navbar-fixed-top{top:0;border-width:0 0 1px}.navbar-fixed-bottom{bottom:0;margin-bottom:0;border-width:1px 0 0}.navbar-brand{float:left;padding:12px 15px;font-size:19px;line-height:21px;height:45px}.navbar-brand:hover,.navbar-brand:focus{text-decoration:none}.navbar-brand>img{display:block}@media (min-width:768px){.navbar>.container .navbar-brand,.navbar>.container-fluid .navbar-brand{margin-left:-15px}}.navbar-toggle{position:relative;float:right;margin-right:15px;padding:9px 10px;margin-top:5.5px;margin-bottom:5.5px;background-color:transparent;background-image:none;border:1px solid transparent;border-radius:0}.navbar-toggle:focus{outline:0}.navbar-toggle .icon-bar{display:block;width:22px;height:2px;border-radius:1px}.navbar-toggle .icon-bar+.icon-bar{margin-top:4px}@media (min-width:768px){.navbar-toggle{display:none}}.navbar-nav{margin:6px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:21px}@media (max-width:767px){.navbar-nav .open .dropdown-menu{position:static;float:none;width:auto;margin-top:0;background-color:transparent;border:0;-webkit-box-shadow:none;box-shadow:none}.navbar-nav .open .dropdown-menu>li>a,.navbar-nav .open .dropdown-menu .dropdown-header{padding:5px 15px 5px 25px}.navbar-nav .open .dropdown-menu>li>a{line-height:21px}.navbar-nav .open .dropdown-menu>li>a:hover,.navbar-nav .open .dropdown-menu>li>a:focus{background-image:none}}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:12px;padding-bottom:12px}}.navbar-form{margin-left:-15px;margin-right:-15px;padding:10px 15px;border-top:1px solid transparent;border-bottom:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,0.1),0 1px 0 rgba(255,255,255,0.1);box-shadow:inset 0 1px 0 rgba(255,255,255,0.1),0 1px 0 rgba(255,255,255,0.1);margin-top:3px;margin-bottom:3px}@media (min-width:768px){.navbar-form .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.navbar-form .form-control{display:inline-block;width:auto;vertical-align:middle}.navbar-form .form-control-static{display:inline-block}.navbar-form .input-group{display:inline-table;vertical-align:middle}.navbar-form .input-group .input-group-addon,.navbar-form .input-group .input-group-btn,.navbar-form .input-group .form-control{width:auto}.navbar-form .input-group>.form-control{width:100%}.navbar-form .control-label{margin-bottom:0;vertical-align:middle}.navbar-form .radio,.navbar-form .checkbox{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.navbar-form .radio label,.navbar-form .checkbox label{padding-left:0}.navbar-form .radio input[type="radio"],.navbar-form .checkbox input[type="checkbox"]{position:relative;margin-left:0}.navbar-form .has-feedback .form-control-feedback{top:0}}@media (max-width:767px){.navbar-form .form-group{margin-bottom:5px}.navbar-form .form-group:last-child{margin-bottom:0}}@media (min-width:768px){.navbar-form{width:auto;border:0;margin-left:0;margin-right:0;padding-top:0;padding-bottom:0;-webkit-box-shadow:none;box-shadow:none}}.navbar-nav>li>.dropdown-menu{margin-top:0;border-top-right-radius:0;border-top-left-radius:0}.navbar-fixed-bottom .navbar-nav>li>.dropdown-menu{margin-bottom:0;border-top-right-radius:0;border-top-left-radius:0;border-bottom-right-radius:0;border-bottom-left-radius:0}.navbar-btn{margin-top:3px;margin-bottom:3px}.navbar-btn.btn-sm{margin-top:4.5px;margin-bottom:4.5px}.navbar-btn.btn-xs{margin-top:11.5px;margin-bottom:11.5px}.navbar-text{margin-top:12px;margin-bottom:12px}@media (min-width:768px){.navbar-text{float:left;margin-left:15px;margin-right:15px}}@media (min-width:768px){.navbar-left{float:left !important}.navbar-right{float:right !important;margin-right:-15px}.navbar-right~.navbar-right{margin-right:0}}.navbar-default{background-color:#333333;border-color:#222222}.navbar-default .navbar-brand{color:#ffffff}.navbar-default .navbar-brand:hover,.navbar-default .navbar-brand:focus{color:#ffffff;background-color:transparent}.navbar-default .navbar-text{color:#ffffff}.navbar-default .navbar-nav>li>a{color:#ffffff}.navbar-default .navbar-nav>li>a:hover,.navbar-default .navbar-nav>li>a:focus{color:#ffffff;background-color:#272727}.navbar-default .navbar-nav>.active>a,.navbar-default .navbar-nav>.active>a:hover,.navbar-default .navbar-nav>.active>a:focus{color:#ffffff;background-color:#272727}.navbar-default .navbar-nav>.disabled>a,.navbar-default .navbar-nav>.disabled>a:hover,.navbar-default .navbar-nav>.disabled>a:focus{color:#cccccc;background-color:transparent}.navbar-default .navbar-toggle{border-color:transparent}.navbar-default .navbar-toggle:hover,.navbar-default .navbar-toggle:focus{background-color:transparent}.navbar-default .navbar-toggle .icon-bar{background-color:#ffffff}.navbar-default .navbar-collapse,.navbar-default .navbar-form{border-color:#222222}.navbar-default .navbar-nav>.open>a,.navbar-default .navbar-nav>.open>a:hover,.navbar-default .navbar-nav>.open>a:focus{background-color:#272727;color:#ffffff}@media (max-width:767px){.navbar-default .navbar-nav .open .dropdown-menu>li>a{color:#ffffff}.navbar-default .navbar-nav .open .dropdown-menu>li>a:hover,.navbar-default .navbar-nav .open .dropdown-menu>li>a:focus{color:#ffffff;background-color:#272727}.navbar-default .navbar-nav .open .dropdown-menu>.active>a,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:hover,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:focus{color:#ffffff;background-color:#272727}.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:hover,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:focus{color:#cccccc;background-color:transparent}}.navbar-default .navbar-link{color:#ffffff}.navbar-default .navbar-link:hover{color:#ffffff}.navbar-default .btn-link{color:#ffffff}.navbar-default .btn-link:hover,.navbar-default .btn-link:focus{color:#ffffff}.navbar-default .btn-link[disabled]:hover,fieldset[disabled] .navbar-default .btn-link:hover,.navbar-default .btn-link[disabled]:focus,fieldset[disabled] .navbar-default .btn-link:focus{color:#cccccc}.navbar-inverse{background-color:#008cba;border-color:#006687}.navbar-inverse .navbar-brand{color:#ffffff}.navbar-inverse .navbar-brand:hover,.navbar-inverse .navbar-brand:focus{color:#ffffff;background-color:transparent}.navbar-inverse .navbar-text{color:#ffffff}.navbar-inverse .navbar-nav>li>a{color:#ffffff}.navbar-inverse .navbar-nav>li>a:hover,.navbar-inverse .navbar-nav>li>a:focus{color:#ffffff;background-color:#006687}.navbar-inverse .navbar-nav>.active>a,.navbar-inverse .navbar-nav>.active>a:hover,.navbar-inverse .navbar-nav>.active>a:focus{color:#ffffff;background-color:#006687}.navbar-inverse .navbar-nav>.disabled>a,.navbar-inverse .navbar-nav>.disabled>a:hover,.navbar-inverse .navbar-nav>.disabled>a:focus{color:#444444;background-color:transparent}.navbar-inverse .navbar-toggle{border-color:transparent}.navbar-inverse .navbar-toggle:hover,.navbar-inverse .navbar-toggle:focus{background-color:transparent}.navbar-inverse .navbar-toggle .icon-bar{background-color:#ffffff}.navbar-inverse .navbar-collapse,.navbar-inverse .navbar-form{border-color:#007196}.navbar-inverse .navbar-nav>.open>a,.navbar-inverse .navbar-nav>.open>a:hover,.navbar-inverse .navbar-nav>.open>a:focus{background-color:#006687;color:#ffffff}@media (max-width:767px){.navbar-inverse .navbar-nav .open .dropdown-menu>.dropdown-header{border-color:#006687}.navbar-inverse .navbar-nav .open .dropdown-menu .divider{background-color:#006687}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a{color:#ffffff}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:hover,.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:focus{color:#ffffff;background-color:#006687}.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:hover,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:focus{color:#ffffff;background-color:#006687}.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:hover,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:focus{color:#444444;background-color:transparent}}.navbar-inverse .navbar-link{color:#ffffff}.navbar-inverse .navbar-link:hover{color:#ffffff}.navbar-inverse .btn-link{color:#ffffff}.navbar-inverse .btn-link:hover,.navbar-inverse .btn-link:focus{color:#ffffff}.navbar-inverse .btn-link[disabled]:hover,fieldset[disabled] .navbar-inverse .btn-link:hover,.navbar-inverse .btn-link[disabled]:focus,fieldset[disabled] .navbar-inverse .btn-link:focus{color:#444444}.breadcrumb{padding:8px 15px;margin-bottom:21px;list-style:none;background-color:#f5f5f5;border-radius:0}.breadcrumb>li{display:inline-block}.breadcrumb>li+li:before{content:"/\00a0";padding:0 5px;color:#999999}.breadcrumb>.active{color:#333333}.pagination{display:inline-block;padding-left:0;margin:21px 0;border-radius:0}.pagination>li{display:inline}.pagination>li>a,.pagination>li>span{position:relative;float:left;padding:8px 12px;line-height:1.4;text-decoration:none;color:#008cba;background-color:transparent;border:1px solid transparent;margin-left:-1px}.pagination>li:first-child>a,.pagination>li:first-child>span{margin-left:0;border-bottom-left-radius:0;border-top-left-radius:0}.pagination>li:last-child>a,.pagination>li:last-child>span{border-bottom-right-radius:0;border-top-right-radius:0}.pagination>li>a:hover,.pagination>li>span:hover,.pagination>li>a:focus,.pagination>li>span:focus{z-index:2;color:#008cba;background-color:#eeeeee;border-color:transparent}.pagination>.active>a,.pagination>.active>span,.pagination>.active>a:hover,.pagination>.active>span:hover,.pagination>.active>a:focus,.pagination>.active>span:focus{z-index:3;color:#ffffff;background-color:#008cba;border-color:transparent;cursor:default}.pagination>.disabled>span,.pagination>.disabled>span:hover,.pagination>.disabled>span:focus,.pagination>.disabled>a,.pagination>.disabled>a:hover,.pagination>.disabled>a:focus{color:#999999;background-color:#ffffff;border-color:transparent;cursor:not-allowed}.pagination-lg>li>a,.pagination-lg>li>span{padding:16px 20px;font-size:19px;line-height:1.3333333}.pagination-lg>li:first-child>a,.pagination-lg>li:first-child>span{border-bottom-left-radius:0;border-top-left-radius:0}.pagination-lg>li:last-child>a,.pagination-lg>li:last-child>span{border-bottom-right-radius:0;border-top-right-radius:0}.pagination-sm>li>a,.pagination-sm>li>span{padding:8px 12px;font-size:12px;line-height:1.5}.pagination-sm>li:first-child>a,.pagination-sm>li:first-child>span{border-bottom-left-radius:0;border-top-left-radius:0}.pagination-sm>li:last-child>a,.pagination-sm>li:last-child>span{border-bottom-right-radius:0;border-top-right-radius:0}.pager{padding-left:0;margin:21px 0;list-style:none;text-align:center}.pager li{display:inline}.pager li>a,.pager li>span{display:inline-block;padding:5px 14px;background-color:transparent;border:1px solid transparent;border-radius:3px}.pager li>a:hover,.pager li>a:focus{text-decoration:none;background-color:#eeeeee}.pager .next>a,.pager .next>span{float:right}.pager .previous>a,.pager .previous>span{float:left}.pager .disabled>a,.pager .disabled>a:hover,.pager .disabled>a:focus,.pager .disabled>span{color:#999999;background-color:transparent;cursor:not-allowed}.label{display:inline;padding:.2em .6em .3em;font-size:75%;font-weight:bold;line-height:1;color:#ffffff;text-align:center;white-space:nowrap;vertical-align:baseline;border-radius:.25em}a.label:hover,a.label:focus{color:#ffffff;text-decoration:none;cursor:pointer}.label:empty{display:none}.btn .label{position:relative;top:-1px}.label-default{background-color:#999999}.label-default[href]:hover,.label-default[href]:focus{background-color:#808080}.label-primary{background-color:#008cba}.label-primary[href]:hover,.label-primary[href]:focus{background-color:#006687}.label-success{background-color:#43ac6a}.label-success[href]:hover,.label-success[href]:focus{background-color:#358753}.label-info{background-color:#5bc0de}.label-info[href]:hover,.label-info[href]:focus{background-color:#31b0d5}.label-warning{background-color:#e99002}.label-warning[href]:hover,.label-warning[href]:focus{background-color:#b67102}.label-danger{background-color:#f04124}.label-danger[href]:hover,.label-danger[href]:focus{background-color:#d32a0e}.badge{display:inline-block;min-width:10px;padding:3px 7px;font-size:12px;font-weight:bold;color:#ffffff;line-height:1;vertical-align:middle;white-space:nowrap;text-align:center;background-color:#008cba;border-radius:10px}.badge:empty{display:none}.btn .badge{position:relative;top:-1px}.btn-xs .badge,.btn-group-xs>.btn .badge{top:0;padding:1px 5px}a.badge:hover,a.badge:focus{color:#ffffff;text-decoration:none;cursor:pointer}.list-group-item.active>.badge,.nav-pills>.active>a>.badge{color:#008cba;background-color:#ffffff}.list-group-item>.badge{float:right}.list-group-item>.badge+.badge{margin-right:5px}.nav-pills>li>a>.badge{margin-left:3px}.jumbotron{padding-top:30px;padding-bottom:30px;margin-bottom:30px;color:inherit;background-color:#fafafa}.jumbotron h1,.jumbotron .h1{color:inherit}.jumbotron p{margin-bottom:15px;font-size:23px;font-weight:200}.jumbotron>hr{border-top-color:#e1e1e1}.container .jumbotron,.container-fluid .jumbotron{border-radius:0;padding-left:15px;padding-right:15px}.jumbotron .container{max-width:100%}@media screen and (min-width:768px){.jumbotron{padding-top:48px;padding-bottom:48px}.container .jumbotron,.container-fluid .jumbotron{padding-left:60px;padding-right:60px}.jumbotron h1,.jumbotron .h1{font-size:68px}}.thumbnail{display:block;padding:4px;margin-bottom:21px;line-height:1.4;background-color:#ffffff;border:1px solid #dddddd;border-radius:0;-webkit-transition:border .2s ease-in-out;-o-transition:border .2s ease-in-out;transition:border .2s ease-in-out}.thumbnail>img,.thumbnail a>img{margin-left:auto;margin-right:auto}a.thumbnail:hover,a.thumbnail:focus,a.thumbnail.active{border-color:#008cba}.thumbnail .caption{padding:9px;color:#222222}.alert{padding:15px;margin-bottom:21px;border:1px solid transparent;border-radius:0}.alert h4{margin-top:0;color:inherit}.alert .alert-link{font-weight:bold}.alert>p,.alert>ul{margin-bottom:0}.alert>p+p{margin-top:5px}.alert-dismissable,.alert-dismissible{padding-right:35px}.alert-dismissable .close,.alert-dismissible .close{position:relative;top:-2px;right:-21px;color:inherit}.alert-success{background-color:#43ac6a;border-color:#3c9a5f;color:#ffffff}.alert-success hr{border-top-color:#358753}.alert-success .alert-link{color:#e6e6e6}.alert-info{background-color:#5bc0de;border-color:#3db5d8;color:#ffffff}.alert-info hr{border-top-color:#2aabd2}.alert-info .alert-link{color:#e6e6e6}.alert-warning{background-color:#e99002;border-color:#d08002;color:#ffffff}.alert-warning hr{border-top-color:#b67102}.alert-warning .alert-link{color:#e6e6e6}.alert-danger{background-color:#f04124;border-color:#ea2f10;color:#ffffff}.alert-danger hr{border-top-color:#d32a0e}.alert-danger .alert-link{color:#e6e6e6}@-webkit-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@-o-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}.progress{overflow:hidden;height:21px;margin-bottom:21px;background-color:#f5f5f5;border-radius:0;-webkit-box-shadow:inset 0 1px 2px rgba(0,0,0,0.1);box-shadow:inset 0 1px 2px rgba(0,0,0,0.1)}.progress-bar{float:left;width:0%;height:100%;font-size:12px;line-height:21px;color:#ffffff;text-align:center;background-color:#008cba;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,0.15);box-shadow:inset 0 -1px 0 rgba(0,0,0,0.15);-webkit-transition:width 0.6s ease;-o-transition:width 0.6s ease;transition:width 0.6s ease}.progress-striped .progress-bar,.progress-bar-striped{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);-webkit-background-size:40px 40px;background-size:40px 40px}.progress.active .progress-bar,.progress-bar.active{-webkit-animation:progress-bar-stripes 2s linear infinite;-o-animation:progress-bar-stripes 2s linear infinite;animation:progress-bar-stripes 2s linear infinite}.progress-bar-success{background-color:#43ac6a}.progress-striped .progress-bar-success{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent)}.progress-bar-info{background-color:#5bc0de}.progress-striped .progress-bar-info{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent)}.progress-bar-warning{background-color:#e99002}.progress-striped .progress-bar-warning{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent)}.progress-bar-danger{background-color:#f04124}.progress-striped .progress-bar-danger{background-image:-webkit-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:-o-linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent);background-image:linear-gradient(45deg, rgba(255,255,255,0.15) 25%, transparent 25%, transparent 50%, rgba(255,255,255,0.15) 50%, rgba(255,255,255,0.15) 75%, transparent 75%, transparent)}.media{margin-top:15px}.media:first-child{margin-top:0}.media,.media-body{zoom:1;overflow:hidden}.media-body{width:10000px}.media-object{display:block}.media-object.img-thumbnail{max-width:none}.media-right,.media>.pull-right{padding-left:10px}.media-left,.media>.pull-left{padding-right:10px}.media-left,.media-right,.media-body{display:table-cell;vertical-align:top}.media-middle{vertical-align:middle}.media-bottom{vertical-align:bottom}.media-heading{margin-top:0;margin-bottom:5px}.media-list{padding-left:0;list-style:none}.list-group{margin-bottom:20px;padding-left:0}.list-group-item{position:relative;display:block;padding:10px 15px;margin-bottom:-1px;background-color:#ffffff;border:1px solid #dddddd}.list-group-item:first-child{border-top-right-radius:0;border-top-left-radius:0}.list-group-item:last-child{margin-bottom:0;border-bottom-right-radius:0;border-bottom-left-radius:0}a.list-group-item,button.list-group-item{color:#555555}a.list-group-item .list-group-item-heading,button.list-group-item .list-group-item-heading{color:#333333}a.list-group-item:hover,button.list-group-item:hover,a.list-group-item:focus,button.list-group-item:focus{text-decoration:none;color:#555555;background-color:#f5f5f5}button.list-group-item{width:100%;text-align:left}.list-group-item.disabled,.list-group-item.disabled:hover,.list-group-item.disabled:focus{background-color:#eeeeee;color:#999999;cursor:not-allowed}.list-group-item.disabled .list-group-item-heading,.list-group-item.disabled:hover .list-group-item-heading,.list-group-item.disabled:focus .list-group-item-heading{color:inherit}.list-group-item.disabled .list-group-item-text,.list-group-item.disabled:hover .list-group-item-text,.list-group-item.disabled:focus .list-group-item-text{color:#999999}.list-group-item.active,.list-group-item.active:hover,.list-group-item.active:focus{z-index:2;color:#ffffff;background-color:#008cba;border-color:#008cba}.list-group-item.active .list-group-item-heading,.list-group-item.active:hover .list-group-item-heading,.list-group-item.active:focus .list-group-item-heading,.list-group-item.active .list-group-item-heading>small,.list-group-item.active:hover .list-group-item-heading>small,.list-group-item.active:focus .list-group-item-heading>small,.list-group-item.active .list-group-item-heading>.small,.list-group-item.active:hover .list-group-item-heading>.small,.list-group-item.active:focus .list-group-item-heading>.small{color:inherit}.list-group-item.active .list-group-item-text,.list-group-item.active:hover .list-group-item-text,.list-group-item.active:focus .list-group-item-text{color:#87e1ff}.list-group-item-success{color:#43ac6a;background-color:#dff0d8}a.list-group-item-success,button.list-group-item-success{color:#43ac6a}a.list-group-item-success .list-group-item-heading,button.list-group-item-success .list-group-item-heading{color:inherit}a.list-group-item-success:hover,button.list-group-item-success:hover,a.list-group-item-success:focus,button.list-group-item-success:focus{color:#43ac6a;background-color:#d0e9c6}a.list-group-item-success.active,button.list-group-item-success.active,a.list-group-item-success.active:hover,button.list-group-item-success.active:hover,a.list-group-item-success.active:focus,button.list-group-item-success.active:focus{color:#fff;background-color:#43ac6a;border-color:#43ac6a}.list-group-item-info{color:#5bc0de;background-color:#d9edf7}a.list-group-item-info,button.list-group-item-info{color:#5bc0de}a.list-group-item-info .list-group-item-heading,button.list-group-item-info .list-group-item-heading{color:inherit}a.list-group-item-info:hover,button.list-group-item-info:hover,a.list-group-item-info:focus,button.list-group-item-info:focus{color:#5bc0de;background-color:#c4e3f3}a.list-group-item-info.active,button.list-group-item-info.active,a.list-group-item-info.active:hover,button.list-group-item-info.active:hover,a.list-group-item-info.active:focus,button.list-group-item-info.active:focus{color:#fff;background-color:#5bc0de;border-color:#5bc0de}.list-group-item-warning{color:#e99002;background-color:#fcf8e3}a.list-group-item-warning,button.list-group-item-warning{color:#e99002}a.list-group-item-warning .list-group-item-heading,button.list-group-item-warning .list-group-item-heading{color:inherit}a.list-group-item-warning:hover,button.list-group-item-warning:hover,a.list-group-item-warning:focus,button.list-group-item-warning:focus{color:#e99002;background-color:#faf2cc}a.list-group-item-warning.active,button.list-group-item-warning.active,a.list-group-item-warning.active:hover,button.list-group-item-warning.active:hover,a.list-group-item-warning.active:focus,button.list-group-item-warning.active:focus{color:#fff;background-color:#e99002;border-color:#e99002}.list-group-item-danger{color:#f04124;background-color:#f2dede}a.list-group-item-danger,button.list-group-item-danger{color:#f04124}a.list-group-item-danger .list-group-item-heading,button.list-group-item-danger .list-group-item-heading{color:inherit}a.list-group-item-danger:hover,button.list-group-item-danger:hover,a.list-group-item-danger:focus,button.list-group-item-danger:focus{color:#f04124;background-color:#ebcccc}a.list-group-item-danger.active,button.list-group-item-danger.active,a.list-group-item-danger.active:hover,button.list-group-item-danger.active:hover,a.list-group-item-danger.active:focus,button.list-group-item-danger.active:focus{color:#fff;background-color:#f04124;border-color:#f04124}.list-group-item-heading{margin-top:0;margin-bottom:5px}.list-group-item-text{margin-bottom:0;line-height:1.3}.panel{margin-bottom:21px;background-color:#ffffff;border:1px solid transparent;border-radius:0;-webkit-box-shadow:0 1px 1px rgba(0,0,0,0.05);box-shadow:0 1px 1px rgba(0,0,0,0.05)}.panel-body{padding:15px}.panel-heading{padding:10px 15px;border-bottom:1px solid transparent;border-top-right-radius:-1;border-top-left-radius:-1}.panel-heading>.dropdown .dropdown-toggle{color:inherit}.panel-title{margin-top:0;margin-bottom:0;font-size:17px;color:inherit}.panel-title>a,.panel-title>small,.panel-title>.small,.panel-title>small>a,.panel-title>.small>a{color:inherit}.panel-footer{padding:10px 15px;background-color:#f5f5f5;border-top:1px solid #dddddd;border-bottom-right-radius:-1;border-bottom-left-radius:-1}.panel>.list-group,.panel>.panel-collapse>.list-group{margin-bottom:0}.panel>.list-group .list-group-item,.panel>.panel-collapse>.list-group .list-group-item{border-width:1px 0;border-radius:0}.panel>.list-group:first-child .list-group-item:first-child,.panel>.panel-collapse>.list-group:first-child .list-group-item:first-child{border-top:0;border-top-right-radius:-1;border-top-left-radius:-1}.panel>.list-group:last-child .list-group-item:last-child,.panel>.panel-collapse>.list-group:last-child .list-group-item:last-child{border-bottom:0;border-bottom-right-radius:-1;border-bottom-left-radius:-1}.panel>.panel-heading+.panel-collapse>.list-group .list-group-item:first-child{border-top-right-radius:0;border-top-left-radius:0}.panel-heading+.list-group .list-group-item:first-child{border-top-width:0}.list-group+.panel-footer{border-top-width:0}.panel>.table,.panel>.table-responsive>.table,.panel>.panel-collapse>.table{margin-bottom:0}.panel>.table caption,.panel>.table-responsive>.table caption,.panel>.panel-collapse>.table caption{padding-left:15px;padding-right:15px}.panel>.table:first-child,.panel>.table-responsive:first-child>.table:first-child{border-top-right-radius:-1;border-top-left-radius:-1}.panel>.table:first-child>thead:first-child>tr:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child{border-top-left-radius:-1;border-top-right-radius:-1}.panel>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table:first-child>thead:first-child>tr:first-child th:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:first-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:first-child{border-top-left-radius:-1}.panel>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table:first-child>thead:first-child>tr:first-child th:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:last-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:last-child{border-top-right-radius:-1}.panel>.table:last-child,.panel>.table-responsive:last-child>.table:last-child{border-bottom-right-radius:-1;border-bottom-left-radius:-1}.panel>.table:last-child>tbody:last-child>tr:last-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child{border-bottom-left-radius:-1;border-bottom-right-radius:-1}.panel>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:first-child{border-bottom-left-radius:-1}.panel>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:last-child{border-bottom-right-radius:-1}.panel>.panel-body+.table,.panel>.panel-body+.table-responsive,.panel>.table+.panel-body,.panel>.table-responsive+.panel-body{border-top:1px solid #dddddd}.panel>.table>tbody:first-child>tr:first-child th,.panel>.table>tbody:first-child>tr:first-child td{border-top:0}.panel>.table-bordered,.panel>.table-responsive>.table-bordered{border:0}.panel>.table-bordered>thead>tr>th:first-child,.panel>.table-responsive>.table-bordered>thead>tr>th:first-child,.panel>.table-bordered>tbody>tr>th:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:first-child,.panel>.table-bordered>tfoot>tr>th:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:first-child,.panel>.table-bordered>thead>tr>td:first-child,.panel>.table-responsive>.table-bordered>thead>tr>td:first-child,.panel>.table-bordered>tbody>tr>td:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:first-child,.panel>.table-bordered>tfoot>tr>td:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:first-child{border-left:0}.panel>.table-bordered>thead>tr>th:last-child,.panel>.table-responsive>.table-bordered>thead>tr>th:last-child,.panel>.table-bordered>tbody>tr>th:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:last-child,.panel>.table-bordered>tfoot>tr>th:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:last-child,.panel>.table-bordered>thead>tr>td:last-child,.panel>.table-responsive>.table-bordered>thead>tr>td:last-child,.panel>.table-bordered>tbody>tr>td:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:last-child,.panel>.table-bordered>tfoot>tr>td:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:last-child{border-right:0}.panel>.table-bordered>thead>tr:first-child>td,.panel>.table-responsive>.table-bordered>thead>tr:first-child>td,.panel>.table-bordered>tbody>tr:first-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>td,.panel>.table-bordered>thead>tr:first-child>th,.panel>.table-responsive>.table-bordered>thead>tr:first-child>th,.panel>.table-bordered>tbody>tr:first-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>th{border-bottom:0}.panel>.table-bordered>tbody>tr:last-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>td,.panel>.table-bordered>tfoot>tr:last-child>td,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>td,.panel>.table-bordered>tbody>tr:last-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>th,.panel>.table-bordered>tfoot>tr:last-child>th,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>th{border-bottom:0}.panel>.table-responsive{border:0;margin-bottom:0}.panel-group{margin-bottom:21px}.panel-group .panel{margin-bottom:0;border-radius:0}.panel-group .panel+.panel{margin-top:5px}.panel-group .panel-heading{border-bottom:0}.panel-group .panel-heading+.panel-collapse>.panel-body,.panel-group .panel-heading+.panel-collapse>.list-group{border-top:1px solid #dddddd}.panel-group .panel-footer{border-top:0}.panel-group .panel-footer+.panel-collapse .panel-body{border-bottom:1px solid #dddddd}.panel-default{border-color:#dddddd}.panel-default>.panel-heading{color:#333333;background-color:#f5f5f5;border-color:#dddddd}.panel-default>.panel-heading+.panel-collapse>.panel-body{border-top-color:#dddddd}.panel-default>.panel-heading .badge{color:#f5f5f5;background-color:#333333}.panel-default>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#dddddd}.panel-primary{border-color:#008cba}.panel-primary>.panel-heading{color:#ffffff;background-color:#008cba;border-color:#008cba}.panel-primary>.panel-heading+.panel-collapse>.panel-body{border-top-color:#008cba}.panel-primary>.panel-heading .badge{color:#008cba;background-color:#ffffff}.panel-primary>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#008cba}.panel-success{border-color:#3c9a5f}.panel-success>.panel-heading{color:#ffffff;background-color:#43ac6a;border-color:#3c9a5f}.panel-success>.panel-heading+.panel-collapse>.panel-body{border-top-color:#3c9a5f}.panel-success>.panel-heading .badge{color:#43ac6a;background-color:#ffffff}.panel-success>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#3c9a5f}.panel-info{border-color:#3db5d8}.panel-info>.panel-heading{color:#ffffff;background-color:#5bc0de;border-color:#3db5d8}.panel-info>.panel-heading+.panel-collapse>.panel-body{border-top-color:#3db5d8}.panel-info>.panel-heading .badge{color:#5bc0de;background-color:#ffffff}.panel-info>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#3db5d8}.panel-warning{border-color:#d08002}.panel-warning>.panel-heading{color:#ffffff;background-color:#e99002;border-color:#d08002}.panel-warning>.panel-heading+.panel-collapse>.panel-body{border-top-color:#d08002}.panel-warning>.panel-heading .badge{color:#e99002;background-color:#ffffff}.panel-warning>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#d08002}.panel-danger{border-color:#ea2f10}.panel-danger>.panel-heading{color:#ffffff;background-color:#f04124;border-color:#ea2f10}.panel-danger>.panel-heading+.panel-collapse>.panel-body{border-top-color:#ea2f10}.panel-danger>.panel-heading .badge{color:#f04124;background-color:#ffffff}.panel-danger>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#ea2f10}.embed-responsive{position:relative;display:block;height:0;padding:0;overflow:hidden}.embed-responsive .embed-responsive-item,.embed-responsive iframe,.embed-responsive embed,.embed-responsive object,.embed-responsive video{position:absolute;top:0;left:0;bottom:0;height:100%;width:100%;border:0}.embed-responsive-16by9{padding-bottom:56.25%}.embed-responsive-4by3{padding-bottom:75%}.well{min-height:20px;padding:19px;margin-bottom:20px;background-color:#fafafa;border:1px solid #e8e8e8;border-radius:0;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,0.05);box-shadow:inset 0 1px 1px rgba(0,0,0,0.05)}.well blockquote{border-color:#ddd;border-color:rgba(0,0,0,0.15)}.well-lg{padding:24px;border-radius:0}.well-sm{padding:9px;border-radius:0}.close{float:right;font-size:22.5px;font-weight:bold;line-height:1;color:#ffffff;text-shadow:0 1px 0 #ffffff;opacity:0.2;filter:alpha(opacity=20)}.close:hover,.close:focus{color:#ffffff;text-decoration:none;cursor:pointer;opacity:0.5;filter:alpha(opacity=50)}button.close{padding:0;cursor:pointer;background:transparent;border:0;-webkit-appearance:none}.modal-open{overflow:hidden}.modal{display:none;overflow:hidden;position:fixed;top:0;right:0;bottom:0;left:0;z-index:1050;-webkit-overflow-scrolling:touch;outline:0}.modal.fade .modal-dialog{-webkit-transform:translate(0, -25%);-ms-transform:translate(0, -25%);-o-transform:translate(0, -25%);transform:translate(0, -25%);-webkit-transition:-webkit-transform .3s ease-out;-o-transition:-o-transform .3s ease-out;transition:transform .3s ease-out}.modal.in .modal-dialog{-webkit-transform:translate(0, 0);-ms-transform:translate(0, 0);-o-transform:translate(0, 0);transform:translate(0, 0)}.modal-open .modal{overflow-x:hidden;overflow-y:auto}.modal-dialog{position:relative;width:auto;margin:10px}.modal-content{position:relative;background-color:#ffffff;border:1px solid #999999;border:1px solid rgba(0,0,0,0.2);border-radius:0;-webkit-box-shadow:0 3px 9px rgba(0,0,0,0.5);box-shadow:0 3px 9px rgba(0,0,0,0.5);-webkit-background-clip:padding-box;background-clip:padding-box;outline:0}.modal-backdrop{position:fixed;top:0;right:0;bottom:0;left:0;z-index:1040;background-color:#000000}.modal-backdrop.fade{opacity:0;filter:alpha(opacity=0)}.modal-backdrop.in{opacity:0.5;filter:alpha(opacity=50)}.modal-header{padding:15px;border-bottom:1px solid #e5e5e5}.modal-header .close{margin-top:-2px}.modal-title{margin:0;line-height:1.4}.modal-body{position:relative;padding:20px}.modal-footer{padding:20px;text-align:right;border-top:1px solid #e5e5e5}.modal-footer .btn+.btn{margin-left:5px;margin-bottom:0}.modal-footer .btn-group .btn+.btn{margin-left:-1px}.modal-footer .btn-block+.btn-block{margin-left:0}.modal-scrollbar-measure{position:absolute;top:-9999px;width:50px;height:50px;overflow:scroll}@media (min-width:768px){.modal-dialog{width:600px;margin:30px auto}.modal-content{-webkit-box-shadow:0 5px 15px rgba(0,0,0,0.5);box-shadow:0 5px 15px rgba(0,0,0,0.5)}.modal-sm{width:300px}}@media (min-width:992px){.modal-lg{width:900px}}.tooltip{position:absolute;z-index:1070;display:block;font-family:"Open Sans","Helvetica Neue",Helvetica,Arial,sans-serif;font-style:normal;font-weight:normal;letter-spacing:normal;line-break:auto;line-height:1.4;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;white-space:normal;word-break:normal;word-spacing:normal;word-wrap:normal;font-size:12px;opacity:0;filter:alpha(opacity=0)}.tooltip.in{opacity:0.9;filter:alpha(opacity=90)}.tooltip.top{margin-top:-3px;padding:5px 0}.tooltip.right{margin-left:3px;padding:0 5px}.tooltip.bottom{margin-top:3px;padding:5px 0}.tooltip.left{margin-left:-3px;padding:0 5px}.tooltip-inner{max-width:200px;padding:3px 8px;color:#ffffff;text-align:center;background-color:#333333;border-radius:0}.tooltip-arrow{position:absolute;width:0;height:0;border-color:transparent;border-style:solid}.tooltip.top .tooltip-arrow{bottom:0;left:50%;margin-left:-5px;border-width:5px 5px 0;border-top-color:#333333}.tooltip.top-left .tooltip-arrow{bottom:0;right:5px;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#333333}.tooltip.top-right .tooltip-arrow{bottom:0;left:5px;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#333333}.tooltip.right .tooltip-arrow{top:50%;left:0;margin-top:-5px;border-width:5px 5px 5px 0;border-right-color:#333333}.tooltip.left .tooltip-arrow{top:50%;right:0;margin-top:-5px;border-width:5px 0 5px 5px;border-left-color:#333333}.tooltip.bottom .tooltip-arrow{top:0;left:50%;margin-left:-5px;border-width:0 5px 5px;border-bottom-color:#333333}.tooltip.bottom-left .tooltip-arrow{top:0;right:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#333333}.tooltip.bottom-right .tooltip-arrow{top:0;left:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#333333}.popover{position:absolute;top:0;left:0;z-index:1060;display:none;max-width:276px;padding:1px;font-family:"Open Sans","Helvetica Neue",Helvetica,Arial,sans-serif;font-style:normal;font-weight:normal;letter-spacing:normal;line-break:auto;line-height:1.4;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;white-space:normal;word-break:normal;word-spacing:normal;word-wrap:normal;font-size:15px;background-color:#333333;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #333333;border:1px solid transparent;border-radius:0;-webkit-box-shadow:0 5px 10px rgba(0,0,0,0.2);box-shadow:0 5px 10px rgba(0,0,0,0.2)}.popover.top{margin-top:-10px}.popover.right{margin-left:10px}.popover.bottom{margin-top:10px}.popover.left{margin-left:-10px}.popover-title{margin:0;padding:8px 14px;font-size:15px;background-color:#333333;border-bottom:1px solid #262626;border-radius:-1 -1 0 0}.popover-content{padding:9px 14px}.popover>.arrow,.popover>.arrow:after{position:absolute;display:block;width:0;height:0;border-color:transparent;border-style:solid}.popover>.arrow{border-width:11px}.popover>.arrow:after{border-width:10px;content:""}.popover.top>.arrow{left:50%;margin-left:-11px;border-bottom-width:0;border-top-color:#000000;border-top-color:rgba(0,0,0,0.05);bottom:-11px}.popover.top>.arrow:after{content:" ";bottom:1px;margin-left:-10px;border-bottom-width:0;border-top-color:#333333}.popover.right>.arrow{top:50%;left:-11px;margin-top:-11px;border-left-width:0;border-right-color:#000000;border-right-color:rgba(0,0,0,0.05)}.popover.right>.arrow:after{content:" ";left:1px;bottom:-10px;border-left-width:0;border-right-color:#333333}.popover.bottom>.arrow{left:50%;margin-left:-11px;border-top-width:0;border-bottom-color:#000000;border-bottom-color:rgba(0,0,0,0.05);top:-11px}.popover.bottom>.arrow:after{content:" ";top:1px;margin-left:-10px;border-top-width:0;border-bottom-color:#333333}.popover.left>.arrow{top:50%;right:-11px;margin-top:-11px;border-right-width:0;border-left-color:#000000;border-left-color:rgba(0,0,0,0.05)}.popover.left>.arrow:after{content:" ";right:1px;border-right-width:0;border-left-color:#333333;bottom:-10px}.carousel{position:relative}.carousel-inner{position:relative;overflow:hidden;width:100%}.carousel-inner>.item{display:none;position:relative;-webkit-transition:.6s ease-in-out left;-o-transition:.6s ease-in-out left;transition:.6s ease-in-out left}.carousel-inner>.item>img,.carousel-inner>.item>a>img{line-height:1}@media all and (transform-3d),(-webkit-transform-3d){.carousel-inner>.item{-webkit-transition:-webkit-transform .6s ease-in-out;-o-transition:-o-transform .6s ease-in-out;transition:transform .6s ease-in-out;-webkit-backface-visibility:hidden;backface-visibility:hidden;-webkit-perspective:1000px;perspective:1000px}.carousel-inner>.item.next,.carousel-inner>.item.active.right{-webkit-transform:translate3d(100%, 0, 0);transform:translate3d(100%, 0, 0);left:0}.carousel-inner>.item.prev,.carousel-inner>.item.active.left{-webkit-transform:translate3d(-100%, 0, 0);transform:translate3d(-100%, 0, 0);left:0}.carousel-inner>.item.next.left,.carousel-inner>.item.prev.right,.carousel-inner>.item.active{-webkit-transform:translate3d(0, 0, 0);transform:translate3d(0, 0, 0);left:0}}.carousel-inner>.active,.carousel-inner>.next,.carousel-inner>.prev{display:block}.carousel-inner>.active{left:0}.carousel-inner>.next,.carousel-inner>.prev{position:absolute;top:0;width:100%}.carousel-inner>.next{left:100%}.carousel-inner>.prev{left:-100%}.carousel-inner>.next.left,.carousel-inner>.prev.right{left:0}.carousel-inner>.active.left{left:-100%}.carousel-inner>.active.right{left:100%}.carousel-control{position:absolute;top:0;left:0;bottom:0;width:15%;opacity:0.5;filter:alpha(opacity=50);font-size:20px;color:#ffffff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,0.6);background-color:rgba(0,0,0,0)}.carousel-control.left{background-image:-webkit-linear-gradient(left, rgba(0,0,0,0.5) 0, rgba(0,0,0,0.0001) 100%);background-image:-o-linear-gradient(left, rgba(0,0,0,0.5) 0, rgba(0,0,0,0.0001) 100%);background-image:-webkit-gradient(linear, left top, right top, from(rgba(0,0,0,0.5)), to(rgba(0,0,0,0.0001)));background-image:linear-gradient(to right, rgba(0,0,0,0.5) 0, rgba(0,0,0,0.0001) 100%);background-repeat:repeat-x;filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#80000000', endColorstr='#00000000', GradientType=1)}.carousel-control.right{left:auto;right:0;background-image:-webkit-linear-gradient(left, rgba(0,0,0,0.0001) 0, rgba(0,0,0,0.5) 100%);background-image:-o-linear-gradient(left, rgba(0,0,0,0.0001) 0, rgba(0,0,0,0.5) 100%);background-image:-webkit-gradient(linear, left top, right top, from(rgba(0,0,0,0.0001)), to(rgba(0,0,0,0.5)));background-image:linear-gradient(to right, rgba(0,0,0,0.0001) 0, rgba(0,0,0,0.5) 100%);background-repeat:repeat-x;filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#00000000', endColorstr='#80000000', GradientType=1)}.carousel-control:hover,.carousel-control:focus{outline:0;color:#ffffff;text-decoration:none;opacity:0.9;filter:alpha(opacity=90)}.carousel-control .icon-prev,.carousel-control .icon-next,.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right{position:absolute;top:50%;margin-top:-10px;z-index:5;display:inline-block}.carousel-control .icon-prev,.carousel-control .glyphicon-chevron-left{left:50%;margin-left:-10px}.carousel-control .icon-next,.carousel-control .glyphicon-chevron-right{right:50%;margin-right:-10px}.carousel-control .icon-prev,.carousel-control .icon-next{width:20px;height:20px;line-height:1;font-family:serif}.carousel-control .icon-prev:before{content:'\2039'}.carousel-control .icon-next:before{content:'\203a'}.carousel-indicators{position:absolute;bottom:10px;left:50%;z-index:15;width:60%;margin-left:-30%;padding-left:0;list-style:none;text-align:center}.carousel-indicators li{display:inline-block;width:10px;height:10px;margin:1px;text-indent:-999px;border:1px solid #ffffff;border-radius:10px;cursor:pointer;background-color:#000 \9;background-color:rgba(0,0,0,0)}.carousel-indicators .active{margin:0;width:12px;height:12px;background-color:#ffffff}.carousel-caption{position:absolute;left:15%;right:15%;bottom:20px;z-index:10;padding-top:20px;padding-bottom:20px;color:#ffffff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,0.6)}.carousel-caption .btn{text-shadow:none}@media screen and (min-width:768px){.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right,.carousel-control .icon-prev,.carousel-control .icon-next{width:30px;height:30px;margin-top:-10px;font-size:30px}.carousel-control .glyphicon-chevron-left,.carousel-control .icon-prev{margin-left:-10px}.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next{margin-right:-10px}.carousel-caption{left:20%;right:20%;padding-bottom:30px}.carousel-indicators{bottom:20px}}.clearfix:before,.clearfix:after,.dl-horizontal dd:before,.dl-horizontal dd:after,.container:before,.container:after,.container-fluid:before,.container-fluid:after,.row:before,.row:after,.form-horizontal .form-group:before,.form-horizontal .form-group:after,.btn-toolbar:before,.btn-toolbar:after,.btn-group-vertical>.btn-group:before,.btn-group-vertical>.btn-group:after,.nav:before,.nav:after,.navbar:before,.navbar:after,.navbar-header:before,.navbar-header:after,.navbar-collapse:before,.navbar-collapse:after,.pager:before,.pager:after,.panel-body:before,.panel-body:after,.modal-header:before,.modal-header:after,.modal-footer:before,.modal-footer:after{content:" ";display:table}.clearfix:after,.dl-horizontal dd:after,.container:after,.container-fluid:after,.row:after,.form-horizontal .form-group:after,.btn-toolbar:after,.btn-group-vertical>.btn-group:after,.nav:after,.navbar:after,.navbar-header:after,.navbar-collapse:after,.pager:after,.panel-body:after,.modal-header:after,.modal-footer:after{clear:both}.center-block{display:block;margin-left:auto;margin-right:auto}.pull-right{float:right !important}.pull-left{float:left !important}.hide{display:none !important}.show{display:block !important}.invisible{visibility:hidden}.text-hide{font:0/0 a;color:transparent;text-shadow:none;background-color:transparent;border:0}.hidden{display:none !important}.affix{position:fixed}@-ms-viewport{width:device-width}.visible-xs,.visible-sm,.visible-md,.visible-lg{display:none !important}.visible-xs-block,.visible-xs-inline,.visible-xs-inline-block,.visible-sm-block,.visible-sm-inline,.visible-sm-inline-block,.visible-md-block,.visible-md-inline,.visible-md-inline-block,.visible-lg-block,.visible-lg-inline,.visible-lg-inline-block{display:none !important}@media (max-width:767px){.visible-xs{display:block !important}table.visible-xs{display:table !important}tr.visible-xs{display:table-row !important}th.visible-xs,td.visible-xs{display:table-cell !important}}@media (max-width:767px){.visible-xs-block{display:block !important}}@media (max-width:767px){.visible-xs-inline{display:inline !important}}@media (max-width:767px){.visible-xs-inline-block{display:inline-block !important}}@media (min-width:768px) and (max-width:991px){.visible-sm{display:block !important}table.visible-sm{display:table !important}tr.visible-sm{display:table-row !important}th.visible-sm,td.visible-sm{display:table-cell !important}}@media (min-width:768px) and (max-width:991px){.visible-sm-block{display:block !important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline{display:inline !important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline-block{display:inline-block !important}}@media (min-width:992px) and (max-width:1199px){.visible-md{display:block !important}table.visible-md{display:table !important}tr.visible-md{display:table-row !important}th.visible-md,td.visible-md{display:table-cell !important}}@media (min-width:992px) and (max-width:1199px){.visible-md-block{display:block !important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline{display:inline !important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline-block{display:inline-block !important}}@media (min-width:1200px){.visible-lg{display:block !important}table.visible-lg{display:table !important}tr.visible-lg{display:table-row !important}th.visible-lg,td.visible-lg{display:table-cell !important}}@media (min-width:1200px){.visible-lg-block{display:block !important}}@media (min-width:1200px){.visible-lg-inline{display:inline !important}}@media (min-width:1200px){.visible-lg-inline-block{display:inline-block !important}}@media (max-width:767px){.hidden-xs{display:none !important}}@media (min-width:768px) and (max-width:991px){.hidden-sm{display:none !important}}@media (min-width:992px) and (max-width:1199px){.hidden-md{display:none !important}}@media (min-width:1200px){.hidden-lg{display:none !important}}.visible-print{display:none !important}@media print{.visible-print{display:block !important}table.visible-print{display:table !important}tr.visible-print{display:table-row !important}th.visible-print,td.visible-print{display:table-cell !important}}.visible-print-block{display:none !important}@media print{.visible-print-block{display:block !important}}.visible-print-inline{display:none !important}@media print{.visible-print-inline{display:inline !important}}.visible-print-inline-block{display:none !important}@media print{.visible-print-inline-block{display:inline-block !important}}@media print{.hidden-print{display:none !important}}.navbar{border:none;font-size:13px;font-weight:300}.navbar .navbar-toggle:hover .icon-bar{background-color:#b3b3b3}.navbar-collapse{border-top-color:rgba(0,0,0,0.2);-webkit-box-shadow:none;box-shadow:none}.navbar .btn{padding-top:6px;padding-bottom:6px}.navbar-form{margin-top:7px;margin-bottom:5px}.navbar-form .form-control{height:auto;padding:4px 6px}.navbar .dropdown-menu{border:none}.navbar .dropdown-menu>li>a,.navbar .dropdown-menu>li>a:focus{background-color:transparent;font-size:13px;font-weight:300}.navbar .dropdown-header{color:rgba(255,255,255,0.5)}.navbar-default .dropdown-menu{background-color:#333333}.navbar-default .dropdown-menu>li>a,.navbar-default .dropdown-menu>li>a:focus{color:#ffffff}.navbar-default .dropdown-menu>li>a:hover,.navbar-default .dropdown-menu>.active>a,.navbar-default .dropdown-menu>.active>a:hover{background-color:#272727}.navbar-inverse .dropdown-menu{background-color:#008cba}.navbar-inverse .dropdown-menu>li>a,.navbar-inverse .dropdown-menu>li>a:focus{color:#ffffff}.navbar-inverse .dropdown-menu>li>a:hover,.navbar-inverse .dropdown-menu>.active>a,.navbar-inverse .dropdown-menu>.active>a:hover{background-color:#006687}.btn{padding:8px 12px}.btn-lg{padding:16px 20px}.btn-sm{padding:8px 12px}.btn-xs{padding:4px 6px}.btn-group .btn~.dropdown-toggle{padding-left:16px;padding-right:16px}.btn-group .dropdown-menu{border-top-width:0}.btn-group.dropup .dropdown-menu{border-top-width:1px;border-bottom-width:0;margin-bottom:0}.btn-group .dropdown-toggle.btn-default~.dropdown-menu{background-color:#e7e7e7;border-color:#cccccc}.btn-group .dropdown-toggle.btn-default~.dropdown-menu>li>a{color:#333333}.btn-group .dropdown-toggle.btn-default~.dropdown-menu>li>a:hover{background-color:#d3d3d3}.btn-group .dropdown-toggle.btn-primary~.dropdown-menu{background-color:#008cba;border-color:#0079a1}.btn-group .dropdown-toggle.btn-primary~.dropdown-menu>li>a{color:#ffffff}.btn-group .dropdown-toggle.btn-primary~.dropdown-menu>li>a:hover{background-color:#006d91}.btn-group .dropdown-toggle.btn-success~.dropdown-menu{background-color:#43ac6a;border-color:#3c9a5f}.btn-group .dropdown-toggle.btn-success~.dropdown-menu>li>a{color:#ffffff}.btn-group .dropdown-toggle.btn-success~.dropdown-menu>li>a:hover{background-color:#388f58}.btn-group .dropdown-toggle.btn-info~.dropdown-menu{background-color:#5bc0de;border-color:#46b8da}.btn-group .dropdown-toggle.btn-info~.dropdown-menu>li>a{color:#ffffff}.btn-group .dropdown-toggle.btn-info~.dropdown-menu>li>a:hover{background-color:#39b3d7}.btn-group .dropdown-toggle.btn-warning~.dropdown-menu{background-color:#e99002;border-color:#d08002}.btn-group .dropdown-toggle.btn-warning~.dropdown-menu>li>a{color:#ffffff}.btn-group .dropdown-toggle.btn-warning~.dropdown-menu>li>a:hover{background-color:#c17702}.btn-group .dropdown-toggle.btn-danger~.dropdown-menu{background-color:#f04124;border-color:#ea2f10}.btn-group .dropdown-toggle.btn-danger~.dropdown-menu>li>a{color:#ffffff}.btn-group .dropdown-toggle.btn-danger~.dropdown-menu>li>a:hover{background-color:#dc2c0f}.lead{color:#6f6f6f}cite{font-style:italic}blockquote{border-left-width:1px;color:#6f6f6f}blockquote.pull-right{border-right-width:1px}blockquote small{font-size:12px;font-weight:300}table{font-size:12px}label,.control-label,.help-block,.checkbox,.radio{font-size:12px;font-weight:normal}input[type="radio"],input[type="checkbox"]{margin-top:1px}.nav .open>a,.nav .open>a:hover,.nav .open>a:focus{border-color:transparent}.nav-tabs>li>a{background-color:#e7e7e7;color:#222222}.nav-tabs .caret{border-top-color:#222222;border-bottom-color:#222222}.nav-pills{font-weight:300}.breadcrumb{border:1px solid #dddddd;border-radius:3px;font-size:10px;font-weight:300;text-transform:uppercase}.pagination{font-size:12px;font-weight:300;color:#999999}.pagination>li>a,.pagination>li>span{margin-left:4px;color:#999999}.pagination>.active>a,.pagination>.active>span{color:#fff}.pagination>li>a,.pagination>li:first-child>a,.pagination>li:last-child>a,.pagination>li>span,.pagination>li:first-child>span,.pagination>li:last-child>span{border-radius:3px}.pagination-lg>li>a,.pagination-lg>li>span{padding-left:22px;padding-right:22px}.pagination-sm>li>a,.pagination-sm>li>span{padding:0 5px}.pager{font-size:12px;font-weight:300;color:#999999}.list-group{font-size:12px;font-weight:300}.close{opacity:0.4;text-decoration:none;text-shadow:none}.close:hover,.close:focus{opacity:1}.alert{font-size:12px;font-weight:300}.alert .alert-link{font-weight:normal;color:#fff;text-decoration:underline}.label{padding-left:1em;padding-right:1em;border-radius:0;font-weight:300}.label-default{background-color:#e7e7e7;color:#333333}.badge{font-weight:300}.progress{height:22px;padding:2px;background-color:#f6f6f6;border:1px solid #ccc;-webkit-box-shadow:none;box-shadow:none}.dropdown-menu{padding:0;margin-top:0;font-size:12px}.dropdown-menu>li>a{padding:12px 15px}.dropdown-header{padding-left:15px;padding-right:15px;font-size:9px;text-transform:uppercase}.popover{color:#fff;font-size:12px;font-weight:300}.panel-heading,.panel-footer{border-top-right-radius:0;border-top-left-radius:0}.panel-default .close{color:#222222}.modal .close{color:#222222}
</style>
<script>/*!
 * Bootstrap v3.3.5 (http://getbootstrap.com)
 * Copyright 2011-2015 Twitter, Inc.
 * Licensed under the MIT license
 */
if("undefined"==typeof jQuery)throw new Error("Bootstrap's JavaScript requires jQuery");+function(a){"use strict";var b=a.fn.jquery.split(" ")[0].split(".");if(b[0]<2&&b[1]<9||1==b[0]&&9==b[1]&&b[2]<1)throw new Error("Bootstrap's JavaScript requires jQuery version 1.9.1 or higher")}(jQuery),+function(a){"use strict";function b(){var a=document.createElement("bootstrap"),b={WebkitTransition:"webkitTransitionEnd",MozTransition:"transitionend",OTransition:"oTransitionEnd otransitionend",transition:"transitionend"};for(var c in b)if(void 0!==a.style[c])return{end:b[c]};return!1}a.fn.emulateTransitionEnd=function(b){var c=!1,d=this;a(this).one("bsTransitionEnd",function(){c=!0});var e=function(){c||a(d).trigger(a.support.transition.end)};return setTimeout(e,b),this},a(function(){a.support.transition=b(),a.support.transition&&(a.event.special.bsTransitionEnd={bindType:a.support.transition.end,delegateType:a.support.transition.end,handle:function(b){return a(b.target).is(this)?b.handleObj.handler.apply(this,arguments):void 0}})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var c=a(this),e=c.data("bs.alert");e||c.data("bs.alert",e=new d(this)),"string"==typeof b&&e[b].call(c)})}var c='[data-dismiss="alert"]',d=function(b){a(b).on("click",c,this.close)};d.VERSION="3.3.5",d.TRANSITION_DURATION=150,d.prototype.close=function(b){function c(){g.detach().trigger("closed.bs.alert").remove()}var e=a(this),f=e.attr("data-target");f||(f=e.attr("href"),f=f&&f.replace(/.*(?=#[^\s]*$)/,""));var g=a(f);b&&b.preventDefault(),g.length||(g=e.closest(".alert")),g.trigger(b=a.Event("close.bs.alert")),b.isDefaultPrevented()||(g.removeClass("in"),a.support.transition&&g.hasClass("fade")?g.one("bsTransitionEnd",c).emulateTransitionEnd(d.TRANSITION_DURATION):c())};var e=a.fn.alert;a.fn.alert=b,a.fn.alert.Constructor=d,a.fn.alert.noConflict=function(){return a.fn.alert=e,this},a(document).on("click.bs.alert.data-api",c,d.prototype.close)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.button"),f="object"==typeof b&&b;e||d.data("bs.button",e=new c(this,f)),"toggle"==b?e.toggle():b&&e.setState(b)})}var c=function(b,d){this.$element=a(b),this.options=a.extend({},c.DEFAULTS,d),this.isLoading=!1};c.VERSION="3.3.5",c.DEFAULTS={loadingText:"loading..."},c.prototype.setState=function(b){var c="disabled",d=this.$element,e=d.is("input")?"val":"html",f=d.data();b+="Text",null==f.resetText&&d.data("resetText",d[e]()),setTimeout(a.proxy(function(){d[e](null==f[b]?this.options[b]:f[b]),"loadingText"==b?(this.isLoading=!0,d.addClass(c).attr(c,c)):this.isLoading&&(this.isLoading=!1,d.removeClass(c).removeAttr(c))},this),0)},c.prototype.toggle=function(){var a=!0,b=this.$element.closest('[data-toggle="buttons"]');if(b.length){var c=this.$element.find("input");"radio"==c.prop("type")?(c.prop("checked")&&(a=!1),b.find(".active").removeClass("active"),this.$element.addClass("active")):"checkbox"==c.prop("type")&&(c.prop("checked")!==this.$element.hasClass("active")&&(a=!1),this.$element.toggleClass("active")),c.prop("checked",this.$element.hasClass("active")),a&&c.trigger("change")}else this.$element.attr("aria-pressed",!this.$element.hasClass("active")),this.$element.toggleClass("active")};var d=a.fn.button;a.fn.button=b,a.fn.button.Constructor=c,a.fn.button.noConflict=function(){return a.fn.button=d,this},a(document).on("click.bs.button.data-api",'[data-toggle^="button"]',function(c){var d=a(c.target);d.hasClass("btn")||(d=d.closest(".btn")),b.call(d,"toggle"),a(c.target).is('input[type="radio"]')||a(c.target).is('input[type="checkbox"]')||c.preventDefault()}).on("focus.bs.button.data-api blur.bs.button.data-api",'[data-toggle^="button"]',function(b){a(b.target).closest(".btn").toggleClass("focus",/^focus(in)?$/.test(b.type))})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.carousel"),f=a.extend({},c.DEFAULTS,d.data(),"object"==typeof b&&b),g="string"==typeof b?b:f.slide;e||d.data("bs.carousel",e=new c(this,f)),"number"==typeof b?e.to(b):g?e[g]():f.interval&&e.pause().cycle()})}var c=function(b,c){this.$element=a(b),this.$indicators=this.$element.find(".carousel-indicators"),this.options=c,this.paused=null,this.sliding=null,this.interval=null,this.$active=null,this.$items=null,this.options.keyboard&&this.$element.on("keydown.bs.carousel",a.proxy(this.keydown,this)),"hover"==this.options.pause&&!("ontouchstart"in document.documentElement)&&this.$element.on("mouseenter.bs.carousel",a.proxy(this.pause,this)).on("mouseleave.bs.carousel",a.proxy(this.cycle,this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=600,c.DEFAULTS={interval:5e3,pause:"hover",wrap:!0,keyboard:!0},c.prototype.keydown=function(a){if(!/input|textarea/i.test(a.target.tagName)){switch(a.which){case 37:this.prev();break;case 39:this.next();break;default:return}a.preventDefault()}},c.prototype.cycle=function(b){return b||(this.paused=!1),this.interval&&clearInterval(this.interval),this.options.interval&&!this.paused&&(this.interval=setInterval(a.proxy(this.next,this),this.options.interval)),this},c.prototype.getItemIndex=function(a){return this.$items=a.parent().children(".item"),this.$items.index(a||this.$active)},c.prototype.getItemForDirection=function(a,b){var c=this.getItemIndex(b),d="prev"==a&&0===c||"next"==a&&c==this.$items.length-1;if(d&&!this.options.wrap)return b;var e="prev"==a?-1:1,f=(c+e)%this.$items.length;return this.$items.eq(f)},c.prototype.to=function(a){var b=this,c=this.getItemIndex(this.$active=this.$element.find(".item.active"));return a>this.$items.length-1||0>a?void 0:this.sliding?this.$element.one("slid.bs.carousel",function(){b.to(a)}):c==a?this.pause().cycle():this.slide(a>c?"next":"prev",this.$items.eq(a))},c.prototype.pause=function(b){return b||(this.paused=!0),this.$element.find(".next, .prev").length&&a.support.transition&&(this.$element.trigger(a.support.transition.end),this.cycle(!0)),this.interval=clearInterval(this.interval),this},c.prototype.next=function(){return this.sliding?void 0:this.slide("next")},c.prototype.prev=function(){return this.sliding?void 0:this.slide("prev")},c.prototype.slide=function(b,d){var e=this.$element.find(".item.active"),f=d||this.getItemForDirection(b,e),g=this.interval,h="next"==b?"left":"right",i=this;if(f.hasClass("active"))return this.sliding=!1;var j=f[0],k=a.Event("slide.bs.carousel",{relatedTarget:j,direction:h});if(this.$element.trigger(k),!k.isDefaultPrevented()){if(this.sliding=!0,g&&this.pause(),this.$indicators.length){this.$indicators.find(".active").removeClass("active");var l=a(this.$indicators.children()[this.getItemIndex(f)]);l&&l.addClass("active")}var m=a.Event("slid.bs.carousel",{relatedTarget:j,direction:h});return a.support.transition&&this.$element.hasClass("slide")?(f.addClass(b),f[0].offsetWidth,e.addClass(h),f.addClass(h),e.one("bsTransitionEnd",function(){f.removeClass([b,h].join(" ")).addClass("active"),e.removeClass(["active",h].join(" ")),i.sliding=!1,setTimeout(function(){i.$element.trigger(m)},0)}).emulateTransitionEnd(c.TRANSITION_DURATION)):(e.removeClass("active"),f.addClass("active"),this.sliding=!1,this.$element.trigger(m)),g&&this.cycle(),this}};var d=a.fn.carousel;a.fn.carousel=b,a.fn.carousel.Constructor=c,a.fn.carousel.noConflict=function(){return a.fn.carousel=d,this};var e=function(c){var d,e=a(this),f=a(e.attr("data-target")||(d=e.attr("href"))&&d.replace(/.*(?=#[^\s]+$)/,""));if(f.hasClass("carousel")){var g=a.extend({},f.data(),e.data()),h=e.attr("data-slide-to");h&&(g.interval=!1),b.call(f,g),h&&f.data("bs.carousel").to(h),c.preventDefault()}};a(document).on("click.bs.carousel.data-api","[data-slide]",e).on("click.bs.carousel.data-api","[data-slide-to]",e),a(window).on("load",function(){a('[data-ride="carousel"]').each(function(){var c=a(this);b.call(c,c.data())})})}(jQuery),+function(a){"use strict";function b(b){var c,d=b.attr("data-target")||(c=b.attr("href"))&&c.replace(/.*(?=#[^\s]+$)/,"");return a(d)}function c(b){return this.each(function(){var c=a(this),e=c.data("bs.collapse"),f=a.extend({},d.DEFAULTS,c.data(),"object"==typeof b&&b);!e&&f.toggle&&/show|hide/.test(b)&&(f.toggle=!1),e||c.data("bs.collapse",e=new d(this,f)),"string"==typeof b&&e[b]()})}var d=function(b,c){this.$element=a(b),this.options=a.extend({},d.DEFAULTS,c),this.$trigger=a('[data-toggle="collapse"][href="#'+b.id+'"],[data-toggle="collapse"][data-target="#'+b.id+'"]'),this.transitioning=null,this.options.parent?this.$parent=this.getParent():this.addAriaAndCollapsedClass(this.$element,this.$trigger),this.options.toggle&&this.toggle()};d.VERSION="3.3.5",d.TRANSITION_DURATION=350,d.DEFAULTS={toggle:!0},d.prototype.dimension=function(){var a=this.$element.hasClass("width");return a?"width":"height"},d.prototype.show=function(){if(!this.transitioning&&!this.$element.hasClass("in")){var b,e=this.$parent&&this.$parent.children(".panel").children(".in, .collapsing");if(!(e&&e.length&&(b=e.data("bs.collapse"),b&&b.transitioning))){var f=a.Event("show.bs.collapse");if(this.$element.trigger(f),!f.isDefaultPrevented()){e&&e.length&&(c.call(e,"hide"),b||e.data("bs.collapse",null));var g=this.dimension();this.$element.removeClass("collapse").addClass("collapsing")[g](0).attr("aria-expanded",!0),this.$trigger.removeClass("collapsed").attr("aria-expanded",!0),this.transitioning=1;var h=function(){this.$element.removeClass("collapsing").addClass("collapse in")[g](""),this.transitioning=0,this.$element.trigger("shown.bs.collapse")};if(!a.support.transition)return h.call(this);var i=a.camelCase(["scroll",g].join("-"));this.$element.one("bsTransitionEnd",a.proxy(h,this)).emulateTransitionEnd(d.TRANSITION_DURATION)[g](this.$element[0][i])}}}},d.prototype.hide=function(){if(!this.transitioning&&this.$element.hasClass("in")){var b=a.Event("hide.bs.collapse");if(this.$element.trigger(b),!b.isDefaultPrevented()){var c=this.dimension();this.$element[c](this.$element[c]())[0].offsetHeight,this.$element.addClass("collapsing").removeClass("collapse in").attr("aria-expanded",!1),this.$trigger.addClass("collapsed").attr("aria-expanded",!1),this.transitioning=1;var e=function(){this.transitioning=0,this.$element.removeClass("collapsing").addClass("collapse").trigger("hidden.bs.collapse")};return a.support.transition?void this.$element[c](0).one("bsTransitionEnd",a.proxy(e,this)).emulateTransitionEnd(d.TRANSITION_DURATION):e.call(this)}}},d.prototype.toggle=function(){this[this.$element.hasClass("in")?"hide":"show"]()},d.prototype.getParent=function(){return a(this.options.parent).find('[data-toggle="collapse"][data-parent="'+this.options.parent+'"]').each(a.proxy(function(c,d){var e=a(d);this.addAriaAndCollapsedClass(b(e),e)},this)).end()},d.prototype.addAriaAndCollapsedClass=function(a,b){var c=a.hasClass("in");a.attr("aria-expanded",c),b.toggleClass("collapsed",!c).attr("aria-expanded",c)};var e=a.fn.collapse;a.fn.collapse=c,a.fn.collapse.Constructor=d,a.fn.collapse.noConflict=function(){return a.fn.collapse=e,this},a(document).on("click.bs.collapse.data-api",'[data-toggle="collapse"]',function(d){var e=a(this);e.attr("data-target")||d.preventDefault();var f=b(e),g=f.data("bs.collapse"),h=g?"toggle":e.data();c.call(f,h)})}(jQuery),+function(a){"use strict";function b(b){var c=b.attr("data-target");c||(c=b.attr("href"),c=c&&/#[A-Za-z]/.test(c)&&c.replace(/.*(?=#[^\s]*$)/,""));var d=c&&a(c);return d&&d.length?d:b.parent()}function c(c){c&&3===c.which||(a(e).remove(),a(f).each(function(){var d=a(this),e=b(d),f={relatedTarget:this};e.hasClass("open")&&(c&&"click"==c.type&&/input|textarea/i.test(c.target.tagName)&&a.contains(e[0],c.target)||(e.trigger(c=a.Event("hide.bs.dropdown",f)),c.isDefaultPrevented()||(d.attr("aria-expanded","false"),e.removeClass("open").trigger("hidden.bs.dropdown",f))))}))}function d(b){return this.each(function(){var c=a(this),d=c.data("bs.dropdown");d||c.data("bs.dropdown",d=new g(this)),"string"==typeof b&&d[b].call(c)})}var e=".dropdown-backdrop",f='[data-toggle="dropdown"]',g=function(b){a(b).on("click.bs.dropdown",this.toggle)};g.VERSION="3.3.5",g.prototype.toggle=function(d){var e=a(this);if(!e.is(".disabled, :disabled")){var f=b(e),g=f.hasClass("open");if(c(),!g){"ontouchstart"in document.documentElement&&!f.closest(".navbar-nav").length&&a(document.createElement("div")).addClass("dropdown-backdrop").insertAfter(a(this)).on("click",c);var h={relatedTarget:this};if(f.trigger(d=a.Event("show.bs.dropdown",h)),d.isDefaultPrevented())return;e.trigger("focus").attr("aria-expanded","true"),f.toggleClass("open").trigger("shown.bs.dropdown",h)}return!1}},g.prototype.keydown=function(c){if(/(38|40|27|32)/.test(c.which)&&!/input|textarea/i.test(c.target.tagName)){var d=a(this);if(c.preventDefault(),c.stopPropagation(),!d.is(".disabled, :disabled")){var e=b(d),g=e.hasClass("open");if(!g&&27!=c.which||g&&27==c.which)return 27==c.which&&e.find(f).trigger("focus"),d.trigger("click");var h=" li:not(.disabled):visible a",i=e.find(".dropdown-menu"+h);if(i.length){var j=i.index(c.target);38==c.which&&j>0&&j--,40==c.which&&j<i.length-1&&j++,~j||(j=0),i.eq(j).trigger("focus")}}}};var h=a.fn.dropdown;a.fn.dropdown=d,a.fn.dropdown.Constructor=g,a.fn.dropdown.noConflict=function(){return a.fn.dropdown=h,this},a(document).on("click.bs.dropdown.data-api",c).on("click.bs.dropdown.data-api",".dropdown form",function(a){a.stopPropagation()}).on("click.bs.dropdown.data-api",f,g.prototype.toggle).on("keydown.bs.dropdown.data-api",f,g.prototype.keydown).on("keydown.bs.dropdown.data-api",".dropdown-menu",g.prototype.keydown)}(jQuery),+function(a){"use strict";function b(b,d){return this.each(function(){var e=a(this),f=e.data("bs.modal"),g=a.extend({},c.DEFAULTS,e.data(),"object"==typeof b&&b);f||e.data("bs.modal",f=new c(this,g)),"string"==typeof b?f[b](d):g.show&&f.show(d)})}var c=function(b,c){this.options=c,this.$body=a(document.body),this.$element=a(b),this.$dialog=this.$element.find(".modal-dialog"),this.$backdrop=null,this.isShown=null,this.originalBodyPad=null,this.scrollbarWidth=0,this.ignoreBackdropClick=!1,this.options.remote&&this.$element.find(".modal-content").load(this.options.remote,a.proxy(function(){this.$element.trigger("loaded.bs.modal")},this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=300,c.BACKDROP_TRANSITION_DURATION=150,c.DEFAULTS={backdrop:!0,keyboard:!0,show:!0},c.prototype.toggle=function(a){return this.isShown?this.hide():this.show(a)},c.prototype.show=function(b){var d=this,e=a.Event("show.bs.modal",{relatedTarget:b});this.$element.trigger(e),this.isShown||e.isDefaultPrevented()||(this.isShown=!0,this.checkScrollbar(),this.setScrollbar(),this.$body.addClass("modal-open"),this.escape(),this.resize(),this.$element.on("click.dismiss.bs.modal",'[data-dismiss="modal"]',a.proxy(this.hide,this)),this.$dialog.on("mousedown.dismiss.bs.modal",function(){d.$element.one("mouseup.dismiss.bs.modal",function(b){a(b.target).is(d.$element)&&(d.ignoreBackdropClick=!0)})}),this.backdrop(function(){var e=a.support.transition&&d.$element.hasClass("fade");d.$element.parent().length||d.$element.appendTo(d.$body),d.$element.show().scrollTop(0),d.adjustDialog(),e&&d.$element[0].offsetWidth,d.$element.addClass("in"),d.enforceFocus();var f=a.Event("shown.bs.modal",{relatedTarget:b});e?d.$dialog.one("bsTransitionEnd",function(){d.$element.trigger("focus").trigger(f)}).emulateTransitionEnd(c.TRANSITION_DURATION):d.$element.trigger("focus").trigger(f)}))},c.prototype.hide=function(b){b&&b.preventDefault(),b=a.Event("hide.bs.modal"),this.$element.trigger(b),this.isShown&&!b.isDefaultPrevented()&&(this.isShown=!1,this.escape(),this.resize(),a(document).off("focusin.bs.modal"),this.$element.removeClass("in").off("click.dismiss.bs.modal").off("mouseup.dismiss.bs.modal"),this.$dialog.off("mousedown.dismiss.bs.modal"),a.support.transition&&this.$element.hasClass("fade")?this.$element.one("bsTransitionEnd",a.proxy(this.hideModal,this)).emulateTransitionEnd(c.TRANSITION_DURATION):this.hideModal())},c.prototype.enforceFocus=function(){a(document).off("focusin.bs.modal").on("focusin.bs.modal",a.proxy(function(a){this.$element[0]===a.target||this.$element.has(a.target).length||this.$element.trigger("focus")},this))},c.prototype.escape=function(){this.isShown&&this.options.keyboard?this.$element.on("keydown.dismiss.bs.modal",a.proxy(function(a){27==a.which&&this.hide()},this)):this.isShown||this.$element.off("keydown.dismiss.bs.modal")},c.prototype.resize=function(){this.isShown?a(window).on("resize.bs.modal",a.proxy(this.handleUpdate,this)):a(window).off("resize.bs.modal")},c.prototype.hideModal=function(){var a=this;this.$element.hide(),this.backdrop(function(){a.$body.removeClass("modal-open"),a.resetAdjustments(),a.resetScrollbar(),a.$element.trigger("hidden.bs.modal")})},c.prototype.removeBackdrop=function(){this.$backdrop&&this.$backdrop.remove(),this.$backdrop=null},c.prototype.backdrop=function(b){var d=this,e=this.$element.hasClass("fade")?"fade":"";if(this.isShown&&this.options.backdrop){var f=a.support.transition&&e;if(this.$backdrop=a(document.createElement("div")).addClass("modal-backdrop "+e).appendTo(this.$body),this.$element.on("click.dismiss.bs.modal",a.proxy(function(a){return this.ignoreBackdropClick?void(this.ignoreBackdropClick=!1):void(a.target===a.currentTarget&&("static"==this.options.backdrop?this.$element[0].focus():this.hide()))},this)),f&&this.$backdrop[0].offsetWidth,this.$backdrop.addClass("in"),!b)return;f?this.$backdrop.one("bsTransitionEnd",b).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):b()}else if(!this.isShown&&this.$backdrop){this.$backdrop.removeClass("in");var g=function(){d.removeBackdrop(),b&&b()};a.support.transition&&this.$element.hasClass("fade")?this.$backdrop.one("bsTransitionEnd",g).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):g()}else b&&b()},c.prototype.handleUpdate=function(){this.adjustDialog()},c.prototype.adjustDialog=function(){var a=this.$element[0].scrollHeight>document.documentElement.clientHeight;this.$element.css({paddingLeft:!this.bodyIsOverflowing&&a?this.scrollbarWidth:"",paddingRight:this.bodyIsOverflowing&&!a?this.scrollbarWidth:""})},c.prototype.resetAdjustments=function(){this.$element.css({paddingLeft:"",paddingRight:""})},c.prototype.checkScrollbar=function(){var a=window.innerWidth;if(!a){var b=document.documentElement.getBoundingClientRect();a=b.right-Math.abs(b.left)}this.bodyIsOverflowing=document.body.clientWidth<a,this.scrollbarWidth=this.measureScrollbar()},c.prototype.setScrollbar=function(){var a=parseInt(this.$body.css("padding-right")||0,10);this.originalBodyPad=document.body.style.paddingRight||"",this.bodyIsOverflowing&&this.$body.css("padding-right",a+this.scrollbarWidth)},c.prototype.resetScrollbar=function(){this.$body.css("padding-right",this.originalBodyPad)},c.prototype.measureScrollbar=function(){var a=document.createElement("div");a.className="modal-scrollbar-measure",this.$body.append(a);var b=a.offsetWidth-a.clientWidth;return this.$body[0].removeChild(a),b};var d=a.fn.modal;a.fn.modal=b,a.fn.modal.Constructor=c,a.fn.modal.noConflict=function(){return a.fn.modal=d,this},a(document).on("click.bs.modal.data-api",'[data-toggle="modal"]',function(c){var d=a(this),e=d.attr("href"),f=a(d.attr("data-target")||e&&e.replace(/.*(?=#[^\s]+$)/,"")),g=f.data("bs.modal")?"toggle":a.extend({remote:!/#/.test(e)&&e},f.data(),d.data());d.is("a")&&c.preventDefault(),f.one("show.bs.modal",function(a){a.isDefaultPrevented()||f.one("hidden.bs.modal",function(){d.is(":visible")&&d.trigger("focus")})}),b.call(f,g,this)})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tooltip"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.tooltip",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.type=null,this.options=null,this.enabled=null,this.timeout=null,this.hoverState=null,this.$element=null,this.inState=null,this.init("tooltip",a,b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.DEFAULTS={animation:!0,placement:"top",selector:!1,template:'<div class="tooltip" role="tooltip"><div class="tooltip-arrow"></div><div class="tooltip-inner"></div></div>',trigger:"hover focus",title:"",delay:0,html:!1,container:!1,viewport:{selector:"body",padding:0}},c.prototype.init=function(b,c,d){if(this.enabled=!0,this.type=b,this.$element=a(c),this.options=this.getOptions(d),this.$viewport=this.options.viewport&&a(a.isFunction(this.options.viewport)?this.options.viewport.call(this,this.$element):this.options.viewport.selector||this.options.viewport),this.inState={click:!1,hover:!1,focus:!1},this.$element[0]instanceof document.constructor&&!this.options.selector)throw new Error("`selector` option must be specified when initializing "+this.type+" on the window.document object!");for(var e=this.options.trigger.split(" "),f=e.length;f--;){var g=e[f];if("click"==g)this.$element.on("click."+this.type,this.options.selector,a.proxy(this.toggle,this));else if("manual"!=g){var h="hover"==g?"mouseenter":"focusin",i="hover"==g?"mouseleave":"focusout";this.$element.on(h+"."+this.type,this.options.selector,a.proxy(this.enter,this)),this.$element.on(i+"."+this.type,this.options.selector,a.proxy(this.leave,this))}}this.options.selector?this._options=a.extend({},this.options,{trigger:"manual",selector:""}):this.fixTitle()},c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.getOptions=function(b){return b=a.extend({},this.getDefaults(),this.$element.data(),b),b.delay&&"number"==typeof b.delay&&(b.delay={show:b.delay,hide:b.delay}),b},c.prototype.getDelegateOptions=function(){var b={},c=this.getDefaults();return this._options&&a.each(this._options,function(a,d){c[a]!=d&&(b[a]=d)}),b},c.prototype.enter=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusin"==b.type?"focus":"hover"]=!0),c.tip().hasClass("in")||"in"==c.hoverState?void(c.hoverState="in"):(clearTimeout(c.timeout),c.hoverState="in",c.options.delay&&c.options.delay.show?void(c.timeout=setTimeout(function(){"in"==c.hoverState&&c.show()},c.options.delay.show)):c.show())},c.prototype.isInStateTrue=function(){for(var a in this.inState)if(this.inState[a])return!0;return!1},c.prototype.leave=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusout"==b.type?"focus":"hover"]=!1),c.isInStateTrue()?void 0:(clearTimeout(c.timeout),c.hoverState="out",c.options.delay&&c.options.delay.hide?void(c.timeout=setTimeout(function(){"out"==c.hoverState&&c.hide()},c.options.delay.hide)):c.hide())},c.prototype.show=function(){var b=a.Event("show.bs."+this.type);if(this.hasContent()&&this.enabled){this.$element.trigger(b);var d=a.contains(this.$element[0].ownerDocument.documentElement,this.$element[0]);if(b.isDefaultPrevented()||!d)return;var e=this,f=this.tip(),g=this.getUID(this.type);this.setContent(),f.attr("id",g),this.$element.attr("aria-describedby",g),this.options.animation&&f.addClass("fade");var h="function"==typeof this.options.placement?this.options.placement.call(this,f[0],this.$element[0]):this.options.placement,i=/\s?auto?\s?/i,j=i.test(h);j&&(h=h.replace(i,"")||"top"),f.detach().css({top:0,left:0,display:"block"}).addClass(h).data("bs."+this.type,this),this.options.container?f.appendTo(this.options.container):f.insertAfter(this.$element),this.$element.trigger("inserted.bs."+this.type);var k=this.getPosition(),l=f[0].offsetWidth,m=f[0].offsetHeight;if(j){var n=h,o=this.getPosition(this.$viewport);h="bottom"==h&&k.bottom+m>o.bottom?"top":"top"==h&&k.top-m<o.top?"bottom":"right"==h&&k.right+l>o.width?"left":"left"==h&&k.left-l<o.left?"right":h,f.removeClass(n).addClass(h)}var p=this.getCalculatedOffset(h,k,l,m);this.applyPlacement(p,h);var q=function(){var a=e.hoverState;e.$element.trigger("shown.bs."+e.type),e.hoverState=null,"out"==a&&e.leave(e)};a.support.transition&&this.$tip.hasClass("fade")?f.one("bsTransitionEnd",q).emulateTransitionEnd(c.TRANSITION_DURATION):q()}},c.prototype.applyPlacement=function(b,c){var d=this.tip(),e=d[0].offsetWidth,f=d[0].offsetHeight,g=parseInt(d.css("margin-top"),10),h=parseInt(d.css("margin-left"),10);isNaN(g)&&(g=0),isNaN(h)&&(h=0),b.top+=g,b.left+=h,a.offset.setOffset(d[0],a.extend({using:function(a){d.css({top:Math.round(a.top),left:Math.round(a.left)})}},b),0),d.addClass("in");var i=d[0].offsetWidth,j=d[0].offsetHeight;"top"==c&&j!=f&&(b.top=b.top+f-j);var k=this.getViewportAdjustedDelta(c,b,i,j);k.left?b.left+=k.left:b.top+=k.top;var l=/top|bottom/.test(c),m=l?2*k.left-e+i:2*k.top-f+j,n=l?"offsetWidth":"offsetHeight";d.offset(b),this.replaceArrow(m,d[0][n],l)},c.prototype.replaceArrow=function(a,b,c){this.arrow().css(c?"left":"top",50*(1-a/b)+"%").css(c?"top":"left","")},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle();a.find(".tooltip-inner")[this.options.html?"html":"text"](b),a.removeClass("fade in top bottom left right")},c.prototype.hide=function(b){function d(){"in"!=e.hoverState&&f.detach(),e.$element.removeAttr("aria-describedby").trigger("hidden.bs."+e.type),b&&b()}var e=this,f=a(this.$tip),g=a.Event("hide.bs."+this.type);return this.$element.trigger(g),g.isDefaultPrevented()?void 0:(f.removeClass("in"),a.support.transition&&f.hasClass("fade")?f.one("bsTransitionEnd",d).emulateTransitionEnd(c.TRANSITION_DURATION):d(),this.hoverState=null,this)},c.prototype.fixTitle=function(){var a=this.$element;(a.attr("title")||"string"!=typeof a.attr("data-original-title"))&&a.attr("data-original-title",a.attr("title")||"").attr("title","")},c.prototype.hasContent=function(){return this.getTitle()},c.prototype.getPosition=function(b){b=b||this.$element;var c=b[0],d="BODY"==c.tagName,e=c.getBoundingClientRect();null==e.width&&(e=a.extend({},e,{width:e.right-e.left,height:e.bottom-e.top}));var f=d?{top:0,left:0}:b.offset(),g={scroll:d?document.documentElement.scrollTop||document.body.scrollTop:b.scrollTop()},h=d?{width:a(window).width(),height:a(window).height()}:null;return a.extend({},e,g,h,f)},c.prototype.getCalculatedOffset=function(a,b,c,d){return"bottom"==a?{top:b.top+b.height,left:b.left+b.width/2-c/2}:"top"==a?{top:b.top-d,left:b.left+b.width/2-c/2}:"left"==a?{top:b.top+b.height/2-d/2,left:b.left-c}:{top:b.top+b.height/2-d/2,left:b.left+b.width}},c.prototype.getViewportAdjustedDelta=function(a,b,c,d){var e={top:0,left:0};if(!this.$viewport)return e;var f=this.options.viewport&&this.options.viewport.padding||0,g=this.getPosition(this.$viewport);if(/right|left/.test(a)){var h=b.top-f-g.scroll,i=b.top+f-g.scroll+d;h<g.top?e.top=g.top-h:i>g.top+g.height&&(e.top=g.top+g.height-i)}else{var j=b.left-f,k=b.left+f+c;j<g.left?e.left=g.left-j:k>g.right&&(e.left=g.left+g.width-k)}return e},c.prototype.getTitle=function(){var a,b=this.$element,c=this.options;return a=b.attr("data-original-title")||("function"==typeof c.title?c.title.call(b[0]):c.title)},c.prototype.getUID=function(a){do a+=~~(1e6*Math.random());while(document.getElementById(a));return a},c.prototype.tip=function(){if(!this.$tip&&(this.$tip=a(this.options.template),1!=this.$tip.length))throw new Error(this.type+" `template` option must consist of exactly 1 top-level element!");return this.$tip},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".tooltip-arrow")},c.prototype.enable=function(){this.enabled=!0},c.prototype.disable=function(){this.enabled=!1},c.prototype.toggleEnabled=function(){this.enabled=!this.enabled},c.prototype.toggle=function(b){var c=this;b&&(c=a(b.currentTarget).data("bs."+this.type),c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c))),b?(c.inState.click=!c.inState.click,c.isInStateTrue()?c.enter(c):c.leave(c)):c.tip().hasClass("in")?c.leave(c):c.enter(c)},c.prototype.destroy=function(){var a=this;clearTimeout(this.timeout),this.hide(function(){a.$element.off("."+a.type).removeData("bs."+a.type),a.$tip&&a.$tip.detach(),a.$tip=null,a.$arrow=null,a.$viewport=null})};var d=a.fn.tooltip;a.fn.tooltip=b,a.fn.tooltip.Constructor=c,a.fn.tooltip.noConflict=function(){return a.fn.tooltip=d,this}}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.popover"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.popover",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.init("popover",a,b)};if(!a.fn.tooltip)throw new Error("Popover requires tooltip.js");c.VERSION="3.3.5",c.DEFAULTS=a.extend({},a.fn.tooltip.Constructor.DEFAULTS,{placement:"right",trigger:"click",content:"",template:'<div class="popover" role="tooltip"><div class="arrow"></div><h3 class="popover-title"></h3><div class="popover-content"></div></div>'}),c.prototype=a.extend({},a.fn.tooltip.Constructor.prototype),c.prototype.constructor=c,c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle(),c=this.getContent();a.find(".popover-title")[this.options.html?"html":"text"](b),a.find(".popover-content").children().detach().end()[this.options.html?"string"==typeof c?"html":"append":"text"](c),a.removeClass("fade top bottom left right in"),a.find(".popover-title").html()||a.find(".popover-title").hide()},c.prototype.hasContent=function(){return this.getTitle()||this.getContent()},c.prototype.getContent=function(){var a=this.$element,b=this.options;return a.attr("data-content")||("function"==typeof b.content?b.content.call(a[0]):b.content)},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".arrow")};var d=a.fn.popover;a.fn.popover=b,a.fn.popover.Constructor=c,a.fn.popover.noConflict=function(){return a.fn.popover=d,this}}(jQuery),+function(a){"use strict";function b(c,d){this.$body=a(document.body),this.$scrollElement=a(a(c).is(document.body)?window:c),this.options=a.extend({},b.DEFAULTS,d),this.selector=(this.options.target||"")+" .nav li > a",this.offsets=[],this.targets=[],this.activeTarget=null,this.scrollHeight=0,this.$scrollElement.on("scroll.bs.scrollspy",a.proxy(this.process,this)),this.refresh(),this.process()}function c(c){return this.each(function(){var d=a(this),e=d.data("bs.scrollspy"),f="object"==typeof c&&c;e||d.data("bs.scrollspy",e=new b(this,f)),"string"==typeof c&&e[c]()})}b.VERSION="3.3.5",b.DEFAULTS={offset:10},b.prototype.getScrollHeight=function(){return this.$scrollElement[0].scrollHeight||Math.max(this.$body[0].scrollHeight,document.documentElement.scrollHeight)},b.prototype.refresh=function(){var b=this,c="offset",d=0;this.offsets=[],this.targets=[],this.scrollHeight=this.getScrollHeight(),a.isWindow(this.$scrollElement[0])||(c="position",d=this.$scrollElement.scrollTop()),this.$body.find(this.selector).map(function(){var b=a(this),e=b.data("target")||b.attr("href"),f=/^#./.test(e)&&a(e);return f&&f.length&&f.is(":visible")&&[[f[c]().top+d,e]]||null}).sort(function(a,b){return a[0]-b[0]}).each(function(){b.offsets.push(this[0]),b.targets.push(this[1])})},b.prototype.process=function(){var a,b=this.$scrollElement.scrollTop()+this.options.offset,c=this.getScrollHeight(),d=this.options.offset+c-this.$scrollElement.height(),e=this.offsets,f=this.targets,g=this.activeTarget;if(this.scrollHeight!=c&&this.refresh(),b>=d)return g!=(a=f[f.length-1])&&this.activate(a);if(g&&b<e[0])return this.activeTarget=null,this.clear();for(a=e.length;a--;)g!=f[a]&&b>=e[a]&&(void 0===e[a+1]||b<e[a+1])&&this.activate(f[a])},b.prototype.activate=function(b){this.activeTarget=b,this.clear();var c=this.selector+'[data-target="'+b+'"],'+this.selector+'[href="'+b+'"]',d=a(c).parents("li").addClass("active");d.parent(".dropdown-menu").length&&(d=d.closest("li.dropdown").addClass("active")),
d.trigger("activate.bs.scrollspy")},b.prototype.clear=function(){a(this.selector).parentsUntil(this.options.target,".active").removeClass("active")};var d=a.fn.scrollspy;a.fn.scrollspy=c,a.fn.scrollspy.Constructor=b,a.fn.scrollspy.noConflict=function(){return a.fn.scrollspy=d,this},a(window).on("load.bs.scrollspy.data-api",function(){a('[data-spy="scroll"]').each(function(){var b=a(this);c.call(b,b.data())})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tab");e||d.data("bs.tab",e=new c(this)),"string"==typeof b&&e[b]()})}var c=function(b){this.element=a(b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.prototype.show=function(){var b=this.element,c=b.closest("ul:not(.dropdown-menu)"),d=b.data("target");if(d||(d=b.attr("href"),d=d&&d.replace(/.*(?=#[^\s]*$)/,"")),!b.parent("li").hasClass("active")){var e=c.find(".active:last a"),f=a.Event("hide.bs.tab",{relatedTarget:b[0]}),g=a.Event("show.bs.tab",{relatedTarget:e[0]});if(e.trigger(f),b.trigger(g),!g.isDefaultPrevented()&&!f.isDefaultPrevented()){var h=a(d);this.activate(b.closest("li"),c),this.activate(h,h.parent(),function(){e.trigger({type:"hidden.bs.tab",relatedTarget:b[0]}),b.trigger({type:"shown.bs.tab",relatedTarget:e[0]})})}}},c.prototype.activate=function(b,d,e){function f(){g.removeClass("active").find("> .dropdown-menu > .active").removeClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!1),b.addClass("active").find('[data-toggle="tab"]').attr("aria-expanded",!0),h?(b[0].offsetWidth,b.addClass("in")):b.removeClass("fade"),b.parent(".dropdown-menu").length&&b.closest("li.dropdown").addClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!0),e&&e()}var g=d.find("> .active"),h=e&&a.support.transition&&(g.length&&g.hasClass("fade")||!!d.find("> .fade").length);g.length&&h?g.one("bsTransitionEnd",f).emulateTransitionEnd(c.TRANSITION_DURATION):f(),g.removeClass("in")};var d=a.fn.tab;a.fn.tab=b,a.fn.tab.Constructor=c,a.fn.tab.noConflict=function(){return a.fn.tab=d,this};var e=function(c){c.preventDefault(),b.call(a(this),"show")};a(document).on("click.bs.tab.data-api",'[data-toggle="tab"]',e).on("click.bs.tab.data-api",'[data-toggle="pill"]',e)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.affix"),f="object"==typeof b&&b;e||d.data("bs.affix",e=new c(this,f)),"string"==typeof b&&e[b]()})}var c=function(b,d){this.options=a.extend({},c.DEFAULTS,d),this.$target=a(this.options.target).on("scroll.bs.affix.data-api",a.proxy(this.checkPosition,this)).on("click.bs.affix.data-api",a.proxy(this.checkPositionWithEventLoop,this)),this.$element=a(b),this.affixed=null,this.unpin=null,this.pinnedOffset=null,this.checkPosition()};c.VERSION="3.3.5",c.RESET="affix affix-top affix-bottom",c.DEFAULTS={offset:0,target:window},c.prototype.getState=function(a,b,c,d){var e=this.$target.scrollTop(),f=this.$element.offset(),g=this.$target.height();if(null!=c&&"top"==this.affixed)return c>e?"top":!1;if("bottom"==this.affixed)return null!=c?e+this.unpin<=f.top?!1:"bottom":a-d>=e+g?!1:"bottom";var h=null==this.affixed,i=h?e:f.top,j=h?g:b;return null!=c&&c>=e?"top":null!=d&&i+j>=a-d?"bottom":!1},c.prototype.getPinnedOffset=function(){if(this.pinnedOffset)return this.pinnedOffset;this.$element.removeClass(c.RESET).addClass("affix");var a=this.$target.scrollTop(),b=this.$element.offset();return this.pinnedOffset=b.top-a},c.prototype.checkPositionWithEventLoop=function(){setTimeout(a.proxy(this.checkPosition,this),1)},c.prototype.checkPosition=function(){if(this.$element.is(":visible")){var b=this.$element.height(),d=this.options.offset,e=d.top,f=d.bottom,g=Math.max(a(document).height(),a(document.body).height());"object"!=typeof d&&(f=e=d),"function"==typeof e&&(e=d.top(this.$element)),"function"==typeof f&&(f=d.bottom(this.$element));var h=this.getState(g,b,e,f);if(this.affixed!=h){null!=this.unpin&&this.$element.css("top","");var i="affix"+(h?"-"+h:""),j=a.Event(i+".bs.affix");if(this.$element.trigger(j),j.isDefaultPrevented())return;this.affixed=h,this.unpin="bottom"==h?this.getPinnedOffset():null,this.$element.removeClass(c.RESET).addClass(i).trigger(i.replace("affix","affixed")+".bs.affix")}"bottom"==h&&this.$element.offset({top:g-b-f})}};var d=a.fn.affix;a.fn.affix=b,a.fn.affix.Constructor=c,a.fn.affix.noConflict=function(){return a.fn.affix=d,this},a(window).on("load",function(){a('[data-spy="affix"]').each(function(){var c=a(this),d=c.data();d.offset=d.offset||{},null!=d.offsetBottom&&(d.offset.bottom=d.offsetBottom),null!=d.offsetTop&&(d.offset.top=d.offsetTop),b.call(c,d)})})}(jQuery);</script>
<script>/**
* @preserve HTML5 Shiv 3.7.2 | @afarkas @jdalton @jon_neal @rem | MIT/GPL2 Licensed
*/
// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a,b){function c(a,b){var c=a.createElement("p"),d=a.getElementsByTagName("head")[0]||a.documentElement;return c.innerHTML="x<style>"+b+"</style>",d.insertBefore(c.lastChild,d.firstChild)}function d(){var a=t.elements;return"string"==typeof a?a.split(" "):a}function e(a,b){var c=t.elements;"string"!=typeof c&&(c=c.join(" ")),"string"!=typeof a&&(a=a.join(" ")),t.elements=c+" "+a,j(b)}function f(a){var b=s[a[q]];return b||(b={},r++,a[q]=r,s[r]=b),b}function g(a,c,d){if(c||(c=b),l)return c.createElement(a);d||(d=f(c));var e;return e=d.cache[a]?d.cache[a].cloneNode():p.test(a)?(d.cache[a]=d.createElem(a)).cloneNode():d.createElem(a),!e.canHaveChildren||o.test(a)||e.tagUrn?e:d.frag.appendChild(e)}function h(a,c){if(a||(a=b),l)return a.createDocumentFragment();c=c||f(a);for(var e=c.frag.cloneNode(),g=0,h=d(),i=h.length;i>g;g++)e.createElement(h[g]);return e}function i(a,b){b.cache||(b.cache={},b.createElem=a.createElement,b.createFrag=a.createDocumentFragment,b.frag=b.createFrag()),a.createElement=function(c){return t.shivMethods?g(c,a,b):b.createElem(c)},a.createDocumentFragment=Function("h,f","return function(){var n=f.cloneNode(),c=n.createElement;h.shivMethods&&("+d().join().replace(/[\w\-:]+/g,function(a){return b.createElem(a),b.frag.createElement(a),'c("'+a+'")'})+");return n}")(t,b.frag)}function j(a){a||(a=b);var d=f(a);return!t.shivCSS||k||d.hasCSS||(d.hasCSS=!!c(a,"article,aside,dialog,figcaption,figure,footer,header,hgroup,main,nav,section{display:block}mark{background:#FF0;color:#000}template{display:none}")),l||i(a,d),a}var k,l,m="3.7.2",n=a.html5||{},o=/^<|^(?:button|map|select|textarea|object|iframe|option|optgroup)$/i,p=/^(?:a|b|code|div|fieldset|h1|h2|h3|h4|h5|h6|i|label|li|ol|p|q|span|strong|style|table|tbody|td|th|tr|ul)$/i,q="_html5shiv",r=0,s={};!function(){try{var a=b.createElement("a");a.innerHTML="<xyz></xyz>",k="hidden"in a,l=1==a.childNodes.length||function(){b.createElement("a");var a=b.createDocumentFragment();return"undefined"==typeof a.cloneNode||"undefined"==typeof a.createDocumentFragment||"undefined"==typeof a.createElement}()}catch(c){k=!0,l=!0}}();var t={elements:n.elements||"abbr article aside audio bdi canvas data datalist details dialog figcaption figure footer header hgroup main mark meter nav output picture progress section summary template time video",version:m,shivCSS:n.shivCSS!==!1,supportsUnknownElements:l,shivMethods:n.shivMethods!==!1,type:"default",shivDocument:j,createElement:g,createDocumentFragment:h,addElements:e};a.html5=t,j(b)}(this,document);
};
</script>
<script>/*! Respond.js v1.4.2: min/max-width media query polyfill * Copyright 2013 Scott Jehl
 * Licensed under https://github.com/scottjehl/Respond/blob/master/LICENSE-MIT
 *  */

// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a){"use strict";a.matchMedia=a.matchMedia||function(a){var b,c=a.documentElement,d=c.firstElementChild||c.firstChild,e=a.createElement("body"),f=a.createElement("div");return f.id="mq-test-1",f.style.cssText="position:absolute;top:-100em",e.style.background="none",e.appendChild(f),function(a){return f.innerHTML='&shy;<style media="'+a+'"> #mq-test-1 { width: 42px; }</style>',c.insertBefore(e,d),b=42===f.offsetWidth,c.removeChild(e),{matches:b,media:a}}}(a.document)}(this),function(a){"use strict";function b(){u(!0)}var c={};a.respond=c,c.update=function(){};var d=[],e=function(){var b=!1;try{b=new a.XMLHttpRequest}catch(c){b=new a.ActiveXObject("Microsoft.XMLHTTP")}return function(){return b}}(),f=function(a,b){var c=e();c&&(c.open("GET",a,!0),c.onreadystatechange=function(){4!==c.readyState||200!==c.status&&304!==c.status||b(c.responseText)},4!==c.readyState&&c.send(null))};if(c.ajax=f,c.queue=d,c.regex={media:/@media[^\{]+\{([^\{\}]*\{[^\}\{]*\})+/gi,keyframes:/@(?:\-(?:o|moz|webkit)\-)?keyframes[^\{]+\{(?:[^\{\}]*\{[^\}\{]*\})+[^\}]*\}/gi,urls:/(url\()['"]?([^\/\)'"][^:\)'"]+)['"]?(\))/g,findStyles:/@media *([^\{]+)\{([\S\s]+?)$/,only:/(only\s+)?([a-zA-Z]+)\s?/,minw:/\([\s]*min\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/,maxw:/\([\s]*max\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/},c.mediaQueriesSupported=a.matchMedia&&null!==a.matchMedia("only all")&&a.matchMedia("only all").matches,!c.mediaQueriesSupported){var g,h,i,j=a.document,k=j.documentElement,l=[],m=[],n=[],o={},p=30,q=j.getElementsByTagName("head")[0]||k,r=j.getElementsByTagName("base")[0],s=q.getElementsByTagName("link"),t=function(){var a,b=j.createElement("div"),c=j.body,d=k.style.fontSize,e=c&&c.style.fontSize,f=!1;return b.style.cssText="position:absolute;font-size:1em;width:1em",c||(c=f=j.createElement("body"),c.style.background="none"),k.style.fontSize="100%",c.style.fontSize="100%",c.appendChild(b),f&&k.insertBefore(c,k.firstChild),a=b.offsetWidth,f?k.removeChild(c):c.removeChild(b),k.style.fontSize=d,e&&(c.style.fontSize=e),a=i=parseFloat(a)},u=function(b){var c="clientWidth",d=k[c],e="CSS1Compat"===j.compatMode&&d||j.body[c]||d,f={},o=s[s.length-1],r=(new Date).getTime();if(b&&g&&p>r-g)return a.clearTimeout(h),h=a.setTimeout(u,p),void 0;g=r;for(var v in l)if(l.hasOwnProperty(v)){var w=l[v],x=w.minw,y=w.maxw,z=null===x,A=null===y,B="em";x&&(x=parseFloat(x)*(x.indexOf(B)>-1?i||t():1)),y&&(y=parseFloat(y)*(y.indexOf(B)>-1?i||t():1)),w.hasquery&&(z&&A||!(z||e>=x)||!(A||y>=e))||(f[w.media]||(f[w.media]=[]),f[w.media].push(m[w.rules]))}for(var C in n)n.hasOwnProperty(C)&&n[C]&&n[C].parentNode===q&&q.removeChild(n[C]);n.length=0;for(var D in f)if(f.hasOwnProperty(D)){var E=j.createElement("style"),F=f[D].join("\n");E.type="text/css",E.media=D,q.insertBefore(E,o.nextSibling),E.styleSheet?E.styleSheet.cssText=F:E.appendChild(j.createTextNode(F)),n.push(E)}},v=function(a,b,d){var e=a.replace(c.regex.keyframes,"").match(c.regex.media),f=e&&e.length||0;b=b.substring(0,b.lastIndexOf("/"));var g=function(a){return a.replace(c.regex.urls,"$1"+b+"$2$3")},h=!f&&d;b.length&&(b+="/"),h&&(f=1);for(var i=0;f>i;i++){var j,k,n,o;h?(j=d,m.push(g(a))):(j=e[i].match(c.regex.findStyles)&&RegExp.$1,m.push(RegExp.$2&&g(RegExp.$2))),n=j.split(","),o=n.length;for(var p=0;o>p;p++)k=n[p],l.push({media:k.split("(")[0].match(c.regex.only)&&RegExp.$2||"all",rules:m.length-1,hasquery:k.indexOf("(")>-1,minw:k.match(c.regex.minw)&&parseFloat(RegExp.$1)+(RegExp.$2||""),maxw:k.match(c.regex.maxw)&&parseFloat(RegExp.$1)+(RegExp.$2||"")})}u()},w=function(){if(d.length){var b=d.shift();f(b.href,function(c){v(c,b.href,b.media),o[b.href]=!0,a.setTimeout(function(){w()},0)})}},x=function(){for(var b=0;b<s.length;b++){var c=s[b],e=c.href,f=c.media,g=c.rel&&"stylesheet"===c.rel.toLowerCase();e&&g&&!o[e]&&(c.styleSheet&&c.styleSheet.rawCssText?(v(c.styleSheet.rawCssText,e,f),o[e]=!0):(!/^([a-zA-Z:]*\/\/)/.test(e)&&!r||e.replace(RegExp.$1,"").split("/")[0]===a.location.host)&&("//"===e.substring(0,2)&&(e=a.location.protocol+e),d.push({href:e,media:f})))}w()};x(),c.update=x,c.getEmValue=t,a.addEventListener?a.addEventListener("resize",b,!1):a.attachEvent&&a.attachEvent("onresize",b)}}(this);
};
</script>
<script>/*! jQuery UI - v1.11.4 - 2016-01-05
* http://jqueryui.com
* Includes: core.js, widget.js, mouse.js, position.js, draggable.js, droppable.js, resizable.js, selectable.js, sortable.js, accordion.js, autocomplete.js, button.js, dialog.js, menu.js, progressbar.js, selectmenu.js, slider.js, spinner.js, tabs.js, tooltip.js, effect.js, effect-blind.js, effect-bounce.js, effect-clip.js, effect-drop.js, effect-explode.js, effect-fade.js, effect-fold.js, effect-highlight.js, effect-puff.js, effect-pulsate.js, effect-scale.js, effect-shake.js, effect-size.js, effect-slide.js, effect-transfer.js
* Copyright jQuery Foundation and other contributors; Licensed MIT */

(function(e){"function"==typeof define&&define.amd?define(["jquery"],e):e(jQuery)})(function(e){function t(t,s){var n,a,o,r=t.nodeName.toLowerCase();return"area"===r?(n=t.parentNode,a=n.name,t.href&&a&&"map"===n.nodeName.toLowerCase()?(o=e("img[usemap='#"+a+"']")[0],!!o&&i(o)):!1):(/^(input|select|textarea|button|object)$/.test(r)?!t.disabled:"a"===r?t.href||s:s)&&i(t)}function i(t){return e.expr.filters.visible(t)&&!e(t).parents().addBack().filter(function(){return"hidden"===e.css(this,"visibility")}).length}function s(e){return function(){var t=this.element.val();e.apply(this,arguments),this._refresh(),t!==this.element.val()&&this._trigger("change")}}e.ui=e.ui||{},e.extend(e.ui,{version:"1.11.4",keyCode:{BACKSPACE:8,COMMA:188,DELETE:46,DOWN:40,END:35,ENTER:13,ESCAPE:27,HOME:36,LEFT:37,PAGE_DOWN:34,PAGE_UP:33,PERIOD:190,RIGHT:39,SPACE:32,TAB:9,UP:38}}),e.fn.extend({scrollParent:function(t){var i=this.css("position"),s="absolute"===i,n=t?/(auto|scroll|hidden)/:/(auto|scroll)/,a=this.parents().filter(function(){var t=e(this);return s&&"static"===t.css("position")?!1:n.test(t.css("overflow")+t.css("overflow-y")+t.css("overflow-x"))}).eq(0);return"fixed"!==i&&a.length?a:e(this[0].ownerDocument||document)},uniqueId:function(){var e=0;return function(){return this.each(function(){this.id||(this.id="ui-id-"+ ++e)})}}(),removeUniqueId:function(){return this.each(function(){/^ui-id-\d+$/.test(this.id)&&e(this).removeAttr("id")})}}),e.extend(e.expr[":"],{data:e.expr.createPseudo?e.expr.createPseudo(function(t){return function(i){return!!e.data(i,t)}}):function(t,i,s){return!!e.data(t,s[3])},focusable:function(i){return t(i,!isNaN(e.attr(i,"tabindex")))},tabbable:function(i){var s=e.attr(i,"tabindex"),n=isNaN(s);return(n||s>=0)&&t(i,!n)}}),e("<a>").outerWidth(1).jquery||e.each(["Width","Height"],function(t,i){function s(t,i,s,a){return e.each(n,function(){i-=parseFloat(e.css(t,"padding"+this))||0,s&&(i-=parseFloat(e.css(t,"border"+this+"Width"))||0),a&&(i-=parseFloat(e.css(t,"margin"+this))||0)}),i}var n="Width"===i?["Left","Right"]:["Top","Bottom"],a=i.toLowerCase(),o={innerWidth:e.fn.innerWidth,innerHeight:e.fn.innerHeight,outerWidth:e.fn.outerWidth,outerHeight:e.fn.outerHeight};e.fn["inner"+i]=function(t){return void 0===t?o["inner"+i].call(this):this.each(function(){e(this).css(a,s(this,t)+"px")})},e.fn["outer"+i]=function(t,n){return"number"!=typeof t?o["outer"+i].call(this,t):this.each(function(){e(this).css(a,s(this,t,!0,n)+"px")})}}),e.fn.addBack||(e.fn.addBack=function(e){return this.add(null==e?this.prevObject:this.prevObject.filter(e))}),e("<a>").data("a-b","a").removeData("a-b").data("a-b")&&(e.fn.removeData=function(t){return function(i){return arguments.length?t.call(this,e.camelCase(i)):t.call(this)}}(e.fn.removeData)),e.ui.ie=!!/msie [\w.]+/.exec(navigator.userAgent.toLowerCase()),e.fn.extend({focus:function(t){return function(i,s){return"number"==typeof i?this.each(function(){var t=this;setTimeout(function(){e(t).focus(),s&&s.call(t)},i)}):t.apply(this,arguments)}}(e.fn.focus),disableSelection:function(){var e="onselectstart"in document.createElement("div")?"selectstart":"mousedown";return function(){return this.bind(e+".ui-disableSelection",function(e){e.preventDefault()})}}(),enableSelection:function(){return this.unbind(".ui-disableSelection")},zIndex:function(t){if(void 0!==t)return this.css("zIndex",t);if(this.length)for(var i,s,n=e(this[0]);n.length&&n[0]!==document;){if(i=n.css("position"),("absolute"===i||"relative"===i||"fixed"===i)&&(s=parseInt(n.css("zIndex"),10),!isNaN(s)&&0!==s))return s;n=n.parent()}return 0}}),e.ui.plugin={add:function(t,i,s){var n,a=e.ui[t].prototype;for(n in s)a.plugins[n]=a.plugins[n]||[],a.plugins[n].push([i,s[n]])},call:function(e,t,i,s){var n,a=e.plugins[t];if(a&&(s||e.element[0].parentNode&&11!==e.element[0].parentNode.nodeType))for(n=0;a.length>n;n++)e.options[a[n][0]]&&a[n][1].apply(e.element,i)}};var n=0,a=Array.prototype.slice;e.cleanData=function(t){return function(i){var s,n,a;for(a=0;null!=(n=i[a]);a++)try{s=e._data(n,"events"),s&&s.remove&&e(n).triggerHandler("remove")}catch(o){}t(i)}}(e.cleanData),e.widget=function(t,i,s){var n,a,o,r,h={},l=t.split(".")[0];return t=t.split(".")[1],n=l+"-"+t,s||(s=i,i=e.Widget),e.expr[":"][n.toLowerCase()]=function(t){return!!e.data(t,n)},e[l]=e[l]||{},a=e[l][t],o=e[l][t]=function(e,t){return this._createWidget?(arguments.length&&this._createWidget(e,t),void 0):new o(e,t)},e.extend(o,a,{version:s.version,_proto:e.extend({},s),_childConstructors:[]}),r=new i,r.options=e.widget.extend({},r.options),e.each(s,function(t,s){return e.isFunction(s)?(h[t]=function(){var e=function(){return i.prototype[t].apply(this,arguments)},n=function(e){return i.prototype[t].apply(this,e)};return function(){var t,i=this._super,a=this._superApply;return this._super=e,this._superApply=n,t=s.apply(this,arguments),this._super=i,this._superApply=a,t}}(),void 0):(h[t]=s,void 0)}),o.prototype=e.widget.extend(r,{widgetEventPrefix:a?r.widgetEventPrefix||t:t},h,{constructor:o,namespace:l,widgetName:t,widgetFullName:n}),a?(e.each(a._childConstructors,function(t,i){var s=i.prototype;e.widget(s.namespace+"."+s.widgetName,o,i._proto)}),delete a._childConstructors):i._childConstructors.push(o),e.widget.bridge(t,o),o},e.widget.extend=function(t){for(var i,s,n=a.call(arguments,1),o=0,r=n.length;r>o;o++)for(i in n[o])s=n[o][i],n[o].hasOwnProperty(i)&&void 0!==s&&(t[i]=e.isPlainObject(s)?e.isPlainObject(t[i])?e.widget.extend({},t[i],s):e.widget.extend({},s):s);return t},e.widget.bridge=function(t,i){var s=i.prototype.widgetFullName||t;e.fn[t]=function(n){var o="string"==typeof n,r=a.call(arguments,1),h=this;return o?this.each(function(){var i,a=e.data(this,s);return"instance"===n?(h=a,!1):a?e.isFunction(a[n])&&"_"!==n.charAt(0)?(i=a[n].apply(a,r),i!==a&&void 0!==i?(h=i&&i.jquery?h.pushStack(i.get()):i,!1):void 0):e.error("no such method '"+n+"' for "+t+" widget instance"):e.error("cannot call methods on "+t+" prior to initialization; "+"attempted to call method '"+n+"'")}):(r.length&&(n=e.widget.extend.apply(null,[n].concat(r))),this.each(function(){var t=e.data(this,s);t?(t.option(n||{}),t._init&&t._init()):e.data(this,s,new i(n,this))})),h}},e.Widget=function(){},e.Widget._childConstructors=[],e.Widget.prototype={widgetName:"widget",widgetEventPrefix:"",defaultElement:"<div>",options:{disabled:!1,create:null},_createWidget:function(t,i){i=e(i||this.defaultElement||this)[0],this.element=e(i),this.uuid=n++,this.eventNamespace="."+this.widgetName+this.uuid,this.bindings=e(),this.hoverable=e(),this.focusable=e(),i!==this&&(e.data(i,this.widgetFullName,this),this._on(!0,this.element,{remove:function(e){e.target===i&&this.destroy()}}),this.document=e(i.style?i.ownerDocument:i.document||i),this.window=e(this.document[0].defaultView||this.document[0].parentWindow)),this.options=e.widget.extend({},this.options,this._getCreateOptions(),t),this._create(),this._trigger("create",null,this._getCreateEventData()),this._init()},_getCreateOptions:e.noop,_getCreateEventData:e.noop,_create:e.noop,_init:e.noop,destroy:function(){this._destroy(),this.element.unbind(this.eventNamespace).removeData(this.widgetFullName).removeData(e.camelCase(this.widgetFullName)),this.widget().unbind(this.eventNamespace).removeAttr("aria-disabled").removeClass(this.widgetFullName+"-disabled "+"ui-state-disabled"),this.bindings.unbind(this.eventNamespace),this.hoverable.removeClass("ui-state-hover"),this.focusable.removeClass("ui-state-focus")},_destroy:e.noop,widget:function(){return this.element},option:function(t,i){var s,n,a,o=t;if(0===arguments.length)return e.widget.extend({},this.options);if("string"==typeof t)if(o={},s=t.split("."),t=s.shift(),s.length){for(n=o[t]=e.widget.extend({},this.options[t]),a=0;s.length-1>a;a++)n[s[a]]=n[s[a]]||{},n=n[s[a]];if(t=s.pop(),1===arguments.length)return void 0===n[t]?null:n[t];n[t]=i}else{if(1===arguments.length)return void 0===this.options[t]?null:this.options[t];o[t]=i}return this._setOptions(o),this},_setOptions:function(e){var t;for(t in e)this._setOption(t,e[t]);return this},_setOption:function(e,t){return this.options[e]=t,"disabled"===e&&(this.widget().toggleClass(this.widgetFullName+"-disabled",!!t),t&&(this.hoverable.removeClass("ui-state-hover"),this.focusable.removeClass("ui-state-focus"))),this},enable:function(){return this._setOptions({disabled:!1})},disable:function(){return this._setOptions({disabled:!0})},_on:function(t,i,s){var n,a=this;"boolean"!=typeof t&&(s=i,i=t,t=!1),s?(i=n=e(i),this.bindings=this.bindings.add(i)):(s=i,i=this.element,n=this.widget()),e.each(s,function(s,o){function r(){return t||a.options.disabled!==!0&&!e(this).hasClass("ui-state-disabled")?("string"==typeof o?a[o]:o).apply(a,arguments):void 0}"string"!=typeof o&&(r.guid=o.guid=o.guid||r.guid||e.guid++);var h=s.match(/^([\w:-]*)\s*(.*)$/),l=h[1]+a.eventNamespace,u=h[2];u?n.delegate(u,l,r):i.bind(l,r)})},_off:function(t,i){i=(i||"").split(" ").join(this.eventNamespace+" ")+this.eventNamespace,t.unbind(i).undelegate(i),this.bindings=e(this.bindings.not(t).get()),this.focusable=e(this.focusable.not(t).get()),this.hoverable=e(this.hoverable.not(t).get())},_delay:function(e,t){function i(){return("string"==typeof e?s[e]:e).apply(s,arguments)}var s=this;return setTimeout(i,t||0)},_hoverable:function(t){this.hoverable=this.hoverable.add(t),this._on(t,{mouseenter:function(t){e(t.currentTarget).addClass("ui-state-hover")},mouseleave:function(t){e(t.currentTarget).removeClass("ui-state-hover")}})},_focusable:function(t){this.focusable=this.focusable.add(t),this._on(t,{focusin:function(t){e(t.currentTarget).addClass("ui-state-focus")},focusout:function(t){e(t.currentTarget).removeClass("ui-state-focus")}})},_trigger:function(t,i,s){var n,a,o=this.options[t];if(s=s||{},i=e.Event(i),i.type=(t===this.widgetEventPrefix?t:this.widgetEventPrefix+t).toLowerCase(),i.target=this.element[0],a=i.originalEvent)for(n in a)n in i||(i[n]=a[n]);return this.element.trigger(i,s),!(e.isFunction(o)&&o.apply(this.element[0],[i].concat(s))===!1||i.isDefaultPrevented())}},e.each({show:"fadeIn",hide:"fadeOut"},function(t,i){e.Widget.prototype["_"+t]=function(s,n,a){"string"==typeof n&&(n={effect:n});var o,r=n?n===!0||"number"==typeof n?i:n.effect||i:t;n=n||{},"number"==typeof n&&(n={duration:n}),o=!e.isEmptyObject(n),n.complete=a,n.delay&&s.delay(n.delay),o&&e.effects&&e.effects.effect[r]?s[t](n):r!==t&&s[r]?s[r](n.duration,n.easing,a):s.queue(function(i){e(this)[t](),a&&a.call(s[0]),i()})}}),e.widget;var o=!1;e(document).mouseup(function(){o=!1}),e.widget("ui.mouse",{version:"1.11.4",options:{cancel:"input,textarea,button,select,option",distance:1,delay:0},_mouseInit:function(){var t=this;this.element.bind("mousedown."+this.widgetName,function(e){return t._mouseDown(e)}).bind("click."+this.widgetName,function(i){return!0===e.data(i.target,t.widgetName+".preventClickEvent")?(e.removeData(i.target,t.widgetName+".preventClickEvent"),i.stopImmediatePropagation(),!1):void 0}),this.started=!1},_mouseDestroy:function(){this.element.unbind("."+this.widgetName),this._mouseMoveDelegate&&this.document.unbind("mousemove."+this.widgetName,this._mouseMoveDelegate).unbind("mouseup."+this.widgetName,this._mouseUpDelegate)},_mouseDown:function(t){if(!o){this._mouseMoved=!1,this._mouseStarted&&this._mouseUp(t),this._mouseDownEvent=t;var i=this,s=1===t.which,n="string"==typeof this.options.cancel&&t.target.nodeName?e(t.target).closest(this.options.cancel).length:!1;return s&&!n&&this._mouseCapture(t)?(this.mouseDelayMet=!this.options.delay,this.mouseDelayMet||(this._mouseDelayTimer=setTimeout(function(){i.mouseDelayMet=!0},this.options.delay)),this._mouseDistanceMet(t)&&this._mouseDelayMet(t)&&(this._mouseStarted=this._mouseStart(t)!==!1,!this._mouseStarted)?(t.preventDefault(),!0):(!0===e.data(t.target,this.widgetName+".preventClickEvent")&&e.removeData(t.target,this.widgetName+".preventClickEvent"),this._mouseMoveDelegate=function(e){return i._mouseMove(e)},this._mouseUpDelegate=function(e){return i._mouseUp(e)},this.document.bind("mousemove."+this.widgetName,this._mouseMoveDelegate).bind("mouseup."+this.widgetName,this._mouseUpDelegate),t.preventDefault(),o=!0,!0)):!0}},_mouseMove:function(t){if(this._mouseMoved){if(e.ui.ie&&(!document.documentMode||9>document.documentMode)&&!t.button)return this._mouseUp(t);if(!t.which)return this._mouseUp(t)}return(t.which||t.button)&&(this._mouseMoved=!0),this._mouseStarted?(this._mouseDrag(t),t.preventDefault()):(this._mouseDistanceMet(t)&&this._mouseDelayMet(t)&&(this._mouseStarted=this._mouseStart(this._mouseDownEvent,t)!==!1,this._mouseStarted?this._mouseDrag(t):this._mouseUp(t)),!this._mouseStarted)},_mouseUp:function(t){return this.document.unbind("mousemove."+this.widgetName,this._mouseMoveDelegate).unbind("mouseup."+this.widgetName,this._mouseUpDelegate),this._mouseStarted&&(this._mouseStarted=!1,t.target===this._mouseDownEvent.target&&e.data(t.target,this.widgetName+".preventClickEvent",!0),this._mouseStop(t)),o=!1,!1},_mouseDistanceMet:function(e){return Math.max(Math.abs(this._mouseDownEvent.pageX-e.pageX),Math.abs(this._mouseDownEvent.pageY-e.pageY))>=this.options.distance},_mouseDelayMet:function(){return this.mouseDelayMet},_mouseStart:function(){},_mouseDrag:function(){},_mouseStop:function(){},_mouseCapture:function(){return!0}}),function(){function t(e,t,i){return[parseFloat(e[0])*(p.test(e[0])?t/100:1),parseFloat(e[1])*(p.test(e[1])?i/100:1)]}function i(t,i){return parseInt(e.css(t,i),10)||0}function s(t){var i=t[0];return 9===i.nodeType?{width:t.width(),height:t.height(),offset:{top:0,left:0}}:e.isWindow(i)?{width:t.width(),height:t.height(),offset:{top:t.scrollTop(),left:t.scrollLeft()}}:i.preventDefault?{width:0,height:0,offset:{top:i.pageY,left:i.pageX}}:{width:t.outerWidth(),height:t.outerHeight(),offset:t.offset()}}e.ui=e.ui||{};var n,a,o=Math.max,r=Math.abs,h=Math.round,l=/left|center|right/,u=/top|center|bottom/,d=/[\+\-]\d+(\.[\d]+)?%?/,c=/^\w+/,p=/%$/,f=e.fn.position;e.position={scrollbarWidth:function(){if(void 0!==n)return n;var t,i,s=e("<div style='display:block;position:absolute;width:50px;height:50px;overflow:hidden;'><div style='height:100px;width:auto;'></div></div>"),a=s.children()[0];return e("body").append(s),t=a.offsetWidth,s.css("overflow","scroll"),i=a.offsetWidth,t===i&&(i=s[0].clientWidth),s.remove(),n=t-i},getScrollInfo:function(t){var i=t.isWindow||t.isDocument?"":t.element.css("overflow-x"),s=t.isWindow||t.isDocument?"":t.element.css("overflow-y"),n="scroll"===i||"auto"===i&&t.width<t.element[0].scrollWidth,a="scroll"===s||"auto"===s&&t.height<t.element[0].scrollHeight;return{width:a?e.position.scrollbarWidth():0,height:n?e.position.scrollbarWidth():0}},getWithinInfo:function(t){var i=e(t||window),s=e.isWindow(i[0]),n=!!i[0]&&9===i[0].nodeType;return{element:i,isWindow:s,isDocument:n,offset:i.offset()||{left:0,top:0},scrollLeft:i.scrollLeft(),scrollTop:i.scrollTop(),width:s||n?i.width():i.outerWidth(),height:s||n?i.height():i.outerHeight()}}},e.fn.position=function(n){if(!n||!n.of)return f.apply(this,arguments);n=e.extend({},n);var p,m,g,v,y,b,_=e(n.of),x=e.position.getWithinInfo(n.within),w=e.position.getScrollInfo(x),k=(n.collision||"flip").split(" "),T={};return b=s(_),_[0].preventDefault&&(n.at="left top"),m=b.width,g=b.height,v=b.offset,y=e.extend({},v),e.each(["my","at"],function(){var e,t,i=(n[this]||"").split(" ");1===i.length&&(i=l.test(i[0])?i.concat(["center"]):u.test(i[0])?["center"].concat(i):["center","center"]),i[0]=l.test(i[0])?i[0]:"center",i[1]=u.test(i[1])?i[1]:"center",e=d.exec(i[0]),t=d.exec(i[1]),T[this]=[e?e[0]:0,t?t[0]:0],n[this]=[c.exec(i[0])[0],c.exec(i[1])[0]]}),1===k.length&&(k[1]=k[0]),"right"===n.at[0]?y.left+=m:"center"===n.at[0]&&(y.left+=m/2),"bottom"===n.at[1]?y.top+=g:"center"===n.at[1]&&(y.top+=g/2),p=t(T.at,m,g),y.left+=p[0],y.top+=p[1],this.each(function(){var s,l,u=e(this),d=u.outerWidth(),c=u.outerHeight(),f=i(this,"marginLeft"),b=i(this,"marginTop"),D=d+f+i(this,"marginRight")+w.width,S=c+b+i(this,"marginBottom")+w.height,N=e.extend({},y),M=t(T.my,u.outerWidth(),u.outerHeight());"right"===n.my[0]?N.left-=d:"center"===n.my[0]&&(N.left-=d/2),"bottom"===n.my[1]?N.top-=c:"center"===n.my[1]&&(N.top-=c/2),N.left+=M[0],N.top+=M[1],a||(N.left=h(N.left),N.top=h(N.top)),s={marginLeft:f,marginTop:b},e.each(["left","top"],function(t,i){e.ui.position[k[t]]&&e.ui.position[k[t]][i](N,{targetWidth:m,targetHeight:g,elemWidth:d,elemHeight:c,collisionPosition:s,collisionWidth:D,collisionHeight:S,offset:[p[0]+M[0],p[1]+M[1]],my:n.my,at:n.at,within:x,elem:u})}),n.using&&(l=function(e){var t=v.left-N.left,i=t+m-d,s=v.top-N.top,a=s+g-c,h={target:{element:_,left:v.left,top:v.top,width:m,height:g},element:{element:u,left:N.left,top:N.top,width:d,height:c},horizontal:0>i?"left":t>0?"right":"center",vertical:0>a?"top":s>0?"bottom":"middle"};d>m&&m>r(t+i)&&(h.horizontal="center"),c>g&&g>r(s+a)&&(h.vertical="middle"),h.important=o(r(t),r(i))>o(r(s),r(a))?"horizontal":"vertical",n.using.call(this,e,h)}),u.offset(e.extend(N,{using:l}))})},e.ui.position={fit:{left:function(e,t){var i,s=t.within,n=s.isWindow?s.scrollLeft:s.offset.left,a=s.width,r=e.left-t.collisionPosition.marginLeft,h=n-r,l=r+t.collisionWidth-a-n;t.collisionWidth>a?h>0&&0>=l?(i=e.left+h+t.collisionWidth-a-n,e.left+=h-i):e.left=l>0&&0>=h?n:h>l?n+a-t.collisionWidth:n:h>0?e.left+=h:l>0?e.left-=l:e.left=o(e.left-r,e.left)},top:function(e,t){var i,s=t.within,n=s.isWindow?s.scrollTop:s.offset.top,a=t.within.height,r=e.top-t.collisionPosition.marginTop,h=n-r,l=r+t.collisionHeight-a-n;t.collisionHeight>a?h>0&&0>=l?(i=e.top+h+t.collisionHeight-a-n,e.top+=h-i):e.top=l>0&&0>=h?n:h>l?n+a-t.collisionHeight:n:h>0?e.top+=h:l>0?e.top-=l:e.top=o(e.top-r,e.top)}},flip:{left:function(e,t){var i,s,n=t.within,a=n.offset.left+n.scrollLeft,o=n.width,h=n.isWindow?n.scrollLeft:n.offset.left,l=e.left-t.collisionPosition.marginLeft,u=l-h,d=l+t.collisionWidth-o-h,c="left"===t.my[0]?-t.elemWidth:"right"===t.my[0]?t.elemWidth:0,p="left"===t.at[0]?t.targetWidth:"right"===t.at[0]?-t.targetWidth:0,f=-2*t.offset[0];0>u?(i=e.left+c+p+f+t.collisionWidth-o-a,(0>i||r(u)>i)&&(e.left+=c+p+f)):d>0&&(s=e.left-t.collisionPosition.marginLeft+c+p+f-h,(s>0||d>r(s))&&(e.left+=c+p+f))},top:function(e,t){var i,s,n=t.within,a=n.offset.top+n.scrollTop,o=n.height,h=n.isWindow?n.scrollTop:n.offset.top,l=e.top-t.collisionPosition.marginTop,u=l-h,d=l+t.collisionHeight-o-h,c="top"===t.my[1],p=c?-t.elemHeight:"bottom"===t.my[1]?t.elemHeight:0,f="top"===t.at[1]?t.targetHeight:"bottom"===t.at[1]?-t.targetHeight:0,m=-2*t.offset[1];0>u?(s=e.top+p+f+m+t.collisionHeight-o-a,(0>s||r(u)>s)&&(e.top+=p+f+m)):d>0&&(i=e.top-t.collisionPosition.marginTop+p+f+m-h,(i>0||d>r(i))&&(e.top+=p+f+m))}},flipfit:{left:function(){e.ui.position.flip.left.apply(this,arguments),e.ui.position.fit.left.apply(this,arguments)},top:function(){e.ui.position.flip.top.apply(this,arguments),e.ui.position.fit.top.apply(this,arguments)}}},function(){var t,i,s,n,o,r=document.getElementsByTagName("body")[0],h=document.createElement("div");t=document.createElement(r?"div":"body"),s={visibility:"hidden",width:0,height:0,border:0,margin:0,background:"none"},r&&e.extend(s,{position:"absolute",left:"-1000px",top:"-1000px"});for(o in s)t.style[o]=s[o];t.appendChild(h),i=r||document.documentElement,i.insertBefore(t,i.firstChild),h.style.cssText="position: absolute; left: 10.7432222px;",n=e(h).offset().left,a=n>10&&11>n,t.innerHTML="",i.removeChild(t)}()}(),e.ui.position,e.widget("ui.draggable",e.ui.mouse,{version:"1.11.4",widgetEventPrefix:"drag",options:{addClasses:!0,appendTo:"parent",axis:!1,connectToSortable:!1,containment:!1,cursor:"auto",cursorAt:!1,grid:!1,handle:!1,helper:"original",iframeFix:!1,opacity:!1,refreshPositions:!1,revert:!1,revertDuration:500,scope:"default",scroll:!0,scrollSensitivity:20,scrollSpeed:20,snap:!1,snapMode:"both",snapTolerance:20,stack:!1,zIndex:!1,drag:null,start:null,stop:null},_create:function(){"original"===this.options.helper&&this._setPositionRelative(),this.options.addClasses&&this.element.addClass("ui-draggable"),this.options.disabled&&this.element.addClass("ui-draggable-disabled"),this._setHandleClassName(),this._mouseInit()},_setOption:function(e,t){this._super(e,t),"handle"===e&&(this._removeHandleClassName(),this._setHandleClassName())},_destroy:function(){return(this.helper||this.element).is(".ui-draggable-dragging")?(this.destroyOnClear=!0,void 0):(this.element.removeClass("ui-draggable ui-draggable-dragging ui-draggable-disabled"),this._removeHandleClassName(),this._mouseDestroy(),void 0)},_mouseCapture:function(t){var i=this.options;return this._blurActiveElement(t),this.helper||i.disabled||e(t.target).closest(".ui-resizable-handle").length>0?!1:(this.handle=this._getHandle(t),this.handle?(this._blockFrames(i.iframeFix===!0?"iframe":i.iframeFix),!0):!1)},_blockFrames:function(t){this.iframeBlocks=this.document.find(t).map(function(){var t=e(this);return e("<div>").css("position","absolute").appendTo(t.parent()).outerWidth(t.outerWidth()).outerHeight(t.outerHeight()).offset(t.offset())[0]})},_unblockFrames:function(){this.iframeBlocks&&(this.iframeBlocks.remove(),delete this.iframeBlocks)},_blurActiveElement:function(t){var i=this.document[0];if(this.handleElement.is(t.target))try{i.activeElement&&"body"!==i.activeElement.nodeName.toLowerCase()&&e(i.activeElement).blur()}catch(s){}},_mouseStart:function(t){var i=this.options;return this.helper=this._createHelper(t),this.helper.addClass("ui-draggable-dragging"),this._cacheHelperProportions(),e.ui.ddmanager&&(e.ui.ddmanager.current=this),this._cacheMargins(),this.cssPosition=this.helper.css("position"),this.scrollParent=this.helper.scrollParent(!0),this.offsetParent=this.helper.offsetParent(),this.hasFixedAncestor=this.helper.parents().filter(function(){return"fixed"===e(this).css("position")}).length>0,this.positionAbs=this.element.offset(),this._refreshOffsets(t),this.originalPosition=this.position=this._generatePosition(t,!1),this.originalPageX=t.pageX,this.originalPageY=t.pageY,i.cursorAt&&this._adjustOffsetFromHelper(i.cursorAt),this._setContainment(),this._trigger("start",t)===!1?(this._clear(),!1):(this._cacheHelperProportions(),e.ui.ddmanager&&!i.dropBehaviour&&e.ui.ddmanager.prepareOffsets(this,t),this._normalizeRightBottom(),this._mouseDrag(t,!0),e.ui.ddmanager&&e.ui.ddmanager.dragStart(this,t),!0)},_refreshOffsets:function(e){this.offset={top:this.positionAbs.top-this.margins.top,left:this.positionAbs.left-this.margins.left,scroll:!1,parent:this._getParentOffset(),relative:this._getRelativeOffset()},this.offset.click={left:e.pageX-this.offset.left,top:e.pageY-this.offset.top}},_mouseDrag:function(t,i){if(this.hasFixedAncestor&&(this.offset.parent=this._getParentOffset()),this.position=this._generatePosition(t,!0),this.positionAbs=this._convertPositionTo("absolute"),!i){var s=this._uiHash();if(this._trigger("drag",t,s)===!1)return this._mouseUp({}),!1;this.position=s.position}return this.helper[0].style.left=this.position.left+"px",this.helper[0].style.top=this.position.top+"px",e.ui.ddmanager&&e.ui.ddmanager.drag(this,t),!1},_mouseStop:function(t){var i=this,s=!1;return e.ui.ddmanager&&!this.options.dropBehaviour&&(s=e.ui.ddmanager.drop(this,t)),this.dropped&&(s=this.dropped,this.dropped=!1),"invalid"===this.options.revert&&!s||"valid"===this.options.revert&&s||this.options.revert===!0||e.isFunction(this.options.revert)&&this.options.revert.call(this.element,s)?e(this.helper).animate(this.originalPosition,parseInt(this.options.revertDuration,10),function(){i._trigger("stop",t)!==!1&&i._clear()}):this._trigger("stop",t)!==!1&&this._clear(),!1},_mouseUp:function(t){return this._unblockFrames(),e.ui.ddmanager&&e.ui.ddmanager.dragStop(this,t),this.handleElement.is(t.target)&&this.element.focus(),e.ui.mouse.prototype._mouseUp.call(this,t)},cancel:function(){return this.helper.is(".ui-draggable-dragging")?this._mouseUp({}):this._clear(),this},_getHandle:function(t){return this.options.handle?!!e(t.target).closest(this.element.find(this.options.handle)).length:!0},_setHandleClassName:function(){this.handleElement=this.options.handle?this.element.find(this.options.handle):this.element,this.handleElement.addClass("ui-draggable-handle")},_removeHandleClassName:function(){this.handleElement.removeClass("ui-draggable-handle")},_createHelper:function(t){var i=this.options,s=e.isFunction(i.helper),n=s?e(i.helper.apply(this.element[0],[t])):"clone"===i.helper?this.element.clone().removeAttr("id"):this.element;return n.parents("body").length||n.appendTo("parent"===i.appendTo?this.element[0].parentNode:i.appendTo),s&&n[0]===this.element[0]&&this._setPositionRelative(),n[0]===this.element[0]||/(fixed|absolute)/.test(n.css("position"))||n.css("position","absolute"),n},_setPositionRelative:function(){/^(?:r|a|f)/.test(this.element.css("position"))||(this.element[0].style.position="relative")},_adjustOffsetFromHelper:function(t){"string"==typeof t&&(t=t.split(" ")),e.isArray(t)&&(t={left:+t[0],top:+t[1]||0}),"left"in t&&(this.offset.click.left=t.left+this.margins.left),"right"in t&&(this.offset.click.left=this.helperProportions.width-t.right+this.margins.left),"top"in t&&(this.offset.click.top=t.top+this.margins.top),"bottom"in t&&(this.offset.click.top=this.helperProportions.height-t.bottom+this.margins.top)},_isRootNode:function(e){return/(html|body)/i.test(e.tagName)||e===this.document[0]},_getParentOffset:function(){var t=this.offsetParent.offset(),i=this.document[0];return"absolute"===this.cssPosition&&this.scrollParent[0]!==i&&e.contains(this.scrollParent[0],this.offsetParent[0])&&(t.left+=this.scrollParent.scrollLeft(),t.top+=this.scrollParent.scrollTop()),this._isRootNode(this.offsetParent[0])&&(t={top:0,left:0}),{top:t.top+(parseInt(this.offsetParent.css("borderTopWidth"),10)||0),left:t.left+(parseInt(this.offsetParent.css("borderLeftWidth"),10)||0)}},_getRelativeOffset:function(){if("relative"!==this.cssPosition)return{top:0,left:0};var e=this.element.position(),t=this._isRootNode(this.scrollParent[0]);return{top:e.top-(parseInt(this.helper.css("top"),10)||0)+(t?0:this.scrollParent.scrollTop()),left:e.left-(parseInt(this.helper.css("left"),10)||0)+(t?0:this.scrollParent.scrollLeft())}},_cacheMargins:function(){this.margins={left:parseInt(this.element.css("marginLeft"),10)||0,top:parseInt(this.element.css("marginTop"),10)||0,right:parseInt(this.element.css("marginRight"),10)||0,bottom:parseInt(this.element.css("marginBottom"),10)||0}},_cacheHelperProportions:function(){this.helperProportions={width:this.helper.outerWidth(),height:this.helper.outerHeight()}},_setContainment:function(){var t,i,s,n=this.options,a=this.document[0];return this.relativeContainer=null,n.containment?"window"===n.containment?(this.containment=[e(window).scrollLeft()-this.offset.relative.left-this.offset.parent.left,e(window).scrollTop()-this.offset.relative.top-this.offset.parent.top,e(window).scrollLeft()+e(window).width()-this.helperProportions.width-this.margins.left,e(window).scrollTop()+(e(window).height()||a.body.parentNode.scrollHeight)-this.helperProportions.height-this.margins.top],void 0):"document"===n.containment?(this.containment=[0,0,e(a).width()-this.helperProportions.width-this.margins.left,(e(a).height()||a.body.parentNode.scrollHeight)-this.helperProportions.height-this.margins.top],void 0):n.containment.constructor===Array?(this.containment=n.containment,void 0):("parent"===n.containment&&(n.containment=this.helper[0].parentNode),i=e(n.containment),s=i[0],s&&(t=/(scroll|auto)/.test(i.css("overflow")),this.containment=[(parseInt(i.css("borderLeftWidth"),10)||0)+(parseInt(i.css("paddingLeft"),10)||0),(parseInt(i.css("borderTopWidth"),10)||0)+(parseInt(i.css("paddingTop"),10)||0),(t?Math.max(s.scrollWidth,s.offsetWidth):s.offsetWidth)-(parseInt(i.css("borderRightWidth"),10)||0)-(parseInt(i.css("paddingRight"),10)||0)-this.helperProportions.width-this.margins.left-this.margins.right,(t?Math.max(s.scrollHeight,s.offsetHeight):s.offsetHeight)-(parseInt(i.css("borderBottomWidth"),10)||0)-(parseInt(i.css("paddingBottom"),10)||0)-this.helperProportions.height-this.margins.top-this.margins.bottom],this.relativeContainer=i),void 0):(this.containment=null,void 0)},_convertPositionTo:function(e,t){t||(t=this.position);var i="absolute"===e?1:-1,s=this._isRootNode(this.scrollParent[0]);return{top:t.top+this.offset.relative.top*i+this.offset.parent.top*i-("fixed"===this.cssPosition?-this.offset.scroll.top:s?0:this.offset.scroll.top)*i,left:t.left+this.offset.relative.left*i+this.offset.parent.left*i-("fixed"===this.cssPosition?-this.offset.scroll.left:s?0:this.offset.scroll.left)*i}},_generatePosition:function(e,t){var i,s,n,a,o=this.options,r=this._isRootNode(this.scrollParent[0]),h=e.pageX,l=e.pageY;return r&&this.offset.scroll||(this.offset.scroll={top:this.scrollParent.scrollTop(),left:this.scrollParent.scrollLeft()}),t&&(this.containment&&(this.relativeContainer?(s=this.relativeContainer.offset(),i=[this.containment[0]+s.left,this.containment[1]+s.top,this.containment[2]+s.left,this.containment[3]+s.top]):i=this.containment,e.pageX-this.offset.click.left<i[0]&&(h=i[0]+this.offset.click.left),e.pageY-this.offset.click.top<i[1]&&(l=i[1]+this.offset.click.top),e.pageX-this.offset.click.left>i[2]&&(h=i[2]+this.offset.click.left),e.pageY-this.offset.click.top>i[3]&&(l=i[3]+this.offset.click.top)),o.grid&&(n=o.grid[1]?this.originalPageY+Math.round((l-this.originalPageY)/o.grid[1])*o.grid[1]:this.originalPageY,l=i?n-this.offset.click.top>=i[1]||n-this.offset.click.top>i[3]?n:n-this.offset.click.top>=i[1]?n-o.grid[1]:n+o.grid[1]:n,a=o.grid[0]?this.originalPageX+Math.round((h-this.originalPageX)/o.grid[0])*o.grid[0]:this.originalPageX,h=i?a-this.offset.click.left>=i[0]||a-this.offset.click.left>i[2]?a:a-this.offset.click.left>=i[0]?a-o.grid[0]:a+o.grid[0]:a),"y"===o.axis&&(h=this.originalPageX),"x"===o.axis&&(l=this.originalPageY)),{top:l-this.offset.click.top-this.offset.relative.top-this.offset.parent.top+("fixed"===this.cssPosition?-this.offset.scroll.top:r?0:this.offset.scroll.top),left:h-this.offset.click.left-this.offset.relative.left-this.offset.parent.left+("fixed"===this.cssPosition?-this.offset.scroll.left:r?0:this.offset.scroll.left)}},_clear:function(){this.helper.removeClass("ui-draggable-dragging"),this.helper[0]===this.element[0]||this.cancelHelperRemoval||this.helper.remove(),this.helper=null,this.cancelHelperRemoval=!1,this.destroyOnClear&&this.destroy()},_normalizeRightBottom:function(){"y"!==this.options.axis&&"auto"!==this.helper.css("right")&&(this.helper.width(this.helper.width()),this.helper.css("right","auto")),"x"!==this.options.axis&&"auto"!==this.helper.css("bottom")&&(this.helper.height(this.helper.height()),this.helper.css("bottom","auto"))},_trigger:function(t,i,s){return s=s||this._uiHash(),e.ui.plugin.call(this,t,[i,s,this],!0),/^(drag|start|stop)/.test(t)&&(this.positionAbs=this._convertPositionTo("absolute"),s.offset=this.positionAbs),e.Widget.prototype._trigger.call(this,t,i,s)},plugins:{},_uiHash:function(){return{helper:this.helper,position:this.position,originalPosition:this.originalPosition,offset:this.positionAbs}}}),e.ui.plugin.add("draggable","connectToSortable",{start:function(t,i,s){var n=e.extend({},i,{item:s.element});s.sortables=[],e(s.options.connectToSortable).each(function(){var i=e(this).sortable("instance");i&&!i.options.disabled&&(s.sortables.push(i),i.refreshPositions(),i._trigger("activate",t,n))})},stop:function(t,i,s){var n=e.extend({},i,{item:s.element});s.cancelHelperRemoval=!1,e.each(s.sortables,function(){var e=this;e.isOver?(e.isOver=0,s.cancelHelperRemoval=!0,e.cancelHelperRemoval=!1,e._storedCSS={position:e.placeholder.css("position"),top:e.placeholder.css("top"),left:e.placeholder.css("left")},e._mouseStop(t),e.options.helper=e.options._helper):(e.cancelHelperRemoval=!0,e._trigger("deactivate",t,n))})},drag:function(t,i,s){e.each(s.sortables,function(){var n=!1,a=this;a.positionAbs=s.positionAbs,a.helperProportions=s.helperProportions,a.offset.click=s.offset.click,a._intersectsWith(a.containerCache)&&(n=!0,e.each(s.sortables,function(){return this.positionAbs=s.positionAbs,this.helperProportions=s.helperProportions,this.offset.click=s.offset.click,this!==a&&this._intersectsWith(this.containerCache)&&e.contains(a.element[0],this.element[0])&&(n=!1),n
})),n?(a.isOver||(a.isOver=1,s._parent=i.helper.parent(),a.currentItem=i.helper.appendTo(a.element).data("ui-sortable-item",!0),a.options._helper=a.options.helper,a.options.helper=function(){return i.helper[0]},t.target=a.currentItem[0],a._mouseCapture(t,!0),a._mouseStart(t,!0,!0),a.offset.click.top=s.offset.click.top,a.offset.click.left=s.offset.click.left,a.offset.parent.left-=s.offset.parent.left-a.offset.parent.left,a.offset.parent.top-=s.offset.parent.top-a.offset.parent.top,s._trigger("toSortable",t),s.dropped=a.element,e.each(s.sortables,function(){this.refreshPositions()}),s.currentItem=s.element,a.fromOutside=s),a.currentItem&&(a._mouseDrag(t),i.position=a.position)):a.isOver&&(a.isOver=0,a.cancelHelperRemoval=!0,a.options._revert=a.options.revert,a.options.revert=!1,a._trigger("out",t,a._uiHash(a)),a._mouseStop(t,!0),a.options.revert=a.options._revert,a.options.helper=a.options._helper,a.placeholder&&a.placeholder.remove(),i.helper.appendTo(s._parent),s._refreshOffsets(t),i.position=s._generatePosition(t,!0),s._trigger("fromSortable",t),s.dropped=!1,e.each(s.sortables,function(){this.refreshPositions()}))})}}),e.ui.plugin.add("draggable","cursor",{start:function(t,i,s){var n=e("body"),a=s.options;n.css("cursor")&&(a._cursor=n.css("cursor")),n.css("cursor",a.cursor)},stop:function(t,i,s){var n=s.options;n._cursor&&e("body").css("cursor",n._cursor)}}),e.ui.plugin.add("draggable","opacity",{start:function(t,i,s){var n=e(i.helper),a=s.options;n.css("opacity")&&(a._opacity=n.css("opacity")),n.css("opacity",a.opacity)},stop:function(t,i,s){var n=s.options;n._opacity&&e(i.helper).css("opacity",n._opacity)}}),e.ui.plugin.add("draggable","scroll",{start:function(e,t,i){i.scrollParentNotHidden||(i.scrollParentNotHidden=i.helper.scrollParent(!1)),i.scrollParentNotHidden[0]!==i.document[0]&&"HTML"!==i.scrollParentNotHidden[0].tagName&&(i.overflowOffset=i.scrollParentNotHidden.offset())},drag:function(t,i,s){var n=s.options,a=!1,o=s.scrollParentNotHidden[0],r=s.document[0];o!==r&&"HTML"!==o.tagName?(n.axis&&"x"===n.axis||(s.overflowOffset.top+o.offsetHeight-t.pageY<n.scrollSensitivity?o.scrollTop=a=o.scrollTop+n.scrollSpeed:t.pageY-s.overflowOffset.top<n.scrollSensitivity&&(o.scrollTop=a=o.scrollTop-n.scrollSpeed)),n.axis&&"y"===n.axis||(s.overflowOffset.left+o.offsetWidth-t.pageX<n.scrollSensitivity?o.scrollLeft=a=o.scrollLeft+n.scrollSpeed:t.pageX-s.overflowOffset.left<n.scrollSensitivity&&(o.scrollLeft=a=o.scrollLeft-n.scrollSpeed))):(n.axis&&"x"===n.axis||(t.pageY-e(r).scrollTop()<n.scrollSensitivity?a=e(r).scrollTop(e(r).scrollTop()-n.scrollSpeed):e(window).height()-(t.pageY-e(r).scrollTop())<n.scrollSensitivity&&(a=e(r).scrollTop(e(r).scrollTop()+n.scrollSpeed))),n.axis&&"y"===n.axis||(t.pageX-e(r).scrollLeft()<n.scrollSensitivity?a=e(r).scrollLeft(e(r).scrollLeft()-n.scrollSpeed):e(window).width()-(t.pageX-e(r).scrollLeft())<n.scrollSensitivity&&(a=e(r).scrollLeft(e(r).scrollLeft()+n.scrollSpeed)))),a!==!1&&e.ui.ddmanager&&!n.dropBehaviour&&e.ui.ddmanager.prepareOffsets(s,t)}}),e.ui.plugin.add("draggable","snap",{start:function(t,i,s){var n=s.options;s.snapElements=[],e(n.snap.constructor!==String?n.snap.items||":data(ui-draggable)":n.snap).each(function(){var t=e(this),i=t.offset();this!==s.element[0]&&s.snapElements.push({item:this,width:t.outerWidth(),height:t.outerHeight(),top:i.top,left:i.left})})},drag:function(t,i,s){var n,a,o,r,h,l,u,d,c,p,f=s.options,m=f.snapTolerance,g=i.offset.left,v=g+s.helperProportions.width,y=i.offset.top,b=y+s.helperProportions.height;for(c=s.snapElements.length-1;c>=0;c--)h=s.snapElements[c].left-s.margins.left,l=h+s.snapElements[c].width,u=s.snapElements[c].top-s.margins.top,d=u+s.snapElements[c].height,h-m>v||g>l+m||u-m>b||y>d+m||!e.contains(s.snapElements[c].item.ownerDocument,s.snapElements[c].item)?(s.snapElements[c].snapping&&s.options.snap.release&&s.options.snap.release.call(s.element,t,e.extend(s._uiHash(),{snapItem:s.snapElements[c].item})),s.snapElements[c].snapping=!1):("inner"!==f.snapMode&&(n=m>=Math.abs(u-b),a=m>=Math.abs(d-y),o=m>=Math.abs(h-v),r=m>=Math.abs(l-g),n&&(i.position.top=s._convertPositionTo("relative",{top:u-s.helperProportions.height,left:0}).top),a&&(i.position.top=s._convertPositionTo("relative",{top:d,left:0}).top),o&&(i.position.left=s._convertPositionTo("relative",{top:0,left:h-s.helperProportions.width}).left),r&&(i.position.left=s._convertPositionTo("relative",{top:0,left:l}).left)),p=n||a||o||r,"outer"!==f.snapMode&&(n=m>=Math.abs(u-y),a=m>=Math.abs(d-b),o=m>=Math.abs(h-g),r=m>=Math.abs(l-v),n&&(i.position.top=s._convertPositionTo("relative",{top:u,left:0}).top),a&&(i.position.top=s._convertPositionTo("relative",{top:d-s.helperProportions.height,left:0}).top),o&&(i.position.left=s._convertPositionTo("relative",{top:0,left:h}).left),r&&(i.position.left=s._convertPositionTo("relative",{top:0,left:l-s.helperProportions.width}).left)),!s.snapElements[c].snapping&&(n||a||o||r||p)&&s.options.snap.snap&&s.options.snap.snap.call(s.element,t,e.extend(s._uiHash(),{snapItem:s.snapElements[c].item})),s.snapElements[c].snapping=n||a||o||r||p)}}),e.ui.plugin.add("draggable","stack",{start:function(t,i,s){var n,a=s.options,o=e.makeArray(e(a.stack)).sort(function(t,i){return(parseInt(e(t).css("zIndex"),10)||0)-(parseInt(e(i).css("zIndex"),10)||0)});o.length&&(n=parseInt(e(o[0]).css("zIndex"),10)||0,e(o).each(function(t){e(this).css("zIndex",n+t)}),this.css("zIndex",n+o.length))}}),e.ui.plugin.add("draggable","zIndex",{start:function(t,i,s){var n=e(i.helper),a=s.options;n.css("zIndex")&&(a._zIndex=n.css("zIndex")),n.css("zIndex",a.zIndex)},stop:function(t,i,s){var n=s.options;n._zIndex&&e(i.helper).css("zIndex",n._zIndex)}}),e.ui.draggable,e.widget("ui.droppable",{version:"1.11.4",widgetEventPrefix:"drop",options:{accept:"*",activeClass:!1,addClasses:!0,greedy:!1,hoverClass:!1,scope:"default",tolerance:"intersect",activate:null,deactivate:null,drop:null,out:null,over:null},_create:function(){var t,i=this.options,s=i.accept;this.isover=!1,this.isout=!0,this.accept=e.isFunction(s)?s:function(e){return e.is(s)},this.proportions=function(){return arguments.length?(t=arguments[0],void 0):t?t:t={width:this.element[0].offsetWidth,height:this.element[0].offsetHeight}},this._addToManager(i.scope),i.addClasses&&this.element.addClass("ui-droppable")},_addToManager:function(t){e.ui.ddmanager.droppables[t]=e.ui.ddmanager.droppables[t]||[],e.ui.ddmanager.droppables[t].push(this)},_splice:function(e){for(var t=0;e.length>t;t++)e[t]===this&&e.splice(t,1)},_destroy:function(){var t=e.ui.ddmanager.droppables[this.options.scope];this._splice(t),this.element.removeClass("ui-droppable ui-droppable-disabled")},_setOption:function(t,i){if("accept"===t)this.accept=e.isFunction(i)?i:function(e){return e.is(i)};else if("scope"===t){var s=e.ui.ddmanager.droppables[this.options.scope];this._splice(s),this._addToManager(i)}this._super(t,i)},_activate:function(t){var i=e.ui.ddmanager.current;this.options.activeClass&&this.element.addClass(this.options.activeClass),i&&this._trigger("activate",t,this.ui(i))},_deactivate:function(t){var i=e.ui.ddmanager.current;this.options.activeClass&&this.element.removeClass(this.options.activeClass),i&&this._trigger("deactivate",t,this.ui(i))},_over:function(t){var i=e.ui.ddmanager.current;i&&(i.currentItem||i.element)[0]!==this.element[0]&&this.accept.call(this.element[0],i.currentItem||i.element)&&(this.options.hoverClass&&this.element.addClass(this.options.hoverClass),this._trigger("over",t,this.ui(i)))},_out:function(t){var i=e.ui.ddmanager.current;i&&(i.currentItem||i.element)[0]!==this.element[0]&&this.accept.call(this.element[0],i.currentItem||i.element)&&(this.options.hoverClass&&this.element.removeClass(this.options.hoverClass),this._trigger("out",t,this.ui(i)))},_drop:function(t,i){var s=i||e.ui.ddmanager.current,n=!1;return s&&(s.currentItem||s.element)[0]!==this.element[0]?(this.element.find(":data(ui-droppable)").not(".ui-draggable-dragging").each(function(){var i=e(this).droppable("instance");return i.options.greedy&&!i.options.disabled&&i.options.scope===s.options.scope&&i.accept.call(i.element[0],s.currentItem||s.element)&&e.ui.intersect(s,e.extend(i,{offset:i.element.offset()}),i.options.tolerance,t)?(n=!0,!1):void 0}),n?!1:this.accept.call(this.element[0],s.currentItem||s.element)?(this.options.activeClass&&this.element.removeClass(this.options.activeClass),this.options.hoverClass&&this.element.removeClass(this.options.hoverClass),this._trigger("drop",t,this.ui(s)),this.element):!1):!1},ui:function(e){return{draggable:e.currentItem||e.element,helper:e.helper,position:e.position,offset:e.positionAbs}}}),e.ui.intersect=function(){function e(e,t,i){return e>=t&&t+i>e}return function(t,i,s,n){if(!i.offset)return!1;var a=(t.positionAbs||t.position.absolute).left+t.margins.left,o=(t.positionAbs||t.position.absolute).top+t.margins.top,r=a+t.helperProportions.width,h=o+t.helperProportions.height,l=i.offset.left,u=i.offset.top,d=l+i.proportions().width,c=u+i.proportions().height;switch(s){case"fit":return a>=l&&d>=r&&o>=u&&c>=h;case"intersect":return a+t.helperProportions.width/2>l&&d>r-t.helperProportions.width/2&&o+t.helperProportions.height/2>u&&c>h-t.helperProportions.height/2;case"pointer":return e(n.pageY,u,i.proportions().height)&&e(n.pageX,l,i.proportions().width);case"touch":return(o>=u&&c>=o||h>=u&&c>=h||u>o&&h>c)&&(a>=l&&d>=a||r>=l&&d>=r||l>a&&r>d);default:return!1}}}(),e.ui.ddmanager={current:null,droppables:{"default":[]},prepareOffsets:function(t,i){var s,n,a=e.ui.ddmanager.droppables[t.options.scope]||[],o=i?i.type:null,r=(t.currentItem||t.element).find(":data(ui-droppable)").addBack();e:for(s=0;a.length>s;s++)if(!(a[s].options.disabled||t&&!a[s].accept.call(a[s].element[0],t.currentItem||t.element))){for(n=0;r.length>n;n++)if(r[n]===a[s].element[0]){a[s].proportions().height=0;continue e}a[s].visible="none"!==a[s].element.css("display"),a[s].visible&&("mousedown"===o&&a[s]._activate.call(a[s],i),a[s].offset=a[s].element.offset(),a[s].proportions({width:a[s].element[0].offsetWidth,height:a[s].element[0].offsetHeight}))}},drop:function(t,i){var s=!1;return e.each((e.ui.ddmanager.droppables[t.options.scope]||[]).slice(),function(){this.options&&(!this.options.disabled&&this.visible&&e.ui.intersect(t,this,this.options.tolerance,i)&&(s=this._drop.call(this,i)||s),!this.options.disabled&&this.visible&&this.accept.call(this.element[0],t.currentItem||t.element)&&(this.isout=!0,this.isover=!1,this._deactivate.call(this,i)))}),s},dragStart:function(t,i){t.element.parentsUntil("body").bind("scroll.droppable",function(){t.options.refreshPositions||e.ui.ddmanager.prepareOffsets(t,i)})},drag:function(t,i){t.options.refreshPositions&&e.ui.ddmanager.prepareOffsets(t,i),e.each(e.ui.ddmanager.droppables[t.options.scope]||[],function(){if(!this.options.disabled&&!this.greedyChild&&this.visible){var s,n,a,o=e.ui.intersect(t,this,this.options.tolerance,i),r=!o&&this.isover?"isout":o&&!this.isover?"isover":null;r&&(this.options.greedy&&(n=this.options.scope,a=this.element.parents(":data(ui-droppable)").filter(function(){return e(this).droppable("instance").options.scope===n}),a.length&&(s=e(a[0]).droppable("instance"),s.greedyChild="isover"===r)),s&&"isover"===r&&(s.isover=!1,s.isout=!0,s._out.call(s,i)),this[r]=!0,this["isout"===r?"isover":"isout"]=!1,this["isover"===r?"_over":"_out"].call(this,i),s&&"isout"===r&&(s.isout=!1,s.isover=!0,s._over.call(s,i)))}})},dragStop:function(t,i){t.element.parentsUntil("body").unbind("scroll.droppable"),t.options.refreshPositions||e.ui.ddmanager.prepareOffsets(t,i)}},e.ui.droppable,e.widget("ui.resizable",e.ui.mouse,{version:"1.11.4",widgetEventPrefix:"resize",options:{alsoResize:!1,animate:!1,animateDuration:"slow",animateEasing:"swing",aspectRatio:!1,autoHide:!1,containment:!1,ghost:!1,grid:!1,handles:"e,s,se",helper:!1,maxHeight:null,maxWidth:null,minHeight:10,minWidth:10,zIndex:90,resize:null,start:null,stop:null},_num:function(e){return parseInt(e,10)||0},_isNumber:function(e){return!isNaN(parseInt(e,10))},_hasScroll:function(t,i){if("hidden"===e(t).css("overflow"))return!1;var s=i&&"left"===i?"scrollLeft":"scrollTop",n=!1;return t[s]>0?!0:(t[s]=1,n=t[s]>0,t[s]=0,n)},_create:function(){var t,i,s,n,a,o=this,r=this.options;if(this.element.addClass("ui-resizable"),e.extend(this,{_aspectRatio:!!r.aspectRatio,aspectRatio:r.aspectRatio,originalElement:this.element,_proportionallyResizeElements:[],_helper:r.helper||r.ghost||r.animate?r.helper||"ui-resizable-helper":null}),this.element[0].nodeName.match(/^(canvas|textarea|input|select|button|img)$/i)&&(this.element.wrap(e("<div class='ui-wrapper' style='overflow: hidden;'></div>").css({position:this.element.css("position"),width:this.element.outerWidth(),height:this.element.outerHeight(),top:this.element.css("top"),left:this.element.css("left")})),this.element=this.element.parent().data("ui-resizable",this.element.resizable("instance")),this.elementIsWrapper=!0,this.element.css({marginLeft:this.originalElement.css("marginLeft"),marginTop:this.originalElement.css("marginTop"),marginRight:this.originalElement.css("marginRight"),marginBottom:this.originalElement.css("marginBottom")}),this.originalElement.css({marginLeft:0,marginTop:0,marginRight:0,marginBottom:0}),this.originalResizeStyle=this.originalElement.css("resize"),this.originalElement.css("resize","none"),this._proportionallyResizeElements.push(this.originalElement.css({position:"static",zoom:1,display:"block"})),this.originalElement.css({margin:this.originalElement.css("margin")}),this._proportionallyResize()),this.handles=r.handles||(e(".ui-resizable-handle",this.element).length?{n:".ui-resizable-n",e:".ui-resizable-e",s:".ui-resizable-s",w:".ui-resizable-w",se:".ui-resizable-se",sw:".ui-resizable-sw",ne:".ui-resizable-ne",nw:".ui-resizable-nw"}:"e,s,se"),this._handles=e(),this.handles.constructor===String)for("all"===this.handles&&(this.handles="n,e,s,w,se,sw,ne,nw"),t=this.handles.split(","),this.handles={},i=0;t.length>i;i++)s=e.trim(t[i]),a="ui-resizable-"+s,n=e("<div class='ui-resizable-handle "+a+"'></div>"),n.css({zIndex:r.zIndex}),"se"===s&&n.addClass("ui-icon ui-icon-gripsmall-diagonal-se"),this.handles[s]=".ui-resizable-"+s,this.element.append(n);this._renderAxis=function(t){var i,s,n,a;t=t||this.element;for(i in this.handles)this.handles[i].constructor===String?this.handles[i]=this.element.children(this.handles[i]).first().show():(this.handles[i].jquery||this.handles[i].nodeType)&&(this.handles[i]=e(this.handles[i]),this._on(this.handles[i],{mousedown:o._mouseDown})),this.elementIsWrapper&&this.originalElement[0].nodeName.match(/^(textarea|input|select|button)$/i)&&(s=e(this.handles[i],this.element),a=/sw|ne|nw|se|n|s/.test(i)?s.outerHeight():s.outerWidth(),n=["padding",/ne|nw|n/.test(i)?"Top":/se|sw|s/.test(i)?"Bottom":/^e$/.test(i)?"Right":"Left"].join(""),t.css(n,a),this._proportionallyResize()),this._handles=this._handles.add(this.handles[i])},this._renderAxis(this.element),this._handles=this._handles.add(this.element.find(".ui-resizable-handle")),this._handles.disableSelection(),this._handles.mouseover(function(){o.resizing||(this.className&&(n=this.className.match(/ui-resizable-(se|sw|ne|nw|n|e|s|w)/i)),o.axis=n&&n[1]?n[1]:"se")}),r.autoHide&&(this._handles.hide(),e(this.element).addClass("ui-resizable-autohide").mouseenter(function(){r.disabled||(e(this).removeClass("ui-resizable-autohide"),o._handles.show())}).mouseleave(function(){r.disabled||o.resizing||(e(this).addClass("ui-resizable-autohide"),o._handles.hide())})),this._mouseInit()},_destroy:function(){this._mouseDestroy();var t,i=function(t){e(t).removeClass("ui-resizable ui-resizable-disabled ui-resizable-resizing").removeData("resizable").removeData("ui-resizable").unbind(".resizable").find(".ui-resizable-handle").remove()};return this.elementIsWrapper&&(i(this.element),t=this.element,this.originalElement.css({position:t.css("position"),width:t.outerWidth(),height:t.outerHeight(),top:t.css("top"),left:t.css("left")}).insertAfter(t),t.remove()),this.originalElement.css("resize",this.originalResizeStyle),i(this.originalElement),this},_mouseCapture:function(t){var i,s,n=!1;for(i in this.handles)s=e(this.handles[i])[0],(s===t.target||e.contains(s,t.target))&&(n=!0);return!this.options.disabled&&n},_mouseStart:function(t){var i,s,n,a=this.options,o=this.element;return this.resizing=!0,this._renderProxy(),i=this._num(this.helper.css("left")),s=this._num(this.helper.css("top")),a.containment&&(i+=e(a.containment).scrollLeft()||0,s+=e(a.containment).scrollTop()||0),this.offset=this.helper.offset(),this.position={left:i,top:s},this.size=this._helper?{width:this.helper.width(),height:this.helper.height()}:{width:o.width(),height:o.height()},this.originalSize=this._helper?{width:o.outerWidth(),height:o.outerHeight()}:{width:o.width(),height:o.height()},this.sizeDiff={width:o.outerWidth()-o.width(),height:o.outerHeight()-o.height()},this.originalPosition={left:i,top:s},this.originalMousePosition={left:t.pageX,top:t.pageY},this.aspectRatio="number"==typeof a.aspectRatio?a.aspectRatio:this.originalSize.width/this.originalSize.height||1,n=e(".ui-resizable-"+this.axis).css("cursor"),e("body").css("cursor","auto"===n?this.axis+"-resize":n),o.addClass("ui-resizable-resizing"),this._propagate("start",t),!0},_mouseDrag:function(t){var i,s,n=this.originalMousePosition,a=this.axis,o=t.pageX-n.left||0,r=t.pageY-n.top||0,h=this._change[a];return this._updatePrevProperties(),h?(i=h.apply(this,[t,o,r]),this._updateVirtualBoundaries(t.shiftKey),(this._aspectRatio||t.shiftKey)&&(i=this._updateRatio(i,t)),i=this._respectSize(i,t),this._updateCache(i),this._propagate("resize",t),s=this._applyChanges(),!this._helper&&this._proportionallyResizeElements.length&&this._proportionallyResize(),e.isEmptyObject(s)||(this._updatePrevProperties(),this._trigger("resize",t,this.ui()),this._applyChanges()),!1):!1},_mouseStop:function(t){this.resizing=!1;var i,s,n,a,o,r,h,l=this.options,u=this;return this._helper&&(i=this._proportionallyResizeElements,s=i.length&&/textarea/i.test(i[0].nodeName),n=s&&this._hasScroll(i[0],"left")?0:u.sizeDiff.height,a=s?0:u.sizeDiff.width,o={width:u.helper.width()-a,height:u.helper.height()-n},r=parseInt(u.element.css("left"),10)+(u.position.left-u.originalPosition.left)||null,h=parseInt(u.element.css("top"),10)+(u.position.top-u.originalPosition.top)||null,l.animate||this.element.css(e.extend(o,{top:h,left:r})),u.helper.height(u.size.height),u.helper.width(u.size.width),this._helper&&!l.animate&&this._proportionallyResize()),e("body").css("cursor","auto"),this.element.removeClass("ui-resizable-resizing"),this._propagate("stop",t),this._helper&&this.helper.remove(),!1},_updatePrevProperties:function(){this.prevPosition={top:this.position.top,left:this.position.left},this.prevSize={width:this.size.width,height:this.size.height}},_applyChanges:function(){var e={};return this.position.top!==this.prevPosition.top&&(e.top=this.position.top+"px"),this.position.left!==this.prevPosition.left&&(e.left=this.position.left+"px"),this.size.width!==this.prevSize.width&&(e.width=this.size.width+"px"),this.size.height!==this.prevSize.height&&(e.height=this.size.height+"px"),this.helper.css(e),e},_updateVirtualBoundaries:function(e){var t,i,s,n,a,o=this.options;a={minWidth:this._isNumber(o.minWidth)?o.minWidth:0,maxWidth:this._isNumber(o.maxWidth)?o.maxWidth:1/0,minHeight:this._isNumber(o.minHeight)?o.minHeight:0,maxHeight:this._isNumber(o.maxHeight)?o.maxHeight:1/0},(this._aspectRatio||e)&&(t=a.minHeight*this.aspectRatio,s=a.minWidth/this.aspectRatio,i=a.maxHeight*this.aspectRatio,n=a.maxWidth/this.aspectRatio,t>a.minWidth&&(a.minWidth=t),s>a.minHeight&&(a.minHeight=s),a.maxWidth>i&&(a.maxWidth=i),a.maxHeight>n&&(a.maxHeight=n)),this._vBoundaries=a},_updateCache:function(e){this.offset=this.helper.offset(),this._isNumber(e.left)&&(this.position.left=e.left),this._isNumber(e.top)&&(this.position.top=e.top),this._isNumber(e.height)&&(this.size.height=e.height),this._isNumber(e.width)&&(this.size.width=e.width)},_updateRatio:function(e){var t=this.position,i=this.size,s=this.axis;return this._isNumber(e.height)?e.width=e.height*this.aspectRatio:this._isNumber(e.width)&&(e.height=e.width/this.aspectRatio),"sw"===s&&(e.left=t.left+(i.width-e.width),e.top=null),"nw"===s&&(e.top=t.top+(i.height-e.height),e.left=t.left+(i.width-e.width)),e},_respectSize:function(e){var t=this._vBoundaries,i=this.axis,s=this._isNumber(e.width)&&t.maxWidth&&t.maxWidth<e.width,n=this._isNumber(e.height)&&t.maxHeight&&t.maxHeight<e.height,a=this._isNumber(e.width)&&t.minWidth&&t.minWidth>e.width,o=this._isNumber(e.height)&&t.minHeight&&t.minHeight>e.height,r=this.originalPosition.left+this.originalSize.width,h=this.position.top+this.size.height,l=/sw|nw|w/.test(i),u=/nw|ne|n/.test(i);return a&&(e.width=t.minWidth),o&&(e.height=t.minHeight),s&&(e.width=t.maxWidth),n&&(e.height=t.maxHeight),a&&l&&(e.left=r-t.minWidth),s&&l&&(e.left=r-t.maxWidth),o&&u&&(e.top=h-t.minHeight),n&&u&&(e.top=h-t.maxHeight),e.width||e.height||e.left||!e.top?e.width||e.height||e.top||!e.left||(e.left=null):e.top=null,e},_getPaddingPlusBorderDimensions:function(e){for(var t=0,i=[],s=[e.css("borderTopWidth"),e.css("borderRightWidth"),e.css("borderBottomWidth"),e.css("borderLeftWidth")],n=[e.css("paddingTop"),e.css("paddingRight"),e.css("paddingBottom"),e.css("paddingLeft")];4>t;t++)i[t]=parseInt(s[t],10)||0,i[t]+=parseInt(n[t],10)||0;return{height:i[0]+i[2],width:i[1]+i[3]}},_proportionallyResize:function(){if(this._proportionallyResizeElements.length)for(var e,t=0,i=this.helper||this.element;this._proportionallyResizeElements.length>t;t++)e=this._proportionallyResizeElements[t],this.outerDimensions||(this.outerDimensions=this._getPaddingPlusBorderDimensions(e)),e.css({height:i.height()-this.outerDimensions.height||0,width:i.width()-this.outerDimensions.width||0})},_renderProxy:function(){var t=this.element,i=this.options;this.elementOffset=t.offset(),this._helper?(this.helper=this.helper||e("<div style='overflow:hidden;'></div>"),this.helper.addClass(this._helper).css({width:this.element.outerWidth()-1,height:this.element.outerHeight()-1,position:"absolute",left:this.elementOffset.left+"px",top:this.elementOffset.top+"px",zIndex:++i.zIndex}),this.helper.appendTo("body").disableSelection()):this.helper=this.element},_change:{e:function(e,t){return{width:this.originalSize.width+t}},w:function(e,t){var i=this.originalSize,s=this.originalPosition;return{left:s.left+t,width:i.width-t}},n:function(e,t,i){var s=this.originalSize,n=this.originalPosition;return{top:n.top+i,height:s.height-i}},s:function(e,t,i){return{height:this.originalSize.height+i}},se:function(t,i,s){return e.extend(this._change.s.apply(this,arguments),this._change.e.apply(this,[t,i,s]))},sw:function(t,i,s){return e.extend(this._change.s.apply(this,arguments),this._change.w.apply(this,[t,i,s]))},ne:function(t,i,s){return e.extend(this._change.n.apply(this,arguments),this._change.e.apply(this,[t,i,s]))},nw:function(t,i,s){return e.extend(this._change.n.apply(this,arguments),this._change.w.apply(this,[t,i,s]))}},_propagate:function(t,i){e.ui.plugin.call(this,t,[i,this.ui()]),"resize"!==t&&this._trigger(t,i,this.ui())},plugins:{},ui:function(){return{originalElement:this.originalElement,element:this.element,helper:this.helper,position:this.position,size:this.size,originalSize:this.originalSize,originalPosition:this.originalPosition}}}),e.ui.plugin.add("resizable","animate",{stop:function(t){var i=e(this).resizable("instance"),s=i.options,n=i._proportionallyResizeElements,a=n.length&&/textarea/i.test(n[0].nodeName),o=a&&i._hasScroll(n[0],"left")?0:i.sizeDiff.height,r=a?0:i.sizeDiff.width,h={width:i.size.width-r,height:i.size.height-o},l=parseInt(i.element.css("left"),10)+(i.position.left-i.originalPosition.left)||null,u=parseInt(i.element.css("top"),10)+(i.position.top-i.originalPosition.top)||null;i.element.animate(e.extend(h,u&&l?{top:u,left:l}:{}),{duration:s.animateDuration,easing:s.animateEasing,step:function(){var s={width:parseInt(i.element.css("width"),10),height:parseInt(i.element.css("height"),10),top:parseInt(i.element.css("top"),10),left:parseInt(i.element.css("left"),10)};n&&n.length&&e(n[0]).css({width:s.width,height:s.height}),i._updateCache(s),i._propagate("resize",t)}})}}),e.ui.plugin.add("resizable","containment",{start:function(){var t,i,s,n,a,o,r,h=e(this).resizable("instance"),l=h.options,u=h.element,d=l.containment,c=d instanceof e?d.get(0):/parent/.test(d)?u.parent().get(0):d;c&&(h.containerElement=e(c),/document/.test(d)||d===document?(h.containerOffset={left:0,top:0},h.containerPosition={left:0,top:0},h.parentData={element:e(document),left:0,top:0,width:e(document).width(),height:e(document).height()||document.body.parentNode.scrollHeight}):(t=e(c),i=[],e(["Top","Right","Left","Bottom"]).each(function(e,s){i[e]=h._num(t.css("padding"+s))}),h.containerOffset=t.offset(),h.containerPosition=t.position(),h.containerSize={height:t.innerHeight()-i[3],width:t.innerWidth()-i[1]},s=h.containerOffset,n=h.containerSize.height,a=h.containerSize.width,o=h._hasScroll(c,"left")?c.scrollWidth:a,r=h._hasScroll(c)?c.scrollHeight:n,h.parentData={element:c,left:s.left,top:s.top,width:o,height:r}))},resize:function(t){var i,s,n,a,o=e(this).resizable("instance"),r=o.options,h=o.containerOffset,l=o.position,u=o._aspectRatio||t.shiftKey,d={top:0,left:0},c=o.containerElement,p=!0;c[0]!==document&&/static/.test(c.css("position"))&&(d=h),l.left<(o._helper?h.left:0)&&(o.size.width=o.size.width+(o._helper?o.position.left-h.left:o.position.left-d.left),u&&(o.size.height=o.size.width/o.aspectRatio,p=!1),o.position.left=r.helper?h.left:0),l.top<(o._helper?h.top:0)&&(o.size.height=o.size.height+(o._helper?o.position.top-h.top:o.position.top),u&&(o.size.width=o.size.height*o.aspectRatio,p=!1),o.position.top=o._helper?h.top:0),n=o.containerElement.get(0)===o.element.parent().get(0),a=/relative|absolute/.test(o.containerElement.css("position")),n&&a?(o.offset.left=o.parentData.left+o.position.left,o.offset.top=o.parentData.top+o.position.top):(o.offset.left=o.element.offset().left,o.offset.top=o.element.offset().top),i=Math.abs(o.sizeDiff.width+(o._helper?o.offset.left-d.left:o.offset.left-h.left)),s=Math.abs(o.sizeDiff.height+(o._helper?o.offset.top-d.top:o.offset.top-h.top)),i+o.size.width>=o.parentData.width&&(o.size.width=o.parentData.width-i,u&&(o.size.height=o.size.width/o.aspectRatio,p=!1)),s+o.size.height>=o.parentData.height&&(o.size.height=o.parentData.height-s,u&&(o.size.width=o.size.height*o.aspectRatio,p=!1)),p||(o.position.left=o.prevPosition.left,o.position.top=o.prevPosition.top,o.size.width=o.prevSize.width,o.size.height=o.prevSize.height)},stop:function(){var t=e(this).resizable("instance"),i=t.options,s=t.containerOffset,n=t.containerPosition,a=t.containerElement,o=e(t.helper),r=o.offset(),h=o.outerWidth()-t.sizeDiff.width,l=o.outerHeight()-t.sizeDiff.height;t._helper&&!i.animate&&/relative/.test(a.css("position"))&&e(this).css({left:r.left-n.left-s.left,width:h,height:l}),t._helper&&!i.animate&&/static/.test(a.css("position"))&&e(this).css({left:r.left-n.left-s.left,width:h,height:l})}}),e.ui.plugin.add("resizable","alsoResize",{start:function(){var t=e(this).resizable("instance"),i=t.options;e(i.alsoResize).each(function(){var t=e(this);t.data("ui-resizable-alsoresize",{width:parseInt(t.width(),10),height:parseInt(t.height(),10),left:parseInt(t.css("left"),10),top:parseInt(t.css("top"),10)})})},resize:function(t,i){var s=e(this).resizable("instance"),n=s.options,a=s.originalSize,o=s.originalPosition,r={height:s.size.height-a.height||0,width:s.size.width-a.width||0,top:s.position.top-o.top||0,left:s.position.left-o.left||0};e(n.alsoResize).each(function(){var t=e(this),s=e(this).data("ui-resizable-alsoresize"),n={},a=t.parents(i.originalElement[0]).length?["width","height"]:["width","height","top","left"];e.each(a,function(e,t){var i=(s[t]||0)+(r[t]||0);i&&i>=0&&(n[t]=i||null)}),t.css(n)})},stop:function(){e(this).removeData("resizable-alsoresize")}}),e.ui.plugin.add("resizable","ghost",{start:function(){var t=e(this).resizable("instance"),i=t.options,s=t.size;t.ghost=t.originalElement.clone(),t.ghost.css({opacity:.25,display:"block",position:"relative",height:s.height,width:s.width,margin:0,left:0,top:0}).addClass("ui-resizable-ghost").addClass("string"==typeof i.ghost?i.ghost:""),t.ghost.appendTo(t.helper)},resize:function(){var t=e(this).resizable("instance");t.ghost&&t.ghost.css({position:"relative",height:t.size.height,width:t.size.width})},stop:function(){var t=e(this).resizable("instance");t.ghost&&t.helper&&t.helper.get(0).removeChild(t.ghost.get(0))}}),e.ui.plugin.add("resizable","grid",{resize:function(){var t,i=e(this).resizable("instance"),s=i.options,n=i.size,a=i.originalSize,o=i.originalPosition,r=i.axis,h="number"==typeof s.grid?[s.grid,s.grid]:s.grid,l=h[0]||1,u=h[1]||1,d=Math.round((n.width-a.width)/l)*l,c=Math.round((n.height-a.height)/u)*u,p=a.width+d,f=a.height+c,m=s.maxWidth&&p>s.maxWidth,g=s.maxHeight&&f>s.maxHeight,v=s.minWidth&&s.minWidth>p,y=s.minHeight&&s.minHeight>f;s.grid=h,v&&(p+=l),y&&(f+=u),m&&(p-=l),g&&(f-=u),/^(se|s|e)$/.test(r)?(i.size.width=p,i.size.height=f):/^(ne)$/.test(r)?(i.size.width=p,i.size.height=f,i.position.top=o.top-c):/^(sw)$/.test(r)?(i.size.width=p,i.size.height=f,i.position.left=o.left-d):((0>=f-u||0>=p-l)&&(t=i._getPaddingPlusBorderDimensions(this)),f-u>0?(i.size.height=f,i.position.top=o.top-c):(f=u-t.height,i.size.height=f,i.position.top=o.top+a.height-f),p-l>0?(i.size.width=p,i.position.left=o.left-d):(p=l-t.width,i.size.width=p,i.position.left=o.left+a.width-p))}}),e.ui.resizable,e.widget("ui.selectable",e.ui.mouse,{version:"1.11.4",options:{appendTo:"body",autoRefresh:!0,distance:0,filter:"*",tolerance:"touch",selected:null,selecting:null,start:null,stop:null,unselected:null,unselecting:null},_create:function(){var t,i=this;this.element.addClass("ui-selectable"),this.dragged=!1,this.refresh=function(){t=e(i.options.filter,i.element[0]),t.addClass("ui-selectee"),t.each(function(){var t=e(this),i=t.offset();e.data(this,"selectable-item",{element:this,$element:t,left:i.left,top:i.top,right:i.left+t.outerWidth(),bottom:i.top+t.outerHeight(),startselected:!1,selected:t.hasClass("ui-selected"),selecting:t.hasClass("ui-selecting"),unselecting:t.hasClass("ui-unselecting")})})},this.refresh(),this.selectees=t.addClass("ui-selectee"),this._mouseInit(),this.helper=e("<div class='ui-selectable-helper'></div>")},_destroy:function(){this.selectees.removeClass("ui-selectee").removeData("selectable-item"),this.element.removeClass("ui-selectable ui-selectable-disabled"),this._mouseDestroy()},_mouseStart:function(t){var i=this,s=this.options;this.opos=[t.pageX,t.pageY],this.options.disabled||(this.selectees=e(s.filter,this.element[0]),this._trigger("start",t),e(s.appendTo).append(this.helper),this.helper.css({left:t.pageX,top:t.pageY,width:0,height:0}),s.autoRefresh&&this.refresh(),this.selectees.filter(".ui-selected").each(function(){var s=e.data(this,"selectable-item");s.startselected=!0,t.metaKey||t.ctrlKey||(s.$element.removeClass("ui-selected"),s.selected=!1,s.$element.addClass("ui-unselecting"),s.unselecting=!0,i._trigger("unselecting",t,{unselecting:s.element}))}),e(t.target).parents().addBack().each(function(){var s,n=e.data(this,"selectable-item");return n?(s=!t.metaKey&&!t.ctrlKey||!n.$element.hasClass("ui-selected"),n.$element.removeClass(s?"ui-unselecting":"ui-selected").addClass(s?"ui-selecting":"ui-unselecting"),n.unselecting=!s,n.selecting=s,n.selected=s,s?i._trigger("selecting",t,{selecting:n.element}):i._trigger("unselecting",t,{unselecting:n.element}),!1):void 0}))},_mouseDrag:function(t){if(this.dragged=!0,!this.options.disabled){var i,s=this,n=this.options,a=this.opos[0],o=this.opos[1],r=t.pageX,h=t.pageY;return a>r&&(i=r,r=a,a=i),o>h&&(i=h,h=o,o=i),this.helper.css({left:a,top:o,width:r-a,height:h-o}),this.selectees.each(function(){var i=e.data(this,"selectable-item"),l=!1;
i&&i.element!==s.element[0]&&("touch"===n.tolerance?l=!(i.left>r||a>i.right||i.top>h||o>i.bottom):"fit"===n.tolerance&&(l=i.left>a&&r>i.right&&i.top>o&&h>i.bottom),l?(i.selected&&(i.$element.removeClass("ui-selected"),i.selected=!1),i.unselecting&&(i.$element.removeClass("ui-unselecting"),i.unselecting=!1),i.selecting||(i.$element.addClass("ui-selecting"),i.selecting=!0,s._trigger("selecting",t,{selecting:i.element}))):(i.selecting&&((t.metaKey||t.ctrlKey)&&i.startselected?(i.$element.removeClass("ui-selecting"),i.selecting=!1,i.$element.addClass("ui-selected"),i.selected=!0):(i.$element.removeClass("ui-selecting"),i.selecting=!1,i.startselected&&(i.$element.addClass("ui-unselecting"),i.unselecting=!0),s._trigger("unselecting",t,{unselecting:i.element}))),i.selected&&(t.metaKey||t.ctrlKey||i.startselected||(i.$element.removeClass("ui-selected"),i.selected=!1,i.$element.addClass("ui-unselecting"),i.unselecting=!0,s._trigger("unselecting",t,{unselecting:i.element})))))}),!1}},_mouseStop:function(t){var i=this;return this.dragged=!1,e(".ui-unselecting",this.element[0]).each(function(){var s=e.data(this,"selectable-item");s.$element.removeClass("ui-unselecting"),s.unselecting=!1,s.startselected=!1,i._trigger("unselected",t,{unselected:s.element})}),e(".ui-selecting",this.element[0]).each(function(){var s=e.data(this,"selectable-item");s.$element.removeClass("ui-selecting").addClass("ui-selected"),s.selecting=!1,s.selected=!0,s.startselected=!0,i._trigger("selected",t,{selected:s.element})}),this._trigger("stop",t),this.helper.remove(),!1}}),e.widget("ui.sortable",e.ui.mouse,{version:"1.11.4",widgetEventPrefix:"sort",ready:!1,options:{appendTo:"parent",axis:!1,connectWith:!1,containment:!1,cursor:"auto",cursorAt:!1,dropOnEmpty:!0,forcePlaceholderSize:!1,forceHelperSize:!1,grid:!1,handle:!1,helper:"original",items:"> *",opacity:!1,placeholder:!1,revert:!1,scroll:!0,scrollSensitivity:20,scrollSpeed:20,scope:"default",tolerance:"intersect",zIndex:1e3,activate:null,beforeStop:null,change:null,deactivate:null,out:null,over:null,receive:null,remove:null,sort:null,start:null,stop:null,update:null},_isOverAxis:function(e,t,i){return e>=t&&t+i>e},_isFloating:function(e){return/left|right/.test(e.css("float"))||/inline|table-cell/.test(e.css("display"))},_create:function(){this.containerCache={},this.element.addClass("ui-sortable"),this.refresh(),this.offset=this.element.offset(),this._mouseInit(),this._setHandleClassName(),this.ready=!0},_setOption:function(e,t){this._super(e,t),"handle"===e&&this._setHandleClassName()},_setHandleClassName:function(){this.element.find(".ui-sortable-handle").removeClass("ui-sortable-handle"),e.each(this.items,function(){(this.instance.options.handle?this.item.find(this.instance.options.handle):this.item).addClass("ui-sortable-handle")})},_destroy:function(){this.element.removeClass("ui-sortable ui-sortable-disabled").find(".ui-sortable-handle").removeClass("ui-sortable-handle"),this._mouseDestroy();for(var e=this.items.length-1;e>=0;e--)this.items[e].item.removeData(this.widgetName+"-item");return this},_mouseCapture:function(t,i){var s=null,n=!1,a=this;return this.reverting?!1:this.options.disabled||"static"===this.options.type?!1:(this._refreshItems(t),e(t.target).parents().each(function(){return e.data(this,a.widgetName+"-item")===a?(s=e(this),!1):void 0}),e.data(t.target,a.widgetName+"-item")===a&&(s=e(t.target)),s?!this.options.handle||i||(e(this.options.handle,s).find("*").addBack().each(function(){this===t.target&&(n=!0)}),n)?(this.currentItem=s,this._removeCurrentsFromItems(),!0):!1:!1)},_mouseStart:function(t,i,s){var n,a,o=this.options;if(this.currentContainer=this,this.refreshPositions(),this.helper=this._createHelper(t),this._cacheHelperProportions(),this._cacheMargins(),this.scrollParent=this.helper.scrollParent(),this.offset=this.currentItem.offset(),this.offset={top:this.offset.top-this.margins.top,left:this.offset.left-this.margins.left},e.extend(this.offset,{click:{left:t.pageX-this.offset.left,top:t.pageY-this.offset.top},parent:this._getParentOffset(),relative:this._getRelativeOffset()}),this.helper.css("position","absolute"),this.cssPosition=this.helper.css("position"),this.originalPosition=this._generatePosition(t),this.originalPageX=t.pageX,this.originalPageY=t.pageY,o.cursorAt&&this._adjustOffsetFromHelper(o.cursorAt),this.domPosition={prev:this.currentItem.prev()[0],parent:this.currentItem.parent()[0]},this.helper[0]!==this.currentItem[0]&&this.currentItem.hide(),this._createPlaceholder(),o.containment&&this._setContainment(),o.cursor&&"auto"!==o.cursor&&(a=this.document.find("body"),this.storedCursor=a.css("cursor"),a.css("cursor",o.cursor),this.storedStylesheet=e("<style>*{ cursor: "+o.cursor+" !important; }</style>").appendTo(a)),o.opacity&&(this.helper.css("opacity")&&(this._storedOpacity=this.helper.css("opacity")),this.helper.css("opacity",o.opacity)),o.zIndex&&(this.helper.css("zIndex")&&(this._storedZIndex=this.helper.css("zIndex")),this.helper.css("zIndex",o.zIndex)),this.scrollParent[0]!==this.document[0]&&"HTML"!==this.scrollParent[0].tagName&&(this.overflowOffset=this.scrollParent.offset()),this._trigger("start",t,this._uiHash()),this._preserveHelperProportions||this._cacheHelperProportions(),!s)for(n=this.containers.length-1;n>=0;n--)this.containers[n]._trigger("activate",t,this._uiHash(this));return e.ui.ddmanager&&(e.ui.ddmanager.current=this),e.ui.ddmanager&&!o.dropBehaviour&&e.ui.ddmanager.prepareOffsets(this,t),this.dragging=!0,this.helper.addClass("ui-sortable-helper"),this._mouseDrag(t),!0},_mouseDrag:function(t){var i,s,n,a,o=this.options,r=!1;for(this.position=this._generatePosition(t),this.positionAbs=this._convertPositionTo("absolute"),this.lastPositionAbs||(this.lastPositionAbs=this.positionAbs),this.options.scroll&&(this.scrollParent[0]!==this.document[0]&&"HTML"!==this.scrollParent[0].tagName?(this.overflowOffset.top+this.scrollParent[0].offsetHeight-t.pageY<o.scrollSensitivity?this.scrollParent[0].scrollTop=r=this.scrollParent[0].scrollTop+o.scrollSpeed:t.pageY-this.overflowOffset.top<o.scrollSensitivity&&(this.scrollParent[0].scrollTop=r=this.scrollParent[0].scrollTop-o.scrollSpeed),this.overflowOffset.left+this.scrollParent[0].offsetWidth-t.pageX<o.scrollSensitivity?this.scrollParent[0].scrollLeft=r=this.scrollParent[0].scrollLeft+o.scrollSpeed:t.pageX-this.overflowOffset.left<o.scrollSensitivity&&(this.scrollParent[0].scrollLeft=r=this.scrollParent[0].scrollLeft-o.scrollSpeed)):(t.pageY-this.document.scrollTop()<o.scrollSensitivity?r=this.document.scrollTop(this.document.scrollTop()-o.scrollSpeed):this.window.height()-(t.pageY-this.document.scrollTop())<o.scrollSensitivity&&(r=this.document.scrollTop(this.document.scrollTop()+o.scrollSpeed)),t.pageX-this.document.scrollLeft()<o.scrollSensitivity?r=this.document.scrollLeft(this.document.scrollLeft()-o.scrollSpeed):this.window.width()-(t.pageX-this.document.scrollLeft())<o.scrollSensitivity&&(r=this.document.scrollLeft(this.document.scrollLeft()+o.scrollSpeed))),r!==!1&&e.ui.ddmanager&&!o.dropBehaviour&&e.ui.ddmanager.prepareOffsets(this,t)),this.positionAbs=this._convertPositionTo("absolute"),this.options.axis&&"y"===this.options.axis||(this.helper[0].style.left=this.position.left+"px"),this.options.axis&&"x"===this.options.axis||(this.helper[0].style.top=this.position.top+"px"),i=this.items.length-1;i>=0;i--)if(s=this.items[i],n=s.item[0],a=this._intersectsWithPointer(s),a&&s.instance===this.currentContainer&&n!==this.currentItem[0]&&this.placeholder[1===a?"next":"prev"]()[0]!==n&&!e.contains(this.placeholder[0],n)&&("semi-dynamic"===this.options.type?!e.contains(this.element[0],n):!0)){if(this.direction=1===a?"down":"up","pointer"!==this.options.tolerance&&!this._intersectsWithSides(s))break;this._rearrange(t,s),this._trigger("change",t,this._uiHash());break}return this._contactContainers(t),e.ui.ddmanager&&e.ui.ddmanager.drag(this,t),this._trigger("sort",t,this._uiHash()),this.lastPositionAbs=this.positionAbs,!1},_mouseStop:function(t,i){if(t){if(e.ui.ddmanager&&!this.options.dropBehaviour&&e.ui.ddmanager.drop(this,t),this.options.revert){var s=this,n=this.placeholder.offset(),a=this.options.axis,o={};a&&"x"!==a||(o.left=n.left-this.offset.parent.left-this.margins.left+(this.offsetParent[0]===this.document[0].body?0:this.offsetParent[0].scrollLeft)),a&&"y"!==a||(o.top=n.top-this.offset.parent.top-this.margins.top+(this.offsetParent[0]===this.document[0].body?0:this.offsetParent[0].scrollTop)),this.reverting=!0,e(this.helper).animate(o,parseInt(this.options.revert,10)||500,function(){s._clear(t)})}else this._clear(t,i);return!1}},cancel:function(){if(this.dragging){this._mouseUp({target:null}),"original"===this.options.helper?this.currentItem.css(this._storedCSS).removeClass("ui-sortable-helper"):this.currentItem.show();for(var t=this.containers.length-1;t>=0;t--)this.containers[t]._trigger("deactivate",null,this._uiHash(this)),this.containers[t].containerCache.over&&(this.containers[t]._trigger("out",null,this._uiHash(this)),this.containers[t].containerCache.over=0)}return this.placeholder&&(this.placeholder[0].parentNode&&this.placeholder[0].parentNode.removeChild(this.placeholder[0]),"original"!==this.options.helper&&this.helper&&this.helper[0].parentNode&&this.helper.remove(),e.extend(this,{helper:null,dragging:!1,reverting:!1,_noFinalSort:null}),this.domPosition.prev?e(this.domPosition.prev).after(this.currentItem):e(this.domPosition.parent).prepend(this.currentItem)),this},serialize:function(t){var i=this._getItemsAsjQuery(t&&t.connected),s=[];return t=t||{},e(i).each(function(){var i=(e(t.item||this).attr(t.attribute||"id")||"").match(t.expression||/(.+)[\-=_](.+)/);i&&s.push((t.key||i[1]+"[]")+"="+(t.key&&t.expression?i[1]:i[2]))}),!s.length&&t.key&&s.push(t.key+"="),s.join("&")},toArray:function(t){var i=this._getItemsAsjQuery(t&&t.connected),s=[];return t=t||{},i.each(function(){s.push(e(t.item||this).attr(t.attribute||"id")||"")}),s},_intersectsWith:function(e){var t=this.positionAbs.left,i=t+this.helperProportions.width,s=this.positionAbs.top,n=s+this.helperProportions.height,a=e.left,o=a+e.width,r=e.top,h=r+e.height,l=this.offset.click.top,u=this.offset.click.left,d="x"===this.options.axis||s+l>r&&h>s+l,c="y"===this.options.axis||t+u>a&&o>t+u,p=d&&c;return"pointer"===this.options.tolerance||this.options.forcePointerForContainers||"pointer"!==this.options.tolerance&&this.helperProportions[this.floating?"width":"height"]>e[this.floating?"width":"height"]?p:t+this.helperProportions.width/2>a&&o>i-this.helperProportions.width/2&&s+this.helperProportions.height/2>r&&h>n-this.helperProportions.height/2},_intersectsWithPointer:function(e){var t="x"===this.options.axis||this._isOverAxis(this.positionAbs.top+this.offset.click.top,e.top,e.height),i="y"===this.options.axis||this._isOverAxis(this.positionAbs.left+this.offset.click.left,e.left,e.width),s=t&&i,n=this._getDragVerticalDirection(),a=this._getDragHorizontalDirection();return s?this.floating?a&&"right"===a||"down"===n?2:1:n&&("down"===n?2:1):!1},_intersectsWithSides:function(e){var t=this._isOverAxis(this.positionAbs.top+this.offset.click.top,e.top+e.height/2,e.height),i=this._isOverAxis(this.positionAbs.left+this.offset.click.left,e.left+e.width/2,e.width),s=this._getDragVerticalDirection(),n=this._getDragHorizontalDirection();return this.floating&&n?"right"===n&&i||"left"===n&&!i:s&&("down"===s&&t||"up"===s&&!t)},_getDragVerticalDirection:function(){var e=this.positionAbs.top-this.lastPositionAbs.top;return 0!==e&&(e>0?"down":"up")},_getDragHorizontalDirection:function(){var e=this.positionAbs.left-this.lastPositionAbs.left;return 0!==e&&(e>0?"right":"left")},refresh:function(e){return this._refreshItems(e),this._setHandleClassName(),this.refreshPositions(),this},_connectWith:function(){var e=this.options;return e.connectWith.constructor===String?[e.connectWith]:e.connectWith},_getItemsAsjQuery:function(t){function i(){r.push(this)}var s,n,a,o,r=[],h=[],l=this._connectWith();if(l&&t)for(s=l.length-1;s>=0;s--)for(a=e(l[s],this.document[0]),n=a.length-1;n>=0;n--)o=e.data(a[n],this.widgetFullName),o&&o!==this&&!o.options.disabled&&h.push([e.isFunction(o.options.items)?o.options.items.call(o.element):e(o.options.items,o.element).not(".ui-sortable-helper").not(".ui-sortable-placeholder"),o]);for(h.push([e.isFunction(this.options.items)?this.options.items.call(this.element,null,{options:this.options,item:this.currentItem}):e(this.options.items,this.element).not(".ui-sortable-helper").not(".ui-sortable-placeholder"),this]),s=h.length-1;s>=0;s--)h[s][0].each(i);return e(r)},_removeCurrentsFromItems:function(){var t=this.currentItem.find(":data("+this.widgetName+"-item)");this.items=e.grep(this.items,function(e){for(var i=0;t.length>i;i++)if(t[i]===e.item[0])return!1;return!0})},_refreshItems:function(t){this.items=[],this.containers=[this];var i,s,n,a,o,r,h,l,u=this.items,d=[[e.isFunction(this.options.items)?this.options.items.call(this.element[0],t,{item:this.currentItem}):e(this.options.items,this.element),this]],c=this._connectWith();if(c&&this.ready)for(i=c.length-1;i>=0;i--)for(n=e(c[i],this.document[0]),s=n.length-1;s>=0;s--)a=e.data(n[s],this.widgetFullName),a&&a!==this&&!a.options.disabled&&(d.push([e.isFunction(a.options.items)?a.options.items.call(a.element[0],t,{item:this.currentItem}):e(a.options.items,a.element),a]),this.containers.push(a));for(i=d.length-1;i>=0;i--)for(o=d[i][1],r=d[i][0],s=0,l=r.length;l>s;s++)h=e(r[s]),h.data(this.widgetName+"-item",o),u.push({item:h,instance:o,width:0,height:0,left:0,top:0})},refreshPositions:function(t){this.floating=this.items.length?"x"===this.options.axis||this._isFloating(this.items[0].item):!1,this.offsetParent&&this.helper&&(this.offset.parent=this._getParentOffset());var i,s,n,a;for(i=this.items.length-1;i>=0;i--)s=this.items[i],s.instance!==this.currentContainer&&this.currentContainer&&s.item[0]!==this.currentItem[0]||(n=this.options.toleranceElement?e(this.options.toleranceElement,s.item):s.item,t||(s.width=n.outerWidth(),s.height=n.outerHeight()),a=n.offset(),s.left=a.left,s.top=a.top);if(this.options.custom&&this.options.custom.refreshContainers)this.options.custom.refreshContainers.call(this);else for(i=this.containers.length-1;i>=0;i--)a=this.containers[i].element.offset(),this.containers[i].containerCache.left=a.left,this.containers[i].containerCache.top=a.top,this.containers[i].containerCache.width=this.containers[i].element.outerWidth(),this.containers[i].containerCache.height=this.containers[i].element.outerHeight();return this},_createPlaceholder:function(t){t=t||this;var i,s=t.options;s.placeholder&&s.placeholder.constructor!==String||(i=s.placeholder,s.placeholder={element:function(){var s=t.currentItem[0].nodeName.toLowerCase(),n=e("<"+s+">",t.document[0]).addClass(i||t.currentItem[0].className+" ui-sortable-placeholder").removeClass("ui-sortable-helper");return"tbody"===s?t._createTrPlaceholder(t.currentItem.find("tr").eq(0),e("<tr>",t.document[0]).appendTo(n)):"tr"===s?t._createTrPlaceholder(t.currentItem,n):"img"===s&&n.attr("src",t.currentItem.attr("src")),i||n.css("visibility","hidden"),n},update:function(e,n){(!i||s.forcePlaceholderSize)&&(n.height()||n.height(t.currentItem.innerHeight()-parseInt(t.currentItem.css("paddingTop")||0,10)-parseInt(t.currentItem.css("paddingBottom")||0,10)),n.width()||n.width(t.currentItem.innerWidth()-parseInt(t.currentItem.css("paddingLeft")||0,10)-parseInt(t.currentItem.css("paddingRight")||0,10)))}}),t.placeholder=e(s.placeholder.element.call(t.element,t.currentItem)),t.currentItem.after(t.placeholder),s.placeholder.update(t,t.placeholder)},_createTrPlaceholder:function(t,i){var s=this;t.children().each(function(){e("<td>&#160;</td>",s.document[0]).attr("colspan",e(this).attr("colspan")||1).appendTo(i)})},_contactContainers:function(t){var i,s,n,a,o,r,h,l,u,d,c=null,p=null;for(i=this.containers.length-1;i>=0;i--)if(!e.contains(this.currentItem[0],this.containers[i].element[0]))if(this._intersectsWith(this.containers[i].containerCache)){if(c&&e.contains(this.containers[i].element[0],c.element[0]))continue;c=this.containers[i],p=i}else this.containers[i].containerCache.over&&(this.containers[i]._trigger("out",t,this._uiHash(this)),this.containers[i].containerCache.over=0);if(c)if(1===this.containers.length)this.containers[p].containerCache.over||(this.containers[p]._trigger("over",t,this._uiHash(this)),this.containers[p].containerCache.over=1);else{for(n=1e4,a=null,u=c.floating||this._isFloating(this.currentItem),o=u?"left":"top",r=u?"width":"height",d=u?"clientX":"clientY",s=this.items.length-1;s>=0;s--)e.contains(this.containers[p].element[0],this.items[s].item[0])&&this.items[s].item[0]!==this.currentItem[0]&&(h=this.items[s].item.offset()[o],l=!1,t[d]-h>this.items[s][r]/2&&(l=!0),n>Math.abs(t[d]-h)&&(n=Math.abs(t[d]-h),a=this.items[s],this.direction=l?"up":"down"));if(!a&&!this.options.dropOnEmpty)return;if(this.currentContainer===this.containers[p])return this.currentContainer.containerCache.over||(this.containers[p]._trigger("over",t,this._uiHash()),this.currentContainer.containerCache.over=1),void 0;a?this._rearrange(t,a,null,!0):this._rearrange(t,null,this.containers[p].element,!0),this._trigger("change",t,this._uiHash()),this.containers[p]._trigger("change",t,this._uiHash(this)),this.currentContainer=this.containers[p],this.options.placeholder.update(this.currentContainer,this.placeholder),this.containers[p]._trigger("over",t,this._uiHash(this)),this.containers[p].containerCache.over=1}},_createHelper:function(t){var i=this.options,s=e.isFunction(i.helper)?e(i.helper.apply(this.element[0],[t,this.currentItem])):"clone"===i.helper?this.currentItem.clone():this.currentItem;return s.parents("body").length||e("parent"!==i.appendTo?i.appendTo:this.currentItem[0].parentNode)[0].appendChild(s[0]),s[0]===this.currentItem[0]&&(this._storedCSS={width:this.currentItem[0].style.width,height:this.currentItem[0].style.height,position:this.currentItem.css("position"),top:this.currentItem.css("top"),left:this.currentItem.css("left")}),(!s[0].style.width||i.forceHelperSize)&&s.width(this.currentItem.width()),(!s[0].style.height||i.forceHelperSize)&&s.height(this.currentItem.height()),s},_adjustOffsetFromHelper:function(t){"string"==typeof t&&(t=t.split(" ")),e.isArray(t)&&(t={left:+t[0],top:+t[1]||0}),"left"in t&&(this.offset.click.left=t.left+this.margins.left),"right"in t&&(this.offset.click.left=this.helperProportions.width-t.right+this.margins.left),"top"in t&&(this.offset.click.top=t.top+this.margins.top),"bottom"in t&&(this.offset.click.top=this.helperProportions.height-t.bottom+this.margins.top)},_getParentOffset:function(){this.offsetParent=this.helper.offsetParent();var t=this.offsetParent.offset();return"absolute"===this.cssPosition&&this.scrollParent[0]!==this.document[0]&&e.contains(this.scrollParent[0],this.offsetParent[0])&&(t.left+=this.scrollParent.scrollLeft(),t.top+=this.scrollParent.scrollTop()),(this.offsetParent[0]===this.document[0].body||this.offsetParent[0].tagName&&"html"===this.offsetParent[0].tagName.toLowerCase()&&e.ui.ie)&&(t={top:0,left:0}),{top:t.top+(parseInt(this.offsetParent.css("borderTopWidth"),10)||0),left:t.left+(parseInt(this.offsetParent.css("borderLeftWidth"),10)||0)}},_getRelativeOffset:function(){if("relative"===this.cssPosition){var e=this.currentItem.position();return{top:e.top-(parseInt(this.helper.css("top"),10)||0)+this.scrollParent.scrollTop(),left:e.left-(parseInt(this.helper.css("left"),10)||0)+this.scrollParent.scrollLeft()}}return{top:0,left:0}},_cacheMargins:function(){this.margins={left:parseInt(this.currentItem.css("marginLeft"),10)||0,top:parseInt(this.currentItem.css("marginTop"),10)||0}},_cacheHelperProportions:function(){this.helperProportions={width:this.helper.outerWidth(),height:this.helper.outerHeight()}},_setContainment:function(){var t,i,s,n=this.options;"parent"===n.containment&&(n.containment=this.helper[0].parentNode),("document"===n.containment||"window"===n.containment)&&(this.containment=[0-this.offset.relative.left-this.offset.parent.left,0-this.offset.relative.top-this.offset.parent.top,"document"===n.containment?this.document.width():this.window.width()-this.helperProportions.width-this.margins.left,("document"===n.containment?this.document.width():this.window.height()||this.document[0].body.parentNode.scrollHeight)-this.helperProportions.height-this.margins.top]),/^(document|window|parent)$/.test(n.containment)||(t=e(n.containment)[0],i=e(n.containment).offset(),s="hidden"!==e(t).css("overflow"),this.containment=[i.left+(parseInt(e(t).css("borderLeftWidth"),10)||0)+(parseInt(e(t).css("paddingLeft"),10)||0)-this.margins.left,i.top+(parseInt(e(t).css("borderTopWidth"),10)||0)+(parseInt(e(t).css("paddingTop"),10)||0)-this.margins.top,i.left+(s?Math.max(t.scrollWidth,t.offsetWidth):t.offsetWidth)-(parseInt(e(t).css("borderLeftWidth"),10)||0)-(parseInt(e(t).css("paddingRight"),10)||0)-this.helperProportions.width-this.margins.left,i.top+(s?Math.max(t.scrollHeight,t.offsetHeight):t.offsetHeight)-(parseInt(e(t).css("borderTopWidth"),10)||0)-(parseInt(e(t).css("paddingBottom"),10)||0)-this.helperProportions.height-this.margins.top])},_convertPositionTo:function(t,i){i||(i=this.position);var s="absolute"===t?1:-1,n="absolute"!==this.cssPosition||this.scrollParent[0]!==this.document[0]&&e.contains(this.scrollParent[0],this.offsetParent[0])?this.scrollParent:this.offsetParent,a=/(html|body)/i.test(n[0].tagName);return{top:i.top+this.offset.relative.top*s+this.offset.parent.top*s-("fixed"===this.cssPosition?-this.scrollParent.scrollTop():a?0:n.scrollTop())*s,left:i.left+this.offset.relative.left*s+this.offset.parent.left*s-("fixed"===this.cssPosition?-this.scrollParent.scrollLeft():a?0:n.scrollLeft())*s}},_generatePosition:function(t){var i,s,n=this.options,a=t.pageX,o=t.pageY,r="absolute"!==this.cssPosition||this.scrollParent[0]!==this.document[0]&&e.contains(this.scrollParent[0],this.offsetParent[0])?this.scrollParent:this.offsetParent,h=/(html|body)/i.test(r[0].tagName);return"relative"!==this.cssPosition||this.scrollParent[0]!==this.document[0]&&this.scrollParent[0]!==this.offsetParent[0]||(this.offset.relative=this._getRelativeOffset()),this.originalPosition&&(this.containment&&(t.pageX-this.offset.click.left<this.containment[0]&&(a=this.containment[0]+this.offset.click.left),t.pageY-this.offset.click.top<this.containment[1]&&(o=this.containment[1]+this.offset.click.top),t.pageX-this.offset.click.left>this.containment[2]&&(a=this.containment[2]+this.offset.click.left),t.pageY-this.offset.click.top>this.containment[3]&&(o=this.containment[3]+this.offset.click.top)),n.grid&&(i=this.originalPageY+Math.round((o-this.originalPageY)/n.grid[1])*n.grid[1],o=this.containment?i-this.offset.click.top>=this.containment[1]&&i-this.offset.click.top<=this.containment[3]?i:i-this.offset.click.top>=this.containment[1]?i-n.grid[1]:i+n.grid[1]:i,s=this.originalPageX+Math.round((a-this.originalPageX)/n.grid[0])*n.grid[0],a=this.containment?s-this.offset.click.left>=this.containment[0]&&s-this.offset.click.left<=this.containment[2]?s:s-this.offset.click.left>=this.containment[0]?s-n.grid[0]:s+n.grid[0]:s)),{top:o-this.offset.click.top-this.offset.relative.top-this.offset.parent.top+("fixed"===this.cssPosition?-this.scrollParent.scrollTop():h?0:r.scrollTop()),left:a-this.offset.click.left-this.offset.relative.left-this.offset.parent.left+("fixed"===this.cssPosition?-this.scrollParent.scrollLeft():h?0:r.scrollLeft())}},_rearrange:function(e,t,i,s){i?i[0].appendChild(this.placeholder[0]):t.item[0].parentNode.insertBefore(this.placeholder[0],"down"===this.direction?t.item[0]:t.item[0].nextSibling),this.counter=this.counter?++this.counter:1;var n=this.counter;this._delay(function(){n===this.counter&&this.refreshPositions(!s)})},_clear:function(e,t){function i(e,t,i){return function(s){i._trigger(e,s,t._uiHash(t))}}this.reverting=!1;var s,n=[];if(!this._noFinalSort&&this.currentItem.parent().length&&this.placeholder.before(this.currentItem),this._noFinalSort=null,this.helper[0]===this.currentItem[0]){for(s in this._storedCSS)("auto"===this._storedCSS[s]||"static"===this._storedCSS[s])&&(this._storedCSS[s]="");this.currentItem.css(this._storedCSS).removeClass("ui-sortable-helper")}else this.currentItem.show();for(this.fromOutside&&!t&&n.push(function(e){this._trigger("receive",e,this._uiHash(this.fromOutside))}),!this.fromOutside&&this.domPosition.prev===this.currentItem.prev().not(".ui-sortable-helper")[0]&&this.domPosition.parent===this.currentItem.parent()[0]||t||n.push(function(e){this._trigger("update",e,this._uiHash())}),this!==this.currentContainer&&(t||(n.push(function(e){this._trigger("remove",e,this._uiHash())}),n.push(function(e){return function(t){e._trigger("receive",t,this._uiHash(this))}}.call(this,this.currentContainer)),n.push(function(e){return function(t){e._trigger("update",t,this._uiHash(this))}}.call(this,this.currentContainer)))),s=this.containers.length-1;s>=0;s--)t||n.push(i("deactivate",this,this.containers[s])),this.containers[s].containerCache.over&&(n.push(i("out",this,this.containers[s])),this.containers[s].containerCache.over=0);if(this.storedCursor&&(this.document.find("body").css("cursor",this.storedCursor),this.storedStylesheet.remove()),this._storedOpacity&&this.helper.css("opacity",this._storedOpacity),this._storedZIndex&&this.helper.css("zIndex","auto"===this._storedZIndex?"":this._storedZIndex),this.dragging=!1,t||this._trigger("beforeStop",e,this._uiHash()),this.placeholder[0].parentNode.removeChild(this.placeholder[0]),this.cancelHelperRemoval||(this.helper[0]!==this.currentItem[0]&&this.helper.remove(),this.helper=null),!t){for(s=0;n.length>s;s++)n[s].call(this,e);this._trigger("stop",e,this._uiHash())}return this.fromOutside=!1,!this.cancelHelperRemoval},_trigger:function(){e.Widget.prototype._trigger.apply(this,arguments)===!1&&this.cancel()},_uiHash:function(t){var i=t||this;return{helper:i.helper,placeholder:i.placeholder||e([]),position:i.position,originalPosition:i.originalPosition,offset:i.positionAbs,item:i.currentItem,sender:t?t.element:null}}}),e.widget("ui.accordion",{version:"1.11.4",options:{active:0,animate:{},collapsible:!1,event:"click",header:"> li > :first-child,> :not(li):even",heightStyle:"auto",icons:{activeHeader:"ui-icon-triangle-1-s",header:"ui-icon-triangle-1-e"},activate:null,beforeActivate:null},hideProps:{borderTopWidth:"hide",borderBottomWidth:"hide",paddingTop:"hide",paddingBottom:"hide",height:"hide"},showProps:{borderTopWidth:"show",borderBottomWidth:"show",paddingTop:"show",paddingBottom:"show",height:"show"},_create:function(){var t=this.options;this.prevShow=this.prevHide=e(),this.element.addClass("ui-accordion ui-widget ui-helper-reset").attr("role","tablist"),t.collapsible||t.active!==!1&&null!=t.active||(t.active=0),this._processPanels(),0>t.active&&(t.active+=this.headers.length),this._refresh()},_getCreateEventData:function(){return{header:this.active,panel:this.active.length?this.active.next():e()}},_createIcons:function(){var t=this.options.icons;t&&(e("<span>").addClass("ui-accordion-header-icon ui-icon "+t.header).prependTo(this.headers),this.active.children(".ui-accordion-header-icon").removeClass(t.header).addClass(t.activeHeader),this.headers.addClass("ui-accordion-icons"))},_destroyIcons:function(){this.headers.removeClass("ui-accordion-icons").children(".ui-accordion-header-icon").remove()},_destroy:function(){var e;this.element.removeClass("ui-accordion ui-widget ui-helper-reset").removeAttr("role"),this.headers.removeClass("ui-accordion-header ui-accordion-header-active ui-state-default ui-corner-all ui-state-active ui-state-disabled ui-corner-top").removeAttr("role").removeAttr("aria-expanded").removeAttr("aria-selected").removeAttr("aria-controls").removeAttr("tabIndex").removeUniqueId(),this._destroyIcons(),e=this.headers.next().removeClass("ui-helper-reset ui-widget-content ui-corner-bottom ui-accordion-content ui-accordion-content-active ui-state-disabled").css("display","").removeAttr("role").removeAttr("aria-hidden").removeAttr("aria-labelledby").removeUniqueId(),"content"!==this.options.heightStyle&&e.css("height","")},_setOption:function(e,t){return"active"===e?(this._activate(t),void 0):("event"===e&&(this.options.event&&this._off(this.headers,this.options.event),this._setupEvents(t)),this._super(e,t),"collapsible"!==e||t||this.options.active!==!1||this._activate(0),"icons"===e&&(this._destroyIcons(),t&&this._createIcons()),"disabled"===e&&(this.element.toggleClass("ui-state-disabled",!!t).attr("aria-disabled",t),this.headers.add(this.headers.next()).toggleClass("ui-state-disabled",!!t)),void 0)},_keydown:function(t){if(!t.altKey&&!t.ctrlKey){var i=e.ui.keyCode,s=this.headers.length,n=this.headers.index(t.target),a=!1;switch(t.keyCode){case i.RIGHT:case i.DOWN:a=this.headers[(n+1)%s];break;case i.LEFT:case i.UP:a=this.headers[(n-1+s)%s];break;case i.SPACE:case i.ENTER:this._eventHandler(t);break;case i.HOME:a=this.headers[0];break;case i.END:a=this.headers[s-1]}a&&(e(t.target).attr("tabIndex",-1),e(a).attr("tabIndex",0),a.focus(),t.preventDefault())}},_panelKeyDown:function(t){t.keyCode===e.ui.keyCode.UP&&t.ctrlKey&&e(t.currentTarget).prev().focus()},refresh:function(){var t=this.options;this._processPanels(),t.active===!1&&t.collapsible===!0||!this.headers.length?(t.active=!1,this.active=e()):t.active===!1?this._activate(0):this.active.length&&!e.contains(this.element[0],this.active[0])?this.headers.length===this.headers.find(".ui-state-disabled").length?(t.active=!1,this.active=e()):this._activate(Math.max(0,t.active-1)):t.active=this.headers.index(this.active),this._destroyIcons(),this._refresh()},_processPanels:function(){var e=this.headers,t=this.panels;this.headers=this.element.find(this.options.header).addClass("ui-accordion-header ui-state-default ui-corner-all"),this.panels=this.headers.next().addClass("ui-accordion-content ui-helper-reset ui-widget-content ui-corner-bottom").filter(":not(.ui-accordion-content-active)").hide(),t&&(this._off(e.not(this.headers)),this._off(t.not(this.panels)))},_refresh:function(){var t,i=this.options,s=i.heightStyle,n=this.element.parent();this.active=this._findActive(i.active).addClass("ui-accordion-header-active ui-state-active ui-corner-top").removeClass("ui-corner-all"),this.active.next().addClass("ui-accordion-content-active").show(),this.headers.attr("role","tab").each(function(){var t=e(this),i=t.uniqueId().attr("id"),s=t.next(),n=s.uniqueId().attr("id");t.attr("aria-controls",n),s.attr("aria-labelledby",i)}).next().attr("role","tabpanel"),this.headers.not(this.active).attr({"aria-selected":"false","aria-expanded":"false",tabIndex:-1}).next().attr({"aria-hidden":"true"}).hide(),this.active.length?this.active.attr({"aria-selected":"true","aria-expanded":"true",tabIndex:0}).next().attr({"aria-hidden":"false"}):this.headers.eq(0).attr("tabIndex",0),this._createIcons(),this._setupEvents(i.event),"fill"===s?(t=n.height(),this.element.siblings(":visible").each(function(){var i=e(this),s=i.css("position");"absolute"!==s&&"fixed"!==s&&(t-=i.outerHeight(!0))}),this.headers.each(function(){t-=e(this).outerHeight(!0)}),this.headers.next().each(function(){e(this).height(Math.max(0,t-e(this).innerHeight()+e(this).height()))}).css("overflow","auto")):"auto"===s&&(t=0,this.headers.next().each(function(){t=Math.max(t,e(this).css("height","").height())}).height(t))},_activate:function(t){var i=this._findActive(t)[0];i!==this.active[0]&&(i=i||this.active[0],this._eventHandler({target:i,currentTarget:i,preventDefault:e.noop}))},_findActive:function(t){return"number"==typeof t?this.headers.eq(t):e()},_setupEvents:function(t){var i={keydown:"_keydown"};t&&e.each(t.split(" "),function(e,t){i[t]="_eventHandler"}),this._off(this.headers.add(this.headers.next())),this._on(this.headers,i),this._on(this.headers.next(),{keydown:"_panelKeyDown"}),this._hoverable(this.headers),this._focusable(this.headers)},_eventHandler:function(t){var i=this.options,s=this.active,n=e(t.currentTarget),a=n[0]===s[0],o=a&&i.collapsible,r=o?e():n.next(),h=s.next(),l={oldHeader:s,oldPanel:h,newHeader:o?e():n,newPanel:r};
t.preventDefault(),a&&!i.collapsible||this._trigger("beforeActivate",t,l)===!1||(i.active=o?!1:this.headers.index(n),this.active=a?e():n,this._toggle(l),s.removeClass("ui-accordion-header-active ui-state-active"),i.icons&&s.children(".ui-accordion-header-icon").removeClass(i.icons.activeHeader).addClass(i.icons.header),a||(n.removeClass("ui-corner-all").addClass("ui-accordion-header-active ui-state-active ui-corner-top"),i.icons&&n.children(".ui-accordion-header-icon").removeClass(i.icons.header).addClass(i.icons.activeHeader),n.next().addClass("ui-accordion-content-active")))},_toggle:function(t){var i=t.newPanel,s=this.prevShow.length?this.prevShow:t.oldPanel;this.prevShow.add(this.prevHide).stop(!0,!0),this.prevShow=i,this.prevHide=s,this.options.animate?this._animate(i,s,t):(s.hide(),i.show(),this._toggleComplete(t)),s.attr({"aria-hidden":"true"}),s.prev().attr({"aria-selected":"false","aria-expanded":"false"}),i.length&&s.length?s.prev().attr({tabIndex:-1,"aria-expanded":"false"}):i.length&&this.headers.filter(function(){return 0===parseInt(e(this).attr("tabIndex"),10)}).attr("tabIndex",-1),i.attr("aria-hidden","false").prev().attr({"aria-selected":"true","aria-expanded":"true",tabIndex:0})},_animate:function(e,t,i){var s,n,a,o=this,r=0,h=e.css("box-sizing"),l=e.length&&(!t.length||e.index()<t.index()),u=this.options.animate||{},d=l&&u.down||u,c=function(){o._toggleComplete(i)};return"number"==typeof d&&(a=d),"string"==typeof d&&(n=d),n=n||d.easing||u.easing,a=a||d.duration||u.duration,t.length?e.length?(s=e.show().outerHeight(),t.animate(this.hideProps,{duration:a,easing:n,step:function(e,t){t.now=Math.round(e)}}),e.hide().animate(this.showProps,{duration:a,easing:n,complete:c,step:function(e,i){i.now=Math.round(e),"height"!==i.prop?"content-box"===h&&(r+=i.now):"content"!==o.options.heightStyle&&(i.now=Math.round(s-t.outerHeight()-r),r=0)}}),void 0):t.animate(this.hideProps,a,n,c):e.animate(this.showProps,a,n,c)},_toggleComplete:function(e){var t=e.oldPanel;t.removeClass("ui-accordion-content-active").prev().removeClass("ui-corner-top").addClass("ui-corner-all"),t.length&&(t.parent()[0].className=t.parent()[0].className),this._trigger("activate",null,e)}}),e.widget("ui.menu",{version:"1.11.4",defaultElement:"<ul>",delay:300,options:{icons:{submenu:"ui-icon-carat-1-e"},items:"> *",menus:"ul",position:{my:"left-1 top",at:"right top"},role:"menu",blur:null,focus:null,select:null},_create:function(){this.activeMenu=this.element,this.mouseHandled=!1,this.element.uniqueId().addClass("ui-menu ui-widget ui-widget-content").toggleClass("ui-menu-icons",!!this.element.find(".ui-icon").length).attr({role:this.options.role,tabIndex:0}),this.options.disabled&&this.element.addClass("ui-state-disabled").attr("aria-disabled","true"),this._on({"mousedown .ui-menu-item":function(e){e.preventDefault()},"click .ui-menu-item":function(t){var i=e(t.target);!this.mouseHandled&&i.not(".ui-state-disabled").length&&(this.select(t),t.isPropagationStopped()||(this.mouseHandled=!0),i.has(".ui-menu").length?this.expand(t):!this.element.is(":focus")&&e(this.document[0].activeElement).closest(".ui-menu").length&&(this.element.trigger("focus",[!0]),this.active&&1===this.active.parents(".ui-menu").length&&clearTimeout(this.timer)))},"mouseenter .ui-menu-item":function(t){if(!this.previousFilter){var i=e(t.currentTarget);i.siblings(".ui-state-active").removeClass("ui-state-active"),this.focus(t,i)}},mouseleave:"collapseAll","mouseleave .ui-menu":"collapseAll",focus:function(e,t){var i=this.active||this.element.find(this.options.items).eq(0);t||this.focus(e,i)},blur:function(t){this._delay(function(){e.contains(this.element[0],this.document[0].activeElement)||this.collapseAll(t)})},keydown:"_keydown"}),this.refresh(),this._on(this.document,{click:function(e){this._closeOnDocumentClick(e)&&this.collapseAll(e),this.mouseHandled=!1}})},_destroy:function(){this.element.removeAttr("aria-activedescendant").find(".ui-menu").addBack().removeClass("ui-menu ui-widget ui-widget-content ui-menu-icons ui-front").removeAttr("role").removeAttr("tabIndex").removeAttr("aria-labelledby").removeAttr("aria-expanded").removeAttr("aria-hidden").removeAttr("aria-disabled").removeUniqueId().show(),this.element.find(".ui-menu-item").removeClass("ui-menu-item").removeAttr("role").removeAttr("aria-disabled").removeUniqueId().removeClass("ui-state-hover").removeAttr("tabIndex").removeAttr("role").removeAttr("aria-haspopup").children().each(function(){var t=e(this);t.data("ui-menu-submenu-carat")&&t.remove()}),this.element.find(".ui-menu-divider").removeClass("ui-menu-divider ui-widget-content")},_keydown:function(t){var i,s,n,a,o=!0;switch(t.keyCode){case e.ui.keyCode.PAGE_UP:this.previousPage(t);break;case e.ui.keyCode.PAGE_DOWN:this.nextPage(t);break;case e.ui.keyCode.HOME:this._move("first","first",t);break;case e.ui.keyCode.END:this._move("last","last",t);break;case e.ui.keyCode.UP:this.previous(t);break;case e.ui.keyCode.DOWN:this.next(t);break;case e.ui.keyCode.LEFT:this.collapse(t);break;case e.ui.keyCode.RIGHT:this.active&&!this.active.is(".ui-state-disabled")&&this.expand(t);break;case e.ui.keyCode.ENTER:case e.ui.keyCode.SPACE:this._activate(t);break;case e.ui.keyCode.ESCAPE:this.collapse(t);break;default:o=!1,s=this.previousFilter||"",n=String.fromCharCode(t.keyCode),a=!1,clearTimeout(this.filterTimer),n===s?a=!0:n=s+n,i=this._filterMenuItems(n),i=a&&-1!==i.index(this.active.next())?this.active.nextAll(".ui-menu-item"):i,i.length||(n=String.fromCharCode(t.keyCode),i=this._filterMenuItems(n)),i.length?(this.focus(t,i),this.previousFilter=n,this.filterTimer=this._delay(function(){delete this.previousFilter},1e3)):delete this.previousFilter}o&&t.preventDefault()},_activate:function(e){this.active.is(".ui-state-disabled")||(this.active.is("[aria-haspopup='true']")?this.expand(e):this.select(e))},refresh:function(){var t,i,s=this,n=this.options.icons.submenu,a=this.element.find(this.options.menus);this.element.toggleClass("ui-menu-icons",!!this.element.find(".ui-icon").length),a.filter(":not(.ui-menu)").addClass("ui-menu ui-widget ui-widget-content ui-front").hide().attr({role:this.options.role,"aria-hidden":"true","aria-expanded":"false"}).each(function(){var t=e(this),i=t.parent(),s=e("<span>").addClass("ui-menu-icon ui-icon "+n).data("ui-menu-submenu-carat",!0);i.attr("aria-haspopup","true").prepend(s),t.attr("aria-labelledby",i.attr("id"))}),t=a.add(this.element),i=t.find(this.options.items),i.not(".ui-menu-item").each(function(){var t=e(this);s._isDivider(t)&&t.addClass("ui-widget-content ui-menu-divider")}),i.not(".ui-menu-item, .ui-menu-divider").addClass("ui-menu-item").uniqueId().attr({tabIndex:-1,role:this._itemRole()}),i.filter(".ui-state-disabled").attr("aria-disabled","true"),this.active&&!e.contains(this.element[0],this.active[0])&&this.blur()},_itemRole:function(){return{menu:"menuitem",listbox:"option"}[this.options.role]},_setOption:function(e,t){"icons"===e&&this.element.find(".ui-menu-icon").removeClass(this.options.icons.submenu).addClass(t.submenu),"disabled"===e&&this.element.toggleClass("ui-state-disabled",!!t).attr("aria-disabled",t),this._super(e,t)},focus:function(e,t){var i,s;this.blur(e,e&&"focus"===e.type),this._scrollIntoView(t),this.active=t.first(),s=this.active.addClass("ui-state-focus").removeClass("ui-state-active"),this.options.role&&this.element.attr("aria-activedescendant",s.attr("id")),this.active.parent().closest(".ui-menu-item").addClass("ui-state-active"),e&&"keydown"===e.type?this._close():this.timer=this._delay(function(){this._close()},this.delay),i=t.children(".ui-menu"),i.length&&e&&/^mouse/.test(e.type)&&this._startOpening(i),this.activeMenu=t.parent(),this._trigger("focus",e,{item:t})},_scrollIntoView:function(t){var i,s,n,a,o,r;this._hasScroll()&&(i=parseFloat(e.css(this.activeMenu[0],"borderTopWidth"))||0,s=parseFloat(e.css(this.activeMenu[0],"paddingTop"))||0,n=t.offset().top-this.activeMenu.offset().top-i-s,a=this.activeMenu.scrollTop(),o=this.activeMenu.height(),r=t.outerHeight(),0>n?this.activeMenu.scrollTop(a+n):n+r>o&&this.activeMenu.scrollTop(a+n-o+r))},blur:function(e,t){t||clearTimeout(this.timer),this.active&&(this.active.removeClass("ui-state-focus"),this.active=null,this._trigger("blur",e,{item:this.active}))},_startOpening:function(e){clearTimeout(this.timer),"true"===e.attr("aria-hidden")&&(this.timer=this._delay(function(){this._close(),this._open(e)},this.delay))},_open:function(t){var i=e.extend({of:this.active},this.options.position);clearTimeout(this.timer),this.element.find(".ui-menu").not(t.parents(".ui-menu")).hide().attr("aria-hidden","true"),t.show().removeAttr("aria-hidden").attr("aria-expanded","true").position(i)},collapseAll:function(t,i){clearTimeout(this.timer),this.timer=this._delay(function(){var s=i?this.element:e(t&&t.target).closest(this.element.find(".ui-menu"));s.length||(s=this.element),this._close(s),this.blur(t),this.activeMenu=s},this.delay)},_close:function(e){e||(e=this.active?this.active.parent():this.element),e.find(".ui-menu").hide().attr("aria-hidden","true").attr("aria-expanded","false").end().find(".ui-state-active").not(".ui-state-focus").removeClass("ui-state-active")},_closeOnDocumentClick:function(t){return!e(t.target).closest(".ui-menu").length},_isDivider:function(e){return!/[^\-\u2014\u2013\s]/.test(e.text())},collapse:function(e){var t=this.active&&this.active.parent().closest(".ui-menu-item",this.element);t&&t.length&&(this._close(),this.focus(e,t))},expand:function(e){var t=this.active&&this.active.children(".ui-menu ").find(this.options.items).first();t&&t.length&&(this._open(t.parent()),this._delay(function(){this.focus(e,t)}))},next:function(e){this._move("next","first",e)},previous:function(e){this._move("prev","last",e)},isFirstItem:function(){return this.active&&!this.active.prevAll(".ui-menu-item").length},isLastItem:function(){return this.active&&!this.active.nextAll(".ui-menu-item").length},_move:function(e,t,i){var s;this.active&&(s="first"===e||"last"===e?this.active["first"===e?"prevAll":"nextAll"](".ui-menu-item").eq(-1):this.active[e+"All"](".ui-menu-item").eq(0)),s&&s.length&&this.active||(s=this.activeMenu.find(this.options.items)[t]()),this.focus(i,s)},nextPage:function(t){var i,s,n;return this.active?(this.isLastItem()||(this._hasScroll()?(s=this.active.offset().top,n=this.element.height(),this.active.nextAll(".ui-menu-item").each(function(){return i=e(this),0>i.offset().top-s-n}),this.focus(t,i)):this.focus(t,this.activeMenu.find(this.options.items)[this.active?"last":"first"]())),void 0):(this.next(t),void 0)},previousPage:function(t){var i,s,n;return this.active?(this.isFirstItem()||(this._hasScroll()?(s=this.active.offset().top,n=this.element.height(),this.active.prevAll(".ui-menu-item").each(function(){return i=e(this),i.offset().top-s+n>0}),this.focus(t,i)):this.focus(t,this.activeMenu.find(this.options.items).first())),void 0):(this.next(t),void 0)},_hasScroll:function(){return this.element.outerHeight()<this.element.prop("scrollHeight")},select:function(t){this.active=this.active||e(t.target).closest(".ui-menu-item");var i={item:this.active};this.active.has(".ui-menu").length||this.collapseAll(t,!0),this._trigger("select",t,i)},_filterMenuItems:function(t){var i=t.replace(/[\-\[\]{}()*+?.,\\\^$|#\s]/g,"\\$&"),s=RegExp("^"+i,"i");return this.activeMenu.find(this.options.items).filter(".ui-menu-item").filter(function(){return s.test(e.trim(e(this).text()))})}}),e.widget("ui.autocomplete",{version:"1.11.4",defaultElement:"<input>",options:{appendTo:null,autoFocus:!1,delay:300,minLength:1,position:{my:"left top",at:"left bottom",collision:"none"},source:null,change:null,close:null,focus:null,open:null,response:null,search:null,select:null},requestIndex:0,pending:0,_create:function(){var t,i,s,n=this.element[0].nodeName.toLowerCase(),a="textarea"===n,o="input"===n;this.isMultiLine=a?!0:o?!1:this.element.prop("isContentEditable"),this.valueMethod=this.element[a||o?"val":"text"],this.isNewMenu=!0,this.element.addClass("ui-autocomplete-input").attr("autocomplete","off"),this._on(this.element,{keydown:function(n){if(this.element.prop("readOnly"))return t=!0,s=!0,i=!0,void 0;t=!1,s=!1,i=!1;var a=e.ui.keyCode;switch(n.keyCode){case a.PAGE_UP:t=!0,this._move("previousPage",n);break;case a.PAGE_DOWN:t=!0,this._move("nextPage",n);break;case a.UP:t=!0,this._keyEvent("previous",n);break;case a.DOWN:t=!0,this._keyEvent("next",n);break;case a.ENTER:this.menu.active&&(t=!0,n.preventDefault(),this.menu.select(n));break;case a.TAB:this.menu.active&&this.menu.select(n);break;case a.ESCAPE:this.menu.element.is(":visible")&&(this.isMultiLine||this._value(this.term),this.close(n),n.preventDefault());break;default:i=!0,this._searchTimeout(n)}},keypress:function(s){if(t)return t=!1,(!this.isMultiLine||this.menu.element.is(":visible"))&&s.preventDefault(),void 0;if(!i){var n=e.ui.keyCode;switch(s.keyCode){case n.PAGE_UP:this._move("previousPage",s);break;case n.PAGE_DOWN:this._move("nextPage",s);break;case n.UP:this._keyEvent("previous",s);break;case n.DOWN:this._keyEvent("next",s)}}},input:function(e){return s?(s=!1,e.preventDefault(),void 0):(this._searchTimeout(e),void 0)},focus:function(){this.selectedItem=null,this.previous=this._value()},blur:function(e){return this.cancelBlur?(delete this.cancelBlur,void 0):(clearTimeout(this.searching),this.close(e),this._change(e),void 0)}}),this._initSource(),this.menu=e("<ul>").addClass("ui-autocomplete ui-front").appendTo(this._appendTo()).menu({role:null}).hide().menu("instance"),this._on(this.menu.element,{mousedown:function(t){t.preventDefault(),this.cancelBlur=!0,this._delay(function(){delete this.cancelBlur});var i=this.menu.element[0];e(t.target).closest(".ui-menu-item").length||this._delay(function(){var t=this;this.document.one("mousedown",function(s){s.target===t.element[0]||s.target===i||e.contains(i,s.target)||t.close()})})},menufocus:function(t,i){var s,n;return this.isNewMenu&&(this.isNewMenu=!1,t.originalEvent&&/^mouse/.test(t.originalEvent.type))?(this.menu.blur(),this.document.one("mousemove",function(){e(t.target).trigger(t.originalEvent)}),void 0):(n=i.item.data("ui-autocomplete-item"),!1!==this._trigger("focus",t,{item:n})&&t.originalEvent&&/^key/.test(t.originalEvent.type)&&this._value(n.value),s=i.item.attr("aria-label")||n.value,s&&e.trim(s).length&&(this.liveRegion.children().hide(),e("<div>").text(s).appendTo(this.liveRegion)),void 0)},menuselect:function(e,t){var i=t.item.data("ui-autocomplete-item"),s=this.previous;this.element[0]!==this.document[0].activeElement&&(this.element.focus(),this.previous=s,this._delay(function(){this.previous=s,this.selectedItem=i})),!1!==this._trigger("select",e,{item:i})&&this._value(i.value),this.term=this._value(),this.close(e),this.selectedItem=i}}),this.liveRegion=e("<span>",{role:"status","aria-live":"assertive","aria-relevant":"additions"}).addClass("ui-helper-hidden-accessible").appendTo(this.document[0].body),this._on(this.window,{beforeunload:function(){this.element.removeAttr("autocomplete")}})},_destroy:function(){clearTimeout(this.searching),this.element.removeClass("ui-autocomplete-input").removeAttr("autocomplete"),this.menu.element.remove(),this.liveRegion.remove()},_setOption:function(e,t){this._super(e,t),"source"===e&&this._initSource(),"appendTo"===e&&this.menu.element.appendTo(this._appendTo()),"disabled"===e&&t&&this.xhr&&this.xhr.abort()},_appendTo:function(){var t=this.options.appendTo;return t&&(t=t.jquery||t.nodeType?e(t):this.document.find(t).eq(0)),t&&t[0]||(t=this.element.closest(".ui-front")),t.length||(t=this.document[0].body),t},_initSource:function(){var t,i,s=this;e.isArray(this.options.source)?(t=this.options.source,this.source=function(i,s){s(e.ui.autocomplete.filter(t,i.term))}):"string"==typeof this.options.source?(i=this.options.source,this.source=function(t,n){s.xhr&&s.xhr.abort(),s.xhr=e.ajax({url:i,data:t,dataType:"json",success:function(e){n(e)},error:function(){n([])}})}):this.source=this.options.source},_searchTimeout:function(e){clearTimeout(this.searching),this.searching=this._delay(function(){var t=this.term===this._value(),i=this.menu.element.is(":visible"),s=e.altKey||e.ctrlKey||e.metaKey||e.shiftKey;(!t||t&&!i&&!s)&&(this.selectedItem=null,this.search(null,e))},this.options.delay)},search:function(e,t){return e=null!=e?e:this._value(),this.term=this._value(),e.length<this.options.minLength?this.close(t):this._trigger("search",t)!==!1?this._search(e):void 0},_search:function(e){this.pending++,this.element.addClass("ui-autocomplete-loading"),this.cancelSearch=!1,this.source({term:e},this._response())},_response:function(){var t=++this.requestIndex;return e.proxy(function(e){t===this.requestIndex&&this.__response(e),this.pending--,this.pending||this.element.removeClass("ui-autocomplete-loading")},this)},__response:function(e){e&&(e=this._normalize(e)),this._trigger("response",null,{content:e}),!this.options.disabled&&e&&e.length&&!this.cancelSearch?(this._suggest(e),this._trigger("open")):this._close()},close:function(e){this.cancelSearch=!0,this._close(e)},_close:function(e){this.menu.element.is(":visible")&&(this.menu.element.hide(),this.menu.blur(),this.isNewMenu=!0,this._trigger("close",e))},_change:function(e){this.previous!==this._value()&&this._trigger("change",e,{item:this.selectedItem})},_normalize:function(t){return t.length&&t[0].label&&t[0].value?t:e.map(t,function(t){return"string"==typeof t?{label:t,value:t}:e.extend({},t,{label:t.label||t.value,value:t.value||t.label})})},_suggest:function(t){var i=this.menu.element.empty();this._renderMenu(i,t),this.isNewMenu=!0,this.menu.refresh(),i.show(),this._resizeMenu(),i.position(e.extend({of:this.element},this.options.position)),this.options.autoFocus&&this.menu.next()},_resizeMenu:function(){var e=this.menu.element;e.outerWidth(Math.max(e.width("").outerWidth()+1,this.element.outerWidth()))},_renderMenu:function(t,i){var s=this;e.each(i,function(e,i){s._renderItemData(t,i)})},_renderItemData:function(e,t){return this._renderItem(e,t).data("ui-autocomplete-item",t)},_renderItem:function(t,i){return e("<li>").text(i.label).appendTo(t)},_move:function(e,t){return this.menu.element.is(":visible")?this.menu.isFirstItem()&&/^previous/.test(e)||this.menu.isLastItem()&&/^next/.test(e)?(this.isMultiLine||this._value(this.term),this.menu.blur(),void 0):(this.menu[e](t),void 0):(this.search(null,t),void 0)},widget:function(){return this.menu.element},_value:function(){return this.valueMethod.apply(this.element,arguments)},_keyEvent:function(e,t){(!this.isMultiLine||this.menu.element.is(":visible"))&&(this._move(e,t),t.preventDefault())}}),e.extend(e.ui.autocomplete,{escapeRegex:function(e){return e.replace(/[\-\[\]{}()*+?.,\\\^$|#\s]/g,"\\$&")},filter:function(t,i){var s=RegExp(e.ui.autocomplete.escapeRegex(i),"i");return e.grep(t,function(e){return s.test(e.label||e.value||e)})}}),e.widget("ui.autocomplete",e.ui.autocomplete,{options:{messages:{noResults:"No search results.",results:function(e){return e+(e>1?" results are":" result is")+" available, use up and down arrow keys to navigate."}}},__response:function(t){var i;this._superApply(arguments),this.options.disabled||this.cancelSearch||(i=t&&t.length?this.options.messages.results(t.length):this.options.messages.noResults,this.liveRegion.children().hide(),e("<div>").text(i).appendTo(this.liveRegion))}}),e.ui.autocomplete;var r,h="ui-button ui-widget ui-state-default ui-corner-all",l="ui-button-icons-only ui-button-icon-only ui-button-text-icons ui-button-text-icon-primary ui-button-text-icon-secondary ui-button-text-only",u=function(){var t=e(this);setTimeout(function(){t.find(":ui-button").button("refresh")},1)},d=function(t){var i=t.name,s=t.form,n=e([]);return i&&(i=i.replace(/'/g,"\\'"),n=s?e(s).find("[name='"+i+"'][type=radio]"):e("[name='"+i+"'][type=radio]",t.ownerDocument).filter(function(){return!this.form})),n};e.widget("ui.button",{version:"1.11.4",defaultElement:"<button>",options:{disabled:null,text:!0,label:null,icons:{primary:null,secondary:null}},_create:function(){this.element.closest("form").unbind("reset"+this.eventNamespace).bind("reset"+this.eventNamespace,u),"boolean"!=typeof this.options.disabled?this.options.disabled=!!this.element.prop("disabled"):this.element.prop("disabled",this.options.disabled),this._determineButtonType(),this.hasTitle=!!this.buttonElement.attr("title");var t=this,i=this.options,s="checkbox"===this.type||"radio"===this.type,n=s?"":"ui-state-active";null===i.label&&(i.label="input"===this.type?this.buttonElement.val():this.buttonElement.html()),this._hoverable(this.buttonElement),this.buttonElement.addClass(h).attr("role","button").bind("mouseenter"+this.eventNamespace,function(){i.disabled||this===r&&e(this).addClass("ui-state-active")}).bind("mouseleave"+this.eventNamespace,function(){i.disabled||e(this).removeClass(n)}).bind("click"+this.eventNamespace,function(e){i.disabled&&(e.preventDefault(),e.stopImmediatePropagation())}),this._on({focus:function(){this.buttonElement.addClass("ui-state-focus")},blur:function(){this.buttonElement.removeClass("ui-state-focus")}}),s&&this.element.bind("change"+this.eventNamespace,function(){t.refresh()}),"checkbox"===this.type?this.buttonElement.bind("click"+this.eventNamespace,function(){return i.disabled?!1:void 0}):"radio"===this.type?this.buttonElement.bind("click"+this.eventNamespace,function(){if(i.disabled)return!1;e(this).addClass("ui-state-active"),t.buttonElement.attr("aria-pressed","true");var s=t.element[0];d(s).not(s).map(function(){return e(this).button("widget")[0]}).removeClass("ui-state-active").attr("aria-pressed","false")}):(this.buttonElement.bind("mousedown"+this.eventNamespace,function(){return i.disabled?!1:(e(this).addClass("ui-state-active"),r=this,t.document.one("mouseup",function(){r=null}),void 0)}).bind("mouseup"+this.eventNamespace,function(){return i.disabled?!1:(e(this).removeClass("ui-state-active"),void 0)}).bind("keydown"+this.eventNamespace,function(t){return i.disabled?!1:((t.keyCode===e.ui.keyCode.SPACE||t.keyCode===e.ui.keyCode.ENTER)&&e(this).addClass("ui-state-active"),void 0)}).bind("keyup"+this.eventNamespace+" blur"+this.eventNamespace,function(){e(this).removeClass("ui-state-active")}),this.buttonElement.is("a")&&this.buttonElement.keyup(function(t){t.keyCode===e.ui.keyCode.SPACE&&e(this).click()})),this._setOption("disabled",i.disabled),this._resetButton()},_determineButtonType:function(){var e,t,i;this.type=this.element.is("[type=checkbox]")?"checkbox":this.element.is("[type=radio]")?"radio":this.element.is("input")?"input":"button","checkbox"===this.type||"radio"===this.type?(e=this.element.parents().last(),t="label[for='"+this.element.attr("id")+"']",this.buttonElement=e.find(t),this.buttonElement.length||(e=e.length?e.siblings():this.element.siblings(),this.buttonElement=e.filter(t),this.buttonElement.length||(this.buttonElement=e.find(t))),this.element.addClass("ui-helper-hidden-accessible"),i=this.element.is(":checked"),i&&this.buttonElement.addClass("ui-state-active"),this.buttonElement.prop("aria-pressed",i)):this.buttonElement=this.element},widget:function(){return this.buttonElement},_destroy:function(){this.element.removeClass("ui-helper-hidden-accessible"),this.buttonElement.removeClass(h+" ui-state-active "+l).removeAttr("role").removeAttr("aria-pressed").html(this.buttonElement.find(".ui-button-text").html()),this.hasTitle||this.buttonElement.removeAttr("title")},_setOption:function(e,t){return this._super(e,t),"disabled"===e?(this.widget().toggleClass("ui-state-disabled",!!t),this.element.prop("disabled",!!t),t&&("checkbox"===this.type||"radio"===this.type?this.buttonElement.removeClass("ui-state-focus"):this.buttonElement.removeClass("ui-state-focus ui-state-active")),void 0):(this._resetButton(),void 0)},refresh:function(){var t=this.element.is("input, button")?this.element.is(":disabled"):this.element.hasClass("ui-button-disabled");t!==this.options.disabled&&this._setOption("disabled",t),"radio"===this.type?d(this.element[0]).each(function(){e(this).is(":checked")?e(this).button("widget").addClass("ui-state-active").attr("aria-pressed","true"):e(this).button("widget").removeClass("ui-state-active").attr("aria-pressed","false")}):"checkbox"===this.type&&(this.element.is(":checked")?this.buttonElement.addClass("ui-state-active").attr("aria-pressed","true"):this.buttonElement.removeClass("ui-state-active").attr("aria-pressed","false"))},_resetButton:function(){if("input"===this.type)return this.options.label&&this.element.val(this.options.label),void 0;var t=this.buttonElement.removeClass(l),i=e("<span></span>",this.document[0]).addClass("ui-button-text").html(this.options.label).appendTo(t.empty()).text(),s=this.options.icons,n=s.primary&&s.secondary,a=[];s.primary||s.secondary?(this.options.text&&a.push("ui-button-text-icon"+(n?"s":s.primary?"-primary":"-secondary")),s.primary&&t.prepend("<span class='ui-button-icon-primary ui-icon "+s.primary+"'></span>"),s.secondary&&t.append("<span class='ui-button-icon-secondary ui-icon "+s.secondary+"'></span>"),this.options.text||(a.push(n?"ui-button-icons-only":"ui-button-icon-only"),this.hasTitle||t.attr("title",e.trim(i)))):a.push("ui-button-text-only"),t.addClass(a.join(" "))}}),e.widget("ui.buttonset",{version:"1.11.4",options:{items:"button, input[type=button], input[type=submit], input[type=reset], input[type=checkbox], input[type=radio], a, :data(ui-button)"},_create:function(){this.element.addClass("ui-buttonset")},_init:function(){this.refresh()},_setOption:function(e,t){"disabled"===e&&this.buttons.button("option",e,t),this._super(e,t)},refresh:function(){var t="rtl"===this.element.css("direction"),i=this.element.find(this.options.items),s=i.filter(":ui-button");i.not(":ui-button").button(),s.button("refresh"),this.buttons=i.map(function(){return e(this).button("widget")[0]}).removeClass("ui-corner-all ui-corner-left ui-corner-right").filter(":first").addClass(t?"ui-corner-right":"ui-corner-left").end().filter(":last").addClass(t?"ui-corner-left":"ui-corner-right").end().end()},_destroy:function(){this.element.removeClass("ui-buttonset"),this.buttons.map(function(){return e(this).button("widget")[0]}).removeClass("ui-corner-left ui-corner-right").end().button("destroy")}}),e.ui.button,e.widget("ui.dialog",{version:"1.11.4",options:{appendTo:"body",autoOpen:!0,buttons:[],closeOnEscape:!0,closeText:"Close",dialogClass:"",draggable:!0,hide:null,height:"auto",maxHeight:null,maxWidth:null,minHeight:150,minWidth:150,modal:!1,position:{my:"center",at:"center",of:window,collision:"fit",using:function(t){var i=e(this).css(t).offset().top;0>i&&e(this).css("top",t.top-i)}},resizable:!0,show:null,title:null,width:300,beforeClose:null,close:null,drag:null,dragStart:null,dragStop:null,focus:null,open:null,resize:null,resizeStart:null,resizeStop:null},sizeRelatedOptions:{buttons:!0,height:!0,maxHeight:!0,maxWidth:!0,minHeight:!0,minWidth:!0,width:!0},resizableRelatedOptions:{maxHeight:!0,maxWidth:!0,minHeight:!0,minWidth:!0},_create:function(){this.originalCss={display:this.element[0].style.display,width:this.element[0].style.width,minHeight:this.element[0].style.minHeight,maxHeight:this.element[0].style.maxHeight,height:this.element[0].style.height},this.originalPosition={parent:this.element.parent(),index:this.element.parent().children().index(this.element)},this.originalTitle=this.element.attr("title"),this.options.title=this.options.title||this.originalTitle,this._createWrapper(),this.element.show().removeAttr("title").addClass("ui-dialog-content ui-widget-content").appendTo(this.uiDialog),this._createTitlebar(),this._createButtonPane(),this.options.draggable&&e.fn.draggable&&this._makeDraggable(),this.options.resizable&&e.fn.resizable&&this._makeResizable(),this._isOpen=!1,this._trackFocus()},_init:function(){this.options.autoOpen&&this.open()},_appendTo:function(){var t=this.options.appendTo;return t&&(t.jquery||t.nodeType)?e(t):this.document.find(t||"body").eq(0)},_destroy:function(){var e,t=this.originalPosition;this._untrackInstance(),this._destroyOverlay(),this.element.removeUniqueId().removeClass("ui-dialog-content ui-widget-content").css(this.originalCss).detach(),this.uiDialog.stop(!0,!0).remove(),this.originalTitle&&this.element.attr("title",this.originalTitle),e=t.parent.children().eq(t.index),e.length&&e[0]!==this.element[0]?e.before(this.element):t.parent.append(this.element)},widget:function(){return this.uiDialog},disable:e.noop,enable:e.noop,close:function(t){var i,s=this;if(this._isOpen&&this._trigger("beforeClose",t)!==!1){if(this._isOpen=!1,this._focusedElement=null,this._destroyOverlay(),this._untrackInstance(),!this.opener.filter(":focusable").focus().length)try{i=this.document[0].activeElement,i&&"body"!==i.nodeName.toLowerCase()&&e(i).blur()}catch(n){}this._hide(this.uiDialog,this.options.hide,function(){s._trigger("close",t)})}},isOpen:function(){return this._isOpen},moveToTop:function(){this._moveToTop()},_moveToTop:function(t,i){var s=!1,n=this.uiDialog.siblings(".ui-front:visible").map(function(){return+e(this).css("z-index")}).get(),a=Math.max.apply(null,n);return a>=+this.uiDialog.css("z-index")&&(this.uiDialog.css("z-index",a+1),s=!0),s&&!i&&this._trigger("focus",t),s},open:function(){var t=this;return this._isOpen?(this._moveToTop()&&this._focusTabbable(),void 0):(this._isOpen=!0,this.opener=e(this.document[0].activeElement),this._size(),this._position(),this._createOverlay(),this._moveToTop(null,!0),this.overlay&&this.overlay.css("z-index",this.uiDialog.css("z-index")-1),this._show(this.uiDialog,this.options.show,function(){t._focusTabbable(),t._trigger("focus")}),this._makeFocusTarget(),this._trigger("open"),void 0)},_focusTabbable:function(){var e=this._focusedElement;e||(e=this.element.find("[autofocus]")),e.length||(e=this.element.find(":tabbable")),e.length||(e=this.uiDialogButtonPane.find(":tabbable")),e.length||(e=this.uiDialogTitlebarClose.filter(":tabbable")),e.length||(e=this.uiDialog),e.eq(0).focus()},_keepFocus:function(t){function i(){var t=this.document[0].activeElement,i=this.uiDialog[0]===t||e.contains(this.uiDialog[0],t);i||this._focusTabbable()}t.preventDefault(),i.call(this),this._delay(i)},_createWrapper:function(){this.uiDialog=e("<div>").addClass("ui-dialog ui-widget ui-widget-content ui-corner-all ui-front "+this.options.dialogClass).hide().attr({tabIndex:-1,role:"dialog"}).appendTo(this._appendTo()),this._on(this.uiDialog,{keydown:function(t){if(this.options.closeOnEscape&&!t.isDefaultPrevented()&&t.keyCode&&t.keyCode===e.ui.keyCode.ESCAPE)return t.preventDefault(),this.close(t),void 0;if(t.keyCode===e.ui.keyCode.TAB&&!t.isDefaultPrevented()){var i=this.uiDialog.find(":tabbable"),s=i.filter(":first"),n=i.filter(":last");t.target!==n[0]&&t.target!==this.uiDialog[0]||t.shiftKey?t.target!==s[0]&&t.target!==this.uiDialog[0]||!t.shiftKey||(this._delay(function(){n.focus()}),t.preventDefault()):(this._delay(function(){s.focus()}),t.preventDefault())}},mousedown:function(e){this._moveToTop(e)&&this._focusTabbable()}}),this.element.find("[aria-describedby]").length||this.uiDialog.attr({"aria-describedby":this.element.uniqueId().attr("id")})},_createTitlebar:function(){var t;this.uiDialogTitlebar=e("<div>").addClass("ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix").prependTo(this.uiDialog),this._on(this.uiDialogTitlebar,{mousedown:function(t){e(t.target).closest(".ui-dialog-titlebar-close")||this.uiDialog.focus()}}),this.uiDialogTitlebarClose=e("<button type='button'></button>").button({label:this.options.closeText,icons:{primary:"ui-icon-closethick"},text:!1}).addClass("ui-dialog-titlebar-close").appendTo(this.uiDialogTitlebar),this._on(this.uiDialogTitlebarClose,{click:function(e){e.preventDefault(),this.close(e)}}),t=e("<span>").uniqueId().addClass("ui-dialog-title").prependTo(this.uiDialogTitlebar),this._title(t),this.uiDialog.attr({"aria-labelledby":t.attr("id")})},_title:function(e){this.options.title||e.html("&#160;"),e.text(this.options.title)
},_createButtonPane:function(){this.uiDialogButtonPane=e("<div>").addClass("ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"),this.uiButtonSet=e("<div>").addClass("ui-dialog-buttonset").appendTo(this.uiDialogButtonPane),this._createButtons()},_createButtons:function(){var t=this,i=this.options.buttons;return this.uiDialogButtonPane.remove(),this.uiButtonSet.empty(),e.isEmptyObject(i)||e.isArray(i)&&!i.length?(this.uiDialog.removeClass("ui-dialog-buttons"),void 0):(e.each(i,function(i,s){var n,a;s=e.isFunction(s)?{click:s,text:i}:s,s=e.extend({type:"button"},s),n=s.click,s.click=function(){n.apply(t.element[0],arguments)},a={icons:s.icons,text:s.showText},delete s.icons,delete s.showText,e("<button></button>",s).button(a).appendTo(t.uiButtonSet)}),this.uiDialog.addClass("ui-dialog-buttons"),this.uiDialogButtonPane.appendTo(this.uiDialog),void 0)},_makeDraggable:function(){function t(e){return{position:e.position,offset:e.offset}}var i=this,s=this.options;this.uiDialog.draggable({cancel:".ui-dialog-content, .ui-dialog-titlebar-close",handle:".ui-dialog-titlebar",containment:"document",start:function(s,n){e(this).addClass("ui-dialog-dragging"),i._blockFrames(),i._trigger("dragStart",s,t(n))},drag:function(e,s){i._trigger("drag",e,t(s))},stop:function(n,a){var o=a.offset.left-i.document.scrollLeft(),r=a.offset.top-i.document.scrollTop();s.position={my:"left top",at:"left"+(o>=0?"+":"")+o+" "+"top"+(r>=0?"+":"")+r,of:i.window},e(this).removeClass("ui-dialog-dragging"),i._unblockFrames(),i._trigger("dragStop",n,t(a))}})},_makeResizable:function(){function t(e){return{originalPosition:e.originalPosition,originalSize:e.originalSize,position:e.position,size:e.size}}var i=this,s=this.options,n=s.resizable,a=this.uiDialog.css("position"),o="string"==typeof n?n:"n,e,s,w,se,sw,ne,nw";this.uiDialog.resizable({cancel:".ui-dialog-content",containment:"document",alsoResize:this.element,maxWidth:s.maxWidth,maxHeight:s.maxHeight,minWidth:s.minWidth,minHeight:this._minHeight(),handles:o,start:function(s,n){e(this).addClass("ui-dialog-resizing"),i._blockFrames(),i._trigger("resizeStart",s,t(n))},resize:function(e,s){i._trigger("resize",e,t(s))},stop:function(n,a){var o=i.uiDialog.offset(),r=o.left-i.document.scrollLeft(),h=o.top-i.document.scrollTop();s.height=i.uiDialog.height(),s.width=i.uiDialog.width(),s.position={my:"left top",at:"left"+(r>=0?"+":"")+r+" "+"top"+(h>=0?"+":"")+h,of:i.window},e(this).removeClass("ui-dialog-resizing"),i._unblockFrames(),i._trigger("resizeStop",n,t(a))}}).css("position",a)},_trackFocus:function(){this._on(this.widget(),{focusin:function(t){this._makeFocusTarget(),this._focusedElement=e(t.target)}})},_makeFocusTarget:function(){this._untrackInstance(),this._trackingInstances().unshift(this)},_untrackInstance:function(){var t=this._trackingInstances(),i=e.inArray(this,t);-1!==i&&t.splice(i,1)},_trackingInstances:function(){var e=this.document.data("ui-dialog-instances");return e||(e=[],this.document.data("ui-dialog-instances",e)),e},_minHeight:function(){var e=this.options;return"auto"===e.height?e.minHeight:Math.min(e.minHeight,e.height)},_position:function(){var e=this.uiDialog.is(":visible");e||this.uiDialog.show(),this.uiDialog.position(this.options.position),e||this.uiDialog.hide()},_setOptions:function(t){var i=this,s=!1,n={};e.each(t,function(e,t){i._setOption(e,t),e in i.sizeRelatedOptions&&(s=!0),e in i.resizableRelatedOptions&&(n[e]=t)}),s&&(this._size(),this._position()),this.uiDialog.is(":data(ui-resizable)")&&this.uiDialog.resizable("option",n)},_setOption:function(e,t){var i,s,n=this.uiDialog;"dialogClass"===e&&n.removeClass(this.options.dialogClass).addClass(t),"disabled"!==e&&(this._super(e,t),"appendTo"===e&&this.uiDialog.appendTo(this._appendTo()),"buttons"===e&&this._createButtons(),"closeText"===e&&this.uiDialogTitlebarClose.button({label:""+t}),"draggable"===e&&(i=n.is(":data(ui-draggable)"),i&&!t&&n.draggable("destroy"),!i&&t&&this._makeDraggable()),"position"===e&&this._position(),"resizable"===e&&(s=n.is(":data(ui-resizable)"),s&&!t&&n.resizable("destroy"),s&&"string"==typeof t&&n.resizable("option","handles",t),s||t===!1||this._makeResizable()),"title"===e&&this._title(this.uiDialogTitlebar.find(".ui-dialog-title")))},_size:function(){var e,t,i,s=this.options;this.element.show().css({width:"auto",minHeight:0,maxHeight:"none",height:0}),s.minWidth>s.width&&(s.width=s.minWidth),e=this.uiDialog.css({height:"auto",width:s.width}).outerHeight(),t=Math.max(0,s.minHeight-e),i="number"==typeof s.maxHeight?Math.max(0,s.maxHeight-e):"none","auto"===s.height?this.element.css({minHeight:t,maxHeight:i,height:"auto"}):this.element.height(Math.max(0,s.height-e)),this.uiDialog.is(":data(ui-resizable)")&&this.uiDialog.resizable("option","minHeight",this._minHeight())},_blockFrames:function(){this.iframeBlocks=this.document.find("iframe").map(function(){var t=e(this);return e("<div>").css({position:"absolute",width:t.outerWidth(),height:t.outerHeight()}).appendTo(t.parent()).offset(t.offset())[0]})},_unblockFrames:function(){this.iframeBlocks&&(this.iframeBlocks.remove(),delete this.iframeBlocks)},_allowInteraction:function(t){return e(t.target).closest(".ui-dialog").length?!0:!!e(t.target).closest(".ui-datepicker").length},_createOverlay:function(){if(this.options.modal){var t=!0;this._delay(function(){t=!1}),this.document.data("ui-dialog-overlays")||this._on(this.document,{focusin:function(e){t||this._allowInteraction(e)||(e.preventDefault(),this._trackingInstances()[0]._focusTabbable())}}),this.overlay=e("<div>").addClass("ui-widget-overlay ui-front").appendTo(this._appendTo()),this._on(this.overlay,{mousedown:"_keepFocus"}),this.document.data("ui-dialog-overlays",(this.document.data("ui-dialog-overlays")||0)+1)}},_destroyOverlay:function(){if(this.options.modal&&this.overlay){var e=this.document.data("ui-dialog-overlays")-1;e?this.document.data("ui-dialog-overlays",e):this.document.unbind("focusin").removeData("ui-dialog-overlays"),this.overlay.remove(),this.overlay=null}}}),e.widget("ui.progressbar",{version:"1.11.4",options:{max:100,value:0,change:null,complete:null},min:0,_create:function(){this.oldValue=this.options.value=this._constrainedValue(),this.element.addClass("ui-progressbar ui-widget ui-widget-content ui-corner-all").attr({role:"progressbar","aria-valuemin":this.min}),this.valueDiv=e("<div class='ui-progressbar-value ui-widget-header ui-corner-left'></div>").appendTo(this.element),this._refreshValue()},_destroy:function(){this.element.removeClass("ui-progressbar ui-widget ui-widget-content ui-corner-all").removeAttr("role").removeAttr("aria-valuemin").removeAttr("aria-valuemax").removeAttr("aria-valuenow"),this.valueDiv.remove()},value:function(e){return void 0===e?this.options.value:(this.options.value=this._constrainedValue(e),this._refreshValue(),void 0)},_constrainedValue:function(e){return void 0===e&&(e=this.options.value),this.indeterminate=e===!1,"number"!=typeof e&&(e=0),this.indeterminate?!1:Math.min(this.options.max,Math.max(this.min,e))},_setOptions:function(e){var t=e.value;delete e.value,this._super(e),this.options.value=this._constrainedValue(t),this._refreshValue()},_setOption:function(e,t){"max"===e&&(t=Math.max(this.min,t)),"disabled"===e&&this.element.toggleClass("ui-state-disabled",!!t).attr("aria-disabled",t),this._super(e,t)},_percentage:function(){return this.indeterminate?100:100*(this.options.value-this.min)/(this.options.max-this.min)},_refreshValue:function(){var t=this.options.value,i=this._percentage();this.valueDiv.toggle(this.indeterminate||t>this.min).toggleClass("ui-corner-right",t===this.options.max).width(i.toFixed(0)+"%"),this.element.toggleClass("ui-progressbar-indeterminate",this.indeterminate),this.indeterminate?(this.element.removeAttr("aria-valuenow"),this.overlayDiv||(this.overlayDiv=e("<div class='ui-progressbar-overlay'></div>").appendTo(this.valueDiv))):(this.element.attr({"aria-valuemax":this.options.max,"aria-valuenow":t}),this.overlayDiv&&(this.overlayDiv.remove(),this.overlayDiv=null)),this.oldValue!==t&&(this.oldValue=t,this._trigger("change")),t===this.options.max&&this._trigger("complete")}}),e.widget("ui.selectmenu",{version:"1.11.4",defaultElement:"<select>",options:{appendTo:null,disabled:null,icons:{button:"ui-icon-triangle-1-s"},position:{my:"left top",at:"left bottom",collision:"none"},width:null,change:null,close:null,focus:null,open:null,select:null},_create:function(){var e=this.element.uniqueId().attr("id");this.ids={element:e,button:e+"-button",menu:e+"-menu"},this._drawButton(),this._drawMenu(),this.options.disabled&&this.disable()},_drawButton:function(){var t=this;this.label=e("label[for='"+this.ids.element+"']").attr("for",this.ids.button),this._on(this.label,{click:function(e){this.button.focus(),e.preventDefault()}}),this.element.hide(),this.button=e("<span>",{"class":"ui-selectmenu-button ui-widget ui-state-default ui-corner-all",tabindex:this.options.disabled?-1:0,id:this.ids.button,role:"combobox","aria-expanded":"false","aria-autocomplete":"list","aria-owns":this.ids.menu,"aria-haspopup":"true"}).insertAfter(this.element),e("<span>",{"class":"ui-icon "+this.options.icons.button}).prependTo(this.button),this.buttonText=e("<span>",{"class":"ui-selectmenu-text"}).appendTo(this.button),this._setText(this.buttonText,this.element.find("option:selected").text()),this._resizeButton(),this._on(this.button,this._buttonEvents),this.button.one("focusin",function(){t.menuItems||t._refreshMenu()}),this._hoverable(this.button),this._focusable(this.button)},_drawMenu:function(){var t=this;this.menu=e("<ul>",{"aria-hidden":"true","aria-labelledby":this.ids.button,id:this.ids.menu}),this.menuWrap=e("<div>",{"class":"ui-selectmenu-menu ui-front"}).append(this.menu).appendTo(this._appendTo()),this.menuInstance=this.menu.menu({role:"listbox",select:function(e,i){e.preventDefault(),t._setSelection(),t._select(i.item.data("ui-selectmenu-item"),e)},focus:function(e,i){var s=i.item.data("ui-selectmenu-item");null!=t.focusIndex&&s.index!==t.focusIndex&&(t._trigger("focus",e,{item:s}),t.isOpen||t._select(s,e)),t.focusIndex=s.index,t.button.attr("aria-activedescendant",t.menuItems.eq(s.index).attr("id"))}}).menu("instance"),this.menu.addClass("ui-corner-bottom").removeClass("ui-corner-all"),this.menuInstance._off(this.menu,"mouseleave"),this.menuInstance._closeOnDocumentClick=function(){return!1},this.menuInstance._isDivider=function(){return!1}},refresh:function(){this._refreshMenu(),this._setText(this.buttonText,this._getSelectedItem().text()),this.options.width||this._resizeButton()},_refreshMenu:function(){this.menu.empty();var e,t=this.element.find("option");t.length&&(this._parseOptions(t),this._renderMenu(this.menu,this.items),this.menuInstance.refresh(),this.menuItems=this.menu.find("li").not(".ui-selectmenu-optgroup"),e=this._getSelectedItem(),this.menuInstance.focus(null,e),this._setAria(e.data("ui-selectmenu-item")),this._setOption("disabled",this.element.prop("disabled")))},open:function(e){this.options.disabled||(this.menuItems?(this.menu.find(".ui-state-focus").removeClass("ui-state-focus"),this.menuInstance.focus(null,this._getSelectedItem())):this._refreshMenu(),this.isOpen=!0,this._toggleAttr(),this._resizeMenu(),this._position(),this._on(this.document,this._documentClick),this._trigger("open",e))},_position:function(){this.menuWrap.position(e.extend({of:this.button},this.options.position))},close:function(e){this.isOpen&&(this.isOpen=!1,this._toggleAttr(),this.range=null,this._off(this.document),this._trigger("close",e))},widget:function(){return this.button},menuWidget:function(){return this.menu},_renderMenu:function(t,i){var s=this,n="";e.each(i,function(i,a){a.optgroup!==n&&(e("<li>",{"class":"ui-selectmenu-optgroup ui-menu-divider"+(a.element.parent("optgroup").prop("disabled")?" ui-state-disabled":""),text:a.optgroup}).appendTo(t),n=a.optgroup),s._renderItemData(t,a)})},_renderItemData:function(e,t){return this._renderItem(e,t).data("ui-selectmenu-item",t)},_renderItem:function(t,i){var s=e("<li>");return i.disabled&&s.addClass("ui-state-disabled"),this._setText(s,i.label),s.appendTo(t)},_setText:function(e,t){t?e.text(t):e.html("&#160;")},_move:function(e,t){var i,s,n=".ui-menu-item";this.isOpen?i=this.menuItems.eq(this.focusIndex):(i=this.menuItems.eq(this.element[0].selectedIndex),n+=":not(.ui-state-disabled)"),s="first"===e||"last"===e?i["first"===e?"prevAll":"nextAll"](n).eq(-1):i[e+"All"](n).eq(0),s.length&&this.menuInstance.focus(t,s)},_getSelectedItem:function(){return this.menuItems.eq(this.element[0].selectedIndex)},_toggle:function(e){this[this.isOpen?"close":"open"](e)},_setSelection:function(){var e;this.range&&(window.getSelection?(e=window.getSelection(),e.removeAllRanges(),e.addRange(this.range)):this.range.select(),this.button.focus())},_documentClick:{mousedown:function(t){this.isOpen&&(e(t.target).closest(".ui-selectmenu-menu, #"+this.ids.button).length||this.close(t))}},_buttonEvents:{mousedown:function(){var e;window.getSelection?(e=window.getSelection(),e.rangeCount&&(this.range=e.getRangeAt(0))):this.range=document.selection.createRange()},click:function(e){this._setSelection(),this._toggle(e)},keydown:function(t){var i=!0;switch(t.keyCode){case e.ui.keyCode.TAB:case e.ui.keyCode.ESCAPE:this.close(t),i=!1;break;case e.ui.keyCode.ENTER:this.isOpen&&this._selectFocusedItem(t);break;case e.ui.keyCode.UP:t.altKey?this._toggle(t):this._move("prev",t);break;case e.ui.keyCode.DOWN:t.altKey?this._toggle(t):this._move("next",t);break;case e.ui.keyCode.SPACE:this.isOpen?this._selectFocusedItem(t):this._toggle(t);break;case e.ui.keyCode.LEFT:this._move("prev",t);break;case e.ui.keyCode.RIGHT:this._move("next",t);break;case e.ui.keyCode.HOME:case e.ui.keyCode.PAGE_UP:this._move("first",t);break;case e.ui.keyCode.END:case e.ui.keyCode.PAGE_DOWN:this._move("last",t);break;default:this.menu.trigger(t),i=!1}i&&t.preventDefault()}},_selectFocusedItem:function(e){var t=this.menuItems.eq(this.focusIndex);t.hasClass("ui-state-disabled")||this._select(t.data("ui-selectmenu-item"),e)},_select:function(e,t){var i=this.element[0].selectedIndex;this.element[0].selectedIndex=e.index,this._setText(this.buttonText,e.label),this._setAria(e),this._trigger("select",t,{item:e}),e.index!==i&&this._trigger("change",t,{item:e}),this.close(t)},_setAria:function(e){var t=this.menuItems.eq(e.index).attr("id");this.button.attr({"aria-labelledby":t,"aria-activedescendant":t}),this.menu.attr("aria-activedescendant",t)},_setOption:function(e,t){"icons"===e&&this.button.find("span.ui-icon").removeClass(this.options.icons.button).addClass(t.button),this._super(e,t),"appendTo"===e&&this.menuWrap.appendTo(this._appendTo()),"disabled"===e&&(this.menuInstance.option("disabled",t),this.button.toggleClass("ui-state-disabled",t).attr("aria-disabled",t),this.element.prop("disabled",t),t?(this.button.attr("tabindex",-1),this.close()):this.button.attr("tabindex",0)),"width"===e&&this._resizeButton()},_appendTo:function(){var t=this.options.appendTo;return t&&(t=t.jquery||t.nodeType?e(t):this.document.find(t).eq(0)),t&&t[0]||(t=this.element.closest(".ui-front")),t.length||(t=this.document[0].body),t},_toggleAttr:function(){this.button.toggleClass("ui-corner-top",this.isOpen).toggleClass("ui-corner-all",!this.isOpen).attr("aria-expanded",this.isOpen),this.menuWrap.toggleClass("ui-selectmenu-open",this.isOpen),this.menu.attr("aria-hidden",!this.isOpen)},_resizeButton:function(){var e=this.options.width;e||(e=this.element.show().outerWidth(),this.element.hide()),this.button.outerWidth(e)},_resizeMenu:function(){this.menu.outerWidth(Math.max(this.button.outerWidth(),this.menu.width("").outerWidth()+1))},_getCreateOptions:function(){return{disabled:this.element.prop("disabled")}},_parseOptions:function(t){var i=[];t.each(function(t,s){var n=e(s),a=n.parent("optgroup");i.push({element:n,index:t,value:n.val(),label:n.text(),optgroup:a.attr("label")||"",disabled:a.prop("disabled")||n.prop("disabled")})}),this.items=i},_destroy:function(){this.menuWrap.remove(),this.button.remove(),this.element.show(),this.element.removeUniqueId(),this.label.attr("for",this.ids.element)}}),e.widget("ui.slider",e.ui.mouse,{version:"1.11.4",widgetEventPrefix:"slide",options:{animate:!1,distance:0,max:100,min:0,orientation:"horizontal",range:!1,step:1,value:0,values:null,change:null,slide:null,start:null,stop:null},numPages:5,_create:function(){this._keySliding=!1,this._mouseSliding=!1,this._animateOff=!0,this._handleIndex=null,this._detectOrientation(),this._mouseInit(),this._calculateNewMax(),this.element.addClass("ui-slider ui-slider-"+this.orientation+" ui-widget"+" ui-widget-content"+" ui-corner-all"),this._refresh(),this._setOption("disabled",this.options.disabled),this._animateOff=!1},_refresh:function(){this._createRange(),this._createHandles(),this._setupEvents(),this._refreshValue()},_createHandles:function(){var t,i,s=this.options,n=this.element.find(".ui-slider-handle").addClass("ui-state-default ui-corner-all"),a="<span class='ui-slider-handle ui-state-default ui-corner-all' tabindex='0'></span>",o=[];for(i=s.values&&s.values.length||1,n.length>i&&(n.slice(i).remove(),n=n.slice(0,i)),t=n.length;i>t;t++)o.push(a);this.handles=n.add(e(o.join("")).appendTo(this.element)),this.handle=this.handles.eq(0),this.handles.each(function(t){e(this).data("ui-slider-handle-index",t)})},_createRange:function(){var t=this.options,i="";t.range?(t.range===!0&&(t.values?t.values.length&&2!==t.values.length?t.values=[t.values[0],t.values[0]]:e.isArray(t.values)&&(t.values=t.values.slice(0)):t.values=[this._valueMin(),this._valueMin()]),this.range&&this.range.length?this.range.removeClass("ui-slider-range-min ui-slider-range-max").css({left:"",bottom:""}):(this.range=e("<div></div>").appendTo(this.element),i="ui-slider-range ui-widget-header ui-corner-all"),this.range.addClass(i+("min"===t.range||"max"===t.range?" ui-slider-range-"+t.range:""))):(this.range&&this.range.remove(),this.range=null)},_setupEvents:function(){this._off(this.handles),this._on(this.handles,this._handleEvents),this._hoverable(this.handles),this._focusable(this.handles)},_destroy:function(){this.handles.remove(),this.range&&this.range.remove(),this.element.removeClass("ui-slider ui-slider-horizontal ui-slider-vertical ui-widget ui-widget-content ui-corner-all"),this._mouseDestroy()},_mouseCapture:function(t){var i,s,n,a,o,r,h,l,u=this,d=this.options;return d.disabled?!1:(this.elementSize={width:this.element.outerWidth(),height:this.element.outerHeight()},this.elementOffset=this.element.offset(),i={x:t.pageX,y:t.pageY},s=this._normValueFromMouse(i),n=this._valueMax()-this._valueMin()+1,this.handles.each(function(t){var i=Math.abs(s-u.values(t));(n>i||n===i&&(t===u._lastChangedValue||u.values(t)===d.min))&&(n=i,a=e(this),o=t)}),r=this._start(t,o),r===!1?!1:(this._mouseSliding=!0,this._handleIndex=o,a.addClass("ui-state-active").focus(),h=a.offset(),l=!e(t.target).parents().addBack().is(".ui-slider-handle"),this._clickOffset=l?{left:0,top:0}:{left:t.pageX-h.left-a.width()/2,top:t.pageY-h.top-a.height()/2-(parseInt(a.css("borderTopWidth"),10)||0)-(parseInt(a.css("borderBottomWidth"),10)||0)+(parseInt(a.css("marginTop"),10)||0)},this.handles.hasClass("ui-state-hover")||this._slide(t,o,s),this._animateOff=!0,!0))},_mouseStart:function(){return!0},_mouseDrag:function(e){var t={x:e.pageX,y:e.pageY},i=this._normValueFromMouse(t);return this._slide(e,this._handleIndex,i),!1},_mouseStop:function(e){return this.handles.removeClass("ui-state-active"),this._mouseSliding=!1,this._stop(e,this._handleIndex),this._change(e,this._handleIndex),this._handleIndex=null,this._clickOffset=null,this._animateOff=!1,!1},_detectOrientation:function(){this.orientation="vertical"===this.options.orientation?"vertical":"horizontal"},_normValueFromMouse:function(e){var t,i,s,n,a;return"horizontal"===this.orientation?(t=this.elementSize.width,i=e.x-this.elementOffset.left-(this._clickOffset?this._clickOffset.left:0)):(t=this.elementSize.height,i=e.y-this.elementOffset.top-(this._clickOffset?this._clickOffset.top:0)),s=i/t,s>1&&(s=1),0>s&&(s=0),"vertical"===this.orientation&&(s=1-s),n=this._valueMax()-this._valueMin(),a=this._valueMin()+s*n,this._trimAlignValue(a)},_start:function(e,t){var i={handle:this.handles[t],value:this.value()};return this.options.values&&this.options.values.length&&(i.value=this.values(t),i.values=this.values()),this._trigger("start",e,i)},_slide:function(e,t,i){var s,n,a;this.options.values&&this.options.values.length?(s=this.values(t?0:1),2===this.options.values.length&&this.options.range===!0&&(0===t&&i>s||1===t&&s>i)&&(i=s),i!==this.values(t)&&(n=this.values(),n[t]=i,a=this._trigger("slide",e,{handle:this.handles[t],value:i,values:n}),s=this.values(t?0:1),a!==!1&&this.values(t,i))):i!==this.value()&&(a=this._trigger("slide",e,{handle:this.handles[t],value:i}),a!==!1&&this.value(i))},_stop:function(e,t){var i={handle:this.handles[t],value:this.value()};this.options.values&&this.options.values.length&&(i.value=this.values(t),i.values=this.values()),this._trigger("stop",e,i)},_change:function(e,t){if(!this._keySliding&&!this._mouseSliding){var i={handle:this.handles[t],value:this.value()};this.options.values&&this.options.values.length&&(i.value=this.values(t),i.values=this.values()),this._lastChangedValue=t,this._trigger("change",e,i)}},value:function(e){return arguments.length?(this.options.value=this._trimAlignValue(e),this._refreshValue(),this._change(null,0),void 0):this._value()},values:function(t,i){var s,n,a;if(arguments.length>1)return this.options.values[t]=this._trimAlignValue(i),this._refreshValue(),this._change(null,t),void 0;if(!arguments.length)return this._values();if(!e.isArray(arguments[0]))return this.options.values&&this.options.values.length?this._values(t):this.value();for(s=this.options.values,n=arguments[0],a=0;s.length>a;a+=1)s[a]=this._trimAlignValue(n[a]),this._change(null,a);this._refreshValue()},_setOption:function(t,i){var s,n=0;switch("range"===t&&this.options.range===!0&&("min"===i?(this.options.value=this._values(0),this.options.values=null):"max"===i&&(this.options.value=this._values(this.options.values.length-1),this.options.values=null)),e.isArray(this.options.values)&&(n=this.options.values.length),"disabled"===t&&this.element.toggleClass("ui-state-disabled",!!i),this._super(t,i),t){case"orientation":this._detectOrientation(),this.element.removeClass("ui-slider-horizontal ui-slider-vertical").addClass("ui-slider-"+this.orientation),this._refreshValue(),this.handles.css("horizontal"===i?"bottom":"left","");break;case"value":this._animateOff=!0,this._refreshValue(),this._change(null,0),this._animateOff=!1;break;case"values":for(this._animateOff=!0,this._refreshValue(),s=0;n>s;s+=1)this._change(null,s);this._animateOff=!1;break;case"step":case"min":case"max":this._animateOff=!0,this._calculateNewMax(),this._refreshValue(),this._animateOff=!1;break;case"range":this._animateOff=!0,this._refresh(),this._animateOff=!1}},_value:function(){var e=this.options.value;return e=this._trimAlignValue(e)},_values:function(e){var t,i,s;if(arguments.length)return t=this.options.values[e],t=this._trimAlignValue(t);if(this.options.values&&this.options.values.length){for(i=this.options.values.slice(),s=0;i.length>s;s+=1)i[s]=this._trimAlignValue(i[s]);return i}return[]},_trimAlignValue:function(e){if(this._valueMin()>=e)return this._valueMin();if(e>=this._valueMax())return this._valueMax();var t=this.options.step>0?this.options.step:1,i=(e-this._valueMin())%t,s=e-i;return 2*Math.abs(i)>=t&&(s+=i>0?t:-t),parseFloat(s.toFixed(5))},_calculateNewMax:function(){var e=this.options.max,t=this._valueMin(),i=this.options.step,s=Math.floor(+(e-t).toFixed(this._precision())/i)*i;e=s+t,this.max=parseFloat(e.toFixed(this._precision()))},_precision:function(){var e=this._precisionOf(this.options.step);return null!==this.options.min&&(e=Math.max(e,this._precisionOf(this.options.min))),e},_precisionOf:function(e){var t=""+e,i=t.indexOf(".");return-1===i?0:t.length-i-1},_valueMin:function(){return this.options.min},_valueMax:function(){return this.max},_refreshValue:function(){var t,i,s,n,a,o=this.options.range,r=this.options,h=this,l=this._animateOff?!1:r.animate,u={};this.options.values&&this.options.values.length?this.handles.each(function(s){i=100*((h.values(s)-h._valueMin())/(h._valueMax()-h._valueMin())),u["horizontal"===h.orientation?"left":"bottom"]=i+"%",e(this).stop(1,1)[l?"animate":"css"](u,r.animate),h.options.range===!0&&("horizontal"===h.orientation?(0===s&&h.range.stop(1,1)[l?"animate":"css"]({left:i+"%"},r.animate),1===s&&h.range[l?"animate":"css"]({width:i-t+"%"},{queue:!1,duration:r.animate})):(0===s&&h.range.stop(1,1)[l?"animate":"css"]({bottom:i+"%"},r.animate),1===s&&h.range[l?"animate":"css"]({height:i-t+"%"},{queue:!1,duration:r.animate}))),t=i}):(s=this.value(),n=this._valueMin(),a=this._valueMax(),i=a!==n?100*((s-n)/(a-n)):0,u["horizontal"===this.orientation?"left":"bottom"]=i+"%",this.handle.stop(1,1)[l?"animate":"css"](u,r.animate),"min"===o&&"horizontal"===this.orientation&&this.range.stop(1,1)[l?"animate":"css"]({width:i+"%"},r.animate),"max"===o&&"horizontal"===this.orientation&&this.range[l?"animate":"css"]({width:100-i+"%"},{queue:!1,duration:r.animate}),"min"===o&&"vertical"===this.orientation&&this.range.stop(1,1)[l?"animate":"css"]({height:i+"%"},r.animate),"max"===o&&"vertical"===this.orientation&&this.range[l?"animate":"css"]({height:100-i+"%"},{queue:!1,duration:r.animate}))},_handleEvents:{keydown:function(t){var i,s,n,a,o=e(t.target).data("ui-slider-handle-index");switch(t.keyCode){case e.ui.keyCode.HOME:case e.ui.keyCode.END:case e.ui.keyCode.PAGE_UP:case e.ui.keyCode.PAGE_DOWN:case e.ui.keyCode.UP:case e.ui.keyCode.RIGHT:case e.ui.keyCode.DOWN:case e.ui.keyCode.LEFT:if(t.preventDefault(),!this._keySliding&&(this._keySliding=!0,e(t.target).addClass("ui-state-active"),i=this._start(t,o),i===!1))return}switch(a=this.options.step,s=n=this.options.values&&this.options.values.length?this.values(o):this.value(),t.keyCode){case e.ui.keyCode.HOME:n=this._valueMin();break;case e.ui.keyCode.END:n=this._valueMax();break;case e.ui.keyCode.PAGE_UP:n=this._trimAlignValue(s+(this._valueMax()-this._valueMin())/this.numPages);break;case e.ui.keyCode.PAGE_DOWN:n=this._trimAlignValue(s-(this._valueMax()-this._valueMin())/this.numPages);break;case e.ui.keyCode.UP:case e.ui.keyCode.RIGHT:if(s===this._valueMax())return;n=this._trimAlignValue(s+a);break;case e.ui.keyCode.DOWN:case e.ui.keyCode.LEFT:if(s===this._valueMin())return;n=this._trimAlignValue(s-a)}this._slide(t,o,n)},keyup:function(t){var i=e(t.target).data("ui-slider-handle-index");this._keySliding&&(this._keySliding=!1,this._stop(t,i),this._change(t,i),e(t.target).removeClass("ui-state-active"))}}}),e.widget("ui.spinner",{version:"1.11.4",defaultElement:"<input>",widgetEventPrefix:"spin",options:{culture:null,icons:{down:"ui-icon-triangle-1-s",up:"ui-icon-triangle-1-n"},incremental:!0,max:null,min:null,numberFormat:null,page:10,step:1,change:null,spin:null,start:null,stop:null},_create:function(){this._setOption("max",this.options.max),this._setOption("min",this.options.min),this._setOption("step",this.options.step),""!==this.value()&&this._value(this.element.val(),!0),this._draw(),this._on(this._events),this._refresh(),this._on(this.window,{beforeunload:function(){this.element.removeAttr("autocomplete")}})},_getCreateOptions:function(){var t={},i=this.element;return e.each(["min","max","step"],function(e,s){var n=i.attr(s);void 0!==n&&n.length&&(t[s]=n)}),t},_events:{keydown:function(e){this._start(e)&&this._keydown(e)&&e.preventDefault()},keyup:"_stop",focus:function(){this.previous=this.element.val()},blur:function(e){return this.cancelBlur?(delete this.cancelBlur,void 0):(this._stop(),this._refresh(),this.previous!==this.element.val()&&this._trigger("change",e),void 0)},mousewheel:function(e,t){if(t){if(!this.spinning&&!this._start(e))return!1;this._spin((t>0?1:-1)*this.options.step,e),clearTimeout(this.mousewheelTimer),this.mousewheelTimer=this._delay(function(){this.spinning&&this._stop(e)},100),e.preventDefault()}},"mousedown .ui-spinner-button":function(t){function i(){var e=this.element[0]===this.document[0].activeElement;e||(this.element.focus(),this.previous=s,this._delay(function(){this.previous=s}))}var s;s=this.element[0]===this.document[0].activeElement?this.previous:this.element.val(),t.preventDefault(),i.call(this),this.cancelBlur=!0,this._delay(function(){delete this.cancelBlur,i.call(this)}),this._start(t)!==!1&&this._repeat(null,e(t.currentTarget).hasClass("ui-spinner-up")?1:-1,t)},"mouseup .ui-spinner-button":"_stop","mouseenter .ui-spinner-button":function(t){return e(t.currentTarget).hasClass("ui-state-active")?this._start(t)===!1?!1:(this._repeat(null,e(t.currentTarget).hasClass("ui-spinner-up")?1:-1,t),void 0):void 0},"mouseleave .ui-spinner-button":"_stop"},_draw:function(){var e=this.uiSpinner=this.element.addClass("ui-spinner-input").attr("autocomplete","off").wrap(this._uiSpinnerHtml()).parent().append(this._buttonHtml());this.element.attr("role","spinbutton"),this.buttons=e.find(".ui-spinner-button").attr("tabIndex",-1).button().removeClass("ui-corner-all"),this.buttons.height()>Math.ceil(.5*e.height())&&e.height()>0&&e.height(e.height()),this.options.disabled&&this.disable()},_keydown:function(t){var i=this.options,s=e.ui.keyCode;switch(t.keyCode){case s.UP:return this._repeat(null,1,t),!0;case s.DOWN:return this._repeat(null,-1,t),!0;case s.PAGE_UP:return this._repeat(null,i.page,t),!0;case s.PAGE_DOWN:return this._repeat(null,-i.page,t),!0}return!1},_uiSpinnerHtml:function(){return"<span class='ui-spinner ui-widget ui-widget-content ui-corner-all'></span>"},_buttonHtml:function(){return"<a class='ui-spinner-button ui-spinner-up ui-corner-tr'><span class='ui-icon "+this.options.icons.up+"'>&#9650;</span>"+"</a>"+"<a class='ui-spinner-button ui-spinner-down ui-corner-br'>"+"<span class='ui-icon "+this.options.icons.down+"'>&#9660;</span>"+"</a>"},_start:function(e){return this.spinning||this._trigger("start",e)!==!1?(this.counter||(this.counter=1),this.spinning=!0,!0):!1},_repeat:function(e,t,i){e=e||500,clearTimeout(this.timer),this.timer=this._delay(function(){this._repeat(40,t,i)},e),this._spin(t*this.options.step,i)},_spin:function(e,t){var i=this.value()||0;this.counter||(this.counter=1),i=this._adjustValue(i+e*this._increment(this.counter)),this.spinning&&this._trigger("spin",t,{value:i})===!1||(this._value(i),this.counter++)},_increment:function(t){var i=this.options.incremental;return i?e.isFunction(i)?i(t):Math.floor(t*t*t/5e4-t*t/500+17*t/200+1):1},_precision:function(){var e=this._precisionOf(this.options.step);return null!==this.options.min&&(e=Math.max(e,this._precisionOf(this.options.min))),e},_precisionOf:function(e){var t=""+e,i=t.indexOf(".");return-1===i?0:t.length-i-1},_adjustValue:function(e){var t,i,s=this.options;return t=null!==s.min?s.min:0,i=e-t,i=Math.round(i/s.step)*s.step,e=t+i,e=parseFloat(e.toFixed(this._precision())),null!==s.max&&e>s.max?s.max:null!==s.min&&s.min>e?s.min:e},_stop:function(e){this.spinning&&(clearTimeout(this.timer),clearTimeout(this.mousewheelTimer),this.counter=0,this.spinning=!1,this._trigger("stop",e))},_setOption:function(e,t){if("culture"===e||"numberFormat"===e){var i=this._parse(this.element.val());return this.options[e]=t,this.element.val(this._format(i)),void 0}("max"===e||"min"===e||"step"===e)&&"string"==typeof t&&(t=this._parse(t)),"icons"===e&&(this.buttons.first().find(".ui-icon").removeClass(this.options.icons.up).addClass(t.up),this.buttons.last().find(".ui-icon").removeClass(this.options.icons.down).addClass(t.down)),this._super(e,t),"disabled"===e&&(this.widget().toggleClass("ui-state-disabled",!!t),this.element.prop("disabled",!!t),this.buttons.button(t?"disable":"enable"))},_setOptions:s(function(e){this._super(e)}),_parse:function(e){return"string"==typeof e&&""!==e&&(e=window.Globalize&&this.options.numberFormat?Globalize.parseFloat(e,10,this.options.culture):+e),""===e||isNaN(e)?null:e
},_format:function(e){return""===e?"":window.Globalize&&this.options.numberFormat?Globalize.format(e,this.options.numberFormat,this.options.culture):e},_refresh:function(){this.element.attr({"aria-valuemin":this.options.min,"aria-valuemax":this.options.max,"aria-valuenow":this._parse(this.element.val())})},isValid:function(){var e=this.value();return null===e?!1:e===this._adjustValue(e)},_value:function(e,t){var i;""!==e&&(i=this._parse(e),null!==i&&(t||(i=this._adjustValue(i)),e=this._format(i))),this.element.val(e),this._refresh()},_destroy:function(){this.element.removeClass("ui-spinner-input").prop("disabled",!1).removeAttr("autocomplete").removeAttr("role").removeAttr("aria-valuemin").removeAttr("aria-valuemax").removeAttr("aria-valuenow"),this.uiSpinner.replaceWith(this.element)},stepUp:s(function(e){this._stepUp(e)}),_stepUp:function(e){this._start()&&(this._spin((e||1)*this.options.step),this._stop())},stepDown:s(function(e){this._stepDown(e)}),_stepDown:function(e){this._start()&&(this._spin((e||1)*-this.options.step),this._stop())},pageUp:s(function(e){this._stepUp((e||1)*this.options.page)}),pageDown:s(function(e){this._stepDown((e||1)*this.options.page)}),value:function(e){return arguments.length?(s(this._value).call(this,e),void 0):this._parse(this.element.val())},widget:function(){return this.uiSpinner}}),e.widget("ui.tabs",{version:"1.11.4",delay:300,options:{active:null,collapsible:!1,event:"click",heightStyle:"content",hide:null,show:null,activate:null,beforeActivate:null,beforeLoad:null,load:null},_isLocal:function(){var e=/#.*$/;return function(t){var i,s;t=t.cloneNode(!1),i=t.href.replace(e,""),s=location.href.replace(e,"");try{i=decodeURIComponent(i)}catch(n){}try{s=decodeURIComponent(s)}catch(n){}return t.hash.length>1&&i===s}}(),_create:function(){var t=this,i=this.options;this.running=!1,this.element.addClass("ui-tabs ui-widget ui-widget-content ui-corner-all").toggleClass("ui-tabs-collapsible",i.collapsible),this._processTabs(),i.active=this._initialActive(),e.isArray(i.disabled)&&(i.disabled=e.unique(i.disabled.concat(e.map(this.tabs.filter(".ui-state-disabled"),function(e){return t.tabs.index(e)}))).sort()),this.active=this.options.active!==!1&&this.anchors.length?this._findActive(i.active):e(),this._refresh(),this.active.length&&this.load(i.active)},_initialActive:function(){var t=this.options.active,i=this.options.collapsible,s=location.hash.substring(1);return null===t&&(s&&this.tabs.each(function(i,n){return e(n).attr("aria-controls")===s?(t=i,!1):void 0}),null===t&&(t=this.tabs.index(this.tabs.filter(".ui-tabs-active"))),(null===t||-1===t)&&(t=this.tabs.length?0:!1)),t!==!1&&(t=this.tabs.index(this.tabs.eq(t)),-1===t&&(t=i?!1:0)),!i&&t===!1&&this.anchors.length&&(t=0),t},_getCreateEventData:function(){return{tab:this.active,panel:this.active.length?this._getPanelForTab(this.active):e()}},_tabKeydown:function(t){var i=e(this.document[0].activeElement).closest("li"),s=this.tabs.index(i),n=!0;if(!this._handlePageNav(t)){switch(t.keyCode){case e.ui.keyCode.RIGHT:case e.ui.keyCode.DOWN:s++;break;case e.ui.keyCode.UP:case e.ui.keyCode.LEFT:n=!1,s--;break;case e.ui.keyCode.END:s=this.anchors.length-1;break;case e.ui.keyCode.HOME:s=0;break;case e.ui.keyCode.SPACE:return t.preventDefault(),clearTimeout(this.activating),this._activate(s),void 0;case e.ui.keyCode.ENTER:return t.preventDefault(),clearTimeout(this.activating),this._activate(s===this.options.active?!1:s),void 0;default:return}t.preventDefault(),clearTimeout(this.activating),s=this._focusNextTab(s,n),t.ctrlKey||t.metaKey||(i.attr("aria-selected","false"),this.tabs.eq(s).attr("aria-selected","true"),this.activating=this._delay(function(){this.option("active",s)},this.delay))}},_panelKeydown:function(t){this._handlePageNav(t)||t.ctrlKey&&t.keyCode===e.ui.keyCode.UP&&(t.preventDefault(),this.active.focus())},_handlePageNav:function(t){return t.altKey&&t.keyCode===e.ui.keyCode.PAGE_UP?(this._activate(this._focusNextTab(this.options.active-1,!1)),!0):t.altKey&&t.keyCode===e.ui.keyCode.PAGE_DOWN?(this._activate(this._focusNextTab(this.options.active+1,!0)),!0):void 0},_findNextTab:function(t,i){function s(){return t>n&&(t=0),0>t&&(t=n),t}for(var n=this.tabs.length-1;-1!==e.inArray(s(),this.options.disabled);)t=i?t+1:t-1;return t},_focusNextTab:function(e,t){return e=this._findNextTab(e,t),this.tabs.eq(e).focus(),e},_setOption:function(e,t){return"active"===e?(this._activate(t),void 0):"disabled"===e?(this._setupDisabled(t),void 0):(this._super(e,t),"collapsible"===e&&(this.element.toggleClass("ui-tabs-collapsible",t),t||this.options.active!==!1||this._activate(0)),"event"===e&&this._setupEvents(t),"heightStyle"===e&&this._setupHeightStyle(t),void 0)},_sanitizeSelector:function(e){return e?e.replace(/[!"$%&'()*+,.\/:;<=>?@\[\]\^`{|}~]/g,"\\$&"):""},refresh:function(){var t=this.options,i=this.tablist.children(":has(a[href])");t.disabled=e.map(i.filter(".ui-state-disabled"),function(e){return i.index(e)}),this._processTabs(),t.active!==!1&&this.anchors.length?this.active.length&&!e.contains(this.tablist[0],this.active[0])?this.tabs.length===t.disabled.length?(t.active=!1,this.active=e()):this._activate(this._findNextTab(Math.max(0,t.active-1),!1)):t.active=this.tabs.index(this.active):(t.active=!1,this.active=e()),this._refresh()},_refresh:function(){this._setupDisabled(this.options.disabled),this._setupEvents(this.options.event),this._setupHeightStyle(this.options.heightStyle),this.tabs.not(this.active).attr({"aria-selected":"false","aria-expanded":"false",tabIndex:-1}),this.panels.not(this._getPanelForTab(this.active)).hide().attr({"aria-hidden":"true"}),this.active.length?(this.active.addClass("ui-tabs-active ui-state-active").attr({"aria-selected":"true","aria-expanded":"true",tabIndex:0}),this._getPanelForTab(this.active).show().attr({"aria-hidden":"false"})):this.tabs.eq(0).attr("tabIndex",0)},_processTabs:function(){var t=this,i=this.tabs,s=this.anchors,n=this.panels;this.tablist=this._getList().addClass("ui-tabs-nav ui-helper-reset ui-helper-clearfix ui-widget-header ui-corner-all").attr("role","tablist").delegate("> li","mousedown"+this.eventNamespace,function(t){e(this).is(".ui-state-disabled")&&t.preventDefault()}).delegate(".ui-tabs-anchor","focus"+this.eventNamespace,function(){e(this).closest("li").is(".ui-state-disabled")&&this.blur()}),this.tabs=this.tablist.find("> li:has(a[href])").addClass("ui-state-default ui-corner-top").attr({role:"tab",tabIndex:-1}),this.anchors=this.tabs.map(function(){return e("a",this)[0]}).addClass("ui-tabs-anchor").attr({role:"presentation",tabIndex:-1}),this.panels=e(),this.anchors.each(function(i,s){var n,a,o,r=e(s).uniqueId().attr("id"),h=e(s).closest("li"),l=h.attr("aria-controls");t._isLocal(s)?(n=s.hash,o=n.substring(1),a=t.element.find(t._sanitizeSelector(n))):(o=h.attr("aria-controls")||e({}).uniqueId()[0].id,n="#"+o,a=t.element.find(n),a.length||(a=t._createPanel(o),a.insertAfter(t.panels[i-1]||t.tablist)),a.attr("aria-live","polite")),a.length&&(t.panels=t.panels.add(a)),l&&h.data("ui-tabs-aria-controls",l),h.attr({"aria-controls":o,"aria-labelledby":r}),a.attr("aria-labelledby",r)}),this.panels.addClass("ui-tabs-panel ui-widget-content ui-corner-bottom").attr("role","tabpanel"),i&&(this._off(i.not(this.tabs)),this._off(s.not(this.anchors)),this._off(n.not(this.panels)))},_getList:function(){return this.tablist||this.element.find("ol,ul").eq(0)},_createPanel:function(t){return e("<div>").attr("id",t).addClass("ui-tabs-panel ui-widget-content ui-corner-bottom").data("ui-tabs-destroy",!0)},_setupDisabled:function(t){e.isArray(t)&&(t.length?t.length===this.anchors.length&&(t=!0):t=!1);for(var i,s=0;i=this.tabs[s];s++)t===!0||-1!==e.inArray(s,t)?e(i).addClass("ui-state-disabled").attr("aria-disabled","true"):e(i).removeClass("ui-state-disabled").removeAttr("aria-disabled");this.options.disabled=t},_setupEvents:function(t){var i={};t&&e.each(t.split(" "),function(e,t){i[t]="_eventHandler"}),this._off(this.anchors.add(this.tabs).add(this.panels)),this._on(!0,this.anchors,{click:function(e){e.preventDefault()}}),this._on(this.anchors,i),this._on(this.tabs,{keydown:"_tabKeydown"}),this._on(this.panels,{keydown:"_panelKeydown"}),this._focusable(this.tabs),this._hoverable(this.tabs)},_setupHeightStyle:function(t){var i,s=this.element.parent();"fill"===t?(i=s.height(),i-=this.element.outerHeight()-this.element.height(),this.element.siblings(":visible").each(function(){var t=e(this),s=t.css("position");"absolute"!==s&&"fixed"!==s&&(i-=t.outerHeight(!0))}),this.element.children().not(this.panels).each(function(){i-=e(this).outerHeight(!0)}),this.panels.each(function(){e(this).height(Math.max(0,i-e(this).innerHeight()+e(this).height()))}).css("overflow","auto")):"auto"===t&&(i=0,this.panels.each(function(){i=Math.max(i,e(this).height("").height())}).height(i))},_eventHandler:function(t){var i=this.options,s=this.active,n=e(t.currentTarget),a=n.closest("li"),o=a[0]===s[0],r=o&&i.collapsible,h=r?e():this._getPanelForTab(a),l=s.length?this._getPanelForTab(s):e(),u={oldTab:s,oldPanel:l,newTab:r?e():a,newPanel:h};t.preventDefault(),a.hasClass("ui-state-disabled")||a.hasClass("ui-tabs-loading")||this.running||o&&!i.collapsible||this._trigger("beforeActivate",t,u)===!1||(i.active=r?!1:this.tabs.index(a),this.active=o?e():a,this.xhr&&this.xhr.abort(),l.length||h.length||e.error("jQuery UI Tabs: Mismatching fragment identifier."),h.length&&this.load(this.tabs.index(a),t),this._toggle(t,u))},_toggle:function(t,i){function s(){a.running=!1,a._trigger("activate",t,i)}function n(){i.newTab.closest("li").addClass("ui-tabs-active ui-state-active"),o.length&&a.options.show?a._show(o,a.options.show,s):(o.show(),s())}var a=this,o=i.newPanel,r=i.oldPanel;this.running=!0,r.length&&this.options.hide?this._hide(r,this.options.hide,function(){i.oldTab.closest("li").removeClass("ui-tabs-active ui-state-active"),n()}):(i.oldTab.closest("li").removeClass("ui-tabs-active ui-state-active"),r.hide(),n()),r.attr("aria-hidden","true"),i.oldTab.attr({"aria-selected":"false","aria-expanded":"false"}),o.length&&r.length?i.oldTab.attr("tabIndex",-1):o.length&&this.tabs.filter(function(){return 0===e(this).attr("tabIndex")}).attr("tabIndex",-1),o.attr("aria-hidden","false"),i.newTab.attr({"aria-selected":"true","aria-expanded":"true",tabIndex:0})},_activate:function(t){var i,s=this._findActive(t);s[0]!==this.active[0]&&(s.length||(s=this.active),i=s.find(".ui-tabs-anchor")[0],this._eventHandler({target:i,currentTarget:i,preventDefault:e.noop}))},_findActive:function(t){return t===!1?e():this.tabs.eq(t)},_getIndex:function(e){return"string"==typeof e&&(e=this.anchors.index(this.anchors.filter("[href$='"+e+"']"))),e},_destroy:function(){this.xhr&&this.xhr.abort(),this.element.removeClass("ui-tabs ui-widget ui-widget-content ui-corner-all ui-tabs-collapsible"),this.tablist.removeClass("ui-tabs-nav ui-helper-reset ui-helper-clearfix ui-widget-header ui-corner-all").removeAttr("role"),this.anchors.removeClass("ui-tabs-anchor").removeAttr("role").removeAttr("tabIndex").removeUniqueId(),this.tablist.unbind(this.eventNamespace),this.tabs.add(this.panels).each(function(){e.data(this,"ui-tabs-destroy")?e(this).remove():e(this).removeClass("ui-state-default ui-state-active ui-state-disabled ui-corner-top ui-corner-bottom ui-widget-content ui-tabs-active ui-tabs-panel").removeAttr("tabIndex").removeAttr("aria-live").removeAttr("aria-busy").removeAttr("aria-selected").removeAttr("aria-labelledby").removeAttr("aria-hidden").removeAttr("aria-expanded").removeAttr("role")}),this.tabs.each(function(){var t=e(this),i=t.data("ui-tabs-aria-controls");i?t.attr("aria-controls",i).removeData("ui-tabs-aria-controls"):t.removeAttr("aria-controls")}),this.panels.show(),"content"!==this.options.heightStyle&&this.panels.css("height","")},enable:function(t){var i=this.options.disabled;i!==!1&&(void 0===t?i=!1:(t=this._getIndex(t),i=e.isArray(i)?e.map(i,function(e){return e!==t?e:null}):e.map(this.tabs,function(e,i){return i!==t?i:null})),this._setupDisabled(i))},disable:function(t){var i=this.options.disabled;if(i!==!0){if(void 0===t)i=!0;else{if(t=this._getIndex(t),-1!==e.inArray(t,i))return;i=e.isArray(i)?e.merge([t],i).sort():[t]}this._setupDisabled(i)}},load:function(t,i){t=this._getIndex(t);var s=this,n=this.tabs.eq(t),a=n.find(".ui-tabs-anchor"),o=this._getPanelForTab(n),r={tab:n,panel:o},h=function(e,t){"abort"===t&&s.panels.stop(!1,!0),n.removeClass("ui-tabs-loading"),o.removeAttr("aria-busy"),e===s.xhr&&delete s.xhr};this._isLocal(a[0])||(this.xhr=e.ajax(this._ajaxSettings(a,i,r)),this.xhr&&"canceled"!==this.xhr.statusText&&(n.addClass("ui-tabs-loading"),o.attr("aria-busy","true"),this.xhr.done(function(e,t,n){setTimeout(function(){o.html(e),s._trigger("load",i,r),h(n,t)},1)}).fail(function(e,t){setTimeout(function(){h(e,t)},1)})))},_ajaxSettings:function(t,i,s){var n=this;return{url:t.attr("href"),beforeSend:function(t,a){return n._trigger("beforeLoad",i,e.extend({jqXHR:t,ajaxSettings:a},s))}}},_getPanelForTab:function(t){var i=e(t).attr("aria-controls");return this.element.find(this._sanitizeSelector("#"+i))}}),e.widget("ui.tooltip",{version:"1.11.4",options:{content:function(){var t=e(this).attr("title")||"";return e("<a>").text(t).html()},hide:!0,items:"[title]:not([disabled])",position:{my:"left top+15",at:"left bottom",collision:"flipfit flip"},show:!0,tooltipClass:null,track:!1,close:null,open:null},_addDescribedBy:function(t,i){var s=(t.attr("aria-describedby")||"").split(/\s+/);s.push(i),t.data("ui-tooltip-id",i).attr("aria-describedby",e.trim(s.join(" ")))},_removeDescribedBy:function(t){var i=t.data("ui-tooltip-id"),s=(t.attr("aria-describedby")||"").split(/\s+/),n=e.inArray(i,s);-1!==n&&s.splice(n,1),t.removeData("ui-tooltip-id"),s=e.trim(s.join(" ")),s?t.attr("aria-describedby",s):t.removeAttr("aria-describedby")},_create:function(){this._on({mouseover:"open",focusin:"open"}),this.tooltips={},this.parents={},this.options.disabled&&this._disable(),this.liveRegion=e("<div>").attr({role:"log","aria-live":"assertive","aria-relevant":"additions"}).addClass("ui-helper-hidden-accessible").appendTo(this.document[0].body)},_setOption:function(t,i){var s=this;return"disabled"===t?(this[i?"_disable":"_enable"](),this.options[t]=i,void 0):(this._super(t,i),"content"===t&&e.each(this.tooltips,function(e,t){s._updateContent(t.element)}),void 0)},_disable:function(){var t=this;e.each(this.tooltips,function(i,s){var n=e.Event("blur");n.target=n.currentTarget=s.element[0],t.close(n,!0)}),this.element.find(this.options.items).addBack().each(function(){var t=e(this);t.is("[title]")&&t.data("ui-tooltip-title",t.attr("title")).removeAttr("title")})},_enable:function(){this.element.find(this.options.items).addBack().each(function(){var t=e(this);t.data("ui-tooltip-title")&&t.attr("title",t.data("ui-tooltip-title"))})},open:function(t){var i=this,s=e(t?t.target:this.element).closest(this.options.items);s.length&&!s.data("ui-tooltip-id")&&(s.attr("title")&&s.data("ui-tooltip-title",s.attr("title")),s.data("ui-tooltip-open",!0),t&&"mouseover"===t.type&&s.parents().each(function(){var t,s=e(this);s.data("ui-tooltip-open")&&(t=e.Event("blur"),t.target=t.currentTarget=this,i.close(t,!0)),s.attr("title")&&(s.uniqueId(),i.parents[this.id]={element:this,title:s.attr("title")},s.attr("title",""))}),this._registerCloseHandlers(t,s),this._updateContent(s,t))},_updateContent:function(e,t){var i,s=this.options.content,n=this,a=t?t.type:null;return"string"==typeof s?this._open(t,e,s):(i=s.call(e[0],function(i){n._delay(function(){e.data("ui-tooltip-open")&&(t&&(t.type=a),this._open(t,e,i))})}),i&&this._open(t,e,i),void 0)},_open:function(t,i,s){function n(e){l.of=e,o.is(":hidden")||o.position(l)}var a,o,r,h,l=e.extend({},this.options.position);if(s){if(a=this._find(i))return a.tooltip.find(".ui-tooltip-content").html(s),void 0;i.is("[title]")&&(t&&"mouseover"===t.type?i.attr("title",""):i.removeAttr("title")),a=this._tooltip(i),o=a.tooltip,this._addDescribedBy(i,o.attr("id")),o.find(".ui-tooltip-content").html(s),this.liveRegion.children().hide(),s.clone?(h=s.clone(),h.removeAttr("id").find("[id]").removeAttr("id")):h=s,e("<div>").html(h).appendTo(this.liveRegion),this.options.track&&t&&/^mouse/.test(t.type)?(this._on(this.document,{mousemove:n}),n(t)):o.position(e.extend({of:i},this.options.position)),o.hide(),this._show(o,this.options.show),this.options.show&&this.options.show.delay&&(r=this.delayedShow=setInterval(function(){o.is(":visible")&&(n(l.of),clearInterval(r))},e.fx.interval)),this._trigger("open",t,{tooltip:o})}},_registerCloseHandlers:function(t,i){var s={keyup:function(t){if(t.keyCode===e.ui.keyCode.ESCAPE){var s=e.Event(t);s.currentTarget=i[0],this.close(s,!0)}}};i[0]!==this.element[0]&&(s.remove=function(){this._removeTooltip(this._find(i).tooltip)}),t&&"mouseover"!==t.type||(s.mouseleave="close"),t&&"focusin"!==t.type||(s.focusout="close"),this._on(!0,i,s)},close:function(t){var i,s=this,n=e(t?t.currentTarget:this.element),a=this._find(n);return a?(i=a.tooltip,a.closing||(clearInterval(this.delayedShow),n.data("ui-tooltip-title")&&!n.attr("title")&&n.attr("title",n.data("ui-tooltip-title")),this._removeDescribedBy(n),a.hiding=!0,i.stop(!0),this._hide(i,this.options.hide,function(){s._removeTooltip(e(this))}),n.removeData("ui-tooltip-open"),this._off(n,"mouseleave focusout keyup"),n[0]!==this.element[0]&&this._off(n,"remove"),this._off(this.document,"mousemove"),t&&"mouseleave"===t.type&&e.each(this.parents,function(t,i){e(i.element).attr("title",i.title),delete s.parents[t]}),a.closing=!0,this._trigger("close",t,{tooltip:i}),a.hiding||(a.closing=!1)),void 0):(n.removeData("ui-tooltip-open"),void 0)},_tooltip:function(t){var i=e("<div>").attr("role","tooltip").addClass("ui-tooltip ui-widget ui-corner-all ui-widget-content "+(this.options.tooltipClass||"")),s=i.uniqueId().attr("id");return e("<div>").addClass("ui-tooltip-content").appendTo(i),i.appendTo(this.document[0].body),this.tooltips[s]={element:t,tooltip:i}},_find:function(e){var t=e.data("ui-tooltip-id");return t?this.tooltips[t]:null},_removeTooltip:function(e){e.remove(),delete this.tooltips[e.attr("id")]},_destroy:function(){var t=this;e.each(this.tooltips,function(i,s){var n=e.Event("blur"),a=s.element;n.target=n.currentTarget=a[0],t.close(n,!0),e("#"+i).remove(),a.data("ui-tooltip-title")&&(a.attr("title")||a.attr("title",a.data("ui-tooltip-title")),a.removeData("ui-tooltip-title"))}),this.liveRegion.remove()}});var c="ui-effects-",p=e;e.effects={effect:{}},function(e,t){function i(e,t,i){var s=d[t.type]||{};return null==e?i||!t.def?null:t.def:(e=s.floor?~~e:parseFloat(e),isNaN(e)?t.def:s.mod?(e+s.mod)%s.mod:0>e?0:e>s.max?s.max:e)}function s(i){var s=l(),n=s._rgba=[];return i=i.toLowerCase(),f(h,function(e,a){var o,r=a.re.exec(i),h=r&&a.parse(r),l=a.space||"rgba";return h?(o=s[l](h),s[u[l].cache]=o[u[l].cache],n=s._rgba=o._rgba,!1):t}),n.length?("0,0,0,0"===n.join()&&e.extend(n,a.transparent),s):a[i]}function n(e,t,i){return i=(i+1)%1,1>6*i?e+6*(t-e)*i:1>2*i?t:2>3*i?e+6*(t-e)*(2/3-i):e}var a,o="backgroundColor borderBottomColor borderLeftColor borderRightColor borderTopColor color columnRuleColor outlineColor textDecorationColor textEmphasisColor",r=/^([\-+])=\s*(\d+\.?\d*)/,h=[{re:/rgba?\(\s*(\d{1,3})\s*,\s*(\d{1,3})\s*,\s*(\d{1,3})\s*(?:,\s*(\d?(?:\.\d+)?)\s*)?\)/,parse:function(e){return[e[1],e[2],e[3],e[4]]}},{re:/rgba?\(\s*(\d+(?:\.\d+)?)\%\s*,\s*(\d+(?:\.\d+)?)\%\s*,\s*(\d+(?:\.\d+)?)\%\s*(?:,\s*(\d?(?:\.\d+)?)\s*)?\)/,parse:function(e){return[2.55*e[1],2.55*e[2],2.55*e[3],e[4]]}},{re:/#([a-f0-9]{2})([a-f0-9]{2})([a-f0-9]{2})/,parse:function(e){return[parseInt(e[1],16),parseInt(e[2],16),parseInt(e[3],16)]}},{re:/#([a-f0-9])([a-f0-9])([a-f0-9])/,parse:function(e){return[parseInt(e[1]+e[1],16),parseInt(e[2]+e[2],16),parseInt(e[3]+e[3],16)]}},{re:/hsla?\(\s*(\d+(?:\.\d+)?)\s*,\s*(\d+(?:\.\d+)?)\%\s*,\s*(\d+(?:\.\d+)?)\%\s*(?:,\s*(\d?(?:\.\d+)?)\s*)?\)/,space:"hsla",parse:function(e){return[e[1],e[2]/100,e[3]/100,e[4]]}}],l=e.Color=function(t,i,s,n){return new e.Color.fn.parse(t,i,s,n)},u={rgba:{props:{red:{idx:0,type:"byte"},green:{idx:1,type:"byte"},blue:{idx:2,type:"byte"}}},hsla:{props:{hue:{idx:0,type:"degrees"},saturation:{idx:1,type:"percent"},lightness:{idx:2,type:"percent"}}}},d={"byte":{floor:!0,max:255},percent:{max:1},degrees:{mod:360,floor:!0}},c=l.support={},p=e("<p>")[0],f=e.each;p.style.cssText="background-color:rgba(1,1,1,.5)",c.rgba=p.style.backgroundColor.indexOf("rgba")>-1,f(u,function(e,t){t.cache="_"+e,t.props.alpha={idx:3,type:"percent",def:1}}),l.fn=e.extend(l.prototype,{parse:function(n,o,r,h){if(n===t)return this._rgba=[null,null,null,null],this;(n.jquery||n.nodeType)&&(n=e(n).css(o),o=t);var d=this,c=e.type(n),p=this._rgba=[];return o!==t&&(n=[n,o,r,h],c="array"),"string"===c?this.parse(s(n)||a._default):"array"===c?(f(u.rgba.props,function(e,t){p[t.idx]=i(n[t.idx],t)}),this):"object"===c?(n instanceof l?f(u,function(e,t){n[t.cache]&&(d[t.cache]=n[t.cache].slice())}):f(u,function(t,s){var a=s.cache;f(s.props,function(e,t){if(!d[a]&&s.to){if("alpha"===e||null==n[e])return;d[a]=s.to(d._rgba)}d[a][t.idx]=i(n[e],t,!0)}),d[a]&&0>e.inArray(null,d[a].slice(0,3))&&(d[a][3]=1,s.from&&(d._rgba=s.from(d[a])))}),this):t},is:function(e){var i=l(e),s=!0,n=this;return f(u,function(e,a){var o,r=i[a.cache];return r&&(o=n[a.cache]||a.to&&a.to(n._rgba)||[],f(a.props,function(e,i){return null!=r[i.idx]?s=r[i.idx]===o[i.idx]:t})),s}),s},_space:function(){var e=[],t=this;return f(u,function(i,s){t[s.cache]&&e.push(i)}),e.pop()},transition:function(e,t){var s=l(e),n=s._space(),a=u[n],o=0===this.alpha()?l("transparent"):this,r=o[a.cache]||a.to(o._rgba),h=r.slice();return s=s[a.cache],f(a.props,function(e,n){var a=n.idx,o=r[a],l=s[a],u=d[n.type]||{};null!==l&&(null===o?h[a]=l:(u.mod&&(l-o>u.mod/2?o+=u.mod:o-l>u.mod/2&&(o-=u.mod)),h[a]=i((l-o)*t+o,n)))}),this[n](h)},blend:function(t){if(1===this._rgba[3])return this;var i=this._rgba.slice(),s=i.pop(),n=l(t)._rgba;return l(e.map(i,function(e,t){return(1-s)*n[t]+s*e}))},toRgbaString:function(){var t="rgba(",i=e.map(this._rgba,function(e,t){return null==e?t>2?1:0:e});return 1===i[3]&&(i.pop(),t="rgb("),t+i.join()+")"},toHslaString:function(){var t="hsla(",i=e.map(this.hsla(),function(e,t){return null==e&&(e=t>2?1:0),t&&3>t&&(e=Math.round(100*e)+"%"),e});return 1===i[3]&&(i.pop(),t="hsl("),t+i.join()+")"},toHexString:function(t){var i=this._rgba.slice(),s=i.pop();return t&&i.push(~~(255*s)),"#"+e.map(i,function(e){return e=(e||0).toString(16),1===e.length?"0"+e:e}).join("")},toString:function(){return 0===this._rgba[3]?"transparent":this.toRgbaString()}}),l.fn.parse.prototype=l.fn,u.hsla.to=function(e){if(null==e[0]||null==e[1]||null==e[2])return[null,null,null,e[3]];var t,i,s=e[0]/255,n=e[1]/255,a=e[2]/255,o=e[3],r=Math.max(s,n,a),h=Math.min(s,n,a),l=r-h,u=r+h,d=.5*u;return t=h===r?0:s===r?60*(n-a)/l+360:n===r?60*(a-s)/l+120:60*(s-n)/l+240,i=0===l?0:.5>=d?l/u:l/(2-u),[Math.round(t)%360,i,d,null==o?1:o]},u.hsla.from=function(e){if(null==e[0]||null==e[1]||null==e[2])return[null,null,null,e[3]];var t=e[0]/360,i=e[1],s=e[2],a=e[3],o=.5>=s?s*(1+i):s+i-s*i,r=2*s-o;return[Math.round(255*n(r,o,t+1/3)),Math.round(255*n(r,o,t)),Math.round(255*n(r,o,t-1/3)),a]},f(u,function(s,n){var a=n.props,o=n.cache,h=n.to,u=n.from;l.fn[s]=function(s){if(h&&!this[o]&&(this[o]=h(this._rgba)),s===t)return this[o].slice();var n,r=e.type(s),d="array"===r||"object"===r?s:arguments,c=this[o].slice();return f(a,function(e,t){var s=d["object"===r?e:t.idx];null==s&&(s=c[t.idx]),c[t.idx]=i(s,t)}),u?(n=l(u(c)),n[o]=c,n):l(c)},f(a,function(t,i){l.fn[t]||(l.fn[t]=function(n){var a,o=e.type(n),h="alpha"===t?this._hsla?"hsla":"rgba":s,l=this[h](),u=l[i.idx];return"undefined"===o?u:("function"===o&&(n=n.call(this,u),o=e.type(n)),null==n&&i.empty?this:("string"===o&&(a=r.exec(n),a&&(n=u+parseFloat(a[2])*("+"===a[1]?1:-1))),l[i.idx]=n,this[h](l)))})})}),l.hook=function(t){var i=t.split(" ");f(i,function(t,i){e.cssHooks[i]={set:function(t,n){var a,o,r="";if("transparent"!==n&&("string"!==e.type(n)||(a=s(n)))){if(n=l(a||n),!c.rgba&&1!==n._rgba[3]){for(o="backgroundColor"===i?t.parentNode:t;(""===r||"transparent"===r)&&o&&o.style;)try{r=e.css(o,"backgroundColor"),o=o.parentNode}catch(h){}n=n.blend(r&&"transparent"!==r?r:"_default")}n=n.toRgbaString()}try{t.style[i]=n}catch(h){}}},e.fx.step[i]=function(t){t.colorInit||(t.start=l(t.elem,i),t.end=l(t.end),t.colorInit=!0),e.cssHooks[i].set(t.elem,t.start.transition(t.end,t.pos))}})},l.hook(o),e.cssHooks.borderColor={expand:function(e){var t={};return f(["Top","Right","Bottom","Left"],function(i,s){t["border"+s+"Color"]=e}),t}},a=e.Color.names={aqua:"#00ffff",black:"#000000",blue:"#0000ff",fuchsia:"#ff00ff",gray:"#808080",green:"#008000",lime:"#00ff00",maroon:"#800000",navy:"#000080",olive:"#808000",purple:"#800080",red:"#ff0000",silver:"#c0c0c0",teal:"#008080",white:"#ffffff",yellow:"#ffff00",transparent:[null,null,null,0],_default:"#ffffff"}}(p),function(){function t(t){var i,s,n=t.ownerDocument.defaultView?t.ownerDocument.defaultView.getComputedStyle(t,null):t.currentStyle,a={};if(n&&n.length&&n[0]&&n[n[0]])for(s=n.length;s--;)i=n[s],"string"==typeof n[i]&&(a[e.camelCase(i)]=n[i]);else for(i in n)"string"==typeof n[i]&&(a[i]=n[i]);return a}function i(t,i){var s,a,o={};for(s in i)a=i[s],t[s]!==a&&(n[s]||(e.fx.step[s]||!isNaN(parseFloat(a)))&&(o[s]=a));return o}var s=["add","remove","toggle"],n={border:1,borderBottom:1,borderColor:1,borderLeft:1,borderRight:1,borderTop:1,borderWidth:1,margin:1,padding:1};e.each(["borderLeftStyle","borderRightStyle","borderBottomStyle","borderTopStyle"],function(t,i){e.fx.step[i]=function(e){("none"!==e.end&&!e.setAttr||1===e.pos&&!e.setAttr)&&(p.style(e.elem,i,e.end),e.setAttr=!0)}}),e.fn.addBack||(e.fn.addBack=function(e){return this.add(null==e?this.prevObject:this.prevObject.filter(e))}),e.effects.animateClass=function(n,a,o,r){var h=e.speed(a,o,r);return this.queue(function(){var a,o=e(this),r=o.attr("class")||"",l=h.children?o.find("*").addBack():o;l=l.map(function(){var i=e(this);return{el:i,start:t(this)}}),a=function(){e.each(s,function(e,t){n[t]&&o[t+"Class"](n[t])})},a(),l=l.map(function(){return this.end=t(this.el[0]),this.diff=i(this.start,this.end),this}),o.attr("class",r),l=l.map(function(){var t=this,i=e.Deferred(),s=e.extend({},h,{queue:!1,complete:function(){i.resolve(t)}});return this.el.animate(this.diff,s),i.promise()}),e.when.apply(e,l.get()).done(function(){a(),e.each(arguments,function(){var t=this.el;e.each(this.diff,function(e){t.css(e,"")})}),h.complete.call(o[0])})})},e.fn.extend({addClass:function(t){return function(i,s,n,a){return s?e.effects.animateClass.call(this,{add:i},s,n,a):t.apply(this,arguments)}}(e.fn.addClass),removeClass:function(t){return function(i,s,n,a){return arguments.length>1?e.effects.animateClass.call(this,{remove:i},s,n,a):t.apply(this,arguments)}}(e.fn.removeClass),toggleClass:function(t){return function(i,s,n,a,o){return"boolean"==typeof s||void 0===s?n?e.effects.animateClass.call(this,s?{add:i}:{remove:i},n,a,o):t.apply(this,arguments):e.effects.animateClass.call(this,{toggle:i},s,n,a)}}(e.fn.toggleClass),switchClass:function(t,i,s,n,a){return e.effects.animateClass.call(this,{add:i,remove:t},s,n,a)}})}(),function(){function t(t,i,s,n){return e.isPlainObject(t)&&(i=t,t=t.effect),t={effect:t},null==i&&(i={}),e.isFunction(i)&&(n=i,s=null,i={}),("number"==typeof i||e.fx.speeds[i])&&(n=s,s=i,i={}),e.isFunction(s)&&(n=s,s=null),i&&e.extend(t,i),s=s||i.duration,t.duration=e.fx.off?0:"number"==typeof s?s:s in e.fx.speeds?e.fx.speeds[s]:e.fx.speeds._default,t.complete=n||i.complete,t}function i(t){return!t||"number"==typeof t||e.fx.speeds[t]?!0:"string"!=typeof t||e.effects.effect[t]?e.isFunction(t)?!0:"object"!=typeof t||t.effect?!1:!0:!0}e.extend(e.effects,{version:"1.11.4",save:function(e,t){for(var i=0;t.length>i;i++)null!==t[i]&&e.data(c+t[i],e[0].style[t[i]])},restore:function(e,t){var i,s;for(s=0;t.length>s;s++)null!==t[s]&&(i=e.data(c+t[s]),void 0===i&&(i=""),e.css(t[s],i))},setMode:function(e,t){return"toggle"===t&&(t=e.is(":hidden")?"show":"hide"),t},getBaseline:function(e,t){var i,s;switch(e[0]){case"top":i=0;break;case"middle":i=.5;break;case"bottom":i=1;break;default:i=e[0]/t.height}switch(e[1]){case"left":s=0;break;case"center":s=.5;break;case"right":s=1;break;default:s=e[1]/t.width}return{x:s,y:i}},createWrapper:function(t){if(t.parent().is(".ui-effects-wrapper"))return t.parent();var i={width:t.outerWidth(!0),height:t.outerHeight(!0),"float":t.css("float")},s=e("<div></div>").addClass("ui-effects-wrapper").css({fontSize:"100%",background:"transparent",border:"none",margin:0,padding:0}),n={width:t.width(),height:t.height()},a=document.activeElement;try{a.id}catch(o){a=document.body}return t.wrap(s),(t[0]===a||e.contains(t[0],a))&&e(a).focus(),s=t.parent(),"static"===t.css("position")?(s.css({position:"relative"}),t.css({position:"relative"})):(e.extend(i,{position:t.css("position"),zIndex:t.css("z-index")}),e.each(["top","left","bottom","right"],function(e,s){i[s]=t.css(s),isNaN(parseInt(i[s],10))&&(i[s]="auto")}),t.css({position:"relative",top:0,left:0,right:"auto",bottom:"auto"})),t.css(n),s.css(i).show()},removeWrapper:function(t){var i=document.activeElement;return t.parent().is(".ui-effects-wrapper")&&(t.parent().replaceWith(t),(t[0]===i||e.contains(t[0],i))&&e(i).focus()),t},setTransition:function(t,i,s,n){return n=n||{},e.each(i,function(e,i){var a=t.cssUnit(i);a[0]>0&&(n[i]=a[0]*s+a[1])}),n}}),e.fn.extend({effect:function(){function i(t){function i(){e.isFunction(a)&&a.call(n[0]),e.isFunction(t)&&t()}var n=e(this),a=s.complete,r=s.mode;(n.is(":hidden")?"hide"===r:"show"===r)?(n[r](),i()):o.call(n[0],s,i)}var s=t.apply(this,arguments),n=s.mode,a=s.queue,o=e.effects.effect[s.effect];return e.fx.off||!o?n?this[n](s.duration,s.complete):this.each(function(){s.complete&&s.complete.call(this)}):a===!1?this.each(i):this.queue(a||"fx",i)},show:function(e){return function(s){if(i(s))return e.apply(this,arguments);var n=t.apply(this,arguments);return n.mode="show",this.effect.call(this,n)}}(e.fn.show),hide:function(e){return function(s){if(i(s))return e.apply(this,arguments);var n=t.apply(this,arguments);return n.mode="hide",this.effect.call(this,n)}}(e.fn.hide),toggle:function(e){return function(s){if(i(s)||"boolean"==typeof s)return e.apply(this,arguments);var n=t.apply(this,arguments);return n.mode="toggle",this.effect.call(this,n)}}(e.fn.toggle),cssUnit:function(t){var i=this.css(t),s=[];return e.each(["em","px","%","pt"],function(e,t){i.indexOf(t)>0&&(s=[parseFloat(i),t])}),s}})}(),function(){var t={};e.each(["Quad","Cubic","Quart","Quint","Expo"],function(e,i){t[i]=function(t){return Math.pow(t,e+2)}}),e.extend(t,{Sine:function(e){return 1-Math.cos(e*Math.PI/2)},Circ:function(e){return 1-Math.sqrt(1-e*e)},Elastic:function(e){return 0===e||1===e?e:-Math.pow(2,8*(e-1))*Math.sin((80*(e-1)-7.5)*Math.PI/15)},Back:function(e){return e*e*(3*e-2)},Bounce:function(e){for(var t,i=4;((t=Math.pow(2,--i))-1)/11>e;);return 1/Math.pow(4,3-i)-7.5625*Math.pow((3*t-2)/22-e,2)}}),e.each(t,function(t,i){e.easing["easeIn"+t]=i,e.easing["easeOut"+t]=function(e){return 1-i(1-e)},e.easing["easeInOut"+t]=function(e){return.5>e?i(2*e)/2:1-i(-2*e+2)/2}})}(),e.effects,e.effects.effect.blind=function(t,i){var s,n,a,o=e(this),r=/up|down|vertical/,h=/up|left|vertical|horizontal/,l=["position","top","bottom","left","right","height","width"],u=e.effects.setMode(o,t.mode||"hide"),d=t.direction||"up",c=r.test(d),p=c?"height":"width",f=c?"top":"left",m=h.test(d),g={},v="show"===u;o.parent().is(".ui-effects-wrapper")?e.effects.save(o.parent(),l):e.effects.save(o,l),o.show(),s=e.effects.createWrapper(o).css({overflow:"hidden"}),n=s[p](),a=parseFloat(s.css(f))||0,g[p]=v?n:0,m||(o.css(c?"bottom":"right",0).css(c?"top":"left","auto").css({position:"absolute"}),g[f]=v?a:n+a),v&&(s.css(p,0),m||s.css(f,a+n)),s.animate(g,{duration:t.duration,easing:t.easing,queue:!1,complete:function(){"hide"===u&&o.hide(),e.effects.restore(o,l),e.effects.removeWrapper(o),i()
}})},e.effects.effect.bounce=function(t,i){var s,n,a,o=e(this),r=["position","top","bottom","left","right","height","width"],h=e.effects.setMode(o,t.mode||"effect"),l="hide"===h,u="show"===h,d=t.direction||"up",c=t.distance,p=t.times||5,f=2*p+(u||l?1:0),m=t.duration/f,g=t.easing,v="up"===d||"down"===d?"top":"left",y="up"===d||"left"===d,b=o.queue(),_=b.length;for((u||l)&&r.push("opacity"),e.effects.save(o,r),o.show(),e.effects.createWrapper(o),c||(c=o["top"===v?"outerHeight":"outerWidth"]()/3),u&&(a={opacity:1},a[v]=0,o.css("opacity",0).css(v,y?2*-c:2*c).animate(a,m,g)),l&&(c/=Math.pow(2,p-1)),a={},a[v]=0,s=0;p>s;s++)n={},n[v]=(y?"-=":"+=")+c,o.animate(n,m,g).animate(a,m,g),c=l?2*c:c/2;l&&(n={opacity:0},n[v]=(y?"-=":"+=")+c,o.animate(n,m,g)),o.queue(function(){l&&o.hide(),e.effects.restore(o,r),e.effects.removeWrapper(o),i()}),_>1&&b.splice.apply(b,[1,0].concat(b.splice(_,f+1))),o.dequeue()},e.effects.effect.clip=function(t,i){var s,n,a,o=e(this),r=["position","top","bottom","left","right","height","width"],h=e.effects.setMode(o,t.mode||"hide"),l="show"===h,u=t.direction||"vertical",d="vertical"===u,c=d?"height":"width",p=d?"top":"left",f={};e.effects.save(o,r),o.show(),s=e.effects.createWrapper(o).css({overflow:"hidden"}),n="IMG"===o[0].tagName?s:o,a=n[c](),l&&(n.css(c,0),n.css(p,a/2)),f[c]=l?a:0,f[p]=l?0:a/2,n.animate(f,{queue:!1,duration:t.duration,easing:t.easing,complete:function(){l||o.hide(),e.effects.restore(o,r),e.effects.removeWrapper(o),i()}})},e.effects.effect.drop=function(t,i){var s,n=e(this),a=["position","top","bottom","left","right","opacity","height","width"],o=e.effects.setMode(n,t.mode||"hide"),r="show"===o,h=t.direction||"left",l="up"===h||"down"===h?"top":"left",u="up"===h||"left"===h?"pos":"neg",d={opacity:r?1:0};e.effects.save(n,a),n.show(),e.effects.createWrapper(n),s=t.distance||n["top"===l?"outerHeight":"outerWidth"](!0)/2,r&&n.css("opacity",0).css(l,"pos"===u?-s:s),d[l]=(r?"pos"===u?"+=":"-=":"pos"===u?"-=":"+=")+s,n.animate(d,{queue:!1,duration:t.duration,easing:t.easing,complete:function(){"hide"===o&&n.hide(),e.effects.restore(n,a),e.effects.removeWrapper(n),i()}})},e.effects.effect.explode=function(t,i){function s(){b.push(this),b.length===d*c&&n()}function n(){p.css({visibility:"visible"}),e(b).remove(),m||p.hide(),i()}var a,o,r,h,l,u,d=t.pieces?Math.round(Math.sqrt(t.pieces)):3,c=d,p=e(this),f=e.effects.setMode(p,t.mode||"hide"),m="show"===f,g=p.show().css("visibility","hidden").offset(),v=Math.ceil(p.outerWidth()/c),y=Math.ceil(p.outerHeight()/d),b=[];for(a=0;d>a;a++)for(h=g.top+a*y,u=a-(d-1)/2,o=0;c>o;o++)r=g.left+o*v,l=o-(c-1)/2,p.clone().appendTo("body").wrap("<div></div>").css({position:"absolute",visibility:"visible",left:-o*v,top:-a*y}).parent().addClass("ui-effects-explode").css({position:"absolute",overflow:"hidden",width:v,height:y,left:r+(m?l*v:0),top:h+(m?u*y:0),opacity:m?0:1}).animate({left:r+(m?0:l*v),top:h+(m?0:u*y),opacity:m?1:0},t.duration||500,t.easing,s)},e.effects.effect.fade=function(t,i){var s=e(this),n=e.effects.setMode(s,t.mode||"toggle");s.animate({opacity:n},{queue:!1,duration:t.duration,easing:t.easing,complete:i})},e.effects.effect.fold=function(t,i){var s,n,a=e(this),o=["position","top","bottom","left","right","height","width"],r=e.effects.setMode(a,t.mode||"hide"),h="show"===r,l="hide"===r,u=t.size||15,d=/([0-9]+)%/.exec(u),c=!!t.horizFirst,p=h!==c,f=p?["width","height"]:["height","width"],m=t.duration/2,g={},v={};e.effects.save(a,o),a.show(),s=e.effects.createWrapper(a).css({overflow:"hidden"}),n=p?[s.width(),s.height()]:[s.height(),s.width()],d&&(u=parseInt(d[1],10)/100*n[l?0:1]),h&&s.css(c?{height:0,width:u}:{height:u,width:0}),g[f[0]]=h?n[0]:u,v[f[1]]=h?n[1]:0,s.animate(g,m,t.easing).animate(v,m,t.easing,function(){l&&a.hide(),e.effects.restore(a,o),e.effects.removeWrapper(a),i()})},e.effects.effect.highlight=function(t,i){var s=e(this),n=["backgroundImage","backgroundColor","opacity"],a=e.effects.setMode(s,t.mode||"show"),o={backgroundColor:s.css("backgroundColor")};"hide"===a&&(o.opacity=0),e.effects.save(s,n),s.show().css({backgroundImage:"none",backgroundColor:t.color||"#ffff99"}).animate(o,{queue:!1,duration:t.duration,easing:t.easing,complete:function(){"hide"===a&&s.hide(),e.effects.restore(s,n),i()}})},e.effects.effect.size=function(t,i){var s,n,a,o=e(this),r=["position","top","bottom","left","right","width","height","overflow","opacity"],h=["position","top","bottom","left","right","overflow","opacity"],l=["width","height","overflow"],u=["fontSize"],d=["borderTopWidth","borderBottomWidth","paddingTop","paddingBottom"],c=["borderLeftWidth","borderRightWidth","paddingLeft","paddingRight"],p=e.effects.setMode(o,t.mode||"effect"),f=t.restore||"effect"!==p,m=t.scale||"both",g=t.origin||["middle","center"],v=o.css("position"),y=f?r:h,b={height:0,width:0,outerHeight:0,outerWidth:0};"show"===p&&o.show(),s={height:o.height(),width:o.width(),outerHeight:o.outerHeight(),outerWidth:o.outerWidth()},"toggle"===t.mode&&"show"===p?(o.from=t.to||b,o.to=t.from||s):(o.from=t.from||("show"===p?b:s),o.to=t.to||("hide"===p?b:s)),a={from:{y:o.from.height/s.height,x:o.from.width/s.width},to:{y:o.to.height/s.height,x:o.to.width/s.width}},("box"===m||"both"===m)&&(a.from.y!==a.to.y&&(y=y.concat(d),o.from=e.effects.setTransition(o,d,a.from.y,o.from),o.to=e.effects.setTransition(o,d,a.to.y,o.to)),a.from.x!==a.to.x&&(y=y.concat(c),o.from=e.effects.setTransition(o,c,a.from.x,o.from),o.to=e.effects.setTransition(o,c,a.to.x,o.to))),("content"===m||"both"===m)&&a.from.y!==a.to.y&&(y=y.concat(u).concat(l),o.from=e.effects.setTransition(o,u,a.from.y,o.from),o.to=e.effects.setTransition(o,u,a.to.y,o.to)),e.effects.save(o,y),o.show(),e.effects.createWrapper(o),o.css("overflow","hidden").css(o.from),g&&(n=e.effects.getBaseline(g,s),o.from.top=(s.outerHeight-o.outerHeight())*n.y,o.from.left=(s.outerWidth-o.outerWidth())*n.x,o.to.top=(s.outerHeight-o.to.outerHeight)*n.y,o.to.left=(s.outerWidth-o.to.outerWidth)*n.x),o.css(o.from),("content"===m||"both"===m)&&(d=d.concat(["marginTop","marginBottom"]).concat(u),c=c.concat(["marginLeft","marginRight"]),l=r.concat(d).concat(c),o.find("*[width]").each(function(){var i=e(this),s={height:i.height(),width:i.width(),outerHeight:i.outerHeight(),outerWidth:i.outerWidth()};f&&e.effects.save(i,l),i.from={height:s.height*a.from.y,width:s.width*a.from.x,outerHeight:s.outerHeight*a.from.y,outerWidth:s.outerWidth*a.from.x},i.to={height:s.height*a.to.y,width:s.width*a.to.x,outerHeight:s.height*a.to.y,outerWidth:s.width*a.to.x},a.from.y!==a.to.y&&(i.from=e.effects.setTransition(i,d,a.from.y,i.from),i.to=e.effects.setTransition(i,d,a.to.y,i.to)),a.from.x!==a.to.x&&(i.from=e.effects.setTransition(i,c,a.from.x,i.from),i.to=e.effects.setTransition(i,c,a.to.x,i.to)),i.css(i.from),i.animate(i.to,t.duration,t.easing,function(){f&&e.effects.restore(i,l)})})),o.animate(o.to,{queue:!1,duration:t.duration,easing:t.easing,complete:function(){0===o.to.opacity&&o.css("opacity",o.from.opacity),"hide"===p&&o.hide(),e.effects.restore(o,y),f||("static"===v?o.css({position:"relative",top:o.to.top,left:o.to.left}):e.each(["top","left"],function(e,t){o.css(t,function(t,i){var s=parseInt(i,10),n=e?o.to.left:o.to.top;return"auto"===i?n+"px":s+n+"px"})})),e.effects.removeWrapper(o),i()}})},e.effects.effect.scale=function(t,i){var s=e(this),n=e.extend(!0,{},t),a=e.effects.setMode(s,t.mode||"effect"),o=parseInt(t.percent,10)||(0===parseInt(t.percent,10)?0:"hide"===a?0:100),r=t.direction||"both",h=t.origin,l={height:s.height(),width:s.width(),outerHeight:s.outerHeight(),outerWidth:s.outerWidth()},u={y:"horizontal"!==r?o/100:1,x:"vertical"!==r?o/100:1};n.effect="size",n.queue=!1,n.complete=i,"effect"!==a&&(n.origin=h||["middle","center"],n.restore=!0),n.from=t.from||("show"===a?{height:0,width:0,outerHeight:0,outerWidth:0}:l),n.to={height:l.height*u.y,width:l.width*u.x,outerHeight:l.outerHeight*u.y,outerWidth:l.outerWidth*u.x},n.fade&&("show"===a&&(n.from.opacity=0,n.to.opacity=1),"hide"===a&&(n.from.opacity=1,n.to.opacity=0)),s.effect(n)},e.effects.effect.puff=function(t,i){var s=e(this),n=e.effects.setMode(s,t.mode||"hide"),a="hide"===n,o=parseInt(t.percent,10)||150,r=o/100,h={height:s.height(),width:s.width(),outerHeight:s.outerHeight(),outerWidth:s.outerWidth()};e.extend(t,{effect:"scale",queue:!1,fade:!0,mode:n,complete:i,percent:a?o:100,from:a?h:{height:h.height*r,width:h.width*r,outerHeight:h.outerHeight*r,outerWidth:h.outerWidth*r}}),s.effect(t)},e.effects.effect.pulsate=function(t,i){var s,n=e(this),a=e.effects.setMode(n,t.mode||"show"),o="show"===a,r="hide"===a,h=o||"hide"===a,l=2*(t.times||5)+(h?1:0),u=t.duration/l,d=0,c=n.queue(),p=c.length;for((o||!n.is(":visible"))&&(n.css("opacity",0).show(),d=1),s=1;l>s;s++)n.animate({opacity:d},u,t.easing),d=1-d;n.animate({opacity:d},u,t.easing),n.queue(function(){r&&n.hide(),i()}),p>1&&c.splice.apply(c,[1,0].concat(c.splice(p,l+1))),n.dequeue()},e.effects.effect.shake=function(t,i){var s,n=e(this),a=["position","top","bottom","left","right","height","width"],o=e.effects.setMode(n,t.mode||"effect"),r=t.direction||"left",h=t.distance||20,l=t.times||3,u=2*l+1,d=Math.round(t.duration/u),c="up"===r||"down"===r?"top":"left",p="up"===r||"left"===r,f={},m={},g={},v=n.queue(),y=v.length;for(e.effects.save(n,a),n.show(),e.effects.createWrapper(n),f[c]=(p?"-=":"+=")+h,m[c]=(p?"+=":"-=")+2*h,g[c]=(p?"-=":"+=")+2*h,n.animate(f,d,t.easing),s=1;l>s;s++)n.animate(m,d,t.easing).animate(g,d,t.easing);n.animate(m,d,t.easing).animate(f,d/2,t.easing).queue(function(){"hide"===o&&n.hide(),e.effects.restore(n,a),e.effects.removeWrapper(n),i()}),y>1&&v.splice.apply(v,[1,0].concat(v.splice(y,u+1))),n.dequeue()},e.effects.effect.slide=function(t,i){var s,n=e(this),a=["position","top","bottom","left","right","width","height"],o=e.effects.setMode(n,t.mode||"show"),r="show"===o,h=t.direction||"left",l="up"===h||"down"===h?"top":"left",u="up"===h||"left"===h,d={};e.effects.save(n,a),n.show(),s=t.distance||n["top"===l?"outerHeight":"outerWidth"](!0),e.effects.createWrapper(n).css({overflow:"hidden"}),r&&n.css(l,u?isNaN(s)?"-"+s:-s:s),d[l]=(r?u?"+=":"-=":u?"-=":"+=")+s,n.animate(d,{queue:!1,duration:t.duration,easing:t.easing,complete:function(){"hide"===o&&n.hide(),e.effects.restore(n,a),e.effects.removeWrapper(n),i()}})},e.effects.effect.transfer=function(t,i){var s=e(this),n=e(t.to),a="fixed"===n.css("position"),o=e("body"),r=a?o.scrollTop():0,h=a?o.scrollLeft():0,l=n.offset(),u={top:l.top-r,left:l.left-h,height:n.innerHeight(),width:n.innerWidth()},d=s.offset(),c=e("<div class='ui-effects-transfer'></div>").appendTo(document.body).addClass(t.className).css({top:d.top-r,left:d.left-h,height:s.innerHeight(),width:s.innerWidth(),position:a?"fixed":"absolute"}).animate(u,t.duration,t.easing,function(){c.remove(),i()})}});</script>
<style type="text/css">

.tocify {
width: 20%;
max-height: 90%;
overflow: auto;
margin-left: 2%;
position: fixed;
border: 1px solid #ccc;
border-radius: 6px;
}

.tocify ul, .tocify li {
list-style: none;
margin: 0;
padding: 0;
border: none;
line-height: 30px;
}

.tocify-header {
text-indent: 10px;
}

.tocify-subheader {
text-indent: 20px;
display: none;
}

.tocify-subheader li {
font-size: 12px;
}

.tocify-subheader .tocify-subheader {
text-indent: 30px;
}
.tocify-subheader .tocify-subheader .tocify-subheader {
text-indent: 40px;
}
.tocify-subheader .tocify-subheader .tocify-subheader .tocify-subheader {
text-indent: 50px;
}
.tocify-subheader .tocify-subheader .tocify-subheader .tocify-subheader .tocify-subheader {
text-indent: 60px;
}

.tocify .tocify-item > a, .tocify .nav-list .nav-header {
margin: 0px;
}

.tocify .tocify-item a, .tocify .list-group-item {
padding: 5px;
}
.tocify .nav-pills > li {
float: none;
}


</style>
<script>/* jquery Tocify - v1.9.1 - 2013-10-22
 * http://www.gregfranko.com/jquery.tocify.js/
 * Copyright (c) 2013 Greg Franko; Licensed MIT */

// Immediately-Invoked Function Expression (IIFE) [Ben Alman Blog Post](http://benalman.com/news/2010/11/immediately-invoked-function-expression/) that calls another IIFE that contains all of the plugin logic.  I used this pattern so that anyone viewing this code would not have to scroll to the bottom of the page to view the local parameters that were passed to the main IIFE.
(function(tocify) {

    // ECMAScript 5 Strict Mode: [John Resig Blog Post](http://ejohn.org/blog/ecmascript-5-strict-mode-json-and-more/)
    "use strict";

    // Calls the second IIFE and locally passes in the global jQuery, window, and document objects
    tocify(window.jQuery, window, document);

  }

  // Locally passes in `jQuery`, the `window` object, the `document` object, and an `undefined` variable.  The `jQuery`, `window` and `document` objects are passed in locally, to improve performance, since javascript first searches for a variable match within the local variables set before searching the global variables set.  All of the global variables are also passed in locally to be minifier friendly. `undefined` can be passed in locally, because it is not a reserved word in JavaScript.
  (function($, window, document, undefined) {

    // ECMAScript 5 Strict Mode: [John Resig Blog Post](http://ejohn.org/blog/ecmascript-5-strict-mode-json-and-more/)
    "use strict";

    var tocClassName = "tocify",
      tocClass = "." + tocClassName,
      tocFocusClassName = "tocify-focus",
      tocHoverClassName = "tocify-hover",
      hideTocClassName = "tocify-hide",
      hideTocClass = "." + hideTocClassName,
      headerClassName = "tocify-header",
      headerClass = "." + headerClassName,
      subheaderClassName = "tocify-subheader",
      subheaderClass = "." + subheaderClassName,
      itemClassName = "tocify-item",
      itemClass = "." + itemClassName,
      extendPageClassName = "tocify-extend-page",
      extendPageClass = "." + extendPageClassName;

    // Calling the jQueryUI Widget Factory Method
    $.widget("toc.tocify", {

      //Plugin version
      version: "1.9.1",

      // These options will be used as defaults
      options: {

        // **context**: Accepts String: Any jQuery selector
        // The container element that holds all of the elements used to generate the table of contents
        context: "body",

        // **ignoreSelector**: Accepts String: Any jQuery selector
        // A selector to any element that would be matched by selectors that you wish to be ignored
        ignoreSelector: null,

        // **selectors**: Accepts an Array of Strings: Any jQuery selectors
        // The element's used to generate the table of contents.  The order is very important since it will determine the table of content's nesting structure
        selectors: "h1, h2, h3",

        // **showAndHide**: Accepts a boolean: true or false
        // Used to determine if elements should be shown and hidden
        showAndHide: true,

        // **showEffect**: Accepts String: "none", "fadeIn", "show", or "slideDown"
        // Used to display any of the table of contents nested items
        showEffect: "slideDown",

        // **showEffectSpeed**: Accepts Number (milliseconds) or String: "slow", "medium", or "fast"
        // The time duration of the show animation
        showEffectSpeed: "medium",

        // **hideEffect**: Accepts String: "none", "fadeOut", "hide", or "slideUp"
        // Used to hide any of the table of contents nested items
        hideEffect: "slideUp",

        // **hideEffectSpeed**: Accepts Number (milliseconds) or String: "slow", "medium", or "fast"
        // The time duration of the hide animation
        hideEffectSpeed: "medium",

        // **smoothScroll**: Accepts a boolean: true or false
        // Determines if a jQuery animation should be used to scroll to specific table of contents items on the page
        smoothScroll: true,

        // **smoothScrollSpeed**: Accepts Number (milliseconds) or String: "slow", "medium", or "fast"
        // The time duration of the smoothScroll animation
        smoothScrollSpeed: "medium",

        // **scrollTo**: Accepts Number (pixels)
        // The amount of space between the top of page and the selected table of contents item after the page has been scrolled
        scrollTo: 0,

        // **showAndHideOnScroll**: Accepts a boolean: true or false
        // Determines if table of contents nested items should be shown and hidden while scrolling
        showAndHideOnScroll: true,

        // **highlightOnScroll**: Accepts a boolean: true or false
        // Determines if table of contents nested items should be highlighted (set to a different color) while scrolling
        highlightOnScroll: true,

        // **highlightOffset**: Accepts a number
        // The offset distance in pixels to trigger the next active table of contents item
        highlightOffset: 40,

        // **theme**: Accepts a string: "bootstrap", "jqueryui", or "none"
        // Determines if Twitter Bootstrap, jQueryUI, or Tocify classes should be added to the table of contents
        theme: "bootstrap",

        // **extendPage**: Accepts a boolean: true or false
        // If a user scrolls to the bottom of the page and the page is not tall enough to scroll to the last table of contents item, then the page height is increased
        extendPage: true,

        // **extendPageOffset**: Accepts a number: pixels
        // How close to the bottom of the page a user must scroll before the page is extended
        extendPageOffset: 100,

        // **history**: Accepts a boolean: true or false
        // Adds a hash to the page url to maintain history
        history: true,

        // **scrollHistory**: Accepts a boolean: true or false
        // Adds a hash to the page url, to maintain history, when scrolling to a TOC item
        scrollHistory: false,

        // **hashGenerator**: How the hash value (the anchor segment of the URL, following the
        // # character) will be generated.
        //
        // "compact" (default) - #CompressesEverythingTogether
        // "pretty" - #looks-like-a-nice-url-and-is-easily-readable
        // function(text, element){} - Your own hash generation function that accepts the text as an
        // argument, and returns the hash value.
        hashGenerator: "compact",

        // **highlightDefault**: Accepts a boolean: true or false
        // Set's the first TOC item as active if no other TOC item is active.
        highlightDefault: true

      },

      // _Create
      // -------
      //      Constructs the plugin.  Only called once.
      _create: function() {

        var self = this;

        self.extendPageScroll = true;

        // Internal array that keeps track of all TOC items (Helps to recognize if there are duplicate TOC item strings)
        self.items = [];

        // Generates the HTML for the dynamic table of contents
        self._generateToc();

        // Adds CSS classes to the newly generated table of contents HTML
        self._addCSSClasses();

        self.webkit = (function() {

          for (var prop in window) {

            if (prop) {

              if (prop.toLowerCase().indexOf("webkit") !== -1) {

                return true;

              }

            }

          }

          return false;

        }());

        // Adds jQuery event handlers to the newly generated table of contents
        self._setEventHandlers();

        // Binding to the Window load event to make sure the correct scrollTop is calculated
        $(window).load(function() {

          // Sets the active TOC item
          self._setActiveElement(true);

          // Once all animations on the page are complete, this callback function will be called
          $("html, body").promise().done(function() {

            setTimeout(function() {

              self.extendPageScroll = false;

            }, 0);

          });

        });

      },

      // _generateToc
      // ------------
      //      Generates the HTML for the dynamic table of contents
      _generateToc: function() {

        // _Local variables_

        // Stores the plugin context in the self variable
        var self = this,

          // All of the HTML tags found within the context provided (i.e. body) that match the top level jQuery selector above
          firstElem,

          // Instantiated variable that will store the top level newly created unordered list DOM element
          ul,
          ignoreSelector = self.options.ignoreSelector;


        // Determine the element to start the toc with
        // get all the top level selectors
        firstElem = [];
        var selectors = this.options.selectors.replace(/ /g, "").split(",");
        // find the first set that have at least one non-ignored element
        for(var i = 0; i < selectors.length; i++) {
          var foundSelectors = $(this.options.context).find(selectors[i]);
          for (var s = 0; s < foundSelectors.length; s++) {
            if (!$(foundSelectors[s]).is(ignoreSelector)) {
              firstElem = foundSelectors;
              break;
            }
          }
          if (firstElem.length> 0)
            break;
        }

        if (!firstElem.length) {

          self.element.addClass(hideTocClassName);

          return;

        }

        self.element.addClass(tocClassName);

        // Loops through each top level selector
        firstElem.each(function(index) {

          //If the element matches the ignoreSelector then we skip it
          if ($(this).is(ignoreSelector)) {
            return;
          }

          // Creates an unordered list HTML element and adds a dynamic ID and standard class name
          ul = $("<ul/>", {
            "id": headerClassName + index,
            "class": headerClassName
          }).

          // Appends a top level list item HTML element to the previously created HTML header
          append(self._nestElements($(this), index));

          // Add the created unordered list element to the HTML element calling the plugin
          self.element.append(ul);

          // Finds all of the HTML tags between the header and subheader elements
          $(this).nextUntil(this.nodeName.toLowerCase()).each(function() {

            // If there are no nested subheader elemements
            if ($(this).find(self.options.selectors).length === 0) {

              // Loops through all of the subheader elements
              $(this).filter(self.options.selectors).each(function() {

                //If the element matches the ignoreSelector then we skip it
                if ($(this).is(ignoreSelector)) {
                  return;
                }

                self._appendSubheaders.call(this, self, ul);

              });

            }

            // If there are nested subheader elements
            else {

              // Loops through all of the subheader elements
              $(this).find(self.options.selectors).each(function() {

                //If the element matches the ignoreSelector then we skip it
                if ($(this).is(ignoreSelector)) {
                  return;
                }

                self._appendSubheaders.call(this, self, ul);

              });

            }

          });

        });

      },

      _setActiveElement: function(pageload) {

        var self = this,

          hash = window.location.hash.substring(1),

          elem = self.element.find('li[data-unique="' + hash + '"]');

        if (hash.length) {

          // Removes highlighting from all of the list item's
          self.element.find("." + self.focusClass).removeClass(self.focusClass);

          // Highlights the current list item that was clicked
          elem.addClass(self.focusClass);

          // Triggers the click event on the currently focused TOC item
          elem.click();

        } else {

          // Removes highlighting from all of the list item's
          self.element.find("." + self.focusClass).removeClass(self.focusClass);

          if (!hash.length && pageload && self.options.highlightDefault) {

            // Highlights the first TOC item if no other items are highlighted
            self.element.find(itemClass).first().addClass(self.focusClass);

          }

        }

        return self;

      },

      // _nestElements
      // -------------
      //      Helps create the table of contents list by appending nested list items
      _nestElements: function(self, index) {

        var arr, item, hashValue;

        arr = $.grep(this.items, function(item) {

          return item === self.text();

        });

        // If there is already a duplicate TOC item
        if (arr.length) {

          // Adds the current TOC item text and index (for slight randomization) to the internal array
          this.items.push(self.text() + index);

        }

        // If there not a duplicate TOC item
        else {

          // Adds the current TOC item text to the internal array
          this.items.push(self.text());

        }

        hashValue = this._generateHashValue(arr, self, index);

        // Appends a list item HTML element to the last unordered list HTML element found within the HTML element calling the plugin
        item = $("<li/>", {

          // Sets a common class name to the list item
          "class": itemClassName,

          "data-unique": hashValue

        });

        if (this.options.theme !== "bootstrap3") {

          item.append($("<a/>", {

            "html": self.html()

          }));

        } else {

          item.html(self.html());

        }

        // Adds an HTML anchor tag before the currently traversed HTML element
        self.before($("<div/>", {

          // Sets a name attribute on the anchor tag to the text of the currently traversed HTML element (also making sure that all whitespace is replaced with an underscore)
          "name": hashValue,

          "data-unique": hashValue

        }));

        return item;

      },

      // _generateHashValue
      // ------------------
      //      Generates the hash value that will be used to refer to each item.
      _generateHashValue: function(arr, self, index) {

        var hashValue = "",
          hashGeneratorOption = this.options.hashGenerator;

        if (hashGeneratorOption === "pretty") {

          // prettify the text
          hashValue = self.text().toLowerCase().replace(/\s/g, "-");

          // fix double hyphens
          while (hashValue.indexOf("--") > -1) {
            hashValue = hashValue.replace(/--/g, "-");
          }

          // fix colon-space instances
          while (hashValue.indexOf(":-") > -1) {
            hashValue = hashValue.replace(/:-/g, "-");
          }

        } else if (typeof hashGeneratorOption === "function") {

          // call the function
          hashValue = hashGeneratorOption(self.text(), self);

        } else {

          // compact - the default
          hashValue = self.text().replace(/\s/g, "");

        }

        // add the index if we need to
        if (arr.length) {
          hashValue += "" + index;
        }

        // return the value
        return hashValue;

      },

      // _appendElements
      // ---------------
      //      Helps create the table of contents list by appending subheader elements

      _appendSubheaders: function(self, ul) {

        // The current element index
        var index = $(this).index(self.options.selectors),

          // Finds the previous header DOM element
          previousHeader = $(self.options.selectors).eq(index - 1),

          currentTagName = +$(this).prop("tagName").charAt(1),

          previousTagName = +previousHeader.prop("tagName").charAt(1),

          lastSubheader;

        // If the current header DOM element is smaller than the previous header DOM element or the first subheader
        if (currentTagName < previousTagName) {

          // Selects the last unordered list HTML found within the HTML element calling the plugin
          self.element.find(subheaderClass + "[data-tag=" + currentTagName + "]").last().append(self._nestElements($(this), index));

        }

        // If the current header DOM element is the same type of header(eg. h4) as the previous header DOM element
        else if (currentTagName === previousTagName) {

          ul.find(itemClass).last().after(self._nestElements($(this), index));

        } else {

          // Selects the last unordered list HTML found within the HTML element calling the plugin
          ul.find(itemClass).last().

          // Appends an unorderedList HTML element to the dynamic `unorderedList` variable and sets a common class name
          after($("<ul/>", {

            "class": subheaderClassName,

            "data-tag": currentTagName

          })).next(subheaderClass).

          // Appends a list item HTML element to the last unordered list HTML element found within the HTML element calling the plugin
          append(self._nestElements($(this), index));
        }

      },

      // _setEventHandlers
      // ----------------
      //      Adds jQuery event handlers to the newly generated table of contents
      _setEventHandlers: function() {

        // _Local variables_

        // Stores the plugin context in the self variable
        var self = this,

          // Instantiates a new variable that will be used to hold a specific element's context
          $self,

          // Instantiates a new variable that will be used to determine the smoothScroll animation time duration
          duration;

        // Event delegation that looks for any clicks on list item elements inside of the HTML element calling the plugin
        this.element.on("click.tocify", "li", function(event) {

          if (self.options.history) {

            window.location.hash = $(this).attr("data-unique");

          }

          // Removes highlighting from all of the list item's
          self.element.find("." + self.focusClass).removeClass(self.focusClass);

          // Highlights the current list item that was clicked
          $(this).addClass(self.focusClass);

          // If the showAndHide option is true
          if (self.options.showAndHide) {

            var elem = $('li[data-unique="' + $(this).attr("data-unique") + '"]');

            self._triggerShow(elem);

          }

          self._scrollTo($(this));

        });

        // Mouseenter and Mouseleave event handlers for the list item's within the HTML element calling the plugin
        this.element.find("li").on({

          // Mouseenter event handler
          "mouseenter.tocify": function() {

            // Adds a hover CSS class to the current list item
            $(this).addClass(self.hoverClass);

            // Makes sure the cursor is set to the pointer icon
            $(this).css("cursor", "pointer");

          },

          // Mouseleave event handler
          "mouseleave.tocify": function() {

            if (self.options.theme !== "bootstrap") {

              // Removes the hover CSS class from the current list item
              $(this).removeClass(self.hoverClass);

            }

          }
        });

        // only attach handler if needed (expensive in IE)
        if (self.options.extendPage || self.options.highlightOnScroll || self.options.scrollHistory || self.options.showAndHideOnScroll) {
          // Window scroll event handler
          $(window).on("scroll.tocify", function() {

            // Once all animations on the page are complete, this callback function will be called
            $("html, body").promise().done(function() {

              // Local variables

              // Stores how far the user has scrolled
              var winScrollTop = $(window).scrollTop(),

                // Stores the height of the window
                winHeight = $(window).height(),

                // Stores the height of the document
                docHeight = $(document).height(),

                scrollHeight = $("body")[0].scrollHeight,

                // Instantiates a variable that will be used to hold a selected HTML element
                elem,

                lastElem,

                lastElemOffset,

                currentElem;

              if (self.options.extendPage) {

                // If the user has scrolled to the bottom of the page and the last toc item is not focused
                if ((self.webkit && winScrollTop >= scrollHeight - winHeight - self.options.extendPageOffset) || (!self.webkit && winHeight + winScrollTop > docHeight - self.options.extendPageOffset)) {

                  if (!$(extendPageClass).length) {

                    lastElem = $('div[data-unique="' + $(itemClass).last().attr("data-unique") + '"]');

                    if (!lastElem.length) return;

                    // Gets the top offset of the page header that is linked to the last toc item
                    lastElemOffset = lastElem.offset().top;

                    // Appends a div to the bottom of the page and sets the height to the difference of the window scrollTop and the last element's position top offset
                    $(self.options.context).append($("<div/>", {

                      "class": extendPageClassName,

                      "height": Math.abs(lastElemOffset - winScrollTop) + "px",

                      "data-unique": extendPageClassName

                    }));

                    if (self.extendPageScroll) {

                      currentElem = self.element.find('li.' + self.focusClass);

                      self._scrollTo($('div[data-unique="' + currentElem.attr("data-unique") + '"]'));

                    }

                  }

                }

              }

              // The zero timeout ensures the following code is run after the scroll events
              setTimeout(function() {

                // _Local variables_

                // Stores the distance to the closest anchor
                var closestAnchorDistance = null,

                  // Stores the index of the closest anchor
                  closestAnchorIdx = null,

                  // Keeps a reference to all anchors
                  anchors = $(self.options.context).find("div[data-unique]"),

                  anchorText;

                // Determines the index of the closest anchor
                anchors.each(function(idx) {
                  var distance = Math.abs(($(this).next().length ? $(this).next() : $(this)).offset().top - winScrollTop - self.options.highlightOffset);
                  if (closestAnchorDistance == null || distance < closestAnchorDistance) {
                    closestAnchorDistance = distance;
                    closestAnchorIdx = idx;
                  } else {
                    return false;
                  }
                });

                anchorText = $(anchors[closestAnchorIdx]).attr("data-unique");

                // Stores the list item HTML element that corresponds to the currently traversed anchor tag
                elem = $('li[data-unique="' + anchorText + '"]');

                // If the `highlightOnScroll` option is true and a next element is found
                if (self.options.highlightOnScroll && elem.length) {

                  // Removes highlighting from all of the list item's
                  self.element.find("." + self.focusClass).removeClass(self.focusClass);

                  // Highlights the corresponding list item
                  elem.addClass(self.focusClass);

                }

                if (self.options.scrollHistory) {

                  if (window.location.hash !== "#" + anchorText) {

                    window.location.replace("#" + anchorText);

                  }
                }

                // If the `showAndHideOnScroll` option is true
                if (self.options.showAndHideOnScroll && self.options.showAndHide) {

                  self._triggerShow(elem, true);

                }

              }, 0);

            });

          });
        }

      },

      // Show
      // ----
      //      Opens the current sub-header
      show: function(elem, scroll) {

        // Stores the plugin context in the `self` variable
        var self = this,
          element = elem;

        // If the sub-header is not already visible
        if (!elem.is(":visible")) {

          // If the current element does not have any nested subheaders, is not a header, and its parent is not visible
          if (!elem.find(subheaderClass).length && !elem.parent().is(headerClass) && !elem.parent().is(":visible")) {

            // Sets the current element to all of the subheaders within the current header
            elem = elem.parents(subheaderClass).add(elem);

          }

          // If the current element does not have any nested subheaders and is not a header
          else if (!elem.children(subheaderClass).length && !elem.parent().is(headerClass)) {

            // Sets the current element to the closest subheader
            elem = elem.closest(subheaderClass);

          }

          //Determines what jQuery effect to use
          switch (self.options.showEffect) {

            //Uses `no effect`
            case "none":

              elem.show();

              break;

              //Uses the jQuery `show` special effect
            case "show":

              elem.show(self.options.showEffectSpeed);

              break;

              //Uses the jQuery `slideDown` special effect
            case "slideDown":

              elem.slideDown(self.options.showEffectSpeed);

              break;

              //Uses the jQuery `fadeIn` special effect
            case "fadeIn":

              elem.fadeIn(self.options.showEffectSpeed);

              break;

              //If none of the above options were passed, then a `jQueryUI show effect` is expected
            default:

              elem.show();

              break;

          }

        }

        // If the current subheader parent element is a header
        if (elem.parent().is(headerClass)) {

          // Hides all non-active sub-headers
          self.hide($(subheaderClass).not(elem));

        }

        // If the current subheader parent element is not a header
        else {

          // Hides all non-active sub-headers
          self.hide($(subheaderClass).not(elem.closest(headerClass).find(subheaderClass).not(elem.siblings())));

        }

        // Maintains chainablity
        return self;

      },

      // Hide
      // ----
      //      Closes the current sub-header
      hide: function(elem) {

        // Stores the plugin context in the `self` variable
        var self = this;

        //Determines what jQuery effect to use
        switch (self.options.hideEffect) {

          // Uses `no effect`
          case "none":

            elem.hide();

            break;

            // Uses the jQuery `hide` special effect
          case "hide":

            elem.hide(self.options.hideEffectSpeed);

            break;

            // Uses the jQuery `slideUp` special effect
          case "slideUp":

            elem.slideUp(self.options.hideEffectSpeed);

            break;

            // Uses the jQuery `fadeOut` special effect
          case "fadeOut":

            elem.fadeOut(self.options.hideEffectSpeed);

            break;

            // If none of the above options were passed, then a `jqueryUI hide effect` is expected
          default:

            elem.hide();

            break;

        }

        // Maintains chainablity
        return self;
      },

      // _triggerShow
      // ------------
      //      Determines what elements get shown on scroll and click
      _triggerShow: function(elem, scroll) {

        var self = this;

        // If the current element's parent is a header element or the next element is a nested subheader element
        if (elem.parent().is(headerClass) || elem.next().is(subheaderClass)) {

          // Shows the next sub-header element
          self.show(elem.next(subheaderClass), scroll);

        }

        // If the current element's parent is a subheader element
        else if (elem.parent().is(subheaderClass)) {

          // Shows the parent sub-header element
          self.show(elem.parent(), scroll);

        }

        // Maintains chainability
        return self;

      },

      // _addCSSClasses
      // --------------
      //      Adds CSS classes to the newly generated table of contents HTML
      _addCSSClasses: function() {

        // If the user wants a jqueryUI theme
        if (this.options.theme === "jqueryui") {

          this.focusClass = "ui-state-default";

          this.hoverClass = "ui-state-hover";

          //Adds the default styling to the dropdown list
          this.element.addClass("ui-widget").find(".toc-title").addClass("ui-widget-header").end().find("li").addClass("ui-widget-content");

        }

        // If the user wants a twitterBootstrap theme
        else if (this.options.theme === "bootstrap") {

          this.element.find(headerClass + "," + subheaderClass).addClass("nav nav-list");

          this.focusClass = "active";

        }

        // If the user wants a twitterBootstrap theme
        else if (this.options.theme === "bootstrap3") {

          this.element.find(headerClass + "," + subheaderClass).addClass("list-group");

          this.element.find(itemClass).addClass("list-group-item");

          this.focusClass = "active";

        }

        // If a user does not want a prebuilt theme
        else {

          // Adds more neutral classes (instead of jqueryui)

          this.focusClass = tocFocusClassName;

          this.hoverClass = tocHoverClassName;

        }

        //Maintains chainability
        return this;

      },

      // setOption
      // ---------
      //      Sets a single Tocify option after the plugin is invoked
      setOption: function() {

        // Calls the jQueryUI Widget Factory setOption method
        $.Widget.prototype._setOption.apply(this, arguments);

      },

      // setOptions
      // ----------
      //      Sets a single or multiple Tocify options after the plugin is invoked
      setOptions: function() {

        // Calls the jQueryUI Widget Factory setOptions method
        $.Widget.prototype._setOptions.apply(this, arguments);

      },

      // _scrollTo
      // ---------
      //      Scrolls to a specific element
      _scrollTo: function(elem) {

        var self = this,
          duration = self.options.smoothScroll || 0,
          scrollTo = self.options.scrollTo,
          currentDiv = $('div[data-unique="' + elem.attr("data-unique") + '"]');

        if (!currentDiv.length) {

          return self;

        }

        // Once all animations on the page are complete, this callback function will be called
        $("html, body").promise().done(function() {

          // Animates the html and body element scrolltops
          $("html, body").animate({

            // Sets the jQuery `scrollTop` to the top offset of the HTML div tag that matches the current list item's `data-unique` tag
            "scrollTop": currentDiv.offset().top - ($.isFunction(scrollTo) ? scrollTo.call() : scrollTo) + "px"

          }, {

            // Sets the smoothScroll animation time duration to the smoothScrollSpeed option
            "duration": duration

          });

        });

        // Maintains chainability
        return self;

      }

    });

  })); //end of plugin
</script>
<script>

/**
 * jQuery Plugin: Sticky Tabs
 *
 * @author Aidan Lister <aidan@php.net>
 * adapted by Ruben Arslan to activate parent tabs too
 * http://www.aidanlister.com/2014/03/persisting-the-tab-state-in-bootstrap/
 */
(function($) {
  "use strict";
  $.fn.rmarkdownStickyTabs = function() {
    var context = this;
    // Show the tab corresponding with the hash in the URL, or the first tab
    var showStuffFromHash = function() {
      var hash = window.location.hash;
      var selector = hash ? 'a[href="' + hash + '"]' : 'li.active > a';
      var $selector = $(selector, context);
      if($selector.data('toggle') === "tab") {
        $selector.tab('show');
        // walk up the ancestors of this element, show any hidden tabs
        $selector.parents('.section.tabset').each(function(i, elm) {
          var link = $('a[href="#' + $(elm).attr('id') + '"]');
          if(link.data('toggle') === "tab") {
            link.tab("show");
          }
        });
      }
    };


    // Set the correct tab when the page loads
    showStuffFromHash(context);

    // Set the correct tab when a user uses their back/forward button
    $(window).on('hashchange', function() {
      showStuffFromHash(context);
    });

    // Change the URL when tabs are clicked
    $('a', context).on('click', function(e) {
      history.pushState(null, null, this.href);
      showStuffFromHash(context);
    });

    return this;
  };
}(jQuery));

window.buildTabsets = function(tocID) {

  // build a tabset from a section div with the .tabset class
  function buildTabset(tabset) {

    // check for fade and pills options
    var fade = tabset.hasClass("tabset-fade");
    var pills = tabset.hasClass("tabset-pills");
    var navClass = pills ? "nav-pills" : "nav-tabs";

    // determine the heading level of the tabset and tabs
    var match = tabset.attr('class').match(/level(\d) /);
    if (match === null)
      return;
    var tabsetLevel = Number(match[1]);
    var tabLevel = tabsetLevel + 1;

    // find all subheadings immediately below
    var tabs = tabset.find("div.section.level" + tabLevel);
    if (!tabs.length)
      return;

    // create tablist and tab-content elements
    var tabList = $('<ul class="nav ' + navClass + '" role="tablist"></ul>');
    $(tabs[0]).before(tabList);
    var tabContent = $('<div class="tab-content"></div>');
    $(tabs[0]).before(tabContent);

    // build the tabset
    var activeTab = 0;
    tabs.each(function(i) {

      // get the tab div
      var tab = $(tabs[i]);

      // get the id then sanitize it for use with bootstrap tabs
      var id = tab.attr('id');

      // see if this is marked as the active tab
      if (tab.hasClass('active'))
        activeTab = i;

      // remove any table of contents entries associated with
      // this ID (since we'll be removing the heading element)
      $("div#" + tocID + " li a[href='#" + id + "']").parent().remove();

      // sanitize the id for use with bootstrap tabs
      id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
      tab.attr('id', id);

      // get the heading element within it, grab it's text, then remove it
      var heading = tab.find('h' + tabLevel + ':first');
      var headingText = heading.html();
      heading.remove();

      // build and append the tab list item
      var a = $('<a role="tab" data-toggle="tab">' + headingText + '</a>');
      a.attr('href', '#' + id);
      a.attr('aria-controls', id);
      var li = $('<li role="presentation"></li>');
      li.append(a);
      tabList.append(li);

      // set it's attributes
      tab.attr('role', 'tabpanel');
      tab.addClass('tab-pane');
      tab.addClass('tabbed-pane');
      if (fade)
        tab.addClass('fade');

      // move it into the tab content div
      tab.detach().appendTo(tabContent);
    });

    // set active tab
    $(tabList.children('li')[activeTab]).addClass('active');
    var active = $(tabContent.children('div.section')[activeTab]);
    active.addClass('active');
    if (fade)
      active.addClass('in');

    if (tabset.hasClass("tabset-sticky"))
      tabset.rmarkdownStickyTabs();
  }

  // convert section divs with the .tabset class to tabsets
  var tabsets = $("div.section.tabset");
  tabsets.each(function(i) {
    buildTabset($(tabsets[i]));
  });
};

</script>




<style type="text/css">
h1 {
  font-size: 34px;
}
h1.title {
  font-size: 38px;
}
h2 {
  font-size: 30px;
}
h3 {
  font-size: 24px;
}
h4 {
  font-size: 18px;
}
h5 {
  font-size: 16px;
}
h6 {
  font-size: 12px;
}
.table th:not([align]) {
  text-align: left;
}
</style>




<style type="text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
code {
  color: inherit;
  background-color: rgba(0, 0, 0, 0.04);
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
</style>



<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  background: white;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "";
  border: none;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->



<style type="text/css">

#TOC {
  margin: 25px 0px 20px 0px;
}
@media (max-width: 768px) {
#TOC {
  position: relative;
  width: 100%;
}
}

@media print {
.toc-content {
  /* see https://github.com/w3c/csswg-drafts/issues/4434 */
  float: right;
}
}

.toc-content {
  padding-left: 30px;
  padding-right: 40px;
}

div.main-container {
  max-width: 1200px;
}

div.tocify {
  width: 20%;
  max-width: 260px;
  max-height: 85%;
}

@media (min-width: 768px) and (max-width: 991px) {
  div.tocify {
    width: 25%;
  }
}

@media (max-width: 767px) {
  div.tocify {
    width: 100%;
    max-width: none;
  }
}

.tocify ul, .tocify li {
  line-height: 20px;
}

.tocify-subheader .tocify-item {
  font-size: 0.90em;
}

.tocify .list-group-item {
  border-radius: 0px;
}


</style>



</head>

<body>


<div class="container-fluid main-container">


<!-- setup 3col/9col grid for toc_float and main content  -->
<div class="row-fluid">
<div class="col-xs-12 col-sm-4 col-md-3">
<div id="TOC" class="tocify">
</div>
</div>

<div class="toc-content col-xs-12 col-sm-8 col-md-9">




<div class="fluid-row" id="header">



<h1 class="title toc-ignore">Health Care Procedure Coding System</h1>
<h4 class="author">William Muir</h4>
<h4 class="date">March 30, 2020</h4>

</div>


<div id="about-the-2020-health-care-procedure-coding-system-hcpcs" class="section level1">
<h1>About the 2020 Health Care Procedure Coding System (HCPCS)</h1>
<ul>
<li><p>The source for these data is <a href="https://www.cms.gov">The Centers for Medicare &amp; Medicaid Services</a></p></li>
<li><p>In some instances, brand names may appear in HCPCS descriptions. These names have been included for indexing purposes only; their inclusion does not convey endorsement of any particular brand.</p></li>
</ul>
</div>
<div id="hcpcs-codes" class="section level1">
<h1>HCPCS Codes</h1>
<div id="short-codes" class="section level2">
<h2>Short Codes</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>A1</td>
<td>0010</td>
<td>7</td>
<td>Dressing for one wound</td>
<td>Dressing for one wound</td>
</tr>
<tr class="even">
<td>A2</td>
<td>0010</td>
<td>7</td>
<td>Dressing for two wounds</td>
<td>Dressing for two wounds</td>
</tr>
<tr class="odd">
<td>A3</td>
<td>0010</td>
<td>7</td>
<td>Dressing for three wounds</td>
<td>Dressing for three wounds</td>
</tr>
<tr class="even">
<td>A4</td>
<td>0010</td>
<td>7</td>
<td>Dressing for four wounds</td>
<td>Dressing for four wounds</td>
</tr>
<tr class="odd">
<td>A5</td>
<td>0010</td>
<td>7</td>
<td>Dressing for five wounds</td>
<td>Dressing for five wounds</td>
</tr>
<tr class="even">
<td>A6</td>
<td>0010</td>
<td>7</td>
<td>Dressing for six wounds</td>
<td>Dressing for six wounds</td>
</tr>
<tr class="odd">
<td>A7</td>
<td>0010</td>
<td>7</td>
<td>Dressing for seven wounds</td>
<td>Dressing for seven wounds</td>
</tr>
<tr class="even">
<td>A8</td>
<td>0010</td>
<td>7</td>
<td>Dressing for eight wounds</td>
<td>Dressing for eight wounds</td>
</tr>
<tr class="odd">
<td>A9</td>
<td>0010</td>
<td>7</td>
<td>Dressing for nine or more wounds</td>
<td>Dressing for 9 or more wound</td>
</tr>
<tr class="even">
<td>AA</td>
<td>0010</td>
<td>7</td>
<td>Anesthesia services performed personally by anesthesiologist</td>
<td>Anesthesia perf by anesgst</td>
</tr>
<tr class="odd">
<td>AD</td>
<td>0010</td>
<td>7</td>
<td>Medical supervision by a physician: more than four concurrent anesthesia procedures</td>
<td>Md supervision, &gt;4 anes proc</td>
</tr>
<tr class="even">
<td>AE</td>
<td>0010</td>
<td>7</td>
<td>Registered dietician</td>
<td>Registered dietician</td>
</tr>
<tr class="odd">
<td>AF</td>
<td>0010</td>
<td>7</td>
<td>Specialty physician</td>
<td>Specialty physician</td>
</tr>
<tr class="even">
<td>AG</td>
<td>0010</td>
<td>7</td>
<td>Primary physician</td>
<td>Primary physician</td>
</tr>
<tr class="odd">
<td>AH</td>
<td>0010</td>
<td>7</td>
<td>Clinical psychologist</td>
<td>Clinical psychologist</td>
</tr>
<tr class="even">
<td>AI</td>
<td>0010</td>
<td>7</td>
<td>Principal physician of record</td>
<td>Principal physician of rec</td>
</tr>
<tr class="odd">
<td>AJ</td>
<td>0010</td>
<td>7</td>
<td>Clinical social worker</td>
<td>Clinical social worker</td>
</tr>
<tr class="even">
<td>AK</td>
<td>0010</td>
<td>7</td>
<td>Non participating physician</td>
<td>Non participating physician</td>
</tr>
<tr class="odd">
<td>AM</td>
<td>0010</td>
<td>7</td>
<td>Physician, team member service</td>
<td>Physician, team member svc</td>
</tr>
<tr class="even">
<td>AO</td>
<td>0010</td>
<td>7</td>
<td>Alternate payment method declined by provider of service</td>
<td>Prov declined alt pmt method</td>
</tr>
<tr class="odd">
<td>AP</td>
<td>0010</td>
<td>7</td>
<td>Determination of refractive state was not performed in the course of diagnostic ophthalmological examination</td>
<td>No dtmn of refractive state</td>
</tr>
<tr class="even">
<td>AQ</td>
<td>0010</td>
<td>7</td>
<td>Physician providing a service in an unlisted health professional shortage area (hpsa)</td>
<td>Physician service hpsa area</td>
</tr>
<tr class="odd">
<td>AR</td>
<td>0010</td>
<td>7</td>
<td>Physician provider services in a physician scarcity area</td>
<td>Physician scarcity area</td>
</tr>
<tr class="even">
<td>AS</td>
<td>0010</td>
<td>7</td>
<td>Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery</td>
<td>Assistant at surgery service</td>
</tr>
<tr class="odd">
<td>AT</td>
<td>0010</td>
<td>7</td>
<td>Acute treatment (this modifier should be used when reporting service 98940, 98941, 98942)</td>
<td>Acute treatment</td>
</tr>
<tr class="even">
<td>AU</td>
<td>0010</td>
<td>7</td>
<td>Item furnished in conjunction with a urological, ostomy, or tracheostomy supply</td>
<td>Uro, ostomy or trach item</td>
</tr>
<tr class="odd">
<td>AV</td>
<td>0010</td>
<td>7</td>
<td>Item furnished in conjunction with a prosthetic device, prosthetic or orthotic</td>
<td>Item w prosthetic/orthotic</td>
</tr>
<tr class="even">
<td>AW</td>
<td>0010</td>
<td>7</td>
<td>Item furnished in conjunction with a surgical dressing</td>
<td>Item w a surgical dressing</td>
</tr>
<tr class="odd">
<td>AX</td>
<td>0010</td>
<td>7</td>
<td>Item furnished in conjunction with dialysis services</td>
<td>Item w dialysis services</td>
</tr>
<tr class="even">
<td>AY</td>
<td>0010</td>
<td>7</td>
<td>Item or service furnished to an esrd patient that is not for the treatment of esrd</td>
<td>Item/service not for esrd tx</td>
</tr>
<tr class="odd">
<td>AZ</td>
<td>0010</td>
<td>7</td>
<td>Physician providing a service in a dental health professional shortage area for the purpose of an electronic health record incentive payment</td>
<td>Physician serv in dent hpsa</td>
</tr>
<tr class="even">
<td>BA</td>
<td>0010</td>
<td>7</td>
<td>Item furnished in conjunction with parenteral enteral nutrition (pen) services</td>
<td>Item w pen services</td>
</tr>
<tr class="odd">
<td>BL</td>
<td>0010</td>
<td>7</td>
<td>Special acquisition of blood and blood products</td>
<td>Spec acquisition blood prods</td>
</tr>
<tr class="even">
<td>BO</td>
<td>0010</td>
<td>7</td>
<td>Orally administered nutrition, not by feeding tube</td>
<td>Nutrition oral admin no tube</td>
</tr>
<tr class="odd">
<td>BP</td>
<td>0010</td>
<td>7</td>
<td>The beneficiary has been informed of the purchase and rental options and has elected to purchase the item</td>
<td>Bene electd to purchase item</td>
</tr>
<tr class="even">
<td>BR</td>
<td>0010</td>
<td>7</td>
<td>The beneficiary has been informed of the purchase and rental options and has elected to rent the item</td>
<td>Bene elected to rent item</td>
</tr>
<tr class="odd">
<td>BU</td>
<td>0010</td>
<td>7</td>
<td>The beneficiary has been informed of the purchase and rental options and after 30 days has not informed the supplier of his/her decision</td>
<td>Bene undecided on purch/rent</td>
</tr>
<tr class="even">
<td>CA</td>
<td>0010</td>
<td>7</td>
<td>Procedure payable only in the inpatient setting when performed emergently on an outpatient who expires prior to admission</td>
<td>Procedure payable inpatient</td>
</tr>
<tr class="odd">
<td>CB</td>
<td>0010</td>
<td>7</td>
<td>Service ordered by a renal dialysis facility (rdf) physician as part of the esrd beneficiary’s dialysis benefit, is not part of the composite rate, and is separately reimbursable</td>
<td>Esrd bene part a snf-sep pay</td>
</tr>
<tr class="even">
<td>CC</td>
<td>0010</td>
<td>7</td>
<td>Procedure code change (use ‘cc’ when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed)</td>
<td>Procedure code change</td>
</tr>
<tr class="odd">
<td>CD</td>
<td>0010</td>
<td>7</td>
<td>Amcc test has been ordered by an esrd facility or mcp physician that is part of the composite rate and is not separately billable</td>
<td>Amcc test for esrd or mcp md</td>
</tr>
<tr class="even">
<td>CE</td>
<td>0010</td>
<td>7</td>
<td>Amcc test has been ordered by an esrd facility or mcp physician that is a composite rate test but is beyond the normal frequency covered under the rate and is separately reimbursable based on medical necessity</td>
<td>Med neces amcc tst sep reimb</td>
</tr>
<tr class="odd">
<td>CF</td>
<td>0010</td>
<td>7</td>
<td>Amcc test has been ordered by an esrd facility or mcp physician that is not part of the composite rate and is separately billable</td>
<td>Amcc tst not composite rate</td>
</tr>
<tr class="even">
<td>CG</td>
<td>0010</td>
<td>7</td>
<td>Policy criteria applied</td>
<td>Policy criteria applied</td>
</tr>
<tr class="odd">
<td>CH</td>
<td>0010</td>
<td>7</td>
<td>0 percent impaired, limited or restricted</td>
<td>0 percent impaired, ltd, res</td>
</tr>
<tr class="even">
<td>CI</td>
<td>0010</td>
<td>7</td>
<td>At least 1 percent but less than 20 percent impaired, limited or restricted</td>
<td>1 to &lt;20 percent impaired</td>
</tr>
<tr class="odd">
<td>CJ</td>
<td>0010</td>
<td>7</td>
<td>At least 20 percent but less than 40 percent impaired, limited or restricted</td>
<td>20 to &lt;40 percent impaired</td>
</tr>
<tr class="even">
<td>CK</td>
<td>0010</td>
<td>7</td>
<td>At least 40 percent but less than 60 percent impaired, limited or restricted</td>
<td>40 to &lt;60 percent impaired</td>
</tr>
<tr class="odd">
<td>CL</td>
<td>0010</td>
<td>7</td>
<td>At least 60 percent but less than 80 percent impaired, limited or restricted</td>
<td>60 to &lt;80 percent impaired</td>
</tr>
<tr class="even">
<td>CM</td>
<td>0010</td>
<td>7</td>
<td>At least 80 percent but less than 100 percent impaired, limited or restricted</td>
<td>80 to &lt;100 percent impaired</td>
</tr>
<tr class="odd">
<td>CN</td>
<td>0010</td>
<td>7</td>
<td>100 percent impaired, limited or restricted</td>
<td>100 percent impaired, ltd</td>
</tr>
<tr class="even">
<td>CO</td>
<td>0010</td>
<td>7</td>
<td>Outpatient occupational therapy services furnished in whole or in part by an occupational therapy assistant</td>
<td>Outpatient ot service by ota</td>
</tr>
<tr class="odd">
<td>CP</td>
<td>0010</td>
<td>7</td>
<td>Adjunctive service related to a procedure assigned to a comprehensive ambulatory payment classification (c-apc) procedure, but reported on a different claim</td>
<td>C-apc adjunctive service</td>
</tr>
<tr class="even">
<td>CQ</td>
<td>0010</td>
<td>7</td>
<td>Outpatient physical therapy services furnished in whole or in part by a physical therapist assistant</td>
<td>Outpatient pt service by pta</td>
</tr>
<tr class="odd">
<td>CR</td>
<td>0010</td>
<td>7</td>
<td>Catastrophe/disaster related</td>
<td>Catastrophe/disaster related</td>
</tr>
<tr class="even">
<td>CS</td>
<td>0010</td>
<td>7</td>
<td>Item or service related, in whole or in part, to an illness, injury, or condition that was caused by or exacerbated by the effects, direct or indirect, of the 2010 oil spill in the gulf of mexico, including but not limited to subsequent clean-up activities</td>
<td>Gulf oil 2010 spill related</td>
</tr>
<tr class="odd">
<td>CT</td>
<td>0010</td>
<td>7</td>
<td>Computed tomography services furnished using equipment that does not meet each of the attributes of the national electrical manufacturers association (nema) xr-29-2013 standard</td>
<td>Ct does not meet nema standa</td>
</tr>
<tr class="even">
<td>DA</td>
<td>0010</td>
<td>7</td>
<td>Oral health assessment by a licensed health professional other than a dentist</td>
<td>Oral health assess, not dent</td>
</tr>
<tr class="odd">
<td>E1</td>
<td>0010</td>
<td>7</td>
<td>Upper left, eyelid</td>
<td>Upper left eyelid</td>
</tr>
<tr class="even">
<td>E2</td>
<td>0010</td>
<td>7</td>
<td>Lower left, eyelid</td>
<td>Lower left eyelid</td>
</tr>
<tr class="odd">
<td>E3</td>
<td>0010</td>
<td>7</td>
<td>Upper right, eyelid</td>
<td>Upper right eyelid</td>
</tr>
<tr class="even">
<td>E4</td>
<td>0010</td>
<td>7</td>
<td>Lower right, eyelid</td>
<td>Lower right eyelid</td>
</tr>
<tr class="odd">
<td>EA</td>
<td>0010</td>
<td>7</td>
<td>Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy</td>
<td>Esa, anemia, chemo-induced</td>
</tr>
<tr class="even">
<td>EB</td>
<td>0010</td>
<td>7</td>
<td>Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy</td>
<td>Esa, anemia, radio-induced</td>
</tr>
<tr class="odd">
<td>EC</td>
<td>0010</td>
<td>7</td>
<td>Erythropoetic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapy</td>
<td>Esa, anemia, non-chemo/radio</td>
</tr>
<tr class="even">
<td>ED</td>
<td>0010</td>
<td>7</td>
<td>Hematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle</td>
<td>Hct&gt;39% or hgb&gt;13g&gt;=3 cycle</td>
</tr>
<tr class="odd">
<td>EE</td>
<td>0010</td>
<td>7</td>
<td>Hematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle</td>
<td>Hct&gt;39% or hgb&gt;13g&lt;3 cycle</td>
</tr>
<tr class="even">
<td>EJ</td>
<td>0010</td>
<td>7</td>
<td>Subsequent claims for a defined course of therapy, e.g., epo, sodium hyaluronate, infliximab</td>
<td>Subsequent claim</td>
</tr>
<tr class="odd">
<td>EM</td>
<td>0010</td>
<td>7</td>
<td>Emergency reserve supply (for esrd benefit only)</td>
<td>Emer reserve supply (esrd)</td>
</tr>
<tr class="even">
<td>EP</td>
<td>0010</td>
<td>7</td>
<td>Service provided as part of medicaid early periodic screening diagnosis and treatment (epsdt) program</td>
<td>Medicaid epsdt program svc</td>
</tr>
<tr class="odd">
<td>ER</td>
<td>0010</td>
<td>7</td>
<td>Items and services furnished by a provider-based, off-campus emergency department</td>
<td>Off-campus ed service</td>
</tr>
<tr class="even">
<td>ET</td>
<td>0010</td>
<td>7</td>
<td>Emergency services</td>
<td>Emergency services</td>
</tr>
<tr class="odd">
<td>EX</td>
<td>0010</td>
<td>7</td>
<td>Expatriate beneficiary</td>
<td>Expatriate beneficiary</td>
</tr>
<tr class="even">
<td>EY</td>
<td>0010</td>
<td>7</td>
<td>No physician or other licensed health care provider order for this item or service</td>
<td>No md order for item/service</td>
</tr>
<tr class="odd">
<td>F1</td>
<td>0010</td>
<td>7</td>
<td>Left hand, second digit</td>
<td>Left hand, second digit</td>
</tr>
<tr class="even">
<td>F2</td>
<td>0010</td>
<td>7</td>
<td>Left hand, third digit</td>
<td>Left hand, third digit</td>
</tr>
<tr class="odd">
<td>F3</td>
<td>0010</td>
<td>7</td>
<td>Left hand, fourth digit</td>
<td>Left hand, fourth digit</td>
</tr>
<tr class="even">
<td>F4</td>
<td>0010</td>
<td>7</td>
<td>Left hand, fifth digit</td>
<td>Left hand, fifth digit</td>
</tr>
<tr class="odd">
<td>F5</td>
<td>0010</td>
<td>7</td>
<td>Right hand, thumb</td>
<td>Right hand, thumb</td>
</tr>
<tr class="even">
<td>F6</td>
<td>0010</td>
<td>7</td>
<td>Right hand, second digit</td>
<td>Right hand, second digit</td>
</tr>
<tr class="odd">
<td>F7</td>
<td>0010</td>
<td>7</td>
<td>Right hand, third digit</td>
<td>Right hand, third digit</td>
</tr>
<tr class="even">
<td>F8</td>
<td>0010</td>
<td>7</td>
<td>Right hand, fourth digit</td>
<td>Right hand, fourth digit</td>
</tr>
<tr class="odd">
<td>F9</td>
<td>0010</td>
<td>7</td>
<td>Right hand, fifth digit</td>
<td>Right hand, fifth digit</td>
</tr>
<tr class="even">
<td>FA</td>
<td>0010</td>
<td>7</td>
<td>Left hand, thumb</td>
<td>Left hand, thumb</td>
</tr>
<tr class="odd">
<td>FB</td>
<td>0010</td>
<td>7</td>
<td>Item provided without cost to provider, supplier or practitioner, or full credit received for replaced device (examples, but not limited to, covered under warranty, replaced due to defect, free samples)</td>
<td>Item provided without cost</td>
</tr>
<tr class="even">
<td>FC</td>
<td>0010</td>
<td>7</td>
<td>Partial credit received for replaced device</td>
<td>Part credit, replaced device</td>
</tr>
<tr class="odd">
<td>FP</td>
<td>0010</td>
<td>7</td>
<td>Service provided as part of family planning program</td>
<td>Svc part of family plan pgm</td>
</tr>
<tr class="even">
<td>FX</td>
<td>0010</td>
<td>7</td>
<td>X-ray taken using film</td>
<td>X-ray taken using film</td>
</tr>
<tr class="odd">
<td>FY</td>
<td>0010</td>
<td>7</td>
<td>X-ray taken using computed radiography technology/cassette-based imaging</td>
<td>Computed radiography x-ray</td>
</tr>
<tr class="even">
<td>G0</td>
<td>0010</td>
<td>7</td>
<td>Telehealth services for diagnosis, evaluation, or treatment, of symptoms of an acute stroke</td>
<td>Telestroke</td>
</tr>
<tr class="odd">
<td>G1</td>
<td>0010</td>
<td>7</td>
<td>Most recent urr reading of less than 60</td>
<td>Urr reading of less than 60</td>
</tr>
<tr class="even">
<td>G2</td>
<td>0010</td>
<td>7</td>
<td>Most recent urr reading of 60 to 64.9</td>
<td>Urr reading of 60 to 64.9</td>
</tr>
<tr class="odd">
<td>G3</td>
<td>0010</td>
<td>7</td>
<td>Most recent urr reading of 65 to 69.9</td>
<td>Urr reading of 65 to 69.9</td>
</tr>
<tr class="even">
<td>G4</td>
<td>0010</td>
<td>7</td>
<td>Most recent urr reading of 70 to 74.9</td>
<td>Urr reading of 70 to 74.9</td>
</tr>
<tr class="odd">
<td>G5</td>
<td>0010</td>
<td>7</td>
<td>Most recent urr reading of 75 or greater</td>
<td>Urr reading of 75 or greater</td>
</tr>
<tr class="even">
<td>G6</td>
<td>0010</td>
<td>7</td>
<td>Esrd patient for whom less than six dialysis sessions have been provided in a month</td>
<td>Esrd patient &lt;6 dialysis/mth</td>
</tr>
<tr class="odd">
<td>G7</td>
<td>0010</td>
<td>7</td>
<td>Pregnancy resulted from rape or incest or pregnancy certified by physician as life threatening</td>
<td>Payment limits do not apply</td>
</tr>
<tr class="even">
<td>G8</td>
<td>0010</td>
<td>7</td>
<td>Monitored anesthesia care (mac) for deep complex, complicated, or markedly invasive surgical procedure</td>
<td>Monitored anesthesia care</td>
</tr>
<tr class="odd">
<td>G9</td>
<td>0010</td>
<td>7</td>
<td>Monitored anesthesia care for patient who has history of severe cardio-pulmonary condition</td>
<td>Mac for at risk patient</td>
</tr>
<tr class="even">
<td>GA</td>
<td>0010</td>
<td>7</td>
<td>Waiver of liability statement issued as required by payer policy, individual case</td>
<td>Liability waiver ind case</td>
</tr>
<tr class="odd">
<td>GB</td>
<td>0010</td>
<td>7</td>
<td>Claim being re-submitted for payment because it is no longer covered under a global payment demonstration</td>
<td>Claim resubmitted</td>
</tr>
<tr class="even">
<td>GC</td>
<td>0010</td>
<td>7</td>
<td>This service has been performed in part by a resident under the direction of a teaching physician</td>
<td>Resident/teaching phys serv</td>
</tr>
<tr class="odd">
<td>GD</td>
<td>0010</td>
<td>7</td>
<td>Units of service exceeds medically unlikely edit value and represents reasonable and necessary services</td>
<td>Unit of service &gt; mue value</td>
</tr>
<tr class="even">
<td>GE</td>
<td>0010</td>
<td>7</td>
<td>This service has been performed by a resident without the presence of a teaching physician under the primary care exception</td>
<td>Resident prim care exception</td>
</tr>
<tr class="odd">
<td>GF</td>
<td>0010</td>
<td>7</td>
<td>Non-physician (e.g. nurse practitioner (np), certified registered nurse anesthetist (crna), certified registered nurse (crn), clinical nurse specialist (cns), physician assistant (pa)) services in a critical access hospital</td>
<td>Nonphysician serv c a hosp</td>
</tr>
<tr class="even">
<td>GG</td>
<td>0010</td>
<td>7</td>
<td>Performance and payment of a screening mammogram and diagnostic mammogram on the same patient, same day</td>
<td>Payment screen mam + diagmam</td>
</tr>
<tr class="odd">
<td>GH</td>
<td>0010</td>
<td>7</td>
<td>Diagnostic mammogram converted from screening mammogram on same day</td>
<td>Diag mammo to screening mamo</td>
</tr>
<tr class="even">
<td>GJ</td>
<td>0010</td>
<td>7</td>
<td>“opt out” physician or practitioner emergency or urgent service</td>
<td>Opt out provider of er srvc</td>
</tr>
<tr class="odd">
<td>GK</td>
<td>0010</td>
<td>7</td>
<td>Reasonable and necessary item/service associated with a ga or gz modifier</td>
<td>Actual item/service ordered</td>
</tr>
<tr class="even">
<td>GL</td>
<td>0010</td>
<td>7</td>
<td>Medically unnecessary upgrade provided instead of non-upgraded item, no charge, no advance beneficiary notice (abn)</td>
<td>Upgraded item, no charge</td>
</tr>
<tr class="odd">
<td>GM</td>
<td>0010</td>
<td>7</td>
<td>Multiple patients on one ambulance trip</td>
<td>Multiple transports</td>
</tr>
<tr class="even">
<td>GN</td>
<td>0010</td>
<td>7</td>
<td>Services delivered under an outpatient speech language pathology plan of care</td>
<td>Op speech language service</td>
</tr>
<tr class="odd">
<td>GO</td>
<td>0010</td>
<td>7</td>
<td>Services delivered under an outpatient occupational therapy plan of care</td>
<td>Op occupational therapy serv</td>
</tr>
<tr class="even">
<td>GP</td>
<td>0010</td>
<td>7</td>
<td>Services delivered under an outpatient physical therapy plan of care</td>
<td>Op pt services</td>
</tr>
<tr class="odd">
<td>GQ</td>
<td>0010</td>
<td>7</td>
<td>Via asynchronous telecommunications system</td>
<td>Telehealth store and forward</td>
</tr>
<tr class="even">
<td>GR</td>
<td>0010</td>
<td>7</td>
<td>This service was performed in whole or in part by a resident in a department of veterans affairs medical center or clinic, supervised in accordance with va policy</td>
<td>Service by va resident</td>
</tr>
<tr class="odd">
<td>GS</td>
<td>0010</td>
<td>7</td>
<td>Dosage of erythropoietin stimulating agent has been reduced and maintained in response to hematocrit or hemoglobin level</td>
<td>Epo/darbepoietin reduced 25%</td>
</tr>
<tr class="even">
<td>GT</td>
<td>0010</td>
<td>7</td>
<td>Via interactive audio and video telecommunication systems</td>
<td>Interactivetelecommunication</td>
</tr>
<tr class="odd">
<td>GU</td>
<td>0010</td>
<td>7</td>
<td>Waiver of liability statement issued as required by payer policy, routine notice</td>
<td>Liability waiver rout notice</td>
</tr>
<tr class="even">
<td>GV</td>
<td>0010</td>
<td>7</td>
<td>Attending physician not employed or paid under arrangement by the patient’s hospice provider</td>
<td>Attending phys not hospice</td>
</tr>
<tr class="odd">
<td>GW</td>
<td>0010</td>
<td>7</td>
<td>Service not related to the hospice patient’s terminal condition</td>
<td>Service unrelated to term co</td>
</tr>
<tr class="even">
<td>GX</td>
<td>0010</td>
<td>7</td>
<td>Notice of liability issued, voluntary under payer policy</td>
<td>Voluntary liability notice</td>
</tr>
<tr class="odd">
<td>GY</td>
<td>0010</td>
<td>7</td>
<td>Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit</td>
<td>Statutorily excluded</td>
</tr>
<tr class="even">
<td>GZ</td>
<td>0010</td>
<td>7</td>
<td>Item or service expected to be denied as not reasonable and necessary</td>
<td>Not reasonable and necessary</td>
</tr>
<tr class="odd">
<td>H9</td>
<td>0010</td>
<td>7</td>
<td>Court-ordered</td>
<td>Court-ordered</td>
</tr>
<tr class="even">
<td>HA</td>
<td>0010</td>
<td>7</td>
<td>Child/adolescent program</td>
<td>Child/adolescent program</td>
</tr>
<tr class="odd">
<td>HB</td>
<td>0010</td>
<td>7</td>
<td>Adult program, non geriatric</td>
<td>Adult program non-geriatric</td>
</tr>
<tr class="even">
<td>HC</td>
<td>0010</td>
<td>7</td>
<td>Adult program, geriatric</td>
<td>Adult program geriatric</td>
</tr>
<tr class="odd">
<td>HD</td>
<td>0010</td>
<td>7</td>
<td>Pregnant/parenting women’s program</td>
<td>Pregnant/parenting program</td>
</tr>
<tr class="even">
<td>HE</td>
<td>0010</td>
<td>7</td>
<td>Mental health program</td>
<td>Mental health program</td>
</tr>
<tr class="odd">
<td>HF</td>
<td>0010</td>
<td>7</td>
<td>Substance abuse program</td>
<td>Substance abuse program</td>
</tr>
<tr class="even">
<td>HG</td>
<td>0010</td>
<td>7</td>
<td>Opioid addiction treatment program</td>
<td>Opioid addiction tx program</td>
</tr>
<tr class="odd">
<td>HH</td>
<td>0010</td>
<td>7</td>
<td>Integrated mental health/substance abuse program</td>
<td>Mental hlth/substance abs pr</td>
</tr>
<tr class="even">
<td>HI</td>
<td>0010</td>
<td>7</td>
<td>Integrated mental health and intellectual disability/developmental disabilities program</td>
<td>Men hlth intel/dev disab pgm</td>
</tr>
<tr class="odd">
<td>HJ</td>
<td>0010</td>
<td>7</td>
<td>Employee assistance program</td>
<td>Employee assistance program</td>
</tr>
<tr class="even">
<td>HK</td>
<td>0010</td>
<td>7</td>
<td>Specialized mental health programs for high-risk populations</td>
<td>Spec hgh rsk mntl hlth pop p</td>
</tr>
<tr class="odd">
<td>HL</td>
<td>0010</td>
<td>7</td>
<td>Intern</td>
<td>Intern</td>
</tr>
<tr class="even">
<td>HM</td>
<td>0010</td>
<td>7</td>
<td>Less than bachelor degree level</td>
<td>Less than bachelor degree lv</td>
</tr>
<tr class="odd">
<td>HN</td>
<td>0010</td>
<td>7</td>
<td>Bachelors degree level</td>
<td>Bachelors degree level</td>
</tr>
<tr class="even">
<td>HO</td>
<td>0010</td>
<td>7</td>
<td>Masters degree level</td>
<td>Masters degree level</td>
</tr>
<tr class="odd">
<td>HP</td>
<td>0010</td>
<td>7</td>
<td>Doctoral level</td>
<td>Doctoral level</td>
</tr>
<tr class="even">
<td>HQ</td>
<td>0010</td>
<td>7</td>
<td>Group setting</td>
<td>Group setting</td>
</tr>
<tr class="odd">
<td>HR</td>
<td>0010</td>
<td>7</td>
<td>Family/couple with client present</td>
<td>Family/couple w client prsnt</td>
</tr>
<tr class="even">
<td>HS</td>
<td>0010</td>
<td>7</td>
<td>Family/couple without client present</td>
<td>Family/couple w/o client prs</td>
</tr>
<tr class="odd">
<td>HT</td>
<td>0010</td>
<td>7</td>
<td>Multi-disciplinary team</td>
<td>Multi-disciplinary team</td>
</tr>
<tr class="even">
<td>HU</td>
<td>0010</td>
<td>7</td>
<td>Funded by child welfare agency</td>
<td>Child welfare agency funded</td>
</tr>
<tr class="odd">
<td>HV</td>
<td>0010</td>
<td>7</td>
<td>Funded state addictions agency</td>
<td>Funded state addiction agncy</td>
</tr>
<tr class="even">
<td>HW</td>
<td>0010</td>
<td>7</td>
<td>Funded by state mental health agency</td>
<td>State mntl hlth agncy funded</td>
</tr>
<tr class="odd">
<td>HX</td>
<td>0010</td>
<td>7</td>
<td>Funded by county/local agency</td>
<td>County/local agency funded</td>
</tr>
<tr class="even">
<td>HY</td>
<td>0010</td>
<td>7</td>
<td>Funded by juvenile justice agency</td>
<td>Funded by juvenile justice</td>
</tr>
<tr class="odd">
<td>HZ</td>
<td>0010</td>
<td>7</td>
<td>Funded by criminal justice agency</td>
<td>Criminal justice agncy fund</td>
</tr>
<tr class="even">
<td>J1</td>
<td>0010</td>
<td>7</td>
<td>Competitive acquisition program no-pay submission for a prescription number</td>
<td>Cap no-pay for prescript num</td>
</tr>
<tr class="odd">
<td>J2</td>
<td>0010</td>
<td>7</td>
<td>Competitive acquisition program, restocking of emergency drugs after emergency administration</td>
<td>Cap restock of emerg drugs</td>
</tr>
<tr class="even">
<td>J3</td>
<td>0010</td>
<td>7</td>
<td>Competitive acquisition program (cap), drug not available through cap as written, reimbursed under average sales price methodology</td>
<td>Cap drug unavail thru cap</td>
</tr>
<tr class="odd">
<td>J4</td>
<td>0010</td>
<td>7</td>
<td>Dmepos item subject to dmepos competitive bidding program that is furnished by a hospital upon discharge</td>
<td>Dmepos comp bid furn by hosp</td>
</tr>
<tr class="even">
<td>JA</td>
<td>0010</td>
<td>7</td>
<td>Administered intravenously</td>
<td>Administered intravenously</td>
</tr>
<tr class="odd">
<td>JB</td>
<td>0010</td>
<td>7</td>
<td>Administered subcutaneously</td>
<td>Administered subcutaneously</td>
</tr>
<tr class="even">
<td>JC</td>
<td>0010</td>
<td>7</td>
<td>Skin substitute used as a graft</td>
<td>Skin substitute graft</td>
</tr>
<tr class="odd">
<td>JD</td>
<td>0010</td>
<td>7</td>
<td>Skin substitute not used as a graft</td>
<td>Skin sub not used as a graft</td>
</tr>
<tr class="even">
<td>JE</td>
<td>0010</td>
<td>7</td>
<td>Administered via dialysate</td>
<td>Administered via dialysate</td>
</tr>
<tr class="odd">
<td>JF</td>
<td>0010</td>
<td>7</td>
<td>Compounded drug</td>
<td>Compounded drug</td>
</tr>
<tr class="even">
<td>JG</td>
<td>0010</td>
<td>7</td>
<td>Drug or biological acquired with 340b drug pricing program discount</td>
<td>340b acquired drug</td>
</tr>
<tr class="odd">
<td>JW</td>
<td>0010</td>
<td>7</td>
<td>Drug amount discarded/not administered to any patient</td>
<td>Discarded drug not administe</td>
</tr>
<tr class="even">
<td>K0</td>
<td>0010</td>
<td>7</td>
<td>Lower extremity prosthesis functional level 0 - does not have the ability or potential to ambulate or transfer safely with or without assistance and a prosthesis does not enhance their quality of life or mobility.</td>
<td>Lwr ext prost functnl lvl 0</td>
</tr>
<tr class="odd">
<td>K1</td>
<td>0010</td>
<td>7</td>
<td>Lower extremity prosthesis functional level 1 - has the ability or potential to use a prosthesis for transfers or ambulation on level surfaces at fixed cadence. typical of the limited and unlimited household ambulator.</td>
<td>Lwr ext prost functnl lvl 1</td>
</tr>
<tr class="even">
<td>K2</td>
<td>0010</td>
<td>7</td>
<td>Lower extremity prosthesis functional level 2 - has the ability or potential for ambulation with the ability to traverse low level environmental barriers such as curbs, stairs or uneven surfaces. typical of the limited community ambulator.</td>
<td>Lwr ext prost functnl lvl 2</td>
</tr>
<tr class="odd">
<td>K3</td>
<td>0010</td>
<td>7</td>
<td>Lower extremity prosthesis functional level 3 - has the ability or potential for ambulation with variable cadence. typical of the community ambulator who has the ability to transverse most environmental barriers and may have vocational, therapeutic, or exercise activity that demands prosthetic utilization beyond simple locomotion.</td>
<td>Lwr ext prost functnl lvl 3</td>
</tr>
<tr class="even">
<td>K4</td>
<td>0010</td>
<td>7</td>
<td>Lower extremity prosthesis functional level 4 - has the ability or potential for prosthetic ambulation that exceeds the basic ambulation skills, exhibiting high impact, stress, or energy levels, typical of the prosthetic demands of the child, active adult, or athlete.</td>
<td>Lwr ext prost functnl lvl 4</td>
</tr>
<tr class="odd">
<td>KA</td>
<td>0010</td>
<td>7</td>
<td>Add on option/accessory for wheelchair</td>
<td>Wheelchair add-on option/acc</td>
</tr>
<tr class="even">
<td>KB</td>
<td>0010</td>
<td>7</td>
<td>Beneficiary requested upgrade for abn, more than 4 modifiers identified on claim</td>
<td>&gt;4 modifiers on claim</td>
</tr>
<tr class="odd">
<td>KC</td>
<td>0010</td>
<td>7</td>
<td>Replacement of special power wheelchair interface</td>
<td>Repl special pwr wc intrface</td>
</tr>
<tr class="even">
<td>KD</td>
<td>0010</td>
<td>7</td>
<td>Drug or biological infused through dme</td>
<td>Drug/biological dme infused</td>
</tr>
<tr class="odd">
<td>KE</td>
<td>0010</td>
<td>7</td>
<td>Bid under round one of the dmepos competitive bidding program for use with non-competitive bid base equipment</td>
<td>Bid under round 1 dmepos cb</td>
</tr>
<tr class="even">
<td>KF</td>
<td>0010</td>
<td>7</td>
<td>Item designated by fda as class iii device</td>
<td>Fda class iii device</td>
</tr>
<tr class="odd">
<td>KG</td>
<td>0010</td>
<td>7</td>
<td>Dmepos item subject to dmepos competitive bidding program number 1</td>
<td>Dmepos comp bid prgm no 1</td>
</tr>
<tr class="even">
<td>KH</td>
<td>0010</td>
<td>7</td>
<td>Dmepos item, initial claim, purchase or first month rental</td>
<td>Dmepos ini clm, pur/1 mo rnt</td>
</tr>
<tr class="odd">
<td>KI</td>
<td>0010</td>
<td>7</td>
<td>Dmepos item, second or third month rental</td>
<td>Dmepos 2nd or 3rd mo rental</td>
</tr>
<tr class="even">
<td>KJ</td>
<td>0010</td>
<td>7</td>
<td>Dmepos item, parenteral enteral nutrition (pen) pump or capped rental, months four to fifteen</td>
<td>Dmepos pen pmp or 4-15mo rnt</td>
</tr>
<tr class="odd">
<td>KK</td>
<td>0010</td>
<td>7</td>
<td>Dmepos item subject to dmepos competitive bidding program number 2</td>
<td>Dmepos comp bid prgm no 2</td>
</tr>
<tr class="even">
<td>KL</td>
<td>0010</td>
<td>7</td>
<td>Dmepos item delivered via mail</td>
<td>Dmepos mailorder comp bid</td>
</tr>
<tr class="odd">
<td>KM</td>
<td>0010</td>
<td>7</td>
<td>Replacement of facial prosthesis including new impression/moulage</td>
<td>Rplc facial prosth new imp</td>
</tr>
<tr class="even">
<td>KN</td>
<td>0010</td>
<td>7</td>
<td>Replacement of facial prosthesis using previous master model</td>
<td>Rplc facial prosth old mod</td>
</tr>
<tr class="odd">
<td>KO</td>
<td>0010</td>
<td>7</td>
<td>Single drug unit dose formulation</td>
<td>Single drug unit dose form</td>
</tr>
<tr class="even">
<td>KP</td>
<td>0010</td>
<td>7</td>
<td>First drug of a multiple drug unit dose formulation</td>
<td>First drug of multi drug u d</td>
</tr>
<tr class="odd">
<td>KQ</td>
<td>0010</td>
<td>7</td>
<td>Second or subsequent drug of a multiple drug unit dose formulation</td>
<td>2nd/subsqnt drg multi drg ud</td>
</tr>
<tr class="even">
<td>KR</td>
<td>0010</td>
<td>7</td>
<td>Rental item, billing for partial month</td>
<td>Rental item partial month</td>
</tr>
<tr class="odd">
<td>KS</td>
<td>0010</td>
<td>7</td>
<td>Glucose monitor supply for diabetic beneficiary not treated with insulin</td>
<td>Glucose monitor supply</td>
</tr>
<tr class="even">
<td>KT</td>
<td>0010</td>
<td>7</td>
<td>Beneficiary resides in a competitive bidding area and travels outside that competitive bidding area and receives a competitive bid item</td>
<td>Item from noncontract supply</td>
</tr>
<tr class="odd">
<td>KU</td>
<td>0010</td>
<td>7</td>
<td>Dmepos item subject to dmepos competitive bidding program number 3</td>
<td>Dmepos comp bid prgm no 3</td>
</tr>
<tr class="even">
<td>KV</td>
<td>0010</td>
<td>7</td>
<td>Dmepos item subject to dmepos competitive bidding program that is furnished as part of a professional service</td>
<td>Dmepos item, profession serv</td>
</tr>
<tr class="odd">
<td>KW</td>
<td>0010</td>
<td>7</td>
<td>Dmepos item subject to dmepos competitive bidding program number 4</td>
<td>Dmepos comp bid prgm no 4</td>
</tr>
<tr class="even">
<td>KX</td>
<td>0010</td>
<td>7</td>
<td>Requirements specified in the medical policy have been met</td>
<td>Documentation on file</td>
</tr>
<tr class="odd">
<td>KY</td>
<td>0010</td>
<td>7</td>
<td>Dmepos item subject to dmepos competitive bidding program number 5</td>
<td>Dmepos comp bid prgm no 5</td>
</tr>
<tr class="even">
<td>KZ</td>
<td>0010</td>
<td>7</td>
<td>New coverage not implemented by managed care</td>
<td>New cov not implement by m+c</td>
</tr>
<tr class="odd">
<td>L1</td>
<td>0010</td>
<td>7</td>
<td>Provider attestation that the hospital laboratory test(s) is not packaged under the hospital opps</td>
<td>Separately payable lab test</td>
</tr>
<tr class="even">
<td>LC</td>
<td>0010</td>
<td>7</td>
<td>Left circumflex coronary artery</td>
<td>Lft circum coronary artery</td>
</tr>
<tr class="odd">
<td>LD</td>
<td>0010</td>
<td>7</td>
<td>Left anterior descending coronary artery</td>
<td>Left ant des coronary artery</td>
</tr>
<tr class="even">
<td>LL</td>
<td>0010</td>
<td>7</td>
<td>Lease/rental (use the ‘ll’ modifier when dme equipment rental is to be applied against the purchase price)</td>
<td>Lease/rental (appld to pur)</td>
</tr>
<tr class="odd">
<td>LM</td>
<td>0010</td>
<td>7</td>
<td>Left main coronary artery</td>
<td>Left main coronary artery</td>
</tr>
<tr class="even">
<td>LR</td>
<td>0010</td>
<td>7</td>
<td>Laboratory round trip</td>
<td>Laboratory round trip</td>
</tr>
<tr class="odd">
<td>LS</td>
<td>0010</td>
<td>7</td>
<td>Fda-monitored intraocular lens implant</td>
<td>Fda-monitored iol implant</td>
</tr>
<tr class="even">
<td>LT</td>
<td>0010</td>
<td>7</td>
<td>Left side (used to identify procedures performed on the left side of the body)</td>
<td>Left side</td>
</tr>
<tr class="odd">
<td>M2</td>
<td>0010</td>
<td>7</td>
<td>Medicare secondary payer (msp)</td>
<td>Medicare secondary payer</td>
</tr>
<tr class="even">
<td>MA</td>
<td>0010</td>
<td>7</td>
<td>Ordering professional is not required to consult a clinical decision support mechanism due to service being rendered to a patient with a suspected or confirmed emergency medical condition</td>
<td>Emer med cond susp/confirm</td>
</tr>
<tr class="odd">
<td>MB</td>
<td>0010</td>
<td>7</td>
<td>Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of insufficient internet access</td>
<td>Auc hardship, insuf internet</td>
</tr>
<tr class="even">
<td>MC</td>
<td>0010</td>
<td>7</td>
<td>Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of electronic health record or clinical decision support mechanism vendor issues</td>
<td>Auc hardship, vendor issues</td>
</tr>
<tr class="odd">
<td>MD</td>
<td>0010</td>
<td>7</td>
<td>Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of extreme and uncontrollable circumstances</td>
<td>Auc hardship, extreme circ</td>
</tr>
<tr class="even">
<td>ME</td>
<td>0010</td>
<td>7</td>
<td>The order for this service adheres to appropriate use criteria in the clinical decision support mechanism consulted by the ordering professional</td>
<td>Order adheres to auc</td>
</tr>
<tr class="odd">
<td>MF</td>
<td>0010</td>
<td>7</td>
<td>The order for this service does not adhere to the appropriate use criteria in the clinical decision support mechanism consulted by the ordering professional</td>
<td>Order does not adhere to auc</td>
</tr>
<tr class="even">
<td>MG</td>
<td>0010</td>
<td>7</td>
<td>The order for this service does not have applicable appropriate use criteria in the qualified clinical decision support mechanism consulted by the ordering professional</td>
<td>Auc not applicable to order</td>
</tr>
<tr class="odd">
<td>MH</td>
<td>0010</td>
<td>7</td>
<td>Unknown if ordering professional consulted a clinical decision support mechanism for this service, related information was not provided to the furnishing professional or provider</td>
<td>Auc consult not provided</td>
</tr>
<tr class="even">
<td>MS</td>
<td>0010</td>
<td>7</td>
<td>Six month maintenance and servicing fee for reasonable and necessary parts and labor which are not covered under any manufacturer or supplier warranty</td>
<td>6-mo maint/svc fee parts/lbr</td>
</tr>
<tr class="odd">
<td>NB</td>
<td>0010</td>
<td>7</td>
<td>Nebulizer system, any type, fda-cleared for use with specific drug</td>
<td>Drug specific nebulizer</td>
</tr>
<tr class="even">
<td>NR</td>
<td>0010</td>
<td>7</td>
<td>New when rented (use the ‘nr’ modifier when dme which was new at the time of rental is subsequently purchased)</td>
<td>New when rented</td>
</tr>
<tr class="odd">
<td>NU</td>
<td>0010</td>
<td>7</td>
<td>New equipment</td>
<td>New equipment</td>
</tr>
<tr class="even">
<td>P1</td>
<td>0010</td>
<td>7</td>
<td>A normal healthy patient</td>
<td>Normal healthy patient</td>
</tr>
<tr class="odd">
<td>P2</td>
<td>0010</td>
<td>7</td>
<td>A patient with mild systemic disease</td>
<td>Patient w/mild syst disease</td>
</tr>
<tr class="even">
<td>P3</td>
<td>0010</td>
<td>7</td>
<td>A patient with severe systemic disease</td>
<td>Patient w/severe sys disease</td>
</tr>
<tr class="odd">
<td>P4</td>
<td>0010</td>
<td>7</td>
<td>A patient with severe systemic disease that is a constant threat to life</td>
<td>Pt w/sev sys dis threat life</td>
</tr>
<tr class="even">
<td>P5</td>
<td>0010</td>
<td>7</td>
<td>A moribund patient who is not expected to survive without the operation</td>
<td>Pt not expect surv w/o oper</td>
</tr>
<tr class="odd">
<td>P6</td>
<td>0010</td>
<td>7</td>
<td>A declared brain-dead patient whose organs are being removed for donor purposes</td>
<td>Brain-dead pt organs removed</td>
</tr>
<tr class="even">
<td>PA</td>
<td>0010</td>
<td>7</td>
<td>Surgical or other invasive procedure on wrong body part</td>
<td>Surgery, wrong body part</td>
</tr>
<tr class="odd">
<td>PB</td>
<td>0010</td>
<td>7</td>
<td>Surgical or other invasive procedure on wrong patient</td>
<td>Surgery, wrong patient</td>
</tr>
<tr class="even">
<td>PC</td>
<td>0010</td>
<td>7</td>
<td>Wrong surgery or other invasive procedure on patient</td>
<td>Wrong surgery on patient</td>
</tr>
<tr class="odd">
<td>PD</td>
<td>0010</td>
<td>7</td>
<td>Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days</td>
<td>Inp admit w/in 3 days</td>
</tr>
<tr class="even">
<td>PI</td>
<td>0010</td>
<td>7</td>
<td>Positron emission tomography (pet) or pet/computed tomography (ct) to inform the initial treatment strategy of tumors that are biopsy proven or strongly suspected of being cancerous based on other diagnostic testing</td>
<td>Pet tumor init tx strat</td>
</tr>
<tr class="odd">
<td>PL</td>
<td>0010</td>
<td>7</td>
<td>Progressive addition lenses</td>
<td>Progressive addition lenses</td>
</tr>
<tr class="even">
<td>PM</td>
<td>0010</td>
<td>7</td>
<td>Post mortem</td>
<td>Post mortem</td>
</tr>
<tr class="odd">
<td>PN</td>
<td>0010</td>
<td>7</td>
<td>Non-excepted service provided at an off-campus, outpatient, provider-based department of a hospital</td>
<td>Non-excepted off-campus svc</td>
</tr>
<tr class="even">
<td>PO</td>
<td>0010</td>
<td>7</td>
<td>Excepted service provided at an off-campus, outpatient, provider-based department of a hospital</td>
<td>Excepted off-campus service</td>
</tr>
<tr class="odd">
<td>PS</td>
<td>0010</td>
<td>7</td>
<td>Positron emission tomography (pet) or pet/computed tomography (ct) to inform the subsequent treatment strategy of cancerous tumors when the beneficiary’s treating physician determines that the pet study is needed to inform subsequent anti-tumor strategy</td>
<td>Pet tumor subsq tx strategy</td>
</tr>
<tr class="even">
<td>PT</td>
<td>0010</td>
<td>7</td>
<td>Colorectal cancer screening test; converted to diagnostic test or other procedure</td>
<td>Clrctal screen to diagn</td>
</tr>
<tr class="odd">
<td>Q0</td>
<td>0010</td>
<td>7</td>
<td>Investigational clinical service provided in a clinical research study that is in an approved clinical research study</td>
<td>Invest clinical research</td>
</tr>
<tr class="even">
<td>Q1</td>
<td>0010</td>
<td>7</td>
<td>Routine clinical service provided in a clinical research study that is in an approved clinical research study</td>
<td>Routine clinical research</td>
</tr>
<tr class="odd">
<td>Q2</td>
<td>0010</td>
<td>7</td>
<td>Demonstration procedure/service</td>
<td>Demo procedure, service</td>
</tr>
<tr class="even">
<td>Q3</td>
<td>0010</td>
<td>7</td>
<td>Live kidney donor surgery and related services</td>
<td>Live donor surgery/services</td>
</tr>
<tr class="odd">
<td>Q4</td>
<td>0010</td>
<td>7</td>
<td>Service for ordering/referring physician qualifies as a service exemption</td>
<td>Svc exempt - ordrg/rfrng md</td>
</tr>
<tr class="even">
<td>Q5</td>
<td>0010</td>
<td>7</td>
<td>Service furnished under a reciprocal billing arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area</td>
<td>Recip bill arr subs md or pt</td>
</tr>
<tr class="odd">
<td>Q6</td>
<td>0010</td>
<td>7</td>
<td>Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area</td>
<td>Fee/time comp subst md or pt</td>
</tr>
<tr class="even">
<td>Q7</td>
<td>0010</td>
<td>7</td>
<td>One class a finding</td>
<td>One class a finding</td>
</tr>
<tr class="odd">
<td>Q8</td>
<td>0010</td>
<td>7</td>
<td>Two class b findings</td>
<td>Two class b findings</td>
</tr>
<tr class="even">
<td>Q9</td>
<td>0010</td>
<td>7</td>
<td>One class b and two class c findings</td>
<td>1 class b &amp; 2 class c fndngs</td>
</tr>
<tr class="odd">
<td>QA</td>
<td>0010</td>
<td>7</td>
<td>Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts is less than 1 liter per minute (lpm)</td>
<td>Avg sta day/night o2 &lt; 1 lpm</td>
</tr>
<tr class="even">
<td>QB</td>
<td>0010</td>
<td>7</td>
<td>Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts exceeds 4 liters per minute (lpm) and portable oxygen is prescribed</td>
<td>Avg day/nite o2 &gt; 4 lpm/port</td>
</tr>
<tr class="odd">
<td>QC</td>
<td>0010</td>
<td>7</td>
<td>Single channel monitoring</td>
<td>Single channel monitoring</td>
</tr>
<tr class="even">
<td>QD</td>
<td>0010</td>
<td>7</td>
<td>Recording and storage in solid state memory by a digital recorder</td>
<td>Rcrdg/strg in sld st memory</td>
</tr>
<tr class="odd">
<td>QE</td>
<td>0010</td>
<td>7</td>
<td>Prescribed amount of stationary oxygen while at rest is less than 1 liter per minute (lpm)</td>
<td>Stationary o2 @ rest &lt;1 lpm</td>
</tr>
<tr class="even">
<td>QF</td>
<td>0010</td>
<td>7</td>
<td>Prescribed amount of stationary oxygen while at rest exceeds 4 liters per minute (lpm) and portable oxygen is prescribed</td>
<td>Station o2 @ rest &gt;4lpm/port</td>
</tr>
<tr class="odd">
<td>QG</td>
<td>0010</td>
<td>7</td>
<td>Prescribed amount of stationary oxygen while at rest is greater than 4 liters per minute (lpm)</td>
<td>Station o2 @ rest &gt; 4 lpm</td>
</tr>
<tr class="even">
<td>QH</td>
<td>0010</td>
<td>7</td>
<td>Oxygen conserving device is being used with an oxygen delivery system</td>
<td>Oxygen cnsrvg dvc w del sys</td>
</tr>
<tr class="odd">
<td>QJ</td>
<td>0010</td>
<td>7</td>
<td>Services/items provided to a prisoner or patient in state or local custody, however the state or local government, as applicable, meets the requirements in 42 cfr 411.4 (b)</td>
<td>Patient in state/locl custod</td>
</tr>
<tr class="even">
<td>QK</td>
<td>0010</td>
<td>7</td>
<td>Medical direction of two, three, or four concurrent anesthesia procedures involving qualified individuals</td>
<td>Med dir 2-4 cncrnt anes proc</td>
</tr>
<tr class="odd">
<td>QL</td>
<td>0010</td>
<td>7</td>
<td>Patient pronounced dead after ambulance called</td>
<td>Patient died after amb call</td>
</tr>
<tr class="even">
<td>QM</td>
<td>0010</td>
<td>7</td>
<td>Ambulance service provided under arrangement by a provider of services</td>
<td>Ambulance arr by provider</td>
</tr>
<tr class="odd">
<td>QN</td>
<td>0010</td>
<td>7</td>
<td>Ambulance service furnished directly by a provider of services</td>
<td>Ambulance furn by provider</td>
</tr>
<tr class="even">
<td>QP</td>
<td>0010</td>
<td>7</td>
<td>Documentation is on file showing that the laboratory test(s) was ordered individually or ordered as a cpt-recognized panel other than automated profile codes 80002-80019, g0058, g0059, and g0060.</td>
<td>Individually ordered lab tst</td>
</tr>
<tr class="odd">
<td>QQ</td>
<td>0010</td>
<td>7</td>
<td>Ordering professional consulted a qualified clinical decision support mechanism for this service and the related data was provided to the furnishing professional</td>
<td>Qualified cdsm consulted</td>
</tr>
<tr class="even">
<td>QR</td>
<td>0010</td>
<td>7</td>
<td>Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts is greater than 4 liters per minute (lpm)</td>
<td>Avg sta day/night o2 &gt; 4 lpm</td>
</tr>
<tr class="odd">
<td>QS</td>
<td>0010</td>
<td>7</td>
<td>Monitored anesthesia care service</td>
<td>Monitored anesthesia care</td>
</tr>
<tr class="even">
<td>QT</td>
<td>0010</td>
<td>7</td>
<td>Recording and storage on tape by an analog tape recorder</td>
<td>Rcrdg/strg tape analog recdr</td>
</tr>
<tr class="odd">
<td>QW</td>
<td>0010</td>
<td>7</td>
<td>Clia waived test</td>
<td>Clia waived test</td>
</tr>
<tr class="even">
<td>QX</td>
<td>0010</td>
<td>7</td>
<td>Crna service: with medical direction by a physician</td>
<td>Crna svc w/ md med direction</td>
</tr>
<tr class="odd">
<td>QY</td>
<td>0010</td>
<td>7</td>
<td>Medical direction of one certified registered nurse anesthetist (crna) by an anesthesiologist</td>
<td>Medically directed crna</td>
</tr>
<tr class="even">
<td>QZ</td>
<td>0010</td>
<td>7</td>
<td>Crna service: without medical direction by a physician</td>
<td>Crna svc w/o med dir by md</td>
</tr>
<tr class="odd">
<td>RA</td>
<td>0010</td>
<td>7</td>
<td>Replacement of a dme, orthotic or prosthetic item</td>
<td>Replacement of dme item</td>
</tr>
<tr class="even">
<td>RB</td>
<td>0010</td>
<td>7</td>
<td>Replacement of a part of a dme, orthotic or prosthetic item furnished as part of a repair</td>
<td>Replacement part, dme item</td>
</tr>
<tr class="odd">
<td>RC</td>
<td>0010</td>
<td>7</td>
<td>Right coronary artery</td>
<td>Right coronary artery</td>
</tr>
<tr class="even">
<td>RD</td>
<td>0010</td>
<td>7</td>
<td>Drug provided to beneficiary, but not administered “incident-to”</td>
<td>Drug admin not incident-to</td>
</tr>
<tr class="odd">
<td>RE</td>
<td>0010</td>
<td>7</td>
<td>Furnished in full compliance with fda-mandated risk evaluation and mitigation strategy (rems)</td>
<td>Furnish full compliance rems</td>
</tr>
<tr class="even">
<td>RI</td>
<td>0010</td>
<td>7</td>
<td>Ramus intermedius coronary artery</td>
<td>Ramus intermedius cor artery</td>
</tr>
<tr class="odd">
<td>RR</td>
<td>0010</td>
<td>7</td>
<td>Rental (use the ‘rr’ modifier when dme is to be rented)</td>
<td>Rental (dme)</td>
</tr>
<tr class="even">
<td>RT</td>
<td>0010</td>
<td>7</td>
<td>Right side (used to identify procedures performed on the right side of the body)</td>
<td>Right side</td>
</tr>
<tr class="odd">
<td>SA</td>
<td>0010</td>
<td>7</td>
<td>Nurse practitioner rendering service in collaboration with a physician</td>
<td>Nurse practitioner w physici</td>
</tr>
<tr class="even">
<td>SB</td>
<td>0010</td>
<td>7</td>
<td>Nurse midwife</td>
<td>Nurse midwife</td>
</tr>
<tr class="odd">
<td>SC</td>
<td>0010</td>
<td>7</td>
<td>Medically necessary service or supply</td>
<td>Medically necessary serv/sup</td>
</tr>
<tr class="even">
<td>SD</td>
<td>0010</td>
<td>7</td>
<td>Services provided by registered nurse with specialized, highly technical home infusion training</td>
<td>Serv by home infusion rn</td>
</tr>
<tr class="odd">
<td>SE</td>
<td>0010</td>
<td>7</td>
<td>State and/or federally-funded programs/services</td>
<td>State/fed funded program/ser</td>
</tr>
<tr class="even">
<td>SF</td>
<td>0010</td>
<td>7</td>
<td>Second opinion ordered by a professional review organization (pro) per section 9401, p.l. 99-272 (100% reimbursement - no medicare deductible or coinsurance)</td>
<td>2nd opinion ordered by pro</td>
</tr>
<tr class="odd">
<td>SG</td>
<td>0010</td>
<td>7</td>
<td>Ambulatory surgical center (asc) facility service</td>
<td>Asc facility service</td>
</tr>
<tr class="even">
<td>SH</td>
<td>0010</td>
<td>7</td>
<td>Second concurrently administered infusion therapy</td>
<td>2nd concurrent infusion ther</td>
</tr>
<tr class="odd">
<td>SJ</td>
<td>0010</td>
<td>7</td>
<td>Third or more concurrently administered infusion therapy</td>
<td>3rd concurrent infusion ther</td>
</tr>
<tr class="even">
<td>SK</td>
<td>0010</td>
<td>7</td>
<td>Member of high risk population (use only with codes for immunization)</td>
<td>High risk population</td>
</tr>
<tr class="odd">
<td>SL</td>
<td>0010</td>
<td>7</td>
<td>State supplied vaccine</td>
<td>State supplied vaccine</td>
</tr>
<tr class="even">
<td>SM</td>
<td>0010</td>
<td>7</td>
<td>Second surgical opinion</td>
<td>Second opinion</td>
</tr>
<tr class="odd">
<td>SN</td>
<td>0010</td>
<td>7</td>
<td>Third surgical opinion</td>
<td>Third opinion</td>
</tr>
<tr class="even">
<td>SQ</td>
<td>0010</td>
<td>7</td>
<td>Item ordered by home health</td>
<td>Item ordered by home health</td>
</tr>
<tr class="odd">
<td>SS</td>
<td>0010</td>
<td>7</td>
<td>Home infusion services provided in the infusion suite of the iv therapy provider</td>
<td>Hit in infusion suite</td>
</tr>
<tr class="even">
<td>ST</td>
<td>0010</td>
<td>7</td>
<td>Related to trauma or injury</td>
<td>Related to trauma or injury</td>
</tr>
<tr class="odd">
<td>SU</td>
<td>0010</td>
<td>7</td>
<td>Procedure performed in physician’s office (to denote use of facility and equipment)</td>
<td>Performed in phys office</td>
</tr>
<tr class="even">
<td>SV</td>
<td>0010</td>
<td>7</td>
<td>Pharmaceuticals delivered to patient’s home but not utilized</td>
<td>Drugs delivered not used</td>
</tr>
<tr class="odd">
<td>SW</td>
<td>0010</td>
<td>7</td>
<td>Services provided by a certified diabetic educator</td>
<td>Serv by cert diab educator</td>
</tr>
<tr class="even">
<td>SY</td>
<td>0010</td>
<td>7</td>
<td>Persons who are in close contact with member of high-risk population (use only with codes for immunization)</td>
<td>Contact w/high-risk pop</td>
</tr>
<tr class="odd">
<td>SZ</td>
<td>0010</td>
<td>7</td>
<td>Habilitative services</td>
<td>Habilitative services</td>
</tr>
<tr class="even">
<td>T1</td>
<td>0010</td>
<td>7</td>
<td>Left foot, second digit</td>
<td>Left foot, second digit</td>
</tr>
<tr class="odd">
<td>T2</td>
<td>0010</td>
<td>7</td>
<td>Left foot, third digit</td>
<td>Left foot, third digit</td>
</tr>
<tr class="even">
<td>T3</td>
<td>0010</td>
<td>7</td>
<td>Left foot, fourth digit</td>
<td>Left foot, fourth digit</td>
</tr>
<tr class="odd">
<td>T4</td>
<td>0010</td>
<td>7</td>
<td>Left foot, fifth digit</td>
<td>Left foot, fifth digit</td>
</tr>
<tr class="even">
<td>T5</td>
<td>0010</td>
<td>7</td>
<td>Right foot, great toe</td>
<td>Right foot, great toe</td>
</tr>
<tr class="odd">
<td>T6</td>
<td>0010</td>
<td>7</td>
<td>Right foot, second digit</td>
<td>Right foot, second digit</td>
</tr>
<tr class="even">
<td>T7</td>
<td>0010</td>
<td>7</td>
<td>Right foot, third digit</td>
<td>Right foot, third digit</td>
</tr>
<tr class="odd">
<td>T8</td>
<td>0010</td>
<td>7</td>
<td>Right foot, fourth digit</td>
<td>Right foot, fourth digit</td>
</tr>
<tr class="even">
<td>T9</td>
<td>0010</td>
<td>7</td>
<td>Right foot, fifth digit</td>
<td>Right foot, fifth digit</td>
</tr>
<tr class="odd">
<td>TA</td>
<td>0010</td>
<td>7</td>
<td>Left foot, great toe</td>
<td>Left foot, great toe</td>
</tr>
<tr class="even">
<td>TB</td>
<td>0010</td>
<td>7</td>
<td>Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes</td>
<td>Tracking 340b acquired drug</td>
</tr>
<tr class="odd">
<td>TC</td>
<td>0010</td>
<td>7</td>
<td>Technical component; under certain circumstances, a charge may be made for the technical component alone; under those circumstances the technical component charge is identified by adding modifier ‘tc’ to the usual procedure number; technical component charges are institutional charges and not billed separately by physicians; however, portable x-ray suppliers only bill for technical component and should utilize modifier tc; the charge data from portable x-ray suppliers will then be used to build customary and prevailing profiles</td>
<td>Technical component</td>
</tr>
<tr class="even">
<td>TD</td>
<td>0010</td>
<td>7</td>
<td>Rn</td>
<td>Rn</td>
</tr>
<tr class="odd">
<td>TE</td>
<td>0010</td>
<td>7</td>
<td>Lpn/lvn</td>
<td>Lpn/lvn</td>
</tr>
<tr class="even">
<td>TF</td>
<td>0010</td>
<td>7</td>
<td>Intermediate level of care</td>
<td>Intermediate level of care</td>
</tr>
<tr class="odd">
<td>TG</td>
<td>0010</td>
<td>7</td>
<td>Complex/high tech level of care</td>
<td>Complex/high tech level care</td>
</tr>
<tr class="even">
<td>TH</td>
<td>0010</td>
<td>7</td>
<td>Obstetrical treatment/services, prenatal or postpartum</td>
<td>Ob tx/srvcs prenatl/postpart</td>
</tr>
<tr class="odd">
<td>TJ</td>
<td>0010</td>
<td>7</td>
<td>Program group, child and/or adolescent</td>
<td>Child/adolescent program gp</td>
</tr>
<tr class="even">
<td>TK</td>
<td>0010</td>
<td>7</td>
<td>Extra patient or passenger, non-ambulance</td>
<td>Extra patient or passenger</td>
</tr>
<tr class="odd">
<td>TL</td>
<td>0010</td>
<td>7</td>
<td>Early intervention/individualized family service plan (ifsp)</td>
<td>Early intervention ifsp</td>
</tr>
<tr class="even">
<td>TM</td>
<td>0010</td>
<td>7</td>
<td>Individualized education program (iep)</td>
<td>Individualized ed prgrm(iep)</td>
</tr>
<tr class="odd">
<td>TN</td>
<td>0010</td>
<td>7</td>
<td>Rural/outside providers’ customary service area</td>
<td>Rural/out of service area</td>
</tr>
<tr class="even">
<td>TP</td>
<td>0010</td>
<td>7</td>
<td>Medical transport, unloaded vehicle</td>
<td>Med transprt unloaded vehicl</td>
</tr>
<tr class="odd">
<td>TQ</td>
<td>0010</td>
<td>7</td>
<td>Basic life support transport by a volunteer ambulance provider</td>
<td>Bls by volunteer amb providr</td>
</tr>
<tr class="even">
<td>TR</td>
<td>0010</td>
<td>7</td>
<td>School-based individualized education program (iep) services provided outside the public school district responsible for the student</td>
<td>School-based iep out of dist</td>
</tr>
<tr class="odd">
<td>TS</td>
<td>0010</td>
<td>7</td>
<td>Follow-up service</td>
<td>Follow-up service</td>
</tr>
<tr class="even">
<td>TT</td>
<td>0010</td>
<td>7</td>
<td>Individualized service provided to more than one patient in same setting</td>
<td>Additional patient</td>
</tr>
<tr class="odd">
<td>TU</td>
<td>0010</td>
<td>7</td>
<td>Special payment rate, overtime</td>
<td>Overtime payment rate</td>
</tr>
<tr class="even">
<td>TV</td>
<td>0010</td>
<td>7</td>
<td>Special payment rates, holidays/weekends</td>
<td>Holiday/weekend payment rate</td>
</tr>
<tr class="odd">
<td>TW</td>
<td>0010</td>
<td>7</td>
<td>Back-up equipment</td>
<td>Back-up equipment</td>
</tr>
<tr class="even">
<td>U1</td>
<td>0010</td>
<td>7</td>
<td>Medicaid level of care 1, as defined by each state</td>
<td>M/caid care lev 1 state def</td>
</tr>
<tr class="odd">
<td>U2</td>
<td>0010</td>
<td>7</td>
<td>Medicaid level of care 2, as defined by each state</td>
<td>M/caid care lev 2 state def</td>
</tr>
<tr class="even">
<td>U3</td>
<td>0010</td>
<td>7</td>
<td>Medicaid level of care 3, as defined by each state</td>
<td>M/caid care lev 3 state def</td>
</tr>
<tr class="odd">
<td>U4</td>
<td>0010</td>
<td>7</td>
<td>Medicaid level of care 4, as defined by each state</td>
<td>M/caid care lev 4 state def</td>
</tr>
<tr class="even">
<td>U5</td>
<td>0010</td>
<td>7</td>
<td>Medicaid level of care 5, as defined by each state</td>
<td>M/caid care lev 5 state def</td>
</tr>
<tr class="odd">
<td>U6</td>
<td>0010</td>
<td>7</td>
<td>Medicaid level of care 6, as defined by each state</td>
<td>M/caid care lev 6 state def</td>
</tr>
<tr class="even">
<td>U7</td>
<td>0010</td>
<td>7</td>
<td>Medicaid level of care 7, as defined by each state</td>
<td>M/caid care lev 7 state def</td>
</tr>
<tr class="odd">
<td>U8</td>
<td>0010</td>
<td>7</td>
<td>Medicaid level of care 8, as defined by each state</td>
<td>M/caid care lev 8 state def</td>
</tr>
<tr class="even">
<td>U9</td>
<td>0010</td>
<td>7</td>
<td>Medicaid level of care 9, as defined by each state</td>
<td>M/caid care lev 9 state def</td>
</tr>
<tr class="odd">
<td>UA</td>
<td>0010</td>
<td>7</td>
<td>Medicaid level of care 10, as defined by each state</td>
<td>M/caid care lev 10 state def</td>
</tr>
<tr class="even">
<td>UB</td>
<td>0010</td>
<td>7</td>
<td>Medicaid level of care 11, as defined by each state</td>
<td>M/caid care lev 11 state def</td>
</tr>
<tr class="odd">
<td>UC</td>
<td>0010</td>
<td>7</td>
<td>Medicaid level of care 12, as defined by each state</td>
<td>M/caid care lev 12 state def</td>
</tr>
<tr class="even">
<td>UD</td>
<td>0010</td>
<td>7</td>
<td>Medicaid level of care 13, as defined by each state</td>
<td>M/caid care lev 13 state def</td>
</tr>
<tr class="odd">
<td>UE</td>
<td>0010</td>
<td>7</td>
<td>Used durable medical equipment</td>
<td>Used durable med equipment</td>
</tr>
<tr class="even">
<td>UF</td>
<td>0010</td>
<td>7</td>
<td>Services provided in the morning</td>
<td>Services provided, morning</td>
</tr>
<tr class="odd">
<td>UG</td>
<td>0010</td>
<td>7</td>
<td>Services provided in the afternoon</td>
<td>Services provided, afternoon</td>
</tr>
<tr class="even">
<td>UH</td>
<td>0010</td>
<td>7</td>
<td>Services provided in the evening</td>
<td>Services provided, evening</td>
</tr>
<tr class="odd">
<td>UJ</td>
<td>0010</td>
<td>7</td>
<td>Services provided at night</td>
<td>Services provided, night</td>
</tr>
<tr class="even">
<td>UK</td>
<td>0010</td>
<td>7</td>
<td>Services provided on behalf of the client to someone other than the client (collateral relationship)</td>
<td>Svc on behalf client-collat</td>
</tr>
<tr class="odd">
<td>UN</td>
<td>0010</td>
<td>7</td>
<td>Two patients served</td>
<td>Two patients served</td>
</tr>
<tr class="even">
<td>UP</td>
<td>0010</td>
<td>7</td>
<td>Three patients served</td>
<td>Three patients served</td>
</tr>
<tr class="odd">
<td>UQ</td>
<td>0010</td>
<td>7</td>
<td>Four patients served</td>
<td>Four patients served</td>
</tr>
<tr class="even">
<td>UR</td>
<td>0010</td>
<td>7</td>
<td>Five patients served</td>
<td>Five patients served</td>
</tr>
<tr class="odd">
<td>US</td>
<td>0010</td>
<td>7</td>
<td>Six or more patients served</td>
<td>Six or more patients served</td>
</tr>
<tr class="even">
<td>V1</td>
<td>0010</td>
<td>7</td>
<td>Demonstration modifier 1</td>
<td>Demonstration modifier 1</td>
</tr>
<tr class="odd">
<td>V2</td>
<td>0010</td>
<td>7</td>
<td>Demonstration modifier 2</td>
<td>Demonstration modifier 2</td>
</tr>
<tr class="even">
<td>V3</td>
<td>0010</td>
<td>7</td>
<td>Demonstration modifier 3</td>
<td>Demonstration modifier 3</td>
</tr>
<tr class="odd">
<td>V5</td>
<td>0010</td>
<td>7</td>
<td>Vascular catheter (alone or with any other vascular access)</td>
<td>Vascular catheter</td>
</tr>
<tr class="even">
<td>V6</td>
<td>0010</td>
<td>7</td>
<td>Arteriovenous graft (or other vascular access not including a vascular catheter)</td>
<td>Arteriovenous graft</td>
</tr>
<tr class="odd">
<td>V7</td>
<td>0010</td>
<td>7</td>
<td>Arteriovenous fistula only (in use with two needles)</td>
<td>Arteriovenous fistula</td>
</tr>
<tr class="even">
<td>V8</td>
<td>0010</td>
<td>7</td>
<td>Infection present</td>
<td>Infection present</td>
</tr>
<tr class="odd">
<td>V9</td>
<td>0010</td>
<td>7</td>
<td>No infection present</td>
<td>No infection present</td>
</tr>
<tr class="even">
<td>VM</td>
<td>0010</td>
<td>7</td>
<td>Medicare diabetes prevention program (mdpp) virtual make-up session</td>
<td>Mdpp virtual make-up session</td>
</tr>
<tr class="odd">
<td>VP</td>
<td>0010</td>
<td>7</td>
<td>Aphakic patient</td>
<td>Aphakic patient</td>
</tr>
<tr class="even">
<td>X1</td>
<td>0010</td>
<td>7</td>
<td>Continuous/broad services: for reporting services by clinicians, who provide the principal care for a patient, with no planned endpoint of the relationship; services in this category represent comprehensive care, dealing with the entire scope of patient problems, either directly or in a care coordination role; reporting clinician service examples include, but are not limited to: primary care, and clinicians providing comprehensive care to patients in addition to specialty care</td>
<td>Continuous/broad services</td>
</tr>
<tr class="odd">
<td>X2</td>
<td>0010</td>
<td>7</td>
<td>Continuous/focused services: for reporting services by clinicians whose expertise is needed for the ongoing management of a chronic disease or a condition that needs to be managed and followed with no planned endpoint to the relationship; reporting clinician service examples include but are not limited to: a rheumatologist taking care of the patient’s rheumatoid arthritis longitudinally but not providing general primary care services</td>
<td>Continuous/focused services</td>
</tr>
<tr class="even">
<td>X3</td>
<td>0010</td>
<td>7</td>
<td>Episodic/broad servies: for reporting services by clinicians who have broad responsibility for the comprehensive needs of the patient that is limited to a defined period and circumstance such as a hospitalization; reporting clinician service examples include but are not limited to the hospitalist’s services rendered providing comprehensive and general care to a patient while admitted to the hospital</td>
<td>Episodic/broad services</td>
</tr>
<tr class="odd">
<td>X4</td>
<td>0010</td>
<td>7</td>
<td>Episodic/focused services: for reporting services by clinicians who provide focused care on particular types of treatment limited to a defined period and circumstance; the patient has a problem, acute or chronic, that will be treated with surgery, radiation, or some other type of generally time-limited intervention; reporting clinician service examples include but are not limited to, the orthopedic surgeon performing a knee replacement and seeing the patient through the postoperative period</td>
<td>Episodic/focused services</td>
</tr>
<tr class="even">
<td>X5</td>
<td>0010</td>
<td>7</td>
<td>Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist’s interpretation of an imaging study requested by another clinician</td>
<td>Svc req by another clinician</td>
</tr>
<tr class="odd">
<td>XE</td>
<td>0010</td>
<td>7</td>
<td>Separate encounter, a service that is distinct because it occurred during a separate encounter</td>
<td>Separate encounter</td>
</tr>
<tr class="even">
<td>XP</td>
<td>0010</td>
<td>7</td>
<td>Separate practitioner, a service that is distinct because it was performed by a different practitioner</td>
<td>Separate practitioner</td>
</tr>
<tr class="odd">
<td>XS</td>
<td>0010</td>
<td>7</td>
<td>Separate structure, a service that is distinct because it was performed on a separate organ/structure</td>
<td>Separate organ/structure</td>
</tr>
<tr class="even">
<td>XU</td>
<td>0010</td>
<td>7</td>
<td>Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service</td>
<td>Unusual separate service</td>
</tr>
<tr class="odd">
<td>ZA</td>
<td>0010</td>
<td>7</td>
<td>Novartis/sandoz</td>
<td>Novartis/sandoz</td>
</tr>
<tr class="even">
<td>ZB</td>
<td>0010</td>
<td>7</td>
<td>Pfizer/hospira</td>
<td>Pfizer/hospira</td>
</tr>
<tr class="odd">
<td>ZC</td>
<td>0010</td>
<td>7</td>
<td>Merck/samsung bioepis</td>
<td>Merck/samsung bioepis</td>
</tr>
</tbody>
</table>
</div>
<div id="a-series-transportation-services-including-ambulance-medical-and-surgical-supplies-a0000-a9999" class="section level2">
<h2>A Series: Transportation Services, Including Ambulance Medical and Surgical Supplies (A0000-A9999)</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>A0021</td>
<td>0010</td>
<td>3</td>
<td>Ambulance service, outside state per mile, transport (medicaid only)</td>
<td>Outside state ambulance serv</td>
</tr>
<tr class="even">
<td>A0080</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation, per mile - vehicle provided by volunteer (individual or organization), with no vested interest</td>
<td>Noninterest escort in non er</td>
</tr>
<tr class="odd">
<td>A0090</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation, per mile - vehicle provided by individual (family member, self, neighbor) with vested interest</td>
<td>Interest escort in non er</td>
</tr>
<tr class="even">
<td>A0100</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation; taxi</td>
<td>Nonemergency transport taxi</td>
</tr>
<tr class="odd">
<td>A0110</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation and bus, intra or inter state carrier</td>
<td>Nonemergency transport bus</td>
</tr>
<tr class="even">
<td>A0120</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation: mini-bus, mountain area transports, or other transportation systems</td>
<td>Noner transport mini-bus</td>
</tr>
<tr class="odd">
<td>A0130</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation: wheelchair van</td>
<td>Noner transport wheelch van</td>
</tr>
<tr class="even">
<td>A0140</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation and air travel (private or commercial) intra or inter state</td>
<td>Nonemergency transport air</td>
</tr>
<tr class="odd">
<td>A0160</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation: per mile - case worker or social worker</td>
<td>Noner transport case worker</td>
</tr>
<tr class="even">
<td>A0170</td>
<td>0010</td>
<td>3</td>
<td>Transportation ancillary: parking fees, tolls, other</td>
<td>Transport parking fees/tolls</td>
</tr>
<tr class="odd">
<td>A0180</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation: ancillary: lodging-recipient</td>
<td>Noner transport lodgng recip</td>
</tr>
<tr class="even">
<td>A0190</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation: ancillary: meals-recipient</td>
<td>Noner transport meals recip</td>
</tr>
<tr class="odd">
<td>A0200</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation: ancillary: lodging escort</td>
<td>Noner transport lodgng escrt</td>
</tr>
<tr class="even">
<td>A0210</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation: ancillary: meals-escort</td>
<td>Noner transport meals escort</td>
</tr>
<tr class="odd">
<td>A0225</td>
<td>0010</td>
<td>3</td>
<td>Ambulance service, neonatal transport, base rate, emergency transport, one way</td>
<td>Neonatal emergency transport</td>
</tr>
<tr class="even">
<td>A0380</td>
<td>0010</td>
<td>3</td>
<td>Bls mileage (per mile)</td>
<td>Basic life support mileage</td>
</tr>
<tr class="odd">
<td>A0382</td>
<td>0010</td>
<td>3</td>
<td>Bls routine disposable supplies</td>
<td>Basic support routine suppls</td>
</tr>
<tr class="even">
<td>A0384</td>
<td>0010</td>
<td>3</td>
<td>Bls specialized service disposable supplies; defibrillation (used by als ambulances and bls ambulances in jurisdictions where defibrillation is permitted in bls ambulances)</td>
<td>Bls defibrillation supplies</td>
</tr>
<tr class="odd">
<td>A0390</td>
<td>0010</td>
<td>3</td>
<td>Als mileage (per mile)</td>
<td>Advanced life support mileag</td>
</tr>
<tr class="even">
<td>A0392</td>
<td>0010</td>
<td>3</td>
<td>Als specialized service disposable supplies; defibrillation (to be used only in jurisdictions where defibrillation cannot be performed in bls ambulances)</td>
<td>Als defibrillation supplies</td>
</tr>
<tr class="odd">
<td>A0394</td>
<td>0010</td>
<td>3</td>
<td>Als specialized service disposable supplies; iv drug therapy</td>
<td>Als iv drug therapy supplies</td>
</tr>
<tr class="even">
<td>A0396</td>
<td>0010</td>
<td>3</td>
<td>Als specialized service disposable supplies; esophageal intubation</td>
<td>Als esophageal intub suppls</td>
</tr>
<tr class="odd">
<td>A0398</td>
<td>0010</td>
<td>3</td>
<td>Als routine disposable supplies</td>
<td>Als routine disposble suppls</td>
</tr>
<tr class="even">
<td>A0420</td>
<td>0010</td>
<td>3</td>
<td>Ambulance waiting time (als or bls), one half (1/2) hour increments</td>
<td>Ambulance waiting 1/2 hr</td>
</tr>
<tr class="odd">
<td>A0422</td>
<td>0010</td>
<td>3</td>
<td>Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation</td>
<td>Ambulance 02 life sustaining</td>
</tr>
<tr class="even">
<td>A0424</td>
<td>0010</td>
<td>3</td>
<td>Extra ambulance attendant, ground (als or bls) or air (fixed or rotary winged); (requires medical review)</td>
<td>Extra ambulance attendant</td>
</tr>
<tr class="odd">
<td>A0425</td>
<td>0010</td>
<td>3</td>
<td>Ground mileage, per statute mile</td>
<td>Ground mileage</td>
</tr>
<tr class="even">
<td>A0426</td>
<td>0010</td>
<td>3</td>
<td>Ambulance service, advanced life support, non-emergency transport, level 1 (als 1)</td>
<td>Als 1</td>
</tr>
<tr class="odd">
<td>A0427</td>
<td>0010</td>
<td>3</td>
<td>Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency)</td>
<td>Als1-emergency</td>
</tr>
<tr class="even">
<td>A0428</td>
<td>0010</td>
<td>3</td>
<td>Ambulance service, basic life support, non-emergency transport, (bls)</td>
<td>Bls</td>
</tr>
<tr class="odd">
<td>A0429</td>
<td>0010</td>
<td>3</td>
<td>Ambulance service, basic life support, emergency transport (bls-emergency)</td>
<td>Bls-emergency</td>
</tr>
<tr class="even">
<td>A0430</td>
<td>0010</td>
<td>3</td>
<td>Ambulance service, conventional air services, transport, one way (fixed wing)</td>
<td>Fixed wing air transport</td>
</tr>
<tr class="odd">
<td>A0431</td>
<td>0010</td>
<td>3</td>
<td>Ambulance service, conventional air services, transport, one way (rotary wing)</td>
<td>Rotary wing air transport</td>
</tr>
<tr class="even">
<td>A0432</td>
<td>0010</td>
<td>3</td>
<td>Paramedic intercept (pi), rural area, transport furnished by a volunteer ambulance company which is prohibited by state law from billing third party payers</td>
<td>Pi volunteer ambulance co</td>
</tr>
<tr class="odd">
<td>A0433</td>
<td>0010</td>
<td>3</td>
<td>Advanced life support, level 2 (als 2)</td>
<td>Als 2</td>
</tr>
<tr class="even">
<td>A0434</td>
<td>0010</td>
<td>3</td>
<td>Specialty care transport (sct)</td>
<td>Specialty care transport</td>
</tr>
<tr class="odd">
<td>A0435</td>
<td>0010</td>
<td>3</td>
<td>Fixed wing air mileage, per statute mile</td>
<td>Fixed wing air mileage</td>
</tr>
<tr class="even">
<td>A0436</td>
<td>0010</td>
<td>3</td>
<td>Rotary wing air mileage, per statute mile</td>
<td>Rotary wing air mileage</td>
</tr>
<tr class="odd">
<td>A0888</td>
<td>0010</td>
<td>3</td>
<td>Noncovered ambulance mileage, per mile (e.g., for miles traveled beyond closest appropriate facility)</td>
<td>Noncovered ambulance mileage</td>
</tr>
<tr class="even">
<td>A0998</td>
<td>0010</td>
<td>3</td>
<td>Ambulance response and treatment, no transport</td>
<td>Ambulance response/treatment</td>
</tr>
<tr class="odd">
<td>A0999</td>
<td>0010</td>
<td>3</td>
<td>Unlisted ambulance service</td>
<td>Unlisted ambulance service</td>
</tr>
<tr class="even">
<td>A4206</td>
<td>0010</td>
<td>3</td>
<td>Syringe with needle, sterile, 1 cc or less, each</td>
<td>1 cc sterile syringe&amp;needle</td>
</tr>
<tr class="odd">
<td>A4207</td>
<td>0010</td>
<td>3</td>
<td>Syringe with needle, sterile 2 cc, each</td>
<td>2 cc sterile syringe&amp;needle</td>
</tr>
<tr class="even">
<td>A4208</td>
<td>0010</td>
<td>3</td>
<td>Syringe with needle, sterile 3 cc, each</td>
<td>3 cc sterile syringe&amp;needle</td>
</tr>
<tr class="odd">
<td>A4209</td>
<td>0010</td>
<td>3</td>
<td>Syringe with needle, sterile 5 cc or greater, each</td>
<td>5+ cc sterile syringe&amp;needle</td>
</tr>
<tr class="even">
<td>A4210</td>
<td>0010</td>
<td>3</td>
<td>Needle-free injection device, each</td>
<td>Nonneedle injection device</td>
</tr>
<tr class="odd">
<td>A4211</td>
<td>0010</td>
<td>3</td>
<td>Supplies for self-administered injections</td>
<td>Supp for self-adm injections</td>
</tr>
<tr class="even">
<td>A4212</td>
<td>0010</td>
<td>3</td>
<td>Non-coring needle or stylet with or without catheter</td>
<td>Non coring needle or stylet</td>
</tr>
<tr class="odd">
<td>A4213</td>
<td>0010</td>
<td>3</td>
<td>Syringe, sterile, 20 cc or greater, each</td>
<td>20+ cc syringe only</td>
</tr>
<tr class="even">
<td>A4215</td>
<td>0010</td>
<td>3</td>
<td>Needle, sterile, any size, each</td>
<td>Sterile needle</td>
</tr>
<tr class="odd">
<td>A4216</td>
<td>0010</td>
<td>3</td>
<td>Sterile water, saline and/or dextrose, diluent/flush, 10 ml</td>
<td>Sterile water/saline, 10 ml</td>
</tr>
<tr class="even">
<td>A4217</td>
<td>0010</td>
<td>3</td>
<td>Sterile water/saline, 500 ml</td>
<td>Sterile water/saline, 500 ml</td>
</tr>
<tr class="odd">
<td>A4218</td>
<td>0010</td>
<td>3</td>
<td>Sterile saline or water, metered dose dispenser, 10 ml</td>
<td>Sterile saline or water</td>
</tr>
<tr class="even">
<td>A4220</td>
<td>0010</td>
<td>3</td>
<td>Refill kit for implantable infusion pump</td>
<td>Infusion pump refill kit</td>
</tr>
<tr class="odd">
<td>A4221</td>
<td>0010</td>
<td>3</td>
<td>Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)</td>
<td>Supp non-insulin inf cath/wk</td>
</tr>
<tr class="even">
<td>A4222</td>
<td>0010</td>
<td>3</td>
<td>Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)</td>
<td>Infusion supplies with pump</td>
</tr>
<tr class="odd">
<td>A4223</td>
<td>0010</td>
<td>3</td>
<td>Infusion supplies not used with external infusion pump, per cassette or bag (list drugs separately)</td>
<td>Infusion supplies w/o pump</td>
</tr>
<tr class="even">
<td>A4224</td>
<td>0010</td>
<td>3</td>
<td>Supplies for maintenance of insulin infusion catheter, per week</td>
<td>Supply insulin inf cath/wk</td>
</tr>
<tr class="odd">
<td>A4225</td>
<td>0010</td>
<td>3</td>
<td>Supplies for external insulin infusion pump, syringe type cartridge, sterile, each</td>
<td>Sup/ext insulin inf pump syr</td>
</tr>
<tr class="even">
<td>A4226</td>
<td>0010</td>
<td>3</td>
<td>Supplies for maintenance of insulin infusion pump with dosage rate adjustment using therapeutic continuous glucose sensing, per week</td>
<td>Weekly supply maint cgs pump</td>
</tr>
<tr class="odd">
<td>A4230</td>
<td>0010</td>
<td>3</td>
<td>Infusion set for external insulin pump, non needle cannula type</td>
<td>Infus insulin pump non needl</td>
</tr>
<tr class="even">
<td>A4231</td>
<td>0010</td>
<td>3</td>
<td>Infusion set for external insulin pump, needle type</td>
<td>Infusion insulin pump needle</td>
</tr>
<tr class="odd">
<td>A4232</td>
<td>0010</td>
<td>3</td>
<td>Syringe with needle for external insulin pump, sterile, 3 cc</td>
<td>Syringe w/needle insulin 3cc</td>
</tr>
<tr class="even">
<td>A4233</td>
<td>0010</td>
<td>3</td>
<td>Replacement battery, alkaline (other than j cell), for use with medically necessary home blood glucose monitor owned by patient, each</td>
<td>Alkalin batt for glucose mon</td>
</tr>
<tr class="odd">
<td>A4234</td>
<td>0010</td>
<td>3</td>
<td>Replacement battery, alkaline, j cell, for use with medically necessary home blood glucose monitor owned by patient, each</td>
<td>J-cell batt for glucose mon</td>
</tr>
<tr class="even">
<td>A4235</td>
<td>0010</td>
<td>3</td>
<td>Replacement battery, lithium, for use with medically necessary home blood glucose monitor owned by patient, each</td>
<td>Lithium batt for glucose mon</td>
</tr>
<tr class="odd">
<td>A4236</td>
<td>0010</td>
<td>3</td>
<td>Replacement battery, silver oxide, for use with medically necessary home blood glucose monitor owned by patient, each</td>
<td>Silvr oxide batt glucose mon</td>
</tr>
<tr class="even">
<td>A4244</td>
<td>0010</td>
<td>3</td>
<td>Alcohol or peroxide, per pint</td>
<td>Alcohol or peroxide per pint</td>
</tr>
<tr class="odd">
<td>A4245</td>
<td>0010</td>
<td>3</td>
<td>Alcohol wipes, per box</td>
<td>Alcohol wipes per box</td>
</tr>
<tr class="even">
<td>A4246</td>
<td>0010</td>
<td>3</td>
<td>Betadine or phisohex solution, per pint</td>
<td>Betadine/phisohex solution</td>
</tr>
<tr class="odd">
<td>A4247</td>
<td>0010</td>
<td>3</td>
<td>Betadine or iodine swabs/wipes, per box</td>
<td>Betadine/iodine swabs/wipes</td>
</tr>
<tr class="even">
<td>A4248</td>
<td>0010</td>
<td>3</td>
<td>Chlorhexidine containing antiseptic, 1 ml</td>
<td>Chlorhexidine antisept</td>
</tr>
<tr class="odd">
<td>A4250</td>
<td>0010</td>
<td>3</td>
<td>Urine test or reagent strips or tablets (100 tablets or strips)</td>
<td>Urine reagent strips/tablets</td>
</tr>
<tr class="even">
<td>A4252</td>
<td>0010</td>
<td>3</td>
<td>Blood ketone test or reagent strip, each</td>
<td>Blood ketone test or strip</td>
</tr>
<tr class="odd">
<td>A4253</td>
<td>0010</td>
<td>3</td>
<td>Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips</td>
<td>Blood glucose/reagent strips</td>
</tr>
<tr class="even">
<td>A4255</td>
<td>0010</td>
<td>3</td>
<td>Platforms for home blood glucose monitor, 50 per box</td>
<td>Glucose monitor platforms</td>
</tr>
<tr class="odd">
<td>A4256</td>
<td>0010</td>
<td>3</td>
<td>Normal, low and high calibrator solution / chips</td>
<td>Calibrator solution/chips</td>
</tr>
<tr class="even">
<td>A4257</td>
<td>0010</td>
<td>3</td>
<td>Replacement lens shield cartridge for use with laser skin piercing device, each</td>
<td>Replace lensshield cartridge</td>
</tr>
<tr class="odd">
<td>A4258</td>
<td>0010</td>
<td>3</td>
<td>Spring-powered device for lancet, each</td>
<td>Lancet device each</td>
</tr>
<tr class="even">
<td>A4259</td>
<td>0010</td>
<td>3</td>
<td>Lancets, per box of 100</td>
<td>Lancets per box</td>
</tr>
<tr class="odd">
<td>A4261</td>
<td>0010</td>
<td>3</td>
<td>Cervical cap for contraceptive use</td>
<td>Cervical cap contraceptive</td>
</tr>
<tr class="even">
<td>A4262</td>
<td>0010</td>
<td>3</td>
<td>Temporary, absorbable lacrimal duct implant, each</td>
<td>Temporary tear duct plug</td>
</tr>
<tr class="odd">
<td>A4263</td>
<td>0010</td>
<td>3</td>
<td>Permanent, long term, non-dissolvable lacrimal duct implant, each</td>
<td>Permanent tear duct plug</td>
</tr>
<tr class="even">
<td>A4264</td>
<td>0010</td>
<td>3</td>
<td>Permanent implantable contraceptive intratubal occlusion device(s) and delivery system</td>
<td>Intratubal occlusion device</td>
</tr>
<tr class="odd">
<td>A4265</td>
<td>0010</td>
<td>3</td>
<td>Paraffin, per pound</td>
<td>Paraffin</td>
</tr>
<tr class="even">
<td>A4266</td>
<td>0010</td>
<td>3</td>
<td>Diaphragm for contraceptive use</td>
<td>Diaphragm</td>
</tr>
<tr class="odd">
<td>A4267</td>
<td>0010</td>
<td>3</td>
<td>Contraceptive supply, condom, male, each</td>
<td>Male condom</td>
</tr>
<tr class="even">
<td>A4268</td>
<td>0010</td>
<td>3</td>
<td>Contraceptive supply, condom, female, each</td>
<td>Female condom</td>
</tr>
<tr class="odd">
<td>A4269</td>
<td>0010</td>
<td>3</td>
<td>Contraceptive supply, spermicide (e.g., foam, gel), each</td>
<td>Spermicide</td>
</tr>
<tr class="even">
<td>A4270</td>
<td>0010</td>
<td>3</td>
<td>Disposable endoscope sheath, each</td>
<td>Disposable endoscope sheath</td>
</tr>
<tr class="odd">
<td>A4280</td>
<td>0010</td>
<td>3</td>
<td>Adhesive skin support attachment for use with external breast prosthesis, each</td>
<td>Brst prsths adhsv attchmnt</td>
</tr>
<tr class="even">
<td>A4281</td>
<td>0010</td>
<td>3</td>
<td>Tubing for breast pump, replacement</td>
<td>Replacement breastpump tube</td>
</tr>
<tr class="odd">
<td>A4282</td>
<td>0010</td>
<td>3</td>
<td>Adapter for breast pump, replacement</td>
<td>Replacement breastpump adpt</td>
</tr>
<tr class="even">
<td>A4283</td>
<td>0010</td>
<td>3</td>
<td>Cap for breast pump bottle, replacement</td>
<td>Replacement breastpump cap</td>
</tr>
<tr class="odd">
<td>A4284</td>
<td>0010</td>
<td>3</td>
<td>Breast shield and splash protector for use with breast pump, replacement</td>
<td>Replcmnt breast pump shield</td>
</tr>
<tr class="even">
<td>A4285</td>
<td>0010</td>
<td>3</td>
<td>Polycarbonate bottle for use with breast pump, replacement</td>
<td>Replcmnt breast pump bottle</td>
</tr>
<tr class="odd">
<td>A4286</td>
<td>0010</td>
<td>3</td>
<td>Locking ring for breast pump, replacement</td>
<td>Replcmnt breastpump lok ring</td>
</tr>
<tr class="even">
<td>A4290</td>
<td>0010</td>
<td>3</td>
<td>Sacral nerve stimulation test lead, each</td>
<td>Sacral nerve stim test lead</td>
</tr>
<tr class="odd">
<td>A4300</td>
<td>0010</td>
<td>3</td>
<td>Implantable access catheter, (e.g., venous, arterial, epidural subarachnoid, or peritoneal, etc.) external access</td>
<td>Cath impl vasc access portal</td>
</tr>
<tr class="even">
<td>A4301</td>
<td>0010</td>
<td>3</td>
<td>Implantable access total catheter, port/reservoir (e.g., venous, arterial, epidural, subarachnoid, peritoneal, etc.)</td>
<td>Implantable access syst perc</td>
</tr>
<tr class="odd">
<td>A4305</td>
<td>0010</td>
<td>3</td>
<td>Disposable drug delivery system, flow rate of 50 ml or greater per hour</td>
<td>Drug delivery system &gt;=50 ml</td>
</tr>
<tr class="even">
<td>A4306</td>
<td>0010</td>
<td>3</td>
<td>Disposable drug delivery system, flow rate of less than 50 ml per hour</td>
<td>Drug delivery system &lt;=50 ml</td>
</tr>
<tr class="odd">
<td>A4310</td>
<td>0010</td>
<td>3</td>
<td>Insertion tray without drainage bag and without catheter (accessories only)</td>
<td>Insert tray w/o bag/cath</td>
</tr>
<tr class="even">
<td>A4311</td>
<td>0010</td>
<td>3</td>
<td>Insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)</td>
<td>Catheter w/o bag 2-way latex</td>
</tr>
<tr class="odd">
<td>A4312</td>
<td>0010</td>
<td>3</td>
<td>Insertion tray without drainage bag with indwelling catheter, foley type, two-way, all silicone</td>
<td>Cath w/o bag 2-way silicone</td>
</tr>
<tr class="even">
<td>A4313</td>
<td>0010</td>
<td>3</td>
<td>Insertion tray without drainage bag with indwelling catheter, foley type, three-way, for continuous irrigation</td>
<td>Catheter w/bag 3-way</td>
</tr>
<tr class="odd">
<td>A4314</td>
<td>0010</td>
<td>3</td>
<td>Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)</td>
<td>Cath w/drainage 2-way latex</td>
</tr>
<tr class="even">
<td>A4315</td>
<td>0010</td>
<td>3</td>
<td>Insertion tray with drainage bag with indwelling catheter, foley type, two-way, all silicone</td>
<td>Cath w/drainage 2-way silcne</td>
</tr>
<tr class="odd">
<td>A4316</td>
<td>0010</td>
<td>3</td>
<td>Insertion tray with drainage bag with indwelling catheter, foley type, three-way, for continuous irrigation</td>
<td>Cath w/drainage 3-way</td>
</tr>
<tr class="even">
<td>A4320</td>
<td>0010</td>
<td>3</td>
<td>Irrigation tray with bulb or piston syringe, any purpose</td>
<td>Irrigation tray</td>
</tr>
<tr class="odd">
<td>A4321</td>
<td>0010</td>
<td>3</td>
<td>Therapeutic agent for urinary catheter irrigation</td>
<td>Cath therapeutic irrig agent</td>
</tr>
<tr class="even">
<td>A4322</td>
<td>0010</td>
<td>3</td>
<td>Irrigation syringe, bulb or piston, each</td>
<td>Irrigation syringe</td>
</tr>
<tr class="odd">
<td>A4326</td>
<td>0010</td>
<td>3</td>
<td>Male external catheter with integral collection chamber, any type, each</td>
<td>Male external catheter</td>
</tr>
<tr class="even">
<td>A4327</td>
<td>0010</td>
<td>3</td>
<td>Female external urinary collection device; meatal cup, each</td>
<td>Fem urinary collect dev cup</td>
</tr>
<tr class="odd">
<td>A4328</td>
<td>0010</td>
<td>3</td>
<td>Female external urinary collection device; pouch, each</td>
<td>Fem urinary collect pouch</td>
</tr>
<tr class="even">
<td>A4330</td>
<td>0010</td>
<td>3</td>
<td>Perianal fecal collection pouch with adhesive, each</td>
<td>Stool collection pouch</td>
</tr>
<tr class="odd">
<td>A4331</td>
<td>0010</td>
<td>3</td>
<td>Extension drainage tubing, any type, any length, with connector/adaptor, for use with urinary leg bag or urostomy pouch, each</td>
<td>Extension drainage tubing</td>
</tr>
<tr class="even">
<td>A4332</td>
<td>0010</td>
<td>3</td>
<td>Lubricant, individual sterile packet, each</td>
<td>Lube sterile packet</td>
</tr>
<tr class="odd">
<td>A4333</td>
<td>0010</td>
<td>3</td>
<td>Urinary catheter anchoring device, adhesive skin attachment, each</td>
<td>Urinary cath anchor device</td>
</tr>
<tr class="even">
<td>A4334</td>
<td>0010</td>
<td>3</td>
<td>Urinary catheter anchoring device, leg strap, each</td>
<td>Urinary cath leg strap</td>
</tr>
<tr class="odd">
<td>A4335</td>
<td>0010</td>
<td>3</td>
<td>Incontinence supply; miscellaneous</td>
<td>Incontinence supply</td>
</tr>
<tr class="even">
<td>A4336</td>
<td>0010</td>
<td>3</td>
<td>Incontinence supply, urethral insert, any type, each</td>
<td>Urethral insert</td>
</tr>
<tr class="odd">
<td>A4337</td>
<td>0010</td>
<td>3</td>
<td>Incontinence supply, rectal insert, any type, each</td>
<td>Incontinent rectal insert</td>
</tr>
<tr class="even">
<td>A4338</td>
<td>0010</td>
<td>3</td>
<td>Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each</td>
<td>Indwelling catheter latex</td>
</tr>
<tr class="odd">
<td>A4340</td>
<td>0010</td>
<td>3</td>
<td>Indwelling catheter; specialty type, (e.g., coude, mushroom, wing, etc.), each</td>
<td>Indwelling catheter special</td>
</tr>
<tr class="even">
<td>A4344</td>
<td>0010</td>
<td>3</td>
<td>Indwelling catheter, foley type, two-way, all silicone, each</td>
<td>Cath indw foley 2 way silicn</td>
</tr>
<tr class="odd">
<td>A4346</td>
<td>0010</td>
<td>3</td>
<td>Indwelling catheter; foley type, three way for continuous irrigation, each</td>
<td>Cath indw foley 3 way</td>
</tr>
<tr class="even">
<td>A4349</td>
<td>0010</td>
<td>3</td>
<td>Male external catheter, with or without adhesive, disposable, each</td>
<td>Disposable male external cat</td>
</tr>
<tr class="odd">
<td>A4351</td>
<td>0010</td>
<td>3</td>
<td>Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each</td>
<td>Straight tip urine catheter</td>
</tr>
<tr class="even">
<td>A4352</td>
<td>0010</td>
<td>3</td>
<td>Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each</td>
<td>Coude tip urinary catheter</td>
</tr>
<tr class="odd">
<td>A4353</td>
<td>0010</td>
<td>3</td>
<td>Intermittent urinary catheter, with insertion supplies</td>
<td>Intermittent urinary cath</td>
</tr>
<tr class="even">
<td>A4354</td>
<td>0010</td>
<td>3</td>
<td>Insertion tray with drainage bag but without catheter</td>
<td>Cath insertion tray w/bag</td>
</tr>
<tr class="odd">
<td>A4355</td>
<td>0010</td>
<td>3</td>
<td>Irrigation tubing set for continuous bladder irrigation through a three-way indwelling foley catheter, each</td>
<td>Bladder irrigation tubing</td>
</tr>
<tr class="even">
<td>A4356</td>
<td>0010</td>
<td>3</td>
<td>External urethral clamp or compression device (not to be used for catheter clamp), each</td>
<td>Ext ureth clmp or compr dvc</td>
</tr>
<tr class="odd">
<td>A4357</td>
<td>0010</td>
<td>3</td>
<td>Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each</td>
<td>Bedside drainage bag</td>
</tr>
<tr class="even">
<td>A4358</td>
<td>0010</td>
<td>3</td>
<td>Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each</td>
<td>Urinary leg or abdomen bag</td>
</tr>
<tr class="odd">
<td>A4360</td>
<td>0010</td>
<td>3</td>
<td>Disposable external urethral clamp or compression device, with pad and/or pouch, each</td>
<td>Disposable ext urethral dev</td>
</tr>
<tr class="even">
<td>A4361</td>
<td>0010</td>
<td>3</td>
<td>Ostomy faceplate, each</td>
<td>Ostomy face plate</td>
</tr>
<tr class="odd">
<td>A4362</td>
<td>0010</td>
<td>3</td>
<td>Skin barrier; solid, 4 x 4 or equivalent; each</td>
<td>Solid skin barrier</td>
</tr>
<tr class="even">
<td>A4363</td>
<td>0010</td>
<td>3</td>
<td>Ostomy clamp, any type, replacement only, each</td>
<td>Ostomy clamp, replacement</td>
</tr>
<tr class="odd">
<td>A4364</td>
<td>0010</td>
<td>3</td>
<td>Adhesive, liquid or equal, any type, per oz</td>
<td>Adhesive, liquid or equal</td>
</tr>
<tr class="even">
<td>A4366</td>
<td>0010</td>
<td>3</td>
<td>Ostomy vent, any type, each</td>
<td>Ostomy vent</td>
</tr>
<tr class="odd">
<td>A4367</td>
<td>0010</td>
<td>3</td>
<td>Ostomy belt, each</td>
<td>Ostomy belt</td>
</tr>
<tr class="even">
<td>A4368</td>
<td>0010</td>
<td>3</td>
<td>Ostomy filter, any type, each</td>
<td>Ostomy filter</td>
</tr>
<tr class="odd">
<td>A4369</td>
<td>0010</td>
<td>3</td>
<td>Ostomy skin barrier, liquid (spray, brush, etc.), per oz</td>
<td>Skin barrier liquid per oz</td>
</tr>
<tr class="even">
<td>A4371</td>
<td>0010</td>
<td>3</td>
<td>Ostomy skin barrier, powder, per oz</td>
<td>Skin barrier powder per oz</td>
</tr>
<tr class="odd">
<td>A4372</td>
<td>0010</td>
<td>3</td>
<td>Ostomy skin barrier, solid 4 x 4 or equivalent, standard wear, with built-in convexity, each</td>
<td>Skin barrier solid 4x4 equiv</td>
</tr>
<tr class="even">
<td>A4373</td>
<td>0010</td>
<td>3</td>
<td>Ostomy skin barrier, with flange (solid, flexible or accordion), with built-in convexity, any size, each</td>
<td>Skin barrier with flange</td>
</tr>
<tr class="odd">
<td>A4375</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable, with faceplate attached, plastic, each</td>
<td>Drainable plastic pch w fcpl</td>
</tr>
<tr class="even">
<td>A4376</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable, with faceplate attached, rubber, each</td>
<td>Drainable rubber pch w fcplt</td>
</tr>
<tr class="odd">
<td>A4377</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable, for use on faceplate, plastic, each</td>
<td>Drainable plstic pch w/o fp</td>
</tr>
<tr class="even">
<td>A4378</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable, for use on faceplate, rubber, each</td>
<td>Drainable rubber pch w/o fp</td>
</tr>
<tr class="odd">
<td>A4379</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary, with faceplate attached, plastic, each</td>
<td>Urinary plastic pouch w fcpl</td>
</tr>
<tr class="even">
<td>A4380</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary, with faceplate attached, rubber, each</td>
<td>Urinary rubber pouch w fcplt</td>
</tr>
<tr class="odd">
<td>A4381</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary, for use on faceplate, plastic, each</td>
<td>Urinary plastic pouch w/o fp</td>
</tr>
<tr class="even">
<td>A4382</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary, for use on faceplate, heavy plastic, each</td>
<td>Urinary hvy plstc pch w/o fp</td>
</tr>
<tr class="odd">
<td>A4383</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary, for use on faceplate, rubber, each</td>
<td>Urinary rubber pouch w/o fp</td>
</tr>
<tr class="even">
<td>A4384</td>
<td>0010</td>
<td>3</td>
<td>Ostomy faceplate equivalent, silicone ring, each</td>
<td>Ostomy faceplt/silicone ring</td>
</tr>
<tr class="odd">
<td>A4385</td>
<td>0010</td>
<td>3</td>
<td>Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each</td>
<td>Ost skn barrier sld ext wear</td>
</tr>
<tr class="even">
<td>A4387</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, closed, with barrier attached, with built-in convexity (1 piece), each</td>
<td>Ost clsd pouch w att st barr</td>
</tr>
<tr class="odd">
<td>A4388</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable, with extended wear barrier attached, (1 piece), each</td>
<td>Drainable pch w ex wear barr</td>
</tr>
<tr class="even">
<td>A4389</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable, with barrier attached, with built-in convexity (1 piece), each</td>
<td>Drainable pch w st wear barr</td>
</tr>
<tr class="odd">
<td>A4390</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable, with extended wear barrier attached, with built-in convexity (1 piece), each</td>
<td>Drainable pch ex wear convex</td>
</tr>
<tr class="even">
<td>A4391</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary, with extended wear barrier attached (1 piece), each</td>
<td>Urinary pouch w ex wear barr</td>
</tr>
<tr class="odd">
<td>A4392</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary, with standard wear barrier attached, with built-in convexity (1 piece), each</td>
<td>Urinary pouch w st wear barr</td>
</tr>
<tr class="even">
<td>A4393</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity (1 piece), each</td>
<td>Urine pch w ex wear bar conv</td>
</tr>
<tr class="odd">
<td>A4394</td>
<td>0010</td>
<td>3</td>
<td>Ostomy deodorant, with or without lubricant, for use in ostomy pouch, per fluid ounce</td>
<td>Ostomy pouch liq deodorant</td>
</tr>
<tr class="even">
<td>A4395</td>
<td>0010</td>
<td>3</td>
<td>Ostomy deodorant for use in ostomy pouch, solid, per tablet</td>
<td>Ostomy pouch solid deodorant</td>
</tr>
<tr class="odd">
<td>A4396</td>
<td>0010</td>
<td>3</td>
<td>Ostomy belt with peristomal hernia support</td>
<td>Peristomal hernia supprt blt</td>
</tr>
<tr class="even">
<td>A4397</td>
<td>0010</td>
<td>3</td>
<td>Irrigation supply; sleeve, each</td>
<td>Irrigation supply sleeve</td>
</tr>
<tr class="odd">
<td>A4398</td>
<td>0010</td>
<td>3</td>
<td>Ostomy irrigation supply; bag, each</td>
<td>Ostomy irrigation bag</td>
</tr>
<tr class="even">
<td>A4399</td>
<td>0010</td>
<td>3</td>
<td>Ostomy irrigation supply; cone/catheter, with or without brush</td>
<td>Ostomy irrig cone/cath w brs</td>
</tr>
<tr class="odd">
<td>A4400</td>
<td>0010</td>
<td>3</td>
<td>Ostomy irrigation set</td>
<td>Ostomy irrigation set</td>
</tr>
<tr class="even">
<td>A4402</td>
<td>0010</td>
<td>3</td>
<td>Lubricant, per ounce</td>
<td>Lubricant per ounce</td>
</tr>
<tr class="odd">
<td>A4404</td>
<td>0010</td>
<td>3</td>
<td>Ostomy ring, each</td>
<td>Ostomy ring each</td>
</tr>
<tr class="even">
<td>A4405</td>
<td>0010</td>
<td>3</td>
<td>Ostomy skin barrier, non-pectin based, paste, per ounce</td>
<td>Nonpectin based ostomy paste</td>
</tr>
<tr class="odd">
<td>A4406</td>
<td>0010</td>
<td>3</td>
<td>Ostomy skin barrier, pectin-based, paste, per ounce</td>
<td>Pectin based ostomy paste</td>
</tr>
<tr class="even">
<td>A4407</td>
<td>0010</td>
<td>3</td>
<td>Ostomy skin barrier, with flange (solid, flexible, or accordion), extended wear, with built-in convexity, 4 x 4 inches or smaller, each</td>
<td>Ext wear ost skn barr &lt;=4sq“</td>
</tr>
<tr class="odd">
<td>A4408</td>
<td>0010</td>
<td>3</td>
<td>Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, with built-in convexity, larger than 4 x 4 inches, each</td>
<td>Ext wear ost skn barr &gt;4sq“</td>
</tr>
<tr class="even">
<td>A4409</td>
<td>0010</td>
<td>3</td>
<td>Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each</td>
<td>Ost skn barr convex &lt;=4 sq i</td>
</tr>
<tr class="odd">
<td>A4410</td>
<td>0010</td>
<td>3</td>
<td>Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, larger than 4 x 4 inches, each</td>
<td>Ost skn barr extnd &gt;4 sq</td>
</tr>
<tr class="even">
<td>A4411</td>
<td>0010</td>
<td>3</td>
<td>Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, with built-in convexity, each</td>
<td>Ost skn barr extnd =4sq</td>
</tr>
<tr class="odd">
<td>A4412</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece system), without filter, each</td>
<td>Ost pouch drain high output</td>
</tr>
<tr class="even">
<td>A4413</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece system), with filter, each</td>
<td>2 pc drainable ost pouch</td>
</tr>
<tr class="odd">
<td>A4414</td>
<td>0010</td>
<td>3</td>
<td>Ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, 4 x 4 inches or smaller, each</td>
<td>Ost sknbar w/o conv&lt;=4 sq in</td>
</tr>
<tr class="even">
<td>A4415</td>
<td>0010</td>
<td>3</td>
<td>Ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, larger than 4 x 4 inches, each</td>
<td>Ost skn barr w/o conv &gt;4 sqi</td>
</tr>
<tr class="odd">
<td>A4416</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, closed, with barrier attached, with filter (1 piece), each</td>
<td>Ost pch clsd w barrier/filtr</td>
</tr>
<tr class="even">
<td>A4417</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, closed, with barrier attached, with built-in convexity, with filter (1 piece), each</td>
<td>Ost pch w bar/bltinconv/fltr</td>
</tr>
<tr class="odd">
<td>A4418</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, closed; without barrier attached, with filter (1 piece), each</td>
<td>Ost pch clsd w/o bar w filtr</td>
</tr>
<tr class="even">
<td>A4419</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, closed; for use on barrier with non-locking flange, with filter (2 piece), each</td>
<td>Ost pch for bar w flange/flt</td>
</tr>
<tr class="odd">
<td>A4420</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, closed; for use on barrier with locking flange (2 piece), each</td>
<td>Ost pch clsd for bar w lk fl</td>
</tr>
<tr class="even">
<td>A4421</td>
<td>0010</td>
<td>3</td>
<td>Ostomy supply; miscellaneous</td>
<td>Ostomy supply misc</td>
</tr>
<tr class="odd">
<td>A4422</td>
<td>0010</td>
<td>3</td>
<td>Ostomy absorbent material (sheet/pad/crystal packet) for use in ostomy pouch to thicken liquid stomal output, each</td>
<td>Ost pouch absorbent material</td>
</tr>
<tr class="even">
<td>A4423</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, closed; for use on barrier with locking flange, with filter (2 piece), each</td>
<td>Ost pch for bar w lk fl/fltr</td>
</tr>
<tr class="odd">
<td>A4424</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable, with barrier attached, with filter (1 piece), each</td>
<td>Ost pch drain w bar &amp; filter</td>
</tr>
<tr class="even">
<td>A4425</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable; for use on barrier with non-locking flange, with filter (2 piece system), each</td>
<td>Ost pch drain for barrier fl</td>
</tr>
<tr class="odd">
<td>A4426</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable; for use on barrier with locking flange (2 piece system), each</td>
<td>Ost pch drain 2 piece system</td>
</tr>
<tr class="even">
<td>A4427</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable; for use on barrier with locking flange, with filter (2 piece system), each</td>
<td>Ost pch drain/barr lk flng/f</td>
</tr>
<tr class="odd">
<td>A4428</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary, with extended wear barrier attached, with faucet-type tap with valve (1 piece), each</td>
<td>Urine ost pouch w faucet/tap</td>
</tr>
<tr class="even">
<td>A4429</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary, with barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each</td>
<td>Urine ost pouch w bltinconv</td>
</tr>
<tr class="odd">
<td>A4430</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each</td>
<td>Ost urine pch w b/bltin conv</td>
</tr>
<tr class="even">
<td>A4431</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary; with barrier attached, with faucet-type tap with valve (1 piece), each</td>
<td>Ost pch urine w barrier/tapv</td>
</tr>
<tr class="odd">
<td>A4432</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary; for use on barrier with non-locking flange, with faucet-type tap with valve (2 piece), each</td>
<td>Os pch urine w bar/fange/tap</td>
</tr>
<tr class="even">
<td>A4433</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary; for use on barrier with locking flange (2 piece), each</td>
<td>Urine ost pch bar w lock fln</td>
</tr>
<tr class="odd">
<td>A4434</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary; for use on barrier with locking flange, with faucet-type tap with valve (2 piece), each</td>
<td>Ost pch urine w lock flng/ft</td>
</tr>
<tr class="even">
<td>A4435</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable, high output, with extended wear barrier (one-piece system), with or without filter, each</td>
<td>1pc ost pch drain hgh output</td>
</tr>
<tr class="odd">
<td>A4450</td>
<td>0010</td>
<td>3</td>
<td>Tape, non-waterproof, per 18 square inches</td>
<td>Non-waterproof tape</td>
</tr>
<tr class="even">
<td>A4452</td>
<td>0010</td>
<td>3</td>
<td>Tape, waterproof, per 18 square inches</td>
<td>Waterproof tape</td>
</tr>
<tr class="odd">
<td>A4455</td>
<td>0010</td>
<td>3</td>
<td>Adhesive remover or solvent (for tape, cement or other adhesive), per ounce</td>
<td>Adhesive remover per ounce</td>
</tr>
<tr class="even">
<td>A4456</td>
<td>0010</td>
<td>3</td>
<td>Adhesive remover, wipes, any type, each</td>
<td>Adhesive remover, wipes</td>
</tr>
<tr class="odd">
<td>A4458</td>
<td>0010</td>
<td>3</td>
<td>Enema bag with tubing, reusable</td>
<td>Reusable enema bag</td>
</tr>
<tr class="even">
<td>A4459</td>
<td>0010</td>
<td>3</td>
<td>Manual pump-operated enema system, includes balloon, catheter and all accessories, reusable, any type</td>
<td>Manual pump enema, reusable</td>
</tr>
<tr class="odd">
<td>A4461</td>
<td>0010</td>
<td>3</td>
<td>Surgical dressing holder, non-reusable, each</td>
<td>Surgicl dress hold non-reuse</td>
</tr>
<tr class="even">
<td>A4463</td>
<td>0010</td>
<td>3</td>
<td>Surgical dressing holder, reusable, each</td>
<td>Surgical dress holder reuse</td>
</tr>
<tr class="odd">
<td>A4465</td>
<td>0010</td>
<td>3</td>
<td>Non-elastic binder for extremity</td>
<td>Non-elastic extremity binder</td>
</tr>
<tr class="even">
<td>A4466</td>
<td>0010</td>
<td>3</td>
<td>Garment, belt, sleeve or other covering, elastic or similar stretchable material, any type, each</td>
<td>Elastic garment/covering</td>
</tr>
<tr class="odd">
<td>A4467</td>
<td>0010</td>
<td>3</td>
<td>Belt, strap, sleeve, garment, or covering, any type</td>
<td>Belt strap sleev grmnt cover</td>
</tr>
<tr class="even">
<td>A4470</td>
<td>0010</td>
<td>3</td>
<td>Gravlee jet washer</td>
<td>Gravlee jet washer</td>
</tr>
<tr class="odd">
<td>A4480</td>
<td>0010</td>
<td>3</td>
<td>Vabra aspirator</td>
<td>Vabra aspirator</td>
</tr>
<tr class="even">
<td>A4481</td>
<td>0010</td>
<td>3</td>
<td>Tracheostoma filter, any type, any size, each</td>
<td>Tracheostoma filter</td>
</tr>
<tr class="odd">
<td>A4483</td>
<td>0010</td>
<td>3</td>
<td>Moisture exchanger, disposable, for use with invasive mechanical ventilation</td>
<td>Moisture exchanger</td>
</tr>
<tr class="even">
<td>A4490</td>
<td>0010</td>
<td>3</td>
<td>Surgical stockings above knee length, each</td>
<td>Above knee surgical stocking</td>
</tr>
<tr class="odd">
<td>A4495</td>
<td>0010</td>
<td>3</td>
<td>Surgical stockings thigh length, each</td>
<td>Thigh length surg stocking</td>
</tr>
<tr class="even">
<td>A4500</td>
<td>0010</td>
<td>3</td>
<td>Surgical stockings below knee length, each</td>
<td>Below knee surgical stocking</td>
</tr>
<tr class="odd">
<td>A4510</td>
<td>0010</td>
<td>3</td>
<td>Surgical stockings full length, each</td>
<td>Full length surg stocking</td>
</tr>
<tr class="even">
<td>A4520</td>
<td>0010</td>
<td>3</td>
<td>Incontinence garment, any type, (e.g., brief, diaper), each</td>
<td>Incontinence garment anytype</td>
</tr>
<tr class="odd">
<td>A4550</td>
<td>0010</td>
<td>3</td>
<td>Surgical trays</td>
<td>Surgical trays</td>
</tr>
<tr class="even">
<td>A4553</td>
<td>0010</td>
<td>3</td>
<td>Non-disposable underpads, all sizes</td>
<td>Nondisp underpads, all sizes</td>
</tr>
<tr class="odd">
<td>A4554</td>
<td>0010</td>
<td>3</td>
<td>Disposable underpads, all sizes</td>
<td>Disposable underpads</td>
</tr>
<tr class="even">
<td>A4555</td>
<td>0010</td>
<td>3</td>
<td>Electrode/transducer for use with electrical stimulation device used for cancer treatment, replacement only</td>
<td>Ca tx e-stim electr/transduc</td>
</tr>
<tr class="odd">
<td>A4556</td>
<td>0010</td>
<td>3</td>
<td>Electrodes, (e.g., apnea monitor), per pair</td>
<td>Electrodes, pair</td>
</tr>
<tr class="even">
<td>A4557</td>
<td>0010</td>
<td>3</td>
<td>Lead wires, (e.g., apnea monitor), per pair</td>
<td>Lead wires, pair</td>
</tr>
<tr class="odd">
<td>A4558</td>
<td>0010</td>
<td>3</td>
<td>Conductive gel or paste, for use with electrical device (e.g., tens, nmes), per oz</td>
<td>Conductive gel or paste</td>
</tr>
<tr class="even">
<td>A4559</td>
<td>0010</td>
<td>3</td>
<td>Coupling gel or paste, for use with ultrasound device, per oz</td>
<td>Coupling gel or paste</td>
</tr>
<tr class="odd">
<td>A4561</td>
<td>0010</td>
<td>3</td>
<td>Pessary, rubber, any type</td>
<td>Pessary rubber, any type</td>
</tr>
<tr class="even">
<td>A4562</td>
<td>0010</td>
<td>3</td>
<td>Pessary, non rubber, any type</td>
<td>Pessary, non rubber,any type</td>
</tr>
<tr class="odd">
<td>A4563</td>
<td>0010</td>
<td>3</td>
<td>Rectal control system for vaginal insertion, for long term use, includes pump and all supplies and accessories, any type each</td>
<td>Vag inser rectal control sys</td>
</tr>
<tr class="even">
<td>A4565</td>
<td>0010</td>
<td>3</td>
<td>Slings</td>
<td>Slings</td>
</tr>
<tr class="odd">
<td>A4566</td>
<td>0010</td>
<td>3</td>
<td>Shoulder sling or vest design, abduction restrainer, with or without swathe control, prefabricated, includes fitting and adjustment</td>
<td>Should sling/vest/abrestrain</td>
</tr>
<tr class="even">
<td>A4570</td>
<td>0010</td>
<td>3</td>
<td>Splint</td>
<td>Splint</td>
</tr>
<tr class="odd">
<td>A4575</td>
<td>0010</td>
<td>3</td>
<td>Topical hyperbaric oxygen chamber, disposable</td>
<td>Hyperbaric o2 chamber disps</td>
</tr>
<tr class="even">
<td>A4580</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies (e.g., plaster)</td>
<td>Cast supplies (plaster)</td>
</tr>
<tr class="odd">
<td>A4590</td>
<td>0010</td>
<td>3</td>
<td>Special casting material (e.g., fiberglass)</td>
<td>Special casting material</td>
</tr>
<tr class="even">
<td>A4595</td>
<td>0010</td>
<td>3</td>
<td>Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes)</td>
<td>Tens suppl 2 lead per month</td>
</tr>
<tr class="odd">
<td>A4600</td>
<td>0010</td>
<td>3</td>
<td>Sleeve for intermittent limb compression device, replacement only, each</td>
<td>Sleeve, inter limb comp dev</td>
</tr>
<tr class="even">
<td>A4601</td>
<td>0010</td>
<td>3</td>
<td>Lithium ion battery, rechargeable, for non-prosthetic use, replacement</td>
<td>Lith ion non prosth recharge</td>
</tr>
<tr class="odd">
<td>A4602</td>
<td>0010</td>
<td>3</td>
<td>Replacement battery for external infusion pump owned by patient, lithium, 1.5 volt, each</td>
<td>Replace lithium battery 1.5v</td>
</tr>
<tr class="even">
<td>A4604</td>
<td>0010</td>
<td>3</td>
<td>Tubing with integrated heating element for use with positive airway pressure device</td>
<td>Tubing with heating element</td>
</tr>
<tr class="odd">
<td>A4605</td>
<td>0010</td>
<td>3</td>
<td>Tracheal suction catheter, closed system, each</td>
<td>Trach suction cath close sys</td>
</tr>
<tr class="even">
<td>A4606</td>
<td>0010</td>
<td>3</td>
<td>Oxygen probe for use with oximeter device, replacement</td>
<td>Oxygen probe used w oximeter</td>
</tr>
<tr class="odd">
<td>A4608</td>
<td>0010</td>
<td>3</td>
<td>Transtracheal oxygen catheter, each</td>
<td>Transtracheal oxygen cath</td>
</tr>
<tr class="even">
<td>A4611</td>
<td>0010</td>
<td>3</td>
<td>Battery, heavy duty; replacement for patient owned ventilator</td>
<td>Heavy duty battery</td>
</tr>
<tr class="odd">
<td>A4612</td>
<td>0010</td>
<td>3</td>
<td>Battery cables; replacement for patient-owned ventilator</td>
<td>Battery cables</td>
</tr>
<tr class="even">
<td>A4613</td>
<td>0010</td>
<td>3</td>
<td>Battery charger; replacement for patient-owned ventilator</td>
<td>Battery charger</td>
</tr>
<tr class="odd">
<td>A4614</td>
<td>0010</td>
<td>3</td>
<td>Peak expiratory flow rate meter, hand held</td>
<td>Hand-held pefr meter</td>
</tr>
<tr class="even">
<td>A4615</td>
<td>0010</td>
<td>3</td>
<td>Cannula, nasal</td>
<td>Cannula nasal</td>
</tr>
<tr class="odd">
<td>A4616</td>
<td>0010</td>
<td>3</td>
<td>Tubing (oxygen), per foot</td>
<td>Tubing (oxygen) per foot</td>
</tr>
<tr class="even">
<td>A4617</td>
<td>0010</td>
<td>3</td>
<td>Mouth piece</td>
<td>Mouth piece</td>
</tr>
<tr class="odd">
<td>A4618</td>
<td>0010</td>
<td>3</td>
<td>Breathing circuits</td>
<td>Breathing circuits</td>
</tr>
<tr class="even">
<td>A4619</td>
<td>0010</td>
<td>3</td>
<td>Face tent</td>
<td>Face tent</td>
</tr>
<tr class="odd">
<td>A4620</td>
<td>0010</td>
<td>3</td>
<td>Variable concentration mask</td>
<td>Variable concentration mask</td>
</tr>
<tr class="even">
<td>A4623</td>
<td>0010</td>
<td>3</td>
<td>Tracheostomy, inner cannula</td>
<td>Tracheostomy inner cannula</td>
</tr>
<tr class="odd">
<td>A4624</td>
<td>0010</td>
<td>3</td>
<td>Tracheal suction catheter, any type other than closed system, each</td>
<td>Tracheal suction tube</td>
</tr>
<tr class="even">
<td>A4625</td>
<td>0010</td>
<td>3</td>
<td>Tracheostomy care kit for new tracheostomy</td>
<td>Trach care kit for new trach</td>
</tr>
<tr class="odd">
<td>A4626</td>
<td>0010</td>
<td>3</td>
<td>Tracheostomy cleaning brush, each</td>
<td>Tracheostomy cleaning brush</td>
</tr>
<tr class="even">
<td>A4627</td>
<td>0010</td>
<td>3</td>
<td>Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler</td>
<td>Spacer bag/reservoir</td>
</tr>
<tr class="odd">
<td>A4628</td>
<td>0010</td>
<td>3</td>
<td>Oropharyngeal suction catheter, each</td>
<td>Oropharyngeal suction cath</td>
</tr>
<tr class="even">
<td>A4629</td>
<td>0010</td>
<td>3</td>
<td>Tracheostomy care kit for established tracheostomy</td>
<td>Tracheostomy care kit</td>
</tr>
<tr class="odd">
<td>A4630</td>
<td>0010</td>
<td>3</td>
<td>Replacement batteries, medically necessary, transcutaneous electrical stimulator, owned by patient</td>
<td>Repl bat t.e.n.s. own by pt</td>
</tr>
<tr class="even">
<td>A4633</td>
<td>0010</td>
<td>3</td>
<td>Replacement bulb/lamp for ultraviolet light therapy system, each</td>
<td>Uvl replacement bulb</td>
</tr>
<tr class="odd">
<td>A4634</td>
<td>0010</td>
<td>3</td>
<td>Replacement bulb for therapeutic light box, tabletop model</td>
<td>Replacement bulb th lightbox</td>
</tr>
<tr class="even">
<td>A4635</td>
<td>0010</td>
<td>3</td>
<td>Underarm pad, crutch, replacement, each</td>
<td>Underarm crutch pad</td>
</tr>
<tr class="odd">
<td>A4636</td>
<td>0010</td>
<td>3</td>
<td>Replacement, handgrip, cane, crutch, or walker, each</td>
<td>Handgrip for cane etc</td>
</tr>
<tr class="even">
<td>A4637</td>
<td>0010</td>
<td>3</td>
<td>Replacement, tip, cane, crutch, walker, each.</td>
<td>Repl tip cane/crutch/walker</td>
</tr>
<tr class="odd">
<td>A4638</td>
<td>0010</td>
<td>3</td>
<td>Replacement battery for patient-owned ear pulse generator, each</td>
<td>Repl batt pulse gen sys</td>
</tr>
<tr class="even">
<td>A4639</td>
<td>0010</td>
<td>3</td>
<td>Replacement pad for infrared heating pad system, each</td>
<td>Infrared ht sys replcmnt pad</td>
</tr>
<tr class="odd">
<td>A4640</td>
<td>0010</td>
<td>3</td>
<td>Replacement pad for use with medically necessary alternating pressure pad owned by patient</td>
<td>Alternating pressure pad</td>
</tr>
<tr class="even">
<td>A4641</td>
<td>0010</td>
<td>3</td>
<td>Radiopharmaceutical, diagnostic, not otherwise classified</td>
<td>Radiopharm dx agent noc</td>
</tr>
<tr class="odd">
<td>A4642</td>
<td>0010</td>
<td>3</td>
<td>Indium in-111 satumomab pendetide, diagnostic, per study dose, up to 6 millicuries</td>
<td>In111 satumomab</td>
</tr>
<tr class="even">
<td>A4648</td>
<td>0010</td>
<td>3</td>
<td>Tissue marker, implantable, any type, each</td>
<td>Implantable tissue marker</td>
</tr>
<tr class="odd">
<td>A4649</td>
<td>0010</td>
<td>3</td>
<td>Surgical supply; miscellaneous</td>
<td>Surgical supplies</td>
</tr>
<tr class="even">
<td>A4650</td>
<td>0010</td>
<td>3</td>
<td>Implantable radiation dosimeter, each</td>
<td>Implant radiation dosimeter</td>
</tr>
<tr class="odd">
<td>A4651</td>
<td>0010</td>
<td>3</td>
<td>Calibrated microcapillary tube, each</td>
<td>Calibrated microcap tube</td>
</tr>
<tr class="even">
<td>A4652</td>
<td>0010</td>
<td>3</td>
<td>Microcapillary tube sealant</td>
<td>Microcapillary tube sealant</td>
</tr>
<tr class="odd">
<td>A4653</td>
<td>0010</td>
<td>3</td>
<td>Peritoneal dialysis catheter anchoring device, belt, each</td>
<td>Pd catheter anchor belt</td>
</tr>
<tr class="even">
<td>A4657</td>
<td>0010</td>
<td>3</td>
<td>Syringe, with or without needle, each</td>
<td>Syringe w/wo needle</td>
</tr>
<tr class="odd">
<td>A4660</td>
<td>0010</td>
<td>3</td>
<td>Sphygmomanometer/blood pressure apparatus with cuff and stethoscope</td>
<td>Sphyg/bp app w cuff and stet</td>
</tr>
<tr class="even">
<td>A4663</td>
<td>0010</td>
<td>3</td>
<td>Blood pressure cuff only</td>
<td>Dialysis blood pressure cuff</td>
</tr>
<tr class="odd">
<td>A4670</td>
<td>0010</td>
<td>3</td>
<td>Automatic blood pressure monitor</td>
<td>Automatic bp monitor, dial</td>
</tr>
<tr class="even">
<td>A4671</td>
<td>0010</td>
<td>3</td>
<td>Disposable cycler set used with cycler dialysis machine, each</td>
<td>Disposable cycler set</td>
</tr>
<tr class="odd">
<td>A4672</td>
<td>0010</td>
<td>3</td>
<td>Drainage extension line, sterile, for dialysis, each</td>
<td>Drainage ext line, dialysis</td>
</tr>
<tr class="even">
<td>A4673</td>
<td>0010</td>
<td>3</td>
<td>Extension line with easy lock connectors, used with dialysis</td>
<td>Ext line w easy lock connect</td>
</tr>
<tr class="odd">
<td>A4674</td>
<td>0010</td>
<td>3</td>
<td>Chemicals/antiseptics solution used to clean/sterilize dialysis equipment, per 8 oz</td>
<td>Chem/antisept solution, 8oz</td>
</tr>
<tr class="even">
<td>A4680</td>
<td>0010</td>
<td>3</td>
<td>Activated carbon filter for hemodialysis, each</td>
<td>Activated carbon filter, ea</td>
</tr>
<tr class="odd">
<td>A4690</td>
<td>0010</td>
<td>3</td>
<td>Dialyzer (artificial kidneys), all types, all sizes, for hemodialysis, each</td>
<td>Dialyzer, each</td>
</tr>
<tr class="even">
<td>A4706</td>
<td>0010</td>
<td>3</td>
<td>Bicarbonate concentrate, solution, for hemodialysis, per gallon</td>
<td>Bicarbonate conc sol per gal</td>
</tr>
<tr class="odd">
<td>A4707</td>
<td>0010</td>
<td>3</td>
<td>Bicarbonate concentrate, powder, for hemodialysis, per packet</td>
<td>Bicarbonate conc pow per pac</td>
</tr>
<tr class="even">
<td>A4708</td>
<td>0010</td>
<td>3</td>
<td>Acetate concentrate solution, for hemodialysis, per gallon</td>
<td>Acetate conc sol per gallon</td>
</tr>
<tr class="odd">
<td>A4709</td>
<td>0010</td>
<td>3</td>
<td>Acid concentrate, solution, for hemodialysis, per gallon</td>
<td>Acid conc sol per gallon</td>
</tr>
<tr class="even">
<td>A4714</td>
<td>0010</td>
<td>3</td>
<td>Treated water (deionized, distilled, or reverse osmosis) for peritoneal dialysis, per gallon</td>
<td>Treated water per gallon</td>
</tr>
<tr class="odd">
<td>A4719</td>
<td>0010</td>
<td>3</td>
<td>“y set” tubing for peritoneal dialysis</td>
<td>“y set” tubing</td>
</tr>
<tr class="even">
<td>A4720</td>
<td>0010</td>
<td>3</td>
<td>Dialysate solution, any concentration of dextrose, fluid volume greater than 249 cc, but less than or equal to 999 cc, for peritoneal dialysis</td>
<td>Dialysat sol fld vol &gt; 249cc</td>
</tr>
<tr class="odd">
<td>A4721</td>
<td>0010</td>
<td>3</td>
<td>Dialysate solution, any concentration of dextrose, fluid volume greater than 999 cc but less than or equal to 1999 cc, for peritoneal dialysis</td>
<td>Dialysat sol fld vol &gt; 999cc</td>
</tr>
<tr class="even">
<td>A4722</td>
<td>0010</td>
<td>3</td>
<td>Dialysate solution, any concentration of dextrose, fluid volume greater than 1999 cc but less than or equal to 2999 cc, for peritoneal dialysis</td>
<td>Dialys sol fld vol &gt; 1999cc</td>
</tr>
<tr class="odd">
<td>A4723</td>
<td>0010</td>
<td>3</td>
<td>Dialysate solution, any concentration of dextrose, fluid volume greater than 2999 cc but less than or equal to 3999 cc, for peritoneal dialysis</td>
<td>Dialys sol fld vol &gt; 2999cc</td>
</tr>
<tr class="even">
<td>A4724</td>
<td>0010</td>
<td>3</td>
<td>Dialysate solution, any concentration of dextrose, fluid volume greater than 3999 cc but less than or equal to 4999 cc, for peritoneal dialysis</td>
<td>Dialys sol fld vol &gt; 3999cc</td>
</tr>
<tr class="odd">
<td>A4725</td>
<td>0010</td>
<td>3</td>
<td>Dialysate solution, any concentration of dextrose, fluid volume greater than 4999 cc but less than or equal to 5999 cc, for peritoneal dialysis</td>
<td>Dialys sol fld vol &gt; 4999cc</td>
</tr>
<tr class="even">
<td>A4726</td>
<td>0010</td>
<td>3</td>
<td>Dialysate solution, any concentration of dextrose, fluid volume greater than 5999 cc, for peritoneal dialysis</td>
<td>Dialys sol fld vol &gt; 5999cc</td>
</tr>
<tr class="odd">
<td>A4728</td>
<td>0010</td>
<td>3</td>
<td>Dialysate solution, non-dextrose containing, 500 ml</td>
<td>Dialysate solution, non-dex</td>
</tr>
<tr class="even">
<td>A4730</td>
<td>0010</td>
<td>3</td>
<td>Fistula cannulation set for hemodialysis, each</td>
<td>Fistula cannulation set, ea</td>
</tr>
<tr class="odd">
<td>A4736</td>
<td>0010</td>
<td>3</td>
<td>Topical anesthetic, for dialysis, per gram</td>
<td>Topical anesthetic, per gram</td>
</tr>
<tr class="even">
<td>A4737</td>
<td>0010</td>
<td>3</td>
<td>Injectable anesthetic, for dialysis, per 10 ml</td>
<td>Inj anesthetic per 10 ml</td>
</tr>
<tr class="odd">
<td>A4740</td>
<td>0010</td>
<td>3</td>
<td>Shunt accessory, for hemodialysis, any type, each</td>
<td>Shunt accessory</td>
</tr>
<tr class="even">
<td>A4750</td>
<td>0010</td>
<td>3</td>
<td>Blood tubing, arterial or venous, for hemodialysis, each</td>
<td>Art or venous blood tubing</td>
</tr>
<tr class="odd">
<td>A4755</td>
<td>0010</td>
<td>3</td>
<td>Blood tubing, arterial and venous combined, for hemodialysis, each</td>
<td>Comb art/venous blood tubing</td>
</tr>
<tr class="even">
<td>A4760</td>
<td>0010</td>
<td>3</td>
<td>Dialysate solution test kit, for peritoneal dialysis, any type, each</td>
<td>Dialysate sol test kit, each</td>
</tr>
<tr class="odd">
<td>A4765</td>
<td>0010</td>
<td>3</td>
<td>Dialysate concentrate, powder, additive for peritoneal dialysis, per packet</td>
<td>Dialysate conc pow per pack</td>
</tr>
<tr class="even">
<td>A4766</td>
<td>0010</td>
<td>3</td>
<td>Dialysate concentrate, solution, additive for peritoneal dialysis, per 10 ml</td>
<td>Dialysate conc sol add 10 ml</td>
</tr>
<tr class="odd">
<td>A4770</td>
<td>0010</td>
<td>3</td>
<td>Blood collection tube, vacuum, for dialysis, per 50</td>
<td>Blood collection tube/vacuum</td>
</tr>
<tr class="even">
<td>A4771</td>
<td>0010</td>
<td>3</td>
<td>Serum clotting time tube, for dialysis, per 50</td>
<td>Serum clotting time tube</td>
</tr>
<tr class="odd">
<td>A4772</td>
<td>0010</td>
<td>3</td>
<td>Blood glucose test strips, for dialysis, per 50</td>
<td>Blood glucose test strips</td>
</tr>
<tr class="even">
<td>A4773</td>
<td>0010</td>
<td>3</td>
<td>Occult blood test strips, for dialysis, per 50</td>
<td>Occult blood test strips</td>
</tr>
<tr class="odd">
<td>A4774</td>
<td>0010</td>
<td>3</td>
<td>Ammonia test strips, for dialysis, per 50</td>
<td>Ammonia test strips</td>
</tr>
<tr class="even">
<td>A4802</td>
<td>0010</td>
<td>3</td>
<td>Protamine sulfate, for hemodialysis, per 50 mg</td>
<td>Protamine sulfate per 50 mg</td>
</tr>
<tr class="odd">
<td>A4860</td>
<td>0010</td>
<td>3</td>
<td>Disposable catheter tips for peritoneal dialysis, per 10</td>
<td>Disposable catheter tips</td>
</tr>
<tr class="even">
<td>A4870</td>
<td>0010</td>
<td>3</td>
<td>Plumbing and/or electrical work for home hemodialysis equipment</td>
<td>Plumb/elec wk hm hemo equip</td>
</tr>
<tr class="odd">
<td>A4890</td>
<td>0010</td>
<td>3</td>
<td>Contracts, repair and maintenance, for hemodialysis equipment</td>
<td>Repair/maint cont hemo equip</td>
</tr>
<tr class="even">
<td>A4911</td>
<td>0010</td>
<td>3</td>
<td>Drain bag/bottle, for dialysis, each</td>
<td>Drain bag/bottle</td>
</tr>
<tr class="odd">
<td>A4913</td>
<td>0010</td>
<td>3</td>
<td>Miscellaneous dialysis supplies, not otherwise specified</td>
<td>Misc dialysis supplies noc</td>
</tr>
<tr class="even">
<td>A4918</td>
<td>0010</td>
<td>3</td>
<td>Venous pressure clamp, for hemodialysis, each</td>
<td>Venous pressure clamp</td>
</tr>
<tr class="odd">
<td>A4927</td>
<td>0010</td>
<td>3</td>
<td>Gloves, non-sterile, per 100</td>
<td>Non-sterile gloves</td>
</tr>
<tr class="even">
<td>A4928</td>
<td>0010</td>
<td>3</td>
<td>Surgical mask, per 20</td>
<td>Surgical mask</td>
</tr>
<tr class="odd">
<td>A4929</td>
<td>0010</td>
<td>3</td>
<td>Tourniquet for dialysis, each</td>
<td>Tourniquet for dialysis, ea</td>
</tr>
<tr class="even">
<td>A4930</td>
<td>0010</td>
<td>3</td>
<td>Gloves, sterile, per pair</td>
<td>Sterile, gloves per pair</td>
</tr>
<tr class="odd">
<td>A4931</td>
<td>0010</td>
<td>3</td>
<td>Oral thermometer, reusable, any type, each</td>
<td>Reusable oral thermometer</td>
</tr>
<tr class="even">
<td>A4932</td>
<td>0010</td>
<td>3</td>
<td>Rectal thermometer, reusable, any type, each</td>
<td>Reusable rectal thermometer</td>
</tr>
<tr class="odd">
<td>A5051</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, closed; with barrier attached (1 piece), each</td>
<td>Pouch clsd w barr attached</td>
</tr>
<tr class="even">
<td>A5052</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, closed; without barrier attached (1 piece), each</td>
<td>Clsd ostomy pouch w/o barr</td>
</tr>
<tr class="odd">
<td>A5053</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, closed; for use on faceplate, each</td>
<td>Clsd ostomy pouch faceplate</td>
</tr>
<tr class="even">
<td>A5054</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, closed; for use on barrier with flange (2 piece), each</td>
<td>Clsd ostomy pouch w/flange</td>
</tr>
<tr class="odd">
<td>A5055</td>
<td>0010</td>
<td>3</td>
<td>Stoma cap</td>
<td>Stoma cap</td>
</tr>
<tr class="even">
<td>A5056</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable, with extended wear barrier attached, with filter, (1 piece), each</td>
<td>1 pc ost pouch w filter</td>
</tr>
<tr class="odd">
<td>A5057</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable, with extended wear barrier attached, with built in convexity, with filter, (1 piece), each</td>
<td>1 pc ost pou w built-in conv</td>
</tr>
<tr class="even">
<td>A5061</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable; with barrier attached, (1 piece), each</td>
<td>Pouch drainable w barrier at</td>
</tr>
<tr class="odd">
<td>A5062</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable; without barrier attached (1 piece), each</td>
<td>Drnble ostomy pouch w/o barr</td>
</tr>
<tr class="even">
<td>A5063</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, drainable; for use on barrier with flange (2 piece system), each</td>
<td>Drain ostomy pouch w/flange</td>
</tr>
<tr class="odd">
<td>A5071</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary; with barrier attached (1 piece), each</td>
<td>Urinary pouch w/barrier</td>
</tr>
<tr class="even">
<td>A5072</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary; without barrier attached (1 piece), each</td>
<td>Urinary pouch w/o barrier</td>
</tr>
<tr class="odd">
<td>A5073</td>
<td>0010</td>
<td>3</td>
<td>Ostomy pouch, urinary; for use on barrier with flange (2 piece), each</td>
<td>Urinary pouch on barr w/flng</td>
</tr>
<tr class="even">
<td>A5081</td>
<td>0010</td>
<td>3</td>
<td>Stoma plug or seal, any type</td>
<td>Stoma plug or seal, any type</td>
</tr>
<tr class="odd">
<td>A5082</td>
<td>0010</td>
<td>3</td>
<td>Continent device; catheter for continent stoma</td>
<td>Continent stoma catheter</td>
</tr>
<tr class="even">
<td>A5083</td>
<td>0010</td>
<td>3</td>
<td>Continent device, stoma absorptive cover for continent stoma</td>
<td>Stoma absorptive cover</td>
</tr>
<tr class="odd">
<td>A5093</td>
<td>0010</td>
<td>3</td>
<td>Ostomy accessory; convex insert</td>
<td>Ostomy accessory convex inse</td>
</tr>
<tr class="even">
<td>A5102</td>
<td>0010</td>
<td>3</td>
<td>Bedside drainage bottle with or without tubing, rigid or expandable, each</td>
<td>Bedside drain btl w/wo tube</td>
</tr>
<tr class="odd">
<td>A5105</td>
<td>0010</td>
<td>3</td>
<td>Urinary suspensory with leg bag, with or without tube, each</td>
<td>Urinary suspensory</td>
</tr>
<tr class="even">
<td>A5112</td>
<td>0010</td>
<td>3</td>
<td>Urinary drainage bag, leg or abdomen, latex, with or without tube, with straps, each</td>
<td>Urinary leg bag</td>
</tr>
<tr class="odd">
<td>A5113</td>
<td>0010</td>
<td>3</td>
<td>Leg strap; latex, replacement only, per set</td>
<td>Latex leg strap</td>
</tr>
<tr class="even">
<td>A5114</td>
<td>0010</td>
<td>3</td>
<td>Leg strap; foam or fabric, replacement only, per set</td>
<td>Foam/fabric leg strap</td>
</tr>
<tr class="odd">
<td>A5120</td>
<td>0010</td>
<td>3</td>
<td>Skin barrier, wipes or swabs, each</td>
<td>Skin barrier, wipe or swab</td>
</tr>
<tr class="even">
<td>A5121</td>
<td>0010</td>
<td>3</td>
<td>Skin barrier; solid, 6 x 6 or equivalent, each</td>
<td>Solid skin barrier 6x6</td>
</tr>
<tr class="odd">
<td>A5122</td>
<td>0010</td>
<td>3</td>
<td>Skin barrier; solid, 8 x 8 or equivalent, each</td>
<td>Solid skin barrier 8x8</td>
</tr>
<tr class="even">
<td>A5126</td>
<td>0010</td>
<td>3</td>
<td>Adhesive or non-adhesive; disk or foam pad</td>
<td>Disk/foam pad +or- adhesive</td>
</tr>
<tr class="odd">
<td>A5131</td>
<td>0010</td>
<td>3</td>
<td>Appliance cleaner, incontinence and ostomy appliances, per 16 oz.</td>
<td>Appliance cleaner</td>
</tr>
<tr class="even">
<td>A5200</td>
<td>0010</td>
<td>3</td>
<td>Percutaneous catheter/tube anchoring device, adhesive skin attachment</td>
<td>Percutaneous catheter anchor</td>
</tr>
<tr class="odd">
<td>A5500</td>
<td>0010</td>
<td>3</td>
<td>For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe</td>
<td>Diab shoe for density insert</td>
</tr>
<tr class="even">
<td>A5501</td>
<td>0010</td>
<td>3</td>
<td>For diabetics only, fitting (including follow-up), custom preparation and supply of shoe molded from cast(s) of patient’s foot (custom molded shoe), per shoe</td>
<td>Diabetic custom molded shoe</td>
</tr>
<tr class="odd">
<td>A5503</td>
<td>0010</td>
<td>3</td>
<td>For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with roller or rigid rocker bottom, per shoe</td>
<td>Diabetic shoe w/roller/rockr</td>
</tr>
<tr class="even">
<td>A5504</td>
<td>0010</td>
<td>3</td>
<td>For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with wedge(s), per shoe</td>
<td>Diabetic shoe with wedge</td>
</tr>
<tr class="odd">
<td>A5505</td>
<td>0010</td>
<td>3</td>
<td>For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with metatarsal bar, per shoe</td>
<td>Diab shoe w/metatarsal bar</td>
</tr>
<tr class="even">
<td>A5506</td>
<td>0010</td>
<td>3</td>
<td>For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with off-set heel(s), per shoe</td>
<td>Diabetic shoe w/off set heel</td>
</tr>
<tr class="odd">
<td>A5507</td>
<td>0010</td>
<td>3</td>
<td>For diabetics only, not otherwise specified modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe</td>
<td>Modification diabetic shoe</td>
</tr>
<tr class="even">
<td>A5508</td>
<td>0010</td>
<td>3</td>
<td>For diabetics only, deluxe feature of off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe</td>
<td>Diabetic deluxe shoe</td>
</tr>
<tr class="odd">
<td>A5510</td>
<td>0010</td>
<td>3</td>
<td>For diabetics only, direct formed, compression molded to patient’s foot without external heat source, multiple-density insert(s) prefabricated, per shoe</td>
<td>Compression form shoe insert</td>
</tr>
<tr class="even">
<td>A5512</td>
<td>0010</td>
<td>3</td>
<td>For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient’s foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each</td>
<td>Multi den insert direct form</td>
</tr>
<tr class="odd">
<td>A5513</td>
<td>0010</td>
<td>3</td>
<td>For diabetics only, multiple density insert, custom molded from model of patient’s foot, total contact with patient’s foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each</td>
<td>Multi den insert custom mold</td>
</tr>
<tr class="even">
<td>A5514</td>
<td>0010</td>
<td>3</td>
<td>For diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient’s foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each</td>
<td>Mult den insert dir carv/cam</td>
</tr>
<tr class="odd">
<td>A6000</td>
<td>0010</td>
<td>3</td>
<td>Non-contact wound warming wound cover for use with the non-contact wound warming device and warming card</td>
<td>Wound warming wound cover</td>
</tr>
<tr class="even">
<td>A6010</td>
<td>0010</td>
<td>3</td>
<td>Collagen based wound filler, dry form, sterile, per gram of collagen</td>
<td>Collagen based wound filler</td>
</tr>
<tr class="odd">
<td>A6011</td>
<td>0010</td>
<td>3</td>
<td>Collagen based wound filler, gel/paste, per gram of collagen</td>
<td>Collagen gel/paste wound fil</td>
</tr>
<tr class="even">
<td>A6021</td>
<td>0010</td>
<td>3</td>
<td>Collagen dressing, sterile, size 16 sq. in. or less, each</td>
<td>Collagen dressing &lt;=16 sq in</td>
</tr>
<tr class="odd">
<td>A6022</td>
<td>0010</td>
<td>3</td>
<td>Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each</td>
<td>Collagen drsg&gt;16&lt;=48 sq in</td>
</tr>
<tr class="even">
<td>A6023</td>
<td>0010</td>
<td>3</td>
<td>Collagen dressing, sterile, size more than 48 sq. in., each</td>
<td>Collagen dressing &gt;48 sq in</td>
</tr>
<tr class="odd">
<td>A6024</td>
<td>0010</td>
<td>3</td>
<td>Collagen dressing wound filler, sterile, per 6 inches</td>
<td>Collagen dsg wound filler</td>
</tr>
<tr class="even">
<td>A6025</td>
<td>0010</td>
<td>3</td>
<td>Gel sheet for dermal or epidermal application, (e.g., silicone, hydrogel, other), each</td>
<td>Silicone gel sheet, each</td>
</tr>
<tr class="odd">
<td>A6154</td>
<td>0010</td>
<td>3</td>
<td>Wound pouch, each</td>
<td>Wound pouch each</td>
</tr>
<tr class="even">
<td>A6196</td>
<td>0010</td>
<td>3</td>
<td>Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing</td>
<td>Alginate dressing &lt;=16 sq in</td>
</tr>
<tr class="odd">
<td>A6197</td>
<td>0010</td>
<td>3</td>
<td>Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing</td>
<td>Alginate drsg &gt;16 &lt;=48 sq in</td>
</tr>
<tr class="even">
<td>A6198</td>
<td>0010</td>
<td>3</td>
<td>Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 48 sq. in., each dressing</td>
<td>Alginate dressing &gt; 48 sq in</td>
</tr>
<tr class="odd">
<td>A6199</td>
<td>0010</td>
<td>3</td>
<td>Alginate or other fiber gelling dressing, wound filler, sterile, per 6 inches</td>
<td>Alginate drsg wound filler</td>
</tr>
<tr class="even">
<td>A6203</td>
<td>0010</td>
<td>3</td>
<td>Composite dressing, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing</td>
<td>Composite drsg &lt;= 16 sq in</td>
</tr>
<tr class="odd">
<td>A6204</td>
<td>0010</td>
<td>3</td>
<td>Composite dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing</td>
<td>Composite drsg &gt;16&lt;=48 sq in</td>
</tr>
<tr class="even">
<td>A6205</td>
<td>0010</td>
<td>3</td>
<td>Composite dressing, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing</td>
<td>Composite drsg &gt; 48 sq in</td>
</tr>
<tr class="odd">
<td>A6206</td>
<td>0010</td>
<td>3</td>
<td>Contact layer, sterile, 16 sq. in. or less, each dressing</td>
<td>Contact layer &lt;= 16 sq in</td>
</tr>
<tr class="even">
<td>A6207</td>
<td>0010</td>
<td>3</td>
<td>Contact layer, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing</td>
<td>Contact layer &gt;16&lt;= 48 sq in</td>
</tr>
<tr class="odd">
<td>A6208</td>
<td>0010</td>
<td>3</td>
<td>Contact layer, sterile, more than 48 sq. in., each dressing</td>
<td>Contact layer &gt; 48 sq in</td>
</tr>
<tr class="even">
<td>A6209</td>
<td>0010</td>
<td>3</td>
<td>Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing</td>
<td>Foam drsg &lt;=16 sq in w/o bdr</td>
</tr>
<tr class="odd">
<td>A6210</td>
<td>0010</td>
<td>3</td>
<td>Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing</td>
<td>Foam drg &gt;16&lt;=48 sq in w/o b</td>
</tr>
<tr class="even">
<td>A6211</td>
<td>0010</td>
<td>3</td>
<td>Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing</td>
<td>Foam drg &gt; 48 sq in w/o brdr</td>
</tr>
<tr class="odd">
<td>A6212</td>
<td>0010</td>
<td>3</td>
<td>Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing</td>
<td>Foam drg &lt;=16 sq in w/border</td>
</tr>
<tr class="even">
<td>A6213</td>
<td>0010</td>
<td>3</td>
<td>Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing</td>
<td>Foam drg &gt;16&lt;=48 sq in w/bdr</td>
</tr>
<tr class="odd">
<td>A6214</td>
<td>0010</td>
<td>3</td>
<td>Foam dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing</td>
<td>Foam drg &gt; 48 sq in w/border</td>
</tr>
<tr class="even">
<td>A6215</td>
<td>0010</td>
<td>3</td>
<td>Foam dressing, wound filler, sterile, per gram</td>
<td>Foam dressing wound filler</td>
</tr>
<tr class="odd">
<td>A6216</td>
<td>0010</td>
<td>3</td>
<td>Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing</td>
<td>Non-sterile gauze&lt;=16 sq in</td>
</tr>
<tr class="even">
<td>A6217</td>
<td>0010</td>
<td>3</td>
<td>Gauze, non-impregnated, non-sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing</td>
<td>Non-sterile gauze&gt;16&lt;=48 sq</td>
</tr>
<tr class="odd">
<td>A6218</td>
<td>0010</td>
<td>3</td>
<td>Gauze, non-impregnated, non-sterile, pad size more than 48 sq. in., without adhesive border, each dressing</td>
<td>Non-sterile gauze &gt; 48 sq in</td>
</tr>
<tr class="even">
<td>A6219</td>
<td>0010</td>
<td>3</td>
<td>Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing</td>
<td>Gauze &lt;= 16 sq in w/border</td>
</tr>
<tr class="odd">
<td>A6220</td>
<td>0010</td>
<td>3</td>
<td>Gauze, non-impregnated, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing</td>
<td>Gauze &gt;16 &lt;=48 sq in w/bordr</td>
</tr>
<tr class="even">
<td>A6221</td>
<td>0010</td>
<td>3</td>
<td>Gauze, non-impregnated, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing</td>
<td>Gauze &gt; 48 sq in w/border</td>
</tr>
<tr class="odd">
<td>A6222</td>
<td>0010</td>
<td>3</td>
<td>Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing</td>
<td>Gauze &lt;=16 in no w/sal w/o b</td>
</tr>
<tr class="even">
<td>A6223</td>
<td>0010</td>
<td>3</td>
<td>Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing</td>
<td>Gauze &gt;16&lt;=48 no w/sal w/o b</td>
</tr>
<tr class="odd">
<td>A6224</td>
<td>0010</td>
<td>3</td>
<td>Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 48 sq. in., without adhesive border, each dressing</td>
<td>Gauze &gt; 48 in no w/sal w/o b</td>
</tr>
<tr class="even">
<td>A6228</td>
<td>0010</td>
<td>3</td>
<td>Gauze, impregnated, water or normal saline, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing</td>
<td>Gauze &lt;= 16 sq in water/sal</td>
</tr>
<tr class="odd">
<td>A6229</td>
<td>0010</td>
<td>3</td>
<td>Gauze, impregnated, water or normal saline, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing</td>
<td>Gauze &gt;16&lt;=48 sq in watr/sal</td>
</tr>
<tr class="even">
<td>A6230</td>
<td>0010</td>
<td>3</td>
<td>Gauze, impregnated, water or normal saline, sterile, pad size more than 48 sq. in., without adhesive border, each dressing</td>
<td>Gauze &gt; 48 sq in water/salne</td>
</tr>
<tr class="odd">
<td>A6231</td>
<td>0010</td>
<td>3</td>
<td>Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size 16 sq. in. or less, each dressing</td>
<td>Hydrogel dsg&lt;=16 sq in</td>
</tr>
<tr class="even">
<td>A6232</td>
<td>0010</td>
<td>3</td>
<td>Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size greater than 16 sq. in., but less than or equal to 48 sq. in., each dressing</td>
<td>Hydrogel dsg&gt;16&lt;=48 sq in</td>
</tr>
<tr class="odd">
<td>A6233</td>
<td>0010</td>
<td>3</td>
<td>Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size more than 48 sq. in., each dressing</td>
<td>Hydrogel dressing &gt;48 sq in</td>
</tr>
<tr class="even">
<td>A6234</td>
<td>0010</td>
<td>3</td>
<td>Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing</td>
<td>Hydrocolld drg &lt;=16 w/o bdr</td>
</tr>
<tr class="odd">
<td>A6235</td>
<td>0010</td>
<td>3</td>
<td>Hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing</td>
<td>Hydrocolld drg &gt;16&lt;=48 w/o b</td>
</tr>
<tr class="even">
<td>A6236</td>
<td>0010</td>
<td>3</td>
<td>Hydrocolloid dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing</td>
<td>Hydrocolld drg &gt; 48 in w/o b</td>
</tr>
<tr class="odd">
<td>A6237</td>
<td>0010</td>
<td>3</td>
<td>Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing</td>
<td>Hydrocolld drg &lt;=16 in w/bdr</td>
</tr>
<tr class="even">
<td>A6238</td>
<td>0010</td>
<td>3</td>
<td>Hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing</td>
<td>Hydrocolld drg &gt;16&lt;=48 w/bdr</td>
</tr>
<tr class="odd">
<td>A6239</td>
<td>0010</td>
<td>3</td>
<td>Hydrocolloid dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing</td>
<td>Hydrocolld drg &gt; 48 in w/bdr</td>
</tr>
<tr class="even">
<td>A6240</td>
<td>0010</td>
<td>3</td>
<td>Hydrocolloid dressing, wound filler, paste, sterile, per ounce</td>
<td>Hydrocolld drg filler paste</td>
</tr>
<tr class="odd">
<td>A6241</td>
<td>0010</td>
<td>3</td>
<td>Hydrocolloid dressing, wound filler, dry form, sterile, per gram</td>
<td>Hydrocolloid drg filler dry</td>
</tr>
<tr class="even">
<td>A6242</td>
<td>0010</td>
<td>3</td>
<td>Hydrogel dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing</td>
<td>Hydrogel drg &lt;=16 in w/o bdr</td>
</tr>
<tr class="odd">
<td>A6243</td>
<td>0010</td>
<td>3</td>
<td>Hydrogel dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing</td>
<td>Hydrogel drg &gt;16&lt;=48 w/o bdr</td>
</tr>
<tr class="even">
<td>A6244</td>
<td>0010</td>
<td>3</td>
<td>Hydrogel dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing</td>
<td>Hydrogel drg &gt;48 in w/o bdr</td>
</tr>
<tr class="odd">
<td>A6245</td>
<td>0010</td>
<td>3</td>
<td>Hydrogel dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing</td>
<td>Hydrogel drg &lt;= 16 in w/bdr</td>
</tr>
<tr class="even">
<td>A6246</td>
<td>0010</td>
<td>3</td>
<td>Hydrogel dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing</td>
<td>Hydrogel drg &gt;16&lt;=48 in w/b</td>
</tr>
<tr class="odd">
<td>A6247</td>
<td>0010</td>
<td>3</td>
<td>Hydrogel dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing</td>
<td>Hydrogel drg &gt; 48 sq in w/b</td>
</tr>
<tr class="even">
<td>A6248</td>
<td>0010</td>
<td>3</td>
<td>Hydrogel dressing, wound filler, gel, per fluid ounce</td>
<td>Hydrogel drsg gel filler</td>
</tr>
<tr class="odd">
<td>A6250</td>
<td>0010</td>
<td>3</td>
<td>Skin sealants, protectants, moisturizers, ointments, any type, any size</td>
<td>Skin seal protect moisturizr</td>
</tr>
<tr class="even">
<td>A6251</td>
<td>0010</td>
<td>3</td>
<td>Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing</td>
<td>Absorpt drg &lt;=16 sq in w/o b</td>
</tr>
<tr class="odd">
<td>A6252</td>
<td>0010</td>
<td>3</td>
<td>Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing</td>
<td>Absorpt drg &gt;16 &lt;=48 w/o bdr</td>
</tr>
<tr class="even">
<td>A6253</td>
<td>0010</td>
<td>3</td>
<td>Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing</td>
<td>Absorpt drg &gt; 48 sq in w/o b</td>
</tr>
<tr class="odd">
<td>A6254</td>
<td>0010</td>
<td>3</td>
<td>Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing</td>
<td>Absorpt drg &lt;=16 sq in w/bdr</td>
</tr>
<tr class="even">
<td>A6255</td>
<td>0010</td>
<td>3</td>
<td>Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing</td>
<td>Absorpt drg &gt;16&lt;=48 in w/bdr</td>
</tr>
<tr class="odd">
<td>A6256</td>
<td>0010</td>
<td>3</td>
<td>Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing</td>
<td>Absorpt drg &gt; 48 sq in w/bdr</td>
</tr>
<tr class="even">
<td>A6257</td>
<td>0010</td>
<td>3</td>
<td>Transparent film, sterile, 16 sq. in. or less, each dressing</td>
<td>Transparent film &lt;= 16 sq in</td>
</tr>
<tr class="odd">
<td>A6258</td>
<td>0010</td>
<td>3</td>
<td>Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing</td>
<td>Transparent film &gt;16&lt;=48 in</td>
</tr>
<tr class="even">
<td>A6259</td>
<td>0010</td>
<td>3</td>
<td>Transparent film, sterile, more than 48 sq. in., each dressing</td>
<td>Transparent film &gt; 48 sq in</td>
</tr>
<tr class="odd">
<td>A6260</td>
<td>0010</td>
<td>3</td>
<td>Wound cleansers, any type, any size</td>
<td>Wound cleanser any type/size</td>
</tr>
<tr class="even">
<td>A6261</td>
<td>0010</td>
<td>3</td>
<td>Wound filler, gel/paste, per fluid ounce, not otherwise specified</td>
<td>Wound filler gel/paste /oz</td>
</tr>
<tr class="odd">
<td>A6262</td>
<td>0010</td>
<td>3</td>
<td>Wound filler, dry form, per gram, not otherwise specified</td>
<td>Wound filler dry form / gram</td>
</tr>
<tr class="even">
<td>A6266</td>
<td>0010</td>
<td>3</td>
<td>Gauze, impregnated, other than water, normal saline, or zinc paste, sterile, any width, per linear yard</td>
<td>Impreg gauze no h20/sal/yard</td>
</tr>
<tr class="odd">
<td>A6402</td>
<td>0010</td>
<td>3</td>
<td>Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing</td>
<td>Sterile gauze &lt;= 16 sq in</td>
</tr>
<tr class="even">
<td>A6403</td>
<td>0010</td>
<td>3</td>
<td>Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing</td>
<td>Sterile gauze&gt;16 &lt;= 48 sq in</td>
</tr>
<tr class="odd">
<td>A6404</td>
<td>0010</td>
<td>3</td>
<td>Gauze, non-impregnated, sterile, pad size more than 48 sq. in., without adhesive border, each dressing</td>
<td>Sterile gauze &gt; 48 sq in</td>
</tr>
<tr class="even">
<td>A6407</td>
<td>0010</td>
<td>3</td>
<td>Packing strips, non-impregnated, sterile, up to 2 inches in width, per linear yard</td>
<td>Packing strips, non-impreg</td>
</tr>
<tr class="odd">
<td>A6410</td>
<td>0010</td>
<td>3</td>
<td>Eye pad, sterile, each</td>
<td>Sterile eye pad</td>
</tr>
<tr class="even">
<td>A6411</td>
<td>0010</td>
<td>3</td>
<td>Eye pad, non-sterile, each</td>
<td>Non-sterile eye pad</td>
</tr>
<tr class="odd">
<td>A6412</td>
<td>0010</td>
<td>3</td>
<td>Eye patch, occlusive, each</td>
<td>Occlusive eye patch</td>
</tr>
<tr class="even">
<td>A6413</td>
<td>0010</td>
<td>3</td>
<td>Adhesive bandage, first-aid type, any size, each</td>
<td>Adhesive bandage, first-aid</td>
</tr>
<tr class="odd">
<td>A6441</td>
<td>0010</td>
<td>3</td>
<td>Padding bandage, non-elastic, non-woven/non-knitted, width greater than or equal to three inches and less than five inches, per yard</td>
<td>Pad band w&gt;=3&quot; &lt;5“/yd</td>
</tr>
<tr class="even">
<td>A6442</td>
<td>0010</td>
<td>3</td>
<td>Conforming bandage, non-elastic, knitted/woven, non-sterile, width less than three inches, per yard</td>
<td>Conform band n/s w&lt;3“/yd</td>
</tr>
<tr class="odd">
<td>A6443</td>
<td>0010</td>
<td>3</td>
<td>Conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than or equal to three inches and less than five inches, per yard</td>
<td>Conform band n/s w&gt;=3“&lt;5”/yd</td>
</tr>
<tr class="even">
<td>A6444</td>
<td>0010</td>
<td>3</td>
<td>Conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than or equal to 5 inches, per yard</td>
<td>Conform band n/s w&gt;=5“/yd</td>
</tr>
<tr class="odd">
<td>A6445</td>
<td>0010</td>
<td>3</td>
<td>Conforming bandage, non-elastic, knitted/woven, sterile, width less than three inches, per yard</td>
<td>Conform band s w &lt;3“/yd</td>
</tr>
<tr class="even">
<td>A6446</td>
<td>0010</td>
<td>3</td>
<td>Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard</td>
<td>Conform band s w&gt;=3&quot; &lt;5“/yd</td>
</tr>
<tr class="odd">
<td>A6447</td>
<td>0010</td>
<td>3</td>
<td>Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to five inches, per yard</td>
<td>Conform band s w &gt;=5“/yd</td>
</tr>
<tr class="even">
<td>A6448</td>
<td>0010</td>
<td>3</td>
<td>Light compression bandage, elastic, knitted/woven, width less than three inches, per yard</td>
<td>Lt compres band &lt;3“/yd</td>
</tr>
<tr class="odd">
<td>A6449</td>
<td>0010</td>
<td>3</td>
<td>Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard</td>
<td>Lt compres band &gt;=3&quot; &lt;5“/yd</td>
</tr>
<tr class="even">
<td>A6450</td>
<td>0010</td>
<td>3</td>
<td>Light compression bandage, elastic, knitted/woven, width greater than or equal to five inches, per yard</td>
<td>Lt compres band &gt;=5“/yd</td>
</tr>
<tr class="odd">
<td>A6451</td>
<td>0010</td>
<td>3</td>
<td>Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard</td>
<td>Mod compres band w&gt;=3“&lt;5”/yd</td>
</tr>
<tr class="even">
<td>A6452</td>
<td>0010</td>
<td>3</td>
<td>High compression bandage, elastic, knitted/woven, load resistance greater than or equal to 1.35 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard</td>
<td>High compres band w&gt;=3“&lt;5”yd</td>
</tr>
<tr class="odd">
<td>A6453</td>
<td>0010</td>
<td>3</td>
<td>Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard</td>
<td>Self-adher band w &lt;3“/yd</td>
</tr>
<tr class="even">
<td>A6454</td>
<td>0010</td>
<td>3</td>
<td>Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard</td>
<td>Self-adher band w&gt;=3&quot; &lt;5“/yd</td>
</tr>
<tr class="odd">
<td>A6455</td>
<td>0010</td>
<td>3</td>
<td>Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to five inches, per yard</td>
<td>Self-adher band &gt;=5“/yd</td>
</tr>
<tr class="even">
<td>A6456</td>
<td>0010</td>
<td>3</td>
<td>Zinc paste impregnated bandage, non-elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard</td>
<td>Zinc paste band w &gt;=3“&lt;5”/yd</td>
</tr>
<tr class="odd">
<td>A6457</td>
<td>0010</td>
<td>3</td>
<td>Tubular dressing with or without elastic, any width, per linear yard</td>
<td>Tubular dressing</td>
</tr>
<tr class="even">
<td>A6460</td>
<td>0010</td>
<td>3</td>
<td>Synthetic resorbable wound dressing, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing</td>
<td>Synthetic drsg &lt;= 16 sq in</td>
</tr>
<tr class="odd">
<td>A6461</td>
<td>0010</td>
<td>3</td>
<td>Synthetic resorbable wound dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing</td>
<td>Synthetic drsg &gt;16&lt;=48 sq in</td>
</tr>
<tr class="even">
<td>A6501</td>
<td>0010</td>
<td>3</td>
<td>Compression burn garment, bodysuit (head to foot), custom fabricated</td>
<td>Compres burngarment bodysuit</td>
</tr>
<tr class="odd">
<td>A6502</td>
<td>0010</td>
<td>3</td>
<td>Compression burn garment, chin strap, custom fabricated</td>
<td>Compres burngarment chinstrp</td>
</tr>
<tr class="even">
<td>A6503</td>
<td>0010</td>
<td>3</td>
<td>Compression burn garment, facial hood, custom fabricated</td>
<td>Compres burngarment facehood</td>
</tr>
<tr class="odd">
<td>A6504</td>
<td>0010</td>
<td>3</td>
<td>Compression burn garment, glove to wrist, custom fabricated</td>
<td>Cmprsburngarment glove-wrist</td>
</tr>
<tr class="even">
<td>A6505</td>
<td>0010</td>
<td>3</td>
<td>Compression burn garment, glove to elbow, custom fabricated</td>
<td>Cmprsburngarment glove-elbow</td>
</tr>
<tr class="odd">
<td>A6506</td>
<td>0010</td>
<td>3</td>
<td>Compression burn garment, glove to axilla, custom fabricated</td>
<td>Cmprsburngrmnt glove-axilla</td>
</tr>
<tr class="even">
<td>A6507</td>
<td>0010</td>
<td>3</td>
<td>Compression burn garment, foot to knee length, custom fabricated</td>
<td>Cmprs burngarment foot-knee</td>
</tr>
<tr class="odd">
<td>A6508</td>
<td>0010</td>
<td>3</td>
<td>Compression burn garment, foot to thigh length, custom fabricated</td>
<td>Cmprs burngarment foot-thigh</td>
</tr>
<tr class="even">
<td>A6509</td>
<td>0010</td>
<td>3</td>
<td>Compression burn garment, upper trunk to waist including arm openings (vest), custom fabricated</td>
<td>Compres burn garment jacket</td>
</tr>
<tr class="odd">
<td>A6510</td>
<td>0010</td>
<td>3</td>
<td>Compression burn garment, trunk, including arms down to leg openings (leotard), custom fabricated</td>
<td>Compres burn garment leotard</td>
</tr>
<tr class="even">
<td>A6511</td>
<td>0010</td>
<td>3</td>
<td>Compression burn garment, lower trunk including leg openings (panty), custom fabricated</td>
<td>Compres burn garment panty</td>
</tr>
<tr class="odd">
<td>A6512</td>
<td>0010</td>
<td>3</td>
<td>Compression burn garment, not otherwise classified</td>
<td>Compres burn garment, noc</td>
</tr>
<tr class="even">
<td>A6513</td>
<td>0010</td>
<td>3</td>
<td>Compression burn mask, face and/or neck, plastic or equal, custom fabricated</td>
<td>Compress burn mask face/neck</td>
</tr>
<tr class="odd">
<td>A6530</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression stocking, below knee, 18-30 mmhg, each</td>
<td>Compression stocking bk18-30</td>
</tr>
<tr class="even">
<td>A6531</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression stocking, below knee, 30-40 mmhg, each</td>
<td>Compression stocking bk30-40</td>
</tr>
<tr class="odd">
<td>A6532</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression stocking, below knee, 40-50 mmhg, each</td>
<td>Compression stocking bk40-50</td>
</tr>
<tr class="even">
<td>A6533</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression stocking, thigh length, 18-30 mmhg, each</td>
<td>Gc stocking thighlngth 18-30</td>
</tr>
<tr class="odd">
<td>A6534</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression stocking, thigh length, 30-40 mmhg, each</td>
<td>Gc stocking thighlngth 30-40</td>
</tr>
<tr class="even">
<td>A6535</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression stocking, thigh length, 40-50 mmhg, each</td>
<td>Gc stocking thighlngth 40-50</td>
</tr>
<tr class="odd">
<td>A6536</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression stocking, full length/chap style, 18-30 mmhg, each</td>
<td>Gc stocking full lngth 18-30</td>
</tr>
<tr class="even">
<td>A6537</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression stocking, full length/chap style, 30-40 mmhg, each</td>
<td>Gc stocking full lngth 30-40</td>
</tr>
<tr class="odd">
<td>A6538</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression stocking, full length/chap style, 40-50 mmhg, each</td>
<td>Gc stocking full lngth 40-50</td>
</tr>
<tr class="even">
<td>A6539</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression stocking, waist length, 18-30 mmhg, each</td>
<td>Gc stocking waistlngth 18-30</td>
</tr>
<tr class="odd">
<td>A6540</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression stocking, waist length, 30-40 mmhg, each</td>
<td>Gc stocking waistlngth 30-40</td>
</tr>
<tr class="even">
<td>A6541</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression stocking, waist length, 40-50 mmhg, each</td>
<td>Gc stocking waistlngth 40-50</td>
</tr>
<tr class="odd">
<td>A6544</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression stocking, garter belt</td>
<td>Gc stocking garter belt</td>
</tr>
<tr class="even">
<td>A6545</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression wrap, non-elastic, below knee, 30-50 mm hg, each</td>
<td>Grad comp non-elastic bk</td>
</tr>
<tr class="odd">
<td>A6549</td>
<td>0010</td>
<td>3</td>
<td>Gradient compression stocking/sleeve, not otherwise specified</td>
<td>G compression stocking</td>
</tr>
<tr class="even">
<td>A6550</td>
<td>0010</td>
<td>3</td>
<td>Wound care set, for negative pressure wound therapy electrical pump, includes all supplies and accessories</td>
<td>Neg pres wound ther drsg set</td>
</tr>
<tr class="odd">
<td>A7000</td>
<td>0010</td>
<td>3</td>
<td>Canister, disposable, used with suction pump, each</td>
<td>Disposable canister for pump</td>
</tr>
<tr class="even">
<td>A7001</td>
<td>0010</td>
<td>3</td>
<td>Canister, non-disposable, used with suction pump, each</td>
<td>Nondisposable pump canister</td>
</tr>
<tr class="odd">
<td>A7002</td>
<td>0010</td>
<td>3</td>
<td>Tubing, used with suction pump, each</td>
<td>Tubing used w suction pump</td>
</tr>
<tr class="even">
<td>A7003</td>
<td>0010</td>
<td>3</td>
<td>Administration set, with small volume nonfiltered pneumatic nebulizer, disposable</td>
<td>Nebulizer administration set</td>
</tr>
<tr class="odd">
<td>A7004</td>
<td>0010</td>
<td>3</td>
<td>Small volume nonfiltered pneumatic nebulizer, disposable</td>
<td>Disposable nebulizer sml vol</td>
</tr>
<tr class="even">
<td>A7005</td>
<td>0010</td>
<td>3</td>
<td>Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable</td>
<td>Nondisposable nebulizer set</td>
</tr>
<tr class="odd">
<td>A7006</td>
<td>0010</td>
<td>3</td>
<td>Administration set, with small volume filtered pneumatic nebulizer</td>
<td>Filtered nebulizer admin set</td>
</tr>
<tr class="even">
<td>A7007</td>
<td>0010</td>
<td>3</td>
<td>Large volume nebulizer, disposable, unfilled, used with aerosol compressor</td>
<td>Lg vol nebulizer disposable</td>
</tr>
<tr class="odd">
<td>A7008</td>
<td>0010</td>
<td>3</td>
<td>Large volume nebulizer, disposable, prefilled, used with aerosol compressor</td>
<td>Disposable nebulizer prefill</td>
</tr>
<tr class="even">
<td>A7009</td>
<td>0010</td>
<td>3</td>
<td>Reservoir bottle, non-disposable, used with large volume ultrasonic nebulizer</td>
<td>Nebulizer reservoir bottle</td>
</tr>
<tr class="odd">
<td>A7010</td>
<td>0010</td>
<td>3</td>
<td>Corrugated tubing, disposable, used with large volume nebulizer, 100 feet</td>
<td>Disposable corrugated tubing</td>
</tr>
<tr class="even">
<td>A7011</td>
<td>0010</td>
<td>3</td>
<td>Corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet</td>
<td>Nondispos corrugated tubing</td>
</tr>
<tr class="odd">
<td>A7012</td>
<td>0010</td>
<td>3</td>
<td>Water collection device, used with large volume nebulizer</td>
<td>Nebulizer water collec devic</td>
</tr>
<tr class="even">
<td>A7013</td>
<td>0010</td>
<td>3</td>
<td>Filter, disposable, used with aerosol compressor or ultrasonic generator</td>
<td>Disposable compressor filter</td>
</tr>
<tr class="odd">
<td>A7014</td>
<td>0010</td>
<td>3</td>
<td>Filter, nondisposable, used with aerosol compressor or ultrasonic generator</td>
<td>Compressor nondispos filter</td>
</tr>
<tr class="even">
<td>A7015</td>
<td>0010</td>
<td>3</td>
<td>Aerosol mask, used with dme nebulizer</td>
<td>Aerosol mask used w nebulize</td>
</tr>
<tr class="odd">
<td>A7016</td>
<td>0010</td>
<td>3</td>
<td>Dome and mouthpiece, used with small volume ultrasonic nebulizer</td>
<td>Nebulizer dome &amp; mouthpiece</td>
</tr>
<tr class="even">
<td>A7017</td>
<td>0010</td>
<td>3</td>
<td>Nebulizer, durable, glass or autoclavable plastic, bottle type, not used with oxygen</td>
<td>Nebulizer not used w oxygen</td>
</tr>
<tr class="odd">
<td>A7018</td>
<td>0010</td>
<td>3</td>
<td>Water, distilled, used with large volume nebulizer, 1000 ml</td>
<td>Water distilled w/nebulizer</td>
</tr>
<tr class="even">
<td>A7020</td>
<td>0010</td>
<td>3</td>
<td>Interface for cough stimulating device, includes all components, replacement only</td>
<td>Interface, cough stim device</td>
</tr>
<tr class="odd">
<td>A7025</td>
<td>0010</td>
<td>3</td>
<td>High frequency chest wall oscillation system vest, replacement for use with patient owned equipment, each</td>
<td>Replace chest compress vest</td>
</tr>
<tr class="even">
<td>A7026</td>
<td>0010</td>
<td>3</td>
<td>High frequency chest wall oscillation system hose, replacement for use with patient owned equipment, each</td>
<td>Replace chst cmprss sys hose</td>
</tr>
<tr class="odd">
<td>A7027</td>
<td>0010</td>
<td>3</td>
<td>Combination oral/nasal mask, used with continuous positive airway pressure device, each</td>
<td>Combination oral/nasal mask</td>
</tr>
<tr class="even">
<td>A7028</td>
<td>0010</td>
<td>3</td>
<td>Oral cushion for combination oral/nasal mask, replacement only, each</td>
<td>Repl oral cushion combo mask</td>
</tr>
<tr class="odd">
<td>A7029</td>
<td>0010</td>
<td>3</td>
<td>Nasal pillows for combination oral/nasal mask, replacement only, pair</td>
<td>Repl nasal pillow comb mask</td>
</tr>
<tr class="even">
<td>A7030</td>
<td>0010</td>
<td>3</td>
<td>Full face mask used with positive airway pressure device, each</td>
<td>Cpap full face mask</td>
</tr>
<tr class="odd">
<td>A7031</td>
<td>0010</td>
<td>3</td>
<td>Face mask interface, replacement for full face mask, each</td>
<td>Replacement facemask interfa</td>
</tr>
<tr class="even">
<td>A7032</td>
<td>0010</td>
<td>3</td>
<td>Cushion for use on nasal mask interface, replacement only, each</td>
<td>Replacement nasal cushion</td>
</tr>
<tr class="odd">
<td>A7033</td>
<td>0010</td>
<td>3</td>
<td>Pillow for use on nasal cannula type interface, replacement only, pair</td>
<td>Replacement nasal pillows</td>
</tr>
<tr class="even">
<td>A7034</td>
<td>0010</td>
<td>3</td>
<td>Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap</td>
<td>Nasal application device</td>
</tr>
<tr class="odd">
<td>A7035</td>
<td>0010</td>
<td>3</td>
<td>Headgear used with positive airway pressure device</td>
<td>Pos airway press headgear</td>
</tr>
<tr class="even">
<td>A7036</td>
<td>0010</td>
<td>3</td>
<td>Chinstrap used with positive airway pressure device</td>
<td>Pos airway press chinstrap</td>
</tr>
<tr class="odd">
<td>A7037</td>
<td>0010</td>
<td>3</td>
<td>Tubing used with positive airway pressure device</td>
<td>Pos airway pressure tubing</td>
</tr>
<tr class="even">
<td>A7038</td>
<td>0010</td>
<td>3</td>
<td>Filter, disposable, used with positive airway pressure device</td>
<td>Pos airway pressure filter</td>
</tr>
<tr class="odd">
<td>A7039</td>
<td>0010</td>
<td>3</td>
<td>Filter, non disposable, used with positive airway pressure device</td>
<td>Filter, non disposable w pap</td>
</tr>
<tr class="even">
<td>A7040</td>
<td>0010</td>
<td>3</td>
<td>One way chest drain valve</td>
<td>One way chest drain valve</td>
</tr>
<tr class="odd">
<td>A7041</td>
<td>0010</td>
<td>3</td>
<td>Water seal drainage container and tubing for use with implanted chest tube</td>
<td>Water seal drain container</td>
</tr>
<tr class="even">
<td>A7042</td>
<td>0010</td>
<td>3</td>
<td>Implanted pleural catheter, each</td>
<td>Implanted pleural catheter</td>
</tr>
<tr class="odd">
<td>A7043</td>
<td>0010</td>
<td>3</td>
<td>Vacuum drainage bottle and tubing for use with implanted catheter</td>
<td>Vacuum drainagebottle/tubing</td>
</tr>
<tr class="even">
<td>A7044</td>
<td>0010</td>
<td>3</td>
<td>Oral interface used with positive airway pressure device, each</td>
<td>Pap oral interface</td>
</tr>
<tr class="odd">
<td>A7045</td>
<td>0010</td>
<td>3</td>
<td>Exhalation port with or without swivel used with accessories for positive airway devices, replacement only</td>
<td>Repl exhalation port for pap</td>
</tr>
<tr class="even">
<td>A7046</td>
<td>0010</td>
<td>3</td>
<td>Water chamber for humidifier, used with positive airway pressure device, replacement, each</td>
<td>Repl water chamber, pap dev</td>
</tr>
<tr class="odd">
<td>A7047</td>
<td>0010</td>
<td>3</td>
<td>Oral interface used with respiratory suction pump, each</td>
<td>Resp suction oral interface</td>
</tr>
<tr class="even">
<td>A7048</td>
<td>0010</td>
<td>3</td>
<td>Vacuum drainage collection unit and tubing kit, including all supplies needed for collection unit change, for use with implanted catheter, each</td>
<td>Vacuum drain bottle/tube kit</td>
</tr>
<tr class="odd">
<td>A7501</td>
<td>0010</td>
<td>3</td>
<td>Tracheostoma valve, including diaphragm, each</td>
<td>Tracheostoma valve w diaphra</td>
</tr>
<tr class="even">
<td>A7502</td>
<td>0010</td>
<td>3</td>
<td>Replacement diaphragm/faceplate for tracheostoma valve, each</td>
<td>Replacement diaphragm/fplate</td>
</tr>
<tr class="odd">
<td>A7503</td>
<td>0010</td>
<td>3</td>
<td>Filter holder or filter cap, reusable, for use in a tracheostoma heat and moisture exchange system, each</td>
<td>Hmes filter holder or cap</td>
</tr>
<tr class="even">
<td>A7504</td>
<td>0010</td>
<td>3</td>
<td>Filter for use in a tracheostoma heat and moisture exchange system, each</td>
<td>Tracheostoma hmes filter</td>
</tr>
<tr class="odd">
<td>A7505</td>
<td>0010</td>
<td>3</td>
<td>Housing, reusable without adhesive, for use in a heat and moisture exchange system and/or with a tracheostoma valve, each</td>
<td>Hmes or trach valve housing</td>
</tr>
<tr class="even">
<td>A7506</td>
<td>0010</td>
<td>3</td>
<td>Adhesive disc for use in a heat and moisture exchange system and/or with tracheostoma valve, any type each</td>
<td>Hmes/trachvalve adhesivedisk</td>
</tr>
<tr class="odd">
<td>A7507</td>
<td>0010</td>
<td>3</td>
<td>Filter holder and integrated filter without adhesive, for use in a tracheostoma heat and moisture exchange system, each</td>
<td>Integrated filter &amp; holder</td>
</tr>
<tr class="even">
<td>A7508</td>
<td>0010</td>
<td>3</td>
<td>Housing and integrated adhesive, for use in a tracheostoma heat and moisture exchange system and/or with a tracheostoma valve, each</td>
<td>Housing &amp; integrated adhesiv</td>
</tr>
<tr class="odd">
<td>A7509</td>
<td>0010</td>
<td>3</td>
<td>Filter holder and integrated filter housing, and adhesive, for use as a tracheostoma heat and moisture exchange system, each</td>
<td>Heat &amp; moisture exchange sys</td>
</tr>
<tr class="even">
<td>A7520</td>
<td>0010</td>
<td>3</td>
<td>Tracheostomy/laryngectomy tube, non-cuffed, polyvinylchloride (pvc), silicone or equal, each</td>
<td>Trach/laryn tube non-cuffed</td>
</tr>
<tr class="odd">
<td>A7521</td>
<td>0010</td>
<td>3</td>
<td>Tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone or equal, each</td>
<td>Trach/laryn tube cuffed</td>
</tr>
<tr class="even">
<td>A7522</td>
<td>0010</td>
<td>3</td>
<td>Tracheostomy/laryngectomy tube, stainless steel or equal (sterilizable and reusable), each</td>
<td>Trach/laryn tube stainless</td>
</tr>
<tr class="odd">
<td>A7523</td>
<td>0010</td>
<td>3</td>
<td>Tracheostomy shower protector, each</td>
<td>Tracheostomy shower protect</td>
</tr>
<tr class="even">
<td>A7524</td>
<td>0010</td>
<td>3</td>
<td>Tracheostoma stent/stud/button, each</td>
<td>Tracheostoma stent/stud/bttn</td>
</tr>
<tr class="odd">
<td>A7525</td>
<td>0010</td>
<td>3</td>
<td>Tracheostomy mask, each</td>
<td>Tracheostomy mask</td>
</tr>
<tr class="even">
<td>A7526</td>
<td>0010</td>
<td>3</td>
<td>Tracheostomy tube collar/holder, each</td>
<td>Tracheostomy tube collar</td>
</tr>
<tr class="odd">
<td>A7527</td>
<td>0010</td>
<td>3</td>
<td>Tracheostomy/laryngectomy tube plug/stop, each</td>
<td>Trach/laryn tube plug/stop</td>
</tr>
<tr class="even">
<td>A8000</td>
<td>0010</td>
<td>3</td>
<td>Helmet, protective, soft, prefabricated, includes all components and accessories</td>
<td>Soft protect helmet prefab</td>
</tr>
<tr class="odd">
<td>A8001</td>
<td>0010</td>
<td>3</td>
<td>Helmet, protective, hard, prefabricated, includes all components and accessories</td>
<td>Hard protect helmet prefab</td>
</tr>
<tr class="even">
<td>A8002</td>
<td>0010</td>
<td>3</td>
<td>Helmet, protective, soft, custom fabricated, includes all components and accessories</td>
<td>Soft protect helmet custom</td>
</tr>
<tr class="odd">
<td>A8003</td>
<td>0010</td>
<td>3</td>
<td>Helmet, protective, hard, custom fabricated, includes all components and accessories</td>
<td>Hard protect helmet custom</td>
</tr>
<tr class="even">
<td>A8004</td>
<td>0010</td>
<td>3</td>
<td>Soft interface for helmet, replacement only</td>
<td>Repl soft interface, helmet</td>
</tr>
<tr class="odd">
<td>A9150</td>
<td>0010</td>
<td>3</td>
<td>Non-prescription drugs</td>
<td>Misc/exper non-prescript dru</td>
</tr>
<tr class="even">
<td>A9152</td>
<td>0010</td>
<td>3</td>
<td>Single vitamin/mineral/trace element, oral, per dose, not otherwise specified</td>
<td>Single vitamin nos</td>
</tr>
<tr class="odd">
<td>A9153</td>
<td>0010</td>
<td>3</td>
<td>Multiple vitamins, with or without minerals and trace elements, oral, per dose, not otherwise specified</td>
<td>Multi-vitamin nos</td>
</tr>
<tr class="even">
<td>A9155</td>
<td>0010</td>
<td>3</td>
<td>Artificial saliva, 30 ml</td>
<td>Artificial saliva</td>
</tr>
<tr class="odd">
<td>A9180</td>
<td>0010</td>
<td>3</td>
<td>Pediculosis (lice infestation) treatment, topical, for administration by patient/caretaker</td>
<td>Lice treatment, topical</td>
</tr>
<tr class="even">
<td>A9270</td>
<td>0010</td>
<td>3</td>
<td>Non-covered item or service</td>
<td>Non-covered item or service</td>
</tr>
<tr class="odd">
<td>A9272</td>
<td>0010</td>
<td>3</td>
<td>Wound suction, disposable, includes dressing, all accessories and components, any type, each</td>
<td>Disp wound suct, drsg/access</td>
</tr>
<tr class="even">
<td>A9273</td>
<td>0010</td>
<td>3</td>
<td>Cold or hot fluid bottle, ice cap or collar, heat and/or cold wrap, any type</td>
<td>Hot/cold botle/cap/col/wrap</td>
</tr>
<tr class="odd">
<td>A9274</td>
<td>0010</td>
<td>3</td>
<td>External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories</td>
<td>Ext amb insulin delivery sys</td>
</tr>
<tr class="even">
<td>A9275</td>
<td>0010</td>
<td>3</td>
<td>Home glucose disposable monitor, includes test strips</td>
<td>Disp home glucose monitor</td>
</tr>
<tr class="odd">
<td>A9276</td>
<td>0010</td>
<td>3</td>
<td>Sensor; invasive (e.g., subcutaneous), disposable, for use with interstitial continuous glucose monitoring system, one unit = 1 day supply</td>
<td>Disposable sensor, cgm sys</td>
</tr>
<tr class="even">
<td>A9277</td>
<td>0010</td>
<td>3</td>
<td>Transmitter; external, for use with interstitial continuous glucose monitoring system</td>
<td>External transmitter, cgm</td>
</tr>
<tr class="odd">
<td>A9278</td>
<td>0010</td>
<td>3</td>
<td>Receiver (monitor); external, for use with interstitial continuous glucose monitoring system</td>
<td>External receiver, cgm sys</td>
</tr>
<tr class="even">
<td>A9279</td>
<td>0010</td>
<td>3</td>
<td>Monitoring feature/device, stand-alone or integrated, any type, includes all accessories, components and electronics, not otherwise classified</td>
<td>Monitoring feature/devicenoc</td>
</tr>
<tr class="odd">
<td>A9280</td>
<td>0010</td>
<td>3</td>
<td>Alert or alarm device, not otherwise classified</td>
<td>Alert device, noc</td>
</tr>
<tr class="even">
<td>A9281</td>
<td>0010</td>
<td>3</td>
<td>Reaching/grabbing device, any type, any length, each</td>
<td>Reaching/grabbing device</td>
</tr>
<tr class="odd">
<td>A9282</td>
<td>0010</td>
<td>3</td>
<td>Wig, any type, each</td>
<td>Wig any type</td>
</tr>
<tr class="even">
<td>A9283</td>
<td>0010</td>
<td>3</td>
<td>Foot pressure off loading/supportive device, any type, each</td>
<td>Foot press off load supp dev</td>
</tr>
<tr class="odd">
<td>A9284</td>
<td>0010</td>
<td>3</td>
<td>Spirometer, non-electronic, includes all accessories</td>
<td>Non-electronic spirometer</td>
</tr>
<tr class="even">
<td>A9285</td>
<td>0010</td>
<td>3</td>
<td>Inversion/eversion correction device</td>
<td>Inversion eversion cor devic</td>
</tr>
<tr class="odd">
<td>A9286</td>
<td>0010</td>
<td>3</td>
<td>Hygienic item or device, disposable or non-disposable, any type, each</td>
<td>Any hygienic item, device</td>
</tr>
<tr class="even">
<td>A9300</td>
<td>0010</td>
<td>3</td>
<td>Exercise equipment</td>
<td>Exercise equipment</td>
</tr>
<tr class="odd">
<td>A9500</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m sestamibi, diagnostic, per study dose</td>
<td>Tc99m sestamibi</td>
</tr>
<tr class="even">
<td>A9501</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m teboroxime, diagnostic, per study dose</td>
<td>Technetium tc-99m teboroxime</td>
</tr>
<tr class="odd">
<td>A9502</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m tetrofosmin, diagnostic, per study dose</td>
<td>Tc99m tetrofosmin</td>
</tr>
<tr class="even">
<td>A9503</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries</td>
<td>Tc99m medronate</td>
</tr>
<tr class="odd">
<td>A9504</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries</td>
<td>Tc99m apcitide</td>
</tr>
<tr class="even">
<td>A9505</td>
<td>0010</td>
<td>3</td>
<td>Thallium tl-201 thallous chloride, diagnostic, per millicurie</td>
<td>Tl201 thallium</td>
</tr>
<tr class="odd">
<td>A9507</td>
<td>0010</td>
<td>3</td>
<td>Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries</td>
<td>In111 capromab</td>
</tr>
<tr class="even">
<td>A9508</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie</td>
<td>I131 iodobenguate, dx</td>
</tr>
<tr class="odd">
<td>A9509</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-123 sodium iodide, diagnostic, per millicurie</td>
<td>Iodine i-123 sod iodide mil</td>
</tr>
<tr class="even">
<td>A9510</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries</td>
<td>Tc99m disofenin</td>
</tr>
<tr class="odd">
<td>A9512</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m pertechnetate, diagnostic, per millicurie</td>
<td>Tc99m pertechnetate</td>
</tr>
<tr class="even">
<td>A9513</td>
<td>0010</td>
<td>3</td>
<td>Lutetium lu 177, dotatate, therapeutic, 1 millicurie</td>
<td>Lutetium lu 177 dotatat ther</td>
</tr>
<tr class="odd">
<td>A9515</td>
<td>0010</td>
<td>3</td>
<td>Choline c-11, diagnostic, per study dose up to 20 millicuries</td>
<td>Choline c-11</td>
</tr>
<tr class="even">
<td>A9516</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-123 sodium iodide, diagnostic, per 100 microcuries, up to 999 microcuries</td>
<td>Iodine i-123 sod iodide mic</td>
</tr>
<tr class="odd">
<td>A9517</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie</td>
<td>I131 iodide cap, rx</td>
</tr>
<tr class="even">
<td>A9520</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuries</td>
<td>Tc99 tilmanocept diag 0.5mci</td>
</tr>
<tr class="odd">
<td>A9521</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m exametazime, diagnostic, per study dose, up to 25 millicuries</td>
<td>Tc99m exametazime</td>
</tr>
<tr class="even">
<td>A9524</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-131 iodinated serum albumin, diagnostic, per 5 microcuries</td>
<td>I131 serum albumin, dx</td>
</tr>
<tr class="odd">
<td>A9526</td>
<td>0010</td>
<td>3</td>
<td>Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries</td>
<td>Nitrogen n-13 ammonia</td>
</tr>
<tr class="even">
<td>A9527</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-125, sodium iodide solution, therapeutic, per millicurie</td>
<td>Iodine i-125 sodium iodide</td>
</tr>
<tr class="odd">
<td>A9528</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-131 sodium iodide capsule(s), diagnostic, per millicurie</td>
<td>Iodine i-131 iodide cap, dx</td>
</tr>
<tr class="even">
<td>A9529</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-131 sodium iodide solution, diagnostic, per millicurie</td>
<td>I131 iodide sol, dx</td>
</tr>
<tr class="odd">
<td>A9530</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-131 sodium iodide solution, therapeutic, per millicurie</td>
<td>I131 iodide sol, rx</td>
</tr>
<tr class="even">
<td>A9531</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-131 sodium iodide, diagnostic, per microcurie (up to 100 microcuries)</td>
<td>I131 max 100uci</td>
</tr>
<tr class="odd">
<td>A9532</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-125 serum albumin, diagnostic, per 5 microcuries</td>
<td>I125 serum albumin, dx</td>
</tr>
<tr class="even">
<td>A9536</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m depreotide, diagnostic, per study dose, up to 35 millicuries</td>
<td>Tc99m depreotide</td>
</tr>
<tr class="odd">
<td>A9537</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries</td>
<td>Tc99m mebrofenin</td>
</tr>
<tr class="even">
<td>A9538</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries</td>
<td>Tc99m pyrophosphate</td>
</tr>
<tr class="odd">
<td>A9539</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries</td>
<td>Tc99m pentetate</td>
</tr>
<tr class="even">
<td>A9540</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries</td>
<td>Tc99m maa</td>
</tr>
<tr class="odd">
<td>A9541</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries</td>
<td>Tc99m sulfur colloid</td>
</tr>
<tr class="even">
<td>A9542</td>
<td>0010</td>
<td>3</td>
<td>Indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries</td>
<td>In111 ibritumomab, dx</td>
</tr>
<tr class="odd">
<td>A9543</td>
<td>0010</td>
<td>3</td>
<td>Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries</td>
<td>Y90 ibritumomab, rx</td>
</tr>
<tr class="even">
<td>A9544</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-131 tositumomab, diagnostic, per study dose</td>
<td>I131 tositumomab, dx</td>
</tr>
<tr class="odd">
<td>A9545</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-131 tositumomab, therapeutic, per treatment dose</td>
<td>I131 tositumomab, rx</td>
</tr>
<tr class="even">
<td>A9546</td>
<td>0010</td>
<td>3</td>
<td>Cobalt co-57/58, cyanocobalamin, diagnostic, per study dose, up to 1 microcurie</td>
<td>Co57/58</td>
</tr>
<tr class="odd">
<td>A9547</td>
<td>0010</td>
<td>3</td>
<td>Indium in-111 oxyquinoline, diagnostic, per 0.5 millicurie</td>
<td>In111 oxyquinoline</td>
</tr>
<tr class="even">
<td>A9548</td>
<td>0010</td>
<td>3</td>
<td>Indium in-111 pentetate, diagnostic, per 0.5 millicurie</td>
<td>In111 pentetate</td>
</tr>
<tr class="odd">
<td>A9550</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m sodium gluceptate, diagnostic, per study dose, up to 25 millicurie</td>
<td>Tc99m gluceptate</td>
</tr>
<tr class="even">
<td>A9551</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m succimer, diagnostic, per study dose, up to 10 millicuries</td>
<td>Tc99m succimer</td>
</tr>
<tr class="odd">
<td>A9552</td>
<td>0010</td>
<td>3</td>
<td>Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries</td>
<td>F18 fdg</td>
</tr>
<tr class="even">
<td>A9553</td>
<td>0010</td>
<td>3</td>
<td>Chromium cr-51 sodium chromate, diagnostic, per study dose, up to 250 microcuries</td>
<td>Cr51 chromate</td>
</tr>
<tr class="odd">
<td>A9554</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-125 sodium iothalamate, diagnostic, per study dose, up to 10 microcuries</td>
<td>I125 iothalamate, dx</td>
</tr>
<tr class="even">
<td>A9555</td>
<td>0010</td>
<td>3</td>
<td>Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries</td>
<td>Rb82 rubidium</td>
</tr>
<tr class="odd">
<td>A9556</td>
<td>0010</td>
<td>3</td>
<td>Gallium ga-67 citrate, diagnostic, per millicurie</td>
<td>Ga67 gallium</td>
</tr>
<tr class="even">
<td>A9557</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m bicisate, diagnostic, per study dose, up to 25 millicuries</td>
<td>Tc99m bicisate</td>
</tr>
<tr class="odd">
<td>A9558</td>
<td>0010</td>
<td>3</td>
<td>Xenon xe-133 gas, diagnostic, per 10 millicuries</td>
<td>Xe133 xenon 10mci</td>
</tr>
<tr class="even">
<td>A9559</td>
<td>0010</td>
<td>3</td>
<td>Cobalt co-57 cyanocobalamin, oral, diagnostic, per study dose, up to 1 microcurie</td>
<td>Co57 cyano</td>
</tr>
<tr class="odd">
<td>A9560</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries</td>
<td>Tc99m labeled rbc</td>
</tr>
<tr class="even">
<td>A9561</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries</td>
<td>Tc99m oxidronate</td>
</tr>
<tr class="odd">
<td>A9562</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries</td>
<td>Tc99m mertiatide</td>
</tr>
<tr class="even">
<td>A9563</td>
<td>0010</td>
<td>3</td>
<td>Sodium phosphate p-32, therapeutic, per millicurie</td>
<td>P32 na phosphate</td>
</tr>
<tr class="odd">
<td>A9564</td>
<td>0010</td>
<td>3</td>
<td>Chromic phosphate p-32 suspension, therapeutic, per millicurie</td>
<td>P32 chromic phosphate</td>
</tr>
<tr class="even">
<td>A9566</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m fanolesomab, diagnostic, per study dose, up to 25 millicuries</td>
<td>Tc99m fanolesomab</td>
</tr>
<tr class="odd">
<td>A9567</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries</td>
<td>Technetium tc-99m aerosol</td>
</tr>
<tr class="even">
<td>A9568</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuries</td>
<td>Technetium tc99m arcitumomab</td>
</tr>
<tr class="odd">
<td>A9569</td>
<td>0010</td>
<td>3</td>
<td>Technetium tc-99m exametazime labeled autologous white blood cells, diagnostic, per study dose</td>
<td>Technetium tc-99m auto wbc</td>
</tr>
<tr class="even">
<td>A9570</td>
<td>0010</td>
<td>3</td>
<td>Indium in-111 labeled autologous white blood cells, diagnostic, per study dose</td>
<td>Indium in-111 auto wbc</td>
</tr>
<tr class="odd">
<td>A9571</td>
<td>0010</td>
<td>3</td>
<td>Indium in-111 labeled autologous platelets, diagnostic, per study dose</td>
<td>Indium in-111 auto platelet</td>
</tr>
<tr class="even">
<td>A9572</td>
<td>0010</td>
<td>3</td>
<td>Indium in-111 pentetreotide, diagnostic, per study dose, up to 6 millicuries</td>
<td>Indium in-111 pentetreotide</td>
</tr>
<tr class="odd">
<td>A9575</td>
<td>0010</td>
<td>3</td>
<td>Injection, gadoterate meglumine, 0.1 ml</td>
<td>Inj gadoterate meglumi 0.1ml</td>
</tr>
<tr class="even">
<td>A9576</td>
<td>0010</td>
<td>3</td>
<td>Injection, gadoteridol, (prohance multipack), per ml</td>
<td>Inj prohance multipack</td>
</tr>
<tr class="odd">
<td>A9577</td>
<td>0010</td>
<td>3</td>
<td>Injection, gadobenate dimeglumine (multihance), per ml</td>
<td>Inj multihance</td>
</tr>
<tr class="even">
<td>A9578</td>
<td>0010</td>
<td>3</td>
<td>Injection, gadobenate dimeglumine (multihance multipack), per ml</td>
<td>Inj multihance multipack</td>
</tr>
<tr class="odd">
<td>A9579</td>
<td>0010</td>
<td>3</td>
<td>Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml</td>
<td>Gad-base mr contrast nos,1ml</td>
</tr>
<tr class="even">
<td>A9580</td>
<td>0010</td>
<td>3</td>
<td>Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries</td>
<td>Sodium fluoride f-18</td>
</tr>
<tr class="odd">
<td>A9581</td>
<td>0010</td>
<td>3</td>
<td>Injection, gadoxetate disodium, 1 ml</td>
<td>Gadoxetate disodium inj</td>
</tr>
<tr class="even">
<td>A9582</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries</td>
<td>Iodine i-123 iobenguane</td>
</tr>
<tr class="odd">
<td>A9583</td>
<td>0010</td>
<td>3</td>
<td>Injection, gadofosveset trisodium, 1 ml</td>
<td>Gadofosveset trisodium inj</td>
</tr>
<tr class="even">
<td>A9584</td>
<td>0010</td>
<td>3</td>
<td>Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries</td>
<td>Iodine i-123 ioflupane</td>
</tr>
<tr class="odd">
<td>A9585</td>
<td>0010</td>
<td>3</td>
<td>Injection, gadobutrol, 0.1 ml</td>
<td>Gadobutrol injection</td>
</tr>
<tr class="even">
<td>A9586</td>
<td>0010</td>
<td>3</td>
<td>Florbetapir f18, diagnostic, per study dose, up to 10 millicuries</td>
<td>Florbetapir f18</td>
</tr>
<tr class="odd">
<td>A9587</td>
<td>0010</td>
<td>3</td>
<td>Gallium ga-68, dotatate, diagnostic, 0.1 millicurie</td>
<td>Gallium ga-68</td>
</tr>
<tr class="even">
<td>A9588</td>
<td>0010</td>
<td>3</td>
<td>Fluciclovine f-18, diagnostic, 1 millicurie</td>
<td>Fluciclovine f-18</td>
</tr>
<tr class="odd">
<td>A9589</td>
<td>0010</td>
<td>3</td>
<td>Instillation, hexaminolevulinate hydrochloride, 100 mg</td>
<td>Insti hexaminolevulinate hcl</td>
</tr>
<tr class="even">
<td>A9590</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-131, iobenguane, 1 millicurie</td>
<td>Iodine i-131 iobenguane 1mci</td>
</tr>
<tr class="odd">
<td>A9597</td>
<td>0010</td>
<td>3</td>
<td>Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified</td>
<td>Pet, dx, for tumor id, noc</td>
</tr>
<tr class="even">
<td>A9598</td>
<td>0010</td>
<td>3</td>
<td>Positron emission tomography radiopharmaceutical, diagnostic, for non-tumor identification, not otherwise classified</td>
<td>Pet dx for non-tumor id, noc</td>
</tr>
<tr class="odd">
<td>A9599</td>
<td>0010</td>
<td>3</td>
<td>Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified</td>
<td>Radioph dx b amyloid pet nos</td>
</tr>
<tr class="even">
<td>A9600</td>
<td>0010</td>
<td>3</td>
<td>Strontium sr-89 chloride, therapeutic, per millicurie</td>
<td>Sr89 strontium</td>
</tr>
<tr class="odd">
<td>A9604</td>
<td>0010</td>
<td>3</td>
<td>Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries</td>
<td>Sm 153 lexidronam</td>
</tr>
<tr class="even">
<td>A9606</td>
<td>0010</td>
<td>3</td>
<td>Radium ra-223 dichloride, therapeutic, per microcurie</td>
<td>Radium ra223 dichloride ther</td>
</tr>
<tr class="odd">
<td>A9698</td>
<td>0010</td>
<td>3</td>
<td>Non-radioactive contrast imaging material, not otherwise classified, per study</td>
<td>Non-rad contrast materialnoc</td>
</tr>
<tr class="even">
<td>A9699</td>
<td>0010</td>
<td>3</td>
<td>Radiopharmaceutical, therapeutic, not otherwise classified</td>
<td>Radiopharm rx agent noc</td>
</tr>
<tr class="odd">
<td>A9700</td>
<td>0010</td>
<td>3</td>
<td>Supply of injectable contrast material for use in echocardiography, per study</td>
<td>Echocardiography contrast</td>
</tr>
<tr class="even">
<td>A9900</td>
<td>0010</td>
<td>3</td>
<td>Miscellaneous dme supply, accessory, and/or service component of another hcpcs code</td>
<td>Supply/accessory/service</td>
</tr>
<tr class="odd">
<td>A9901</td>
<td>0010</td>
<td>3</td>
<td>Dme delivery, set up, and/or dispensing service component of another hcpcs code</td>
<td>Delivery/set up/dispensing</td>
</tr>
<tr class="even">
<td>A9999</td>
<td>0010</td>
<td>3</td>
<td>Miscellaneous dme supply or accessory, not otherwise specified</td>
<td>Dme supply or accessory, nos</td>
</tr>
</tbody>
</table>
</div>
<div id="b-series-enteral-and-perenteral-therapy-b4000-b9999" class="section level2">
<h2>B Series: Enteral and Perenteral Therapy (B4000-B9999(</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>B4034</td>
<td>0010</td>
<td>3</td>
<td>Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape</td>
<td>Enter feed supkit syr by day</td>
</tr>
<tr class="even">
<td>B4035</td>
<td>0010</td>
<td>3</td>
<td>Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape</td>
<td>Enteral feed supp pump per d</td>
</tr>
<tr class="odd">
<td>B4036</td>
<td>0010</td>
<td>3</td>
<td>Enteral feeding supply kit; gravity fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape</td>
<td>Enteral feed sup kit grav by</td>
</tr>
<tr class="even">
<td>B4081</td>
<td>0010</td>
<td>3</td>
<td>Nasogastric tubing with stylet</td>
<td>Enteral ng tubing w/ stylet</td>
</tr>
<tr class="odd">
<td>B4082</td>
<td>0010</td>
<td>3</td>
<td>Nasogastric tubing without stylet</td>
<td>Enteral ng tubing w/o stylet</td>
</tr>
<tr class="even">
<td>B4083</td>
<td>0010</td>
<td>3</td>
<td>Stomach tube - levine type</td>
<td>Enteral stomach tube levine</td>
</tr>
<tr class="odd">
<td>B4087</td>
<td>0010</td>
<td>3</td>
<td>Gastrostomy/jejunostomy tube, standard, any material, any type, each</td>
<td>Gastro/jejuno tube, std</td>
</tr>
<tr class="even">
<td>B4088</td>
<td>0010</td>
<td>3</td>
<td>Gastrostomy/jejunostomy tube, low-profile, any material, any type, each</td>
<td>Gastro/jejuno tube, low-pro</td>
</tr>
<tr class="odd">
<td>B4100</td>
<td>0010</td>
<td>3</td>
<td>Food thickener, administered orally, per ounce</td>
<td>Food thickener oral</td>
</tr>
<tr class="even">
<td>B4102</td>
<td>0010</td>
<td>3</td>
<td>Enteral formula, for adults, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit</td>
<td>Ef adult fluids and electro</td>
</tr>
<tr class="odd">
<td>B4103</td>
<td>0010</td>
<td>3</td>
<td>Enteral formula, for pediatrics, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit</td>
<td>Ef ped fluid and electrolyte</td>
</tr>
<tr class="even">
<td>B4104</td>
<td>0010</td>
<td>3</td>
<td>Additive for enteral formula (e.g., fiber)</td>
<td>Additive for enteral formula</td>
</tr>
<tr class="odd">
<td>B4105</td>
<td>0010</td>
<td>3</td>
<td>In-line cartridge containing digestive enzyme(s) for enteral feeding, each</td>
<td>Enzyme cartridge enteral nut</td>
</tr>
<tr class="even">
<td>B4149</td>
<td>0010</td>
<td>3</td>
<td>Enteral formula, manufactured blenderized natural foods with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit</td>
<td>Ef blenderized foods</td>
</tr>
<tr class="odd">
<td>B4150</td>
<td>0010</td>
<td>3</td>
<td>Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit</td>
<td>Ef complet w/intact nutrient</td>
</tr>
<tr class="even">
<td>B4152</td>
<td>0010</td>
<td>3</td>
<td>Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit</td>
<td>Ef calorie dense&gt;/=1.5kcal</td>
</tr>
<tr class="odd">
<td>B4153</td>
<td>0010</td>
<td>3</td>
<td>Enteral formula, nutritionally complete, hydrolyzed proteins (amino acids and peptide chain), includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit</td>
<td>Ef hydrolyzed/amino acids</td>
</tr>
<tr class="even">
<td>B4154</td>
<td>0010</td>
<td>3</td>
<td>Enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit</td>
<td>Ef spec metabolic noninherit</td>
</tr>
<tr class="odd">
<td>B4155</td>
<td>0010</td>
<td>3</td>
<td>Enteral formula, nutritionally incomplete/modular nutrients, includes specific nutrients, carbohydrates (e.g., glucose polymers), proteins/amino acids (e.g., glutamine, arginine), fat (e.g., medium chain triglycerides) or combination, administered through an enteral feeding tube, 100 calories = 1 unit</td>
<td>Ef incomplete/modular</td>
</tr>
<tr class="even">
<td>B4157</td>
<td>0010</td>
<td>3</td>
<td>Enteral formula, nutritionally complete, for special metabolic needs for inherited disease of metabolism, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit</td>
<td>Ef special metabolic inherit</td>
</tr>
<tr class="odd">
<td>B4158</td>
<td>0010</td>
<td>3</td>
<td>Enteral formula, for pediatrics, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber and/or iron, administered through an enteral feeding tube, 100 calories = 1 unit</td>
<td>Ef ped complete intact nut</td>
</tr>
<tr class="even">
<td>B4159</td>
<td>0010</td>
<td>3</td>
<td>Enteral formula, for pediatrics, nutritionally complete soy based with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber and/or iron, administered through an enteral feeding tube, 100 calories = 1 unit</td>
<td>Ef ped complete soy based</td>
</tr>
<tr class="odd">
<td>B4160</td>
<td>0010</td>
<td>3</td>
<td>Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit</td>
<td>Ef ped caloric dense&gt;/=0.7kc</td>
</tr>
<tr class="even">
<td>B4161</td>
<td>0010</td>
<td>3</td>
<td>Enteral formula, for pediatrics, hydrolyzed/amino acids and peptide chain proteins, includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit</td>
<td>Ef ped hydrolyzed/amino acid</td>
</tr>
<tr class="odd">
<td>B4162</td>
<td>0010</td>
<td>3</td>
<td>Enteral formula, for pediatrics, special metabolic needs for inherited disease of metabolism, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit</td>
<td>Ef ped specmetabolic inherit</td>
</tr>
<tr class="even">
<td>B4164</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition solution: carbohydrates (dextrose), 50% or less (500 ml = 1 unit) - home mix</td>
<td>Parenteral 50% dextrose solu</td>
</tr>
<tr class="odd">
<td>B4168</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition solution; amino acid, 3.5%, (500 ml = 1 unit) - home mix</td>
<td>Parenteral sol amino acid 3.</td>
</tr>
<tr class="even">
<td>B4172</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition solution; amino acid, 5.5% through 7%, (500 ml = 1 unit) - home mix</td>
<td>Parenteral sol amino acid 5.</td>
</tr>
<tr class="odd">
<td>B4176</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition solution; amino acid, 7% through 8.5%, (500 ml = 1 unit) - home mix</td>
<td>Parenteral sol amino acid 7-</td>
</tr>
<tr class="even">
<td>B4178</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition solution: amino acid, greater than 8.5% (500 ml = 1 unit) - home mix</td>
<td>Parenteral sol amino acid &gt;</td>
</tr>
<tr class="odd">
<td>B4180</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition solution; carbohydrates (dextrose), greater than 50% (500 ml = 1 unit) - home mix</td>
<td>Parenteral sol carb &gt; 50%</td>
</tr>
<tr class="even">
<td>B4185</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition solution, not otherwise specified, 10 grams lipids</td>
<td>Pn soln nos 10 grams lipids</td>
</tr>
<tr class="odd">
<td>B4187</td>
<td>0010</td>
<td>3</td>
<td>Omegaven, 10 grams lipids</td>
<td>Omegaven, 10 grams lipids</td>
</tr>
<tr class="even">
<td>B4189</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 10 to 51 grams of protein - premix</td>
<td>Parenteral sol amino acid &amp;</td>
</tr>
<tr class="odd">
<td>B4193</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 52 to 73 grams of protein - premix</td>
<td>Parenteral sol 52-73 gm prot</td>
</tr>
<tr class="even">
<td>B4197</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, 74 to 100 grams of protein - premix</td>
<td>Parenteral sol 74-100 gm pro</td>
</tr>
<tr class="odd">
<td>B4199</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, over 100 grams of protein - premix</td>
<td>Parenteral sol &gt; 100gm prote</td>
</tr>
<tr class="even">
<td>B4216</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition; additives (vitamins, trace elements, heparin, electrolytes), home mix, per day</td>
<td>Parenteral nutrition additiv</td>
</tr>
<tr class="odd">
<td>B4220</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition supply kit; premix, per day</td>
<td>Parenteral supply kit premix</td>
</tr>
<tr class="even">
<td>B4222</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition supply kit; home mix, per day</td>
<td>Parenteral supply kit homemi</td>
</tr>
<tr class="odd">
<td>B4224</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition administration kit, per day</td>
<td>Parenteral administration ki</td>
</tr>
<tr class="even">
<td>B5000</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, renal-aminosyn-rf, nephramine, renamine-premix</td>
<td>Parenteral sol renal-amirosy</td>
</tr>
<tr class="odd">
<td>B5100</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, hepatic, hepatamine-premix</td>
<td>Parenteral solution hepatic</td>
</tr>
<tr class="even">
<td>B5200</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, stress-branch chain amino acids-freamine-hbc-premix</td>
<td>Parenteral sol hepatic fream</td>
</tr>
<tr class="odd">
<td>B9000</td>
<td>0010</td>
<td>3</td>
<td>Enteral nutrition infusion pump - without alarm</td>
<td>Enter infusion pump w/o alrm</td>
</tr>
<tr class="even">
<td>B9002</td>
<td>0010</td>
<td>3</td>
<td>Enteral nutrition infusion pump, any type</td>
<td>Enter nutr inf pump any type</td>
</tr>
<tr class="odd">
<td>B9004</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition infusion pump, portable</td>
<td>Parenteral infus pump portab</td>
</tr>
<tr class="even">
<td>B9006</td>
<td>0010</td>
<td>3</td>
<td>Parenteral nutrition infusion pump, stationary</td>
<td>Parenteral infus pump statio</td>
</tr>
<tr class="odd">
<td>B9998</td>
<td>0010</td>
<td>3</td>
<td>Noc for enteral supplies</td>
<td>Enteral supp not otherwise c</td>
</tr>
<tr class="even">
<td>B9999</td>
<td>0010</td>
<td>3</td>
<td>Noc for parenteral supplies</td>
<td>Parenteral supp not othrws c</td>
</tr>
</tbody>
</table>
</div>
<div id="c-series-outpatient-pps-c1000-c9999" class="section level2">
<h2>C Series: Outpatient PPS (C1000-C9999)</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>C1300</td>
<td>0010</td>
<td>3</td>
<td>Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval</td>
<td>Hyperbaric oxygen</td>
</tr>
<tr class="even">
<td>C1713</td>
<td>0010</td>
<td>3</td>
<td>Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)</td>
<td>Anchor/screw bn/bn,tis/bn</td>
</tr>
<tr class="odd">
<td>C1714</td>
<td>0010</td>
<td>3</td>
<td>Catheter, transluminal atherectomy, directional</td>
<td>Cath, trans atherectomy, dir</td>
</tr>
<tr class="even">
<td>C1715</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy needle</td>
<td>Brachytherapy needle</td>
</tr>
<tr class="odd">
<td>C1716</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, non-stranded, gold-198, per source</td>
<td>Brachytx, non-str, gold-198</td>
</tr>
<tr class="even">
<td>C1717</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, non-stranded, high dose rate iridium-192, per source</td>
<td>Brachytx, non-str,hdr ir-192</td>
</tr>
<tr class="odd">
<td>C1719</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source</td>
<td>Brachytx, ns, non-hdrir-192</td>
</tr>
<tr class="even">
<td>C1721</td>
<td>0010</td>
<td>3</td>
<td>Cardioverter-defibrillator, dual chamber (implantable)</td>
<td>Aicd, dual chamber</td>
</tr>
<tr class="odd">
<td>C1722</td>
<td>0010</td>
<td>3</td>
<td>Cardioverter-defibrillator, single chamber (implantable)</td>
<td>Aicd, single chamber</td>
</tr>
<tr class="even">
<td>C1724</td>
<td>0010</td>
<td>3</td>
<td>Catheter, transluminal atherectomy, rotational</td>
<td>Cath, trans atherec,rotation</td>
</tr>
<tr class="odd">
<td>C1725</td>
<td>0010</td>
<td>3</td>
<td>Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)</td>
<td>Cath, translumin non-laser</td>
</tr>
<tr class="even">
<td>C1726</td>
<td>0010</td>
<td>3</td>
<td>Catheter, balloon dilatation, non-vascular</td>
<td>Cath, bal dil, non-vascular</td>
</tr>
<tr class="odd">
<td>C1727</td>
<td>0010</td>
<td>3</td>
<td>Catheter, balloon tissue dissector, non-vascular (insertable)</td>
<td>Cath, bal tis dis, non-vas</td>
</tr>
<tr class="even">
<td>C1728</td>
<td>0010</td>
<td>3</td>
<td>Catheter, brachytherapy seed administration</td>
<td>Cath, brachytx seed adm</td>
</tr>
<tr class="odd">
<td>C1729</td>
<td>0010</td>
<td>3</td>
<td>Catheter, drainage</td>
<td>Cath, drainage</td>
</tr>
<tr class="even">
<td>C1730</td>
<td>0010</td>
<td>3</td>
<td>Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)</td>
<td>Cath, ep, 19 or few elect</td>
</tr>
<tr class="odd">
<td>C1731</td>
<td>0010</td>
<td>3</td>
<td>Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes)</td>
<td>Cath, ep, 20 or more elec</td>
</tr>
<tr class="even">
<td>C1732</td>
<td>0010</td>
<td>3</td>
<td>Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping</td>
<td>Cath, ep, diag/abl, 3d/vect</td>
</tr>
<tr class="odd">
<td>C1733</td>
<td>0010</td>
<td>3</td>
<td>Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip</td>
<td>Cath, ep, othr than cool-tip</td>
</tr>
<tr class="even">
<td>C1734</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable)</td>
<td>Orth/devic/drug bn/bn,tis/bn</td>
</tr>
<tr class="odd">
<td>C1749</td>
<td>0010</td>
<td>3</td>
<td>Endoscope, retrograde imaging/illumination colonoscope device (implantable)</td>
<td>Endo, colon, retro imaging</td>
</tr>
<tr class="even">
<td>C1750</td>
<td>0010</td>
<td>3</td>
<td>Catheter, hemodialysis/peritoneal, long-term</td>
<td>Cath, hemodialysis,long-term</td>
</tr>
<tr class="odd">
<td>C1751</td>
<td>0010</td>
<td>3</td>
<td>Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)</td>
<td>Cath, inf, per/cent/midline</td>
</tr>
<tr class="even">
<td>C1752</td>
<td>0010</td>
<td>3</td>
<td>Catheter, hemodialysis/peritoneal, short-term</td>
<td>Cath,hemodialysis,short-term</td>
</tr>
<tr class="odd">
<td>C1753</td>
<td>0010</td>
<td>3</td>
<td>Catheter, intravascular ultrasound</td>
<td>Cath, intravas ultrasound</td>
</tr>
<tr class="even">
<td>C1754</td>
<td>0010</td>
<td>3</td>
<td>Catheter, intradiscal</td>
<td>Catheter, intradiscal</td>
</tr>
<tr class="odd">
<td>C1755</td>
<td>0010</td>
<td>3</td>
<td>Catheter, intraspinal</td>
<td>Catheter, intraspinal</td>
</tr>
<tr class="even">
<td>C1756</td>
<td>0010</td>
<td>3</td>
<td>Catheter, pacing, transesophageal</td>
<td>Cath, pacing, transesoph</td>
</tr>
<tr class="odd">
<td>C1757</td>
<td>0010</td>
<td>3</td>
<td>Catheter, thrombectomy/embolectomy</td>
<td>Cath, thrombectomy/embolect</td>
</tr>
<tr class="even">
<td>C1758</td>
<td>0010</td>
<td>3</td>
<td>Catheter, ureteral</td>
<td>Catheter, ureteral</td>
</tr>
<tr class="odd">
<td>C1759</td>
<td>0010</td>
<td>3</td>
<td>Catheter, intracardiac echocardiography</td>
<td>Cath, intra echocardiography</td>
</tr>
<tr class="even">
<td>C1760</td>
<td>0010</td>
<td>3</td>
<td>Closure device, vascular (implantable/insertable)</td>
<td>Closure dev, vasc</td>
</tr>
<tr class="odd">
<td>C1762</td>
<td>0010</td>
<td>3</td>
<td>Connective tissue, human (includes fascia lata)</td>
<td>Conn tiss, human(inc fascia)</td>
</tr>
<tr class="even">
<td>C1763</td>
<td>0010</td>
<td>3</td>
<td>Connective tissue, non-human (includes synthetic)</td>
<td>Conn tiss, non-human</td>
</tr>
<tr class="odd">
<td>C1764</td>
<td>0010</td>
<td>3</td>
<td>Event recorder, cardiac (implantable)</td>
<td>Event recorder, cardiac</td>
</tr>
<tr class="even">
<td>C1765</td>
<td>0010</td>
<td>3</td>
<td>Adhesion barrier</td>
<td>Adhesion barrier</td>
</tr>
<tr class="odd">
<td>C1766</td>
<td>0010</td>
<td>3</td>
<td>Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away</td>
<td>Intro/sheath,strble,non-peel</td>
</tr>
<tr class="even">
<td>C1767</td>
<td>0010</td>
<td>3</td>
<td>Generator, neurostimulator (implantable), non-rechargeable</td>
<td>Generator, neuro non-recharg</td>
</tr>
<tr class="odd">
<td>C1768</td>
<td>0010</td>
<td>3</td>
<td>Graft, vascular</td>
<td>Graft, vascular</td>
</tr>
<tr class="even">
<td>C1769</td>
<td>0010</td>
<td>3</td>
<td>Guide wire</td>
<td>Guide wire</td>
</tr>
<tr class="odd">
<td>C1770</td>
<td>0010</td>
<td>3</td>
<td>Imaging coil, magnetic resonance (insertable)</td>
<td>Imaging coil, mr, insertable</td>
</tr>
<tr class="even">
<td>C1771</td>
<td>0010</td>
<td>3</td>
<td>Repair device, urinary, incontinence, with sling graft</td>
<td>Rep dev, urinary, w/sling</td>
</tr>
<tr class="odd">
<td>C1772</td>
<td>0010</td>
<td>3</td>
<td>Infusion pump, programmable (implantable)</td>
<td>Infusion pump, programmable</td>
</tr>
<tr class="even">
<td>C1773</td>
<td>0010</td>
<td>3</td>
<td>Retrieval device, insertable (used to retrieve fractured medical devices)</td>
<td>Ret dev, insertable</td>
</tr>
<tr class="odd">
<td>C1776</td>
<td>0010</td>
<td>3</td>
<td>Joint device (implantable)</td>
<td>Joint device (implantable)</td>
</tr>
<tr class="even">
<td>C1777</td>
<td>0010</td>
<td>3</td>
<td>Lead, cardioverter-defibrillator, endocardial single coil (implantable)</td>
<td>Lead, aicd, endo single coil</td>
</tr>
<tr class="odd">
<td>C1778</td>
<td>0010</td>
<td>3</td>
<td>Lead, neurostimulator (implantable)</td>
<td>Lead, neurostimulator</td>
</tr>
<tr class="even">
<td>C1779</td>
<td>0010</td>
<td>3</td>
<td>Lead, pacemaker, transvenous vdd single pass</td>
<td>Lead, pmkr, transvenous vdd</td>
</tr>
<tr class="odd">
<td>C1780</td>
<td>0010</td>
<td>3</td>
<td>Lens, intraocular (new technology)</td>
<td>Lens, intraocular (new tech)</td>
</tr>
<tr class="even">
<td>C1781</td>
<td>0010</td>
<td>3</td>
<td>Mesh (implantable)</td>
<td>Mesh (implantable)</td>
</tr>
<tr class="odd">
<td>C1782</td>
<td>0010</td>
<td>3</td>
<td>Morcellator</td>
<td>Morcellator</td>
</tr>
<tr class="even">
<td>C1783</td>
<td>0010</td>
<td>3</td>
<td>Ocular implant, aqueous drainage assist device</td>
<td>Ocular imp, aqueous drain de</td>
</tr>
<tr class="odd">
<td>C1784</td>
<td>0010</td>
<td>3</td>
<td>Ocular device, intraoperative, detached retina</td>
<td>Ocular dev, intraop, det ret</td>
</tr>
<tr class="even">
<td>C1785</td>
<td>0010</td>
<td>3</td>
<td>Pacemaker, dual chamber, rate-responsive (implantable)</td>
<td>Pmkr, dual, rate-resp</td>
</tr>
<tr class="odd">
<td>C1786</td>
<td>0010</td>
<td>3</td>
<td>Pacemaker, single chamber, rate-responsive (implantable)</td>
<td>Pmkr, single, rate-resp</td>
</tr>
<tr class="even">
<td>C1787</td>
<td>0010</td>
<td>3</td>
<td>Patient programmer, neurostimulator</td>
<td>Patient progr, neurostim</td>
</tr>
<tr class="odd">
<td>C1788</td>
<td>0010</td>
<td>3</td>
<td>Port, indwelling (implantable)</td>
<td>Port, indwelling, imp</td>
</tr>
<tr class="even">
<td>C1789</td>
<td>0010</td>
<td>3</td>
<td>Prosthesis, breast (implantable)</td>
<td>Prosthesis, breast, imp</td>
</tr>
<tr class="odd">
<td>C1813</td>
<td>0010</td>
<td>3</td>
<td>Prosthesis, penile, inflatable</td>
<td>Prosthesis, penile, inflatab</td>
</tr>
<tr class="even">
<td>C1814</td>
<td>0010</td>
<td>3</td>
<td>Retinal tamponade device, silicone oil</td>
<td>Retinal tamp, silicone oil</td>
</tr>
<tr class="odd">
<td>C1815</td>
<td>0010</td>
<td>3</td>
<td>Prosthesis, urinary sphincter (implantable)</td>
<td>Pros, urinary sph, imp</td>
</tr>
<tr class="even">
<td>C1816</td>
<td>0010</td>
<td>3</td>
<td>Receiver and/or transmitter, neurostimulator (implantable)</td>
<td>Receiver/transmitter, neuro</td>
</tr>
<tr class="odd">
<td>C1817</td>
<td>0010</td>
<td>3</td>
<td>Septal defect implant system, intracardiac</td>
<td>Septal defect imp sys</td>
</tr>
<tr class="even">
<td>C1818</td>
<td>0010</td>
<td>3</td>
<td>Integrated keratoprosthesis</td>
<td>Integrated keratoprosthesis</td>
</tr>
<tr class="odd">
<td>C1819</td>
<td>0010</td>
<td>3</td>
<td>Surgical tissue localization and excision device (implantable)</td>
<td>Tissue localization-excision</td>
</tr>
<tr class="even">
<td>C1820</td>
<td>0010</td>
<td>3</td>
<td>Generator, neurostimulator (implantable), with rechargeable battery and charging system</td>
<td>Generator neuro rechg bat sy</td>
</tr>
<tr class="odd">
<td>C1821</td>
<td>0010</td>
<td>3</td>
<td>Interspinous process distraction device (implantable)</td>
<td>Interspinous implant</td>
</tr>
<tr class="even">
<td>C1822</td>
<td>0010</td>
<td>3</td>
<td>Generator, neurostimulator (implantable), high frequency, with rechargeable battery and charging system</td>
<td>Gen, neuro, hf, rechg bat</td>
</tr>
<tr class="odd">
<td>C1823</td>
<td>0010</td>
<td>3</td>
<td>Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads</td>
<td>Gen, neuro, trans sen/stim</td>
</tr>
<tr class="even">
<td>C1824</td>
<td>0010</td>
<td>3</td>
<td>Generator, cardiac contractility modulation (implantable)</td>
<td>Generator, ccm, implant</td>
</tr>
<tr class="odd">
<td>C1830</td>
<td>0010</td>
<td>3</td>
<td>Powered bone marrow biopsy needle</td>
<td>Power bone marrow bx needle</td>
</tr>
<tr class="even">
<td>C1839</td>
<td>0010</td>
<td>3</td>
<td>Iris prosthesis</td>
<td>Iris prosthesis</td>
</tr>
<tr class="odd">
<td>C1840</td>
<td>0010</td>
<td>3</td>
<td>Lens, intraocular (telescopic)</td>
<td>Telescopic intraocular lens</td>
</tr>
<tr class="even">
<td>C1841</td>
<td>0010</td>
<td>3</td>
<td>Retinal prosthesis, includes all internal and external components</td>
<td>Retinal prosth int/ext comp</td>
</tr>
<tr class="odd">
<td>C1842</td>
<td>0010</td>
<td>3</td>
<td>Retinal prosthesis, includes all internal and external components; add-on to c1841</td>
<td>Retinal prosth, add-on</td>
</tr>
<tr class="even">
<td>C1874</td>
<td>0010</td>
<td>3</td>
<td>Stent, coated/covered, with delivery system</td>
<td>Stent, coated/cov w/del sys</td>
</tr>
<tr class="odd">
<td>C1875</td>
<td>0010</td>
<td>3</td>
<td>Stent, coated/covered, without delivery system</td>
<td>Stent, coated/cov w/o del sy</td>
</tr>
<tr class="even">
<td>C1876</td>
<td>0010</td>
<td>3</td>
<td>Stent, non-coated/non-covered, with delivery system</td>
<td>Stent, non-coa/non-cov w/del</td>
</tr>
<tr class="odd">
<td>C1877</td>
<td>0010</td>
<td>3</td>
<td>Stent, non-coated/non-covered, without delivery system</td>
<td>Stent, non-coat/cov w/o del</td>
</tr>
<tr class="even">
<td>C1878</td>
<td>0010</td>
<td>3</td>
<td>Material for vocal cord medialization, synthetic (implantable)</td>
<td>Matrl for vocal cord</td>
</tr>
<tr class="odd">
<td>C1880</td>
<td>0010</td>
<td>3</td>
<td>Vena cava filter</td>
<td>Vena cava filter</td>
</tr>
<tr class="even">
<td>C1881</td>
<td>0010</td>
<td>3</td>
<td>Dialysis access system (implantable)</td>
<td>Dialysis access system</td>
</tr>
<tr class="odd">
<td>C1882</td>
<td>0010</td>
<td>3</td>
<td>Cardioverter-defibrillator, other than single or dual chamber (implantable)</td>
<td>Aicd, other than sing/dual</td>
</tr>
<tr class="even">
<td>C1883</td>
<td>0010</td>
<td>3</td>
<td>Adapter/extension, pacing lead or neurostimulator lead (implantable)</td>
<td>Adapt/ext, pacing/neuro lead</td>
</tr>
<tr class="odd">
<td>C1884</td>
<td>0010</td>
<td>3</td>
<td>Embolization protective system</td>
<td>Embolization protect syst</td>
</tr>
<tr class="even">
<td>C1885</td>
<td>0010</td>
<td>3</td>
<td>Catheter, transluminal angioplasty, laser</td>
<td>Cath, translumin angio laser</td>
</tr>
<tr class="odd">
<td>C1886</td>
<td>0010</td>
<td>3</td>
<td>Catheter, extravascular tissue ablation, any modality (insertable)</td>
<td>Catheter, ablation</td>
</tr>
<tr class="even">
<td>C1887</td>
<td>0010</td>
<td>3</td>
<td>Catheter, guiding (may include infusion/perfusion capability)</td>
<td>Catheter, guiding</td>
</tr>
<tr class="odd">
<td>C1888</td>
<td>0010</td>
<td>3</td>
<td>Catheter, ablation, non-cardiac, endovascular (implantable)</td>
<td>Endovas non-cardiac abl cath</td>
</tr>
<tr class="even">
<td>C1889</td>
<td>0010</td>
<td>3</td>
<td>Implantable/insertable device, not otherwise classified</td>
<td>Implant/insert device, noc</td>
</tr>
<tr class="odd">
<td>C1890</td>
<td>0010</td>
<td>3</td>
<td>No implantable/insertable device used with device-intensive procedures</td>
<td>No device w/dev-intensive px</td>
</tr>
<tr class="even">
<td>C1891</td>
<td>0010</td>
<td>3</td>
<td>Infusion pump, non-programmable, permanent (implantable)</td>
<td>Infusion pump,non-prog, perm</td>
</tr>
<tr class="odd">
<td>C1892</td>
<td>0010</td>
<td>3</td>
<td>Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away</td>
<td>Intro/sheath,fixed,peel-away</td>
</tr>
<tr class="even">
<td>C1893</td>
<td>0010</td>
<td>3</td>
<td>Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away</td>
<td>Intro/sheath, fixed,non-peel</td>
</tr>
<tr class="odd">
<td>C1894</td>
<td>0010</td>
<td>3</td>
<td>Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser</td>
<td>Intro/sheath, non-laser</td>
</tr>
<tr class="even">
<td>C1895</td>
<td>0010</td>
<td>3</td>
<td>Lead, cardioverter-defibrillator, endocardial dual coil (implantable)</td>
<td>Lead, aicd, endo dual coil</td>
</tr>
<tr class="odd">
<td>C1896</td>
<td>0010</td>
<td>3</td>
<td>Lead, cardioverter-defibrillator, other than endocardial single or dual coil (implantable)</td>
<td>Lead, aicd, non sing/dual</td>
</tr>
<tr class="even">
<td>C1897</td>
<td>0010</td>
<td>3</td>
<td>Lead, neurostimulator test kit (implantable)</td>
<td>Lead, neurostim test kit</td>
</tr>
<tr class="odd">
<td>C1898</td>
<td>0010</td>
<td>3</td>
<td>Lead, pacemaker, other than transvenous vdd single pass</td>
<td>Lead, pmkr, other than trans</td>
</tr>
<tr class="even">
<td>C1899</td>
<td>0010</td>
<td>3</td>
<td>Lead, pacemaker/cardioverter-defibrillator combination (implantable)</td>
<td>Lead, pmkr/aicd combination</td>
</tr>
<tr class="odd">
<td>C1900</td>
<td>0010</td>
<td>3</td>
<td>Lead, left ventricular coronary venous system</td>
<td>Lead, coronary venous</td>
</tr>
<tr class="even">
<td>C1982</td>
<td>0010</td>
<td>3</td>
<td>Catheter, pressure-generating, one-way valve, intermittently occlusive</td>
<td>Cath, pressure,valve-occlu</td>
</tr>
<tr class="odd">
<td>C2596</td>
<td>0010</td>
<td>3</td>
<td>Probe, image-guided, robotic, waterjet ablation</td>
<td>Probe, robotic, water-jet</td>
</tr>
<tr class="even">
<td>C2613</td>
<td>0010</td>
<td>3</td>
<td>Lung biopsy plug with delivery system</td>
<td>Lung bx plug w/del sys</td>
</tr>
<tr class="odd">
<td>C2614</td>
<td>0010</td>
<td>3</td>
<td>Probe, percutaneous lumbar discectomy</td>
<td>Probe, perc lumb disc</td>
</tr>
<tr class="even">
<td>C2615</td>
<td>0010</td>
<td>3</td>
<td>Sealant, pulmonary, liquid</td>
<td>Sealant, pulmonary, liquid</td>
</tr>
<tr class="odd">
<td>C2616</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, non-stranded, yttrium-90, per source</td>
<td>Brachytx, non-str,yttrium-90</td>
</tr>
<tr class="even">
<td>C2617</td>
<td>0010</td>
<td>3</td>
<td>Stent, non-coronary, temporary, without delivery system</td>
<td>Stent, non-cor, tem w/o del</td>
</tr>
<tr class="odd">
<td>C2618</td>
<td>0010</td>
<td>3</td>
<td>Probe/needle, cryoablation</td>
<td>Probe/needle, cryo</td>
</tr>
<tr class="even">
<td>C2619</td>
<td>0010</td>
<td>3</td>
<td>Pacemaker, dual chamber, non rate-responsive (implantable)</td>
<td>Pmkr, dual, non rate-resp</td>
</tr>
<tr class="odd">
<td>C2620</td>
<td>0010</td>
<td>3</td>
<td>Pacemaker, single chamber, non rate-responsive (implantable)</td>
<td>Pmkr, single, non rate-resp</td>
</tr>
<tr class="even">
<td>C2621</td>
<td>0010</td>
<td>3</td>
<td>Pacemaker, other than single or dual chamber (implantable)</td>
<td>Pmkr, other than sing/dual</td>
</tr>
<tr class="odd">
<td>C2622</td>
<td>0010</td>
<td>3</td>
<td>Prosthesis, penile, non-inflatable</td>
<td>Prosthesis, penile, non-inf</td>
</tr>
<tr class="even">
<td>C2623</td>
<td>0010</td>
<td>3</td>
<td>Catheter, transluminal angioplasty, drug-coated, non-laser</td>
<td>Cath, translumin, drug-coat</td>
</tr>
<tr class="odd">
<td>C2624</td>
<td>0010</td>
<td>3</td>
<td>Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components</td>
<td>Wireless pressure sensor</td>
</tr>
<tr class="even">
<td>C2625</td>
<td>0010</td>
<td>3</td>
<td>Stent, non-coronary, temporary, with delivery system</td>
<td>Stent, non-cor, tem w/del sy</td>
</tr>
<tr class="odd">
<td>C2626</td>
<td>0010</td>
<td>3</td>
<td>Infusion pump, non-programmable, temporary (implantable)</td>
<td>Infusion pump, non-prog,temp</td>
</tr>
<tr class="even">
<td>C2627</td>
<td>0010</td>
<td>3</td>
<td>Catheter, suprapubic/cystoscopic</td>
<td>Cath, suprapubic/cystoscopic</td>
</tr>
<tr class="odd">
<td>C2628</td>
<td>0010</td>
<td>3</td>
<td>Catheter, occlusion</td>
<td>Catheter, occlusion</td>
</tr>
<tr class="even">
<td>C2629</td>
<td>0010</td>
<td>3</td>
<td>Introducer/sheath, other than guiding, other than intracardiac electrophysiological, laser</td>
<td>Intro/sheath, laser</td>
</tr>
<tr class="odd">
<td>C2630</td>
<td>0010</td>
<td>3</td>
<td>Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, cool-tip</td>
<td>Cath, ep, cool-tip</td>
</tr>
<tr class="even">
<td>C2631</td>
<td>0010</td>
<td>3</td>
<td>Repair device, urinary, incontinence, without sling graft</td>
<td>Rep dev, urinary, w/o sling</td>
</tr>
<tr class="odd">
<td>C2634</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source</td>
<td>Brachytx, non-str, ha, i-125</td>
</tr>
<tr class="even">
<td>C2635</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source</td>
<td>Brachytx, non-str, ha, p-103</td>
</tr>
<tr class="odd">
<td>C2636</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy linear source, non-stranded, palladium-103, per 1 mm</td>
<td>Brachy linear, non-str,p-103</td>
</tr>
<tr class="even">
<td>C2637</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, non-stranded, ytterbium-169, per source</td>
<td>Brachy,non-str,ytterbium-169</td>
</tr>
<tr class="odd">
<td>C2638</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, stranded, iodine-125, per source</td>
<td>Brachytx, stranded, i-125</td>
</tr>
<tr class="even">
<td>C2639</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, non-stranded, iodine-125, per source</td>
<td>Brachytx, non-stranded,i-125</td>
</tr>
<tr class="odd">
<td>C2640</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, stranded, palladium-103, per source</td>
<td>Brachytx, stranded, p-103</td>
</tr>
<tr class="even">
<td>C2641</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, non-stranded, palladium-103, per source</td>
<td>Brachytx, non-stranded,p-103</td>
</tr>
<tr class="odd">
<td>C2642</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, stranded, cesium-131, per source</td>
<td>Brachytx, stranded, c-131</td>
</tr>
<tr class="even">
<td>C2643</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, non-stranded, cesium-131, per source</td>
<td>Brachytx, non-stranded,c-131</td>
</tr>
<tr class="odd">
<td>C2644</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, cesium-131 chloride solution, per millicurie</td>
<td>Brachytx cesium-131 chloride</td>
</tr>
<tr class="even">
<td>C2645</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy planar source, palladium-103, per square millimeter</td>
<td>Brachytx planar, p-103</td>
</tr>
<tr class="odd">
<td>C2698</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, stranded, not otherwise specified, per source</td>
<td>Brachytx, stranded, nos</td>
</tr>
<tr class="even">
<td>C2699</td>
<td>0010</td>
<td>3</td>
<td>Brachytherapy source, non-stranded, not otherwise specified, per source</td>
<td>Brachytx, non-stranded, nos</td>
</tr>
<tr class="odd">
<td>C5271</td>
<td>0010</td>
<td>3</td>
<td>Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area</td>
<td>Low cost skin substitute app</td>
</tr>
<tr class="even">
<td>C5272</td>
<td>0010</td>
<td>3</td>
<td>Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)</td>
<td>Low cost skin substitute app</td>
</tr>
<tr class="odd">
<td>C5273</td>
<td>0010</td>
<td>3</td>
<td>Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children</td>
<td>Low cost skin substitute app</td>
</tr>
<tr class="even">
<td>C5274</td>
<td>0010</td>
<td>3</td>
<td>Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)</td>
<td>Low cost skin substitute app</td>
</tr>
<tr class="odd">
<td>C5275</td>
<td>0010</td>
<td>3</td>
<td>Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area</td>
<td>Low cost skin substitute app</td>
</tr>
<tr class="even">
<td>C5276</td>
<td>0010</td>
<td>3</td>
<td>Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)</td>
<td>Low cost skin substitute app</td>
</tr>
<tr class="odd">
<td>C5277</td>
<td>0010</td>
<td>3</td>
<td>Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children</td>
<td>Low cost skin substitute app</td>
</tr>
<tr class="even">
<td>C5278</td>
<td>0010</td>
<td>3</td>
<td>Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)</td>
<td>Low cost skin substitute app</td>
</tr>
<tr class="odd">
<td>C8900</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography with contrast, abdomen</td>
<td>Mra w/cont, abd</td>
</tr>
<tr class="even">
<td>C8901</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography without contrast, abdomen</td>
<td>Mra w/o cont, abd</td>
</tr>
<tr class="odd">
<td>C8902</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography without contrast followed by with contrast, abdomen</td>
<td>Mra w/o fol w/cont, abd</td>
</tr>
<tr class="even">
<td>C8903</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance imaging with contrast, breast; unilateral</td>
<td>Mri w/cont, breast, uni</td>
</tr>
<tr class="odd">
<td>C8904</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance imaging without contrast, breast; unilateral</td>
<td>Mri w/o cont, breast, uni</td>
</tr>
<tr class="even">
<td>C8905</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral</td>
<td>Mri w/o fol w/cont, brst, un</td>
</tr>
<tr class="odd">
<td>C8906</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance imaging with contrast, breast; bilateral</td>
<td>Mri w/cont, breast, bi</td>
</tr>
<tr class="even">
<td>C8907</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance imaging without contrast, breast; bilateral</td>
<td>Mri w/o cont, breast, bi</td>
</tr>
<tr class="odd">
<td>C8908</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral</td>
<td>Mri w/o fol w/cont, breast,</td>
</tr>
<tr class="even">
<td>C8909</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography with contrast, chest (excluding myocardium)</td>
<td>Mra w/cont, chest</td>
</tr>
<tr class="odd">
<td>C8910</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography without contrast, chest (excluding myocardium)</td>
<td>Mra w/o cont, chest</td>
</tr>
<tr class="even">
<td>C8911</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium)</td>
<td>Mra w/o fol w/cont, chest</td>
</tr>
<tr class="odd">
<td>C8912</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography with contrast, lower extremity</td>
<td>Mra w/cont, lwr ext</td>
</tr>
<tr class="even">
<td>C8913</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography without contrast, lower extremity</td>
<td>Mra w/o cont, lwr ext</td>
</tr>
<tr class="odd">
<td>C8914</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography without contrast followed by with contrast, lower extremity</td>
<td>Mra w/o fol w/cont, lwr ext</td>
</tr>
<tr class="even">
<td>C8918</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography with contrast, pelvis</td>
<td>Mra w/cont, pelvis</td>
</tr>
<tr class="odd">
<td>C8919</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography without contrast, pelvis</td>
<td>Mra w/o cont, pelvis</td>
</tr>
<tr class="even">
<td>C8920</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography without contrast followed by with contrast, pelvis</td>
<td>Mra w/o fol w/cont, pelvis</td>
</tr>
<tr class="odd">
<td>C8921</td>
<td>0010</td>
<td>3</td>
<td>Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete</td>
<td>Tte w or w/o fol w/cont, com</td>
</tr>
<tr class="even">
<td>C8922</td>
<td>0010</td>
<td>3</td>
<td>Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study</td>
<td>Tte w or w/o fol w/cont, f/u</td>
</tr>
<tr class="odd">
<td>C8923</td>
<td>0010</td>
<td>3</td>
<td>Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography</td>
<td>2d tte w or w/o fol w/con,co</td>
</tr>
<tr class="even">
<td>C8924</td>
<td>0010</td>
<td>3</td>
<td>Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study</td>
<td>2d tte w or w/o fol w/con,fu</td>
</tr>
<tr class="odd">
<td>C8925</td>
<td>0010</td>
<td>3</td>
<td>Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report</td>
<td>2d tee w or w/o fol w/con,in</td>
</tr>
<tr class="even">
<td>C8926</td>
<td>0010</td>
<td>3</td>
<td>Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report</td>
<td>Tee w or w/o fol w/cont,cong</td>
</tr>
<tr class="odd">
<td>C8927</td>
<td>0010</td>
<td>3</td>
<td>Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis</td>
<td>Tee w or w/o fol w/cont, mon</td>
</tr>
<tr class="even">
<td>C8928</td>
<td>0010</td>
<td>3</td>
<td>Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report</td>
<td>Tte w or w/o fol w/con,stres</td>
</tr>
<tr class="odd">
<td>C8929</td>
<td>0010</td>
<td>3</td>
<td>Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography</td>
<td>Tte w or wo fol wcon,doppler</td>
</tr>
<tr class="even">
<td>C8930</td>
<td>0010</td>
<td>3</td>
<td>Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision</td>
<td>Tte w or w/o contr, cont ecg</td>
</tr>
<tr class="odd">
<td>C8931</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography with contrast, spinal canal and contents</td>
<td>Mra, w/dye, spinal canal</td>
</tr>
<tr class="even">
<td>C8932</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography without contrast, spinal canal and contents</td>
<td>Mra, w/o dye, spinal canal</td>
</tr>
<tr class="odd">
<td>C8933</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents</td>
<td>Mra, w/o&amp;w/dye, spinal canal</td>
</tr>
<tr class="even">
<td>C8934</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography with contrast, upper extremity</td>
<td>Mra, w/dye, upper extremity</td>
</tr>
<tr class="odd">
<td>C8935</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography without contrast, upper extremity</td>
<td>Mra, w/o dye, upper extr</td>
</tr>
<tr class="even">
<td>C8936</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance angiography without contrast followed by with contrast, upper extremity</td>
<td>Mra, w/o&amp;w/dye, upper extr</td>
</tr>
<tr class="odd">
<td>C8937</td>
<td>0010</td>
<td>3</td>
<td>Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)</td>
<td>Cad breast mri</td>
</tr>
<tr class="even">
<td>C8957</td>
<td>0010</td>
<td>3</td>
<td>Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump</td>
<td>Prolonged iv inf, req pump</td>
</tr>
<tr class="odd">
<td>C9014</td>
<td>0010</td>
<td>3</td>
<td>Injection, cerliponase alfa, 1 mg</td>
<td>Injection, cerliponase alfa</td>
</tr>
<tr class="even">
<td>C9015</td>
<td>0010</td>
<td>3</td>
<td>Injection, c-1 esterase inhibitor (human), haegarda, 10 units</td>
<td>C-1 esterase, haegarda</td>
</tr>
<tr class="odd">
<td>C9016</td>
<td>0010</td>
<td>3</td>
<td>Injection, triptorelin extended release, 3.75 mg</td>
<td>Inj, triptorelin ext rel</td>
</tr>
<tr class="even">
<td>C9021</td>
<td>0010</td>
<td>3</td>
<td>Injection, obinutuzumab, 10 mg</td>
<td>Injection, obinutuzumab</td>
</tr>
<tr class="odd">
<td>C9022</td>
<td>0010</td>
<td>3</td>
<td>Injection, elosulfase alfa, 1mg</td>
<td>Injection, elosulfase alfa</td>
</tr>
<tr class="even">
<td>C9023</td>
<td>0010</td>
<td>3</td>
<td>Injection, testosterone undecanoate, 1 mg</td>
<td>Inj testosterone undecanoate</td>
</tr>
<tr class="odd">
<td>C9024</td>
<td>0010</td>
<td>3</td>
<td>Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine</td>
<td>Inj, daunorubicin-cytarabine</td>
</tr>
<tr class="even">
<td>C9025</td>
<td>0010</td>
<td>3</td>
<td>Injection, ramucirumab, 5 mg</td>
<td>Injection, ramucirumab</td>
</tr>
<tr class="odd">
<td>C9026</td>
<td>0010</td>
<td>3</td>
<td>Injection, vedolizumab, 1 mg</td>
<td>Injection, vedolizumab</td>
</tr>
<tr class="even">
<td>C9027</td>
<td>0010</td>
<td>3</td>
<td>Injection, pembrolizumab, 1 mg</td>
<td>Injection, pembrolizumab</td>
</tr>
<tr class="odd">
<td>C9028</td>
<td>0010</td>
<td>3</td>
<td>Injection, inotuzumab ozogamicin, 0.1 mg</td>
<td>Inj. inotuzumab ozogamicin</td>
</tr>
<tr class="even">
<td>C9029</td>
<td>0010</td>
<td>3</td>
<td>Injection, guselkumab, 1 mg</td>
<td>Injection, guselkumab</td>
</tr>
<tr class="odd">
<td>C9030</td>
<td>0010</td>
<td>3</td>
<td>Injection, copanlisib, 1 mg</td>
<td>Inj copanlisib</td>
</tr>
<tr class="even">
<td>C9031</td>
<td>0010</td>
<td>3</td>
<td>Lutetium lu 177, dotatate, therapeutic, 1 mci</td>
<td>Lutetium lu 177 dotatate, tx</td>
</tr>
<tr class="odd">
<td>C9032</td>
<td>0010</td>
<td>3</td>
<td>Injection, voretigene neparvovec-rzyl, 1 billion vector genome</td>
<td>Voretigene neparvovec-rzyl</td>
</tr>
<tr class="even">
<td>C9033</td>
<td>0010</td>
<td>3</td>
<td>Injection, fosnetupitant 235 mg and palonosetron 0.25 mg</td>
<td>Inj, akynzeo</td>
</tr>
<tr class="odd">
<td>C9034</td>
<td>0010</td>
<td>3</td>
<td>Injection, dexamethasone 9%, intraocular, 1 mcg</td>
<td>Injection, dexamethasone 9%</td>
</tr>
<tr class="even">
<td>C9035</td>
<td>0010</td>
<td>3</td>
<td>Injection, aripiprazole lauroxil (aristada initio), 1 mg</td>
<td>Injection, aristada initio</td>
</tr>
<tr class="odd">
<td>C9036</td>
<td>0010</td>
<td>3</td>
<td>Injection, patisiran, 0.1 mg</td>
<td>Injection, patisiran</td>
</tr>
<tr class="even">
<td>C9037</td>
<td>0010</td>
<td>3</td>
<td>Injection, risperidone (perseris), 0.5 mg</td>
<td>Injection, risperidone</td>
</tr>
<tr class="odd">
<td>C9038</td>
<td>0010</td>
<td>3</td>
<td>Injection, mogamulizumab-kpkc, 1 mg</td>
<td>Inj mogamulizumab-kpkc</td>
</tr>
<tr class="even">
<td>C9039</td>
<td>0010</td>
<td>3</td>
<td>Injection, plazomicin, 5 mg</td>
<td>Injection, plazomicin</td>
</tr>
<tr class="odd">
<td>C9040</td>
<td>0010</td>
<td>3</td>
<td>Injection, fremanezumab-vfrm, 1mg</td>
<td>Injection, fremanezumab-vfrm</td>
</tr>
<tr class="even">
<td>C9041</td>
<td>0010</td>
<td>3</td>
<td>Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg</td>
<td>Inj, coagulation factor xa</td>
</tr>
<tr class="odd">
<td>C9042</td>
<td>0010</td>
<td>3</td>
<td>Injection, bendamustine hcl (belrapzo), 1 mg</td>
<td>Inj., belrapzo 1 mg</td>
</tr>
<tr class="even">
<td>C9043</td>
<td>0010</td>
<td>3</td>
<td>Injection, levoleucovorin, 1 mg</td>
<td>Injection, levoleucovorin</td>
</tr>
<tr class="odd">
<td>C9044</td>
<td>0010</td>
<td>3</td>
<td>Injection, cemiplimab-rwlc, 1 mg</td>
<td>Injection, cemiplimab-rwlc</td>
</tr>
<tr class="even">
<td>C9045</td>
<td>0010</td>
<td>3</td>
<td>Injection, moxetumomab pasudotox-tdfk, 0.01 mg</td>
<td>Moxetumomab pasudotox-tdfk</td>
</tr>
<tr class="odd">
<td>C9046</td>
<td>0010</td>
<td>3</td>
<td>Cocaine hydrochloride nasal solution for topical administration, 1 mg</td>
<td>Cocaine hcl nasal solution</td>
</tr>
<tr class="even">
<td>C9047</td>
<td>0010</td>
<td>3</td>
<td>Injection, caplacizumab-yhdp, 1 mg</td>
<td>Injection, caplacizumab-yhdp</td>
</tr>
<tr class="odd">
<td>C9048</td>
<td>0010</td>
<td>3</td>
<td>Dexamethasone, lacrimal ophthalmic insert, 0.1 mg</td>
<td>Dexamethasone ophth insert</td>
</tr>
<tr class="even">
<td>C9049</td>
<td>0010</td>
<td>3</td>
<td>Injection, tagraxofusp-erzs, 10 mcg</td>
<td>Injection, tagraxofusp-erzs</td>
</tr>
<tr class="odd">
<td>C9050</td>
<td>0010</td>
<td>3</td>
<td>Injection, emapalumab-lzsg, 1 mg</td>
<td>Injection, emapalumab-lzsg</td>
</tr>
<tr class="even">
<td>C9051</td>
<td>0010</td>
<td>3</td>
<td>Injection, omadacycline, 1 mg</td>
<td>Injection, omadacycline</td>
</tr>
<tr class="odd">
<td>C9052</td>
<td>0010</td>
<td>3</td>
<td>Injection, ravulizumab-cwvz, 10 mg</td>
<td>Injection, ravulizumab-cwv</td>
</tr>
<tr class="even">
<td>C9054</td>
<td>0010</td>
<td>3</td>
<td>Injection, lefamulin (xenleta), 1 mg</td>
<td>Injection, lefamulin</td>
</tr>
<tr class="odd">
<td>C9055</td>
<td>0010</td>
<td>3</td>
<td>Injection, brexanolone, 1mg</td>
<td>Inj, brexanolone</td>
</tr>
<tr class="even">
<td>C9113</td>
<td>0010</td>
<td>3</td>
<td>Injection, pantoprazole sodium, per vial</td>
<td>Inj pantoprazole sodium, via</td>
</tr>
<tr class="odd">
<td>C9121</td>
<td>0010</td>
<td>3</td>
<td>Injection, argatroban, per 5 mg</td>
<td>Injection, argatroban</td>
</tr>
<tr class="even">
<td>C9132</td>
<td>0010</td>
<td>3</td>
<td>Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity</td>
<td>Kcentra, per i.u.</td>
</tr>
<tr class="odd">
<td>C9133</td>
<td>0010</td>
<td>3</td>
<td>Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.</td>
<td>Factor ix recombinant</td>
</tr>
<tr class="even">
<td>C9134</td>
<td>0010</td>
<td>3</td>
<td>Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.</td>
<td>Factor xiii a-subunit recomb</td>
</tr>
<tr class="odd">
<td>C9135</td>
<td>0010</td>
<td>3</td>
<td>Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.</td>
<td>Factor ix (alprolix)</td>
</tr>
<tr class="even">
<td>C9136</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii, fc fusion protein, (recombinant), per i.u.</td>
<td>Factor viii (eloctate)</td>
</tr>
<tr class="odd">
<td>C9137</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.</td>
<td>Adynovate factor viii recom</td>
</tr>
<tr class="even">
<td>C9138</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.</td>
<td>Nuwiq factor viii recomb</td>
</tr>
<tr class="odd">
<td>C9139</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.</td>
<td>Idelvion, 1 i.u.</td>
</tr>
<tr class="even">
<td>C9140</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.</td>
<td>Afstyla factor viii recomb</td>
</tr>
<tr class="odd">
<td>C9141</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.</td>
<td>Factor viii pegylated-aucl</td>
</tr>
<tr class="even">
<td>C9248</td>
<td>0010</td>
<td>3</td>
<td>Injection, clevidipine butyrate, 1 mg</td>
<td>Inj, clevidipine butyrate</td>
</tr>
<tr class="odd">
<td>C9250</td>
<td>0010</td>
<td>3</td>
<td>Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml</td>
<td>Artiss fibrin sealant</td>
</tr>
<tr class="even">
<td>C9254</td>
<td>0010</td>
<td>3</td>
<td>Injection, lacosamide, 1 mg</td>
<td>Injection, lacosamide</td>
</tr>
<tr class="odd">
<td>C9257</td>
<td>0010</td>
<td>3</td>
<td>Injection, bevacizumab, 0.25 mg</td>
<td>Bevacizumab injection</td>
</tr>
<tr class="even">
<td>C9275</td>
<td>0010</td>
<td>3</td>
<td>Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose</td>
<td>Hexaminolevulinate hcl</td>
</tr>
<tr class="odd">
<td>C9285</td>
<td>0010</td>
<td>3</td>
<td>Lidocaine 70 mg/tetracaine 70 mg, per patch</td>
<td>Patch, lidocaine/tetracaine</td>
</tr>
<tr class="even">
<td>C9290</td>
<td>0010</td>
<td>3</td>
<td>Injection, bupivacaine liposome, 1 mg</td>
<td>Inj, bupivacaine liposome</td>
</tr>
<tr class="odd">
<td>C9293</td>
<td>0010</td>
<td>3</td>
<td>Injection, glucarpidase, 10 units</td>
<td>Injection, glucarpidase</td>
</tr>
<tr class="even">
<td>C9349</td>
<td>0010</td>
<td>3</td>
<td>Puraply, and puraply antimicrobial, any type, per square centimeter</td>
<td>Puraply, puraply antimic</td>
</tr>
<tr class="odd">
<td>C9352</td>
<td>0010</td>
<td>3</td>
<td>Microporous collagen implantable tube (neuragen nerve guide), per centimeter length</td>
<td>Neuragen nerve guide, per cm</td>
</tr>
<tr class="even">
<td>C9353</td>
<td>0010</td>
<td>3</td>
<td>Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length</td>
<td>Neurawrap nerve protector,cm</td>
</tr>
<tr class="odd">
<td>C9354</td>
<td>0010</td>
<td>3</td>
<td>Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter</td>
<td>Veritas collagen matrix, cm2</td>
</tr>
<tr class="even">
<td>C9355</td>
<td>0010</td>
<td>3</td>
<td>Collagen nerve cuff (neuromatrix), per 0.5 centimeter length</td>
<td>Neuromatrix nerve cuff, cm</td>
</tr>
<tr class="odd">
<td>C9356</td>
<td>0010</td>
<td>3</td>
<td>Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter</td>
<td>Tenoglide tendon prot, cm2</td>
</tr>
<tr class="even">
<td>C9358</td>
<td>0010</td>
<td>3</td>
<td>Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters</td>
<td>Surgimend, fetal</td>
</tr>
<tr class="odd">
<td>C9359</td>
<td>0010</td>
<td>3</td>
<td>Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc</td>
<td>Implnt,bon void filler-putty</td>
</tr>
<tr class="even">
<td>C9360</td>
<td>0010</td>
<td>3</td>
<td>Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters</td>
<td>Surgimend, neonatal</td>
</tr>
<tr class="odd">
<td>C9361</td>
<td>0010</td>
<td>3</td>
<td>Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length</td>
<td>Neuromend nerve wrap</td>
</tr>
<tr class="even">
<td>C9362</td>
<td>0010</td>
<td>3</td>
<td>Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc</td>
<td>Implnt,bon void filler-strip</td>
</tr>
<tr class="odd">
<td>C9363</td>
<td>0010</td>
<td>3</td>
<td>Skin substitute, integra meshed bilayer wound matrix, per square centimeter</td>
<td>Integra meshed bil wound mat</td>
</tr>
<tr class="even">
<td>C9364</td>
<td>0010</td>
<td>3</td>
<td>Porcine implant, permacol, per square centimeter</td>
<td>Porcine implant, permacol</td>
</tr>
<tr class="odd">
<td>C9399</td>
<td>0010</td>
<td>3</td>
<td>Unclassified drugs or biologicals</td>
<td>Unclassified drugs or biolog</td>
</tr>
<tr class="even">
<td>C9407</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-131 iobenguane, diagnostic, 1 millicurie</td>
<td>Iodine i-131 iobenguane, dx</td>
</tr>
<tr class="odd">
<td>C9408</td>
<td>0010</td>
<td>3</td>
<td>Iodine i-131 iobenguane, therapeutic, 1 millicurie</td>
<td>Iodine i-131 iobenguane, tx</td>
</tr>
<tr class="even">
<td>C9441</td>
<td>0010</td>
<td>3</td>
<td>Injection, ferric carboxymaltose, 1 mg</td>
<td>Inj, ferric carboxymaltose</td>
</tr>
<tr class="odd">
<td>C9442</td>
<td>0010</td>
<td>3</td>
<td>Injection, belinostat, 10 mg</td>
<td>Injection, belinostat</td>
</tr>
<tr class="even">
<td>C9443</td>
<td>0010</td>
<td>3</td>
<td>Injection, dalbavancin, 10 mg</td>
<td>Injection, dalbavancin</td>
</tr>
<tr class="odd">
<td>C9444</td>
<td>0010</td>
<td>3</td>
<td>Injection, oritavancin, 10 mg</td>
<td>Injection, oritavancin</td>
</tr>
<tr class="even">
<td>C9445</td>
<td>0010</td>
<td>3</td>
<td>Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units</td>
<td>C-1 esterase, ruconest</td>
</tr>
<tr class="odd">
<td>C9446</td>
<td>0010</td>
<td>3</td>
<td>Injection, tedizolid phosphate, 1 mg</td>
<td>Inj, tedizolid phosphate</td>
</tr>
<tr class="even">
<td>C9447</td>
<td>0010</td>
<td>3</td>
<td>Injection, phenylephrine and ketorolac, 4 ml vial</td>
<td>Inj, phenylephrine ketorolac</td>
</tr>
<tr class="odd">
<td>C9448</td>
<td>0010</td>
<td>3</td>
<td>Netupitant 300 mg and palonosetron 0.5 mg, oral</td>
<td>Oral netupitant palonosetron</td>
</tr>
<tr class="even">
<td>C9449</td>
<td>0010</td>
<td>3</td>
<td>Injection, blinatumomab, 1 mcg</td>
<td>Inj, blinatumomab</td>
</tr>
<tr class="odd">
<td>C9450</td>
<td>0010</td>
<td>3</td>
<td>Injection, fluocinolone acetonide intravitreal implant, 0.01 mg</td>
<td>Fluocinolone acetonide implt</td>
</tr>
<tr class="even">
<td>C9451</td>
<td>0010</td>
<td>3</td>
<td>Injection, peramivir, 1 mg</td>
<td>Injection, peramivir</td>
</tr>
<tr class="odd">
<td>C9452</td>
<td>0010</td>
<td>3</td>
<td>Injection, ceftolozane 50 mg and tazobactam 25 mg</td>
<td>Inj, ceftolozane/tazobactam</td>
</tr>
<tr class="even">
<td>C9453</td>
<td>0010</td>
<td>3</td>
<td>Injection, nivolumab, 1 mg</td>
<td>Injection, nivolumab</td>
</tr>
<tr class="odd">
<td>C9454</td>
<td>0010</td>
<td>3</td>
<td>Injection, pasireotide long acting, 1 mg</td>
<td>Inj, pasireotide long acting</td>
</tr>
<tr class="even">
<td>C9455</td>
<td>0010</td>
<td>3</td>
<td>Injection, siltuximab, 10 mg</td>
<td>Injection, siltuximab</td>
</tr>
<tr class="odd">
<td>C9456</td>
<td>0010</td>
<td>3</td>
<td>Injection, isavuconazonium sulfate, 1 mg</td>
<td>Inj, isavuconazonium sulfate</td>
</tr>
<tr class="even">
<td>C9457</td>
<td>0010</td>
<td>3</td>
<td>Injection, sulfur hexafluoride lipid microsphere, per ml</td>
<td>Lumason contrast agent</td>
</tr>
<tr class="odd">
<td>C9458</td>
<td>0010</td>
<td>3</td>
<td>Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries</td>
<td>Florbetaben f18</td>
</tr>
<tr class="even">
<td>C9459</td>
<td>0010</td>
<td>3</td>
<td>Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries</td>
<td>Flutemetamol f18</td>
</tr>
<tr class="odd">
<td>C9460</td>
<td>0010</td>
<td>3</td>
<td>Injection, cangrelor, 1 mg</td>
<td>Injection, cangrelor</td>
</tr>
<tr class="even">
<td>C9461</td>
<td>0010</td>
<td>3</td>
<td>Choline c 11, diagnostic, per study dose</td>
<td>Choline c 11, diagnostic</td>
</tr>
<tr class="odd">
<td>C9462</td>
<td>0010</td>
<td>3</td>
<td>Injection, delafloxacin, 1 mg</td>
<td>Injection, delafloxacin</td>
</tr>
<tr class="even">
<td>C9463</td>
<td>0010</td>
<td>3</td>
<td>Injection, aprepitant, 1 mg</td>
<td>Injection, aprepitant</td>
</tr>
<tr class="odd">
<td>C9464</td>
<td>0010</td>
<td>3</td>
<td>Injection, rolapitant, 0.5 mg</td>
<td>Injection, rolapitant</td>
</tr>
<tr class="even">
<td>C9465</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, durolane, for intra-articular injection, per dose</td>
<td>Injection, durolane</td>
</tr>
<tr class="odd">
<td>C9466</td>
<td>0010</td>
<td>3</td>
<td>Injection, benralizumab, 1 mg</td>
<td>Injection, benralizumab</td>
</tr>
<tr class="even">
<td>C9467</td>
<td>0010</td>
<td>3</td>
<td>Injection, rituximab and hyaluronidase, 10 mg</td>
<td>Inj rituximab hyaluronidase</td>
</tr>
<tr class="odd">
<td>C9468</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.</td>
<td>Inj, factor ix, rebinyn</td>
</tr>
<tr class="even">
<td>C9469</td>
<td>0010</td>
<td>3</td>
<td>Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg</td>
<td>Inj triamcinolone acetonide</td>
</tr>
<tr class="odd">
<td>C9470</td>
<td>0010</td>
<td>3</td>
<td>Injection, aripiprazole lauroxil, 1 mg</td>
<td>Aripiprazole lauroxil im</td>
</tr>
<tr class="even">
<td>C9471</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg</td>
<td>Hymovis, 1 mg</td>
</tr>
<tr class="odd">
<td>C9472</td>
<td>0010</td>
<td>3</td>
<td>Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)</td>
<td>Inj talimogene laherparepvec</td>
</tr>
<tr class="even">
<td>C9473</td>
<td>0010</td>
<td>3</td>
<td>Injection, mepolizumab, 1 mg</td>
<td>Injection, mepolizumab</td>
</tr>
<tr class="odd">
<td>C9474</td>
<td>0010</td>
<td>3</td>
<td>Injection, irinotecan liposome, 1 mg</td>
<td>Inj, irinotecan liposome</td>
</tr>
<tr class="even">
<td>C9475</td>
<td>0010</td>
<td>3</td>
<td>Injection, necitumumab, 1 mg</td>
<td>Injection, necitumumab</td>
</tr>
<tr class="odd">
<td>C9476</td>
<td>0010</td>
<td>3</td>
<td>Injection, daratumumab, 10 mg</td>
<td>Injection, daratumumab</td>
</tr>
<tr class="even">
<td>C9477</td>
<td>0010</td>
<td>3</td>
<td>Injection, elotuzumab, 1 mg</td>
<td>Injection, elotuzumab</td>
</tr>
<tr class="odd">
<td>C9478</td>
<td>0010</td>
<td>3</td>
<td>Injection, sebelipase alfa, 1 mg</td>
<td>Injection, sebelipase alfa</td>
</tr>
<tr class="even">
<td>C9479</td>
<td>0010</td>
<td>3</td>
<td>Instillation, ciprofloxacin otic suspension, 6 mg</td>
<td>Instill, ciprofloxacin otic</td>
</tr>
<tr class="odd">
<td>C9480</td>
<td>0010</td>
<td>3</td>
<td>Injection, trabectedin, 0.1 mg</td>
<td>Injection, trabectedin</td>
</tr>
<tr class="even">
<td>C9481</td>
<td>0010</td>
<td>3</td>
<td>Injection, reslizumab, 1 mg</td>
<td>Injection, reslizumab</td>
</tr>
<tr class="odd">
<td>C9482</td>
<td>0010</td>
<td>3</td>
<td>Injection, sotalol hydrochloride, 1 mg</td>
<td>Sotalol hydrochloride iv</td>
</tr>
<tr class="even">
<td>C9483</td>
<td>0010</td>
<td>3</td>
<td>Injection, atezolizumab, 10 mg</td>
<td>Injection, atezolizumab</td>
</tr>
<tr class="odd">
<td>C9484</td>
<td>0010</td>
<td>3</td>
<td>Injection, eteplirsen, 10 mg</td>
<td>Injection, eteplirsen</td>
</tr>
<tr class="even">
<td>C9485</td>
<td>0010</td>
<td>3</td>
<td>Injection, olaratumab, 10 mg</td>
<td>Injection, olaratumab</td>
</tr>
<tr class="odd">
<td>C9486</td>
<td>0010</td>
<td>3</td>
<td>Injection, granisetron extended release, 0.1 mg</td>
<td>Inj, granisetron ext</td>
</tr>
<tr class="even">
<td>C9487</td>
<td>0010</td>
<td>3</td>
<td>Ustekinumab, for intravenous injection, 1 mg</td>
<td>Ustekinumab iv inj, 1 mg</td>
</tr>
<tr class="odd">
<td>C9488</td>
<td>0010</td>
<td>3</td>
<td>Injection, conivaptan hydrochloride, 1 mg</td>
<td>Conivaptan hcl</td>
</tr>
<tr class="even">
<td>C9489</td>
<td>0010</td>
<td>3</td>
<td>Injection, nusinersen, 0.1 mg</td>
<td>Injection, nusinersen</td>
</tr>
<tr class="odd">
<td>C9490</td>
<td>0010</td>
<td>3</td>
<td>Injection, bezlotoxumab, 10 mg</td>
<td>Injection, bezlotoxumab</td>
</tr>
<tr class="even">
<td>C9491</td>
<td>0010</td>
<td>3</td>
<td>Injection, avelumab, 10 mg</td>
<td>Injection, avelumab</td>
</tr>
<tr class="odd">
<td>C9492</td>
<td>0010</td>
<td>3</td>
<td>Injection, durvalumab, 10 mg</td>
<td>Injection, durvalumab</td>
</tr>
<tr class="even">
<td>C9493</td>
<td>0010</td>
<td>3</td>
<td>Injection, edaravone, 1 mg</td>
<td>Injection, edaravone</td>
</tr>
<tr class="odd">
<td>C9494</td>
<td>0010</td>
<td>3</td>
<td>Injection, ocrelizumab, 1 mg</td>
<td>Injection, ocrelizumab</td>
</tr>
<tr class="even">
<td>C9497</td>
<td>0010</td>
<td>3</td>
<td>Loxapine, inhalation powder, 10 mg</td>
<td>Loxapine, inhalation powder</td>
</tr>
<tr class="odd">
<td>C9600</td>
<td>0010</td>
<td>3</td>
<td>Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch</td>
<td>Perc drug-el cor stent sing</td>
</tr>
<tr class="even">
<td>C9601</td>
<td>0010</td>
<td>3</td>
<td>Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)</td>
<td>Perc drug-el cor stent bran</td>
</tr>
<tr class="odd">
<td>C9602</td>
<td>0010</td>
<td>3</td>
<td>Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch</td>
<td>Perc d-e cor stent ather s</td>
</tr>
<tr class="even">
<td>C9603</td>
<td>0010</td>
<td>3</td>
<td>Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)</td>
<td>Perc d-e cor stent ather br</td>
</tr>
<tr class="odd">
<td>C9604</td>
<td>0010</td>
<td>3</td>
<td>Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel</td>
<td>Perc d-e cor revasc t cabg s</td>
</tr>
<tr class="even">
<td>C9605</td>
<td>0010</td>
<td>3</td>
<td>Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure)</td>
<td>Perc d-e cor revasc t cabg b</td>
</tr>
<tr class="odd">
<td>C9606</td>
<td>0010</td>
<td>3</td>
<td>Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel</td>
<td>Perc d-e cor revasc w ami s</td>
</tr>
<tr class="even">
<td>C9607</td>
<td>0010</td>
<td>3</td>
<td>Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel</td>
<td>Perc d-e cor revasc chro sin</td>
</tr>
<tr class="odd">
<td>C9608</td>
<td>0010</td>
<td>3</td>
<td>Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure)</td>
<td>Perc d-e cor revasc chro add</td>
</tr>
<tr class="even">
<td>C9724</td>
<td>0010</td>
<td>3</td>
<td>Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy</td>
<td>Eps stomach plic</td>
</tr>
<tr class="odd">
<td>C9725</td>
<td>0010</td>
<td>3</td>
<td>Placement of endorectal intracavitary applicator for high intensity brachytherapy</td>
<td>Place endorectal app</td>
</tr>
<tr class="even">
<td>C9726</td>
<td>0010</td>
<td>3</td>
<td>Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure</td>
<td>Rxt breast appl place/remov</td>
</tr>
<tr class="odd">
<td>C9727</td>
<td>0010</td>
<td>3</td>
<td>Insertion of implants into the soft palate; minimum of three implants</td>
<td>Insert palate implants</td>
</tr>
<tr class="even">
<td>C9728</td>
<td>0010</td>
<td>3</td>
<td>Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple</td>
<td>Place device/marker, non pro</td>
</tr>
<tr class="odd">
<td>C9733</td>
<td>0010</td>
<td>3</td>
<td>Non-ophthalmic fluorescent vascular angiography</td>
<td>Non-ophthalmic fva</td>
</tr>
<tr class="even">
<td>C9734</td>
<td>0010</td>
<td>3</td>
<td>Focused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance</td>
<td>U/s trtmt, not leiomyomata</td>
</tr>
<tr class="odd">
<td>C9735</td>
<td>0010</td>
<td>3</td>
<td>Anoscopy; with directed submucosal injection(s), any substance</td>
<td>Anoscopy, submucosal inj</td>
</tr>
<tr class="even">
<td>C9737</td>
<td>0010</td>
<td>3</td>
<td>Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band)</td>
<td>Lap esoph augmentation</td>
</tr>
<tr class="odd">
<td>C9738</td>
<td>0010</td>
<td>3</td>
<td>Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure)</td>
<td>Blue light cysto imag agent</td>
</tr>
<tr class="even">
<td>C9739</td>
<td>0010</td>
<td>3</td>
<td>Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants</td>
<td>Cystoscopy prostatic imp 1-3</td>
</tr>
<tr class="odd">
<td>C9740</td>
<td>0010</td>
<td>3</td>
<td>Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants</td>
<td>Cysto impl 4 or more</td>
</tr>
<tr class="even">
<td>C9741</td>
<td>0010</td>
<td>3</td>
<td>Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report</td>
<td>Impl pressure sensor w/angio</td>
</tr>
<tr class="odd">
<td>C9742</td>
<td>0010</td>
<td>3</td>
<td>Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performed</td>
<td>Laryngoscopy with injection</td>
</tr>
<tr class="even">
<td>C9743</td>
<td>0010</td>
<td>3</td>
<td>Injection/implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies)</td>
<td>Bulking/spacer material impl</td>
</tr>
<tr class="odd">
<td>C9744</td>
<td>0010</td>
<td>3</td>
<td>Ultrasound, abdominal, with contrast</td>
<td>Abd us w/contrast</td>
</tr>
<tr class="even">
<td>C9745</td>
<td>0010</td>
<td>3</td>
<td>Nasal endoscopy, surgical; balloon dilation of eustachian tube</td>
<td>Nasal endo eustachian tube</td>
</tr>
<tr class="odd">
<td>C9746</td>
<td>0010</td>
<td>3</td>
<td>Transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and/or fluoroscopy, when performed</td>
<td>Trans imp balloon cont</td>
</tr>
<tr class="even">
<td>C9747</td>
<td>0010</td>
<td>3</td>
<td>Ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidance</td>
<td>Ablation, hifu, prostate</td>
</tr>
<tr class="odd">
<td>C9748</td>
<td>0010</td>
<td>3</td>
<td>Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy</td>
<td>Prostatic rf water vapor tx</td>
</tr>
<tr class="even">
<td>C9749</td>
<td>0010</td>
<td>3</td>
<td>Repair of nasal vestibular lateral wall stenosis with implant(s)</td>
<td>Repair nasal stenosis w/imp</td>
</tr>
<tr class="odd">
<td>C9750</td>
<td>0010</td>
<td>3</td>
<td>Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode)</td>
<td>Ins/rem-replace compl iims</td>
</tr>
<tr class="even">
<td>C9751</td>
<td>0010</td>
<td>3</td>
<td>Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (eg, aspiration[s]/biopsy[ies]) and all mediastinal and/or hilar lymph node stations or structures and therapeutic intervention(s)</td>
<td>Microwave bronch, 3d, ebus</td>
</tr>
<tr class="odd">
<td>C9752</td>
<td>0010</td>
<td>3</td>
<td>Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum</td>
<td>Intraosseous des lumb/sacrum</td>
</tr>
<tr class="even">
<td>C9753</td>
<td>0010</td>
<td>3</td>
<td>Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure)</td>
<td>Intraosseous destruct add’l</td>
</tr>
<tr class="odd">
<td>C9754</td>
<td>0010</td>
<td>3</td>
<td>Creation of arteriovenous fistula, percutaneous; direct, any site, including all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed)</td>
<td>Perc av fistula, direct</td>
</tr>
<tr class="even">
<td>C9755</td>
<td>0010</td>
<td>3</td>
<td>Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and/or ultrasound, with radiologic supervision and interpretation, when performed</td>
<td>Rf magnetic-guide av fistula</td>
</tr>
<tr class="odd">
<td>C9756</td>
<td>0010</td>
<td>3</td>
<td>Intraoperative near-infrared fluorescence lymphatic mapping of lymph node(s) (sentinel or tumor draining) with administration of indocyanine green (icg) (list separately in addition to code for primary procedure)</td>
<td>Fluorescence lymph map w/icg</td>
</tr>
<tr class="even">
<td>C9757</td>
<td>0010</td>
<td>3</td>
<td>Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and excision of herniated intervertebral disc, and repair of annular defect with implantation of bone anchored annular closure device, including annular defect measurement, alignment and sizing assessment, and image guidance; 1 interspace, lumbar</td>
<td>Spine/lumbar disk surgery</td>
</tr>
<tr class="odd">
<td>C9758</td>
<td>0010</td>
<td>3</td>
<td>Blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study</td>
<td>Interatrial shunt ide</td>
</tr>
<tr class="even">
<td>C9800</td>
<td>0010</td>
<td>3</td>
<td>Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies</td>
<td>Dermal filler inj px/suppl</td>
</tr>
<tr class="odd">
<td>C9898</td>
<td>0010</td>
<td>3</td>
<td>Radiolabeled product provided during a hospital inpatient stay</td>
<td>Inpnt stay radiolabeled item</td>
</tr>
<tr class="even">
<td>C9899</td>
<td>0010</td>
<td>3</td>
<td>Implanted prosthetic device, payable only for inpatients who do not have inpatient coverage</td>
<td>Inpt implant pros dev,no cov</td>
</tr>
</tbody>
</table>
</div>
<div id="d-series-dental-procedures-d0000-d9999" class="section level2">
<h2>D Series: Dental Procedures (D0000-D9999)</h2>
<table>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
</tbody>
</table>
</div>
<div id="e-series-durable-medical-equipment-e0100-e9999" class="section level2">
<h2>E Series: Durable Medical Equipment (E0100-E9999)</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>E0100</td>
<td>0010</td>
<td>3</td>
<td>Cane, includes canes of all materials, adjustable or fixed, with tip</td>
<td>Cane adjust/fixed with tip</td>
</tr>
<tr class="even">
<td>E0105</td>
<td>0010</td>
<td>3</td>
<td>Cane, quad or three prong, includes canes of all materials, adjustable or fixed, with tips</td>
<td>Cane adjust/fixed quad/3 pro</td>
</tr>
<tr class="odd">
<td>E0110</td>
<td>0010</td>
<td>3</td>
<td>Crutches, forearm, includes crutches of various materials, adjustable or fixed, pair, complete with tips and handgrips</td>
<td>Crutch forearm pair</td>
</tr>
<tr class="even">
<td>E0111</td>
<td>0010</td>
<td>3</td>
<td>Crutch forearm, includes crutches of various materials, adjustable or fixed, each, with tip and handgrips</td>
<td>Crutch forearm each</td>
</tr>
<tr class="odd">
<td>E0112</td>
<td>0010</td>
<td>3</td>
<td>Crutches underarm, wood, adjustable or fixed, pair, with pads, tips and handgrips</td>
<td>Crutch underarm pair wood</td>
</tr>
<tr class="even">
<td>E0113</td>
<td>0010</td>
<td>3</td>
<td>Crutch underarm, wood, adjustable or fixed, each, with pad, tip and handgrip</td>
<td>Crutch underarm each wood</td>
</tr>
<tr class="odd">
<td>E0114</td>
<td>0010</td>
<td>3</td>
<td>Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips</td>
<td>Crutch underarm pair no wood</td>
</tr>
<tr class="even">
<td>E0116</td>
<td>0010</td>
<td>3</td>
<td>Crutch, underarm, other than wood, adjustable or fixed, with pad, tip, handgrip, with or without shock absorber, each</td>
<td>Crutch underarm each no wood</td>
</tr>
<tr class="odd">
<td>E0117</td>
<td>0010</td>
<td>3</td>
<td>Crutch, underarm, articulating, spring assisted, each</td>
<td>Underarm springassist crutch</td>
</tr>
<tr class="even">
<td>E0118</td>
<td>0010</td>
<td>3</td>
<td>Crutch substitute, lower leg platform, with or without wheels, each</td>
<td>Crutch substitute</td>
</tr>
<tr class="odd">
<td>E0130</td>
<td>0010</td>
<td>3</td>
<td>Walker, rigid (pickup), adjustable or fixed height</td>
<td>Walker rigid adjust/fixed ht</td>
</tr>
<tr class="even">
<td>E0135</td>
<td>0010</td>
<td>3</td>
<td>Walker, folding (pickup), adjustable or fixed height</td>
<td>Walker folding adjust/fixed</td>
</tr>
<tr class="odd">
<td>E0140</td>
<td>0010</td>
<td>3</td>
<td>Walker, with trunk support, adjustable or fixed height, any type</td>
<td>Walker w trunk support</td>
</tr>
<tr class="even">
<td>E0141</td>
<td>0010</td>
<td>3</td>
<td>Walker, rigid, wheeled, adjustable or fixed height</td>
<td>Rigid wheeled walker adj/fix</td>
</tr>
<tr class="odd">
<td>E0143</td>
<td>0010</td>
<td>3</td>
<td>Walker, folding, wheeled, adjustable or fixed height</td>
<td>Walker folding wheeled w/o s</td>
</tr>
<tr class="even">
<td>E0144</td>
<td>0010</td>
<td>3</td>
<td>Walker, enclosed, four sided framed, rigid or folding, wheeled with posterior seat</td>
<td>Enclosed walker w rear seat</td>
</tr>
<tr class="odd">
<td>E0147</td>
<td>0010</td>
<td>3</td>
<td>Walker, heavy duty, multiple braking system, variable wheel resistance</td>
<td>Walker variable wheel resist</td>
</tr>
<tr class="even">
<td>E0148</td>
<td>0010</td>
<td>3</td>
<td>Walker, heavy duty, without wheels, rigid or folding, any type, each</td>
<td>Heavyduty walker no wheels</td>
</tr>
<tr class="odd">
<td>E0149</td>
<td>0010</td>
<td>3</td>
<td>Walker, heavy duty, wheeled, rigid or folding, any type</td>
<td>Heavy duty wheeled walker</td>
</tr>
<tr class="even">
<td>E0153</td>
<td>0010</td>
<td>3</td>
<td>Platform attachment, forearm crutch, each</td>
<td>Forearm crutch platform atta</td>
</tr>
<tr class="odd">
<td>E0154</td>
<td>0010</td>
<td>3</td>
<td>Platform attachment, walker, each</td>
<td>Walker platform attachment</td>
</tr>
<tr class="even">
<td>E0155</td>
<td>0010</td>
<td>3</td>
<td>Wheel attachment, rigid pick-up walker, per pair</td>
<td>Walker wheel attachment,pair</td>
</tr>
<tr class="odd">
<td>E0156</td>
<td>0010</td>
<td>3</td>
<td>Seat attachment, walker</td>
<td>Walker seat attachment</td>
</tr>
<tr class="even">
<td>E0157</td>
<td>0010</td>
<td>3</td>
<td>Crutch attachment, walker, each</td>
<td>Walker crutch attachment</td>
</tr>
<tr class="odd">
<td>E0158</td>
<td>0010</td>
<td>3</td>
<td>Leg extensions for walker, per set of four (4)</td>
<td>Walker leg extenders set of4</td>
</tr>
<tr class="even">
<td>E0159</td>
<td>0010</td>
<td>3</td>
<td>Brake attachment for wheeled walker, replacement, each</td>
<td>Brake for wheeled walker</td>
</tr>
<tr class="odd">
<td>E0160</td>
<td>0010</td>
<td>3</td>
<td>Sitz type bath or equipment, portable, used with or without commode</td>
<td>Sitz type bath or equipment</td>
</tr>
<tr class="even">
<td>E0161</td>
<td>0010</td>
<td>3</td>
<td>Sitz type bath or equipment, portable, used with or without commode, with faucet attachment/s</td>
<td>Sitz bath/equipment w/faucet</td>
</tr>
<tr class="odd">
<td>E0162</td>
<td>0010</td>
<td>3</td>
<td>Sitz bath chair</td>
<td>Sitz bath chair</td>
</tr>
<tr class="even">
<td>E0163</td>
<td>0010</td>
<td>3</td>
<td>Commode chair, mobile or stationary, with fixed arms</td>
<td>Commode chair with fixed arm</td>
</tr>
<tr class="odd">
<td>E0165</td>
<td>0010</td>
<td>3</td>
<td>Commode chair, mobile or stationary, with detachable arms</td>
<td>Commode chair with detacharm</td>
</tr>
<tr class="even">
<td>E0167</td>
<td>0010</td>
<td>3</td>
<td>Pail or pan for use with commode chair, replacement only</td>
<td>Commode chair pail or pan</td>
</tr>
<tr class="odd">
<td>E0168</td>
<td>0010</td>
<td>3</td>
<td>Commode chair, extra wide and/or heavy duty, stationary or mobile, with or without arms, any type, each</td>
<td>Heavyduty/wide commode chair</td>
</tr>
<tr class="even">
<td>E0170</td>
<td>0010</td>
<td>3</td>
<td>Commode chair with integrated seat lift mechanism, electric, any type</td>
<td>Commode chair electric</td>
</tr>
<tr class="odd">
<td>E0171</td>
<td>0010</td>
<td>3</td>
<td>Commode chair with integrated seat lift mechanism, non-electric, any type</td>
<td>Commode chair non-electric</td>
</tr>
<tr class="even">
<td>E0172</td>
<td>0010</td>
<td>3</td>
<td>Seat lift mechanism placed over or on top of toilet, any type</td>
<td>Seat lift mechanism toilet</td>
</tr>
<tr class="odd">
<td>E0175</td>
<td>0010</td>
<td>3</td>
<td>Foot rest, for use with commode chair, each</td>
<td>Commode chair foot rest</td>
</tr>
<tr class="even">
<td>E0181</td>
<td>0010</td>
<td>3</td>
<td>Powered pressure reducing mattress overlay/pad, alternating, with pump, includes heavy duty</td>
<td>Press pad alternating w/ pum</td>
</tr>
<tr class="odd">
<td>E0182</td>
<td>0010</td>
<td>3</td>
<td>Pump for alternating pressure pad, for replacement only</td>
<td>Replace pump, alt press pad</td>
</tr>
<tr class="even">
<td>E0184</td>
<td>0010</td>
<td>3</td>
<td>Dry pressure mattress</td>
<td>Dry pressure mattress</td>
</tr>
<tr class="odd">
<td>E0185</td>
<td>0010</td>
<td>3</td>
<td>Gel or gel-like pressure pad for mattress, standard mattress length and width</td>
<td>Gel pressure mattress pad</td>
</tr>
<tr class="even">
<td>E0186</td>
<td>0010</td>
<td>3</td>
<td>Air pressure mattress</td>
<td>Air pressure mattress</td>
</tr>
<tr class="odd">
<td>E0187</td>
<td>0010</td>
<td>3</td>
<td>Water pressure mattress</td>
<td>Water pressure mattress</td>
</tr>
<tr class="even">
<td>E0188</td>
<td>0010</td>
<td>3</td>
<td>Synthetic sheepskin pad</td>
<td>Synthetic sheepskin pad</td>
</tr>
<tr class="odd">
<td>E0189</td>
<td>0010</td>
<td>3</td>
<td>Lambswool sheepskin pad, any size</td>
<td>Lambswool sheepskin pad</td>
</tr>
<tr class="even">
<td>E0190</td>
<td>0010</td>
<td>3</td>
<td>Positioning cushion/pillow/wedge, any shape or size, includes all components and accessories</td>
<td>Positioning cushion</td>
</tr>
<tr class="odd">
<td>E0191</td>
<td>0010</td>
<td>3</td>
<td>Heel or elbow protector, each</td>
<td>Protector heel or elbow</td>
</tr>
<tr class="even">
<td>E0193</td>
<td>0010</td>
<td>3</td>
<td>Powered air flotation bed (low air loss therapy)</td>
<td>Powered air flotation bed</td>
</tr>
<tr class="odd">
<td>E0194</td>
<td>0010</td>
<td>3</td>
<td>Air fluidized bed</td>
<td>Air fluidized bed</td>
</tr>
<tr class="even">
<td>E0196</td>
<td>0010</td>
<td>3</td>
<td>Gel pressure mattress</td>
<td>Gel pressure mattress</td>
</tr>
<tr class="odd">
<td>E0197</td>
<td>0010</td>
<td>3</td>
<td>Air pressure pad for mattress, standard mattress length and width</td>
<td>Air pressure pad for mattres</td>
</tr>
<tr class="even">
<td>E0198</td>
<td>0010</td>
<td>3</td>
<td>Water pressure pad for mattress, standard mattress length and width</td>
<td>Water pressure pad for mattr</td>
</tr>
<tr class="odd">
<td>E0199</td>
<td>0010</td>
<td>3</td>
<td>Dry pressure pad for mattress, standard mattress length and width</td>
<td>Dry pressure pad for mattres</td>
</tr>
<tr class="even">
<td>E0200</td>
<td>0010</td>
<td>3</td>
<td>Heat lamp, without stand (table model), includes bulb, or infrared element</td>
<td>Heat lamp without stand</td>
</tr>
<tr class="odd">
<td>E0202</td>
<td>0010</td>
<td>3</td>
<td>Phototherapy (bilirubin) light with photometer</td>
<td>Phototherapy light w/ photom</td>
</tr>
<tr class="even">
<td>E0203</td>
<td>0010</td>
<td>3</td>
<td>Therapeutic lightbox, minimum 10,000 lux, table top model</td>
<td>Therapeutic lightbox tabletp</td>
</tr>
<tr class="odd">
<td>E0205</td>
<td>0010</td>
<td>3</td>
<td>Heat lamp, with stand, includes bulb, or infrared element</td>
<td>Heat lamp with stand</td>
</tr>
<tr class="even">
<td>E0210</td>
<td>0010</td>
<td>3</td>
<td>Electric heat pad, standard</td>
<td>Electric heat pad standard</td>
</tr>
<tr class="odd">
<td>E0215</td>
<td>0010</td>
<td>3</td>
<td>Electric heat pad, moist</td>
<td>Electric heat pad moist</td>
</tr>
<tr class="even">
<td>E0217</td>
<td>0010</td>
<td>3</td>
<td>Water circulating heat pad with pump</td>
<td>Water circ heat pad w pump</td>
</tr>
<tr class="odd">
<td>E0218</td>
<td>0010</td>
<td>3</td>
<td>Fluid circulating cold pad with pump, any type</td>
<td>Fluid circ cold pad w pump</td>
</tr>
<tr class="even">
<td>E0221</td>
<td>0010</td>
<td>3</td>
<td>Infrared heating pad system</td>
<td>Infrared heating pad system</td>
</tr>
<tr class="odd">
<td>E0225</td>
<td>0010</td>
<td>3</td>
<td>Hydrocollator unit, includes pads</td>
<td>Hydrocollator unit</td>
</tr>
<tr class="even">
<td>E0231</td>
<td>0010</td>
<td>3</td>
<td>Non-contact wound warming device (temperature control unit, ac adapter and power cord) for use with warming card and wound cover</td>
<td>Wound warming device</td>
</tr>
<tr class="odd">
<td>E0232</td>
<td>0010</td>
<td>3</td>
<td>Warming card for use with the non contact wound warming device and non contact wound warming wound cover</td>
<td>Warming card for nwt</td>
</tr>
<tr class="even">
<td>E0235</td>
<td>0010</td>
<td>3</td>
<td>Paraffin bath unit, portable (see medical supply code a4265 for paraffin)</td>
<td>Paraffin bath unit portable</td>
</tr>
<tr class="odd">
<td>E0236</td>
<td>0010</td>
<td>3</td>
<td>Pump for water circulating pad</td>
<td>Pump for water circulating p</td>
</tr>
<tr class="even">
<td>E0239</td>
<td>0010</td>
<td>3</td>
<td>Hydrocollator unit, portable</td>
<td>Hydrocollator unit portable</td>
</tr>
<tr class="odd">
<td>E0240</td>
<td>0010</td>
<td>3</td>
<td>Bath/shower chair, with or without wheels, any size</td>
<td>Bath/shower chair</td>
</tr>
<tr class="even">
<td>E0241</td>
<td>0010</td>
<td>3</td>
<td>Bath tub wall rail, each</td>
<td>Bath tub wall rail</td>
</tr>
<tr class="odd">
<td>E0242</td>
<td>0010</td>
<td>3</td>
<td>Bath tub rail, floor base</td>
<td>Bath tub rail floor</td>
</tr>
<tr class="even">
<td>E0243</td>
<td>0010</td>
<td>3</td>
<td>Toilet rail, each</td>
<td>Toilet rail</td>
</tr>
<tr class="odd">
<td>E0244</td>
<td>0010</td>
<td>3</td>
<td>Raised toilet seat</td>
<td>Toilet seat raised</td>
</tr>
<tr class="even">
<td>E0245</td>
<td>0010</td>
<td>3</td>
<td>Tub stool or bench</td>
<td>Tub stool or bench</td>
</tr>
<tr class="odd">
<td>E0246</td>
<td>0010</td>
<td>3</td>
<td>Transfer tub rail attachment</td>
<td>Transfer tub rail attachment</td>
</tr>
<tr class="even">
<td>E0247</td>
<td>0010</td>
<td>3</td>
<td>Transfer bench for tub or toilet with or without commode opening</td>
<td>Trans bench w/wo comm open</td>
</tr>
<tr class="odd">
<td>E0248</td>
<td>0010</td>
<td>3</td>
<td>Transfer bench, heavy duty, for tub or toilet with or without commode opening</td>
<td>Hdtrans bench w/wo comm open</td>
</tr>
<tr class="even">
<td>E0249</td>
<td>0010</td>
<td>3</td>
<td>Pad for water circulating heat unit, for replacement only</td>
<td>Pad water circulating heat u</td>
</tr>
<tr class="odd">
<td>E0250</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, fixed height, with any type side rails, with mattress</td>
<td>Hosp bed fixed ht w/ mattres</td>
</tr>
<tr class="even">
<td>E0251</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, fixed height, with any type side rails, without mattress</td>
<td>Hosp bed fixd ht w/o mattres</td>
</tr>
<tr class="odd">
<td>E0255</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, variable height, hi-lo, with any type side rails, with mattress</td>
<td>Hospital bed var ht w/ mattr</td>
</tr>
<tr class="even">
<td>E0256</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, variable height, hi-lo, with any type side rails, without mattress</td>
<td>Hospital bed var ht w/o matt</td>
</tr>
<tr class="odd">
<td>E0260</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress</td>
<td>Hosp bed semi-electr w/ matt</td>
</tr>
<tr class="even">
<td>E0261</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, semi-electric (head and foot adjustment), with any type side rails, without mattress</td>
<td>Hosp bed semi-electr w/o mat</td>
</tr>
<tr class="odd">
<td>E0265</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, total electric (head, foot and height adjustments), with any type side rails, with mattress</td>
<td>Hosp bed total electr w/ mat</td>
</tr>
<tr class="even">
<td>E0266</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, total electric (head, foot and height adjustments), with any type side rails, without mattress</td>
<td>Hosp bed total elec w/o matt</td>
</tr>
<tr class="odd">
<td>E0270</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, institutional type includes: oscillating, circulating and stryker frame, with mattress</td>
<td>Hospital bed institutional t</td>
</tr>
<tr class="even">
<td>E0271</td>
<td>0010</td>
<td>3</td>
<td>Mattress, innerspring</td>
<td>Mattress innerspring</td>
</tr>
<tr class="odd">
<td>E0272</td>
<td>0010</td>
<td>3</td>
<td>Mattress, foam rubber</td>
<td>Mattress foam rubber</td>
</tr>
<tr class="even">
<td>E0273</td>
<td>0010</td>
<td>3</td>
<td>Bed board</td>
<td>Bed board</td>
</tr>
<tr class="odd">
<td>E0274</td>
<td>0010</td>
<td>3</td>
<td>Over-bed table</td>
<td>Over-bed table</td>
</tr>
<tr class="even">
<td>E0275</td>
<td>0010</td>
<td>3</td>
<td>Bed pan, standard, metal or plastic</td>
<td>Bed pan standard</td>
</tr>
<tr class="odd">
<td>E0276</td>
<td>0010</td>
<td>3</td>
<td>Bed pan, fracture, metal or plastic</td>
<td>Bed pan fracture</td>
</tr>
<tr class="even">
<td>E0277</td>
<td>0010</td>
<td>3</td>
<td>Powered pressure-reducing air mattress</td>
<td>Powered pres-redu air mattrs</td>
</tr>
<tr class="odd">
<td>E0280</td>
<td>0010</td>
<td>3</td>
<td>Bed cradle, any type</td>
<td>Bed cradle</td>
</tr>
<tr class="even">
<td>E0290</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, fixed height, without side rails, with mattress</td>
<td>Hosp bed fx ht w/o rails w/m</td>
</tr>
<tr class="odd">
<td>E0291</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, fixed height, without side rails, without mattress</td>
<td>Hosp bed fx ht w/o rail w/o</td>
</tr>
<tr class="even">
<td>E0292</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, variable height, hi-lo, without side rails, with mattress</td>
<td>Hosp bed var ht no sr w/matt</td>
</tr>
<tr class="odd">
<td>E0293</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, variable height, hi-lo, without side rails, without mattress</td>
<td>Hosp bed var ht no sr no mat</td>
</tr>
<tr class="even">
<td>E0294</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, semi-electric (head and foot adjustment), without side rails, with mattress</td>
<td>Hosp bed semi-elect w/ mattr</td>
</tr>
<tr class="odd">
<td>E0295</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, semi-electric (head and foot adjustment), without side rails, without mattress</td>
<td>Hosp bed semi-elect w/o matt</td>
</tr>
<tr class="even">
<td>E0296</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, total electric (head, foot and height adjustments), without side rails, with mattress</td>
<td>Hosp bed total elect w/ matt</td>
</tr>
<tr class="odd">
<td>E0297</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, total electric (head, foot and height adjustments), without side rails, without mattress</td>
<td>Hosp bed total elect w/o mat</td>
</tr>
<tr class="even">
<td>E0300</td>
<td>0010</td>
<td>3</td>
<td>Pediatric crib, hospital grade, fully enclosed, with or without top enclosure</td>
<td>Enclosed ped crib hosp grade</td>
</tr>
<tr class="odd">
<td>E0301</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, heavy duty, extra wide, with weight capacity greater than 350 pounds, but less than or equal to 600 pounds, with any type side rails, without mattress</td>
<td>Hd hosp bed, 350-600 lbs</td>
</tr>
<tr class="even">
<td>E0302</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, extra heavy duty, extra wide, with weight capacity greater than 600 pounds, with any type side rails, without mattress</td>
<td>Ex hd hosp bed &gt; 600 lbs</td>
</tr>
<tr class="odd">
<td>E0303</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, heavy duty, extra wide, with weight capacity greater than 350 pounds, but less than or equal to 600 pounds, with any type side rails, with mattress</td>
<td>Hosp bed hvy dty xtra wide</td>
</tr>
<tr class="even">
<td>E0304</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, extra heavy duty, extra wide, with weight capacity greater than 600 pounds, with any type side rails, with mattress</td>
<td>Hosp bed xtra hvy dty x wide</td>
</tr>
<tr class="odd">
<td>E0305</td>
<td>0010</td>
<td>3</td>
<td>Bed side rails, half length</td>
<td>Rails bed side half length</td>
</tr>
<tr class="even">
<td>E0310</td>
<td>0010</td>
<td>3</td>
<td>Bed side rails, full length</td>
<td>Rails bed side full length</td>
</tr>
<tr class="odd">
<td>E0315</td>
<td>0010</td>
<td>3</td>
<td>Bed accessory: board, table, or support device, any type</td>
<td>Bed accessory brd/tbl/supprt</td>
</tr>
<tr class="even">
<td>E0316</td>
<td>0010</td>
<td>3</td>
<td>Safety enclosure frame/canopy for use with hospital bed, any type</td>
<td>Bed safety enclosure</td>
</tr>
<tr class="odd">
<td>E0325</td>
<td>0010</td>
<td>3</td>
<td>Urinal; male, jug-type, any material</td>
<td>Urinal male jug-type</td>
</tr>
<tr class="even">
<td>E0326</td>
<td>0010</td>
<td>3</td>
<td>Urinal; female, jug-type, any material</td>
<td>Urinal female jug-type</td>
</tr>
<tr class="odd">
<td>E0328</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, pediatric, manual, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress</td>
<td>Ped hospital bed, manual</td>
</tr>
<tr class="even">
<td>E0329</td>
<td>0010</td>
<td>3</td>
<td>Hospital bed, pediatric, electric or semi-electric, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress</td>
<td>Ped hospital bed semi/elect</td>
</tr>
<tr class="odd">
<td>E0350</td>
<td>0010</td>
<td>3</td>
<td>Control unit for electronic bowel irrigation/evacuation system</td>
<td>Control unit bowel system</td>
</tr>
<tr class="even">
<td>E0352</td>
<td>0010</td>
<td>3</td>
<td>Disposable pack (water reservoir bag, speculum, valving mechanism and collection bag/box) for use with the electronic bowel irrigation/evacuation system</td>
<td>Disposable pack w/bowel syst</td>
</tr>
<tr class="odd">
<td>E0370</td>
<td>0010</td>
<td>3</td>
<td>Air pressure elevator for heel</td>
<td>Air elevator for heel</td>
</tr>
<tr class="even">
<td>E0371</td>
<td>0010</td>
<td>3</td>
<td>Nonpowered advanced pressure reducing overlay for mattress, standard mattress length and width</td>
<td>Nonpower mattress overlay</td>
</tr>
<tr class="odd">
<td>E0372</td>
<td>0010</td>
<td>3</td>
<td>Powered air overlay for mattress, standard mattress length and width</td>
<td>Powered air mattress overlay</td>
</tr>
<tr class="even">
<td>E0373</td>
<td>0010</td>
<td>3</td>
<td>Nonpowered advanced pressure reducing mattress</td>
<td>Nonpowered pressure mattress</td>
</tr>
<tr class="odd">
<td>E0424</td>
<td>0010</td>
<td>3</td>
<td>Stationary compressed gaseous oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing</td>
<td>Stationary compressed gas 02</td>
</tr>
<tr class="even">
<td>E0425</td>
<td>0010</td>
<td>3</td>
<td>Stationary compressed gas system, purchase; includes regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing</td>
<td>Gas system stationary compre</td>
</tr>
<tr class="odd">
<td>E0430</td>
<td>0010</td>
<td>3</td>
<td>Portable gaseous oxygen system, purchase; includes regulator, flowmeter, humidifier, cannula or mask, and tubing</td>
<td>Oxygen system gas portable</td>
</tr>
<tr class="even">
<td>E0431</td>
<td>0010</td>
<td>3</td>
<td>Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing</td>
<td>Portable gaseous 02</td>
</tr>
<tr class="odd">
<td>E0433</td>
<td>0010</td>
<td>3</td>
<td>Portable liquid oxygen system, rental; home liquefier used to fill portable liquid oxygen containers, includes portable containers, regulator, flowmeter, humidifier, cannula or mask and tubing, with or without supply reservoir and contents gauge</td>
<td>Portable liquid oxygen sys</td>
</tr>
<tr class="even">
<td>E0434</td>
<td>0010</td>
<td>3</td>
<td>Portable liquid oxygen system, rental; includes portable container, supply reservoir, humidifier, flowmeter, refill adaptor, contents gauge, cannula or mask, and tubing</td>
<td>Portable liquid 02</td>
</tr>
<tr class="odd">
<td>E0435</td>
<td>0010</td>
<td>3</td>
<td>Portable liquid oxygen system, purchase; includes portable container, supply reservoir, flowmeter, humidifier, contents gauge, cannula or mask, tubing and refill adaptor</td>
<td>Oxygen system liquid portabl</td>
</tr>
<tr class="even">
<td>E0439</td>
<td>0010</td>
<td>3</td>
<td>Stationary liquid oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, &amp; tubing</td>
<td>Stationary liquid 02</td>
</tr>
<tr class="odd">
<td>E0440</td>
<td>0010</td>
<td>3</td>
<td>Stationary liquid oxygen system, purchase; includes use of reservoir, contents indicator, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing</td>
<td>Oxygen system liquid station</td>
</tr>
<tr class="even">
<td>E0441</td>
<td>0010</td>
<td>3</td>
<td>Stationary oxygen contents, gaseous, 1 month’s supply = 1 unit</td>
<td>Stationary o2 contents, gas</td>
</tr>
<tr class="odd">
<td>E0442</td>
<td>0010</td>
<td>3</td>
<td>Stationary oxygen contents, liquid, 1 month’s supply = 1 unit</td>
<td>Stationary o2 contents, liq</td>
</tr>
<tr class="even">
<td>E0443</td>
<td>0010</td>
<td>3</td>
<td>Portable oxygen contents, gaseous, 1 month’s supply = 1 unit</td>
<td>Portable 02 contents, gas</td>
</tr>
<tr class="odd">
<td>E0444</td>
<td>0010</td>
<td>3</td>
<td>Portable oxygen contents, liquid, 1 month’s supply = 1 unit</td>
<td>Portable 02 contents, liquid</td>
</tr>
<tr class="even">
<td>E0445</td>
<td>0010</td>
<td>3</td>
<td>Oximeter device for measuring blood oxygen levels non-invasively</td>
<td>Oximeter non-invasive</td>
</tr>
<tr class="odd">
<td>E0446</td>
<td>0010</td>
<td>3</td>
<td>Topical oxygen delivery system, not otherwise specified, includes all supplies and accessories</td>
<td>Topical ox deliver sys, nos</td>
</tr>
<tr class="even">
<td>E0447</td>
<td>0010</td>
<td>3</td>
<td>Portable oxygen contents, liquid, 1 month’s supply = 1 unit, prescribed amount at rest or nighttime exceeds 4 liters per minute (lpm)</td>
<td>Port o2 cont, liq over 4 lpm</td>
</tr>
<tr class="odd">
<td>E0450</td>
<td>0010</td>
<td>3</td>
<td>Volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)</td>
<td>Vol control vent invasiv int</td>
</tr>
<tr class="even">
<td>E0455</td>
<td>0010</td>
<td>3</td>
<td>Oxygen tent, excluding croup or pediatric tents</td>
<td>Oxygen tent excl croup/ped t</td>
</tr>
<tr class="odd">
<td>E0457</td>
<td>0010</td>
<td>3</td>
<td>Chest shell (cuirass)</td>
<td>Chest shell</td>
</tr>
<tr class="even">
<td>E0459</td>
<td>0010</td>
<td>3</td>
<td>Chest wrap</td>
<td>Chest wrap</td>
</tr>
<tr class="odd">
<td>E0460</td>
<td>0010</td>
<td>3</td>
<td>Negative pressure ventilator; portable or stationary</td>
<td>Neg press vent portabl/statn</td>
</tr>
<tr class="even">
<td>E0461</td>
<td>0010</td>
<td>3</td>
<td>Volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask)</td>
<td>Vol control vent noninv int</td>
</tr>
<tr class="odd">
<td>E0462</td>
<td>0010</td>
<td>3</td>
<td>Rocking bed with or without side rails</td>
<td>Rocking bed w/ or w/o side r</td>
</tr>
<tr class="even">
<td>E0463</td>
<td>0010</td>
<td>3</td>
<td>Pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)</td>
<td>Press supp vent invasive int</td>
</tr>
<tr class="odd">
<td>E0464</td>
<td>0010</td>
<td>3</td>
<td>Pressure support ventilator with volume control mode, may include pressure control mode, used with non-invasive interface (e.g., mask)</td>
<td>Press supp vent noninv int</td>
</tr>
<tr class="even">
<td>E0465</td>
<td>0010</td>
<td>3</td>
<td>Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)</td>
<td>Home vent invasive interface</td>
</tr>
<tr class="odd">
<td>E0466</td>
<td>0010</td>
<td>3</td>
<td>Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)</td>
<td>Home vent non-invasive inter</td>
</tr>
<tr class="even">
<td>E0467</td>
<td>0010</td>
<td>3</td>
<td>Home ventilator, multi-function respiratory device, also performs any or all of the additional functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation, includes all accessories, components and supplies for all functions</td>
<td>Home vent multi-function</td>
</tr>
<tr class="odd">
<td>E0470</td>
<td>0010</td>
<td>3</td>
<td>Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)</td>
<td>Rad w/o backup non-inv intfc</td>
</tr>
<tr class="even">
<td>E0471</td>
<td>0010</td>
<td>3</td>
<td>Respiratory assist device, bi-level pressure capability, with back-up rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)</td>
<td>Rad w/backup non inv intrfc</td>
</tr>
<tr class="odd">
<td>E0472</td>
<td>0010</td>
<td>3</td>
<td>Respiratory assist device, bi-level pressure capability, with backup rate feature, used with invasive interface, e.g., tracheostomy tube (intermittent assist device with continuous positive airway pressure device)</td>
<td>Rad w backup invasive intrfc</td>
</tr>
<tr class="even">
<td>E0480</td>
<td>0010</td>
<td>3</td>
<td>Percussor, electric or pneumatic, home model</td>
<td>Percussor elect/pneum home m</td>
</tr>
<tr class="odd">
<td>E0481</td>
<td>0010</td>
<td>3</td>
<td>Intrapulmonary percussive ventilation system and related accessories</td>
<td>Intrpulmnry percuss vent sys</td>
</tr>
<tr class="even">
<td>E0482</td>
<td>0010</td>
<td>3</td>
<td>Cough stimulating device, alternating positive and negative airway pressure</td>
<td>Cough stimulating device</td>
</tr>
<tr class="odd">
<td>E0483</td>
<td>0010</td>
<td>3</td>
<td>High frequency chest wall oscillation system, includes all accessories and supplies, each</td>
<td>Hi freq chest wall oscil sys</td>
</tr>
<tr class="even">
<td>E0484</td>
<td>0010</td>
<td>3</td>
<td>Oscillatory positive expiratory pressure device, non-electric, any type, each</td>
<td>Non-elec oscillatory pep dvc</td>
</tr>
<tr class="odd">
<td>E0485</td>
<td>0010</td>
<td>3</td>
<td>Oral device/appliance used to reduce upper airway collapsibility, adjustable or non-adjustable, prefabricated, includes fitting and adjustment</td>
<td>Oral device/appliance prefab</td>
</tr>
<tr class="even">
<td>E0486</td>
<td>0010</td>
<td>3</td>
<td>Oral device/appliance used to reduce upper airway collapsibility, adjustable or non-adjustable, custom fabricated, includes fitting and adjustment</td>
<td>Oral device/appliance cusfab</td>
</tr>
<tr class="odd">
<td>E0487</td>
<td>0010</td>
<td>3</td>
<td>Spirometer, electronic, includes all accessories</td>
<td>Electronic spirometer</td>
</tr>
<tr class="even">
<td>E0500</td>
<td>0010</td>
<td>3</td>
<td>Ippb machine, all types, with built-in nebulization; manual or automatic valves; internal or external power source</td>
<td>Ippb all types</td>
</tr>
<tr class="odd">
<td>E0550</td>
<td>0010</td>
<td>3</td>
<td>Humidifier, durable for extensive supplemental humidification during ippb treatments or oxygen delivery</td>
<td>Humidif extens supple w ippb</td>
</tr>
<tr class="even">
<td>E0555</td>
<td>0010</td>
<td>3</td>
<td>Humidifier, durable, glass or autoclavable plastic bottle type, for use with regulator or flowmeter</td>
<td>Humidifier for use w/ regula</td>
</tr>
<tr class="odd">
<td>E0560</td>
<td>0010</td>
<td>3</td>
<td>Humidifier, durable for supplemental humidification during ippb treatment or oxygen delivery</td>
<td>Humidifier supplemental w/ i</td>
</tr>
<tr class="even">
<td>E0561</td>
<td>0010</td>
<td>3</td>
<td>Humidifier, non-heated, used with positive airway pressure device</td>
<td>Humidifier nonheated w pap</td>
</tr>
<tr class="odd">
<td>E0562</td>
<td>0010</td>
<td>3</td>
<td>Humidifier, heated, used with positive airway pressure device</td>
<td>Humidifier heated used w pap</td>
</tr>
<tr class="even">
<td>E0565</td>
<td>0010</td>
<td>3</td>
<td>Compressor, air power source for equipment which is not self-contained or cylinder driven</td>
<td>Compressor air power source</td>
</tr>
<tr class="odd">
<td>E0570</td>
<td>0010</td>
<td>3</td>
<td>Nebulizer, with compressor</td>
<td>Nebulizer with compression</td>
</tr>
<tr class="even">
<td>E0572</td>
<td>0010</td>
<td>3</td>
<td>Aerosol compressor, adjustable pressure, light duty for intermittent use</td>
<td>Aerosol compressor adjust pr</td>
</tr>
<tr class="odd">
<td>E0574</td>
<td>0010</td>
<td>3</td>
<td>Ultrasonic/electronic aerosol generator with small volume nebulizer</td>
<td>Ultrasonic generator w svneb</td>
</tr>
<tr class="even">
<td>E0575</td>
<td>0010</td>
<td>3</td>
<td>Nebulizer, ultrasonic, large volume</td>
<td>Nebulizer ultrasonic</td>
</tr>
<tr class="odd">
<td>E0580</td>
<td>0010</td>
<td>3</td>
<td>Nebulizer, durable, glass or autoclavable plastic, bottle type, for use with regulator or flowmeter</td>
<td>Nebulizer for use w/ regulat</td>
</tr>
<tr class="even">
<td>E0585</td>
<td>0010</td>
<td>3</td>
<td>Nebulizer, with compressor and heater</td>
<td>Nebulizer w/ compressor &amp; he</td>
</tr>
<tr class="odd">
<td>E0600</td>
<td>0010</td>
<td>3</td>
<td>Respiratory suction pump, home model, portable or stationary, electric</td>
<td>Suction pump portab hom modl</td>
</tr>
<tr class="even">
<td>E0601</td>
<td>0010</td>
<td>3</td>
<td>Continuous positive airway pressure (cpap) device</td>
<td>Cont airway pressure device</td>
</tr>
<tr class="odd">
<td>E0602</td>
<td>0010</td>
<td>3</td>
<td>Breast pump, manual, any type</td>
<td>Manual breast pump</td>
</tr>
<tr class="even">
<td>E0603</td>
<td>0010</td>
<td>3</td>
<td>Breast pump, electric (ac and/or dc), any type</td>
<td>Electric breast pump</td>
</tr>
<tr class="odd">
<td>E0604</td>
<td>0010</td>
<td>3</td>
<td>Breast pump, hospital grade, electric (ac and / or dc), any type</td>
<td>Hosp grade elec breast pump</td>
</tr>
<tr class="even">
<td>E0605</td>
<td>0010</td>
<td>3</td>
<td>Vaporizer, room type</td>
<td>Vaporizer room type</td>
</tr>
<tr class="odd">
<td>E0606</td>
<td>0010</td>
<td>3</td>
<td>Postural drainage board</td>
<td>Drainage board postural</td>
</tr>
<tr class="even">
<td>E0607</td>
<td>0010</td>
<td>3</td>
<td>Home blood glucose monitor</td>
<td>Blood glucose monitor home</td>
</tr>
<tr class="odd">
<td>E0610</td>
<td>0010</td>
<td>3</td>
<td>Pacemaker monitor, self-contained, (checks battery depletion, includes audible and visible check systems)</td>
<td>Pacemaker monitr audible/vis</td>
</tr>
<tr class="even">
<td>E0615</td>
<td>0010</td>
<td>3</td>
<td>Pacemaker monitor, self contained, checks battery depletion and other pacemaker components, includes digital/visible check systems</td>
<td>Pacemaker monitr digital/vis</td>
</tr>
<tr class="odd">
<td>E0616</td>
<td>0010</td>
<td>3</td>
<td>Implantable cardiac event recorder with memory, activator and programmer</td>
<td>Cardiac event recorder</td>
</tr>
<tr class="even">
<td>E0617</td>
<td>0010</td>
<td>3</td>
<td>External defibrillator with integrated electrocardiogram analysis</td>
<td>Automatic ext defibrillator</td>
</tr>
<tr class="odd">
<td>E0618</td>
<td>0010</td>
<td>3</td>
<td>Apnea monitor, without recording feature</td>
<td>Apnea monitor</td>
</tr>
<tr class="even">
<td>E0619</td>
<td>0010</td>
<td>3</td>
<td>Apnea monitor, with recording feature</td>
<td>Apnea monitor w recorder</td>
</tr>
<tr class="odd">
<td>E0620</td>
<td>0010</td>
<td>3</td>
<td>Skin piercing device for collection of capillary blood, laser, each</td>
<td>Cap bld skin piercing laser</td>
</tr>
<tr class="even">
<td>E0621</td>
<td>0010</td>
<td>3</td>
<td>Sling or seat, patient lift, canvas or nylon</td>
<td>Patient lift sling or seat</td>
</tr>
<tr class="odd">
<td>E0625</td>
<td>0010</td>
<td>3</td>
<td>Patient lift, bathroom or toilet, not otherwise classified</td>
<td>Patient lift bathroom or toi</td>
</tr>
<tr class="even">
<td>E0627</td>
<td>0010</td>
<td>3</td>
<td>Seat lift mechanism, electric, any type</td>
<td>Seat lift mech, electric any</td>
</tr>
<tr class="odd">
<td>E0628</td>
<td>0010</td>
<td>3</td>
<td>Separate seat lift mechanism for use with patient owned furniture-electric</td>
<td>Seat lift for pt furn-electr</td>
</tr>
<tr class="even">
<td>E0629</td>
<td>0010</td>
<td>3</td>
<td>Seat lift mechanism, non-electric, any type</td>
<td>Seat lift mech, non-electric</td>
</tr>
<tr class="odd">
<td>E0630</td>
<td>0010</td>
<td>3</td>
<td>Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)</td>
<td>Patient lift hydraulic</td>
</tr>
<tr class="even">
<td>E0635</td>
<td>0010</td>
<td>3</td>
<td>Patient lift, electric with seat or sling</td>
<td>Patient lift electric</td>
</tr>
<tr class="odd">
<td>E0636</td>
<td>0010</td>
<td>3</td>
<td>Multipositional patient support system, with integrated lift, patient accessible controls</td>
<td>Pt support &amp; positioning sys</td>
</tr>
<tr class="even">
<td>E0637</td>
<td>0010</td>
<td>3</td>
<td>Combination sit to stand frame/table system, any size including pediatric, with seat lift feature, with or without wheels</td>
<td>Combination sit to stand sys</td>
</tr>
<tr class="odd">
<td>E0638</td>
<td>0010</td>
<td>3</td>
<td>Standing frame/table system, one position (e.g., upright, supine or prone stander), any size including pediatric, with or without wheels</td>
<td>Standing frame sys</td>
</tr>
<tr class="even">
<td>E0639</td>
<td>0010</td>
<td>3</td>
<td>Patient lift, moveable from room to room with disassembly and reassembly, includes all components/accessories</td>
<td>Moveable patient lift system</td>
</tr>
<tr class="odd">
<td>E0640</td>
<td>0010</td>
<td>3</td>
<td>Patient lift, fixed system, includes all components/accessories</td>
<td>Fixed patient lift system</td>
</tr>
<tr class="even">
<td>E0641</td>
<td>0010</td>
<td>3</td>
<td>Standing frame/table system, multi-position (e.g., three-way stander), any size including pediatric, with or without wheels</td>
<td>Multi-position stnd fram sys</td>
</tr>
<tr class="odd">
<td>E0642</td>
<td>0010</td>
<td>3</td>
<td>Standing frame/table system, mobile (dynamic stander), any size including pediatric</td>
<td>Dynamic standing frame</td>
</tr>
<tr class="even">
<td>E0650</td>
<td>0010</td>
<td>3</td>
<td>Pneumatic compressor, non-segmental home model</td>
<td>Pneuma compresor non-segment</td>
</tr>
<tr class="odd">
<td>E0651</td>
<td>0010</td>
<td>3</td>
<td>Pneumatic compressor, segmental home model without calibrated gradient pressure</td>
<td>Pneum compressor segmental</td>
</tr>
<tr class="even">
<td>E0652</td>
<td>0010</td>
<td>3</td>
<td>Pneumatic compressor, segmental home model with calibrated gradient pressure</td>
<td>Pneum compres w/cal pressure</td>
</tr>
<tr class="odd">
<td>E0655</td>
<td>0010</td>
<td>3</td>
<td>Non-segmental pneumatic appliance for use with pneumatic compressor, half arm</td>
<td>Pneumatic appliance half arm</td>
</tr>
<tr class="even">
<td>E0656</td>
<td>0010</td>
<td>3</td>
<td>Segmental pneumatic appliance for use with pneumatic compressor, trunk</td>
<td>Segmental pneumatic trunk</td>
</tr>
<tr class="odd">
<td>E0657</td>
<td>0010</td>
<td>3</td>
<td>Segmental pneumatic appliance for use with pneumatic compressor, chest</td>
<td>Segmental pneumatic chest</td>
</tr>
<tr class="even">
<td>E0660</td>
<td>0010</td>
<td>3</td>
<td>Non-segmental pneumatic appliance for use with pneumatic compressor, full leg</td>
<td>Pneumatic appliance full leg</td>
</tr>
<tr class="odd">
<td>E0665</td>
<td>0010</td>
<td>3</td>
<td>Non-segmental pneumatic appliance for use with pneumatic compressor, full arm</td>
<td>Pneumatic appliance full arm</td>
</tr>
<tr class="even">
<td>E0666</td>
<td>0010</td>
<td>3</td>
<td>Non-segmental pneumatic appliance for use with pneumatic compressor, half leg</td>
<td>Pneumatic appliance half leg</td>
</tr>
<tr class="odd">
<td>E0667</td>
<td>0010</td>
<td>3</td>
<td>Segmental pneumatic appliance for use with pneumatic compressor, full leg</td>
<td>Seg pneumatic appl full leg</td>
</tr>
<tr class="even">
<td>E0668</td>
<td>0010</td>
<td>3</td>
<td>Segmental pneumatic appliance for use with pneumatic compressor, full arm</td>
<td>Seg pneumatic appl full arm</td>
</tr>
<tr class="odd">
<td>E0669</td>
<td>0010</td>
<td>3</td>
<td>Segmental pneumatic appliance for use with pneumatic compressor, half leg</td>
<td>Seg pneumatic appli half leg</td>
</tr>
<tr class="even">
<td>E0670</td>
<td>0010</td>
<td>3</td>
<td>Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full legs and trunk</td>
<td>Seg pneum int legs/trunk</td>
</tr>
<tr class="odd">
<td>E0671</td>
<td>0010</td>
<td>3</td>
<td>Segmental gradient pressure pneumatic appliance, full leg</td>
<td>Pressure pneum appl full leg</td>
</tr>
<tr class="even">
<td>E0672</td>
<td>0010</td>
<td>3</td>
<td>Segmental gradient pressure pneumatic appliance, full arm</td>
<td>Pressure pneum appl full arm</td>
</tr>
<tr class="odd">
<td>E0673</td>
<td>0010</td>
<td>3</td>
<td>Segmental gradient pressure pneumatic appliance, half leg</td>
<td>Pressure pneum appl half leg</td>
</tr>
<tr class="even">
<td>E0675</td>
<td>0010</td>
<td>3</td>
<td>Pneumatic compression device, high pressure, rapid inflation/deflation cycle, for arterial insufficiency (unilateral or bilateral system)</td>
<td>Pneumatic compression device</td>
</tr>
<tr class="odd">
<td>E0676</td>
<td>0010</td>
<td>3</td>
<td>Intermittent limb compression device (includes all accessories), not otherwise specified</td>
<td>Inter limb compress dev nos</td>
</tr>
<tr class="even">
<td>E0691</td>
<td>0010</td>
<td>3</td>
<td>Ultraviolet light therapy system, includes bulbs/lamps, timer and eye protection; treatment area 2 square feet or less</td>
<td>Uvl pnl 2 sq ft or less</td>
</tr>
<tr class="odd">
<td>E0692</td>
<td>0010</td>
<td>3</td>
<td>Ultraviolet light therapy system panel, includes bulbs/lamps, timer and eye protection, 4 foot panel</td>
<td>Uvl sys panel 4 ft</td>
</tr>
<tr class="even">
<td>E0693</td>
<td>0010</td>
<td>3</td>
<td>Ultraviolet light therapy system panel, includes bulbs/lamps, timer and eye protection, 6 foot panel</td>
<td>Uvl sys panel 6 ft</td>
</tr>
<tr class="odd">
<td>E0694</td>
<td>0010</td>
<td>3</td>
<td>Ultraviolet multidirectional light therapy system in 6 foot cabinet, includes bulbs/lamps, timer and eye protection</td>
<td>Uvl md cabinet sys 6 ft</td>
</tr>
<tr class="even">
<td>E0700</td>
<td>0010</td>
<td>3</td>
<td>Safety equipment, device or accessory, any type</td>
<td>Safety equipment</td>
</tr>
<tr class="odd">
<td>E0705</td>
<td>0010</td>
<td>3</td>
<td>Transfer device, any type, each</td>
<td>Transfer device</td>
</tr>
<tr class="even">
<td>E0710</td>
<td>0010</td>
<td>3</td>
<td>Restraints, any type (body, chest, wrist or ankle)</td>
<td>Restraints any type</td>
</tr>
<tr class="odd">
<td>E0720</td>
<td>0010</td>
<td>3</td>
<td>Transcutaneous electrical nerve stimulation (tens) device, two lead, localized stimulation</td>
<td>Tens two lead</td>
</tr>
<tr class="even">
<td>E0730</td>
<td>0010</td>
<td>3</td>
<td>Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation</td>
<td>Tens four lead</td>
</tr>
<tr class="odd">
<td>E0731</td>
<td>0010</td>
<td>3</td>
<td>Form fitting conductive garment for delivery of tens or nmes (with conductive fibers separated from the patient’s skin by layers of fabric)</td>
<td>Conductive garment for tens/</td>
</tr>
<tr class="even">
<td>E0740</td>
<td>0010</td>
<td>3</td>
<td>Non-implanted pelvic floor electrical stimulator, complete system</td>
<td>Non-implant pelv flr e-stim</td>
</tr>
<tr class="odd">
<td>E0744</td>
<td>0010</td>
<td>3</td>
<td>Neuromuscular stimulator for scoliosis</td>
<td>Neuromuscular stim for scoli</td>
</tr>
<tr class="even">
<td>E0745</td>
<td>0010</td>
<td>3</td>
<td>Neuromuscular stimulator, electronic shock unit</td>
<td>Neuromuscular stim for shock</td>
</tr>
<tr class="odd">
<td>E0746</td>
<td>0010</td>
<td>3</td>
<td>Electromyography (emg), biofeedback device</td>
<td>Electromyograph biofeedback</td>
</tr>
<tr class="even">
<td>E0747</td>
<td>0010</td>
<td>3</td>
<td>Osteogenesis stimulator, electrical, non-invasive, other than spinal applications</td>
<td>Elec osteogen stim not spine</td>
</tr>
<tr class="odd">
<td>E0748</td>
<td>0010</td>
<td>3</td>
<td>Osteogenesis stimulator, electrical, non-invasive, spinal applications</td>
<td>Elec osteogen stim spinal</td>
</tr>
<tr class="even">
<td>E0749</td>
<td>0010</td>
<td>3</td>
<td>Osteogenesis stimulator, electrical, surgically implanted</td>
<td>Elec osteogen stim implanted</td>
</tr>
<tr class="odd">
<td>E0755</td>
<td>0010</td>
<td>3</td>
<td>Electronic salivary reflex stimulator (intra-oral/non-invasive)</td>
<td>Electronic salivary reflex s</td>
</tr>
<tr class="even">
<td>E0760</td>
<td>0010</td>
<td>3</td>
<td>Osteogenesis stimulator, low intensity ultrasound, non-invasive</td>
<td>Osteogen ultrasound stimltor</td>
</tr>
<tr class="odd">
<td>E0761</td>
<td>0010</td>
<td>3</td>
<td>Non-thermal pulsed high frequency radiowaves, high peak power electromagnetic energy treatment device</td>
<td>Nontherm electromgntc device</td>
</tr>
<tr class="even">
<td>E0762</td>
<td>0010</td>
<td>3</td>
<td>Transcutaneous electrical joint stimulation device system, includes all accessories</td>
<td>Trans elec jt stim dev sys</td>
</tr>
<tr class="odd">
<td>E0764</td>
<td>0010</td>
<td>3</td>
<td>Functional neuromuscular stimulation, transcutaneous stimulation of sequential muscle groups of ambulation with computer control, used for walking by spinal cord injured, entire system, after completion of training program</td>
<td>Functional neuromuscularstim</td>
</tr>
<tr class="even">
<td>E0765</td>
<td>0010</td>
<td>3</td>
<td>Fda approved nerve stimulator, with replaceable batteries, for treatment of nausea and vomiting</td>
<td>Nerve stimulator for tx n&amp;v</td>
</tr>
<tr class="odd">
<td>E0766</td>
<td>0010</td>
<td>3</td>
<td>Electrical stimulation device used for cancer treatment, includes all accessories, any type</td>
<td>Elec stim cancer treatment</td>
</tr>
<tr class="even">
<td>E0769</td>
<td>0010</td>
<td>3</td>
<td>Electrical stimulation or electromagnetic wound treatment device, not otherwise classified</td>
<td>Electric wound treatment dev</td>
</tr>
<tr class="odd">
<td>E0770</td>
<td>0010</td>
<td>3</td>
<td>Functional electrical stimulator, transcutaneous stimulation of nerve and/or muscle groups, any type, complete system, not otherwise specified</td>
<td>Functional electric stim nos</td>
</tr>
<tr class="even">
<td>E0776</td>
<td>0010</td>
<td>3</td>
<td>Iv pole</td>
<td>Iv pole</td>
</tr>
<tr class="odd">
<td>E0779</td>
<td>0010</td>
<td>3</td>
<td>Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater</td>
<td>Amb infusion pump mechanical</td>
</tr>
<tr class="even">
<td>E0780</td>
<td>0010</td>
<td>3</td>
<td>Ambulatory infusion pump, mechanical, reusable, for infusion less than 8 hours</td>
<td>Mech amb infusion pump &lt;8hrs</td>
</tr>
<tr class="odd">
<td>E0781</td>
<td>0010</td>
<td>3</td>
<td>Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient</td>
<td>External ambulatory infus pu</td>
</tr>
<tr class="even">
<td>E0782</td>
<td>0010</td>
<td>3</td>
<td>Infusion pump, implantable, non-programmable (includes all components, e.g., pump, catheter, connectors, etc.)</td>
<td>Non-programble infusion pump</td>
</tr>
<tr class="odd">
<td>E0783</td>
<td>0010</td>
<td>3</td>
<td>Infusion pump system, implantable, programmable (includes all components, e.g., pump, catheter, connectors, etc.)</td>
<td>Programmable infusion pump</td>
</tr>
<tr class="even">
<td>E0784</td>
<td>0010</td>
<td>3</td>
<td>External ambulatory infusion pump, insulin</td>
<td>Ext amb infusn pump insulin</td>
</tr>
<tr class="odd">
<td>E0785</td>
<td>0010</td>
<td>3</td>
<td>Implantable intraspinal (epidural/intrathecal) catheter used with implantable infusion pump, replacement</td>
<td>Replacement impl pump cathet</td>
</tr>
<tr class="even">
<td>E0786</td>
<td>0010</td>
<td>3</td>
<td>Implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter)</td>
<td>Implantable pump replacement</td>
</tr>
<tr class="odd">
<td>E0787</td>
<td>0010</td>
<td>3</td>
<td>External ambulatory infusion pump, insulin, dosage rate adjustment using therapeutic continuous glucose sensing</td>
<td>Cgs dose adj insulin inf pmp</td>
</tr>
<tr class="even">
<td>E0791</td>
<td>0010</td>
<td>3</td>
<td>Parenteral infusion pump, stationary, single or multi-channel</td>
<td>Parenteral infusion pump sta</td>
</tr>
<tr class="odd">
<td>E0830</td>
<td>0010</td>
<td>3</td>
<td>Ambulatory traction device, all types, each</td>
<td>Ambulatory traction device</td>
</tr>
<tr class="even">
<td>E0840</td>
<td>0010</td>
<td>3</td>
<td>Traction frame, attached to headboard, cervical traction</td>
<td>Tract frame attach headboard</td>
</tr>
<tr class="odd">
<td>E0849</td>
<td>0010</td>
<td>3</td>
<td>Traction equipment, cervical, free-standing stand/frame, pneumatic, applying traction force to other than mandible</td>
<td>Cervical pneum trac equip</td>
</tr>
<tr class="even">
<td>E0850</td>
<td>0010</td>
<td>3</td>
<td>Traction stand, free standing, cervical traction</td>
<td>Traction stand free standing</td>
</tr>
<tr class="odd">
<td>E0855</td>
<td>0010</td>
<td>3</td>
<td>Cervical traction equipment not requiring additional stand or frame</td>
<td>Cervical traction equipment</td>
</tr>
<tr class="even">
<td>E0856</td>
<td>0010</td>
<td>3</td>
<td>Cervical traction device, with inflatable air bladder(s)</td>
<td>Cervic collar w air bladders</td>
</tr>
<tr class="odd">
<td>E0860</td>
<td>0010</td>
<td>3</td>
<td>Traction equipment, overdoor, cervical</td>
<td>Tract equip cervical tract</td>
</tr>
<tr class="even">
<td>E0870</td>
<td>0010</td>
<td>3</td>
<td>Traction frame, attached to footboard, extremity traction, (e.g., buck’s)</td>
<td>Tract frame attach footboard</td>
</tr>
<tr class="odd">
<td>E0880</td>
<td>0010</td>
<td>3</td>
<td>Traction stand, free standing, extremity traction, (e.g., buck’s)</td>
<td>Trac stand free stand extrem</td>
</tr>
<tr class="even">
<td>E0890</td>
<td>0010</td>
<td>3</td>
<td>Traction frame, attached to footboard, pelvic traction</td>
<td>Traction frame attach pelvic</td>
</tr>
<tr class="odd">
<td>E0900</td>
<td>0010</td>
<td>3</td>
<td>Traction stand, free standing, pelvic traction, (e.g., buck’s)</td>
<td>Trac stand free stand pelvic</td>
</tr>
<tr class="even">
<td>E0910</td>
<td>0010</td>
<td>3</td>
<td>Trapeze bars, a/k/a patient helper, attached to bed, with grab bar</td>
<td>Trapeze bar attached to bed</td>
</tr>
<tr class="odd">
<td>E0911</td>
<td>0010</td>
<td>3</td>
<td>Trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds, attached to bed, with grab bar</td>
<td>Hd trapeze bar attach to bed</td>
</tr>
<tr class="even">
<td>E0912</td>
<td>0010</td>
<td>3</td>
<td>Trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds, free standing, complete with grab bar</td>
<td>Hd trapeze bar free standing</td>
</tr>
<tr class="odd">
<td>E0920</td>
<td>0010</td>
<td>3</td>
<td>Fracture frame, attached to bed, includes weights</td>
<td>Fracture frame attached to b</td>
</tr>
<tr class="even">
<td>E0930</td>
<td>0010</td>
<td>3</td>
<td>Fracture frame, free standing, includes weights</td>
<td>Fracture frame free standing</td>
</tr>
<tr class="odd">
<td>E0935</td>
<td>0010</td>
<td>3</td>
<td>Continuous passive motion exercise device for use on knee only</td>
<td>Cont pas motion exercise dev</td>
</tr>
<tr class="even">
<td>E0936</td>
<td>0010</td>
<td>3</td>
<td>Continuous passive motion exercise device for use other than knee</td>
<td>Cpm device, other than knee</td>
</tr>
<tr class="odd">
<td>E0940</td>
<td>0010</td>
<td>3</td>
<td>Trapeze bar, free standing, complete with grab bar</td>
<td>Trapeze bar free standing</td>
</tr>
<tr class="even">
<td>E0941</td>
<td>0010</td>
<td>3</td>
<td>Gravity assisted traction device, any type</td>
<td>Gravity assisted traction de</td>
</tr>
<tr class="odd">
<td>E0942</td>
<td>0010</td>
<td>3</td>
<td>Cervical head harness/halter</td>
<td>Cervical head harness/halter</td>
</tr>
<tr class="even">
<td>E0944</td>
<td>0010</td>
<td>3</td>
<td>Pelvic belt/harness/boot</td>
<td>Pelvic belt/harness/boot</td>
</tr>
<tr class="odd">
<td>E0945</td>
<td>0010</td>
<td>3</td>
<td>Extremity belt/harness</td>
<td>Belt/harness extremity</td>
</tr>
<tr class="even">
<td>E0946</td>
<td>0010</td>
<td>3</td>
<td>Fracture, frame, dual with cross bars, attached to bed, (e.g., balken, 4 poster)</td>
<td>Fracture frame dual w cross</td>
</tr>
<tr class="odd">
<td>E0947</td>
<td>0010</td>
<td>3</td>
<td>Fracture frame, attachments for complex pelvic traction</td>
<td>Fracture frame attachmnts pe</td>
</tr>
<tr class="even">
<td>E0948</td>
<td>0010</td>
<td>3</td>
<td>Fracture frame, attachments for complex cervical traction</td>
<td>Fracture frame attachmnts ce</td>
</tr>
<tr class="odd">
<td>E0950</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, tray, each</td>
<td>Tray</td>
</tr>
<tr class="even">
<td>E0951</td>
<td>0010</td>
<td>3</td>
<td>Heel loop/holder, any type, with or without ankle strap, each</td>
<td>Loop heel</td>
</tr>
<tr class="odd">
<td>E0952</td>
<td>0010</td>
<td>3</td>
<td>Toe loop/holder, any type, each</td>
<td>Toe loop/holder, each</td>
</tr>
<tr class="even">
<td>E0953</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, lateral thigh or knee support, any type including fixed mounting hardware, each</td>
<td>W/c lateral thigh/knee sup</td>
</tr>
<tr class="odd">
<td>E0954</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, foot box, any type, includes attachment and mounting hardware, each foot</td>
<td>Foot box, any type each foot</td>
</tr>
<tr class="even">
<td>E0955</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, headrest, cushioned, any type, including fixed mounting hardware, each</td>
<td>Cushioned headrest</td>
</tr>
<tr class="odd">
<td>E0956</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, lateral trunk or hip support, any type, including fixed mounting hardware, each</td>
<td>W/c lateral trunk/hip suppor</td>
</tr>
<tr class="even">
<td>E0957</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, medial thigh support, any type, including fixed mounting hardware, each</td>
<td>W/c medial thigh support</td>
</tr>
<tr class="odd">
<td>E0958</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, one-arm drive attachment, each</td>
<td>Whlchr att- conv 1 arm drive</td>
</tr>
<tr class="even">
<td>E0959</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, adapter for amputee, each</td>
<td>Amputee adapter</td>
</tr>
<tr class="odd">
<td>E0960</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, shoulder harness/straps or chest strap, including any type mounting hardware</td>
<td>W/c shoulder harness/straps</td>
</tr>
<tr class="even">
<td>E0961</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, wheel lock brake extension (handle), each</td>
<td>Wheelchair brake extension</td>
</tr>
<tr class="odd">
<td>E0966</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, headrest extension, each</td>
<td>Wheelchair head rest extensi</td>
</tr>
<tr class="even">
<td>E0967</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, hand rim with projections, any type, replacement only, each</td>
<td>Man wc rim/projection rep ea</td>
</tr>
<tr class="odd">
<td>E0968</td>
<td>0010</td>
<td>3</td>
<td>Commode seat, wheelchair</td>
<td>Wheelchair commode seat</td>
</tr>
<tr class="even">
<td>E0969</td>
<td>0010</td>
<td>3</td>
<td>Narrowing device, wheelchair</td>
<td>Wheelchair narrowing device</td>
</tr>
<tr class="odd">
<td>E0970</td>
<td>0010</td>
<td>3</td>
<td>No. 2 footplates, except for elevating leg rest</td>
<td>Wheelchair no. 2 footplates</td>
</tr>
<tr class="even">
<td>E0971</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, anti-tipping device, each</td>
<td>Wheelchair anti-tipping devi</td>
</tr>
<tr class="odd">
<td>E0973</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, adjustable height, detachable armrest, complete assembly, each</td>
<td>W/ch access det adj armrest</td>
</tr>
<tr class="even">
<td>E0974</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, anti-rollback device, each</td>
<td>W/ch access anti-rollback</td>
</tr>
<tr class="odd">
<td>E0978</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, positioning belt/safety belt/pelvic strap, each</td>
<td>W/c acc,saf belt pelv strap</td>
</tr>
<tr class="even">
<td>E0980</td>
<td>0010</td>
<td>3</td>
<td>Safety vest, wheelchair</td>
<td>Wheelchair safety vest</td>
</tr>
<tr class="odd">
<td>E0981</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, seat upholstery, replacement only, each</td>
<td>Seat upholstery, replacement</td>
</tr>
<tr class="even">
<td>E0982</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, back upholstery, replacement only, each</td>
<td>Back upholstery, replacement</td>
</tr>
<tr class="odd">
<td>E0983</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, power add-on to convert manual wheelchair to motorized wheelchair, joystick control</td>
<td>Add pwr joystick</td>
</tr>
<tr class="even">
<td>E0984</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, power add-on to convert manual wheelchair to motorized wheelchair, tiller control</td>
<td>Add pwr tiller</td>
</tr>
<tr class="odd">
<td>E0985</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, seat lift mechanism</td>
<td>W/c seat lift mechanism</td>
</tr>
<tr class="even">
<td>E0986</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, push-rim activated power assist system</td>
<td>Man w/c push-rim powr system</td>
</tr>
<tr class="odd">
<td>E0988</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, lever-activated, wheel drive, pair</td>
<td>Lever-activated wheel drive</td>
</tr>
<tr class="even">
<td>E0990</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, elevating leg rest, complete assembly, each</td>
<td>Wheelchair elevating leg res</td>
</tr>
<tr class="odd">
<td>E0992</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, solid seat insert</td>
<td>Wheelchair solid seat insert</td>
</tr>
<tr class="even">
<td>E0994</td>
<td>0010</td>
<td>3</td>
<td>Arm rest, each</td>
<td>Wheelchair arm rest</td>
</tr>
<tr class="odd">
<td>E0995</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, calf rest/pad, replacement only, each</td>
<td>Wc calf rest, pad replacemnt</td>
</tr>
<tr class="even">
<td>E1002</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, power seating system, tilt only</td>
<td>Pwr seat tilt</td>
</tr>
<tr class="odd">
<td>E1003</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, power seating system, recline only, without shear reduction</td>
<td>Pwr seat recline</td>
</tr>
<tr class="even">
<td>E1004</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, power seating system, recline only, with mechanical shear reduction</td>
<td>Pwr seat recline mech</td>
</tr>
<tr class="odd">
<td>E1005</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, power seatng system, recline only, with power shear reduction</td>
<td>Pwr seat recline pwr</td>
</tr>
<tr class="even">
<td>E1006</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, power seating system, combination tilt and recline, without shear reduction</td>
<td>Pwr seat combo w/o shear</td>
</tr>
<tr class="odd">
<td>E1007</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, power seating system, combination tilt and recline, with mechanical shear reduction</td>
<td>Pwr seat combo w/shear</td>
</tr>
<tr class="even">
<td>E1008</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, power seating system, combination tilt and recline, with power shear reduction</td>
<td>Pwr seat combo pwr shear</td>
</tr>
<tr class="odd">
<td>E1009</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, addition to power seating system, mechanically linked leg elevation system, including pushrod and leg rest, each</td>
<td>Add mech leg elevation</td>
</tr>
<tr class="even">
<td>E1010</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, addition to power seating system, power leg elevation system, including leg rest, pair</td>
<td>Add pwr leg elevation</td>
</tr>
<tr class="odd">
<td>E1011</td>
<td>0010</td>
<td>3</td>
<td>Modification to pediatric size wheelchair, width adjustment package (not to be dispensed with initial chair)</td>
<td>Ped wc modify width adjustm</td>
</tr>
<tr class="even">
<td>E1012</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, addition to power seating system, center mount power elevating leg rest/platform, complete system, any type, each</td>
<td>Ctr mount pwr elev leg rest</td>
</tr>
<tr class="odd">
<td>E1014</td>
<td>0010</td>
<td>3</td>
<td>Reclining back, addition to pediatric size wheelchair</td>
<td>Reclining back add ped w/c</td>
</tr>
<tr class="even">
<td>E1015</td>
<td>0010</td>
<td>3</td>
<td>Shock absorber for manual wheelchair, each</td>
<td>Shock absorber for man w/c</td>
</tr>
<tr class="odd">
<td>E1016</td>
<td>0010</td>
<td>3</td>
<td>Shock absorber for power wheelchair, each</td>
<td>Shock absorber for power w/c</td>
</tr>
<tr class="even">
<td>E1017</td>
<td>0010</td>
<td>3</td>
<td>Heavy duty shock absorber for heavy duty or extra heavy duty manual wheelchair, each</td>
<td>Hd shck absrbr for hd man wc</td>
</tr>
<tr class="odd">
<td>E1018</td>
<td>0010</td>
<td>3</td>
<td>Heavy duty shock absorber for heavy duty or extra heavy duty power wheelchair, each</td>
<td>Hd shck absrber for hd powwc</td>
</tr>
<tr class="even">
<td>E1020</td>
<td>0010</td>
<td>3</td>
<td>Residual limb support system for wheelchair, any type</td>
<td>Residual limb support system</td>
</tr>
<tr class="odd">
<td>E1028</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, manual swingaway, retractable or removable mounting hardware for joystick, other control interface or positioning accessory</td>
<td>W/c manual swingaway</td>
</tr>
<tr class="even">
<td>E1029</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, ventilator tray, fixed</td>
<td>W/c vent tray fixed</td>
</tr>
<tr class="odd">
<td>E1030</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, ventilator tray, gimbaled</td>
<td>W/c vent tray gimbaled</td>
</tr>
<tr class="even">
<td>E1031</td>
<td>0010</td>
<td>3</td>
<td>Rollabout chair, any and all types with casters 5&quot; or greater</td>
<td>Rollabout chair with casters</td>
</tr>
<tr class="odd">
<td>E1035</td>
<td>0010</td>
<td>3</td>
<td>Multi-positional patient transfer system, with integrated seat, operated by care giver, patient weight capacity up to and including 300 lbs</td>
<td>Patient transfer system &lt;300</td>
</tr>
<tr class="even">
<td>E1036</td>
<td>0010</td>
<td>3</td>
<td>Multi-positional patient transfer system, extra-wide, with integrated seat, operated by caregiver, patient weight capacity greater than 300 lbs</td>
<td>Patient transfer system &gt;300</td>
</tr>
<tr class="odd">
<td>E1037</td>
<td>0010</td>
<td>3</td>
<td>Transport chair, pediatric size</td>
<td>Transport chair, ped size</td>
</tr>
<tr class="even">
<td>E1038</td>
<td>0010</td>
<td>3</td>
<td>Transport chair, adult size, patient weight capacity up to and including 300 pounds</td>
<td>Transport chair pt wt&lt;=300lb</td>
</tr>
<tr class="odd">
<td>E1039</td>
<td>0010</td>
<td>3</td>
<td>Transport chair, adult size, heavy duty, patient weight capacity greater than 300 pounds</td>
<td>Transport chair pt wt &gt;300lb</td>
</tr>
<tr class="even">
<td>E1050</td>
<td>0010</td>
<td>3</td>
<td>Fully-reclining wheelchair, fixed full length arms, swing away detachable elevating leg rests</td>
<td>Whelchr fxd full length arms</td>
</tr>
<tr class="odd">
<td>E1060</td>
<td>0010</td>
<td>3</td>
<td>Fully-reclining wheelchair, detachable arms, desk or full length, swing away detachable elevating legrests</td>
<td>Wheelchair detachable arms</td>
</tr>
<tr class="even">
<td>E1070</td>
<td>0010</td>
<td>3</td>
<td>Fully-reclining wheelchair, detachable arms (desk or full length) swing away detachable footrest</td>
<td>Wheelchair detachable foot r</td>
</tr>
<tr class="odd">
<td>E1083</td>
<td>0010</td>
<td>3</td>
<td>Hemi-wheelchair, fixed full length arms, swing away detachable elevating leg rest</td>
<td>Hemi-wheelchair fixed arms</td>
</tr>
<tr class="even">
<td>E1084</td>
<td>0010</td>
<td>3</td>
<td>Hemi-wheelchair, detachable arms desk or full length arms, swing away detachable elevating leg rests</td>
<td>Hemi-wheelchair detachable a</td>
</tr>
<tr class="odd">
<td>E1085</td>
<td>0010</td>
<td>3</td>
<td>Hemi-wheelchair, fixed full length arms, swing away detachable foot rests</td>
<td>Hemi-wheelchair fixed arms</td>
</tr>
<tr class="even">
<td>E1086</td>
<td>0010</td>
<td>3</td>
<td>Hemi-wheelchair detachable arms desk or full length, swing away detachable footrests</td>
<td>Hemi-wheelchair detachable a</td>
</tr>
<tr class="odd">
<td>E1087</td>
<td>0010</td>
<td>3</td>
<td>High strength lightweight wheelchair, fixed full length arms, swing away detachable elevating leg rests</td>
<td>Wheelchair lightwt fixed arm</td>
</tr>
<tr class="even">
<td>E1088</td>
<td>0010</td>
<td>3</td>
<td>High strength lightweight wheelchair, detachable arms desk or full length, swing away detachable elevating leg rests</td>
<td>Wheelchair lightweight det a</td>
</tr>
<tr class="odd">
<td>E1089</td>
<td>0010</td>
<td>3</td>
<td>High strength lightweight wheelchair, fixed length arms, swing away detachable footrest</td>
<td>Wheelchair lightwt fixed arm</td>
</tr>
<tr class="even">
<td>E1090</td>
<td>0010</td>
<td>3</td>
<td>High strength lightweight wheelchair, detachable arms desk or full length, swing away detachable foot rests</td>
<td>Wheelchair lightweight det a</td>
</tr>
<tr class="odd">
<td>E1092</td>
<td>0010</td>
<td>3</td>
<td>Wide heavy duty wheel chair, detachable arms (desk or full length), swing away detachable elevating leg rests</td>
<td>Wheelchair wide w/ leg rests</td>
</tr>
<tr class="even">
<td>E1093</td>
<td>0010</td>
<td>3</td>
<td>Wide heavy duty wheelchair, detachable arms desk or full length arms, swing away detachable footrests</td>
<td>Wheelchair wide w/ foot rest</td>
</tr>
<tr class="odd">
<td>E1100</td>
<td>0010</td>
<td>3</td>
<td>Semi-reclining wheelchair, fixed full length arms, swing away detachable elevating leg rests</td>
<td>Whchr s-recl fxd arm leg res</td>
</tr>
<tr class="even">
<td>E1110</td>
<td>0010</td>
<td>3</td>
<td>Semi-reclining wheelchair, detachable arms (desk or full length) elevating leg rest</td>
<td>Wheelchair semi-recl detach</td>
</tr>
<tr class="odd">
<td>E1130</td>
<td>0010</td>
<td>3</td>
<td>Standard wheelchair, fixed full length arms, fixed or swing away detachable footrests</td>
<td>Whlchr stand fxd arm ft rest</td>
</tr>
<tr class="even">
<td>E1140</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair, detachable arms, desk or full length, swing away detachable footrests</td>
<td>Wheelchair standard detach a</td>
</tr>
<tr class="odd">
<td>E1150</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair, detachable arms, desk or full length swing away detachable elevating legrests</td>
<td>Wheelchair standard w/ leg r</td>
</tr>
<tr class="even">
<td>E1160</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair, fixed full length arms, swing away detachable elevating legrests</td>
<td>Wheelchair fixed arms</td>
</tr>
<tr class="odd">
<td>E1161</td>
<td>0010</td>
<td>3</td>
<td>Manual adult size wheelchair, includes tilt in space</td>
<td>Manual adult wc w tiltinspac</td>
</tr>
<tr class="even">
<td>E1170</td>
<td>0010</td>
<td>3</td>
<td>Amputee wheelchair, fixed full length arms, swing away detachable elevating legrests</td>
<td>Whlchr ampu fxd arm leg rest</td>
</tr>
<tr class="odd">
<td>E1171</td>
<td>0010</td>
<td>3</td>
<td>Amputee wheelchair, fixed full length arms, without footrests or legrest</td>
<td>Wheelchair amputee w/o leg r</td>
</tr>
<tr class="even">
<td>E1172</td>
<td>0010</td>
<td>3</td>
<td>Amputee wheelchair, detachable arms (desk or full length) without footrests or legrest</td>
<td>Wheelchair amputee detach ar</td>
</tr>
<tr class="odd">
<td>E1180</td>
<td>0010</td>
<td>3</td>
<td>Amputee wheelchair, detachable arms (desk or full length) swing away detachable footrests</td>
<td>Wheelchair amputee w/ foot r</td>
</tr>
<tr class="even">
<td>E1190</td>
<td>0010</td>
<td>3</td>
<td>Amputee wheelchair, detachable arms (desk or full length) swing away detachable elevating legrests</td>
<td>Wheelchair amputee w/ leg re</td>
</tr>
<tr class="odd">
<td>E1195</td>
<td>0010</td>
<td>3</td>
<td>Heavy duty wheelchair, fixed full length arms, swing away detachable elevating legrests</td>
<td>Wheelchair amputee heavy dut</td>
</tr>
<tr class="even">
<td>E1200</td>
<td>0010</td>
<td>3</td>
<td>Amputee wheelchair, fixed full length arms, swing away detachable footrest</td>
<td>Wheelchair amputee fixed arm</td>
</tr>
<tr class="odd">
<td>E1220</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair; specially sized or constructed, (indicate brand name, model number, if any) and justification</td>
<td>Whlchr special size/constrc</td>
</tr>
<tr class="even">
<td>E1221</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair with fixed arm, footrests</td>
<td>Wheelchair spec size w foot</td>
</tr>
<tr class="odd">
<td>E1222</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair with fixed arm, elevating legrests</td>
<td>Wheelchair spec size w/ leg</td>
</tr>
<tr class="even">
<td>E1223</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair with detachable arms, footrests</td>
<td>Wheelchair spec size w foot</td>
</tr>
<tr class="odd">
<td>E1224</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair with detachable arms, elevating legrests</td>
<td>Wheelchair spec size w/ leg</td>
</tr>
<tr class="even">
<td>E1225</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, manual semi-reclining back, (recline greater than 15 degrees, but less than 80 degrees), each</td>
<td>Manual semi-reclining back</td>
</tr>
<tr class="odd">
<td>E1226</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, manual fully reclining back, (recline greater than 80 degrees), each</td>
<td>Manual fully reclining back</td>
</tr>
<tr class="even">
<td>E1227</td>
<td>0010</td>
<td>3</td>
<td>Special height arms for wheelchair</td>
<td>Wheelchair spec sz spec ht a</td>
</tr>
<tr class="odd">
<td>E1228</td>
<td>0010</td>
<td>3</td>
<td>Special back height for wheelchair</td>
<td>Wheelchair spec sz spec ht b</td>
</tr>
<tr class="even">
<td>E1229</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair, pediatric size, not otherwise specified</td>
<td>Pediatric wheelchair nos</td>
</tr>
<tr class="odd">
<td>E1230</td>
<td>0010</td>
<td>3</td>
<td>Power operated vehicle (three or four wheel nonhighway) specify brand name and model number</td>
<td>Power operated vehicle</td>
</tr>
<tr class="even">
<td>E1231</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair, pediatric size, tilt-in-space, rigid, adjustable, with seating system</td>
<td>Rigid ped w/c tilt-in-space</td>
</tr>
<tr class="odd">
<td>E1232</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair, pediatric size, tilt-in-space, folding, adjustable, with seating system</td>
<td>Folding ped wc tilt-in-space</td>
</tr>
<tr class="even">
<td>E1233</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair, pediatric size, tilt-in-space, rigid, adjustable, without seating system</td>
<td>Rig ped wc tltnspc w/o seat</td>
</tr>
<tr class="odd">
<td>E1234</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair, pediatric size, tilt-in-space, folding, adjustable, without seating system</td>
<td>Fld ped wc tltnspc w/o seat</td>
</tr>
<tr class="even">
<td>E1235</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair, pediatric size, rigid, adjustable, with seating system</td>
<td>Rigid ped wc adjustable</td>
</tr>
<tr class="odd">
<td>E1236</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair, pediatric size, folding, adjustable, with seating system</td>
<td>Folding ped wc adjustable</td>
</tr>
<tr class="even">
<td>E1237</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair, pediatric size, rigid, adjustable, without seating system</td>
<td>Rgd ped wc adjstabl w/o seat</td>
</tr>
<tr class="odd">
<td>E1238</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair, pediatric size, folding, adjustable, without seating system</td>
<td>Fld ped wc adjstabl w/o seat</td>
</tr>
<tr class="even">
<td>E1239</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, pediatric size, not otherwise specified</td>
<td>Ped power wheelchair nos</td>
</tr>
<tr class="odd">
<td>E1240</td>
<td>0010</td>
<td>3</td>
<td>Lightweight wheelchair, detachable arms, (desk or full length) swing away detachable, elevating legrest</td>
<td>Whchr litwt det arm leg rest</td>
</tr>
<tr class="even">
<td>E1250</td>
<td>0010</td>
<td>3</td>
<td>Lightweight wheelchair, fixed full length arms, swing away detachable footrest</td>
<td>Wheelchair lightwt fixed arm</td>
</tr>
<tr class="odd">
<td>E1260</td>
<td>0010</td>
<td>3</td>
<td>Lightweight wheelchair, detachable arms (desk or full length) swing away detachable footrest</td>
<td>Wheelchair lightwt foot rest</td>
</tr>
<tr class="even">
<td>E1270</td>
<td>0010</td>
<td>3</td>
<td>Lightweight wheelchair, fixed full length arms, swing away detachable elevating legrests</td>
<td>Wheelchair lightweight leg r</td>
</tr>
<tr class="odd">
<td>E1280</td>
<td>0010</td>
<td>3</td>
<td>Heavy duty wheelchair, detachable arms (desk or full length) elevating legrests</td>
<td>Whchr h-duty det arm leg res</td>
</tr>
<tr class="even">
<td>E1285</td>
<td>0010</td>
<td>3</td>
<td>Heavy duty wheelchair, fixed full length arms, swing away detachable footrest</td>
<td>Wheelchair heavy duty fixed</td>
</tr>
<tr class="odd">
<td>E1290</td>
<td>0010</td>
<td>3</td>
<td>Heavy duty wheelchair, detachable arms (desk or full length) swing away detachable footrest</td>
<td>Wheelchair hvy duty detach a</td>
</tr>
<tr class="even">
<td>E1295</td>
<td>0010</td>
<td>3</td>
<td>Heavy duty wheelchair, fixed full length arms, elevating legrest</td>
<td>Wheelchair heavy duty fixed</td>
</tr>
<tr class="odd">
<td>E1296</td>
<td>0010</td>
<td>3</td>
<td>Special wheelchair seat height from floor</td>
<td>Wheelchair special seat heig</td>
</tr>
<tr class="even">
<td>E1297</td>
<td>0010</td>
<td>3</td>
<td>Special wheelchair seat depth, by upholstery</td>
<td>Wheelchair special seat dept</td>
</tr>
<tr class="odd">
<td>E1298</td>
<td>0010</td>
<td>3</td>
<td>Special wheelchair seat depth and/or width, by construction</td>
<td>Wheelchair spec seat depth/w</td>
</tr>
<tr class="even">
<td>E1300</td>
<td>0010</td>
<td>3</td>
<td>Whirlpool, portable (overtub type)</td>
<td>Whirlpool portable</td>
</tr>
<tr class="odd">
<td>E1310</td>
<td>0010</td>
<td>3</td>
<td>Whirlpool, non-portable (built-in type)</td>
<td>Whirlpool non-portable</td>
</tr>
<tr class="even">
<td>E1352</td>
<td>0010</td>
<td>3</td>
<td>Oxygen accessory, flow regulator capable of positive inspiratory pressure</td>
<td>O2 flow reg pos inspir press</td>
</tr>
<tr class="odd">
<td>E1353</td>
<td>0010</td>
<td>3</td>
<td>Regulator</td>
<td>Oxygen supplies regulator</td>
</tr>
<tr class="even">
<td>E1354</td>
<td>0010</td>
<td>3</td>
<td>Oxygen accessory, wheeled cart for portable cylinder or portable concentrator, any type, replacement only, each</td>
<td>Wheeled cart, port cyl/conc</td>
</tr>
<tr class="odd">
<td>E1355</td>
<td>0010</td>
<td>3</td>
<td>Stand/rack</td>
<td>Oxygen supplies stand/rack</td>
</tr>
<tr class="even">
<td>E1356</td>
<td>0010</td>
<td>3</td>
<td>Oxygen accessory, battery pack/cartridge for portable concentrator, any type, replacement only, each</td>
<td>Batt pack/cart, port conc</td>
</tr>
<tr class="odd">
<td>E1357</td>
<td>0010</td>
<td>3</td>
<td>Oxygen accessory, battery charger for portable concentrator, any type, replacement only, each</td>
<td>Battery charger, port conc</td>
</tr>
<tr class="even">
<td>E1358</td>
<td>0010</td>
<td>3</td>
<td>Oxygen accessory, dc power adapter for portable concentrator, any type, replacement only, each</td>
<td>Dc power adapter, port conc</td>
</tr>
<tr class="odd">
<td>E1372</td>
<td>0010</td>
<td>3</td>
<td>Immersion external heater for nebulizer</td>
<td>Oxy suppl heater for nebuliz</td>
</tr>
<tr class="even">
<td>E1390</td>
<td>0010</td>
<td>3</td>
<td>Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate</td>
<td>Oxygen concentrator</td>
</tr>
<tr class="odd">
<td>E1391</td>
<td>0010</td>
<td>3</td>
<td>Oxygen concentrator, dual delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate, each</td>
<td>Oxygen concentrator, dual</td>
</tr>
<tr class="even">
<td>E1392</td>
<td>0010</td>
<td>3</td>
<td>Portable oxygen concentrator, rental</td>
<td>Portable oxygen concentrator</td>
</tr>
<tr class="odd">
<td>E1399</td>
<td>0010</td>
<td>3</td>
<td>Durable medical equipment, miscellaneous</td>
<td>Durable medical equipment mi</td>
</tr>
<tr class="even">
<td>E1405</td>
<td>0010</td>
<td>3</td>
<td>Oxygen and water vapor enriching system with heated delivery</td>
<td>O2/water vapor enrich w/heat</td>
</tr>
<tr class="odd">
<td>E1406</td>
<td>0010</td>
<td>3</td>
<td>Oxygen and water vapor enriching system without heated delivery</td>
<td>O2/water vapor enrich w/o he</td>
</tr>
<tr class="even">
<td>E1500</td>
<td>0010</td>
<td>3</td>
<td>Centrifuge, for dialysis</td>
<td>Centrifuge</td>
</tr>
<tr class="odd">
<td>E1510</td>
<td>0010</td>
<td>3</td>
<td>Kidney, dialysate delivery syst kidney machine, pump recirculating, air removal syst, flowrate meter, power off, heater and temperature control with alarm, i.v. poles, pressure gauge, concentrate container</td>
<td>Kidney dialysate delivry sys</td>
</tr>
<tr class="even">
<td>E1520</td>
<td>0010</td>
<td>3</td>
<td>Heparin infusion pump for hemodialysis</td>
<td>Heparin infusion pump</td>
</tr>
<tr class="odd">
<td>E1530</td>
<td>0010</td>
<td>3</td>
<td>Air bubble detector for hemodialysis, each, replacement</td>
<td>Replacement air bubble detec</td>
</tr>
<tr class="even">
<td>E1540</td>
<td>0010</td>
<td>3</td>
<td>Pressure alarm for hemodialysis, each, replacement</td>
<td>Replacement pressure alarm</td>
</tr>
<tr class="odd">
<td>E1550</td>
<td>0010</td>
<td>3</td>
<td>Bath conductivity meter for hemodialysis, each</td>
<td>Bath conductivity meter</td>
</tr>
<tr class="even">
<td>E1560</td>
<td>0010</td>
<td>3</td>
<td>Blood leak detector for hemodialysis, each, replacement</td>
<td>Replace blood leak detector</td>
</tr>
<tr class="odd">
<td>E1570</td>
<td>0010</td>
<td>3</td>
<td>Adjustable chair, for esrd patients</td>
<td>Adjustable chair for esrd pt</td>
</tr>
<tr class="even">
<td>E1575</td>
<td>0010</td>
<td>3</td>
<td>Transducer protectors/fluid barriers, for hemodialysis, any size, per 10</td>
<td>Transducer protect/fld bar</td>
</tr>
<tr class="odd">
<td>E1580</td>
<td>0010</td>
<td>3</td>
<td>Unipuncture control system for hemodialysis</td>
<td>Unipuncture control system</td>
</tr>
<tr class="even">
<td>E1590</td>
<td>0010</td>
<td>3</td>
<td>Hemodialysis machine</td>
<td>Hemodialysis machine</td>
</tr>
<tr class="odd">
<td>E1592</td>
<td>0010</td>
<td>3</td>
<td>Automatic intermittent peritoneal dialysis system</td>
<td>Auto interm peritoneal dialy</td>
</tr>
<tr class="even">
<td>E1594</td>
<td>0010</td>
<td>3</td>
<td>Cycler dialysis machine for peritoneal dialysis</td>
<td>Cycler dialysis machine</td>
</tr>
<tr class="odd">
<td>E1600</td>
<td>0010</td>
<td>3</td>
<td>Delivery and/or installation charges for hemodialysis equipment</td>
<td>Deli/install chrg hemo equip</td>
</tr>
<tr class="even">
<td>E1610</td>
<td>0010</td>
<td>3</td>
<td>Reverse osmosis water purification system, for hemodialysis</td>
<td>Reverse osmosis h2o puri sys</td>
</tr>
<tr class="odd">
<td>E1615</td>
<td>0010</td>
<td>3</td>
<td>Deionizer water purification system, for hemodialysis</td>
<td>Deionizer h2o puri system</td>
</tr>
<tr class="even">
<td>E1620</td>
<td>0010</td>
<td>3</td>
<td>Blood pump for hemodialysis, replacement</td>
<td>Replacement blood pump</td>
</tr>
<tr class="odd">
<td>E1625</td>
<td>0010</td>
<td>3</td>
<td>Water softening system, for hemodialysis</td>
<td>Water softening system</td>
</tr>
<tr class="even">
<td>E1630</td>
<td>0010</td>
<td>3</td>
<td>Reciprocating peritoneal dialysis system</td>
<td>Reciprocating peritoneal dia</td>
</tr>
<tr class="odd">
<td>E1632</td>
<td>0010</td>
<td>3</td>
<td>Wearable artificial kidney, each</td>
<td>Wearable artificial kidney</td>
</tr>
<tr class="even">
<td>E1634</td>
<td>0010</td>
<td>3</td>
<td>Peritoneal dialysis clamps, each</td>
<td>Peritoneal dialysis clamp</td>
</tr>
<tr class="odd">
<td>E1635</td>
<td>0010</td>
<td>3</td>
<td>Compact (portable) travel hemodialyzer system</td>
<td>Compact travel hemodialyzer</td>
</tr>
<tr class="even">
<td>E1636</td>
<td>0010</td>
<td>3</td>
<td>Sorbent cartridges, for hemodialysis, per 10</td>
<td>Sorbent cartridges per 10</td>
</tr>
<tr class="odd">
<td>E1637</td>
<td>0010</td>
<td>3</td>
<td>Hemostats, each</td>
<td>Hemostats for dialysis, each</td>
</tr>
<tr class="even">
<td>E1639</td>
<td>0010</td>
<td>3</td>
<td>Scale, each</td>
<td>Scale, each</td>
</tr>
<tr class="odd">
<td>E1699</td>
<td>0010</td>
<td>3</td>
<td>Dialysis equipment, not otherwise specified</td>
<td>Dialysis equipment noc</td>
</tr>
<tr class="even">
<td>E1700</td>
<td>0010</td>
<td>3</td>
<td>Jaw motion rehabilitation system</td>
<td>Jaw motion rehab system</td>
</tr>
<tr class="odd">
<td>E1701</td>
<td>0010</td>
<td>3</td>
<td>Replacement cushions for jaw motion rehabilitation system, pkg. of 6</td>
<td>Repl cushions for jaw motion</td>
</tr>
<tr class="even">
<td>E1702</td>
<td>0010</td>
<td>3</td>
<td>Replacement measuring scales for jaw motion rehabilitation system, pkg. of 200</td>
<td>Repl measr scales jaw motion</td>
</tr>
<tr class="odd">
<td>E1800</td>
<td>0010</td>
<td>3</td>
<td>Dynamic adjustable elbow extension/flexion device, includes soft interface material</td>
<td>Adjust elbow ext/flex device</td>
</tr>
<tr class="even">
<td>E1801</td>
<td>0010</td>
<td>3</td>
<td>Static progressive stretch elbow device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories</td>
<td>Sps elbow device</td>
</tr>
<tr class="odd">
<td>E1802</td>
<td>0010</td>
<td>3</td>
<td>Dynamic adjustable forearm pronation/supination device, includes soft interface material</td>
<td>Adjst forearm pro/sup device</td>
</tr>
<tr class="even">
<td>E1805</td>
<td>0010</td>
<td>3</td>
<td>Dynamic adjustable wrist extension / flexion device, includes soft interface material</td>
<td>Adjust wrist ext/flex device</td>
</tr>
<tr class="odd">
<td>E1806</td>
<td>0010</td>
<td>3</td>
<td>Static progressive stretch wrist device, flexion and/or extension, with or without range of motion adjustment, includes all components and accessories</td>
<td>Sps wrist device</td>
</tr>
<tr class="even">
<td>E1810</td>
<td>0010</td>
<td>3</td>
<td>Dynamic adjustable knee extension / flexion device, includes soft interface material</td>
<td>Adjust knee ext/flex device</td>
</tr>
<tr class="odd">
<td>E1811</td>
<td>0010</td>
<td>3</td>
<td>Static progressive stretch knee device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories</td>
<td>Sps knee device</td>
</tr>
<tr class="even">
<td>E1812</td>
<td>0010</td>
<td>3</td>
<td>Dynamic knee, extension/flexion device with active resistance control</td>
<td>Knee ext/flex w act res ctrl</td>
</tr>
<tr class="odd">
<td>E1815</td>
<td>0010</td>
<td>3</td>
<td>Dynamic adjustable ankle extension/flexion device, includes soft interface material</td>
<td>Adjust ankle ext/flex device</td>
</tr>
<tr class="even">
<td>E1816</td>
<td>0010</td>
<td>3</td>
<td>Static progressive stretch ankle device, flexion and/or extension, with or without range of motion adjustment, includes all components and accessories</td>
<td>Sps ankle device</td>
</tr>
<tr class="odd">
<td>E1818</td>
<td>0010</td>
<td>3</td>
<td>Static progressive stretch forearm pronation / supination device, with or without range of motion adjustment, includes all components and accessories</td>
<td>Sps forearm device</td>
</tr>
<tr class="even">
<td>E1820</td>
<td>0010</td>
<td>3</td>
<td>Replacement soft interface material, dynamic adjustable extension/flexion device</td>
<td>Soft interface material</td>
</tr>
<tr class="odd">
<td>E1821</td>
<td>0010</td>
<td>3</td>
<td>Replacement soft interface material/cuffs for bi-directional static progressive stretch device</td>
<td>Replacement interface spsd</td>
</tr>
<tr class="even">
<td>E1825</td>
<td>0010</td>
<td>3</td>
<td>Dynamic adjustable finger extension/flexion device, includes soft interface material</td>
<td>Adjust finger ext/flex devc</td>
</tr>
<tr class="odd">
<td>E1830</td>
<td>0010</td>
<td>3</td>
<td>Dynamic adjustable toe extension/flexion device, includes soft interface material</td>
<td>Adjust toe ext/flex device</td>
</tr>
<tr class="even">
<td>E1831</td>
<td>0010</td>
<td>3</td>
<td>Static progressive stretch toe device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories</td>
<td>Static str toe dev ext/flex</td>
</tr>
<tr class="odd">
<td>E1840</td>
<td>0010</td>
<td>3</td>
<td>Dynamic adjustable shoulder flexion / abduction / rotation device, includes soft interface material</td>
<td>Adj shoulder ext/flex device</td>
</tr>
<tr class="even">
<td>E1841</td>
<td>0010</td>
<td>3</td>
<td>Static progressive stretch shoulder device, with or without range of motion adjustment, includes all components and accessories</td>
<td>Static str shldr dev rom adj</td>
</tr>
<tr class="odd">
<td>E1902</td>
<td>0010</td>
<td>3</td>
<td>Communication board, non-electronic augmentative or alternative communication device</td>
<td>Aac non-electronic board</td>
</tr>
<tr class="even">
<td>E2000</td>
<td>0010</td>
<td>3</td>
<td>Gastric suction pump, home model, portable or stationary, electric</td>
<td>Gastric suction pump hme mdl</td>
</tr>
<tr class="odd">
<td>E2100</td>
<td>0010</td>
<td>3</td>
<td>Blood glucose monitor with integrated voice synthesizer</td>
<td>Bld glucose monitor w voice</td>
</tr>
<tr class="even">
<td>E2101</td>
<td>0010</td>
<td>3</td>
<td>Blood glucose monitor with integrated lancing/blood sample</td>
<td>Bld glucose monitor w lance</td>
</tr>
<tr class="odd">
<td>E2120</td>
<td>0010</td>
<td>3</td>
<td>Pulse generator system for tympanic treatment of inner ear endolymphatic fluid</td>
<td>Pulse gen sys tx endolymp fl</td>
</tr>
<tr class="even">
<td>E2201</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, nonstandard seat frame, width greater than or equal to 20 inches and less than 24 inches</td>
<td>Man w/ch acc seat w&gt;=20“&lt;24”</td>
</tr>
<tr class="odd">
<td>E2202</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, nonstandard seat frame width, 24-27 inches</td>
<td>Seat width 24-27 in</td>
</tr>
<tr class="even">
<td>E2203</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, nonstandard seat frame depth, 20 to less than 22 inches</td>
<td>Frame depth less than 22 in</td>
</tr>
<tr class="odd">
<td>E2204</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, nonstandard seat frame depth, 22 to 25 inches</td>
<td>Frame depth 22 to 25 in</td>
</tr>
<tr class="even">
<td>E2205</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, handrim without projections (includes ergonomic or contoured), any type, replacement only, each</td>
<td>Manual wc accessory, handrim</td>
</tr>
<tr class="odd">
<td>E2206</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, wheel lock assembly, complete, replacement only, each</td>
<td>Man wc whl lock comp repl ea</td>
</tr>
<tr class="even">
<td>E2207</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, crutch and cane holder, each</td>
<td>Crutch and cane holder</td>
</tr>
<tr class="odd">
<td>E2208</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, cylinder tank carrier, each</td>
<td>Cylinder tank carrier</td>
</tr>
<tr class="even">
<td>E2209</td>
<td>0010</td>
<td>3</td>
<td>Accessory, arm trough, with or without hand support, each</td>
<td>Arm trough each</td>
</tr>
<tr class="odd">
<td>E2210</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, bearings, any type, replacement only, each</td>
<td>Wheelchair bearings</td>
</tr>
<tr class="even">
<td>E2211</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, pneumatic propulsion tire, any size, each</td>
<td>Pneumatic propulsion tire</td>
</tr>
<tr class="odd">
<td>E2212</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, tube for pneumatic propulsion tire, any size, each</td>
<td>Pneumatic prop tire tube</td>
</tr>
<tr class="even">
<td>E2213</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, insert for pneumatic propulsion tire (removable), any type, any size, each</td>
<td>Pneumatic prop tire insert</td>
</tr>
<tr class="odd">
<td>E2214</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, pneumatic caster tire, any size, each</td>
<td>Pneumatic caster tire each</td>
</tr>
<tr class="even">
<td>E2215</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, tube for pneumatic caster tire, any size, each</td>
<td>Pneumatic caster tire tube</td>
</tr>
<tr class="odd">
<td>E2216</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, foam filled propulsion tire, any size, each</td>
<td>Foam filled propulsion tire</td>
</tr>
<tr class="even">
<td>E2217</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, foam filled caster tire, any size, each</td>
<td>Foam filled caster tire each</td>
</tr>
<tr class="odd">
<td>E2218</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, foam propulsion tire, any size, each</td>
<td>Foam propulsion tire each</td>
</tr>
<tr class="even">
<td>E2219</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, foam caster tire, any size, each</td>
<td>Foam caster tire any size ea</td>
</tr>
<tr class="odd">
<td>E2220</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, solid (rubber/plastic) propulsion tire, any size, replacement only, each</td>
<td>Solid propuls tire, repl, ea</td>
</tr>
<tr class="even">
<td>E2221</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each</td>
<td>Solid caster tire repl, each</td>
</tr>
<tr class="odd">
<td>E2222</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each</td>
<td>Solid caster integ whl, repl</td>
</tr>
<tr class="even">
<td>E2224</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, propulsion wheel excludes tire, any size, replacement only, each</td>
<td>Propulsion whl excl tire rep</td>
</tr>
<tr class="odd">
<td>E2225</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, caster wheel excludes tire, any size, replacement only, each</td>
<td>Caster wheel excludes tire</td>
</tr>
<tr class="even">
<td>E2226</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, caster fork, any size, replacement only, each</td>
<td>Caster fork replacement only</td>
</tr>
<tr class="odd">
<td>E2227</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, gear reduction drive wheel, each</td>
<td>Gear reduction drive wheel</td>
</tr>
<tr class="even">
<td>E2228</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, wheel braking system and lock, complete, each</td>
<td>Mwc acc, wheelchair brake</td>
</tr>
<tr class="odd">
<td>E2230</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, manual standing system</td>
<td>Manual standing system</td>
</tr>
<tr class="even">
<td>E2231</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, solid seat support base (replaces sling seat), includes any type mounting hardware</td>
<td>Solid seat support base</td>
</tr>
<tr class="odd">
<td>E2291</td>
<td>0010</td>
<td>3</td>
<td>Back, planar, for pediatric size wheelchair including fixed attaching hardware</td>
<td>Planar back for ped size wc</td>
</tr>
<tr class="even">
<td>E2292</td>
<td>0010</td>
<td>3</td>
<td>Seat, planar, for pediatric size wheelchair including fixed attaching hardware</td>
<td>Planar seat for ped size wc</td>
</tr>
<tr class="odd">
<td>E2293</td>
<td>0010</td>
<td>3</td>
<td>Back, contoured, for pediatric size wheelchair including fixed attaching hardware</td>
<td>Contour back for ped size wc</td>
</tr>
<tr class="even">
<td>E2294</td>
<td>0010</td>
<td>3</td>
<td>Seat, contoured, for pediatric size wheelchair including fixed attaching hardware</td>
<td>Contour seat for ped size wc</td>
</tr>
<tr class="odd">
<td>E2295</td>
<td>0010</td>
<td>3</td>
<td>Manual wheelchair accessory, for pediatric size wheelchair, dynamic seating frame, allows coordinated movement of multiple positioning features</td>
<td>Ped dynamic seating frame</td>
</tr>
<tr class="even">
<td>E2300</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, power seat elevation system, any type</td>
<td>Pwr seat elevation sys</td>
</tr>
<tr class="odd">
<td>E2301</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, power standing system, any type</td>
<td>Pwr standing</td>
</tr>
<tr class="even">
<td>E2310</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, electronic connection between wheelchair controller and one power seating system motor, including all related electronics, indicator feature, mechanical function selection switch, and fixed mounting hardware</td>
<td>Electro connect btw control</td>
</tr>
<tr class="odd">
<td>E2311</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, electronic connection between wheelchair controller and two or more power seating system motors, including all related electronics, indicator feature, mechanical function selection switch, and fixed mounting hardware</td>
<td>Electro connect btw 2 sys</td>
</tr>
<tr class="even">
<td>E2312</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, hand or chin control interface, mini-proportional remote joystick, proportional, including fixed mounting hardware</td>
<td>Mini-prop remote joystick</td>
</tr>
<tr class="odd">
<td>E2313</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, harness for upgrade to expandable controller, including all fasteners, connectors and mounting hardware, each</td>
<td>Pwc harness, expand control</td>
</tr>
<tr class="even">
<td>E2321</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, hand control interface, remote joystick, nonproportional, including all related electronics, mechanical stop switch, and fixed mounting hardware</td>
<td>Hand interface joystick</td>
</tr>
<tr class="odd">
<td>E2322</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, hand control interface, multiple mechanical switches, nonproportional, including all related electronics, mechanical stop switch, and fixed mounting hardware</td>
<td>Mult mech switches</td>
</tr>
<tr class="even">
<td>E2323</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, specialty joystick handle for hand control interface, prefabricated</td>
<td>Special joystick handle</td>
</tr>
<tr class="odd">
<td>E2324</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, chin cup for chin control interface</td>
<td>Chin cup interface</td>
</tr>
<tr class="even">
<td>E2325</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, sip and puff interface, nonproportional, including all related electronics, mechanical stop switch, and manual swingaway mounting hardware</td>
<td>Sip and puff interface</td>
</tr>
<tr class="odd">
<td>E2326</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, breath tube kit for sip and puff interface</td>
<td>Breath tube kit</td>
</tr>
<tr class="even">
<td>E2327</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, head control interface, mechanical, proportional, including all related electronics, mechanical direction change switch, and fixed mounting hardware</td>
<td>Head control interface mech</td>
</tr>
<tr class="odd">
<td>E2328</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, head control or extremity control interface, electronic, proportional, including all related electronics and fixed mounting hardware</td>
<td>Head/extremity control inter</td>
</tr>
<tr class="even">
<td>E2329</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, head control interface, contact switch mechanism, nonproportional, including all related electronics, mechanical stop switch, mechanical direction change switch, head array, and fixed mounting hardware</td>
<td>Head control nonproportional</td>
</tr>
<tr class="odd">
<td>E2330</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, head control interface, proximity switch mechanism, nonproportional, including all related electronics, mechanical stop switch, mechanical direction change switch, head array, and fixed mounting hardware</td>
<td>Head control proximity switc</td>
</tr>
<tr class="even">
<td>E2331</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, attendant control, proportional, including all related electronics and fixed mounting hardware</td>
<td>Attendant control</td>
</tr>
<tr class="odd">
<td>E2340</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, nonstandard seat frame width, 20-23 inches</td>
<td>W/c wdth 20-23 in seat frame</td>
</tr>
<tr class="even">
<td>E2341</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, nonstandard seat frame width, 24-27 inches</td>
<td>W/c wdth 24-27 in seat frame</td>
</tr>
<tr class="odd">
<td>E2342</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, nonstandard seat frame depth, 20 or 21 inches</td>
<td>W/c dpth 20-21 in seat frame</td>
</tr>
<tr class="even">
<td>E2343</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, nonstandard seat frame depth, 22-25 inches</td>
<td>W/c dpth 22-25 in seat frame</td>
</tr>
<tr class="odd">
<td>E2351</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, electronic interface to operate speech generating device using power wheelchair control interface</td>
<td>Electronic sgd interface</td>
</tr>
<tr class="even">
<td>E2358</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, group 34 non-sealed lead acid battery, each</td>
<td>Gr 34 nonsealed leadacid</td>
</tr>
<tr class="odd">
<td>E2359</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, group 34 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)</td>
<td>Gr34 sealed leadacid battery</td>
</tr>
<tr class="even">
<td>E2360</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, 22nf non-sealed lead acid battery, each</td>
<td>22nf nonsealed leadacid</td>
</tr>
<tr class="odd">
<td>E2361</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, 22nf sealed lead acid battery, each, (e.g., gel cell, absorbed glassmat)</td>
<td>22nf sealed leadacid battery</td>
</tr>
<tr class="even">
<td>E2362</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, group 24 non-sealed lead acid battery, each</td>
<td>Gr24 nonsealed leadacid</td>
</tr>
<tr class="odd">
<td>E2363</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, group 24 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)</td>
<td>Gr24 sealed leadacid battery</td>
</tr>
<tr class="even">
<td>E2364</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, u-1 non-sealed lead acid battery, each</td>
<td>U1nonsealed leadacid battery</td>
</tr>
<tr class="odd">
<td>E2365</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, u-1 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)</td>
<td>U1 sealed leadacid battery</td>
</tr>
<tr class="even">
<td>E2366</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, battery charger, single mode, for use with only one battery type, sealed or non-sealed, each</td>
<td>Battery charger, single mode</td>
</tr>
<tr class="odd">
<td>E2367</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, battery charger, dual mode, for use with either battery type, sealed or non-sealed, each</td>
<td>Battery charger, dual mode</td>
</tr>
<tr class="even">
<td>E2368</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair component, drive wheel motor, replacement only</td>
<td>Pwr wc drivewheel motor repl</td>
</tr>
<tr class="odd">
<td>E2369</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair component, drive wheel gear box, replacement only</td>
<td>Pwr wc drivewheel gear repl</td>
</tr>
<tr class="even">
<td>E2370</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair component, integrated drive wheel motor and gear box combination, replacement only</td>
<td>Pwr wc dr wh motor/gear comb</td>
</tr>
<tr class="odd">
<td>E2371</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, group 27 sealed lead acid battery, (e.g., gel cell, absorbed glassmat), each</td>
<td>Gr27 sealed leadacid battery</td>
</tr>
<tr class="even">
<td>E2372</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, group 27 non-sealed lead acid battery, each</td>
<td>Gr27 non-sealed leadacid</td>
</tr>
<tr class="odd">
<td>E2373</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, hand or chin control interface, compact remote joystick, proportional, including fixed mounting hardware</td>
<td>Hand/chin ctrl spec joystick</td>
</tr>
<tr class="even">
<td>E2374</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, hand or chin control interface, standard remote joystick (not including controller), proportional, including all related electronics and fixed mounting hardware, replacement only</td>
<td>Hand/chin ctrl std joystick</td>
</tr>
<tr class="odd">
<td>E2375</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, non-expandable controller, including all related electronics and mounting hardware, replacement only</td>
<td>Non-expandable controller</td>
</tr>
<tr class="even">
<td>E2376</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, replacement only</td>
<td>Expandable controller, repl</td>
</tr>
<tr class="odd">
<td>E2377</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, upgrade provided at initial issue</td>
<td>Expandable controller, initl</td>
</tr>
<tr class="even">
<td>E2378</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair component, actuator, replacement only</td>
<td>Pw actuator replacement</td>
</tr>
<tr class="odd">
<td>E2381</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, pneumatic drive wheel tire, any size, replacement only, each</td>
<td>Pneum drive wheel tire</td>
</tr>
<tr class="even">
<td>E2382</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, tube for pneumatic drive wheel tire, any size, replacement only, each</td>
<td>Tube, pneum wheel drive tire</td>
</tr>
<tr class="odd">
<td>E2383</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, insert for pneumatic drive wheel tire (removable), any type, any size, replacement only, each</td>
<td>Insert, pneum wheel drive</td>
</tr>
<tr class="even">
<td>E2384</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, pneumatic caster tire, any size, replacement only, each</td>
<td>Pneumatic caster tire</td>
</tr>
<tr class="odd">
<td>E2385</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, tube for pneumatic caster tire, any size, replacement only, each</td>
<td>Tube, pneumatic caster tire</td>
</tr>
<tr class="even">
<td>E2386</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, foam filled drive wheel tire, any size, replacement only, each</td>
<td>Foam filled drive wheel tire</td>
</tr>
<tr class="odd">
<td>E2387</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, foam filled caster tire, any size, replacement only, each</td>
<td>Foam filled caster tire</td>
</tr>
<tr class="even">
<td>E2388</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, foam drive wheel tire, any size, replacement only, each</td>
<td>Foam drive wheel tire</td>
</tr>
<tr class="odd">
<td>E2389</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, foam caster tire, any size, replacement only, each</td>
<td>Foam caster tire</td>
</tr>
<tr class="even">
<td>E2390</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, solid (rubber/plastic) drive wheel tire, any size, replacement only, each</td>
<td>Solid drive wheel tire</td>
</tr>
<tr class="odd">
<td>E2391</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each</td>
<td>Solid caster tire</td>
</tr>
<tr class="even">
<td>E2392</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each</td>
<td>Solid caster tire, integrate</td>
</tr>
<tr class="odd">
<td>E2394</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, drive wheel excludes tire, any size, replacement only, each</td>
<td>Drive wheel excludes tire</td>
</tr>
<tr class="even">
<td>E2395</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, caster wheel excludes tire, any size, replacement only, each</td>
<td>Caster wheel excludes tire</td>
</tr>
<tr class="odd">
<td>E2396</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, caster fork, any size, replacement only, each</td>
<td>Caster fork</td>
</tr>
<tr class="even">
<td>E2397</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, lithium-based battery, each</td>
<td>Pwc acc, lith-based battery</td>
</tr>
<tr class="odd">
<td>E2398</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, dynamic positioning hardware for back</td>
<td>Wc dynamic pos back hardware</td>
</tr>
<tr class="even">
<td>E2402</td>
<td>0010</td>
<td>3</td>
<td>Negative pressure wound therapy electrical pump, stationary or portable</td>
<td>Neg press wound therapy pump</td>
</tr>
<tr class="odd">
<td>E2500</td>
<td>0010</td>
<td>3</td>
<td>Speech generating device, digitized speech, using pre-recorded messages, less than or equal to 8 minutes recording time</td>
<td>Sgd digitized pre-rec &lt;=8min</td>
</tr>
<tr class="even">
<td>E2502</td>
<td>0010</td>
<td>3</td>
<td>Speech generating device, digitized speech, using pre-recorded messages, greater than 8 minutes but less than or equal to 20 minutes recording time</td>
<td>Sgd prerec msg &gt;8min &lt;=20min</td>
</tr>
<tr class="odd">
<td>E2504</td>
<td>0010</td>
<td>3</td>
<td>Speech generating device, digitized speech, using pre-recorded messages, greater than 20 minutes but less than or equal to 40 minutes recording time</td>
<td>Sgd prerec msg&gt;20min &lt;=40min</td>
</tr>
<tr class="even">
<td>E2506</td>
<td>0010</td>
<td>3</td>
<td>Speech generating device, digitized speech, using pre-recorded messages, greater than 40 minutes recording time</td>
<td>Sgd prerec msg &gt; 40 min</td>
</tr>
<tr class="odd">
<td>E2508</td>
<td>0010</td>
<td>3</td>
<td>Speech generating device, synthesized speech, requiring message formulation by spelling and access by physical contact with the device</td>
<td>Sgd spelling phys contact</td>
</tr>
<tr class="even">
<td>E2510</td>
<td>0010</td>
<td>3</td>
<td>Speech generating device, synthesized speech, permitting multiple methods of message formulation and multiple methods of device access</td>
<td>Sgd w multi methods msg/accs</td>
</tr>
<tr class="odd">
<td>E2511</td>
<td>0010</td>
<td>3</td>
<td>Speech generating software program, for personal computer or personal digital assistant</td>
<td>Sgd sftwre prgrm for pc/pda</td>
</tr>
<tr class="even">
<td>E2512</td>
<td>0010</td>
<td>3</td>
<td>Accessory for speech generating device, mounting system</td>
<td>Sgd accessory, mounting sys</td>
</tr>
<tr class="odd">
<td>E2599</td>
<td>0010</td>
<td>3</td>
<td>Accessory for speech generating device, not otherwise classified</td>
<td>Sgd accessory noc</td>
</tr>
<tr class="even">
<td>E2601</td>
<td>0010</td>
<td>3</td>
<td>General use wheelchair seat cushion, width less than 22 inches, any depth</td>
<td>Gen w/c cushion wdth &lt; 22 in</td>
</tr>
<tr class="odd">
<td>E2602</td>
<td>0010</td>
<td>3</td>
<td>General use wheelchair seat cushion, width 22 inches or greater, any depth</td>
<td>Gen w/c cushion wdth &gt;=22 in</td>
</tr>
<tr class="even">
<td>E2603</td>
<td>0010</td>
<td>3</td>
<td>Skin protection wheelchair seat cushion, width less than 22 inches, any depth</td>
<td>Skin protect wc cus wd &lt;22in</td>
</tr>
<tr class="odd">
<td>E2604</td>
<td>0010</td>
<td>3</td>
<td>Skin protection wheelchair seat cushion, width 22 inches or greater, any depth</td>
<td>Skin protect wc cus wd&gt;=22in</td>
</tr>
<tr class="even">
<td>E2605</td>
<td>0010</td>
<td>3</td>
<td>Positioning wheelchair seat cushion, width less than 22 inches, any depth</td>
<td>Position wc cush wdth &lt;22 in</td>
</tr>
<tr class="odd">
<td>E2606</td>
<td>0010</td>
<td>3</td>
<td>Positioning wheelchair seat cushion, width 22 inches or greater, any depth</td>
<td>Position wc cush wdth&gt;=22 in</td>
</tr>
<tr class="even">
<td>E2607</td>
<td>0010</td>
<td>3</td>
<td>Skin protection and positioning wheelchair seat cushion, width less than 22 inches, any depth</td>
<td>Skin pro/pos wc cus wd &lt;22in</td>
</tr>
<tr class="odd">
<td>E2608</td>
<td>0010</td>
<td>3</td>
<td>Skin protection and positioning wheelchair seat cushion, width 22 inches or greater, any depth</td>
<td>Skin pro/pos wc cus wd&gt;=22in</td>
</tr>
<tr class="even">
<td>E2609</td>
<td>0010</td>
<td>3</td>
<td>Custom fabricated wheelchair seat cushion, any size</td>
<td>Custom fabricate w/c cushion</td>
</tr>
<tr class="odd">
<td>E2610</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair seat cushion, powered</td>
<td>Powered w/c cushion</td>
</tr>
<tr class="even">
<td>E2611</td>
<td>0010</td>
<td>3</td>
<td>General use wheelchair back cushion, width less than 22 inches, any height, including any type mounting hardware</td>
<td>Gen use back cush wdth &lt;22in</td>
</tr>
<tr class="odd">
<td>E2612</td>
<td>0010</td>
<td>3</td>
<td>General use wheelchair back cushion, width 22 inches or greater, any height, including any type mounting hardware</td>
<td>Gen use back cush wdth&gt;=22in</td>
</tr>
<tr class="even">
<td>E2613</td>
<td>0010</td>
<td>3</td>
<td>Positioning wheelchair back cushion, posterior, width less than 22 inches, any height, including any type mounting hardware</td>
<td>Position back cush wd &lt;22in</td>
</tr>
<tr class="odd">
<td>E2614</td>
<td>0010</td>
<td>3</td>
<td>Positioning wheelchair back cushion, posterior, width 22 inches or greater, any height, including any type mounting hardware</td>
<td>Position back cush wd&gt;=22in</td>
</tr>
<tr class="even">
<td>E2615</td>
<td>0010</td>
<td>3</td>
<td>Positioning wheelchair back cushion, posterior-lateral, width less than 22 inches, any height, including any type mounting hardware</td>
<td>Pos back post/lat wdth &lt;22in</td>
</tr>
<tr class="odd">
<td>E2616</td>
<td>0010</td>
<td>3</td>
<td>Positioning wheelchair back cushion, posterior-lateral, width 22 inches or greater, any height, including any type mounting hardware</td>
<td>Pos back post/lat wdth&gt;=22in</td>
</tr>
<tr class="even">
<td>E2617</td>
<td>0010</td>
<td>3</td>
<td>Custom fabricated wheelchair back cushion, any size, including any type mounting hardware</td>
<td>Custom fab w/c back cushion</td>
</tr>
<tr class="odd">
<td>E2619</td>
<td>0010</td>
<td>3</td>
<td>Replacement cover for wheelchair seat cushion or back cushion, each</td>
<td>Replace cover w/c seat cush</td>
</tr>
<tr class="even">
<td>E2620</td>
<td>0010</td>
<td>3</td>
<td>Positioning wheelchair back cushion, planar back with lateral supports, width less than 22 inches, any height, including any type mounting hardware</td>
<td>Wc planar back cush wd &lt;22in</td>
</tr>
<tr class="odd">
<td>E2621</td>
<td>0010</td>
<td>3</td>
<td>Positioning wheelchair back cushion, planar back with lateral supports, width 22 inches or greater, any height, including any type mounting hardware</td>
<td>Wc planar back cush wd&gt;=22in</td>
</tr>
<tr class="even">
<td>E2622</td>
<td>0010</td>
<td>3</td>
<td>Skin protection wheelchair seat cushion, adjustable, width less than 22 inches, any depth</td>
<td>Adj skin pro w/c cus wd&lt;22in</td>
</tr>
<tr class="odd">
<td>E2623</td>
<td>0010</td>
<td>3</td>
<td>Skin protection wheelchair seat cushion, adjustable, width 22 inches or greater, any depth</td>
<td>Adj skin pro wc cus wd&gt;=22in</td>
</tr>
<tr class="even">
<td>E2624</td>
<td>0010</td>
<td>3</td>
<td>Skin protection and positioning wheelchair seat cushion, adjustable, width less than 22 inches, any depth</td>
<td>Adj skin pro/pos cus&lt;22in</td>
</tr>
<tr class="odd">
<td>E2625</td>
<td>0010</td>
<td>3</td>
<td>Skin protection and positioning wheelchair seat cushion, adjustable, width 22 inches or greater, any depth</td>
<td>Adj skin pro/pos wc cus&gt;=22</td>
</tr>
<tr class="even">
<td>E2626</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, adjustable</td>
<td>Seo mobile arm sup att to wc</td>
</tr>
<tr class="odd">
<td>E2627</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, adjustable rancho type</td>
<td>Arm supp att to wc rancho ty</td>
</tr>
<tr class="even">
<td>E2628</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, reclining</td>
<td>Mobile arm supports reclinin</td>
</tr>
<tr class="odd">
<td>E2629</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, friction arm support (friction dampening to proximal and distal joints)</td>
<td>Friction dampening arm supp</td>
</tr>
<tr class="even">
<td>E2630</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, shoulder elbow, mobile arm support, monosuspension arm and hand support, overhead elbow forearm hand sling support, yoke type suspension support</td>
<td>Monosuspension arm/hand supp</td>
</tr>
<tr class="odd">
<td>E2631</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, addition to mobile arm support, elevating proximal arm</td>
<td>Elevat proximal arm support</td>
</tr>
<tr class="even">
<td>E2632</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, addition to mobile arm support, offset or lateral rocker arm with elastic balance control</td>
<td>Offset/lat rocker arm w/ela</td>
</tr>
<tr class="odd">
<td>E2633</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, addition to mobile arm support, supinator</td>
<td>Mobile arm support supinator</td>
</tr>
<tr class="even">
<td>E8000</td>
<td>0010</td>
<td>3</td>
<td>Gait trainer, pediatric size, posterior support, includes all accessories and components</td>
<td>Posterior gait trainer</td>
</tr>
<tr class="odd">
<td>E8001</td>
<td>0010</td>
<td>3</td>
<td>Gait trainer, pediatric size, upright support, includes all accessories and components</td>
<td>Upright gait trainer</td>
</tr>
<tr class="even">
<td>E8002</td>
<td>0010</td>
<td>3</td>
<td>Gait trainer, pediatric size, anterior support, includes all accessories and components</td>
<td>Anterior gait trainer</td>
</tr>
</tbody>
</table>
</div>
<div id="g-series-proceduresprofessional-services-g0000-g9999" class="section level2">
<h2>G Series: Procedures/Professional Services (G0000-G9999)</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>G0008</td>
<td>0010</td>
<td>3</td>
<td>Administration of influenza virus vaccine</td>
<td>Admin influenza virus vac</td>
</tr>
<tr class="even">
<td>G0009</td>
<td>0010</td>
<td>3</td>
<td>Administration of pneumococcal vaccine</td>
<td>Admin pneumococcal vaccine</td>
</tr>
<tr class="odd">
<td>G0010</td>
<td>0010</td>
<td>3</td>
<td>Administration of hepatitis b vaccine</td>
<td>Admin hepatitis b vaccine</td>
</tr>
<tr class="even">
<td>G0027</td>
<td>0010</td>
<td>3</td>
<td>Semen analysis; presence and/or motility of sperm excluding huhner</td>
<td>Semen analysis</td>
</tr>
<tr class="odd">
<td>G0068</td>
<td>0010</td>
<td>3</td>
<td>Professional services for the administration of anti-infective, pain management, chelation, pulmonary hypertension, and/or inotropic infusion drug(s) for each infusion drug administration calendar day in the individual’s home, each 15 minutes</td>
<td>Adm of infusion drug in home</td>
</tr>
<tr class="even">
<td>G0069</td>
<td>0010</td>
<td>3</td>
<td>Professional services for the administration of subcutaneous immunotherapy for each infusion drug administration calendar day in the individual’s home, each 15 minutes</td>
<td>Adm of immune drug in home</td>
</tr>
<tr class="odd">
<td>G0070</td>
<td>0010</td>
<td>3</td>
<td>Professional services for the administration of chemotherapy for each infusion drug administration calendar day in the individual’s home, each 15 minutes</td>
<td>Adm of chemo drug in home</td>
</tr>
<tr class="even">
<td>G0071</td>
<td>0010</td>
<td>3</td>
<td>Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only</td>
<td>Comm svcs by rhc/fqhc 5 min</td>
</tr>
<tr class="odd">
<td>G0076</td>
<td>0010</td>
<td>3</td>
<td>Brief (20 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility)</td>
<td>Care manag h vst new pt 20 m</td>
</tr>
<tr class="even">
<td>G0077</td>
<td>0010</td>
<td>3</td>
<td>Limited (30 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility)</td>
<td>Care manag h vst new pt 30 m</td>
</tr>
<tr class="odd">
<td>G0078</td>
<td>0010</td>
<td>3</td>
<td>Moderate (45 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility)</td>
<td>Care manag h vst new pt 45 m</td>
</tr>
<tr class="even">
<td>G0079</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive (60 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility)</td>
<td>Care manag h vst new pt 60 m</td>
</tr>
<tr class="odd">
<td>G0080</td>
<td>0010</td>
<td>3</td>
<td>Extensive (75 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility)</td>
<td>Care manag h vst new pt 75 m</td>
</tr>
<tr class="even">
<td>G0081</td>
<td>0010</td>
<td>3</td>
<td>Brief (20 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility)</td>
<td>Care man h v ext pt 20 mi</td>
</tr>
<tr class="odd">
<td>G0082</td>
<td>0010</td>
<td>3</td>
<td>Limited (30 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility)</td>
<td>Care man h v ext pt 30 m</td>
</tr>
<tr class="even">
<td>G0083</td>
<td>0010</td>
<td>3</td>
<td>Moderate (45 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility)</td>
<td>Care man h v ext pt 45 m</td>
</tr>
<tr class="odd">
<td>G0084</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive (60 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility)</td>
<td>Care man h v ext pt 60 m</td>
</tr>
<tr class="even">
<td>G0085</td>
<td>0010</td>
<td>3</td>
<td>Extensive (75 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility)</td>
<td>Care man h v ext pt 75 m</td>
</tr>
<tr class="odd">
<td>G0086</td>
<td>0010</td>
<td>3</td>
<td>Limited (30 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility)</td>
<td>Care man home care plan 30 m</td>
</tr>
<tr class="even">
<td>G0087</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive (60 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility)</td>
<td>Care man home care plan 60 m</td>
</tr>
<tr class="odd">
<td>G0101</td>
<td>0010</td>
<td>3</td>
<td>Cervical or vaginal cancer screening; pelvic and clinical breast examination</td>
<td>Ca screen;pelvic/breast exam</td>
</tr>
<tr class="even">
<td>G0102</td>
<td>0010</td>
<td>3</td>
<td>Prostate cancer screening; digital rectal examination</td>
<td>Prostate ca screening; dre</td>
</tr>
<tr class="odd">
<td>G0103</td>
<td>0010</td>
<td>3</td>
<td>Prostate cancer screening; prostate specific antigen test (psa)</td>
<td>Psa screening</td>
</tr>
<tr class="even">
<td>G0104</td>
<td>0010</td>
<td>3</td>
<td>Colorectal cancer screening; flexible sigmoidoscopy</td>
<td>Ca screen;flexi sigmoidscope</td>
</tr>
<tr class="odd">
<td>G0105</td>
<td>0010</td>
<td>3</td>
<td>Colorectal cancer screening; colonoscopy on individual at high risk</td>
<td>Colorectal scrn; hi risk ind</td>
</tr>
<tr class="even">
<td>G0106</td>
<td>0010</td>
<td>3</td>
<td>Colorectal cancer screening; alternative to g0104, screening sigmoidoscopy, barium enema</td>
<td>Colon ca screen;barium enema</td>
</tr>
<tr class="odd">
<td>G0108</td>
<td>0010</td>
<td>3</td>
<td>Diabetes outpatient self-management training services, individual, per 30 minutes</td>
<td>Diab manage trn per indiv</td>
</tr>
<tr class="even">
<td>G0109</td>
<td>0010</td>
<td>3</td>
<td>Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes</td>
<td>Diab manage trn ind/group</td>
</tr>
<tr class="odd">
<td>G0117</td>
<td>0010</td>
<td>3</td>
<td>Glaucoma screening for high risk patients furnished by an optometrist or ophthalmologist</td>
<td>Glaucoma scrn hgh risk direc</td>
</tr>
<tr class="even">
<td>G0118</td>
<td>0010</td>
<td>3</td>
<td>Glaucoma screening for high risk patient furnished under the direct supervision of an optometrist or ophthalmologist</td>
<td>Glaucoma scrn hgh risk direc</td>
</tr>
<tr class="odd">
<td>G0120</td>
<td>0010</td>
<td>3</td>
<td>Colorectal cancer screening; alternative to g0105, screening colonoscopy, barium enema.</td>
<td>Colon ca scrn; barium enema</td>
</tr>
<tr class="even">
<td>G0121</td>
<td>0010</td>
<td>3</td>
<td>Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk</td>
<td>Colon ca scrn not hi rsk ind</td>
</tr>
<tr class="odd">
<td>G0122</td>
<td>0010</td>
<td>3</td>
<td>Colorectal cancer screening; barium enema</td>
<td>Colon ca scrn; barium enema</td>
</tr>
<tr class="even">
<td>G0123</td>
<td>0010</td>
<td>3</td>
<td>Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision</td>
<td>Screen cerv/vag thin layer</td>
</tr>
<tr class="odd">
<td>G0124</td>
<td>0010</td>
<td>3</td>
<td>Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician</td>
<td>Screen c/v thin layer by md</td>
</tr>
<tr class="even">
<td>G0127</td>
<td>0010</td>
<td>3</td>
<td>Trimming of dystrophic nails, any number</td>
<td>Trim nail(s)</td>
</tr>
<tr class="odd">
<td>G0128</td>
<td>0010</td>
<td>3</td>
<td>Direct (face-to-face with patient) skilled nursing services of a registered nurse provided in a comprehensive outpatient rehabilitation facility, each 10 minutes beyond the first 5 minutes</td>
<td>Corf skilled nursing service</td>
</tr>
<tr class="even">
<td>G0129</td>
<td>0010</td>
<td>3</td>
<td>Occupational therapy services requiring the skills of a qualified occupational therapist, furnished as a component of a partial hospitalization treatment program, per session (45 minutes or more)</td>
<td>Partial hosp prog service</td>
</tr>
<tr class="odd">
<td>G0130</td>
<td>0010</td>
<td>3</td>
<td>Single energy x-ray absorptiometry (sexa) bone density study, one or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel)</td>
<td>Single energy x-ray study</td>
</tr>
<tr class="even">
<td>G0141</td>
<td>0010</td>
<td>3</td>
<td>Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician</td>
<td>Scr c/v cyto,autosys and md</td>
</tr>
<tr class="odd">
<td>G0143</td>
<td>0010</td>
<td>3</td>
<td>Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision</td>
<td>Scr c/v cyto,thinlayer,rescr</td>
</tr>
<tr class="even">
<td>G0144</td>
<td>0010</td>
<td>3</td>
<td>Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision</td>
<td>Scr c/v cyto,thinlayer,rescr</td>
</tr>
<tr class="odd">
<td>G0145</td>
<td>0010</td>
<td>3</td>
<td>Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision</td>
<td>Scr c/v cyto,thinlayer,rescr</td>
</tr>
<tr class="even">
<td>G0147</td>
<td>0010</td>
<td>3</td>
<td>Screening cytopathology smears, cervical or vaginal, performed by automated system under physician supervision</td>
<td>Scr c/v cyto, automated sys</td>
</tr>
<tr class="odd">
<td>G0148</td>
<td>0010</td>
<td>3</td>
<td>Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening</td>
<td>Scr c/v cyto, autosys, rescr</td>
</tr>
<tr class="even">
<td>G0151</td>
<td>0010</td>
<td>3</td>
<td>Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes</td>
<td>Hhcp-serv of pt,ea 15 min</td>
</tr>
<tr class="odd">
<td>G0152</td>
<td>0010</td>
<td>3</td>
<td>Services performed by a qualified occupational therapist in the home health or hospice setting, each 15 minutes</td>
<td>Hhcp-serv of ot,ea 15 min</td>
</tr>
<tr class="even">
<td>G0153</td>
<td>0010</td>
<td>3</td>
<td>Services performed by a qualified speech-language pathologist in the home health or hospice setting, each 15 minutes</td>
<td>Hhcp-svs of s/l path,ea 15mn</td>
</tr>
<tr class="odd">
<td>G0154</td>
<td>0010</td>
<td>3</td>
<td>Direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes</td>
<td>Hhcp-svs of rn,ea 15 min</td>
</tr>
<tr class="even">
<td>G0155</td>
<td>0010</td>
<td>3</td>
<td>Services of clinical social worker in home health or hospice settings, each 15 minutes</td>
<td>Hhcp-svs of csw,ea 15 min</td>
</tr>
<tr class="odd">
<td>G0156</td>
<td>0010</td>
<td>3</td>
<td>Services of home health/hospice aide in home health or hospice settings, each 15 minutes</td>
<td>Hhcp-svs of aide,ea 15 min</td>
</tr>
<tr class="even">
<td>G0157</td>
<td>0010</td>
<td>3</td>
<td>Services performed by a qualified physical therapist assistant in the home health or hospice setting, each 15 minutes</td>
<td>Hhc pt assistant ea 15</td>
</tr>
<tr class="odd">
<td>G0158</td>
<td>0010</td>
<td>3</td>
<td>Services performed by a qualified occupational therapist assistant in the home health or hospice setting, each 15 minutes</td>
<td>Hhc ot assistant ea 15</td>
</tr>
<tr class="even">
<td>G0159</td>
<td>0010</td>
<td>3</td>
<td>Services performed by a qualified physical therapist, in the home health setting, in the establishment or delivery of a safe and effective physical therapy maintenance program, each 15 minutes</td>
<td>Hhc pt maint ea 15 min</td>
</tr>
<tr class="odd">
<td>G0160</td>
<td>0010</td>
<td>3</td>
<td>Services performed by a qualified occupational therapist, in the home health setting, in the establishment or delivery of a safe and effective occupational therapy maintenance program, each 15 minutes</td>
<td>Hhc occup therapy ea 15</td>
</tr>
<tr class="even">
<td>G0161</td>
<td>0010</td>
<td>3</td>
<td>Services performed by a qualified speech-language pathologist, in the home health setting, in the establishment or delivery of a safe and effective speech-language pathology maintenance program, each 15 minutes</td>
<td>Hhc slp ea 15 min</td>
</tr>
<tr class="odd">
<td>G0162</td>
<td>0010</td>
<td>3</td>
<td>Skilled services by a registered nurse (rn) for management and evaluation of the plan of care; each 15 minutes (the patient’s underlying condition or complication requires an rn to ensure that essential non-skilled care achieves its purpose in the home health or hospice setting)</td>
<td>Hhc rn e&amp;m plan svs, 15 min</td>
</tr>
<tr class="even">
<td>G0163</td>
<td>0010</td>
<td>3</td>
<td>Skilled services of a licensed nurse (lpn or rn) for the observation and assessment of the patient’s condition, each 15 minutes (the change in the patient’s condition requires skilled nursing personnel to identify and evaluate the patient’s need for possible modification of treatment in the home health or hospice setting)</td>
<td>Hhc lpn/rn obs/asses ea 15</td>
</tr>
<tr class="odd">
<td>G0164</td>
<td>0010</td>
<td>3</td>
<td>Skilled services of a licensed nurse (lpn or rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes</td>
<td>Hhc lis nurse train ea 15</td>
</tr>
<tr class="even">
<td>G0166</td>
<td>0010</td>
<td>3</td>
<td>External counterpulsation, per treatment session</td>
<td>Extrnl counterpulse, per tx</td>
</tr>
<tr class="odd">
<td>G0168</td>
<td>0010</td>
<td>3</td>
<td>Wound closure utilizing tissue adhesive(s) only</td>
<td>Wound closure by adhesive</td>
</tr>
<tr class="even">
<td>G0173</td>
<td>0010</td>
<td>3</td>
<td>Linear accelerator based stereotactic radiosurgery, complete course of therapy in one session</td>
<td>Linear acc stereo radsur com</td>
</tr>
<tr class="odd">
<td>G0175</td>
<td>0010</td>
<td>3</td>
<td>Scheduled interdisciplinary team conference (minimum of three exclusive of patient care nursing staff) with patient present</td>
<td>Opps service,sched team conf</td>
</tr>
<tr class="even">
<td>G0176</td>
<td>0010</td>
<td>3</td>
<td>Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient’s disabling mental health problems, per session (45 minutes or more)</td>
<td>Opps/php;activity therapy</td>
</tr>
<tr class="odd">
<td>G0177</td>
<td>0010</td>
<td>3</td>
<td>Training and educational services related to the care and treatment of patient’s disabling mental health problems per session (45 minutes or more)</td>
<td>Opps/php; train &amp; educ serv</td>
</tr>
<tr class="even">
<td>G0179</td>
<td>0010</td>
<td>3</td>
<td>Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implementation of the plan of care that meets patient’s needs, per re-certification period</td>
<td>Md recertification hha pt</td>
</tr>
<tr class="odd">
<td>G0180</td>
<td>0010</td>
<td>3</td>
<td>Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implementation of the plan of care that meets patient’s needs, per certification period</td>
<td>Md certification hha patient</td>
</tr>
<tr class="even">
<td>G0181</td>
<td>0010</td>
<td>3</td>
<td>Physician supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of laboratory and other studies, communication (including telephone calls) with other health care professionals involved in the patient’s care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month, 30 minutes or more</td>
<td>Home health care supervision</td>
</tr>
<tr class="odd">
<td>G0182</td>
<td>0010</td>
<td>3</td>
<td>Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of laboratory and other studies, communication (including telephone calls) with other health care professionals involved in the patient’s care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month, 30 minutes or more</td>
<td>Hospice care supervision</td>
</tr>
<tr class="even">
<td>G0186</td>
<td>0010</td>
<td>3</td>
<td>Destruction of localized lesion of choroid (for example, choroidal neovascularization); photocoagulation, feeder vessel technique (one or more sessions)</td>
<td>Dstry eye lesn,fdr vssl tech</td>
</tr>
<tr class="odd">
<td>G0202</td>
<td>0010</td>
<td>3</td>
<td>Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed</td>
<td>Scr mammo bi incl cad</td>
</tr>
<tr class="even">
<td>G0204</td>
<td>0010</td>
<td>3</td>
<td>Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral</td>
<td>Dx mammo incl cad bi</td>
</tr>
<tr class="odd">
<td>G0206</td>
<td>0010</td>
<td>3</td>
<td>Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral</td>
<td>Dx mammo incl cad uni</td>
</tr>
<tr class="even">
<td>G0219</td>
<td>0010</td>
<td>3</td>
<td>Pet imaging whole body; melanoma for non-covered indications</td>
<td>Pet img wholbod melano nonco</td>
</tr>
<tr class="odd">
<td>G0235</td>
<td>0010</td>
<td>3</td>
<td>Pet imaging, any site, not otherwise specified</td>
<td>Pet not otherwise specified</td>
</tr>
<tr class="even">
<td>G0237</td>
<td>0010</td>
<td>3</td>
<td>Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring)</td>
<td>Therapeutic procd strg endur</td>
</tr>
<tr class="odd">
<td>G0238</td>
<td>0010</td>
<td>3</td>
<td>Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring)</td>
<td>Oth resp proc, indiv</td>
</tr>
<tr class="even">
<td>G0239</td>
<td>0010</td>
<td>3</td>
<td>Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring)</td>
<td>Oth resp proc, group</td>
</tr>
<tr class="odd">
<td>G0245</td>
<td>0010</td>
<td>3</td>
<td>Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that consists of at least the following elements: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of a protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear and (4) patient education</td>
<td>Initial foot exam pt lops</td>
</tr>
<tr class="even">
<td>G0246</td>
<td>0010</td>
<td>3</td>
<td>Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education</td>
<td>Followup eval of foot pt lop</td>
</tr>
<tr class="odd">
<td>G0247</td>
<td>0010</td>
<td>3</td>
<td>Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds, (2) debridement of corns and calluses, and (3) trimming and debridement of nails</td>
<td>Routine footcare pt w lops</td>
</tr>
<tr class="even">
<td>G0248</td>
<td>0010</td>
<td>3</td>
<td>Demonstration, prior to initiation of home inr monitoring, for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria, under the direction of a physician; includes: face-to-face demonstration of use and care of the inr monitor, obtaining at least one blood sample, provision of instructions for reporting home inr test results, and documentation of patient’s ability to perform testing and report results</td>
<td>Demonstrate use home inr mon</td>
</tr>
<tr class="odd">
<td>G0249</td>
<td>0010</td>
<td>3</td>
<td>Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests</td>
<td>Provide inr test mater/equip</td>
</tr>
<tr class="even">
<td>G0250</td>
<td>0010</td>
<td>3</td>
<td>Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequently than once a week; billing units of service include 4 tests</td>
<td>Md inr test revie inter mgmt</td>
</tr>
<tr class="odd">
<td>G0251</td>
<td>0010</td>
<td>3</td>
<td>Linear accelerator based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, maximum five sessions per course of treatment</td>
<td>Linear acc based stero radio</td>
</tr>
<tr class="even">
<td>G0252</td>
<td>0010</td>
<td>3</td>
<td>Pet imaging, full and partial-ring pet scanners only, for initial diagnosis of breast cancer and/or surgical planning for breast cancer (e.g., initial staging of axillary lymph nodes)</td>
<td>Pet imaging initial dx</td>
</tr>
<tr class="odd">
<td>G0255</td>
<td>0010</td>
<td>3</td>
<td>Current perception threshold/sensory nerve conduction test, (snct) per limb, any nerve</td>
<td>Current percep threshold tst</td>
</tr>
<tr class="even">
<td>G0257</td>
<td>0010</td>
<td>3</td>
<td>Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility</td>
<td>Unsched dialysis esrd pt hos</td>
</tr>
<tr class="odd">
<td>G0259</td>
<td>0010</td>
<td>3</td>
<td>Injection procedure for sacroiliac joint; arthrography</td>
<td>Inject for sacroiliac joint</td>
</tr>
<tr class="even">
<td>G0260</td>
<td>0010</td>
<td>3</td>
<td>Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography</td>
<td>Inj for sacroiliac jt anesth</td>
</tr>
<tr class="odd">
<td>G0268</td>
<td>0010</td>
<td>3</td>
<td>Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing</td>
<td>Removal of impacted wax md</td>
</tr>
<tr class="even">
<td>G0269</td>
<td>0010</td>
<td>3</td>
<td>Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (e.g., angioseal plug, vascular plug)</td>
<td>Occlusive device in vein art</td>
</tr>
<tr class="odd">
<td>G0270</td>
<td>0010</td>
<td>3</td>
<td>Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes</td>
<td>Mnt subs tx for change dx</td>
</tr>
<tr class="even">
<td>G0271</td>
<td>0010</td>
<td>3</td>
<td>Medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), group (2 or more individuals), each 30 minutes</td>
<td>Group mnt 2 or more 30 mins</td>
</tr>
<tr class="odd">
<td>G0276</td>
<td>0010</td>
<td>3</td>
<td>Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (pild) or placebo-control, performed in an approved coverage with evidence development (ced) clinical trial</td>
<td>Pild/placebo control clin tr</td>
</tr>
<tr class="even">
<td>G0277</td>
<td>0010</td>
<td>3</td>
<td>Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval</td>
<td>Hbot, full body chamber, 30m</td>
</tr>
<tr class="odd">
<td>G0278</td>
<td>0010</td>
<td>3</td>
<td>Iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation (list separately in addition to primary procedure)</td>
<td>Iliac art angio,cardiac cath</td>
</tr>
<tr class="even">
<td>G0279</td>
<td>0010</td>
<td>3</td>
<td>Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)</td>
<td>Tomosynthesis, mammo</td>
</tr>
<tr class="odd">
<td>G0281</td>
<td>0010</td>
<td>3</td>
<td>Electrical stimulation, (unattended), to one or more areas, for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care, as part of a therapy plan of care</td>
<td>Elec stim unattend for press</td>
</tr>
<tr class="even">
<td>G0282</td>
<td>0010</td>
<td>3</td>
<td>Electrical stimulation, (unattended), to one or more areas, for wound care other than described in g0281</td>
<td>Elect stim wound care not pd</td>
</tr>
<tr class="odd">
<td>G0283</td>
<td>0010</td>
<td>3</td>
<td>Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care</td>
<td>Elec stim other than wound</td>
</tr>
<tr class="even">
<td>G0288</td>
<td>0010</td>
<td>3</td>
<td>Reconstruction, computed tomographic angiography of aorta for surgical planning for vascular surgery</td>
<td>Recon, cta for surg plan</td>
</tr>
<tr class="odd">
<td>G0289</td>
<td>0010</td>
<td>3</td>
<td>Arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee</td>
<td>Arthro, loose body + chondro</td>
</tr>
<tr class="even">
<td>G0293</td>
<td>0010</td>
<td>3</td>
<td>Noncovered surgical procedure(s) using conscious sedation, regional, general or spinal anesthesia in a medicare qualifying clinical trial, per day</td>
<td>Non-cov surg proc,clin trial</td>
</tr>
<tr class="odd">
<td>G0294</td>
<td>0010</td>
<td>3</td>
<td>Noncovered procedure(s) using either no anesthesia or local anesthesia only, in a medicare qualifying clinical trial, per day</td>
<td>Non-cov proc, clinical trial</td>
</tr>
<tr class="even">
<td>G0295</td>
<td>0010</td>
<td>3</td>
<td>Electromagnetic therapy, to one or more areas, for wound care other than described in g0329 or for other uses</td>
<td>Electromagnetic therapy onc</td>
</tr>
<tr class="odd">
<td>G0296</td>
<td>0010</td>
<td>3</td>
<td>Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)</td>
<td>Visit to determ ldct elig</td>
</tr>
<tr class="even">
<td>G0297</td>
<td>0010</td>
<td>3</td>
<td>Low dose ct scan (ldct) for lung cancer screening</td>
<td>Ldct for lung ca screen</td>
</tr>
<tr class="odd">
<td>G0299</td>
<td>0010</td>
<td>3</td>
<td>Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes</td>
<td>Hhs/hospice of rn ea 15 min</td>
</tr>
<tr class="even">
<td>G0300</td>
<td>0010</td>
<td>3</td>
<td>Direct skilled nursing services of a licensed practical nurse (lpn) in the home health or hospice setting, each 15 minutes</td>
<td>Hhs/hospice of lpn ea 15 min</td>
</tr>
<tr class="odd">
<td>G0302</td>
<td>0010</td>
<td>3</td>
<td>Pre-operative pulmonary surgery services for preparation for lvrs, complete course of services, to include a minimum of 16 days of services</td>
<td>Pre-op service lvrs complete</td>
</tr>
<tr class="even">
<td>G0303</td>
<td>0010</td>
<td>3</td>
<td>Pre-operative pulmonary surgery services for preparation for lvrs, 10 to 15 days of services</td>
<td>Pre-op service lvrs 10-15dos</td>
</tr>
<tr class="odd">
<td>G0304</td>
<td>0010</td>
<td>3</td>
<td>Pre-operative pulmonary surgery services for preparation for lvrs, 1 to 9 days of services</td>
<td>Pre-op service lvrs 1-9 dos</td>
</tr>
<tr class="even">
<td>G0305</td>
<td>0010</td>
<td>3</td>
<td>Post-discharge pulmonary surgery services after lvrs, minimum of 6 days of services</td>
<td>Post op service lvrs min 6</td>
</tr>
<tr class="odd">
<td>G0306</td>
<td>0010</td>
<td>3</td>
<td>Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count</td>
<td>Cbc/diffwbc w/o platelet</td>
</tr>
<tr class="even">
<td>G0307</td>
<td>0010</td>
<td>3</td>
<td>Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count)</td>
<td>Cbc without platelet</td>
</tr>
<tr class="odd">
<td>G0328</td>
<td>0010</td>
<td>3</td>
<td>Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous</td>
<td>Fecal blood scrn immunoassay</td>
</tr>
<tr class="even">
<td>G0329</td>
<td>0010</td>
<td>3</td>
<td>Electromagnetic therapy, to one or more areas for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care as part of a therapy plan of care</td>
<td>Electromagntic tx for ulcers</td>
</tr>
<tr class="odd">
<td>G0333</td>
<td>0010</td>
<td>3</td>
<td>Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary</td>
<td>Dispense fee initial 30 day</td>
</tr>
<tr class="even">
<td>G0337</td>
<td>0010</td>
<td>3</td>
<td>Hospice evaluation and counseling services, pre-election</td>
<td>Hospice evaluation preelecti</td>
</tr>
<tr class="odd">
<td>G0339</td>
<td>0010</td>
<td>3</td>
<td>Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment</td>
<td>Robot lin-radsurg com, first</td>
</tr>
<tr class="even">
<td>G0340</td>
<td>0010</td>
<td>3</td>
<td>Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatment</td>
<td>Robt lin-radsurg fractx 2-5</td>
</tr>
<tr class="odd">
<td>G0341</td>
<td>0010</td>
<td>3</td>
<td>Percutaneous islet cell transplant, includes portal vein catheterization and infusion</td>
<td>Percutaneous islet celltrans</td>
</tr>
<tr class="even">
<td>G0342</td>
<td>0010</td>
<td>3</td>
<td>Laparoscopy for islet cell transplant, includes portal vein catheterization and infusion</td>
<td>Laparoscopy islet cell trans</td>
</tr>
<tr class="odd">
<td>G0343</td>
<td>0010</td>
<td>3</td>
<td>Laparotomy for islet cell transplant, includes portal vein catheterization and infusion</td>
<td>Laparotomy islet cell transp</td>
</tr>
<tr class="even">
<td>G0364</td>
<td>0010</td>
<td>3</td>
<td>Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service</td>
<td>Bone marrow aspirate &amp;biopsy</td>
</tr>
<tr class="odd">
<td>G0365</td>
<td>0010</td>
<td>3</td>
<td>Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow)</td>
<td>Vessel mapping hemo access</td>
</tr>
<tr class="even">
<td>G0372</td>
<td>0010</td>
<td>3</td>
<td>Physician service required to establish and document the need for a power mobility device</td>
<td>Md service required for pmd</td>
</tr>
<tr class="odd">
<td>G0378</td>
<td>0010</td>
<td>3</td>
<td>Hospital observation service, per hour</td>
<td>Hospital observation per hr</td>
</tr>
<tr class="even">
<td>G0379</td>
<td>0010</td>
<td>3</td>
<td>Direct admission of patient for hospital observation care</td>
<td>Direct refer hospital observ</td>
</tr>
<tr class="odd">
<td>G0380</td>
<td>0010</td>
<td>3</td>
<td>Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)</td>
<td>Lev 1 hosp type b ed visit</td>
</tr>
<tr class="even">
<td>G0381</td>
<td>0010</td>
<td>3</td>
<td>Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)</td>
<td>Lev 2 hosp type b ed visit</td>
</tr>
<tr class="odd">
<td>G0382</td>
<td>0010</td>
<td>3</td>
<td>Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)</td>
<td>Lev 3 hosp type b ed visit</td>
</tr>
<tr class="even">
<td>G0383</td>
<td>0010</td>
<td>3</td>
<td>Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)</td>
<td>Lev 4 hosp type b ed visit</td>
</tr>
<tr class="odd">
<td>G0384</td>
<td>0010</td>
<td>3</td>
<td>Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)</td>
<td>Lev 5 hosp type b ed visit</td>
</tr>
<tr class="even">
<td>G0389</td>
<td>0010</td>
<td>3</td>
<td>Ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screening</td>
<td>Ultrasound exam aaa screen</td>
</tr>
<tr class="odd">
<td>G0390</td>
<td>0010</td>
<td>3</td>
<td>Trauma response team associated with hospital critical care service</td>
<td>Trauma respons w/hosp criti</td>
</tr>
<tr class="even">
<td>G0396</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or substance (other than tobacco) abuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes</td>
<td>Alcohol/subs interv 15-30mn</td>
</tr>
<tr class="odd">
<td>G0397</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or substance (other than tobacco) abuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes</td>
<td>Alcohol/subs interv &gt;30 min</td>
</tr>
<tr class="even">
<td>G0398</td>
<td>0010</td>
<td>3</td>
<td>Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation</td>
<td>Home sleep test/type 2 porta</td>
</tr>
<tr class="odd">
<td>G0399</td>
<td>0010</td>
<td>3</td>
<td>Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation</td>
<td>Home sleep test/type 3 porta</td>
</tr>
<tr class="even">
<td>G0400</td>
<td>0010</td>
<td>3</td>
<td>Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels</td>
<td>Home sleep test/type 4 porta</td>
</tr>
<tr class="odd">
<td>G0402</td>
<td>0010</td>
<td>3</td>
<td>Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment</td>
<td>Initial preventive exam</td>
</tr>
<tr class="even">
<td>G0403</td>
<td>0010</td>
<td>3</td>
<td>Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report</td>
<td>Ekg for initial prevent exam</td>
</tr>
<tr class="odd">
<td>G0404</td>
<td>0010</td>
<td>3</td>
<td>Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination</td>
<td>Ekg tracing for initial prev</td>
</tr>
<tr class="even">
<td>G0405</td>
<td>0010</td>
<td>3</td>
<td>Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination</td>
<td>Ekg interpret &amp; report preve</td>
</tr>
<tr class="odd">
<td>G0406</td>
<td>0010</td>
<td>3</td>
<td>Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth</td>
<td>Inpt/tele follow up 15</td>
</tr>
<tr class="even">
<td>G0407</td>
<td>0010</td>
<td>3</td>
<td>Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth</td>
<td>Inpt/tele follow up 25</td>
</tr>
<tr class="odd">
<td>G0408</td>
<td>0010</td>
<td>3</td>
<td>Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth</td>
<td>Inpt/tele follow up 35</td>
</tr>
<tr class="even">
<td>G0409</td>
<td>0010</td>
<td>3</td>
<td>Social work and psychological services, directly relating to and/or furthering the patient’s rehabilitation goals, each 15 minutes, face-to-face; individual (services provided by a corf-qualified social worker or psychologist in a corf)</td>
<td>Corf related serv 15 mins ea</td>
</tr>
<tr class="odd">
<td>G0410</td>
<td>0010</td>
<td>3</td>
<td>Group psychotherapy other than of a multiple-family group, in a partial hospitalization setting, approximately 45 to 50 minutes</td>
<td>Grp psych partial hosp 45-50</td>
</tr>
<tr class="even">
<td>G0411</td>
<td>0010</td>
<td>3</td>
<td>Interactive group psychotherapy, in a partial hospitalization setting, approximately 45 to 50 minutes</td>
<td>Inter active grp psych parti</td>
</tr>
<tr class="odd">
<td>G0412</td>
<td>0010</td>
<td>3</td>
<td>Open treatment of iliac spine(s), tuberosity avulsion, or iliac wing fracture(s), unilateral or bilateral for pelvic bone fracture patterns which do not disrupt the pelvic ring includes internal fixation, when performed</td>
<td>Open tx iliac spine uni/bil</td>
</tr>
<tr class="even">
<td>G0413</td>
<td>0010</td>
<td>3</td>
<td>Percutaneous skeletal fixation of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, (includes ilium, sacroiliac joint and/or sacrum)</td>
<td>Pelvic ring fracture uni/bil</td>
</tr>
<tr class="odd">
<td>G0414</td>
<td>0010</td>
<td>3</td>
<td>Open treatment of anterior pelvic bone fracture and/or dislocation for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation when performed (includes pubic symphysis and/or superior/inferior rami)</td>
<td>Pelvic ring fx treat int fix</td>
</tr>
<tr class="even">
<td>G0415</td>
<td>0010</td>
<td>3</td>
<td>Open treatment of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation, when performed (includes ilium, sacroiliac joint and/or sacrum)</td>
<td>Open tx post pelvic fxcture</td>
</tr>
<tr class="odd">
<td>G0416</td>
<td>0010</td>
<td>3</td>
<td>Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method</td>
<td>Prostate biopsy, any mthd</td>
</tr>
<tr class="even">
<td>G0417</td>
<td>0010</td>
<td>3</td>
<td>Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens</td>
<td>Sat biopsy prostate 21-40</td>
</tr>
<tr class="odd">
<td>G0418</td>
<td>0010</td>
<td>3</td>
<td>Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 41-60 specimens</td>
<td>Sat biopsy prostate 41-60</td>
</tr>
<tr class="even">
<td>G0419</td>
<td>0010</td>
<td>3</td>
<td>Surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, &gt;60 specimens</td>
<td>Sat biopsy prostate: &gt;60</td>
</tr>
<tr class="odd">
<td>G0420</td>
<td>0010</td>
<td>3</td>
<td>Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour</td>
<td>Ed svc ckd ind per session</td>
</tr>
<tr class="even">
<td>G0421</td>
<td>0010</td>
<td>3</td>
<td>Face-to-face educational services related to the care of chronic kidney disease; group, per session, per one hour</td>
<td>Ed svc ckd grp per session</td>
</tr>
<tr class="odd">
<td>G0422</td>
<td>0010</td>
<td>3</td>
<td>Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session</td>
<td>Intens cardiac rehab w/exerc</td>
</tr>
<tr class="even">
<td>G0423</td>
<td>0010</td>
<td>3</td>
<td>Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session</td>
<td>Intens cardiac rehab no exer</td>
</tr>
<tr class="odd">
<td>G0424</td>
<td>0010</td>
<td>3</td>
<td>Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day</td>
<td>Pulmonary rehab w exer</td>
</tr>
<tr class="even">
<td>G0425</td>
<td>0010</td>
<td>3</td>
<td>Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth</td>
<td>Inpt/ed teleconsult30</td>
</tr>
<tr class="odd">
<td>G0426</td>
<td>0010</td>
<td>3</td>
<td>Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth</td>
<td>Inpt/ed teleconsult50</td>
</tr>
<tr class="even">
<td>G0427</td>
<td>0010</td>
<td>3</td>
<td>Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth</td>
<td>Inpt/ed teleconsult70</td>
</tr>
<tr class="odd">
<td>G0428</td>
<td>0010</td>
<td>3</td>
<td>Collagen meniscus implant procedure for filling meniscal defects (e.g., cmi, collagen scaffold, menaflex)</td>
<td>Collagen meniscus implant</td>
</tr>
<tr class="even">
<td>G0429</td>
<td>0010</td>
<td>3</td>
<td>Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy)</td>
<td>Dermal filler injection(s)</td>
</tr>
<tr class="odd">
<td>G0431</td>
<td>0010</td>
<td>3</td>
<td>Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter</td>
<td>Drug screen multiple class</td>
</tr>
<tr class="even">
<td>G0432</td>
<td>0010</td>
<td>3</td>
<td>Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening</td>
<td>Eia hiv-1/hiv-2 screen</td>
</tr>
<tr class="odd">
<td>G0433</td>
<td>0010</td>
<td>3</td>
<td>Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening</td>
<td>Elisa hiv-1/hiv-2 screen</td>
</tr>
<tr class="even">
<td>G0434</td>
<td>0010</td>
<td>3</td>
<td>Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter</td>
<td>Drug screen multi drug class</td>
</tr>
<tr class="odd">
<td>G0435</td>
<td>0010</td>
<td>3</td>
<td>Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening</td>
<td>Oral hiv-1/hiv-2 screen</td>
</tr>
<tr class="even">
<td>G0436</td>
<td>0010</td>
<td>3</td>
<td>Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes</td>
<td>Tobacco-use counsel 3-10 min</td>
</tr>
<tr class="odd">
<td>G0437</td>
<td>0010</td>
<td>3</td>
<td>Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutes</td>
<td>Tobacco-use counsel&gt;10min</td>
</tr>
<tr class="even">
<td>G0438</td>
<td>0010</td>
<td>3</td>
<td>Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit</td>
<td>Ppps, initial visit</td>
</tr>
<tr class="odd">
<td>G0439</td>
<td>0010</td>
<td>3</td>
<td>Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit</td>
<td>Ppps, subseq visit</td>
</tr>
<tr class="even">
<td>G0442</td>
<td>0010</td>
<td>3</td>
<td>Annual alcohol misuse screening, 15 minutes</td>
<td>Annual alcohol screen 15 min</td>
</tr>
<tr class="odd">
<td>G0443</td>
<td>0010</td>
<td>3</td>
<td>Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes</td>
<td>Brief alcohol misuse counsel</td>
</tr>
<tr class="even">
<td>G0444</td>
<td>0010</td>
<td>3</td>
<td>Annual depression screening, 15 minutes</td>
<td>Depression screen annual</td>
</tr>
<tr class="odd">
<td>G0445</td>
<td>0010</td>
<td>3</td>
<td>High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes</td>
<td>High inten beh couns std 30m</td>
</tr>
<tr class="even">
<td>G0446</td>
<td>0010</td>
<td>3</td>
<td>Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes</td>
<td>Intens behave ther cardio dx</td>
</tr>
<tr class="odd">
<td>G0447</td>
<td>0010</td>
<td>3</td>
<td>Face-to-face behavioral counseling for obesity, 15 minutes</td>
<td>Behavior counsel obesity 15m</td>
</tr>
<tr class="even">
<td>G0448</td>
<td>0010</td>
<td>3</td>
<td>Insertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber with insertion of pacing electrode, cardiac venous system, for left ventricular pacing</td>
<td>Place perm pacing cardiovert</td>
</tr>
<tr class="odd">
<td>G0451</td>
<td>0010</td>
<td>3</td>
<td>Development testing, with interpretation and report, per standardized instrument form</td>
<td>Devlopment test interpt&amp;rep</td>
</tr>
<tr class="even">
<td>G0452</td>
<td>0010</td>
<td>3</td>
<td>Molecular pathology procedure; physician interpretation and report</td>
<td>Molecular pathology interpr</td>
</tr>
<tr class="odd">
<td>G0453</td>
<td>0010</td>
<td>3</td>
<td>Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)</td>
<td>Cont intraop neuro monitor</td>
</tr>
<tr class="even">
<td>G0454</td>
<td>0010</td>
<td>3</td>
<td>Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist</td>
<td>Md document visit by npp</td>
</tr>
<tr class="odd">
<td>G0455</td>
<td>0010</td>
<td>3</td>
<td>Preparation with instillation of fecal microbiota by any method, including assessment of donor specimen</td>
<td>Fecal microbiota prep instil</td>
</tr>
<tr class="even">
<td>G0456</td>
<td>0010</td>
<td>3</td>
<td>Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area less than or equal to 50 square centimeters</td>
<td>Neg pre wound &lt;=50 sq cm</td>
</tr>
<tr class="odd">
<td>G0457</td>
<td>0010</td>
<td>3</td>
<td>Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area greater than 50 square centimeters</td>
<td>Neg pres wound &gt;50 sq cm</td>
</tr>
<tr class="even">
<td>G0458</td>
<td>0010</td>
<td>3</td>
<td>Low dose rate (ldr) prostate brachytherapy services, composite rate</td>
<td>Ldr prostate brachy comp rat</td>
</tr>
<tr class="odd">
<td>G0459</td>
<td>0010</td>
<td>3</td>
<td>Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy</td>
<td>Telehealth inpt pharm mgmt</td>
</tr>
<tr class="even">
<td>G0460</td>
<td>0010</td>
<td>3</td>
<td>Autologous platelet rich plasma for chronic wounds/ulcers, including phlebotomy, centrifugation, and all other preparatory procedures, administration and dressings, per treatment</td>
<td>Autologous prp for ulcers</td>
</tr>
<tr class="odd">
<td>G0461</td>
<td>0010</td>
<td>3</td>
<td>Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain</td>
<td>Immunohisto/cyto chem 1st st</td>
</tr>
<tr class="even">
<td>G0462</td>
<td>0010</td>
<td>3</td>
<td>Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)</td>
<td>Immunohisto/cyto chem add</td>
</tr>
<tr class="odd">
<td>G0463</td>
<td>0010</td>
<td>3</td>
<td>Hospital outpatient clinic visit for assessment and management of a patient</td>
<td>Hospital outpt clinic visit</td>
</tr>
<tr class="even">
<td>G0464</td>
<td>0010</td>
<td>3</td>
<td>Colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g., kras, ndrg4 and bmp3)</td>
<td>Colorec ca scr, sto bas dna</td>
</tr>
<tr class="odd">
<td>G0466</td>
<td>0010</td>
<td>3</td>
<td>Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit</td>
<td>Fqhc visit new patient</td>
</tr>
<tr class="even">
<td>G0467</td>
<td>0010</td>
<td>3</td>
<td>Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit</td>
<td>Fqhc visit, estab pt</td>
</tr>
<tr class="odd">
<td>G0468</td>
<td>0010</td>
<td>3</td>
<td>Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv</td>
<td>Fqhc visit, ippe or awv</td>
</tr>
<tr class="even">
<td>G0469</td>
<td>0010</td>
<td>3</td>
<td>Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit</td>
<td>Fqhc visit, mh new pt</td>
</tr>
<tr class="odd">
<td>G0470</td>
<td>0010</td>
<td>3</td>
<td>Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit</td>
<td>Fqhc visit, mh estab pt</td>
</tr>
<tr class="even">
<td>G0471</td>
<td>0010</td>
<td>3</td>
<td>Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)</td>
<td>Ven blood coll snf/hha</td>
</tr>
<tr class="odd">
<td>G0472</td>
<td>0010</td>
<td>3</td>
<td>Hepatitis c antibody screening, for individual at high risk and other covered indication(s)</td>
<td>Hep c screen high risk/other</td>
</tr>
<tr class="even">
<td>G0473</td>
<td>0010</td>
<td>3</td>
<td>Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes</td>
<td>Group behave couns 2-10</td>
</tr>
<tr class="odd">
<td>G0475</td>
<td>0010</td>
<td>3</td>
<td>Hiv antigen/antibody, combination assay, screening</td>
<td>Hiv combination assay</td>
</tr>
<tr class="even">
<td>G0476</td>
<td>0010</td>
<td>3</td>
<td>Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test</td>
<td>Hpv combo assay ca screen</td>
</tr>
<tr class="odd">
<td>G0477</td>
<td>0010</td>
<td>3</td>
<td>Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical observation only (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service</td>
<td>Drug test presump optical</td>
</tr>
<tr class="even">
<td>G0478</td>
<td>0010</td>
<td>3</td>
<td>Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) read by instrument-assisted direct optical observation (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service</td>
<td>Drug test presump opt inst</td>
</tr>
<tr class="odd">
<td>G0479</td>
<td>0010</td>
<td>3</td>
<td>Drug test(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, tof, maldi, ldtd, desi, dart, ghpc, gc mass spectrometry), includes sample validation when performed, per date of service</td>
<td>Drug test presump not opt</td>
</tr>
<tr class="even">
<td>G0480</td>
<td>0010</td>
<td>3</td>
<td>Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed</td>
<td>Drug test def 1-7 classes</td>
</tr>
<tr class="odd">
<td>G0481</td>
<td>0010</td>
<td>3</td>
<td>Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed</td>
<td>Drug test def 8-14 classes</td>
</tr>
<tr class="even">
<td>G0482</td>
<td>0010</td>
<td>3</td>
<td>Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed</td>
<td>Drug test def 15-21 classes</td>
</tr>
<tr class="odd">
<td>G0483</td>
<td>0010</td>
<td>3</td>
<td>Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed</td>
<td>Drug test def 22+ classes</td>
</tr>
<tr class="even">
<td>G0490</td>
<td>0010</td>
<td>3</td>
<td>Face-to-face home health nursing visit by a rural health clinic (rhc) or federally qualified health center (fqhc) in an area with a shortage of home health agencies; (services limited to rn or lpn only)</td>
<td>Home visit rn, lpn by rhc/fq</td>
</tr>
<tr class="odd">
<td>G0491</td>
<td>0010</td>
<td>3</td>
<td>Dialysis procedure at a medicare certified esrd facility for acute kidney injury without esrd</td>
<td>Dialysis acu kidney no esrd</td>
</tr>
<tr class="even">
<td>G0492</td>
<td>0010</td>
<td>3</td>
<td>Dialysis procedure with single evaluation by a physician or other qualified health care professional for acute kidney injury without esrd</td>
<td>Md/oth eval acut kid no esrd</td>
</tr>
<tr class="odd">
<td>G0493</td>
<td>0010</td>
<td>3</td>
<td>Skilled services of a registered nurse (rn) for the observation and assessment of the patient’s condition, each 15 minutes (the change in the patient’s condition requires skilled nursing personnel to identify and evaluate the patient’s need for possible modification of treatment in the home health or hospice setting)</td>
<td>Rn care ea 15 min hh/hospice</td>
</tr>
<tr class="even">
<td>G0494</td>
<td>0010</td>
<td>3</td>
<td>Skilled services of a licensed practical nurse (lpn) for the observation and assessment of the patient’s condition, each 15 minutes (the change in the patient’s condition requires skilled nursing personnel to identify and evaluate the patient’s need for possible modification of treatment in the home health or hospice setting)</td>
<td>Lpn care ea 15min hh/hospice</td>
</tr>
<tr class="odd">
<td>G0495</td>
<td>0010</td>
<td>3</td>
<td>Skilled services of a registered nurse (rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes</td>
<td>Rn care train/edu in hh</td>
</tr>
<tr class="even">
<td>G0496</td>
<td>0010</td>
<td>3</td>
<td>Skilled services of a licensed practical nurse (lpn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes</td>
<td>Lpn care train/edu in hh</td>
</tr>
<tr class="odd">
<td>G0498</td>
<td>0010</td>
<td>3</td>
<td>Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion</td>
<td>Chemo extend iv infus w/pump</td>
</tr>
<tr class="even">
<td>G0499</td>
<td>0010</td>
<td>3</td>
<td>Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result</td>
<td>Hepb screen high risk indiv</td>
</tr>
<tr class="odd">
<td>G0500</td>
<td>0010</td>
<td>3</td>
<td>Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient’s level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)</td>
<td>Mod sedat endo service &gt;5yrs</td>
</tr>
<tr class="even">
<td>G0501</td>
<td>0010</td>
<td>3</td>
<td>Resource-intensive services for patients for whom the use of specialized mobility-assistive technology (such as adjustable height chairs or tables, patient lift, and adjustable padded leg supports) is medically necessary and used during the provision of an office/outpatient, evaluation and management visit (list separately in addition to primary service)</td>
<td>Resource-inten svc during ov</td>
</tr>
<tr class="odd">
<td>G0502</td>
<td>0010</td>
<td>3</td>
<td>Initial psychiatric collaborative care management, first 70 minutes in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional; initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan; review by the psychiatric consultant with modifications of the plan if recommended; entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant; and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies</td>
<td>Init psych care manag, 70min</td>
</tr>
<tr class="even">
<td>G0503</td>
<td>0010</td>
<td>3</td>
<td>Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation; participation in weekly caseload consultation with the psychiatric consultant; ongoing collaboration with and coordination of the patient’s mental health care with the treating physician or other qualified health care professional and any other treating mental health providers; additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant; provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies; monitoring of patient outcomes using validated rating scales; and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment</td>
<td>Subseq psych care man,60mi</td>
</tr>
<tr class="odd">
<td>G0503</td>
<td>0020</td>
<td>4</td>
<td>goals and are prepared for discharge from active treatment</td>
<td></td>
</tr>
<tr class="even">
<td>G0504</td>
<td>0010</td>
<td>3</td>
<td>Initial or subsequent psychiatric collaborative care management, each additional 30 minutes in a calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional (list separately in addition to code for primary procedure); (use g0504 in conjunction with g0502, g0503)</td>
<td>Init/sub psych care add 30 m</td>
</tr>
<tr class="odd">
<td>G0505</td>
<td>0010</td>
<td>3</td>
<td>Cognition and functional assessment using standardized instruments with development of recorded care plan for the patient with cognitive impairment, history obtained from patient and/or caregiver, in office or other outpatient setting or home or domiciliary or rest home</td>
<td>Cog/func assessment outpt</td>
</tr>
<tr class="even">
<td>G0506</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)</td>
<td>Comp asses care plan ccm svc</td>
</tr>
<tr class="odd">
<td>G0507</td>
<td>0010</td>
<td>3</td>
<td>Care management services for behavioral health conditions, at least 20 minutes of clinical staff time, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team</td>
<td>Care manage serv minimum 20</td>
</tr>
<tr class="even">
<td>G0508</td>
<td>0010</td>
<td>3</td>
<td>Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth</td>
<td>Crit care telehea consult 60</td>
</tr>
<tr class="odd">
<td>G0509</td>
<td>0010</td>
<td>3</td>
<td>Telehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth</td>
<td>Crit care telehea consult 50</td>
</tr>
<tr class="even">
<td>G0511</td>
<td>0010</td>
<td>3</td>
<td>Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month</td>
<td>Ccm/bhi by rhc/fqhc 20min mo</td>
</tr>
<tr class="odd">
<td>G0512</td>
<td>0010</td>
<td>3</td>
<td>Rural health clinic or federally qualified health center (rhc/fqhc) only, psychiatric collaborative care model (psychiatric cocm), 60 minutes or more of clinical staff time for psychiatric cocm services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm) and including services furnished by a behavioral health care manager and consultation with a psychiatric consultant, per calendar month</td>
<td>Cocm by rhc/fqhc 60 min mo</td>
</tr>
<tr class="even">
<td>G0513</td>
<td>0010</td>
<td>3</td>
<td>Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preventive service)</td>
<td>Prolong prev svcs, first 30m</td>
</tr>
<tr class="odd">
<td>G0514</td>
<td>0010</td>
<td>3</td>
<td>Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; each additional 30 minutes (list separately in addition to code g0513 for additional 30 minutes of preventive service)</td>
<td>Prolong prev svcs, addl 30m</td>
</tr>
<tr class="even">
<td>G0515</td>
<td>0010</td>
<td>3</td>
<td>Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes</td>
<td>Cognitive skills development</td>
</tr>
<tr class="odd">
<td>G0516</td>
<td>0010</td>
<td>3</td>
<td>Insertion of non-biodegradable drug delivery implants, 4 or more (services for subdermal rod implant)</td>
<td>Insert drug del implant, &gt;=4</td>
</tr>
<tr class="even">
<td>G0517</td>
<td>0010</td>
<td>3</td>
<td>Removal of non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)</td>
<td>Remove drug implant</td>
</tr>
<tr class="odd">
<td>G0518</td>
<td>0010</td>
<td>3</td>
<td>Removal with reinsertion, non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)</td>
<td>Remove w insert drug implant</td>
</tr>
<tr class="even">
<td>G0659</td>
<td>0010</td>
<td>3</td>
<td>Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes</td>
<td>Drug test def simple all cl</td>
</tr>
<tr class="odd">
<td>G0908</td>
<td>0010</td>
<td>3</td>
<td>Most recent hemoglobin (hgb) level &gt; 12.0 g/dl</td>
<td>Hgb &gt; 12 g/dl</td>
</tr>
<tr class="even">
<td>G0909</td>
<td>0010</td>
<td>3</td>
<td>Hemoglobin level measurement not documented, reason not given</td>
<td>Hbg not doc</td>
</tr>
<tr class="odd">
<td>G0910</td>
<td>0010</td>
<td>3</td>
<td>Most recent hemoglobin level &lt;= 12.0 g/dl</td>
<td>Hgb &lt;= 12 g/dl</td>
</tr>
<tr class="even">
<td>G0913</td>
<td>0010</td>
<td>3</td>
<td>Improvement in visual function achieved within 90 days following cataract surgery</td>
<td>Improve visual funct</td>
</tr>
<tr class="odd">
<td>G0914</td>
<td>0010</td>
<td>3</td>
<td>Patient care survey was not completed by patient</td>
<td>Survey not complete</td>
</tr>
<tr class="even">
<td>G0915</td>
<td>0010</td>
<td>3</td>
<td>Improvement in visual function not achieved within 90 days following cataract surgery</td>
<td>No improve visual funct</td>
</tr>
<tr class="odd">
<td>G0916</td>
<td>0010</td>
<td>3</td>
<td>Satisfaction with care achieved within 90 days following cataract surgery</td>
<td>Satisfy with care</td>
</tr>
<tr class="even">
<td>G0917</td>
<td>0010</td>
<td>3</td>
<td>Patient satisfaction survey was not completed by patient</td>
<td>Satisfy survey not complete</td>
</tr>
<tr class="odd">
<td>G0918</td>
<td>0010</td>
<td>3</td>
<td>Satisfaction with care not achieved within 90 days following cataract surgery</td>
<td>No satisfy with care</td>
</tr>
<tr class="even">
<td>G0919</td>
<td>0010</td>
<td>3</td>
<td>Influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit</td>
<td>Flu immunize not avail</td>
</tr>
<tr class="odd">
<td>G0920</td>
<td>0010</td>
<td>3</td>
<td>Type, anatomic location, and activity all documented</td>
<td>Type loc act doc</td>
</tr>
<tr class="even">
<td>G0921</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment)</td>
<td>Doc pt reas no assess</td>
</tr>
<tr class="odd">
<td>G0922</td>
<td>0010</td>
<td>3</td>
<td>No documentation of disease type, anatomic location, and activity, reason not given</td>
<td>Type loc act not doc</td>
</tr>
<tr class="even">
<td>G1000</td>
<td>0010</td>
<td>3</td>
<td>Clinical decision support mechanism applied pathways, as defined by the medicare appropriate use criteria program</td>
<td>Cdsm applied pathways</td>
</tr>
<tr class="odd">
<td>G1001</td>
<td>0010</td>
<td>3</td>
<td>Clinical decision support mechanism evicore, as defined by the medicare appropriate use criteria program</td>
<td>Cdsm evicore</td>
</tr>
<tr class="even">
<td>G1002</td>
<td>0010</td>
<td>3</td>
<td>Clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria program</td>
<td>Cdsm medcurrent</td>
</tr>
<tr class="odd">
<td>G1003</td>
<td>0010</td>
<td>3</td>
<td>Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program</td>
<td>Cdsm medicalis</td>
</tr>
<tr class="even">
<td>G1004</td>
<td>0010</td>
<td>3</td>
<td>Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program</td>
<td>Cdsm ndsc</td>
</tr>
<tr class="odd">
<td>G1005</td>
<td>0010</td>
<td>3</td>
<td>Clinical decision support mechanism national imaging associates, as defined by the medicare appropriate use criteria program</td>
<td>Cdsm nia</td>
</tr>
<tr class="even">
<td>G1006</td>
<td>0010</td>
<td>3</td>
<td>Clinical decision support mechanism test appropriate, as defined by the medicare appropriate use criteria program</td>
<td>Cdsm test approp</td>
</tr>
<tr class="odd">
<td>G1007</td>
<td>0010</td>
<td>3</td>
<td>Clinical decision support mechanism aim specialty health, as defined by the medicare appropriate use criteria program</td>
<td>Cdsm aim</td>
</tr>
<tr class="even">
<td>G1008</td>
<td>0010</td>
<td>3</td>
<td>Clinical decision support mechanism cranberry peak, as defined by the medicare appropriate use criteria program</td>
<td>Cdsm cranberry pk</td>
</tr>
<tr class="odd">
<td>G1009</td>
<td>0010</td>
<td>3</td>
<td>Clinical decision support mechanism sage health management solutions, as defined by the medicare appropriate use criteria program</td>
<td>Cdsm sage health</td>
</tr>
<tr class="even">
<td>G1010</td>
<td>0010</td>
<td>3</td>
<td>Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program</td>
<td>Cdsm stanson</td>
</tr>
<tr class="odd">
<td>G1011</td>
<td>0010</td>
<td>3</td>
<td>Clinical decision support mechanism, qualified tool not otherwise specified, as defined by the medicare appropriate use criteria program</td>
<td>Cdsm qualified nos</td>
</tr>
<tr class="even">
<td>G2000</td>
<td>0010</td>
<td>3</td>
<td>Blinded administration of convulsive therapy procedure, either electroconvulsive therapy (ect, current covered gold standard) or magnetic seizure therapy (mst, non-covered experimental therapy), performed in an approved ide-based clinical trial, per treatment session</td>
<td>Blinded conv. tx mdd clin tr</td>
</tr>
<tr class="odd">
<td>G2001</td>
<td>0010</td>
<td>3</td>
<td>Brief (20 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)</td>
<td>Post d/c h vst new pt 20 m</td>
</tr>
<tr class="even">
<td>G2002</td>
<td>0010</td>
<td>3</td>
<td>Limited (30 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)</td>
<td>Post-d/c h vst new pt 30 m</td>
</tr>
<tr class="odd">
<td>G2003</td>
<td>0010</td>
<td>3</td>
<td>Moderate (45 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)</td>
<td>Post-d/c h vst new pt 45 m</td>
</tr>
<tr class="even">
<td>G2004</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive (60 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)</td>
<td>Post-d/c h vst new pt 60 m</td>
</tr>
<tr class="odd">
<td>G2005</td>
<td>0010</td>
<td>3</td>
<td>Extensive (75 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)</td>
<td>Post-d/c h vst new pt 75 m</td>
</tr>
<tr class="even">
<td>G2006</td>
<td>0010</td>
<td>3</td>
<td>Brief (20 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)</td>
<td>Post-d/c h vst ext pt 20 m</td>
</tr>
<tr class="odd">
<td>G2007</td>
<td>0010</td>
<td>3</td>
<td>Limited (30 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)</td>
<td>Post-d/c h vst ext pt 30 m</td>
</tr>
<tr class="even">
<td>G2008</td>
<td>0010</td>
<td>3</td>
<td>Moderate (45 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)</td>
<td>Post-d/c h vst ext pt 45 m</td>
</tr>
<tr class="odd">
<td>G2009</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive (60 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)</td>
<td>Post-d/c h vst ext pt 60 m</td>
</tr>
<tr class="even">
<td>G2010</td>
<td>0010</td>
<td>3</td>
<td>Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment</td>
<td>Remot image submit by pt</td>
</tr>
<tr class="odd">
<td>G2011</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or substance (other than tobacco) abuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes</td>
<td>Alcohol/sub abuse assess</td>
</tr>
<tr class="even">
<td>G2012</td>
<td>0010</td>
<td>3</td>
<td>Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion</td>
<td>Brief check in by md/qhp</td>
</tr>
<tr class="odd">
<td>G2013</td>
<td>0010</td>
<td>3</td>
<td>Extensive (75 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)</td>
<td>Post-d/c h vst ext pt 75 m</td>
</tr>
<tr class="even">
<td>G2014</td>
<td>0010</td>
<td>3</td>
<td>Limited (30 minutes) care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)</td>
<td>Post-d/c care plan overs 30m</td>
</tr>
<tr class="odd">
<td>G2015</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive (60 mins) home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary’s home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility.)</td>
<td>Post-d/c care plan overs 60m</td>
</tr>
<tr class="even">
<td>G2021</td>
<td>0010</td>
<td>3</td>
<td>Health care practitioners rendering treatment in place (tip)</td>
<td>Hea care pract tx in place</td>
</tr>
<tr class="odd">
<td>G2022</td>
<td>0010</td>
<td>3</td>
<td>A model participant (ambulance supplier/provider), the beneficiary refuses services covered under the model (transport to an alternate destination/treatment in place)</td>
<td>Benef refuses service, mod</td>
</tr>
<tr class="even">
<td>G2058</td>
<td>0010</td>
<td>3</td>
<td>Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)).</td>
<td>Ccm add 20min</td>
</tr>
<tr class="odd">
<td>G2061</td>
<td>0010</td>
<td>3</td>
<td>Qualified nonphysician healthcare professional online assessment, for an established patient, for up to seven days, cumulative time during the 7 days; 5-10 minutes</td>
<td>Qual nonmd est pt 5-10m</td>
</tr>
<tr class="even">
<td>G2062</td>
<td>0010</td>
<td>3</td>
<td>Qualified nonphysician healthcare professional online assessment service, for an established patient, for up to seven days, cumulative time during the 7 days; 11-20 minutes</td>
<td>Qual nonmd est pt 11-20m</td>
</tr>
<tr class="odd">
<td>G2063</td>
<td>0010</td>
<td>3</td>
<td>Qualified nonphysician qualified healthcare professional assessment service, for an established patient, for up to seven days, cumulative time during the 7 days; 21 or more minutes</td>
<td>Qual nonmd est pt 21&gt;min</td>
</tr>
<tr class="even">
<td>G2064</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive care management services for a single high-risk disease, e.g., principal care management, at least 30 minutes of physician or other qualified health care professional time per calendar month with the following elements: one complex chronic condition lasting at least 3 months, which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been the cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities</td>
<td>Md mang high risk dx 30</td>
</tr>
<tr class="odd">
<td>G2065</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive care management for a single high-risk disease services, e.g. principal care management, at least 30 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month with the following elements: one complex chronic condition lasting at least 3 months, which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities</td>
<td>Clin mang h risk dx 30</td>
</tr>
<tr class="even">
<td>G2066</td>
<td>0010</td>
<td>3</td>
<td>Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results</td>
<td>Inter devc remote 30d</td>
</tr>
<tr class="odd">
<td>G2067</td>
<td>0010</td>
<td>3</td>
<td>Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)</td>
<td>Med assist tx meth wk</td>
</tr>
<tr class="even">
<td>G2068</td>
<td>0010</td>
<td>3</td>
<td>Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)</td>
<td>Med assist tx bupre oral</td>
</tr>
<tr class="odd">
<td>G2069</td>
<td>0010</td>
<td>3</td>
<td>Medication assisted treatment, buprenorphine (injectable); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)</td>
<td>Med assist tx inject</td>
</tr>
<tr class="even">
<td>G2070</td>
<td>0010</td>
<td>3</td>
<td>Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)</td>
<td>Med assist tx implant</td>
</tr>
<tr class="odd">
<td>G2071</td>
<td>0010</td>
<td>3</td>
<td>Medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)</td>
<td>Med tx remove implant</td>
</tr>
<tr class="even">
<td>G2072</td>
<td>0010</td>
<td>3</td>
<td>Medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)</td>
<td>Med tx insert/remove imp</td>
</tr>
<tr class="odd">
<td>G2073</td>
<td>0010</td>
<td>3</td>
<td>Medication assisted treatment, naltrexone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)</td>
<td>Med tx naltrexone</td>
</tr>
<tr class="even">
<td>G2074</td>
<td>0010</td>
<td>3</td>
<td>Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)</td>
<td>Med assist tx no drug</td>
</tr>
<tr class="odd">
<td>G2075</td>
<td>0010</td>
<td>3</td>
<td>Medication assisted treatment, medication not otherwise specified; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)</td>
<td>Med tx meds nos</td>
</tr>
<tr class="even">
<td>G2076</td>
<td>0010</td>
<td>3</td>
<td>Intake activities, including initial medical examination that is a complete, fully documented physical evaluation and initial assessment by a program physician or a primary care physician, or an authorized healthcare professional under the supervision of a program physician qualified personnel that includes preparation of a treatment plan that includes the patient’s short-term goals and the tasks the patient must perform to complete the short-term goals; the patient’s requirements for education, vocational rehabilitation, and employment; and the medical, psycho- social, economic, legal, or other supportive services that a patient needs, conducted by qualified personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure</td>
<td>Intake act w/med exam</td>
</tr>
<tr class="odd">
<td>G2077</td>
<td>0010</td>
<td>3</td>
<td>Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure</td>
<td>Periodic assessment</td>
</tr>
<tr class="even">
<td>G2078</td>
<td>0010</td>
<td>3</td>
<td>Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure</td>
<td>Take-home meth</td>
</tr>
<tr class="odd">
<td>G2079</td>
<td>0010</td>
<td>3</td>
<td>Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure</td>
<td>Take-hom buprenorphine</td>
</tr>
<tr class="even">
<td>G2080</td>
<td>0010</td>
<td>3</td>
<td>Each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure</td>
<td>Add 30 mins counsel</td>
</tr>
<tr class="odd">
<td>G2081</td>
<td>0010</td>
<td>3</td>
<td>Patients age 66 and older in institutional special needs plans (snp) or residing in long-term care with a pos code 32, 33, 34, 54 or 56 for more than 90 days during the measurement period</td>
<td>Pt 66+ snp or ltc pos &gt; 90d</td>
</tr>
<tr class="even">
<td>G2082</td>
<td>0010</td>
<td>3</td>
<td>Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of up to 56 mg of esketamine nasal self-administration, includes 2 hours post-administration observation</td>
<td>Visit esketamine 56m or less</td>
</tr>
<tr class="odd">
<td>G2083</td>
<td>0010</td>
<td>3</td>
<td>Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, includes 2 hours post-administration observation</td>
<td>Visit esketamine, &gt; 56m</td>
</tr>
<tr class="even">
<td>G2086</td>
<td>0010</td>
<td>3</td>
<td>Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month</td>
<td>Off base opioid tx 70min</td>
</tr>
<tr class="odd">
<td>G2087</td>
<td>0010</td>
<td>3</td>
<td>Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month</td>
<td>Off base opioid tx, 60 m</td>
</tr>
<tr class="even">
<td>G2088</td>
<td>0010</td>
<td>3</td>
<td>Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; each additional 30 minutes beyond the first 120 minutes (list separately in addition to code for primary procedure)</td>
<td>Off base opioid tx, add30</td>
</tr>
<tr class="odd">
<td>G2089</td>
<td>0010</td>
<td>3</td>
<td>Most recent hemoglobin a1c (hba1c) level 7.0 to 9.0%</td>
<td>A1c level 7 to 9%</td>
</tr>
<tr class="even">
<td>G2090</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ frailty and med dem</td>
</tr>
<tr class="odd">
<td>G2091</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ frailty and adv ill</td>
</tr>
<tr class="even">
<td>G2092</td>
<td>0010</td>
<td>3</td>
<td>Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy prescribed or currently being taken</td>
<td>Ace arb arni</td>
</tr>
<tr class="odd">
<td>G2093</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., hypotensive patients who are at immediate risk of cardiogenic shock, hospitalized patients who have experienced marked azotemia, allergy, intolerance, other medical reasons)</td>
<td>Med doc rsn no ace arn arni</td>
</tr>
<tr class="even">
<td>G2094</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., patient declined, other patient reasons)</td>
<td>Pt rsn no ace arn arni</td>
</tr>
<tr class="odd">
<td>G2095</td>
<td>0010</td>
<td>3</td>
<td>Documentation of system reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., other system reasons)</td>
<td>Sys rsn no ace arn arni</td>
</tr>
<tr class="even">
<td>G2096</td>
<td>0010</td>
<td>3</td>
<td>Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy was not prescribed, reason not given</td>
<td>No rsn ace arb arni</td>
</tr>
<tr class="odd">
<td>G2097</td>
<td>0010</td>
<td>3</td>
<td>Children with a competing diagnosis for upper respiratory infection within three days of diagnosis of pharyngitis (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti</td>
<td>Child dx uri 3d of other dx</td>
</tr>
<tr class="even">
<td>G2098</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ frailty and med dem</td>
</tr>
<tr class="odd">
<td>G2099</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ frailty and adv ill</td>
</tr>
<tr class="even">
<td>G2100</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ frailty and med dem</td>
</tr>
<tr class="odd">
<td>G2101</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ frailty and adv ill</td>
</tr>
<tr class="even">
<td>G2102</td>
<td>0010</td>
<td>3</td>
<td>Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed</td>
<td>Dil retinal eye exam</td>
</tr>
<tr class="odd">
<td>G2103</td>
<td>0010</td>
<td>3</td>
<td>Seven standard field stereoscopic photos with interpretation by an ophthalmologist or optometrist documented and reviewed</td>
<td>7 stereo photos interpret</td>
</tr>
<tr class="even">
<td>G2104</td>
<td>0010</td>
<td>3</td>
<td>Eye imaging validated to match diagnosis from seven standard field stereoscopic photos results documented and reviewed</td>
<td>Eye img valid w/7 stereo</td>
</tr>
<tr class="odd">
<td>G2105</td>
<td>0010</td>
<td>3</td>
<td>Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 days during the measurement period</td>
<td>Pt 66+ lt ints &gt; 90</td>
</tr>
<tr class="even">
<td>G2106</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ lt ints &gt; 90</td>
</tr>
<tr class="odd">
<td>G2107</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ frailty and adv ill</td>
</tr>
<tr class="even">
<td>G2108</td>
<td>0010</td>
<td>3</td>
<td>Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 days during the measurement period</td>
<td>Pt 66+ lt ints &gt; 90</td>
</tr>
<tr class="odd">
<td>G2109</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ frailty and med dem</td>
</tr>
<tr class="even">
<td>G2110</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ frailty and adv ill</td>
</tr>
<tr class="odd">
<td>G2112</td>
<td>0010</td>
<td>3</td>
<td>Patient receiving &lt;=5 mg daily prednisone (or equivalent), or ra activity is worsening, or glucocorticoid use is for less than 6 months</td>
<td>Pred&lt;=5 mg ra glu &lt;6m</td>
</tr>
<tr class="even">
<td>G2113</td>
<td>0010</td>
<td>3</td>
<td>Patient receiving &gt;5 mg daily prednisone (or equivalent) for longer than 6 months, and improvement or no change in disease activity</td>
<td>Pred&gt;5 mg &gt;6m, no chg da</td>
</tr>
<tr class="odd">
<td>G2114</td>
<td>0010</td>
<td>3</td>
<td>Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period</td>
<td>Pt 66-80 frailty and med dem</td>
</tr>
<tr class="even">
<td>G2115</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ frailty and med dem</td>
</tr>
<tr class="odd">
<td>G2116</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ frailty and adv ill</td>
</tr>
<tr class="even">
<td>G2117</td>
<td>0010</td>
<td>3</td>
<td>Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period</td>
<td>Pt 66-80 frailty and adv ill</td>
</tr>
<tr class="odd">
<td>G2118</td>
<td>0010</td>
<td>3</td>
<td>Patients 81 years of age and older with a evidence of frailty during the measurement period</td>
<td>Pt 81+ frailty</td>
</tr>
<tr class="even">
<td>G2119</td>
<td>0010</td>
<td>3</td>
<td>Within the past 2 years, calcium and/or vitamin d optimization has been ordered or performed</td>
<td>Calc vitd opt</td>
</tr>
<tr class="odd">
<td>G2120</td>
<td>0010</td>
<td>3</td>
<td>Within the past 2 years, calcium and/or vitamin d optimization has not been ordered or performed</td>
<td>No calc vitd opt</td>
</tr>
<tr class="even">
<td>G2121</td>
<td>0010</td>
<td>3</td>
<td>Psychosis, depression, anxiety, apathy, and impulse control disorder assessed</td>
<td>Psy dep anx ap and icd asse</td>
</tr>
<tr class="odd">
<td>G2122</td>
<td>0010</td>
<td>3</td>
<td>Psychosis, depression, anxiety, apathy, and impulse control disorder not assessed</td>
<td>Psy/dep/anx/apandicd noasse</td>
</tr>
<tr class="even">
<td>G2123</td>
<td>0010</td>
<td>3</td>
<td>Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period</td>
<td>Pt 66-80 frailty med dem</td>
</tr>
<tr class="odd">
<td>G2124</td>
<td>0010</td>
<td>3</td>
<td>Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and a dispensed dementia medication</td>
<td>Pt 66-80 frailty adv ill</td>
</tr>
<tr class="even">
<td>G2125</td>
<td>0010</td>
<td>3</td>
<td>Patients 81 years of age and older with evidence of frailty during the measurement period</td>
<td>Pt 81+ frailty</td>
</tr>
<tr class="odd">
<td>G2126</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age or older and had at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ frailty adv ill</td>
</tr>
<tr class="even">
<td>G2127</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age or older and had at least one claim/encounter for frailty during the measurement period and a dispensed dementia medication</td>
<td>Pt 66+ frailty med dem</td>
</tr>
<tr class="odd">
<td>G2128</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g. history of gastrointestinal bleed, intra-cranial bleed, blood disorders, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)</td>
<td>No aspirin med rsn</td>
</tr>
<tr class="even">
<td>G2129</td>
<td>0010</td>
<td>3</td>
<td>Procedure-related bp’s not taken during an outpatient visit. examples include same day surgery, ambulatory service center, g.i. lab, dialysis, infusion center, chemotherapy</td>
<td>No bp outpt</td>
</tr>
<tr class="odd">
<td>G2130</td>
<td>0010</td>
<td>3</td>
<td>Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 days during the measurement period</td>
<td>Pt 66+ lt inst &gt; 90</td>
</tr>
<tr class="even">
<td>G2131</td>
<td>0010</td>
<td>3</td>
<td>Patients 81 years and older with a diagnosis of frailty</td>
<td>Pt 81+ frailty</td>
</tr>
<tr class="odd">
<td>G2132</td>
<td>0010</td>
<td>3</td>
<td>Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period</td>
<td>Pt 66-80 frailty and med dem</td>
</tr>
<tr class="even">
<td>G2133</td>
<td>0010</td>
<td>3</td>
<td>Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period</td>
<td>Pt 66-80 frailty and adv ill</td>
</tr>
<tr class="odd">
<td>G2134</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ frailty and med dem</td>
</tr>
<tr class="even">
<td>G2135</td>
<td>0010</td>
<td>3</td>
<td>Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period</td>
<td>Pt 66+ frailty and adv ill</td>
</tr>
<tr class="odd">
<td>G2136</td>
<td>0010</td>
<td>3</td>
<td>Back pain measured by the visual analog scale (vas) at three months (6 ? 20 weeks) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) within three months preoperatively and at three months (6 ? 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater</td>
<td>Bk pain vas 6-20wk = 3</td>
</tr>
<tr class="even">
<td>G2137</td>
<td>0010</td>
<td>3</td>
<td>Back pain measured by the visual analog scale (vas) at three months (6 ? 20 weeks) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) within three months preoperatively and at three months (6 ? 20 weeks) postoperatively demonstrated a change of less than an improvement of 5.0 points</td>
<td>Bk pain vas 6-20wk &gt; 3</td>
</tr>
<tr class="odd">
<td>G2138</td>
<td>0010</td>
<td>3</td>
<td>Back pain as measured by the visual analog scale (vas) at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated a change of 5.0 points or greater</td>
<td>Bk pain vas 9-15mo = 3</td>
</tr>
<tr class="even">
<td>G2139</td>
<td>0010</td>
<td>3</td>
<td>Back pain measured by the visual analog scale (vas) pain at one year (9 to 15 months) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated a change of less than 5.0</td>
<td>Bk pain vas 9-20mo &gt; 3</td>
</tr>
<tr class="odd">
<td>G2140</td>
<td>0010</td>
<td>3</td>
<td>Leg pain measured by the visual analog scale (vas) at three months (6 ? 20 weeks) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater</td>
<td>Leg pain vas 6-20wk = 3</td>
</tr>
<tr class="even">
<td>G2141</td>
<td>0010</td>
<td>3</td>
<td>Leg pain measured by the visual analog scale (vas) at three months (6 ? 20 weeks) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated less than an improvement of 5.0 points</td>
<td>Leg pain vas 6-20wk &gt; 3</td>
</tr>
<tr class="odd">
<td>G2142</td>
<td>0010</td>
<td>3</td>
<td>Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated a change of 30 points or greater</td>
<td>Fs odi 9-15mo postop&lt;= 22</td>
</tr>
<tr class="even">
<td>G2143</td>
<td>0010</td>
<td>3</td>
<td>Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated a change of less than 30 points</td>
<td>Fs odi 9-15mo &gt; 22</td>
</tr>
<tr class="odd">
<td>G2144</td>
<td>0010</td>
<td>3</td>
<td>Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6 ? 20 weeks) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated a change of 30 points or greater</td>
<td>Fs odi 6-20wk postop &gt; 22</td>
</tr>
<tr class="even">
<td>G2145</td>
<td>0010</td>
<td>3</td>
<td>Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6 ? 20 weeks) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated a change of less than 30 points</td>
<td>Fsodi 6-20wk &gt;22 or chg 30pt</td>
</tr>
<tr class="odd">
<td>G2146</td>
<td>0010</td>
<td>3</td>
<td>Leg pain as measured by the visual analog scale (vas) at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 5.0 points or greater</td>
<td>Leg pain vas 9-15mo &lt;= 3</td>
</tr>
<tr class="even">
<td>G2147</td>
<td>0010</td>
<td>3</td>
<td>Leg pain measured by the visual analog scale (vas) at one year (9 to 15 months) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated less than an improvement of 5.0 points</td>
<td>Leg pain vas 9-15mo &gt; 3</td>
</tr>
<tr class="odd">
<td>G2148</td>
<td>0010</td>
<td>3</td>
<td>Performance met: multimodal pain management was used</td>
<td>Mpm used</td>
</tr>
<tr class="even">
<td>G2149</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not using multimodal pain management (e.g., allergy to multiple classes of analgesics, intubated patient, hepatic failure, patient reports no pain during pacu stay, other medical reason(s))</td>
<td>No mpm med rsn</td>
</tr>
<tr class="odd">
<td>G2150</td>
<td>0010</td>
<td>3</td>
<td>Performance not met: multimodal pain management was not used</td>
<td>No mpm</td>
</tr>
<tr class="even">
<td>G2151</td>
<td>0010</td>
<td>3</td>
<td>Patients with diagnosis of a degenerative neurological condition such as als, ms, parkinson’s diagnosed at any time before or during the episode of care</td>
<td>Dx degen neuro</td>
</tr>
<tr class="odd">
<td>G2152</td>
<td>0010</td>
<td>3</td>
<td>Performance met: the residual change score is equal to or greater than 0</td>
<td>Res change sc =0</td>
</tr>
<tr class="even">
<td>G2153</td>
<td>0010</td>
<td>3</td>
<td>In hospice or using hospice services during the measurement period</td>
<td>Hosp dur meas pd</td>
</tr>
<tr class="odd">
<td>G2154</td>
<td>0010</td>
<td>3</td>
<td>Patient received at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period</td>
<td>Td 9 yrs start end meas</td>
</tr>
<tr class="even">
<td>G2155</td>
<td>0010</td>
<td>3</td>
<td>Patient had history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)</td>
<td>Hist contraindications</td>
</tr>
<tr class="odd">
<td>G2156</td>
<td>0010</td>
<td>3</td>
<td>Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period; or have history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)</td>
<td>No prior td or hx contra</td>
</tr>
<tr class="even">
<td>G2157</td>
<td>0010</td>
<td>3</td>
<td>Patients received both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during the measurement period</td>
<td>Pneum vacc 12 mo 60+</td>
</tr>
<tr class="odd">
<td>G2158</td>
<td>0010</td>
<td>3</td>
<td>Patient had prior pneumococcal vaccine adverse reaction any time during or before the measurement period</td>
<td>Pneum vacc adv rx</td>
</tr>
<tr class="even">
<td>G2159</td>
<td>0010</td>
<td>3</td>
<td>Patient did not receive both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during measurement period; or have prior pneumococcal vaccine adverse reaction any time during or before the measurement period</td>
<td>No pneum vacc 12 mo 60+</td>
</tr>
<tr class="odd">
<td>G2160</td>
<td>0010</td>
<td>3</td>
<td>Patient received at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient’s 50th birthday before or during the measurement period</td>
<td>Herpzos 50+</td>
</tr>
<tr class="even">
<td>G2161</td>
<td>0010</td>
<td>3</td>
<td>Patient had prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period</td>
<td>Adv rx zos</td>
</tr>
<tr class="odd">
<td>G2162</td>
<td>0010</td>
<td>3</td>
<td>Patient did not receive at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient’s 50th birthday before or during the measurement period; or have prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period</td>
<td>No herpzos 50+</td>
</tr>
<tr class="even">
<td>G2163</td>
<td>0010</td>
<td>3</td>
<td>Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period</td>
<td>Infl vacc 07/01 to 06/30</td>
</tr>
<tr class="odd">
<td>G2164</td>
<td>0010</td>
<td>3</td>
<td>Patient had a prior influenza virus vaccine adverse reaction any time before or during the measurement period</td>
<td>Adv rx infl vacc</td>
</tr>
<tr class="even">
<td>G2165</td>
<td>0010</td>
<td>3</td>
<td>Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period; or did not have a prior influenza virus vaccine adverse reaction any time before or during the measurement period</td>
<td>No infl vacc 07/01 to 06/30</td>
</tr>
<tr class="odd">
<td>G2166</td>
<td>0010</td>
<td>3</td>
<td>Patient refused to participate at admission and/or discharge; patient unable to complete the neck fs prom at admission or discharge due to cognitive deficit, visual deficit, motor deficit, language barrier, or low reading level, and a suitable proxy/recorder is not available; patient self-discharged early; medical reason</td>
<td>No pt adm dx no neck fs prom</td>
</tr>
<tr class="even">
<td>G2167</td>
<td>0010</td>
<td>3</td>
<td>Performance not met: the residual change score is less than 0</td>
<td>Res change sc &lt; 0</td>
</tr>
<tr class="odd">
<td>G3001</td>
<td>0010</td>
<td>3</td>
<td>Administration and supply of tositumomab, 450 mg</td>
<td>Admin + supply, tositumomab</td>
</tr>
<tr class="even">
<td>G6001</td>
<td>0010</td>
<td>3</td>
<td>Ultrasonic guidance for placement of radiation therapy fields</td>
<td>Echo guidance radiotherapy</td>
</tr>
<tr class="odd">
<td>G6002</td>
<td>0010</td>
<td>3</td>
<td>Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy</td>
<td>Stereoscopic x-ray guidance</td>
</tr>
<tr class="even">
<td>G6003</td>
<td>0010</td>
<td>3</td>
<td>Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: up to 5 mev</td>
<td>Radiation treatment delivery</td>
</tr>
<tr class="odd">
<td>G6004</td>
<td>0010</td>
<td>3</td>
<td>Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 6-10 mev</td>
<td>Radiation treatment delivery</td>
</tr>
<tr class="even">
<td>G6005</td>
<td>0010</td>
<td>3</td>
<td>Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 11-19 mev</td>
<td>Radiation treatment delivery</td>
</tr>
<tr class="odd">
<td>G6006</td>
<td>0010</td>
<td>3</td>
<td>Radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 20 mev or greater</td>
<td>Radiation treatment delivery</td>
</tr>
<tr class="even">
<td>G6007</td>
<td>0010</td>
<td>3</td>
<td>Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: up to 5 mev</td>
<td>Radiation treatment delivery</td>
</tr>
<tr class="odd">
<td>G6008</td>
<td>0010</td>
<td>3</td>
<td>Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 6-10 mev</td>
<td>Radiation treatment delivery</td>
</tr>
<tr class="even">
<td>G6009</td>
<td>0010</td>
<td>3</td>
<td>Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 11-19 mev</td>
<td>Radiation treatment delivery</td>
</tr>
<tr class="odd">
<td>G6010</td>
<td>0010</td>
<td>3</td>
<td>Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 20 mev or greater</td>
<td>Radiation treatment delivery</td>
</tr>
<tr class="even">
<td>G6011</td>
<td>0010</td>
<td>3</td>
<td>Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; up to 5 mev</td>
<td>Radiation treatment delivery</td>
</tr>
<tr class="odd">
<td>G6012</td>
<td>0010</td>
<td>3</td>
<td>Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev</td>
<td>Radiation treatment delivery</td>
</tr>
<tr class="even">
<td>G6013</td>
<td>0010</td>
<td>3</td>
<td>Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev</td>
<td>Radiation treatment delivery</td>
</tr>
<tr class="odd">
<td>G6014</td>
<td>0010</td>
<td>3</td>
<td>Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20 mev or greater</td>
<td>Radiation treatment delivery</td>
</tr>
<tr class="even">
<td>G6015</td>
<td>0010</td>
<td>3</td>
<td>Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session</td>
<td>Radiation tx delivery imrt</td>
</tr>
<tr class="odd">
<td>G6016</td>
<td>0010</td>
<td>3</td>
<td>Compensator-based beam modulation treatment delivery of inverse planned treatment using 3 or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment session</td>
<td>Delivery comp imrt</td>
</tr>
<tr class="even">
<td>G6017</td>
<td>0010</td>
<td>3</td>
<td>Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment</td>
<td>Intrafraction track motion</td>
</tr>
<tr class="odd">
<td>G6018</td>
<td>0010</td>
<td>3</td>
<td>Ileoscopy, through stoma; with transendoscopic stent placement (includes predilation)</td>
<td>Ileoscopy w/stent</td>
</tr>
<tr class="even">
<td>G6019</td>
<td>0010</td>
<td>3</td>
<td>Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique</td>
<td>Colonoscopy lesion removal</td>
</tr>
<tr class="odd">
<td>G6020</td>
<td>0010</td>
<td>3</td>
<td>Colonoscopy through stoma; with transendoscopic stent placement (includes predilation)</td>
<td>Colonoscopy w/stent</td>
</tr>
<tr class="even">
<td>G6021</td>
<td>0010</td>
<td>3</td>
<td>Unlisted procedure, intestine</td>
<td>Unlisted px small intestine</td>
</tr>
<tr class="odd">
<td>G6022</td>
<td>0010</td>
<td>3</td>
<td>Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique</td>
<td>Sigmoidoscopy w/ablate tumr</td>
</tr>
<tr class="even">
<td>G6023</td>
<td>0010</td>
<td>3</td>
<td>Sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation)</td>
<td>Sigmoidoscopy w/stent</td>
</tr>
<tr class="odd">
<td>G6024</td>
<td>0010</td>
<td>3</td>
<td>Colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique</td>
<td>Lesion removal colonoscopy</td>
</tr>
<tr class="even">
<td>G6025</td>
<td>0010</td>
<td>3</td>
<td>Colonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent placement (includes predilation)</td>
<td>Colonoscopy w/stent</td>
</tr>
<tr class="odd">
<td>G6027</td>
<td>0010</td>
<td>3</td>
<td>Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed</td>
<td>Anoscopy hra w/spec collect</td>
</tr>
<tr class="even">
<td>G6028</td>
<td>0010</td>
<td>3</td>
<td>Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies)</td>
<td>Anoscopy hra w/biopsy</td>
</tr>
<tr class="odd">
<td>G6030</td>
<td>0010</td>
<td>3</td>
<td>Amitriptyline</td>
<td>Assay of amitriptyline</td>
</tr>
<tr class="even">
<td>G6031</td>
<td>0010</td>
<td>3</td>
<td>Benzodiazepines</td>
<td>Assay of benzodiazepines</td>
</tr>
<tr class="odd">
<td>G6032</td>
<td>0010</td>
<td>3</td>
<td>Desipramine</td>
<td>Assay of desipramine</td>
</tr>
<tr class="even">
<td>G6034</td>
<td>0010</td>
<td>3</td>
<td>Doxepin</td>
<td>Assay of doxepin</td>
</tr>
<tr class="odd">
<td>G6035</td>
<td>0010</td>
<td>3</td>
<td>Gold</td>
<td>Assay of gold</td>
</tr>
<tr class="even">
<td>G6036</td>
<td>0010</td>
<td>3</td>
<td>Assay of imipramine</td>
<td>Assay of imipramine</td>
</tr>
<tr class="odd">
<td>G6037</td>
<td>0010</td>
<td>3</td>
<td>Nortriptyline</td>
<td>Assay of nortiptyline</td>
</tr>
<tr class="even">
<td>G6038</td>
<td>0010</td>
<td>3</td>
<td>Salicylate</td>
<td>Assay of salicylate</td>
</tr>
<tr class="odd">
<td>G6039</td>
<td>0010</td>
<td>3</td>
<td>Acetaminophen</td>
<td>Assay of acetaminophen</td>
</tr>
<tr class="even">
<td>G6040</td>
<td>0010</td>
<td>3</td>
<td>Alcohol (ethanol); any specimen except breath</td>
<td>Assay of ethanol</td>
</tr>
<tr class="odd">
<td>G6041</td>
<td>0010</td>
<td>3</td>
<td>Alkaloids, urine, quantitative</td>
<td>Assay of urine alkaloids</td>
</tr>
<tr class="even">
<td>G6042</td>
<td>0010</td>
<td>3</td>
<td>Amphetamine or methamphetamine</td>
<td>Assay of amphetamines</td>
</tr>
<tr class="odd">
<td>G6043</td>
<td>0010</td>
<td>3</td>
<td>Barbiturates, not elsewhere specified</td>
<td>Assay of barbiturates</td>
</tr>
<tr class="even">
<td>G6044</td>
<td>0010</td>
<td>3</td>
<td>Cocaine or metabolite</td>
<td>Assay of cocaine</td>
</tr>
<tr class="odd">
<td>G6045</td>
<td>0010</td>
<td>3</td>
<td>Dihydrocodeinone</td>
<td>Assay of dihydrocodeinone</td>
</tr>
<tr class="even">
<td>G6046</td>
<td>0010</td>
<td>3</td>
<td>Dihydromorphinone</td>
<td>Assay of dihydromorphinone</td>
</tr>
<tr class="odd">
<td>G6047</td>
<td>0010</td>
<td>3</td>
<td>Dihydrotestosterone</td>
<td>Assay of dihydrotestosterone</td>
</tr>
<tr class="even">
<td>G6048</td>
<td>0010</td>
<td>3</td>
<td>Dimethadione</td>
<td>Assay of dimethadione</td>
</tr>
<tr class="odd">
<td>G6049</td>
<td>0010</td>
<td>3</td>
<td>Epiandrosterone</td>
<td>Asssay of epiandrosterone</td>
</tr>
<tr class="even">
<td>G6050</td>
<td>0010</td>
<td>3</td>
<td>Ethchlorvynol</td>
<td>Assay of ethchlorvynol</td>
</tr>
<tr class="odd">
<td>G6051</td>
<td>0010</td>
<td>3</td>
<td>Flurazepam</td>
<td>Assay of flurazepam</td>
</tr>
<tr class="even">
<td>G6052</td>
<td>0010</td>
<td>3</td>
<td>Meprobamate</td>
<td>Assay of meprobamate</td>
</tr>
<tr class="odd">
<td>G6053</td>
<td>0010</td>
<td>3</td>
<td>Methadone</td>
<td>Assay of methadone</td>
</tr>
<tr class="even">
<td>G6054</td>
<td>0010</td>
<td>3</td>
<td>Methsuximide</td>
<td>Assay of methsuximide</td>
</tr>
<tr class="odd">
<td>G6055</td>
<td>0010</td>
<td>3</td>
<td>Nicotine</td>
<td>Assay of nicotine</td>
</tr>
<tr class="even">
<td>G6056</td>
<td>0010</td>
<td>3</td>
<td>Opiate(s), drug and metabolites, each procedure</td>
<td>Assay of opiates</td>
</tr>
<tr class="odd">
<td>G6057</td>
<td>0010</td>
<td>3</td>
<td>Phenothiazine</td>
<td>Assay of phenothiazine</td>
</tr>
<tr class="even">
<td>G6058</td>
<td>0010</td>
<td>3</td>
<td>Drug confirmation, each procedure</td>
<td>Drug confirmation</td>
</tr>
<tr class="odd">
<td>G8126</td>
<td>0010</td>
<td>3</td>
<td>Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase</td>
<td>Pt treat w/antidepress12wks</td>
</tr>
<tr class="even">
<td>G8127</td>
<td>0010</td>
<td>3</td>
<td>Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase</td>
<td>Pt not treat w/antidepres12w</td>
</tr>
<tr class="odd">
<td>G8128</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented that patient was not an eligible candidate for antidepressant medication during the entire 12 week acute treatment phase measure</td>
<td>Pt inelig for antidepres med</td>
</tr>
<tr class="even">
<td>G8395</td>
<td>0010</td>
<td>3</td>
<td>Left ventricular ejection fraction (lvef) &gt;= 40% or documentation as normal or mildly depressed left ventricular systolic function</td>
<td>Lvef&gt;=40% doc normal or mild</td>
</tr>
<tr class="odd">
<td>G8396</td>
<td>0010</td>
<td>3</td>
<td>Left ventricular ejection fraction (lvef) not performed or documented</td>
<td>Lvef not performed</td>
</tr>
<tr class="even">
<td>G8397</td>
<td>0010</td>
<td>3</td>
<td>Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy</td>
<td>Dil macula/fundus exam/w doc</td>
</tr>
<tr class="odd">
<td>G8398</td>
<td>0010</td>
<td>3</td>
<td>Dilated macular or fundus exam not performed</td>
<td>Dil macular/fundus not perfo</td>
</tr>
<tr class="even">
<td>G8399</td>
<td>0010</td>
<td>3</td>
<td>Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed</td>
<td>Pt w/dxa results document</td>
</tr>
<tr class="odd">
<td>G8400</td>
<td>0010</td>
<td>3</td>
<td>Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given</td>
<td>Pt w/dxa no results doc</td>
</tr>
<tr class="even">
<td>G8401</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented that patient was not an eligible candidate for screening</td>
<td>Pt inelig osteo screen measu</td>
</tr>
<tr class="odd">
<td>G8404</td>
<td>0010</td>
<td>3</td>
<td>Lower extremity neurological exam performed and documented</td>
<td>Low extemity neur exam docum</td>
</tr>
<tr class="even">
<td>G8405</td>
<td>0010</td>
<td>3</td>
<td>Lower extremity neurological exam not performed</td>
<td>Low extemity neur not perfor</td>
</tr>
<tr class="odd">
<td>G8406</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure</td>
<td>Pt inelig lower extrem neuro</td>
</tr>
<tr class="even">
<td>G8410</td>
<td>0010</td>
<td>3</td>
<td>Footwear evaluation performed and documented</td>
<td>Eval on foot documented</td>
</tr>
<tr class="odd">
<td>G8415</td>
<td>0010</td>
<td>3</td>
<td>Footwear evaluation was not performed</td>
<td>Eval on foot not performed</td>
</tr>
<tr class="even">
<td>G8416</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented that patient was not an eligible candidate for footwear evaluation measure</td>
<td>Pt inelig footwear evaluatio</td>
</tr>
<tr class="odd">
<td>G8417</td>
<td>0010</td>
<td>3</td>
<td>Bmi is documented above normal parameters and a follow-up plan is documented</td>
<td>Calc bmi abv up param f/u</td>
</tr>
<tr class="even">
<td>G8418</td>
<td>0010</td>
<td>3</td>
<td>Bmi is documented below normal parameters and a follow-up plan is documented</td>
<td>Calc bmi blw low param f/u</td>
</tr>
<tr class="odd">
<td>G8419</td>
<td>0010</td>
<td>3</td>
<td>Bmi documented outside normal parameters, no follow-up plan documented, no reason given</td>
<td>Calc bmi out nrm param nof/u</td>
</tr>
<tr class="even">
<td>G8420</td>
<td>0010</td>
<td>3</td>
<td>Bmi is documented within normal parameters and no follow-up plan is required</td>
<td>Calc bmi norm parameters</td>
</tr>
<tr class="odd">
<td>G8421</td>
<td>0010</td>
<td>3</td>
<td>Bmi not documented and no reason is given</td>
<td>Bmi not calculated</td>
</tr>
<tr class="even">
<td>G8422</td>
<td>0010</td>
<td>3</td>
<td>Bmi not documented, documentation the patient is not eligible for bmi calculation</td>
<td>Pt inelig bmi calculation</td>
</tr>
<tr class="odd">
<td>G8427</td>
<td>0010</td>
<td>3</td>
<td>Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient’s current medications</td>
<td>Docrev cur meds by elig clin</td>
</tr>
<tr class="even">
<td>G8428</td>
<td>0010</td>
<td>3</td>
<td>Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given</td>
<td>Cur meds not document</td>
</tr>
<tr class="odd">
<td>G8430</td>
<td>0010</td>
<td>3</td>
<td>Eligible clinician attests to documenting in the medical record the patient is not eligible for a current list of medications being obtained, updated, or reviewed by the eligible clinician</td>
<td>Ec at doc medrec pt not elig</td>
</tr>
<tr class="even">
<td>G8431</td>
<td>0010</td>
<td>3</td>
<td>Screening for depression is documented as being positive and a follow-up plan is documented</td>
<td>Pos clin depres scrn f/u doc</td>
</tr>
<tr class="odd">
<td>G8432</td>
<td>0010</td>
<td>3</td>
<td>Depression screening not documented, reason not given</td>
<td>Dep scr not doc, rng</td>
</tr>
<tr class="even">
<td>G8433</td>
<td>0010</td>
<td>3</td>
<td>Screening for depression not completed, documented reason</td>
<td>Scr for dep not cpt doc rsn</td>
</tr>
<tr class="odd">
<td>G8442</td>
<td>0010</td>
<td>3</td>
<td>Pain assessment not documented as being performed, documentation the patient is not eligible for a pain assessment using a standardized tool at the time of the encounter</td>
<td>Doc pain as nt perf, not elg</td>
</tr>
<tr class="even">
<td>G8450</td>
<td>0010</td>
<td>3</td>
<td>Beta-blocker therapy prescribed</td>
<td>Beta-bloc rx pt w/abn lvef</td>
</tr>
<tr class="odd">
<td>G8451</td>
<td>0010</td>
<td>3</td>
<td>Beta-blocker therapy for lvef &lt; 40% not prescribed for reasons documented by the clinician (e.g., low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons, patient declined, other patient reasons, or other reasons attributable to the healthcare system)</td>
<td>Pt w/abn lvef inelig b-bloc</td>
</tr>
<tr class="even">
<td>G8452</td>
<td>0010</td>
<td>3</td>
<td>Beta-blocker therapy not prescribed</td>
<td>Pt w/abn lvef b-bloc no rx</td>
</tr>
<tr class="odd">
<td>G8458</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented that patient is not an eligible candidate for genotype testing; patient not receiving antiviral treatment for hepatitis c during the measurement period (e.g. genotype test done prior to the reporting period, patient declines, patient not a candidate for antiviral treatment)</td>
<td>Pt inelig geno no antvir tx</td>
</tr>
<tr class="even">
<td>G8460</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented that patient is not an eligible candidate for quantitative rna testing at week 12; patient not receiving antiviral treatment for hepatitis c</td>
<td>Pt inelig rna no antvir tx</td>
</tr>
<tr class="odd">
<td>G8461</td>
<td>0010</td>
<td>3</td>
<td>Patient receiving antiviral treatment for hepatitis c during the measurement period</td>
<td>Pt rec antivir treat hep c</td>
</tr>
<tr class="even">
<td>G8464</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented that prostate cancer patient is not an eligible candidate for adjuvant hormonal therapy; low or intermediate risk of recurrence or risk of recurrence not determined</td>
<td>Pt inelig; lo to no dter rsk</td>
</tr>
<tr class="odd">
<td>G8465</td>
<td>0010</td>
<td>3</td>
<td>High or very high risk of recurrence of prostate cancer</td>
<td>High risk recurrence pro ca</td>
</tr>
<tr class="even">
<td>G8473</td>
<td>0010</td>
<td>3</td>
<td>Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed</td>
<td>Ace/arb thxpy rx’d</td>
</tr>
<tr class="odd">
<td>G8474</td>
<td>0010</td>
<td>3</td>
<td>Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for reasons documented by the clinician (e.g., allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (e.g., patient declined, other patient reasons) or (e.g., lack of drug availability, other reasons attributable to the health care system)</td>
<td>Ace/arb not rx’d; doc reas</td>
</tr>
<tr class="even">
<td>G8475</td>
<td>0010</td>
<td>3</td>
<td>Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed, reason not given</td>
<td>Ace/arb thxpy not rx’d</td>
</tr>
<tr class="odd">
<td>G8476</td>
<td>0010</td>
<td>3</td>
<td>Most recent blood pressure has a systolic measurement of &lt; 140 mmhg and a diastolic measurement of &lt; 90 mmhg</td>
<td>Bp sys &lt;140 and dias &lt;90</td>
</tr>
<tr class="even">
<td>G8477</td>
<td>0010</td>
<td>3</td>
<td>Most recent blood pressure has a systolic measurement of &gt;= 140 mmhg and/or a diastolic measurement of &gt;= 90 mmhg</td>
<td>Bp sys&gt;=140 and/or dias &gt;=90</td>
</tr>
<tr class="odd">
<td>G8478</td>
<td>0010</td>
<td>3</td>
<td>Blood pressure measurement not performed or documented, reason not given</td>
<td>Bp not performed/doc</td>
</tr>
<tr class="even">
<td>G8482</td>
<td>0010</td>
<td>3</td>
<td>Influenza immunization administered or previously received</td>
<td>Flu immunize order/admin</td>
</tr>
<tr class="odd">
<td>G8483</td>
<td>0010</td>
<td>3</td>
<td>Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)</td>
<td>Flu imm no admin doc rea</td>
</tr>
<tr class="even">
<td>G8484</td>
<td>0010</td>
<td>3</td>
<td>Influenza immunization was not administered, reason not given</td>
<td>Flu immunize no admin</td>
</tr>
<tr class="odd">
<td>G8485</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the diabetes mellitus (dm) measures group</td>
<td>Report, diabetes measures</td>
</tr>
<tr class="even">
<td>G8486</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the preventive care measures group</td>
<td>Report, prev care measures</td>
</tr>
<tr class="odd">
<td>G8487</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the chronic kidney disease (ckd) measures group</td>
<td>Report ckd measures</td>
</tr>
<tr class="even">
<td>G8489</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the coronary artery disease (cad) measures group</td>
<td>Cad measures grp</td>
</tr>
<tr class="odd">
<td>G8490</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the rheumatoid arthritis (ra) measures group</td>
<td>Ra measures grp</td>
</tr>
<tr class="even">
<td>G8491</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the hiv/aids measures group</td>
<td>Hiv/aids measures grp</td>
</tr>
<tr class="odd">
<td>G8492</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the perioperative care measures group</td>
<td>Periop care measures grp</td>
</tr>
<tr class="even">
<td>G8493</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the back pain measures group</td>
<td>Back pain measures grp</td>
</tr>
<tr class="odd">
<td>G8494</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the diabetes mellitus (dm) measures group have been performed for this patient</td>
<td>Dm meas qual act perform</td>
</tr>
<tr class="even">
<td>G8495</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the chronic kidney disease (ckd) measures group have been performed for this patient</td>
<td>Ckd meas qual act perform</td>
</tr>
<tr class="odd">
<td>G8496</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the preventive care measures group have been performed for this patient</td>
<td>Prev care mg qual act perfrm</td>
</tr>
<tr class="even">
<td>G8497</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the coronary artery bypass graft (cabg) measures group have been performed for this patient</td>
<td>Cabg meas qual act perform</td>
</tr>
<tr class="odd">
<td>G8498</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the coronary artery disease (cad) measures group have been performed for this patient</td>
<td>Cad meas qual act perform</td>
</tr>
<tr class="even">
<td>G8499</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the rheumatoid arthritis (ra) measures group have been performed for this patient</td>
<td>Ra meas qual act perform</td>
</tr>
<tr class="odd">
<td>G8500</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient</td>
<td>Hiv meas qual act perform</td>
</tr>
<tr class="even">
<td>G8501</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the perioperative care measures group have been performed for this patient</td>
<td>Perio meas qual act perform</td>
</tr>
<tr class="odd">
<td>G8502</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the back pain measures group have been performed for this patient</td>
<td>Back pain mg qual act perfrm</td>
</tr>
<tr class="even">
<td>G8506</td>
<td>0010</td>
<td>3</td>
<td>Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy</td>
<td>Pt rec ace/arb</td>
</tr>
<tr class="odd">
<td>G8509</td>
<td>0010</td>
<td>3</td>
<td>Pain assessment documented as positive using a standardized tool, follow-up plan not documented, reason not given</td>
<td>Pos pain assess no f/u doc</td>
</tr>
<tr class="even">
<td>G8510</td>
<td>0010</td>
<td>3</td>
<td>Screening for depression is documented as negative, a follow-up plan is not required</td>
<td>Scr dep neg, no plan reqd</td>
</tr>
<tr class="odd">
<td>G8511</td>
<td>0010</td>
<td>3</td>
<td>Screening for depression documented as positive, follow-up plan not documented, reason not given</td>
<td>Scr dep pos, no plan doc rng</td>
</tr>
<tr class="even">
<td>G8530</td>
<td>0010</td>
<td>3</td>
<td>Autogenous av fistula received</td>
<td>Auto av fistula recd</td>
</tr>
<tr class="odd">
<td>G8531</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented that patient was not an eligible candidate for autogenous av fistula</td>
<td>Pt inelig; auto av fistula</td>
</tr>
<tr class="even">
<td>G8532</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented that patient received vascular access other than autogenous av fistula, reason not given</td>
<td>No auto av fistula; no reas</td>
</tr>
<tr class="odd">
<td>G8535</td>
<td>0010</td>
<td>3</td>
<td>Elder maltreatment screen not documented; documentation that patient is not eligible for the elder maltreatment screen at the time of the encounter</td>
<td>Eld maltreatment not doc</td>
</tr>
<tr class="even">
<td>G8536</td>
<td>0010</td>
<td>3</td>
<td>No documentation of an elder maltreatment screen, reason not given</td>
<td>No doc elder mal scrn</td>
</tr>
<tr class="odd">
<td>G8539</td>
<td>0010</td>
<td>3</td>
<td>Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies on the date of functional outcome assessment, is documented</td>
<td>Doc funct and care plan</td>
</tr>
<tr class="even">
<td>G8540</td>
<td>0010</td>
<td>3</td>
<td>Functional outcome assessment not documented as being performed, documentation the patient is not eligible for a functional outcome assessment using a standardized tool at the time of the encounter</td>
<td>Foa not doc as being perf</td>
</tr>
<tr class="odd">
<td>G8541</td>
<td>0010</td>
<td>3</td>
<td>Functional outcome assessment using a standardized tool not documented, reason not given</td>
<td>No doc cur funct assess</td>
</tr>
<tr class="even">
<td>G8542</td>
<td>0010</td>
<td>3</td>
<td>Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required</td>
<td>Doc funct no deficiencies</td>
</tr>
<tr class="odd">
<td>G8543</td>
<td>0010</td>
<td>3</td>
<td>Documentation of a positive functional outcome assessment using a standardized tool; care plan not documented, reason not given</td>
<td>Cur funct asses; no care pln</td>
</tr>
<tr class="even">
<td>G8544</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the coronary artery bypass graft (cabg) measures group</td>
<td>Cabg measures grp</td>
</tr>
<tr class="odd">
<td>G8545</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the hepatitis c measures group</td>
<td>Hepc measures grp</td>
</tr>
<tr class="even">
<td>G8547</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the ischemic vascular disease (ivd) measures group</td>
<td>Ivd measures grp</td>
</tr>
<tr class="odd">
<td>G8548</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the heart failure (hf) measures group</td>
<td>Hf measures grp</td>
</tr>
<tr class="even">
<td>G8549</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the hepatitis c measures group have been performed for this patient</td>
<td>Hepc mg qual act perform</td>
</tr>
<tr class="odd">
<td>G8551</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the heart failure (hf) measures group have been performed for this patient</td>
<td>Hf mg qual act perform</td>
</tr>
<tr class="even">
<td>G8552</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the ischemic vascular disease (ivd) measures group have been performed for this patient</td>
<td>Ivd mg qual act perform</td>
</tr>
<tr class="odd">
<td>G8559</td>
<td>0010</td>
<td>3</td>
<td>Patient referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation</td>
<td>Pt ref doc oto eval</td>
</tr>
<tr class="even">
<td>G8560</td>
<td>0010</td>
<td>3</td>
<td>Patient has a history of active drainage from the ear within the previous 90 days</td>
<td>Pt hx act drain prev 90 days</td>
</tr>
<tr class="odd">
<td>G8561</td>
<td>0010</td>
<td>3</td>
<td>Patient is not eligible for the referral for otologic evaluation for patients with a history of active drainage measure</td>
<td>Pt inelig for ref oto eval</td>
</tr>
<tr class="even">
<td>G8562</td>
<td>0010</td>
<td>3</td>
<td>Patient does not have a history of active drainage from the ear within the previous 90 days</td>
<td>Pt no hx act drain 90 d</td>
</tr>
<tr class="odd">
<td>G8563</td>
<td>0010</td>
<td>3</td>
<td>Patient not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given</td>
<td>Pt no ref oto reas no spec</td>
</tr>
<tr class="even">
<td>G8564</td>
<td>0010</td>
<td>3</td>
<td>Patient was referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not specified)</td>
<td>Pt ref oto eval</td>
</tr>
<tr class="odd">
<td>G8565</td>
<td>0010</td>
<td>3</td>
<td>Verification and documentation of sudden or rapidly progressive hearing loss</td>
<td>Ver doc hear loss</td>
</tr>
<tr class="even">
<td>G8566</td>
<td>0010</td>
<td>3</td>
<td>Patient is not eligible for the “referral for otologic evaluation for sudden or rapidly progressive hearing loss” measure</td>
<td>Pt inelig ref oto eval</td>
</tr>
<tr class="odd">
<td>G8567</td>
<td>0010</td>
<td>3</td>
<td>Patient does not have verification and documentation of sudden or rapidly progressive hearing loss</td>
<td>Pt no doc hear loss</td>
</tr>
<tr class="even">
<td>G8568</td>
<td>0010</td>
<td>3</td>
<td>Patient was not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given</td>
<td>Pt no ref otolo no spec</td>
</tr>
<tr class="odd">
<td>G8569</td>
<td>0010</td>
<td>3</td>
<td>Prolonged postoperative intubation (&gt; 24 hrs) required</td>
<td>Prol intubation req</td>
</tr>
<tr class="even">
<td>G8570</td>
<td>0010</td>
<td>3</td>
<td>Prolonged postoperative intubation (&gt; 24 hrs) not required</td>
<td>No prol intub req</td>
</tr>
<tr class="odd">
<td>G8571</td>
<td>0010</td>
<td>3</td>
<td>Development of deep sternal wound infection/mediastinitis within 30 days postoperatively</td>
<td>Ster wd ifx 30 d postop</td>
</tr>
<tr class="even">
<td>G8572</td>
<td>0010</td>
<td>3</td>
<td>No deep sternal wound infection/mediastinitis</td>
<td>No ster wd ifx</td>
</tr>
<tr class="odd">
<td>G8573</td>
<td>0010</td>
<td>3</td>
<td>Stroke following isolated cabg surgery</td>
<td>Stk cabg</td>
</tr>
<tr class="even">
<td>G8574</td>
<td>0010</td>
<td>3</td>
<td>No stroke following isolated cabg surgery</td>
<td>No strk cabg</td>
</tr>
<tr class="odd">
<td>G8575</td>
<td>0010</td>
<td>3</td>
<td>Developed postoperative renal failure or required dialysis</td>
<td>Postop ren fail</td>
</tr>
<tr class="even">
<td>G8576</td>
<td>0010</td>
<td>3</td>
<td>No postoperative renal failure/dialysis not required</td>
<td>No postop ren fail</td>
</tr>
<tr class="odd">
<td>G8577</td>
<td>0010</td>
<td>3</td>
<td>Re-exploration required due to mediastinal bleeding with or without tamponade, graft occlusion, valve dysfunction or other cardiac reason</td>
<td>Reop req bld grft oth</td>
</tr>
<tr class="even">
<td>G8578</td>
<td>0010</td>
<td>3</td>
<td>Re-exploration not required due to mediastinal bleeding with or without tamponade, graft occlusion, valve dysfunction or other cardiac reason</td>
<td>No reop req bld grft oth</td>
</tr>
<tr class="odd">
<td>G8579</td>
<td>0010</td>
<td>3</td>
<td>Antiplatelet medication at discharge</td>
<td>Antplt med disch</td>
</tr>
<tr class="even">
<td>G8580</td>
<td>0010</td>
<td>3</td>
<td>Antiplatelet medication contraindicated</td>
<td>Antplt med contraind</td>
</tr>
<tr class="odd">
<td>G8581</td>
<td>0010</td>
<td>3</td>
<td>No antiplatelet medication at discharge</td>
<td>No antplt med disch</td>
</tr>
<tr class="even">
<td>G8582</td>
<td>0010</td>
<td>3</td>
<td>Beta-blocker at discharge</td>
<td>Bblock disch</td>
</tr>
<tr class="odd">
<td>G8583</td>
<td>0010</td>
<td>3</td>
<td>Beta-blocker contraindicated</td>
<td>Bblock contraind</td>
</tr>
<tr class="even">
<td>G8584</td>
<td>0010</td>
<td>3</td>
<td>No beta-blocker at discharge</td>
<td>No bblock disch</td>
</tr>
<tr class="odd">
<td>G8585</td>
<td>0010</td>
<td>3</td>
<td>Anti-lipid treatment at discharge</td>
<td>Antilipid treat disch</td>
</tr>
<tr class="even">
<td>G8586</td>
<td>0010</td>
<td>3</td>
<td>Anti-lipid treatment contraindicated</td>
<td>Antlip disch contra</td>
</tr>
<tr class="odd">
<td>G8587</td>
<td>0010</td>
<td>3</td>
<td>No anti-lipid treatment at discharge</td>
<td>No antlipid treat disch</td>
</tr>
<tr class="even">
<td>G8593</td>
<td>0010</td>
<td>3</td>
<td>Lipid profile results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)</td>
<td>Lipid pn results</td>
</tr>
<tr class="odd">
<td>G8594</td>
<td>0010</td>
<td>3</td>
<td>Lipid profile not performed, reason not given</td>
<td>No lipid prof perf</td>
</tr>
<tr class="even">
<td>G8595</td>
<td>0010</td>
<td>3</td>
<td>Most recent ldl-c &lt; 100 mg/dl</td>
<td>Ldl &lt; 100</td>
</tr>
<tr class="odd">
<td>G8597</td>
<td>0010</td>
<td>3</td>
<td>Most recent ldl-c &gt;= 100 mg/dl</td>
<td>Ldl &gt;= 100</td>
</tr>
<tr class="even">
<td>G8598</td>
<td>0010</td>
<td>3</td>
<td>Aspirin or another antiplatelet therapy used</td>
<td>Asa/antiplat ther used</td>
</tr>
<tr class="odd">
<td>G8599</td>
<td>0010</td>
<td>3</td>
<td>Aspirin or another antiplatelet therapy not used, reason not given</td>
<td>No asa/antiplat ther use rng</td>
</tr>
<tr class="even">
<td>G8600</td>
<td>0010</td>
<td>3</td>
<td>Iv t-pa initiated within three hours (&lt;= 180 minutes) of time last known well</td>
<td>Tpa initi w/in 3 hrs</td>
</tr>
<tr class="odd">
<td>G8601</td>
<td>0010</td>
<td>3</td>
<td>Iv t-pa not initiated within three hours (&lt;= 180 minutes) of time last known well for reasons documented by clinician</td>
<td>No elig tpa init w/in 3 hrs</td>
</tr>
<tr class="even">
<td>G8602</td>
<td>0010</td>
<td>3</td>
<td>Iv t-pa not initiated within three hours (&lt;= 180 minutes) of time last known well, reason not given</td>
<td>No tpa init w/in 3 hrs</td>
</tr>
<tr class="odd">
<td>G8627</td>
<td>0010</td>
<td>3</td>
<td>Surgical procedure performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)</td>
<td>Surg proc w/in 30 days</td>
</tr>
<tr class="even">
<td>G8628</td>
<td>0010</td>
<td>3</td>
<td>Surgical procedure not performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)</td>
<td>No surg proc w/in 30 days</td>
</tr>
<tr class="odd">
<td>G8629</td>
<td>0010</td>
<td>3</td>
<td>Documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)</td>
<td>Doc antibio order b/4 surg</td>
</tr>
<tr class="even">
<td>G8630</td>
<td>0010</td>
<td>3</td>
<td>Documentation that administration of prophylactic parenteral antibiotics was initiated within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required), as ordered</td>
<td>Doc antibio given b/4 surg</td>
</tr>
<tr class="odd">
<td>G8631</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented that patient was not an eligible candidate for ordering prophylactic parenteral antibiotics to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)</td>
<td>Pt no elg 4 order antbi give</td>
</tr>
<tr class="even">
<td>G8632</td>
<td>0010</td>
<td>3</td>
<td>Prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given</td>
<td>Doc no antibi order b/4 surg</td>
</tr>
<tr class="odd">
<td>G8633</td>
<td>0010</td>
<td>3</td>
<td>Pharmacologic therapy (other than minierals/vitamins) for osteoporosis prescribed</td>
<td>Pharm ther osteo rx</td>
</tr>
<tr class="even">
<td>G8634</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented patient not an eligible candidate to receive pharmacologic therapy for osteoporosis</td>
<td>Pt no elg phar ther osteo</td>
</tr>
<tr class="odd">
<td>G8635</td>
<td>0010</td>
<td>3</td>
<td>Pharmacologic therapy for osteoporosis was not prescribed, reason not given</td>
<td>No pharm ther osteo rx</td>
</tr>
<tr class="even">
<td>G8645</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the asthma measures group</td>
<td>Asthma measures grp</td>
</tr>
<tr class="odd">
<td>G8646</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the asthma measures group have been performed for this patient</td>
<td>Asthma mg qual act perform</td>
</tr>
<tr class="even">
<td>G8647</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the knee impairment successfully calculated and the score was equal to zero (0) or greater than zero (&gt; 0)</td>
<td>Rafscrs ki scor &gt;= 0</td>
</tr>
<tr class="odd">
<td>G8648</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the knee impairment successfully calculated and the score was less than zero (&lt; 0)</td>
<td>Rafscrs ki scor &lt; 0</td>
</tr>
<tr class="even">
<td>G8649</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the knee impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate</td>
<td>Rafscrs ki no scor</td>
</tr>
<tr class="odd">
<td>G8650</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the knee impairment not measured because the patient did not complete the knee fs prom at initial evaluation and/or near discharge, reason not given</td>
<td>Rafs crs ki no scor no surv</td>
</tr>
<tr class="even">
<td>G8651</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the hip impairment successfully calculated and the score was equal to zero (0) or greater than zero (&gt; 0)</td>
<td>Rafscrs hi scor &gt;=0</td>
</tr>
<tr class="odd">
<td>G8652</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the hip impairment successfully calculated and the score was less than zero (&lt; 0)</td>
<td>Rafscrs hi scor &lt; 0</td>
</tr>
<tr class="even">
<td>G8653</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual scores for the hip impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate</td>
<td>Rafscrs hi no scor</td>
</tr>
<tr class="odd">
<td>G8654</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the hip impairment not measured because the patient did not complete the fs intake survey on admission and/or follow up fs status survey near discharge, reason not given</td>
<td>Rafs crs hi no scor no surv</td>
</tr>
<tr class="even">
<td>G8655</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the lower leg, foot or ankle impairment successfully calculated and the score was equal to zero (0) or greater than zero ( &gt; 0)</td>
<td>Rafscrs llfai scor &gt;= 0</td>
</tr>
<tr class="odd">
<td>G8656</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the lower leg, foot or ankle impairment successfully calculated and the score was less than zero (&lt; 0)</td>
<td>Rafscrs llfai scor &lt; 0</td>
</tr>
<tr class="even">
<td>G8657</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the lower leg, foot or ankle impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate</td>
<td>Rafscrs llfai no scor</td>
</tr>
<tr class="odd">
<td>G8658</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the lower leg, foot or ankle impairment not measured because the patient did not complete the fs intake survey on admission and/or follow up fs status survey near discharge, reason not given</td>
<td>Rafscrs llfai no scor + surv</td>
</tr>
<tr class="even">
<td>G8659</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the low back impairment successfully calculated and the score was equal to zero (0) or greater than zero (&gt; 0)</td>
<td>Rafscrs lbi scor &gt;= 0</td>
</tr>
<tr class="odd">
<td>G8660</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the low back impairment successfully calculated and the score was less than zero (&lt; 0)</td>
<td>Rafscrs lbi scor &lt; 0</td>
</tr>
<tr class="even">
<td>G8661</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the low back impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate</td>
<td>Rafscrs lbi no scor</td>
</tr>
<tr class="odd">
<td>G8662</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the low back impairment not measured because the patient did not complete the low back fs prom at initial evaluation and/or near discharge, reason not given</td>
<td>Rafs crs lbi no scor no surv</td>
</tr>
<tr class="even">
<td>G8663</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the shoulder impairment successfully calculated and the score was equal to zero (0) or greater than zero (&gt; 0)</td>
<td>Rafscrs si scor &gt;= 0</td>
</tr>
<tr class="odd">
<td>G8664</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the shoulder impairment successfully calculated and the score was less than zero (&lt; 0)</td>
<td>Rafscrs si scor &lt; 0</td>
</tr>
<tr class="even">
<td>G8665</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the shoulder impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate</td>
<td>Rafscrs si no scor</td>
</tr>
<tr class="odd">
<td>G8666</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the shoulder impairment not measured because the patient did not complete the shoulder fs prom at initial evaluation and/or near discharge, reason not given</td>
<td>Rafs crs si no scor no surv</td>
</tr>
<tr class="even">
<td>G8667</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the elbow, wrist or hand impairment successfully calculated and the score was equal to zero (0) or greater than zero (&gt; 0)</td>
<td>Rafscrs ewh scor &gt;= 0</td>
</tr>
<tr class="odd">
<td>G8668</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the elbow, wrist or hand impairment successfully calculated and the score was less than zero (&lt; 0)</td>
<td>Rafscrs ewh scor &lt; 0</td>
</tr>
<tr class="even">
<td>G8669</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the elbow, wrist or hand impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate</td>
<td>Rafscrs</td>
</tr>
<tr class="odd">
<td>G8670</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the elbow, wrist or hand impairment not measured because the patient did not complete the elbow/wrist/hand fs prom at initial evaluation and/or near discharge, reason not given</td>
<td>Rafs crs ewh no scor no surv</td>
</tr>
<tr class="even">
<td>G8671</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment successfully calculated and the score was equal to zero (0) or greater than zero (&gt; 0)</td>
<td>Rafscrs goi scor &gt;= 0</td>
</tr>
<tr class="odd">
<td>G8672</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment successfully calculated and the score was less than zero (&lt; 0)</td>
<td>Rafscrs goi scor &lt; 0</td>
</tr>
<tr class="even">
<td>G8673</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate</td>
<td>Rafscrs goi no scor</td>
</tr>
<tr class="odd">
<td>G8674</td>
<td>0010</td>
<td>3</td>
<td>Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the general orthopedic fs prom at initial evaluation and/or near discharge, reason not given</td>
<td>Rafscrs neck, no msr/no foto</td>
</tr>
<tr class="even">
<td>G8682</td>
<td>0010</td>
<td>3</td>
<td>Lvf testing documented as being performed prior to discharge or in the previous 12 months</td>
<td>Lvg test perf</td>
</tr>
<tr class="odd">
<td>G8683</td>
<td>0010</td>
<td>3</td>
<td>Lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason</td>
<td>Pt not elig for lvf test</td>
</tr>
<tr class="even">
<td>G8685</td>
<td>0010</td>
<td>3</td>
<td>Lvf testing not documented as being performed prior to discharge or in the previous 12 months, reason not given</td>
<td>Lvf test not perf</td>
</tr>
<tr class="odd">
<td>G8694</td>
<td>0010</td>
<td>3</td>
<td>Left ventricular ejection fraction (lvef) &lt; 40%</td>
<td>Lvef &lt;40%</td>
</tr>
<tr class="even">
<td>G8696</td>
<td>0010</td>
<td>3</td>
<td>Antithrombotic therapy prescribed at discharge</td>
<td>Antithromb thx presc</td>
</tr>
<tr class="odd">
<td>G8697</td>
<td>0010</td>
<td>3</td>
<td>Antithrombotic therapy not prescribed for documented reasons (e.g., patient had stroke during hospital stay, patient expired during inpatient stay, other medical reason(s)); (e.g., patient left against medical advice, other patient reason(s))</td>
<td>Antithromb no presc doc reas</td>
</tr>
<tr class="even">
<td>G8698</td>
<td>0010</td>
<td>3</td>
<td>Antithrombotic therapy was not prescribed at discharge, reason not given</td>
<td>Antithromb no presc no reas</td>
</tr>
<tr class="odd">
<td>G8699</td>
<td>0010</td>
<td>3</td>
<td>Rehabilitation services (occupational, physical or speech) ordered at or prior to discharge</td>
<td>Rehab ordered disch</td>
</tr>
<tr class="even">
<td>G8700</td>
<td>0010</td>
<td>3</td>
<td>Rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge</td>
<td>Rehab not indicated disch</td>
</tr>
<tr class="odd">
<td>G8701</td>
<td>0010</td>
<td>3</td>
<td>Rehabilitation services were not ordered, reason not otherwise specified</td>
<td>Rehab not ordered</td>
</tr>
<tr class="even">
<td>G8702</td>
<td>0010</td>
<td>3</td>
<td>Documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or intraoperatively</td>
<td>Antiobiotics 4 hr prior surg</td>
</tr>
<tr class="odd">
<td>G8703</td>
<td>0010</td>
<td>3</td>
<td>Documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor intraoperatively</td>
<td>Antibiotics not prior surg</td>
</tr>
<tr class="even">
<td>G8704</td>
<td>0010</td>
<td>3</td>
<td>12-lead electrocardiogram (ecg) performed</td>
<td>Ecg performed</td>
</tr>
<tr class="odd">
<td>G8705</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg)</td>
<td>Med reas no ecg</td>
</tr>
<tr class="even">
<td>G8706</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient reason(s) for not performing a 12-lead electrocardiogram (ecg)</td>
<td>Pt reas no ecg</td>
</tr>
<tr class="odd">
<td>G8707</td>
<td>0010</td>
<td>3</td>
<td>12-lead electrocardiogram (ecg) not performed, reason not given</td>
<td>Ecg not performed</td>
</tr>
<tr class="even">
<td>G8708</td>
<td>0010</td>
<td>3</td>
<td>Patient not prescribed or dispensed antibiotic</td>
<td>Antibiotic not pres</td>
</tr>
<tr class="odd">
<td>G8709</td>
<td>0010</td>
<td>3</td>
<td>Patient prescribed or dispensed antibiotic for documented medical reason(s) within three days after the initial diagnosis of uri (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases (female reproductive organs)), infections of the kidney, cystitis or uti, and acne)</td>
<td>Pt presc doc med rsn id uri</td>
</tr>
<tr class="even">
<td>G8710</td>
<td>0010</td>
<td>3</td>
<td>Patient prescribed or dispensed antibiotic</td>
<td>Pt pres antibiotic</td>
</tr>
<tr class="odd">
<td>G8711</td>
<td>0010</td>
<td>3</td>
<td>Prescribed or dispensed antibiotic</td>
<td>Pres antibiotic</td>
</tr>
<tr class="even">
<td>G8712</td>
<td>0010</td>
<td>3</td>
<td>Antibiotic not prescribed or dispensed</td>
<td>Not pres antibiotic</td>
</tr>
<tr class="odd">
<td>G8713</td>
<td>0010</td>
<td>3</td>
<td>Spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v])</td>
<td>Spkt/v great 1.2 kt/v</td>
</tr>
<tr class="even">
<td>G8714</td>
<td>0010</td>
<td>3</td>
<td>Hemodialysis treatment performed exactly three times per week for &gt; 90 days</td>
<td>Hemodialysis 3 times week</td>
</tr>
<tr class="odd">
<td>G8717</td>
<td>0010</td>
<td>3</td>
<td>Spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given</td>
<td>Less 1.2 kt/v</td>
</tr>
<tr class="even">
<td>G8718</td>
<td>0010</td>
<td>3</td>
<td>Total kt/v greater than or equal to 1.7 per week (total clearance of urea [kt] / volume [v])</td>
<td>Great 1.7 kt/v per week</td>
</tr>
<tr class="odd">
<td>G8720</td>
<td>0010</td>
<td>3</td>
<td>Total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v])</td>
<td>Less 1.7 kt/v per week</td>
</tr>
<tr class="even">
<td>G8721</td>
<td>0010</td>
<td>3</td>
<td>Pt category (primary tumor), pn category (regional lymph nodes), and histologic grade were documented in pathology report</td>
<td>Pt, pn, hist grade doc</td>
</tr>
<tr class="odd">
<td>G8722</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not including the pt category, the pn category or the histologic grade in the pathology report (e.g., re-excision without residual tumor; non-carcinomasanal canal)</td>
<td>Med reas pt, pn, not doc</td>
</tr>
<tr class="even">
<td>G8723</td>
<td>0010</td>
<td>3</td>
<td>Specimen site is other than anatomic location of primary tumor</td>
<td>Spec sit not prim tumor</td>
</tr>
<tr class="odd">
<td>G8724</td>
<td>0010</td>
<td>3</td>
<td>Pt category, pn category and histologic grade were not documented in the pathology report, reason not given</td>
<td>Pt, pn, hist grade not doc</td>
</tr>
<tr class="even">
<td>G8725</td>
<td>0010</td>
<td>3</td>
<td>Fasting lipid profile performed (triglycerides, ldl-c, hdl-c and total cholesterol)</td>
<td>Lipid profile perf doc</td>
</tr>
<tr class="odd">
<td>G8726</td>
<td>0010</td>
<td>3</td>
<td>Clinician has documented reason for not performing fasting lipid profile (e.g., patient declined, other patient reasons)</td>
<td>Doc reas no lipid profile</td>
</tr>
<tr class="even">
<td>G8728</td>
<td>0010</td>
<td>3</td>
<td>Fasting lipid profile not performed, reason not given</td>
<td>Lipid profile not perf</td>
</tr>
<tr class="odd">
<td>G8730</td>
<td>0010</td>
<td>3</td>
<td>Pain assessment documented as positive using a standardized tool and a follow-up plan is documented</td>
<td>Pain doc pos and plan</td>
</tr>
<tr class="even">
<td>G8731</td>
<td>0010</td>
<td>3</td>
<td>Pain assessment using a standardized tool is documented as negative, no follow-up plan required</td>
<td>Pain neg no plan</td>
</tr>
<tr class="odd">
<td>G8732</td>
<td>0010</td>
<td>3</td>
<td>No documentation of pain assessment, reason not given</td>
<td>No doc of pain</td>
</tr>
<tr class="even">
<td>G8733</td>
<td>0010</td>
<td>3</td>
<td>Elder maltreatment screen documented as positive and a follow-up plan is documented</td>
<td>Doc pos elder mal scrn plan</td>
</tr>
<tr class="odd">
<td>G8734</td>
<td>0010</td>
<td>3</td>
<td>Elder maltreatment screen documented as negative, no follow-up required</td>
<td>Doc neg elder mal no plan</td>
</tr>
<tr class="even">
<td>G8735</td>
<td>0010</td>
<td>3</td>
<td>Elder maltreatment screen documented as positive, follow-up plan not documented, reason not given</td>
<td>Eld mal scrn pos no plan</td>
</tr>
<tr class="odd">
<td>G8736</td>
<td>0010</td>
<td>3</td>
<td>Most current ldl-c &lt;100mg/dl</td>
<td>Ldl-c &lt;100mg/dl</td>
</tr>
<tr class="even">
<td>G8737</td>
<td>0010</td>
<td>3</td>
<td>Most current ldl-c &gt;=100mg/dl</td>
<td>Ldl-c &gt;=100mg/dl</td>
</tr>
<tr class="odd">
<td>G8738</td>
<td>0010</td>
<td>3</td>
<td>Left ventricular ejection fraction (lvef) &lt; 40% or documentation of severely or moderately depressed left ventricular systolic function</td>
<td>Lvef &lt; 40%</td>
</tr>
<tr class="even">
<td>G8739</td>
<td>0010</td>
<td>3</td>
<td>Left ventricular ejection fraction (lvef) &gt;= 40% or documentation as normal or mildly depressed left ventricular systolic function</td>
<td>Lvef &gt;= 40%</td>
</tr>
<tr class="odd">
<td>G8740</td>
<td>0010</td>
<td>3</td>
<td>Left ventricular ejection fraction (lvef) not performed or assessed, reason not given</td>
<td>Lvef not perfrmd</td>
</tr>
<tr class="even">
<td>G8749</td>
<td>0010</td>
<td>3</td>
<td>Absence of signs of melanoma (tenderness, jaundice, localized neurologic signs such as weakness, or any other sign suggesting systemic spread) or absence of symptoms of melanoma (cough, dyspnea, pain, paresthesia, or any other symptom suggesting the possibility of systemic spread of melanoma)</td>
<td>No signs melanoma</td>
</tr>
<tr class="odd">
<td>G8751</td>
<td>0010</td>
<td>3</td>
<td>Smoking status and exposure to second hand smoke in the home not assessed, reason not given</td>
<td>Smkg status not assess</td>
</tr>
<tr class="even">
<td>G8752</td>
<td>0010</td>
<td>3</td>
<td>Most recent systolic blood pressure &lt; 140 mmhg</td>
<td>Sys bp less 140</td>
</tr>
<tr class="odd">
<td>G8753</td>
<td>0010</td>
<td>3</td>
<td>Most recent systolic blood pressure &gt;= 140 mmhg</td>
<td>Sys bp &gt; or = 140</td>
</tr>
<tr class="even">
<td>G8754</td>
<td>0010</td>
<td>3</td>
<td>Most recent diastolic blood pressure &lt; 90 mmhg</td>
<td>Dias bp less 90</td>
</tr>
<tr class="odd">
<td>G8755</td>
<td>0010</td>
<td>3</td>
<td>Most recent diastolic blood pressure &gt;= 90 mmhg</td>
<td>Dias bp &gt; or = 90</td>
</tr>
<tr class="even">
<td>G8756</td>
<td>0010</td>
<td>3</td>
<td>No documentation of blood pressure measurement, reason not given</td>
<td>No bp measure doc</td>
</tr>
<tr class="odd">
<td>G8757</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the chronic obstructive pulmonary disease (copd) measures group have been performed for this patient</td>
<td>Copd mg qual act perform</td>
</tr>
<tr class="even">
<td>G8758</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the inflammatory bowel disease (ibd) measures group have been performed for this patient</td>
<td>Ibd mg qual act perform</td>
</tr>
<tr class="odd">
<td>G8759</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the sleep apnea measures group have been performed for this patient</td>
<td>Osa mg qual act perform</td>
</tr>
<tr class="even">
<td>G8761</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the dementia measures group have been performed for this patient</td>
<td>Dementia mg qual act perform</td>
</tr>
<tr class="odd">
<td>G8762</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the parkinson’s disease measures group have been performed for this patient</td>
<td>Pd mg qual act perform</td>
</tr>
<tr class="even">
<td>G8763</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the hypertension (htn) measures group have been performed for this patient</td>
<td>Hyperten mg qual act perform</td>
</tr>
<tr class="odd">
<td>G8764</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patient</td>
<td>Car prev mg qual act perform</td>
</tr>
<tr class="even">
<td>G8765</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the cataract measures group have been performed for this patient</td>
<td>Cataract mg qual act perform</td>
</tr>
<tr class="odd">
<td>G8767</td>
<td>0010</td>
<td>3</td>
<td>Lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)</td>
<td>Lipid panel res doc rev</td>
</tr>
<tr class="even">
<td>G8768</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not performing lipid profile (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)</td>
<td>Doc med reas no lipid profle</td>
</tr>
<tr class="odd">
<td>G8769</td>
<td>0010</td>
<td>3</td>
<td>Lipid profile not performed, reason not given</td>
<td>Lipid profile not perform</td>
</tr>
<tr class="even">
<td>G8770</td>
<td>0010</td>
<td>3</td>
<td>Urine protein test result documented and reviewed</td>
<td>Urine protein test doc rev</td>
</tr>
<tr class="odd">
<td>G8771</td>
<td>0010</td>
<td>3</td>
<td>Documentation of diagnosis of chronic kidney disease</td>
<td>Doc dx ckd</td>
</tr>
<tr class="even">
<td>G8772</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not performing urine protein test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not cllinically appropriate)</td>
<td>Doc med reas no urine protn</td>
</tr>
<tr class="odd">
<td>G8773</td>
<td>0010</td>
<td>3</td>
<td>Urine protein test was not performed, reason not given</td>
<td>No urine protein test</td>
</tr>
<tr class="even">
<td>G8774</td>
<td>0010</td>
<td>3</td>
<td>Serum creatinine test result documented and reviewed</td>
<td>Serum creatinine doc rev</td>
</tr>
<tr class="odd">
<td>G8775</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not performing serum creatinine test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)</td>
<td>Doc med reas no serum crtn</td>
</tr>
<tr class="even">
<td>G8776</td>
<td>0010</td>
<td>3</td>
<td>Serum creatinine test not performed, reason not given</td>
<td>No serum creatinine test</td>
</tr>
<tr class="odd">
<td>G8777</td>
<td>0010</td>
<td>3</td>
<td>Diabetes screening test performed</td>
<td>Diabetes screen</td>
</tr>
<tr class="even">
<td>G8778</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)</td>
<td>Doc med reas no diabete scrn</td>
</tr>
<tr class="odd">
<td>G8779</td>
<td>0010</td>
<td>3</td>
<td>Diabetes screening test not performed, reason not given</td>
<td>No diabetes screen</td>
</tr>
<tr class="even">
<td>G8780</td>
<td>0010</td>
<td>3</td>
<td>Counseling for diet and physical activity performed</td>
<td>Counsel diet phys activity</td>
</tr>
<tr class="odd">
<td>G8781</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for patient not receiving counseling for diet and physical activity (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)</td>
<td>Doc med reas no counsel diet</td>
</tr>
<tr class="even">
<td>G8782</td>
<td>0010</td>
<td>3</td>
<td>Counseling for diet and physical activity not performed, reason not given</td>
<td>No counsel diet phys act</td>
</tr>
<tr class="odd">
<td>G8783</td>
<td>0010</td>
<td>3</td>
<td>Normal blood pressure reading documented, follow-up not required</td>
<td>Bp scrn perf rec interval</td>
</tr>
<tr class="even">
<td>G8784</td>
<td>0010</td>
<td>3</td>
<td>Patient not eligible (e.g., documentation the patient is not eligible due to active diagnosis of hypertension, patient refuses, urgent or emergent situation)</td>
<td>Pt no elig for bp assess</td>
</tr>
<tr class="odd">
<td>G8785</td>
<td>0010</td>
<td>3</td>
<td>Blood pressure reading not documented, reason not given</td>
<td>Bp scrn no perf at interval</td>
</tr>
<tr class="even">
<td>G8797</td>
<td>0010</td>
<td>3</td>
<td>Specimen site other than anatomic location of esophagus</td>
<td>Specimen site not esophagus</td>
</tr>
<tr class="odd">
<td>G8798</td>
<td>0010</td>
<td>3</td>
<td>Specimen site other than anatomic location of prostate</td>
<td>Specimen site not prostate</td>
</tr>
<tr class="even">
<td>G8806</td>
<td>0010</td>
<td>3</td>
<td>Performance of trans-abdominal or trans-vaginal ultrasound and pregnancy location documented</td>
<td>Perf ultrsnd to lct preg doc</td>
</tr>
<tr class="odd">
<td>G8807</td>
<td>0010</td>
<td>3</td>
<td>Trans-abdominal or trans-vaginal ultrasound not performed for reasons documented by clinician (e.g., patient has visited the ed multiple times within 72 hours, patient has a documented intrauterine pregnancy [iup])</td>
<td>No ta tv ultrasnd</td>
</tr>
<tr class="even">
<td>G8808</td>
<td>0010</td>
<td>3</td>
<td>Trans-abdominal or trans-vaginal ultrasound not performed, reason not given</td>
<td>Ultrasound not perf, rng</td>
</tr>
<tr class="odd">
<td>G8809</td>
<td>0010</td>
<td>3</td>
<td>Rh-immunoglobulin (rhogam) ordered</td>
<td>Rh-immunoglobulin order</td>
</tr>
<tr class="even">
<td>G8810</td>
<td>0010</td>
<td>3</td>
<td>Rh-immunoglobulin (rhogam) not ordered for reasons documented by clinician (e.g., patient had prior documented receipt of rhogam within 12 weeks, patient refusal)</td>
<td>Doc reas no rh-immuno</td>
</tr>
<tr class="odd">
<td>G8811</td>
<td>0010</td>
<td>3</td>
<td>Documentation rh-immunoglobulin (rhogam) was not ordered, reason not given</td>
<td>No rh-immunoglobulin order</td>
</tr>
<tr class="even">
<td>G8815</td>
<td>0010</td>
<td>3</td>
<td>Documented reason in the medical records for why the statin therapy was not prescribed (i.e., lower extremity bypass was for a patient with non-artherosclerotic disease)</td>
<td>Doc reas no statin therapy</td>
</tr>
<tr class="odd">
<td>G8816</td>
<td>0010</td>
<td>3</td>
<td>Statin medication prescribed at discharge</td>
<td>Statin med pres at disch</td>
</tr>
<tr class="even">
<td>G8817</td>
<td>0010</td>
<td>3</td>
<td>Statin therapy not prescribed at discharge, reason not given</td>
<td>Doc reas no statin med disch</td>
</tr>
<tr class="odd">
<td>G8818</td>
<td>0010</td>
<td>3</td>
<td>Patient discharge to home no later than post-operative day #7</td>
<td>Pt disch to home by day#7</td>
</tr>
<tr class="even">
<td>G8825</td>
<td>0010</td>
<td>3</td>
<td>Patient not discharged to home by post-operative day #7</td>
<td>Pt not disch to home day#7</td>
</tr>
<tr class="odd">
<td>G8826</td>
<td>0010</td>
<td>3</td>
<td>Patient discharge to home no later than post-operative day #2 following evar</td>
<td>Pt disch home day #2 evar</td>
</tr>
<tr class="even">
<td>G8833</td>
<td>0010</td>
<td>3</td>
<td>Patient not discharged to home by post-operative day #2 following evar</td>
<td>Pt not disch home day#2 evar</td>
</tr>
<tr class="odd">
<td>G8834</td>
<td>0010</td>
<td>3</td>
<td>Patient discharged to home no later than post-operative day #2 following cea</td>
<td>Pt disch home day #2 cea</td>
</tr>
<tr class="even">
<td>G8838</td>
<td>0010</td>
<td>3</td>
<td>Patient not discharged to home by post-operative day #2 following cea</td>
<td>Not disch home by day #2</td>
</tr>
<tr class="odd">
<td>G8839</td>
<td>0010</td>
<td>3</td>
<td>Sleep apnea symptoms assessed, including presence or absence of snoring and daytime sleepiness</td>
<td>Sleep apnea assess</td>
</tr>
<tr class="even">
<td>G8840</td>
<td>0010</td>
<td>3</td>
<td>Documentation of reason(s) for not documenting an assessment of sleep symptoms (e.g., patient didn’t have initial daytime sleepiness, patient visited between initial testing and initiation of therapy)</td>
<td>Doc reas no sleep apnea</td>
</tr>
<tr class="odd">
<td>G8841</td>
<td>0010</td>
<td>3</td>
<td>Sleep apnea symptoms not assessed, reason not given</td>
<td>No sleep apnea assess</td>
</tr>
<tr class="even">
<td>G8842</td>
<td>0010</td>
<td>3</td>
<td>Apnea hypopnea index (ahi) or respiratory disturbance index (rdi) measured at the time of initial diagnosis</td>
<td>Ahi or rdi initial dx</td>
</tr>
<tr class="odd">
<td>G8843</td>
<td>0010</td>
<td>3</td>
<td>Documentation of reason(s) for not measuring an apnea hypopnea index (ahi) or a respiratory disturbance index (rdi) at the time of initial diagnosis (e.g., psychiatric disease, dementia, patient declined, financial, insurance coverage, test ordered but not yet completed)</td>
<td>Doc reas no ahi or rdi</td>
</tr>
<tr class="even">
<td>G8844</td>
<td>0010</td>
<td>3</td>
<td>Apnea hypopnea index (ahi) or respiratory disturbance index (rdi) not measured at the time of initial diagnosis, reason not given</td>
<td>No ahi or rdi initial dx</td>
</tr>
<tr class="odd">
<td>G8845</td>
<td>0010</td>
<td>3</td>
<td>Positive airway pressure therapy prescribed</td>
<td>Pos airway press prescribed</td>
</tr>
<tr class="even">
<td>G8846</td>
<td>0010</td>
<td>3</td>
<td>Moderate or severe obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of 15 or greater)</td>
<td>Mod or severe osa</td>
</tr>
<tr class="odd">
<td>G8848</td>
<td>0010</td>
<td>3</td>
<td>Mild obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of less than 15)</td>
<td>Mild osa</td>
</tr>
<tr class="even">
<td>G8849</td>
<td>0010</td>
<td>3</td>
<td>Documentation of reason(s) for not prescribing positive airway pressure therapy (e.g., patient unable to tolerate, alternative therapies use, patient declined, financial, insurance coverage)</td>
<td>Doc reas no pos air press</td>
</tr>
<tr class="odd">
<td>G8850</td>
<td>0010</td>
<td>3</td>
<td>Positive airway pressure therapy not prescribed, reason not given</td>
<td>No pap prescribed</td>
</tr>
<tr class="even">
<td>G8851</td>
<td>0010</td>
<td>3</td>
<td>Objective measurement of adherence to positive airway pressure therapy, documented</td>
<td>Adhere pos air press therapy</td>
</tr>
<tr class="odd">
<td>G8852</td>
<td>0010</td>
<td>3</td>
<td>Positive airway pressure therapy prescribed</td>
<td>Pos air press prescribe</td>
</tr>
<tr class="even">
<td>G8853</td>
<td>0010</td>
<td>3</td>
<td>Positive airway pressure therapy not prescribed</td>
<td>Pos air press not prescribe</td>
</tr>
<tr class="odd">
<td>G8854</td>
<td>0010</td>
<td>3</td>
<td>Documentation of reason(s) for not objectively measuring adherence to positive airway pressure therapy (e.g., patient didn’t bring data from continous positive airway pressure [cpap], therapy not yet initiated, not available on machine)</td>
<td>Reas no adhere pos air pres</td>
</tr>
<tr class="even">
<td>G8855</td>
<td>0010</td>
<td>3</td>
<td>Objective measurement of adherence to positive airway pressure therapy not performed, reason not given</td>
<td>Pos air press adhere no perf</td>
</tr>
<tr class="odd">
<td>G8856</td>
<td>0010</td>
<td>3</td>
<td>Referral to a physician for an otologic evaluation performed</td>
<td>Ref for oto eval</td>
</tr>
<tr class="even">
<td>G8857</td>
<td>0010</td>
<td>3</td>
<td>Patient is not eligible for the referral for otologic evaluation measure (e.g., patients who are already under the care of a physician for acute or chronic dizziness)</td>
<td>No elig ref for oto eval</td>
</tr>
<tr class="odd">
<td>G8858</td>
<td>0010</td>
<td>3</td>
<td>Referral to a physician for an otologic evaluation not performed, reason not given</td>
<td>Not ref for oto eval</td>
</tr>
<tr class="even">
<td>G8859</td>
<td>0010</td>
<td>3</td>
<td>Patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days</td>
<td>Corticosteroids 10mg 60 days</td>
</tr>
<tr class="odd">
<td>G8860</td>
<td>0010</td>
<td>3</td>
<td>Patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days</td>
<td>Corticosteroid 10 mg 60 days</td>
</tr>
<tr class="even">
<td>G8861</td>
<td>0010</td>
<td>3</td>
<td>Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) ordered and documented, review of systems and medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed</td>
<td>Dxa ordered for osteo</td>
</tr>
<tr class="odd">
<td>G8862</td>
<td>0010</td>
<td>3</td>
<td>Patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days</td>
<td>No corticostrd 10mg 60 days</td>
</tr>
<tr class="even">
<td>G8863</td>
<td>0010</td>
<td>3</td>
<td>Patients not assessed for risk of bone loss, reason not given</td>
<td>No assess bone loss</td>
</tr>
<tr class="odd">
<td>G8864</td>
<td>0010</td>
<td>3</td>
<td>Pneumococcal vaccine administered or previously received</td>
<td>Pneumococcal vaccine admin</td>
</tr>
<tr class="even">
<td>G8865</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction)</td>
<td>Doc med reas no pneumococcal</td>
</tr>
<tr class="odd">
<td>G8866</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal)</td>
<td>Doc pt reas no pneumococcal</td>
</tr>
<tr class="even">
<td>G8867</td>
<td>0010</td>
<td>3</td>
<td>Pneumococcal vaccine not administered or previously received, reason not given</td>
<td>No pneumococcal admin</td>
</tr>
<tr class="odd">
<td>G8868</td>
<td>0010</td>
<td>3</td>
<td>Patients receiving a first course of anti-tnf therapy</td>
<td>1st course antitnf</td>
</tr>
<tr class="even">
<td>G8869</td>
<td>0010</td>
<td>3</td>
<td>Patient has documented immunity to hepatitis b and initiating anti-tnf therapy</td>
<td>Doc immune hep b antitnf</td>
</tr>
<tr class="odd">
<td>G8870</td>
<td>0010</td>
<td>3</td>
<td>Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapy</td>
<td>Hepb admin 1st antitnf</td>
</tr>
<tr class="even">
<td>G8871</td>
<td>0010</td>
<td>3</td>
<td>Patient not receiving a first course of anti-tnf therapy</td>
<td>No 1st antitnf</td>
</tr>
<tr class="odd">
<td>G8872</td>
<td>0010</td>
<td>3</td>
<td>Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion</td>
<td>Intraop image confirm excise</td>
</tr>
<tr class="even">
<td>G8873</td>
<td>0010</td>
<td>3</td>
<td>Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site)</td>
<td>Specimen not intraop image</td>
</tr>
<tr class="odd">
<td>G8874</td>
<td>0010</td>
<td>3</td>
<td>Excised tissue not evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion</td>
<td>Tissue not image intraop</td>
</tr>
<tr class="even">
<td>G8875</td>
<td>0010</td>
<td>3</td>
<td>Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method</td>
<td>Breast cancer dx min invsive</td>
</tr>
<tr class="odd">
<td>G8876</td>
<td>0010</td>
<td>3</td>
<td>Documentation of reason(s) for not performing minimally invasive biopsy to diagnose breast cancer preoperatively (e.g., lesion too close to skin, implant, chest wall, etc., lesion could not be adequately visualized for needle biopsy, patient condition prevents needle biopsy [weight, breast thickness, etc.], duct excision without imaging abnormality, prophylactic mastectomy, reduction mammoplasty, excisional biopsy performed by another physician)</td>
<td>Doc reas no min inv dx</td>
</tr>
<tr class="even">
<td>G8877</td>
<td>0010</td>
<td>3</td>
<td>Clinician did not attempt to achieve the diagnosis of breast cancer preoperatively by a minimally invasive biopsy method, reason not given</td>
<td>No brst cncr dx min invasive</td>
</tr>
<tr class="odd">
<td>G8878</td>
<td>0010</td>
<td>3</td>
<td>Sentinel lymph node biopsy procedure performed</td>
<td>Sent lymph node biopsy</td>
</tr>
<tr class="even">
<td>G8879</td>
<td>0010</td>
<td>3</td>
<td>Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer</td>
<td>Node neg inv brst cncr</td>
</tr>
<tr class="odd">
<td>G8880</td>
<td>0010</td>
<td>3</td>
<td>Documentation of reason(s) sentinel lymph node biopsy not performed (e.g., reasons could include but not limited to; non-invasive cancer, incidental discovery of breast cancer on prophylactic mastectomy, incidental discovery of breast cancer on reduction mammoplasty, pre-operative biopsy proven lymph node (ln) metastases, inflammatory carcinoma, stage 3 locally advanced cancer, recurrent invasive breast cancer, clinically node positive after neoadjuvant systemic therapy, patient refusal after informed consent, patient with significant age, comorbidities, or limited life expectancy and favorable tumor; adjuvant systemic therapy unlikely to change)</td>
<td>Sen lym p node biop not perf</td>
</tr>
<tr class="even">
<td>G8881</td>
<td>0010</td>
<td>3</td>
<td>Stage of breast cancer is greater than t1n0m0 or t2n0m0</td>
<td>Brst cncr stage &gt; t1n0m0</td>
</tr>
<tr class="odd">
<td>G8882</td>
<td>0010</td>
<td>3</td>
<td>Sentinel lymph node biopsy procedure not performed, reason not given</td>
<td>No sent lymph node biopsy</td>
</tr>
<tr class="even">
<td>G8883</td>
<td>0010</td>
<td>3</td>
<td>Biopsy results reviewed, communicated, tracked and documented</td>
<td>Rev, comm, track, doc biopsy</td>
</tr>
<tr class="odd">
<td>G8884</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented reason that patient’s biopsy results were not reviewed</td>
<td>Doc reas biopsy not review</td>
</tr>
<tr class="even">
<td>G8885</td>
<td>0010</td>
<td>3</td>
<td>Biopsy results not reviewed, communicated, tracked or documented</td>
<td>No rev, comm, track biopsy</td>
</tr>
<tr class="odd">
<td>G8886</td>
<td>0010</td>
<td>3</td>
<td>Most recent blood pressure under control</td>
<td>Bp under control</td>
</tr>
<tr class="even">
<td>G8887</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)</td>
<td>Doc med reas bp not control</td>
</tr>
<tr class="odd">
<td>G8888</td>
<td>0010</td>
<td>3</td>
<td>Most recent blood pressure not under control, results documented and reviewed</td>
<td>Bp not under control</td>
</tr>
<tr class="even">
<td>G8889</td>
<td>0010</td>
<td>3</td>
<td>No documentation of blood pressure measurement, reason not given</td>
<td>No doc bp</td>
</tr>
<tr class="odd">
<td>G8890</td>
<td>0010</td>
<td>3</td>
<td>Most recent ldl-c under control, results documented and reviewed</td>
<td>Ldl-c under control</td>
</tr>
<tr class="even">
<td>G8891</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for whom treatment of hypertension with standard treatment goals is not clinically appropriate)</td>
<td>Doc med reas no ldl-c contrl</td>
</tr>
<tr class="odd">
<td>G8892</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)</td>
<td>Doc med reas no ldl-c test</td>
</tr>
<tr class="even">
<td>G8893</td>
<td>0010</td>
<td>3</td>
<td>Most recent ldl-c not under control, results documented and reviewed</td>
<td>Ldl-c not under control</td>
</tr>
<tr class="odd">
<td>G8894</td>
<td>0010</td>
<td>3</td>
<td>Ldl-c not performed, reason not given</td>
<td>Ldl-c not performed</td>
</tr>
<tr class="even">
<td>G8895</td>
<td>0010</td>
<td>3</td>
<td>Oral aspirin or other antithrombotic therapy prescribed</td>
<td>Antrom prescribe</td>
</tr>
<tr class="odd">
<td>G8896</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not prescribing oral aspirin or other antithrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically appropriate, or for whom risk of aspirin or other antithrombotic therapy exceeds potential benefits such as for individuals whose blood pressure is poorly controlled)</td>
<td>Doc med reas no antihtrom</td>
</tr>
<tr class="even">
<td>G8897</td>
<td>0010</td>
<td>3</td>
<td>Oral aspirin or other antithrombotic therapy was not prescribed, reason not given</td>
<td>Antithrom not prescribe</td>
</tr>
<tr class="odd">
<td>G8898</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the chronic obstructive pulmonary disease (copd) measures group</td>
<td>Copd measures group</td>
</tr>
<tr class="even">
<td>G8899</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the inflammatory bowel disease (ibd) measures group</td>
<td>Inflammatory bowel dis mg</td>
</tr>
<tr class="odd">
<td>G8900</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the sleep apnea measures group</td>
<td>Obstructive sleep apnea mg</td>
</tr>
<tr class="even">
<td>G8902</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the dementia measures group</td>
<td>Dementia measures group</td>
</tr>
<tr class="odd">
<td>G8903</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the parkinson’s disease measures group</td>
<td>Parkinson’s disease mg</td>
</tr>
<tr class="even">
<td>G8904</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the hypertension (htn) measures group</td>
<td>Hypertension mg</td>
</tr>
<tr class="odd">
<td>G8905</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the cardiovascular prevention measures group</td>
<td>Cardiovascular prevention mg</td>
</tr>
<tr class="even">
<td>G8906</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the cataract measures group</td>
<td>Cataract measures group</td>
</tr>
<tr class="odd">
<td>G8907</td>
<td>0010</td>
<td>3</td>
<td>Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility</td>
<td>Pt doc no events on discharg</td>
</tr>
<tr class="even">
<td>G8908</td>
<td>0010</td>
<td>3</td>
<td>Patient documented to have received a burn prior to discharge</td>
<td>Pt doc w burn prior to d/c</td>
</tr>
<tr class="odd">
<td>G8909</td>
<td>0010</td>
<td>3</td>
<td>Patient documented not to have received a burn prior to discharge</td>
<td>Pt doc no burn prior to d/c</td>
</tr>
<tr class="even">
<td>G8910</td>
<td>0010</td>
<td>3</td>
<td>Patient documented to have experienced a fall within asc</td>
<td>Pt doc to have fall in asc</td>
</tr>
<tr class="odd">
<td>G8911</td>
<td>0010</td>
<td>3</td>
<td>Patient documented not to have experienced a fall within ambulatory surgical center</td>
<td>Pt doc no fall in asc</td>
</tr>
<tr class="even">
<td>G8912</td>
<td>0010</td>
<td>3</td>
<td>Patient documented to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event</td>
<td>Pt doc with wrong event</td>
</tr>
<tr class="odd">
<td>G8913</td>
<td>0010</td>
<td>3</td>
<td>Patient documented not to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event</td>
<td>Pt doc no wrong event</td>
</tr>
<tr class="even">
<td>G8914</td>
<td>0010</td>
<td>3</td>
<td>Patient documented to have experienced a hospital transfer or hospital admission upon discharge from asc</td>
<td>Pt trans to hosp post d/c</td>
</tr>
<tr class="odd">
<td>G8915</td>
<td>0010</td>
<td>3</td>
<td>Patient documented not to have experienced a hospital transfer or hospital admission upon discharge from asc</td>
<td>Pt not trans to hosp at d/c</td>
</tr>
<tr class="even">
<td>G8916</td>
<td>0010</td>
<td>3</td>
<td>Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time</td>
<td>Pt w iv ab given on time</td>
</tr>
<tr class="odd">
<td>G8917</td>
<td>0010</td>
<td>3</td>
<td>Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic not initiated on time</td>
<td>Pt w iv ab not given on time</td>
</tr>
<tr class="even">
<td>G8918</td>
<td>0010</td>
<td>3</td>
<td>Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis</td>
<td>Pt w/o preop order iv ab pro</td>
</tr>
<tr class="odd">
<td>G8923</td>
<td>0010</td>
<td>3</td>
<td>Left ventricular ejection fraction (lvef) &lt; 40% or documentation of moderately or severely depressed left ventricular systolic function</td>
<td>Lvef &lt; 40% or lvsd</td>
</tr>
<tr class="even">
<td>G8924</td>
<td>0010</td>
<td>3</td>
<td>Spirometry test results demonstrate fev1/fvc &lt; 70%, fev &lt; 60% predicted and patient has copd symptoms (e.g., dyspnea, cough/sputum, wheezing)</td>
<td>Spir fev1/fvc&lt;70%,fev&lt;60%</td>
</tr>
<tr class="odd">
<td>G8925</td>
<td>0010</td>
<td>3</td>
<td>Spirometry test results demonstrate fev1 &gt;= 60% fev1/fvc &gt;= 70%, predicted or patient does not have copd symptoms</td>
<td>Spir fev1/fvc&gt;=60% &amp; no copd</td>
</tr>
<tr class="even">
<td>G8926</td>
<td>0010</td>
<td>3</td>
<td>Spirometry test not performed or documented, reason not given</td>
<td>Spiro no perf or doc</td>
</tr>
<tr class="odd">
<td>G8927</td>
<td>0010</td>
<td>3</td>
<td>Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer</td>
<td>Adj chem pres ajcc iii</td>
</tr>
<tr class="even">
<td>G8928</td>
<td>0010</td>
<td>3</td>
<td>Adjuvant chemotherapy not prescribed or previously received, for documented reasons (e.g., medical co-morbidities, diagnosis date more than 5 years prior to the current visit date, patient’s diagnosis date is within 120 days of the end of the 12 month reporting period, patient’s cancer has metastasized, medical contraindication/allergy, poor performance status, other medical reasons, patient refusal, other patient reasons, patient is currently enrolled in a clinical trial that precludes prescription of chemotherapy, other system reasons)</td>
<td>Adj chem not pres rsn spec</td>
</tr>
<tr class="odd">
<td>G8929</td>
<td>0010</td>
<td>3</td>
<td>Adjuvant chemotherapy not prescribed or previously received, reason not given</td>
<td>Adj cmo not pres rsn not gvn</td>
</tr>
<tr class="even">
<td>G8930</td>
<td>0010</td>
<td>3</td>
<td>Assessment of depression severity at the initial evaluation</td>
<td>Assess of dep @ initial eval</td>
</tr>
<tr class="odd">
<td>G8931</td>
<td>0010</td>
<td>3</td>
<td>Assessment of depression severity not documented, reason not given</td>
<td>Asses of dep not documented</td>
</tr>
<tr class="even">
<td>G8932</td>
<td>0010</td>
<td>3</td>
<td>Suicide risk assessed at the initial evaluation</td>
<td>Suicd rsk assessed init eval</td>
</tr>
<tr class="odd">
<td>G8933</td>
<td>0010</td>
<td>3</td>
<td>Suicide risk not assessed at the initial evaluation, reason not given</td>
<td>Suicide risk not assessed</td>
</tr>
<tr class="even">
<td>G8934</td>
<td>0010</td>
<td>3</td>
<td>Left ventricular ejection fraction (lvef) &lt;40% or documentation of moderately or severely depressed left ventricular systolic function</td>
<td>Lvef &lt;40% or dep lv sys fcn</td>
</tr>
<tr class="odd">
<td>G8935</td>
<td>0010</td>
<td>3</td>
<td>Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy</td>
<td>Rx ace or arb therapy</td>
</tr>
<tr class="even">
<td>G8936</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy (eg, allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (eg, patient declined, other patient reasons) or (eg, lack of drug availability, other reasons attributable to the health care system)</td>
<td>Pt not eligible ace/arb</td>
</tr>
<tr class="odd">
<td>G8937</td>
<td>0010</td>
<td>3</td>
<td>Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given</td>
<td>No rx ace/arb therapy</td>
</tr>
<tr class="even">
<td>G8938</td>
<td>0010</td>
<td>3</td>
<td>Bmi is documented as being outside of normal limits, follow-up plan is not documented, documentation the patient is not eligible</td>
<td>Bmi doc onl fup nt doc</td>
</tr>
<tr class="odd">
<td>G8939</td>
<td>0010</td>
<td>3</td>
<td>Pain assessment documented as positive, follow-up plan not documented, documentation the patient is not eligible at the time of the encounter</td>
<td>Pain as doc positive, no f/u</td>
</tr>
<tr class="even">
<td>G8940</td>
<td>0010</td>
<td>3</td>
<td>Screening for depression documented as positive, a follow-up plan not completed, documented reason</td>
<td>Scr dep pos, no plan done</td>
</tr>
<tr class="odd">
<td>G8941</td>
<td>0010</td>
<td>3</td>
<td>Elder maltreatment screen documented as positive, follow-up plan not documented, documentation the patient is not eligible for follow-up plan at the time of the encounter</td>
<td>Eld maltreatment doc as pos</td>
</tr>
<tr class="even">
<td>G8942</td>
<td>0010</td>
<td>3</td>
<td>Functional outcomes assessment using a standardized tool is documented within the previous 30 days and care plan, based on identified deficiencies on the date of the functional outcome assessment, is documented</td>
<td>Doc fcn/care plan w/30 days</td>
</tr>
<tr class="odd">
<td>G8943</td>
<td>0010</td>
<td>3</td>
<td>Ldl-c result not present or not within 12 months prior</td>
<td>Ldlc not pres w/i 12 mo prir</td>
</tr>
<tr class="even">
<td>G8944</td>
<td>0010</td>
<td>3</td>
<td>Ajcc melanoma cancer stage 0 through iic melanoma</td>
<td>Ajcc mel cnr stg 0 - iic</td>
</tr>
<tr class="odd">
<td>G8946</td>
<td>0010</td>
<td>3</td>
<td>Minimally invasive biopsy method attempted but not diagnostic of breast cancer (e.g., high risk lesion of breast such as atypical ductal hyperplasia, lobular neoplasia, atypical lobular hyperplasia, lobular carcinoma in situ, atypical columnar hyperplasia, flat epithelial atypia, radial scar, complex sclerosing lesion, papillary lesion, or any lesion with spindle cells)</td>
<td>Mibm but no dx of breast ca</td>
</tr>
<tr class="even">
<td>G8947</td>
<td>0010</td>
<td>3</td>
<td>One or more neuropsychiatric symptoms</td>
<td>1 or more neuropsych</td>
</tr>
<tr class="odd">
<td>G8948</td>
<td>0010</td>
<td>3</td>
<td>No neuropsychiatric symptoms</td>
<td>No neuropsych symptoms</td>
</tr>
<tr class="even">
<td>G8949</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make these changes)</td>
<td>Doc pt reas on counsel diet</td>
</tr>
<tr class="odd">
<td>G8950</td>
<td>0010</td>
<td>3</td>
<td>Pre-hypertensive or hypertensive blood pressure reading documented, and the indicated follow-up is documented</td>
<td>Pre-htn or htn doc, f/u indc</td>
</tr>
<tr class="even">
<td>G8951</td>
<td>0010</td>
<td>3</td>
<td>Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, documentation the patient is not eligible</td>
<td>Pre-htn/htn doc, no pt f/u</td>
</tr>
<tr class="odd">
<td>G8952</td>
<td>0010</td>
<td>3</td>
<td>Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given</td>
<td>Pre-htn/htn, no f/u, not gvn</td>
</tr>
<tr class="even">
<td>G8953</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the oncology measures group have been performed for this patient</td>
<td>Oncology mg qual act perform</td>
</tr>
<tr class="odd">
<td>G8955</td>
<td>0010</td>
<td>3</td>
<td>Most recent assessment of adequacy of volume management documented</td>
<td>Most recent assess vol mgmt</td>
</tr>
<tr class="even">
<td>G8956</td>
<td>0010</td>
<td>3</td>
<td>Patient receiving maintenance hemodialysis in an outpatient dialysis facility</td>
<td>Pt rcv hedia outpt dyls fac</td>
</tr>
<tr class="odd">
<td>G8957</td>
<td>0010</td>
<td>3</td>
<td>Patient not receiving maintenance hemodialysis in an outpatient dialysis facility</td>
<td>Pt no hedia in outpt fac</td>
</tr>
<tr class="even">
<td>G8958</td>
<td>0010</td>
<td>3</td>
<td>Assessment of adequacy of volume management not documented, reason not given</td>
<td>Assess vol mgmt not doc</td>
</tr>
<tr class="odd">
<td>G8959</td>
<td>0010</td>
<td>3</td>
<td>Clinician treating major depressive disorder communicates to clinician treating comorbid condition</td>
<td>Clin tx mdd comm to tx clin</td>
</tr>
<tr class="even">
<td>G8960</td>
<td>0010</td>
<td>3</td>
<td>Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition, reason not given</td>
<td>Clin tx mdd not comm</td>
</tr>
<tr class="odd">
<td>G8961</td>
<td>0010</td>
<td>3</td>
<td>Cardiac stress imaging test primarily performed on low-risk surgery patient for preoperative evaluation within 30 days preceding this surgery</td>
<td>Csit lowrisk surg pts preop</td>
</tr>
<tr class="even">
<td>G8962</td>
<td>0010</td>
<td>3</td>
<td>Cardiac stress imaging test performed on patient for any reason including those who did not have low risk surgery or test that was performed more than 30 days preceding low risk surgery</td>
<td>Csit on pt any reas 30 days</td>
</tr>
<tr class="odd">
<td>G8963</td>
<td>0010</td>
<td>3</td>
<td>Cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 years</td>
<td>Csi per asx pt w/pci 2 yrs</td>
</tr>
<tr class="even">
<td>G8964</td>
<td>0010</td>
<td>3</td>
<td>Cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.g., symptomatic patient, patient greater than 2 years since pci, initial evaluation, etc)</td>
<td>Csi any other than pci 2 yr</td>
</tr>
<tr class="odd">
<td>G8965</td>
<td>0010</td>
<td>3</td>
<td>Cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessment</td>
<td>Csit perf on low chd rsk</td>
</tr>
<tr class="even">
<td>G8966</td>
<td>0010</td>
<td>3</td>
<td>Cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessment</td>
<td>Csit perf sx or high chd rsk</td>
</tr>
<tr class="odd">
<td>G8967</td>
<td>0010</td>
<td>3</td>
<td>Warfarin or another fda approved oral anticoagulant is prescribed</td>
<td>Warf or other fda drug presc</td>
</tr>
<tr class="even">
<td>G8968</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not prescribing warfarin or another fda-approved anticoagulant (e.g., atrial appendage device in place)</td>
<td>Doc med not presb</td>
</tr>
<tr class="odd">
<td>G8969</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient reason(s) for not prescribing warfarin or another fda-approved oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g., patient choice of having atrial appendage device placed)</td>
<td>Doc pt rsn no presc warf/fda</td>
</tr>
<tr class="even">
<td>G8970</td>
<td>0010</td>
<td>3</td>
<td>No risk factors or one moderate risk factor for thromboembolism</td>
<td>No rsk fac or 1 mod risk te</td>
</tr>
<tr class="odd">
<td>G8971</td>
<td>0010</td>
<td>3</td>
<td>Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given</td>
<td>Warfrn or othr antcog no rx</td>
</tr>
<tr class="even">
<td>G8972</td>
<td>0010</td>
<td>3</td>
<td>One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism</td>
<td>1&gt;=risk or&gt;= mod risk for te</td>
</tr>
<tr class="odd">
<td>G8973</td>
<td>0010</td>
<td>3</td>
<td>Most recent hemoglobin (hgb) level &lt; 10 g/dl</td>
<td>Mst rcnt hbb &lt; 10g/dl</td>
</tr>
<tr class="even">
<td>G8974</td>
<td>0010</td>
<td>3</td>
<td>Hemoglobin level measurement not documented, reason not given</td>
<td>Hgb not doc rns not gvn</td>
</tr>
<tr class="odd">
<td>G8975</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for patient having a hemoglobin level &lt; 10 g/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons)</td>
<td>Hgb &lt;10g/dl, med rsn</td>
</tr>
<tr class="even">
<td>G8976</td>
<td>0010</td>
<td>3</td>
<td>Most recent hemoglobin (hgb) level &gt;= 10 g/dl</td>
<td>Hgb &gt;= 10 g/dl</td>
</tr>
<tr class="odd">
<td>G8977</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the oncology measures group</td>
<td>Oncology measures grp</td>
</tr>
<tr class="even">
<td>G8978</td>
<td>0010</td>
<td>3</td>
<td>Mobility: walking &amp; moving around functional limitation, current status, at therapy episode outset and at reporting intervals</td>
<td>Mobility current status</td>
</tr>
<tr class="odd">
<td>G8979</td>
<td>0010</td>
<td>3</td>
<td>Mobility: walking &amp; moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting</td>
<td>Mobility goal status</td>
</tr>
<tr class="even">
<td>G8980</td>
<td>0010</td>
<td>3</td>
<td>Mobility: walking &amp; moving around functional limitation, discharge status, at discharge from therapy or to end reporting</td>
<td>Mobility d/c status</td>
</tr>
<tr class="odd">
<td>G8981</td>
<td>0010</td>
<td>3</td>
<td>Changing &amp; maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals</td>
<td>Body pos current status</td>
</tr>
<tr class="even">
<td>G8982</td>
<td>0010</td>
<td>3</td>
<td>Changing &amp; maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting</td>
<td>Body pos goal status</td>
</tr>
<tr class="odd">
<td>G8983</td>
<td>0010</td>
<td>3</td>
<td>Changing &amp; maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting</td>
<td>Body pos d/c status</td>
</tr>
<tr class="even">
<td>G8984</td>
<td>0010</td>
<td>3</td>
<td>Carrying, moving &amp; handling objects functional limitation, current status, at therapy episode outset and at reporting intervals</td>
<td>Carry current status</td>
</tr>
<tr class="odd">
<td>G8985</td>
<td>0010</td>
<td>3</td>
<td>Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting</td>
<td>Carry goal status</td>
</tr>
<tr class="even">
<td>G8986</td>
<td>0010</td>
<td>3</td>
<td>Carrying, moving &amp; handling objects functional limitation, discharge status, at discharge from therapy or to end reporting</td>
<td>Carry d/c status</td>
</tr>
<tr class="odd">
<td>G8987</td>
<td>0010</td>
<td>3</td>
<td>Self care functional limitation, current status, at therapy episode outset and at reporting intervals</td>
<td>Self care current status</td>
</tr>
<tr class="even">
<td>G8988</td>
<td>0010</td>
<td>3</td>
<td>Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting</td>
<td>Self care goal status</td>
</tr>
<tr class="odd">
<td>G8989</td>
<td>0010</td>
<td>3</td>
<td>Self care functional limitation, discharge status, at discharge from therapy or to end reporting</td>
<td>Self care d/c status</td>
</tr>
<tr class="even">
<td>G8990</td>
<td>0010</td>
<td>3</td>
<td>Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals</td>
<td>Other pt/ot current status</td>
</tr>
<tr class="odd">
<td>G8991</td>
<td>0010</td>
<td>3</td>
<td>Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting</td>
<td>Other pt/ot goal status</td>
</tr>
<tr class="even">
<td>G8992</td>
<td>0010</td>
<td>3</td>
<td>Other physical or occupational therapy primary functional limitation, discharge status, at discharge from therapy or to end reporting</td>
<td>Other pt/ot d/c status</td>
</tr>
<tr class="odd">
<td>G8993</td>
<td>0010</td>
<td>3</td>
<td>Other physical or occupational therapy subsequent functional limitation, current status, at therapy episode outset and at reporting intervals</td>
<td>Sub pt/ot current status</td>
</tr>
<tr class="even">
<td>G8994</td>
<td>0010</td>
<td>3</td>
<td>Other physical or occupational therapy subsequent functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting</td>
<td>Sub pt/ot goal status</td>
</tr>
<tr class="odd">
<td>G8995</td>
<td>0010</td>
<td>3</td>
<td>Other physical or occupational therapy subsequent functional limitation, discharge status, at discharge from therapy or to end reporting</td>
<td>Sub pt/ot d/c status</td>
</tr>
<tr class="even">
<td>G8996</td>
<td>0010</td>
<td>3</td>
<td>Swallowing functional limitation, current status at therapy episode outset and at reporting intervals</td>
<td>Swallow current status</td>
</tr>
<tr class="odd">
<td>G8997</td>
<td>0010</td>
<td>3</td>
<td>Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting</td>
<td>Swallow goal status</td>
</tr>
<tr class="even">
<td>G8998</td>
<td>0010</td>
<td>3</td>
<td>Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting</td>
<td>Swallow d/c status</td>
</tr>
<tr class="odd">
<td>G8999</td>
<td>0010</td>
<td>3</td>
<td>Motor speech functional limitation, current status at therapy episode outset and at reporting intervals</td>
<td>Motor speech current status</td>
</tr>
<tr class="even">
<td>G9001</td>
<td>0010</td>
<td>3</td>
<td>Coordinated care fee, initial rate</td>
<td>Mccd, initial rate</td>
</tr>
<tr class="odd">
<td>G9002</td>
<td>0010</td>
<td>3</td>
<td>Coordinated care fee, maintenance rate</td>
<td>Mccd,maintenance rate</td>
</tr>
<tr class="even">
<td>G9003</td>
<td>0010</td>
<td>3</td>
<td>Coordinated care fee, risk adjusted high, initial</td>
<td>Mccd, risk adj hi, initial</td>
</tr>
<tr class="odd">
<td>G9004</td>
<td>0010</td>
<td>3</td>
<td>Coordinated care fee, risk adjusted low, initial</td>
<td>Mccd, risk adj lo, initial</td>
</tr>
<tr class="even">
<td>G9005</td>
<td>0010</td>
<td>3</td>
<td>Coordinated care fee, risk adjusted maintenance</td>
<td>Mccd, risk adj, maintenance</td>
</tr>
<tr class="odd">
<td>G9006</td>
<td>0010</td>
<td>3</td>
<td>Coordinated care fee, home monitoring</td>
<td>Mccd, home monitoring</td>
</tr>
<tr class="even">
<td>G9007</td>
<td>0010</td>
<td>3</td>
<td>Coordinated care fee, scheduled team conference</td>
<td>Mccd, sch team conf</td>
</tr>
<tr class="odd">
<td>G9008</td>
<td>0010</td>
<td>3</td>
<td>Coordinated care fee, physician coordinated care oversight services</td>
<td>Mccd,phys coor-care ovrsght</td>
</tr>
<tr class="even">
<td>G9009</td>
<td>0010</td>
<td>3</td>
<td>Coordinated care fee, risk adjusted maintenance, level 3</td>
<td>Mccd, risk adj, level 3</td>
</tr>
<tr class="odd">
<td>G9010</td>
<td>0010</td>
<td>3</td>
<td>Coordinated care fee, risk adjusted maintenance, level 4</td>
<td>Mccd, risk adj, level 4</td>
</tr>
<tr class="even">
<td>G9011</td>
<td>0010</td>
<td>3</td>
<td>Coordinated care fee, risk adjusted maintenance, level 5</td>
<td>Mccd, risk adj, level 5</td>
</tr>
<tr class="odd">
<td>G9012</td>
<td>0010</td>
<td>3</td>
<td>Other specified case management service not elsewhere classified</td>
<td>Other specified case mgmt</td>
</tr>
<tr class="even">
<td>G9013</td>
<td>0010</td>
<td>3</td>
<td>Esrd demo basic bundle level i</td>
<td>Esrd demo bundle level i</td>
</tr>
<tr class="odd">
<td>G9014</td>
<td>0010</td>
<td>3</td>
<td>Esrd demo expanded bundle including venous access and related services</td>
<td>Esrd demo bundle-level ii</td>
</tr>
<tr class="even">
<td>G9016</td>
<td>0010</td>
<td>3</td>
<td>Smoking cessation counseling, individual, in the absence of or in addition to any other evaluation and management service, per session (6-10 minutes) [demo project code only]</td>
<td>Demo-smoking cessation coun</td>
</tr>
<tr class="odd">
<td>G9017</td>
<td>0010</td>
<td>3</td>
<td>Amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)</td>
<td>Amantadine hcl 100mg oral</td>
</tr>
<tr class="even">
<td>G9018</td>
<td>0010</td>
<td>3</td>
<td>Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project)</td>
<td>Zanamivir,inhalation pwd 10m</td>
</tr>
<tr class="odd">
<td>G9019</td>
<td>0010</td>
<td>3</td>
<td>Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project)</td>
<td>Oseltamivir phosphate 75mg</td>
</tr>
<tr class="even">
<td>G9020</td>
<td>0010</td>
<td>3</td>
<td>Rimantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)</td>
<td>Rimantadine hcl 100mg oral</td>
</tr>
<tr class="odd">
<td>G9033</td>
<td>0010</td>
<td>3</td>
<td>Amantadine hydrochloride, oral brand, per 100 mg (for use in a medicare-approved demonstration project)</td>
<td>Amantadine hcl oral brand</td>
</tr>
<tr class="even">
<td>G9034</td>
<td>0010</td>
<td>3</td>
<td>Zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg (for use in a medicare-approved demonstration project)</td>
<td>Zanamivir, inh pwdr, brand</td>
</tr>
<tr class="odd">
<td>G9035</td>
<td>0010</td>
<td>3</td>
<td>Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project)</td>
<td>Oseltamivir phosp, brand</td>
</tr>
<tr class="even">
<td>G9036</td>
<td>0010</td>
<td>3</td>
<td>Rimantadine hydrochloride, oral, brand, per 100 mg (for use in a medicare-approved demonstration project)</td>
<td>Rimantadine hcl, brand</td>
</tr>
<tr class="odd">
<td>G9050</td>
<td>0010</td>
<td>3</td>
<td>Oncology; primary focus of visit; work-up, evaluation, or staging at the time of cancer diagnosis or recurrence (for use in a medicare-approved demonstration project)</td>
<td>Oncology work-up evaluation</td>
</tr>
<tr class="even">
<td>G9051</td>
<td>0010</td>
<td>3</td>
<td>Oncology; primary focus of visit; treatment decision-making after disease is staged or restaged, discussion of treatment options, supervising/coordinating active cancer directed therapy or managing consequences of cancer directed therapy (for use in a medicare-approved demonstration project)</td>
<td>Oncology tx decision-mgmt</td>
</tr>
<tr class="odd">
<td>G9052</td>
<td>0010</td>
<td>3</td>
<td>Oncology; primary focus of visit; surveillance for disease recurrence for patient who has completed definitive cancer-directed therapy and currently lacks evidence of recurrent disease; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project)</td>
<td>Onc surveillance for disease</td>
</tr>
<tr class="even">
<td>G9053</td>
<td>0010</td>
<td>3</td>
<td>Oncology; primary focus of visit; expectant management of patient with evidence of cancer for whom no cancer directed therapy is being administered or arranged at present; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project)</td>
<td>Onc expectant management pt</td>
</tr>
<tr class="odd">
<td>G9054</td>
<td>0010</td>
<td>3</td>
<td>Oncology; primary focus of visit; supervising, coordinating or managing care of patient with terminal cancer or for whom other medical illness prevents further cancer treatment; includes symptom management, end-of-life care planning, management of palliative therapies (for use in a medicare-approved demonstration project)</td>
<td>Onc supervision palliative</td>
</tr>
<tr class="even">
<td>G9055</td>
<td>0010</td>
<td>3</td>
<td>Oncology; primary focus of visit; other, unspecified service not otherwise listed (for use in a medicare-approved demonstration project)</td>
<td>Onc visit unspecified nos</td>
</tr>
<tr class="odd">
<td>G9056</td>
<td>0010</td>
<td>3</td>
<td>Oncology; practice guidelines; management adheres to guidelines (for use in a medicare-approved demonstration project)</td>
<td>Onc prac mgmt adheres guide</td>
</tr>
<tr class="even">
<td>G9057</td>
<td>0010</td>
<td>3</td>
<td>Oncology; practice guidelines; management differs from guidelines as a result of patient enrollment in an institutional review board approved clinical trial (for use in a medicare-approved demonstration project)</td>
<td>Onc pract mgmt differs trial</td>
</tr>
<tr class="odd">
<td>G9058</td>
<td>0010</td>
<td>3</td>
<td>Oncology; practice guidelines; management differs from guidelines because the treating physician disagrees with guideline recommendations (for use in a medicare-approved demonstration project)</td>
<td>Onc prac mgmt disagree w/gui</td>
</tr>
<tr class="even">
<td>G9059</td>
<td>0010</td>
<td>3</td>
<td>Oncology; practice guidelines; management differs from guidelines because the patient, after being offered treatment consistent with guidelines, has opted for alternative treatment or management, including no treatment (for use in a medicare-approved demonstration project)</td>
<td>Onc prac mgmt pt opt alterna</td>
</tr>
<tr class="odd">
<td>G9060</td>
<td>0010</td>
<td>3</td>
<td>Oncology; practice guidelines; management differs from guidelines for reason(s) associated with patient comorbid illness or performance status not factored into guidelines (for use in a medicare-approved demonstration project)</td>
<td>Onc prac mgmt dif pt comorb</td>
</tr>
<tr class="even">
<td>G9061</td>
<td>0010</td>
<td>3</td>
<td>Oncology; practice guidelines; patient’s condition not addressed by available guidelines (for use in a medicare-approved demonstration project)</td>
<td>Onc prac cond noadd by guide</td>
</tr>
<tr class="odd">
<td>G9062</td>
<td>0010</td>
<td>3</td>
<td>Oncology; practice guidelines; management differs from guidelines for other reason(s) not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc prac guide differs nos</td>
</tr>
<tr class="even">
<td>G9063</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage i (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx nsclc stgi no progres</td>
</tr>
<tr class="odd">
<td>G9064</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage ii (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx nsclc stg2 no progres</td>
</tr>
<tr class="even">
<td>G9065</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage iii a (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx nsclc stg3a no progre</td>
</tr>
<tr class="odd">
<td>G9066</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; limited to non-small cell lung cancer; stage iii b- iv at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)</td>
<td>Onc dx nsclc stg3b-4 metasta</td>
</tr>
<tr class="even">
<td>G9067</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; limited to non-small cell lung cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc dx nsclc dx unknown nos</td>
</tr>
<tr class="odd">
<td>G9068</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; limited to small cell and combined small cell/non-small cell; extent of disease initially established as limited with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx sclc/nsclc limited</td>
</tr>
<tr class="even">
<td>G9069</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small cell; extensive stage at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)</td>
<td>Onc dx sclc/nsclc ext at dx</td>
</tr>
<tr class="odd">
<td>G9070</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc dx sclc/nsclc ext unknwn</td>
</tr>
<tr class="even">
<td>G9071</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx brst stg1-2b hr,nopro</td>
</tr>
<tr class="odd">
<td>G9072</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i, or stage iia-iib; or t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx brst stg1-2 noprogres</td>
</tr>
<tr class="even">
<td>G9073</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx brst stg3-hr, no pro</td>
</tr>
<tr class="odd">
<td>G9074</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx brst stg3-noprogress</td>
</tr>
<tr class="even">
<td>G9075</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)</td>
<td>Onc dx brst metastic/ recur</td>
</tr>
<tr class="odd">
<td>G9077</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa &lt; or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx prostate t1no progres</td>
</tr>
<tr class="even">
<td>G9078</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t2 or t3a gleason 8-10 or psa &gt; 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx prostate t2no progres</td>
</tr>
<tr class="odd">
<td>G9079</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t3b-t4, any n; any t, n1 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx prostate t3b-t4noprog</td>
</tr>
<tr class="even">
<td>G9080</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; prostate cancer, limited to adenocarcinoma; after initial treatment with rising psa or failure of psa decline (for use in a medicare-approved demonstration project)</td>
<td>Onc dx prostate w/rise psa</td>
</tr>
<tr class="odd">
<td>G9083</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; prostate cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc dx prostate unknwn nos</td>
</tr>
<tr class="even">
<td>G9084</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx colon t1-3,n1-2,no pr</td>
</tr>
<tr class="odd">
<td>G9085</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx colon t4, n0 w/o prog</td>
</tr>
<tr class="even">
<td>G9086</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-4, n1-2, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx colon t1-4 no dx prog</td>
</tr>
<tr class="odd">
<td>G9087</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive with current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project)</td>
<td>Onc dx colon metas evid dx</td>
</tr>
<tr class="even">
<td>G9088</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive without current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project)</td>
<td>Onc dx colon metas noevid dx</td>
</tr>
<tr class="odd">
<td>G9089</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc dx colon extent unknown</td>
</tr>
<tr class="even">
<td>G9090</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-2, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx rectal t1-2 no progr</td>
</tr>
<tr class="odd">
<td>G9091</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t3, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx rectal t3 n0 no prog</td>
</tr>
<tr class="even">
<td>G9092</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx rectal t1-3,n1-2noprg</td>
</tr>
<tr class="odd">
<td>G9093</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx rectal t4,n,m0 no prg</td>
</tr>
<tr class="even">
<td>G9094</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)</td>
<td>Onc dx rectal m1 w/mets prog</td>
</tr>
<tr class="odd">
<td>G9095</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc dx rectal extent unknwn</td>
</tr>
<tr class="even">
<td>G9096</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t1-t3, n0-n1 or nx (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx esophag t1-t3 noprog</td>
</tr>
<tr class="odd">
<td>G9097</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx esophageal t4 no prog</td>
</tr>
<tr class="even">
<td>G9098</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)</td>
<td>Onc dx esophageal mets recur</td>
</tr>
<tr class="odd">
<td>G9099</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc dx esophageal unknown</td>
</tr>
<tr class="even">
<td>G9100</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r0 resection (with or without neoadjuvant therapy) with no evidence of disease recurrence, progression, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx gastric no recurrence</td>
</tr>
<tr class="odd">
<td>G9101</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r1 or r2 resection (with or without neoadjuvant therapy) with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx gastric p r1-r2noprog</td>
</tr>
<tr class="even">
<td>G9102</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m0, unresectable with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx gastric unresectable</td>
</tr>
<tr class="odd">
<td>G9103</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)</td>
<td>Onc dx gastric recurrent</td>
</tr>
<tr class="even">
<td>G9104</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc dx gastric unknown nos</td>
</tr>
<tr class="odd">
<td>G9105</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; pancreatic cancer, limited to adenocarcinoma as predominant cell type; post r0 resection without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx pancreatc p r0 res no</td>
</tr>
<tr class="even">
<td>G9106</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; post r1 or r2 resection with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx pancreatc p r1/r2 no</td>
</tr>
<tr class="odd">
<td>G9107</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; unresectable at diagnosis, m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)</td>
<td>Onc dx pancreatic unresectab</td>
</tr>
<tr class="even">
<td>G9108</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc dx pancreatic unknwn nos</td>
</tr>
<tr class="odd">
<td>G9109</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t1-t2 and n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx head/neck t1-t2no prg</td>
</tr>
<tr class="even">
<td>G9110</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t3-4 and/or n1-3, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx head/neck t3-4 noprog</td>
</tr>
<tr class="odd">
<td>G9111</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)</td>
<td>Onc dx head/neck m1 mets rec</td>
</tr>
<tr class="even">
<td>G9112</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc dx head/neck ext unknown</td>
</tr>
<tr class="odd">
<td>G9113</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 1) without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx ovarian stg1a-b no pr</td>
</tr>
<tr class="even">
<td>G9114</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 2-3); or stage ic (all grades); or stage ii; without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx ovarian stg1a-b or 2</td>
</tr>
<tr class="odd">
<td>G9115</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage iii-iv; without evidence of progression, recurrence, or metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx ovarian stg3/4 noprog</td>
</tr>
<tr class="even">
<td>G9116</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; ovarian cancer, limited to epithelial cancer; evidence of disease progression, or recurrence, and/or platinum resistance (for use in a medicare-approved demonstration project)</td>
<td>Onc dx ovarian recurrence</td>
</tr>
<tr class="odd">
<td>G9117</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; ovarian cancer, limited to epithelial cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc dx ovarian unknown nos</td>
</tr>
<tr class="even">
<td>G9123</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; chronic phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)</td>
<td>Onc dx cml chronic phase</td>
</tr>
<tr class="odd">
<td>G9124</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; accelerated phase not in hematologic cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)</td>
<td>Onc dx cml acceler phase</td>
</tr>
<tr class="even">
<td>G9125</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; blast phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)</td>
<td>Onc dx cml blast phase</td>
</tr>
<tr class="odd">
<td>G9126</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)</td>
<td>Onc dx cml remission</td>
</tr>
<tr class="even">
<td>G9128</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; limited to multiple myeloma, systemic disease; smoldering, stage i (for use in a medicare-approved demonstration project)</td>
<td>Onc dx multi myeloma stage i</td>
</tr>
<tr class="odd">
<td>G9129</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; limited to multiple myeloma, systemic disease; stage ii or higher (for use in a medicare-approved demonstration project)</td>
<td>Onc dx mult myeloma stg2 hig</td>
</tr>
<tr class="even">
<td>G9130</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; limited to multiple myeloma, systemic disease; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc dx multi myeloma unknown</td>
</tr>
<tr class="odd">
<td>G9131</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc dx brst unknown nos</td>
</tr>
<tr class="even">
<td>G9132</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)</td>
<td>Onc dx prostate mets no cast</td>
</tr>
<tr class="odd">
<td>G9133</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project)</td>
<td>Onc dx prostate clinical met</td>
</tr>
<tr class="even">
<td>G9134</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; non-hodgkin’s lymphoma, any cellular classification; stage i, ii at diagnosis, not relapsed, not refractory (for use in a medicare-approved demonstration project)</td>
<td>Onc nhlstg 1-2 no relap no</td>
</tr>
<tr class="odd">
<td>G9135</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; non-hodgkin’s lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project)</td>
<td>Onc dx nhl stg 3-4 not relap</td>
</tr>
<tr class="even">
<td>G9136</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; non-hodgkin’s lymphoma, transformed from original cellular diagnosis to a second cellular classification (for use in a medicare-approved demonstration project)</td>
<td>Onc dx nhl trans to lg bcell</td>
</tr>
<tr class="odd">
<td>G9137</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; non-hodgkin’s lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project)</td>
<td>Onc dx nhl relapse/refractor</td>
</tr>
<tr class="even">
<td>G9138</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; non-hodgkin’s lymphoma, any cellular classification; diagnostic evaluation, stage not determined, evaluation of possible relapse or non-response to therapy, or not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc dx nhl stg unknown</td>
</tr>
<tr class="odd">
<td>G9139</td>
<td>0010</td>
<td>3</td>
<td>Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; extent of disease unknown, staging in progress, not listed (for use in a medicare-approved demonstration project)</td>
<td>Onc dx cml dx status unknown</td>
</tr>
<tr class="even">
<td>G9140</td>
<td>0010</td>
<td>3</td>
<td>Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours, except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours, after the first 4 hours</td>
<td>Frontier extended stay demo</td>
</tr>
<tr class="odd">
<td>G9143</td>
<td>0010</td>
<td>3</td>
<td>Warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)</td>
<td>Warfarin respon genetic test</td>
</tr>
<tr class="even">
<td>G9147</td>
<td>0010</td>
<td>3</td>
<td>Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potassium concentration</td>
<td>Outpt iv insulin tx any mea</td>
</tr>
<tr class="odd">
<td>G9148</td>
<td>0010</td>
<td>3</td>
<td>National committee for quality assurance - level 1 medical home</td>
<td>Medical home level 1</td>
</tr>
<tr class="even">
<td>G9149</td>
<td>0010</td>
<td>3</td>
<td>National committee for quality assurance - level 2 medical home</td>
<td>Medical home level ii</td>
</tr>
<tr class="odd">
<td>G9150</td>
<td>0010</td>
<td>3</td>
<td>National committee for quality assurance - level 3 medical home</td>
<td>Medical home level iii</td>
</tr>
<tr class="even">
<td>G9151</td>
<td>0010</td>
<td>3</td>
<td>Mapcp demonstration - state provided services</td>
<td>Mapcp demo state</td>
</tr>
<tr class="odd">
<td>G9152</td>
<td>0010</td>
<td>3</td>
<td>Mapcp demonstration - community health teams</td>
<td>Mapcp demo community</td>
</tr>
<tr class="even">
<td>G9153</td>
<td>0010</td>
<td>3</td>
<td>Mapcp demonstration - physician incentive pool</td>
<td>Mapcp demo physician</td>
</tr>
<tr class="odd">
<td>G9156</td>
<td>0010</td>
<td>3</td>
<td>Evaluation for wheelchair requiring face to face visit with physician</td>
<td>Evaluation for wheelchair</td>
</tr>
<tr class="even">
<td>G9157</td>
<td>0010</td>
<td>3</td>
<td>Transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes</td>
<td>Transesoph doppl cardiac mon</td>
</tr>
<tr class="odd">
<td>G9158</td>
<td>0010</td>
<td>3</td>
<td>Motor speech functional limitation, discharge status, at discharge from therapy or to end reporting</td>
<td>Motor speech d/c status</td>
</tr>
<tr class="even">
<td>G9159</td>
<td>0010</td>
<td>3</td>
<td>Spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals</td>
<td>Lang comp current status</td>
</tr>
<tr class="odd">
<td>G9160</td>
<td>0010</td>
<td>3</td>
<td>Spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting</td>
<td>Lang comp goal status</td>
</tr>
<tr class="even">
<td>G9161</td>
<td>0010</td>
<td>3</td>
<td>Spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting</td>
<td>Lang comp d/c status</td>
</tr>
<tr class="odd">
<td>G9162</td>
<td>0010</td>
<td>3</td>
<td>Spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals</td>
<td>Lang express current status</td>
</tr>
<tr class="even">
<td>G9163</td>
<td>0010</td>
<td>3</td>
<td>Spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting</td>
<td>Lang express goal status</td>
</tr>
<tr class="odd">
<td>G9164</td>
<td>0010</td>
<td>3</td>
<td>Spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting</td>
<td>Lang express d/c status</td>
</tr>
<tr class="even">
<td>G9165</td>
<td>0010</td>
<td>3</td>
<td>Attention functional limitation, current status at therapy episode outset and at reporting intervals</td>
<td>Atten current status</td>
</tr>
<tr class="odd">
<td>G9166</td>
<td>0010</td>
<td>3</td>
<td>Attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting</td>
<td>Atten goal status</td>
</tr>
<tr class="even">
<td>G9167</td>
<td>0010</td>
<td>3</td>
<td>Attention functional limitation, discharge status at discharge from therapy or to end reporting</td>
<td>Atten d/c status</td>
</tr>
<tr class="odd">
<td>G9168</td>
<td>0010</td>
<td>3</td>
<td>Memory functional limitation, current status at therapy episode outset and at reporting intervals</td>
<td>Memory current status</td>
</tr>
<tr class="even">
<td>G9169</td>
<td>0010</td>
<td>3</td>
<td>Memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting</td>
<td>Memory goal status</td>
</tr>
<tr class="odd">
<td>G9170</td>
<td>0010</td>
<td>3</td>
<td>Memory functional limitation, discharge status at discharge from therapy or to end reporting</td>
<td>Memory d/c status</td>
</tr>
<tr class="even">
<td>G9171</td>
<td>0010</td>
<td>3</td>
<td>Voice functional limitation, current status at therapy episode outset and at reporting intervals</td>
<td>Voice current status</td>
</tr>
<tr class="odd">
<td>G9172</td>
<td>0010</td>
<td>3</td>
<td>Voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting</td>
<td>Voice goal status</td>
</tr>
<tr class="even">
<td>G9173</td>
<td>0010</td>
<td>3</td>
<td>Voice functional limitation, discharge status at discharge from therapy or to end reporting</td>
<td>Voice d/c status</td>
</tr>
<tr class="odd">
<td>G9174</td>
<td>0010</td>
<td>3</td>
<td>Other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals</td>
<td>Speech lang current status</td>
</tr>
<tr class="even">
<td>G9175</td>
<td>0010</td>
<td>3</td>
<td>Other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting</td>
<td>Speech lang goal status</td>
</tr>
<tr class="odd">
<td>G9176</td>
<td>0010</td>
<td>3</td>
<td>Other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting</td>
<td>Speech lang d/c status</td>
</tr>
<tr class="even">
<td>G9186</td>
<td>0010</td>
<td>3</td>
<td>Motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting</td>
<td>Motor speech goal status</td>
</tr>
<tr class="odd">
<td>G9187</td>
<td>0010</td>
<td>3</td>
<td>Bundled payments for care improvement initiative home visit for patient assessment performed by a qualified health care professional for individuals not considered homebound including, but not limited to, assessment of safety, falls, clinical status, fluid status, medication reconciliation/management, patient compliance with orders/plan of care, performance of activities of daily living, appropriateness of care setting; (for use only in the meidcare-approved bundled payments for care improvement initiative); may not be billed for a 30-day period covered by a transitional care management code</td>
<td>Bpci home visit</td>
</tr>
<tr class="even">
<td>G9188</td>
<td>0010</td>
<td>3</td>
<td>Beta-blocker therapy not prescribed, reason not given</td>
<td>Beta not given no reason</td>
</tr>
<tr class="odd">
<td>G9189</td>
<td>0010</td>
<td>3</td>
<td>Beta-blocker therapy prescribed or currently being taken</td>
<td>Beta pres or already taking</td>
</tr>
<tr class="even">
<td>G9190</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)</td>
<td>Medical reason for no beta</td>
</tr>
<tr class="odd">
<td>G9191</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)</td>
<td>Pt reason for no beta</td>
</tr>
<tr class="even">
<td>G9192</td>
<td>0010</td>
<td>3</td>
<td>Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)</td>
<td>System reason for no beta</td>
</tr>
<tr class="odd">
<td>G9193</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression</td>
<td>Doc not eligible for dep med</td>
</tr>
<tr class="even">
<td>G9194</td>
<td>0010</td>
<td>3</td>
<td>Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase</td>
<td>Mdd pt treated for 180d</td>
</tr>
<tr class="odd">
<td>G9195</td>
<td>0010</td>
<td>3</td>
<td>Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase</td>
<td>Mdd pt not treated for 180d</td>
</tr>
<tr class="even">
<td>G9196</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not ordering a first or second generation cephalosporin for antimicrobial prophylaxis (e.g., patients enrolled in clinical trials, patients with documented infection prior to surgical procedure of interest, patients who were receiving antibiotics more than 24 hours prior to surgery [except colon surgery patients taking oral prophylactic antibiotics], patients who were receiving antibiotics within 24 hours prior to arrival [except colon surgery patients taking oral prophylactic antibiotics], other medical reason(s))</td>
<td>Med reason for no ceph</td>
</tr>
<tr class="odd">
<td>G9197</td>
<td>0010</td>
<td>3</td>
<td>Documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis</td>
<td>Order for ceph</td>
</tr>
<tr class="even">
<td>G9198</td>
<td>0010</td>
<td>3</td>
<td>Order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given</td>
<td>No order for ceph no reason</td>
</tr>
<tr class="odd">
<td>G9199</td>
<td>0010</td>
<td>3</td>
<td>Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during inpatient stay, patient already on warfarin or another anticoagulant, other medical reason(s) or eg, patient left against medical advice, other patient reason(s))</td>
<td>Doc reason for no vte</td>
</tr>
<tr class="even">
<td>G9200</td>
<td>0010</td>
<td>3</td>
<td>Venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given</td>
<td>No reason for no vte</td>
</tr>
<tr class="odd">
<td>G9201</td>
<td>0010</td>
<td>3</td>
<td>Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission</td>
<td>Vte given upon admission</td>
</tr>
<tr class="even">
<td>G9202</td>
<td>0010</td>
<td>3</td>
<td>Patients with a positive hepatitis c antibody test</td>
<td>Hep c aby pos</td>
</tr>
<tr class="odd">
<td>G9203</td>
<td>0010</td>
<td>3</td>
<td>Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c</td>
<td>Hep c rna done prior to med</td>
</tr>
<tr class="even">
<td>G9204</td>
<td>0010</td>
<td>3</td>
<td>Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given</td>
<td>No reason for no hep c rna</td>
</tr>
<tr class="odd">
<td>G9205</td>
<td>0010</td>
<td>3</td>
<td>Patient starting antiviral treatmentfor hepatitis c during the measurement period</td>
<td>Hep c antiviral started</td>
</tr>
<tr class="even">
<td>G9206</td>
<td>0010</td>
<td>3</td>
<td>Patient starting antiviral treatment for hepatitis c during the measurement period</td>
<td>Hep c therapy started</td>
</tr>
<tr class="odd">
<td>G9207</td>
<td>0010</td>
<td>3</td>
<td>Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c</td>
<td>Hep c genotype prior to med</td>
</tr>
<tr class="even">
<td>G9208</td>
<td>0010</td>
<td>3</td>
<td>Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given</td>
<td>No reason for no hep c geno</td>
</tr>
<tr class="odd">
<td>G9209</td>
<td>0010</td>
<td>3</td>
<td>Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment</td>
<td>Hep c rna 4to12 wk after med</td>
</tr>
<tr class="even">
<td>G9210</td>
<td>0010</td>
<td>3</td>
<td>Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)</td>
<td>No hepc rna after med docrsn</td>
</tr>
<tr class="odd">
<td>G9211</td>
<td>0010</td>
<td>3</td>
<td>Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given</td>
<td>No hepc rna after med no rsn</td>
</tr>
<tr class="even">
<td>G9212</td>
<td>0010</td>
<td>3</td>
<td>Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation</td>
<td>Doc of dsm-iv init eval</td>
</tr>
<tr class="odd">
<td>G9213</td>
<td>0010</td>
<td>3</td>
<td>Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified</td>
<td>No doc of dsm-iv</td>
</tr>
<tr class="even">
<td>G9214</td>
<td>0010</td>
<td>3</td>
<td>Cd4+ cell count or cd4+ cell percentage results documented</td>
<td>Cd4 count documented</td>
</tr>
<tr class="odd">
<td>G9215</td>
<td>0010</td>
<td>3</td>
<td>Cd4+ cell count or percentage not documented as performed, reason not given</td>
<td>No cd4 count no reason</td>
</tr>
<tr class="even">
<td>G9216</td>
<td>0010</td>
<td>3</td>
<td>Pcp prophylaxis was not prescribed at time of diagnosis of hiv, reason not given</td>
<td>No pcp proph at dx no reason</td>
</tr>
<tr class="odd">
<td>G9217</td>
<td>0010</td>
<td>3</td>
<td>Pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given</td>
<td>No pcp proph low cd4 norsn</td>
</tr>
<tr class="even">
<td>G9218</td>
<td>0010</td>
<td>3</td>
<td>Pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given</td>
<td>No pcp prop low at cd4 norsn</td>
</tr>
<tr class="odd">
<td>G9219</td>
<td>0010</td>
<td>3</td>
<td>Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3 for medical reason (i.e., patient’s cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient’s cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)</td>
<td>No oder pjp for med reason</td>
</tr>
<tr class="even">
<td>G9220</td>
<td>0010</td>
<td>3</td>
<td>Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% for medical reason (i.e., patient’s cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient’s cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)</td>
<td>No order for pjp for medrsn</td>
</tr>
<tr class="odd">
<td>G9221</td>
<td>0010</td>
<td>3</td>
<td>Pneumocystis jiroveci pneumonia prophlaxis prescribed</td>
<td>Pjp proph prescribed</td>
</tr>
<tr class="even">
<td>G9222</td>
<td>0010</td>
<td>3</td>
<td>Pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3</td>
<td>Pjp proph ordered low cd4</td>
</tr>
<tr class="odd">
<td>G9223</td>
<td>0010</td>
<td>3</td>
<td>Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%</td>
<td>Pjp proph ordered cd4 low</td>
</tr>
<tr class="even">
<td>G9224</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation)</td>
<td>Medrsn no foot exam</td>
</tr>
<tr class="odd">
<td>G9225</td>
<td>0010</td>
<td>3</td>
<td>Foot exam was not performed, reason not given</td>
<td>Norsn no foot exam</td>
</tr>
<tr class="even">
<td>G9226</td>
<td>0010</td>
<td>3</td>
<td>Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed)</td>
<td>3 comp foot exam completed</td>
</tr>
<tr class="odd">
<td>G9227</td>
<td>0010</td>
<td>3</td>
<td>Functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan at the time of the encounter</td>
<td>Foa doc, care plan not doc</td>
</tr>
<tr class="even">
<td>G9228</td>
<td>0010</td>
<td>3</td>
<td>Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)</td>
<td>Gc chl syp documented</td>
</tr>
<tr class="odd">
<td>G9229</td>
<td>0010</td>
<td>3</td>
<td>Chlamydia, gonorrhea, and syphilis screening results not documented (patient refusal is the only allowed exception)</td>
<td>Ptrsn no gc chl syp test</td>
</tr>
<tr class="even">
<td>G9230</td>
<td>0010</td>
<td>3</td>
<td>Chlamydia, gonorrhea, and syphilis not screened, reason not given</td>
<td>Norsn for gc chl syp test</td>
</tr>
<tr class="odd">
<td>G9231</td>
<td>0010</td>
<td>3</td>
<td>Documentation of end stage renal disease (esrd), dialysis, renal transplant before or during the measurement period or pregnancy during the measurement period</td>
<td>Doc esrd dia trans preg</td>
</tr>
<tr class="even">
<td>G9232</td>
<td>0010</td>
<td>3</td>
<td>Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason (e.g., patient is unable to communicate the diagnosis of a comorbid condition; the patient is unwilling to communicate the diagnosis of a comorbid condition; or the patient is unaware of the comorbid condition, or any other specified patient reason)</td>
<td>Ptrsn no comm comorbid</td>
</tr>
<tr class="odd">
<td>G9233</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient</td>
<td>Tkr composite</td>
</tr>
<tr class="even">
<td>G9234</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the total knee replacement measures group</td>
<td>Tkr intent</td>
</tr>
<tr class="odd">
<td>G9235</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the general surgery measures group have been performed for this patient</td>
<td>Gs mg composite</td>
</tr>
<tr class="even">
<td>G9236</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient</td>
<td>Op rad mg composite</td>
</tr>
<tr class="odd">
<td>G9237</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the general surgery measures group</td>
<td>Gs mg intent</td>
</tr>
<tr class="even">
<td>G9238</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the optimizing patient exposure to ionizing radiation measures group</td>
<td>Op rad mg intent</td>
</tr>
<tr class="odd">
<td>G9239</td>
<td>0010</td>
<td>3</td>
<td>Documentation of reasons for patient initiating maintenance hemodialysis with a catheter as the mode of vascular access (e.g., patient has a maturing arteriovenous fistula (avf)/arteriovenous graft (avg), time-limited trial of hemodialysis, other medical reasons, patient declined avf/avg, other patient reasons, patient followed by reporting nephrologist for fewer than 90 days, other system reasons)</td>
<td>Doc rsn hemod &amp; cath acc</td>
</tr>
<tr class="even">
<td>G9240</td>
<td>0010</td>
<td>3</td>
<td>Patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated</td>
<td>Doc pt w cath maint dia</td>
</tr>
<tr class="odd">
<td>G9241</td>
<td>0010</td>
<td>3</td>
<td>Patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated</td>
<td>Doc pt w out cath maint dia</td>
</tr>
<tr class="even">
<td>G9242</td>
<td>0010</td>
<td>3</td>
<td>Documentation of viral load equal to or greater than 200 copies/ml or viral load not performed</td>
<td>Doc viral load &gt;=200</td>
</tr>
<tr class="odd">
<td>G9243</td>
<td>0010</td>
<td>3</td>
<td>Documentation of viral load less than 200 copies/ml</td>
<td>Doc viral load &lt;200</td>
</tr>
<tr class="even">
<td>G9244</td>
<td>0010</td>
<td>3</td>
<td>Antiretroviral thereapy not prescribed</td>
<td>Antiviral not ordered</td>
</tr>
<tr class="odd">
<td>G9245</td>
<td>0010</td>
<td>3</td>
<td>Antiretroviral therapy prescribed</td>
<td>Antiviral ordered</td>
</tr>
<tr class="even">
<td>G9246</td>
<td>0010</td>
<td>3</td>
<td>Patient did not have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits</td>
<td>No med visit in 24mo</td>
</tr>
<tr class="odd">
<td>G9247</td>
<td>0010</td>
<td>3</td>
<td>Patient had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits</td>
<td>1 med visit in 24mo</td>
</tr>
<tr class="even">
<td>G9248</td>
<td>0010</td>
<td>3</td>
<td>Patient did not have a medical visit in the last 6 months</td>
<td>No med visit 6mo</td>
</tr>
<tr class="odd">
<td>G9249</td>
<td>0010</td>
<td>3</td>
<td>Patient had a medical visit in the last 6 months</td>
<td>Med visit w in 6mo</td>
</tr>
<tr class="even">
<td>G9250</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient pain brought to a comfortable level within 48 hours from initial assessment</td>
<td>Doc of pain comfort 48hr</td>
</tr>
<tr class="odd">
<td>G9251</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment</td>
<td>Doc no pain comfort 48hr</td>
</tr>
<tr class="even">
<td>G9252</td>
<td>0010</td>
<td>3</td>
<td>Adenoma(s) or other neoplasm detected during screening colonoscopy</td>
<td>Neo detect scrn colo</td>
</tr>
<tr class="odd">
<td>G9253</td>
<td>0010</td>
<td>3</td>
<td>Adenoma(s) or other neoplasm not detected during screening colonoscopy</td>
<td>No neo detect scrn colo</td>
</tr>
<tr class="even">
<td>G9254</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient discharged to home later than post-operative day 2 following cas</td>
<td>Doc pt dischg &gt;2d</td>
</tr>
<tr class="odd">
<td>G9255</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient discharged to home no later than post operative day 2 following cas</td>
<td>Doc pt dischg &lt;=2d</td>
</tr>
<tr class="even">
<td>G9256</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient death following cas</td>
<td>Doc of pat death after cas</td>
</tr>
<tr class="odd">
<td>G9257</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient stroke following cas</td>
<td>Doc of pat stroke after cas</td>
</tr>
<tr class="even">
<td>G9258</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient stroke following cea</td>
<td>Doc of pat stroke after cea</td>
</tr>
<tr class="odd">
<td>G9259</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient survival and absence of stroke following cas</td>
<td>Survive/no stroke post cas</td>
</tr>
<tr class="even">
<td>G9260</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient death following cea</td>
<td>Doc of pat death after cea</td>
</tr>
<tr class="odd">
<td>G9261</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient survival and absence of stroke following cea</td>
<td>Survive/no stroke post cea</td>
</tr>
<tr class="even">
<td>G9262</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient death in the hospital following endovascular aaa repair</td>
<td>Doc of death post-aaa repair</td>
</tr>
<tr class="odd">
<td>G9263</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient discharged alive following endovascular aaa repair</td>
<td>Doc of disch post-aaa repair</td>
</tr>
<tr class="even">
<td>G9264</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter for documented reasons (e.g., other medical reasons, patient declined arteriovenous fistula (avf)/arteriovenous graft (avg), other patient reasons)</td>
<td>Doc rsn hemod w/cath &gt;=90d</td>
</tr>
<tr class="odd">
<td>G9265</td>
<td>0010</td>
<td>3</td>
<td>Patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access</td>
<td>Doc cath &gt;90d for maint dia</td>
</tr>
<tr class="even">
<td>G9266</td>
<td>0010</td>
<td>3</td>
<td>Patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access</td>
<td>Norsn pt cath &gt;=90d</td>
</tr>
<tr class="odd">
<td>G9267</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient with one or more complications or mortality within 30 days</td>
<td>Doc comp or mort w in 30d</td>
</tr>
<tr class="even">
<td>G9268</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient with one or more complications within 90 days</td>
<td>Doc comp or mort w in 90d</td>
</tr>
<tr class="odd">
<td>G9269</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient without one or more complications and without mortality within 30 days</td>
<td>Doc no comp or mort w in 30d</td>
</tr>
<tr class="even">
<td>G9270</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient without one or more complications within 90 days</td>
<td>Doc no comp or mort w in 90d</td>
</tr>
<tr class="odd">
<td>G9271</td>
<td>0010</td>
<td>3</td>
<td>Ldl value &lt; 100</td>
<td>Ldl under 100</td>
</tr>
<tr class="even">
<td>G9272</td>
<td>0010</td>
<td>3</td>
<td>Ldl value &gt;= 100</td>
<td>Ldl 100 and over</td>
</tr>
<tr class="odd">
<td>G9273</td>
<td>0010</td>
<td>3</td>
<td>Blood pressure has a systolic value of &lt; 140 and a diastolic value of &lt; 90</td>
<td>Sys&lt;140 and dia&lt;90</td>
</tr>
<tr class="even">
<td>G9274</td>
<td>0010</td>
<td>3</td>
<td>Blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value &lt; 140 and diastolic value = 90 or systolic value = 140 and diastolic value &lt; 90</td>
<td>Bp out of nrml limits</td>
</tr>
<tr class="odd">
<td>G9275</td>
<td>0010</td>
<td>3</td>
<td>Documentation that patient is a current non-tobacco user</td>
<td>Doc of non tobacco user</td>
</tr>
<tr class="even">
<td>G9276</td>
<td>0010</td>
<td>3</td>
<td>Documentation that patient is a current tobacco user</td>
<td>Doc of tobacco user</td>
</tr>
<tr class="odd">
<td>G9277</td>
<td>0010</td>
<td>3</td>
<td>Documentation that the patient is on daily aspirin or anti-platelet or has documentation of a valid contraindication or exception to aspirin/anti-platelet; contraindications/exceptions include anti-coagulant use, allergy to aspirin or anti-platelets, history of gastrointestinal bleed and bleeding disorder; additionally, the following exceptions documented by the physician as a reason for not taking daily aspirin or anti-platelet are acceptable (use of non-steroidal anti-inflammatory agents, documented risk for drug interaction, uncontrolled hypertension defined as &gt;180 systolic or &gt;110 diastolic or gastroesophageal reflux)</td>
<td>Doc daily aspirin or contra</td>
</tr>
<tr class="even">
<td>G9278</td>
<td>0010</td>
<td>3</td>
<td>Documentation that the patient is not on daily aspirin or anti-platelet regimen</td>
<td>Doc no daily aspirin</td>
</tr>
<tr class="odd">
<td>G9279</td>
<td>0010</td>
<td>3</td>
<td>Pneumococcal screening performed and documentation of vaccination received prior to discharge</td>
<td>Pne scrn done doc vac done</td>
</tr>
<tr class="even">
<td>G9280</td>
<td>0010</td>
<td>3</td>
<td>Pneumococcal vaccination not administered prior to discharge, reason not specified</td>
<td>Pne not given norsn</td>
</tr>
<tr class="odd">
<td>G9281</td>
<td>0010</td>
<td>3</td>
<td>Screening performed and documentation that vaccination not indicated/patient refusal</td>
<td>Pne scrn done doc not ind</td>
</tr>
<tr class="even">
<td>G9282</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reasons)</td>
<td>Doc medrsn no histo type</td>
</tr>
<tr class="odd">
<td>G9283</td>
<td>0010</td>
<td>3</td>
<td>Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation</td>
<td>Hist type doc on report</td>
</tr>
<tr class="even">
<td>G9284</td>
<td>0010</td>
<td>3</td>
<td>Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation</td>
<td>No hist type doc on report</td>
</tr>
<tr class="odd">
<td>G9285</td>
<td>0010</td>
<td>3</td>
<td>Specimen site other than anatomic location of lung or is not classified as non small cell lung cancer</td>
<td>Site not small cell lung ca</td>
</tr>
<tr class="even">
<td>G9286</td>
<td>0010</td>
<td>3</td>
<td>Antibiotic regimen prescribed within 10 days after onset of symptoms</td>
<td>Antibio rx w in 10d of sympt</td>
</tr>
<tr class="odd">
<td>G9287</td>
<td>0010</td>
<td>3</td>
<td>Antibiotic regimen not prescribed within 10 days after onset of symptoms</td>
<td>No antibio w in 10d of sympt</td>
</tr>
<tr class="even">
<td>G9288</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons)</td>
<td>Doc medrsn no hist type rpt</td>
</tr>
<tr class="odd">
<td>G9289</td>
<td>0010</td>
<td>3</td>
<td>Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation</td>
<td>Doc type nsm lung ca</td>
</tr>
<tr class="even">
<td>G9290</td>
<td>0010</td>
<td>3</td>
<td>Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation</td>
<td>No doc type nsm lung ca</td>
</tr>
<tr class="odd">
<td>G9291</td>
<td>0010</td>
<td>3</td>
<td>Specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos</td>
<td>Not nsm lung ca</td>
</tr>
<tr class="even">
<td>G9292</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)</td>
<td>Medrsn no pt category</td>
</tr>
<tr class="odd">
<td>G9293</td>
<td>0010</td>
<td>3</td>
<td>Pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate</td>
<td>No pt category on report</td>
</tr>
<tr class="even">
<td>G9294</td>
<td>0010</td>
<td>3</td>
<td>Pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate</td>
<td>Pt cat and thck on report</td>
</tr>
<tr class="odd">
<td>G9295</td>
<td>0010</td>
<td>3</td>
<td>Specimen site other than anatomic cutaneous location</td>
<td>Non cutaneous loc</td>
</tr>
<tr class="even">
<td>G9296</td>
<td>0010</td>
<td>3</td>
<td>Patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure</td>
<td>Doc share dec prior proc</td>
</tr>
<tr class="odd">
<td>G9297</td>
<td>0010</td>
<td>3</td>
<td>Shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given</td>
<td>No doc share dec prior proc</td>
</tr>
<tr class="even">
<td>G9298</td>
<td>0010</td>
<td>3</td>
<td>Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke)</td>
<td>Eval risk vte card 30d prior</td>
</tr>
<tr class="odd">
<td>G9299</td>
<td>0010</td>
<td>3</td>
<td>Patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure including (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)</td>
<td>No eval riskk vte card prior</td>
</tr>
<tr class="even">
<td>G9300</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)</td>
<td>Doc medrsn no compl antibio</td>
</tr>
<tr class="odd">
<td>G9301</td>
<td>0010</td>
<td>3</td>
<td>Patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet</td>
<td>Doc compl inf antibio</td>
</tr>
<tr class="even">
<td>G9302</td>
<td>0010</td>
<td>3</td>
<td>Prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given</td>
<td>Norsn incomp inf antibio</td>
</tr>
<tr class="odd">
<td>G9303</td>
<td>0010</td>
<td>3</td>
<td>Operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not given</td>
<td>Norsn no pros info op rpt</td>
</tr>
<tr class="even">
<td>G9304</td>
<td>0010</td>
<td>3</td>
<td>Operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant</td>
<td>Pros info op rpt</td>
</tr>
<tr class="odd">
<td>G9305</td>
<td>0010</td>
<td>3</td>
<td>Intervention for presence of leak of endoluminal contents through an anastomosis not required</td>
<td>No interv req for leak</td>
</tr>
<tr class="even">
<td>G9306</td>
<td>0010</td>
<td>3</td>
<td>Intervention for presence of leak of endoluminal contents through an anastomosis required</td>
<td>Interv req for leak</td>
</tr>
<tr class="odd">
<td>G9307</td>
<td>0010</td>
<td>3</td>
<td>No return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure</td>
<td>No ret for surg w in 30d</td>
</tr>
<tr class="even">
<td>G9308</td>
<td>0010</td>
<td>3</td>
<td>Unplanned return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure</td>
<td>Unpl ret or w/compl w/in 30d</td>
</tr>
<tr class="odd">
<td>G9309</td>
<td>0010</td>
<td>3</td>
<td>No unplanned hospital readmission within 30 days of principal procedure</td>
<td>No unplnd hosp readm in 30d</td>
</tr>
<tr class="even">
<td>G9310</td>
<td>0010</td>
<td>3</td>
<td>Unplanned hospital readmission within 30 days of principal procedure</td>
<td>Unplnd hosp readm in 30d</td>
</tr>
<tr class="odd">
<td>G9311</td>
<td>0010</td>
<td>3</td>
<td>No surgical site infection</td>
<td>No surg site infection</td>
</tr>
<tr class="even">
<td>G9312</td>
<td>0010</td>
<td>3</td>
<td>Surgical site infection</td>
<td>Surgical site infection</td>
</tr>
<tr class="odd">
<td>G9313</td>
<td>0010</td>
<td>3</td>
<td>Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason</td>
<td>Amoxic not presc as 1st line</td>
</tr>
<tr class="even">
<td>G9314</td>
<td>0010</td>
<td>3</td>
<td>Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given</td>
<td>Norsn not first line amox</td>
</tr>
<tr class="odd">
<td>G9315</td>
<td>0010</td>
<td>3</td>
<td>Documentation amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis</td>
<td>Doc first line amox</td>
</tr>
<tr class="even">
<td>G9316</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family</td>
<td>Doc comm risk calc</td>
</tr>
<tr class="odd">
<td>G9317</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family not completed</td>
<td>No doc comm risk calc</td>
</tr>
<tr class="even">
<td>G9318</td>
<td>0010</td>
<td>3</td>
<td>Imaging study named according to standardized nomenclature</td>
<td>Image std nomenclature</td>
</tr>
<tr class="odd">
<td>G9319</td>
<td>0010</td>
<td>3</td>
<td>Imaging study not named according to standardized nomenclature, reason not given</td>
<td>Image not std nomenclature</td>
</tr>
<tr class="even">
<td>G9320</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)</td>
<td>Medrsn no std nomenclature</td>
</tr>
<tr class="odd">
<td>G9321</td>
<td>0010</td>
<td>3</td>
<td>Count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion) studies documented in the 12-month period prior to the current study</td>
<td>Doc count of ct in 12mo</td>
</tr>
<tr class="even">
<td>G9322</td>
<td>0010</td>
<td>3</td>
<td>Count of previous ct and cardiac nuclear medicine (myocardial perfusion) studies not documented in the 12-month period prior to the current study, reason not given</td>
<td>No doc count of ct in 12mo</td>
</tr>
<tr class="odd">
<td>G9323</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)</td>
<td>Mdrsn no doc cnt of ct</td>
</tr>
<tr class="even">
<td>G9324</td>
<td>0010</td>
<td>3</td>
<td>All necessary data elements not included, reason not given</td>
<td>Not all data norsn</td>
</tr>
<tr class="odd">
<td>G9325</td>
<td>0010</td>
<td>3</td>
<td>Ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)</td>
<td>Medrsn no ct rpt to reg</td>
</tr>
<tr class="even">
<td>G9326</td>
<td>0010</td>
<td>3</td>
<td>Ct studies performed not reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements, reason not given</td>
<td>Ct done no rad ds index, nrg</td>
</tr>
<tr class="odd">
<td>G9327</td>
<td>0010</td>
<td>3</td>
<td>Ct studies performed reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements</td>
<td>Ct done rad ds index</td>
</tr>
<tr class="even">
<td>G9328</td>
<td>0010</td>
<td>3</td>
<td>Dicom format image data availability not documented in final report due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)</td>
<td>Medrsn no dicom format doc</td>
</tr>
<tr class="odd">
<td>G9329</td>
<td>0010</td>
<td>3</td>
<td>Dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study not documented in final report, reason not given</td>
<td>Norsn no dicom format doc</td>
</tr>
<tr class="even">
<td>G9340</td>
<td>0010</td>
<td>3</td>
<td>Final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study</td>
<td>Dicom format doc on rpt</td>
</tr>
<tr class="odd">
<td>G9341</td>
<td>0010</td>
<td>3</td>
<td>Search conducted for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive prior to an imaging study being performed</td>
<td>Srch for ct w in 12 mos</td>
</tr>
<tr class="even">
<td>G9342</td>
<td>0010</td>
<td>3</td>
<td>Search not conducted prior to an imaging study being performed for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive, reason not given</td>
<td>No srch for ct in 12mo norsn</td>
</tr>
<tr class="odd">
<td>G9343</td>
<td>0010</td>
<td>3</td>
<td>Due to medical reasons, search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)</td>
<td>Medrsn no dicom srch</td>
</tr>
<tr class="even">
<td>G9344</td>
<td>0010</td>
<td>3</td>
<td>Due to system reasons search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., non-affiliated external healthcare facilities or entities does not have archival abilities through a shared archival system)</td>
<td>Sysrsn no dicom srch</td>
</tr>
<tr class="odd">
<td>G9345</td>
<td>0010</td>
<td>3</td>
<td>Follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules (e.g., follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors</td>
<td>Follow up pulm nod</td>
</tr>
<tr class="even">
<td>G9346</td>
<td>0010</td>
<td>3</td>
<td>Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules due to medical reasons (e.g., patients with known malignant disease, patients with unexplained fever, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)</td>
<td>No follow up pulm nod</td>
</tr>
<tr class="odd">
<td>G9347</td>
<td>0010</td>
<td>3</td>
<td>Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given</td>
<td>No follow up pulm nod norsn</td>
</tr>
<tr class="even">
<td>G9348</td>
<td>0010</td>
<td>3</td>
<td>Ct scan of the paranasal sinuses ordered at the time of diagnosis for documented reasons</td>
<td>Doc rsn for ord ct scan</td>
</tr>
<tr class="odd">
<td>G9349</td>
<td>0010</td>
<td>3</td>
<td>Ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis</td>
<td>Ct within 28 days</td>
</tr>
<tr class="even">
<td>G9350</td>
<td>0010</td>
<td>3</td>
<td>Ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis</td>
<td>No doc sinus ct 28d or dx</td>
</tr>
<tr class="odd">
<td>G9351</td>
<td>0010</td>
<td>3</td>
<td>More than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis</td>
<td>Doc &gt;1 sinus ct w 90d dx</td>
</tr>
<tr class="even">
<td>G9352</td>
<td>0010</td>
<td>3</td>
<td>More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given</td>
<td>Not &gt;1 sinus ct w 90d dx</td>
</tr>
<tr class="odd">
<td>G9353</td>
<td>0010</td>
<td>3</td>
<td>More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)</td>
<td>Medrsn &gt;1 sinus ct w 90d dx</td>
</tr>
<tr class="even">
<td>G9354</td>
<td>0010</td>
<td>3</td>
<td>One ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis</td>
<td>1 or no ct sinus w/in 90d dx</td>
</tr>
<tr class="odd">
<td>G9355</td>
<td>0010</td>
<td>3</td>
<td>Early elective delivery or early induction not performed (less than 39 weeks gestation)</td>
<td>No early ind/delivery</td>
</tr>
<tr class="even">
<td>G9356</td>
<td>0010</td>
<td>3</td>
<td>Early elective delivery or early induction performed (less than 39 week gestation)</td>
<td>Early ind/delivery</td>
</tr>
<tr class="odd">
<td>G9357</td>
<td>0010</td>
<td>3</td>
<td>Post-partum screenings, evaluations and education performed</td>
<td>Pp eval/edu perf</td>
</tr>
<tr class="even">
<td>G9358</td>
<td>0010</td>
<td>3</td>
<td>Post-partum screenings, evaluations and education not performed</td>
<td>Pp eval/edu not perf</td>
</tr>
<tr class="odd">
<td>G9359</td>
<td>0010</td>
<td>3</td>
<td>Documentation of negative or managed positive tb screen with further evidence that tb is not active prior to the treatment with a biologic immune response modifier</td>
<td>Neg mgd pos tb notact</td>
</tr>
<tr class="even">
<td>G9360</td>
<td>0010</td>
<td>3</td>
<td>No documentation of negative or managed positive tb screen</td>
<td>No doc of neg or man pos tb</td>
</tr>
<tr class="odd">
<td>G9361</td>
<td>0010</td>
<td>3</td>
<td>Medical indication for induction [documentation of reason(s) for elective delivery (c-section) or early induction (e.g., hemorrhage and placental complications, hypertension, preeclampsia and eclampsia, rupture of membranes-premature or prolonged, maternal conditions complicating pregnancy/delivery, fetal conditions complicating pregnancy/delivery, late pregnancy, prior uterine surgery, or participation in clinical trial)]</td>
<td>Doc rsn elect c-sec/induct</td>
</tr>
<tr class="even">
<td>G9362</td>
<td>0010</td>
<td>3</td>
<td>Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure 60 minutes or longer, as documented in the anesthesia record</td>
<td>Mac or pnb w/o genanes &gt;60m</td>
</tr>
<tr class="odd">
<td>G9363</td>
<td>0010</td>
<td>3</td>
<td>Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record</td>
<td>Mac or pnb w/o genanes &lt;60m</td>
</tr>
<tr class="even">
<td>G9364</td>
<td>0010</td>
<td>3</td>
<td>Sinusitis caused by, or presumed to be caused by, bacterial infection</td>
<td>Sinus caus bac inx</td>
</tr>
<tr class="odd">
<td>G9365</td>
<td>0010</td>
<td>3</td>
<td>One high-risk medication ordered</td>
<td>1high risk med ord</td>
</tr>
<tr class="even">
<td>G9366</td>
<td>0010</td>
<td>3</td>
<td>One high-risk medication not ordered</td>
<td>1high risk no ord</td>
</tr>
<tr class="odd">
<td>G9367</td>
<td>0010</td>
<td>3</td>
<td>At least two orders for the same high-risk medication</td>
<td>&gt;= 2 same hi-rsk med ord</td>
</tr>
<tr class="even">
<td>G9368</td>
<td>0010</td>
<td>3</td>
<td>At least two orders for the same high-risk medications not ordered</td>
<td>&gt;= 2 same hi-rsk med not ord</td>
</tr>
<tr class="odd">
<td>G9369</td>
<td>0010</td>
<td>3</td>
<td>Individual filled at least two prescriptions for any antipsychotic medication and had a pdc of 0.8 or greater</td>
<td>Fill 2 rx antipsych</td>
</tr>
<tr class="even">
<td>G9370</td>
<td>0010</td>
<td>3</td>
<td>Individual who did not fill at least two prescriptions for any antipsychotic medication or did not have a pdc of 0.8 or greater</td>
<td>Not fill 2 rx antipsych</td>
</tr>
<tr class="odd">
<td>G9376</td>
<td>0010</td>
<td>3</td>
<td>Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery</td>
<td>Contd ret attach at 6mth f/u</td>
</tr>
<tr class="even">
<td>G9377</td>
<td>0010</td>
<td>3</td>
<td>Patient did not have the retina attached after 6 months following only one surgery</td>
<td>No ret attach after 6mt</td>
</tr>
<tr class="odd">
<td>G9378</td>
<td>0010</td>
<td>3</td>
<td>Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month)</td>
<td>Contd ret attach f/u vis</td>
</tr>
<tr class="even">
<td>G9379</td>
<td>0010</td>
<td>3</td>
<td>Patient did not achieve flat retinas six months post surgery</td>
<td>No acheive flat ret 6mth</td>
</tr>
<tr class="odd">
<td>G9380</td>
<td>0010</td>
<td>3</td>
<td>Patient offered assistance with end of life issues during the measurement period</td>
<td>Off assis eol iss</td>
</tr>
<tr class="even">
<td>G9381</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not offering assistance with end of life issues (e.g., patient in hospice care, patient in terminal phase) during the measurement period</td>
<td>Doc med reas no offer eol</td>
</tr>
<tr class="odd">
<td>G9382</td>
<td>0010</td>
<td>3</td>
<td>Patient not offered assistance with end of life issues during the measurement period</td>
<td>No off assis eol</td>
</tr>
<tr class="even">
<td>G9383</td>
<td>0010</td>
<td>3</td>
<td>Patient received screening for hcv infection within the 12 month reporting period</td>
<td>Recd scrn hcv infec</td>
</tr>
<tr class="odd">
<td>G9384</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not receiving annual screening for hcv infection (e.g., decompensated cirrhosis indicating advanced disease [i.e., ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocellular carcinoma, waitlist for organ transplant, limited life expectancy, other medical reasons)</td>
<td>Doc med rsn no hcv scrn</td>
</tr>
<tr class="even">
<td>G9385</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)</td>
<td>Doc pt reas not rec hcv srn</td>
</tr>
<tr class="odd">
<td>G9386</td>
<td>0010</td>
<td>3</td>
<td>Screening for hcv infection not received within the 12 month reporting period, reason not given</td>
<td>Scrn hcv infec not recd</td>
</tr>
<tr class="even">
<td>G9389</td>
<td>0010</td>
<td>3</td>
<td>Unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery</td>
<td>Unpln rup post cap</td>
</tr>
<tr class="odd">
<td>G9390</td>
<td>0010</td>
<td>3</td>
<td>No unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery</td>
<td>No unpln rup post cap</td>
</tr>
<tr class="even">
<td>G9391</td>
<td>0010</td>
<td>3</td>
<td>Patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit</td>
<td>Achv refrac +1d</td>
</tr>
<tr class="odd">
<td>G9392</td>
<td>0010</td>
<td>3</td>
<td>Patient does not achieve refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit</td>
<td>Not achv refrac +1d</td>
</tr>
<tr class="even">
<td>G9393</td>
<td>0010</td>
<td>3</td>
<td>Patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five</td>
<td>Ini phq9 &gt;9 remiss &lt;5</td>
</tr>
<tr class="odd">
<td>G9394</td>
<td>0010</td>
<td>3</td>
<td>Patient who had a diagnosis of bipolar disorder or personality disorder, death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement or assessment period</td>
<td>Dx bipol, death, nhres, hosp</td>
</tr>
<tr class="even">
<td>G9395</td>
<td>0010</td>
<td>3</td>
<td>Patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five</td>
<td>Ini phq9 &gt;9 no remiss &gt;=5</td>
</tr>
<tr class="odd">
<td>G9396</td>
<td>0010</td>
<td>3</td>
<td>Patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days)</td>
<td>Ini phq9 &gt;9 not assess</td>
</tr>
<tr class="even">
<td>G9399</td>
<td>0010</td>
<td>3</td>
<td>Documentation in the patient record of a discussion between the physician/clinician and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward the outcome of the treatment</td>
<td>Doc disc tx choices</td>
</tr>
<tr class="odd">
<td>G9400</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical or patient reason(s) for not discussing treatment options; medical reasons: patient is not a candidate for treatment due to advanced physical or mental health comorbidity (including active substance use); currently receiving antiviral treatment; successful antiviral treatment (with sustained virologic response) prior to reporting period; other documented medical reasons; patient reasons: patient unable or unwilling to participate in the discussion or other patient reasons</td>
<td>Doc reas no disc tx opt</td>
</tr>
<tr class="even">
<td>G9401</td>
<td>0010</td>
<td>3</td>
<td>No documentation of a discussion in the patient record of a discussion between the physician or other qualfied healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward treatment</td>
<td>No disc tx choices</td>
</tr>
<tr class="odd">
<td>G9402</td>
<td>0010</td>
<td>3</td>
<td>Patient received follow-up on the date of discharge or within 30 days after discharge</td>
<td>Recd f/u w/in 30d disch</td>
</tr>
<tr class="even">
<td>G9403</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented reason patient was not able to complete 30 day follow-up from acute inpatient setting discharge (e.g., patient death prior to follow-up visit, patient non-compliant for visit follow-up)</td>
<td>Doc reas no 30 day f/u</td>
</tr>
<tr class="odd">
<td>G9404</td>
<td>0010</td>
<td>3</td>
<td>Patient did not receive follow-up on the date of discharge or within 30 days after discharge</td>
<td>No 30 day f/u</td>
</tr>
<tr class="even">
<td>G9405</td>
<td>0010</td>
<td>3</td>
<td>Patient received follow-up within 7 days after discharge</td>
<td>Recd f/u w/in 7d dc</td>
</tr>
<tr class="odd">
<td>G9406</td>
<td>0010</td>
<td>3</td>
<td>Clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit, patient non-compliance for visit follow-up)</td>
<td>Doc reas no 7d f/u</td>
</tr>
<tr class="even">
<td>G9407</td>
<td>0010</td>
<td>3</td>
<td>Patient did not receive follow-up on or within 7 days after discharge</td>
<td>No 7d f/u</td>
</tr>
<tr class="odd">
<td>G9408</td>
<td>0010</td>
<td>3</td>
<td>Patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days</td>
<td>Card tamp w/in 30d</td>
</tr>
<tr class="even">
<td>G9409</td>
<td>0010</td>
<td>3</td>
<td>Patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days</td>
<td>No card tamp e/in 30d</td>
</tr>
<tr class="odd">
<td>G9410</td>
<td>0010</td>
<td>3</td>
<td>Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision</td>
<td>Admit w/in 180d req remov</td>
</tr>
<tr class="even">
<td>G9411</td>
<td>0010</td>
<td>3</td>
<td>Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision</td>
<td>No admit w/in 180d req remov</td>
</tr>
<tr class="odd">
<td>G9412</td>
<td>0010</td>
<td>3</td>
<td>Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision</td>
<td>Admit w/in 180d req surg rev</td>
</tr>
<tr class="even">
<td>G9413</td>
<td>0010</td>
<td>3</td>
<td>Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision</td>
<td>No admit req surg rev</td>
</tr>
<tr class="odd">
<td>G9414</td>
<td>0010</td>
<td>3</td>
<td>Patient had one dose of meningococcal vaccine (serogroups a, c, w, y) on or between the patient’s 11th and 13th birthdays</td>
<td>1dose menig vac btwn 11 &amp; 13</td>
</tr>
<tr class="even">
<td>G9415</td>
<td>0010</td>
<td>3</td>
<td>Patient did not have one dose of meningococcal vaccine on or between the patient’s 11th and 13th birthdays</td>
<td>No 1dose meni vac btwn 11&amp;13</td>
</tr>
<tr class="odd">
<td>G9416</td>
<td>0010</td>
<td>3</td>
<td>Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient’s 10th and 13th birthdays</td>
<td>Pt 1 tdap betw 10-13 yrs</td>
</tr>
<tr class="even">
<td>G9417</td>
<td>0010</td>
<td>3</td>
<td>Patient did not have one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient’s 10th and 13th birthdays</td>
<td>Pt not 1 tdap betw 10-13 yrs</td>
</tr>
<tr class="odd">
<td>G9418</td>
<td>0010</td>
<td>3</td>
<td>Primary non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation</td>
<td>Lungcx bx rpt docs class</td>
</tr>
<tr class="even">
<td>G9419</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not including the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of primary non-small cell lung cancer or other documented medical reasons)</td>
<td>Med reas not incl histo type</td>
</tr>
<tr class="odd">
<td>G9420</td>
<td>0010</td>
<td>3</td>
<td>Specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer</td>
<td>Spec site no lung</td>
</tr>
<tr class="even">
<td>G9421</td>
<td>0010</td>
<td>3</td>
<td>Primary non-small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation</td>
<td>Lung cx bx rpt no doc class</td>
</tr>
<tr class="odd">
<td>G9422</td>
<td>0010</td>
<td>3</td>
<td>Primary lung carcinoma resection report documents pt category, pn category and for non-small cell lung cancer, histologic type (squamous cell carcinoma, adenocarcinoma and not nsclc-nos)</td>
<td>Rpt doc class histo type</td>
</tr>
<tr class="even">
<td>G9423</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason for not including pt category, pn category and histologic type [for patient with appropriate exclusion criteria (e.g., metastatic disease, benign tumors, malignant tumors other than carcinomas, inadequate surgical specimens)]</td>
<td>Med reas rpt no histo type</td>
</tr>
<tr class="odd">
<td>G9424</td>
<td>0010</td>
<td>3</td>
<td>Specimen site other than anatomic location of lung, or classified as nsclc-nos</td>
<td>Site no lung or lung cx</td>
</tr>
<tr class="even">
<td>G9425</td>
<td>0010</td>
<td>3</td>
<td>Primary lung carcinoma resection report does not document pt category, pn category and for non-small cell lung cancer, histologic type (squamous cell carcinoma, adenocarcinoma)</td>
<td>Spec rpt no doc class histo</td>
</tr>
<tr class="odd">
<td>G9426</td>
<td>0010</td>
<td>3</td>
<td>Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients</td>
<td>Impr med time edarr pain med</td>
</tr>
<tr class="even">
<td>G9427</td>
<td>0010</td>
<td>3</td>
<td>Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients</td>
<td>No impro med time pain med</td>
</tr>
<tr class="odd">
<td>G9428</td>
<td>0010</td>
<td>3</td>
<td>Pathology report includes the pt category and a statement on thickness, ulceration and mitotic rate</td>
<td>Patho rpt incl pt ctg</td>
</tr>
<tr class="even">
<td>G9429</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not including pt category and a statement on thickness, ulceration and mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)</td>
<td>Doc med rsn no pt cat</td>
</tr>
<tr class="odd">
<td>G9430</td>
<td>0010</td>
<td>3</td>
<td>Specimen site other than anatomic cutaneous location</td>
<td>Spec site no cutaneous</td>
</tr>
<tr class="even">
<td>G9431</td>
<td>0010</td>
<td>3</td>
<td>Pathology report does not include the pt category and a statement on thickness, ulceration and mitotic rate</td>
<td>Patho rpt no pt ctg</td>
</tr>
<tr class="odd">
<td>G9432</td>
<td>0010</td>
<td>3</td>
<td>Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented</td>
<td>Asth controlled</td>
</tr>
<tr class="even">
<td>G9433</td>
<td>0010</td>
<td>3</td>
<td>Death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement period</td>
<td>Death, nhres, hospice</td>
</tr>
<tr class="odd">
<td>G9434</td>
<td>0010</td>
<td>3</td>
<td>Asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given</td>
<td>Asth not controlled</td>
</tr>
<tr class="even">
<td>G9435</td>
<td>0010</td>
<td>3</td>
<td>Aspirin prescribed at discharge</td>
<td>Asp presc disch</td>
</tr>
<tr class="odd">
<td>G9436</td>
<td>0010</td>
<td>3</td>
<td>Aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)</td>
<td>Asp not presc doc reas</td>
</tr>
<tr class="even">
<td>G9437</td>
<td>0010</td>
<td>3</td>
<td>Aspirin not prescribed at discharge</td>
<td>Asp not presc disch</td>
</tr>
<tr class="odd">
<td>G9438</td>
<td>0010</td>
<td>3</td>
<td>P2y inhibitor prescribed at discharge</td>
<td>P2y inhib presc</td>
</tr>
<tr class="even">
<td>G9439</td>
<td>0010</td>
<td>3</td>
<td>P2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)</td>
<td>P2y inhib not presc doc reas</td>
</tr>
<tr class="odd">
<td>G9440</td>
<td>0010</td>
<td>3</td>
<td>P2y inhibitor not prescribed at discharge</td>
<td>P2y inhib not presc</td>
</tr>
<tr class="even">
<td>G9441</td>
<td>0010</td>
<td>3</td>
<td>Statin prescribed at discharge</td>
<td>Statin presc disch</td>
</tr>
<tr class="odd">
<td>G9442</td>
<td>0010</td>
<td>3</td>
<td>Statin not prescribed for documented reasons (e.g., allergy, medical intolerance)</td>
<td>Statin not presc doc reas</td>
</tr>
<tr class="even">
<td>G9443</td>
<td>0010</td>
<td>3</td>
<td>Statin not prescribed at discharge</td>
<td>Statin not presc disch</td>
</tr>
<tr class="odd">
<td>G9448</td>
<td>0010</td>
<td>3</td>
<td>Patients who were born in the years 1945?1965</td>
<td>Born 1945-1965</td>
</tr>
<tr class="even">
<td>G9449</td>
<td>0010</td>
<td>3</td>
<td>History of receiving blood transfusions prior to 1992</td>
<td>Hx bld transf b/f 1992</td>
</tr>
<tr class="odd">
<td>G9450</td>
<td>0010</td>
<td>3</td>
<td>History of injection drug use</td>
<td>Hx injec drug use</td>
</tr>
<tr class="even">
<td>G9451</td>
<td>0010</td>
<td>3</td>
<td>Patient received one-time screening for hcv infection</td>
<td>1x scrn hcv infect</td>
</tr>
<tr class="odd">
<td>G9452</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not receiving one-time screening for hcv infection (e.g., decompensated cirrhosis indicating advanced disease [ie, ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocellular carcinoma, waitlist for organ transplant, limited life expectancy, other medical reasons)</td>
<td>Doc med reas no scrn hcv</td>
</tr>
<tr class="even">
<td>G9453</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)</td>
<td>Pt reas no hcv infect</td>
</tr>
<tr class="odd">
<td>G9454</td>
<td>0010</td>
<td>3</td>
<td>One-time screening for hcv infection not received within 12-month reporting period and no documentation of prior screening for hcv infection, reason not given</td>
<td>No scr hcv inf 12 mth rp</td>
</tr>
<tr class="even">
<td>G9455</td>
<td>0010</td>
<td>3</td>
<td>Patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc</td>
<td>Abd imag w/us, ct or mri</td>
</tr>
<tr class="odd">
<td>G9456</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical or patient reason(s) for not ordering or performing screening for hcc. medical reason: comorbid medical conditions with expected survival &lt; 5 years, hepatic decompensation and not a candidate for liver transplantation, or other medical reasons; patient reasons: patient declined or other patient reasons (e.g., cost of tests, time related to accessing testing equipment)</td>
<td>Doc med pt reas no hcc scrn</td>
</tr>
<tr class="even">
<td>G9457</td>
<td>0010</td>
<td>3</td>
<td>Patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the submission period</td>
<td>Pt no abd img no doc rsn</td>
</tr>
<tr class="odd">
<td>G9458</td>
<td>0010</td>
<td>3</td>
<td>Patient documented as tobacco user and received tobacco cessation intervention (must include at least one of the following: advice given to quit smoking or tobacco use, counseling on the benefits of quitting smoking or tobacco use, assistance with or referral to external smoking or tobacco cessation support programs, or current enrollment in smoking or tobacco use cessation program) if identified as a tobacco user</td>
<td>Tob user recd cess interv</td>
</tr>
<tr class="even">
<td>G9459</td>
<td>0010</td>
<td>3</td>
<td>Currently a tobacco non-user</td>
<td>Tob non-user</td>
</tr>
<tr class="odd">
<td>G9460</td>
<td>0010</td>
<td>3</td>
<td>Tobacco assessment or tobacco cessation intervention not performed, reason not given</td>
<td>No tob assess or cess inter</td>
</tr>
<tr class="even">
<td>G9463</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the sinusitis measures group</td>
<td>Sinusitis intent</td>
</tr>
<tr class="odd">
<td>G9464</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the sinusitis measures group have been performed for this patient</td>
<td>Sinusitis comp</td>
</tr>
<tr class="even">
<td>G9465</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the acute otitis externa (aoe) measures group</td>
<td>Aoe intent</td>
</tr>
<tr class="odd">
<td>G9466</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the aoe measures group have been performed for this patient</td>
<td>Aoe comp</td>
</tr>
<tr class="even">
<td>G9467</td>
<td>0010</td>
<td>3</td>
<td>Patient who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills within the last twelve months</td>
<td>Recd cortico &gt;=10mg/day &gt;60d</td>
</tr>
<tr class="odd">
<td>G9468</td>
<td>0010</td>
<td>3</td>
<td>Patient not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills</td>
<td>No recd cortico&gt;=10mg/d &gt;60d</td>
</tr>
<tr class="even">
<td>G9469</td>
<td>0010</td>
<td>3</td>
<td>Patients who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 90 or greater consecutive days or a single prescription equating to 900 mg prednisone or greater for all fills</td>
<td>Rec cortico&gt;90d or 1rx 900mg</td>
</tr>
<tr class="odd">
<td>G9470</td>
<td>0010</td>
<td>3</td>
<td>Patients not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills</td>
<td>No rec cortico&gt;60d 1rx 600mg</td>
</tr>
<tr class="even">
<td>G9471</td>
<td>0010</td>
<td>3</td>
<td>Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented</td>
<td>W/in 2yr dxa not order</td>
</tr>
<tr class="odd">
<td>G9472</td>
<td>0010</td>
<td>3</td>
<td>Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered and documented, no review of systems and no medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed</td>
<td>No dxa no med hx no rv sx</td>
</tr>
<tr class="even">
<td>G9473</td>
<td>0010</td>
<td>3</td>
<td>Services performed by chaplain in the hospice setting, each 15 minutes</td>
<td>Chap services at hospice</td>
</tr>
<tr class="odd">
<td>G9474</td>
<td>0010</td>
<td>3</td>
<td>Services performed by dietary counselor in the hospice setting, each 15 minutes</td>
<td>Diet counsel at hospice</td>
</tr>
<tr class="even">
<td>G9475</td>
<td>0010</td>
<td>3</td>
<td>Services performed by other counselor in the hospice setting, each 15 minutes</td>
<td>Other counselor at hospice</td>
</tr>
<tr class="odd">
<td>G9476</td>
<td>0010</td>
<td>3</td>
<td>Services performed by volunteer in the hospice setting, each 15 minutes</td>
<td>Volun service at hospice</td>
</tr>
<tr class="even">
<td>G9477</td>
<td>0010</td>
<td>3</td>
<td>Services performed by care coordinator in the hospice setting, each 15 minutes</td>
<td>Care coord at hospice</td>
</tr>
<tr class="odd">
<td>G9478</td>
<td>0010</td>
<td>3</td>
<td>Services performed by other qualified therapist in the hospice setting, each 15 minutes</td>
<td>Othe therapist at hospice</td>
</tr>
<tr class="even">
<td>G9479</td>
<td>0010</td>
<td>3</td>
<td>Services performed by qualified pharmacist in the hospice setting, each 15 minutes</td>
<td>Pharmacist at hospice</td>
</tr>
<tr class="odd">
<td>G9480</td>
<td>0010</td>
<td>3</td>
<td>Admission to medicare care choice model program (mccm)</td>
<td>Admission to mccm</td>
</tr>
<tr class="even">
<td>G9481</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m new pt 10mins</td>
</tr>
<tr class="odd">
<td>G9482</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 20 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m new pt 20mins</td>
</tr>
<tr class="even">
<td>G9483</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate severity. typically, 30 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m new pt 30mins</td>
</tr>
<tr class="odd">
<td>G9484</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 45 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m new pt 45mins</td>
</tr>
<tr class="even">
<td>G9485</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 60 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m new pt 60mins</td>
</tr>
<tr class="odd">
<td>G9486</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m est. pt 10mins</td>
</tr>
<tr class="even">
<td>G9487</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 15 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m est. pt 15mins</td>
</tr>
<tr class="odd">
<td>G9488</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: a detailed history; a detailed examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 25 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m est. pt 25mins</td>
</tr>
<tr class="even">
<td>G9489</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved coms innovation center demonstration project, which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 40 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m est. pt 40mins</td>
</tr>
<tr class="odd">
<td>G9490</td>
<td>0010</td>
<td>3</td>
<td>Cms innovation center models, home visit for patient assessment performed by clinical staff for an individual not considered homebound, including, but not necessarily limited to patient assessment of clinical status, safety/fall prevention, functional status/ambulation, medication reconciliation/management, compliance with orders/plan of care, performance of activities of daily living, and ensuring beneficiary connections to community and other services. (for use only in medicare-approved cms innovation center models); may not be billed for a 30 day period covered by a transitional care management code</td>
<td>Cmmi mod home visit</td>
</tr>
<tr class="even">
<td>G9496</td>
<td>0010</td>
<td>3</td>
<td>Documentation of reason for not detecting adenoma(s) or other neoplasm. (e.g., neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma</td>
<td>Doc rsn no adeno/neopl detec</td>
</tr>
<tr class="odd">
<td>G9497</td>
<td>0010</td>
<td>3</td>
<td>Received instruction from the anesthesiologist or proxy prior to the day of surgery to abstain from smoking on the day of surgery</td>
<td>Rec inst no smoke day surg</td>
</tr>
<tr class="even">
<td>G9498</td>
<td>0010</td>
<td>3</td>
<td>Antibiotic regimen prescribed</td>
<td>Abx reg prescribed</td>
</tr>
<tr class="odd">
<td>G9499</td>
<td>0010</td>
<td>3</td>
<td>Patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period</td>
<td>No start/rec antvir tx hep c</td>
</tr>
<tr class="even">
<td>G9500</td>
<td>0010</td>
<td>3</td>
<td>Radiation exposure indices, or exposure time and number of fluorographic images in final report for procedures using fluoroscopy, documented</td>
<td>Rad expos ind/exp tm doc</td>
</tr>
<tr class="odd">
<td>G9501</td>
<td>0010</td>
<td>3</td>
<td>Radiation exposure indices, or exposure time and number of fluorographic images not documented in final report for procedure using fluoroscopy, reason not given</td>
<td>Rad expos ind/exp tm no doc</td>
</tr>
<tr class="even">
<td>G9502</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason for not performing foot exam (i.e., patients who have had either a bilateral amputation above or below the knee, or both a left and right amputation above or below the knee before or during the measurement period)</td>
<td>Med reas no perf foot exam</td>
</tr>
<tr class="odd">
<td>G9503</td>
<td>0010</td>
<td>3</td>
<td>Patient taking tamsulosin hydrochloride</td>
<td>Pt tk tams hcl</td>
</tr>
<tr class="even">
<td>G9504</td>
<td>0010</td>
<td>3</td>
<td>Documented reason for not assessing hepatitis b virus (hbv) status (e.g., patient not initiating anti-tnf therapy, patient declined) prior to initiating anti-tnf therapy</td>
<td>Doc rsn hep b stat not asses</td>
</tr>
<tr class="odd">
<td>G9505</td>
<td>0010</td>
<td>3</td>
<td>Antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason</td>
<td>Abx pres w/in 10 dys of symp</td>
</tr>
<tr class="even">
<td>G9506</td>
<td>0010</td>
<td>3</td>
<td>Biologic immune response modifier prescribed</td>
<td>Bio imm resp mod presc</td>
</tr>
<tr class="odd">
<td>G9507</td>
<td>0010</td>
<td>3</td>
<td>Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs)</td>
<td>Doc reas on statin or contra</td>
</tr>
<tr class="even">
<td>G9508</td>
<td>0010</td>
<td>3</td>
<td>Documentation that the patient is not on a statin medication</td>
<td>Doc pt not on statin</td>
</tr>
<tr class="odd">
<td>G9509</td>
<td>0010</td>
<td>3</td>
<td>Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5</td>
<td>Adit mdd dys rem 12 mnths</td>
</tr>
<tr class="even">
<td>G9510</td>
<td>0010</td>
<td>3</td>
<td>Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq- 9 or phq-9m score was not assessed or is greater than or equal to 5</td>
<td>Remis12m not phq-9 score &lt;5</td>
</tr>
<tr class="odd">
<td>G9511</td>
<td>0010</td>
<td>3</td>
<td>Index event date phq-9 or phq-9m score greater than 9 documented during the twelve month denominator identification period</td>
<td>Idx evt dte phq&gt;9 doc 12 mo</td>
</tr>
<tr class="even">
<td>G9512</td>
<td>0010</td>
<td>3</td>
<td>Individual had a pdc of 0.8 or greater</td>
<td>Indiv pdc &gt; 0.8</td>
</tr>
<tr class="odd">
<td>G9513</td>
<td>0010</td>
<td>3</td>
<td>Individual did not have a pdc of 0.8 or greater</td>
<td>Indiv pdc not &gt; 0.8</td>
</tr>
<tr class="even">
<td>G9514</td>
<td>0010</td>
<td>3</td>
<td>Patient required a return to the operating room within 90 days of surgery</td>
<td>Req ret or w/in 90d of surg</td>
</tr>
<tr class="odd">
<td>G9515</td>
<td>0010</td>
<td>3</td>
<td>Patient did not require a return to the operating room within 90 days of surgery</td>
<td>No reas, no ret or w/in 90d</td>
</tr>
<tr class="even">
<td>G9516</td>
<td>0010</td>
<td>3</td>
<td>Patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery</td>
<td>Impr vis acuit w/in 90d</td>
</tr>
<tr class="odd">
<td>G9517</td>
<td>0010</td>
<td>3</td>
<td>Patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given</td>
<td>No impr vis acuit w/in 90d</td>
</tr>
<tr class="even">
<td>G9518</td>
<td>0010</td>
<td>3</td>
<td>Documentation of active injection drug use</td>
<td>Doc active inj drug use</td>
</tr>
<tr class="odd">
<td>G9519</td>
<td>0010</td>
<td>3</td>
<td>Patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery</td>
<td>Final ref +/- 1.0 w/in 90d</td>
</tr>
<tr class="even">
<td>G9520</td>
<td>0010</td>
<td>3</td>
<td>Patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery</td>
<td>Refract not +/- 1.0 w/in 90d</td>
</tr>
<tr class="odd">
<td>G9521</td>
<td>0010</td>
<td>3</td>
<td>Total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months</td>
<td>Er and ip hosp &lt;2 in 12 mos</td>
</tr>
<tr class="even">
<td>G9522</td>
<td>0010</td>
<td>3</td>
<td>Total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given</td>
<td>Er/ip hosp =/&gt;2 in 12 mos</td>
</tr>
<tr class="odd">
<td>G9523</td>
<td>0010</td>
<td>3</td>
<td>Patient discontinued from hemodialysis or peritoneal dialysis</td>
<td>D/c hemo or perit dialysis</td>
</tr>
<tr class="even">
<td>G9524</td>
<td>0010</td>
<td>3</td>
<td>Patient was referred to hospice care</td>
<td>Refer to hospice</td>
</tr>
<tr class="odd">
<td>G9525</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons)</td>
<td>Doc pt reas no hospice refer</td>
</tr>
<tr class="even">
<td>G9526</td>
<td>0010</td>
<td>3</td>
<td>Patient was not referred to hospice care, reason not given</td>
<td>No reason, no refer hospice</td>
</tr>
<tr class="odd">
<td>G9529</td>
<td>0010</td>
<td>3</td>
<td>Patient with minor blunt head trauma had an appropriate indication(s) for a head ct</td>
<td>Minor blunt trauma w/head ct</td>
</tr>
<tr class="even">
<td>G9530</td>
<td>0010</td>
<td>3</td>
<td>Patient presented with a minor blunt head trauma and had a head ct ordered for trauma by an emergency care provider</td>
<td>Pt mbht hd ct ord ec prov</td>
</tr>
<tr class="odd">
<td>G9531</td>
<td>0010</td>
<td>3</td>
<td>Patient has documentation of ventricular shunt, brain tumor, multisystem trauma, or is currently taking an antiplatelet medication including: abciximab, anagrelide, cangrelor, cilostazol, clopidogrel, dipyridamole, eptifibatide, prasugrel, ticlopidine, ticagrelor, tirofiban, or vorapaxar</td>
<td>Pt doc</td>
</tr>
<tr class="even">
<td>G9532</td>
<td>0010</td>
<td>3</td>
<td>Patient had a head ct for trauma ordered by someone other than an emergency care provider or was ordered for a reason other than trauma</td>
<td>Pt hd ct ord</td>
</tr>
<tr class="odd">
<td>G9533</td>
<td>0010</td>
<td>3</td>
<td>Patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct</td>
<td>Indic for head ct not valid</td>
</tr>
<tr class="even">
<td>G9534</td>
<td>0010</td>
<td>3</td>
<td>Advanced brain imaging (cta, ct, mra or mri) was not ordered</td>
<td>Adv brain image not ordered</td>
</tr>
<tr class="odd">
<td>G9535</td>
<td>0010</td>
<td>3</td>
<td>Patients with a normal neurological examination</td>
<td>Normal neuro exam</td>
</tr>
<tr class="even">
<td>G9536</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for ordering an advanced brain imaging study (i.e., patient has an abnormal neurological examination; patient has the coexistence of seizures, or both; recent onset of severe headache; change in the type of headache; signs of increased intracranial pressure (e.g., papilledema, absent venous pulsations on funduscopic examination, altered mental status, focal neurologic deficits, signs of meningeal irritation); hiv-positive patients with a new type of headache; immunocompromised patient with unexplained headache symptoms; patient on coagulopathy/anti-coagulation or anti-platelet therapy; very young patients with unexplained headache symptoms)</td>
<td>Doc med reas adv brain image</td>
</tr>
<tr class="odd">
<td>G9537</td>
<td>0010</td>
<td>3</td>
<td>Documentation of system reason(s) for obtaining imaging of the head (ct or mri) (i.e., needed as part of a clinical trial; other clinician ordered the study)</td>
<td>Doc sysm rsn img hd</td>
</tr>
<tr class="even">
<td>G9538</td>
<td>0010</td>
<td>3</td>
<td>Advanced brain imaging (cta, ct, mra or mri) was ordered</td>
<td>Adv brain image ordered</td>
</tr>
<tr class="odd">
<td>G9539</td>
<td>0010</td>
<td>3</td>
<td>Intent for potential removal at time of placement</td>
<td>Intent pot remv time placemt</td>
</tr>
<tr class="even">
<td>G9540</td>
<td>0010</td>
<td>3</td>
<td>Patient alive 3 months post procedure</td>
<td>Pt alive 3 mos post proc</td>
</tr>
<tr class="odd">
<td>G9541</td>
<td>0010</td>
<td>3</td>
<td>Filter removed within 3 months of placement</td>
<td>Filter rem 3 mon plmt</td>
</tr>
<tr class="even">
<td>G9542</td>
<td>0010</td>
<td>3</td>
<td>Documented re-assessment for the appropriateness of filter removal within 3 months of placement</td>
<td>Doc reass appr remo filt 3ms</td>
</tr>
<tr class="odd">
<td>G9543</td>
<td>0010</td>
<td>3</td>
<td>Documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement</td>
<td>Doc 2x re-assess filt remov</td>
</tr>
<tr class="even">
<td>G9544</td>
<td>0010</td>
<td>3</td>
<td>Patients that do not have the filter removed, documented re-assessment for the appropriateness of filter removal, or documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement</td>
<td>No filt remov w/in 3mos plcm</td>
</tr>
<tr class="odd">
<td>G9547</td>
<td>0010</td>
<td>3</td>
<td>Cystic renal lesion that is simple appearing (bosniak i or ii) , or adrenal lesion less than or equal to 1.0 cm or adrenal lesion greater than 1.0 cm but less than or equal to 4.0 cm classified as likely benign by unenhanced ct or washout protocol ct, or mri with in- and opposed-phase sequences or other equivalent institutional imaging protocols</td>
<td>Cys ren les or adren</td>
</tr>
<tr class="even">
<td>G9548</td>
<td>0010</td>
<td>3</td>
<td>Final reports for imaging studies stating no follow-up imaging is recommended</td>
<td>No f/u rec image study</td>
</tr>
<tr class="odd">
<td>G9549</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) that follow-up imaging is indicated (e.g., patient has lymphadenopathy, signs of metastasis or an active diagnosis or history of cancer, and other medical reason(s))</td>
<td>Doc med rsn for f/u imag</td>
</tr>
<tr class="even">
<td>G9550</td>
<td>0010</td>
<td>3</td>
<td>Final reports for imaging studies with follow-up imaging recommended</td>
<td>Imag rec</td>
</tr>
<tr class="odd">
<td>G9551</td>
<td>0010</td>
<td>3</td>
<td>Final reports for imaging studies without an incidentally found lesion noted</td>
<td>Imag no les</td>
</tr>
<tr class="even">
<td>G9552</td>
<td>0010</td>
<td>3</td>
<td>Incidental thyroid nodule &lt; 1.0 cm noted in report</td>
<td>Inc thyr node &lt;1.0 in rpt</td>
</tr>
<tr class="odd">
<td>G9553</td>
<td>0010</td>
<td>3</td>
<td>Prior thyroid disease diagnosis</td>
<td>Prior thyroid dise dx</td>
</tr>
<tr class="even">
<td>G9554</td>
<td>0010</td>
<td>3</td>
<td>Final reports for ct, cta, mri or mra of the chest or neck or ultrasound of the neck with follow-up imaging recommended</td>
<td>Ct/cta/mri/a chst foll rec</td>
</tr>
<tr class="odd">
<td>G9555</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for recommending follow up imaging (e.g., patient has multiple endocrine neoplasia, patient has cervical lymphadenopathy, other medical reason(s))</td>
<td>Doc med rsn for follup image</td>
</tr>
<tr class="even">
<td>G9556</td>
<td>0010</td>
<td>3</td>
<td>Final reports for ct, cta, mri or mra of the chest or neck or ultrasound of the neck with follow-up imaging not recommended</td>
<td>Ct/cta/mri/a no follup imag</td>
</tr>
<tr class="odd">
<td>G9557</td>
<td>0010</td>
<td>3</td>
<td>Final reports for ct, cta, mri or mra studies of the chest or neck or ultrasound of the neck without an incidentally found thyroid nodule &lt; 1.0 cm noted or no nodule found</td>
<td>Ct/cta/mri/a no thyr &lt;1.0cm</td>
</tr>
<tr class="even">
<td>G9558</td>
<td>0010</td>
<td>3</td>
<td>Patient treated with a beta-lactam antibiotic as definitive therapy</td>
<td>Tx beta-lactam abx therapy</td>
</tr>
<tr class="odd">
<td>G9559</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta-lactam antibiotics)</td>
<td>Doc med reas no abx therapy</td>
</tr>
<tr class="even">
<td>G9560</td>
<td>0010</td>
<td>3</td>
<td>Patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given</td>
<td>No beta-lactam abx ther, rng</td>
</tr>
<tr class="odd">
<td>G9561</td>
<td>0010</td>
<td>3</td>
<td>Patients prescribed opiates for longer than six weeks</td>
<td>Presc opiates &gt;6 wks</td>
</tr>
<tr class="even">
<td>G9562</td>
<td>0010</td>
<td>3</td>
<td>Patients who had a follow-up evaluation conducted at least every three months during opioid therapy</td>
<td>Foll-up eval q3mo opiod tx</td>
</tr>
<tr class="odd">
<td>G9563</td>
<td>0010</td>
<td>3</td>
<td>Patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy</td>
<td>No f/u eval q3mo opiod tx</td>
</tr>
<tr class="even">
<td>G9572</td>
<td>0010</td>
<td>3</td>
<td>Index date phq-score greater than 9 documented during the twelve month denominator identification period</td>
<td>Phq-scr &gt;9 doc in 12m time</td>
</tr>
<tr class="odd">
<td>G9573</td>
<td>0010</td>
<td>3</td>
<td>Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five</td>
<td>Adl pt md or dys rem 6 mon</td>
</tr>
<tr class="even">
<td>G9574</td>
<td>0010</td>
<td>3</td>
<td>Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five; either phq-9 or phq-9m score was not assessed or is greater than or equal to five</td>
<td>Adl pt md dys no rem 6 mon</td>
</tr>
<tr class="odd">
<td>G9577</td>
<td>0010</td>
<td>3</td>
<td>Patients prescribed opiates for longer than six weeks</td>
<td>Presc opiates &gt;6 wks</td>
</tr>
<tr class="even">
<td>G9578</td>
<td>0010</td>
<td>3</td>
<td>Documentation of signed opioid treatment agreement at least once during opioid therapy</td>
<td>Doc opioid tx 1x during ther</td>
</tr>
<tr class="odd">
<td>G9579</td>
<td>0010</td>
<td>3</td>
<td>No documentation of signed an opioid treatment agreement at least once during opioid therapy</td>
<td>No doc opioid tx 1x at ther</td>
</tr>
<tr class="even">
<td>G9580</td>
<td>0010</td>
<td>3</td>
<td>Door to puncture time of less than 2 hours</td>
<td>Door to punc time &lt;2hrs</td>
</tr>
<tr class="odd">
<td>G9581</td>
<td>0010</td>
<td>3</td>
<td>Door to puncture time of greater than 2 hours for reasons documented by clinician (e.g., patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment; hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment)</td>
<td>Md doc, door to punc tm &gt;2hr</td>
</tr>
<tr class="even">
<td>G9582</td>
<td>0010</td>
<td>3</td>
<td>Door to puncture time of greater than 2 hours, no reason given</td>
<td>Door to punc time &gt;2hr, nrg</td>
</tr>
<tr class="odd">
<td>G9583</td>
<td>0010</td>
<td>3</td>
<td>Patients prescribed opiates for longer than six weeks</td>
<td>Presc opiates &gt;6 wks</td>
</tr>
<tr class="even">
<td>G9584</td>
<td>0010</td>
<td>3</td>
<td>Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy</td>
<td>Eval opioid use instr/pt int</td>
</tr>
<tr class="odd">
<td>G9585</td>
<td>0010</td>
<td>3</td>
<td>Patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient not interviewed at least once during opioid therapy</td>
<td>No eval opi use instr/intv</td>
</tr>
<tr class="even">
<td>G9593</td>
<td>0010</td>
<td>3</td>
<td>Pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules</td>
<td>Low pecarn ped head trauma</td>
</tr>
<tr class="odd">
<td>G9594</td>
<td>0010</td>
<td>3</td>
<td>Patient presented with a minor blunt head trauma and had a head ct ordered for trauma by an emergency care provider</td>
<td>Pt mbht hd ct ord ec prov</td>
</tr>
<tr class="even">
<td>G9595</td>
<td>0010</td>
<td>3</td>
<td>Patient has documentation of ventricular shunt, brain tumor, or coagulopathy</td>
<td>Doc shnt/tum/coag</td>
</tr>
<tr class="odd">
<td>G9596</td>
<td>0010</td>
<td>3</td>
<td>Pediatric patient had a head ct for trauma ordered by someone other than an emergency care provider or was ordered for a reason other than trauma</td>
<td>Ped pt hd ct ord</td>
</tr>
<tr class="even">
<td>G9597</td>
<td>0010</td>
<td>3</td>
<td>Pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules</td>
<td>No low pecarn ped head traum</td>
</tr>
<tr class="odd">
<td>G9598</td>
<td>0010</td>
<td>3</td>
<td>Aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct</td>
<td>Aor ane 5.5-5.9 cm max diam</td>
</tr>
<tr class="even">
<td>G9599</td>
<td>0010</td>
<td>3</td>
<td>Aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct</td>
<td>Aor ane &gt;=6.0 cm max diam</td>
</tr>
<tr class="odd">
<td>G9600</td>
<td>0010</td>
<td>3</td>
<td>Symptomatic aaas that required urgent/emergent (non-elective) repair</td>
<td>Symp aaa urgent repair</td>
</tr>
<tr class="even">
<td>G9601</td>
<td>0010</td>
<td>3</td>
<td>Patient discharge to home no later than post-operative day #7</td>
<td>Pt dchg home post op day 7</td>
</tr>
<tr class="odd">
<td>G9602</td>
<td>0010</td>
<td>3</td>
<td>Patient not discharged to home by post-operative day #7</td>
<td>Pt no dchg home postop day 7</td>
</tr>
<tr class="even">
<td>G9603</td>
<td>0010</td>
<td>3</td>
<td>Patient survey score improved from baseline following treatment</td>
<td>Pt surv improv bsline tx</td>
</tr>
<tr class="odd">
<td>G9604</td>
<td>0010</td>
<td>3</td>
<td>Patient survey results not available</td>
<td>Pt surv results not avail</td>
</tr>
<tr class="even">
<td>G9605</td>
<td>0010</td>
<td>3</td>
<td>Patient survey score did not improve from baseline following treatment</td>
<td>Surv score no improv w/tx</td>
</tr>
<tr class="odd">
<td>G9606</td>
<td>0010</td>
<td>3</td>
<td>Intraoperative cystoscopy performed to evaluate for lower tract injury</td>
<td>Intraop cyst eval trac inj</td>
</tr>
<tr class="even">
<td>G9607</td>
<td>0010</td>
<td>3</td>
<td>Documented medical reasons for not performing intraoperative cystoscopy (e.g., urethral pathology precluding cystoscopy, any patient who has a congenital or acquired absence of the urethra) or in the case of patient death</td>
<td>Doc med rsn not perf cystosc</td>
</tr>
<tr class="odd">
<td>G9608</td>
<td>0010</td>
<td>3</td>
<td>Intraoperative cystoscopy not performed to evaluate for lower tract injury</td>
<td>Intraop cyst eval not done</td>
</tr>
<tr class="even">
<td>G9609</td>
<td>0010</td>
<td>3</td>
<td>Documentation of an order for anti-platelet agents</td>
<td>Doc order anti-plat</td>
</tr>
<tr class="odd">
<td>G9610</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) in the patient’s record for not ordering anti-platelet agents</td>
<td>Doc md rsn no antipla</td>
</tr>
<tr class="even">
<td>G9611</td>
<td>0010</td>
<td>3</td>
<td>Order for anti-platelet agents was not documented in the patient’s record, reason not given</td>
<td>No doc order anti-plat rng</td>
</tr>
<tr class="odd">
<td>G9612</td>
<td>0010</td>
<td>3</td>
<td>Photodocumentation of two or more cecal landmarks to establish a complete examination</td>
<td>Phodoc 2 mr cec lndmk</td>
</tr>
<tr class="even">
<td>G9613</td>
<td>0010</td>
<td>3</td>
<td>Documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)</td>
<td>Doc post surg anatomy</td>
</tr>
<tr class="odd">
<td>G9614</td>
<td>0010</td>
<td>3</td>
<td>Photodocumentation of less than two cecal landmarks (i.e., no cecal landmarks or only one cecal landmark) to establish a complete examination</td>
<td>Photodoc &lt; 2 cec lndmk</td>
</tr>
<tr class="even">
<td>G9615</td>
<td>0010</td>
<td>3</td>
<td>Preoperative assessment documented</td>
<td>Pre-op asst doc</td>
</tr>
<tr class="odd">
<td>G9616</td>
<td>0010</td>
<td>3</td>
<td>Documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)</td>
<td>Doc rsn no preop assmt</td>
</tr>
<tr class="even">
<td>G9617</td>
<td>0010</td>
<td>3</td>
<td>Preoperative assessment not documented, reason not given</td>
<td>Pre-op asst not doc, rng</td>
</tr>
<tr class="odd">
<td>G9618</td>
<td>0010</td>
<td>3</td>
<td>Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind</td>
<td>Doc scr uter mal or us/samp</td>
</tr>
<tr class="even">
<td>G9619</td>
<td>0010</td>
<td>3</td>
<td>Documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)</td>
<td>Doc rsn no scr uter malig</td>
</tr>
<tr class="odd">
<td>G9620</td>
<td>0010</td>
<td>3</td>
<td>Patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given</td>
<td>No scr utr malig/us/samp rng</td>
</tr>
<tr class="even">
<td>G9621</td>
<td>0010</td>
<td>3</td>
<td>Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling</td>
<td>Scr unheal etoh w/counsel</td>
</tr>
<tr class="odd">
<td>G9622</td>
<td>0010</td>
<td>3</td>
<td>Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method</td>
<td>No unheal etoh user</td>
</tr>
<tr class="even">
<td>G9623</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)</td>
<td>Doc med rsn no scr etoh use</td>
</tr>
<tr class="odd">
<td>G9624</td>
<td>0010</td>
<td>3</td>
<td>Patient not screened for unhealthy alcohol use using a systematic screening method or patient did not receive brief counseling if identified as an unhealthy alcohol user, reason not given</td>
<td>Pt not scrn or no counseling</td>
</tr>
<tr class="even">
<td>G9625</td>
<td>0010</td>
<td>3</td>
<td>Patient sustained bladder injury at the time of surgery or discovered subsequently up to 30 days post-surgery</td>
<td>Pt bl srg 30 day pst srg</td>
</tr>
<tr class="odd">
<td>G9626</td>
<td>0010</td>
<td>3</td>
<td>Documented medical reason for not reporting bladder injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bladder injury)</td>
<td>Med rsn no rpt baldder inj</td>
</tr>
<tr class="even">
<td>G9627</td>
<td>0010</td>
<td>3</td>
<td>Patient did not sustain bladder injury at the time of surgery nor discovered subsequently up to 30n days post-surgery</td>
<td>Pt no bl srg 30 day pst srg</td>
</tr>
<tr class="odd">
<td>G9628</td>
<td>0010</td>
<td>3</td>
<td>Patient sustained bowel injury at the time of surgery or discovered subsequently up to 30 days post-surgery</td>
<td>Pt bwli srg 30 day pst srg</td>
</tr>
<tr class="even">
<td>G9629</td>
<td>0010</td>
<td>3</td>
<td>Documented medical reasons for not reporting bowel injury (e.g., gynecologic or other pelvic malignancy documented, planned (e.g., not due to an unexpected bowel injury) resection and/or re-anastomosis of bowel, or patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bowel injury)</td>
<td>Med rsn no rpt bowel inj</td>
</tr>
<tr class="odd">
<td>G9630</td>
<td>0010</td>
<td>3</td>
<td>Patient did not sustain a bowel injury at the time of surgery nor discovered subsequently up to 30 days post-surgery</td>
<td>Pt no bwli srg 30 day srg</td>
</tr>
<tr class="even">
<td>G9631</td>
<td>0010</td>
<td>3</td>
<td>Patient sustained ureter injury at the time of surgery or discovered subsequently up to 30 days post-surgery</td>
<td>Pt ui srg 30 day pst srg</td>
</tr>
<tr class="odd">
<td>G9632</td>
<td>0010</td>
<td>3</td>
<td>Documented medical reasons for not reporting ureter injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of ureter injury)</td>
<td>Med rsn for no rpt uret inj</td>
</tr>
<tr class="even">
<td>G9633</td>
<td>0010</td>
<td>3</td>
<td>Patient did not sustain ureter injury at the time of surgery nor discovered subsequently up to 30 days post-surgery</td>
<td>Pt no ui srg 30 day pst srg</td>
</tr>
<tr class="odd">
<td>G9634</td>
<td>0010</td>
<td>3</td>
<td>Health-related quality of life assessed with tool during at least two visits and quality of life score remained the same or improved</td>
<td>Qual life tool 2x same/impr</td>
</tr>
<tr class="even">
<td>G9635</td>
<td>0010</td>
<td>3</td>
<td>Health-related quality of life not assessed with tool for documented reason(s) (e.g., patient has a cognitive or neuropsychiatric impairment that impairs his/her ability to complete the hrqol survey, patient has the inability to read and/or write in order to complete the hrqol questionnaire)</td>
<td>No doc rsn do qual life assm</td>
</tr>
<tr class="odd">
<td>G9636</td>
<td>0010</td>
<td>3</td>
<td>Health-related quality of life not assessed with tool during at least two visits or quality of life score declined</td>
<td>No life asst 2x same/decr</td>
</tr>
<tr class="even">
<td>G9637</td>
<td>0010</td>
<td>3</td>
<td>Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)</td>
<td>Doc &gt;1 dose reduc tech</td>
</tr>
<tr class="odd">
<td>G9638</td>
<td>0010</td>
<td>3</td>
<td>Final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)</td>
<td>No doc &gt;1 dose reduc tech</td>
</tr>
<tr class="even">
<td>G9639</td>
<td>0010</td>
<td>3</td>
<td>Major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure</td>
<td>Amp no reqd in48h ieler proc</td>
</tr>
<tr class="odd">
<td>G9640</td>
<td>0010</td>
<td>3</td>
<td>Documentation of planned hybrid or staged procedure</td>
<td>Doc plan hybrid/stage proc</td>
</tr>
<tr class="even">
<td>G9641</td>
<td>0010</td>
<td>3</td>
<td>Major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure</td>
<td>Amp reqd w/in 48h ieler proc</td>
</tr>
<tr class="odd">
<td>G9642</td>
<td>0010</td>
<td>3</td>
<td>Current smokers (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)</td>
<td>Current smoker</td>
</tr>
<tr class="even">
<td>G9643</td>
<td>0010</td>
<td>3</td>
<td>Elective surgery</td>
<td>Elective surgery</td>
</tr>
<tr class="odd">
<td>G9644</td>
<td>0010</td>
<td>3</td>
<td>Patients who abstained from smoking prior to anesthesia on the day of surgery or procedure</td>
<td>No smok b/4 anes day of surg</td>
</tr>
<tr class="even">
<td>G9645</td>
<td>0010</td>
<td>3</td>
<td>Patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure</td>
<td>Had smoke b/4 anes day surg</td>
</tr>
<tr class="odd">
<td>G9646</td>
<td>0010</td>
<td>3</td>
<td>Patients with 90 day mrs score of 0 to 2</td>
<td>Pt w/90d mrs 0-2</td>
</tr>
<tr class="even">
<td>G9647</td>
<td>0010</td>
<td>3</td>
<td>Patients in whom mrs score could not be obtained at 90 day follow-up</td>
<td>No mrs score in 90d followup</td>
</tr>
<tr class="odd">
<td>G9648</td>
<td>0010</td>
<td>3</td>
<td>Patients with 90 day mrs score greater than 2</td>
<td>Pt w/90d mrs &gt;2</td>
</tr>
<tr class="even">
<td>G9649</td>
<td>0010</td>
<td>3</td>
<td>Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))</td>
<td>Psor as doc spc bm</td>
</tr>
<tr class="odd">
<td>G9650</td>
<td>0010</td>
<td>3</td>
<td>Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi</td>
<td>Doc pt no ther chg or contra</td>
</tr>
<tr class="even">
<td>G9651</td>
<td>0010</td>
<td>3</td>
<td>Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented</td>
<td>Psor as doc no spc bm</td>
</tr>
<tr class="odd">
<td>G9652</td>
<td>0010</td>
<td>3</td>
<td>Patient has been treated with a systemic or biologic medication for psoriasis for at least six months</td>
<td>Pt tx sys bio med psori 6mth</td>
</tr>
<tr class="even">
<td>G9653</td>
<td>0010</td>
<td>3</td>
<td>Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months</td>
<td>Pt no tx sys bio rx 6 mths</td>
</tr>
<tr class="odd">
<td>G9654</td>
<td>0010</td>
<td>3</td>
<td>Monitored anesthesia care (mac)</td>
<td>Mon anesth care</td>
</tr>
<tr class="even">
<td>G9655</td>
<td>0010</td>
<td>3</td>
<td>A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used</td>
<td>Toc tool incl key elem</td>
</tr>
<tr class="odd">
<td>G9656</td>
<td>0010</td>
<td>3</td>
<td>Patient transferred directly from anesthetizing location to pacu or other non-icu location</td>
<td>Pt trans from anest to pacu</td>
</tr>
<tr class="even">
<td>G9657</td>
<td>0010</td>
<td>3</td>
<td>Transfer of care during an anesthetic or to the intensive care unit</td>
<td>Toc dur aneth to icu</td>
</tr>
<tr class="odd">
<td>G9658</td>
<td>0010</td>
<td>3</td>
<td>A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used</td>
<td>Toc tool incl elem not used</td>
</tr>
<tr class="even">
<td>G9659</td>
<td>0010</td>
<td>3</td>
<td>Patients greater than 85 years of age who did not have a history of colorectal cancer or valid medical reason for the colonoscopy, including: iron deficiency anemia, lower gastrointestinal bleeding, crohn’s disease (i.e., regional enteritis), familial adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease, ulcerative colitis, abnormal finding of gastrointestinal tract, or changes in bowel habits</td>
<td>&gt;85y no hx colo ca/rsn scope</td>
</tr>
<tr class="odd">
<td>G9660</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for a colonoscopy performed on a patient greater than 85 years of age (e.g., last colonoscopy incomplete, last colonoscopy had inadequate prep, iron deficiency anemia, lower gastrointestinal bleeding, crohn’s disease (i.e., regional enteritis), familial history of adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease, ulcerative colitis, abnormal finding of gastrointestinal tract, or changes in bowel habits)</td>
<td>Doc med rsn scope pt &gt;85y</td>
</tr>
<tr class="even">
<td>G9661</td>
<td>0010</td>
<td>3</td>
<td>Patients greater than 85 years of age who received a routine colonoscopy for a reason other than the following: an assessment of signs/symptoms of gi tract illness, and/or the patient is considered high risk, and/or to follow-up on previously diagnosed advance lesions</td>
<td>&gt;85y scope othr rsn</td>
</tr>
<tr class="odd">
<td>G9662</td>
<td>0010</td>
<td>3</td>
<td>Previously diagnosed or have an active diagnosis of clinical ascvd</td>
<td>Prior dx/active clin ascvd</td>
</tr>
<tr class="even">
<td>G9663</td>
<td>0010</td>
<td>3</td>
<td>Any fasting or direct ldl-c laboratory test result &lt;= 190 mg/dl</td>
<td>Fast/dir ldl &lt;= 190 mg/dl</td>
</tr>
<tr class="odd">
<td>G9664</td>
<td>0010</td>
<td>3</td>
<td>Patients who are currently statin therapy users or received an order (prescription) for statin therapy</td>
<td>Taking statin or rec’d order</td>
</tr>
<tr class="even">
<td>G9665</td>
<td>0010</td>
<td>3</td>
<td>Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy</td>
<td>No statin/no order statin</td>
</tr>
<tr class="odd">
<td>G9666</td>
<td>0010</td>
<td>3</td>
<td>The highest fasting or direct ldl-c laboratory test result of 70-189 mg/dl in the measurement period or two years prior to the beginning of the measurement period</td>
<td>Fas/dir ldl 70-189mg/dl mst</td>
</tr>
<tr class="even">
<td>G9667</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result &lt; 70 mg/dl and are not taking statin therapy)</td>
<td>Doc med rsn no stat tx/presc</td>
</tr>
<tr class="odd">
<td>G9669</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the multiple chronic conditions measures group</td>
<td>Intend rpt mult chr msr grp</td>
</tr>
<tr class="even">
<td>G9670</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient</td>
<td>Qty act mcc mg perf</td>
</tr>
<tr class="odd">
<td>G9671</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the diabetic retinopathy measures group</td>
<td>Intend rpt dia retin msr grp</td>
</tr>
<tr class="even">
<td>G9672</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient</td>
<td>Qty act diab retin mg perf</td>
</tr>
<tr class="odd">
<td>G9673</td>
<td>0010</td>
<td>3</td>
<td>I intend to report the cardiovascular prevention measures group</td>
<td>Intend rpt card prev msr grp</td>
</tr>
<tr class="even">
<td>G9674</td>
<td>0010</td>
<td>3</td>
<td>Patients with clinical ascvd diagnosis</td>
<td>Pt w/clin ascvd dx</td>
</tr>
<tr class="odd">
<td>G9675</td>
<td>0010</td>
<td>3</td>
<td>Patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl</td>
<td>Pt w/fast/dir lab ldl-c &gt;190</td>
</tr>
<tr class="even">
<td>G9676</td>
<td>0010</td>
<td>3</td>
<td>Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c result of 70?189 mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period</td>
<td>40-75y w/type 1/2 w/ldl-c rs</td>
</tr>
<tr class="odd">
<td>G9677</td>
<td>0010</td>
<td>3</td>
<td>All quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient</td>
<td>Qty act card prev mg perf</td>
</tr>
<tr class="even">
<td>G9678</td>
<td>0010</td>
<td>3</td>
<td>Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement</td>
<td>Oncology care model service</td>
</tr>
<tr class="odd">
<td>G9679</td>
<td>0010</td>
<td>3</td>
<td>This code is for onsite acute care treatment of a nursing facility resident with pneumonia; may only be billed once per day per beneficiary</td>
<td>Acute care pneumonia</td>
</tr>
<tr class="even">
<td>G9680</td>
<td>0010</td>
<td>3</td>
<td>This code is for onsite acute care treatment of a nursing facility resident with chf; may only be billed once per day per beneficiary</td>
<td>Acute care congestive heart</td>
</tr>
<tr class="odd">
<td>G9681</td>
<td>0010</td>
<td>3</td>
<td>This code is for onsite acute care treatment of a resident with copd or asthma; may only be billed once per day per beneficiary</td>
<td>Acute care chronic obstruct</td>
</tr>
<tr class="even">
<td>G9682</td>
<td>0010</td>
<td>3</td>
<td>This code is for the onsite acute care treatment a nursing facility resident with a skin infection; may only be billed once per day per beneficiary</td>
<td>Acute care skin infection</td>
</tr>
<tr class="odd">
<td>G9683</td>
<td>0010</td>
<td>3</td>
<td>Facility service(s) for the onsite acute care treatment of a nursing facility resident with fluid or electrolyte disorder. (may only be billed once per day per beneficiary). this service is for a demonstration project</td>
<td>Acute fluid/electro disorder</td>
</tr>
<tr class="even">
<td>G9684</td>
<td>0010</td>
<td>3</td>
<td>This code is for the onsite acute care treatment of a nursing facility resident for a uti; may only be billed once per day per beneficiary</td>
<td>Acute care urinary tract inf</td>
</tr>
<tr class="odd">
<td>G9685</td>
<td>0010</td>
<td>3</td>
<td>Physician service or other qualified health care professional for the evaluation and management of a beneficiary’s acute change in condition in a nursing facility. this service is for a demonstration project</td>
<td>Acute nursing facility care</td>
</tr>
<tr class="even">
<td>G9686</td>
<td>0010</td>
<td>3</td>
<td>Onsite nursing facility conference, that is separate and distinct from an evaluation and management visit, including qualified practitioner and at least one member of the nursing facility interdisciplinary care team</td>
<td>Nursing facility conference</td>
</tr>
<tr class="odd">
<td>G9687</td>
<td>0010</td>
<td>3</td>
<td>Hospice services provided to patient any time during the measurement period</td>
<td>Hospice anytime msmt per</td>
</tr>
<tr class="even">
<td>G9688</td>
<td>0010</td>
<td>3</td>
<td>Patients using hospice services any time during the measurement period</td>
<td>Pt w/hosp anytime msmt per</td>
</tr>
<tr class="odd">
<td>G9689</td>
<td>0010</td>
<td>3</td>
<td>Patient admitted for performance of elective carotid intervention</td>
<td>Inpt elect carotid intervent</td>
</tr>
<tr class="even">
<td>G9690</td>
<td>0010</td>
<td>3</td>
<td>Patient receiving hospice services any time during the measurement period</td>
<td>Pt in hos</td>
</tr>
<tr class="odd">
<td>G9691</td>
<td>0010</td>
<td>3</td>
<td>Patient had hospice services any time during the measurement period</td>
<td>Pt hosp dur msmt period</td>
</tr>
<tr class="even">
<td>G9692</td>
<td>0010</td>
<td>3</td>
<td>Hospice services received by patient any time during the measurement period</td>
<td>Hosp recd by pt dur msmt per</td>
</tr>
<tr class="odd">
<td>G9693</td>
<td>0010</td>
<td>3</td>
<td>Patient use of hospice services any time during the measurement period</td>
<td>Pt use hosp during msmt per</td>
</tr>
<tr class="even">
<td>G9694</td>
<td>0010</td>
<td>3</td>
<td>Hospice services utilized by patient any time during the measurement period</td>
<td>Hosp srv used pt in msmt per</td>
</tr>
<tr class="odd">
<td>G9695</td>
<td>0010</td>
<td>3</td>
<td>Long-acting inhaled bronchodilator prescribed</td>
<td>Long act inhal bronchdil pre</td>
</tr>
<tr class="even">
<td>G9696</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not prescribing a long-acting inhaled bronchodilator</td>
<td>Med rsn no presc bronchdil</td>
</tr>
<tr class="odd">
<td>G9697</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient reason(s) for not prescribing a long-acting inhaled bronchodilator</td>
<td>Pt rsn no presc bronchdil</td>
</tr>
<tr class="even">
<td>G9698</td>
<td>0010</td>
<td>3</td>
<td>Documentation of system reason(s) for not prescribing a long-acting inhaled bronchodilator</td>
<td>Sys rsn no presc bronchdil</td>
</tr>
<tr class="odd">
<td>G9699</td>
<td>0010</td>
<td>3</td>
<td>Long-acting inhaled bronchodilator not prescribed, reason not otherwise specified</td>
<td>Long inhal bronchdil no pres</td>
</tr>
<tr class="even">
<td>G9700</td>
<td>0010</td>
<td>3</td>
<td>Patients who use hospice services any time during the measurement period</td>
<td>Pt is w/hosp during msmt per</td>
</tr>
<tr class="odd">
<td>G9701</td>
<td>0010</td>
<td>3</td>
<td>Children who are taking antibiotics in the 30 days prior to the date of the encounter during which the diagnosis was established</td>
<td>Child anbx 30 prior dx estab</td>
</tr>
<tr class="even">
<td>G9702</td>
<td>0010</td>
<td>3</td>
<td>Patients who use hospice services any time during the measurement period</td>
<td>Pt use hosp during msmt per</td>
</tr>
<tr class="odd">
<td>G9703</td>
<td>0010</td>
<td>3</td>
<td>Children who are taking antibiotics in the 30 days prior to the diagnosis of pharyngitis</td>
<td>Child anbx 30 prior dx phary</td>
</tr>
<tr class="even">
<td>G9704</td>
<td>0010</td>
<td>3</td>
<td>Ajcc breast cancer stage i: t1 mic or t1a documented</td>
<td>Ajcc br ca stg i: t1 mic/t1a</td>
</tr>
<tr class="odd">
<td>G9705</td>
<td>0010</td>
<td>3</td>
<td>Ajcc breast cancer stage i: t1b (tumor &gt; 0.5 cm but &lt;= 1 cm in greatest dimension) documented</td>
<td>Ajcc br ca stg ib</td>
</tr>
<tr class="even">
<td>G9706</td>
<td>0010</td>
<td>3</td>
<td>Low (or very low) risk of recurrence, prostate cancer</td>
<td>Low recur prost ca</td>
</tr>
<tr class="odd">
<td>G9707</td>
<td>0010</td>
<td>3</td>
<td>Patient received hospice services any time during the measurement period</td>
<td>Pt had hosp dur msmt per</td>
</tr>
<tr class="even">
<td>G9708</td>
<td>0010</td>
<td>3</td>
<td>Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy</td>
<td>Bilat mast/hx bi /unilat mas</td>
</tr>
<tr class="odd">
<td>G9709</td>
<td>0010</td>
<td>3</td>
<td>Hospice services used by patient any time during the measurement period</td>
<td>Hosp srv used pt in msmt per</td>
</tr>
<tr class="even">
<td>G9710</td>
<td>0010</td>
<td>3</td>
<td>Patient was provided hospice services any time during the measurement period</td>
<td>Pt prov hosp srv msmt per</td>
</tr>
<tr class="odd">
<td>G9711</td>
<td>0010</td>
<td>3</td>
<td>Patients with a diagnosis or past history of total colectomy or colorectal cancer</td>
<td>Pt hx tot col or colon ca</td>
</tr>
<tr class="even">
<td>G9712</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for prescribing or dispensing antibiotic (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis/ mastoiditis/bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia, gonococcal infections/venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis/uti, acne, hiv disease/asymptomatic hiv, cystic fibrosis, disorders of the immune system, malignancy neoplasms, chronic bronchitis, emphysema, bronchiectasis, extrinsic allergic alveolitis, chronic airway obstruction, chronic obstructive asthma, pneumoconiosis and other lung disease due to external agents, other diseases of the respiratory system, and tuberculosis</td>
<td>Doc med rsn presc anbx</td>
</tr>
<tr class="odd">
<td>G9713</td>
<td>0010</td>
<td>3</td>
<td>Patients who use hospice services any time during the measurement period</td>
<td>Pt use hosp during msmt per</td>
</tr>
<tr class="even">
<td>G9714</td>
<td>0010</td>
<td>3</td>
<td>Patient is using hospice services any time during the measurement period</td>
<td>Pt is w/hosp during msmt per</td>
</tr>
<tr class="odd">
<td>G9715</td>
<td>0010</td>
<td>3</td>
<td>Patients who use hospice services any time during the measurement period</td>
<td>Pt w/hosp anytime msmt per</td>
</tr>
<tr class="even">
<td>G9716</td>
<td>0010</td>
<td>3</td>
<td>Bmi is documented as being outside of normal limits, follow-up plan is not completed for documented reason</td>
<td>Bmi doc onl fup not cmpltd</td>
</tr>
<tr class="odd">
<td>G9717</td>
<td>0010</td>
<td>3</td>
<td>Documentation stating the patient has an active diagnosis of depression or has a diagnosed bipolar disorder, therefore screening or follow-up not required</td>
<td>Doc pt dx dep/bp f/u nt req</td>
</tr>
<tr class="even">
<td>G9718</td>
<td>0010</td>
<td>3</td>
<td>Hospice services for patient provided any time during the measurement period</td>
<td>Hospice anytime msmt per</td>
</tr>
<tr class="odd">
<td>G9719</td>
<td>0010</td>
<td>3</td>
<td>Patient is not ambulatory, bed ridden, immobile, confined to chair, wheelchair bound, dependent on helper pushing wheelchair, independent in wheelchair or minimal help in wheelchair</td>
<td>Pt not ambul/immob/wc</td>
</tr>
<tr class="even">
<td>G9720</td>
<td>0010</td>
<td>3</td>
<td>Hospice services for patient occurred any time during the measurement period</td>
<td>Hospice anytime msmt per</td>
</tr>
<tr class="odd">
<td>G9721</td>
<td>0010</td>
<td>3</td>
<td>Patient not ambulatory, bed ridden, immobile, confined to chair, wheelchair bound, dependent on helper pushing wheelchair, independent in wheelchair or minimal help in wheelchair</td>
<td>Pt not ambul/immob/wc</td>
</tr>
<tr class="even">
<td>G9722</td>
<td>0010</td>
<td>3</td>
<td>Documented history of renal failure or baseline serum creatinine = 4.0 mg/dl; renal transplant recipients are not considered to have preoperative renal failure, unless, since transplantation the cr has been or is 4.0 or higher</td>
<td>Doc hx renal fail or cr+ &gt;4</td>
</tr>
<tr class="odd">
<td>G9723</td>
<td>0010</td>
<td>3</td>
<td>Hospice services for patient received any time during the measurement period</td>
<td>Hosp recd by pt dur msmt per</td>
</tr>
<tr class="even">
<td>G9724</td>
<td>0010</td>
<td>3</td>
<td>Patients who had documentation of use of anticoagulant medications overlapping the measurement year</td>
<td>Pt w/doc use anticoag mst yr</td>
</tr>
<tr class="odd">
<td>G9725</td>
<td>0010</td>
<td>3</td>
<td>Patients who use hospice services any time during the measurement period</td>
<td>Pt w/hosp anytime msmt per</td>
</tr>
<tr class="even">
<td>G9726</td>
<td>0010</td>
<td>3</td>
<td>Patient refused to participate</td>
<td>Refused to participate</td>
</tr>
<tr class="odd">
<td>G9727</td>
<td>0010</td>
<td>3</td>
<td>Patient unable to complete the knee fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available</td>
<td>Pt unable cmplt knee fs prom</td>
</tr>
<tr class="even">
<td>G9728</td>
<td>0010</td>
<td>3</td>
<td>Patient refused to participate</td>
<td>Refused to participate</td>
</tr>
<tr class="odd">
<td>G9729</td>
<td>0010</td>
<td>3</td>
<td>Patient unable to complete the hip fs prom at initial evaluation and discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available</td>
<td>Pt unbl cmplt hip fs prom</td>
</tr>
<tr class="even">
<td>G9730</td>
<td>0010</td>
<td>3</td>
<td>Patient refused to participate</td>
<td>Refused to participate</td>
</tr>
<tr class="odd">
<td>G9731</td>
<td>0010</td>
<td>3</td>
<td>Patient unable to complete the ankle/foot fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available</td>
<td>Pt unbl cmplt ft/ank fs prom</td>
</tr>
<tr class="even">
<td>G9732</td>
<td>0010</td>
<td>3</td>
<td>Patient refused to participate</td>
<td>Refused to participate</td>
</tr>
<tr class="odd">
<td>G9733</td>
<td>0010</td>
<td>3</td>
<td>Patient unable to complete the low back fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available</td>
<td>Pt unbl cmplt lb fs prom</td>
</tr>
<tr class="even">
<td>G9734</td>
<td>0010</td>
<td>3</td>
<td>Patient refused to participate</td>
<td>Refused to participate</td>
</tr>
<tr class="odd">
<td>G9735</td>
<td>0010</td>
<td>3</td>
<td>Patient unable to complete the shoulder fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available</td>
<td>Pt unbl cmplt shld fs prom</td>
</tr>
<tr class="even">
<td>G9736</td>
<td>0010</td>
<td>3</td>
<td>Patient refused to participate</td>
<td>Refused to participate</td>
</tr>
<tr class="odd">
<td>G9737</td>
<td>0010</td>
<td>3</td>
<td>Patient unable to complete the elbow/wrist/hand fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available</td>
<td>Pt unbl cmplt ewh fs prom</td>
</tr>
<tr class="even">
<td>G9738</td>
<td>0010</td>
<td>3</td>
<td>Patient refused to participate</td>
<td>Refused to participate</td>
</tr>
<tr class="odd">
<td>G9739</td>
<td>0010</td>
<td>3</td>
<td>Patient unable to complete the general orthopedic fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available</td>
<td>Pt unbl cmplt go fs prom</td>
</tr>
<tr class="even">
<td>G9740</td>
<td>0010</td>
<td>3</td>
<td>Hospice services given to patient any time during the measurement period</td>
<td>Hosp srv to pt dur msmt per</td>
</tr>
<tr class="odd">
<td>G9741</td>
<td>0010</td>
<td>3</td>
<td>Patients who use hospice services any time during the measurement period</td>
<td>Pt w/hosp anytime msmt per</td>
</tr>
<tr class="even">
<td>G9742</td>
<td>0010</td>
<td>3</td>
<td>Psychiatric symptoms assessed</td>
<td>Psych sympt assessed</td>
</tr>
<tr class="odd">
<td>G9743</td>
<td>0010</td>
<td>3</td>
<td>Psychiatric symptoms not assessed, reason not otherwise specified</td>
<td>Psych symp not assessed, rns</td>
</tr>
<tr class="even">
<td>G9744</td>
<td>0010</td>
<td>3</td>
<td>Patient not eligible due to active diagnosis of hypertension</td>
<td>Pt not eli d/t act dig htn</td>
</tr>
<tr class="odd">
<td>G9745</td>
<td>0010</td>
<td>3</td>
<td>Documented reason for not screening or recommending a follow-up for high blood pressure</td>
<td>Doc rsn no hbp scrn or f/u</td>
</tr>
<tr class="even">
<td>G9746</td>
<td>0010</td>
<td>3</td>
<td>Patient has mitral stenosis or prosthetic heart valves or patient has transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)</td>
<td>Mit sten, valve or trans af</td>
</tr>
<tr class="odd">
<td>G9747</td>
<td>0010</td>
<td>3</td>
<td>Patient is undergoing palliative dialysis with a catheter</td>
<td>Pall dialysis with catheter</td>
</tr>
<tr class="even">
<td>G9748</td>
<td>0010</td>
<td>3</td>
<td>Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant</td>
<td>App transpl lvg kidney donor</td>
</tr>
<tr class="odd">
<td>G9749</td>
<td>0010</td>
<td>3</td>
<td>Patient is undergoing palliative dialysis with a catheter</td>
<td>Pall dialysis with catheter</td>
</tr>
<tr class="even">
<td>G9750</td>
<td>0010</td>
<td>3</td>
<td>Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant</td>
<td>App transpl lvg kidney donor</td>
</tr>
<tr class="odd">
<td>G9751</td>
<td>0010</td>
<td>3</td>
<td>Patient died at any time during the 24-month measurement period</td>
<td>Pt died w/in 24 mos rpt time</td>
</tr>
<tr class="even">
<td>G9752</td>
<td>0010</td>
<td>3</td>
<td>Emergency surgery</td>
<td>Urgent surgery</td>
</tr>
<tr class="odd">
<td>G9753</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason for not conducting a search for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., trauma, acute myocardial infarction, stroke, aortic aneurysm where time is of the essence)</td>
<td>Doc no dicom, ct other fac</td>
</tr>
<tr class="even">
<td>G9754</td>
<td>0010</td>
<td>3</td>
<td>A finding of an incidental pulmonary nodule</td>
<td>Incid pulm nodule</td>
</tr>
<tr class="odd">
<td>G9755</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not including a recommended interval and modality for follow-up or for no follow-up, and source of recommendations (e.g., patients with unexplained fever, immunocompromised patients who are at risk for infection)</td>
<td>Doc med rsn no fllw up</td>
</tr>
<tr class="even">
<td>G9756</td>
<td>0010</td>
<td>3</td>
<td>Surgical procedures that included the use of silicone oil</td>
<td>Surg proc w/silicone oil</td>
</tr>
<tr class="odd">
<td>G9757</td>
<td>0010</td>
<td>3</td>
<td>Surgical procedures that included the use of silicone oil</td>
<td>Surg proc w/silicone oil</td>
</tr>
<tr class="even">
<td>G9758</td>
<td>0010</td>
<td>3</td>
<td>Patient in hospice at any time during the measurement period</td>
<td>Pt in hos</td>
</tr>
<tr class="odd">
<td>G9759</td>
<td>0010</td>
<td>3</td>
<td>History of preoperative posterior capsule rupture</td>
<td>Hx preop post cap rup</td>
</tr>
<tr class="even">
<td>G9760</td>
<td>0010</td>
<td>3</td>
<td>Patients who use hospice services any time during the measurement period</td>
<td>Pt w/hosp anytime msmt per</td>
</tr>
<tr class="odd">
<td>G9761</td>
<td>0010</td>
<td>3</td>
<td>Patients who use hospice services any time during the measurement period</td>
<td>Pt w/hosp anytime msmt per</td>
</tr>
<tr class="even">
<td>G9762</td>
<td>0010</td>
<td>3</td>
<td>Patient had at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient’s 9th and 13th birthdays</td>
<td>Pt had &gt;= 2-3 hpv vaccines</td>
</tr>
<tr class="odd">
<td>G9763</td>
<td>0010</td>
<td>3</td>
<td>Patient did not have at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient’s 9th and 13th birthdays</td>
<td>Pt not have 2-3 hpv vaccines</td>
</tr>
<tr class="even">
<td>G9764</td>
<td>0010</td>
<td>3</td>
<td>Patient has been treated with a systemic medication for psoriasis vulgaris</td>
<td>Pt treatd w/oral syst or bio</td>
</tr>
<tr class="odd">
<td>G9765</td>
<td>0010</td>
<td>3</td>
<td>Documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic medication for at least six consecutive months (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi</td>
<td>Doc pat declined therapy</td>
</tr>
<tr class="even">
<td>G9766</td>
<td>0010</td>
<td>3</td>
<td>Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment</td>
<td>Cva stroke dx tx transf fac</td>
</tr>
<tr class="odd">
<td>G9767</td>
<td>0010</td>
<td>3</td>
<td>Hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment</td>
<td>Hosp new dx cva consid evst</td>
</tr>
<tr class="even">
<td>G9768</td>
<td>0010</td>
<td>3</td>
<td>Patients who utilize hospice services any time during the measurement period</td>
<td>Pt w/hosp anytime msmt per</td>
</tr>
<tr class="odd">
<td>G9769</td>
<td>0010</td>
<td>3</td>
<td>Patient had a bone mineral density test in the past two years or received osteoporosis medication or therapy in the past 12 months</td>
<td>Bn den 2yr/got ost med/ther</td>
</tr>
<tr class="even">
<td>G9770</td>
<td>0010</td>
<td>3</td>
<td>Peripheral nerve block (pnb)</td>
<td>Perip nerve block</td>
</tr>
<tr class="odd">
<td>G9771</td>
<td>0010</td>
<td>3</td>
<td>At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) achieved within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time</td>
<td>Anes end, 1 temp &gt;35.5(95.9)</td>
</tr>
<tr class="even">
<td>G9772</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not achieving at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time (e.g., emergency cases, intentional hypothermia, etc.)</td>
<td>Doc med rsn no temp &gt;= 35.5</td>
</tr>
<tr class="odd">
<td>G9773</td>
<td>0010</td>
<td>3</td>
<td>At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) not achieved within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time, reason not given</td>
<td>1 bod temp &gt;=35.5</td>
</tr>
<tr class="even">
<td>G9774</td>
<td>0010</td>
<td>3</td>
<td>Patients who have had a hysterectomy</td>
<td>Pt had hyst</td>
</tr>
<tr class="odd">
<td>G9775</td>
<td>0010</td>
<td>3</td>
<td>Patient received at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively</td>
<td>Recd 2 anti-emet pre/intraop</td>
</tr>
<tr class="even">
<td>G9776</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason)</td>
<td>Doc med rsn no proph antiem</td>
</tr>
<tr class="odd">
<td>G9777</td>
<td>0010</td>
<td>3</td>
<td>Patient did not receive at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively</td>
<td>Pt no antiemet pre/intraop</td>
</tr>
<tr class="even">
<td>G9778</td>
<td>0010</td>
<td>3</td>
<td>Patients who have a diagnosis of pregnancy</td>
<td>Pts dx w/pregn</td>
</tr>
<tr class="odd">
<td>G9779</td>
<td>0010</td>
<td>3</td>
<td>Patients who are breastfeeding</td>
<td>Pts breastfeeding</td>
</tr>
<tr class="even">
<td>G9780</td>
<td>0010</td>
<td>3</td>
<td>Patients who have a diagnosis of rhabdomyolysis</td>
<td>Pts dx w/rhabdomyolysis</td>
</tr>
<tr class="odd">
<td>G9781</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, and patients with end stage renal disease (esrd))</td>
<td>Doc rsn no statin</td>
</tr>
<tr class="even">
<td>G9782</td>
<td>0010</td>
<td>3</td>
<td>History of or active diagnosis of familial or pure hypercholesterolemia</td>
<td>Hx dx fam/pure hypercholes</td>
</tr>
<tr class="odd">
<td>G9783</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result &lt; 70 mg/dl and are not taking statin therapy</td>
<td>Doc dx dm, fast &lt;70, no stat</td>
</tr>
<tr class="even">
<td>G9784</td>
<td>0010</td>
<td>3</td>
<td>Pathologists/dermatopathologists providing a second opinion on a biopsy</td>
<td>Path/derm prov 2nd biop opin</td>
</tr>
<tr class="odd">
<td>G9785</td>
<td>0010</td>
<td>3</td>
<td>Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist</td>
<td>Path report sent</td>
</tr>
<tr class="even">
<td>G9786</td>
<td>0010</td>
<td>3</td>
<td>Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) was not sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist</td>
<td>Path report not sent</td>
</tr>
<tr class="odd">
<td>G9787</td>
<td>0010</td>
<td>3</td>
<td>Patient alive as of the last day of the measurement year</td>
<td>Pt alive</td>
</tr>
<tr class="even">
<td>G9788</td>
<td>0010</td>
<td>3</td>
<td>Most recent bp is less than or equal to 140/90 mm hg</td>
<td>Most rct bp &lt;/= 140/90</td>
</tr>
<tr class="odd">
<td>G9789</td>
<td>0010</td>
<td>3</td>
<td>Blood pressure recorded during inpatient stays, emergency room visits, urgent care visits, and patient self-reported bp’s (home and health fair bp results)</td>
<td>Record bp ip, er, urg/self</td>
</tr>
<tr class="even">
<td>G9790</td>
<td>0010</td>
<td>3</td>
<td>Most recent bp is greater than 140/90 mm hg, or blood pressure not documented</td>
<td>Most rct bp &gt;/= 140/90</td>
</tr>
<tr class="odd">
<td>G9791</td>
<td>0010</td>
<td>3</td>
<td>Most recent tobacco status is tobacco free</td>
<td>Most rct tob stat free</td>
</tr>
<tr class="even">
<td>G9792</td>
<td>0010</td>
<td>3</td>
<td>Most recent tobacco status is not tobacco free</td>
<td>Most rct tob stat not free</td>
</tr>
<tr class="odd">
<td>G9793</td>
<td>0010</td>
<td>3</td>
<td>Patient is currently on a daily aspirin or other antiplatelet</td>
<td>Pt on daily asa/antiplat</td>
</tr>
<tr class="even">
<td>G9794</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g., history of gastrointestinal bleed, intra-cranial bleed, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)</td>
<td>Doc med rsn no daily aspirin</td>
</tr>
<tr class="odd">
<td>G9795</td>
<td>0010</td>
<td>3</td>
<td>Patient is not currently on a daily aspirin or other antiplatelet</td>
<td>Pt no daily asa/antiplat</td>
</tr>
<tr class="even">
<td>G9796</td>
<td>0010</td>
<td>3</td>
<td>Patient is currently on a statin therapy</td>
<td>Pt not currently on statin</td>
</tr>
<tr class="odd">
<td>G9797</td>
<td>0010</td>
<td>3</td>
<td>Patient is not on a statin therapy</td>
<td>Pt currently on statin</td>
</tr>
<tr class="even">
<td>G9798</td>
<td>0010</td>
<td>3</td>
<td>Discharge(s) for ami between july 1 of the year prior measurement period to june 30 of the measurement period</td>
<td>D/c ami btw 7/1-6/30 meas pd</td>
</tr>
<tr class="odd">
<td>G9799</td>
<td>0010</td>
<td>3</td>
<td>Patients with a medication dispensing event indicator of a history of asthma any time during the patient’s history through the end of the measure period</td>
<td>Med disp evt indic hx asth</td>
</tr>
<tr class="even">
<td>G9800</td>
<td>0010</td>
<td>3</td>
<td>Patients who are identified as having an intolerance or allergy to beta-blocker therapy</td>
<td>Pt id intol/alleg beta-block</td>
</tr>
<tr class="odd">
<td>G9801</td>
<td>0010</td>
<td>3</td>
<td>Hospitalizations in which the patient was transferred directly to a non-acute care facility for any diagnosis</td>
<td>Nonacut transf from inpt</td>
</tr>
<tr class="even">
<td>G9802</td>
<td>0010</td>
<td>3</td>
<td>Patients who use hospice services any time during the measurement period</td>
<td>Pt w/hosp anytime msmt per</td>
</tr>
<tr class="odd">
<td>G9803</td>
<td>0010</td>
<td>3</td>
<td>Patient prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami</td>
<td>Pt presc 135 day trmt</td>
</tr>
<tr class="even">
<td>G9804</td>
<td>0010</td>
<td>3</td>
<td>Patient was not prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami</td>
<td>Pt not presc 135 day trmt</td>
</tr>
<tr class="odd">
<td>G9805</td>
<td>0010</td>
<td>3</td>
<td>Patients who use hospice services any time during the measurement period</td>
<td>Pt w/hosp anytime msmt per</td>
</tr>
<tr class="even">
<td>G9806</td>
<td>0010</td>
<td>3</td>
<td>Patients who received cervical cytology or an hpv test</td>
<td>Pt recd cerv cyto/hpv</td>
</tr>
<tr class="odd">
<td>G9807</td>
<td>0010</td>
<td>3</td>
<td>Patients who did not receive cervical cytology or an hpv test</td>
<td>Pt no recd cerv cyto/hpv</td>
</tr>
<tr class="even">
<td>G9808</td>
<td>0010</td>
<td>3</td>
<td>Any patients who had no asthma controller medications dispensed during the measurement year</td>
<td>Pt no asthm cont med mst per</td>
</tr>
<tr class="odd">
<td>G9809</td>
<td>0010</td>
<td>3</td>
<td>Patients who use hospice services any time during the measurement period</td>
<td>Pt w/hosp anytime msmt per</td>
</tr>
<tr class="even">
<td>G9810</td>
<td>0010</td>
<td>3</td>
<td>Patient achieved a pdc of at least 75% for their asthma controller medication</td>
<td>Pdc 75% w/asth cont med</td>
</tr>
<tr class="odd">
<td>G9811</td>
<td>0010</td>
<td>3</td>
<td>Patient did not achieve a pdc of at least 75% for their asthma controller medication</td>
<td>No pdc 75% w/asth cont med</td>
</tr>
<tr class="even">
<td>G9812</td>
<td>0010</td>
<td>3</td>
<td>Patient died including all deaths occurring during the hospitalization in which the operation was performed, even if after 30 days, and those deaths occurring after discharge from the hospital, but within 30 days of the procedure</td>
<td>Pt died during inpt/30d aft</td>
</tr>
<tr class="odd">
<td>G9813</td>
<td>0010</td>
<td>3</td>
<td>Patient did not die within 30 days of the procedure or during the index hospitalization</td>
<td>Pt not died w/in 30d of proc</td>
</tr>
<tr class="even">
<td>G9814</td>
<td>0010</td>
<td>3</td>
<td>Death occurring during the index acute care hospitalization</td>
<td>Death during index hosp</td>
</tr>
<tr class="odd">
<td>G9815</td>
<td>0010</td>
<td>3</td>
<td>Death did not occur during the index acute care hospitalization</td>
<td>Death not during index hosp</td>
</tr>
<tr class="even">
<td>G9816</td>
<td>0010</td>
<td>3</td>
<td>Death occurring after discharge from the hospital but within 30 days post procedure</td>
<td>Death &lt;30 day post discharge</td>
</tr>
<tr class="odd">
<td>G9817</td>
<td>0010</td>
<td>3</td>
<td>Death did not occur after discharge from the hospital within 30 days post procedure</td>
<td>No death 30-days post-disch</td>
</tr>
<tr class="even">
<td>G9818</td>
<td>0010</td>
<td>3</td>
<td>Documentation of sexual activity</td>
<td>Doc sex activity</td>
</tr>
<tr class="odd">
<td>G9819</td>
<td>0010</td>
<td>3</td>
<td>Patients who use hospice services any time during the measurement period</td>
<td>Pt w/hosp anytime msmt per</td>
</tr>
<tr class="even">
<td>G9820</td>
<td>0010</td>
<td>3</td>
<td>Documentation of a chlamydia screening test with proper follow-up</td>
<td>Doc chlam scr test w/follow</td>
</tr>
<tr class="odd">
<td>G9821</td>
<td>0010</td>
<td>3</td>
<td>No documentation of a chlamydia screening test with proper follow-up</td>
<td>No doc chlam scr ts w/follow</td>
</tr>
<tr class="even">
<td>G9822</td>
<td>0010</td>
<td>3</td>
<td>Women who had an endometrial ablation procedure during the year prior to the index date (exclusive of the index date)</td>
<td>Endo abl proc yr prev ind dt</td>
</tr>
<tr class="odd">
<td>G9823</td>
<td>0010</td>
<td>3</td>
<td>Endometrial sampling or hysteroscopy with biopsy and results documented</td>
<td>Endo smpl/hyst bx res doc</td>
</tr>
<tr class="even">
<td>G9824</td>
<td>0010</td>
<td>3</td>
<td>Endometrial sampling or hysteroscopy with biopsy and results not documented</td>
<td>Endo smpl/hyst bx res no doc</td>
</tr>
<tr class="odd">
<td>G9825</td>
<td>0010</td>
<td>3</td>
<td>Her-2/neu negative or undocumented/unknown</td>
<td>Her-2 neg,undoc/unkn</td>
</tr>
<tr class="even">
<td>G9826</td>
<td>0010</td>
<td>3</td>
<td>Patient transferred to practice after initiation of chemotherapy</td>
<td>Transf pract aft init chemo</td>
</tr>
<tr class="odd">
<td>G9827</td>
<td>0010</td>
<td>3</td>
<td>Her2-targeted therapies not administered during the initial course of treatment</td>
<td>Her-2 targ ther no init tx</td>
</tr>
<tr class="even">
<td>G9828</td>
<td>0010</td>
<td>3</td>
<td>Her2-targeted therapies administered during the initial course of treatment</td>
<td>Her-2 targ ther dur init tx</td>
</tr>
<tr class="odd">
<td>G9829</td>
<td>0010</td>
<td>3</td>
<td>Breast adjuvant chemotherapy administered</td>
<td>Breast adj chemo admin</td>
</tr>
<tr class="even">
<td>G9830</td>
<td>0010</td>
<td>3</td>
<td>Her-2/neu positive</td>
<td>Her-2 pos</td>
</tr>
<tr class="odd">
<td>G9831</td>
<td>0010</td>
<td>3</td>
<td>Ajcc stage at breast cancer diagnosis = ii or iii</td>
<td>Ajcc stg brt ca dx ii or iii</td>
</tr>
<tr class="even">
<td>G9832</td>
<td>0010</td>
<td>3</td>
<td>Ajcc stage at breast cancer diagnosis = i (ia or ib) and t-stage at breast cancer diagnosis does not equal = t1, t1a, t1b</td>
<td>Brt ca dx i, no t1/t1a/t1b</td>
</tr>
<tr class="odd">
<td>G9833</td>
<td>0010</td>
<td>3</td>
<td>Patient transfer to practice after initiation of chemotherapy</td>
<td>Transf pract aft init chemo</td>
</tr>
<tr class="even">
<td>G9834</td>
<td>0010</td>
<td>3</td>
<td>Patient has metastatic disease at diagnosis</td>
<td>Pt met dis at dx</td>
</tr>
<tr class="odd">
<td>G9835</td>
<td>0010</td>
<td>3</td>
<td>Trastuzumab administered within 12 months of diagnosis</td>
<td>Trastuz given w/in 12 mos dx</td>
</tr>
<tr class="even">
<td>G9836</td>
<td>0010</td>
<td>3</td>
<td>Reason for not administering trastuzumab documented (e.g. patient declined, patient died, patient transferred, contraindication or other clinical exclusion, neoadjuvant chemotherapy or radiation not complete)</td>
<td>Rsn no trast given doc</td>
</tr>
<tr class="odd">
<td>G9837</td>
<td>0010</td>
<td>3</td>
<td>Trastuzumab not administered within 12 months of diagnosis</td>
<td>Trastuz not in 12 mos dx</td>
</tr>
<tr class="even">
<td>G9838</td>
<td>0010</td>
<td>3</td>
<td>Patient has metastatic disease at diagnosis</td>
<td>Pt met dis at dx</td>
</tr>
<tr class="odd">
<td>G9839</td>
<td>0010</td>
<td>3</td>
<td>Anti-egfr monoclonal antibody therapy</td>
<td>Anti-egfr mon anti ther</td>
</tr>
<tr class="even">
<td>G9840</td>
<td>0010</td>
<td>3</td>
<td>Ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab</td>
<td>Gene testing performed</td>
</tr>
<tr class="odd">
<td>G9841</td>
<td>0010</td>
<td>3</td>
<td>Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab</td>
<td>Gene testing not performed</td>
</tr>
<tr class="even">
<td>G9842</td>
<td>0010</td>
<td>3</td>
<td>Patient has metastatic disease at diagnosis</td>
<td>Pt met dis at dx</td>
</tr>
<tr class="odd">
<td>G9843</td>
<td>0010</td>
<td>3</td>
<td>Ras (kras or nras) gene mutation</td>
<td>Kras or nras gene mutation</td>
</tr>
<tr class="even">
<td>G9844</td>
<td>0010</td>
<td>3</td>
<td>Patient did not receive anti-egfr monoclonal antibody therapy</td>
<td>Pt no recd anti-egfr ther</td>
</tr>
<tr class="odd">
<td>G9845</td>
<td>0010</td>
<td>3</td>
<td>Patient received anti-egfr monoclonal antibody therapy</td>
<td>Pt recd anti-egfr ther</td>
</tr>
<tr class="even">
<td>G9846</td>
<td>0010</td>
<td>3</td>
<td>Patients who died from cancer</td>
<td>Pt died from cancer</td>
</tr>
<tr class="odd">
<td>G9847</td>
<td>0010</td>
<td>3</td>
<td>Patient received chemotherapy in the last 14 days of life</td>
<td>Pt recd chemo last 14d life</td>
</tr>
<tr class="even">
<td>G9848</td>
<td>0010</td>
<td>3</td>
<td>Patient did not receive chemotherapy in the last 14 days of life</td>
<td>Pt no chemo last 14d life</td>
</tr>
<tr class="odd">
<td>G9849</td>
<td>0010</td>
<td>3</td>
<td>Patients who died from cancer</td>
<td>Pt died from cancer</td>
</tr>
<tr class="even">
<td>G9850</td>
<td>0010</td>
<td>3</td>
<td>Patient had more than one emergency department visit in the last 30 days of life</td>
<td>1/more ed last 30d life</td>
</tr>
<tr class="odd">
<td>G9851</td>
<td>0010</td>
<td>3</td>
<td>Patient had one or less emergency department visits in the last 30 days of life</td>
<td>1/no ed visit last 30d life</td>
</tr>
<tr class="even">
<td>G9852</td>
<td>0010</td>
<td>3</td>
<td>Patients who died from cancer</td>
<td>Pt died from cancer</td>
</tr>
<tr class="odd">
<td>G9853</td>
<td>0010</td>
<td>3</td>
<td>Patient admitted to the icu in the last 30 days of life</td>
<td>Icu stay last 30d life</td>
</tr>
<tr class="even">
<td>G9854</td>
<td>0010</td>
<td>3</td>
<td>Patient was not admitted to the icu in the last 30 days of life</td>
<td>No icu stay last 30d life</td>
</tr>
<tr class="odd">
<td>G9855</td>
<td>0010</td>
<td>3</td>
<td>Patients who died from cancer</td>
<td>Pt died from cancer</td>
</tr>
<tr class="even">
<td>G9856</td>
<td>0010</td>
<td>3</td>
<td>Patient was not admitted to hospice</td>
<td>Pt no hospice</td>
</tr>
<tr class="odd">
<td>G9857</td>
<td>0010</td>
<td>3</td>
<td>Patient admitted to hospice</td>
<td>Pt admit hospice</td>
</tr>
<tr class="even">
<td>G9858</td>
<td>0010</td>
<td>3</td>
<td>Patient enrolled in hospice</td>
<td>Pt enroll hospice</td>
</tr>
<tr class="odd">
<td>G9859</td>
<td>0010</td>
<td>3</td>
<td>Patients who died from cancer</td>
<td>Pt died from cancer</td>
</tr>
<tr class="even">
<td>G9860</td>
<td>0010</td>
<td>3</td>
<td>Patient spent less than three days in hospice care</td>
<td>Pt less 3d hospice</td>
</tr>
<tr class="odd">
<td>G9861</td>
<td>0010</td>
<td>3</td>
<td>Patient spent greater than or equal to three days in hospice care</td>
<td>Pt more than 3d hospice</td>
</tr>
<tr class="even">
<td>G9862</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not recommending at least a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is = 66 years old, or life expectancy &lt; 10 years old, other medical reasons)</td>
<td>Doc rsn no 10 yr follow</td>
</tr>
<tr class="odd">
<td>G9868</td>
<td>0010</td>
<td>3</td>
<td>Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use under the next generation aco model, less than 10 minutes</td>
<td>Next gen aco model &lt;10min</td>
</tr>
<tr class="even">
<td>G9869</td>
<td>0010</td>
<td>3</td>
<td>Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use under the next generation aco model, 10-20 minutes</td>
<td>Next gen aco model 10-20min</td>
</tr>
<tr class="odd">
<td>G9870</td>
<td>0010</td>
<td>3</td>
<td>Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use under the next generation aco model, 20 or more minutes</td>
<td>Next gen aco model &gt;20min</td>
</tr>
<tr class="even">
<td>G9873</td>
<td>0010</td>
<td>3</td>
<td>First medicare diabetes prevention program (mdpp) core session was attended by an mdpp beneficiary under the mdpp expanded model (em). a core session is an mdpp service that: (1) is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions</td>
<td>1 em core session</td>
</tr>
<tr class="odd">
<td>G9874</td>
<td>0010</td>
<td>3</td>
<td>Four total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em). a core session is an mdpp service that: (1) is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions</td>
<td>4 em core sessions</td>
</tr>
<tr class="even">
<td>G9875</td>
<td>0010</td>
<td>3</td>
<td>Nine total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em). a core session is an mdpp service that: (1) is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions</td>
<td>9 em core sessions</td>
</tr>
<tr class="odd">
<td>G9876</td>
<td>0010</td>
<td>3</td>
<td>Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em). a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 7-9</td>
<td>2 em core ms mo 7-9 no wl</td>
</tr>
<tr class="even">
<td>G9877</td>
<td>0010</td>
<td>3</td>
<td>Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em). a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 10-12</td>
<td>2 em core ms mo 10-12 no wl</td>
</tr>
<tr class="odd">
<td>G9878</td>
<td>0010</td>
<td>3</td>
<td>Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em). a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 7-9</td>
<td>2 em core ms mo 7-9 wl</td>
</tr>
<tr class="even">
<td>G9879</td>
<td>0010</td>
<td>3</td>
<td>Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em). a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 10-12</td>
<td>2 em core ms mo 10-12 wl</td>
</tr>
<tr class="odd">
<td>G9880</td>
<td>0010</td>
<td>3</td>
<td>The mdpp beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight in months 1-12 of the mdpp services period under the mdpp expanded model (em). this is a one-time payment available when a beneficiary first achieves at least 5% weight loss from baseline as measured by an in-person weight measurement at a core session or core maintenance session</td>
<td>Em 5 percent wl</td>
</tr>
<tr class="even">
<td>G9881</td>
<td>0010</td>
<td>3</td>
<td>The mdpp beneficiary achieved at least 9% weight loss (wl) from his/her baseline weight in months 1-24 under the mdpp expanded model (em). this is a one-time payment available when a beneficiary first achieves at least 9% weight loss from baseline as measured by an in-person weight measurement at a core session, core maintenance session, or ongoing maintenance session</td>
<td>Em 9 percent wl</td>
</tr>
<tr class="odd">
<td>G9882</td>
<td>0010</td>
<td>3</td>
<td>Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 13-15 under the mdpp expanded model (em). an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 13-15</td>
<td>2 em ongoing ms mo 13-15 wl</td>
</tr>
<tr class="even">
<td>G9883</td>
<td>0010</td>
<td>3</td>
<td>Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 16-18 under the mdpp expanded model (em). an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 16-18</td>
<td>2 em ongoing ms mo 16-18 wl</td>
</tr>
<tr class="odd">
<td>G9884</td>
<td>0010</td>
<td>3</td>
<td>Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 19-21 under the mdpp expanded model (em). an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 19-21</td>
<td>2 em ongoing ms mo 19-21 wl</td>
</tr>
<tr class="even">
<td>G9885</td>
<td>0010</td>
<td>3</td>
<td>Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 22-24 under the mdpp expanded model (em). an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 22-24</td>
<td>2 em ongoing ms mo 22-24 wl</td>
</tr>
<tr class="odd">
<td>G9890</td>
<td>0010</td>
<td>3</td>
<td>Bridge payment: a one-time payment for the first medicare diabetes prevention program (mdpp) core session, core maintenance session, or ongoing maintenance session furnished by an mdpp supplier to an mdpp beneficiary during months 1-24 of the mdpp expanded model (em) who has previously received mdpp services from a different mdpp supplier under the mdpp expanded model. a supplier may only receive one bridge payment per mdpp beneficiary</td>
<td>Em bridge payment</td>
</tr>
<tr class="even">
<td>G9891</td>
<td>0010</td>
<td>3</td>
<td>Mdpp session reported as a line-item on a claim for a payable mdpp expanded model (em) hcpcs code for a session furnished by the billing supplier under the mdpp expanded model and counting toward achievement of the attendance performance goal for the payable mdpp expanded model hcpcs code (this code is for reporting purposes only)</td>
<td>Em session reporting</td>
</tr>
<tr class="odd">
<td>G9892</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient reason(s) for not performing a dilated macular examination</td>
<td>Doc pt rsn no dil mac exam</td>
</tr>
<tr class="even">
<td>G9893</td>
<td>0010</td>
<td>3</td>
<td>Dilated macular exam was not performed, reason not otherwise specified</td>
<td>No mac exam</td>
</tr>
<tr class="odd">
<td>G9894</td>
<td>0010</td>
<td>3</td>
<td>Androgen deprivation therapy prescribed/administered in combination with external beam radiotherapy to the prostate</td>
<td>Adr dep thrpy prescribed</td>
</tr>
<tr class="even">
<td>G9895</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate (e.g., salvage therapy)</td>
<td>Doc med rsn no adr dep thrpy</td>
</tr>
<tr class="odd">
<td>G9896</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate</td>
<td>Doc pt rsn no adr dep thrpy</td>
</tr>
<tr class="even">
<td>G9897</td>
<td>0010</td>
<td>3</td>
<td>Patients who were not prescribed/administered androgen deprivation therapy in combination with external beam radiotherapy to the prostate, reason not given</td>
<td>Pt nt prsc adr dep thrpy rng</td>
</tr>
<tr class="odd">
<td>G9898</td>
<td>0010</td>
<td>3</td>
<td>Patient age 65 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 days during the measurement period</td>
<td>Pt 66+ snp or ltc pos</td>
</tr>
<tr class="even">
<td>G9899</td>
<td>0010</td>
<td>3</td>
<td>Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed</td>
<td>Scrn mam perf rslts doc</td>
</tr>
<tr class="odd">
<td>G9900</td>
<td>0010</td>
<td>3</td>
<td>Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified</td>
<td>Scrn mam perf rslts not doc</td>
</tr>
<tr class="even">
<td>G9901</td>
<td>0010</td>
<td>3</td>
<td>Patient age 65 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 days during the measurement period</td>
<td>Pt 66+ snp or ltc pos</td>
</tr>
<tr class="odd">
<td>G9902</td>
<td>0010</td>
<td>3</td>
<td>Patient screened for tobacco use and identified as a tobacco user</td>
<td>Pt scrn tbco and id as user</td>
</tr>
<tr class="even">
<td>G9903</td>
<td>0010</td>
<td>3</td>
<td>Patient screened for tobacco use and identified as a tobacco non-user</td>
<td>Pt scrn tbco id as non user</td>
</tr>
<tr class="odd">
<td>G9904</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason)</td>
<td>Doc med rsn no tbco scrn</td>
</tr>
<tr class="even">
<td>G9905</td>
<td>0010</td>
<td>3</td>
<td>Patient not screened for tobacco use, reason not given</td>
<td>No pt tbco scrn rng</td>
</tr>
<tr class="odd">
<td>G9906</td>
<td>0010</td>
<td>3</td>
<td>Patient identified as a tobacco user received tobacco cessation intervention (counseling and/or pharmacotherapy)</td>
<td>Pt recv tbco cess interv</td>
</tr>
<tr class="even">
<td>G9907</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not providing tobacco cessation intervention (e.g., limited life expectancy, other medical reason)</td>
<td>Doc med rsn no tbco interv</td>
</tr>
<tr class="odd">
<td>G9908</td>
<td>0010</td>
<td>3</td>
<td>Patient identified as tobacco user did not receive tobacco cessation intervention (counseling and/or pharmacotherapy), reason not given</td>
<td>No pt tbco cess interv rng</td>
</tr>
<tr class="even">
<td>G9909</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not providing tobacco cessation intervention if identified as a tobacco user (eg, limited life expectancy, other medical reason)</td>
<td>Doc med rsn no tbco interv</td>
</tr>
<tr class="odd">
<td>G9910</td>
<td>0010</td>
<td>3</td>
<td>Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 days during the measurement period</td>
<td>Pt 66+ snp or ltc pos</td>
</tr>
<tr class="even">
<td>G9911</td>
<td>0010</td>
<td>3</td>
<td>Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant systemic therapy</td>
<td>Node neg pre/post syst ther</td>
</tr>
<tr class="odd">
<td>G9912</td>
<td>0010</td>
<td>3</td>
<td>Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy</td>
<td>Hbv status assesed and int</td>
</tr>
<tr class="even">
<td>G9913</td>
<td>0010</td>
<td>3</td>
<td>Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not given</td>
<td>No hbv status assesd and int</td>
</tr>
<tr class="odd">
<td>G9914</td>
<td>0010</td>
<td>3</td>
<td>Patient receiving an anti-tnf agent</td>
<td>Pt receiving anti-tnf agent</td>
</tr>
<tr class="even">
<td>G9915</td>
<td>0010</td>
<td>3</td>
<td>No record of hbv results documented</td>
<td>No documntd hbv results rcd</td>
</tr>
<tr class="odd">
<td>G9916</td>
<td>0010</td>
<td>3</td>
<td>Functional status performed once in the last 12 months</td>
<td>Funct status past 12 months</td>
</tr>
<tr class="even">
<td>G9917</td>
<td>0010</td>
<td>3</td>
<td>Documentation of advanced stage dementia and caregiver knowledge is limited</td>
<td>Adv dem crgvr limited</td>
</tr>
<tr class="odd">
<td>G9918</td>
<td>0010</td>
<td>3</td>
<td>Functional status not performed, reason not otherwise specified</td>
<td>No funct stat perf, rsn nos</td>
</tr>
<tr class="even">
<td>G9919</td>
<td>0010</td>
<td>3</td>
<td>Screening performed and positive and provision of recommendations</td>
<td>Scrn nd pos nd prov of rec</td>
</tr>
<tr class="odd">
<td>G9920</td>
<td>0010</td>
<td>3</td>
<td>Screening performed and negative</td>
<td>Scrning perf and negative</td>
</tr>
<tr class="even">
<td>G9921</td>
<td>0010</td>
<td>3</td>
<td>No screening performed, partial screening performed or positive screen without recommendations and reason is not given or otherwise specified</td>
<td>No or part scrn nd rng or os</td>
</tr>
<tr class="odd">
<td>G9922</td>
<td>0010</td>
<td>3</td>
<td>Safety concerns screen provided and if positive then documented mitigation recommendations</td>
<td>Sfty cncrns scrn nd mit recs</td>
</tr>
<tr class="even">
<td>G9923</td>
<td>0010</td>
<td>3</td>
<td>Safety concerns screen provided and negative</td>
<td>Safty cncrns scrn and neg</td>
</tr>
<tr class="odd">
<td>G9924</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not providing safety concerns screen or for not providing recommendations, orders or referrals for positive screen (e.g., patient in palliative care, other medical reason)</td>
<td>Doc med rsn no scrn or recs</td>
</tr>
<tr class="even">
<td>G9925</td>
<td>0010</td>
<td>3</td>
<td>Safety concerns screening not provided, reason not otherwise specified</td>
<td>No scrn prov rsn nos</td>
</tr>
<tr class="odd">
<td>G9926</td>
<td>0010</td>
<td>3</td>
<td>Safety concerns screening positive screen is without provision of mitigation recommendations, including but not limited to referral to other resources</td>
<td>Sfty cncrns scrn but no recs</td>
</tr>
<tr class="even">
<td>G9927</td>
<td>0010</td>
<td>3</td>
<td>Documentation of system reason(s) for not prescribing warfarin or another fda-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatment</td>
<td>Doc no warf /fda pt trial</td>
</tr>
<tr class="odd">
<td>G9928</td>
<td>0010</td>
<td>3</td>
<td>Warfarin or another fda-approved anticoagulant not prescribed, reason not given</td>
<td>No warf or fda drug presc</td>
</tr>
<tr class="even">
<td>G9929</td>
<td>0010</td>
<td>3</td>
<td>Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)</td>
<td>Trs/rev af</td>
</tr>
<tr class="odd">
<td>G9930</td>
<td>0010</td>
<td>3</td>
<td>Patients who are receiving comfort care only</td>
<td>Com care</td>
</tr>
<tr class="even">
<td>G9931</td>
<td>0010</td>
<td>3</td>
<td>Documentation of cha2ds2-vasc risk score of 0 or 1</td>
<td>No chad or chad scr 0 or 1</td>
</tr>
<tr class="odd">
<td>G9932</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patient reason(s) for not having records of negative or managed positive tb screen (e.g., patient does not return for mantoux (ppd) skin test evaluation)</td>
<td>Doc pt rsn no tb scrn recrds</td>
</tr>
<tr class="even">
<td>G9933</td>
<td>0010</td>
<td>3</td>
<td>Adenoma(s) or colorectal cancer detected during screening colonoscopy</td>
<td>Canc detectd during col scrn</td>
</tr>
<tr class="odd">
<td>G9934</td>
<td>0010</td>
<td>3</td>
<td>Documentation that neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma</td>
<td>Doc rsn not detecting cancer</td>
</tr>
<tr class="even">
<td>G9935</td>
<td>0010</td>
<td>3</td>
<td>Adenoma(s) or colorectal cancer not detected during screening colonoscopy</td>
<td>Canc not detectd during srcn</td>
</tr>
<tr class="odd">
<td>G9936</td>
<td>0010</td>
<td>3</td>
<td>Surveillance colonoscopy - personal history of colonic polyps, colon cancer, or other malignant neoplasm of rectum, rectosigmoid junction, and anus</td>
<td>Pmh plyp/neo co/rect/jun/ans</td>
</tr>
<tr class="even">
<td>G9937</td>
<td>0010</td>
<td>3</td>
<td>Diagnostic colonoscopy</td>
<td>Dig or surv colsco</td>
</tr>
<tr class="odd">
<td>G9938</td>
<td>0010</td>
<td>3</td>
<td>Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 days during the measurement period</td>
<td>Pt 66+ snp or ltc pos</td>
</tr>
<tr class="even">
<td>G9939</td>
<td>0010</td>
<td>3</td>
<td>Pathologists/dermatopathologists is the same clinician who performed the biopsy</td>
<td>Same path/derm perf biopsy</td>
</tr>
<tr class="odd">
<td>G9940</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not on a statin (e.g., pregnancy, in vitro fertilization, clomiphene rx, esrd, cirrhosis, muscular pain and disease during the measurement period or prior year)</td>
<td>Doc reas no statin therapy</td>
</tr>
<tr class="even">
<td>G9941</td>
<td>0010</td>
<td>3</td>
<td>Back pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively</td>
<td>Pre and post vas wthn 3 mos</td>
</tr>
<tr class="odd">
<td>G9942</td>
<td>0010</td>
<td>3</td>
<td>Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy</td>
<td>Adtl spine proc on same date</td>
</tr>
<tr class="even">
<td>G9943</td>
<td>0010</td>
<td>3</td>
<td>Back pain was not measured by the visual analog scale (vas) within three months preoperatively and at three months ( 6 - 20 weeks) postoperatively</td>
<td>Bk pn nt msr vas scl pre/pst</td>
</tr>
<tr class="odd">
<td>G9944</td>
<td>0010</td>
<td>3</td>
<td>Back pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively</td>
<td>Vas 3 mon pre and 1 yr post</td>
</tr>
<tr class="even">
<td>G9945</td>
<td>0010</td>
<td>3</td>
<td>Patient had cancer, fracture or infection related to the lumbar spine or patient had idiopathic or congenital scoliosis</td>
<td>Pt w/cancer scoliosis</td>
</tr>
<tr class="odd">
<td>G9946</td>
<td>0010</td>
<td>3</td>
<td>Back pain was not measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively</td>
<td>Bk pain no vas</td>
</tr>
<tr class="even">
<td>G9947</td>
<td>0010</td>
<td>3</td>
<td>Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 to 20 weeks) postoperatively</td>
<td>Pre and post vas wthn 3 mos</td>
</tr>
<tr class="odd">
<td>G9948</td>
<td>0010</td>
<td>3</td>
<td>Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy</td>
<td>Adtl spine proc on same date</td>
</tr>
<tr class="even">
<td>G9949</td>
<td>0010</td>
<td>3</td>
<td>Leg pain was not measured by the visual analog scale (vas) at three months (6 ? 20 weeks) postoperatively</td>
<td>Leg pain no vas</td>
</tr>
<tr class="odd">
<td>G9954</td>
<td>0010</td>
<td>3</td>
<td>Patient exhibits 2 or more risk factors for post-operative vomiting</td>
<td>Pt &gt;2 rsk fac post-op vomit</td>
</tr>
<tr class="even">
<td>G9955</td>
<td>0010</td>
<td>3</td>
<td>Cases in which an inhalational anesthetic is used only for induction</td>
<td>Inhlnt anesth only for induc</td>
</tr>
<tr class="odd">
<td>G9956</td>
<td>0010</td>
<td>3</td>
<td>Patient received combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively</td>
<td>Combo thrpy of &gt;= 2 prophly</td>
</tr>
<tr class="even">
<td>G9957</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason for not receiving combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason)</td>
<td>Doc med rsn no combo thrpy</td>
</tr>
<tr class="odd">
<td>G9958</td>
<td>0010</td>
<td>3</td>
<td>Patient did not receive combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively</td>
<td>No combo prohpyl thrp for pt</td>
</tr>
<tr class="even">
<td>G9959</td>
<td>0010</td>
<td>3</td>
<td>Systemic antimicrobials not prescribed</td>
<td>Systemic antimicro not presc</td>
</tr>
<tr class="odd">
<td>G9960</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for prescribing systemic antimicrobials</td>
<td>Med rsn sys antimi nt rx</td>
</tr>
<tr class="even">
<td>G9961</td>
<td>0010</td>
<td>3</td>
<td>Systemic antimicrobials prescribed</td>
<td>Systemic antimicro presc</td>
</tr>
<tr class="odd">
<td>G9962</td>
<td>0010</td>
<td>3</td>
<td>Embolization endpoints are documented separately for each embolized vessel and ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy</td>
<td>Embolization doc separatly</td>
</tr>
<tr class="even">
<td>G9963</td>
<td>0010</td>
<td>3</td>
<td>Embolization endpoints are not documented separately for each embolized vessel or ovarian artery angiography or embolization not performed in the presence of variant uterine artery anatomy</td>
<td>Embolization not doc separat</td>
</tr>
<tr class="odd">
<td>G9964</td>
<td>0010</td>
<td>3</td>
<td>Patient received at least one well-child visit with a pcp during the performance period</td>
<td>Pt recv &gt;=1 well-chld visit</td>
</tr>
<tr class="even">
<td>G9965</td>
<td>0010</td>
<td>3</td>
<td>Patient did not receive at least one well-child visit with a pcp during the performance period</td>
<td>No well-chld vist recv by pt</td>
</tr>
<tr class="odd">
<td>G9966</td>
<td>0010</td>
<td>3</td>
<td>Children who were screened for risk of developmental, behavioral and social delays using a standardized tool with interpretation and report</td>
<td>Scrn, inter, report child</td>
</tr>
<tr class="even">
<td>G9967</td>
<td>0010</td>
<td>3</td>
<td>Children who were not screened for risk of developmental, behavioral and social delays using a standardized tool with interpretation and report</td>
<td>No scrn, inter, reprt child</td>
</tr>
<tr class="odd">
<td>G9968</td>
<td>0010</td>
<td>3</td>
<td>Patient was referred to another provider or specialist during the performance period</td>
<td>Pt refrd 2 pvdr/spclst in pp</td>
</tr>
<tr class="even">
<td>G9969</td>
<td>0010</td>
<td>3</td>
<td>Provider who referred the patient to another provider received a report from the provider to whom the patient was referred</td>
<td>Pvdr rfrd pt rprt rcvd</td>
</tr>
<tr class="odd">
<td>G9970</td>
<td>0010</td>
<td>3</td>
<td>Provider who referred the patient to another provider did not receive a report from the provider to whom the patient was referred</td>
<td>Pvdr rfrd pt no rprt rcvd</td>
</tr>
<tr class="even">
<td>G9974</td>
<td>0010</td>
<td>3</td>
<td>Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity</td>
<td>Mac exam perf</td>
</tr>
<tr class="odd">
<td>G9975</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason(s) for not performing a dilated macular examination</td>
<td>Doc med rsn no dil mac exam</td>
</tr>
<tr class="even">
<td>G9978</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m new pt 10mins</td>
</tr>
<tr class="odd">
<td>G9979</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 20 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m new pt 20mins</td>
</tr>
<tr class="even">
<td>G9980</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate severity. typically, 30 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m new pt 30 mins</td>
</tr>
<tr class="odd">
<td>G9981</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 45 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m new pt 45mins</td>
</tr>
<tr class="even">
<td>G9982</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 60 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m new pt 60mins</td>
</tr>
<tr class="odd">
<td>G9983</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m est. pt 10mins</td>
</tr>
<tr class="even">
<td>G9984</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 15 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m est. pt 15mins</td>
</tr>
<tr class="odd">
<td>G9985</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a detailed history; a detailed examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 25 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m est. pt 25mins</td>
</tr>
<tr class="even">
<td>G9986</td>
<td>0010</td>
<td>3</td>
<td>Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 40 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology</td>
<td>Remote e/m est. pt 40mins</td>
</tr>
<tr class="odd">
<td>G9987</td>
<td>0010</td>
<td>3</td>
<td>Bundled payments for care improvement advanced (bpci advanced) model home visit for patient assessment performed by clinical staff for an individual not considered homebound, including, but not necessarily limited to patient assessment of clinical status, safety/fall prevention, functional status/ambulation, medication reconciliation/management, compliance with orders/plan of care, performance of activities of daily living, and ensuring beneficiary connections to community and other services; for use only for a bpci advanced model episode of care; may not be billed for a 30-day period covered by a transitional care management code</td>
<td>Bpci advanced in home visit</td>
</tr>
</tbody>
</table>
</div>
<div id="h-series-alcohol-and-drug-abuse-treatment-services-h0001-h2037" class="section level2">
<h2>H Series: Alcohol and Drug Abuse Treatment Services (H0001-H2037)</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>H0001</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug assessment</td>
<td>Alcohol and/or drug assess</td>
</tr>
<tr class="even">
<td>H0002</td>
<td>0010</td>
<td>3</td>
<td>Behavioral health screening to determine eligibility for admission to treatment program</td>
<td>Alcohol and/or drug screenin</td>
</tr>
<tr class="odd">
<td>H0003</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs</td>
<td>Alcohol and/or drug screenin</td>
</tr>
<tr class="even">
<td>H0004</td>
<td>0010</td>
<td>3</td>
<td>Behavioral health counseling and therapy, per 15 minutes</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="odd">
<td>H0005</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug services; group counseling by a clinician</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="even">
<td>H0006</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug services; case management</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="odd">
<td>H0007</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug services; crisis intervention (outpatient)</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="even">
<td>H0008</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug services; sub-acute detoxification (hospital inpatient)</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="odd">
<td>H0009</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug services; acute detoxification (hospital inpatient)</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="even">
<td>H0010</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient)</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="odd">
<td>H0011</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug services; acute detoxification (residential addiction program inpatient)</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="even">
<td>H0012</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient)</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="odd">
<td>H0013</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug services; acute detoxification (residential addiction program outpatient)</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="even">
<td>H0014</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug services; ambulatory detoxification</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="odd">
<td>H0015</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="even">
<td>H0016</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting)</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="odd">
<td>H0017</td>
<td>0010</td>
<td>3</td>
<td>Behavioral health; residential (hospital residential treatment program), without room and board, per diem</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="even">
<td>H0018</td>
<td>0010</td>
<td>3</td>
<td>Behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="odd">
<td>H0019</td>
<td>0010</td>
<td>3</td>
<td>Behavioral health; long-term residential (non-medical, non-acute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diem</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="even">
<td>H0020</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)</td>
<td>Alcohol and/or drug services</td>
</tr>
<tr class="odd">
<td>H0021</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug training service (for staff and personnel not employed by providers)</td>
<td>Alcohol and/or drug training</td>
</tr>
<tr class="even">
<td>H0022</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug intervention service (planned facilitation)</td>
<td>Alcohol and/or drug interven</td>
</tr>
<tr class="odd">
<td>H0023</td>
<td>0010</td>
<td>3</td>
<td>Behavioral health outreach service (planned approach to reach a targeted population)</td>
<td>Alcohol and/or drug outreach</td>
</tr>
<tr class="even">
<td>H0024</td>
<td>0010</td>
<td>3</td>
<td>Behavioral health prevention information dissemination service (one-way direct or non-direct contact with service audiences to affect knowledge and attitude)</td>
<td>Alcohol and/or drug preventi</td>
</tr>
<tr class="odd">
<td>H0025</td>
<td>0010</td>
<td>3</td>
<td>Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior)</td>
<td>Alcohol and/or drug preventi</td>
</tr>
<tr class="even">
<td>H0026</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug prevention process service, community-based (delivery of services to develop skills of impactors)</td>
<td>Alcohol and/or drug preventi</td>
</tr>
<tr class="odd">
<td>H0027</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug prevention environmental service (broad range of external activities geared toward modifying systems in order to mainstream prevention through policy and law)</td>
<td>Alcohol and/or drug preventi</td>
</tr>
<tr class="even">
<td>H0028</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug prevention problem identification and referral service (e.g., student assistance and employee assistance programs), does not include assessment</td>
<td>Alcohol and/or drug preventi</td>
</tr>
<tr class="odd">
<td>H0029</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug prevention alternatives service (services for populations that exclude alcohol and other drug use e.g., alcohol free social events)</td>
<td>Alcohol and/or drug preventi</td>
</tr>
<tr class="even">
<td>H0030</td>
<td>0010</td>
<td>3</td>
<td>Behavioral health hotline service</td>
<td>Alcohol and/or drug hotline</td>
</tr>
<tr class="odd">
<td>H0031</td>
<td>0010</td>
<td>3</td>
<td>Mental health assessment, by non-physician</td>
<td>Mh health assess by non-md</td>
</tr>
<tr class="even">
<td>H0032</td>
<td>0010</td>
<td>3</td>
<td>Mental health service plan development by non-physician</td>
<td>Mh svc plan dev by non-md</td>
</tr>
<tr class="odd">
<td>H0033</td>
<td>0010</td>
<td>3</td>
<td>Oral medication administration, direct observation</td>
<td>Oral med adm direct observe</td>
</tr>
<tr class="even">
<td>H0034</td>
<td>0010</td>
<td>3</td>
<td>Medication training and support, per 15 minutes</td>
<td>Med trng &amp; support per 15min</td>
</tr>
<tr class="odd">
<td>H0035</td>
<td>0010</td>
<td>3</td>
<td>Mental health partial hospitalization, treatment, less than 24 hours</td>
<td>Mh partial hosp tx under 24h</td>
</tr>
<tr class="even">
<td>H0036</td>
<td>0010</td>
<td>3</td>
<td>Community psychiatric supportive treatment, face-to-face, per 15 minutes</td>
<td>Comm psy face-face per 15min</td>
</tr>
<tr class="odd">
<td>H0037</td>
<td>0010</td>
<td>3</td>
<td>Community psychiatric supportive treatment program, per diem</td>
<td>Comm psy sup tx pgm per diem</td>
</tr>
<tr class="even">
<td>H0038</td>
<td>0010</td>
<td>3</td>
<td>Self-help/peer services, per 15 minutes</td>
<td>Self-help/peer svc per 15min</td>
</tr>
<tr class="odd">
<td>H0039</td>
<td>0010</td>
<td>3</td>
<td>Assertive community treatment, face-to-face, per 15 minutes</td>
<td>Asser com tx face-face/15min</td>
</tr>
<tr class="even">
<td>H0040</td>
<td>0010</td>
<td>3</td>
<td>Assertive community treatment program, per diem</td>
<td>Assert comm tx pgm per diem</td>
</tr>
<tr class="odd">
<td>H0041</td>
<td>0010</td>
<td>3</td>
<td>Foster care, child, non-therapeutic, per diem</td>
<td>Fos c chld non-ther per diem</td>
</tr>
<tr class="even">
<td>H0042</td>
<td>0010</td>
<td>3</td>
<td>Foster care, child, non-therapeutic, per month</td>
<td>Fos c chld non-ther per mon</td>
</tr>
<tr class="odd">
<td>H0043</td>
<td>0010</td>
<td>3</td>
<td>Supported housing, per diem</td>
<td>Supported housing, per diem</td>
</tr>
<tr class="even">
<td>H0044</td>
<td>0010</td>
<td>3</td>
<td>Supported housing, per month</td>
<td>Supported housing, per month</td>
</tr>
<tr class="odd">
<td>H0045</td>
<td>0010</td>
<td>3</td>
<td>Respite care services, not in the home, per diem</td>
<td>Respite not-in-home per diem</td>
</tr>
<tr class="even">
<td>H0046</td>
<td>0010</td>
<td>3</td>
<td>Mental health services, not otherwise specified</td>
<td>Mental health service, nos</td>
</tr>
<tr class="odd">
<td>H0047</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or other drug abuse services, not otherwise specified</td>
<td>Alcohol/drug abuse svc nos</td>
</tr>
<tr class="even">
<td>H0048</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or other drug testing: collection and handling only, specimens other than blood</td>
<td>Spec coll non-blood:a/d test</td>
</tr>
<tr class="odd">
<td>H0049</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug screening</td>
<td>Alcohol/drug screening</td>
</tr>
<tr class="even">
<td>H0050</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug services, brief intervention, per 15 minutes</td>
<td>Alcohol/drug service 15 min</td>
</tr>
<tr class="odd">
<td>H1000</td>
<td>0010</td>
<td>3</td>
<td>Prenatal care, at-risk assessment</td>
<td>Prenatal care atrisk assessm</td>
</tr>
<tr class="even">
<td>H1001</td>
<td>0010</td>
<td>3</td>
<td>Prenatal care, at-risk enhanced service; antepartum management</td>
<td>Antepartum management</td>
</tr>
<tr class="odd">
<td>H1002</td>
<td>0010</td>
<td>3</td>
<td>Prenatal care, at risk enhanced service; care coordination</td>
<td>Carecoordination prenatal</td>
</tr>
<tr class="even">
<td>H1003</td>
<td>0010</td>
<td>3</td>
<td>Prenatal care, at-risk enhanced service; education</td>
<td>Prenatal at risk education</td>
</tr>
<tr class="odd">
<td>H1004</td>
<td>0010</td>
<td>3</td>
<td>Prenatal care, at-risk enhanced service; follow-up home visit</td>
<td>Follow up home visit/prental</td>
</tr>
<tr class="even">
<td>H1005</td>
<td>0010</td>
<td>3</td>
<td>Prenatal care, at-risk enhanced service package (includes h1001-h1004)</td>
<td>Prenatalcare enhanced srv pk</td>
</tr>
<tr class="odd">
<td>H1010</td>
<td>0010</td>
<td>3</td>
<td>Non-medical family planning education, per session</td>
<td>Nonmed family planning ed</td>
</tr>
<tr class="even">
<td>H1011</td>
<td>0010</td>
<td>3</td>
<td>Family assessment by licensed behavioral health professional for state defined purposes</td>
<td>Family assessment</td>
</tr>
<tr class="odd">
<td>H2000</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive multidisciplinary evaluation</td>
<td>Comp multidisipln evaluation</td>
</tr>
<tr class="even">
<td>H2001</td>
<td>0010</td>
<td>3</td>
<td>Rehabilitation program, per 1/2 day</td>
<td>Rehabilitation program 1/2 d</td>
</tr>
<tr class="odd">
<td>H2010</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive medication services, per 15 minutes</td>
<td>Comprehensive med svc 15 min</td>
</tr>
<tr class="even">
<td>H2011</td>
<td>0010</td>
<td>3</td>
<td>Crisis intervention service, per 15 minutes</td>
<td>Crisis interven svc, 15 min</td>
</tr>
<tr class="odd">
<td>H2012</td>
<td>0010</td>
<td>3</td>
<td>Behavioral health day treatment, per hour</td>
<td>Behav hlth day treat, per hr</td>
</tr>
<tr class="even">
<td>H2013</td>
<td>0010</td>
<td>3</td>
<td>Psychiatric health facility service, per diem</td>
<td>Psych hlth fac svc, per diem</td>
</tr>
<tr class="odd">
<td>H2014</td>
<td>0010</td>
<td>3</td>
<td>Skills training and development, per 15 minutes</td>
<td>Skills train and dev, 15 min</td>
</tr>
<tr class="even">
<td>H2015</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive community support services, per 15 minutes</td>
<td>Comp comm supp svc, 15 min</td>
</tr>
<tr class="odd">
<td>H2016</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive community support services, per diem</td>
<td>Comp comm supp svc, per diem</td>
</tr>
<tr class="even">
<td>H2017</td>
<td>0010</td>
<td>3</td>
<td>Psychosocial rehabilitation services, per 15 minutes</td>
<td>Psysoc rehab svc, per 15 min</td>
</tr>
<tr class="odd">
<td>H2018</td>
<td>0010</td>
<td>3</td>
<td>Psychosocial rehabilitation services, per diem</td>
<td>Psysoc rehab svc, per diem</td>
</tr>
<tr class="even">
<td>H2019</td>
<td>0010</td>
<td>3</td>
<td>Therapeutic behavioral services, per 15 minutes</td>
<td>Ther behav svc, per 15 min</td>
</tr>
<tr class="odd">
<td>H2020</td>
<td>0010</td>
<td>3</td>
<td>Therapeutic behavioral services, per diem</td>
<td>Ther behav svc, per diem</td>
</tr>
<tr class="even">
<td>H2021</td>
<td>0010</td>
<td>3</td>
<td>Community-based wrap-around services, per 15 minutes</td>
<td>Com wrap-around sv, 15 min</td>
</tr>
<tr class="odd">
<td>H2022</td>
<td>0010</td>
<td>3</td>
<td>Community-based wrap-around services, per diem</td>
<td>Com wrap-around sv, per diem</td>
</tr>
<tr class="even">
<td>H2023</td>
<td>0010</td>
<td>3</td>
<td>Supported employment, per 15 minutes</td>
<td>Supported employ, per 15 min</td>
</tr>
<tr class="odd">
<td>H2024</td>
<td>0010</td>
<td>3</td>
<td>Supported employment, per diem</td>
<td>Supported employ, per diem</td>
</tr>
<tr class="even">
<td>H2025</td>
<td>0010</td>
<td>3</td>
<td>Ongoing support to maintain employment, per 15 minutes</td>
<td>Supp maint employ, 15 min</td>
</tr>
<tr class="odd">
<td>H2026</td>
<td>0010</td>
<td>3</td>
<td>Ongoing support to maintain employment, per diem</td>
<td>Supp maint employ, per diem</td>
</tr>
<tr class="even">
<td>H2027</td>
<td>0010</td>
<td>3</td>
<td>Psychoeducational service, per 15 minutes</td>
<td>Psychoed svc, per 15 min</td>
</tr>
<tr class="odd">
<td>H2028</td>
<td>0010</td>
<td>3</td>
<td>Sexual offender treatment service, per 15 minutes</td>
<td>Sex offend tx svc, 15 min</td>
</tr>
<tr class="even">
<td>H2029</td>
<td>0010</td>
<td>3</td>
<td>Sexual offender treatment service, per diem</td>
<td>Sex offend tx svc, per diem</td>
</tr>
<tr class="odd">
<td>H2030</td>
<td>0010</td>
<td>3</td>
<td>Mental health clubhouse services, per 15 minutes</td>
<td>Mh clubhouse svc, per 15 min</td>
</tr>
<tr class="even">
<td>H2031</td>
<td>0010</td>
<td>3</td>
<td>Mental health clubhouse services, per diem</td>
<td>Mh clubhouse svc, per diem</td>
</tr>
<tr class="odd">
<td>H2032</td>
<td>0010</td>
<td>3</td>
<td>Activity therapy, per 15 minutes</td>
<td>Activity therapy, per 15 min</td>
</tr>
<tr class="even">
<td>H2033</td>
<td>0010</td>
<td>3</td>
<td>Multisystemic therapy for juveniles, per 15 minutes</td>
<td>Multisys ther/juvenile 15min</td>
</tr>
<tr class="odd">
<td>H2034</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or drug abuse halfway house services, per diem</td>
<td>A/d halfway house, per diem</td>
</tr>
<tr class="even">
<td>H2035</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or other drug treatment program, per hour</td>
<td>A/d tx program, per hour</td>
</tr>
<tr class="odd">
<td>H2036</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or other drug treatment program, per diem</td>
<td>A/d tx program, per diem</td>
</tr>
<tr class="even">
<td>H2037</td>
<td>0010</td>
<td>3</td>
<td>Developmental delay prevention activities, dependent child of client, per 15 minutes</td>
<td>Dev delay prev dp ch, 15 min</td>
</tr>
</tbody>
</table>
</div>
<div id="j-series-drugs-administered-other-than-oral-method-j0000-j9999" class="section level2">
<h2>J Series: Drugs Administered Other Than Oral Method (J0000-J9999)</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>J0120</td>
<td>0010</td>
<td>3</td>
<td>Injection, tetracycline, up to 250 mg</td>
<td>Tetracyclin injection</td>
</tr>
<tr class="even">
<td>J0121</td>
<td>0010</td>
<td>3</td>
<td>Injection, omadacycline, 1 mg</td>
<td>Inj., omadacycline, 1 mg</td>
</tr>
<tr class="odd">
<td>J0122</td>
<td>0010</td>
<td>3</td>
<td>Injection, eravacycline, 1 mg</td>
<td>Inj., eravacycline, 1 mg</td>
</tr>
<tr class="even">
<td>J0129</td>
<td>0010</td>
<td>3</td>
<td>Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)</td>
<td>Abatacept injection</td>
</tr>
<tr class="odd">
<td>J0130</td>
<td>0010</td>
<td>3</td>
<td>Injection abciximab, 10 mg</td>
<td>Abciximab injection</td>
</tr>
<tr class="even">
<td>J0131</td>
<td>0010</td>
<td>3</td>
<td>Injection, acetaminophen, 10 mg</td>
<td>Acetaminophen injection</td>
</tr>
<tr class="odd">
<td>J0132</td>
<td>0010</td>
<td>3</td>
<td>Injection, acetylcysteine, 100 mg</td>
<td>Acetylcysteine injection</td>
</tr>
<tr class="even">
<td>J0133</td>
<td>0010</td>
<td>3</td>
<td>Injection, acyclovir, 5 mg</td>
<td>Acyclovir injection</td>
</tr>
<tr class="odd">
<td>J0135</td>
<td>0010</td>
<td>3</td>
<td>Injection, adalimumab, 20 mg</td>
<td>Adalimumab injection</td>
</tr>
<tr class="even">
<td>J0150</td>
<td>0010</td>
<td>3</td>
<td>Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)</td>
<td>Injection adenosine 6 mg</td>
</tr>
<tr class="odd">
<td>J0151</td>
<td>0010</td>
<td>3</td>
<td>Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)</td>
<td>Inj adenosine diag 1mg</td>
</tr>
<tr class="even">
<td>J0153</td>
<td>0010</td>
<td>3</td>
<td>Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)</td>
<td>Adenosine inj 1mg</td>
</tr>
<tr class="odd">
<td>J0171</td>
<td>0010</td>
<td>3</td>
<td>Injection, adrenalin, epinephrine, 0.1 mg</td>
<td>Adrenalin epinephrine inject</td>
</tr>
<tr class="even">
<td>J0178</td>
<td>0010</td>
<td>3</td>
<td>Injection, aflibercept, 1 mg</td>
<td>Aflibercept injection</td>
</tr>
<tr class="odd">
<td>J0179</td>
<td>0010</td>
<td>3</td>
<td>Injection, brolucizumab-dbll, 1 mg</td>
<td>Inj, brolucizumab-dbll, 1 mg</td>
</tr>
<tr class="even">
<td>J0180</td>
<td>0010</td>
<td>3</td>
<td>Injection, agalsidase beta, 1 mg</td>
<td>Agalsidase beta injection</td>
</tr>
<tr class="odd">
<td>J0185</td>
<td>0010</td>
<td>3</td>
<td>Injection, aprepitant, 1 mg</td>
<td>Inj., aprepitant, 1 mg</td>
</tr>
<tr class="even">
<td>J0190</td>
<td>0010</td>
<td>3</td>
<td>Injection, biperiden lactate, per 5 mg</td>
<td>Inj biperiden lactate/5 mg</td>
</tr>
<tr class="odd">
<td>J0200</td>
<td>0010</td>
<td>3</td>
<td>Injection, alatrofloxacin mesylate, 100 mg</td>
<td>Alatrofloxacin mesylate</td>
</tr>
<tr class="even">
<td>J0202</td>
<td>0010</td>
<td>3</td>
<td>Injection, alemtuzumab, 1 mg</td>
<td>Injection, alemtuzumab</td>
</tr>
<tr class="odd">
<td>J0205</td>
<td>0010</td>
<td>3</td>
<td>Injection, alglucerase, per 10 units</td>
<td>Alglucerase injection</td>
</tr>
<tr class="even">
<td>J0207</td>
<td>0010</td>
<td>3</td>
<td>Injection, amifostine, 500 mg</td>
<td>Amifostine</td>
</tr>
<tr class="odd">
<td>J0210</td>
<td>0010</td>
<td>3</td>
<td>Injection, methyldopate hcl, up to 250 mg</td>
<td>Methyldopate hcl injection</td>
</tr>
<tr class="even">
<td>J0215</td>
<td>0010</td>
<td>3</td>
<td>Injection, alefacept, 0.5 mg</td>
<td>Alefacept</td>
</tr>
<tr class="odd">
<td>J0220</td>
<td>0010</td>
<td>3</td>
<td>Injection, alglucosidase alfa, 10 mg, not otherwise specified</td>
<td>Alglucosidase alfa injection</td>
</tr>
<tr class="even">
<td>J0221</td>
<td>0010</td>
<td>3</td>
<td>Injection, alglucosidase alfa, (lumizyme), 10 mg</td>
<td>Lumizyme injection</td>
</tr>
<tr class="odd">
<td>J0222</td>
<td>0010</td>
<td>3</td>
<td>Injection, patisiran, 0.1 mg</td>
<td>Inj., patisiran, 0.1 mg</td>
</tr>
<tr class="even">
<td>J0256</td>
<td>0010</td>
<td>3</td>
<td>Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg</td>
<td>Alpha 1 proteinase inhibitor</td>
</tr>
<tr class="odd">
<td>J0257</td>
<td>0010</td>
<td>3</td>
<td>Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg</td>
<td>Glassia injection</td>
</tr>
<tr class="even">
<td>J0270</td>
<td>0010</td>
<td>3</td>
<td>Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)</td>
<td>Alprostadil for injection</td>
</tr>
<tr class="odd">
<td>J0275</td>
<td>0010</td>
<td>3</td>
<td>Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)</td>
<td>Alprostadil urethral suppos</td>
</tr>
<tr class="even">
<td>J0278</td>
<td>0010</td>
<td>3</td>
<td>Injection, amikacin sulfate, 100 mg</td>
<td>Amikacin sulfate injection</td>
</tr>
<tr class="odd">
<td>J0280</td>
<td>0010</td>
<td>3</td>
<td>Injection, aminophyllin, up to 250 mg</td>
<td>Aminophyllin 250 mg inj</td>
</tr>
<tr class="even">
<td>J0282</td>
<td>0010</td>
<td>3</td>
<td>Injection, amiodarone hydrochloride, 30 mg</td>
<td>Amiodarone hcl</td>
</tr>
<tr class="odd">
<td>J0285</td>
<td>0010</td>
<td>3</td>
<td>Injection, amphotericin b, 50 mg</td>
<td>Amphotericin b</td>
</tr>
<tr class="even">
<td>J0287</td>
<td>0010</td>
<td>3</td>
<td>Injection, amphotericin b lipid complex, 10 mg</td>
<td>Amphotericin b lipid complex</td>
</tr>
<tr class="odd">
<td>J0288</td>
<td>0010</td>
<td>3</td>
<td>Injection, amphotericin b cholesteryl sulfate complex, 10 mg</td>
<td>Ampho b cholesteryl sulfate</td>
</tr>
<tr class="even">
<td>J0289</td>
<td>0010</td>
<td>3</td>
<td>Injection, amphotericin b liposome, 10 mg</td>
<td>Amphotericin b liposome inj</td>
</tr>
<tr class="odd">
<td>J0290</td>
<td>0010</td>
<td>3</td>
<td>Injection, ampicillin sodium, 500 mg</td>
<td>Ampicillin 500 mg inj</td>
</tr>
<tr class="even">
<td>J0291</td>
<td>0010</td>
<td>3</td>
<td>Injection, plazomicin, 5 mg</td>
<td>Inj., plazomicin, 5 mg</td>
</tr>
<tr class="odd">
<td>J0295</td>
<td>0010</td>
<td>3</td>
<td>Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm</td>
<td>Ampicillin sulbactam 1.5 gm</td>
</tr>
<tr class="even">
<td>J0300</td>
<td>0010</td>
<td>3</td>
<td>Injection, amobarbital, up to 125 mg</td>
<td>Amobarbital 125 mg inj</td>
</tr>
<tr class="odd">
<td>J0330</td>
<td>0010</td>
<td>3</td>
<td>Injection, succinylcholine chloride, up to 20 mg</td>
<td>Succinycholine chloride inj</td>
</tr>
<tr class="even">
<td>J0348</td>
<td>0010</td>
<td>3</td>
<td>Injection, anidulafungin, 1 mg</td>
<td>Anidulafungin injection</td>
</tr>
<tr class="odd">
<td>J0350</td>
<td>0010</td>
<td>3</td>
<td>Injection, anistreplase, per 30 units</td>
<td>Injection anistreplase 30 u</td>
</tr>
<tr class="even">
<td>J0360</td>
<td>0010</td>
<td>3</td>
<td>Injection, hydralazine hcl, up to 20 mg</td>
<td>Hydralazine hcl injection</td>
</tr>
<tr class="odd">
<td>J0364</td>
<td>0010</td>
<td>3</td>
<td>Injection, apomorphine hydrochloride, 1 mg</td>
<td>Apomorphine hydrochloride</td>
</tr>
<tr class="even">
<td>J0365</td>
<td>0010</td>
<td>3</td>
<td>Injection, aprotonin, 10,000 kiu</td>
<td>Aprotonin, 10,000 kiu</td>
</tr>
<tr class="odd">
<td>J0380</td>
<td>0010</td>
<td>3</td>
<td>Injection, metaraminol bitartrate, per 10 mg</td>
<td>Inj metaraminol bitartrate</td>
</tr>
<tr class="even">
<td>J0390</td>
<td>0010</td>
<td>3</td>
<td>Injection, chloroquine hydrochloride, up to 250 mg</td>
<td>Chloroquine injection</td>
</tr>
<tr class="odd">
<td>J0395</td>
<td>0010</td>
<td>3</td>
<td>Injection, arbutamine hcl, 1 mg</td>
<td>Arbutamine hcl injection</td>
</tr>
<tr class="even">
<td>J0400</td>
<td>0010</td>
<td>3</td>
<td>Injection, aripiprazole, intramuscular, 0.25 mg</td>
<td>Aripiprazole injection</td>
</tr>
<tr class="odd">
<td>J0401</td>
<td>0010</td>
<td>3</td>
<td>Injection, aripiprazole, extended release, 1 mg</td>
<td>Inj aripiprazole ext rel 1mg</td>
</tr>
<tr class="even">
<td>J0456</td>
<td>0010</td>
<td>3</td>
<td>Injection, azithromycin, 500 mg</td>
<td>Azithromycin</td>
</tr>
<tr class="odd">
<td>J0461</td>
<td>0010</td>
<td>3</td>
<td>Injection, atropine sulfate, 0.01 mg</td>
<td>Atropine sulfate injection</td>
</tr>
<tr class="even">
<td>J0470</td>
<td>0010</td>
<td>3</td>
<td>Injection, dimercaprol, per 100 mg</td>
<td>Dimecaprol injection</td>
</tr>
<tr class="odd">
<td>J0475</td>
<td>0010</td>
<td>3</td>
<td>Injection, baclofen, 10 mg</td>
<td>Baclofen 10 mg injection</td>
</tr>
<tr class="even">
<td>J0476</td>
<td>0010</td>
<td>3</td>
<td>Injection, baclofen, 50 mcg for intrathecal trial</td>
<td>Baclofen intrathecal trial</td>
</tr>
<tr class="odd">
<td>J0480</td>
<td>0010</td>
<td>3</td>
<td>Injection, basiliximab, 20 mg</td>
<td>Basiliximab</td>
</tr>
<tr class="even">
<td>J0485</td>
<td>0010</td>
<td>3</td>
<td>Injection, belatacept, 1 mg</td>
<td>Belatacept injection</td>
</tr>
<tr class="odd">
<td>J0490</td>
<td>0010</td>
<td>3</td>
<td>Injection, belimumab, 10 mg</td>
<td>Belimumab injection</td>
</tr>
<tr class="even">
<td>J0500</td>
<td>0010</td>
<td>3</td>
<td>Injection, dicyclomine hcl, up to 20 mg</td>
<td>Dicyclomine injection</td>
</tr>
<tr class="odd">
<td>J0515</td>
<td>0010</td>
<td>3</td>
<td>Injection, benztropine mesylate, per 1 mg</td>
<td>Inj benztropine mesylate</td>
</tr>
<tr class="even">
<td>J0517</td>
<td>0010</td>
<td>3</td>
<td>Injection, benralizumab, 1 mg</td>
<td>Inj., benralizumab, 1 mg</td>
</tr>
<tr class="odd">
<td>J0520</td>
<td>0010</td>
<td>3</td>
<td>Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg</td>
<td>Bethanechol chloride inject</td>
</tr>
<tr class="even">
<td>J0558</td>
<td>0010</td>
<td>3</td>
<td>Injection, penicillin g benzathine and penicillin g procaine, 100,000 units</td>
<td>Peng benzathine/procaine inj</td>
</tr>
<tr class="odd">
<td>J0561</td>
<td>0010</td>
<td>3</td>
<td>Injection, penicillin g benzathine, 100,000 units</td>
<td>Penicillin g benzathine inj</td>
</tr>
<tr class="even">
<td>J0565</td>
<td>0010</td>
<td>3</td>
<td>Injection, bezlotoxumab, 10 mg</td>
<td>Inj, bezlotoxumab, 10 mg</td>
</tr>
<tr class="odd">
<td>J0567</td>
<td>0010</td>
<td>3</td>
<td>Injection, cerliponase alfa, 1 mg</td>
<td>Inj., cerliponase alfa 1 mg</td>
</tr>
<tr class="even">
<td>J0570</td>
<td>0010</td>
<td>3</td>
<td>Buprenorphine implant, 74.2 mg</td>
<td>Buprenorphine implant 74.2mg</td>
</tr>
<tr class="odd">
<td>J0571</td>
<td>0010</td>
<td>3</td>
<td>Buprenorphine, oral, 1 mg</td>
<td>Buprenorphine oral 1mg</td>
</tr>
<tr class="even">
<td>J0572</td>
<td>0010</td>
<td>3</td>
<td>Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine</td>
<td>Bupren/nal up to 3mg bupreno</td>
</tr>
<tr class="odd">
<td>J0573</td>
<td>0010</td>
<td>3</td>
<td>Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine</td>
<td>Bupren/nal 3.1 to 6mg bupren</td>
</tr>
<tr class="even">
<td>J0574</td>
<td>0010</td>
<td>3</td>
<td>Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine</td>
<td>Bupren/nal 6.1 to 10mg bupre</td>
</tr>
<tr class="odd">
<td>J0575</td>
<td>0010</td>
<td>3</td>
<td>Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine</td>
<td>Bupren/nal over 10mg bupreno</td>
</tr>
<tr class="even">
<td>J0583</td>
<td>0010</td>
<td>3</td>
<td>Injection, bivalirudin, 1 mg</td>
<td>Bivalirudin</td>
</tr>
<tr class="odd">
<td>J0584</td>
<td>0010</td>
<td>3</td>
<td>Injection, burosumab-twza 1 mg</td>
<td>Injection, burosumab-twza 1m</td>
</tr>
<tr class="even">
<td>J0585</td>
<td>0010</td>
<td>3</td>
<td>Injection, onabotulinumtoxina, 1 unit</td>
<td>Injection,onabotulinumtoxina</td>
</tr>
<tr class="odd">
<td>J0586</td>
<td>0010</td>
<td>3</td>
<td>Injection, abobotulinumtoxina, 5 units</td>
<td>Abobotulinumtoxina</td>
</tr>
<tr class="even">
<td>J0587</td>
<td>0010</td>
<td>3</td>
<td>Injection, rimabotulinumtoxinb, 100 units</td>
<td>Inj, rimabotulinumtoxinb</td>
</tr>
<tr class="odd">
<td>J0588</td>
<td>0010</td>
<td>3</td>
<td>Injection, incobotulinumtoxin a, 1 unit</td>
<td>Incobotulinumtoxin a</td>
</tr>
<tr class="even">
<td>J0592</td>
<td>0010</td>
<td>3</td>
<td>Injection, buprenorphine hydrochloride, 0.1 mg</td>
<td>Buprenorphine hydrochloride</td>
</tr>
<tr class="odd">
<td>J0593</td>
<td>0010</td>
<td>3</td>
<td>Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)</td>
<td>Inj., lanadelumab-flyo, 1 mg</td>
</tr>
<tr class="even">
<td>J0594</td>
<td>0010</td>
<td>3</td>
<td>injection, busulfan, 1 mg</td>
<td>Busulfan injection</td>
</tr>
<tr class="odd">
<td>J0595</td>
<td>0010</td>
<td>3</td>
<td>Injection, butorphanol tartrate, 1 mg</td>
<td>Butorphanol tartrate 1 mg</td>
</tr>
<tr class="even">
<td>J0596</td>
<td>0010</td>
<td>3</td>
<td>Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units</td>
<td>Injection, ruconest</td>
</tr>
<tr class="odd">
<td>J0597</td>
<td>0010</td>
<td>3</td>
<td>Injection, c-1 esterase inhibitor (human), berinert, 10 units</td>
<td>C-1 esterase, berinert</td>
</tr>
<tr class="even">
<td>J0598</td>
<td>0010</td>
<td>3</td>
<td>Injection, c-1 esterase inhibitor (human), cinryze, 10 units</td>
<td>C-1 esterase, cinryze</td>
</tr>
<tr class="odd">
<td>J0599</td>
<td>0010</td>
<td>3</td>
<td>Injection, c-1 esterase inhibitor (human), (haegarda), 10 units</td>
<td>Inj., haegarda 10 units</td>
</tr>
<tr class="even">
<td>J0600</td>
<td>0010</td>
<td>3</td>
<td>Injection, edetate calcium disodium, up to 1000 mg</td>
<td>Edetate calcium disodium inj</td>
</tr>
<tr class="odd">
<td>J0604</td>
<td>0010</td>
<td>3</td>
<td>Cinacalcet, oral, 1 mg, (for esrd on dialysis)</td>
<td>Cinacalcet, esrd on dialysis</td>
</tr>
<tr class="even">
<td>J0606</td>
<td>0010</td>
<td>3</td>
<td>Injection, etelcalcetide, 0.1 mg</td>
<td>Inj, etelcalcetide, 0.1 mg</td>
</tr>
<tr class="odd">
<td>J0610</td>
<td>0010</td>
<td>3</td>
<td>Injection, calcium gluconate, per 10 ml</td>
<td>Calcium gluconate injection</td>
</tr>
<tr class="even">
<td>J0620</td>
<td>0010</td>
<td>3</td>
<td>Injection, calcium glycerophosphate and calcium lactate, per 10 ml</td>
<td>Calcium glycer &amp; lact/10 ml</td>
</tr>
<tr class="odd">
<td>J0630</td>
<td>0010</td>
<td>3</td>
<td>Injection, calcitonin salmon, up to 400 units</td>
<td>Calcitonin salmon injection</td>
</tr>
<tr class="even">
<td>J0636</td>
<td>0010</td>
<td>3</td>
<td>Injection, calcitriol, 0.1 mcg</td>
<td>Inj calcitriol per 0.1 mcg</td>
</tr>
<tr class="odd">
<td>J0637</td>
<td>0010</td>
<td>3</td>
<td>Injection, caspofungin acetate, 5 mg</td>
<td>Caspofungin acetate</td>
</tr>
<tr class="even">
<td>J0638</td>
<td>0010</td>
<td>3</td>
<td>Injection, canakinumab, 1 mg</td>
<td>Canakinumab injection</td>
</tr>
<tr class="odd">
<td>J0640</td>
<td>0010</td>
<td>3</td>
<td>Injection, leucovorin calcium, per 50 mg</td>
<td>Leucovorin calcium injection</td>
</tr>
<tr class="even">
<td>J0641</td>
<td>0010</td>
<td>3</td>
<td>Injection, levoleucovorin, not otherwise specified, 0.5 mg</td>
<td>Inj levoleucovorin nos 0.5mg</td>
</tr>
<tr class="odd">
<td>J0642</td>
<td>0010</td>
<td>3</td>
<td>Injection, levoleucovorin (khapzory), 0.5 mg</td>
<td>Injection, khapzory, 0.5 mg</td>
</tr>
<tr class="even">
<td>J0670</td>
<td>0010</td>
<td>3</td>
<td>Injection, mepivacaine hydrochloride, per 10 ml</td>
<td>Inj mepivacaine hcl/10 ml</td>
</tr>
<tr class="odd">
<td>J0690</td>
<td>0010</td>
<td>3</td>
<td>Injection, cefazolin sodium, 500 mg</td>
<td>Cefazolin sodium injection</td>
</tr>
<tr class="even">
<td>J0692</td>
<td>0010</td>
<td>3</td>
<td>Injection, cefepime hydrochloride, 500 mg</td>
<td>Cefepime hcl for injection</td>
</tr>
<tr class="odd">
<td>J0694</td>
<td>0010</td>
<td>3</td>
<td>Injection, cefoxitin sodium, 1 gm</td>
<td>Cefoxitin sodium injection</td>
</tr>
<tr class="even">
<td>J0695</td>
<td>0010</td>
<td>3</td>
<td>Injection, ceftolozane 50 mg and tazobactam 25 mg</td>
<td>Inj ceftolozane tazobactam</td>
</tr>
<tr class="odd">
<td>J0696</td>
<td>0010</td>
<td>3</td>
<td>Injection, ceftriaxone sodium, per 250 mg</td>
<td>Ceftriaxone sodium injection</td>
</tr>
<tr class="even">
<td>J0697</td>
<td>0010</td>
<td>3</td>
<td>Injection, sterile cefuroxime sodium, per 750 mg</td>
<td>Sterile cefuroxime injection</td>
</tr>
<tr class="odd">
<td>J0698</td>
<td>0010</td>
<td>3</td>
<td>Injection, cefotaxime sodium, per gm</td>
<td>Cefotaxime sodium injection</td>
</tr>
<tr class="even">
<td>J0702</td>
<td>0010</td>
<td>3</td>
<td>Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg</td>
<td>Betamethasone acet&amp;sod phosp</td>
</tr>
<tr class="odd">
<td>J0706</td>
<td>0010</td>
<td>3</td>
<td>Injection, caffeine citrate, 5 mg</td>
<td>Caffeine citrate injection</td>
</tr>
<tr class="even">
<td>J0710</td>
<td>0010</td>
<td>3</td>
<td>Injection, cephapirin sodium, up to 1 gm</td>
<td>Cephapirin sodium injection</td>
</tr>
<tr class="odd">
<td>J0712</td>
<td>0010</td>
<td>3</td>
<td>Injection, ceftaroline fosamil, 10 mg</td>
<td>Ceftaroline fosamil inj</td>
</tr>
<tr class="even">
<td>J0713</td>
<td>0010</td>
<td>3</td>
<td>Injection, ceftazidime, per 500 mg</td>
<td>Inj ceftazidime per 500 mg</td>
</tr>
<tr class="odd">
<td>J0714</td>
<td>0010</td>
<td>3</td>
<td>Injection, ceftazidime and avibactam, 0.5 g/0.125 g</td>
<td>Ceftazidime and avibactam</td>
</tr>
<tr class="even">
<td>J0715</td>
<td>0010</td>
<td>3</td>
<td>Injection, ceftizoxime sodium, per 500 mg</td>
<td>Ceftizoxime sodium / 500 mg</td>
</tr>
<tr class="odd">
<td>J0716</td>
<td>0010</td>
<td>3</td>
<td>Injection, centruroides immune f(ab)2, up to 120 milligrams</td>
<td>Centruroides immune f(ab)</td>
</tr>
<tr class="even">
<td>J0717</td>
<td>0010</td>
<td>3</td>
<td>Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)</td>
<td>Certolizumab pegol inj 1mg</td>
</tr>
<tr class="odd">
<td>J0720</td>
<td>0010</td>
<td>3</td>
<td>Injection, chloramphenicol sodium succinate, up to 1 gm</td>
<td>Chloramphenicol sodium injec</td>
</tr>
<tr class="even">
<td>J0725</td>
<td>0010</td>
<td>3</td>
<td>Injection, chorionic gonadotropin, per 1,000 usp units</td>
<td>Chorionic gonadotropin/1000u</td>
</tr>
<tr class="odd">
<td>J0735</td>
<td>0010</td>
<td>3</td>
<td>Injection, clonidine hydrochloride, 1 mg</td>
<td>Clonidine hydrochloride</td>
</tr>
<tr class="even">
<td>J0740</td>
<td>0010</td>
<td>3</td>
<td>Injection, cidofovir, 375 mg</td>
<td>Cidofovir injection</td>
</tr>
<tr class="odd">
<td>J0743</td>
<td>0010</td>
<td>3</td>
<td>Injection, cilastatin sodium; imipenem, per 250 mg</td>
<td>Cilastatin sodium injection</td>
</tr>
<tr class="even">
<td>J0744</td>
<td>0010</td>
<td>3</td>
<td>Injection, ciprofloxacin for intravenous infusion, 200 mg</td>
<td>Ciprofloxacin iv</td>
</tr>
<tr class="odd">
<td>J0745</td>
<td>0010</td>
<td>3</td>
<td>Injection, codeine phosphate, per 30 mg</td>
<td>Inj codeine phosphate /30 mg</td>
</tr>
<tr class="even">
<td>J0760</td>
<td>0010</td>
<td>3</td>
<td>Injection, colchicine, per 1 mg</td>
<td>Colchicine injection</td>
</tr>
<tr class="odd">
<td>J0770</td>
<td>0010</td>
<td>3</td>
<td>Injection, colistimethate sodium, up to 150 mg</td>
<td>Colistimethate sodium inj</td>
</tr>
<tr class="even">
<td>J0775</td>
<td>0010</td>
<td>3</td>
<td>Injection, collagenase, clostridium histolyticum, 0.01 mg</td>
<td>Collagenase, clost hist inj</td>
</tr>
<tr class="odd">
<td>J0780</td>
<td>0010</td>
<td>3</td>
<td>Injection, prochlorperazine, up to 10 mg</td>
<td>Prochlorperazine injection</td>
</tr>
<tr class="even">
<td>J0795</td>
<td>0010</td>
<td>3</td>
<td>Injection, corticorelin ovine triflutate, 1 microgram</td>
<td>Corticorelin ovine triflutal</td>
</tr>
<tr class="odd">
<td>J0800</td>
<td>0010</td>
<td>3</td>
<td>Injection, corticotropin, up to 40 units</td>
<td>Corticotropin injection</td>
</tr>
<tr class="even">
<td>J0833</td>
<td>0010</td>
<td>3</td>
<td>Injection, cosyntropin, not otherwise specified, 0.25 mg</td>
<td>Cosyntropin injection nos</td>
</tr>
<tr class="odd">
<td>J0834</td>
<td>0010</td>
<td>3</td>
<td>Injection, cosyntropin, 0.25 mg</td>
<td>Inj., cosyntropin, 0.25 mg</td>
</tr>
<tr class="even">
<td>J0840</td>
<td>0010</td>
<td>3</td>
<td>Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram</td>
<td>Crotalidae poly immune fab</td>
</tr>
<tr class="odd">
<td>J0841</td>
<td>0010</td>
<td>3</td>
<td>Injection, crotalidae immune f(ab’)2 (equine), 120 mg</td>
<td>Inj crotalidae im f(ab’)2 eq</td>
</tr>
<tr class="even">
<td>J0850</td>
<td>0010</td>
<td>3</td>
<td>Injection, cytomegalovirus immune globulin intravenous (human), per vial</td>
<td>Cytomegalovirus imm iv /vial</td>
</tr>
<tr class="odd">
<td>J0875</td>
<td>0010</td>
<td>3</td>
<td>Injection, dalbavancin, 5 mg</td>
<td>Injection, dalbavancin</td>
</tr>
<tr class="even">
<td>J0878</td>
<td>0010</td>
<td>3</td>
<td>Injection, daptomycin, 1 mg</td>
<td>Daptomycin injection</td>
</tr>
<tr class="odd">
<td>J0881</td>
<td>0010</td>
<td>3</td>
<td>Injection, darbepoetin alfa, 1 microgram (non-esrd use)</td>
<td>Darbepoetin alfa, non-esrd</td>
</tr>
<tr class="even">
<td>J0882</td>
<td>0010</td>
<td>3</td>
<td>Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)</td>
<td>Darbepoetin alfa, esrd use</td>
</tr>
<tr class="odd">
<td>J0883</td>
<td>0010</td>
<td>3</td>
<td>Injection, argatroban, 1 mg (for non-esrd use)</td>
<td>Argatroban nonesrd use 1mg</td>
</tr>
<tr class="even">
<td>J0884</td>
<td>0010</td>
<td>3</td>
<td>Injection, argatroban, 1 mg (for esrd on dialysis)</td>
<td>Argatroban esrd dialysis 1mg</td>
</tr>
<tr class="odd">
<td>J0885</td>
<td>0010</td>
<td>3</td>
<td>Injection, epoetin alfa, (for non-esrd use), 1000 units</td>
<td>Epoetin alfa, non-esrd</td>
</tr>
<tr class="even">
<td>J0886</td>
<td>0010</td>
<td>3</td>
<td>Injection, epoetin alfa, 1000 units (for esrd on dialysis)</td>
<td>Epoetin alfa 1000 units esrd</td>
</tr>
<tr class="odd">
<td>J0887</td>
<td>0010</td>
<td>3</td>
<td>Injection, epoetin beta, 1 microgram, (for esrd on dialysis)</td>
<td>Epoetin beta esrd use</td>
</tr>
<tr class="even">
<td>J0888</td>
<td>0010</td>
<td>3</td>
<td>Injection, epoetin beta, 1 microgram, (for non esrd use)</td>
<td>Epoetin beta non esrd</td>
</tr>
<tr class="odd">
<td>J0890</td>
<td>0010</td>
<td>3</td>
<td>Injection, peginesatide, 0.1 mg (for esrd on dialysis)</td>
<td>Peginesatide injection</td>
</tr>
<tr class="even">
<td>J0894</td>
<td>0010</td>
<td>3</td>
<td>Injection, decitabine, 1 mg</td>
<td>Decitabine injection</td>
</tr>
<tr class="odd">
<td>J0895</td>
<td>0010</td>
<td>3</td>
<td>Injection, deferoxamine mesylate, 500 mg</td>
<td>Deferoxamine mesylate inj</td>
</tr>
<tr class="even">
<td>J0897</td>
<td>0010</td>
<td>3</td>
<td>Injection, denosumab, 1 mg</td>
<td>Denosumab injection</td>
</tr>
<tr class="odd">
<td>J0900</td>
<td>0010</td>
<td>3</td>
<td>Injection, testosterone enanthate and estradiol valerate, up to 1 cc</td>
<td>Testosterone enanthate inj</td>
</tr>
<tr class="even">
<td>J0945</td>
<td>0010</td>
<td>3</td>
<td>Injection, brompheniramine maleate, per 10 mg</td>
<td>Brompheniramine maleate inj</td>
</tr>
<tr class="odd">
<td>J1000</td>
<td>0010</td>
<td>3</td>
<td>Injection, depo-estradiol cypionate, up to 5 mg</td>
<td>Depo-estradiol cypionate inj</td>
</tr>
<tr class="even">
<td>J1020</td>
<td>0010</td>
<td>3</td>
<td>Injection, methylprednisolone acetate, 20 mg</td>
<td>Methylprednisolone 20 mg inj</td>
</tr>
<tr class="odd">
<td>J1030</td>
<td>0010</td>
<td>3</td>
<td>Injection, methylprednisolone acetate, 40 mg</td>
<td>Methylprednisolone 40 mg inj</td>
</tr>
<tr class="even">
<td>J1040</td>
<td>0010</td>
<td>3</td>
<td>Injection, methylprednisolone acetate, 80 mg</td>
<td>Methylprednisolone 80 mg inj</td>
</tr>
<tr class="odd">
<td>J1050</td>
<td>0010</td>
<td>3</td>
<td>Injection, medroxyprogesterone acetate, 1 mg</td>
<td>Medroxyprogesterone acetate</td>
</tr>
<tr class="even">
<td>J1060</td>
<td>0010</td>
<td>3</td>
<td>Injection, testosterone cypionate and estradiol cypionate, up to 1 ml</td>
<td>Testosterone cypionate 1 ml</td>
</tr>
<tr class="odd">
<td>J1070</td>
<td>0010</td>
<td>3</td>
<td>Injection, testosterone cypionate, up to 100 mg</td>
<td>Testosterone cypionat 100 mg</td>
</tr>
<tr class="even">
<td>J1071</td>
<td>0010</td>
<td>3</td>
<td>Injection, testosterone cypionate, 1 mg</td>
<td>Inj testosterone cypionate</td>
</tr>
<tr class="odd">
<td>J1080</td>
<td>0010</td>
<td>3</td>
<td>Injection, testosterone cypionate, 1 cc, 200 mg</td>
<td>Testosterone cypionat 200 mg</td>
</tr>
<tr class="even">
<td>J1094</td>
<td>0010</td>
<td>3</td>
<td>Injection, dexamethasone acetate, 1 mg</td>
<td>Inj dexamethasone acetate</td>
</tr>
<tr class="odd">
<td>J1095</td>
<td>0010</td>
<td>3</td>
<td>Injection, dexamethasone 9 percent, intraocular, 1 microgram</td>
<td>Injection, dexamethasone 9%</td>
</tr>
<tr class="even">
<td>J1096</td>
<td>0010</td>
<td>3</td>
<td>Dexamethasone, lacrimal ophthalmic insert, 0.1 mg</td>
<td>Dexametha opth insert 0.1 mg</td>
</tr>
<tr class="odd">
<td>J1097</td>
<td>0010</td>
<td>3</td>
<td>Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml</td>
<td>Phenylep ketorolac opth soln</td>
</tr>
<tr class="even">
<td>J1100</td>
<td>0010</td>
<td>3</td>
<td>Injection, dexamethasone sodium phosphate, 1 mg</td>
<td>Dexamethasone sodium phos</td>
</tr>
<tr class="odd">
<td>J1110</td>
<td>0010</td>
<td>3</td>
<td>Injection, dihydroergotamine mesylate, per 1 mg</td>
<td>Inj dihydroergotamine mesylt</td>
</tr>
<tr class="even">
<td>J1120</td>
<td>0010</td>
<td>3</td>
<td>Injection, acetazolamide sodium, up to 500 mg</td>
<td>Acetazolamid sodium injectio</td>
</tr>
<tr class="odd">
<td>J1130</td>
<td>0010</td>
<td>3</td>
<td>Injection, diclofenac sodium, 0.5 mg</td>
<td>Inj diclofenac sodium 0.5mg</td>
</tr>
<tr class="even">
<td>J1160</td>
<td>0010</td>
<td>3</td>
<td>Injection, digoxin, up to 0.5 mg</td>
<td>Digoxin injection</td>
</tr>
<tr class="odd">
<td>J1162</td>
<td>0010</td>
<td>3</td>
<td>Injection, digoxin immune fab (ovine), per vial</td>
<td>Digoxin immune fab (ovine)</td>
</tr>
<tr class="even">
<td>J1165</td>
<td>0010</td>
<td>3</td>
<td>Injection, phenytoin sodium, per 50 mg</td>
<td>Phenytoin sodium injection</td>
</tr>
<tr class="odd">
<td>J1170</td>
<td>0010</td>
<td>3</td>
<td>Injection, hydromorphone, up to 4 mg</td>
<td>Hydromorphone injection</td>
</tr>
<tr class="even">
<td>J1180</td>
<td>0010</td>
<td>3</td>
<td>Injection, dyphylline, up to 500 mg</td>
<td>Dyphylline injection</td>
</tr>
<tr class="odd">
<td>J1190</td>
<td>0010</td>
<td>3</td>
<td>Injection, dexrazoxane hydrochloride, per 250 mg</td>
<td>Dexrazoxane hcl injection</td>
</tr>
<tr class="even">
<td>J1200</td>
<td>0010</td>
<td>3</td>
<td>Injection, diphenhydramine hcl, up to 50 mg</td>
<td>Diphenhydramine hcl injectio</td>
</tr>
<tr class="odd">
<td>J1205</td>
<td>0010</td>
<td>3</td>
<td>Injection, chlorothiazide sodium, per 500 mg</td>
<td>Chlorothiazide sodium inj</td>
</tr>
<tr class="even">
<td>J1212</td>
<td>0010</td>
<td>3</td>
<td>Injection, dmso, dimethyl sulfoxide, 50%, 50 ml</td>
<td>Dimethyl sulfoxide 50% 50 ml</td>
</tr>
<tr class="odd">
<td>J1230</td>
<td>0010</td>
<td>3</td>
<td>Injection, methadone hcl, up to 10 mg</td>
<td>Methadone injection</td>
</tr>
<tr class="even">
<td>J1240</td>
<td>0010</td>
<td>3</td>
<td>Injection, dimenhydrinate, up to 50 mg</td>
<td>Dimenhydrinate injection</td>
</tr>
<tr class="odd">
<td>J1245</td>
<td>0010</td>
<td>3</td>
<td>Injection, dipyridamole, per 10 mg</td>
<td>Dipyridamole injection</td>
</tr>
<tr class="even">
<td>J1250</td>
<td>0010</td>
<td>3</td>
<td>Injection, dobutamine hydrochloride, per 250 mg</td>
<td>Inj dobutamine hcl/250 mg</td>
</tr>
<tr class="odd">
<td>J1260</td>
<td>0010</td>
<td>3</td>
<td>Injection, dolasetron mesylate, 10 mg</td>
<td>Dolasetron mesylate</td>
</tr>
<tr class="even">
<td>J1265</td>
<td>0010</td>
<td>3</td>
<td>Injection, dopamine hcl, 40 mg</td>
<td>Dopamine injection</td>
</tr>
<tr class="odd">
<td>J1267</td>
<td>0010</td>
<td>3</td>
<td>Injection, doripenem, 10 mg</td>
<td>Doripenem injection</td>
</tr>
<tr class="even">
<td>J1270</td>
<td>0010</td>
<td>3</td>
<td>Injection, doxercalciferol, 1 mcg</td>
<td>Injection, doxercalciferol</td>
</tr>
<tr class="odd">
<td>J1290</td>
<td>0010</td>
<td>3</td>
<td>Injection, ecallantide, 1 mg</td>
<td>Ecallantide injection</td>
</tr>
<tr class="even">
<td>J1300</td>
<td>0010</td>
<td>3</td>
<td>Injection, eculizumab, 10 mg</td>
<td>Eculizumab injection</td>
</tr>
<tr class="odd">
<td>J1301</td>
<td>0010</td>
<td>3</td>
<td>Injection, edaravone, 1 mg</td>
<td>Injection, edaravone, 1 mg</td>
</tr>
<tr class="even">
<td>J1303</td>
<td>0010</td>
<td>3</td>
<td>Injection, ravulizumab-cwvz, 10 mg</td>
<td>Inj., ravulizumab-cwvz 10 mg</td>
</tr>
<tr class="odd">
<td>J1320</td>
<td>0010</td>
<td>3</td>
<td>Injection, amitriptyline hcl, up to 20 mg</td>
<td>Amitriptyline injection</td>
</tr>
<tr class="even">
<td>J1322</td>
<td>0010</td>
<td>3</td>
<td>Injection, elosulfase alfa, 1 mg</td>
<td>Elosulfase alfa, injection</td>
</tr>
<tr class="odd">
<td>J1324</td>
<td>0010</td>
<td>3</td>
<td>Injection, enfuvirtide, 1 mg</td>
<td>Enfuvirtide injection</td>
</tr>
<tr class="even">
<td>J1325</td>
<td>0010</td>
<td>3</td>
<td>Injection, epoprostenol, 0.5 mg</td>
<td>Epoprostenol injection</td>
</tr>
<tr class="odd">
<td>J1327</td>
<td>0010</td>
<td>3</td>
<td>Injection, eptifibatide, 5 mg</td>
<td>Eptifibatide injection</td>
</tr>
<tr class="even">
<td>J1330</td>
<td>0010</td>
<td>3</td>
<td>Injection, ergonovine maleate, up to 0.2 mg</td>
<td>Ergonovine maleate injection</td>
</tr>
<tr class="odd">
<td>J1335</td>
<td>0010</td>
<td>3</td>
<td>Injection, ertapenem sodium, 500 mg</td>
<td>Ertapenem injection</td>
</tr>
<tr class="even">
<td>J1364</td>
<td>0010</td>
<td>3</td>
<td>Injection, erythromycin lactobionate, per 500 mg</td>
<td>Erythro lactobionate /500 mg</td>
</tr>
<tr class="odd">
<td>J1380</td>
<td>0010</td>
<td>3</td>
<td>Injection, estradiol valerate, up to 10 mg</td>
<td>Estradiol valerate 10 mg inj</td>
</tr>
<tr class="even">
<td>J1410</td>
<td>0010</td>
<td>3</td>
<td>Injection, estrogen conjugated, per 25 mg</td>
<td>Inj estrogen conjugate 25 mg</td>
</tr>
<tr class="odd">
<td>J1428</td>
<td>0010</td>
<td>3</td>
<td>Injection, eteplirsen, 10 mg</td>
<td>Inj, eteplirsen, 10 mg</td>
</tr>
<tr class="even">
<td>J1430</td>
<td>0010</td>
<td>3</td>
<td>Injection, ethanolamine oleate, 100 mg</td>
<td>Ethanolamine oleate 100 mg</td>
</tr>
<tr class="odd">
<td>J1435</td>
<td>0010</td>
<td>3</td>
<td>Injection, estrone, per 1 mg</td>
<td>Injection estrone per 1 mg</td>
</tr>
<tr class="even">
<td>J1436</td>
<td>0010</td>
<td>3</td>
<td>Injection, etidronate disodium, per 300 mg</td>
<td>Etidronate disodium inj</td>
</tr>
<tr class="odd">
<td>J1438</td>
<td>0010</td>
<td>3</td>
<td>Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)</td>
<td>Etanercept injection</td>
</tr>
<tr class="even">
<td>J1439</td>
<td>0010</td>
<td>3</td>
<td>Injection, ferric carboxymaltose, 1 mg</td>
<td>Inj ferric carboxymaltos 1mg</td>
</tr>
<tr class="odd">
<td>J1442</td>
<td>0010</td>
<td>3</td>
<td>Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram</td>
<td>Inj filgrastim excl biosimil</td>
</tr>
<tr class="even">
<td>J1443</td>
<td>0010</td>
<td>3</td>
<td>Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron</td>
<td>Inj ferric pyrophosphate cit</td>
</tr>
<tr class="odd">
<td>J1444</td>
<td>0010</td>
<td>3</td>
<td>Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron</td>
<td>Fe pyro cit pow 0.1 mg iron</td>
</tr>
<tr class="even">
<td>J1446</td>
<td>0010</td>
<td>3</td>
<td>Injection, tbo-filgrastim, 5 micrograms</td>
<td>Inj, tbo-filgrastim, 5 mcg</td>
</tr>
<tr class="odd">
<td>J1447</td>
<td>0010</td>
<td>3</td>
<td>Injection, tbo-filgrastim, 1 microgram</td>
<td>Inj tbo filgrastim 1 microg</td>
</tr>
<tr class="even">
<td>J1450</td>
<td>0010</td>
<td>3</td>
<td>Injection fluconazole, 200 mg</td>
<td>Fluconazole</td>
</tr>
<tr class="odd">
<td>J1451</td>
<td>0010</td>
<td>3</td>
<td>Injection, fomepizole, 15 mg</td>
<td>Fomepizole, 15 mg</td>
</tr>
<tr class="even">
<td>J1452</td>
<td>0010</td>
<td>3</td>
<td>Injection, fomivirsen sodium, intraocular, 1.65 mg</td>
<td>Intraocular fomivirsen na</td>
</tr>
<tr class="odd">
<td>J1453</td>
<td>0010</td>
<td>3</td>
<td>Injection, fosaprepitant, 1 mg</td>
<td>Fosaprepitant injection</td>
</tr>
<tr class="even">
<td>J1454</td>
<td>0010</td>
<td>3</td>
<td>Injection, fosnetupitant 235 mg and palonosetron 0.25 mg</td>
<td>Inj fosnetupitant, palonoset</td>
</tr>
<tr class="odd">
<td>J1455</td>
<td>0010</td>
<td>3</td>
<td>Injection, foscarnet sodium, per 1000 mg</td>
<td>Foscarnet sodium injection</td>
</tr>
<tr class="even">
<td>J1457</td>
<td>0010</td>
<td>3</td>
<td>Injection, gallium nitrate, 1 mg</td>
<td>Gallium nitrate injection</td>
</tr>
<tr class="odd">
<td>J1458</td>
<td>0010</td>
<td>3</td>
<td>Injection, galsulfase, 1 mg</td>
<td>Galsulfase injection</td>
</tr>
<tr class="even">
<td>J1459</td>
<td>0010</td>
<td>3</td>
<td>Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg</td>
<td>Inj ivig privigen 500 mg</td>
</tr>
<tr class="odd">
<td>J1460</td>
<td>0010</td>
<td>3</td>
<td>Injection, gamma globulin, intramuscular, 1 cc</td>
<td>Gamma globulin 1 cc inj</td>
</tr>
<tr class="even">
<td>J1555</td>
<td>0010</td>
<td>3</td>
<td>Injection, immune globulin (cuvitru), 100 mg</td>
<td>Inj cuvitru, 100 mg</td>
</tr>
<tr class="odd">
<td>J1556</td>
<td>0010</td>
<td>3</td>
<td>Injection, immune globulin (bivigam), 500 mg</td>
<td>Inj, imm glob bivigam, 500mg</td>
</tr>
<tr class="even">
<td>J1557</td>
<td>0010</td>
<td>3</td>
<td>Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg</td>
<td>Gammaplex injection</td>
</tr>
<tr class="odd">
<td>J1559</td>
<td>0010</td>
<td>3</td>
<td>Injection, immune globulin (hizentra), 100 mg</td>
<td>Hizentra injection</td>
</tr>
<tr class="even">
<td>J1560</td>
<td>0010</td>
<td>3</td>
<td>Injection, gamma globulin, intramuscular, over 10 cc</td>
<td>Gamma globulin &gt; 10 cc inj</td>
</tr>
<tr class="odd">
<td>J1561</td>
<td>0010</td>
<td>3</td>
<td>Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg</td>
<td>Gamunex-c/gammaked</td>
</tr>
<tr class="even">
<td>J1562</td>
<td>0010</td>
<td>3</td>
<td>Injection, immune globulin (vivaglobin), 100 mg</td>
<td>Vivaglobin, inj</td>
</tr>
<tr class="odd">
<td>J1566</td>
<td>0010</td>
<td>3</td>
<td>Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg</td>
<td>Immune globulin, powder</td>
</tr>
<tr class="even">
<td>J1568</td>
<td>0010</td>
<td>3</td>
<td>Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg</td>
<td>Octagam injection</td>
</tr>
<tr class="odd">
<td>J1569</td>
<td>0010</td>
<td>3</td>
<td>Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg</td>
<td>Gammagard liquid injection</td>
</tr>
<tr class="even">
<td>J1570</td>
<td>0010</td>
<td>3</td>
<td>Injection, ganciclovir sodium, 500 mg</td>
<td>Ganciclovir sodium injection</td>
</tr>
<tr class="odd">
<td>J1571</td>
<td>0010</td>
<td>3</td>
<td>Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml</td>
<td>Hepagam b im injection</td>
</tr>
<tr class="even">
<td>J1572</td>
<td>0010</td>
<td>3</td>
<td>Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg</td>
<td>Flebogamma injection</td>
</tr>
<tr class="odd">
<td>J1573</td>
<td>0010</td>
<td>3</td>
<td>Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml</td>
<td>Hepagam b intravenous, inj</td>
</tr>
<tr class="even">
<td>J1575</td>
<td>0010</td>
<td>3</td>
<td>Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin</td>
<td>Hyqvia 100mg immuneglobulin</td>
</tr>
<tr class="odd">
<td>J1580</td>
<td>0010</td>
<td>3</td>
<td>Injection, garamycin, gentamicin, up to 80 mg</td>
<td>Garamycin gentamicin inj</td>
</tr>
<tr class="even">
<td>J1590</td>
<td>0010</td>
<td>3</td>
<td>Injection, gatifloxacin, 10 mg</td>
<td>Gatifloxacin injection</td>
</tr>
<tr class="odd">
<td>J1595</td>
<td>0010</td>
<td>3</td>
<td>Injection, glatiramer acetate, 20 mg</td>
<td>Injection glatiramer acetate</td>
</tr>
<tr class="even">
<td>J1599</td>
<td>0010</td>
<td>3</td>
<td>Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg</td>
<td>Ivig non-lyophilized, nos</td>
</tr>
<tr class="odd">
<td>J1600</td>
<td>0010</td>
<td>3</td>
<td>Injection, gold sodium thiomalate, up to 50 mg</td>
<td>Gold sodium thiomaleate inj</td>
</tr>
<tr class="even">
<td>J1602</td>
<td>0010</td>
<td>3</td>
<td>Injection, golimumab, 1 mg, for intravenous use</td>
<td>Golimumab for iv use 1mg</td>
</tr>
<tr class="odd">
<td>J1610</td>
<td>0010</td>
<td>3</td>
<td>Injection, glucagon hydrochloride, per 1 mg</td>
<td>Glucagon hydrochloride/1 mg</td>
</tr>
<tr class="even">
<td>J1620</td>
<td>0010</td>
<td>3</td>
<td>Injection, gonadorelin hydrochloride, per 100 mcg</td>
<td>Gonadorelin hydroch/ 100 mcg</td>
</tr>
<tr class="odd">
<td>J1626</td>
<td>0010</td>
<td>3</td>
<td>Injection, granisetron hydrochloride, 100 mcg</td>
<td>Granisetron hcl injection</td>
</tr>
<tr class="even">
<td>J1627</td>
<td>0010</td>
<td>3</td>
<td>Injection, granisetron, extended-release, 0.1 mg</td>
<td>Inj, granisetron, xr, 0.1 mg</td>
</tr>
<tr class="odd">
<td>J1628</td>
<td>0010</td>
<td>3</td>
<td>Injection, guselkumab, 1 mg</td>
<td>Inj., guselkumab, 1 mg</td>
</tr>
<tr class="even">
<td>J1630</td>
<td>0010</td>
<td>3</td>
<td>Injection, haloperidol, up to 5 mg</td>
<td>Haloperidol injection</td>
</tr>
<tr class="odd">
<td>J1631</td>
<td>0010</td>
<td>3</td>
<td>Injection, haloperidol decanoate, per 50 mg</td>
<td>Haloperidol decanoate inj</td>
</tr>
<tr class="even">
<td>J1640</td>
<td>0010</td>
<td>3</td>
<td>Injection, hemin, 1 mg</td>
<td>Hemin, 1 mg</td>
</tr>
<tr class="odd">
<td>J1642</td>
<td>0010</td>
<td>3</td>
<td>Injection, heparin sodium, (heparin lock flush), per 10 units</td>
<td>Inj heparin sodium per 10 u</td>
</tr>
<tr class="even">
<td>J1644</td>
<td>0010</td>
<td>3</td>
<td>Injection, heparin sodium, per 1000 units</td>
<td>Inj heparin sodium per 1000u</td>
</tr>
<tr class="odd">
<td>J1645</td>
<td>0010</td>
<td>3</td>
<td>Injection, dalteparin sodium, per 2500 iu</td>
<td>Dalteparin sodium</td>
</tr>
<tr class="even">
<td>J1650</td>
<td>0010</td>
<td>3</td>
<td>Injection, enoxaparin sodium, 10 mg</td>
<td>Inj enoxaparin sodium</td>
</tr>
<tr class="odd">
<td>J1652</td>
<td>0010</td>
<td>3</td>
<td>Injection, fondaparinux sodium, 0.5 mg</td>
<td>Fondaparinux sodium</td>
</tr>
<tr class="even">
<td>J1655</td>
<td>0010</td>
<td>3</td>
<td>Injection, tinzaparin sodium, 1000 iu</td>
<td>Tinzaparin sodium injection</td>
</tr>
<tr class="odd">
<td>J1670</td>
<td>0010</td>
<td>3</td>
<td>Injection, tetanus immune globulin, human, up to 250 units</td>
<td>Tetanus immune globulin inj</td>
</tr>
<tr class="even">
<td>J1675</td>
<td>0010</td>
<td>3</td>
<td>Injection, histrelin acetate, 10 micrograms</td>
<td>Histrelin acetate</td>
</tr>
<tr class="odd">
<td>J1700</td>
<td>0010</td>
<td>3</td>
<td>Injection, hydrocortisone acetate, up to 25 mg</td>
<td>Hydrocortisone acetate inj</td>
</tr>
<tr class="even">
<td>J1710</td>
<td>0010</td>
<td>3</td>
<td>Injection, hydrocortisone sodium phosphate, up to 50 mg</td>
<td>Hydrocortisone sodium ph inj</td>
</tr>
<tr class="odd">
<td>J1720</td>
<td>0010</td>
<td>3</td>
<td>Injection, hydrocortisone sodium succinate, up to 100 mg</td>
<td>Hydrocortisone sodium succ i</td>
</tr>
<tr class="even">
<td>J1725</td>
<td>0010</td>
<td>3</td>
<td>Injection, hydroxyprogesterone caproate, 1 mg</td>
<td>Hydroxyprogesterone caproate</td>
</tr>
<tr class="odd">
<td>J1726</td>
<td>0010</td>
<td>3</td>
<td>Injection, hydroxyprogesterone caproate, (makena), 10 mg</td>
<td>Makena, 10 mg</td>
</tr>
<tr class="even">
<td>J1729</td>
<td>0010</td>
<td>3</td>
<td>Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg</td>
<td>Inj hydroxyprogst capoat nos</td>
</tr>
<tr class="odd">
<td>J1730</td>
<td>0010</td>
<td>3</td>
<td>Injection, diazoxide, up to 300 mg</td>
<td>Diazoxide injection</td>
</tr>
<tr class="even">
<td>J1740</td>
<td>0010</td>
<td>3</td>
<td>Injection, ibandronate sodium, 1 mg</td>
<td>Ibandronate sodium injection</td>
</tr>
<tr class="odd">
<td>J1741</td>
<td>0010</td>
<td>3</td>
<td>Injection, ibuprofen, 100 mg</td>
<td>Ibuprofen injection</td>
</tr>
<tr class="even">
<td>J1742</td>
<td>0010</td>
<td>3</td>
<td>Injection, ibutilide fumarate, 1 mg</td>
<td>Ibutilide fumarate injection</td>
</tr>
<tr class="odd">
<td>J1743</td>
<td>0010</td>
<td>3</td>
<td>Injection, idursulfase, 1 mg</td>
<td>Idursulfase injection</td>
</tr>
<tr class="even">
<td>J1744</td>
<td>0010</td>
<td>3</td>
<td>Injection, icatibant, 1 mg</td>
<td>Icatibant injection</td>
</tr>
<tr class="odd">
<td>J1745</td>
<td>0010</td>
<td>3</td>
<td>Injection, infliximab, excludes biosimilar, 10 mg</td>
<td>Infliximab not biosimil 10mg</td>
</tr>
<tr class="even">
<td>J1746</td>
<td>0010</td>
<td>3</td>
<td>Injection, ibalizumab-uiyk, 10 mg</td>
<td>Inj., ibalizumab-uiyk, 10 mg</td>
</tr>
<tr class="odd">
<td>J1750</td>
<td>0010</td>
<td>3</td>
<td>Injection, iron dextran, 50 mg</td>
<td>Inj iron dextran</td>
</tr>
<tr class="even">
<td>J1756</td>
<td>0010</td>
<td>3</td>
<td>Injection, iron sucrose, 1 mg</td>
<td>Iron sucrose injection</td>
</tr>
<tr class="odd">
<td>J1786</td>
<td>0010</td>
<td>3</td>
<td>Injection, imiglucerase, 10 units</td>
<td>Imuglucerase injection</td>
</tr>
<tr class="even">
<td>J1790</td>
<td>0010</td>
<td>3</td>
<td>Injection, droperidol, up to 5 mg</td>
<td>Droperidol injection</td>
</tr>
<tr class="odd">
<td>J1800</td>
<td>0010</td>
<td>3</td>
<td>Injection, propranolol hcl, up to 1 mg</td>
<td>Propranolol injection</td>
</tr>
<tr class="even">
<td>J1810</td>
<td>0010</td>
<td>3</td>
<td>Injection, droperidol and fentanyl citrate, up to 2 ml ampule</td>
<td>Droperidol/fentanyl inj</td>
</tr>
<tr class="odd">
<td>J1815</td>
<td>0010</td>
<td>3</td>
<td>Injection, insulin, per 5 units</td>
<td>Insulin injection</td>
</tr>
<tr class="even">
<td>J1817</td>
<td>0010</td>
<td>3</td>
<td>Insulin for administration through dme (i.e., insulin pump) per 50 units</td>
<td>Insulin for insulin pump use</td>
</tr>
<tr class="odd">
<td>J1826</td>
<td>0010</td>
<td>3</td>
<td>Injection, interferon beta-1a, 30 mcg</td>
<td>Interferon beta-1a inj</td>
</tr>
<tr class="even">
<td>J1830</td>
<td>0010</td>
<td>3</td>
<td>Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)</td>
<td>Interferon beta-1b / .25 mg</td>
</tr>
<tr class="odd">
<td>J1833</td>
<td>0010</td>
<td>3</td>
<td>Injection, isavuconazonium, 1 mg</td>
<td>Injection, isavuconazonium</td>
</tr>
<tr class="even">
<td>J1835</td>
<td>0010</td>
<td>3</td>
<td>Injection, itraconazole, 50 mg</td>
<td>Itraconazole injection</td>
</tr>
<tr class="odd">
<td>J1840</td>
<td>0010</td>
<td>3</td>
<td>Injection, kanamycin sulfate, up to 500 mg</td>
<td>Kanamycin sulfate 500 mg inj</td>
</tr>
<tr class="even">
<td>J1850</td>
<td>0010</td>
<td>3</td>
<td>Injection, kanamycin sulfate, up to 75 mg</td>
<td>Kanamycin sulfate 75 mg inj</td>
</tr>
<tr class="odd">
<td>J1885</td>
<td>0010</td>
<td>3</td>
<td>Injection, ketorolac tromethamine, per 15 mg</td>
<td>Ketorolac tromethamine inj</td>
</tr>
<tr class="even">
<td>J1890</td>
<td>0010</td>
<td>3</td>
<td>Injection, cephalothin sodium, up to 1 gram</td>
<td>Cephalothin sodium injection</td>
</tr>
<tr class="odd">
<td>J1930</td>
<td>0010</td>
<td>3</td>
<td>Injection, lanreotide, 1 mg</td>
<td>Lanreotide injection</td>
</tr>
<tr class="even">
<td>J1931</td>
<td>0010</td>
<td>3</td>
<td>Injection, laronidase, 0.1 mg</td>
<td>Laronidase injection</td>
</tr>
<tr class="odd">
<td>J1940</td>
<td>0010</td>
<td>3</td>
<td>Injection, furosemide, up to 20 mg</td>
<td>Furosemide injection</td>
</tr>
<tr class="even">
<td>J1942</td>
<td>0010</td>
<td>3</td>
<td>Injection, aripiprazole lauroxil, 1 mg</td>
<td>Aripiprazole lauroxil 1mg</td>
</tr>
<tr class="odd">
<td>J1943</td>
<td>0010</td>
<td>3</td>
<td>Injection, aripiprazole lauroxil, (aristada initio), 1 mg</td>
<td>Inj., aristada initio, 1 mg</td>
</tr>
<tr class="even">
<td>J1944</td>
<td>0010</td>
<td>3</td>
<td>Injection, aripiprazole lauroxil, (aristada), 1 mg</td>
<td>Aripirazole lauroxil 1 mg</td>
</tr>
<tr class="odd">
<td>J1945</td>
<td>0010</td>
<td>3</td>
<td>Injection, lepirudin, 50 mg</td>
<td>Lepirudin</td>
</tr>
<tr class="even">
<td>J1950</td>
<td>0010</td>
<td>3</td>
<td>Injection, leuprolide acetate (for depot suspension), per 3.75 mg</td>
<td>Leuprolide acetate /3.75 mg</td>
</tr>
<tr class="odd">
<td>J1953</td>
<td>0010</td>
<td>3</td>
<td>Injection, levetiracetam, 10 mg</td>
<td>Levetiracetam injection</td>
</tr>
<tr class="even">
<td>J1955</td>
<td>0010</td>
<td>3</td>
<td>Injection, levocarnitine, per 1 gm</td>
<td>Inj levocarnitine per 1 gm</td>
</tr>
<tr class="odd">
<td>J1956</td>
<td>0010</td>
<td>3</td>
<td>Injection, levofloxacin, 250 mg</td>
<td>Levofloxacin injection</td>
</tr>
<tr class="even">
<td>J1960</td>
<td>0010</td>
<td>3</td>
<td>Injection, levorphanol tartrate, up to 2 mg</td>
<td>Levorphanol tartrate inj</td>
</tr>
<tr class="odd">
<td>J1980</td>
<td>0010</td>
<td>3</td>
<td>Injection, hyoscyamine sulfate, up to 0.25 mg</td>
<td>Hyoscyamine sulfate inj</td>
</tr>
<tr class="even">
<td>J1990</td>
<td>0010</td>
<td>3</td>
<td>Injection, chlordiazepoxide hcl, up to 100 mg</td>
<td>Chlordiazepoxide injection</td>
</tr>
<tr class="odd">
<td>J2001</td>
<td>0010</td>
<td>3</td>
<td>Injection, lidocaine hcl for intravenous infusion, 10 mg</td>
<td>Lidocaine injection</td>
</tr>
<tr class="even">
<td>J2010</td>
<td>0010</td>
<td>3</td>
<td>Injection, lincomycin hcl, up to 300 mg</td>
<td>Lincomycin injection</td>
</tr>
<tr class="odd">
<td>J2020</td>
<td>0010</td>
<td>3</td>
<td>Injection, linezolid, 200 mg</td>
<td>Linezolid injection</td>
</tr>
<tr class="even">
<td>J2060</td>
<td>0010</td>
<td>3</td>
<td>Injection, lorazepam, 2 mg</td>
<td>Lorazepam injection</td>
</tr>
<tr class="odd">
<td>J2062</td>
<td>0010</td>
<td>3</td>
<td>Loxapine for inhalation, 1 mg</td>
<td>Loxapine for inhalation 1 mg</td>
</tr>
<tr class="even">
<td>J2150</td>
<td>0010</td>
<td>3</td>
<td>Injection, mannitol, 25% in 50 ml</td>
<td>Mannitol injection</td>
</tr>
<tr class="odd">
<td>J2170</td>
<td>0010</td>
<td>3</td>
<td>Injection, mecasermin, 1 mg</td>
<td>Mecasermin injection</td>
</tr>
<tr class="even">
<td>J2175</td>
<td>0010</td>
<td>3</td>
<td>Injection, meperidine hydrochloride, per 100 mg</td>
<td>Meperidine hydrochl /100 mg</td>
</tr>
<tr class="odd">
<td>J2180</td>
<td>0010</td>
<td>3</td>
<td>Injection, meperidine and promethazine hcl, up to 50 mg</td>
<td>Meperidine/promethazine inj</td>
</tr>
<tr class="even">
<td>J2182</td>
<td>0010</td>
<td>3</td>
<td>Injection, mepolizumab, 1 mg</td>
<td>Injection, mepolizumab, 1mg</td>
</tr>
<tr class="odd">
<td>J2185</td>
<td>0010</td>
<td>3</td>
<td>Injection, meropenem, 100 mg</td>
<td>Meropenem</td>
</tr>
<tr class="even">
<td>J2186</td>
<td>0010</td>
<td>3</td>
<td>Injection, meropenem and vaborbactam, 10mg/10mg (20mg)</td>
<td>Inj., meropenem, vaborbactam</td>
</tr>
<tr class="odd">
<td>J2210</td>
<td>0010</td>
<td>3</td>
<td>Injection, methylergonovine maleate, up to 0.2 mg</td>
<td>Methylergonovin maleate inj</td>
</tr>
<tr class="even">
<td>J2212</td>
<td>0010</td>
<td>3</td>
<td>Injection, methylnaltrexone, 0.1 mg</td>
<td>Methylnaltrexone injection</td>
</tr>
<tr class="odd">
<td>J2248</td>
<td>0010</td>
<td>3</td>
<td>Injection, micafungin sodium, 1 mg</td>
<td>Micafungin sodium injection</td>
</tr>
<tr class="even">
<td>J2250</td>
<td>0010</td>
<td>3</td>
<td>Injection, midazolam hydrochloride, per 1 mg</td>
<td>Inj midazolam hydrochloride</td>
</tr>
<tr class="odd">
<td>J2260</td>
<td>0010</td>
<td>3</td>
<td>Injection, milrinone lactate, 5 mg</td>
<td>Inj milrinone lactate / 5 mg</td>
</tr>
<tr class="even">
<td>J2265</td>
<td>0010</td>
<td>3</td>
<td>Injection, minocycline hydrochloride, 1 mg</td>
<td>Minocycline hydrochloride</td>
</tr>
<tr class="odd">
<td>J2270</td>
<td>0010</td>
<td>3</td>
<td>Injection, morphine sulfate, up to 10 mg</td>
<td>Morphine sulfate injection</td>
</tr>
<tr class="even">
<td>J2271</td>
<td>0010</td>
<td>3</td>
<td>Injection, morphine sulfate, 100mg</td>
<td>Morphine so4 injection 100mg</td>
</tr>
<tr class="odd">
<td>J2274</td>
<td>0010</td>
<td>3</td>
<td>Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg</td>
<td>Inj morphine pf epid ithc</td>
</tr>
<tr class="even">
<td>J2275</td>
<td>0010</td>
<td>3</td>
<td>Injection, morphine sulfate (preservative-free sterile solution), per 10 mg</td>
<td>Morphine sulfate injection</td>
</tr>
<tr class="odd">
<td>J2278</td>
<td>0010</td>
<td>3</td>
<td>Injection, ziconotide, 1 microgram</td>
<td>Ziconotide injection</td>
</tr>
<tr class="even">
<td>J2280</td>
<td>0010</td>
<td>3</td>
<td>Injection, moxifloxacin, 100 mg</td>
<td>Inj, moxifloxacin 100 mg</td>
</tr>
<tr class="odd">
<td>J2300</td>
<td>0010</td>
<td>3</td>
<td>Injection, nalbuphine hydrochloride, per 10 mg</td>
<td>Inj nalbuphine hydrochloride</td>
</tr>
<tr class="even">
<td>J2310</td>
<td>0010</td>
<td>3</td>
<td>Injection, naloxone hydrochloride, per 1 mg</td>
<td>Inj naloxone hydrochloride</td>
</tr>
<tr class="odd">
<td>J2315</td>
<td>0010</td>
<td>3</td>
<td>Injection, naltrexone, depot form, 1 mg</td>
<td>Naltrexone, depot form</td>
</tr>
<tr class="even">
<td>J2320</td>
<td>0010</td>
<td>3</td>
<td>Injection, nandrolone decanoate, up to 50 mg</td>
<td>Nandrolone decanoate 50 mg</td>
</tr>
<tr class="odd">
<td>J2323</td>
<td>0010</td>
<td>3</td>
<td>Injection, natalizumab, 1 mg</td>
<td>Natalizumab injection</td>
</tr>
<tr class="even">
<td>J2325</td>
<td>0010</td>
<td>3</td>
<td>Injection, nesiritide, 0.1 mg</td>
<td>Nesiritide injection</td>
</tr>
<tr class="odd">
<td>J2326</td>
<td>0010</td>
<td>3</td>
<td>Injection, nusinersen, 0.1 mg</td>
<td>Inj, nusinersen, 0.1mg</td>
</tr>
<tr class="even">
<td>J2350</td>
<td>0010</td>
<td>3</td>
<td>Injection, ocrelizumab, 1 mg</td>
<td>Injection, ocrelizumab, 1 mg</td>
</tr>
<tr class="odd">
<td>J2353</td>
<td>0010</td>
<td>3</td>
<td>Injection, octreotide, depot form for intramuscular injection, 1 mg</td>
<td>Octreotide injection, depot</td>
</tr>
<tr class="even">
<td>J2354</td>
<td>0010</td>
<td>3</td>
<td>Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg</td>
<td>Octreotide inj, non-depot</td>
</tr>
<tr class="odd">
<td>J2355</td>
<td>0010</td>
<td>3</td>
<td>Injection, oprelvekin, 5 mg</td>
<td>Oprelvekin injection</td>
</tr>
<tr class="even">
<td>J2357</td>
<td>0010</td>
<td>3</td>
<td>Injection, omalizumab, 5 mg</td>
<td>Omalizumab injection</td>
</tr>
<tr class="odd">
<td>J2358</td>
<td>0010</td>
<td>3</td>
<td>Injection, olanzapine, long-acting, 1 mg</td>
<td>Olanzapine long-acting inj</td>
</tr>
<tr class="even">
<td>J2360</td>
<td>0010</td>
<td>3</td>
<td>Injection, orphenadrine citrate, up to 60 mg</td>
<td>Orphenadrine injection</td>
</tr>
<tr class="odd">
<td>J2370</td>
<td>0010</td>
<td>3</td>
<td>Injection, phenylephrine hcl, up to 1 ml</td>
<td>Phenylephrine hcl injection</td>
</tr>
<tr class="even">
<td>J2400</td>
<td>0010</td>
<td>3</td>
<td>Injection, chloroprocaine hydrochloride, per 30 ml</td>
<td>Chloroprocaine hcl injection</td>
</tr>
<tr class="odd">
<td>J2405</td>
<td>0010</td>
<td>3</td>
<td>Injection, ondansetron hydrochloride, per 1 mg</td>
<td>Ondansetron hcl injection</td>
</tr>
<tr class="even">
<td>J2407</td>
<td>0010</td>
<td>3</td>
<td>Injection, oritavancin, 10 mg</td>
<td>Injection, oritavancin</td>
</tr>
<tr class="odd">
<td>J2410</td>
<td>0010</td>
<td>3</td>
<td>Injection, oxymorphone hcl, up to 1 mg</td>
<td>Oxymorphone hcl injection</td>
</tr>
<tr class="even">
<td>J2425</td>
<td>0010</td>
<td>3</td>
<td>Injection, palifermin, 50 micrograms</td>
<td>Palifermin injection</td>
</tr>
<tr class="odd">
<td>J2426</td>
<td>0010</td>
<td>3</td>
<td>Injection, paliperidone palmitate extended release, 1 mg</td>
<td>Paliperidone palmitate inj</td>
</tr>
<tr class="even">
<td>J2430</td>
<td>0010</td>
<td>3</td>
<td>Injection, pamidronate disodium, per 30 mg</td>
<td>Pamidronate disodium /30 mg</td>
</tr>
<tr class="odd">
<td>J2440</td>
<td>0010</td>
<td>3</td>
<td>Injection, papaverine hcl, up to 60 mg</td>
<td>Papaverin hcl injection</td>
</tr>
<tr class="even">
<td>J2460</td>
<td>0010</td>
<td>3</td>
<td>Injection, oxytetracycline hcl, up to 50 mg</td>
<td>Oxytetracycline injection</td>
</tr>
<tr class="odd">
<td>J2469</td>
<td>0010</td>
<td>3</td>
<td>Injection, palonosetron hcl, 25 mcg</td>
<td>Palonosetron hcl</td>
</tr>
<tr class="even">
<td>J2501</td>
<td>0010</td>
<td>3</td>
<td>Injection, paricalcitol, 1 mcg</td>
<td>Paricalcitol</td>
</tr>
<tr class="odd">
<td>J2502</td>
<td>0010</td>
<td>3</td>
<td>Injection, pasireotide long acting, 1 mg</td>
<td>Inj, pasireotide long acting</td>
</tr>
<tr class="even">
<td>J2503</td>
<td>0010</td>
<td>3</td>
<td>Injection, pegaptanib sodium, 0.3 mg</td>
<td>Pegaptanib sodium injection</td>
</tr>
<tr class="odd">
<td>J2504</td>
<td>0010</td>
<td>3</td>
<td>Injection, pegademase bovine, 25 iu</td>
<td>Pegademase bovine, 25 iu</td>
</tr>
<tr class="even">
<td>J2505</td>
<td>0010</td>
<td>3</td>
<td>Injection, pegfilgrastim, 6 mg</td>
<td>Injection, pegfilgrastim 6mg</td>
</tr>
<tr class="odd">
<td>J2507</td>
<td>0010</td>
<td>3</td>
<td>Injection, pegloticase, 1 mg</td>
<td>Pegloticase injection</td>
</tr>
<tr class="even">
<td>J2510</td>
<td>0010</td>
<td>3</td>
<td>Injection, penicillin g procaine, aqueous, up to 600,000 units</td>
<td>Penicillin g procaine inj</td>
</tr>
<tr class="odd">
<td>J2513</td>
<td>0010</td>
<td>3</td>
<td>Injection, pentastarch, 10% solution, 100 ml</td>
<td>Pentastarch 10% solution</td>
</tr>
<tr class="even">
<td>J2515</td>
<td>0010</td>
<td>3</td>
<td>Injection, pentobarbital sodium, per 50 mg</td>
<td>Pentobarbital sodium inj</td>
</tr>
<tr class="odd">
<td>J2540</td>
<td>0010</td>
<td>3</td>
<td>Injection, penicillin g potassium, up to 600,000 units</td>
<td>Penicillin g potassium inj</td>
</tr>
<tr class="even">
<td>J2543</td>
<td>0010</td>
<td>3</td>
<td>Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)</td>
<td>Piperacillin/tazobactam</td>
</tr>
<tr class="odd">
<td>J2545</td>
<td>0010</td>
<td>3</td>
<td>Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg</td>
<td>Pentamidine non-comp unit</td>
</tr>
<tr class="even">
<td>J2547</td>
<td>0010</td>
<td>3</td>
<td>Injection, peramivir, 1 mg</td>
<td>Injection, peramivir</td>
</tr>
<tr class="odd">
<td>J2550</td>
<td>0010</td>
<td>3</td>
<td>Injection, promethazine hcl, up to 50 mg</td>
<td>Promethazine hcl injection</td>
</tr>
<tr class="even">
<td>J2560</td>
<td>0010</td>
<td>3</td>
<td>Injection, phenobarbital sodium, up to 120 mg</td>
<td>Phenobarbital sodium inj</td>
</tr>
<tr class="odd">
<td>J2562</td>
<td>0010</td>
<td>3</td>
<td>Injection, plerixafor, 1 mg</td>
<td>Plerixafor injection</td>
</tr>
<tr class="even">
<td>J2590</td>
<td>0010</td>
<td>3</td>
<td>Injection, oxytocin, up to 10 units</td>
<td>Oxytocin injection</td>
</tr>
<tr class="odd">
<td>J2597</td>
<td>0010</td>
<td>3</td>
<td>Injection, desmopressin acetate, per 1 mcg</td>
<td>Inj desmopressin acetate</td>
</tr>
<tr class="even">
<td>J2650</td>
<td>0010</td>
<td>3</td>
<td>Injection, prednisolone acetate, up to 1 ml</td>
<td>Prednisolone acetate inj</td>
</tr>
<tr class="odd">
<td>J2670</td>
<td>0010</td>
<td>3</td>
<td>Injection, tolazoline hcl, up to 25 mg</td>
<td>Totazoline hcl injection</td>
</tr>
<tr class="even">
<td>J2675</td>
<td>0010</td>
<td>3</td>
<td>Injection, progesterone, per 50 mg</td>
<td>Inj progesterone per 50 mg</td>
</tr>
<tr class="odd">
<td>J2680</td>
<td>0010</td>
<td>3</td>
<td>Injection, fluphenazine decanoate, up to 25 mg</td>
<td>Fluphenazine decanoate 25 mg</td>
</tr>
<tr class="even">
<td>J2690</td>
<td>0010</td>
<td>3</td>
<td>Injection, procainamide hcl, up to 1 gm</td>
<td>Procainamide hcl injection</td>
</tr>
<tr class="odd">
<td>J2700</td>
<td>0010</td>
<td>3</td>
<td>Injection, oxacillin sodium, up to 250 mg</td>
<td>Oxacillin sodium injeciton</td>
</tr>
<tr class="even">
<td>J2704</td>
<td>0010</td>
<td>3</td>
<td>Injection, propofol, 10 mg</td>
<td>Inj, propofol, 10 mg</td>
</tr>
<tr class="odd">
<td>J2710</td>
<td>0010</td>
<td>3</td>
<td>Injection, neostigmine methylsulfate, up to 0.5 mg</td>
<td>Neostigmine methylslfte inj</td>
</tr>
<tr class="even">
<td>J2720</td>
<td>0010</td>
<td>3</td>
<td>Injection, protamine sulfate, per 10 mg</td>
<td>Inj protamine sulfate/10 mg</td>
</tr>
<tr class="odd">
<td>J2724</td>
<td>0010</td>
<td>3</td>
<td>Injection, protein c concentrate, intravenous, human, 10 iu</td>
<td>Protein c concentrate</td>
</tr>
<tr class="even">
<td>J2725</td>
<td>0010</td>
<td>3</td>
<td>Injection, protirelin, per 250 mcg</td>
<td>Inj protirelin per 250 mcg</td>
</tr>
<tr class="odd">
<td>J2730</td>
<td>0010</td>
<td>3</td>
<td>Injection, pralidoxime chloride, up to 1 gm</td>
<td>Pralidoxime chloride inj</td>
</tr>
<tr class="even">
<td>J2760</td>
<td>0010</td>
<td>3</td>
<td>Injection, phentolamine mesylate, up to 5 mg</td>
<td>Phentolaine mesylate inj</td>
</tr>
<tr class="odd">
<td>J2765</td>
<td>0010</td>
<td>3</td>
<td>Injection, metoclopramide hcl, up to 10 mg</td>
<td>Metoclopramide hcl injection</td>
</tr>
<tr class="even">
<td>J2770</td>
<td>0010</td>
<td>3</td>
<td>Injection, quinupristin/dalfopristin, 500 mg (150/350)</td>
<td>Quinupristin/dalfopristin</td>
</tr>
<tr class="odd">
<td>J2778</td>
<td>0010</td>
<td>3</td>
<td>Injection, ranibizumab, 0.1 mg</td>
<td>Ranibizumab injection</td>
</tr>
<tr class="even">
<td>J2780</td>
<td>0010</td>
<td>3</td>
<td>Injection, ranitidine hydrochloride, 25 mg</td>
<td>Ranitidine hydrochloride inj</td>
</tr>
<tr class="odd">
<td>J2783</td>
<td>0010</td>
<td>3</td>
<td>Injection, rasburicase, 0.5 mg</td>
<td>Rasburicase</td>
</tr>
<tr class="even">
<td>J2785</td>
<td>0010</td>
<td>3</td>
<td>Injection, regadenoson, 0.1 mg</td>
<td>Regadenoson injection</td>
</tr>
<tr class="odd">
<td>J2786</td>
<td>0010</td>
<td>3</td>
<td>Injection, reslizumab, 1 mg</td>
<td>Injection, reslizumab, 1mg</td>
</tr>
<tr class="even">
<td>J2787</td>
<td>0010</td>
<td>3</td>
<td>Riboflavin 5’-phosphate, ophthalmic solution, up to 3 ml</td>
<td>Riboflavin 5’phos opth&lt;=3ml</td>
</tr>
<tr class="odd">
<td>J2788</td>
<td>0010</td>
<td>3</td>
<td>Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)</td>
<td>Rho d immune globulin 50 mcg</td>
</tr>
<tr class="even">
<td>J2790</td>
<td>0010</td>
<td>3</td>
<td>Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)</td>
<td>Rho d immune globulin inj</td>
</tr>
<tr class="odd">
<td>J2791</td>
<td>0010</td>
<td>3</td>
<td>Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu</td>
<td>Rhophylac injection</td>
</tr>
<tr class="even">
<td>J2792</td>
<td>0010</td>
<td>3</td>
<td>Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu</td>
<td>Rho(d) immune globulin h, sd</td>
</tr>
<tr class="odd">
<td>J2793</td>
<td>0010</td>
<td>3</td>
<td>Injection, rilonacept, 1 mg</td>
<td>Rilonacept injection</td>
</tr>
<tr class="even">
<td>J2794</td>
<td>0010</td>
<td>3</td>
<td>Injection, risperidone (risperdal consta), 0.5 mg</td>
<td>Inj risperdal consta, 0.5 mg</td>
</tr>
<tr class="odd">
<td>J2795</td>
<td>0010</td>
<td>3</td>
<td>Injection, ropivacaine hydrochloride, 1 mg</td>
<td>Ropivacaine hcl injection</td>
</tr>
<tr class="even">
<td>J2796</td>
<td>0010</td>
<td>3</td>
<td>Injection, romiplostim, 10 micrograms</td>
<td>Romiplostim injection</td>
</tr>
<tr class="odd">
<td>J2797</td>
<td>0010</td>
<td>3</td>
<td>Injection, rolapitant, 0.5 mg</td>
<td>Inj., rolapitant, 0.5 mg</td>
</tr>
<tr class="even">
<td>J2798</td>
<td>0010</td>
<td>3</td>
<td>Injection, risperidone, (perseris), 0.5 mg</td>
<td>Inj., perseris, 0.5 mg</td>
</tr>
<tr class="odd">
<td>J2800</td>
<td>0010</td>
<td>3</td>
<td>Injection, methocarbamol, up to 10 ml</td>
<td>Methocarbamol injection</td>
</tr>
<tr class="even">
<td>J2805</td>
<td>0010</td>
<td>3</td>
<td>Injection, sincalide, 5 micrograms</td>
<td>Sincalide injection</td>
</tr>
<tr class="odd">
<td>J2810</td>
<td>0010</td>
<td>3</td>
<td>Injection, theophylline, per 40 mg</td>
<td>Inj theophylline per 40 mg</td>
</tr>
<tr class="even">
<td>J2820</td>
<td>0010</td>
<td>3</td>
<td>Injection, sargramostim (gm-csf), 50 mcg</td>
<td>Sargramostim injection</td>
</tr>
<tr class="odd">
<td>J2840</td>
<td>0010</td>
<td>3</td>
<td>Injection, sebelipase alfa, 1 mg</td>
<td>Inj sebelipase alfa 1 mg</td>
</tr>
<tr class="even">
<td>J2850</td>
<td>0010</td>
<td>3</td>
<td>Injection, secretin, synthetic, human, 1 microgram</td>
<td>Inj secretin synthetic human</td>
</tr>
<tr class="odd">
<td>J2860</td>
<td>0010</td>
<td>3</td>
<td>Injection, siltuximab, 10 mg</td>
<td>Injection, siltuximab</td>
</tr>
<tr class="even">
<td>J2910</td>
<td>0010</td>
<td>3</td>
<td>Injection, aurothioglucose, up to 50 mg</td>
<td>Aurothioglucose injeciton</td>
</tr>
<tr class="odd">
<td>J2916</td>
<td>0010</td>
<td>3</td>
<td>Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg</td>
<td>Na ferric gluconate complex</td>
</tr>
<tr class="even">
<td>J2920</td>
<td>0010</td>
<td>3</td>
<td>Injection, methylprednisolone sodium succinate, up to 40 mg</td>
<td>Methylprednisolone injection</td>
</tr>
<tr class="odd">
<td>J2930</td>
<td>0010</td>
<td>3</td>
<td>Injection, methylprednisolone sodium succinate, up to 125 mg</td>
<td>Methylprednisolone injection</td>
</tr>
<tr class="even">
<td>J2940</td>
<td>0010</td>
<td>3</td>
<td>Injection, somatrem, 1 mg</td>
<td>Somatrem injection</td>
</tr>
<tr class="odd">
<td>J2941</td>
<td>0010</td>
<td>3</td>
<td>Injection, somatropin, 1 mg</td>
<td>Somatropin injection</td>
</tr>
<tr class="even">
<td>J2950</td>
<td>0010</td>
<td>3</td>
<td>Injection, promazine hcl, up to 25 mg</td>
<td>Promazine hcl injection</td>
</tr>
<tr class="odd">
<td>J2993</td>
<td>0010</td>
<td>3</td>
<td>Injection, reteplase, 18.1 mg</td>
<td>Reteplase injection</td>
</tr>
<tr class="even">
<td>J2995</td>
<td>0010</td>
<td>3</td>
<td>Injection, streptokinase, per 250,000 iu</td>
<td>Inj streptokinase /250000 iu</td>
</tr>
<tr class="odd">
<td>J2997</td>
<td>0010</td>
<td>3</td>
<td>Injection, alteplase recombinant, 1 mg</td>
<td>Alteplase recombinant</td>
</tr>
<tr class="even">
<td>J3000</td>
<td>0010</td>
<td>3</td>
<td>Injection, streptomycin, up to 1 gm</td>
<td>Streptomycin injection</td>
</tr>
<tr class="odd">
<td>J3010</td>
<td>0010</td>
<td>3</td>
<td>Injection, fentanyl citrate, 0.1 mg</td>
<td>Fentanyl citrate injection</td>
</tr>
<tr class="even">
<td>J3030</td>
<td>0010</td>
<td>3</td>
<td>Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)</td>
<td>Sumatriptan succinate / 6 mg</td>
</tr>
<tr class="odd">
<td>J3031</td>
<td>0010</td>
<td>3</td>
<td>Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)</td>
<td>Inj., fremanezumab-vfrm 1 mg</td>
</tr>
<tr class="even">
<td>J3060</td>
<td>0010</td>
<td>3</td>
<td>Injection, taliglucerase alfa, 10 units</td>
<td>Inj, taliglucerase alfa 10 u</td>
</tr>
<tr class="odd">
<td>J3070</td>
<td>0010</td>
<td>3</td>
<td>Injection, pentazocine, 30 mg</td>
<td>Pentazocine injection</td>
</tr>
<tr class="even">
<td>J3090</td>
<td>0010</td>
<td>3</td>
<td>Injection, tedizolid phosphate, 1 mg</td>
<td>Inj tedizolid phosphate</td>
</tr>
<tr class="odd">
<td>J3095</td>
<td>0010</td>
<td>3</td>
<td>Injection, telavancin, 10 mg</td>
<td>Telavancin injection</td>
</tr>
<tr class="even">
<td>J3101</td>
<td>0010</td>
<td>3</td>
<td>Injection, tenecteplase, 1 mg</td>
<td>Tenecteplase injection</td>
</tr>
<tr class="odd">
<td>J3105</td>
<td>0010</td>
<td>3</td>
<td>Injection, terbutaline sulfate, up to 1 mg</td>
<td>Terbutaline sulfate inj</td>
</tr>
<tr class="even">
<td>J3110</td>
<td>0010</td>
<td>3</td>
<td>Injection, teriparatide, 10 mcg</td>
<td>Teriparatide injection</td>
</tr>
<tr class="odd">
<td>J3111</td>
<td>0010</td>
<td>3</td>
<td>Injection, romosozumab-aqqg, 1 mg</td>
<td>Inj. romosozumab-aqqg 1 mg</td>
</tr>
<tr class="even">
<td>J3120</td>
<td>0010</td>
<td>3</td>
<td>Injection, testosterone enanthate, up to 100 mg</td>
<td>Testosterone enanthate inj</td>
</tr>
<tr class="odd">
<td>J3121</td>
<td>0010</td>
<td>3</td>
<td>Injection, testosterone enanthate, 1 mg</td>
<td>Inj testostero enanthate 1mg</td>
</tr>
<tr class="even">
<td>J3130</td>
<td>0010</td>
<td>3</td>
<td>Injection, testosterone enanthate, up to 200 mg</td>
<td>Testosterone enanthate inj</td>
</tr>
<tr class="odd">
<td>J3140</td>
<td>0010</td>
<td>3</td>
<td>Injection, testosterone suspension, up to 50 mg</td>
<td>Testosterone suspension inj</td>
</tr>
<tr class="even">
<td>J3145</td>
<td>0010</td>
<td>3</td>
<td>Injection, testosterone undecanoate, 1 mg</td>
<td>Testosterone undecanoate 1mg</td>
</tr>
<tr class="odd">
<td>J3150</td>
<td>0010</td>
<td>3</td>
<td>Injection, testosterone propionate, up to 100 mg</td>
<td>Testosteron propionate inj</td>
</tr>
<tr class="even">
<td>J3230</td>
<td>0010</td>
<td>3</td>
<td>Injection, chlorpromazine hcl, up to 50 mg</td>
<td>Chlorpromazine hcl injection</td>
</tr>
<tr class="odd">
<td>J3240</td>
<td>0010</td>
<td>3</td>
<td>Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial</td>
<td>Thyrotropin injection</td>
</tr>
<tr class="even">
<td>J3243</td>
<td>0010</td>
<td>3</td>
<td>Injection, tigecycline, 1 mg</td>
<td>Tigecycline injection</td>
</tr>
<tr class="odd">
<td>J3245</td>
<td>0010</td>
<td>3</td>
<td>Injection, tildrakizumab, 1 mg</td>
<td>Inj., tildrakizumab, 1 mg</td>
</tr>
<tr class="even">
<td>J3246</td>
<td>0010</td>
<td>3</td>
<td>Injection, tirofiban hcl, 0.25 mg</td>
<td>Tirofiban hcl</td>
</tr>
<tr class="odd">
<td>J3250</td>
<td>0010</td>
<td>3</td>
<td>Injection, trimethobenzamide hcl, up to 200 mg</td>
<td>Trimethobenzamide hcl inj</td>
</tr>
<tr class="even">
<td>J3260</td>
<td>0010</td>
<td>3</td>
<td>Injection, tobramycin sulfate, up to 80 mg</td>
<td>Tobramycin sulfate injection</td>
</tr>
<tr class="odd">
<td>J3262</td>
<td>0010</td>
<td>3</td>
<td>Injection, tocilizumab, 1 mg</td>
<td>Tocilizumab injection</td>
</tr>
<tr class="even">
<td>J3265</td>
<td>0010</td>
<td>3</td>
<td>Injection, torsemide, 10 mg/ml</td>
<td>Injection torsemide 10 mg/ml</td>
</tr>
<tr class="odd">
<td>J3280</td>
<td>0010</td>
<td>3</td>
<td>Injection, thiethylperazine maleate, up to 10 mg</td>
<td>Thiethylperazine maleate inj</td>
</tr>
<tr class="even">
<td>J3285</td>
<td>0010</td>
<td>3</td>
<td>Injection, treprostinil, 1 mg</td>
<td>Treprostinil injection</td>
</tr>
<tr class="odd">
<td>J3300</td>
<td>0010</td>
<td>3</td>
<td>Injection, triamcinolone acetonide, preservative free, 1 mg</td>
<td>Triamcinolone a inj prs-free</td>
</tr>
<tr class="even">
<td>J3301</td>
<td>0010</td>
<td>3</td>
<td>Injection, triamcinolone acetonide, not otherwise specified, 10 mg</td>
<td>Triamcinolone acet inj nos</td>
</tr>
<tr class="odd">
<td>J3302</td>
<td>0010</td>
<td>3</td>
<td>Injection, triamcinolone diacetate, per 5 mg</td>
<td>Triamcinolone diacetate inj</td>
</tr>
<tr class="even">
<td>J3303</td>
<td>0010</td>
<td>3</td>
<td>Injection, triamcinolone hexacetonide, per 5 mg</td>
<td>Triamcinolone hexacetonl inj</td>
</tr>
<tr class="odd">
<td>J3304</td>
<td>0010</td>
<td>3</td>
<td>Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg</td>
<td>Inj triamcinolone ace xr 1mg</td>
</tr>
<tr class="even">
<td>J3305</td>
<td>0010</td>
<td>3</td>
<td>Injection, trimetrexate glucuronate, per 25 mg</td>
<td>Inj trimetrexate glucoronate</td>
</tr>
<tr class="odd">
<td>J3310</td>
<td>0010</td>
<td>3</td>
<td>Injection, perphenazine, up to 5 mg</td>
<td>Perphenazine injeciton</td>
</tr>
<tr class="even">
<td>J3315</td>
<td>0010</td>
<td>3</td>
<td>Injection, triptorelin pamoate, 3.75 mg</td>
<td>Triptorelin pamoate</td>
</tr>
<tr class="odd">
<td>J3316</td>
<td>0010</td>
<td>3</td>
<td>Injection, triptorelin, extended-release, 3.75 mg</td>
<td>Inj., triptorelin xr 3.75 mg</td>
</tr>
<tr class="even">
<td>J3320</td>
<td>0010</td>
<td>3</td>
<td>Injection, spectinomycin dihydrochloride, up to 2 gm</td>
<td>Spectinomycn di-hcl inj</td>
</tr>
<tr class="odd">
<td>J3350</td>
<td>0010</td>
<td>3</td>
<td>Injection, urea, up to 40 gm</td>
<td>Urea injection</td>
</tr>
<tr class="even">
<td>J3355</td>
<td>0010</td>
<td>3</td>
<td>Injection, urofollitropin, 75 iu</td>
<td>Urofollitropin, 75 iu</td>
</tr>
<tr class="odd">
<td>J3357</td>
<td>0010</td>
<td>3</td>
<td>Ustekinumab, for subcutaneous injection, 1 mg</td>
<td>Ustekinumab sub cu inj, 1 mg</td>
</tr>
<tr class="even">
<td>J3358</td>
<td>0010</td>
<td>3</td>
<td>Ustekinumab, for intravenous injection, 1 mg</td>
<td>Ustekinumab, iv inject, 1 mg</td>
</tr>
<tr class="odd">
<td>J3360</td>
<td>0010</td>
<td>3</td>
<td>Injection, diazepam, up to 5 mg</td>
<td>Diazepam injection</td>
</tr>
<tr class="even">
<td>J3364</td>
<td>0010</td>
<td>3</td>
<td>Injection, urokinase, 5000 iu vial</td>
<td>Urokinase 5000 iu injection</td>
</tr>
<tr class="odd">
<td>J3365</td>
<td>0010</td>
<td>3</td>
<td>Injection, iv, urokinase, 250,000 i.u. vial</td>
<td>Urokinase 250,000 iu inj</td>
</tr>
<tr class="even">
<td>J3370</td>
<td>0010</td>
<td>3</td>
<td>Injection, vancomycin hcl, 500 mg</td>
<td>Vancomycin hcl injection</td>
</tr>
<tr class="odd">
<td>J3380</td>
<td>0010</td>
<td>3</td>
<td>Injection, vedolizumab, 1 mg</td>
<td>Injection, vedolizumab</td>
</tr>
<tr class="even">
<td>J3385</td>
<td>0010</td>
<td>3</td>
<td>Injection, velaglucerase alfa, 100 units</td>
<td>Velaglucerase alfa</td>
</tr>
<tr class="odd">
<td>J3396</td>
<td>0010</td>
<td>3</td>
<td>Injection, verteporfin, 0.1 mg</td>
<td>Verteporfin injection</td>
</tr>
<tr class="even">
<td>J3397</td>
<td>0010</td>
<td>3</td>
<td>Injection, vestronidase alfa-vjbk, 1 mg</td>
<td>Inj., vestronidase alfa-vjbk</td>
</tr>
<tr class="odd">
<td>J3398</td>
<td>0010</td>
<td>3</td>
<td>Injection, voretigene neparvovec-rzyl, 1 billion vector genomes</td>
<td>Inj luxturna 1 billion vec g</td>
</tr>
<tr class="even">
<td>J3400</td>
<td>0010</td>
<td>3</td>
<td>Injection, triflupromazine hcl, up to 20 mg</td>
<td>Triflupromazine hcl inj</td>
</tr>
<tr class="odd">
<td>J3410</td>
<td>0010</td>
<td>3</td>
<td>Injection, hydroxyzine hcl, up to 25 mg</td>
<td>Hydroxyzine hcl injection</td>
</tr>
<tr class="even">
<td>J3411</td>
<td>0010</td>
<td>3</td>
<td>Injection, thiamine hcl, 100 mg</td>
<td>Thiamine hcl 100 mg</td>
</tr>
<tr class="odd">
<td>J3415</td>
<td>0010</td>
<td>3</td>
<td>Injection, pyridoxine hcl, 100 mg</td>
<td>Pyridoxine hcl 100 mg</td>
</tr>
<tr class="even">
<td>J3420</td>
<td>0010</td>
<td>3</td>
<td>Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg</td>
<td>Vitamin b12 injection</td>
</tr>
<tr class="odd">
<td>J3430</td>
<td>0010</td>
<td>3</td>
<td>Injection, phytonadione (vitamin k), per 1 mg</td>
<td>Vitamin k phytonadione inj</td>
</tr>
<tr class="even">
<td>J3465</td>
<td>0010</td>
<td>3</td>
<td>Injection, voriconazole, 10 mg</td>
<td>Injection, voriconazole</td>
</tr>
<tr class="odd">
<td>J3470</td>
<td>0010</td>
<td>3</td>
<td>Injection, hyaluronidase, up to 150 units</td>
<td>Hyaluronidase injection</td>
</tr>
<tr class="even">
<td>J3471</td>
<td>0010</td>
<td>3</td>
<td>Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)</td>
<td>Ovine, up to 999 usp units</td>
</tr>
<tr class="odd">
<td>J3472</td>
<td>0010</td>
<td>3</td>
<td>Injection, hyaluronidase, ovine, preservative free, per 1000 usp units</td>
<td>Ovine, 1000 usp units</td>
</tr>
<tr class="even">
<td>J3473</td>
<td>0010</td>
<td>3</td>
<td>Injection, hyaluronidase, recombinant, 1 usp unit</td>
<td>Hyaluronidase recombinant</td>
</tr>
<tr class="odd">
<td>J3475</td>
<td>0010</td>
<td>3</td>
<td>Injection, magnesium sulfate, per 500 mg</td>
<td>Inj magnesium sulfate</td>
</tr>
<tr class="even">
<td>J3480</td>
<td>0010</td>
<td>3</td>
<td>Injection, potassium chloride, per 2 meq</td>
<td>Inj potassium chloride</td>
</tr>
<tr class="odd">
<td>J3485</td>
<td>0010</td>
<td>3</td>
<td>Injection, zidovudine, 10 mg</td>
<td>Zidovudine</td>
</tr>
<tr class="even">
<td>J3486</td>
<td>0010</td>
<td>3</td>
<td>Injection, ziprasidone mesylate, 10 mg</td>
<td>Ziprasidone mesylate</td>
</tr>
<tr class="odd">
<td>J3489</td>
<td>0010</td>
<td>3</td>
<td>Injection, zoledronic acid, 1 mg</td>
<td>Zoledronic acid 1mg</td>
</tr>
<tr class="even">
<td>J3490</td>
<td>0010</td>
<td>3</td>
<td>Unclassified drugs</td>
<td>Drugs unclassified injection</td>
</tr>
<tr class="odd">
<td>J3520</td>
<td>0010</td>
<td>3</td>
<td>Edetate disodium, per 150 mg</td>
<td>Edetate disodium per 150 mg</td>
</tr>
<tr class="even">
<td>J3530</td>
<td>0010</td>
<td>3</td>
<td>Nasal vaccine inhalation</td>
<td>Nasal vaccine inhalation</td>
</tr>
<tr class="odd">
<td>J3535</td>
<td>0010</td>
<td>3</td>
<td>Drug administered through a metered dose inhaler</td>
<td>Metered dose inhaler drug</td>
</tr>
<tr class="even">
<td>J3570</td>
<td>0010</td>
<td>3</td>
<td>Laetrile, amygdalin, vitamin b17</td>
<td>Laetrile amygdalin vit b17</td>
</tr>
<tr class="odd">
<td>J3590</td>
<td>0010</td>
<td>3</td>
<td>Unclassified biologics</td>
<td>Unclassified biologics</td>
</tr>
<tr class="even">
<td>J3591</td>
<td>0010</td>
<td>3</td>
<td>Unclassified drug or biological used for esrd on dialysis</td>
<td>Esrd on dialysi drug/bio noc</td>
</tr>
<tr class="odd">
<td>J7030</td>
<td>0010</td>
<td>3</td>
<td>Infusion, normal saline solution , 1000 cc</td>
<td>Normal saline solution infus</td>
</tr>
<tr class="even">
<td>J7040</td>
<td>0010</td>
<td>3</td>
<td>Infusion, normal saline solution, sterile (500 ml = 1 unit)</td>
<td>Normal saline solution infus</td>
</tr>
<tr class="odd">
<td>J7042</td>
<td>0010</td>
<td>3</td>
<td>5% dextrose/normal saline (500 ml = 1 unit)</td>
<td>5% dextrose/normal saline</td>
</tr>
<tr class="even">
<td>J7050</td>
<td>0010</td>
<td>3</td>
<td>Infusion, normal saline solution, 250 cc</td>
<td>Normal saline solution infus</td>
</tr>
<tr class="odd">
<td>J7060</td>
<td>0010</td>
<td>3</td>
<td>5% dextrose/water (500 ml = 1 unit)</td>
<td>5% dextrose/water</td>
</tr>
<tr class="even">
<td>J7070</td>
<td>0010</td>
<td>3</td>
<td>Infusion, d5w, 1000 cc</td>
<td>D5w infusion</td>
</tr>
<tr class="odd">
<td>J7100</td>
<td>0010</td>
<td>3</td>
<td>Infusion, dextran 40, 500 ml</td>
<td>Dextran 40 infusion</td>
</tr>
<tr class="even">
<td>J7110</td>
<td>0010</td>
<td>3</td>
<td>Infusion, dextran 75, 500 ml</td>
<td>Dextran 75 infusion</td>
</tr>
<tr class="odd">
<td>J7120</td>
<td>0010</td>
<td>3</td>
<td>Ringers lactate infusion, up to 1000 cc</td>
<td>Ringers lactate infusion</td>
</tr>
<tr class="even">
<td>J7121</td>
<td>0010</td>
<td>3</td>
<td>5% dextrose in lactated ringers infusion, up to 1000 cc</td>
<td>5% dextrose in lac ringers</td>
</tr>
<tr class="odd">
<td>J7131</td>
<td>0010</td>
<td>3</td>
<td>Hypertonic saline solution, 1 ml</td>
<td>Hypertonic saline sol</td>
</tr>
<tr class="even">
<td>J7170</td>
<td>0010</td>
<td>3</td>
<td>Injection, emicizumab-kxwh, 0.5 mg</td>
<td>Inj., emicizumab-kxwh 0.5 mg</td>
</tr>
<tr class="odd">
<td>J7175</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor x, (human), 1 i.u.</td>
<td>Inj, factor x, (human), 1iu</td>
</tr>
<tr class="even">
<td>J7177</td>
<td>0010</td>
<td>3</td>
<td>Injection, human fibrinogen concentrate (fibryga), 1 mg</td>
<td>Inj., fibryga, 1 mg</td>
</tr>
<tr class="odd">
<td>J7178</td>
<td>0010</td>
<td>3</td>
<td>Injection, human fibrinogen concentrate, not otherwise specified, 1 mg</td>
<td>Inj human fibrinogen con nos</td>
</tr>
<tr class="even">
<td>J7179</td>
<td>0010</td>
<td>3</td>
<td>Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco</td>
<td>Vonvendi inj 1 iu vwf:rco</td>
</tr>
<tr class="odd">
<td>J7180</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor xiii (antihemophilic factor, human), 1 i.u.</td>
<td>Factor xiii anti-hem factor</td>
</tr>
<tr class="even">
<td>J7181</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor xiii a-subunit, (recombinant), per iu</td>
<td>Factor xiii recomb a-subunit</td>
</tr>
<tr class="odd">
<td>J7182</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu</td>
<td>Factor viii recomb novoeight</td>
</tr>
<tr class="even">
<td>J7183</td>
<td>0010</td>
<td>3</td>
<td>Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco</td>
<td>Wilate injection</td>
</tr>
<tr class="odd">
<td>J7185</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.</td>
<td>Xyntha inj</td>
</tr>
<tr class="even">
<td>J7186</td>
<td>0010</td>
<td>3</td>
<td>Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.</td>
<td>Antihemophilic viii/vwf comp</td>
</tr>
<tr class="odd">
<td>J7187</td>
<td>0010</td>
<td>3</td>
<td>Injection, von willebrand factor complex (humate-p), per iu vwf:rco</td>
<td>Humate-p, inj</td>
</tr>
<tr class="even">
<td>J7188</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.</td>
<td>Factor viii recomb obizur</td>
</tr>
<tr class="odd">
<td>J7189</td>
<td>0010</td>
<td>3</td>
<td>Factor viia (antihemophilic factor, recombinant), per 1 microgram</td>
<td>Factor viia</td>
</tr>
<tr class="even">
<td>J7190</td>
<td>0010</td>
<td>3</td>
<td>Factor viii (antihemophilic factor, human) per i.u.</td>
<td>Factor viii</td>
</tr>
<tr class="odd">
<td>J7191</td>
<td>0010</td>
<td>3</td>
<td>Factor viii (antihemophilic factor (porcine)), per i.u.</td>
<td>Factor viii (porcine)</td>
</tr>
<tr class="even">
<td>J7192</td>
<td>0010</td>
<td>3</td>
<td>Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified</td>
<td>Factor viii recombinant nos</td>
</tr>
<tr class="odd">
<td>J7193</td>
<td>0010</td>
<td>3</td>
<td>Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.</td>
<td>Factor ix non-recombinant</td>
</tr>
<tr class="even">
<td>J7194</td>
<td>0010</td>
<td>3</td>
<td>Factor ix, complex, per i.u.</td>
<td>Factor ix complex</td>
</tr>
<tr class="odd">
<td>J7195</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified</td>
<td>Factor ix recombinant nos</td>
</tr>
<tr class="even">
<td>J7196</td>
<td>0010</td>
<td>3</td>
<td>Injection, antithrombin recombinant, 50 i.u.</td>
<td>Antithrombin recombinant</td>
</tr>
<tr class="odd">
<td>J7197</td>
<td>0010</td>
<td>3</td>
<td>Antithrombin iii (human), per i.u.</td>
<td>Antithrombin iii injection</td>
</tr>
<tr class="even">
<td>J7198</td>
<td>0010</td>
<td>3</td>
<td>Anti-inhibitor, per i.u.</td>
<td>Anti-inhibitor</td>
</tr>
<tr class="odd">
<td>J7199</td>
<td>0010</td>
<td>3</td>
<td>Hemophilia clotting factor, not otherwise classified</td>
<td>Hemophilia clot factor noc</td>
</tr>
<tr class="even">
<td>J7200</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu</td>
<td>Factor ix recombinan rixubis</td>
</tr>
<tr class="odd">
<td>J7201</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.</td>
<td>Factor ix alprolix recomb</td>
</tr>
<tr class="even">
<td>J7202</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.</td>
<td>Factor ix idelvion inj</td>
</tr>
<tr class="odd">
<td>J7203</td>
<td>0010</td>
<td>3</td>
<td>Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu</td>
<td>Factor ix recomb gly rebinyn</td>
</tr>
<tr class="even">
<td>J7205</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii fc fusion protein (recombinant), per iu</td>
<td>Factor viii fc fusion recomb</td>
</tr>
<tr class="odd">
<td>J7207</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.</td>
<td>Factor viii pegylated recomb</td>
</tr>
<tr class="even">
<td>J7208</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.</td>
<td>Inj. jivi 1 iu</td>
</tr>
<tr class="odd">
<td>J7209</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.</td>
<td>Factor viii nuwiq recomb 1iu</td>
</tr>
<tr class="even">
<td>J7210</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.</td>
<td>Inj, afstyla, 1 i.u.</td>
</tr>
<tr class="odd">
<td>J7211</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.</td>
<td>Inj, kovaltry, 1 i.u.</td>
</tr>
<tr class="even">
<td>J7296</td>
<td>0010</td>
<td>3</td>
<td>Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg</td>
<td>Kyleena, 19.5 mg</td>
</tr>
<tr class="odd">
<td>J7297</td>
<td>0010</td>
<td>3</td>
<td>Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg</td>
<td>Liletta, 52 mg</td>
</tr>
<tr class="even">
<td>J7298</td>
<td>0010</td>
<td>3</td>
<td>Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg</td>
<td>Mirena, 52 mg</td>
</tr>
<tr class="odd">
<td>J7300</td>
<td>0010</td>
<td>3</td>
<td>Intrauterine copper contraceptive</td>
<td>Intraut copper contraceptive</td>
</tr>
<tr class="even">
<td>J7301</td>
<td>0010</td>
<td>3</td>
<td>Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg</td>
<td>Skyla, 13.5 mg</td>
</tr>
<tr class="odd">
<td>J7302</td>
<td>0010</td>
<td>3</td>
<td>Levonorgestrel-releasing intrauterine contraceptive system, 52 mg</td>
<td>Levonorgestrel iu 52 mg</td>
</tr>
<tr class="even">
<td>J7303</td>
<td>0010</td>
<td>3</td>
<td>Contraceptive supply, hormone containing vaginal ring, each</td>
<td>Contraceptive vaginal ring</td>
</tr>
<tr class="odd">
<td>J7304</td>
<td>0010</td>
<td>3</td>
<td>Contraceptive supply, hormone containing patch, each</td>
<td>Contraceptive hormone patch</td>
</tr>
<tr class="even">
<td>J7306</td>
<td>0010</td>
<td>3</td>
<td>Levonorgestrel (contraceptive) implant system, including implants and supplies</td>
<td>Levonorgestrel implant sys</td>
</tr>
<tr class="odd">
<td>J7307</td>
<td>0010</td>
<td>3</td>
<td>Etonogestrel (contraceptive) implant system, including implant and supplies</td>
<td>Etonogestrel implant system</td>
</tr>
<tr class="even">
<td>J7308</td>
<td>0010</td>
<td>3</td>
<td>Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)</td>
<td>Aminolevulinic acid hcl top</td>
</tr>
<tr class="odd">
<td>J7309</td>
<td>0010</td>
<td>3</td>
<td>Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram</td>
<td>Methyl aminolevulinate, top</td>
</tr>
<tr class="even">
<td>J7310</td>
<td>0010</td>
<td>3</td>
<td>Ganciclovir, 4.5 mg, long-acting implant</td>
<td>Ganciclovir long act implant</td>
</tr>
<tr class="odd">
<td>J7311</td>
<td>0010</td>
<td>3</td>
<td>Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg</td>
<td>Inj., retisert, 0.01 mg</td>
</tr>
<tr class="even">
<td>J7312</td>
<td>0010</td>
<td>3</td>
<td>Injection, dexamethasone, intravitreal implant, 0.1 mg</td>
<td>Dexamethasone intra implant</td>
</tr>
<tr class="odd">
<td>J7313</td>
<td>0010</td>
<td>3</td>
<td>Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg</td>
<td>Inj., iluvien, 0.01 mg</td>
</tr>
<tr class="even">
<td>J7314</td>
<td>0010</td>
<td>3</td>
<td>Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg</td>
<td>Inj., yutiq, 0.01 mg</td>
</tr>
<tr class="odd">
<td>J7315</td>
<td>0010</td>
<td>3</td>
<td>Mitomycin, ophthalmic, 0.2 mg</td>
<td>Ophthalmic mitomycin</td>
</tr>
<tr class="even">
<td>J7316</td>
<td>0010</td>
<td>3</td>
<td>Injection, ocriplasmin, 0.125 mg</td>
<td>Inj, ocriplasmin, 0.125 mg</td>
</tr>
<tr class="odd">
<td>J7318</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg</td>
<td>Inj, durolane 1 mg</td>
</tr>
<tr class="even">
<td>J7320</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg</td>
<td>Genvisc 850, inj, 1mg</td>
</tr>
<tr class="odd">
<td>J7321</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose</td>
<td>Hyalgan supartz visco-3 dose</td>
</tr>
<tr class="even">
<td>J7322</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg</td>
<td>Hymovis injection 1 mg</td>
</tr>
<tr class="odd">
<td>J7323</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose</td>
<td>Euflexxa inj per dose</td>
</tr>
<tr class="even">
<td>J7324</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose</td>
<td>Orthovisc inj per dose</td>
</tr>
<tr class="odd">
<td>J7325</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg</td>
<td>Synvisc or synvisc-one</td>
</tr>
<tr class="even">
<td>J7326</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, gel-one, for intra-articular injection, per dose</td>
<td>Gel-one</td>
</tr>
<tr class="odd">
<td>J7327</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, monovisc, for intra-articular injection, per dose</td>
<td>Monovisc inj per dose</td>
</tr>
<tr class="even">
<td>J7328</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg</td>
<td>Gelsyn-3 injection 0.1 mg</td>
</tr>
<tr class="odd">
<td>J7329</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg</td>
<td>Inj, trivisc 1 mg</td>
</tr>
<tr class="even">
<td>J7330</td>
<td>0010</td>
<td>3</td>
<td>Autologous cultured chondrocytes, implant</td>
<td>Cultured chondrocytes implnt</td>
</tr>
<tr class="odd">
<td>J7331</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg</td>
<td>Synojoynt, inj., 1 mg</td>
</tr>
<tr class="even">
<td>J7332</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg</td>
<td>Inj., triluron, 1 mg</td>
</tr>
<tr class="odd">
<td>J7335</td>
<td>0010</td>
<td>3</td>
<td>Capsaicin 8% patch, per 10 square centimeters</td>
<td>Capsaicin 8% patch</td>
</tr>
<tr class="even">
<td>J7336</td>
<td>0010</td>
<td>3</td>
<td>Capsaicin 8% patch, per square centimeter</td>
<td>Capsaicin 8% patch</td>
</tr>
<tr class="odd">
<td>J7340</td>
<td>0010</td>
<td>3</td>
<td>Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml</td>
<td>Carbidopa levodopa ent 100ml</td>
</tr>
<tr class="even">
<td>J7342</td>
<td>0010</td>
<td>3</td>
<td>Instillation, ciprofloxacin otic suspension, 6 mg</td>
<td>Ciprofloxacin otic susp 6 mg</td>
</tr>
<tr class="odd">
<td>J7345</td>
<td>0010</td>
<td>3</td>
<td>Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg</td>
<td>Aminolevulinic acid, 10% gel</td>
</tr>
<tr class="even">
<td>J7401</td>
<td>0010</td>
<td>3</td>
<td>Mometasone furoate sinus implant, 10 micrograms</td>
<td>Mometasone furoate sinus imp</td>
</tr>
<tr class="odd">
<td>J7500</td>
<td>0010</td>
<td>3</td>
<td>Azathioprine, oral, 50 mg</td>
<td>Azathioprine oral 50mg</td>
</tr>
<tr class="even">
<td>J7501</td>
<td>0010</td>
<td>3</td>
<td>Azathioprine, parenteral, 100 mg</td>
<td>Azathioprine parenteral</td>
</tr>
<tr class="odd">
<td>J7502</td>
<td>0010</td>
<td>3</td>
<td>Cyclosporine, oral, 100 mg</td>
<td>Cyclosporine oral 100 mg</td>
</tr>
<tr class="even">
<td>J7503</td>
<td>0010</td>
<td>3</td>
<td>Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg</td>
<td>Tacrol envarsus ex rel oral</td>
</tr>
<tr class="odd">
<td>J7504</td>
<td>0010</td>
<td>3</td>
<td>Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg</td>
<td>Lymphocyte immune globulin</td>
</tr>
<tr class="even">
<td>J7505</td>
<td>0010</td>
<td>3</td>
<td>Muromonab-cd3, parenteral, 5 mg</td>
<td>Monoclonal antibodies</td>
</tr>
<tr class="odd">
<td>J7506</td>
<td>0010</td>
<td>3</td>
<td>Prednisone, oral, per 5 mg</td>
<td>Prednisone oral</td>
</tr>
<tr class="even">
<td>J7507</td>
<td>0010</td>
<td>3</td>
<td>Tacrolimus, immediate release, oral, 1 mg</td>
<td>Tacrolimus imme rel oral 1mg</td>
</tr>
<tr class="odd">
<td>J7508</td>
<td>0010</td>
<td>3</td>
<td>Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg</td>
<td>Tacrol astagraf ex rel oral</td>
</tr>
<tr class="even">
<td>J7509</td>
<td>0010</td>
<td>3</td>
<td>Methylprednisolone oral, per 4 mg</td>
<td>Methylprednisolone oral</td>
</tr>
<tr class="odd">
<td>J7510</td>
<td>0010</td>
<td>3</td>
<td>Prednisolone oral, per 5 mg</td>
<td>Prednisolone oral per 5 mg</td>
</tr>
<tr class="even">
<td>J7511</td>
<td>0010</td>
<td>3</td>
<td>Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg</td>
<td>Antithymocyte globuln rabbit</td>
</tr>
<tr class="odd">
<td>J7512</td>
<td>0010</td>
<td>3</td>
<td>Prednisone, immediate release or delayed release, oral, 1 mg</td>
<td>Prednisone ir or dr oral 1mg</td>
</tr>
<tr class="even">
<td>J7513</td>
<td>0010</td>
<td>3</td>
<td>Daclizumab, parenteral, 25 mg</td>
<td>Daclizumab, parenteral</td>
</tr>
<tr class="odd">
<td>J7515</td>
<td>0010</td>
<td>3</td>
<td>Cyclosporine, oral, 25 mg</td>
<td>Cyclosporine oral 25 mg</td>
</tr>
<tr class="even">
<td>J7516</td>
<td>0010</td>
<td>3</td>
<td>Cyclosporin, parenteral, 250 mg</td>
<td>Cyclosporin parenteral 250mg</td>
</tr>
<tr class="odd">
<td>J7517</td>
<td>0010</td>
<td>3</td>
<td>Mycophenolate mofetil, oral, 250 mg</td>
<td>Mycophenolate mofetil oral</td>
</tr>
<tr class="even">
<td>J7518</td>
<td>0010</td>
<td>3</td>
<td>Mycophenolic acid, oral, 180 mg</td>
<td>Mycophenolic acid</td>
</tr>
<tr class="odd">
<td>J7520</td>
<td>0010</td>
<td>3</td>
<td>Sirolimus, oral, 1 mg</td>
<td>Sirolimus, oral</td>
</tr>
<tr class="even">
<td>J7525</td>
<td>0010</td>
<td>3</td>
<td>Tacrolimus, parenteral, 5 mg</td>
<td>Tacrolimus injection</td>
</tr>
<tr class="odd">
<td>J7527</td>
<td>0010</td>
<td>3</td>
<td>Everolimus, oral, 0.25 mg</td>
<td>Oral everolimus</td>
</tr>
<tr class="even">
<td>J7599</td>
<td>0010</td>
<td>3</td>
<td>Immunosuppressive drug, not otherwise classified</td>
<td>Immunosuppressive drug noc</td>
</tr>
<tr class="odd">
<td>J7604</td>
<td>0010</td>
<td>3</td>
<td>Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram</td>
<td>Acetylcysteine comp unit</td>
</tr>
<tr class="even">
<td>J7605</td>
<td>0010</td>
<td>3</td>
<td>Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms</td>
<td>Arformoterol non-comp unit</td>
</tr>
<tr class="odd">
<td>J7606</td>
<td>0010</td>
<td>3</td>
<td>Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms</td>
<td>Formoterol fumarate, inh</td>
</tr>
<tr class="even">
<td>J7607</td>
<td>0010</td>
<td>3</td>
<td>Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg</td>
<td>Levalbuterol comp con</td>
</tr>
<tr class="odd">
<td>J7608</td>
<td>0010</td>
<td>3</td>
<td>Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram</td>
<td>Acetylcysteine non-comp unit</td>
</tr>
<tr class="even">
<td>J7609</td>
<td>0010</td>
<td>3</td>
<td>Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg</td>
<td>Albuterol comp unit</td>
</tr>
<tr class="odd">
<td>J7610</td>
<td>0010</td>
<td>3</td>
<td>Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg</td>
<td>Albuterol comp con</td>
</tr>
<tr class="even">
<td>J7611</td>
<td>0010</td>
<td>3</td>
<td>Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg</td>
<td>Albuterol non-comp con</td>
</tr>
<tr class="odd">
<td>J7612</td>
<td>0010</td>
<td>3</td>
<td>Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg</td>
<td>Levalbuterol non-comp con</td>
</tr>
<tr class="even">
<td>J7613</td>
<td>0010</td>
<td>3</td>
<td>Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg</td>
<td>Albuterol non-comp unit</td>
</tr>
<tr class="odd">
<td>J7614</td>
<td>0010</td>
<td>3</td>
<td>Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg</td>
<td>Levalbuterol non-comp unit</td>
</tr>
<tr class="even">
<td>J7615</td>
<td>0010</td>
<td>3</td>
<td>Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg</td>
<td>Levalbuterol comp unit</td>
</tr>
<tr class="odd">
<td>J7620</td>
<td>0010</td>
<td>3</td>
<td>Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme</td>
<td>Albuterol ipratrop non-comp</td>
</tr>
<tr class="even">
<td>J7622</td>
<td>0010</td>
<td>3</td>
<td>Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram</td>
<td>Beclomethasone comp unit</td>
</tr>
<tr class="odd">
<td>J7624</td>
<td>0010</td>
<td>3</td>
<td>Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram</td>
<td>Betamethasone comp unit</td>
</tr>
<tr class="even">
<td>J7626</td>
<td>0010</td>
<td>3</td>
<td>Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg</td>
<td>Budesonide non-comp unit</td>
</tr>
<tr class="odd">
<td>J7627</td>
<td>0010</td>
<td>3</td>
<td>Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg</td>
<td>Budesonide comp unit</td>
</tr>
<tr class="even">
<td>J7628</td>
<td>0010</td>
<td>3</td>
<td>Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram</td>
<td>Bitolterol mesylate comp con</td>
</tr>
<tr class="odd">
<td>J7629</td>
<td>0010</td>
<td>3</td>
<td>Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram</td>
<td>Bitolterol mesylate comp unt</td>
</tr>
<tr class="even">
<td>J7631</td>
<td>0010</td>
<td>3</td>
<td>Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams</td>
<td>Cromolyn sodium noncomp unit</td>
</tr>
<tr class="odd">
<td>J7632</td>
<td>0010</td>
<td>3</td>
<td>Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams</td>
<td>Cromolyn sodium comp unit</td>
</tr>
<tr class="even">
<td>J7633</td>
<td>0010</td>
<td>3</td>
<td>Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram</td>
<td>Budesonide non-comp con</td>
</tr>
<tr class="odd">
<td>J7634</td>
<td>0010</td>
<td>3</td>
<td>Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram</td>
<td>Budesonide comp con</td>
</tr>
<tr class="even">
<td>J7635</td>
<td>0010</td>
<td>3</td>
<td>Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram</td>
<td>Atropine comp con</td>
</tr>
<tr class="odd">
<td>J7636</td>
<td>0010</td>
<td>3</td>
<td>Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram</td>
<td>Atropine comp unit</td>
</tr>
<tr class="even">
<td>J7637</td>
<td>0010</td>
<td>3</td>
<td>Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram</td>
<td>Dexamethasone comp con</td>
</tr>
<tr class="odd">
<td>J7638</td>
<td>0010</td>
<td>3</td>
<td>Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram</td>
<td>Dexamethasone comp unit</td>
</tr>
<tr class="even">
<td>J7639</td>
<td>0010</td>
<td>3</td>
<td>Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram</td>
<td>Dornase alfa non-comp unit</td>
</tr>
<tr class="odd">
<td>J7640</td>
<td>0010</td>
<td>3</td>
<td>Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms</td>
<td>Formoterol comp unit</td>
</tr>
<tr class="even">
<td>J7641</td>
<td>0010</td>
<td>3</td>
<td>Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram</td>
<td>Flunisolide comp unit</td>
</tr>
<tr class="odd">
<td>J7642</td>
<td>0010</td>
<td>3</td>
<td>Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram</td>
<td>Glycopyrrolate comp con</td>
</tr>
<tr class="even">
<td>J7643</td>
<td>0010</td>
<td>3</td>
<td>Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram</td>
<td>Glycopyrrolate comp unit</td>
</tr>
<tr class="odd">
<td>J7644</td>
<td>0010</td>
<td>3</td>
<td>Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram</td>
<td>Ipratropium bromide non-comp</td>
</tr>
<tr class="even">
<td>J7645</td>
<td>0010</td>
<td>3</td>
<td>Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram</td>
<td>Ipratropium bromide comp</td>
</tr>
<tr class="odd">
<td>J7647</td>
<td>0010</td>
<td>3</td>
<td>Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram</td>
<td>Isoetharine comp con</td>
</tr>
<tr class="even">
<td>J7648</td>
<td>0010</td>
<td>3</td>
<td>Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram</td>
<td>Isoetharine non-comp con</td>
</tr>
<tr class="odd">
<td>J7649</td>
<td>0010</td>
<td>3</td>
<td>Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram</td>
<td>Isoetharine non-comp unit</td>
</tr>
<tr class="even">
<td>J7650</td>
<td>0010</td>
<td>3</td>
<td>Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram</td>
<td>Isoetharine comp unit</td>
</tr>
<tr class="odd">
<td>J7657</td>
<td>0010</td>
<td>3</td>
<td>Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram</td>
<td>Isoproterenol comp con</td>
</tr>
<tr class="even">
<td>J7658</td>
<td>0010</td>
<td>3</td>
<td>Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram</td>
<td>Isoproterenol non-comp con</td>
</tr>
<tr class="odd">
<td>J7659</td>
<td>0010</td>
<td>3</td>
<td>Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram</td>
<td>Isoproterenol non-comp unit</td>
</tr>
<tr class="even">
<td>J7660</td>
<td>0010</td>
<td>3</td>
<td>Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram</td>
<td>Isoproterenol comp unit</td>
</tr>
<tr class="odd">
<td>J7665</td>
<td>0010</td>
<td>3</td>
<td>Mannitol, administered through an inhaler, 5 mg</td>
<td>Mannitol for inhaler</td>
</tr>
<tr class="even">
<td>J7667</td>
<td>0010</td>
<td>3</td>
<td>Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams</td>
<td>Metaproterenol comp con</td>
</tr>
<tr class="odd">
<td>J7668</td>
<td>0010</td>
<td>3</td>
<td>Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams</td>
<td>Metaproterenol non-comp con</td>
</tr>
<tr class="even">
<td>J7669</td>
<td>0010</td>
<td>3</td>
<td>Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams</td>
<td>Metaproterenol non-comp unit</td>
</tr>
<tr class="odd">
<td>J7670</td>
<td>0010</td>
<td>3</td>
<td>Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams</td>
<td>Metaproterenol comp unit</td>
</tr>
<tr class="even">
<td>J7674</td>
<td>0010</td>
<td>3</td>
<td>Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg</td>
<td>Methacholine chloride, neb</td>
</tr>
<tr class="odd">
<td>J7676</td>
<td>0010</td>
<td>3</td>
<td>Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg</td>
<td>Pentamidine comp unit dose</td>
</tr>
<tr class="even">
<td>J7677</td>
<td>0010</td>
<td>3</td>
<td>Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram</td>
<td>Revefenacin inh non-com 1mcg</td>
</tr>
<tr class="odd">
<td>J7680</td>
<td>0010</td>
<td>3</td>
<td>Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram</td>
<td>Terbutaline sulf comp con</td>
</tr>
<tr class="even">
<td>J7681</td>
<td>0010</td>
<td>3</td>
<td>Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram</td>
<td>Terbutaline sulf comp unit</td>
</tr>
<tr class="odd">
<td>J7682</td>
<td>0010</td>
<td>3</td>
<td>Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams</td>
<td>Tobramycin non-comp unit</td>
</tr>
<tr class="even">
<td>J7683</td>
<td>0010</td>
<td>3</td>
<td>Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram</td>
<td>Triamcinolone comp con</td>
</tr>
<tr class="odd">
<td>J7684</td>
<td>0010</td>
<td>3</td>
<td>Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram</td>
<td>Triamcinolone comp unit</td>
</tr>
<tr class="even">
<td>J7685</td>
<td>0010</td>
<td>3</td>
<td>Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams</td>
<td>Tobramycin comp unit</td>
</tr>
<tr class="odd">
<td>J7686</td>
<td>0010</td>
<td>3</td>
<td>Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg</td>
<td>Treprostinil, non-comp unit</td>
</tr>
<tr class="even">
<td>J7699</td>
<td>0010</td>
<td>3</td>
<td>Noc drugs, inhalation solution administered through dme</td>
<td>Inhalation solution for dme</td>
</tr>
<tr class="odd">
<td>J7799</td>
<td>0010</td>
<td>3</td>
<td>Noc drugs, other than inhalation drugs, administered through dme</td>
<td>Non-inhalation drug for dme</td>
</tr>
<tr class="even">
<td>J7999</td>
<td>0010</td>
<td>3</td>
<td>Compounded drug, not otherwise classified</td>
<td>Compounded drug, noc</td>
</tr>
<tr class="odd">
<td>J8498</td>
<td>0010</td>
<td>3</td>
<td>Antiemetic drug, rectal/suppository, not otherwise specified</td>
<td>Antiemetic rectal/supp nos</td>
</tr>
<tr class="even">
<td>J8499</td>
<td>0010</td>
<td>3</td>
<td>Prescription drug, oral, non chemotherapeutic, nos</td>
<td>Oral prescrip drug non chemo</td>
</tr>
<tr class="odd">
<td>J8501</td>
<td>0010</td>
<td>3</td>
<td>Aprepitant, oral, 5 mg</td>
<td>Oral aprepitant</td>
</tr>
<tr class="even">
<td>J8510</td>
<td>0010</td>
<td>3</td>
<td>Busulfan; oral, 2 mg</td>
<td>Oral busulfan</td>
</tr>
<tr class="odd">
<td>J8515</td>
<td>0010</td>
<td>3</td>
<td>Cabergoline, oral, 0.25 mg</td>
<td>Cabergoline, oral 0.25mg</td>
</tr>
<tr class="even">
<td>J8520</td>
<td>0010</td>
<td>3</td>
<td>Capecitabine, oral, 150 mg</td>
<td>Capecitabine, oral, 150 mg</td>
</tr>
<tr class="odd">
<td>J8521</td>
<td>0010</td>
<td>3</td>
<td>Capecitabine, oral, 500 mg</td>
<td>Capecitabine, oral, 500 mg</td>
</tr>
<tr class="even">
<td>J8530</td>
<td>0010</td>
<td>3</td>
<td>Cyclophosphamide; oral, 25 mg</td>
<td>Cyclophosphamide oral 25 mg</td>
</tr>
<tr class="odd">
<td>J8540</td>
<td>0010</td>
<td>3</td>
<td>Dexamethasone, oral, 0.25 mg</td>
<td>Oral dexamethasone</td>
</tr>
<tr class="even">
<td>J8560</td>
<td>0010</td>
<td>3</td>
<td>Etoposide; oral, 50 mg</td>
<td>Etoposide oral 50 mg</td>
</tr>
<tr class="odd">
<td>J8562</td>
<td>0010</td>
<td>3</td>
<td>Fludarabine phosphate, oral, 10 mg</td>
<td>Oral fludarabine phosphate</td>
</tr>
<tr class="even">
<td>J8565</td>
<td>0010</td>
<td>3</td>
<td>Gefitinib, oral, 250 mg</td>
<td>Gefitinib oral</td>
</tr>
<tr class="odd">
<td>J8597</td>
<td>0010</td>
<td>3</td>
<td>Antiemetic drug, oral, not otherwise specified</td>
<td>Antiemetic drug oral nos</td>
</tr>
<tr class="even">
<td>J8600</td>
<td>0010</td>
<td>3</td>
<td>Melphalan; oral, 2 mg</td>
<td>Melphalan oral 2 mg</td>
</tr>
<tr class="odd">
<td>J8610</td>
<td>0010</td>
<td>3</td>
<td>Methotrexate; oral, 2.5 mg</td>
<td>Methotrexate oral 2.5 mg</td>
</tr>
<tr class="even">
<td>J8650</td>
<td>0010</td>
<td>3</td>
<td>Nabilone, oral, 1 mg</td>
<td>Nabilone oral</td>
</tr>
<tr class="odd">
<td>J8655</td>
<td>0010</td>
<td>3</td>
<td>Netupitant 300 mg and palonosetron 0.5 mg, oral</td>
<td>Oral netupitant, palonosetro</td>
</tr>
<tr class="even">
<td>J8670</td>
<td>0010</td>
<td>3</td>
<td>Rolapitant, oral, 1 mg</td>
<td>Rolapitant, oral, 1mg</td>
</tr>
<tr class="odd">
<td>J8700</td>
<td>0010</td>
<td>3</td>
<td>Temozolomide, oral, 5 mg</td>
<td>Temozolomide</td>
</tr>
<tr class="even">
<td>J8705</td>
<td>0010</td>
<td>3</td>
<td>Topotecan, oral, 0.25 mg</td>
<td>Topotecan oral</td>
</tr>
<tr class="odd">
<td>J8999</td>
<td>0010</td>
<td>3</td>
<td>Prescription drug, oral, chemotherapeutic, nos</td>
<td>Oral prescription drug chemo</td>
</tr>
<tr class="even">
<td>J9000</td>
<td>0010</td>
<td>3</td>
<td>Injection, doxorubicin hydrochloride, 10 mg</td>
<td>Doxorubicin hcl injection</td>
</tr>
<tr class="odd">
<td>J9010</td>
<td>0010</td>
<td>3</td>
<td>Injection, alemtuzumab, 10 mg</td>
<td>Alemtuzumab injection</td>
</tr>
<tr class="even">
<td>J9015</td>
<td>0010</td>
<td>3</td>
<td>Injection, aldesleukin, per single use vial</td>
<td>Aldesleukin injection</td>
</tr>
<tr class="odd">
<td>J9017</td>
<td>0010</td>
<td>3</td>
<td>Injection, arsenic trioxide, 1 mg</td>
<td>Arsenic trioxide injection</td>
</tr>
<tr class="even">
<td>J9019</td>
<td>0010</td>
<td>3</td>
<td>Injection, asparaginase (erwinaze), 1,000 iu</td>
<td>Erwinaze injection</td>
</tr>
<tr class="odd">
<td>J9020</td>
<td>0010</td>
<td>3</td>
<td>Injection, asparaginase, not otherwise specified, 10,000 units</td>
<td>Asparaginase, nos</td>
</tr>
<tr class="even">
<td>J9022</td>
<td>0010</td>
<td>3</td>
<td>Injection, atezolizumab, 10 mg</td>
<td>Inj, atezolizumab,10 mg</td>
</tr>
<tr class="odd">
<td>J9023</td>
<td>0010</td>
<td>3</td>
<td>Injection, avelumab, 10 mg</td>
<td>Injection, avelumab, 10 mg</td>
</tr>
<tr class="even">
<td>J9025</td>
<td>0010</td>
<td>3</td>
<td>Injection, azacitidine, 1 mg</td>
<td>Azacitidine injection</td>
</tr>
<tr class="odd">
<td>J9027</td>
<td>0010</td>
<td>3</td>
<td>Injection, clofarabine, 1 mg</td>
<td>Clofarabine injection</td>
</tr>
<tr class="even">
<td>J9030</td>
<td>0010</td>
<td>3</td>
<td>Bcg live intravesical instillation, 1 mg</td>
<td>Bcg live intravesical 1mg</td>
</tr>
<tr class="odd">
<td>J9031</td>
<td>0010</td>
<td>3</td>
<td>Bcg (intravesical) per instillation</td>
<td>Bcg live intravesical vac</td>
</tr>
<tr class="even">
<td>J9032</td>
<td>0010</td>
<td>3</td>
<td>Injection, belinostat, 10 mg</td>
<td>Injection, belinostat, 10mg</td>
</tr>
<tr class="odd">
<td>J9033</td>
<td>0010</td>
<td>3</td>
<td>Injection, bendamustine hcl (treanda), 1 mg</td>
<td>Inj., treanda 1 mg</td>
</tr>
<tr class="even">
<td>J9034</td>
<td>0010</td>
<td>3</td>
<td>Injection, bendamustine hcl (bendeka), 1 mg</td>
<td>Inj., bendeka 1 mg</td>
</tr>
<tr class="odd">
<td>J9035</td>
<td>0010</td>
<td>3</td>
<td>Injection, bevacizumab, 10 mg</td>
<td>Bevacizumab injection</td>
</tr>
<tr class="even">
<td>J9036</td>
<td>0010</td>
<td>3</td>
<td>Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg</td>
<td>Inj. belrapzo/bendamustine</td>
</tr>
<tr class="odd">
<td>J9039</td>
<td>0010</td>
<td>3</td>
<td>Injection, blinatumomab, 1 microgram</td>
<td>Injection, blinatumomab</td>
</tr>
<tr class="even">
<td>J9040</td>
<td>0010</td>
<td>3</td>
<td>Injection, bleomycin sulfate, 15 units</td>
<td>Bleomycin sulfate injection</td>
</tr>
<tr class="odd">
<td>J9041</td>
<td>0010</td>
<td>3</td>
<td>Injection, bortezomib (velcade), 0.1 mg</td>
<td>Inj., velcade 0.1 mg</td>
</tr>
<tr class="even">
<td>J9042</td>
<td>0010</td>
<td>3</td>
<td>Injection, brentuximab vedotin, 1 mg</td>
<td>Brentuximab vedotin inj</td>
</tr>
<tr class="odd">
<td>J9043</td>
<td>0010</td>
<td>3</td>
<td>Injection, cabazitaxel, 1 mg</td>
<td>Cabazitaxel injection</td>
</tr>
<tr class="even">
<td>J9044</td>
<td>0010</td>
<td>3</td>
<td>Injection, bortezomib, not otherwise specified, 0.1 mg</td>
<td>Inj, bortezomib, nos, 0.1 mg</td>
</tr>
<tr class="odd">
<td>J9045</td>
<td>0010</td>
<td>3</td>
<td>Injection, carboplatin, 50 mg</td>
<td>Carboplatin injection</td>
</tr>
<tr class="even">
<td>J9047</td>
<td>0010</td>
<td>3</td>
<td>Injection, carfilzomib, 1 mg</td>
<td>Injection, carfilzomib, 1 mg</td>
</tr>
<tr class="odd">
<td>J9050</td>
<td>0010</td>
<td>3</td>
<td>Injection, carmustine, 100 mg</td>
<td>Carmustine injection</td>
</tr>
<tr class="even">
<td>J9055</td>
<td>0010</td>
<td>3</td>
<td>Injection, cetuximab, 10 mg</td>
<td>Cetuximab injection</td>
</tr>
<tr class="odd">
<td>J9057</td>
<td>0010</td>
<td>3</td>
<td>Injection, copanlisib, 1 mg</td>
<td>Inj., copanlisib, 1 mg</td>
</tr>
<tr class="even">
<td>J9060</td>
<td>0010</td>
<td>3</td>
<td>Injection, cisplatin, powder or solution, 10 mg</td>
<td>Cisplatin 10 mg injection</td>
</tr>
<tr class="odd">
<td>J9065</td>
<td>0010</td>
<td>3</td>
<td>Injection, cladribine, per 1 mg</td>
<td>Inj cladribine per 1 mg</td>
</tr>
<tr class="even">
<td>J9070</td>
<td>0010</td>
<td>3</td>
<td>Cyclophosphamide, 100 mg</td>
<td>Cyclophosphamide 100 mg inj</td>
</tr>
<tr class="odd">
<td>J9098</td>
<td>0010</td>
<td>3</td>
<td>Injection, cytarabine liposome, 10 mg</td>
<td>Cytarabine liposome inj</td>
</tr>
<tr class="even">
<td>J9100</td>
<td>0010</td>
<td>3</td>
<td>Injection, cytarabine, 100 mg</td>
<td>Cytarabine hcl 100 mg inj</td>
</tr>
<tr class="odd">
<td>J9118</td>
<td>0010</td>
<td>3</td>
<td>Injection, calaspargase pegol-mknl, 10 units</td>
<td>Inj. calaspargase pegol-mknl</td>
</tr>
<tr class="even">
<td>J9119</td>
<td>0010</td>
<td>3</td>
<td>Injection, cemiplimab-rwlc, 1 mg</td>
<td>Inj., cemiplimab-rwlc, 1 mg</td>
</tr>
<tr class="odd">
<td>J9120</td>
<td>0010</td>
<td>3</td>
<td>Injection, dactinomycin, 0.5 mg</td>
<td>Dactinomycin injection</td>
</tr>
<tr class="even">
<td>J9130</td>
<td>0010</td>
<td>3</td>
<td>Dacarbazine, 100 mg</td>
<td>Dacarbazine 100 mg inj</td>
</tr>
<tr class="odd">
<td>J9145</td>
<td>0010</td>
<td>3</td>
<td>Injection, daratumumab, 10 mg</td>
<td>Injection, daratumumab 10 mg</td>
</tr>
<tr class="even">
<td>J9150</td>
<td>0010</td>
<td>3</td>
<td>Injection, daunorubicin, 10 mg</td>
<td>Daunorubicin injection</td>
</tr>
<tr class="odd">
<td>J9151</td>
<td>0010</td>
<td>3</td>
<td>Injection, daunorubicin citrate, liposomal formulation, 10 mg</td>
<td>Daunorubicin citrate inj</td>
</tr>
<tr class="even">
<td>J9153</td>
<td>0010</td>
<td>3</td>
<td>Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine</td>
<td>Inj daunorubicin, cytarabine</td>
</tr>
<tr class="odd">
<td>J9155</td>
<td>0010</td>
<td>3</td>
<td>Injection, degarelix, 1 mg</td>
<td>Degarelix injection</td>
</tr>
<tr class="even">
<td>J9160</td>
<td>0010</td>
<td>3</td>
<td>Injection, denileukin diftitox, 300 micrograms</td>
<td>Denileukin diftitox inj</td>
</tr>
<tr class="odd">
<td>J9165</td>
<td>0010</td>
<td>3</td>
<td>Injection, diethylstilbestrol diphosphate, 250 mg</td>
<td>Diethylstilbestrol injection</td>
</tr>
<tr class="even">
<td>J9171</td>
<td>0010</td>
<td>3</td>
<td>Injection, docetaxel, 1 mg</td>
<td>Docetaxel injection</td>
</tr>
<tr class="odd">
<td>J9173</td>
<td>0010</td>
<td>3</td>
<td>Injection, durvalumab, 10 mg</td>
<td>Inj., durvalumab, 10 mg</td>
</tr>
<tr class="even">
<td>J9175</td>
<td>0010</td>
<td>3</td>
<td>Injection, elliotts’ b solution, 1 ml</td>
<td>Elliotts b solution per ml</td>
</tr>
<tr class="odd">
<td>J9176</td>
<td>0010</td>
<td>3</td>
<td>Injection, elotuzumab, 1 mg</td>
<td>Injection, elotuzumab, 1mg</td>
</tr>
<tr class="even">
<td>J9178</td>
<td>0010</td>
<td>3</td>
<td>Injection, epirubicin hcl, 2 mg</td>
<td>Inj, epirubicin hcl, 2 mg</td>
</tr>
<tr class="odd">
<td>J9179</td>
<td>0010</td>
<td>3</td>
<td>Injection, eribulin mesylate, 0.1 mg</td>
<td>Eribulin mesylate injection</td>
</tr>
<tr class="even">
<td>J9181</td>
<td>0010</td>
<td>3</td>
<td>Injection, etoposide, 10 mg</td>
<td>Etoposide injection</td>
</tr>
<tr class="odd">
<td>J9185</td>
<td>0010</td>
<td>3</td>
<td>Injection, fludarabine phosphate, 50 mg</td>
<td>Fludarabine phosphate inj</td>
</tr>
<tr class="even">
<td>J9190</td>
<td>0010</td>
<td>3</td>
<td>Injection, fluorouracil, 500 mg</td>
<td>Fluorouracil injection</td>
</tr>
<tr class="odd">
<td>J9199</td>
<td>0010</td>
<td>3</td>
<td>Injection, gemcitabine hydrochloride (infugem), 200 mg</td>
<td>Injection, infugem, 200 mg</td>
</tr>
<tr class="even">
<td>J9200</td>
<td>0010</td>
<td>3</td>
<td>Injection, floxuridine, 500 mg</td>
<td>Floxuridine injection</td>
</tr>
<tr class="odd">
<td>J9201</td>
<td>0010</td>
<td>3</td>
<td>Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg</td>
<td>In gemcitabine hcl nos 200mg</td>
</tr>
<tr class="even">
<td>J9202</td>
<td>0010</td>
<td>3</td>
<td>Goserelin acetate implant, per 3.6 mg</td>
<td>Goserelin acetate implant</td>
</tr>
<tr class="odd">
<td>J9203</td>
<td>0010</td>
<td>3</td>
<td>Injection, gemtuzumab ozogamicin, 0.1 mg</td>
<td>Gemtuzumab ozogamicin 0.1 mg</td>
</tr>
<tr class="even">
<td>J9204</td>
<td>0010</td>
<td>3</td>
<td>Injection, mogamulizumab-kpkc, 1 mg</td>
<td>Inj mogamulizumab-kpkc, 1 mg</td>
</tr>
<tr class="odd">
<td>J9205</td>
<td>0010</td>
<td>3</td>
<td>Injection, irinotecan liposome, 1 mg</td>
<td>Inj irinotecan liposome 1 mg</td>
</tr>
<tr class="even">
<td>J9206</td>
<td>0010</td>
<td>3</td>
<td>Injection, irinotecan, 20 mg</td>
<td>Irinotecan injection</td>
</tr>
<tr class="odd">
<td>J9207</td>
<td>0010</td>
<td>3</td>
<td>Injection, ixabepilone, 1 mg</td>
<td>Ixabepilone injection</td>
</tr>
<tr class="even">
<td>J9208</td>
<td>0010</td>
<td>3</td>
<td>Injection, ifosfamide, 1 gram</td>
<td>Ifosfamide injection</td>
</tr>
<tr class="odd">
<td>J9209</td>
<td>0010</td>
<td>3</td>
<td>Injection, mesna, 200 mg</td>
<td>Mesna injection</td>
</tr>
<tr class="even">
<td>J9210</td>
<td>0010</td>
<td>3</td>
<td>Injection, emapalumab-lzsg, 1 mg</td>
<td>Inj., emapalumab-lzsg, 1 mg</td>
</tr>
<tr class="odd">
<td>J9211</td>
<td>0010</td>
<td>3</td>
<td>Injection, idarubicin hydrochloride, 5 mg</td>
<td>Idarubicin hcl injection</td>
</tr>
<tr class="even">
<td>J9212</td>
<td>0010</td>
<td>3</td>
<td>Injection, interferon alfacon-1, recombinant, 1 microgram</td>
<td>Interferon alfacon-1 inj</td>
</tr>
<tr class="odd">
<td>J9213</td>
<td>0010</td>
<td>3</td>
<td>Injection, interferon, alfa-2a, recombinant, 3 million units</td>
<td>Interferon alfa-2a inj</td>
</tr>
<tr class="even">
<td>J9214</td>
<td>0010</td>
<td>3</td>
<td>Injection, interferon, alfa-2b, recombinant, 1 million units</td>
<td>Interferon alfa-2b inj</td>
</tr>
<tr class="odd">
<td>J9215</td>
<td>0010</td>
<td>3</td>
<td>Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu</td>
<td>Interferon alfa-n3 inj</td>
</tr>
<tr class="even">
<td>J9216</td>
<td>0010</td>
<td>3</td>
<td>Injection, interferon, gamma 1-b, 3 million units</td>
<td>Interferon gamma 1-b inj</td>
</tr>
<tr class="odd">
<td>J9217</td>
<td>0010</td>
<td>3</td>
<td>Leuprolide acetate (for depot suspension), 7.5 mg</td>
<td>Leuprolide acetate suspnsion</td>
</tr>
<tr class="even">
<td>J9218</td>
<td>0010</td>
<td>3</td>
<td>Leuprolide acetate, per 1 mg</td>
<td>Leuprolide acetate injeciton</td>
</tr>
<tr class="odd">
<td>J9219</td>
<td>0010</td>
<td>3</td>
<td>Leuprolide acetate implant, 65 mg</td>
<td>Leuprolide acetate implant</td>
</tr>
<tr class="even">
<td>J9225</td>
<td>0010</td>
<td>3</td>
<td>Histrelin implant (vantas), 50 mg</td>
<td>Vantas implant</td>
</tr>
<tr class="odd">
<td>J9226</td>
<td>0010</td>
<td>3</td>
<td>Histrelin implant (supprelin la), 50 mg</td>
<td>Supprelin la implant</td>
</tr>
<tr class="even">
<td>J9228</td>
<td>0010</td>
<td>3</td>
<td>Injection, ipilimumab, 1 mg</td>
<td>Ipilimumab injection</td>
</tr>
<tr class="odd">
<td>J9229</td>
<td>0010</td>
<td>3</td>
<td>Injection, inotuzumab ozogamicin, 0.1 mg</td>
<td>Inj inotuzumab ozogam 0.1 mg</td>
</tr>
<tr class="even">
<td>J9230</td>
<td>0010</td>
<td>3</td>
<td>Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg</td>
<td>Mechlorethamine hcl inj</td>
</tr>
<tr class="odd">
<td>J9245</td>
<td>0010</td>
<td>3</td>
<td>Injection, melphalan hydrochloride, 50 mg</td>
<td>Inj melphalan hydrochl 50 mg</td>
</tr>
<tr class="even">
<td>J9250</td>
<td>0010</td>
<td>3</td>
<td>Methotrexate sodium, 5 mg</td>
<td>Methotrexate sodium inj</td>
</tr>
<tr class="odd">
<td>J9260</td>
<td>0010</td>
<td>3</td>
<td>Methotrexate sodium, 50 mg</td>
<td>Methotrexate sodium inj</td>
</tr>
<tr class="even">
<td>J9261</td>
<td>0010</td>
<td>3</td>
<td>Injection, nelarabine, 50 mg</td>
<td>Nelarabine injection</td>
</tr>
<tr class="odd">
<td>J9262</td>
<td>0010</td>
<td>3</td>
<td>Injection, omacetaxine mepesuccinate, 0.01 mg</td>
<td>Inj, omacetaxine mep, 0.01mg</td>
</tr>
<tr class="even">
<td>J9263</td>
<td>0010</td>
<td>3</td>
<td>Injection, oxaliplatin, 0.5 mg</td>
<td>Oxaliplatin</td>
</tr>
<tr class="odd">
<td>J9264</td>
<td>0010</td>
<td>3</td>
<td>Injection, paclitaxel protein-bound particles, 1 mg</td>
<td>Paclitaxel protein bound</td>
</tr>
<tr class="even">
<td>J9265</td>
<td>0010</td>
<td>3</td>
<td>Injection, paclitaxel, 30 mg</td>
<td>Paclitaxel injection</td>
</tr>
<tr class="odd">
<td>J9266</td>
<td>0010</td>
<td>3</td>
<td>Injection, pegaspargase, per single dose vial</td>
<td>Pegaspargase injection</td>
</tr>
<tr class="even">
<td>J9267</td>
<td>0010</td>
<td>3</td>
<td>Injection, paclitaxel, 1 mg</td>
<td>Paclitaxel injection</td>
</tr>
<tr class="odd">
<td>J9268</td>
<td>0010</td>
<td>3</td>
<td>Injection, pentostatin, 10 mg</td>
<td>Pentostatin injection</td>
</tr>
<tr class="even">
<td>J9269</td>
<td>0010</td>
<td>3</td>
<td>Injection, tagraxofusp-erzs, 10 micrograms</td>
<td>Inj. tagraxofusp-erzs 10 mcg</td>
</tr>
<tr class="odd">
<td>J9270</td>
<td>0010</td>
<td>3</td>
<td>Injection, plicamycin, 2.5 mg</td>
<td>Plicamycin (mithramycin) inj</td>
</tr>
<tr class="even">
<td>J9271</td>
<td>0010</td>
<td>3</td>
<td>Injection, pembrolizumab, 1 mg</td>
<td>Inj pembrolizumab</td>
</tr>
<tr class="odd">
<td>J9280</td>
<td>0010</td>
<td>3</td>
<td>Injection, mitomycin, 5 mg</td>
<td>Mitomycin injection</td>
</tr>
<tr class="even">
<td>J9285</td>
<td>0010</td>
<td>3</td>
<td>Injection, olaratumab, 10 mg</td>
<td>Inj, olaratumab, 10 mg</td>
</tr>
<tr class="odd">
<td>J9293</td>
<td>0010</td>
<td>3</td>
<td>Injection, mitoxantrone hydrochloride, per 5 mg</td>
<td>Mitoxantrone hydrochl / 5 mg</td>
</tr>
<tr class="even">
<td>J9295</td>
<td>0010</td>
<td>3</td>
<td>Injection, necitumumab, 1 mg</td>
<td>Injection, necitumumab, 1 mg</td>
</tr>
<tr class="odd">
<td>J9299</td>
<td>0010</td>
<td>3</td>
<td>Injection, nivolumab, 1 mg</td>
<td>Injection, nivolumab</td>
</tr>
<tr class="even">
<td>J9300</td>
<td>0010</td>
<td>3</td>
<td>Injection, gemtuzumab ozogamicin, 5 mg</td>
<td>Gemtuzumab ozogamicin inj</td>
</tr>
<tr class="odd">
<td>J9301</td>
<td>0010</td>
<td>3</td>
<td>Injection, obinutuzumab, 10 mg</td>
<td>Obinutuzumab inj</td>
</tr>
<tr class="even">
<td>J9302</td>
<td>0010</td>
<td>3</td>
<td>Injection, ofatumumab, 10 mg</td>
<td>Ofatumumab injection</td>
</tr>
<tr class="odd">
<td>J9303</td>
<td>0010</td>
<td>3</td>
<td>Injection, panitumumab, 10 mg</td>
<td>Panitumumab injection</td>
</tr>
<tr class="even">
<td>J9305</td>
<td>0010</td>
<td>3</td>
<td>Injection, pemetrexed, 10 mg</td>
<td>Pemetrexed injection</td>
</tr>
<tr class="odd">
<td>J9306</td>
<td>0010</td>
<td>3</td>
<td>Injection, pertuzumab, 1 mg</td>
<td>Injection, pertuzumab, 1 mg</td>
</tr>
<tr class="even">
<td>J9307</td>
<td>0010</td>
<td>3</td>
<td>Injection, pralatrexate, 1 mg</td>
<td>Pralatrexate injection</td>
</tr>
<tr class="odd">
<td>J9308</td>
<td>0010</td>
<td>3</td>
<td>Injection, ramucirumab, 5 mg</td>
<td>Injection, ramucirumab</td>
</tr>
<tr class="even">
<td>J9309</td>
<td>0010</td>
<td>3</td>
<td>Injection, polatuzumab vedotin-piiq, 1 mg</td>
<td>Inj, polatuzumab vedotin 1mg</td>
</tr>
<tr class="odd">
<td>J9310</td>
<td>0010</td>
<td>3</td>
<td>Injection, rituximab, 100 mg</td>
<td>Rituximab injection</td>
</tr>
<tr class="even">
<td>J9311</td>
<td>0010</td>
<td>3</td>
<td>Injection, rituximab 10 mg and hyaluronidase</td>
<td>Inj rituximab, hyaluronidase</td>
</tr>
<tr class="odd">
<td>J9312</td>
<td>0010</td>
<td>3</td>
<td>Injection, rituximab, 10 mg</td>
<td>Inj., rituximab, 10 mg</td>
</tr>
<tr class="even">
<td>J9313</td>
<td>0010</td>
<td>3</td>
<td>Injection, moxetumomab pasudotox-tdfk, 0.01 mg</td>
<td>Inj., lumoxiti, 0.01 mg</td>
</tr>
<tr class="odd">
<td>J9315</td>
<td>0010</td>
<td>3</td>
<td>Injection, romidepsin, 1 mg</td>
<td>Romidepsin injection</td>
</tr>
<tr class="even">
<td>J9320</td>
<td>0010</td>
<td>3</td>
<td>Injection, streptozocin, 1 gram</td>
<td>Streptozocin injection</td>
</tr>
<tr class="odd">
<td>J9325</td>
<td>0010</td>
<td>3</td>
<td>Injection, talimogene laherparepvec, per 1 million plaque forming units</td>
<td>Inj talimogene laherparepvec</td>
</tr>
<tr class="even">
<td>J9328</td>
<td>0010</td>
<td>3</td>
<td>Injection, temozolomide, 1 mg</td>
<td>Temozolomide injection</td>
</tr>
<tr class="odd">
<td>J9330</td>
<td>0010</td>
<td>3</td>
<td>Injection, temsirolimus, 1 mg</td>
<td>Temsirolimus injection</td>
</tr>
<tr class="even">
<td>J9340</td>
<td>0010</td>
<td>3</td>
<td>Injection, thiotepa, 15 mg</td>
<td>Thiotepa injection</td>
</tr>
<tr class="odd">
<td>J9351</td>
<td>0010</td>
<td>3</td>
<td>Injection, topotecan, 0.1 mg</td>
<td>Topotecan injection</td>
</tr>
<tr class="even">
<td>J9352</td>
<td>0010</td>
<td>3</td>
<td>Injection, trabectedin, 0.1 mg</td>
<td>Injection trabectedin 0.1mg</td>
</tr>
<tr class="odd">
<td>J9354</td>
<td>0010</td>
<td>3</td>
<td>Injection, ado-trastuzumab emtansine, 1 mg</td>
<td>Inj, ado-trastuzumab emt 1mg</td>
</tr>
<tr class="even">
<td>J9355</td>
<td>0010</td>
<td>3</td>
<td>Injection, trastuzumab, excludes biosimilar, 10 mg</td>
<td>Inj trastuzumab excl biosimi</td>
</tr>
<tr class="odd">
<td>J9356</td>
<td>0010</td>
<td>3</td>
<td>Injection, trastuzumab, 10 mg and hyaluronidase-oysk</td>
<td>Inj. herceptin hylecta, 10mg</td>
</tr>
<tr class="even">
<td>J9357</td>
<td>0010</td>
<td>3</td>
<td>Injection, valrubicin, intravesical, 200 mg</td>
<td>Valrubicin injection</td>
</tr>
<tr class="odd">
<td>J9360</td>
<td>0010</td>
<td>3</td>
<td>Injection, vinblastine sulfate, 1 mg</td>
<td>Vinblastine sulfate inj</td>
</tr>
<tr class="even">
<td>J9370</td>
<td>0010</td>
<td>3</td>
<td>Vincristine sulfate, 1 mg</td>
<td>Vincristine sulfate 1 mg inj</td>
</tr>
<tr class="odd">
<td>J9371</td>
<td>0010</td>
<td>3</td>
<td>Injection, vincristine sulfate liposome, 1 mg</td>
<td>Inj, vincristine sul lip 1mg</td>
</tr>
<tr class="even">
<td>J9390</td>
<td>0010</td>
<td>3</td>
<td>Injection, vinorelbine tartrate, 10 mg</td>
<td>Vinorelbine tartrate inj</td>
</tr>
<tr class="odd">
<td>J9395</td>
<td>0010</td>
<td>3</td>
<td>Injection, fulvestrant, 25 mg</td>
<td>Injection, fulvestrant</td>
</tr>
<tr class="even">
<td>J9400</td>
<td>0010</td>
<td>3</td>
<td>Injection, ziv-aflibercept, 1 mg</td>
<td>Inj, ziv-aflibercept, 1mg</td>
</tr>
<tr class="odd">
<td>J9600</td>
<td>0010</td>
<td>3</td>
<td>Injection, porfimer sodium, 75 mg</td>
<td>Porfimer sodium injection</td>
</tr>
<tr class="even">
<td>J9999</td>
<td>0010</td>
<td>3</td>
<td>Not otherwise classified, antineoplastic drugs</td>
<td>Chemotherapy drug</td>
</tr>
</tbody>
</table>
</div>
<div id="k-series-temporary-codes-k0000-k9999" class="section level2">
<h2>K Series: Temporary Codes (K0000-K9999)</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>K0001</td>
<td>0010</td>
<td>3</td>
<td>Standard wheelchair</td>
<td>Standard wheelchair</td>
</tr>
<tr class="even">
<td>K0002</td>
<td>0010</td>
<td>3</td>
<td>Standard hemi (low seat) wheelchair</td>
<td>Stnd hemi (low seat) whlchr</td>
</tr>
<tr class="odd">
<td>K0003</td>
<td>0010</td>
<td>3</td>
<td>Lightweight wheelchair</td>
<td>Lightweight wheelchair</td>
</tr>
<tr class="even">
<td>K0004</td>
<td>0010</td>
<td>3</td>
<td>High strength, lightweight wheelchair</td>
<td>High strength ltwt whlchr</td>
</tr>
<tr class="odd">
<td>K0005</td>
<td>0010</td>
<td>3</td>
<td>Ultralightweight wheelchair</td>
<td>Ultralightweight wheelchair</td>
</tr>
<tr class="even">
<td>K0006</td>
<td>0010</td>
<td>3</td>
<td>Heavy duty wheelchair</td>
<td>Heavy duty wheelchair</td>
</tr>
<tr class="odd">
<td>K0007</td>
<td>0010</td>
<td>3</td>
<td>Extra heavy duty wheelchair</td>
<td>Extra heavy duty wheelchair</td>
</tr>
<tr class="even">
<td>K0008</td>
<td>0010</td>
<td>3</td>
<td>Custom manual wheelchair/base</td>
<td>Cstm manual wheelchair/base</td>
</tr>
<tr class="odd">
<td>K0009</td>
<td>0010</td>
<td>3</td>
<td>Other manual wheelchair/base</td>
<td>Other manual wheelchair/base</td>
</tr>
<tr class="even">
<td>K0010</td>
<td>0010</td>
<td>3</td>
<td>Standard - weight frame motorized/power wheelchair</td>
<td>Stnd wt frame power whlchr</td>
</tr>
<tr class="odd">
<td>K0011</td>
<td>0010</td>
<td>3</td>
<td>Standard - weight frame motorized/power wheelchair with programmable control parameters for speed adjustment, tremor dampening, acceleration control and braking</td>
<td>Stnd wt pwr whlchr w control</td>
</tr>
<tr class="even">
<td>K0012</td>
<td>0010</td>
<td>3</td>
<td>Lightweight portable motorized/power wheelchair</td>
<td>Ltwt portbl power whlchr</td>
</tr>
<tr class="odd">
<td>K0013</td>
<td>0010</td>
<td>3</td>
<td>Custom motorized/power wheelchair base</td>
<td>Custom power whlchr base</td>
</tr>
<tr class="even">
<td>K0014</td>
<td>0010</td>
<td>3</td>
<td>Other motorized/power wheelchair base</td>
<td>Other power whlchr base</td>
</tr>
<tr class="odd">
<td>K0015</td>
<td>0010</td>
<td>3</td>
<td>Detachable, non-adjustable height armrest, replacement only, each</td>
<td>Detach non-adj ht armrst rep</td>
</tr>
<tr class="even">
<td>K0017</td>
<td>0010</td>
<td>3</td>
<td>Detachable, adjustable height armrest, base, replacement only, each</td>
<td>Detach adjust armrest base</td>
</tr>
<tr class="odd">
<td>K0018</td>
<td>0010</td>
<td>3</td>
<td>Detachable, adjustable height armrest, upper portion, replacement only, each</td>
<td>Detach adjust armrst upper</td>
</tr>
<tr class="even">
<td>K0019</td>
<td>0010</td>
<td>3</td>
<td>Arm pad, replacement only, each</td>
<td>Arm pad repl, each</td>
</tr>
<tr class="odd">
<td>K0020</td>
<td>0010</td>
<td>3</td>
<td>Fixed, adjustable height armrest, pair</td>
<td>Fixed adjust armrest pair</td>
</tr>
<tr class="even">
<td>K0037</td>
<td>0010</td>
<td>3</td>
<td>High mount flip-up footrest, each</td>
<td>Hi mount flip-up footrest ea</td>
</tr>
<tr class="odd">
<td>K0038</td>
<td>0010</td>
<td>3</td>
<td>Leg strap, each</td>
<td>Leg strap each</td>
</tr>
<tr class="even">
<td>K0039</td>
<td>0010</td>
<td>3</td>
<td>Leg strap, h style, each</td>
<td>Leg strap h style each</td>
</tr>
<tr class="odd">
<td>K0040</td>
<td>0010</td>
<td>3</td>
<td>Adjustable angle footplate, each</td>
<td>Adjustable angle footplate</td>
</tr>
<tr class="even">
<td>K0041</td>
<td>0010</td>
<td>3</td>
<td>Large size footplate, each</td>
<td>Large size footplate each</td>
</tr>
<tr class="odd">
<td>K0042</td>
<td>0010</td>
<td>3</td>
<td>Standard size footplate, replacement only, each</td>
<td>Standard size ftplate rep ea</td>
</tr>
<tr class="even">
<td>K0043</td>
<td>0010</td>
<td>3</td>
<td>Footrest, lower extension tube, replacement only, each</td>
<td>Ftrst lowr exten tube rep ea</td>
</tr>
<tr class="odd">
<td>K0044</td>
<td>0010</td>
<td>3</td>
<td>Footrest, upper hanger bracket, replacement only, each</td>
<td>Ftrst upr hanger brac rep ea</td>
</tr>
<tr class="even">
<td>K0045</td>
<td>0010</td>
<td>3</td>
<td>Footrest, complete assembly, replacement only, each</td>
<td>Ftrst compl assembly repl ea</td>
</tr>
<tr class="odd">
<td>K0046</td>
<td>0010</td>
<td>3</td>
<td>Elevating legrest, lower extension tube, replacement only, each</td>
<td>Elev lgrst lwr exten repl ea</td>
</tr>
<tr class="even">
<td>K0047</td>
<td>0010</td>
<td>3</td>
<td>Elevating legrest, upper hanger bracket, replacement only, each</td>
<td>Elev legrst upr hangr rep ea</td>
</tr>
<tr class="odd">
<td>K0050</td>
<td>0010</td>
<td>3</td>
<td>Ratchet assembly, replacement only</td>
<td>Ratchet assembly replacement</td>
</tr>
<tr class="even">
<td>K0051</td>
<td>0010</td>
<td>3</td>
<td>Cam release assembly, footrest or legrest, replacement only, each</td>
<td>Cam rel asm ft/legrst rep ea</td>
</tr>
<tr class="odd">
<td>K0052</td>
<td>0010</td>
<td>3</td>
<td>Swingaway, detachable footrests, replacement only, each</td>
<td>Swingaway detach ftrest repl</td>
</tr>
<tr class="even">
<td>K0053</td>
<td>0010</td>
<td>3</td>
<td>Elevating footrests, articulating (telescoping), each</td>
<td>Elevate footrest articulate</td>
</tr>
<tr class="odd">
<td>K0056</td>
<td>0010</td>
<td>3</td>
<td>Seat height less than 17&quot; or equal to or greater than 21&quot; for a high strength, lightweight, or ultralightweight wheelchair</td>
<td>Seat ht &lt;17 or &gt;=21 ltwt wc</td>
</tr>
<tr class="even">
<td>K0065</td>
<td>0010</td>
<td>3</td>
<td>Spoke protectors, each</td>
<td>Spoke protectors</td>
</tr>
<tr class="odd">
<td>K0069</td>
<td>0010</td>
<td>3</td>
<td>Rear wheel assembly, complete, with solid tire, spokes or molded, replacement only, each</td>
<td>Rr whl compl sol tire rep ea</td>
</tr>
<tr class="even">
<td>K0070</td>
<td>0010</td>
<td>3</td>
<td>Rear wheel assembly, complete, with pneumatic tire, spokes or molded, replacement only, each</td>
<td>Rr whl compl pne tire rep ea</td>
</tr>
<tr class="odd">
<td>K0071</td>
<td>0010</td>
<td>3</td>
<td>Front caster assembly, complete, with pneumatic tire, replacement only, each</td>
<td>Fr cstr comp pne tire rep ea</td>
</tr>
<tr class="even">
<td>K0072</td>
<td>0010</td>
<td>3</td>
<td>Front caster assembly, complete, with semi-pneumatic tire, replacement only, each</td>
<td>Fr cstr semi-pne tire rep ea</td>
</tr>
<tr class="odd">
<td>K0073</td>
<td>0010</td>
<td>3</td>
<td>Caster pin lock, each</td>
<td>Caster pin lock each</td>
</tr>
<tr class="even">
<td>K0077</td>
<td>0010</td>
<td>3</td>
<td>Front caster assembly, complete, with solid tire, replacement only, each</td>
<td>Fr cstr asmb sol tire rep ea</td>
</tr>
<tr class="odd">
<td>K0098</td>
<td>0010</td>
<td>3</td>
<td>Drive belt for power wheelchair, replacement only</td>
<td>Drive belt for pwc, repl</td>
</tr>
<tr class="even">
<td>K0105</td>
<td>0010</td>
<td>3</td>
<td>Iv hanger, each</td>
<td>Iv hanger</td>
</tr>
<tr class="odd">
<td>K0108</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair component or accessory, not otherwise specified</td>
<td>W/c component-accessory nos</td>
</tr>
<tr class="even">
<td>K0195</td>
<td>0010</td>
<td>3</td>
<td>Elevating leg rests, pair (for use with capped rental wheelchair base)</td>
<td>Elevating whlchair leg rests</td>
</tr>
<tr class="odd">
<td>K0455</td>
<td>0010</td>
<td>3</td>
<td>Infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol)</td>
<td>Pump uninterrupted infusion</td>
</tr>
<tr class="even">
<td>K0462</td>
<td>0010</td>
<td>3</td>
<td>Temporary replacement for patient owned equipment being repaired, any type</td>
<td>Temporary replacement eqpmnt</td>
</tr>
<tr class="odd">
<td>K0552</td>
<td>0010</td>
<td>3</td>
<td>Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each</td>
<td>Sup/ext non-ins inf pump syr</td>
</tr>
<tr class="even">
<td>K0553</td>
<td>0010</td>
<td>3</td>
<td>Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service</td>
<td>Ther cgm supply allowance</td>
</tr>
<tr class="odd">
<td>K0554</td>
<td>0010</td>
<td>3</td>
<td>Receiver (monitor), dedicated, for use with therapeutic glucose continuous monitor system</td>
<td>Ther cgm receiver/monitor</td>
</tr>
<tr class="even">
<td>K0601</td>
<td>0010</td>
<td>3</td>
<td>Replacement battery for external infusion pump owned by patient, silver oxide, 1.5 volt, each</td>
<td>Repl batt silver oxide 1.5 v</td>
</tr>
<tr class="odd">
<td>K0602</td>
<td>0010</td>
<td>3</td>
<td>Replacement battery for external infusion pump owned by patient, silver oxide, 3 volt, each</td>
<td>Repl batt silver oxide 3 v</td>
</tr>
<tr class="even">
<td>K0603</td>
<td>0010</td>
<td>3</td>
<td>Replacement battery for external infusion pump owned by patient, alkaline, 1.5 volt, each</td>
<td>Repl batt alkaline 1.5 v</td>
</tr>
<tr class="odd">
<td>K0604</td>
<td>0010</td>
<td>3</td>
<td>Replacement battery for external infusion pump owned by patient, lithium, 3.6 volt, each</td>
<td>Repl batt lithium 3.6 v</td>
</tr>
<tr class="even">
<td>K0605</td>
<td>0010</td>
<td>3</td>
<td>Replacement battery for external infusion pump owned by patient, lithium, 4.5 volt, each</td>
<td>Repl batt lithium 4.5 v</td>
</tr>
<tr class="odd">
<td>K0606</td>
<td>0010</td>
<td>3</td>
<td>Automatic external defibrillator, with integrated electrocardiogram analysis, garment type</td>
<td>Aed garment w elec analysis</td>
</tr>
<tr class="even">
<td>K0607</td>
<td>0010</td>
<td>3</td>
<td>Replacement battery for automated external defibrillator, garment type only, each</td>
<td>Repl batt for aed</td>
</tr>
<tr class="odd">
<td>K0608</td>
<td>0010</td>
<td>3</td>
<td>Replacement garment for use with automated external defibrillator, each</td>
<td>Repl garment for aed</td>
</tr>
<tr class="even">
<td>K0609</td>
<td>0010</td>
<td>3</td>
<td>Replacement electrodes for use with automated external defibrillator, garment type only, each</td>
<td>Repl electrode for aed</td>
</tr>
<tr class="odd">
<td>K0669</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair accessory, wheelchair seat or back cushion, does not meet specific code criteria or no written coding verification from dme pdac</td>
<td>Seat/back cus no dmepdac ver</td>
</tr>
<tr class="even">
<td>K0672</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, removable soft interface, all components, replacement only, each</td>
<td>Removable soft interface le</td>
</tr>
<tr class="odd">
<td>K0730</td>
<td>0010</td>
<td>3</td>
<td>Controlled dose inhalation drug delivery system</td>
<td>Ctrl dose inh drug deliv sys</td>
</tr>
<tr class="even">
<td>K0733</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair accessory, 12 to 24 amp hour sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)</td>
<td>12-24hr sealed lead acid</td>
</tr>
<tr class="odd">
<td>K0738</td>
<td>0010</td>
<td>3</td>
<td>Portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubing</td>
<td>Portable gas oxygen system</td>
</tr>
<tr class="even">
<td>K0739</td>
<td>0010</td>
<td>3</td>
<td>Repair or nonroutine service for durable medical equipment other than oxygen equipment requiring the skill of a technician, labor component, per 15 minutes</td>
<td>Repair/svc dme non-oxygen eq</td>
</tr>
<tr class="odd">
<td>K0740</td>
<td>0010</td>
<td>3</td>
<td>Repair or nonroutine service for oxygen equipment requiring the skill of a technician, labor component, per 15 minutes</td>
<td>Repair/svc oxygen equipment</td>
</tr>
<tr class="even">
<td>K0743</td>
<td>0010</td>
<td>3</td>
<td>Suction pump, home model, portable, for use on wounds</td>
<td>Portable home suction pump</td>
</tr>
<tr class="odd">
<td>K0744</td>
<td>0010</td>
<td>3</td>
<td>Absorptive wound dressing for use with suction pump, home model, portable, pad size 16 square inches or less</td>
<td>Absorp drg &lt;= 16 suc pump</td>
</tr>
<tr class="even">
<td>K0745</td>
<td>0010</td>
<td>3</td>
<td>Absorptive wound dressing for use with suction pump, home model, portable, pad size more than 16 square inches but less than or equal to 48 square inches</td>
<td>Absorp drg &gt;16&lt;=48 suc pump</td>
</tr>
<tr class="odd">
<td>K0746</td>
<td>0010</td>
<td>3</td>
<td>Absorptive wound dressing for use with suction pump, home model, portable, pad size greater than 48 square inches</td>
<td>Absorp drg &gt;48 suc pump</td>
</tr>
<tr class="even">
<td>K0800</td>
<td>0010</td>
<td>3</td>
<td>Power operated vehicle, group 1 standard, patient weight capacity up to and including 300 pounds</td>
<td>Pov group 1 std up to 300lbs</td>
</tr>
<tr class="odd">
<td>K0801</td>
<td>0010</td>
<td>3</td>
<td>Power operated vehicle, group 1 heavy duty, patient weight capacity 301 to 450 pounds</td>
<td>Pov group 1 hd 301-450 lbs</td>
</tr>
<tr class="even">
<td>K0802</td>
<td>0010</td>
<td>3</td>
<td>Power operated vehicle, group 1 very heavy duty, patient weight capacity 451 to 600 pounds</td>
<td>Pov group 1 vhd 451-600 lbs</td>
</tr>
<tr class="odd">
<td>K0806</td>
<td>0010</td>
<td>3</td>
<td>Power operated vehicle, group 2 standard, patient weight capacity up to and including 300 pounds</td>
<td>Pov group 2 std up to 300lbs</td>
</tr>
<tr class="even">
<td>K0807</td>
<td>0010</td>
<td>3</td>
<td>Power operated vehicle, group 2 heavy duty, patient weight capacity 301 to 450 pounds</td>
<td>Pov group 2 hd 301-450 lbs</td>
</tr>
<tr class="odd">
<td>K0808</td>
<td>0010</td>
<td>3</td>
<td>Power operated vehicle, group 2 very heavy duty, patient weight capacity 451 to 600 pounds</td>
<td>Pov group 2 vhd 451-600 lbs</td>
</tr>
<tr class="even">
<td>K0812</td>
<td>0010</td>
<td>3</td>
<td>Power operated vehicle, not otherwise classified</td>
<td>Power operated vehicle noc</td>
</tr>
<tr class="odd">
<td>K0813</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 1 standard, portable, sling/solid seat and back, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp 1 std port seat/back</td>
</tr>
<tr class="even">
<td>K0814</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 1 standard, portable, captains chair, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp 1 std port cap chair</td>
</tr>
<tr class="odd">
<td>K0815</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 1 standard, sling/solid seat and back, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp 1 std seat/back</td>
</tr>
<tr class="even">
<td>K0816</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 1 standard, captains chair, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp 1 std cap chair</td>
</tr>
<tr class="odd">
<td>K0820</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 standard, portable, sling/solid seat/back, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp 2 std port seat/back</td>
</tr>
<tr class="even">
<td>K0821</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 standard, portable, captains chair, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp 2 std port cap chair</td>
</tr>
<tr class="odd">
<td>K0822</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp 2 std seat/back</td>
</tr>
<tr class="even">
<td>K0823</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp 2 std cap chair</td>
</tr>
<tr class="odd">
<td>K0824</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds</td>
<td>Pwc gp 2 hd seat/back</td>
</tr>
<tr class="even">
<td>K0825</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 heavy duty, captains chair, patient weight capacity 301 to 450 pounds</td>
<td>Pwc gp 2 hd cap chair</td>
</tr>
<tr class="odd">
<td>K0826</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds</td>
<td>Pwc gp 2 vhd seat/back</td>
</tr>
<tr class="even">
<td>K0827</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 very heavy duty, captains chair, patient weight capacity 451 to 600 pounds</td>
<td>Pwc gp vhd cap chair</td>
</tr>
<tr class="odd">
<td>K0828</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 extra heavy duty, sling/solid seat/back, patient weight capacity 601 pounds or more</td>
<td>Pwc gp 2 xtra hd seat/back</td>
</tr>
<tr class="even">
<td>K0829</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 extra heavy duty, captains chair, patient weight 601 pounds or more</td>
<td>Pwc gp 2 xtra hd cap chair</td>
</tr>
<tr class="odd">
<td>K0830</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 standard, seat elevator, sling/solid seat/back, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp2 std seat elevate s/b</td>
</tr>
<tr class="even">
<td>K0831</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 standard, seat elevator, captains chair, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp2 std seat elevate cap</td>
</tr>
<tr class="odd">
<td>K0835</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp2 std sing pow opt s/b</td>
</tr>
<tr class="even">
<td>K0836</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp2 std sing pow opt cap</td>
</tr>
<tr class="odd">
<td>K0837</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 heavy duty, single power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds</td>
<td>Pwc gp 2 hd sing pow opt s/b</td>
</tr>
<tr class="even">
<td>K0838</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 heavy duty, single power option, captains chair, patient weight capacity 301 to 450 pounds</td>
<td>Pwc gp 2 hd sing pow opt cap</td>
</tr>
<tr class="odd">
<td>K0839</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 very heavy duty, single power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds</td>
<td>Pwc gp2 vhd sing pow opt s/b</td>
</tr>
<tr class="even">
<td>K0840</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 extra heavy duty, single power option, sling/solid seat/back, patient weight capacity 601 pounds or more</td>
<td>Pwc gp2 xhd sing pow opt s/b</td>
</tr>
<tr class="odd">
<td>K0841</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp2 std mult pow opt s/b</td>
</tr>
<tr class="even">
<td>K0842</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 standard, multiple power option, captains chair, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp2 std mult pow opt cap</td>
</tr>
<tr class="odd">
<td>K0843</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 2 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds</td>
<td>Pwc gp2 hd mult pow opt s/b</td>
</tr>
<tr class="even">
<td>K0848</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp 3 std seat/back</td>
</tr>
<tr class="odd">
<td>K0849</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 standard, captains chair, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp 3 std cap chair</td>
</tr>
<tr class="even">
<td>K0850</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds</td>
<td>Pwc gp 3 hd seat/back</td>
</tr>
<tr class="odd">
<td>K0851</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 heavy duty, captains chair, patient weight capacity 301 to 450 pounds</td>
<td>Pwc gp 3 hd cap chair</td>
</tr>
<tr class="even">
<td>K0852</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds</td>
<td>Pwc gp 3 vhd seat/back</td>
</tr>
<tr class="odd">
<td>K0853</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 very heavy duty, captains chair, patient weight capacity 451 to 600 pounds</td>
<td>Pwc gp 3 vhd cap chair</td>
</tr>
<tr class="even">
<td>K0854</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 extra heavy duty, sling/solid seat/back, patient weight capacity 601 pounds or more</td>
<td>Pwc gp 3 xhd seat/back</td>
</tr>
<tr class="odd">
<td>K0855</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 extra heavy duty, captains chair, patient weight capacity 601 pounds or more</td>
<td>Pwc gp 3 xhd cap chair</td>
</tr>
<tr class="even">
<td>K0856</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp3 std sing pow opt s/b</td>
</tr>
<tr class="odd">
<td>K0857</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp3 std sing pow opt cap</td>
</tr>
<tr class="even">
<td>K0858</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 heavy duty, single power option, sling/solid seat/back, patient weight 301 to 450 pounds</td>
<td>Pwc gp3 hd sing pow opt s/b</td>
</tr>
<tr class="odd">
<td>K0859</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 heavy duty, single power option, captains chair, patient weight capacity 301 to 450 pounds</td>
<td>Pwc gp3 hd sing pow opt cap</td>
</tr>
<tr class="even">
<td>K0860</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 very heavy duty, single power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds</td>
<td>Pwc gp3 vhd sing pow opt s/b</td>
</tr>
<tr class="odd">
<td>K0861</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp3 std mult pow opt s/b</td>
</tr>
<tr class="even">
<td>K0862</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds</td>
<td>Pwc gp3 hd mult pow opt s/b</td>
</tr>
<tr class="odd">
<td>K0863</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 very heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds</td>
<td>Pwc gp3 vhd mult pow opt s/b</td>
</tr>
<tr class="even">
<td>K0864</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 3 extra heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 601 pounds or more</td>
<td>Pwc gp3 xhd mult pow opt s/b</td>
</tr>
<tr class="odd">
<td>K0868</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 4 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp 4 std seat/back</td>
</tr>
<tr class="even">
<td>K0869</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 4 standard, captains chair, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp 4 std cap chair</td>
</tr>
<tr class="odd">
<td>K0870</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 4 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds</td>
<td>Pwc gp 4 hd seat/back</td>
</tr>
<tr class="even">
<td>K0871</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 4 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds</td>
<td>Pwc gp 4 vhd seat/back</td>
</tr>
<tr class="odd">
<td>K0877</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 4 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp4 std sing pow opt s/b</td>
</tr>
<tr class="even">
<td>K0878</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 4 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp4 std sing pow opt cap</td>
</tr>
<tr class="odd">
<td>K0879</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 4 heavy duty, single power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds</td>
<td>Pwc gp4 hd sing pow opt s/b</td>
</tr>
<tr class="even">
<td>K0880</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 4 very heavy duty, single power option, sling/solid seat/back, patient weight 451 to 600 pounds</td>
<td>Pwc gp4 vhd sing pow opt s/b</td>
</tr>
<tr class="odd">
<td>K0884</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 4 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp4 std mult pow opt s/b</td>
</tr>
<tr class="even">
<td>K0885</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 4 standard, multiple power option, captains chair, patient weight capacity up to and including 300 pounds</td>
<td>Pwc gp4 std mult pow opt cap</td>
</tr>
<tr class="odd">
<td>K0886</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 4 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds</td>
<td>Pwc gp4 hd mult pow s/b</td>
</tr>
<tr class="even">
<td>K0890</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 5 pediatric, single power option, sling/solid seat/back, patient weight capacity up to and including 125 pounds</td>
<td>Pwc gp5 ped sing pow opt s/b</td>
</tr>
<tr class="odd">
<td>K0891</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, group 5 pediatric, multiple power option, sling/solid seat/back, patient weight capacity up to and including 125 pounds</td>
<td>Pwc gp5 ped mult pow opt s/b</td>
</tr>
<tr class="even">
<td>K0898</td>
<td>0010</td>
<td>3</td>
<td>Power wheelchair, not otherwise classified</td>
<td>Power wheelchair noc</td>
</tr>
<tr class="odd">
<td>K0899</td>
<td>0010</td>
<td>3</td>
<td>Power mobility device, not coded by dme pdac or does not meet criteria</td>
<td>Pow mobil dev no dmepdac</td>
</tr>
<tr class="even">
<td>K0900</td>
<td>0010</td>
<td>3</td>
<td>Customized durable medical equipment, other than wheelchair</td>
<td>Cstm dme other than wheelchr</td>
</tr>
<tr class="odd">
<td>K0901</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf</td>
<td>Ko single upright pre ots</td>
</tr>
<tr class="even">
<td>K0902</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf</td>
<td>Ko double upright pre ots</td>
</tr>
<tr class="odd">
<td>K0903</td>
<td>0010</td>
<td>3</td>
<td>For diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient’s foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each</td>
<td>Mult den insert dir carv/cam</td>
</tr>
<tr class="even">
<td>K1001</td>
<td>0010</td>
<td>3</td>
<td>Electronic positional obstructive sleep apnea treatment, with sensor, includes all components and accessories, any type</td>
<td>Electronic posa treatment</td>
</tr>
<tr class="odd">
<td>K1002</td>
<td>0010</td>
<td>3</td>
<td>Cranial electrotherapy stimulation (ces) system, includes all supplies and accessories, any type</td>
<td>Ces system w/supplies access</td>
</tr>
<tr class="even">
<td>K1003</td>
<td>0010</td>
<td>3</td>
<td>Whirlpool tub, walk-in, portable</td>
<td>Whirlpool tub walkin portabl</td>
</tr>
<tr class="odd">
<td>K1004</td>
<td>0010</td>
<td>3</td>
<td>Low frequency ultrasonic diathermy treatment device for home use, includes all components and accessories</td>
<td>Lo freq us diathermy device</td>
</tr>
<tr class="even">
<td>K1005</td>
<td>0010</td>
<td>3</td>
<td>Disposable collection and storage bag for breast milk, any size, any type, each</td>
<td>Disp col sto bag breast milk</td>
</tr>
</tbody>
</table>
</div>
<div id="l-series-no-description" class="section level2">
<h2>L Series: No Description</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>L0112</td>
<td>0010</td>
<td>3</td>
<td>Cranial cervical orthosis, congenital torticollis type, with or without soft interface material, adjustable range of motion joint, custom fabricated</td>
<td>Cranial cervical orthosis</td>
</tr>
<tr class="even">
<td>L0113</td>
<td>0010</td>
<td>3</td>
<td>Cranial cervical orthosis, torticollis type, with or without joint, with or without soft interface material, prefabricated, includes fitting and adjustment</td>
<td>Cranial cervical torticollis</td>
</tr>
<tr class="odd">
<td>L0120</td>
<td>0010</td>
<td>3</td>
<td>Cervical, flexible, non-adjustable, prefabricated, off-the-shelf (foam collar)</td>
<td>Cerv flex n/adj foam pre ots</td>
</tr>
<tr class="even">
<td>L0130</td>
<td>0010</td>
<td>3</td>
<td>Cervical, flexible, thermoplastic collar, molded to patient</td>
<td>Flex thermoplastic collar mo</td>
</tr>
<tr class="odd">
<td>L0140</td>
<td>0010</td>
<td>3</td>
<td>Cervical, semi-rigid, adjustable (plastic collar)</td>
<td>Cervical semi-rigid adjustab</td>
</tr>
<tr class="even">
<td>L0150</td>
<td>0010</td>
<td>3</td>
<td>Cervical, semi-rigid, adjustable molded chin cup (plastic collar with mandibular/occipital piece)</td>
<td>Cerv semi-rig adj molded chn</td>
</tr>
<tr class="odd">
<td>L0160</td>
<td>0010</td>
<td>3</td>
<td>Cervical, semi-rigid, wire frame occipital/mandibular support, prefabricated, off-the-shelf</td>
<td>Cerv sr wire occ/man pre ots</td>
</tr>
<tr class="even">
<td>L0170</td>
<td>0010</td>
<td>3</td>
<td>Cervical, collar, molded to patient model</td>
<td>Cervical collar molded to pt</td>
</tr>
<tr class="odd">
<td>L0172</td>
<td>0010</td>
<td>3</td>
<td>Cervical, collar, semi-rigid thermoplastic foam, two-piece, prefabricated, off-the-shelf</td>
<td>Cerv col sr foam 2pc pre ots</td>
</tr>
<tr class="even">
<td>L0174</td>
<td>0010</td>
<td>3</td>
<td>Cervical, collar, semi-rigid, thermoplastic foam, two piece with thoracic extension, prefabricated, off-the-shelf</td>
<td>Cerv sr 2pc thor ext pre ots</td>
</tr>
<tr class="odd">
<td>L0180</td>
<td>0010</td>
<td>3</td>
<td>Cervical, multiple post collar, occipital/mandibular supports, adjustable</td>
<td>Cer post col occ/man sup adj</td>
</tr>
<tr class="even">
<td>L0190</td>
<td>0010</td>
<td>3</td>
<td>Cervical, multiple post collar, occipital/mandibular supports, adjustable cervical bars (somi, guilford, taylor types)</td>
<td>Cerv collar supp adj cerv ba</td>
</tr>
<tr class="odd">
<td>L0200</td>
<td>0010</td>
<td>3</td>
<td>Cervical, multiple post collar, occipital/mandibular supports, adjustable cervical bars, and thoracic extension</td>
<td>Cerv col supp adj bar &amp; thor</td>
</tr>
<tr class="even">
<td>L0220</td>
<td>0010</td>
<td>3</td>
<td>Thoracic, rib belt, custom fabricated</td>
<td>Thor rib belt custom fabrica</td>
</tr>
<tr class="odd">
<td>L0450</td>
<td>0010</td>
<td>3</td>
<td>Tlso, flexible, provides trunk support, upper thoracic region, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated, off-the-shelf</td>
<td>Tlso flex trunk/thor pre ots</td>
</tr>
<tr class="even">
<td>L0452</td>
<td>0010</td>
<td>3</td>
<td>Tlso, flexible, provides trunk support, upper thoracic region, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, custom fabricated</td>
<td>Tlso flex custom fab thoraci</td>
</tr>
<tr class="odd">
<td>L0454</td>
<td>0010</td>
<td>3</td>
<td>Tlso flexible, provides trunk support, extends from sacrococcygeal junction to above t-9 vertebra, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Tlso trnk sj-t9 pre cst</td>
</tr>
<tr class="even">
<td>L0455</td>
<td>0010</td>
<td>3</td>
<td>Tlso, flexible, provides trunk support, extends from sacrococcygeal junction to above t-9 vertebra, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated, off-the-shelf</td>
<td>Tlso flex trnk sj-t9 pre ots</td>
</tr>
<tr class="odd">
<td>L0456</td>
<td>0010</td>
<td>3</td>
<td>Tlso, flexible, provides trunk support, thoracic region, rigid posterior panel and soft anterior apron, extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks, includes straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Tlso flex trnk sj-ss pre cst</td>
</tr>
<tr class="even">
<td>L0457</td>
<td>0010</td>
<td>3</td>
<td>Tlso, flexible, provides trunk support, thoracic region, rigid posterior panel and soft anterior apron, extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks, includes straps and closures, prefabricated, off-the-shelf</td>
<td>Tlso flex trnk sj-ss pre ots</td>
</tr>
<tr class="odd">
<td>L0458</td>
<td>0010</td>
<td>3</td>
<td>Tlso, triplanar control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment</td>
<td>Tlso 2mod symphis-xipho pre</td>
</tr>
<tr class="even">
<td>L0460</td>
<td>0010</td>
<td>3</td>
<td>Tlso, triplanar control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Tlso 2 shl symphys-stern cst</td>
</tr>
<tr class="odd">
<td>L0462</td>
<td>0010</td>
<td>3</td>
<td>Tlso, triplanar control, modular segmented spinal system, three rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment</td>
<td>Tlso 3mod sacro-scap pre</td>
</tr>
<tr class="even">
<td>L0464</td>
<td>0010</td>
<td>3</td>
<td>Tlso, triplanar control, modular segmented spinal system, four rigid plastic shells, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment</td>
<td>Tlso 4mod sacro-scap pre</td>
</tr>
<tr class="odd">
<td>L0466</td>
<td>0010</td>
<td>3</td>
<td>Tlso, sagittal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, restricts gross trunk motion in sagittal plane, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Tlso r fram soft ant pre cst</td>
</tr>
<tr class="even">
<td>L0467</td>
<td>0010</td>
<td>3</td>
<td>Tlso, sagittal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, restricts gross trunk motion in sagittal plane, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated, off-the-shelf</td>
<td>Tlso r fram soft pre ots</td>
</tr>
<tr class="odd">
<td>L0468</td>
<td>0010</td>
<td>3</td>
<td>Tlso, sagittal-coronal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction over scapulae, lateral strength provided by pelvic, thoracic, and lateral frame pieces, restricts gross trunk motion in sagittal, and coronal planes, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Tlso rig fram pelvic pre cst</td>
</tr>
<tr class="even">
<td>L0469</td>
<td>0010</td>
<td>3</td>
<td>Tlso, sagittal-coronal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction over scapulae, lateral strength provided by pelvic, thoracic, and lateral frame pieces, restricts gross trunk motion in sagittal and coronal planes, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated, off-the-shelf</td>
<td>Tlso rig fram pelvic pre ots</td>
</tr>
<tr class="odd">
<td>L0470</td>
<td>0010</td>
<td>3</td>
<td>Tlso, triplanar control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction to scapula, lateral strength provided by pelvic, thoracic, and lateral frame pieces, rotational strength provided by subclavicular extensions, restricts gross trunk motion in sagittal, coronal, and transverse planes, provides intracavitary pressure to reduce load on the intervertebral disks, includes fitting and shaping the frame, prefabricated, includes fitting and adjustment</td>
<td>Tlso rigid frame pre subclav</td>
</tr>
<tr class="even">
<td>L0472</td>
<td>0010</td>
<td>3</td>
<td>Tlso, triplanar control, hyperextension, rigid anterior and lateral frame extends from symphysis pubis to sternal notch with two anterior components (one pubic and one sternal), posterior and lateral pads with straps and closures, limits spinal flexion, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes fitting and shaping the frame, prefabricated, includes fitting and adjustment</td>
<td>Tlso rigid frame hyperex pre</td>
</tr>
<tr class="odd">
<td>L0480</td>
<td>0010</td>
<td>3</td>
<td>Tlso, triplanar control, one piece rigid plastic shell without interface liner, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated</td>
<td>Tlso rigid plastic custom fa</td>
</tr>
<tr class="even">
<td>L0482</td>
<td>0010</td>
<td>3</td>
<td>Tlso, triplanar control, one piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated</td>
<td>Tlso rigid lined custom fab</td>
</tr>
<tr class="odd">
<td>L0484</td>
<td>0010</td>
<td>3</td>
<td>Tlso, triplanar control, two piece rigid plastic shell without interface liner, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, lateral strength is enhanced by overlapping plastic, restricts gross trunk motion in the sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated</td>
<td>Tlso rigid plastic cust fab</td>
</tr>
<tr class="even">
<td>L0486</td>
<td>0010</td>
<td>3</td>
<td>Tlso, triplanar control, two piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, lateral strength is enhanced by overlapping plastic, restricts gross trunk motion in the sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated</td>
<td>Tlso rigidlined cust fab two</td>
</tr>
<tr class="odd">
<td>L0488</td>
<td>0010</td>
<td>3</td>
<td>Tlso, triplanar control, one piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, prefabricated, includes fitting and adjustment</td>
<td>Tlso rigid lined pre one pie</td>
</tr>
<tr class="even">
<td>L0490</td>
<td>0010</td>
<td>3</td>
<td>Tlso, sagittal-coronal control, one piece rigid plastic shell, with overlapping reinforced anterior, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates at or before the t-9 vertebra, anterior extends from symphysis pubis to xiphoid, anterior opening, restricts gross trunk motion in sagittal and coronal planes, prefabricated, includes fitting and adjustment</td>
<td>Tlso rigid plastic pre one</td>
</tr>
<tr class="odd">
<td>L0491</td>
<td>0010</td>
<td>3</td>
<td>Tlso, sagittal-coronal control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal and coronal planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment</td>
<td>Tlso 2 piece rigid shell</td>
</tr>
<tr class="even">
<td>L0492</td>
<td>0010</td>
<td>3</td>
<td>Tlso, sagittal-coronal control, modular segmented spinal system, three rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal and coronal planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment</td>
<td>Tlso 3 piece rigid shell</td>
</tr>
<tr class="odd">
<td>L0621</td>
<td>0010</td>
<td>3</td>
<td>Sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, prefabricated, off-the-shelf</td>
<td>Sio flex pelvic/sacr pre ots</td>
</tr>
<tr class="even">
<td>L0622</td>
<td>0010</td>
<td>3</td>
<td>Sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, custom fabricated</td>
<td>Sio flex pelvisacral custom</td>
</tr>
<tr class="odd">
<td>L0623</td>
<td>0010</td>
<td>3</td>
<td>Sacroiliac orthosis, provides pelvic-sacral support, with rigid or semi-rigid panels over the sacrum and abdomen, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, prefabricated, off-the-shelf</td>
<td>Sio rig pnl pelv/sac pre ots</td>
</tr>
<tr class="even">
<td>L0624</td>
<td>0010</td>
<td>3</td>
<td>Sacroiliac orthosis, provides pelvic-sacral support, with rigid or semi-rigid panels placed over the sacrum and abdomen, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, custom fabricated</td>
<td>Sio panel custom</td>
</tr>
<tr class="odd">
<td>L0625</td>
<td>0010</td>
<td>3</td>
<td>Lumbar orthosis, flexible, provides lumbar support, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include pendulous abdomen design, shoulder straps, stays, prefabricated, off-the-shelf</td>
<td>Lo flex l1-below l5 pre ots</td>
</tr>
<tr class="even">
<td>L0626</td>
<td>0010</td>
<td>3</td>
<td>Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Lo sag rig pnl stays pre cst</td>
</tr>
<tr class="odd">
<td>L0627</td>
<td>0010</td>
<td>3</td>
<td>Lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Lo sag ri an/pos pnl pre cst</td>
</tr>
<tr class="even">
<td>L0628</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf</td>
<td>Lso flex no ri stays pre ots</td>
</tr>
<tr class="odd">
<td>L0629</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include stays, shoulder straps, pendulous abdomen design, custom fabricated</td>
<td>Lso flex w/rigid stays cust</td>
</tr>
<tr class="even">
<td>L0630</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Lso r post pnl sj-t9 pre cst</td>
</tr>
<tr class="odd">
<td>L0631</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Lso sag r an/pos pnl pre cst</td>
</tr>
<tr class="even">
<td>L0632</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, custom fabricated</td>
<td>Lso sag rigid frame cust</td>
</tr>
<tr class="odd">
<td>L0633</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Lso sc r pos/lat pnl pre cst</td>
</tr>
<tr class="even">
<td>L0634</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, custom fabricated</td>
<td>Lso flexion control custom</td>
</tr>
<tr class="odd">
<td>L0635</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal-coronal control, lumbar flexion, rigid posterior frame/panel(s), lateral articulating design to flex the lumbar spine, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, anterior panel, pendulous abdomen design, prefabricated, includes fitting and adjustment</td>
<td>Lso sagit rigid panel prefab</td>
</tr>
<tr class="even">
<td>L0636</td>
<td>0010</td>
<td>3</td>
<td>Lumbar sacral orthosis, sagittal-coronal control, lumbar flexion, rigid posterior frame/panels, lateral articulating design to flex the lumbar spine, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, anterior panel, pendulous abdomen design, custom fabricated</td>
<td>Lso sagittal rigid panel cus</td>
</tr>
<tr class="odd">
<td>L0637</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Lso sc r ant/pos pnl pre cst</td>
</tr>
<tr class="even">
<td>L0638</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, custom fabricated</td>
<td>Lso sag-coronal panel custom</td>
</tr>
<tr class="odd">
<td>L0639</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Lso s/c shell/panel prefab</td>
</tr>
<tr class="even">
<td>L0640</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, custom fabricated</td>
<td>Lso s/c shell/panel custom</td>
</tr>
<tr class="odd">
<td>L0641</td>
<td>0010</td>
<td>3</td>
<td>Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf</td>
<td>Lo rig pos pnl l1-l5 pre ots</td>
</tr>
<tr class="even">
<td>L0642</td>
<td>0010</td>
<td>3</td>
<td>Lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf</td>
<td>Lo sag ri an/pos pnl pre ots</td>
</tr>
<tr class="odd">
<td>L0643</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf</td>
<td>Lso sag ctr rigi pos pre ots</td>
</tr>
<tr class="even">
<td>L0648</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf</td>
<td>Lso sag r an/pos pnl pre ots</td>
</tr>
<tr class="odd">
<td>L0649</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf</td>
<td>Lso sc r pos/lat pnl pre ots</td>
</tr>
<tr class="even">
<td>L0650</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf</td>
<td>Lso sc r ant/pos pnl pre ots</td>
</tr>
<tr class="odd">
<td>L0651</td>
<td>0010</td>
<td>3</td>
<td>Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated, off-the-shelf</td>
<td>Lso sag-co shell pnl pre ots</td>
</tr>
<tr class="even">
<td>L0700</td>
<td>0010</td>
<td>3</td>
<td>Cervical-thoracic-lumbar-sacral-orthoses (ctlso), anterior-posterior-lateral control, molded to patient model, (minerva type)</td>
<td>Ctlso a-p-l control molded</td>
</tr>
<tr class="odd">
<td>L0710</td>
<td>0010</td>
<td>3</td>
<td>Ctlso, anterior-posterior-lateral-control, molded to patient model, with interface material, (minerva type)</td>
<td>Ctlso a-p-l control w/ inter</td>
</tr>
<tr class="even">
<td>L0810</td>
<td>0010</td>
<td>3</td>
<td>Halo procedure, cervical halo incorporated into jacket vest</td>
<td>Halo cervical into jckt vest</td>
</tr>
<tr class="odd">
<td>L0820</td>
<td>0010</td>
<td>3</td>
<td>Halo procedure, cervical halo incorporated into plaster body jacket</td>
<td>Halo cervical into body jack</td>
</tr>
<tr class="even">
<td>L0830</td>
<td>0010</td>
<td>3</td>
<td>Halo procedure, cervical halo incorporated into milwaukee type orthosis</td>
<td>Halo cerv into milwaukee typ</td>
</tr>
<tr class="odd">
<td>L0859</td>
<td>0010</td>
<td>3</td>
<td>Addition to halo procedure, magnetic resonance image compatible systems, rings and pins, any material</td>
<td>Mri compatible system</td>
</tr>
<tr class="even">
<td>L0861</td>
<td>0010</td>
<td>3</td>
<td>Addition to halo procedure, replacement liner/interface material</td>
<td>Halo repl liner/interface</td>
</tr>
<tr class="odd">
<td>L0970</td>
<td>0010</td>
<td>3</td>
<td>Tlso, corset front</td>
<td>Tlso corset front</td>
</tr>
<tr class="even">
<td>L0972</td>
<td>0010</td>
<td>3</td>
<td>Lso, corset front</td>
<td>Lso corset front</td>
</tr>
<tr class="odd">
<td>L0974</td>
<td>0010</td>
<td>3</td>
<td>Tlso, full corset</td>
<td>Tlso full corset</td>
</tr>
<tr class="even">
<td>L0976</td>
<td>0010</td>
<td>3</td>
<td>Lso, full corset</td>
<td>Lso full corset</td>
</tr>
<tr class="odd">
<td>L0978</td>
<td>0010</td>
<td>3</td>
<td>Axillary crutch extension</td>
<td>Axillary crutch extension</td>
</tr>
<tr class="even">
<td>L0980</td>
<td>0010</td>
<td>3</td>
<td>Peroneal straps, prefabricated, off-the-shelf, pair</td>
<td>Peroneal straps pair pre ots</td>
</tr>
<tr class="odd">
<td>L0982</td>
<td>0010</td>
<td>3</td>
<td>Stocking supporter grips, prefabricated, off-the-shelf, set of four (4)</td>
<td>Stocking sup grips 4 pre ots</td>
</tr>
<tr class="even">
<td>L0984</td>
<td>0010</td>
<td>3</td>
<td>Protective body sock, prefabricated, off-the-shelf, each</td>
<td>Protect body sock ea pre ots</td>
</tr>
<tr class="odd">
<td>L0999</td>
<td>0010</td>
<td>3</td>
<td>Addition to spinal orthosis, not otherwise specified</td>
<td>Add to spinal orthosis nos</td>
</tr>
<tr class="even">
<td>L1000</td>
<td>0010</td>
<td>3</td>
<td>Cervical-thoracic-lumbar-sacral orthosis (ctlso) (milwaukee), inclusive of furnishing initial orthosis, including model</td>
<td>Ctlso milwauke initial model</td>
</tr>
<tr class="odd">
<td>L1001</td>
<td>0010</td>
<td>3</td>
<td>Cervical thoracic lumbar sacral orthosis, immobilizer, infant size, prefabricated, includes fitting and adjustment</td>
<td>Ctlso infant immobilizer</td>
</tr>
<tr class="even">
<td>L1005</td>
<td>0010</td>
<td>3</td>
<td>Tension based scoliosis orthosis and accessory pads, includes fitting and adjustment</td>
<td>Tension based scoliosis orth</td>
</tr>
<tr class="odd">
<td>L1010</td>
<td>0010</td>
<td>3</td>
<td>Addition to cervical-thoracic-lumbar-sacral orthosis (ctlso) or scoliosis orthosis, axilla sling</td>
<td>Ctlso axilla sling</td>
</tr>
<tr class="even">
<td>L1020</td>
<td>0010</td>
<td>3</td>
<td>Addition to ctlso or scoliosis orthosis, kyphosis pad</td>
<td>Kyphosis pad</td>
</tr>
<tr class="odd">
<td>L1025</td>
<td>0010</td>
<td>3</td>
<td>Addition to ctlso or scoliosis orthosis, kyphosis pad, floating</td>
<td>Kyphosis pad floating</td>
</tr>
<tr class="even">
<td>L1030</td>
<td>0010</td>
<td>3</td>
<td>Addition to ctlso or scoliosis orthosis, lumbar bolster pad</td>
<td>Lumbar bolster pad</td>
</tr>
<tr class="odd">
<td>L1040</td>
<td>0010</td>
<td>3</td>
<td>Addition to ctlso or scoliosis orthosis, lumbar or lumbar rib pad</td>
<td>Lumbar or lumbar rib pad</td>
</tr>
<tr class="even">
<td>L1050</td>
<td>0010</td>
<td>3</td>
<td>Addition to ctlso or scoliosis orthosis, sternal pad</td>
<td>Sternal pad</td>
</tr>
<tr class="odd">
<td>L1060</td>
<td>0010</td>
<td>3</td>
<td>Addition to ctlso or scoliosis orthosis, thoracic pad</td>
<td>Thoracic pad</td>
</tr>
<tr class="even">
<td>L1070</td>
<td>0010</td>
<td>3</td>
<td>Addition to ctlso or scoliosis orthosis, trapezius sling</td>
<td>Trapezius sling</td>
</tr>
<tr class="odd">
<td>L1080</td>
<td>0010</td>
<td>3</td>
<td>Addition to ctlso or scoliosis orthosis, outrigger</td>
<td>Outrigger</td>
</tr>
<tr class="even">
<td>L1085</td>
<td>0010</td>
<td>3</td>
<td>Addition to ctlso or scoliosis orthosis, outrigger, bilateral with vertical extensions</td>
<td>Outrigger bil w/ vert extens</td>
</tr>
<tr class="odd">
<td>L1090</td>
<td>0010</td>
<td>3</td>
<td>Addition to ctlso or scoliosis orthosis, lumbar sling</td>
<td>Lumbar sling</td>
</tr>
<tr class="even">
<td>L1100</td>
<td>0010</td>
<td>3</td>
<td>Addition to ctlso or scoliosis orthosis, ring flange, plastic or leather</td>
<td>Ring flange plastic/leather</td>
</tr>
<tr class="odd">
<td>L1110</td>
<td>0010</td>
<td>3</td>
<td>Addition to ctlso or scoliosis orthosis, ring flange, plastic or leather, molded to patient model</td>
<td>Ring flange plas/leather mol</td>
</tr>
<tr class="even">
<td>L1120</td>
<td>0010</td>
<td>3</td>
<td>Addition to ctlso, scoliosis orthosis, cover for upright, each</td>
<td>Covers for upright each</td>
</tr>
<tr class="odd">
<td>L1200</td>
<td>0010</td>
<td>3</td>
<td>Thoracic-lumbar-sacral-orthosis (tlso), inclusive of furnishing initial orthosis only</td>
<td>Furnsh initial orthosis only</td>
</tr>
<tr class="even">
<td>L1210</td>
<td>0010</td>
<td>3</td>
<td>Addition to tlso, (low profile), lateral thoracic extension</td>
<td>Lateral thoracic extension</td>
</tr>
<tr class="odd">
<td>L1220</td>
<td>0010</td>
<td>3</td>
<td>Addition to tlso, (low profile), anterior thoracic extension</td>
<td>Anterior thoracic extension</td>
</tr>
<tr class="even">
<td>L1230</td>
<td>0010</td>
<td>3</td>
<td>Addition to tlso, (low profile), milwaukee type superstructure</td>
<td>Milwaukee type superstructur</td>
</tr>
<tr class="odd">
<td>L1240</td>
<td>0010</td>
<td>3</td>
<td>Addition to tlso, (low profile), lumbar derotation pad</td>
<td>Lumbar derotation pad</td>
</tr>
<tr class="even">
<td>L1250</td>
<td>0010</td>
<td>3</td>
<td>Addition to tlso, (low profile), anterior asis pad</td>
<td>Anterior asis pad</td>
</tr>
<tr class="odd">
<td>L1260</td>
<td>0010</td>
<td>3</td>
<td>Addition to tlso, (low profile), anterior thoracic derotation pad</td>
<td>Anterior thoracic derotation</td>
</tr>
<tr class="even">
<td>L1270</td>
<td>0010</td>
<td>3</td>
<td>Addition to tlso, (low profile), abdominal pad</td>
<td>Abdominal pad</td>
</tr>
<tr class="odd">
<td>L1280</td>
<td>0010</td>
<td>3</td>
<td>Addition to tlso, (low profile), rib gusset (elastic), each</td>
<td>Rib gusset (elastic) each</td>
</tr>
<tr class="even">
<td>L1290</td>
<td>0010</td>
<td>3</td>
<td>Addition to tlso, (low profile), lateral trochanteric pad</td>
<td>Lateral trochanteric pad</td>
</tr>
<tr class="odd">
<td>L1300</td>
<td>0010</td>
<td>3</td>
<td>Other scoliosis procedure, body jacket molded to patient model</td>
<td>Body jacket mold to patient</td>
</tr>
<tr class="even">
<td>L1310</td>
<td>0010</td>
<td>3</td>
<td>Other scoliosis procedure, post-operative body jacket</td>
<td>Post-operative body jacket</td>
</tr>
<tr class="odd">
<td>L1499</td>
<td>0010</td>
<td>3</td>
<td>Spinal orthosis, not otherwise specified</td>
<td>Spinal orthosis nos</td>
</tr>
<tr class="even">
<td>L1600</td>
<td>0010</td>
<td>3</td>
<td>Hip orthosis, abduction control of hip joints, flexible, frejka type with cover, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an inidividual with expertise</td>
<td>Ho flex frejka w/cov pre cst</td>
</tr>
<tr class="odd">
<td>L1610</td>
<td>0010</td>
<td>3</td>
<td>Hip orthosis, abduction control of hip joints, flexible, (frejka cover only), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Ho frejka cov only pre cst</td>
</tr>
<tr class="even">
<td>L1620</td>
<td>0010</td>
<td>3</td>
<td>Hip orthosis, abduction control of hip joints, flexible, (pavlik harness), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Ho flex pavlik harns pre cst</td>
</tr>
<tr class="odd">
<td>L1630</td>
<td>0010</td>
<td>3</td>
<td>Hip orthosis, abduction control of hip joints, semi-flexible (von rosen type), custom fabricated</td>
<td>Abduct control hip semi-flex</td>
</tr>
<tr class="even">
<td>L1640</td>
<td>0010</td>
<td>3</td>
<td>Hip orthosis, abduction control of hip joints, static, pelvic band or spreader bar, thigh cuffs, custom fabricated</td>
<td>Pelv band/spread bar thigh c</td>
</tr>
<tr class="odd">
<td>L1650</td>
<td>0010</td>
<td>3</td>
<td>Hip orthosis, abduction control of hip joints, static, adjustable, (ilfled type), prefabricated, includes fitting and adjustment</td>
<td>Ho abduction hip adjustable</td>
</tr>
<tr class="even">
<td>L1652</td>
<td>0010</td>
<td>3</td>
<td>Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, includes fitting and adjustment, any type</td>
<td>Ho bi thighcuffs w sprdr bar</td>
</tr>
<tr class="odd">
<td>L1660</td>
<td>0010</td>
<td>3</td>
<td>Hip orthosis, abduction control of hip joints, static, plastic, prefabricated, includes fitting and adjustment</td>
<td>Ho abduction static plastic</td>
</tr>
<tr class="even">
<td>L1680</td>
<td>0010</td>
<td>3</td>
<td>Hip orthosis, abduction control of hip joints, dynamic, pelvic control, adjustable hip motion control, thigh cuffs (rancho hip action type), custom fabricated</td>
<td>Pelvic &amp; hip control thigh c</td>
</tr>
<tr class="odd">
<td>L1685</td>
<td>0010</td>
<td>3</td>
<td>Hip orthosis, abduction control of hip joint, postoperative hip abduction type, custom fabricated</td>
<td>Post-op hip abduct custom fa</td>
</tr>
<tr class="even">
<td>L1686</td>
<td>0010</td>
<td>3</td>
<td>Hip orthosis, abduction control of hip joint, postoperative hip abduction type, prefabricated, includes fitting and adjustment</td>
<td>Ho post-op hip abduction</td>
</tr>
<tr class="odd">
<td>L1690</td>
<td>0010</td>
<td>3</td>
<td>Combination, bilateral, lumbo-sacral, hip, femur orthosis providing adduction and internal rotation control, prefabricated, includes fitting and adjustment</td>
<td>Combination bilateral ho</td>
</tr>
<tr class="even">
<td>L1700</td>
<td>0010</td>
<td>3</td>
<td>Legg perthes orthosis, (toronto type), custom fabricated</td>
<td>Leg perthes orth toronto typ</td>
</tr>
<tr class="odd">
<td>L1710</td>
<td>0010</td>
<td>3</td>
<td>Legg perthes orthosis, (newington type), custom fabricated</td>
<td>Legg perthes orth newington</td>
</tr>
<tr class="even">
<td>L1720</td>
<td>0010</td>
<td>3</td>
<td>Legg perthes orthosis, trilateral, (tachdijan type), custom fabricated</td>
<td>Legg perthes orthosis trilat</td>
</tr>
<tr class="odd">
<td>L1730</td>
<td>0010</td>
<td>3</td>
<td>Legg perthes orthosis, (scottish rite type), custom fabricated</td>
<td>Legg perthes orth scottish r</td>
</tr>
<tr class="even">
<td>L1755</td>
<td>0010</td>
<td>3</td>
<td>Legg perthes orthosis, (patten bottom type), custom fabricated</td>
<td>Legg perthes patten bottom t</td>
</tr>
<tr class="odd">
<td>L1810</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, elastic with joints, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Ko elastic with joints</td>
</tr>
<tr class="even">
<td>L1812</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, elastic with joints, prefabricated, off-the-shelf</td>
<td>Ko elastic w/joints pre ots</td>
</tr>
<tr class="odd">
<td>L1820</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated, includes fitting and adjustment</td>
<td>Ko elas w/ condyle pads &amp; jo</td>
</tr>
<tr class="even">
<td>L1830</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf</td>
<td>Ko immob canvas long pre ots</td>
</tr>
<tr class="odd">
<td>L1831</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, locking knee joint(s), positional orthosis, prefabricated, includes fitting and adjustment</td>
<td>Knee orth pos locking joint</td>
</tr>
<tr class="even">
<td>L1832</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Ko adj jnt pos r sup pre cst</td>
</tr>
<tr class="odd">
<td>L1833</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated, off-the shelf</td>
<td>Ko adj jnt pos r sup pre ots</td>
</tr>
<tr class="even">
<td>L1834</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, without knee joint, rigid, custom fabricated</td>
<td>Ko w/0 joint rigid molded to</td>
</tr>
<tr class="odd">
<td>L1836</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, rigid, without joint(s), includes soft interface material, prefabricated, off-the-shelf</td>
<td>Ko rigid w/o joints pre ots</td>
</tr>
<tr class="even">
<td>L1840</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, derotation, medial-lateral, anterior cruciate ligament, custom fabricated</td>
<td>Ko derot ant cruciate custom</td>
</tr>
<tr class="odd">
<td>L1843</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Ko single upright pre cst</td>
</tr>
<tr class="even">
<td>L1844</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated</td>
<td>Ko w/adj jt rot cntrl molded</td>
</tr>
<tr class="odd">
<td>L1845</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Ko double upright pre cst</td>
</tr>
<tr class="even">
<td>L1846</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated</td>
<td>Ko w adj flex/ext rotat mold</td>
</tr>
<tr class="odd">
<td>L1847</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Ko dbl upright w/air pre cst</td>
</tr>
<tr class="even">
<td>L1848</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated, off-the-shelf</td>
<td>Ko dbl upright w/air pre ots</td>
</tr>
<tr class="odd">
<td>L1850</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, swedish type, prefabricated, off-the-shelf</td>
<td>Ko swedish type pre ots</td>
</tr>
<tr class="even">
<td>L1851</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf</td>
<td>Ko single upright prefab ots</td>
</tr>
<tr class="odd">
<td>L1852</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf</td>
<td>Ko double upright prefab ots</td>
</tr>
<tr class="even">
<td>L1860</td>
<td>0010</td>
<td>3</td>
<td>Knee orthosis, modification of supracondylar prosthetic socket, custom fabricated (sk)</td>
<td>Ko supracondylar socket mold</td>
</tr>
<tr class="odd">
<td>L1900</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, spring wire, dorsiflexion assist calf band, custom fabricated</td>
<td>Afo sprng wir drsflx calf bd</td>
</tr>
<tr class="even">
<td>L1902</td>
<td>0010</td>
<td>3</td>
<td>Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf</td>
<td>Afo ankle gauntlet pre ots</td>
</tr>
<tr class="odd">
<td>L1904</td>
<td>0010</td>
<td>3</td>
<td>Ankle orthosis, ankle gauntlet or similar, with or without joints, custom fabricated</td>
<td>Afo molded ankle gauntlet</td>
</tr>
<tr class="even">
<td>L1906</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, multiligamentous ankle support, prefabricated, off-the-shelf</td>
<td>Afo multilig ank sup pre ots</td>
</tr>
<tr class="odd">
<td>L1907</td>
<td>0010</td>
<td>3</td>
<td>Ankle orthosis, supramalleolar with straps, with or without interface/pads, custom fabricated</td>
<td>Afo supramalleolar custom</td>
</tr>
<tr class="even">
<td>L1910</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, posterior, single bar, clasp attachment to shoe counter, prefabricated, includes fitting and adjustment</td>
<td>Afo sing bar clasp attach sh</td>
</tr>
<tr class="odd">
<td>L1920</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, single upright with static or adjustable stop (phelps or perlstein type), custom fabricated</td>
<td>Afo sing upright w/ adjust s</td>
</tr>
<tr class="even">
<td>L1930</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, plastic or other material, prefabricated, includes fitting and adjustment</td>
<td>Afo plastic</td>
</tr>
<tr class="odd">
<td>L1932</td>
<td>0010</td>
<td>3</td>
<td>Afo, rigid anterior tibial section, total carbon fiber or equal material, prefabricated, includes fitting and adjustment</td>
<td>Afo rig ant tib prefab tcf/=</td>
</tr>
<tr class="even">
<td>L1940</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, plastic or other material, custom fabricated</td>
<td>Afo molded to patient plasti</td>
</tr>
<tr class="odd">
<td>L1945</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, plastic, rigid anterior tibial section (floor reaction), custom fabricated</td>
<td>Afo molded plas rig ant tib</td>
</tr>
<tr class="even">
<td>L1950</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic, custom fabricated</td>
<td>Afo spiral molded to pt plas</td>
</tr>
<tr class="odd">
<td>L1951</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic or other material, prefabricated, includes fitting and adjustment</td>
<td>Afo spiral prefabricated</td>
</tr>
<tr class="even">
<td>L1960</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, posterior solid ankle, plastic, custom fabricated</td>
<td>Afo pos solid ank plastic mo</td>
</tr>
<tr class="odd">
<td>L1970</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, plastic with ankle joint, custom fabricated</td>
<td>Afo plastic molded w/ankle j</td>
</tr>
<tr class="even">
<td>L1971</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, plastic or other material with ankle joint, prefabricated, includes fitting and adjustment</td>
<td>Afo w/ankle joint, prefab</td>
</tr>
<tr class="odd">
<td>L1980</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, single upright free plantar dorsiflexion, solid stirrup, calf band/cuff (single bar ‘bk’ orthosis), custom fabricated</td>
<td>Afo sing solid stirrup calf</td>
</tr>
<tr class="even">
<td>L1990</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, double upright free plantar dorsiflexion, solid stirrup, calf band/cuff (double bar ‘bk’ orthosis), custom fabricated</td>
<td>Afo doub solid stirrup calf</td>
</tr>
<tr class="odd">
<td>L2000</td>
<td>0010</td>
<td>3</td>
<td>Knee ankle foot orthosis, single upright, free knee, free ankle, solid stirrup, thigh and calf bands/cuffs (single bar ‘ak’ orthosis), custom fabricated</td>
<td>Kafo sing fre stirr thi/calf</td>
</tr>
<tr class="even">
<td>L2005</td>
<td>0010</td>
<td>3</td>
<td>Knee ankle foot orthosis, any material, single or double upright, stance control, automatic lock and swing phase release, any type activation, includes ankle joint, any type, custom fabricated</td>
<td>Kafo sng/dbl mechanical act</td>
</tr>
<tr class="odd">
<td>L2006</td>
<td>0010</td>
<td>3</td>
<td>Knee ankle foot device, any material, single or double upright, swing and/or stance phase microprocessor control with adjustability, includes all components (e.g., sensors, batteries, charger), any type activation, with or without ankle joint(s), custom fabricated</td>
<td>Kaf sng/dbl swg/stn mcpr cus</td>
</tr>
<tr class="even">
<td>L2010</td>
<td>0010</td>
<td>3</td>
<td>Knee ankle foot orthosis, single upright, free ankle, solid stirrup, thigh and calf bands/cuffs (single bar ‘ak’ orthosis), without knee joint, custom fabricated</td>
<td>Kafo sng solid stirrup w/o j</td>
</tr>
<tr class="odd">
<td>L2020</td>
<td>0010</td>
<td>3</td>
<td>Knee ankle foot orthosis, double upright, free ankle, solid stirrup, thigh and calf bands/cuffs (double bar ‘ak’ orthosis), custom fabricated</td>
<td>Kafo dbl solid stirrup band/</td>
</tr>
<tr class="even">
<td>L2030</td>
<td>0010</td>
<td>3</td>
<td>Knee ankle foot orthosis, double upright, free ankle, solid stirrup, thigh and calf bands/cuffs, (double bar ‘ak’ orthosis), without knee joint, custom fabricated</td>
<td>Kafo dbl solid stirrup w/o j</td>
</tr>
<tr class="odd">
<td>L2034</td>
<td>0010</td>
<td>3</td>
<td>Knee ankle foot orthosis, full plastic, single upright, with or without free motion knee, medial lateral rotation control, with or without free motion ankle, custom fabricated</td>
<td>Kafo pla sin up w/wo k/a cus</td>
</tr>
<tr class="even">
<td>L2035</td>
<td>0010</td>
<td>3</td>
<td>Knee ankle foot orthosis, full plastic, static (pediatric size), without free motion ankle, prefabricated, includes fitting and adjustment</td>
<td>Kafo plastic pediatric size</td>
</tr>
<tr class="odd">
<td>L2036</td>
<td>0010</td>
<td>3</td>
<td>Knee ankle foot orthosis, full plastic, double upright, with or without free motion knee, with or without free motion ankle, custom fabricated</td>
<td>Kafo plas doub free knee mol</td>
</tr>
<tr class="even">
<td>L2037</td>
<td>0010</td>
<td>3</td>
<td>Knee ankle foot orthosis, full plastic, single upright, with or without free motion knee, with or without free motion ankle, custom fabricated</td>
<td>Kafo plas sing free knee mol</td>
</tr>
<tr class="odd">
<td>L2038</td>
<td>0010</td>
<td>3</td>
<td>Knee ankle foot orthosis, full plastic, with or without free motion knee, multi-axis ankle, custom fabricated</td>
<td>Kafo w/o joint multi-axis an</td>
</tr>
<tr class="even">
<td>L2040</td>
<td>0010</td>
<td>3</td>
<td>Hip knee ankle foot orthosis, torsion control, bilateral rotation straps, pelvic band/belt, custom fabricated</td>
<td>Hkafo torsion bil rot straps</td>
</tr>
<tr class="odd">
<td>L2050</td>
<td>0010</td>
<td>3</td>
<td>Hip knee ankle foot orthosis, torsion control, bilateral torsion cables, hip joint, pelvic band/belt, custom fabricated</td>
<td>Hkafo torsion cable hip pelv</td>
</tr>
<tr class="even">
<td>L2060</td>
<td>0010</td>
<td>3</td>
<td>Hip knee ankle foot orthosis, torsion control, bilateral torsion cables, ball bearing hip joint, pelvic band/ belt, custom fabricated</td>
<td>Hkafo torsion ball bearing j</td>
</tr>
<tr class="odd">
<td>L2070</td>
<td>0010</td>
<td>3</td>
<td>Hip knee ankle foot orthosis, torsion control, unilateral rotation straps, pelvic band/belt, custom fabricated</td>
<td>Hkafo torsion unilat rot str</td>
</tr>
<tr class="even">
<td>L2080</td>
<td>0010</td>
<td>3</td>
<td>Hip knee ankle foot orthosis, torsion control, unilateral torsion cable, hip joint, pelvic band/belt, custom fabricated</td>
<td>Hkafo unilat torsion cable</td>
</tr>
<tr class="odd">
<td>L2090</td>
<td>0010</td>
<td>3</td>
<td>Hip knee ankle foot orthosis, torsion control, unilateral torsion cable, ball bearing hip joint, pelvic band/ belt, custom fabricated</td>
<td>Hkafo unilat torsion ball br</td>
</tr>
<tr class="even">
<td>L2106</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, fracture orthosis, tibial fracture cast orthosis, thermoplastic type casting material, custom fabricated</td>
<td>Afo tib fx cast plaster mold</td>
</tr>
<tr class="odd">
<td>L2108</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, fracture orthosis, tibial fracture cast orthosis, custom fabricated</td>
<td>Afo tib fx cast molded to pt</td>
</tr>
<tr class="even">
<td>L2112</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, soft, prefabricated, includes fitting and adjustment</td>
<td>Afo tibial fracture soft</td>
</tr>
<tr class="odd">
<td>L2114</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, semi-rigid, prefabricated, includes fitting and adjustment</td>
<td>Afo tib fx semi-rigid</td>
</tr>
<tr class="even">
<td>L2116</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, rigid, prefabricated, includes fitting and adjustment</td>
<td>Afo tibial fracture rigid</td>
</tr>
<tr class="odd">
<td>L2126</td>
<td>0010</td>
<td>3</td>
<td>Knee ankle foot orthosis, fracture orthosis, femoral fracture cast orthosis, thermoplastic type casting material, custom fabricated</td>
<td>Kafo fem fx cast thermoplas</td>
</tr>
<tr class="even">
<td>L2128</td>
<td>0010</td>
<td>3</td>
<td>Knee ankle foot orthosis, fracture orthosis, femoral fracture cast orthosis, custom fabricated</td>
<td>Kafo fem fx cast molded to p</td>
</tr>
<tr class="odd">
<td>L2132</td>
<td>0010</td>
<td>3</td>
<td>Kafo, fracture orthosis, femoral fracture cast orthosis, soft, prefabricated, includes fitting and adjustment</td>
<td>Kafo femoral fx cast soft</td>
</tr>
<tr class="even">
<td>L2134</td>
<td>0010</td>
<td>3</td>
<td>Kafo, fracture orthosis, femoral fracture cast orthosis, semi-rigid, prefabricated, includes fitting and adjustment</td>
<td>Kafo fem fx cast semi-rigid</td>
</tr>
<tr class="odd">
<td>L2136</td>
<td>0010</td>
<td>3</td>
<td>Kafo, fracture orthosis, femoral fracture cast orthosis, rigid, prefabricated, includes fitting and adjustment</td>
<td>Kafo femoral fx cast rigid</td>
</tr>
<tr class="even">
<td>L2180</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity fracture orthosis, plastic shoe insert with ankle joints</td>
<td>Plas shoe insert w ank joint</td>
</tr>
<tr class="odd">
<td>L2182</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity fracture orthosis, drop lock knee joint</td>
<td>Drop lock knee</td>
</tr>
<tr class="even">
<td>L2184</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity fracture orthosis, limited motion knee joint</td>
<td>Limited motion knee joint</td>
</tr>
<tr class="odd">
<td>L2186</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity fracture orthosis, adjustable motion knee joint, lerman type</td>
<td>Adj motion knee jnt lerman t</td>
</tr>
<tr class="even">
<td>L2188</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity fracture orthosis, quadrilateral brim</td>
<td>Quadrilateral brim</td>
</tr>
<tr class="odd">
<td>L2190</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity fracture orthosis, waist belt</td>
<td>Waist belt</td>
</tr>
<tr class="even">
<td>L2192</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity fracture orthosis, hip joint, pelvic band, thigh flange, and pelvic belt</td>
<td>Pelvic band &amp; belt thigh fla</td>
</tr>
<tr class="odd">
<td>L2200</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, limited ankle motion, each joint</td>
<td>Limited ankle motion ea jnt</td>
</tr>
<tr class="even">
<td>L2210</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, dorsiflexion assist (plantar flexion resist), each joint</td>
<td>Dorsiflexion assist each joi</td>
</tr>
<tr class="odd">
<td>L2220</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, dorsiflexion and plantar flexion assist/resist, each joint</td>
<td>Dorsi &amp; plantar flex ass/res</td>
</tr>
<tr class="even">
<td>L2230</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, split flat caliper stirrups and plate attachment</td>
<td>Split flat caliper stirr &amp; p</td>
</tr>
<tr class="odd">
<td>L2232</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, rocker bottom for total contact ankle foot orthosis, for custom fabricated orthosis only</td>
<td>Rocker bottom, contact afo</td>
</tr>
<tr class="even">
<td>L2240</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, round caliper and plate attachment</td>
<td>Round caliper and plate atta</td>
</tr>
<tr class="odd">
<td>L2250</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, foot plate, molded to patient model, stirrup attachment</td>
<td>Foot plate molded stirrup at</td>
</tr>
<tr class="even">
<td>L2260</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, reinforced solid stirrup (scott-craig type)</td>
<td>Reinforced solid stirrup</td>
</tr>
<tr class="odd">
<td>L2265</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, long tongue stirrup</td>
<td>Long tongue stirrup</td>
</tr>
<tr class="even">
<td>L2270</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, varus/valgus correction (‘t’) strap, padded/lined or malleolus pad</td>
<td>Varus/valgus strap padded/li</td>
</tr>
<tr class="odd">
<td>L2275</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, varus/valgus correction, plastic modification, padded/lined</td>
<td>Plastic mod low ext pad/line</td>
</tr>
<tr class="even">
<td>L2280</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, molded inner boot</td>
<td>Molded inner boot</td>
</tr>
<tr class="odd">
<td>L2300</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, abduction bar (bilateral hip involvement), jointed, adjustable</td>
<td>Abduction bar jointed adjust</td>
</tr>
<tr class="even">
<td>L2310</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, abduction bar-straight</td>
<td>Abduction bar-straight</td>
</tr>
<tr class="odd">
<td>L2320</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, non-molded lacer, for custom fabricated orthosis only</td>
<td>Non-molded lacer</td>
</tr>
<tr class="even">
<td>L2330</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, lacer molded to patient model, for custom fabricated orthosis only</td>
<td>Lacer molded to patient mode</td>
</tr>
<tr class="odd">
<td>L2335</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, anterior swing band</td>
<td>Anterior swing band</td>
</tr>
<tr class="even">
<td>L2340</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, pre-tibial shell, molded to patient model</td>
<td>Pre-tibial shell molded to p</td>
</tr>
<tr class="odd">
<td>L2350</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, prosthetic type, (bk) socket, molded to patient model, (used for ‘ptb’ ‘afo’ orthoses)</td>
<td>Prosthetic type socket molde</td>
</tr>
<tr class="even">
<td>L2360</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, extended steel shank</td>
<td>Extended steel shank</td>
</tr>
<tr class="odd">
<td>L2370</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, patten bottom</td>
<td>Patten bottom</td>
</tr>
<tr class="even">
<td>L2375</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, torsion control, ankle joint and half solid stirrup</td>
<td>Torsion ank &amp; half solid sti</td>
</tr>
<tr class="odd">
<td>L2380</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, torsion control, straight knee joint, each joint</td>
<td>Torsion straight knee joint</td>
</tr>
<tr class="even">
<td>L2385</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, straight knee joint, heavy duty, each joint</td>
<td>Straight knee joint heavy du</td>
</tr>
<tr class="odd">
<td>L2387</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, polycentric knee joint, for custom fabricated knee ankle foot orthosis, each joint</td>
<td>Add le poly knee custom kafo</td>
</tr>
<tr class="even">
<td>L2390</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, offset knee joint, each joint</td>
<td>Offset knee joint each</td>
</tr>
<tr class="odd">
<td>L2395</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, offset knee joint, heavy duty, each joint</td>
<td>Offset knee joint heavy duty</td>
</tr>
<tr class="even">
<td>L2397</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, suspension sleeve</td>
<td>Suspension sleeve lower ext</td>
</tr>
<tr class="odd">
<td>L2405</td>
<td>0010</td>
<td>3</td>
<td>Addition to knee joint, drop lock, each</td>
<td>Knee joint drop lock ea jnt</td>
</tr>
<tr class="even">
<td>L2415</td>
<td>0010</td>
<td>3</td>
<td>Addition to knee lock with integrated release mechanism (bail, cable, or equal), any material, each joint</td>
<td>Knee joint cam lock each joi</td>
</tr>
<tr class="odd">
<td>L2425</td>
<td>0010</td>
<td>3</td>
<td>Addition to knee joint, disc or dial lock for adjustable knee flexion, each joint</td>
<td>Knee disc/dial lock/adj flex</td>
</tr>
<tr class="even">
<td>L2430</td>
<td>0010</td>
<td>3</td>
<td>Addition to knee joint, ratchet lock for active and progressive knee extension, each joint</td>
<td>Knee jnt ratchet lock ea jnt</td>
</tr>
<tr class="odd">
<td>L2492</td>
<td>0010</td>
<td>3</td>
<td>Addition to knee joint, lift loop for drop lock ring</td>
<td>Knee lift loop drop lock rin</td>
</tr>
<tr class="even">
<td>L2500</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, thigh/weight bearing, gluteal/ ischial weight bearing, ring</td>
<td>Thi/glut/ischia wgt bearing</td>
</tr>
<tr class="odd">
<td>L2510</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, thigh/weight bearing, quadri- lateral brim, molded to patient model</td>
<td>Th/wght bear quad-lat brim m</td>
</tr>
<tr class="even">
<td>L2520</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, thigh/weight bearing, quadri- lateral brim, custom fitted</td>
<td>Th/wght bear quad-lat brim c</td>
</tr>
<tr class="odd">
<td>L2525</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, thigh/weight bearing, ischial containment/narrow m-l brim molded to patient model</td>
<td>Th/wght bear nar m-l brim mo</td>
</tr>
<tr class="even">
<td>L2526</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, thigh/weight bearing, ischial containment/narrow m-l brim, custom fitted</td>
<td>Th/wght bear nar m-l brim cu</td>
</tr>
<tr class="odd">
<td>L2530</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, thigh-weight bearing, lacer, non-molded</td>
<td>Thigh/wght bear lacer non-mo</td>
</tr>
<tr class="even">
<td>L2540</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, thigh/weight bearing, lacer, molded to patient model</td>
<td>Thigh/wght bear lacer molded</td>
</tr>
<tr class="odd">
<td>L2550</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, thigh/weight bearing, high roll cuff</td>
<td>Thigh/wght bear high roll cu</td>
</tr>
<tr class="even">
<td>L2570</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, pelvic control, hip joint, clevis type two position joint, each</td>
<td>Hip clevis type 2 posit jnt</td>
</tr>
<tr class="odd">
<td>L2580</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, pelvic control, pelvic sling</td>
<td>Pelvic control pelvic sling</td>
</tr>
<tr class="even">
<td>L2600</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, pelvic control, hip joint, clevis type, or thrust bearing, free, each</td>
<td>Hip clevis/thrust bearing fr</td>
</tr>
<tr class="odd">
<td>L2610</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, pelvic control, hip joint, clevis or thrust bearing, lock, each</td>
<td>Hip clevis/thrust bearing lo</td>
</tr>
<tr class="even">
<td>L2620</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, pelvic control, hip joint, heavy duty, each</td>
<td>Pelvic control hip heavy dut</td>
</tr>
<tr class="odd">
<td>L2622</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, pelvic control, hip joint, adjustable flexion, each</td>
<td>Hip joint adjustable flexion</td>
</tr>
<tr class="even">
<td>L2624</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, pelvic control, hip joint, adjustable flexion, extension, abduction control, each</td>
<td>Hip adj flex ext abduct cont</td>
</tr>
<tr class="odd">
<td>L2627</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, pelvic control, plastic, molded to patient model, reciprocating hip joint and cables</td>
<td>Plastic mold recipro hip &amp; c</td>
</tr>
<tr class="even">
<td>L2628</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, pelvic control, metal frame, reciprocating hip joint and cables</td>
<td>Metal frame recipro hip &amp; ca</td>
</tr>
<tr class="odd">
<td>L2630</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, pelvic control, band and belt, unilateral</td>
<td>Pelvic control band &amp; belt u</td>
</tr>
<tr class="even">
<td>L2640</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, pelvic control, band and belt, bilateral</td>
<td>Pelvic control band &amp; belt b</td>
</tr>
<tr class="odd">
<td>L2650</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, pelvic and thoracic control, gluteal pad, each</td>
<td>Pelv &amp; thor control gluteal</td>
</tr>
<tr class="even">
<td>L2660</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, thoracic control, thoracic band</td>
<td>Thoracic control thoracic ba</td>
</tr>
<tr class="odd">
<td>L2670</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, thoracic control, paraspinal uprights</td>
<td>Thorac cont paraspinal uprig</td>
</tr>
<tr class="even">
<td>L2680</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, thoracic control, lateral support uprights</td>
<td>Thorac cont lat support upri</td>
</tr>
<tr class="odd">
<td>L2750</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, plating chrome or nickel, per bar</td>
<td>Plating chrome/nickel pr bar</td>
</tr>
<tr class="even">
<td>L2755</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, high strength, lightweight material, all hybrid lamination/prepreg composite, per segment, for custom fabricated orthosis only</td>
<td>Carbon graphite lamination</td>
</tr>
<tr class="odd">
<td>L2760</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, extension, per extension, per bar (for lineal adjustment for growth)</td>
<td>Extension per extension per</td>
</tr>
<tr class="even">
<td>L2768</td>
<td>0010</td>
<td>3</td>
<td>Orthotic side bar disconnect device, per bar</td>
<td>Ortho sidebar disconnect</td>
</tr>
<tr class="odd">
<td>L2780</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, non-corrosive finish, per bar</td>
<td>Non-corrosive finish</td>
</tr>
<tr class="even">
<td>L2785</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, drop lock retainer, each</td>
<td>Drop lock retainer each</td>
</tr>
<tr class="odd">
<td>L2795</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, knee control, full kneecap</td>
<td>Knee control full kneecap</td>
</tr>
<tr class="even">
<td>L2800</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, knee control, knee cap, medial or lateral pull, for use with custom fabricated orthosis only</td>
<td>Knee cap medial or lateral p</td>
</tr>
<tr class="odd">
<td>L2810</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, knee control, condylar pad</td>
<td>Knee control condylar pad</td>
</tr>
<tr class="even">
<td>L2820</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, soft interface for molded plastic, below knee section</td>
<td>Soft interface below knee se</td>
</tr>
<tr class="odd">
<td>L2830</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, soft interface for molded plastic, above knee section</td>
<td>Soft interface above knee se</td>
</tr>
<tr class="even">
<td>L2840</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, tibial length sock, fracture or equal, each</td>
<td>Tibial length sock fx or equ</td>
</tr>
<tr class="odd">
<td>L2850</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity orthosis, femoral length sock, fracture or equal, each</td>
<td>Femoral lgth sock fx or equa</td>
</tr>
<tr class="even">
<td>L2861</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity joint, knee or ankle, concentric adjustable torsion style mechanism for custom fabricated orthotics only, each</td>
<td>Torsion mechanism knee/ankle</td>
</tr>
<tr class="odd">
<td>L2999</td>
<td>0010</td>
<td>3</td>
<td>Lower extremity orthoses, not otherwise specified</td>
<td>Lower extremity orthosis nos</td>
</tr>
<tr class="even">
<td>L3000</td>
<td>0010</td>
<td>3</td>
<td>Foot, insert, removable, molded to patient model, ‘ucb’ type, berkeley shell, each</td>
<td>Ft insert ucb berkeley shell</td>
</tr>
<tr class="odd">
<td>L3001</td>
<td>0010</td>
<td>3</td>
<td>Foot, insert, removable, molded to patient model, spenco, each</td>
<td>Foot insert remov molded spe</td>
</tr>
<tr class="even">
<td>L3002</td>
<td>0010</td>
<td>3</td>
<td>Foot, insert, removable, molded to patient model, plastazote or equal, each</td>
<td>Foot insert plastazote or eq</td>
</tr>
<tr class="odd">
<td>L3003</td>
<td>0010</td>
<td>3</td>
<td>Foot, insert, removable, molded to patient model, silicone gel, each</td>
<td>Foot insert silicone gel eac</td>
</tr>
<tr class="even">
<td>L3010</td>
<td>0010</td>
<td>3</td>
<td>Foot, insert, removable, molded to patient model, longitudinal arch support, each</td>
<td>Foot longitudinal arch suppo</td>
</tr>
<tr class="odd">
<td>L3020</td>
<td>0010</td>
<td>3</td>
<td>Foot, insert, removable, molded to patient model, longitudinal/ metatarsal support, each</td>
<td>Foot longitud/metatarsal sup</td>
</tr>
<tr class="even">
<td>L3030</td>
<td>0010</td>
<td>3</td>
<td>Foot, insert, removable, formed to patient foot, each</td>
<td>Foot arch support remov prem</td>
</tr>
<tr class="odd">
<td>L3031</td>
<td>0010</td>
<td>3</td>
<td>Foot, insert/plate, removable, addition to lower extremity orthosis, high strength, lightweight material, all hybrid lamination/prepreg composite, each</td>
<td>Foot lamin/prepreg composite</td>
</tr>
<tr class="even">
<td>L3040</td>
<td>0010</td>
<td>3</td>
<td>Foot, arch support, removable, premolded, longitudinal, each</td>
<td>Ft arch suprt premold longit</td>
</tr>
<tr class="odd">
<td>L3050</td>
<td>0010</td>
<td>3</td>
<td>Foot, arch support, removable, premolded, metatarsal, each</td>
<td>Foot arch supp premold metat</td>
</tr>
<tr class="even">
<td>L3060</td>
<td>0010</td>
<td>3</td>
<td>Foot, arch support, removable, premolded, longitudinal/ metatarsal, each</td>
<td>Foot arch supp longitud/meta</td>
</tr>
<tr class="odd">
<td>L3070</td>
<td>0010</td>
<td>3</td>
<td>Foot, arch support, non-removable attached to shoe, longitudinal, each</td>
<td>Arch suprt att to sho longit</td>
</tr>
<tr class="even">
<td>L3080</td>
<td>0010</td>
<td>3</td>
<td>Foot, arch support, non-removable attached to shoe, metatarsal, each</td>
<td>Arch supp att to shoe metata</td>
</tr>
<tr class="odd">
<td>L3090</td>
<td>0010</td>
<td>3</td>
<td>Foot, arch support, non-removable attached to shoe, longitudinal/metatarsal, each</td>
<td>Arch supp att to shoe long/m</td>
</tr>
<tr class="even">
<td>L3100</td>
<td>0010</td>
<td>3</td>
<td>Hallus-valgus night dynamic splint, prefabricated, off-the-shelf</td>
<td>Hallus-valgus nt dyn pre ots</td>
</tr>
<tr class="odd">
<td>L3140</td>
<td>0010</td>
<td>3</td>
<td>Foot, abduction rotation bar, including shoes</td>
<td>Abduction rotation bar shoe</td>
</tr>
<tr class="even">
<td>L3150</td>
<td>0010</td>
<td>3</td>
<td>Foot, abduction rotation bar, without shoes</td>
<td>Abduct rotation bar w/o shoe</td>
</tr>
<tr class="odd">
<td>L3160</td>
<td>0010</td>
<td>3</td>
<td>Foot, adjustable shoe-styled positioning device</td>
<td>Shoe styled positioning dev</td>
</tr>
<tr class="even">
<td>L3170</td>
<td>0010</td>
<td>3</td>
<td>Foot, plastic, silicone or equal, heel stabilizer, prefabricated, off-the-shelf, each</td>
<td>Foot plas heel stabi pre ots</td>
</tr>
<tr class="odd">
<td>L3201</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe, oxford with supinator or pronator, infant</td>
<td>Oxford w supinat/pronat inf</td>
</tr>
<tr class="even">
<td>L3202</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe, oxford with supinator or pronator, child</td>
<td>Oxford w/ supinat/pronator c</td>
</tr>
<tr class="odd">
<td>L3203</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe, oxford with supinator or pronator, junior</td>
<td>Oxford w/ supinator/pronator</td>
</tr>
<tr class="even">
<td>L3204</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe, hightop with supinator or pronator, infant</td>
<td>Hightop w/ supp/pronator inf</td>
</tr>
<tr class="odd">
<td>L3206</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe, hightop with supinator or pronator, child</td>
<td>Hightop w/ supp/pronator chi</td>
</tr>
<tr class="even">
<td>L3207</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe, hightop with supinator or pronator, junior</td>
<td>Hightop w/ supp/pronator jun</td>
</tr>
<tr class="odd">
<td>L3208</td>
<td>0010</td>
<td>3</td>
<td>Surgical boot, each, infant</td>
<td>Surgical boot each infant</td>
</tr>
<tr class="even">
<td>L3209</td>
<td>0010</td>
<td>3</td>
<td>Surgical boot, each, child</td>
<td>Surgical boot each child</td>
</tr>
<tr class="odd">
<td>L3211</td>
<td>0010</td>
<td>3</td>
<td>Surgical boot, each, junior</td>
<td>Surgical boot each junior</td>
</tr>
<tr class="even">
<td>L3212</td>
<td>0010</td>
<td>3</td>
<td>Benesch boot, pair, infant</td>
<td>Benesch boot pair infant</td>
</tr>
<tr class="odd">
<td>L3213</td>
<td>0010</td>
<td>3</td>
<td>Benesch boot, pair, child</td>
<td>Benesch boot pair child</td>
</tr>
<tr class="even">
<td>L3214</td>
<td>0010</td>
<td>3</td>
<td>Benesch boot, pair, junior</td>
<td>Benesch boot pair junior</td>
</tr>
<tr class="odd">
<td>L3215</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic footwear, ladies shoe, oxford, each</td>
<td>Orthopedic ftwear ladies oxf</td>
</tr>
<tr class="even">
<td>L3216</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic footwear, ladies shoe, depth inlay, each</td>
<td>Orthoped ladies shoes dpth i</td>
</tr>
<tr class="odd">
<td>L3217</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic footwear, ladies shoe, hightop, depth inlay, each</td>
<td>Ladies shoes hightop depth i</td>
</tr>
<tr class="even">
<td>L3219</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic footwear, mens shoe, oxford, each</td>
<td>Orthopedic mens shoes oxford</td>
</tr>
<tr class="odd">
<td>L3221</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic footwear, mens shoe, depth inlay, each</td>
<td>Orthopedic mens shoes dpth i</td>
</tr>
<tr class="even">
<td>L3222</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic footwear, mens shoe, hightop, depth inlay, each</td>
<td>Mens shoes hightop depth inl</td>
</tr>
<tr class="odd">
<td>L3224</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic footwear, woman’s shoe, oxford, used as an integral part of a brace (orthosis)</td>
<td>Woman’s shoe oxford brace</td>
</tr>
<tr class="even">
<td>L3225</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic footwear, man’s shoe, oxford, used as an integral part of a brace (orthosis)</td>
<td>Man’s shoe oxford brace</td>
</tr>
<tr class="odd">
<td>L3230</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic footwear, custom shoe, depth inlay, each</td>
<td>Custom shoes depth inlay</td>
</tr>
<tr class="even">
<td>L3250</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic footwear, custom molded shoe, removable inner mold, prosthetic shoe, each</td>
<td>Custom mold shoe remov prost</td>
</tr>
<tr class="odd">
<td>L3251</td>
<td>0010</td>
<td>3</td>
<td>Foot, shoe molded to patient model, silicone shoe, each</td>
<td>Shoe molded to pt silicone s</td>
</tr>
<tr class="even">
<td>L3252</td>
<td>0010</td>
<td>3</td>
<td>Foot, shoe molded to patient model, plastazote (or similar), custom fabricated, each</td>
<td>Shoe molded plastazote cust</td>
</tr>
<tr class="odd">
<td>L3253</td>
<td>0010</td>
<td>3</td>
<td>Foot, molded shoe plastazote (or similar) custom fitted, each</td>
<td>Shoe molded plastazote cust</td>
</tr>
<tr class="even">
<td>L3254</td>
<td>0010</td>
<td>3</td>
<td>Non-standard size or width</td>
<td>Orth foot non-stndard size/w</td>
</tr>
<tr class="odd">
<td>L3255</td>
<td>0010</td>
<td>3</td>
<td>Non-standard size or length</td>
<td>Orth foot non-standard size/</td>
</tr>
<tr class="even">
<td>L3257</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic footwear, additional charge for split size</td>
<td>Orth foot add charge split s</td>
</tr>
<tr class="odd">
<td>L3260</td>
<td>0010</td>
<td>3</td>
<td>Surgical boot/shoe, each</td>
<td>Ambulatory surgical boot eac</td>
</tr>
<tr class="even">
<td>L3265</td>
<td>0010</td>
<td>3</td>
<td>Plastazote sandal, each</td>
<td>Plastazote sandal each</td>
</tr>
<tr class="odd">
<td>L3300</td>
<td>0010</td>
<td>3</td>
<td>Lift, elevation, heel, tapered to metatarsals, per inch</td>
<td>Sho lift taper to metatarsal</td>
</tr>
<tr class="even">
<td>L3310</td>
<td>0010</td>
<td>3</td>
<td>Lift, elevation, heel and sole, neoprene, per inch</td>
<td>Shoe lift elev heel/sole neo</td>
</tr>
<tr class="odd">
<td>L3320</td>
<td>0010</td>
<td>3</td>
<td>Lift, elevation, heel and sole, cork, per inch</td>
<td>Shoe lift elev heel/sole cor</td>
</tr>
<tr class="even">
<td>L3330</td>
<td>0010</td>
<td>3</td>
<td>Lift, elevation, metal extension (skate)</td>
<td>Lifts elevation metal extens</td>
</tr>
<tr class="odd">
<td>L3332</td>
<td>0010</td>
<td>3</td>
<td>Lift, elevation, inside shoe, tapered, up to one-half inch</td>
<td>Shoe lifts tapered to one-ha</td>
</tr>
<tr class="even">
<td>L3334</td>
<td>0010</td>
<td>3</td>
<td>Lift, elevation, heel, per inch</td>
<td>Shoe lifts elevation heel /i</td>
</tr>
<tr class="odd">
<td>L3340</td>
<td>0010</td>
<td>3</td>
<td>Heel wedge, sach</td>
<td>Shoe wedge sach</td>
</tr>
<tr class="even">
<td>L3350</td>
<td>0010</td>
<td>3</td>
<td>Heel wedge</td>
<td>Shoe heel wedge</td>
</tr>
<tr class="odd">
<td>L3360</td>
<td>0010</td>
<td>3</td>
<td>Sole wedge, outside sole</td>
<td>Shoe sole wedge outside sole</td>
</tr>
<tr class="even">
<td>L3370</td>
<td>0010</td>
<td>3</td>
<td>Sole wedge, between sole</td>
<td>Shoe sole wedge between sole</td>
</tr>
<tr class="odd">
<td>L3380</td>
<td>0010</td>
<td>3</td>
<td>Clubfoot wedge</td>
<td>Shoe clubfoot wedge</td>
</tr>
<tr class="even">
<td>L3390</td>
<td>0010</td>
<td>3</td>
<td>Outflare wedge</td>
<td>Shoe outflare wedge</td>
</tr>
<tr class="odd">
<td>L3400</td>
<td>0010</td>
<td>3</td>
<td>Metatarsal bar wedge, rocker</td>
<td>Shoe metatarsal bar wedge ro</td>
</tr>
<tr class="even">
<td>L3410</td>
<td>0010</td>
<td>3</td>
<td>Metatarsal bar wedge, between sole</td>
<td>Shoe metatarsal bar between</td>
</tr>
<tr class="odd">
<td>L3420</td>
<td>0010</td>
<td>3</td>
<td>Full sole and heel wedge, between sole</td>
<td>Full sole/heel wedge btween</td>
</tr>
<tr class="even">
<td>L3430</td>
<td>0010</td>
<td>3</td>
<td>Heel, counter, plastic reinforced</td>
<td>Sho heel count plast reinfor</td>
</tr>
<tr class="odd">
<td>L3440</td>
<td>0010</td>
<td>3</td>
<td>Heel, counter, leather reinforced</td>
<td>Heel leather reinforced</td>
</tr>
<tr class="even">
<td>L3450</td>
<td>0010</td>
<td>3</td>
<td>Heel, sach cushion type</td>
<td>Shoe heel sach cushion type</td>
</tr>
<tr class="odd">
<td>L3455</td>
<td>0010</td>
<td>3</td>
<td>Heel, new leather, standard</td>
<td>Shoe heel new leather standa</td>
</tr>
<tr class="even">
<td>L3460</td>
<td>0010</td>
<td>3</td>
<td>Heel, new rubber, standard</td>
<td>Shoe heel new rubber standar</td>
</tr>
<tr class="odd">
<td>L3465</td>
<td>0010</td>
<td>3</td>
<td>Heel, thomas with wedge</td>
<td>Shoe heel thomas with wedge</td>
</tr>
<tr class="even">
<td>L3470</td>
<td>0010</td>
<td>3</td>
<td>Heel, thomas extended to ball</td>
<td>Shoe heel thomas extend to b</td>
</tr>
<tr class="odd">
<td>L3480</td>
<td>0010</td>
<td>3</td>
<td>Heel, pad and depression for spur</td>
<td>Shoe heel pad &amp; depress for</td>
</tr>
<tr class="even">
<td>L3485</td>
<td>0010</td>
<td>3</td>
<td>Heel, pad, removable for spur</td>
<td>Shoe heel pad removable for</td>
</tr>
<tr class="odd">
<td>L3500</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe addition, insole, leather</td>
<td>Ortho shoe add leather insol</td>
</tr>
<tr class="even">
<td>L3510</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe addition, insole, rubber</td>
<td>Orthopedic shoe add rub insl</td>
</tr>
<tr class="odd">
<td>L3520</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe addition, insole, felt covered with leather</td>
<td>O shoe add felt w leath insl</td>
</tr>
<tr class="even">
<td>L3530</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe addition, sole, half</td>
<td>Ortho shoe add half sole</td>
</tr>
<tr class="odd">
<td>L3540</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe addition, sole, full</td>
<td>Ortho shoe add full sole</td>
</tr>
<tr class="even">
<td>L3550</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe addition, toe tap standard</td>
<td>O shoe add standard toe tap</td>
</tr>
<tr class="odd">
<td>L3560</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe addition, toe tap, horseshoe</td>
<td>O shoe add horseshoe toe tap</td>
</tr>
<tr class="even">
<td>L3570</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe addition, special extension to instep (leather with eyelets)</td>
<td>O shoe add instep extension</td>
</tr>
<tr class="odd">
<td>L3580</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe addition, convert instep to velcro closure</td>
<td>O shoe add instep velcro clo</td>
</tr>
<tr class="even">
<td>L3590</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe addition, convert firm shoe counter to soft counter</td>
<td>O shoe convert to sof counte</td>
</tr>
<tr class="odd">
<td>L3595</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe addition, march bar</td>
<td>Ortho shoe add march bar</td>
</tr>
<tr class="even">
<td>L3600</td>
<td>0010</td>
<td>3</td>
<td>Transfer of an orthosis from one shoe to another, caliper plate, existing</td>
<td>Trans shoe calip plate exist</td>
</tr>
<tr class="odd">
<td>L3610</td>
<td>0010</td>
<td>3</td>
<td>Transfer of an orthosis from one shoe to another, caliper plate, new</td>
<td>Trans shoe caliper plate new</td>
</tr>
<tr class="even">
<td>L3620</td>
<td>0010</td>
<td>3</td>
<td>Transfer of an orthosis from one shoe to another, solid stirrup, existing</td>
<td>Trans shoe solid stirrup exi</td>
</tr>
<tr class="odd">
<td>L3630</td>
<td>0010</td>
<td>3</td>
<td>Transfer of an orthosis from one shoe to another, solid stirrup, new</td>
<td>Trans shoe solid stirrup new</td>
</tr>
<tr class="even">
<td>L3640</td>
<td>0010</td>
<td>3</td>
<td>Transfer of an orthosis from one shoe to another, dennis browne splint (riveton), both shoes</td>
<td>Shoe dennis browne splint bo</td>
</tr>
<tr class="odd">
<td>L3649</td>
<td>0010</td>
<td>3</td>
<td>Orthopedic shoe, modification, addition or transfer, not otherwise specified</td>
<td>Orthopedic shoe modifica nos</td>
</tr>
<tr class="even">
<td>L3650</td>
<td>0010</td>
<td>3</td>
<td>Shoulder orthosis, figure of eight design abduction restrainer, prefabricated, off-the-shelf</td>
<td>So 8 abd restraint pre ots</td>
</tr>
<tr class="odd">
<td>L3660</td>
<td>0010</td>
<td>3</td>
<td>Shoulder orthosis, figure of eight design abduction restrainer, canvas and webbing, prefabricated, off-the-shelf</td>
<td>So 8 ab rstr can/web pre ots</td>
</tr>
<tr class="even">
<td>L3670</td>
<td>0010</td>
<td>3</td>
<td>Shoulder orthosis, acromio/clavicular (canvas and webbing type), prefabricated, off-the-shelf</td>
<td>So acro/clav can web pre ots</td>
</tr>
<tr class="odd">
<td>L3671</td>
<td>0010</td>
<td>3</td>
<td>Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>So cap design w/o jnts cf</td>
</tr>
<tr class="even">
<td>L3674</td>
<td>0010</td>
<td>3</td>
<td>Shoulder orthosis, abduction positioning (airplane design), thoracic component and support bar, with or without nontorsion joint/turnbuckle, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>So airplane w/wo joint cf</td>
</tr>
<tr class="odd">
<td>L3675</td>
<td>0010</td>
<td>3</td>
<td>Shoulder orthosis, vest type abduction restrainer, canvas webbing type or equal, prefabricated, off-the-shelf</td>
<td>So vest canvas/web pre ots</td>
</tr>
<tr class="even">
<td>L3677</td>
<td>0010</td>
<td>3</td>
<td>Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>So hard plas stabili pre cst</td>
</tr>
<tr class="odd">
<td>L3678</td>
<td>0010</td>
<td>3</td>
<td>Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, prefabricated, off-the-shelf</td>
<td>So hard plas stabili pre ots</td>
</tr>
<tr class="even">
<td>L3702</td>
<td>0010</td>
<td>3</td>
<td>Elbow orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Eo w/o joints cf</td>
</tr>
<tr class="odd">
<td>L3710</td>
<td>0010</td>
<td>3</td>
<td>Elbow orthosis, elastic with metal joints, prefabricated, off-the-shelf</td>
<td>Eo elas w/metal jnts pre ots</td>
</tr>
<tr class="even">
<td>L3720</td>
<td>0010</td>
<td>3</td>
<td>Elbow orthosis, double upright with forearm/arm cuffs, free motion, custom fabricated</td>
<td>Forearm/arm cuffs free motio</td>
</tr>
<tr class="odd">
<td>L3730</td>
<td>0010</td>
<td>3</td>
<td>Elbow orthosis, double upright with forearm/arm cuffs, extension/ flexion assist, custom fabricated</td>
<td>Forearm/arm cuffs ext/flex a</td>
</tr>
<tr class="even">
<td>L3740</td>
<td>0010</td>
<td>3</td>
<td>Elbow orthosis, double upright with forearm/arm cuffs, adjustable position lock with active control, custom fabricated</td>
<td>Cuffs adj lock w/ active con</td>
</tr>
<tr class="odd">
<td>L3760</td>
<td>0010</td>
<td>3</td>
<td>Elbow orthosis (eo), with adjustable position locking joint(s), prefabricated, item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Eo adj jt prefab custom fit</td>
</tr>
<tr class="even">
<td>L3761</td>
<td>0010</td>
<td>3</td>
<td>Elbow orthosis (eo), with adjustable position locking joint(s), prefabricated, off-the-shelf</td>
<td>Eo, adj lock joint prefab ot</td>
</tr>
<tr class="odd">
<td>L3762</td>
<td>0010</td>
<td>3</td>
<td>Elbow orthosis, rigid, without joints, includes soft interface material, prefabricated, off-the-shelf</td>
<td>Eo rigid w/o joints pre ots</td>
</tr>
<tr class="even">
<td>L3763</td>
<td>0010</td>
<td>3</td>
<td>Elbow wrist hand orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Ewho rigid w/o jnts cf</td>
</tr>
<tr class="odd">
<td>L3764</td>
<td>0010</td>
<td>3</td>
<td>Elbow wrist hand orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Ewho w/joint(s) cf</td>
</tr>
<tr class="even">
<td>L3765</td>
<td>0010</td>
<td>3</td>
<td>Elbow wrist hand finger orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Ewhfo rigid w/o jnts cf</td>
</tr>
<tr class="odd">
<td>L3766</td>
<td>0010</td>
<td>3</td>
<td>Elbow wrist hand finger orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Ewhfo w/joint(s) cf</td>
</tr>
<tr class="even">
<td>L3806</td>
<td>0010</td>
<td>3</td>
<td>Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, custom fabricated, includes fitting and adjustment</td>
<td>Whfo w/joint(s) custom fab</td>
</tr>
<tr class="odd">
<td>L3807</td>
<td>0010</td>
<td>3</td>
<td>Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Whfo w/o joints pre cst</td>
</tr>
<tr class="even">
<td>L3808</td>
<td>0010</td>
<td>3</td>
<td>Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment</td>
<td>Whfo, rigid w/o joints</td>
</tr>
<tr class="odd">
<td>L3809</td>
<td>0010</td>
<td>3</td>
<td>Wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any type</td>
<td>Whfo w/o joints pre ots</td>
</tr>
<tr class="even">
<td>L3891</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity joint, wrist or elbow, concentric adjustable torsion style mechanism for custom fabricated orthotics only, each</td>
<td>Torsion mechanism wrist/elbo</td>
</tr>
<tr class="odd">
<td>L3900</td>
<td>0010</td>
<td>3</td>
<td>Wrist hand finger orthosis, dynamic flexor hinge, reciprocal wrist extension/ flexion, finger flexion/extension, wrist or finger driven, custom fabricated</td>
<td>Hinge extension/flex wrist/f</td>
</tr>
<tr class="even">
<td>L3901</td>
<td>0010</td>
<td>3</td>
<td>Wrist hand finger orthosis, dynamic flexor hinge, reciprocal wrist extension/ flexion, finger flexion/extension, cable driven, custom fabricated</td>
<td>Hinge ext/flex wrist finger</td>
</tr>
<tr class="odd">
<td>L3904</td>
<td>0010</td>
<td>3</td>
<td>Wrist hand finger orthosis, external powered, electric, custom fabricated</td>
<td>Whfo electric custom fitted</td>
</tr>
<tr class="even">
<td>L3905</td>
<td>0010</td>
<td>3</td>
<td>Wrist hand orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Who w/nontorsion jnt(s) cf</td>
</tr>
<tr class="odd">
<td>L3906</td>
<td>0010</td>
<td>3</td>
<td>Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Who w/o joints cf</td>
</tr>
<tr class="even">
<td>L3908</td>
<td>0010</td>
<td>3</td>
<td>Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf</td>
<td>Who cock-up nonmolde pre ots</td>
</tr>
<tr class="odd">
<td>L3912</td>
<td>0010</td>
<td>3</td>
<td>Hand finger orthosis (hfo), flexion glove with elastic finger control, prefabricated, off-the-shelf</td>
<td>Hfo flexion glove pre ots</td>
</tr>
<tr class="even">
<td>L3913</td>
<td>0010</td>
<td>3</td>
<td>Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Hfo w/o joints cf</td>
</tr>
<tr class="odd">
<td>L3915</td>
<td>0010</td>
<td>3</td>
<td>Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Who nontorsion jnts pre cst</td>
</tr>
<tr class="even">
<td>L3916</td>
<td>0010</td>
<td>3</td>
<td>Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated, off-the-shelf</td>
<td>Who nontorsion jnts pre ots</td>
</tr>
<tr class="odd">
<td>L3917</td>
<td>0010</td>
<td>3</td>
<td>Hand orthosis, metacarpal fracture orthosis, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Metacarp fx orthosis pre cst</td>
</tr>
<tr class="even">
<td>L3918</td>
<td>0010</td>
<td>3</td>
<td>Hand orthosis, metacarpal fracture orthosis, prefabricated, off-the-shelf</td>
<td>Metacarp fx orthosis pre ots</td>
</tr>
<tr class="odd">
<td>L3919</td>
<td>0010</td>
<td>3</td>
<td>Hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Ho w/o joints cf</td>
</tr>
<tr class="even">
<td>L3921</td>
<td>0010</td>
<td>3</td>
<td>Hand finger orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Hfo w/joint(s) cf</td>
</tr>
<tr class="odd">
<td>L3923</td>
<td>0010</td>
<td>3</td>
<td>Hand finger orthosis, without joints, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Hfo without joints pre cst</td>
</tr>
<tr class="even">
<td>L3924</td>
<td>0010</td>
<td>3</td>
<td>Hand finger orthosis, without joints, may include soft interface, straps, prefabricated, off-the-shelf</td>
<td>Hfo without joints pre ots</td>
</tr>
<tr class="odd">
<td>L3925</td>
<td>0010</td>
<td>3</td>
<td>Finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip), non torsion joint/spring, extension/flexion, may include soft interface material, prefabricated, off-the-shelf</td>
<td>Fo pip dip jnt/sprng pre ots</td>
</tr>
<tr class="even">
<td>L3927</td>
<td>0010</td>
<td>3</td>
<td>Finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip), without joint/spring, extension/flexion (e.g., static or ring type), may include soft interface material, prefabricated, off-the-shelf</td>
<td>Fo pip dip no jt spr pre ots</td>
</tr>
<tr class="odd">
<td>L3929</td>
<td>0010</td>
<td>3</td>
<td>Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Hfo nontorsion jnts pre cst</td>
</tr>
<tr class="even">
<td>L3930</td>
<td>0010</td>
<td>3</td>
<td>Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, off-the-shelf</td>
<td>Hfo nontorsion jnts pre ots</td>
</tr>
<tr class="odd">
<td>L3931</td>
<td>0010</td>
<td>3</td>
<td>Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, includes fitting and adjustment</td>
<td>Whfo nontorsion joint prefab</td>
</tr>
<tr class="even">
<td>L3933</td>
<td>0010</td>
<td>3</td>
<td>Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment</td>
<td>Fo w/o joints cf</td>
</tr>
<tr class="odd">
<td>L3935</td>
<td>0010</td>
<td>3</td>
<td>Finger orthosis, nontorsion joint, may include soft interface, custom fabricated, includes fitting and adjustment</td>
<td>Fo nontorsion joint cf</td>
</tr>
<tr class="even">
<td>L3956</td>
<td>0010</td>
<td>3</td>
<td>Addition of joint to upper extremity orthosis, any material; per joint</td>
<td>Add joint upper ext orthosis</td>
</tr>
<tr class="odd">
<td>L3960</td>
<td>0010</td>
<td>3</td>
<td>Shoulder elbow wrist hand orthosis, abduction positioning, airplane design, prefabricated, includes fitting and adjustment</td>
<td>Sewho airplan desig abdu pos</td>
</tr>
<tr class="even">
<td>L3961</td>
<td>0010</td>
<td>3</td>
<td>Shoulder elbow wrist hand orthosis, shoulder cap design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Sewho cap design w/o jnts cf</td>
</tr>
<tr class="odd">
<td>L3962</td>
<td>0010</td>
<td>3</td>
<td>Shoulder elbow wrist hand orthosis, abduction positioning, erb’s palsey design, prefabricated, includes fitting and adjustment</td>
<td>Sewho erbs palsey design abd</td>
</tr>
<tr class="even">
<td>L3967</td>
<td>0010</td>
<td>3</td>
<td>Shoulder elbow wrist hand orthosis, abduction positioning (airplane design), thoracic component and support bar, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Sewho airplane w/o jnts cf</td>
</tr>
<tr class="odd">
<td>L3971</td>
<td>0010</td>
<td>3</td>
<td>Shoulder elbow wrist hand orthosis, shoulder cap design, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Sewho cap design w/jnt(s) cf</td>
</tr>
<tr class="even">
<td>L3973</td>
<td>0010</td>
<td>3</td>
<td>Shoulder elbow wrist hand orthosis, abduction positioning (airplane design), thoracic component and support bar, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Sewho airplane w/jnt(s) cf</td>
</tr>
<tr class="odd">
<td>L3975</td>
<td>0010</td>
<td>3</td>
<td>Shoulder elbow wrist hand finger orthosis, shoulder cap design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Sewhfo cap design w/o jnt cf</td>
</tr>
<tr class="even">
<td>L3976</td>
<td>0010</td>
<td>3</td>
<td>Shoulder elbow wrist hand finger orthosis, abduction positioning (airplane design), thoracic component and support bar, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Sewhfo airplane w/o jnts cf</td>
</tr>
<tr class="odd">
<td>L3977</td>
<td>0010</td>
<td>3</td>
<td>Shoulder elbow wrist hand finger orthosis, shoulder cap design, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Sewhfo cap desgn w/jnt(s) cf</td>
</tr>
<tr class="even">
<td>L3978</td>
<td>0010</td>
<td>3</td>
<td>Shoulder elbow wrist hand finger orthosis, abduction positioning (airplane design), thoracic component and support bar, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment</td>
<td>Sewhfo airplane w/jnt(s) cf</td>
</tr>
<tr class="odd">
<td>L3980</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity fracture orthosis, humeral, prefabricated, includes fitting and adjustment</td>
<td>Up ext fx orthos humeral nos</td>
</tr>
<tr class="even">
<td>L3981</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity fracture orthosis, humeral, prefabricated, includes shoulder cap design, with or without joints, forearm section, may include soft interface, straps, includes fitting and adjustments</td>
<td>Ue fx orth shoul cap forearm</td>
</tr>
<tr class="odd">
<td>L3982</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity fracture orthosis, radius/ulnar, prefabricated, includes fitting and adjustment</td>
<td>Upper ext fx orthosis rad/ul</td>
</tr>
<tr class="even">
<td>L3984</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity fracture orthosis, wrist, prefabricated, includes fitting and adjustment</td>
<td>Upper ext fx orthosis wrist</td>
</tr>
<tr class="odd">
<td>L3995</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity orthosis, sock, fracture or equal, each</td>
<td>Sock fracture or equal each</td>
</tr>
<tr class="even">
<td>L3999</td>
<td>0010</td>
<td>3</td>
<td>Upper limb orthosis, not otherwise specified</td>
<td>Upper limb orthosis nos</td>
</tr>
<tr class="odd">
<td>L4000</td>
<td>0010</td>
<td>3</td>
<td>Replace girdle for spinal orthosis (ctlso or so)</td>
<td>Repl girdle milwaukee orth</td>
</tr>
<tr class="even">
<td>L4002</td>
<td>0010</td>
<td>3</td>
<td>Replacement strap, any orthosis, includes all components, any length, any type</td>
<td>Replace strap, any orthosis</td>
</tr>
<tr class="odd">
<td>L4010</td>
<td>0010</td>
<td>3</td>
<td>Replace trilateral socket brim</td>
<td>Replace trilateral socket br</td>
</tr>
<tr class="even">
<td>L4020</td>
<td>0010</td>
<td>3</td>
<td>Replace quadrilateral socket brim, molded to patient model</td>
<td>Replace quadlat socket brim</td>
</tr>
<tr class="odd">
<td>L4030</td>
<td>0010</td>
<td>3</td>
<td>Replace quadrilateral socket brim, custom fitted</td>
<td>Replace socket brim cust fit</td>
</tr>
<tr class="even">
<td>L4040</td>
<td>0010</td>
<td>3</td>
<td>Replace molded thigh lacer, for custom fabricated orthosis only</td>
<td>Replace molded thigh lacer</td>
</tr>
<tr class="odd">
<td>L4045</td>
<td>0010</td>
<td>3</td>
<td>Replace non-molded thigh lacer, for custom fabricated orthosis only</td>
<td>Replace non-molded thigh lac</td>
</tr>
<tr class="even">
<td>L4050</td>
<td>0010</td>
<td>3</td>
<td>Replace molded calf lacer, for custom fabricated orthosis only</td>
<td>Replace molded calf lacer</td>
</tr>
<tr class="odd">
<td>L4055</td>
<td>0010</td>
<td>3</td>
<td>Replace non-molded calf lacer, for custom fabricated orthosis only</td>
<td>Replace non-molded calf lace</td>
</tr>
<tr class="even">
<td>L4060</td>
<td>0010</td>
<td>3</td>
<td>Replace high roll cuff</td>
<td>Replace high roll cuff</td>
</tr>
<tr class="odd">
<td>L4070</td>
<td>0010</td>
<td>3</td>
<td>Replace proximal and distal upright for kafo</td>
<td>Replace prox &amp; dist upright</td>
</tr>
<tr class="even">
<td>L4080</td>
<td>0010</td>
<td>3</td>
<td>Replace metal bands kafo, proximal thigh</td>
<td>Repl met band kafo-afo prox</td>
</tr>
<tr class="odd">
<td>L4090</td>
<td>0010</td>
<td>3</td>
<td>Replace metal bands kafo-afo, calf or distal thigh</td>
<td>Repl met band kafo-afo calf/</td>
</tr>
<tr class="even">
<td>L4100</td>
<td>0010</td>
<td>3</td>
<td>Replace leather cuff kafo, proximal thigh</td>
<td>Repl leath cuff kafo prox th</td>
</tr>
<tr class="odd">
<td>L4110</td>
<td>0010</td>
<td>3</td>
<td>Replace leather cuff kafo-afo, calf or distal thigh</td>
<td>Repl leath cuff kafo-afo cal</td>
</tr>
<tr class="even">
<td>L4130</td>
<td>0010</td>
<td>3</td>
<td>Replace pretibial shell</td>
<td>Replace pretibial shell</td>
</tr>
<tr class="odd">
<td>L4205</td>
<td>0010</td>
<td>3</td>
<td>Repair of orthotic device, labor component, per 15 minutes</td>
<td>Ortho dvc repair per 15 min</td>
</tr>
<tr class="even">
<td>L4210</td>
<td>0010</td>
<td>3</td>
<td>Repair of orthotic device, repair or replace minor parts</td>
<td>Orth dev repair/repl minor p</td>
</tr>
<tr class="odd">
<td>L4350</td>
<td>0010</td>
<td>3</td>
<td>Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf</td>
<td>Ankle control ortho pre ots</td>
</tr>
<tr class="even">
<td>L4360</td>
<td>0010</td>
<td>3</td>
<td>Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Pneumat walking boot pre cst</td>
</tr>
<tr class="odd">
<td>L4361</td>
<td>0010</td>
<td>3</td>
<td>Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf</td>
<td>Pneuma/vac walk boot pre ots</td>
</tr>
<tr class="even">
<td>L4370</td>
<td>0010</td>
<td>3</td>
<td>Pneumatic full leg splint, prefabricated, off-the-shelf</td>
<td>Pneum full leg splnt pre ots</td>
</tr>
<tr class="odd">
<td>L4386</td>
<td>0010</td>
<td>3</td>
<td>Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Non-pneum walk boot pre cst</td>
</tr>
<tr class="even">
<td>L4387</td>
<td>0010</td>
<td>3</td>
<td>Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf</td>
<td>Non-pneum walk boot pre ots</td>
</tr>
<tr class="odd">
<td>L4392</td>
<td>0010</td>
<td>3</td>
<td>Replacement, soft interface material, static afo</td>
<td>Replace afo soft interface</td>
</tr>
<tr class="even">
<td>L4394</td>
<td>0010</td>
<td>3</td>
<td>Replace soft interface material, foot drop splint</td>
<td>Replace foot drop spint</td>
</tr>
<tr class="odd">
<td>L4396</td>
<td>0010</td>
<td>3</td>
<td>Static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise</td>
<td>Static or dynami afo pre cst</td>
</tr>
<tr class="even">
<td>L4397</td>
<td>0010</td>
<td>3</td>
<td>Static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated, off-the-shelf</td>
<td>Static or dynami afo pre ots</td>
</tr>
<tr class="odd">
<td>L4398</td>
<td>0010</td>
<td>3</td>
<td>Foot drop splint, recumbent positioning device, prefabricated, off-the-shelf</td>
<td>Foot drop splint pre ots</td>
</tr>
<tr class="even">
<td>L4631</td>
<td>0010</td>
<td>3</td>
<td>Ankle foot orthosis, walking boot type, varus/valgus correction, rocker bottom, anterior tibial shell, soft interface, custom arch support, plastic or other material, includes straps and closures, custom fabricated</td>
<td>Afo, walk boot type, cus fab</td>
</tr>
<tr class="odd">
<td>L5000</td>
<td>0010</td>
<td>3</td>
<td>Partial foot, shoe insert with longitudinal arch, toe filler</td>
<td>Sho insert w arch toe filler</td>
</tr>
<tr class="even">
<td>L5010</td>
<td>0010</td>
<td>3</td>
<td>Partial foot, molded socket, ankle height, with toe filler</td>
<td>Mold socket ank hgt w/ toe f</td>
</tr>
<tr class="odd">
<td>L5020</td>
<td>0010</td>
<td>3</td>
<td>Partial foot, molded socket, tibial tubercle height, with toe filler</td>
<td>Tibial tubercle hgt w/ toe f</td>
</tr>
<tr class="even">
<td>L5050</td>
<td>0010</td>
<td>3</td>
<td>Ankle, symes, molded socket, sach foot</td>
<td>Ank symes mold sckt sach ft</td>
</tr>
<tr class="odd">
<td>L5060</td>
<td>0010</td>
<td>3</td>
<td>Ankle, symes, metal frame, molded leather socket, articulated ankle/foot</td>
<td>Symes met fr leath socket ar</td>
</tr>
<tr class="even">
<td>L5100</td>
<td>0010</td>
<td>3</td>
<td>Below knee, molded socket, shin, sach foot</td>
<td>Molded socket shin sach foot</td>
</tr>
<tr class="odd">
<td>L5105</td>
<td>0010</td>
<td>3</td>
<td>Below knee, plastic socket, joints and thigh lacer, sach foot</td>
<td>Plast socket jts/thgh lacer</td>
</tr>
<tr class="even">
<td>L5150</td>
<td>0010</td>
<td>3</td>
<td>Knee disarticulation (or through knee), molded socket, external knee joints, shin, sach foot</td>
<td>Mold sckt ext knee shin sach</td>
</tr>
<tr class="odd">
<td>L5160</td>
<td>0010</td>
<td>3</td>
<td>Knee disarticulation (or through knee), molded socket, bent knee configuration, external knee joints, shin, sach foot</td>
<td>Mold socket bent knee shin s</td>
</tr>
<tr class="even">
<td>L5200</td>
<td>0010</td>
<td>3</td>
<td>Above knee, molded socket, single axis constant friction knee, shin, sach foot</td>
<td>Kne sing axis fric shin sach</td>
</tr>
<tr class="odd">
<td>L5210</td>
<td>0010</td>
<td>3</td>
<td>Above knee, short prosthesis, no knee joint (‘stubbies’), with foot blocks, no ankle joints, each</td>
<td>No knee/ankle joints w/ ft b</td>
</tr>
<tr class="even">
<td>L5220</td>
<td>0010</td>
<td>3</td>
<td>Above knee, short prosthesis, no knee joint (‘stubbies’), with articulated ankle/foot, dynamically aligned, each</td>
<td>No knee joint with artic ali</td>
</tr>
<tr class="odd">
<td>L5230</td>
<td>0010</td>
<td>3</td>
<td>Above knee, for proximal femoral focal deficiency, constant friction knee, shin, sach foot</td>
<td>Fem focal defic constant fri</td>
</tr>
<tr class="even">
<td>L5250</td>
<td>0010</td>
<td>3</td>
<td>Hip disarticulation, canadian type; molded socket, hip joint, single axis constant friction knee, shin, sach foot</td>
<td>Hip canad sing axi cons fric</td>
</tr>
<tr class="odd">
<td>L5270</td>
<td>0010</td>
<td>3</td>
<td>Hip disarticulation, tilt table type; molded socket, locking hip joint, single axis constant friction knee, shin, sach foot</td>
<td>Tilt table locking hip sing</td>
</tr>
<tr class="even">
<td>L5280</td>
<td>0010</td>
<td>3</td>
<td>Hemipelvectomy, canadian type; molded socket, hip joint, single axis constant friction knee, shin, sach foot</td>
<td>Hemipelvect canad sing axis</td>
</tr>
<tr class="odd">
<td>L5301</td>
<td>0010</td>
<td>3</td>
<td>Below knee, molded socket, shin, sach foot, endoskeletal system</td>
<td>Bk mold socket sach ft endo</td>
</tr>
<tr class="even">
<td>L5312</td>
<td>0010</td>
<td>3</td>
<td>Knee disarticulation (or through knee), molded socket, single axis knee, pylon, sach foot, endoskeletal system</td>
<td>Knee disart, sach ft, endo</td>
</tr>
<tr class="odd">
<td>L5321</td>
<td>0010</td>
<td>3</td>
<td>Above knee, molded socket, open end, sach foot, endoskeletal system, single axis knee</td>
<td>Ak open end sach</td>
</tr>
<tr class="even">
<td>L5331</td>
<td>0010</td>
<td>3</td>
<td>Hip disarticulation, canadian type, molded socket, endoskeletal system, hip joint, single axis knee, sach foot</td>
<td>Hip disart canadian sach ft</td>
</tr>
<tr class="odd">
<td>L5341</td>
<td>0010</td>
<td>3</td>
<td>Hemipelvectomy, canadian type, molded socket, endoskeletal system, hip joint, single axis knee, sach foot</td>
<td>Hemipelvectomy canadian sach</td>
</tr>
<tr class="even">
<td>L5400</td>
<td>0010</td>
<td>3</td>
<td>Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment, suspension, and one cast change, below knee</td>
<td>Postop dress &amp; 1 cast chg bk</td>
</tr>
<tr class="odd">
<td>L5410</td>
<td>0010</td>
<td>3</td>
<td>Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension, below knee, each additional cast change and realignment</td>
<td>Postop dsg bk ea add cast ch</td>
</tr>
<tr class="even">
<td>L5420</td>
<td>0010</td>
<td>3</td>
<td>Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension and one cast change ‘ak’ or knee disarticulation</td>
<td>Postop dsg &amp; 1 cast chg ak/d</td>
</tr>
<tr class="odd">
<td>L5430</td>
<td>0010</td>
<td>3</td>
<td>Immediate post surgical or early fitting, application of initial rigid dressing, incl. fitting, alignment and supension, ‘ak’ or knee disarticulation, each additional cast change and realignment</td>
<td>Postop dsg ak ea add cast ch</td>
</tr>
<tr class="even">
<td>L5450</td>
<td>0010</td>
<td>3</td>
<td>Immediate post surgical or early fitting, application of non-weight bearing rigid dressing, below knee</td>
<td>Postop app non-wgt bear dsg</td>
</tr>
<tr class="odd">
<td>L5460</td>
<td>0010</td>
<td>3</td>
<td>Immediate post surgical or early fitting, application of non-weight bearing rigid dressing, above knee</td>
<td>Postop app non-wgt bear dsg</td>
</tr>
<tr class="even">
<td>L5500</td>
<td>0010</td>
<td>3</td>
<td>Initial, below knee ‘ptb’ type socket, non-alignable system, pylon, no cover, sach foot, plaster socket, direct formed</td>
<td>Init bk ptb plaster direct</td>
</tr>
<tr class="odd">
<td>L5505</td>
<td>0010</td>
<td>3</td>
<td>Initial, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, plaster socket, direct formed</td>
<td>Init ak ischal plstr direct</td>
</tr>
<tr class="even">
<td>L5510</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, below knee ‘ptb’ type socket, non-alignable system, pylon, no cover, sach foot, plaster socket, molded to model</td>
<td>Prep bk ptb plaster molded</td>
</tr>
<tr class="odd">
<td>L5520</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, below knee ‘ptb’ type socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, direct formed</td>
<td>Perp bk ptb thermopls direct</td>
</tr>
<tr class="even">
<td>L5530</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, below knee ‘ptb’ type socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, molded to model</td>
<td>Prep bk ptb thermopls molded</td>
</tr>
<tr class="odd">
<td>L5535</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, below knee ‘ptb’ type socket, non-alignable system, no cover, sach foot, prefabricated, adjustable open end socket</td>
<td>Prep bk ptb open end socket</td>
</tr>
<tr class="even">
<td>L5540</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, below knee ‘ptb’ type socket, non-alignable system, pylon, no cover, sach foot, laminated socket, molded to model</td>
<td>Prep bk ptb laminated socket</td>
</tr>
<tr class="odd">
<td>L5560</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, above knee- knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, plaster socket, molded to model</td>
<td>Prep ak ischial plast molded</td>
</tr>
<tr class="even">
<td>L5570</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, direct formed</td>
<td>Prep ak ischial direct form</td>
</tr>
<tr class="odd">
<td>L5580</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, above knee - knee disarticulation ischial level socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, molded to model</td>
<td>Prep ak ischial thermo mold</td>
</tr>
<tr class="even">
<td>L5585</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, prefabricated adjustable open end socket</td>
<td>Prep ak ischial open end</td>
</tr>
<tr class="odd">
<td>L5590</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, above knee - knee disarticulation ischial level socket, non-alignable system, pylon no cover, sach foot, laminated socket, molded to model</td>
<td>Prep ak ischial laminated</td>
</tr>
<tr class="even">
<td>L5595</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, hip disarticulation-hemipelvectomy, pylon, no cover, sach foot, thermoplastic or equal, molded to patient model</td>
<td>Hip disartic sach thermopls</td>
</tr>
<tr class="odd">
<td>L5600</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, hip disarticulation-hemipelvectomy, pylon, no cover, sach foot, laminated socket, molded to patient model</td>
<td>Hip disart sach laminat mold</td>
</tr>
<tr class="even">
<td>L5610</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, endoskeletal system, above knee, hydracadence system</td>
<td>Above knee hydracadence</td>
</tr>
<tr class="odd">
<td>L5611</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, endoskeletal system, above knee - knee disarticulation, 4 bar linkage, with friction swing phase control</td>
<td>Ak 4 bar link w/fric swing</td>
</tr>
<tr class="even">
<td>L5613</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, endoskeletal system, above knee-knee disarticulation, 4 bar linkage, with hydraulic swing phase control</td>
<td>Ak 4 bar ling w/hydraul swig</td>
</tr>
<tr class="odd">
<td>L5614</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, exoskeletal system, above knee-knee disarticulation, 4 bar linkage, with pneumatic swing phase control</td>
<td>4-bar link above knee w/swng</td>
</tr>
<tr class="even">
<td>L5616</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, endoskeletal system, above knee, universal multiplex system, friction swing phase control</td>
<td>Ak univ multiplex sys frict</td>
</tr>
<tr class="odd">
<td>L5617</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, quick change self-aligning unit, above knee or below knee, each</td>
<td>Ak/bk self-aligning unit ea</td>
</tr>
<tr class="even">
<td>L5618</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, test socket, symes</td>
<td>Test socket symes</td>
</tr>
<tr class="odd">
<td>L5620</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, test socket, below knee</td>
<td>Test socket below knee</td>
</tr>
<tr class="even">
<td>L5622</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, test socket, knee disarticulation</td>
<td>Test socket knee disarticula</td>
</tr>
<tr class="odd">
<td>L5624</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, test socket, above knee</td>
<td>Test socket above knee</td>
</tr>
<tr class="even">
<td>L5626</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, test socket, hip disarticulation</td>
<td>Test socket hip disarticulat</td>
</tr>
<tr class="odd">
<td>L5628</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, test socket, hemipelvectomy</td>
<td>Test socket hemipelvectomy</td>
</tr>
<tr class="even">
<td>L5629</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, acrylic socket</td>
<td>Below knee acrylic socket</td>
</tr>
<tr class="odd">
<td>L5630</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, symes type, expandable wall socket</td>
<td>Syme typ expandabl wall sckt</td>
</tr>
<tr class="even">
<td>L5631</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, above knee or knee disarticulation, acrylic socket</td>
<td>Ak/knee disartic acrylic soc</td>
</tr>
<tr class="odd">
<td>L5632</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, symes type, ‘ptb’ brim design socket</td>
<td>Symes type ptb brim design s</td>
</tr>
<tr class="even">
<td>L5634</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, symes type, posterior opening (canadian) socket</td>
<td>Symes type poster opening so</td>
</tr>
<tr class="odd">
<td>L5636</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, symes type, medial opening socket</td>
<td>Symes type medial opening so</td>
</tr>
<tr class="even">
<td>L5637</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, total contact</td>
<td>Below knee total contact</td>
</tr>
<tr class="odd">
<td>L5638</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, leather socket</td>
<td>Below knee leather socket</td>
</tr>
<tr class="even">
<td>L5639</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, wood socket</td>
<td>Below knee wood socket</td>
</tr>
<tr class="odd">
<td>L5640</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, knee disarticulation, leather socket</td>
<td>Knee disarticulat leather so</td>
</tr>
<tr class="even">
<td>L5642</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, above knee, leather socket</td>
<td>Above knee leather socket</td>
</tr>
<tr class="odd">
<td>L5643</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, hip disarticulation, flexible inner socket, external frame</td>
<td>Hip flex inner socket ext fr</td>
</tr>
<tr class="even">
<td>L5644</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, above knee, wood socket</td>
<td>Above knee wood socket</td>
</tr>
<tr class="odd">
<td>L5645</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, flexible inner socket, external frame</td>
<td>Bk flex inner socket ext fra</td>
</tr>
<tr class="even">
<td>L5646</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, air, fluid, gel or equal, cushion socket</td>
<td>Below knee cushion socket</td>
</tr>
<tr class="odd">
<td>L5647</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee suction socket</td>
<td>Below knee suction socket</td>
</tr>
<tr class="even">
<td>L5648</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, above knee, air, fluid, gel or equal, cushion socket</td>
<td>Above knee cushion socket</td>
</tr>
<tr class="odd">
<td>L5649</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, ischial containment/narrow m-l socket</td>
<td>Isch containmt/narrow m-l so</td>
</tr>
<tr class="even">
<td>L5650</td>
<td>0010</td>
<td>3</td>
<td>Additions to lower extremity, total contact, above knee or knee disarticulation socket</td>
<td>Tot contact ak/knee disart s</td>
</tr>
<tr class="odd">
<td>L5651</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, above knee, flexible inner socket, external frame</td>
<td>Ak flex inner socket ext fra</td>
</tr>
<tr class="even">
<td>L5652</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, suction suspension, above knee or knee disarticulation socket</td>
<td>Suction susp ak/knee disart</td>
</tr>
<tr class="odd">
<td>L5653</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, knee disarticulation, expandable wall socket</td>
<td>Knee disart expand wall sock</td>
</tr>
<tr class="even">
<td>L5654</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, socket insert, symes, (kemblo, pelite, aliplast, plastazote or equal)</td>
<td>Socket insert symes</td>
</tr>
<tr class="odd">
<td>L5655</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, socket insert, below knee (kemblo, pelite, aliplast, plastazote or equal)</td>
<td>Socket insert below knee</td>
</tr>
<tr class="even">
<td>L5656</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, socket insert, knee disarticulation (kemblo, pelite, aliplast, plastazote or equal)</td>
<td>Socket insert knee articulat</td>
</tr>
<tr class="odd">
<td>L5658</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, socket insert, above knee (kemblo, pelite, aliplast, plastazote or equal)</td>
<td>Socket insert above knee</td>
</tr>
<tr class="even">
<td>L5661</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, socket insert, multi-durometer symes</td>
<td>Multi-durometer symes</td>
</tr>
<tr class="odd">
<td>L5665</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, socket insert, multi-durometer, below knee</td>
<td>Multi-durometer below knee</td>
</tr>
<tr class="even">
<td>L5666</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, cuff suspension</td>
<td>Below knee cuff suspension</td>
</tr>
<tr class="odd">
<td>L5668</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, molded distal cushion</td>
<td>Bk molded distal cushion</td>
</tr>
<tr class="even">
<td>L5670</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, molded supracondylar suspension (‘pts’ or similar)</td>
<td>Bk molded supracondylar susp</td>
</tr>
<tr class="odd">
<td>L5671</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee / above knee suspension locking mechanism (shuttle, lanyard or equal), excludes socket insert</td>
<td>Bk/ak locking mechanism</td>
</tr>
<tr class="even">
<td>L5672</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, removable medial brim suspension</td>
<td>Bk removable medial brim sus</td>
</tr>
<tr class="odd">
<td>L5673</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee/above knee, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, for use with locking mechanism</td>
<td>Socket insert w lock mech</td>
</tr>
<tr class="even">
<td>L5676</td>
<td>0010</td>
<td>3</td>
<td>Additions to lower extremity, below knee, knee joints, single axis, pair</td>
<td>Bk knee joints single axis p</td>
</tr>
<tr class="odd">
<td>L5677</td>
<td>0010</td>
<td>3</td>
<td>Additions to lower extremity, below knee, knee joints, polycentric, pair</td>
<td>Bk knee joints polycentric p</td>
</tr>
<tr class="even">
<td>L5678</td>
<td>0010</td>
<td>3</td>
<td>Additions to lower extremity, below knee, joint covers, pair</td>
<td>Bk joint covers pair</td>
</tr>
<tr class="odd">
<td>L5679</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee/above knee, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, not for use with locking mechanism</td>
<td>Socket insert w/o lock mech</td>
</tr>
<tr class="even">
<td>L5680</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, thigh lacer, nonmolded</td>
<td>Bk thigh lacer non-molded</td>
</tr>
<tr class="odd">
<td>L5681</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee/above knee, custom fabricated socket insert for congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l5673 or l5679)</td>
<td>Intl custm cong/latyp insert</td>
</tr>
<tr class="even">
<td>L5682</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, thigh lacer, gluteal/ischial, molded</td>
<td>Bk thigh lacer glut/ischia m</td>
</tr>
<tr class="odd">
<td>L5683</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee/above knee, custom fabricated socket insert for other than congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l5673 or l5679)</td>
<td>Initial custom socket insert</td>
</tr>
<tr class="even">
<td>L5684</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, fork strap</td>
<td>Bk fork strap</td>
</tr>
<tr class="odd">
<td>L5685</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity prosthesis, below knee, suspension/sealing sleeve, with or without valve, any material, each</td>
<td>Below knee sus/seal sleeve</td>
</tr>
<tr class="even">
<td>L5686</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, back check (extension control)</td>
<td>Bk back check</td>
</tr>
<tr class="odd">
<td>L5688</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, waist belt, webbing</td>
<td>Bk waist belt webbing</td>
</tr>
<tr class="even">
<td>L5690</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, below knee, waist belt, padded and lined</td>
<td>Bk waist belt padded and lin</td>
</tr>
<tr class="odd">
<td>L5692</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, above knee, pelvic control belt, light</td>
<td>Ak pelvic control belt light</td>
</tr>
<tr class="even">
<td>L5694</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, above knee, pelvic control belt, padded and lined</td>
<td>Ak pelvic control belt pad/l</td>
</tr>
<tr class="odd">
<td>L5695</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, above knee, pelvic control, sleeve suspension, neoprene or equal, each</td>
<td>Ak sleeve susp neoprene/equa</td>
</tr>
<tr class="even">
<td>L5696</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, above knee or knee disarticulation, pelvic joint</td>
<td>Ak/knee disartic pelvic join</td>
</tr>
<tr class="odd">
<td>L5697</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, above knee or knee disarticulation, pelvic band</td>
<td>Ak/knee disartic pelvic band</td>
</tr>
<tr class="even">
<td>L5698</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity, above knee or knee disarticulation, silesian bandage</td>
<td>Ak/knee disartic silesian ba</td>
</tr>
<tr class="odd">
<td>L5699</td>
<td>0010</td>
<td>3</td>
<td>All lower extremity prostheses, shoulder harness</td>
<td>Shoulder harness</td>
</tr>
<tr class="even">
<td>L5700</td>
<td>0010</td>
<td>3</td>
<td>Replacement, socket, below knee, molded to patient model</td>
<td>Replace socket below knee</td>
</tr>
<tr class="odd">
<td>L5701</td>
<td>0010</td>
<td>3</td>
<td>Replacement, socket, above knee/knee disarticulation, including attachment plate, molded to patient model</td>
<td>Replace socket above knee</td>
</tr>
<tr class="even">
<td>L5702</td>
<td>0010</td>
<td>3</td>
<td>Replacement, socket, hip disarticulation, including hip joint, molded to patient model</td>
<td>Replace socket hip</td>
</tr>
<tr class="odd">
<td>L5703</td>
<td>0010</td>
<td>3</td>
<td>Ankle, symes, molded to patient model, socket without solid ankle cushion heel (sach) foot, replacement only</td>
<td>Symes ankle w/o (sach) foot</td>
</tr>
<tr class="even">
<td>L5704</td>
<td>0010</td>
<td>3</td>
<td>Custom shaped protective cover, below knee</td>
<td>Custom shape cover bk</td>
</tr>
<tr class="odd">
<td>L5705</td>
<td>0010</td>
<td>3</td>
<td>Custom shaped protective cover, above knee</td>
<td>Custom shape cover ak</td>
</tr>
<tr class="even">
<td>L5706</td>
<td>0010</td>
<td>3</td>
<td>Custom shaped protective cover, knee disarticulation</td>
<td>Custom shape cvr knee disart</td>
</tr>
<tr class="odd">
<td>L5707</td>
<td>0010</td>
<td>3</td>
<td>Custom shaped protective cover, hip disarticulation</td>
<td>Custom shape cvr hip disart</td>
</tr>
<tr class="even">
<td>L5710</td>
<td>0010</td>
<td>3</td>
<td>Addition, exoskeletal knee-shin system, single axis, manual lock</td>
<td>Kne-shin exo sng axi mnl loc</td>
</tr>
<tr class="odd">
<td>L5711</td>
<td>0010</td>
<td>3</td>
<td>Additions exoskeletal knee-shin system, single axis, manual lock, ultra-light material</td>
<td>Knee-shin exo mnl lock ultra</td>
</tr>
<tr class="even">
<td>L5712</td>
<td>0010</td>
<td>3</td>
<td>Addition, exoskeletal knee-shin system, single axis, friction swing and stance phase control (safety knee)</td>
<td>Knee-shin exo frict swg &amp; st</td>
</tr>
<tr class="odd">
<td>L5714</td>
<td>0010</td>
<td>3</td>
<td>Addition, exoskeletal knee-shin system, single axis, variable friction swing phase control</td>
<td>Knee-shin exo variable frict</td>
</tr>
<tr class="even">
<td>L5716</td>
<td>0010</td>
<td>3</td>
<td>Addition, exoskeletal knee-shin system, polycentric, mechanical stance phase lock</td>
<td>Knee-shin exo mech stance ph</td>
</tr>
<tr class="odd">
<td>L5718</td>
<td>0010</td>
<td>3</td>
<td>Addition, exoskeletal knee-shin system, polycentric, friction swing and stance phase control</td>
<td>Knee-shin exo frct swg &amp; sta</td>
</tr>
<tr class="even">
<td>L5722</td>
<td>0010</td>
<td>3</td>
<td>Addition, exoskeletal knee-shin system, single axis, pneumatic swing, friction stance phase control</td>
<td>Knee-shin pneum swg frct exo</td>
</tr>
<tr class="odd">
<td>L5724</td>
<td>0010</td>
<td>3</td>
<td>Addition, exoskeletal knee-shin system, single axis, fluid swing phase control</td>
<td>Knee-shin exo fluid swing ph</td>
</tr>
<tr class="even">
<td>L5726</td>
<td>0010</td>
<td>3</td>
<td>Addition, exoskeletal knee-shin system, single axis, external joints fluid swing phase control</td>
<td>Knee-shin ext jnts fld swg e</td>
</tr>
<tr class="odd">
<td>L5728</td>
<td>0010</td>
<td>3</td>
<td>Addition, exoskeletal knee-shin system, single axis, fluid swing and stance phase control</td>
<td>Knee-shin fluid swg &amp; stance</td>
</tr>
<tr class="even">
<td>L5780</td>
<td>0010</td>
<td>3</td>
<td>Addition, exoskeletal knee-shin system, single axis, pneumatic/hydra pneumatic swing phase control</td>
<td>Knee-shin pneum/hydra pneum</td>
</tr>
<tr class="odd">
<td>L5781</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower limb prosthesis, vacuum pump, residual limb volume management and moisture evacuation system</td>
<td>Lower limb pros vacuum pump</td>
</tr>
<tr class="even">
<td>L5782</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower limb prosthesis, vacuum pump, residual limb volume management and moisture evacuation system, heavy duty</td>
<td>Hd low limb pros vacuum pump</td>
</tr>
<tr class="odd">
<td>L5785</td>
<td>0010</td>
<td>3</td>
<td>Addition, exoskeletal system, below knee, ultra-light material (titanium, carbon fiber or equal)</td>
<td>Exoskeletal bk ultralt mater</td>
</tr>
<tr class="even">
<td>L5790</td>
<td>0010</td>
<td>3</td>
<td>Addition, exoskeletal system, above knee, ultra-light material (titanium, carbon fiber or equal)</td>
<td>Exoskeletal ak ultra-light m</td>
</tr>
<tr class="odd">
<td>L5795</td>
<td>0010</td>
<td>3</td>
<td>Addition, exoskeletal system, hip disarticulation, ultra-light material (titanium, carbon fiber or equal)</td>
<td>Exoskel hip ultra-light mate</td>
</tr>
<tr class="even">
<td>L5810</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal knee-shin system, single axis, manual lock</td>
<td>Endoskel knee-shin mnl lock</td>
</tr>
<tr class="odd">
<td>L5811</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal knee-shin system, single axis, manual lock, ultra-light material</td>
<td>Endo knee-shin mnl lck ultra</td>
</tr>
<tr class="even">
<td>L5812</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal knee-shin system, single axis, friction swing and stance phase control (safety knee)</td>
<td>Endo knee-shin frct swg &amp; st</td>
</tr>
<tr class="odd">
<td>L5814</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal knee-shin system, polycentric, hydraulic swing phase control, mechanical stance phase lock</td>
<td>Endo knee-shin hydral swg ph</td>
</tr>
<tr class="even">
<td>L5816</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal knee-shin system, polycentric, mechanical stance phase lock</td>
<td>Endo knee-shin polyc mch sta</td>
</tr>
<tr class="odd">
<td>L5818</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal knee-shin system, polycentric, friction swing, and stance phase control</td>
<td>Endo knee-shin frct swg &amp; st</td>
</tr>
<tr class="even">
<td>L5822</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal knee-shin system, single axis, pneumatic swing, friction stance phase control</td>
<td>Endo knee-shin pneum swg frc</td>
</tr>
<tr class="odd">
<td>L5824</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal knee-shin system, single axis, fluid swing phase control</td>
<td>Endo knee-shin fluid swing p</td>
</tr>
<tr class="even">
<td>L5826</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal knee-shin system, single axis, hydraulic swing phase control, with miniature high activity frame</td>
<td>Miniature knee joint</td>
</tr>
<tr class="odd">
<td>L5828</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal knee-shin system, single axis, fluid swing and stance phase control</td>
<td>Endo knee-shin fluid swg/sta</td>
</tr>
<tr class="even">
<td>L5830</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal knee-shin system, single axis, pneumatic/ swing phase control</td>
<td>Endo knee-shin pneum/swg pha</td>
</tr>
<tr class="odd">
<td>L5840</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal knee/shin system, 4-bar linkage or multiaxial, pneumatic swing phase control</td>
<td>Multi-axial knee/shin system</td>
</tr>
<tr class="even">
<td>L5845</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal, knee-shin system, stance flexion feature, adjustable</td>
<td>Knee-shin sys stance flexion</td>
</tr>
<tr class="odd">
<td>L5848</td>
<td>0010</td>
<td>3</td>
<td>Addition to endoskeletal knee-shin system, fluid stance extension, dampening feature, with or without adjustability</td>
<td>Knee-shin sys hydraul stance</td>
</tr>
<tr class="even">
<td>L5850</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal system, above knee or hip disarticulation, knee extension assist</td>
<td>Endo ak/hip knee extens assi</td>
</tr>
<tr class="odd">
<td>L5855</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal system, hip disarticulation, mechanical hip extension assist</td>
<td>Mech hip extension assist</td>
</tr>
<tr class="even">
<td>L5856</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing and stance phase, includes electronic sensor(s), any type</td>
<td>Elec knee-shin swing/stance</td>
</tr>
<tr class="odd">
<td>L5857</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing phase only, includes electronic sensor(s), any type</td>
<td>Elec knee-shin swing only</td>
</tr>
<tr class="even">
<td>L5858</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity prosthesis, endoskeletal knee shin system, microprocessor control feature, stance phase only, includes electronic sensor(s), any type</td>
<td>Stance phase only</td>
</tr>
<tr class="odd">
<td>L5859</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity prosthesis, endoskeletal knee-shin system, powered and programmable flexion/extension assist control, includes any type motor(s)</td>
<td>Knee-shin pro flex/ext cont</td>
</tr>
<tr class="even">
<td>L5910</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal system, below knee, alignable system</td>
<td>Endo below knee alignable sy</td>
</tr>
<tr class="odd">
<td>L5920</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal system, above knee or hip disarticulation, alignable system</td>
<td>Endo ak/hip alignable system</td>
</tr>
<tr class="even">
<td>L5925</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal system, above knee, knee disarticulation or hip disarticulation, manual lock</td>
<td>Above knee manual lock</td>
</tr>
<tr class="odd">
<td>L5930</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal system, high activity knee control frame</td>
<td>High activity knee frame</td>
</tr>
<tr class="even">
<td>L5940</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal system, below knee, ultra-light material (titanium, carbon fiber or equal)</td>
<td>Endo bk ultra-light material</td>
</tr>
<tr class="odd">
<td>L5950</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal system, above knee, ultra-light material (titanium, carbon fiber or equal)</td>
<td>Endo ak ultra-light material</td>
</tr>
<tr class="even">
<td>L5960</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal system, hip disarticulation, ultra-light material (titanium, carbon fiber or equal)</td>
<td>Endo hip ultra-light materia</td>
</tr>
<tr class="odd">
<td>L5961</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal system, polycentric hip joint, pneumatic or hydraulic control, rotation control, with or without flexion and/or extension control</td>
<td>Endo poly hip, pneu/hyd/rot</td>
</tr>
<tr class="even">
<td>L5962</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal system, below knee, flexible protective outer surface covering system</td>
<td>Below knee flex cover system</td>
</tr>
<tr class="odd">
<td>L5964</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal system, above knee, flexible protective outer surface covering system</td>
<td>Above knee flex cover system</td>
</tr>
<tr class="even">
<td>L5966</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal system, hip disarticulation, flexible protective outer surface covering system</td>
<td>Hip flexible cover system</td>
</tr>
<tr class="odd">
<td>L5968</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower limb prosthesis, multiaxial ankle with swing phase active dorsiflexion feature</td>
<td>Multiaxial ankle w dorsiflex</td>
</tr>
<tr class="even">
<td>L5969</td>
<td>0010</td>
<td>3</td>
<td>Addition, endoskeletal ankle-foot or ankle system, power assist, includes any type motor(s)</td>
<td>Ak/ft power asst incl motors</td>
</tr>
<tr class="odd">
<td>L5970</td>
<td>0010</td>
<td>3</td>
<td>All lower extremity prostheses, foot, external keel, sach foot</td>
<td>Foot external keel sach foot</td>
</tr>
<tr class="even">
<td>L5971</td>
<td>0010</td>
<td>3</td>
<td>All lower extremity prosthesis, solid ankle cushion heel (sach) foot, replacement only</td>
<td>Sach foot, replacement</td>
</tr>
<tr class="odd">
<td>L5972</td>
<td>0010</td>
<td>3</td>
<td>All lower extremity prostheses, foot, flexible keel</td>
<td>Flexible keel foot</td>
</tr>
<tr class="even">
<td>L5973</td>
<td>0010</td>
<td>3</td>
<td>Endoskeletal ankle foot system, microprocessor controlled feature, dorsiflexion and/or plantar flexion control, includes power source</td>
<td>Ank-foot sys dors-plant flex</td>
</tr>
<tr class="odd">
<td>L5974</td>
<td>0010</td>
<td>3</td>
<td>All lower extremity prostheses, foot, single axis ankle/foot</td>
<td>Foot single axis ankle/foot</td>
</tr>
<tr class="even">
<td>L5975</td>
<td>0010</td>
<td>3</td>
<td>All lower extremity prosthesis, combination single axis ankle and flexible keel foot</td>
<td>Combo ankle/foot prosthesis</td>
</tr>
<tr class="odd">
<td>L5976</td>
<td>0010</td>
<td>3</td>
<td>All lower extremity prostheses, energy storing foot (seattle carbon copy ii or equal)</td>
<td>Energy storing foot</td>
</tr>
<tr class="even">
<td>L5978</td>
<td>0010</td>
<td>3</td>
<td>All lower extremity prostheses, foot, multiaxial ankle/foot</td>
<td>Ft prosth multiaxial ankl/ft</td>
</tr>
<tr class="odd">
<td>L5979</td>
<td>0010</td>
<td>3</td>
<td>All lower extremity prosthesis, multi-axial ankle, dynamic response foot, one piece system</td>
<td>Multi-axial ankle/ft prosth</td>
</tr>
<tr class="even">
<td>L5980</td>
<td>0010</td>
<td>3</td>
<td>All lower extremity prostheses, flex foot system</td>
<td>Flex foot system</td>
</tr>
<tr class="odd">
<td>L5981</td>
<td>0010</td>
<td>3</td>
<td>All lower extremity prostheses, flex-walk system or equal</td>
<td>Flex-walk sys low ext prosth</td>
</tr>
<tr class="even">
<td>L5982</td>
<td>0010</td>
<td>3</td>
<td>All exoskeletal lower extremity prostheses, axial rotation unit</td>
<td>Exoskeletal axial rotation u</td>
</tr>
<tr class="odd">
<td>L5984</td>
<td>0010</td>
<td>3</td>
<td>All endoskeletal lower extremity prosthesis, axial rotation unit, with or without adjustability</td>
<td>Endoskeletal axial rotation</td>
</tr>
<tr class="even">
<td>L5985</td>
<td>0010</td>
<td>3</td>
<td>All endoskeletal lower extremity prostheses, dynamic prosthetic pylon</td>
<td>Lwr ext dynamic prosth pylon</td>
</tr>
<tr class="odd">
<td>L5986</td>
<td>0010</td>
<td>3</td>
<td>All lower extremity prostheses, multi-axial rotation unit (‘mcp’ or equal)</td>
<td>Multi-axial rotation unit</td>
</tr>
<tr class="even">
<td>L5987</td>
<td>0010</td>
<td>3</td>
<td>All lower extremity prosthesis, shank foot system with vertical loading pylon</td>
<td>Shank ft w vert load pylon</td>
</tr>
<tr class="odd">
<td>L5988</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower limb prosthesis, vertical shock reducing pylon feature</td>
<td>Vertical shock reducing pylo</td>
</tr>
<tr class="even">
<td>L5990</td>
<td>0010</td>
<td>3</td>
<td>Addition to lower extremity prosthesis, user adjustable heel height</td>
<td>User adjustable heel height</td>
</tr>
<tr class="odd">
<td>L5999</td>
<td>0010</td>
<td>3</td>
<td>Lower extremity prosthesis, not otherwise specified</td>
<td>Lowr extremity prosthes nos</td>
</tr>
<tr class="even">
<td>L6000</td>
<td>0010</td>
<td>3</td>
<td>Partial hand, thumb remaining</td>
<td>Part hand thumb rem</td>
</tr>
<tr class="odd">
<td>L6010</td>
<td>0010</td>
<td>3</td>
<td>Partial hand, little and/or ring finger remaining</td>
<td>Part hand little/ring</td>
</tr>
<tr class="even">
<td>L6020</td>
<td>0010</td>
<td>3</td>
<td>Partial hand, no finger remaining</td>
<td>Part hand no fingers</td>
</tr>
<tr class="odd">
<td>L6025</td>
<td>0010</td>
<td>3</td>
<td>Transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device</td>
<td>Part hand disart myoelectric</td>
</tr>
<tr class="even">
<td>L6026</td>
<td>0010</td>
<td>3</td>
<td>Transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device, excludes terminal device(s)</td>
<td>Part hand myo exclu term dev</td>
</tr>
<tr class="odd">
<td>L6050</td>
<td>0010</td>
<td>3</td>
<td>Wrist disarticulation, molded socket, flexible elbow hinges, triceps pad</td>
<td>Wrst mld sck flx hng tri pad</td>
</tr>
<tr class="even">
<td>L6055</td>
<td>0010</td>
<td>3</td>
<td>Wrist disarticulation, molded socket with expandable interface, flexible elbow hinges, triceps pad</td>
<td>Wrst mold sock w/exp interfa</td>
</tr>
<tr class="odd">
<td>L6100</td>
<td>0010</td>
<td>3</td>
<td>Below elbow, molded socket, flexible elbow hinge, triceps pad</td>
<td>Elb mold sock flex hinge pad</td>
</tr>
<tr class="even">
<td>L6110</td>
<td>0010</td>
<td>3</td>
<td>Below elbow, molded socket, (muenster or northwestern suspension types)</td>
<td>Elbow mold sock suspension t</td>
</tr>
<tr class="odd">
<td>L6120</td>
<td>0010</td>
<td>3</td>
<td>Below elbow, molded double wall split socket, step-up hinges, half cuff</td>
<td>Elbow mold doub splt soc ste</td>
</tr>
<tr class="even">
<td>L6130</td>
<td>0010</td>
<td>3</td>
<td>Below elbow, molded double wall split socket, stump activated locking hinge, half cuff</td>
<td>Elbow stump activated lock h</td>
</tr>
<tr class="odd">
<td>L6200</td>
<td>0010</td>
<td>3</td>
<td>Elbow disarticulation, molded socket, outside locking hinge, forearm</td>
<td>Elbow mold outsid lock hinge</td>
</tr>
<tr class="even">
<td>L6205</td>
<td>0010</td>
<td>3</td>
<td>Elbow disarticulation, molded socket with expandable interface, outside locking hinges, forearm</td>
<td>Elbow molded w/ expand inter</td>
</tr>
<tr class="odd">
<td>L6250</td>
<td>0010</td>
<td>3</td>
<td>Above elbow, molded double wall socket, internal locking elbow, forearm</td>
<td>Elbow inter loc elbow forarm</td>
</tr>
<tr class="even">
<td>L6300</td>
<td>0010</td>
<td>3</td>
<td>Shoulder disarticulation, molded socket, shoulder bulkhead, humeral section, internal locking elbow, forearm</td>
<td>Shlder disart int lock elbow</td>
</tr>
<tr class="odd">
<td>L6310</td>
<td>0010</td>
<td>3</td>
<td>Shoulder disarticulation, passive restoration (complete prosthesis)</td>
<td>Shoulder passive restor comp</td>
</tr>
<tr class="even">
<td>L6320</td>
<td>0010</td>
<td>3</td>
<td>Shoulder disarticulation, passive restoration (shoulder cap only)</td>
<td>Shoulder passive restor cap</td>
</tr>
<tr class="odd">
<td>L6350</td>
<td>0010</td>
<td>3</td>
<td>Interscapular thoracic, molded socket, shoulder bulkhead, humeral section, internal locking elbow, forearm</td>
<td>Thoracic intern lock elbow</td>
</tr>
<tr class="even">
<td>L6360</td>
<td>0010</td>
<td>3</td>
<td>Interscapular thoracic, passive restoration (complete prosthesis)</td>
<td>Thoracic passive restor comp</td>
</tr>
<tr class="odd">
<td>L6370</td>
<td>0010</td>
<td>3</td>
<td>Interscapular thoracic, passive restoration (shoulder cap only)</td>
<td>Thoracic passive restor cap</td>
</tr>
<tr class="even">
<td>L6380</td>
<td>0010</td>
<td>3</td>
<td>Immediate post surgical or early fitting, application of initial rigid dressing, including fitting alignment and suspension of components, and one cast change, wrist disarticulation or below elbow</td>
<td>Postop dsg cast chg wrst/elb</td>
</tr>
<tr class="odd">
<td>L6382</td>
<td>0010</td>
<td>3</td>
<td>Immediate post surgical or early fitting, application of initial rigid dressing including fitting alignment and suspension of components, and one cast change, elbow disarticulation or above elbow</td>
<td>Postop dsg cast chg elb dis/</td>
</tr>
<tr class="even">
<td>L6384</td>
<td>0010</td>
<td>3</td>
<td>Immediate post surgical or early fitting, application of initial rigid dressing including fitting alignment and suspension of components, and one cast change, shoulder disarticulation or interscapular thoracic</td>
<td>Postop dsg cast chg shlder/t</td>
</tr>
<tr class="odd">
<td>L6386</td>
<td>0010</td>
<td>3</td>
<td>Immediate post surgical or early fitting, each additional cast change and realignment</td>
<td>Postop ea cast chg &amp; realign</td>
</tr>
<tr class="even">
<td>L6388</td>
<td>0010</td>
<td>3</td>
<td>Immediate post surgical or early fitting, application of rigid dressing only</td>
<td>Postop applicat rigid dsg on</td>
</tr>
<tr class="odd">
<td>L6400</td>
<td>0010</td>
<td>3</td>
<td>Below elbow, molded socket, endoskeletal system, including soft prosthetic tissue shaping</td>
<td>Below elbow prosth tiss shap</td>
</tr>
<tr class="even">
<td>L6450</td>
<td>0010</td>
<td>3</td>
<td>Elbow disarticulation, molded socket, endoskeletal system, including soft prosthetic tissue shaping</td>
<td>Elb disart prosth tiss shap</td>
</tr>
<tr class="odd">
<td>L6500</td>
<td>0010</td>
<td>3</td>
<td>Above elbow, molded socket, endoskeletal system, including soft prosthetic tissue shaping</td>
<td>Above elbow prosth tiss shap</td>
</tr>
<tr class="even">
<td>L6550</td>
<td>0010</td>
<td>3</td>
<td>Shoulder disarticulation, molded socket, endoskeletal system, including soft prosthetic tissue shaping</td>
<td>Shldr disar prosth tiss shap</td>
</tr>
<tr class="odd">
<td>L6570</td>
<td>0010</td>
<td>3</td>
<td>Interscapular thoracic, molded socket, endoskeletal system, including soft prosthetic tissue shaping</td>
<td>Scap thorac prosth tiss shap</td>
</tr>
<tr class="even">
<td>L6580</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, wrist disarticulation or below elbow, single wall plastic socket, friction wrist, flexible elbow hinges, figure of eight harness, humeral cuff, bowden cable control, usmc or equal pylon, no cover, molded to patient model</td>
<td>Wrist/elbow bowden cable mol</td>
</tr>
<tr class="odd">
<td>L6582</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, wrist disarticulation or below elbow, single wall socket, friction wrist, flexible elbow hinges, figure of eight harness, humeral cuff, bowden cable control, usmc or equal pylon, no cover, direct formed</td>
<td>Wrist/elbow bowden cbl dir f</td>
</tr>
<tr class="even">
<td>L6584</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, elbow disarticulation or above elbow, single wall plastic socket, friction wrist, locking elbow, figure of eight harness, fair lead cable control, usmc or equal pylon, no cover, molded to patient model</td>
<td>Elbow fair lead cable molded</td>
</tr>
<tr class="odd">
<td>L6586</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, elbow disarticulation or above elbow, single wall socket, friction wrist, locking elbow, figure of eight harness, fair lead cable control, usmc or equal pylon, no cover, direct formed</td>
<td>Elbow fair lead cable dir fo</td>
</tr>
<tr class="even">
<td>L6588</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, shoulder disarticulation or interscapular thoracic, single wall plastic socket, shoulder joint, locking elbow, friction wrist, chest strap, fair lead cable control, usmc or equal pylon, no cover, molded to patient model</td>
<td>Shdr fair lead cable molded</td>
</tr>
<tr class="odd">
<td>L6590</td>
<td>0010</td>
<td>3</td>
<td>Preparatory, shoulder disarticulation or interscapular thoracic, single wall socket, shoulder joint, locking elbow, friction wrist, chest strap, fair lead cable control, usmc or equal pylon, no cover, direct formed</td>
<td>Shdr fair lead cable direct</td>
</tr>
<tr class="even">
<td>L6600</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity additions, polycentric hinge, pair</td>
<td>Polycentric hinge pair</td>
</tr>
<tr class="odd">
<td>L6605</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity additions, single pivot hinge, pair</td>
<td>Single pivot hinge pair</td>
</tr>
<tr class="even">
<td>L6610</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity additions, flexible metal hinge, pair</td>
<td>Flexible metal hinge pair</td>
</tr>
<tr class="odd">
<td>L6611</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity prosthesis, external powered, additional switch, any type</td>
<td>Additional switch, ext power</td>
</tr>
<tr class="even">
<td>L6615</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, disconnect locking wrist unit</td>
<td>Disconnect locking wrist uni</td>
</tr>
<tr class="odd">
<td>L6616</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, additional disconnect insert for locking wrist unit, each</td>
<td>Disconnect insert locking wr</td>
</tr>
<tr class="even">
<td>L6620</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, flexion/extension wrist unit, with or without friction</td>
<td>Flexion/extension wrist unit</td>
</tr>
<tr class="odd">
<td>L6621</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity prosthesis addition, flexion/extension wrist with or without friction, for use with external powered terminal device</td>
<td>Flex/ext wrist w/wo friction</td>
</tr>
<tr class="even">
<td>L6623</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, spring assisted rotational wrist unit with latch release</td>
<td>Spring-ass rot wrst w/ latch</td>
</tr>
<tr class="odd">
<td>L6624</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, flexion/extension and rotation wrist unit</td>
<td>Flex/ext/rotation wrist unit</td>
</tr>
<tr class="even">
<td>L6625</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, rotation wrist unit with cable lock</td>
<td>Rotation wrst w/ cable lock</td>
</tr>
<tr class="odd">
<td>L6628</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, quick disconnect hook adapter, otto bock or equal</td>
<td>Quick disconn hook adapter o</td>
</tr>
<tr class="even">
<td>L6629</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, quick disconnect lamination collar with coupling piece, otto bock or equal</td>
<td>Lamination collar w/ couplin</td>
</tr>
<tr class="odd">
<td>L6630</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, stainless steel, any wrist</td>
<td>Stainless steel any wrist</td>
</tr>
<tr class="even">
<td>L6632</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, latex suspension sleeve, each</td>
<td>Latex suspension sleeve each</td>
</tr>
<tr class="odd">
<td>L6635</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, lift assist for elbow</td>
<td>Lift assist for elbow</td>
</tr>
<tr class="even">
<td>L6637</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, nudge control elbow lock</td>
<td>Nudge control elbow lock</td>
</tr>
<tr class="odd">
<td>L6638</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition to prosthesis, electric locking feature, only for use with manually powered elbow</td>
<td>Elec lock on manual pw elbow</td>
</tr>
<tr class="even">
<td>L6640</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity additions, shoulder abduction joint, pair</td>
<td>Shoulder abduction joint pai</td>
</tr>
<tr class="odd">
<td>L6641</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, excursion amplifier, pulley type</td>
<td>Excursion amplifier pulley t</td>
</tr>
<tr class="even">
<td>L6642</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, excursion amplifier, lever type</td>
<td>Excursion amplifier lever ty</td>
</tr>
<tr class="odd">
<td>L6645</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, shoulder flexion-abduction joint, each</td>
<td>Shoulder flexion-abduction j</td>
</tr>
<tr class="even">
<td>L6646</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, shoulder joint, multipositional locking, flexion, adjustable abduction friction control, for use with body powered or external powered system</td>
<td>Multipo locking shoulder jnt</td>
</tr>
<tr class="odd">
<td>L6647</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, shoulder lock mechanism, body powered actuator</td>
<td>Shoulder lock actuator</td>
</tr>
<tr class="even">
<td>L6648</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, shoulder lock mechanism, external powered actuator</td>
<td>Ext pwrd shlder lock/unlock</td>
</tr>
<tr class="odd">
<td>L6650</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, shoulder universal joint, each</td>
<td>Shoulder universal joint</td>
</tr>
<tr class="even">
<td>L6655</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, standard control cable, extra</td>
<td>Standard control cable extra</td>
</tr>
<tr class="odd">
<td>L6660</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, heavy duty control cable</td>
<td>Heavy duty control cable</td>
</tr>
<tr class="even">
<td>L6665</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, teflon, or equal, cable lining</td>
<td>Teflon or equal cable lining</td>
</tr>
<tr class="odd">
<td>L6670</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, hook to hand, cable adapter</td>
<td>Hook to hand cable adapter</td>
</tr>
<tr class="even">
<td>L6672</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, harness, chest or shoulder, saddle type</td>
<td>Harness chest/shlder saddle</td>
</tr>
<tr class="odd">
<td>L6675</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, harness, (e.g., figure of eight type), single cable design</td>
<td>Harness figure of 8 sing con</td>
</tr>
<tr class="even">
<td>L6676</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, harness, (e.g., figure of eight type), dual cable design</td>
<td>Harness figure of 8 dual con</td>
</tr>
<tr class="odd">
<td>L6677</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, harness, triple control, simultaneous operation of terminal device and elbow</td>
<td>Ue triple control harness</td>
</tr>
<tr class="even">
<td>L6680</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, test socket, wrist disarticulation or below elbow</td>
<td>Test sock wrist disart/bel e</td>
</tr>
<tr class="odd">
<td>L6682</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, test socket, elbow disarticulation or above elbow</td>
<td>Test sock elbw disart/above</td>
</tr>
<tr class="even">
<td>L6684</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, test socket, shoulder disarticulation or interscapular thoracic</td>
<td>Test socket shldr disart/tho</td>
</tr>
<tr class="odd">
<td>L6686</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, suction socket</td>
<td>Suction socket</td>
</tr>
<tr class="even">
<td>L6687</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, frame type socket, below elbow or wrist disarticulation</td>
<td>Frame typ socket bel elbow/w</td>
</tr>
<tr class="odd">
<td>L6688</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, frame type socket, above elbow or elbow disarticulation</td>
<td>Frame typ sock above elb/dis</td>
</tr>
<tr class="even">
<td>L6689</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, frame type socket, shoulder disarticulation</td>
<td>Frame typ socket shoulder di</td>
</tr>
<tr class="odd">
<td>L6690</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, frame type socket, interscapular-thoracic</td>
<td>Frame typ sock interscap-tho</td>
</tr>
<tr class="even">
<td>L6691</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, removable insert, each</td>
<td>Removable insert each</td>
</tr>
<tr class="odd">
<td>L6692</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, silicone gel insert or equal, each</td>
<td>Silicone gel insert or equal</td>
</tr>
<tr class="even">
<td>L6693</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity addition, locking elbow, forearm counterbalance</td>
<td>Lockingelbow forearm cntrbal</td>
</tr>
<tr class="odd">
<td>L6694</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, for use with locking mechanism</td>
<td>Elbow socket ins use w/lock</td>
</tr>
<tr class="even">
<td>L6695</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, not for use with locking mechanism</td>
<td>Elbow socket ins use w/o lck</td>
</tr>
<tr class="odd">
<td>L6696</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated socket insert for congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l6694 or l6695)</td>
<td>Cus elbo skt in for con/atyp</td>
</tr>
<tr class="even">
<td>L6697</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated socket insert for other than congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l6694 or l6695)</td>
<td>Cus elbo skt in not con/atyp</td>
</tr>
<tr class="odd">
<td>L6698</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity prosthesis, below elbow/above elbow, lock mechanism, excludes socket insert</td>
<td>Below/above elbow lock mech</td>
</tr>
<tr class="even">
<td>L6703</td>
<td>0010</td>
<td>3</td>
<td>Terminal device, passive hand/mitt, any material, any size</td>
<td>Term dev, passive hand mitt</td>
</tr>
<tr class="odd">
<td>L6704</td>
<td>0010</td>
<td>3</td>
<td>Terminal device, sport/recreational/work attachment, any material, any size</td>
<td>Term dev, sport/rec/work att</td>
</tr>
<tr class="even">
<td>L6706</td>
<td>0010</td>
<td>3</td>
<td>Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined</td>
<td>Term dev mech hook vol open</td>
</tr>
<tr class="odd">
<td>L6707</td>
<td>0010</td>
<td>3</td>
<td>Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined</td>
<td>Term dev mech hook vol close</td>
</tr>
<tr class="even">
<td>L6708</td>
<td>0010</td>
<td>3</td>
<td>Terminal device, hand, mechanical, voluntary opening, any material, any size</td>
<td>Term dev mech hand vol open</td>
</tr>
<tr class="odd">
<td>L6709</td>
<td>0010</td>
<td>3</td>
<td>Terminal device, hand, mechanical, voluntary closing, any material, any size</td>
<td>Term dev mech hand vol close</td>
</tr>
<tr class="even">
<td>L6711</td>
<td>0010</td>
<td>3</td>
<td>Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined, pediatric</td>
<td>Ped term dev, hook, vol open</td>
</tr>
<tr class="odd">
<td>L6712</td>
<td>0010</td>
<td>3</td>
<td>Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined, pediatric</td>
<td>Ped term dev, hook, vol clos</td>
</tr>
<tr class="even">
<td>L6713</td>
<td>0010</td>
<td>3</td>
<td>Terminal device, hand, mechanical, voluntary opening, any material, any size, pediatric</td>
<td>Ped term dev, hand, vol open</td>
</tr>
<tr class="odd">
<td>L6714</td>
<td>0010</td>
<td>3</td>
<td>Terminal device, hand, mechanical, voluntary closing, any material, any size, pediatric</td>
<td>Ped term dev, hand, vol clos</td>
</tr>
<tr class="even">
<td>L6715</td>
<td>0010</td>
<td>3</td>
<td>Terminal device, multiple articulating digit, includes motor(s), initial issue or replacement</td>
<td>Term device, multi art digit</td>
</tr>
<tr class="odd">
<td>L6721</td>
<td>0010</td>
<td>3</td>
<td>Terminal device, hook or hand, heavy duty, mechanical, voluntary opening, any material, any size, lined or unlined</td>
<td>Hook/hand, hvy dty, vol open</td>
</tr>
<tr class="even">
<td>L6722</td>
<td>0010</td>
<td>3</td>
<td>Terminal device, hook or hand, heavy duty, mechanical, voluntary closing, any material, any size, lined or unlined</td>
<td>Hook/hand, hvy dty, vol clos</td>
</tr>
<tr class="odd">
<td>L6805</td>
<td>0010</td>
<td>3</td>
<td>Addition to terminal device, modifier wrist unit</td>
<td>Term dev modifier wrist unit</td>
</tr>
<tr class="even">
<td>L6810</td>
<td>0010</td>
<td>3</td>
<td>Addition to terminal device, precision pinch device</td>
<td>Term dev precision pinch dev</td>
</tr>
<tr class="odd">
<td>L6880</td>
<td>0010</td>
<td>3</td>
<td>Electric hand, switch or myoelectric controlled, independently articulating digits, any grasp pattern or combination of grasp patterns, includes motor(s)</td>
<td>Elec hand ind art digits</td>
</tr>
<tr class="even">
<td>L6881</td>
<td>0010</td>
<td>3</td>
<td>Automatic grasp feature, addition to upper limb electric prosthetic terminal device</td>
<td>Term dev auto grasp feature</td>
</tr>
<tr class="odd">
<td>L6882</td>
<td>0010</td>
<td>3</td>
<td>Microprocessor control feature, addition to upper limb prosthetic terminal device</td>
<td>Microprocessor control uplmb</td>
</tr>
<tr class="even">
<td>L6883</td>
<td>0010</td>
<td>3</td>
<td>Replacement socket, below elbow/wrist disarticulation, molded to patient model, for use with or without external power</td>
<td>Replc sockt below e/w disa</td>
</tr>
<tr class="odd">
<td>L6884</td>
<td>0010</td>
<td>3</td>
<td>Replacement socket, above elbow/elbow disarticulation, molded to patient model, for use with or without external power</td>
<td>Replc sockt above elbow disa</td>
</tr>
<tr class="even">
<td>L6885</td>
<td>0010</td>
<td>3</td>
<td>Replacement socket, shoulder disarticulation/interscapular thoracic, molded to patient model, for use with or without external power</td>
<td>Replc sockt shldr dis/interc</td>
</tr>
<tr class="odd">
<td>L6890</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity prosthesis, glove for terminal device, any material, prefabricated, includes fitting and adjustment</td>
<td>Prefab glove for term device</td>
</tr>
<tr class="even">
<td>L6895</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity prosthesis, glove for terminal device, any material, custom fabricated</td>
<td>Custom glove for term device</td>
</tr>
<tr class="odd">
<td>L6900</td>
<td>0010</td>
<td>3</td>
<td>Hand restoration (casts, shading and measurements included), partial hand, with glove, thumb or one finger remaining</td>
<td>Hand restorat thumb/1 finger</td>
</tr>
<tr class="even">
<td>L6905</td>
<td>0010</td>
<td>3</td>
<td>Hand restoration (casts, shading and measurements included), partial hand, with glove, multiple fingers remaining</td>
<td>Hand restoration multiple fi</td>
</tr>
<tr class="odd">
<td>L6910</td>
<td>0010</td>
<td>3</td>
<td>Hand restoration (casts, shading and measurements included), partial hand, with glove, no fingers remaining</td>
<td>Hand restoration no fingers</td>
</tr>
<tr class="even">
<td>L6915</td>
<td>0010</td>
<td>3</td>
<td>Hand restoration (shading, and measurements included), replacement glove for above</td>
<td>Hand restoration replacmnt g</td>
</tr>
<tr class="odd">
<td>L6920</td>
<td>0010</td>
<td>3</td>
<td>Wrist disarticulation, external power, self-suspended inner socket, removable forearm shell, otto bock or equal, switch, cables, two batteries and one charger, switch control of terminal device</td>
<td>Wrist disarticul switch ctrl</td>
</tr>
<tr class="even">
<td>L6925</td>
<td>0010</td>
<td>3</td>
<td>Wrist disarticulation, external power, self-suspended inner socket, removable forearm shell, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device</td>
<td>Wrist disart myoelectronic c</td>
</tr>
<tr class="odd">
<td>L6930</td>
<td>0010</td>
<td>3</td>
<td>Below elbow, external power, self-suspended inner socket, removable forearm shell, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device</td>
<td>Below elbow switch control</td>
</tr>
<tr class="even">
<td>L6935</td>
<td>0010</td>
<td>3</td>
<td>Below elbow, external power, self-suspended inner socket, removable forearm shell, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device</td>
<td>Below elbow myoelectronic ct</td>
</tr>
<tr class="odd">
<td>L6940</td>
<td>0010</td>
<td>3</td>
<td>Elbow disarticulation, external power, molded inner socket, removable humeral shell, outside locking hinges, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device</td>
<td>Elbow disarticulation switch</td>
</tr>
<tr class="even">
<td>L6945</td>
<td>0010</td>
<td>3</td>
<td>Elbow disarticulation, external power, molded inner socket, removable humeral shell, outside locking hinges, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device</td>
<td>Elbow disart myoelectronic c</td>
</tr>
<tr class="odd">
<td>L6950</td>
<td>0010</td>
<td>3</td>
<td>Above elbow, external power, molded inner socket, removable humeral shell, internal locking elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device</td>
<td>Above elbow switch control</td>
</tr>
<tr class="even">
<td>L6955</td>
<td>0010</td>
<td>3</td>
<td>Above elbow, external power, molded inner socket, removable humeral shell, internal locking elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device</td>
<td>Above elbow myoelectronic ct</td>
</tr>
<tr class="odd">
<td>L6960</td>
<td>0010</td>
<td>3</td>
<td>Shoulder disarticulation, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device</td>
<td>Shldr disartic switch contro</td>
</tr>
<tr class="even">
<td>L6965</td>
<td>0010</td>
<td>3</td>
<td>Shoulder disarticulation, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device</td>
<td>Shldr disartic myoelectronic</td>
</tr>
<tr class="odd">
<td>L6970</td>
<td>0010</td>
<td>3</td>
<td>Interscapular-thoracic, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device</td>
<td>Interscapular-thor switch ct</td>
</tr>
<tr class="even">
<td>L6975</td>
<td>0010</td>
<td>3</td>
<td>Interscapular-thoracic, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device</td>
<td>Interscap-thor myoelectronic</td>
</tr>
<tr class="odd">
<td>L7007</td>
<td>0010</td>
<td>3</td>
<td>Electric hand, switch or myoelectric controlled, adult</td>
<td>Adult electric hand</td>
</tr>
<tr class="even">
<td>L7008</td>
<td>0010</td>
<td>3</td>
<td>Electric hand, switch or myoelectric, controlled, pediatric</td>
<td>Pediatric electric hand</td>
</tr>
<tr class="odd">
<td>L7009</td>
<td>0010</td>
<td>3</td>
<td>Electric hook, switch or myoelectric controlled, adult</td>
<td>Adult electric hook</td>
</tr>
<tr class="even">
<td>L7040</td>
<td>0010</td>
<td>3</td>
<td>Prehensile actuator, switch controlled</td>
<td>Prehensile actuator</td>
</tr>
<tr class="odd">
<td>L7045</td>
<td>0010</td>
<td>3</td>
<td>Electric hook, switch or myoelectric controlled, pediatric</td>
<td>Pediatric electric hook</td>
</tr>
<tr class="even">
<td>L7170</td>
<td>0010</td>
<td>3</td>
<td>Electronic elbow, hosmer or equal, switch controlled</td>
<td>Electronic elbow hosmer swit</td>
</tr>
<tr class="odd">
<td>L7180</td>
<td>0010</td>
<td>3</td>
<td>Electronic elbow, microprocessor sequential control of elbow and terminal device</td>
<td>Electronic elbow sequential</td>
</tr>
<tr class="even">
<td>L7181</td>
<td>0010</td>
<td>3</td>
<td>Electronic elbow, microprocessor simultaneous control of elbow and terminal device</td>
<td>Electronic elbo simultaneous</td>
</tr>
<tr class="odd">
<td>L7185</td>
<td>0010</td>
<td>3</td>
<td>Electronic elbow, adolescent, variety village or equal, switch controlled</td>
<td>Electron elbow adolescent sw</td>
</tr>
<tr class="even">
<td>L7186</td>
<td>0010</td>
<td>3</td>
<td>Electronic elbow, child, variety village or equal, switch controlled</td>
<td>Electron elbow child switch</td>
</tr>
<tr class="odd">
<td>L7190</td>
<td>0010</td>
<td>3</td>
<td>Electronic elbow, adolescent, variety village or equal, myoelectronically controlled</td>
<td>Elbow adolescent myoelectron</td>
</tr>
<tr class="even">
<td>L7191</td>
<td>0010</td>
<td>3</td>
<td>Electronic elbow, child, variety village or equal, myoelectronically controlled</td>
<td>Elbow child myoelectronic ct</td>
</tr>
<tr class="odd">
<td>L7259</td>
<td>0010</td>
<td>3</td>
<td>Electronic wrist rotator, any type</td>
<td>Electronic wrist rotator any</td>
</tr>
<tr class="even">
<td>L7260</td>
<td>0010</td>
<td>3</td>
<td>Electronic wrist rotator, otto bock or equal</td>
<td>Electron wrist rotator otto</td>
</tr>
<tr class="odd">
<td>L7261</td>
<td>0010</td>
<td>3</td>
<td>Electronic wrist rotator, for utah arm</td>
<td>Electron wrist rotator utah</td>
</tr>
<tr class="even">
<td>L7360</td>
<td>0010</td>
<td>3</td>
<td>Six volt battery, each</td>
<td>Six volt bat otto bock/eq ea</td>
</tr>
<tr class="odd">
<td>L7362</td>
<td>0010</td>
<td>3</td>
<td>Battery charger, six volt, each</td>
<td>Battery chrgr six volt otto</td>
</tr>
<tr class="even">
<td>L7364</td>
<td>0010</td>
<td>3</td>
<td>Twelve volt battery, each</td>
<td>Twelve volt battery utah/equ</td>
</tr>
<tr class="odd">
<td>L7366</td>
<td>0010</td>
<td>3</td>
<td>Battery charger, twelve volt, each</td>
<td>Battery chrgr 12 volt utah/e</td>
</tr>
<tr class="even">
<td>L7367</td>
<td>0010</td>
<td>3</td>
<td>Lithium ion battery, rechargeable, replacement</td>
<td>Replacemnt lithium ionbatter</td>
</tr>
<tr class="odd">
<td>L7368</td>
<td>0010</td>
<td>3</td>
<td>Lithium ion battery charger, replacement only</td>
<td>Lithium ion battery charger</td>
</tr>
<tr class="even">
<td>L7400</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity prosthesis, below elbow/wrist disarticulation, ultralight material (titanium, carbon fiber or equal)</td>
<td>Add ue prost be/wd, ultlite</td>
</tr>
<tr class="odd">
<td>L7401</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity prosthesis, above elbow disarticulation, ultralight material (titanium, carbon fiber or equal)</td>
<td>Add ue prost a/e ultlite mat</td>
</tr>
<tr class="even">
<td>L7402</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity prosthesis, shoulder disarticulation/interscapular thoracic, ultralight material (titanium, carbon fiber or equal)</td>
<td>Add ue prost s/d ultlite mat</td>
</tr>
<tr class="odd">
<td>L7403</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity prosthesis, below elbow/wrist disarticulation, acrylic material</td>
<td>Add ue prost b/e acrylic</td>
</tr>
<tr class="even">
<td>L7404</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity prosthesis, above elbow disarticulation, acrylic material</td>
<td>Add ue prost a/e acrylic</td>
</tr>
<tr class="odd">
<td>L7405</td>
<td>0010</td>
<td>3</td>
<td>Addition to upper extremity prosthesis, shoulder disarticulation/interscapular thoracic, acrylic material</td>
<td>Add ue prost s/d acrylic</td>
</tr>
<tr class="even">
<td>L7499</td>
<td>0010</td>
<td>3</td>
<td>Upper extremity prosthesis, not otherwise specified</td>
<td>Upper extremity prosthes nos</td>
</tr>
<tr class="odd">
<td>L7510</td>
<td>0010</td>
<td>3</td>
<td>Repair of prosthetic device, repair or replace minor parts</td>
<td>Prosthetic device repair rep</td>
</tr>
<tr class="even">
<td>L7520</td>
<td>0010</td>
<td>3</td>
<td>Repair prosthetic device, labor component, per 15 minutes</td>
<td>Repair prosthesis per 15 min</td>
</tr>
<tr class="odd">
<td>L7600</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic donning sleeve, any material, each</td>
<td>Prosthetic donning sleeve</td>
</tr>
<tr class="even">
<td>L7700</td>
<td>0010</td>
<td>3</td>
<td>Gasket or seal, for use with prosthetic socket insert, any type, each</td>
<td>Pros soc insert gasket/seal</td>
</tr>
<tr class="odd">
<td>L7900</td>
<td>0010</td>
<td>3</td>
<td>Male vacuum erection system</td>
<td>Male vacuum erection system</td>
</tr>
<tr class="even">
<td>L7902</td>
<td>0010</td>
<td>3</td>
<td>Tension ring, for vacuum erection device, any type, replacement only, each</td>
<td>Tension ring, vac erect dev</td>
</tr>
<tr class="odd">
<td>L8000</td>
<td>0010</td>
<td>3</td>
<td>Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type</td>
<td>Mastectomy bra</td>
</tr>
<tr class="even">
<td>L8001</td>
<td>0010</td>
<td>3</td>
<td>Breast prosthesis, mastectomy bra, with integrated breast prosthesis form, unilateral, any size, any type</td>
<td>Breast prosthesis bra &amp; form</td>
</tr>
<tr class="odd">
<td>L8002</td>
<td>0010</td>
<td>3</td>
<td>Breast prosthesis, mastectomy bra, with integrated breast prosthesis form, bilateral, any size, any type</td>
<td>Brst prsth bra &amp; bilat form</td>
</tr>
<tr class="even">
<td>L8010</td>
<td>0010</td>
<td>3</td>
<td>Breast prosthesis, mastectomy sleeve</td>
<td>Mastectomy sleeve</td>
</tr>
<tr class="odd">
<td>L8015</td>
<td>0010</td>
<td>3</td>
<td>External breast prosthesis garment, with mastectomy form, post mastectomy</td>
<td>Ext breastprosthesis garment</td>
</tr>
<tr class="even">
<td>L8020</td>
<td>0010</td>
<td>3</td>
<td>Breast prosthesis, mastectomy form</td>
<td>Mastectomy form</td>
</tr>
<tr class="odd">
<td>L8030</td>
<td>0010</td>
<td>3</td>
<td>Breast prosthesis, silicone or equal, without integral adhesive</td>
<td>Breast prosthes w/o adhesive</td>
</tr>
<tr class="even">
<td>L8031</td>
<td>0010</td>
<td>3</td>
<td>Breast prosthesis, silicone or equal, with integral adhesive</td>
<td>Breast prosthesis w adhesive</td>
</tr>
<tr class="odd">
<td>L8032</td>
<td>0010</td>
<td>3</td>
<td>Nipple prosthesis, prefabricated, reusable, any type, each</td>
<td>Reusable nipple prosthesis</td>
</tr>
<tr class="even">
<td>L8033</td>
<td>0010</td>
<td>3</td>
<td>Nipple prosthesis, custom fabricated, reusable, any material, any type, each</td>
<td>Nipple prosthesis custom, ea</td>
</tr>
<tr class="odd">
<td>L8035</td>
<td>0010</td>
<td>3</td>
<td>Custom breast prosthesis, post mastectomy, molded to patient model</td>
<td>Custom breast prosthesis</td>
</tr>
<tr class="even">
<td>L8039</td>
<td>0010</td>
<td>3</td>
<td>Breast prosthesis, not otherwise specified</td>
<td>Breast prosthesis nos</td>
</tr>
<tr class="odd">
<td>L8040</td>
<td>0010</td>
<td>3</td>
<td>Nasal prosthesis, provided by a non-physician</td>
<td>Nasal prosthesis</td>
</tr>
<tr class="even">
<td>L8041</td>
<td>0010</td>
<td>3</td>
<td>Midfacial prosthesis, provided by a non-physician</td>
<td>Midfacial prosthesis</td>
</tr>
<tr class="odd">
<td>L8042</td>
<td>0010</td>
<td>3</td>
<td>Orbital prosthesis, provided by a non-physician</td>
<td>Orbital prosthesis</td>
</tr>
<tr class="even">
<td>L8043</td>
<td>0010</td>
<td>3</td>
<td>Upper facial prosthesis, provided by a non-physician</td>
<td>Upper facial prosthesis</td>
</tr>
<tr class="odd">
<td>L8044</td>
<td>0010</td>
<td>3</td>
<td>Hemi-facial prosthesis, provided by a non-physician</td>
<td>Hemi-facial prosthesis</td>
</tr>
<tr class="even">
<td>L8045</td>
<td>0010</td>
<td>3</td>
<td>Auricular prosthesis, provided by a non-physician</td>
<td>Auricular prosthesis</td>
</tr>
<tr class="odd">
<td>L8046</td>
<td>0010</td>
<td>3</td>
<td>Partial facial prosthesis, provided by a non-physician</td>
<td>Partial facial prosthesis</td>
</tr>
<tr class="even">
<td>L8047</td>
<td>0010</td>
<td>3</td>
<td>Nasal septal prosthesis, provided by a non-physician</td>
<td>Nasal septal prosthesis</td>
</tr>
<tr class="odd">
<td>L8048</td>
<td>0010</td>
<td>3</td>
<td>Unspecified maxillofacial prosthesis, by report, provided by a non-physician</td>
<td>Unspec maxillofacial prosth</td>
</tr>
<tr class="even">
<td>L8049</td>
<td>0010</td>
<td>3</td>
<td>Repair or modification of maxillofacial prosthesis, labor component, 15 minute increments, provided by a non-physician</td>
<td>Repair maxillofacial prosth</td>
</tr>
<tr class="odd">
<td>L8300</td>
<td>0010</td>
<td>3</td>
<td>Truss, single with standard pad</td>
<td>Truss single w/ standard pad</td>
</tr>
<tr class="even">
<td>L8310</td>
<td>0010</td>
<td>3</td>
<td>Truss, double with standard pads</td>
<td>Truss double w/ standard pad</td>
</tr>
<tr class="odd">
<td>L8320</td>
<td>0010</td>
<td>3</td>
<td>Truss, addition to standard pad, water pad</td>
<td>Truss addition to std pad wa</td>
</tr>
<tr class="even">
<td>L8330</td>
<td>0010</td>
<td>3</td>
<td>Truss, addition to standard pad, scrotal pad</td>
<td>Truss add to std pad scrotal</td>
</tr>
<tr class="odd">
<td>L8400</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic sheath, below knee, each</td>
<td>Sheath below knee</td>
</tr>
<tr class="even">
<td>L8410</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic sheath, above knee, each</td>
<td>Sheath above knee</td>
</tr>
<tr class="odd">
<td>L8415</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic sheath, upper limb, each</td>
<td>Sheath upper limb</td>
</tr>
<tr class="even">
<td>L8417</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic sheath/sock, including a gel cushion layer, below knee or above knee, each</td>
<td>Pros sheath/sock w gel cushn</td>
</tr>
<tr class="odd">
<td>L8420</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic sock, multiple ply, below knee, each</td>
<td>Prosthetic sock multi ply bk</td>
</tr>
<tr class="even">
<td>L8430</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic sock, multiple ply, above knee, each</td>
<td>Prosthetic sock multi ply ak</td>
</tr>
<tr class="odd">
<td>L8435</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic sock, multiple ply, upper limb, each</td>
<td>Pros sock multi ply upper lm</td>
</tr>
<tr class="even">
<td>L8440</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic shrinker, below knee, each</td>
<td>Shrinker below knee</td>
</tr>
<tr class="odd">
<td>L8460</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic shrinker, above knee, each</td>
<td>Shrinker above knee</td>
</tr>
<tr class="even">
<td>L8465</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic shrinker, upper limb, each</td>
<td>Shrinker upper limb</td>
</tr>
<tr class="odd">
<td>L8470</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic sock, single ply, fitting, below knee, each</td>
<td>Pros sock single ply bk</td>
</tr>
<tr class="even">
<td>L8480</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic sock, single ply, fitting, above knee, each</td>
<td>Pros sock single ply ak</td>
</tr>
<tr class="odd">
<td>L8485</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic sock, single ply, fitting, upper limb, each</td>
<td>Pros sock single ply upper l</td>
</tr>
<tr class="even">
<td>L8499</td>
<td>0010</td>
<td>3</td>
<td>Unlisted procedure for miscellaneous prosthetic services</td>
<td>Unlisted misc prosthetic ser</td>
</tr>
<tr class="odd">
<td>L8500</td>
<td>0010</td>
<td>3</td>
<td>Artificial larynx, any type</td>
<td>Artificial larynx</td>
</tr>
<tr class="even">
<td>L8501</td>
<td>0010</td>
<td>3</td>
<td>Tracheostomy speaking valve</td>
<td>Tracheostomy speaking valve</td>
</tr>
<tr class="odd">
<td>L8505</td>
<td>0010</td>
<td>3</td>
<td>Artificial larynx replacement battery / accessory, any type</td>
<td>Artificial larynx, accessory</td>
</tr>
<tr class="even">
<td>L8507</td>
<td>0010</td>
<td>3</td>
<td>Tracheo-esophageal voice prosthesis, patient inserted, any type, each</td>
<td>Trach-esoph voice pros pt in</td>
</tr>
<tr class="odd">
<td>L8509</td>
<td>0010</td>
<td>3</td>
<td>Tracheo-esophageal voice prosthesis, inserted by a licensed health care provider, any type</td>
<td>Trach-esoph voice pros md in</td>
</tr>
<tr class="even">
<td>L8510</td>
<td>0010</td>
<td>3</td>
<td>Voice amplifier</td>
<td>Voice amplifier</td>
</tr>
<tr class="odd">
<td>L8511</td>
<td>0010</td>
<td>3</td>
<td>Insert for indwelling tracheoesophageal prosthesis, with or without valve, replacement only, each</td>
<td>Indwelling trach insert</td>
</tr>
<tr class="even">
<td>L8512</td>
<td>0010</td>
<td>3</td>
<td>Gelatin capsules or equivalent, for use with tracheoesophageal voice prosthesis, replacement only, per 10</td>
<td>Gel cap for trach voice pros</td>
</tr>
<tr class="odd">
<td>L8513</td>
<td>0010</td>
<td>3</td>
<td>Cleaning device used with tracheoesophageal voice prosthesis, pipet, brush, or equal, replacement only, each</td>
<td>Trach pros cleaning device</td>
</tr>
<tr class="even">
<td>L8514</td>
<td>0010</td>
<td>3</td>
<td>Tracheoesophageal puncture dilator, replacement only, each</td>
<td>Repl trach puncture dilator</td>
</tr>
<tr class="odd">
<td>L8515</td>
<td>0010</td>
<td>3</td>
<td>Gelatin capsule, application device for use with tracheoesophageal voice prosthesis, each</td>
<td>Gel cap app device for trach</td>
</tr>
<tr class="even">
<td>L8600</td>
<td>0010</td>
<td>3</td>
<td>Implantable breast prosthesis, silicone or equal</td>
<td>Implant breast silicone/eq</td>
</tr>
<tr class="odd">
<td>L8603</td>
<td>0010</td>
<td>3</td>
<td>Injectable bulking agent, collagen implant, urinary tract, 2.5 ml syringe, includes shipping and necessary supplies</td>
<td>Collagen imp urinary 2.5 ml</td>
</tr>
<tr class="even">
<td>L8604</td>
<td>0010</td>
<td>3</td>
<td>Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, urinary tract, 1 ml, includes shipping and necessary supplies</td>
<td>Dextranomer/hyaluronic acid</td>
</tr>
<tr class="odd">
<td>L8605</td>
<td>0010</td>
<td>3</td>
<td>Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, anal canal, 1 ml, includes shipping and necessary supplies</td>
<td>Inj bulking agent anal canal</td>
</tr>
<tr class="even">
<td>L8606</td>
<td>0010</td>
<td>3</td>
<td>Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies</td>
<td>Synthetic implnt urinary 1ml</td>
</tr>
<tr class="odd">
<td>L8607</td>
<td>0010</td>
<td>3</td>
<td>Injectable bulking agent for vocal cord medialization, 0.1 ml, includes shipping and necessary supplies</td>
<td>Inj vocal cord bulking agent</td>
</tr>
<tr class="even">
<td>L8608</td>
<td>0010</td>
<td>3</td>
<td>Miscellaneous external component, supply or accessory for use with the argus ii retinal prosthesis system</td>
<td>Arg ii ext com/sup/acc misc</td>
</tr>
<tr class="odd">
<td>L8609</td>
<td>0010</td>
<td>3</td>
<td>Artificial cornea</td>
<td>Artificial cornea</td>
</tr>
<tr class="even">
<td>L8610</td>
<td>0010</td>
<td>3</td>
<td>Ocular implant</td>
<td>Ocular implant</td>
</tr>
<tr class="odd">
<td>L8612</td>
<td>0010</td>
<td>3</td>
<td>Aqueous shunt</td>
<td>Aqueous shunt prosthesis</td>
</tr>
<tr class="even">
<td>L8613</td>
<td>0010</td>
<td>3</td>
<td>Ossicula implant</td>
<td>Ossicular implant</td>
</tr>
<tr class="odd">
<td>L8614</td>
<td>0010</td>
<td>3</td>
<td>Cochlear device, includes all internal and external components</td>
<td>Cochlear device</td>
</tr>
<tr class="even">
<td>L8615</td>
<td>0010</td>
<td>3</td>
<td>Headset/headpiece for use with cochlear implant device, replacement</td>
<td>Coch implant headset replace</td>
</tr>
<tr class="odd">
<td>L8616</td>
<td>0010</td>
<td>3</td>
<td>Microphone for use with cochlear implant device, replacement</td>
<td>Coch implant microphone repl</td>
</tr>
<tr class="even">
<td>L8617</td>
<td>0010</td>
<td>3</td>
<td>Transmitting coil for use with cochlear implant device, replacement</td>
<td>Coch implant trans coil repl</td>
</tr>
<tr class="odd">
<td>L8618</td>
<td>0010</td>
<td>3</td>
<td>Transmitter cable for use with cochlear implant device or auditory osseointegrated device, replacement</td>
<td>Coch implant tran cable repl</td>
</tr>
<tr class="even">
<td>L8619</td>
<td>0010</td>
<td>3</td>
<td>Cochlear implant, external speech processor and controller, integrated system, replacement</td>
<td>Coch imp ext proc/contr rplc</td>
</tr>
<tr class="odd">
<td>L8621</td>
<td>0010</td>
<td>3</td>
<td>Zinc air battery for use with cochlear implant device and auditory osseointegrated sound processors, replacement, each</td>
<td>Repl zinc air battery</td>
</tr>
<tr class="even">
<td>L8622</td>
<td>0010</td>
<td>3</td>
<td>Alkaline battery for use with cochlear implant device, any size, replacement, each</td>
<td>Repl alkaline battery</td>
</tr>
<tr class="odd">
<td>L8623</td>
<td>0010</td>
<td>3</td>
<td>Lithium ion battery for use with cochlear implant device speech processor, other than ear level, replacement, each</td>
<td>Lith ion batt cid,non-earlvl</td>
</tr>
<tr class="even">
<td>L8624</td>
<td>0010</td>
<td>3</td>
<td>Lithium ion battery for use with cochlear implant or auditory osseointegrated device speech processor, ear level, replacement, each</td>
<td>Lith ion batt cid, ear level</td>
</tr>
<tr class="odd">
<td>L8625</td>
<td>0010</td>
<td>3</td>
<td>External recharging system for battery for use with cochlear implant or auditory osseointegrated device, replacement only, each</td>
<td>Charger coch impl/aoi battry</td>
</tr>
<tr class="even">
<td>L8627</td>
<td>0010</td>
<td>3</td>
<td>Cochlear implant, external speech processor, component, replacement</td>
<td>Cid ext speech process repl</td>
</tr>
<tr class="odd">
<td>L8628</td>
<td>0010</td>
<td>3</td>
<td>Cochlear implant, external controller component, replacement</td>
<td>Cid ext controller repl</td>
</tr>
<tr class="even">
<td>L8629</td>
<td>0010</td>
<td>3</td>
<td>Transmitting coil and cable, integrated, for use with cochlear implant device, replacement</td>
<td>Cid transmit coil and cable</td>
</tr>
<tr class="odd">
<td>L8630</td>
<td>0010</td>
<td>3</td>
<td>Metacarpophalangeal joint implant</td>
<td>Metacarpophalangeal implant</td>
</tr>
<tr class="even">
<td>L8631</td>
<td>0010</td>
<td>3</td>
<td>Metacarpal phalangeal joint replacement, two or more pieces, metal (e.g., stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon), for surgical implantation (all sizes, includes entire system)</td>
<td>Mcp joint repl 2 pc or more</td>
</tr>
<tr class="odd">
<td>L8641</td>
<td>0010</td>
<td>3</td>
<td>Metatarsal joint implant</td>
<td>Metatarsal joint implant</td>
</tr>
<tr class="even">
<td>L8642</td>
<td>0010</td>
<td>3</td>
<td>Hallux implant</td>
<td>Hallux implant</td>
</tr>
<tr class="odd">
<td>L8658</td>
<td>0010</td>
<td>3</td>
<td>Interphalangeal joint spacer, silicone or equal, each</td>
<td>Interphalangeal joint spacer</td>
</tr>
<tr class="even">
<td>L8659</td>
<td>0010</td>
<td>3</td>
<td>Interphalangeal finger joint replacement, 2 or more pieces, metal (e.g., stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon) for surgical implantation, any size</td>
<td>Interphalangeal joint repl</td>
</tr>
<tr class="odd">
<td>L8670</td>
<td>0010</td>
<td>3</td>
<td>Vascular graft material, synthetic, implant</td>
<td>Vascular graft, synthetic</td>
</tr>
<tr class="even">
<td>L8679</td>
<td>0010</td>
<td>3</td>
<td>Implantable neurostimulator, pulse generator, any type</td>
<td>Imp neurosti pls gn any type</td>
</tr>
<tr class="odd">
<td>L8680</td>
<td>0010</td>
<td>3</td>
<td>Implantable neurostimulator electrode, each</td>
<td>Implt neurostim elctr each</td>
</tr>
<tr class="even">
<td>L8681</td>
<td>0010</td>
<td>3</td>
<td>Patient programmer (external) for use with implantable programmable neurostimulator pulse generator, replacement only</td>
<td>Pt prgrm for implt neurostim</td>
</tr>
<tr class="odd">
<td>L8682</td>
<td>0010</td>
<td>3</td>
<td>Implantable neurostimulator radiofrequency receiver</td>
<td>Implt neurostim radiofq rec</td>
</tr>
<tr class="even">
<td>L8683</td>
<td>0010</td>
<td>3</td>
<td>Radiofrequency transmitter (external) for use with implantable neurostimulator radiofrequency receiver</td>
<td>Radiofq trsmtr for implt neu</td>
</tr>
<tr class="odd">
<td>L8684</td>
<td>0010</td>
<td>3</td>
<td>Radiofrequency transmitter (external) for use with implantable sacral root neurostimulator receiver for bowel and bladder management, replacement</td>
<td>Radiof trsmtr implt scrl neu</td>
</tr>
<tr class="even">
<td>L8685</td>
<td>0010</td>
<td>3</td>
<td>Implantable neurostimulator pulse generator, single array, rechargeable, includes extension</td>
<td>Implt nrostm pls gen sng rec</td>
</tr>
<tr class="odd">
<td>L8686</td>
<td>0010</td>
<td>3</td>
<td>Implantable neurostimulator pulse generator, single array, non-rechargeable, includes extension</td>
<td>Implt nrostm pls gen sng non</td>
</tr>
<tr class="even">
<td>L8687</td>
<td>0010</td>
<td>3</td>
<td>Implantable neurostimulator pulse generator, dual array, rechargeable, includes extension</td>
<td>Implt nrostm pls gen dua rec</td>
</tr>
<tr class="odd">
<td>L8688</td>
<td>0010</td>
<td>3</td>
<td>Implantable neurostimulator pulse generator, dual array, non-rechargeable, includes extension</td>
<td>Implt nrostm pls gen dua non</td>
</tr>
<tr class="even">
<td>L8689</td>
<td>0010</td>
<td>3</td>
<td>External recharging system for battery (internal) for use with implantable neurostimulator, replacement only</td>
<td>External recharg sys intern</td>
</tr>
<tr class="odd">
<td>L8690</td>
<td>0010</td>
<td>3</td>
<td>Auditory osseointegrated device, includes all internal and external components</td>
<td>Aud osseo dev, int/ext comp</td>
</tr>
<tr class="even">
<td>L8691</td>
<td>0010</td>
<td>3</td>
<td>Auditory osseointegrated device, external sound processor, excludes transducer/actuator, replacement only, each</td>
<td>Aoi snd proc repl excl actua</td>
</tr>
<tr class="odd">
<td>L8692</td>
<td>0010</td>
<td>3</td>
<td>Auditory osseointegrated device, external sound processor, used without osseointegration, body worn, includes headband or other means of external attachment</td>
<td>Non-osseointegrated snd proc</td>
</tr>
<tr class="even">
<td>L8693</td>
<td>0010</td>
<td>3</td>
<td>Auditory osseointegrated device abutment, any length, replacement only</td>
<td>Aud osseo dev, abutment</td>
</tr>
<tr class="odd">
<td>L8694</td>
<td>0010</td>
<td>3</td>
<td>Auditory osseointegrated device, transducer/actuator, replacement only, each</td>
<td>Aoi transducer/actuator repl</td>
</tr>
<tr class="even">
<td>L8695</td>
<td>0010</td>
<td>3</td>
<td>External recharging system for battery (external) for use with implantable neurostimulator, replacement only</td>
<td>External recharg sys extern</td>
</tr>
<tr class="odd">
<td>L8696</td>
<td>0010</td>
<td>3</td>
<td>Antenna (external) for use with implantable diaphragmatic/phrenic nerve stimulation device, replacement, each</td>
<td>Ext antenna phren nerve stim</td>
</tr>
<tr class="even">
<td>L8698</td>
<td>0010</td>
<td>3</td>
<td>Miscellaneous component, supply or accessory for use with total artificial heart system</td>
<td>Misc used with tot art heart</td>
</tr>
<tr class="odd">
<td>L8699</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic implant, not otherwise specified</td>
<td>Prosthetic implant nos</td>
</tr>
<tr class="even">
<td>L8701</td>
<td>0010</td>
<td>3</td>
<td>Powered upper extremity range of motion assist device, elbow, wrist, hand with single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated</td>
<td>Pow ue rom dev ewh uprt cust</td>
</tr>
<tr class="odd">
<td>L8702</td>
<td>0010</td>
<td>3</td>
<td>Powered upper extremity range of motion assist device, elbow, wrist, hand, finger, single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated</td>
<td>Pow ue rom dev ewhf uprt cus</td>
</tr>
<tr class="even">
<td>L9900</td>
<td>0010</td>
<td>3</td>
<td>Orthotic and prosthetic supply, accessory, and/or service component of another hcpcs “l” code</td>
<td>O&amp;p supply/accessory/service</td>
</tr>
</tbody>
</table>
</div>
<div id="m-series-no-description" class="section level2">
<h2>M Series: No Description</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>M0064</td>
<td>0010</td>
<td>3</td>
<td>Brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders</td>
<td>Visit for drug monitoring</td>
</tr>
<tr class="even">
<td>M0075</td>
<td>0010</td>
<td>3</td>
<td>Cellular therapy</td>
<td>Cellular therapy</td>
</tr>
<tr class="odd">
<td>M0076</td>
<td>0010</td>
<td>3</td>
<td>Prolotherapy</td>
<td>Prolotherapy</td>
</tr>
<tr class="even">
<td>M0100</td>
<td>0010</td>
<td>3</td>
<td>Intragastric hypothermia using gastric freezing</td>
<td>Intragastric hypothermia</td>
</tr>
<tr class="odd">
<td>M0300</td>
<td>0010</td>
<td>3</td>
<td>Iv chelation therapy (chemical endarterectomy)</td>
<td>Iv chelationtherapy</td>
</tr>
<tr class="even">
<td>M0301</td>
<td>0010</td>
<td>3</td>
<td>Fabric wrapping of abdominal aneurysm</td>
<td>Fabric wrapping of aneurysm</td>
</tr>
<tr class="odd">
<td>M1000</td>
<td>0010</td>
<td>3</td>
<td>Pain screened as moderate to severe</td>
<td>Pain scr as mod to sevr</td>
</tr>
<tr class="even">
<td>M1001</td>
<td>0010</td>
<td>3</td>
<td>Plan of care to address moderate to severe pain documented on or before the date of the second visit with a clinician</td>
<td>Pln to adrs pain doc</td>
</tr>
<tr class="odd">
<td>M1002</td>
<td>0010</td>
<td>3</td>
<td>Plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not given</td>
<td>Pln to adrs pain not doc</td>
</tr>
<tr class="even">
<td>M1003</td>
<td>0010</td>
<td>3</td>
<td>Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic disease modifying anti-rheumatic drug therapy for ra</td>
<td>Tb scr 12 mo pri fst bio dz</td>
</tr>
<tr class="odd">
<td>M1004</td>
<td>0010</td>
<td>3</td>
<td>Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)</td>
<td>Doc med rsn no srn tb</td>
</tr>
<tr class="even">
<td>M1005</td>
<td>0010</td>
<td>3</td>
<td>Tb screening not performed or results not interpreted, reason not given</td>
<td>Tb scr no perf</td>
</tr>
<tr class="odd">
<td>M1006</td>
<td>0010</td>
<td>3</td>
<td>Disease activity not assessed, reason not given</td>
<td>Dz not ases, no rsn</td>
</tr>
<tr class="even">
<td>M1007</td>
<td>0010</td>
<td>3</td>
<td>&gt;=50% of total number of a patient’s outpatient ra encounters assessed</td>
<td>&gt;=50% total pt outpt ra enct</td>
</tr>
<tr class="odd">
<td>M1008</td>
<td>0010</td>
<td>3</td>
<td>&lt;50% of total number of a patient’s outpatient ra encounters assessed</td>
<td>&lt;50% total pt outpt ra encts</td>
</tr>
<tr class="even">
<td>M1009</td>
<td>0010</td>
<td>3</td>
<td>Discharge/discontinuation of the episode of care documented in the medical record</td>
<td>Dc eoc doc med rec</td>
</tr>
<tr class="odd">
<td>M1010</td>
<td>0010</td>
<td>3</td>
<td>Discharge/discontinuation of the episode of care documented in the medical record</td>
<td>Dc eoc doc med rec</td>
</tr>
<tr class="even">
<td>M1011</td>
<td>0010</td>
<td>3</td>
<td>Discharge/discontinuation of the episode of care documented in the medical record</td>
<td>Dc eoc doc med rec</td>
</tr>
<tr class="odd">
<td>M1012</td>
<td>0010</td>
<td>3</td>
<td>Discharge/discontinuation of the episode of care documented in the medical record</td>
<td>Dc eoc doc med rec</td>
</tr>
<tr class="even">
<td>M1013</td>
<td>0010</td>
<td>3</td>
<td>Discharge/discontinuation of the episode of care documented in the medical record</td>
<td>Dc eoc doc med rec</td>
</tr>
<tr class="odd">
<td>M1014</td>
<td>0010</td>
<td>3</td>
<td>Discharge/discontinuation of the episode of care documented in the medical record</td>
<td>Dc epi care doc medrec</td>
</tr>
<tr class="even">
<td>M1015</td>
<td>0010</td>
<td>3</td>
<td>Discharge/discontinuation of the episode of care documented in the medical record</td>
<td>Dc eoc doc med rec</td>
</tr>
<tr class="odd">
<td>M1016</td>
<td>0010</td>
<td>3</td>
<td>Female patients unable to bear children</td>
<td>Pt dx meop or sur steri</td>
</tr>
<tr class="even">
<td>M1017</td>
<td>0010</td>
<td>3</td>
<td>Patient admitted to palliative care services</td>
<td>Pt admt to palitve serv</td>
</tr>
<tr class="odd">
<td>M1018</td>
<td>0010</td>
<td>3</td>
<td>Patients with an active diagnosis or history of cancer (except basal cell and squamous cell skin carcinoma), patients who are heavy tobacco smokers, lung cancer screening patients</td>
<td>Pt dx hst cr pt sk lg cr scr</td>
</tr>
<tr class="even">
<td>M1019</td>
<td>0010</td>
<td>3</td>
<td>Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5</td>
<td>Adl pt mj dep ds rs 12 phq&lt;5</td>
</tr>
<tr class="odd">
<td>M1020</td>
<td>0010</td>
<td>3</td>
<td>Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score was not assessed or is greater than or equal to 5</td>
<td>Adl pt mj dep ds no rs 12 mo</td>
</tr>
<tr class="even">
<td>M1021</td>
<td>0010</td>
<td>3</td>
<td>Patient had only urgent care visits during the performance period</td>
<td>Pt uc in pp</td>
</tr>
<tr class="odd">
<td>M1022</td>
<td>0010</td>
<td>3</td>
<td>Patients who were in hospice at any time during the performance period</td>
<td>Pt hospice during perf pd</td>
</tr>
<tr class="even">
<td>M1023</td>
<td>0010</td>
<td>3</td>
<td>Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five</td>
<td>Adl pt mj dep ds rs 6 phq&lt;5</td>
</tr>
<tr class="odd">
<td>M1024</td>
<td>0010</td>
<td>3</td>
<td>Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to five</td>
<td>Adl pt mj dep ds no rs 6 mo</td>
</tr>
<tr class="even">
<td>M1025</td>
<td>0010</td>
<td>3</td>
<td>Patients who were in hospice at any time during the performance period</td>
<td>Pt hospice during perf pd</td>
</tr>
<tr class="odd">
<td>M1026</td>
<td>0010</td>
<td>3</td>
<td>Patients who were in hospice at any time during the performance period</td>
<td>Pt hospice during perf pd</td>
</tr>
<tr class="even">
<td>M1027</td>
<td>0010</td>
<td>3</td>
<td>Imaging of the head (ct or mri) was obtained</td>
<td>Img head (ct or mri) obtnd</td>
</tr>
<tr class="odd">
<td>M1028</td>
<td>0010</td>
<td>3</td>
<td>Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained</td>
<td>Doc of pt prm hda dx and otr</td>
</tr>
<tr class="even">
<td>M1029</td>
<td>0010</td>
<td>3</td>
<td>Imaging of the head (ct or mri) was not obtained, reason not given</td>
<td>Doc sysm rsn img hd</td>
</tr>
<tr class="odd">
<td>M1030</td>
<td>0010</td>
<td>3</td>
<td>Patients with clinical indications for imaging of the head</td>
<td>Pt clin ind img hd</td>
</tr>
<tr class="even">
<td>M1031</td>
<td>0010</td>
<td>3</td>
<td>Patients with no clinical indications for imaging of the head</td>
<td>Pt clin ind img hd</td>
</tr>
<tr class="odd">
<td>M1032</td>
<td>0010</td>
<td>3</td>
<td>Adults currently taking pharmacotherapy for oud</td>
<td>Adt tkng pharmthry for oud</td>
</tr>
<tr class="even">
<td>M1033</td>
<td>0010</td>
<td>3</td>
<td>Pharmacotherapy for oud initiated after june 30th of performance period</td>
<td>Pharmthry for oud afr 6.30</td>
</tr>
<tr class="odd">
<td>M1034</td>
<td>0010</td>
<td>3</td>
<td>Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days</td>
<td>Adt 180 dys pharmthry oud</td>
</tr>
<tr class="even">
<td>M1035</td>
<td>0010</td>
<td>3</td>
<td>Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment</td>
<td>Adt pd out mat pr 180 dys tx</td>
</tr>
<tr class="odd">
<td>M1036</td>
<td>0010</td>
<td>3</td>
<td>Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days</td>
<td>Adt no 180 dys pharmthry oud</td>
</tr>
<tr class="even">
<td>M1037</td>
<td>0010</td>
<td>3</td>
<td>Patients with a diagnosis of lumbar spine region cancer at the time of the procedure</td>
<td>Pt dx lum sp reg cacr</td>
</tr>
<tr class="odd">
<td>M1038</td>
<td>0010</td>
<td>3</td>
<td>Patients with a diagnosis of lumbar spine region fracture at the time of the procedure</td>
<td>Pt dx lum sp reg fract</td>
</tr>
<tr class="even">
<td>M1039</td>
<td>0010</td>
<td>3</td>
<td>Patients with a diagnosis of lumbar spine region infection at the time of the procedure</td>
<td>Pt dx lum sp reg inf</td>
</tr>
<tr class="odd">
<td>M1040</td>
<td>0010</td>
<td>3</td>
<td>Patients with a diagnosis of lumbar idiopathic or congenital scoliosis</td>
<td>Pt dx lum idi or cong scol</td>
</tr>
<tr class="even">
<td>M1041</td>
<td>0010</td>
<td>3</td>
<td>Patient had cancer, fracture or infection related to the lumbar spine or patient had idiopathic or congenital scoliosis</td>
<td>Pt cr ft inf lm or pt id sl</td>
</tr>
<tr class="odd">
<td>M1042</td>
<td>0010</td>
<td>3</td>
<td>Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively</td>
<td>Ftl st mea sco ot odi 3 mo</td>
</tr>
<tr class="even">
<td>M1043</td>
<td>0010</td>
<td>3</td>
<td>Functional status was not measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively</td>
<td>Fs no odi 9-15mo</td>
</tr>
<tr class="odd">
<td>M1044</td>
<td>0010</td>
<td>3</td>
<td>Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively</td>
<td>Ftl st mea odi 3 mo</td>
</tr>
<tr class="even">
<td>M1045</td>
<td>0010</td>
<td>3</td>
<td>Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was greater than or equal to 37</td>
<td>Fs oks 9-15mo = 37</td>
</tr>
<tr class="odd">
<td>M1046</td>
<td>0010</td>
<td>3</td>
<td>Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was less than 37</td>
<td>Fs oks 9-15mo = 37</td>
</tr>
<tr class="even">
<td>M1047</td>
<td>0010</td>
<td>3</td>
<td>Functional status was measured by the oxford knee score (oks) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively</td>
<td>Fs msrd oks pre and post</td>
</tr>
<tr class="odd">
<td>M1048</td>
<td>0010</td>
<td>3</td>
<td>Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively</td>
<td>Fsm wth scr odi pre and post</td>
</tr>
<tr class="even">
<td>M1049</td>
<td>0010</td>
<td>3</td>
<td>Functional status was not measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively</td>
<td>Fs wth scr no odi pre and p</td>
</tr>
<tr class="odd">
<td>M1050</td>
<td>0010</td>
<td>3</td>
<td>Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively</td>
<td>Fs msrd odi pre and post</td>
</tr>
<tr class="even">
<td>M1051</td>
<td>0010</td>
<td>3</td>
<td>Patient had cancer, fracture or infection related to the lumbar spine or patient had idiopathic or congenital scoliosis</td>
<td>Pt w/cancer scoliosis</td>
</tr>
<tr class="odd">
<td>M1052</td>
<td>0010</td>
<td>3</td>
<td>Leg pain was not measured by the visual analog scale (vas) at one year (9 to 15 months) postoperatively</td>
<td>Lg pn not meas w/ vas 1yr po</td>
</tr>
<tr class="even">
<td>M1053</td>
<td>0010</td>
<td>3</td>
<td>Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively</td>
<td>Pre and post vas wthn 3 mos</td>
</tr>
<tr class="odd">
<td>M1054</td>
<td>0010</td>
<td>3</td>
<td>Patient had only urgent care visits during the performance period</td>
<td>Pt uc in pp</td>
</tr>
<tr class="even">
<td>M1055</td>
<td>0010</td>
<td>3</td>
<td>Aspirin or another antiplatelet therapy used</td>
<td>Aspirin used</td>
</tr>
<tr class="odd">
<td>M1056</td>
<td>0010</td>
<td>3</td>
<td>Prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension &gt; 180/110 mmhg or gastroesophageal reflux disease</td>
<td>Presc antico med in pp</td>
</tr>
<tr class="even">
<td>M1057</td>
<td>0010</td>
<td>3</td>
<td>Aspirin or another antiplatelet therapy not used, reason not given</td>
<td>Aspirin not used, no rsn</td>
</tr>
<tr class="odd">
<td>M1058</td>
<td>0010</td>
<td>3</td>
<td>Patient was a permanent nursing home resident at any time during the performance period</td>
<td>Pt prm nurs hm res in pp</td>
</tr>
<tr class="even">
<td>M1059</td>
<td>0010</td>
<td>3</td>
<td>Patient was in hospice or receiving palliative care at any time during the performance period</td>
<td>Pt no prm nurs hm res in pp</td>
</tr>
<tr class="odd">
<td>M1060</td>
<td>0010</td>
<td>3</td>
<td>Patient died prior to the end of the performance period</td>
<td>Pt died in pp</td>
</tr>
<tr class="even">
<td>M1061</td>
<td>0010</td>
<td>3</td>
<td>Patient pregnancy</td>
<td>Pt preg</td>
</tr>
<tr class="odd">
<td>M1062</td>
<td>0010</td>
<td>3</td>
<td>Patient immunocompromised</td>
<td>Pt imcomprmd</td>
</tr>
<tr class="even">
<td>M1063</td>
<td>0010</td>
<td>3</td>
<td>Patients receiving high doses of immunosuppressive therapy</td>
<td>Pt rec hg dos imsup thpy</td>
</tr>
<tr class="odd">
<td>M1064</td>
<td>0010</td>
<td>3</td>
<td>Shingrix vaccine documented as administered or previously received</td>
<td>Shing vac doc adm or pv rec</td>
</tr>
<tr class="even">
<td>M1065</td>
<td>0010</td>
<td>3</td>
<td>Shingrix vaccine was not administered for reasons documented by clinician (e.g. patient administered vaccine other than shingrix, patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)</td>
<td>Shing vac no adm clinc rsn</td>
</tr>
<tr class="odd">
<td>M1066</td>
<td>0010</td>
<td>3</td>
<td>Shingrix vaccine not documented as administered, reason not given</td>
<td>Shing vac no doc no rsn</td>
</tr>
<tr class="even">
<td>M1067</td>
<td>0010</td>
<td>3</td>
<td>Hospice services for patient provided any time during the measurement period</td>
<td>Hspc pt prv time meam per</td>
</tr>
<tr class="odd">
<td>M1068</td>
<td>0010</td>
<td>3</td>
<td>Adults who are not ambulatory</td>
<td>Pt not ambulatory</td>
</tr>
<tr class="even">
<td>M1069</td>
<td>0010</td>
<td>3</td>
<td>Patient screened for future fall risk</td>
<td>Pt scr ft fall rsk</td>
</tr>
<tr class="odd">
<td>M1070</td>
<td>0010</td>
<td>3</td>
<td>Patient not screened for future fall risk, reason not given</td>
<td>Pt not scrn fut fall no rsn</td>
</tr>
<tr class="even">
<td>M1071</td>
<td>0010</td>
<td>3</td>
<td>Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminotomy</td>
<td>Pt had add’l sp pcr perf</td>
</tr>
<tr class="odd">
<td>M1106</td>
<td>0010</td>
<td>3</td>
<td>The start of an episode of care documented in the medical record</td>
<td>Start eoc doc med rec</td>
</tr>
<tr class="even">
<td>M1107</td>
<td>0010</td>
<td>3</td>
<td>Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson’s diagnosed at any time before or during the episode of care</td>
<td>Docu dx degen neuro</td>
</tr>
<tr class="odd">
<td>M1108</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only)</td>
<td>Oc ni pt 1-2 vis</td>
</tr>
<tr class="even">
<td>M1109</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery or hospitalized</td>
<td>Oc ni pt dc 1-2 vis</td>
</tr>
<tr class="odd">
<td>M1110</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown)</td>
<td>Oc ni pt selfdc 1-2 vis</td>
</tr>
<tr class="even">
<td>M1111</td>
<td>0010</td>
<td>3</td>
<td>The start of an episode of care documented in the medical record</td>
<td>Start eoc doc med rec</td>
</tr>
<tr class="odd">
<td>M1112</td>
<td>0010</td>
<td>3</td>
<td>Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson’s diagnosed at any time before or during the episode of care</td>
<td>Docu dx degen neuro</td>
</tr>
<tr class="even">
<td>M1113</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only)</td>
<td>Oc ni pt 1-2 vis</td>
</tr>
<tr class="odd">
<td>M1114</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery or hospitalized</td>
<td>Oc ni pt dc 1-2 vis</td>
</tr>
<tr class="even">
<td>M1115</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown)</td>
<td>Oc ni pt selfdc 1-2 vis</td>
</tr>
<tr class="odd">
<td>M1116</td>
<td>0010</td>
<td>3</td>
<td>The start of an episode of care documented in the medical record</td>
<td>Start eoc doc med rec</td>
</tr>
<tr class="even">
<td>M1117</td>
<td>0010</td>
<td>3</td>
<td>Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson’s diagnosed at any time before or during the episode of care</td>
<td>Docu dx degen neuro</td>
</tr>
<tr class="odd">
<td>M1118</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only)</td>
<td>Oc ni pt 1-2 vis</td>
</tr>
<tr class="even">
<td>M1119</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery or hospitalized</td>
<td>Oc ni pt dc 1-2 vis</td>
</tr>
<tr class="odd">
<td>M1120</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown)</td>
<td>Oc ni pt selfdc 1-2 vis</td>
</tr>
<tr class="even">
<td>M1121</td>
<td>0010</td>
<td>3</td>
<td>The start of an episode of care documented in the medical record</td>
<td>Start eoc doc med rec</td>
</tr>
<tr class="odd">
<td>M1122</td>
<td>0010</td>
<td>3</td>
<td>Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson’s diagnosed at any time before or during the episode of care</td>
<td>Docu dx degen neuro</td>
</tr>
<tr class="even">
<td>M1123</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only)</td>
<td>Oc ni pt 1-2 vis</td>
</tr>
<tr class="odd">
<td>M1124</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery</td>
<td>Oc ni pt dc 1-2 vis</td>
</tr>
<tr class="even">
<td>M1125</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown)</td>
<td>Oc ni pt selfdc 1-2 vis</td>
</tr>
<tr class="odd">
<td>M1126</td>
<td>0010</td>
<td>3</td>
<td>The start of an episode of care documented in the medical record</td>
<td>Start eoc doc med rec</td>
</tr>
<tr class="even">
<td>M1127</td>
<td>0010</td>
<td>3</td>
<td>Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson’s diagnosed at any time before or during the episode of care</td>
<td>Docu dx degen neuro</td>
</tr>
<tr class="odd">
<td>M1128</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only)</td>
<td>Oc ni pt 1-2 vis</td>
</tr>
<tr class="even">
<td>M1129</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery</td>
<td>Oc ni pt dc 1-2 vis</td>
</tr>
<tr class="odd">
<td>M1130</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown)</td>
<td>Oc ni pt self dc 1-2 vis</td>
</tr>
<tr class="even">
<td>M1131</td>
<td>0010</td>
<td>3</td>
<td>Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson’s diagnosed at any time before or during the episode of care</td>
<td>Docu dx degen neuro</td>
</tr>
<tr class="odd">
<td>M1132</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only)</td>
<td>Oc ni pt 1-2 vis</td>
</tr>
<tr class="even">
<td>M1133</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery</td>
<td>Oc ni pt dc 1-2 vis</td>
</tr>
<tr class="odd">
<td>M1134</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown</td>
<td>Oc ni pt self dc 1-2 vis</td>
</tr>
<tr class="even">
<td>M1135</td>
<td>0010</td>
<td>3</td>
<td>The start of an episode of care documented in the medical record</td>
<td>Start eoc doc med rec</td>
</tr>
<tr class="odd">
<td>M1136</td>
<td>0010</td>
<td>3</td>
<td>The start of an episode of care documented in the medical record</td>
<td>Start eoc doc med rec</td>
</tr>
<tr class="even">
<td>M1137</td>
<td>0010</td>
<td>3</td>
<td>Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson’s diagnosed at any time before or during the episode of care</td>
<td>Docu dx degen neuro</td>
</tr>
<tr class="odd">
<td>M1138</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only)</td>
<td>Oc ni pt 1-2 vis</td>
</tr>
<tr class="even">
<td>M1139</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown)</td>
<td>Oc ni pt self dc 1-2 vis</td>
</tr>
<tr class="odd">
<td>M1140</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery for surgery or hospitalized</td>
<td>Oc ni pt dc 1-2 vis</td>
</tr>
<tr class="even">
<td>M1141</td>
<td>0010</td>
<td>3</td>
<td>Functional status was not measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively</td>
<td>Fs no oks</td>
</tr>
<tr class="odd">
<td>M1142</td>
<td>0010</td>
<td>3</td>
<td>Emergent cases</td>
<td>Emerge cases</td>
</tr>
<tr class="even">
<td>M1143</td>
<td>0010</td>
<td>3</td>
<td>Initiated episode of rehabilitation therapy, medical, or chiropractic care for neck impairment</td>
<td>Ni rehab med chiro</td>
</tr>
<tr class="odd">
<td>M1144</td>
<td>0010</td>
<td>3</td>
<td>Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only</td>
<td>Oc no ind pt 1-2 vis</td>
</tr>
</tbody>
</table>
</div>
<div id="p-series-no-description" class="section level2">
<h2>P Series: No Description</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>P2028</td>
<td>0010</td>
<td>3</td>
<td>Cephalin floculation, blood</td>
<td>Cephalin floculation test</td>
</tr>
<tr class="even">
<td>P2029</td>
<td>0010</td>
<td>3</td>
<td>Congo red, blood</td>
<td>Congo red blood test</td>
</tr>
<tr class="odd">
<td>P2031</td>
<td>0010</td>
<td>3</td>
<td>Hair analysis (excluding arsenic)</td>
<td>Hair analysis</td>
</tr>
<tr class="even">
<td>P2033</td>
<td>0010</td>
<td>3</td>
<td>Thymol turbidity, blood</td>
<td>Blood thymol turbidity</td>
</tr>
<tr class="odd">
<td>P2038</td>
<td>0010</td>
<td>3</td>
<td>Mucoprotein, blood (seromucoid) (medical necessity procedure)</td>
<td>Blood mucoprotein</td>
</tr>
<tr class="even">
<td>P3000</td>
<td>0010</td>
<td>3</td>
<td>Screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision</td>
<td>Screen pap by tech w md supv</td>
</tr>
<tr class="odd">
<td>P3001</td>
<td>0010</td>
<td>3</td>
<td>Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician</td>
<td>Screening pap smear by phys</td>
</tr>
<tr class="even">
<td>P7001</td>
<td>0010</td>
<td>3</td>
<td>Culture, bacterial, urine; quantitative, sensitivity study</td>
<td>Culture bacterial urine</td>
</tr>
<tr class="odd">
<td>P9010</td>
<td>0010</td>
<td>3</td>
<td>Blood (whole), for transfusion, per unit</td>
<td>Whole blood for transfusion</td>
</tr>
<tr class="even">
<td>P9011</td>
<td>0010</td>
<td>3</td>
<td>Blood, split unit</td>
<td>Blood split unit</td>
</tr>
<tr class="odd">
<td>P9012</td>
<td>0010</td>
<td>3</td>
<td>Cryoprecipitate, each unit</td>
<td>Cryoprecipitate each unit</td>
</tr>
<tr class="even">
<td>P9016</td>
<td>0010</td>
<td>3</td>
<td>Red blood cells, leukocytes reduced, each unit</td>
<td>Rbc leukocytes reduced</td>
</tr>
<tr class="odd">
<td>P9017</td>
<td>0010</td>
<td>3</td>
<td>Fresh frozen plasma (single donor), frozen within 8 hours of collection, each unit</td>
<td>Plasma 1 donor frz w/in 8 hr</td>
</tr>
<tr class="even">
<td>P9019</td>
<td>0010</td>
<td>3</td>
<td>Platelets, each unit</td>
<td>Platelets, each unit</td>
</tr>
<tr class="odd">
<td>P9020</td>
<td>0010</td>
<td>3</td>
<td>Platelet rich plasma, each unit</td>
<td>Plaelet rich plasma unit</td>
</tr>
<tr class="even">
<td>P9021</td>
<td>0010</td>
<td>3</td>
<td>Red blood cells, each unit</td>
<td>Red blood cells unit</td>
</tr>
<tr class="odd">
<td>P9022</td>
<td>0010</td>
<td>3</td>
<td>Red blood cells, washed, each unit</td>
<td>Washed red blood cells unit</td>
</tr>
<tr class="even">
<td>P9023</td>
<td>0010</td>
<td>3</td>
<td>Plasma, pooled multiple donor, solvent/detergent treated, frozen, each unit</td>
<td>Frozen plasma, pooled, sd</td>
</tr>
<tr class="odd">
<td>P9031</td>
<td>0010</td>
<td>3</td>
<td>Platelets, leukocytes reduced, each unit</td>
<td>Platelets leukocytes reduced</td>
</tr>
<tr class="even">
<td>P9032</td>
<td>0010</td>
<td>3</td>
<td>Platelets, irradiated, each unit</td>
<td>Platelets, irradiated</td>
</tr>
<tr class="odd">
<td>P9033</td>
<td>0010</td>
<td>3</td>
<td>Platelets, leukocytes reduced, irradiated, each unit</td>
<td>Platelets leukoreduced irrad</td>
</tr>
<tr class="even">
<td>P9034</td>
<td>0010</td>
<td>3</td>
<td>Platelets, pheresis, each unit</td>
<td>Platelets, pheresis</td>
</tr>
<tr class="odd">
<td>P9035</td>
<td>0010</td>
<td>3</td>
<td>Platelets, pheresis, leukocytes reduced, each unit</td>
<td>Platelet pheres leukoreduced</td>
</tr>
<tr class="even">
<td>P9036</td>
<td>0010</td>
<td>3</td>
<td>Platelets, pheresis, irradiated, each unit</td>
<td>Platelet pheresis irradiated</td>
</tr>
<tr class="odd">
<td>P9037</td>
<td>0010</td>
<td>3</td>
<td>Platelets, pheresis, leukocytes reduced, irradiated, each unit</td>
<td>Plate pheres leukoredu irrad</td>
</tr>
<tr class="even">
<td>P9038</td>
<td>0010</td>
<td>3</td>
<td>Red blood cells, irradiated, each unit</td>
<td>Rbc irradiated</td>
</tr>
<tr class="odd">
<td>P9039</td>
<td>0010</td>
<td>3</td>
<td>Red blood cells, deglycerolized, each unit</td>
<td>Rbc deglycerolized</td>
</tr>
<tr class="even">
<td>P9040</td>
<td>0010</td>
<td>3</td>
<td>Red blood cells, leukocytes reduced, irradiated, each unit</td>
<td>Rbc leukoreduced irradiated</td>
</tr>
<tr class="odd">
<td>P9041</td>
<td>0010</td>
<td>3</td>
<td>Infusion, albumin (human), 5%, 50 ml</td>
<td>Albumin (human),5%, 50ml</td>
</tr>
<tr class="even">
<td>P9043</td>
<td>0010</td>
<td>3</td>
<td>Infusion, plasma protein fraction (human), 5%, 50 ml</td>
<td>Plasma protein fract,5%,50ml</td>
</tr>
<tr class="odd">
<td>P9044</td>
<td>0010</td>
<td>3</td>
<td>Plasma, cryoprecipitate reduced, each unit</td>
<td>Cryoprecipitatereducedplasma</td>
</tr>
<tr class="even">
<td>P9045</td>
<td>0010</td>
<td>3</td>
<td>Infusion, albumin (human), 5%, 250 ml</td>
<td>Albumin (human), 5%, 250 ml</td>
</tr>
<tr class="odd">
<td>P9046</td>
<td>0010</td>
<td>3</td>
<td>Infusion, albumin (human), 25%, 20 ml</td>
<td>Albumin (human), 25%, 20 ml</td>
</tr>
<tr class="even">
<td>P9047</td>
<td>0010</td>
<td>3</td>
<td>Infusion, albumin (human), 25%, 50 ml</td>
<td>Albumin (human), 25%, 50ml</td>
</tr>
<tr class="odd">
<td>P9048</td>
<td>0010</td>
<td>3</td>
<td>Infusion, plasma protein fraction (human), 5%, 250 ml</td>
<td>Plasmaprotein fract,5%,250ml</td>
</tr>
<tr class="even">
<td>P9050</td>
<td>0010</td>
<td>3</td>
<td>Granulocytes, pheresis, each unit</td>
<td>Granulocytes, pheresis unit</td>
</tr>
<tr class="odd">
<td>P9051</td>
<td>0010</td>
<td>3</td>
<td>Whole blood or red blood cells, leukocytes reduced, cmv-negative, each unit</td>
<td>Blood, l/r, cmv-neg</td>
</tr>
<tr class="even">
<td>P9052</td>
<td>0010</td>
<td>3</td>
<td>Platelets, hla-matched leukocytes reduced, apheresis/pheresis, each unit</td>
<td>Platelets, hla-m, l/r, unit</td>
</tr>
<tr class="odd">
<td>P9053</td>
<td>0010</td>
<td>3</td>
<td>Platelets, pheresis, leukocytes reduced, cmv-negative, irradiated, each unit</td>
<td>Plt, pher, l/r cmv-neg, irr</td>
</tr>
<tr class="even">
<td>P9054</td>
<td>0010</td>
<td>3</td>
<td>Whole blood or red blood cells, leukocytes reduced, frozen, deglycerol, washed, each unit</td>
<td>Blood, l/r, froz/degly/wash</td>
</tr>
<tr class="odd">
<td>P9055</td>
<td>0010</td>
<td>3</td>
<td>Platelets, leukocytes reduced, cmv-negative, apheresis/pheresis, each unit</td>
<td>Plt, aph/pher, l/r, cmv-neg</td>
</tr>
<tr class="even">
<td>P9056</td>
<td>0010</td>
<td>3</td>
<td>Whole blood, leukocytes reduced, irradiated, each unit</td>
<td>Blood, l/r, irradiated</td>
</tr>
<tr class="odd">
<td>P9057</td>
<td>0010</td>
<td>3</td>
<td>Red blood cells, frozen/deglycerolized/washed, leukocytes reduced, irradiated, each unit</td>
<td>Rbc, frz/deg/wsh, l/r, irrad</td>
</tr>
<tr class="even">
<td>P9058</td>
<td>0010</td>
<td>3</td>
<td>Red blood cells, leukocytes reduced, cmv-negative, irradiated, each unit</td>
<td>Rbc, l/r, cmv-neg, irrad</td>
</tr>
<tr class="odd">
<td>P9059</td>
<td>0010</td>
<td>3</td>
<td>Fresh frozen plasma between 8-24 hours of collection, each unit</td>
<td>Plasma, frz between 8-24hour</td>
</tr>
<tr class="even">
<td>P9060</td>
<td>0010</td>
<td>3</td>
<td>Fresh frozen plasma, donor retested, each unit</td>
<td>Fr frz plasma donor retested</td>
</tr>
<tr class="odd">
<td>P9070</td>
<td>0010</td>
<td>3</td>
<td>Plasma, pooled multiple donor, pathogen reduced, frozen, each unit</td>
<td>Pathogen reduced plasma pool</td>
</tr>
<tr class="even">
<td>P9071</td>
<td>0010</td>
<td>3</td>
<td>Plasma (single donor), pathogen reduced, frozen, each unit</td>
<td>Pathogen reduced plasma sing</td>
</tr>
<tr class="odd">
<td>P9072</td>
<td>0010</td>
<td>3</td>
<td>Platelets, pheresis, pathogen reduced or rapid bacterial tested, each unit</td>
<td>Plate path red/rapid bac tes</td>
</tr>
<tr class="even">
<td>P9073</td>
<td>0010</td>
<td>3</td>
<td>Platelets, pheresis, pathogen-reduced, each unit</td>
<td>Platelets pheresis path redu</td>
</tr>
<tr class="odd">
<td>P9099</td>
<td>0010</td>
<td>3</td>
<td>Blood component or product not otherwise classified</td>
<td>Blood component/product noc</td>
</tr>
<tr class="even">
<td>P9100</td>
<td>0010</td>
<td>3</td>
<td>Pathogen(s) test for platelets</td>
<td>Pathogen test for platelets</td>
</tr>
<tr class="odd">
<td>P9603</td>
<td>0010</td>
<td>3</td>
<td>Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled</td>
<td>One-way allow prorated miles</td>
</tr>
<tr class="even">
<td>P9604</td>
<td>0010</td>
<td>3</td>
<td>Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge</td>
<td>One-way allow prorated trip</td>
</tr>
<tr class="odd">
<td>P9612</td>
<td>0010</td>
<td>3</td>
<td>Catheterization for collection of specimen, single patient, all places of service</td>
<td>Catheterize for urine spec</td>
</tr>
<tr class="even">
<td>P9615</td>
<td>0010</td>
<td>3</td>
<td>Catheterization for collection of specimen(s) (multiple patients)</td>
<td>Urine specimen collect mult</td>
</tr>
</tbody>
</table>
</div>
<div id="q-series-no-description" class="section level2">
<h2>Q Series: No Description</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Q0035</td>
<td>0010</td>
<td>3</td>
<td>Cardiokymography</td>
<td>Cardiokymography</td>
</tr>
<tr class="even">
<td>Q0081</td>
<td>0010</td>
<td>3</td>
<td>Infusion therapy, using other than chemotherapeutic drugs, per visit</td>
<td>Infusion ther other than che</td>
</tr>
<tr class="odd">
<td>Q0083</td>
<td>0010</td>
<td>3</td>
<td>Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit</td>
<td>Chemo by other than infusion</td>
</tr>
<tr class="even">
<td>Q0084</td>
<td>0010</td>
<td>3</td>
<td>Chemotherapy administration by infusion technique only, per visit</td>
<td>Chemotherapy by infusion</td>
</tr>
<tr class="odd">
<td>Q0085</td>
<td>0010</td>
<td>3</td>
<td>Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit</td>
<td>Chemo by both infusion and o</td>
</tr>
<tr class="even">
<td>Q0091</td>
<td>0010</td>
<td>3</td>
<td>Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory</td>
<td>Obtaining screen pap smear</td>
</tr>
<tr class="odd">
<td>Q0092</td>
<td>0010</td>
<td>3</td>
<td>Set-up portable x-ray equipment</td>
<td>Set up port xray equipment</td>
</tr>
<tr class="even">
<td>Q0111</td>
<td>0010</td>
<td>3</td>
<td>Wet mounts, including preparations of vaginal, cervical or skin specimens</td>
<td>Wet mounts/ w preparations</td>
</tr>
<tr class="odd">
<td>Q0112</td>
<td>0010</td>
<td>3</td>
<td>All potassium hydroxide (koh) preparations</td>
<td>Potassium hydroxide preps</td>
</tr>
<tr class="even">
<td>Q0113</td>
<td>0010</td>
<td>3</td>
<td>Pinworm examinations</td>
<td>Pinworm examinations</td>
</tr>
<tr class="odd">
<td>Q0114</td>
<td>0010</td>
<td>3</td>
<td>Fern test</td>
<td>Fern test</td>
</tr>
<tr class="even">
<td>Q0115</td>
<td>0010</td>
<td>3</td>
<td>Post-coital direct, qualitative examinations of vaginal or cervical mucous</td>
<td>Post-coital mucous exam</td>
</tr>
<tr class="odd">
<td>Q0138</td>
<td>0010</td>
<td>3</td>
<td>Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)</td>
<td>Ferumoxytol, non-esrd</td>
</tr>
<tr class="even">
<td>Q0139</td>
<td>0010</td>
<td>3</td>
<td>Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)</td>
<td>Ferumoxytol, esrd use</td>
</tr>
<tr class="odd">
<td>Q0144</td>
<td>0010</td>
<td>3</td>
<td>Azithromycin dihydrate, oral, capsules/powder, 1 gram</td>
<td>Azithromycin dihydrate, oral</td>
</tr>
<tr class="even">
<td>Q0161</td>
<td>0010</td>
<td>3</td>
<td>Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen</td>
<td>Chlorpromazine hcl 5mg oral</td>
</tr>
<tr class="odd">
<td>Q0162</td>
<td>0010</td>
<td>3</td>
<td>Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen</td>
<td>Ondansetron oral</td>
</tr>
<tr class="even">
<td>Q0163</td>
<td>0010</td>
<td>3</td>
<td>Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen</td>
<td>Diphenhydramine hcl 50mg</td>
</tr>
<tr class="odd">
<td>Q0164</td>
<td>0010</td>
<td>3</td>
<td>Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen</td>
<td>Prochlorperazine maleate 5mg</td>
</tr>
<tr class="even">
<td>Q0166</td>
<td>0010</td>
<td>3</td>
<td>Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen</td>
<td>Granisetron hcl 1 mg oral</td>
</tr>
<tr class="odd">
<td>Q0167</td>
<td>0010</td>
<td>3</td>
<td>Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen</td>
<td>Dronabinol 2.5mg oral</td>
</tr>
<tr class="even">
<td>Q0169</td>
<td>0010</td>
<td>3</td>
<td>Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen</td>
<td>Promethazine hcl 12.5mg oral</td>
</tr>
<tr class="odd">
<td>Q0173</td>
<td>0010</td>
<td>3</td>
<td>Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen</td>
<td>Trimethobenzamide hcl 250mg</td>
</tr>
<tr class="even">
<td>Q0174</td>
<td>0010</td>
<td>3</td>
<td>Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen</td>
<td>Thiethylperazine maleate10mg</td>
</tr>
<tr class="odd">
<td>Q0175</td>
<td>0010</td>
<td>3</td>
<td>Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen</td>
<td>Perphenazine 4mg oral</td>
</tr>
<tr class="even">
<td>Q0177</td>
<td>0010</td>
<td>3</td>
<td>Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen</td>
<td>Hydroxyzine pamoate 25mg</td>
</tr>
<tr class="odd">
<td>Q0180</td>
<td>0010</td>
<td>3</td>
<td>Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen</td>
<td>Dolasetron mesylate oral</td>
</tr>
<tr class="even">
<td>Q0181</td>
<td>0010</td>
<td>3</td>
<td>Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen</td>
<td>Unspecified oral anti-emetic</td>
</tr>
<tr class="odd">
<td>Q0477</td>
<td>0010</td>
<td>3</td>
<td>Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only</td>
<td>Pwr module pt cable lvad rpl</td>
</tr>
<tr class="even">
<td>Q0478</td>
<td>0010</td>
<td>3</td>
<td>Power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type</td>
<td>Power adapter, combo vad</td>
</tr>
<tr class="odd">
<td>Q0479</td>
<td>0010</td>
<td>3</td>
<td>Power module for use with electric or electric/pneumatic ventricular assist device, replacement only</td>
<td>Power module combo vad, rep</td>
</tr>
<tr class="even">
<td>Q0480</td>
<td>0010</td>
<td>3</td>
<td>Driver for use with pneumatic ventricular assist device, replacement only</td>
<td>Driver pneumatic vad, rep</td>
</tr>
<tr class="odd">
<td>Q0481</td>
<td>0010</td>
<td>3</td>
<td>Microprocessor control unit for use with electric ventricular assist device, replacement only</td>
<td>Microprcsr cu elec vad, rep</td>
</tr>
<tr class="even">
<td>Q0482</td>
<td>0010</td>
<td>3</td>
<td>Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only</td>
<td>Microprcsr cu combo vad, rep</td>
</tr>
<tr class="odd">
<td>Q0483</td>
<td>0010</td>
<td>3</td>
<td>Monitor/display module for use with electric ventricular assist device, replacement only</td>
<td>Monitor elec vad, rep</td>
</tr>
<tr class="even">
<td>Q0484</td>
<td>0010</td>
<td>3</td>
<td>Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only</td>
<td>Monitor elec or comb vad rep</td>
</tr>
<tr class="odd">
<td>Q0485</td>
<td>0010</td>
<td>3</td>
<td>Monitor control cable for use with electric ventricular assist device, replacement only</td>
<td>Monitor cable elec vad, rep</td>
</tr>
<tr class="even">
<td>Q0486</td>
<td>0010</td>
<td>3</td>
<td>Monitor control cable for use with electric/pneumatic ventricular assist device, replacement only</td>
<td>Mon cable elec/pneum vad rep</td>
</tr>
<tr class="odd">
<td>Q0487</td>
<td>0010</td>
<td>3</td>
<td>Leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only</td>
<td>Leads any type vad, rep only</td>
</tr>
<tr class="even">
<td>Q0488</td>
<td>0010</td>
<td>3</td>
<td>Power pack base for use with electric ventricular assist device, replacement only</td>
<td>Pwr pack base elec vad, rep</td>
</tr>
<tr class="odd">
<td>Q0489</td>
<td>0010</td>
<td>3</td>
<td>Power pack base for use with electric/pneumatic ventricular assist device, replacement only</td>
<td>Pwr pck base combo vad, rep</td>
</tr>
<tr class="even">
<td>Q0490</td>
<td>0010</td>
<td>3</td>
<td>Emergency power source for use with electric ventricular assist device, replacement only</td>
<td>Emr pwr source elec vad, rep</td>
</tr>
<tr class="odd">
<td>Q0491</td>
<td>0010</td>
<td>3</td>
<td>Emergency power source for use with electric/pneumatic ventricular assist device, replacement only</td>
<td>Emr pwr source combo vad rep</td>
</tr>
<tr class="even">
<td>Q0492</td>
<td>0010</td>
<td>3</td>
<td>Emergency power supply cable for use with electric ventricular assist device, replacement only</td>
<td>Emr pwr cbl elec vad, rep</td>
</tr>
<tr class="odd">
<td>Q0493</td>
<td>0010</td>
<td>3</td>
<td>Emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only</td>
<td>Emr pwr cbl combo vad, rep</td>
</tr>
<tr class="even">
<td>Q0494</td>
<td>0010</td>
<td>3</td>
<td>Emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only</td>
<td>Emr hd pmp elec/combo, rep</td>
</tr>
<tr class="odd">
<td>Q0495</td>
<td>0010</td>
<td>3</td>
<td>Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only</td>
<td>Charger elec/combo vad, rep</td>
</tr>
<tr class="even">
<td>Q0496</td>
<td>0010</td>
<td>3</td>
<td>Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only</td>
<td>Battery elec/combo vad, rep</td>
</tr>
<tr class="odd">
<td>Q0497</td>
<td>0010</td>
<td>3</td>
<td>Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only</td>
<td>Bat clps elec/comb vad, rep</td>
</tr>
<tr class="even">
<td>Q0498</td>
<td>0010</td>
<td>3</td>
<td>Holster for use with electric or electric/pneumatic ventricular assist device, replacement only</td>
<td>Holster elec/combo vad, rep</td>
</tr>
<tr class="odd">
<td>Q0499</td>
<td>0010</td>
<td>3</td>
<td>Belt/vest/bag for use to carry external peripheral components of any type ventricular assist device, replacement only</td>
<td>Belt/vest elec/combo vad rep</td>
</tr>
<tr class="even">
<td>Q0500</td>
<td>0010</td>
<td>3</td>
<td>Filters for use with electric or electric/pneumatic ventricular assist device, replacement only</td>
<td>Filters elec/combo vad, rep</td>
</tr>
<tr class="odd">
<td>Q0501</td>
<td>0010</td>
<td>3</td>
<td>Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only</td>
<td>Shwr cov elec/combo vad, rep</td>
</tr>
<tr class="even">
<td>Q0502</td>
<td>0010</td>
<td>3</td>
<td>Mobility cart for pneumatic ventricular assist device, replacement only</td>
<td>Mobility cart pneum vad, rep</td>
</tr>
<tr class="odd">
<td>Q0503</td>
<td>0010</td>
<td>3</td>
<td>Battery for pneumatic ventricular assist device, replacement only, each</td>
<td>Battery pneum vad replacemnt</td>
</tr>
<tr class="even">
<td>Q0504</td>
<td>0010</td>
<td>3</td>
<td>Power adapter for pneumatic ventricular assist device, replacement only, vehicle type</td>
<td>Pwr adpt pneum vad, rep veh</td>
</tr>
<tr class="odd">
<td>Q0506</td>
<td>0010</td>
<td>3</td>
<td>Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only</td>
<td>Lith-ion batt elec/pneum vad</td>
</tr>
<tr class="even">
<td>Q0507</td>
<td>0010</td>
<td>3</td>
<td>Miscellaneous supply or accessory for use with an external ventricular assist device</td>
<td>Misc sup/acc ext vad</td>
</tr>
<tr class="odd">
<td>Q0508</td>
<td>0010</td>
<td>3</td>
<td>Miscellaneous supply or accessory for use with an implanted ventricular assist device</td>
<td>Mis sup/acc imp vad</td>
</tr>
<tr class="even">
<td>Q0509</td>
<td>0010</td>
<td>3</td>
<td>Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a</td>
<td>Mis sup/ac imp vad nopay med</td>
</tr>
<tr class="odd">
<td>Q0510</td>
<td>0010</td>
<td>3</td>
<td>Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant</td>
<td>Dispens fee immunosupressive</td>
</tr>
<tr class="even">
<td>Q0511</td>
<td>0010</td>
<td>3</td>
<td>Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period</td>
<td>Sup fee antiem,antica,immuno</td>
</tr>
<tr class="odd">
<td>Q0512</td>
<td>0010</td>
<td>3</td>
<td>Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period</td>
<td>Px sup fee anti-can sub pres</td>
</tr>
<tr class="even">
<td>Q0513</td>
<td>0010</td>
<td>3</td>
<td>Pharmacy dispensing fee for inhalation drug(s); per 30 days</td>
<td>Disp fee inhal drugs/30 days</td>
</tr>
<tr class="odd">
<td>Q0514</td>
<td>0010</td>
<td>3</td>
<td>Pharmacy dispensing fee for inhalation drug(s); per 90 days</td>
<td>Disp fee inhal drugs/90 days</td>
</tr>
<tr class="even">
<td>Q0515</td>
<td>0010</td>
<td>3</td>
<td>Injection, sermorelin acetate, 1 microgram</td>
<td>Sermorelin acetate injection</td>
</tr>
<tr class="odd">
<td>Q1004</td>
<td>0010</td>
<td>3</td>
<td>New technology intraocular lens category 4 as defined in federal register notice</td>
<td>Ntiol category 4</td>
</tr>
<tr class="even">
<td>Q1005</td>
<td>0010</td>
<td>3</td>
<td>New technology intraocular lens category 5 as defined in federal register notice</td>
<td>Ntiol category 5</td>
</tr>
<tr class="odd">
<td>Q2004</td>
<td>0010</td>
<td>3</td>
<td>Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml</td>
<td>Bladder calculi irrig sol</td>
</tr>
<tr class="even">
<td>Q2009</td>
<td>0010</td>
<td>3</td>
<td>Injection, fosphenytoin, 50 mg phenytoin equivalent</td>
<td>Fosphenytoin inj pe</td>
</tr>
<tr class="odd">
<td>Q2017</td>
<td>0010</td>
<td>3</td>
<td>Injection, teniposide, 50 mg</td>
<td>Teniposide, 50 mg</td>
</tr>
<tr class="even">
<td>Q2026</td>
<td>0010</td>
<td>3</td>
<td>Injection, radiesse, 0.1 ml</td>
<td>Radiesse injection</td>
</tr>
<tr class="odd">
<td>Q2028</td>
<td>0010</td>
<td>3</td>
<td>Injection, sculptra, 0.5 mg</td>
<td>Inj, sculptra, 0.5mg</td>
</tr>
<tr class="even">
<td>Q2034</td>
<td>0010</td>
<td>3</td>
<td>Influenza virus vaccine, split virus, for intramuscular use (agriflu)</td>
<td>Agriflu vaccine</td>
</tr>
<tr class="odd">
<td>Q2035</td>
<td>0010</td>
<td>3</td>
<td>Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)</td>
<td>Afluria vacc, 3 yrs &amp; &gt;, im</td>
</tr>
<tr class="even">
<td>Q2036</td>
<td>0010</td>
<td>3</td>
<td>Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)</td>
<td>Flulaval vacc, 3 yrs &amp; &gt;, im</td>
</tr>
<tr class="odd">
<td>Q2037</td>
<td>0010</td>
<td>3</td>
<td>Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)</td>
<td>Fluvirin vacc, 3 yrs &amp; &gt;, im</td>
</tr>
<tr class="even">
<td>Q2038</td>
<td>0010</td>
<td>3</td>
<td>Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)</td>
<td>Fluzone vacc, 3 yrs &amp; &gt;, im</td>
</tr>
<tr class="odd">
<td>Q2039</td>
<td>0010</td>
<td>3</td>
<td>Influenza virus vaccine, not otherwise specified</td>
<td>Influenza virus vaccine, nos</td>
</tr>
<tr class="even">
<td>Q2040</td>
<td>0010</td>
<td>3</td>
<td>Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion</td>
<td>Tisagenlecleucel car-pos t</td>
</tr>
<tr class="odd">
<td>Q2041</td>
<td>0010</td>
<td>3</td>
<td>Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose</td>
<td>Axicabtagene ciloleucel car+</td>
</tr>
<tr class="even">
<td>Q2042</td>
<td>0010</td>
<td>3</td>
<td>Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose</td>
<td>Tisagenlecleucel car-pos t</td>
</tr>
<tr class="odd">
<td>Q2043</td>
<td>0010</td>
<td>3</td>
<td>Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion</td>
<td>Sipuleucel-t auto cd54+</td>
</tr>
<tr class="even">
<td>Q2049</td>
<td>0010</td>
<td>3</td>
<td>Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg</td>
<td>Imported lipodox inj</td>
</tr>
<tr class="odd">
<td>Q2050</td>
<td>0010</td>
<td>3</td>
<td>Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg</td>
<td>Doxorubicin inj 10mg</td>
</tr>
<tr class="even">
<td>Q2052</td>
<td>0010</td>
<td>3</td>
<td>Services, supplies and accessories used in the home under the medicare intravenous immune globulin (ivig) demonstration</td>
<td>Ivig demo, services/supplies</td>
</tr>
<tr class="odd">
<td>Q3001</td>
<td>0010</td>
<td>3</td>
<td>Radioelements for brachytherapy, any type, each</td>
<td>Brachytherapy radioelements</td>
</tr>
<tr class="even">
<td>Q3014</td>
<td>0010</td>
<td>3</td>
<td>Telehealth originating site facility fee</td>
<td>Telehealth facility fee</td>
</tr>
<tr class="odd">
<td>Q3027</td>
<td>0010</td>
<td>3</td>
<td>Injection, interferon beta-1a, 1 mcg for intramuscular use</td>
<td>Inj beta interferon im 1 mcg</td>
</tr>
<tr class="even">
<td>Q3028</td>
<td>0010</td>
<td>3</td>
<td>Injection, interferon beta-1a, 1 mcg for subcutaneous use</td>
<td>Inj beta interferon sq 1 mcg</td>
</tr>
<tr class="odd">
<td>Q3031</td>
<td>0010</td>
<td>3</td>
<td>Collagen skin test</td>
<td>Collagen skin test</td>
</tr>
<tr class="even">
<td>Q4001</td>
<td>0010</td>
<td>3</td>
<td>Casting supplies, body cast adult, with or without head, plaster</td>
<td>Cast sup body cast plaster</td>
</tr>
<tr class="odd">
<td>Q4002</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, body cast adult, with or without head, fiberglass</td>
<td>Cast sup body cast fiberglas</td>
</tr>
<tr class="even">
<td>Q4003</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, shoulder cast, adult (11 years +), plaster</td>
<td>Cast sup shoulder cast plstr</td>
</tr>
<tr class="odd">
<td>Q4004</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, shoulder cast, adult (11 years +), fiberglass</td>
<td>Cast sup shoulder cast fbrgl</td>
</tr>
<tr class="even">
<td>Q4005</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long arm cast, adult (11 years +), plaster</td>
<td>Cast sup long arm adult plst</td>
</tr>
<tr class="odd">
<td>Q4006</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long arm cast, adult (11 years +), fiberglass</td>
<td>Cast sup long arm adult fbrg</td>
</tr>
<tr class="even">
<td>Q4007</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long arm cast, pediatric (0-10 years), plaster</td>
<td>Cast sup long arm ped plster</td>
</tr>
<tr class="odd">
<td>Q4008</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long arm cast, pediatric (0-10 years), fiberglass</td>
<td>Cast sup long arm ped fbrgls</td>
</tr>
<tr class="even">
<td>Q4009</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short arm cast, adult (11 years +), plaster</td>
<td>Cast sup sht arm adult plstr</td>
</tr>
<tr class="odd">
<td>Q4010</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short arm cast, adult (11 years +), fiberglass</td>
<td>Cast sup sht arm adult fbrgl</td>
</tr>
<tr class="even">
<td>Q4011</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short arm cast, pediatric (0-10 years), plaster</td>
<td>Cast sup sht arm ped plaster</td>
</tr>
<tr class="odd">
<td>Q4012</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short arm cast, pediatric (0-10 years), fiberglass</td>
<td>Cast sup sht arm ped fbrglas</td>
</tr>
<tr class="even">
<td>Q4013</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), plaster</td>
<td>Cast sup gauntlet plaster</td>
</tr>
<tr class="odd">
<td>Q4014</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass</td>
<td>Cast sup gauntlet fiberglass</td>
</tr>
<tr class="even">
<td>Q4015</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), plaster</td>
<td>Cast sup gauntlet ped plster</td>
</tr>
<tr class="odd">
<td>Q4016</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), fiberglass</td>
<td>Cast sup gauntlet ped fbrgls</td>
</tr>
<tr class="even">
<td>Q4017</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long arm splint, adult (11 years +), plaster</td>
<td>Cast sup lng arm splint plst</td>
</tr>
<tr class="odd">
<td>Q4018</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long arm splint, adult (11 years +), fiberglass</td>
<td>Cast sup lng arm splint fbrg</td>
</tr>
<tr class="even">
<td>Q4019</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long arm splint, pediatric (0-10 years), plaster</td>
<td>Cast sup lng arm splnt ped p</td>
</tr>
<tr class="odd">
<td>Q4020</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long arm splint, pediatric (0-10 years), fiberglass</td>
<td>Cast sup lng arm splnt ped f</td>
</tr>
<tr class="even">
<td>Q4021</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short arm splint, adult (11 years +), plaster</td>
<td>Cast sup sht arm splint plst</td>
</tr>
<tr class="odd">
<td>Q4022</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short arm splint, adult (11 years +), fiberglass</td>
<td>Cast sup sht arm splint fbrg</td>
</tr>
<tr class="even">
<td>Q4023</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short arm splint, pediatric (0-10 years), plaster</td>
<td>Cast sup sht arm splnt ped p</td>
</tr>
<tr class="odd">
<td>Q4024</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short arm splint, pediatric (0-10 years), fiberglass</td>
<td>Cast sup sht arm splnt ped f</td>
</tr>
<tr class="even">
<td>Q4025</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, hip spica (one or both legs), adult (11 years +), plaster</td>
<td>Cast sup hip spica plaster</td>
</tr>
<tr class="odd">
<td>Q4026</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, hip spica (one or both legs), adult (11 years +), fiberglass</td>
<td>Cast sup hip spica fiberglas</td>
</tr>
<tr class="even">
<td>Q4027</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, hip spica (one or both legs), pediatric (0-10 years), plaster</td>
<td>Cast sup hip spica ped plstr</td>
</tr>
<tr class="odd">
<td>Q4028</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, hip spica (one or both legs), pediatric (0-10 years), fiberglass</td>
<td>Cast sup hip spica ped fbrgl</td>
</tr>
<tr class="even">
<td>Q4029</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long leg cast, adult (11 years +), plaster</td>
<td>Cast sup long leg plaster</td>
</tr>
<tr class="odd">
<td>Q4030</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long leg cast, adult (11 years +), fiberglass</td>
<td>Cast sup long leg fiberglass</td>
</tr>
<tr class="even">
<td>Q4031</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long leg cast, pediatric (0-10 years), plaster</td>
<td>Cast sup lng leg ped plaster</td>
</tr>
<tr class="odd">
<td>Q4032</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long leg cast, pediatric (0-10 years), fiberglass</td>
<td>Cast sup lng leg ped fbrgls</td>
</tr>
<tr class="even">
<td>Q4033</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long leg cylinder cast, adult (11 years +), plaster</td>
<td>Cast sup lng leg cylinder pl</td>
</tr>
<tr class="odd">
<td>Q4034</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long leg cylinder cast, adult (11 years +), fiberglass</td>
<td>Cast sup lng leg cylinder fb</td>
</tr>
<tr class="even">
<td>Q4035</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long leg cylinder cast, pediatric (0-10 years), plaster</td>
<td>Cast sup lngleg cylndr ped p</td>
</tr>
<tr class="odd">
<td>Q4036</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass</td>
<td>Cast sup lngleg cylndr ped f</td>
</tr>
<tr class="even">
<td>Q4037</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short leg cast, adult (11 years +), plaster</td>
<td>Cast sup shrt leg plaster</td>
</tr>
<tr class="odd">
<td>Q4038</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short leg cast, adult (11 years +), fiberglass</td>
<td>Cast sup shrt leg fiberglass</td>
</tr>
<tr class="even">
<td>Q4039</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short leg cast, pediatric (0-10 years), plaster</td>
<td>Cast sup shrt leg ped plster</td>
</tr>
<tr class="odd">
<td>Q4040</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short leg cast, pediatric (0-10 years), fiberglass</td>
<td>Cast sup shrt leg ped fbrgls</td>
</tr>
<tr class="even">
<td>Q4041</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long leg splint, adult (11 years +), plaster</td>
<td>Cast sup lng leg splnt plstr</td>
</tr>
<tr class="odd">
<td>Q4042</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long leg splint, adult (11 years +), fiberglass</td>
<td>Cast sup lng leg splnt fbrgl</td>
</tr>
<tr class="even">
<td>Q4043</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long leg splint, pediatric (0-10 years), plaster</td>
<td>Cast sup lng leg splnt ped p</td>
</tr>
<tr class="odd">
<td>Q4044</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, long leg splint, pediatric (0-10 years), fiberglass</td>
<td>Cast sup lng leg splnt ped f</td>
</tr>
<tr class="even">
<td>Q4045</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short leg splint, adult (11 years +), plaster</td>
<td>Cast sup sht leg splnt plstr</td>
</tr>
<tr class="odd">
<td>Q4046</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short leg splint, adult (11 years +), fiberglass</td>
<td>Cast sup sht leg splnt fbrgl</td>
</tr>
<tr class="even">
<td>Q4047</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short leg splint, pediatric (0-10 years), plaster</td>
<td>Cast sup sht leg splnt ped p</td>
</tr>
<tr class="odd">
<td>Q4048</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, short leg splint, pediatric (0-10 years), fiberglass</td>
<td>Cast sup sht leg splnt ped f</td>
</tr>
<tr class="even">
<td>Q4049</td>
<td>0010</td>
<td>3</td>
<td>Finger splint, static</td>
<td>Finger splint, static</td>
</tr>
<tr class="odd">
<td>Q4050</td>
<td>0010</td>
<td>3</td>
<td>Cast supplies, for unlisted types and materials of casts</td>
<td>Cast supplies unlisted</td>
</tr>
<tr class="even">
<td>Q4051</td>
<td>0010</td>
<td>3</td>
<td>Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)</td>
<td>Splint supplies misc</td>
</tr>
<tr class="odd">
<td>Q4074</td>
<td>0010</td>
<td>3</td>
<td>Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms</td>
<td>Iloprost non-comp unit dose</td>
</tr>
<tr class="even">
<td>Q4081</td>
<td>0010</td>
<td>3</td>
<td>Injection, epoetin alfa, 100 units (for esrd on dialysis)</td>
<td>Epoetin alfa, 100 units esrd</td>
</tr>
<tr class="odd">
<td>Q4082</td>
<td>0010</td>
<td>3</td>
<td>Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)</td>
<td>Drug/bio noc part b drug cap</td>
</tr>
<tr class="even">
<td>Q4100</td>
<td>0010</td>
<td>3</td>
<td>Skin substitute, not otherwise specified</td>
<td>Skin substitute, nos</td>
</tr>
<tr class="odd">
<td>Q4101</td>
<td>0010</td>
<td>3</td>
<td>Apligraf, per square centimeter</td>
<td>Apligraf</td>
</tr>
<tr class="even">
<td>Q4102</td>
<td>0010</td>
<td>3</td>
<td>Oasis wound matrix, per square centimeter</td>
<td>Oasis wound matrix</td>
</tr>
<tr class="odd">
<td>Q4103</td>
<td>0010</td>
<td>3</td>
<td>Oasis burn matrix, per square centimeter</td>
<td>Oasis burn matrix</td>
</tr>
<tr class="even">
<td>Q4104</td>
<td>0010</td>
<td>3</td>
<td>Integra bilayer matrix wound dressing (bmwd), per square centimeter</td>
<td>Integra bmwd</td>
</tr>
<tr class="odd">
<td>Q4105</td>
<td>0010</td>
<td>3</td>
<td>Integra dermal regeneration template (drt) or integra omnigraft dermal regeneration matrix, per square centimeter</td>
<td>Integra drt or omnigraft</td>
</tr>
<tr class="even">
<td>Q4106</td>
<td>0010</td>
<td>3</td>
<td>Dermagraft, per square centimeter</td>
<td>Dermagraft</td>
</tr>
<tr class="odd">
<td>Q4107</td>
<td>0010</td>
<td>3</td>
<td>Graftjacket, per square centimeter</td>
<td>Graftjacket</td>
</tr>
<tr class="even">
<td>Q4108</td>
<td>0010</td>
<td>3</td>
<td>Integra matrix, per square centimeter</td>
<td>Integra matrix</td>
</tr>
<tr class="odd">
<td>Q4110</td>
<td>0010</td>
<td>3</td>
<td>Primatrix, per square centimeter</td>
<td>Primatrix</td>
</tr>
<tr class="even">
<td>Q4111</td>
<td>0010</td>
<td>3</td>
<td>Gammagraft, per square centimeter</td>
<td>Gammagraft</td>
</tr>
<tr class="odd">
<td>Q4112</td>
<td>0010</td>
<td>3</td>
<td>Cymetra, injectable, 1 cc</td>
<td>Cymetra injectable</td>
</tr>
<tr class="even">
<td>Q4113</td>
<td>0010</td>
<td>3</td>
<td>Graftjacket xpress, injectable, 1 cc</td>
<td>Graftjacket xpress</td>
</tr>
<tr class="odd">
<td>Q4114</td>
<td>0010</td>
<td>3</td>
<td>Integra flowable wound matrix, injectable, 1 cc</td>
<td>Integra flowable wound matri</td>
</tr>
<tr class="even">
<td>Q4115</td>
<td>0010</td>
<td>3</td>
<td>Alloskin, per square centimeter</td>
<td>Alloskin</td>
</tr>
<tr class="odd">
<td>Q4116</td>
<td>0010</td>
<td>3</td>
<td>Alloderm, per square centimeter</td>
<td>Alloderm</td>
</tr>
<tr class="even">
<td>Q4117</td>
<td>0010</td>
<td>3</td>
<td>Hyalomatrix, per square centimeter</td>
<td>Hyalomatrix</td>
</tr>
<tr class="odd">
<td>Q4118</td>
<td>0010</td>
<td>3</td>
<td>Matristem micromatrix, 1 mg</td>
<td>Matristem micromatrix</td>
</tr>
<tr class="even">
<td>Q4119</td>
<td>0010</td>
<td>3</td>
<td>Matristem wound matrix, per square centimeter</td>
<td>Matristem wound matrix</td>
</tr>
<tr class="odd">
<td>Q4120</td>
<td>0010</td>
<td>3</td>
<td>Matristem burn matrix, per square centimeter</td>
<td>Matristem burn matrix</td>
</tr>
<tr class="even">
<td>Q4121</td>
<td>0010</td>
<td>3</td>
<td>Theraskin, per square centimeter</td>
<td>Theraskin</td>
</tr>
<tr class="odd">
<td>Q4122</td>
<td>0010</td>
<td>3</td>
<td>Dermacell, dermacell awm or dermacell awm porous, per square centimeter</td>
<td>Dermacell, awm, porous sq cm</td>
</tr>
<tr class="even">
<td>Q4123</td>
<td>0010</td>
<td>3</td>
<td>Alloskin rt, per square centimeter</td>
<td>Alloskin</td>
</tr>
<tr class="odd">
<td>Q4124</td>
<td>0010</td>
<td>3</td>
<td>Oasis ultra tri-layer wound matrix, per square centimeter</td>
<td>Oasis tri-layer wound matrix</td>
</tr>
<tr class="even">
<td>Q4125</td>
<td>0010</td>
<td>3</td>
<td>Arthroflex, per square centimeter</td>
<td>Arthroflex</td>
</tr>
<tr class="odd">
<td>Q4126</td>
<td>0010</td>
<td>3</td>
<td>Memoderm, dermaspan, tranzgraft or integuply, per square centimeter</td>
<td>Memoderm/derma/tranz/integup</td>
</tr>
<tr class="even">
<td>Q4127</td>
<td>0010</td>
<td>3</td>
<td>Talymed, per square centimeter</td>
<td>Talymed</td>
</tr>
<tr class="odd">
<td>Q4128</td>
<td>0010</td>
<td>3</td>
<td>Flex hd, allopatch hd, or matrix hd, per square centimeter</td>
<td>Flexhd/allopatchhd/matrixhd</td>
</tr>
<tr class="even">
<td>Q4129</td>
<td>0010</td>
<td>3</td>
<td>Unite biomatrix, per square centimeter</td>
<td>Unite biomatrix</td>
</tr>
<tr class="odd">
<td>Q4130</td>
<td>0010</td>
<td>3</td>
<td>Strattice tm, per square centimeter</td>
<td>Strattice tm</td>
</tr>
<tr class="even">
<td>Q4131</td>
<td>0010</td>
<td>3</td>
<td>Epifix or epicord, per square centimeter</td>
<td>Epifix or epicord</td>
</tr>
<tr class="odd">
<td>Q4132</td>
<td>0010</td>
<td>3</td>
<td>Grafix core and grafixpl core, per square centimeter</td>
<td>Grafix core, grafixpl core</td>
</tr>
<tr class="even">
<td>Q4133</td>
<td>0010</td>
<td>3</td>
<td>Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter</td>
<td>Grafix stravix prime pl sqcm</td>
</tr>
<tr class="odd">
<td>Q4134</td>
<td>0010</td>
<td>3</td>
<td>Hmatrix, per square centimeter</td>
<td>Hmatrix</td>
</tr>
<tr class="even">
<td>Q4135</td>
<td>0010</td>
<td>3</td>
<td>Mediskin, per square centimeter</td>
<td>Mediskin</td>
</tr>
<tr class="odd">
<td>Q4136</td>
<td>0010</td>
<td>3</td>
<td>Ez-derm, per square centimeter</td>
<td>Ezderm</td>
</tr>
<tr class="even">
<td>Q4137</td>
<td>0010</td>
<td>3</td>
<td>Amnioexcel, amnioexcel plus or biodexcel, per square centimeter</td>
<td>Amnioexcel biodexcel 1sq cm</td>
</tr>
<tr class="odd">
<td>Q4138</td>
<td>0010</td>
<td>3</td>
<td>Biodfence dryflex, per square centimeter</td>
<td>Biodfence dryflex, 1cm</td>
</tr>
<tr class="even">
<td>Q4139</td>
<td>0010</td>
<td>3</td>
<td>Amniomatrix or biodmatrix, injectable, 1 cc</td>
<td>Amnio or biodmatrix, inj 1cc</td>
</tr>
<tr class="odd">
<td>Q4140</td>
<td>0010</td>
<td>3</td>
<td>Biodfence, per square centimeter</td>
<td>Biodfence 1cm</td>
</tr>
<tr class="even">
<td>Q4141</td>
<td>0010</td>
<td>3</td>
<td>Alloskin ac, per square centimeter</td>
<td>Alloskin ac, 1 cm</td>
</tr>
<tr class="odd">
<td>Q4142</td>
<td>0010</td>
<td>3</td>
<td>Xcm biologic tissue matrix, per square centimeter</td>
<td>Xcm biologic tiss matrix 1cm</td>
</tr>
<tr class="even">
<td>Q4143</td>
<td>0010</td>
<td>3</td>
<td>Repriza, per square centimeter</td>
<td>Repriza, 1cm</td>
</tr>
<tr class="odd">
<td>Q4145</td>
<td>0010</td>
<td>3</td>
<td>Epifix, injectable, 1 mg</td>
<td>Epifix, inj, 1mg</td>
</tr>
<tr class="even">
<td>Q4146</td>
<td>0010</td>
<td>3</td>
<td>Tensix, per square centimeter</td>
<td>Tensix, 1cm</td>
</tr>
<tr class="odd">
<td>Q4147</td>
<td>0010</td>
<td>3</td>
<td>Architect, architect px, or architect fx, extracellular matrix, per square centimeter</td>
<td>Architect ecm px fx 1 sq cm</td>
</tr>
<tr class="even">
<td>Q4148</td>
<td>0010</td>
<td>3</td>
<td>Neox cord 1k, neox cord rt, or clarix cord 1k, per square centimeter</td>
<td>Neox neox rt or clarix cord</td>
</tr>
<tr class="odd">
<td>Q4149</td>
<td>0010</td>
<td>3</td>
<td>Excellagen, 0.1 cc</td>
<td>Excellagen, 0.1 cc</td>
</tr>
<tr class="even">
<td>Q4150</td>
<td>0010</td>
<td>3</td>
<td>Allowrap ds or dry, per square centimeter</td>
<td>Allowrap ds or dry 1 sq cm</td>
</tr>
<tr class="odd">
<td>Q4151</td>
<td>0010</td>
<td>3</td>
<td>Amnioband or guardian, per square centimeter</td>
<td>Amnioband, guardian 1 sq cm</td>
</tr>
<tr class="even">
<td>Q4152</td>
<td>0010</td>
<td>3</td>
<td>Dermapure, per square centimeter</td>
<td>Dermapure 1 square cm</td>
</tr>
<tr class="odd">
<td>Q4153</td>
<td>0010</td>
<td>3</td>
<td>Dermavest and plurivest, per square centimeter</td>
<td>Dermavest, plurivest sq cm</td>
</tr>
<tr class="even">
<td>Q4154</td>
<td>0010</td>
<td>3</td>
<td>Biovance, per square centimeter</td>
<td>Biovance 1 square cm</td>
</tr>
<tr class="odd">
<td>Q4155</td>
<td>0010</td>
<td>3</td>
<td>Neoxflo or clarixflo, 1 mg</td>
<td>Neoxflo or clarixflo 1 mg</td>
</tr>
<tr class="even">
<td>Q4156</td>
<td>0010</td>
<td>3</td>
<td>Neox 100 or clarix 100, per square centimeter</td>
<td>Neox 100 or clarix 100</td>
</tr>
<tr class="odd">
<td>Q4157</td>
<td>0010</td>
<td>3</td>
<td>Revitalon, per square centimeter</td>
<td>Revitalon 1 square cm</td>
</tr>
<tr class="even">
<td>Q4158</td>
<td>0010</td>
<td>3</td>
<td>Kerecis omega3, per square centimeter</td>
<td>Kerecis omega3, per sq cm</td>
</tr>
<tr class="odd">
<td>Q4159</td>
<td>0010</td>
<td>3</td>
<td>Affinity, per square centimeter</td>
<td>Affinity1 square cm</td>
</tr>
<tr class="even">
<td>Q4160</td>
<td>0010</td>
<td>3</td>
<td>Nushield, per square centimeter</td>
<td>Nushield 1 square cm</td>
</tr>
<tr class="odd">
<td>Q4161</td>
<td>0010</td>
<td>3</td>
<td>Bio-connekt wound matrix, per square centimeter</td>
<td>Bio-connekt per square cm</td>
</tr>
<tr class="even">
<td>Q4162</td>
<td>0010</td>
<td>3</td>
<td>Woundex flow, bioskin flow, 0.5 cc</td>
<td>Wndex flw, bioskn flw, 0.5cc</td>
</tr>
<tr class="odd">
<td>Q4163</td>
<td>0010</td>
<td>3</td>
<td>Woundex, bioskin, per square centimeter</td>
<td>Woundex, bioskin, per sq cm</td>
</tr>
<tr class="even">
<td>Q4164</td>
<td>0010</td>
<td>3</td>
<td>Helicoll, per square centimeter</td>
<td>Helicoll, per square cm</td>
</tr>
<tr class="odd">
<td>Q4165</td>
<td>0010</td>
<td>3</td>
<td>Keramatrix or kerasorb, per square centimeter</td>
<td>Keramatrix, kerasorb sq cm</td>
</tr>
<tr class="even">
<td>Q4166</td>
<td>0010</td>
<td>3</td>
<td>Cytal, per square centimeter</td>
<td>Cytal, per square centimeter</td>
</tr>
<tr class="odd">
<td>Q4167</td>
<td>0010</td>
<td>3</td>
<td>Truskin, per square centimeter</td>
<td>Truskin, per sq centimeter</td>
</tr>
<tr class="even">
<td>Q4168</td>
<td>0010</td>
<td>3</td>
<td>Amnioband, 1 mg</td>
<td>Amnioband, 1 mg</td>
</tr>
<tr class="odd">
<td>Q4169</td>
<td>0010</td>
<td>3</td>
<td>Artacent wound, per square centimeter</td>
<td>Artacent wound, per sq cm</td>
</tr>
<tr class="even">
<td>Q4170</td>
<td>0010</td>
<td>3</td>
<td>Cygnus, per square centimeter</td>
<td>Cygnus, per sq cm</td>
</tr>
<tr class="odd">
<td>Q4171</td>
<td>0010</td>
<td>3</td>
<td>Interfyl, 1 mg</td>
<td>Interfyl, 1 mg</td>
</tr>
<tr class="even">
<td>Q4172</td>
<td>0010</td>
<td>3</td>
<td>Puraply or puraply am, per square centimeter</td>
<td>Puraply or puraply am</td>
</tr>
<tr class="odd">
<td>Q4173</td>
<td>0010</td>
<td>3</td>
<td>Palingen or palingen xplus, per square centimeter</td>
<td>Palingen or palingen xplus</td>
</tr>
<tr class="even">
<td>Q4174</td>
<td>0010</td>
<td>3</td>
<td>Palingen or promatrx, 0.36 mg per 0.25 cc</td>
<td>Palingen or promatrx</td>
</tr>
<tr class="odd">
<td>Q4175</td>
<td>0010</td>
<td>3</td>
<td>Miroderm, per square centimeter</td>
<td>Miroderm</td>
</tr>
<tr class="even">
<td>Q4176</td>
<td>0010</td>
<td>3</td>
<td>Neopatch, per square centimeter</td>
<td>Neopatch, per sq centimeter</td>
</tr>
<tr class="odd">
<td>Q4177</td>
<td>0010</td>
<td>3</td>
<td>Floweramnioflo, 0.1 cc</td>
<td>Floweramnioflo, 0.1 cc</td>
</tr>
<tr class="even">
<td>Q4178</td>
<td>0010</td>
<td>3</td>
<td>Floweramniopatch, per square centimeter</td>
<td>Floweramniopatch, per sq cm</td>
</tr>
<tr class="odd">
<td>Q4179</td>
<td>0010</td>
<td>3</td>
<td>Flowerderm, per square centimeter</td>
<td>Flowerderm, per sq cm</td>
</tr>
<tr class="even">
<td>Q4180</td>
<td>0010</td>
<td>3</td>
<td>Revita, per square centimeter</td>
<td>Revita, per sq cm</td>
</tr>
<tr class="odd">
<td>Q4181</td>
<td>0010</td>
<td>3</td>
<td>Amnio wound, per square centimeter</td>
<td>Amnio wound, per square cm</td>
</tr>
<tr class="even">
<td>Q4182</td>
<td>0010</td>
<td>3</td>
<td>Transcyte, per square centimeter</td>
<td>Transcyte, per sq centimeter</td>
</tr>
<tr class="odd">
<td>Q4183</td>
<td>0010</td>
<td>3</td>
<td>Surgigraft, per square centimeter</td>
<td>Surgigraft, 1 sq cm</td>
</tr>
<tr class="even">
<td>Q4184</td>
<td>0010</td>
<td>3</td>
<td>Cellesta or cellesta duo, per square centimeter</td>
<td>Cellesta or duo per sq cm</td>
</tr>
<tr class="odd">
<td>Q4185</td>
<td>0010</td>
<td>3</td>
<td>Cellesta flowable amnion (25 mg per cc); per 0.5 cc</td>
<td>Cellesta flowab amnion 0.5cc</td>
</tr>
<tr class="even">
<td>Q4186</td>
<td>0010</td>
<td>3</td>
<td>Epifix, per square centimeter</td>
<td>Epifix 1 sq cm</td>
</tr>
<tr class="odd">
<td>Q4187</td>
<td>0010</td>
<td>3</td>
<td>Epicord, per square centimeter</td>
<td>Epicord 1 sq cm</td>
</tr>
<tr class="even">
<td>Q4188</td>
<td>0010</td>
<td>3</td>
<td>Amnioarmor, per square centimeter</td>
<td>Amnioarmor 1 sq cm</td>
</tr>
<tr class="odd">
<td>Q4189</td>
<td>0010</td>
<td>3</td>
<td>Artacent ac, 1 mg</td>
<td>Artacent ac, 1 mg</td>
</tr>
<tr class="even">
<td>Q4190</td>
<td>0010</td>
<td>3</td>
<td>Artacent ac, per square centimeter</td>
<td>Artacent ac 1 sq cm</td>
</tr>
<tr class="odd">
<td>Q4191</td>
<td>0010</td>
<td>3</td>
<td>Restorigin, per square centimeter</td>
<td>Restorigin 1 sq cm</td>
</tr>
<tr class="even">
<td>Q4192</td>
<td>0010</td>
<td>3</td>
<td>Restorigin, 1 cc</td>
<td>Restorigin, 1 cc</td>
</tr>
<tr class="odd">
<td>Q4193</td>
<td>0010</td>
<td>3</td>
<td>Coll-e-derm, per square centimeter</td>
<td>Coll-e-derm 1 sq cm</td>
</tr>
<tr class="even">
<td>Q4194</td>
<td>0010</td>
<td>3</td>
<td>Novachor, per square centimeter</td>
<td>Novachor 1 sq cm</td>
</tr>
<tr class="odd">
<td>Q4195</td>
<td>0010</td>
<td>3</td>
<td>Puraply, per square centimeter</td>
<td>Puraply 1 sq cm</td>
</tr>
<tr class="even">
<td>Q4196</td>
<td>0010</td>
<td>3</td>
<td>Puraply am, per square centimeter</td>
<td>Puraply am 1 sq cm</td>
</tr>
<tr class="odd">
<td>Q4197</td>
<td>0010</td>
<td>3</td>
<td>Puraply xt, per square centimeter</td>
<td>Puraply xt 1 sq cm</td>
</tr>
<tr class="even">
<td>Q4198</td>
<td>0010</td>
<td>3</td>
<td>Genesis amniotic membrane, per square centimeter</td>
<td>Genesis amnio membrane 1sqcm</td>
</tr>
<tr class="odd">
<td>Q4200</td>
<td>0010</td>
<td>3</td>
<td>Skin te, per square centimeter</td>
<td>Skin te 1 sq cm</td>
</tr>
<tr class="even">
<td>Q4201</td>
<td>0010</td>
<td>3</td>
<td>Matrion, per square centimeter</td>
<td>Matrion 1 sq cm</td>
</tr>
<tr class="odd">
<td>Q4202</td>
<td>0010</td>
<td>3</td>
<td>Keroxx (2.5g/cc), 1cc</td>
<td>Keroxx (2.5g/cc), 1cc</td>
</tr>
<tr class="even">
<td>Q4203</td>
<td>0010</td>
<td>3</td>
<td>Derma-gide, per square centimeter</td>
<td>Derma-gide, 1 sq cm</td>
</tr>
<tr class="odd">
<td>Q4204</td>
<td>0010</td>
<td>3</td>
<td>Xwrap, per square centimeter</td>
<td>Xwrap 1 sq cm</td>
</tr>
<tr class="even">
<td>Q4205</td>
<td>0010</td>
<td>3</td>
<td>Membrane graft or membrane wrap, per square centimeter</td>
<td>Membrane graft or wrap sq cm</td>
</tr>
<tr class="odd">
<td>Q4206</td>
<td>0010</td>
<td>3</td>
<td>Fluid flow or fluid gf, 1 cc</td>
<td>Fluid flow or fluid gf 1 cc</td>
</tr>
<tr class="even">
<td>Q4208</td>
<td>0010</td>
<td>3</td>
<td>Novafix, per square cenitmeter</td>
<td>Novafix per sq cm</td>
</tr>
<tr class="odd">
<td>Q4209</td>
<td>0010</td>
<td>3</td>
<td>Surgraft, per square centimeter</td>
<td>Surgraft per sq cm</td>
</tr>
<tr class="even">
<td>Q4210</td>
<td>0010</td>
<td>3</td>
<td>Axolotl graft or axolotl dualgraft, per square centimeter</td>
<td>Axolotl graf dualgraf sq cm</td>
</tr>
<tr class="odd">
<td>Q4211</td>
<td>0010</td>
<td>3</td>
<td>Amnion bio or axobiomembrane, per square centimeter</td>
<td>Amnion bio or axobio sq cm</td>
</tr>
<tr class="even">
<td>Q4212</td>
<td>0010</td>
<td>3</td>
<td>Allogen, per cc</td>
<td>Allogen, per cc</td>
</tr>
<tr class="odd">
<td>Q4213</td>
<td>0010</td>
<td>3</td>
<td>Ascent, 0.5 mg</td>
<td>Ascent, 0.5 mg</td>
</tr>
<tr class="even">
<td>Q4214</td>
<td>0010</td>
<td>3</td>
<td>Cellesta cord, per square centimeter</td>
<td>Cellesta cord per sq cm</td>
</tr>
<tr class="odd">
<td>Q4215</td>
<td>0010</td>
<td>3</td>
<td>Axolotl ambient or axolotl cryo, 0.1 mg</td>
<td>Axolotl ambient, cryo 0.1 mg</td>
</tr>
<tr class="even">
<td>Q4216</td>
<td>0010</td>
<td>3</td>
<td>Artacent cord, per square centimeter</td>
<td>Artacent cord per sq cm</td>
</tr>
<tr class="odd">
<td>Q4217</td>
<td>0010</td>
<td>3</td>
<td>Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter</td>
<td>Woundfix biowound plus xplus</td>
</tr>
<tr class="even">
<td>Q4218</td>
<td>0010</td>
<td>3</td>
<td>Surgicord, per square centimeter</td>
<td>Surgicord per sq cm</td>
</tr>
<tr class="odd">
<td>Q4219</td>
<td>0010</td>
<td>3</td>
<td>Surgigraft-dual, per square centimeter</td>
<td>Surgigraft dual per sq cm</td>
</tr>
<tr class="even">
<td>Q4220</td>
<td>0010</td>
<td>3</td>
<td>Bellacell hd or surederm, per square centimeter</td>
<td>Bellacell hd, surederm sq cm</td>
</tr>
<tr class="odd">
<td>Q4221</td>
<td>0010</td>
<td>3</td>
<td>Amniowrap2, per square centimeter</td>
<td>Amniowrap2 per sq cm</td>
</tr>
<tr class="even">
<td>Q4222</td>
<td>0010</td>
<td>3</td>
<td>Progenamatrix, per square centimeter</td>
<td>Progenamatrix, per sq cm</td>
</tr>
<tr class="odd">
<td>Q4226</td>
<td>0010</td>
<td>3</td>
<td>Myown skin, includes harvesting and preparation procedures, per square centimeter</td>
<td>Myown harv prep proc sq cm</td>
</tr>
<tr class="even">
<td>Q5001</td>
<td>0010</td>
<td>3</td>
<td>Hospice or home health care provided in patient’s home/residence</td>
<td>Hospice or home hlth in home</td>
</tr>
<tr class="odd">
<td>Q5002</td>
<td>0010</td>
<td>3</td>
<td>Hospice or home health care provided in assisted living facility</td>
<td>Hospice/home hlth in asst lv</td>
</tr>
<tr class="even">
<td>Q5003</td>
<td>0010</td>
<td>3</td>
<td>Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)</td>
<td>Hospice in lt/non-skilled nf</td>
</tr>
<tr class="odd">
<td>Q5004</td>
<td>0010</td>
<td>3</td>
<td>Hospice care provided in skilled nursing facility (snf)</td>
<td>Hospice in snf</td>
</tr>
<tr class="even">
<td>Q5005</td>
<td>0010</td>
<td>3</td>
<td>Hospice care provided in inpatient hospital</td>
<td>Hospice, inpatient hospital</td>
</tr>
<tr class="odd">
<td>Q5006</td>
<td>0010</td>
<td>3</td>
<td>Hospice care provided in inpatient hospice facility</td>
<td>Hospice in hospice facility</td>
</tr>
<tr class="even">
<td>Q5007</td>
<td>0010</td>
<td>3</td>
<td>Hospice care provided in long term care facility</td>
<td>Hospice in ltch</td>
</tr>
<tr class="odd">
<td>Q5008</td>
<td>0010</td>
<td>3</td>
<td>Hospice care provided in inpatient psychiatric facility</td>
<td>Hospice in inpatient psych</td>
</tr>
<tr class="even">
<td>Q5009</td>
<td>0010</td>
<td>3</td>
<td>Hospice or home health care provided in place not otherwise specified (nos)</td>
<td>Hospice/home hlth, place nos</td>
</tr>
<tr class="odd">
<td>Q5010</td>
<td>0010</td>
<td>3</td>
<td>Hospice home care provided in a hospice facility</td>
<td>Hospice home care in hospice</td>
</tr>
<tr class="even">
<td>Q5101</td>
<td>0010</td>
<td>3</td>
<td>Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram</td>
<td>Injection, zarxio</td>
</tr>
<tr class="odd">
<td>Q5102</td>
<td>0010</td>
<td>3</td>
<td>Injection, infliximab, biosimilar, 10 mg</td>
<td>Inj., infliximab biosimilar</td>
</tr>
<tr class="even">
<td>Q5103</td>
<td>0010</td>
<td>3</td>
<td>Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg</td>
<td>Injection, inflectra</td>
</tr>
<tr class="odd">
<td>Q5104</td>
<td>0010</td>
<td>3</td>
<td>Injection, infliximab-abda, biosimilar, (renflexis), 10 mg</td>
<td>Injection, renflexis</td>
</tr>
<tr class="even">
<td>Q5105</td>
<td>0010</td>
<td>3</td>
<td>Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units</td>
<td>Inj retacrit esrd on dialysi</td>
</tr>
<tr class="odd">
<td>Q5106</td>
<td>0010</td>
<td>3</td>
<td>Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units</td>
<td>Inj retacrit non-esrd use</td>
</tr>
<tr class="even">
<td>Q5107</td>
<td>0010</td>
<td>3</td>
<td>Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg</td>
<td>Inj mvasi 10 mg</td>
</tr>
<tr class="odd">
<td>Q5108</td>
<td>0010</td>
<td>3</td>
<td>Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg</td>
<td>Injection, fulphila</td>
</tr>
<tr class="even">
<td>Q5109</td>
<td>0010</td>
<td>3</td>
<td>Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg</td>
<td>Injection, ixifi, 10 mg</td>
</tr>
<tr class="odd">
<td>Q5110</td>
<td>0010</td>
<td>3</td>
<td>Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram</td>
<td>Nivestym</td>
</tr>
<tr class="even">
<td>Q5111</td>
<td>0010</td>
<td>3</td>
<td>Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg</td>
<td>Injection, udenyca 0.5 mg</td>
</tr>
<tr class="odd">
<td>Q5112</td>
<td>0010</td>
<td>3</td>
<td>Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg</td>
<td>Inj ontruzant 10 mg</td>
</tr>
<tr class="even">
<td>Q5113</td>
<td>0010</td>
<td>3</td>
<td>Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg</td>
<td>Inj herzuma 10 mg</td>
</tr>
<tr class="odd">
<td>Q5114</td>
<td>0010</td>
<td>3</td>
<td>Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg</td>
<td>Inj ogivri 10 mg</td>
</tr>
<tr class="even">
<td>Q5115</td>
<td>0010</td>
<td>3</td>
<td>Injection, rituximab-abbs, biosimilar, (truxima), 10 mg</td>
<td>Inj truxima 10 mg</td>
</tr>
<tr class="odd">
<td>Q5116</td>
<td>0010</td>
<td>3</td>
<td>Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg</td>
<td>Inj., trazimera, 10 mg</td>
</tr>
<tr class="even">
<td>Q5117</td>
<td>0010</td>
<td>3</td>
<td>Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg</td>
<td>Inj., kanjinti, 10 mg</td>
</tr>
<tr class="odd">
<td>Q5118</td>
<td>0010</td>
<td>3</td>
<td>Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg</td>
<td>Inj., zirabev, 10 mg</td>
</tr>
<tr class="even">
<td>Q9950</td>
<td>0010</td>
<td>3</td>
<td>Injection, sulfur hexafluoride lipid microspheres, per ml</td>
<td>Inj sulf hexa lipid microsph</td>
</tr>
<tr class="odd">
<td>Q9951</td>
<td>0010</td>
<td>3</td>
<td>Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml</td>
<td>Locm &gt;= 400 mg/ml iodine,1ml</td>
</tr>
<tr class="even">
<td>Q9953</td>
<td>0010</td>
<td>3</td>
<td>Injection, iron-based magnetic resonance contrast agent, per ml</td>
<td>Inj fe-based mr contrast,1ml</td>
</tr>
<tr class="odd">
<td>Q9954</td>
<td>0010</td>
<td>3</td>
<td>Oral magnetic resonance contrast agent, per 100 ml</td>
<td>Oral mr contrast, 100 ml</td>
</tr>
<tr class="even">
<td>Q9955</td>
<td>0010</td>
<td>3</td>
<td>Injection, perflexane lipid microspheres, per ml</td>
<td>Inj perflexane lip micros,ml</td>
</tr>
<tr class="odd">
<td>Q9956</td>
<td>0010</td>
<td>3</td>
<td>Injection, octafluoropropane microspheres, per ml</td>
<td>Inj octafluoropropane mic,ml</td>
</tr>
<tr class="even">
<td>Q9957</td>
<td>0010</td>
<td>3</td>
<td>Injection, perflutren lipid microspheres, per ml</td>
<td>Inj perflutren lip micros,ml</td>
</tr>
<tr class="odd">
<td>Q9958</td>
<td>0010</td>
<td>3</td>
<td>High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml</td>
<td>Hocm &lt;=149 mg/ml iodine, 1ml</td>
</tr>
<tr class="even">
<td>Q9959</td>
<td>0010</td>
<td>3</td>
<td>High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml</td>
<td>Hocm 150-199mg/ml iodine,1ml</td>
</tr>
<tr class="odd">
<td>Q9960</td>
<td>0010</td>
<td>3</td>
<td>High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml</td>
<td>Hocm 200-249mg/ml iodine,1ml</td>
</tr>
<tr class="even">
<td>Q9961</td>
<td>0010</td>
<td>3</td>
<td>High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml</td>
<td>Hocm 250-299mg/ml iodine,1ml</td>
</tr>
<tr class="odd">
<td>Q9962</td>
<td>0010</td>
<td>3</td>
<td>High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml</td>
<td>Hocm 300-349mg/ml iodine,1ml</td>
</tr>
<tr class="even">
<td>Q9963</td>
<td>0010</td>
<td>3</td>
<td>High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml</td>
<td>Hocm 350-399mg/ml iodine,1ml</td>
</tr>
<tr class="odd">
<td>Q9964</td>
<td>0010</td>
<td>3</td>
<td>High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml</td>
<td>Hocm&gt;= 400mg/ml iodine, 1ml</td>
</tr>
<tr class="even">
<td>Q9965</td>
<td>0010</td>
<td>3</td>
<td>Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml</td>
<td>Locm 100-199mg/ml iodine,1ml</td>
</tr>
<tr class="odd">
<td>Q9966</td>
<td>0010</td>
<td>3</td>
<td>Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml</td>
<td>Locm 200-299mg/ml iodine,1ml</td>
</tr>
<tr class="even">
<td>Q9967</td>
<td>0010</td>
<td>3</td>
<td>Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml</td>
<td>Locm 300-399mg/ml iodine,1ml</td>
</tr>
<tr class="odd">
<td>Q9968</td>
<td>0010</td>
<td>3</td>
<td>Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg</td>
<td>Visualization adjunct</td>
</tr>
<tr class="even">
<td>Q9969</td>
<td>0010</td>
<td>3</td>
<td>Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose</td>
<td>Non-heu tc-99m add-on/dose</td>
</tr>
<tr class="odd">
<td>Q9970</td>
<td>0010</td>
<td>3</td>
<td>Injection, ferric carboxymaltose, 1mg</td>
<td>Inj ferric carboxymaltos 1mg</td>
</tr>
<tr class="even">
<td>Q9972</td>
<td>0010</td>
<td>3</td>
<td>Injection, epoetin beta, 1 microgram, (for esrd on dialysis)</td>
<td>Epoetin beta esrd use</td>
</tr>
<tr class="odd">
<td>Q9973</td>
<td>0010</td>
<td>3</td>
<td>Injection, epoetin beta, 1 microgram, (non-esrd use)</td>
<td>Epoetin beta non esrd</td>
</tr>
<tr class="even">
<td>Q9974</td>
<td>0010</td>
<td>3</td>
<td>Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg</td>
<td>Morphine epidural/intratheca</td>
</tr>
<tr class="odd">
<td>Q9975</td>
<td>0010</td>
<td>3</td>
<td>Injection, factor viii fc fusion protein (recombinant), per iu</td>
<td>Factor viii fc fusion recomb</td>
</tr>
<tr class="even">
<td>Q9976</td>
<td>0010</td>
<td>3</td>
<td>Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron</td>
<td>Inj ferric pyrophosphate cit</td>
</tr>
<tr class="odd">
<td>Q9977</td>
<td>0010</td>
<td>3</td>
<td>Compounded drug, not otherwise classified</td>
<td>Compounded drug noc</td>
</tr>
<tr class="even">
<td>Q9978</td>
<td>0010</td>
<td>3</td>
<td>Netupitant 300 mg and palonosetron 0.5 mg</td>
<td>Netupitant palonosetron oral</td>
</tr>
<tr class="odd">
<td>Q9979</td>
<td>0010</td>
<td>3</td>
<td>Injection, alemtuzumab, 1 mg</td>
<td>Injection, alemtuzumab</td>
</tr>
<tr class="even">
<td>Q9980</td>
<td>0010</td>
<td>3</td>
<td>Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg</td>
<td>Genvisc, inj, 1mg</td>
</tr>
<tr class="odd">
<td>Q9981</td>
<td>0010</td>
<td>3</td>
<td>Rolapitant, oral, 1 mg</td>
<td>Rolapitant, oral, 1mg</td>
</tr>
<tr class="even">
<td>Q9982</td>
<td>0010</td>
<td>3</td>
<td>Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries</td>
<td>Flutemetamol f18 diagnostic</td>
</tr>
<tr class="odd">
<td>Q9983</td>
<td>0010</td>
<td>3</td>
<td>Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries</td>
<td>Florbetaben f18 diagnostic</td>
</tr>
<tr class="even">
<td>Q9984</td>
<td>0010</td>
<td>3</td>
<td>Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg</td>
<td>Kyleena, 19.5 mg</td>
</tr>
<tr class="odd">
<td>Q9985</td>
<td>0010</td>
<td>3</td>
<td>Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg</td>
<td>Inj hydroxyprogst capoat nos</td>
</tr>
<tr class="even">
<td>Q9986</td>
<td>0010</td>
<td>3</td>
<td>Injection, hydroxyprogesterone caproate, (makena), 10 mg</td>
<td>Makena, 10 mg</td>
</tr>
<tr class="odd">
<td>Q9987</td>
<td>0010</td>
<td>3</td>
<td>Pathogen(s) test for platelets</td>
<td>Pathogen test for platelets</td>
</tr>
<tr class="even">
<td>Q9988</td>
<td>0010</td>
<td>3</td>
<td>Platelets, pheresis, pathogen-reduced, each unit</td>
<td>Platelets, pathogen reduced</td>
</tr>
<tr class="odd">
<td>Q9989</td>
<td>0010</td>
<td>3</td>
<td>Ustekinumab, for intravenous injection, 1 mg</td>
<td>Ustekinumab, iv inject,1 mg</td>
</tr>
<tr class="even">
<td>Q9991</td>
<td>0010</td>
<td>3</td>
<td>Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg</td>
<td>Buprenorph xr 100 mg or less</td>
</tr>
<tr class="odd">
<td>Q9992</td>
<td>0010</td>
<td>3</td>
<td>Injection, buprenorphine extended-release (sublocade), greater than 100 mg</td>
<td>Buprenorphine xr over 100 mg</td>
</tr>
<tr class="even">
<td>Q9993</td>
<td>0010</td>
<td>3</td>
<td>Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg</td>
<td>Inj., triamcinolone ext rel</td>
</tr>
<tr class="odd">
<td>Q9994</td>
<td>0010</td>
<td>3</td>
<td>In-line cartridge containing digestive enzyme(s) for enteral feeding, each</td>
<td>Enzyme cartridge enteral nut</td>
</tr>
<tr class="even">
<td>Q9995</td>
<td>0010</td>
<td>3</td>
<td>Injection, emicizumab-kxwh, 0.5 mg</td>
<td>Inj., emicizumab-kxwh 0.5 mg</td>
</tr>
</tbody>
</table>
</div>
<div id="r-series-no-description" class="section level2">
<h2>R Series: No Description</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>R0070</td>
<td>0010</td>
<td>3</td>
<td>Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, one patient seen</td>
<td>Transport portable x-ray</td>
</tr>
<tr class="even">
<td>R0075</td>
<td>0010</td>
<td>3</td>
<td>Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, more than one patient seen</td>
<td>Transport port x-ray multipl</td>
</tr>
<tr class="odd">
<td>R0076</td>
<td>0010</td>
<td>3</td>
<td>Transportation of portable ekg to facility or location, per patient</td>
<td>Transport portable ekg</td>
</tr>
</tbody>
</table>
</div>
<div id="s-series-no-description" class="section level2">
<h2>S Series: No Description</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>S0012</td>
<td>0010</td>
<td>3</td>
<td>Butorphanol tartrate, nasal spray, 25 mg</td>
<td>Butorphanol tartrate, nasal</td>
</tr>
<tr class="even">
<td>S0014</td>
<td>0010</td>
<td>3</td>
<td>Tacrine hydrochloride, 10 mg</td>
<td>Tacrine hydrochloride, 10 mg</td>
</tr>
<tr class="odd">
<td>S0017</td>
<td>0010</td>
<td>3</td>
<td>Injection, aminocaproic acid, 5 grams</td>
<td>Injection, aminocaproic acid</td>
</tr>
<tr class="even">
<td>S0020</td>
<td>0010</td>
<td>3</td>
<td>Injection, bupivicaine hydrochloride, 30 ml</td>
<td>Injection, bupivicaine hydro</td>
</tr>
<tr class="odd">
<td>S0021</td>
<td>0010</td>
<td>3</td>
<td>Injection, cefoperazone sodium, 1 gram</td>
<td>Injection, cefoperazone sod</td>
</tr>
<tr class="even">
<td>S0023</td>
<td>0010</td>
<td>3</td>
<td>Injection, cimetidine hydrochloride, 300 mg</td>
<td>Injection, cimetidine hydroc</td>
</tr>
<tr class="odd">
<td>S0028</td>
<td>0010</td>
<td>3</td>
<td>Injection, famotidine, 20 mg</td>
<td>Injection, famotidine, 20 mg</td>
</tr>
<tr class="even">
<td>S0030</td>
<td>0010</td>
<td>3</td>
<td>Injection, metronidazole, 500 mg</td>
<td>Injection, metronidazole</td>
</tr>
<tr class="odd">
<td>S0032</td>
<td>0010</td>
<td>3</td>
<td>Injection, nafcillin sodium, 2 grams</td>
<td>Injection, nafcillin sodium</td>
</tr>
<tr class="even">
<td>S0034</td>
<td>0010</td>
<td>3</td>
<td>Injection, ofloxacin, 400 mg</td>
<td>Injection, ofloxacin, 400 mg</td>
</tr>
<tr class="odd">
<td>S0039</td>
<td>0010</td>
<td>3</td>
<td>Injection, sulfamethoxazole and trimethoprim, 10 ml</td>
<td>Injection, sulfamethoxazole</td>
</tr>
<tr class="even">
<td>S0040</td>
<td>0010</td>
<td>3</td>
<td>Injection, ticarcillin disodium and clavulanate potassium, 3.1 grams</td>
<td>Injection, ticarcillin disod</td>
</tr>
<tr class="odd">
<td>S0073</td>
<td>0010</td>
<td>3</td>
<td>Injection, aztreonam, 500 mg</td>
<td>Injection, aztreonam, 500 mg</td>
</tr>
<tr class="even">
<td>S0074</td>
<td>0010</td>
<td>3</td>
<td>Injection, cefotetan disodium, 500 mg</td>
<td>Injection, cefotetan disodiu</td>
</tr>
<tr class="odd">
<td>S0077</td>
<td>0010</td>
<td>3</td>
<td>Injection, clindamycin phosphate, 300 mg</td>
<td>Injection, clindamycin phosp</td>
</tr>
<tr class="even">
<td>S0078</td>
<td>0010</td>
<td>3</td>
<td>Injection, fosphenytoin sodium, 750 mg</td>
<td>Injection, fosphenytoin sodi</td>
</tr>
<tr class="odd">
<td>S0080</td>
<td>0010</td>
<td>3</td>
<td>Injection, pentamidine isethionate, 300 mg</td>
<td>Injection, pentamidine iseth</td>
</tr>
<tr class="even">
<td>S0081</td>
<td>0010</td>
<td>3</td>
<td>Injection, piperacillin sodium, 500 mg</td>
<td>Injection, piperacillin sodi</td>
</tr>
<tr class="odd">
<td>S0088</td>
<td>0010</td>
<td>3</td>
<td>Imatinib, 100 mg</td>
<td>Imatinib 100 mg</td>
</tr>
<tr class="even">
<td>S0090</td>
<td>0010</td>
<td>3</td>
<td>Sildenafil citrate, 25 mg</td>
<td>Sildenafil citrate, 25 mg</td>
</tr>
<tr class="odd">
<td>S0091</td>
<td>0010</td>
<td>3</td>
<td>Granisetron hydrochloride, 1 mg (for circumstances falling under the medicare statute, use q0166)</td>
<td>Granisetron 1mg</td>
</tr>
<tr class="even">
<td>S0092</td>
<td>0010</td>
<td>3</td>
<td>Injection, hydromorphone hydrochloride, 250 mg (loading dose for infusion pump)</td>
<td>Hydromorphone 250 mg</td>
</tr>
<tr class="odd">
<td>S0093</td>
<td>0010</td>
<td>3</td>
<td>Injection, morphine sulfate, 500 mg (loading dose for infusion pump)</td>
<td>Morphine 500 mg</td>
</tr>
<tr class="even">
<td>S0104</td>
<td>0010</td>
<td>3</td>
<td>Zidovudine, oral, 100 mg</td>
<td>Zidovudine, oral, 100 mg</td>
</tr>
<tr class="odd">
<td>S0106</td>
<td>0010</td>
<td>3</td>
<td>Bupropion hcl sustained release tablet, 150 mg, per bottle of 60 tablets</td>
<td>Bupropion hcl sr 60 tablets</td>
</tr>
<tr class="even">
<td>S0108</td>
<td>0010</td>
<td>3</td>
<td>Mercaptopurine, oral, 50 mg</td>
<td>Mercaptopurine 50 mg</td>
</tr>
<tr class="odd">
<td>S0109</td>
<td>0010</td>
<td>3</td>
<td>Methadone, oral, 5 mg</td>
<td>Methadone oral 5mg</td>
</tr>
<tr class="even">
<td>S0117</td>
<td>0010</td>
<td>3</td>
<td>Tretinoin, topical, 5 grams</td>
<td>Tretinoin topical 5 g</td>
</tr>
<tr class="odd">
<td>S0119</td>
<td>0010</td>
<td>3</td>
<td>Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)</td>
<td>Ondansetron 4 mg</td>
</tr>
<tr class="even">
<td>S0122</td>
<td>0010</td>
<td>3</td>
<td>Injection, menotropins, 75 iu</td>
<td>Inj menotropins 75 iu</td>
</tr>
<tr class="odd">
<td>S0126</td>
<td>0010</td>
<td>3</td>
<td>Injection, follitropin alfa, 75 iu</td>
<td>Inj follitropin alfa 75 iu</td>
</tr>
<tr class="even">
<td>S0128</td>
<td>0010</td>
<td>3</td>
<td>Injection, follitropin beta, 75 iu</td>
<td>Inj follitropin beta 75 iu</td>
</tr>
<tr class="odd">
<td>S0132</td>
<td>0010</td>
<td>3</td>
<td>Injection, ganirelix acetate, 250 mcg</td>
<td>Inj ganirelix acetat 250 mcg</td>
</tr>
<tr class="even">
<td>S0136</td>
<td>0010</td>
<td>3</td>
<td>Clozapine, 25 mg</td>
<td>Clozapine, 25 mg</td>
</tr>
<tr class="odd">
<td>S0137</td>
<td>0010</td>
<td>3</td>
<td>Didanosine (ddi), 25 mg</td>
<td>Didanosine, 25 mg</td>
</tr>
<tr class="even">
<td>S0138</td>
<td>0010</td>
<td>3</td>
<td>Finasteride, 5 mg</td>
<td>Finasteride, 5 mg</td>
</tr>
<tr class="odd">
<td>S0139</td>
<td>0010</td>
<td>3</td>
<td>Minoxidil, 10 mg</td>
<td>Minoxidil, 10 mg</td>
</tr>
<tr class="even">
<td>S0140</td>
<td>0010</td>
<td>3</td>
<td>Saquinavir, 200 mg</td>
<td>Saquinavir, 200 mg</td>
</tr>
<tr class="odd">
<td>S0142</td>
<td>0010</td>
<td>3</td>
<td>Colistimethate sodium, inhalation solution administered through dme, concentrated form, per mg</td>
<td>Colistimethate inh sol mg</td>
</tr>
<tr class="even">
<td>S0144</td>
<td>0010</td>
<td>3</td>
<td>Injection, propofol, 10 mg</td>
<td>Inj, propofol, 10 mg</td>
</tr>
<tr class="odd">
<td>S0145</td>
<td>0010</td>
<td>3</td>
<td>Injection, pegylated interferon alfa-2a, 180 mcg per ml</td>
<td>Peg interferon alfa-2a/180</td>
</tr>
<tr class="even">
<td>S0148</td>
<td>0010</td>
<td>3</td>
<td>Injection, pegylated interferon alfa-2b, 10 mcg</td>
<td>Peg interferon alfa-2b/10</td>
</tr>
<tr class="odd">
<td>S0155</td>
<td>0010</td>
<td>3</td>
<td>Sterile dilutant for epoprostenol, 50 ml</td>
<td>Epoprostenol dilutant</td>
</tr>
<tr class="even">
<td>S0156</td>
<td>0010</td>
<td>3</td>
<td>Exemestane, 25 mg</td>
<td>Exemestane, 25 mg</td>
</tr>
<tr class="odd">
<td>S0157</td>
<td>0010</td>
<td>3</td>
<td>Becaplermin gel 0.01%, 0.5 gm</td>
<td>Becaplermin gel 1%, 0.5 gm</td>
</tr>
<tr class="even">
<td>S0160</td>
<td>0010</td>
<td>3</td>
<td>Dextroamphetamine sulfate, 5 mg</td>
<td>Dextroamphetamine</td>
</tr>
<tr class="odd">
<td>S0164</td>
<td>0010</td>
<td>3</td>
<td>Injection, pantoprazole sodium, 40 mg</td>
<td>Injection pantroprazole</td>
</tr>
<tr class="even">
<td>S0166</td>
<td>0010</td>
<td>3</td>
<td>Injection, olanzapine, 2.5 mg</td>
<td>Inj olanzapine 2.5mg</td>
</tr>
<tr class="odd">
<td>S0169</td>
<td>0010</td>
<td>3</td>
<td>Calcitrol, 0.25 microgram</td>
<td>Calcitrol</td>
</tr>
<tr class="even">
<td>S0170</td>
<td>0010</td>
<td>3</td>
<td>Anastrozole, oral, 1 mg</td>
<td>Anastrozole 1 mg</td>
</tr>
<tr class="odd">
<td>S0171</td>
<td>0010</td>
<td>3</td>
<td>Injection, bumetanide, 0.5 mg</td>
<td>Bumetanide 0.5 mg</td>
</tr>
<tr class="even">
<td>S0172</td>
<td>0010</td>
<td>3</td>
<td>Chlorambucil, oral, 2 mg</td>
<td>Chlorambucil 2 mg</td>
</tr>
<tr class="odd">
<td>S0174</td>
<td>0010</td>
<td>3</td>
<td>Dolasetron mesylate, oral 50 mg (for circumstances falling under the medicare statute, use q0180)</td>
<td>Dolasetron 50 mg</td>
</tr>
<tr class="even">
<td>S0175</td>
<td>0010</td>
<td>3</td>
<td>Flutamide, oral, 125 mg</td>
<td>Flutamide 125 mg</td>
</tr>
<tr class="odd">
<td>S0176</td>
<td>0010</td>
<td>3</td>
<td>Hydroxyurea, oral, 500 mg</td>
<td>Hydroxyurea 500 mg</td>
</tr>
<tr class="even">
<td>S0177</td>
<td>0010</td>
<td>3</td>
<td>Levamisole hydrochloride, oral, 50 mg</td>
<td>Levamisole 50 mg</td>
</tr>
<tr class="odd">
<td>S0178</td>
<td>0010</td>
<td>3</td>
<td>Lomustine, oral, 10 mg</td>
<td>Lomustine 10 mg</td>
</tr>
<tr class="even">
<td>S0179</td>
<td>0010</td>
<td>3</td>
<td>Megestrol acetate, oral, 20 mg</td>
<td>Megestrol 20 mg</td>
</tr>
<tr class="odd">
<td>S0182</td>
<td>0010</td>
<td>3</td>
<td>Procarbazine hydrochloride, oral, 50 mg</td>
<td>Procarbazine, oral</td>
</tr>
<tr class="even">
<td>S0183</td>
<td>0010</td>
<td>3</td>
<td>Prochlorperazine maleate, oral, 5 mg (for circumstances falling under the medicare statute, use q0164)</td>
<td>Prochlorperazine 5 mg</td>
</tr>
<tr class="odd">
<td>S0187</td>
<td>0010</td>
<td>3</td>
<td>Tamoxifen citrate, oral, 10 mg</td>
<td>Tamoxifen 10 mg</td>
</tr>
<tr class="even">
<td>S0189</td>
<td>0010</td>
<td>3</td>
<td>Testosterone pellet, 75 mg</td>
<td>Testosterone pellet 75 mg</td>
</tr>
<tr class="odd">
<td>S0190</td>
<td>0010</td>
<td>3</td>
<td>Mifepristone, oral, 200 mg</td>
<td>Mifepristone, oral, 200 mg</td>
</tr>
<tr class="even">
<td>S0191</td>
<td>0010</td>
<td>3</td>
<td>Misoprostol, oral, 200 mcg</td>
<td>Misoprostol, oral, 200 mcg</td>
</tr>
<tr class="odd">
<td>S0194</td>
<td>0010</td>
<td>3</td>
<td>Dialysis/stress vitamin supplement, oral, 100 capsules</td>
<td>Vitamin suppl 100 caps</td>
</tr>
<tr class="even">
<td>S0195</td>
<td>0010</td>
<td>3</td>
<td>Pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine</td>
<td>Pneumo vaccine 5-9 yrs</td>
</tr>
<tr class="odd">
<td>S0197</td>
<td>0010</td>
<td>3</td>
<td>Prenatal vitamins, 30-day supply</td>
<td>Prenatal vitamins 30 day</td>
</tr>
<tr class="even">
<td>S0199</td>
<td>0010</td>
<td>3</td>
<td>Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs</td>
<td>Med abortion inc all ex drug</td>
</tr>
<tr class="odd">
<td>S0201</td>
<td>0010</td>
<td>3</td>
<td>Partial hospitalization services, less than 24 hours, per diem</td>
<td>Partial hospitalization serv</td>
</tr>
<tr class="even">
<td>S0207</td>
<td>0010</td>
<td>3</td>
<td>Paramedic intercept, non-hospital-based als service (non-voluntary), non-transport</td>
<td>Paramedicintercep nonhospals</td>
</tr>
<tr class="odd">
<td>S0208</td>
<td>0010</td>
<td>3</td>
<td>Paramedic intercept, hospital-based als service (non-voluntary), non-transport</td>
<td>Paramed intrcept nonvol</td>
</tr>
<tr class="even">
<td>S0209</td>
<td>0010</td>
<td>3</td>
<td>Wheelchair van, mileage, per mile</td>
<td>Wc van mileage per mi</td>
</tr>
<tr class="odd">
<td>S0215</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation; mileage, per mile</td>
<td>Nonemerg transp mileage</td>
</tr>
<tr class="even">
<td>S0220</td>
<td>0010</td>
<td>3</td>
<td>Medical conference by a physician with interdisciplinary team of health professionals or representatives of community agencies to coordinate activities of patient care (patient is present); approximately 30 minutes</td>
<td>Medical conference by physic</td>
</tr>
<tr class="odd">
<td>S0221</td>
<td>0010</td>
<td>3</td>
<td>Medical conference by a physician with interdisciplinary team of health professionals or representatives of community agencies to coordinate activities of patient care (patient is present); approximately 60 minutes</td>
<td>Medical conference, 60 min</td>
</tr>
<tr class="even">
<td>S0250</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive geriatric assessment and treatment planning performed by assessment team</td>
<td>Comp geriatr assmt team</td>
</tr>
<tr class="odd">
<td>S0255</td>
<td>0010</td>
<td>3</td>
<td>Hospice referral visit (advising patient and family of care options) performed by nurse, social worker, or other designated staff</td>
<td>Hospice refer visit nonmd</td>
</tr>
<tr class="even">
<td>S0257</td>
<td>0010</td>
<td>3</td>
<td>Counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service)</td>
<td>End of life counseling</td>
</tr>
<tr class="odd">
<td>S0260</td>
<td>0010</td>
<td>3</td>
<td>History and physical (outpatient or office) related to surgical procedure (list separately in addition to code for appropriate evaluation and management service)</td>
<td>H&amp;p for surgery</td>
</tr>
<tr class="even">
<td>S0265</td>
<td>0010</td>
<td>3</td>
<td>Genetic counseling, under physician supervision, each 15 minutes</td>
<td>Genetic counsel 15 mins</td>
</tr>
<tr class="odd">
<td>S0270</td>
<td>0010</td>
<td>3</td>
<td>Physician management of patient home care, standard monthly case rate (per 30 days)</td>
<td>Home std case rate 30 days</td>
</tr>
<tr class="even">
<td>S0271</td>
<td>0010</td>
<td>3</td>
<td>Physician management of patient home care, hospice monthly case rate (per 30 days)</td>
<td>Home hospice case 30 days</td>
</tr>
<tr class="odd">
<td>S0272</td>
<td>0010</td>
<td>3</td>
<td>Physician management of patient home care, episodic care monthly case rate (per 30 days)</td>
<td>Home episodic case 30 days</td>
</tr>
<tr class="even">
<td>S0273</td>
<td>0010</td>
<td>3</td>
<td>Physician visit at member’s home, outside of a capitation arrangement</td>
<td>Md home visit outside cap</td>
</tr>
<tr class="odd">
<td>S0274</td>
<td>0010</td>
<td>3</td>
<td>Nurse practitioner visit at member’s home, outside of a capitation arrangement</td>
<td>Nurse practr visit outs cap</td>
</tr>
<tr class="even">
<td>S0280</td>
<td>0010</td>
<td>3</td>
<td>Medical home program, comprehensive care coordination and planning, initial plan</td>
<td>Medical home, initial plan</td>
</tr>
<tr class="odd">
<td>S0281</td>
<td>0010</td>
<td>3</td>
<td>Medical home program, comprehensive care coordination and planning, maintenance of plan</td>
<td>Medical home, maintenance</td>
</tr>
<tr class="even">
<td>S0285</td>
<td>0010</td>
<td>3</td>
<td>Colonoscopy consultation performed prior to a screening colonoscopy procedure</td>
<td>Cnslt before screen colonosc</td>
</tr>
<tr class="odd">
<td>S0302</td>
<td>0010</td>
<td>3</td>
<td>Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service)</td>
<td>Completed epsdt</td>
</tr>
<tr class="even">
<td>S0310</td>
<td>0010</td>
<td>3</td>
<td>Hospitalist services (list separately in addition to code for appropriate evaluation and management service)</td>
<td>Hospitalist visit</td>
</tr>
<tr class="odd">
<td>S0311</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive management and care coordination for advanced illness, per calendar month</td>
<td>Comp mgmt care coord adv ill</td>
</tr>
<tr class="even">
<td>S0315</td>
<td>0010</td>
<td>3</td>
<td>Disease management program; initial assessment and initiation of the program</td>
<td>Disease management program</td>
</tr>
<tr class="odd">
<td>S0316</td>
<td>0010</td>
<td>3</td>
<td>Disease management program, follow-up/reassessment</td>
<td>Follow-up/reassessment</td>
</tr>
<tr class="even">
<td>S0317</td>
<td>0010</td>
<td>3</td>
<td>Disease management program; per diem</td>
<td>Disease mgmt per diem</td>
</tr>
<tr class="odd">
<td>S0320</td>
<td>0010</td>
<td>3</td>
<td>Telephone calls by a registered nurse to a disease management program member for monitoring purposes; per month</td>
<td>Rn telephone calls to dmp</td>
</tr>
<tr class="even">
<td>S0340</td>
<td>0010</td>
<td>3</td>
<td>Lifestyle modification program for management of coronary artery disease, including all supportive services; first quarter / stage</td>
<td>Lifestyle mod 1st stage</td>
</tr>
<tr class="odd">
<td>S0341</td>
<td>0010</td>
<td>3</td>
<td>Lifestyle modification program for management of coronary artery disease, including all supportive services; second or third quarter / stage</td>
<td>Lifestyle mod 2 or 3 stage</td>
</tr>
<tr class="even">
<td>S0342</td>
<td>0010</td>
<td>3</td>
<td>Lifestyle modification program for management of coronary artery disease, including all supportive services; fourth quarter / stage</td>
<td>Lifestyle mod 4th stage</td>
</tr>
<tr class="odd">
<td>S0353</td>
<td>0010</td>
<td>3</td>
<td>Treatment planning and care coordination management for cancer, initial treatment</td>
<td>Cancer treatmentplan initial</td>
</tr>
<tr class="even">
<td>S0354</td>
<td>0010</td>
<td>3</td>
<td>Treatment planning and care coordination management for cancer, established patient with a change of regimen</td>
<td>Cancer treatment plan change</td>
</tr>
<tr class="odd">
<td>S0390</td>
<td>0010</td>
<td>3</td>
<td>Routine foot care; removal and/or trimming of corns, calluses and/or nails and preventive maintenance in specific medical conditions (e.g., diabetes), per visit</td>
<td>Rout foot care per visit</td>
</tr>
<tr class="even">
<td>S0395</td>
<td>0010</td>
<td>3</td>
<td>Impression casting of a foot performed by a practitioner other than the manufacturer of the orthotic</td>
<td>Impression casting ft</td>
</tr>
<tr class="odd">
<td>S0400</td>
<td>0010</td>
<td>3</td>
<td>Global fee for extracorporeal shock wave lithotripsy treatment of kidney stone(s)</td>
<td>Global eswl kidney</td>
</tr>
<tr class="even">
<td>S0500</td>
<td>0010</td>
<td>3</td>
<td>Disposable contact lens, per lens</td>
<td>Dispos cont lens</td>
</tr>
<tr class="odd">
<td>S0504</td>
<td>0010</td>
<td>3</td>
<td>Single vision prescription lens (safety, athletic, or sunglass), per lens</td>
<td>Singl prscrp lens</td>
</tr>
<tr class="even">
<td>S0506</td>
<td>0010</td>
<td>3</td>
<td>Bifocal vision prescription lens (safety, athletic, or sunglass), per lens</td>
<td>Bifoc prscp lens</td>
</tr>
<tr class="odd">
<td>S0508</td>
<td>0010</td>
<td>3</td>
<td>Trifocal vision prescription lens (safety, athletic, or sunglass), per lens</td>
<td>Trifoc prscrp lens</td>
</tr>
<tr class="even">
<td>S0510</td>
<td>0010</td>
<td>3</td>
<td>Non-prescription lens (safety, athletic, or sunglass), per lens</td>
<td>Non-prscrp lens</td>
</tr>
<tr class="odd">
<td>S0512</td>
<td>0010</td>
<td>3</td>
<td>Daily wear specialty contact lens, per lens</td>
<td>Daily cont lens</td>
</tr>
<tr class="even">
<td>S0514</td>
<td>0010</td>
<td>3</td>
<td>Color contact lens, per lens</td>
<td>Color cont lens</td>
</tr>
<tr class="odd">
<td>S0515</td>
<td>0010</td>
<td>3</td>
<td>Scleral lens, liquid bandage device, per lens</td>
<td>Scleral lens liquid bandage</td>
</tr>
<tr class="even">
<td>S0516</td>
<td>0010</td>
<td>3</td>
<td>Safety eyeglass frames</td>
<td>Safety frames</td>
</tr>
<tr class="odd">
<td>S0518</td>
<td>0010</td>
<td>3</td>
<td>Sunglasses frames</td>
<td>Sunglass frames</td>
</tr>
<tr class="even">
<td>S0580</td>
<td>0010</td>
<td>3</td>
<td>Polycarbonate lens (list this code in addition to the basic code for the lens)</td>
<td>Polycarb lens</td>
</tr>
<tr class="odd">
<td>S0581</td>
<td>0010</td>
<td>3</td>
<td>Nonstandard lens (list this code in addition to the basic code for the lens)</td>
<td>Nonstnd lens</td>
</tr>
<tr class="even">
<td>S0590</td>
<td>0010</td>
<td>3</td>
<td>Integral lens service, miscellaneous services reported separately</td>
<td>Misc integral lens serv</td>
</tr>
<tr class="odd">
<td>S0592</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive contact lens evaluation</td>
<td>Comp cont lens eval</td>
</tr>
<tr class="even">
<td>S0595</td>
<td>0010</td>
<td>3</td>
<td>Dispensing new spectacle lenses for patient supplied frame</td>
<td>New lenses in pts old frame</td>
</tr>
<tr class="odd">
<td>S0596</td>
<td>0010</td>
<td>3</td>
<td>Phakic intraocular lens for correction of refractive error</td>
<td>Phakic iol refractive error</td>
</tr>
<tr class="even">
<td>S0601</td>
<td>0010</td>
<td>3</td>
<td>Screening proctoscopy</td>
<td>Screening proctoscopy</td>
</tr>
<tr class="odd">
<td>S0610</td>
<td>0010</td>
<td>3</td>
<td>Annual gynecological examination, new patient</td>
<td>Annual gynecological examina</td>
</tr>
<tr class="even">
<td>S0612</td>
<td>0010</td>
<td>3</td>
<td>Annual gynecological examination, established patient</td>
<td>Annual gynecological examina</td>
</tr>
<tr class="odd">
<td>S0613</td>
<td>0010</td>
<td>3</td>
<td>Annual gynecological examination; clinical breast examination without pelvic evaluation</td>
<td>Ann breast exam</td>
</tr>
<tr class="even">
<td>S0618</td>
<td>0010</td>
<td>3</td>
<td>Audiometry for hearing aid evaluation to determine the level and degree of hearing loss</td>
<td>Audiometry for hearing aid</td>
</tr>
<tr class="odd">
<td>S0620</td>
<td>0010</td>
<td>3</td>
<td>Routine ophthalmological examination including refraction; new patient</td>
<td>Routine ophthalmological exa</td>
</tr>
<tr class="even">
<td>S0621</td>
<td>0010</td>
<td>3</td>
<td>Routine ophthalmological examination including refraction; established patient</td>
<td>Routine ophthalmological exa</td>
</tr>
<tr class="odd">
<td>S0622</td>
<td>0010</td>
<td>3</td>
<td>Physical exam for college, new or established patient (list separately in addition to appropriate evaluation and management code)</td>
<td>Phys exam for college</td>
</tr>
<tr class="even">
<td>S0630</td>
<td>0010</td>
<td>3</td>
<td>Removal of sutures; by a physician other than the physician who originally closed the wound</td>
<td>Removal of sutures</td>
</tr>
<tr class="odd">
<td>S0800</td>
<td>0010</td>
<td>3</td>
<td>Laser in situ keratomileusis (lasik)</td>
<td>Laser in situ keratomileusis</td>
</tr>
<tr class="even">
<td>S0810</td>
<td>0010</td>
<td>3</td>
<td>Photorefractive keratectomy (prk)</td>
<td>Photorefractive keratectomy</td>
</tr>
<tr class="odd">
<td>S0812</td>
<td>0010</td>
<td>3</td>
<td>Phototherapeutic keratectomy (ptk)</td>
<td>Phototherap keratect</td>
</tr>
<tr class="even">
<td>S1001</td>
<td>0010</td>
<td>3</td>
<td>Deluxe item, patient aware (list in addition to code for basic item)</td>
<td>Deluxe item</td>
</tr>
<tr class="odd">
<td>S1002</td>
<td>0010</td>
<td>3</td>
<td>Customized item (list in addition to code for basic item)</td>
<td>Custom item</td>
</tr>
<tr class="even">
<td>S1015</td>
<td>0010</td>
<td>3</td>
<td>Iv tubing extension set</td>
<td>Iv tubing extension set</td>
</tr>
<tr class="odd">
<td>S1016</td>
<td>0010</td>
<td>3</td>
<td>Non-pvc (polyvinyl chloride) intravenous administration set, for use with drugs that are not stable in pvc e.g., paclitaxel</td>
<td>Non-pvc intravenous administ</td>
</tr>
<tr class="even">
<td>S1030</td>
<td>0010</td>
<td>3</td>
<td>Continuous noninvasive glucose monitoring device, purchase (for physician interpretation of data, use cpt code)</td>
<td>Gluc monitor purchase</td>
</tr>
<tr class="odd">
<td>S1031</td>
<td>0010</td>
<td>3</td>
<td>Continuous noninvasive glucose monitoring device, rental, including sensor, sensor replacement, and download to monitor (for physician interpretation of data, use cpt code)</td>
<td>Gluc monitor rental</td>
</tr>
<tr class="even">
<td>S1034</td>
<td>0010</td>
<td>3</td>
<td>Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices</td>
<td>Art pancreas system</td>
</tr>
<tr class="odd">
<td>S1035</td>
<td>0010</td>
<td>3</td>
<td>Sensor; invasive (e.g., subcutaneous), disposable, for use with artificial pancreas device system</td>
<td>Art pancreas inv disp sensor</td>
</tr>
<tr class="even">
<td>S1036</td>
<td>0010</td>
<td>3</td>
<td>Transmitter; external, for use with artificial pancreas device system</td>
<td>Art pancreas ext transmitter</td>
</tr>
<tr class="odd">
<td>S1037</td>
<td>0010</td>
<td>3</td>
<td>Receiver (monitor); external, for use with artificial pancreas device system</td>
<td>Art pancreas ext receiver</td>
</tr>
<tr class="even">
<td>S1040</td>
<td>0010</td>
<td>3</td>
<td>Cranial remolding orthosis, pediatric, rigid, with soft interface material, custom fabricated, includes fitting and adjustment(s)</td>
<td>Cranial remolding orthosis</td>
</tr>
<tr class="odd">
<td>S1090</td>
<td>0010</td>
<td>3</td>
<td>Mometasone furoate sinus implant, 370 micrograms</td>
<td>Mometasone sinus implant</td>
</tr>
<tr class="even">
<td>S2053</td>
<td>0010</td>
<td>3</td>
<td>Transplantation of small intestine and liver allografts</td>
<td>Transplantation of small int</td>
</tr>
<tr class="odd">
<td>S2054</td>
<td>0010</td>
<td>3</td>
<td>Transplantation of multivisceral organs</td>
<td>Transplantation of multivisc</td>
</tr>
<tr class="even">
<td>S2055</td>
<td>0010</td>
<td>3</td>
<td>Harvesting of donor multivisceral organs, with preparation and maintenance of allografts; from cadaver donor</td>
<td>Harvesting of donor multivis</td>
</tr>
<tr class="odd">
<td>S2060</td>
<td>0010</td>
<td>3</td>
<td>Lobar lung transplantation</td>
<td>Lobar lung transplantation</td>
</tr>
<tr class="even">
<td>S2061</td>
<td>0010</td>
<td>3</td>
<td>Donor lobectomy (lung) for transplantation, living donor</td>
<td>Donor lobectomy (lung)</td>
</tr>
<tr class="odd">
<td>S2065</td>
<td>0010</td>
<td>3</td>
<td>Simultaneous pancreas kidney transplantation</td>
<td>Simult panc kidn trans</td>
</tr>
<tr class="even">
<td>S2066</td>
<td>0010</td>
<td>3</td>
<td>Breast reconstruction with gluteal artery perforator (gap) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral</td>
<td>Breast gap flap reconst</td>
</tr>
<tr class="odd">
<td>S2067</td>
<td>0010</td>
<td>3</td>
<td>Breast reconstruction of a single breast with “stacked” deep inferior epigastric perforator (diep) flap(s) and/or gluteal artery perforator (gap) flap(s), including harvesting of the flap(s), microvascular transfer, closure of donor site(s) and shaping the flap into a breast, unilateral</td>
<td>Breast “stacked” diep/gap</td>
</tr>
<tr class="even">
<td>S2068</td>
<td>0010</td>
<td>3</td>
<td>Breast reconstruction with deep inferior epigastric perforator (diep) flap or superficial inferior epigastric artery (siea) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral</td>
<td>Breast diep or siea flap</td>
</tr>
<tr class="odd">
<td>S2070</td>
<td>0010</td>
<td>3</td>
<td>Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with endoscopic laser treatment of ureteral calculi (includes ureteral catheterization)</td>
<td>Cysto laser tx ureteral calc</td>
</tr>
<tr class="even">
<td>S2079</td>
<td>0010</td>
<td>3</td>
<td>Laparoscopic esophagomyotomy (heller type)</td>
<td>Lap esophagomyotomy</td>
</tr>
<tr class="odd">
<td>S2080</td>
<td>0010</td>
<td>3</td>
<td>Laser-assisted uvulopalatoplasty (laup)</td>
<td>Laup</td>
</tr>
<tr class="even">
<td>S2083</td>
<td>0010</td>
<td>3</td>
<td>Adjustment of gastric band diameter via subcutaneous port by injection or aspiration of saline</td>
<td>Adjustment gastric band</td>
</tr>
<tr class="odd">
<td>S2095</td>
<td>0010</td>
<td>3</td>
<td>Transcatheter occlusion or embolization for tumor destruction, percutaneous, any method, using yttrium-90 microspheres</td>
<td>Transcath emboliz microspher</td>
</tr>
<tr class="even">
<td>S2102</td>
<td>0010</td>
<td>3</td>
<td>Islet cell tissue transplant from pancreas; allogeneic</td>
<td>Islet cell tissue transplant</td>
</tr>
<tr class="odd">
<td>S2103</td>
<td>0010</td>
<td>3</td>
<td>Adrenal tissue transplant to brain</td>
<td>Adrenal tissue transplant</td>
</tr>
<tr class="even">
<td>S2107</td>
<td>0010</td>
<td>3</td>
<td>Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment</td>
<td>Adoptive immunotherapy</td>
</tr>
<tr class="odd">
<td>S2112</td>
<td>0010</td>
<td>3</td>
<td>Arthroscopy, knee, surgical for harvesting of cartilage (chondrocyte cells)</td>
<td>Knee arthroscp harv</td>
</tr>
<tr class="even">
<td>S2115</td>
<td>0010</td>
<td>3</td>
<td>Osteotomy, periacetabular, with internal fixation</td>
<td>Periacetabular osteotomy</td>
</tr>
<tr class="odd">
<td>S2117</td>
<td>0010</td>
<td>3</td>
<td>Arthroereisis, subtalar</td>
<td>Arthroereisis, subtalar</td>
</tr>
<tr class="even">
<td>S2118</td>
<td>0010</td>
<td>3</td>
<td>Metal-on-metal total hip resurfacing, including acetabular and femoral components</td>
<td>Total hip resurfacing</td>
</tr>
<tr class="odd">
<td>S2120</td>
<td>0010</td>
<td>3</td>
<td>Low density lipoprotein (ldl) apheresis using heparin-induced extracorporeal ldl precipitation</td>
<td>Low density lipoprotein(ldl)</td>
</tr>
<tr class="even">
<td>S2140</td>
<td>0010</td>
<td>3</td>
<td>Cord blood harvesting for transplantation, allogeneic</td>
<td>Cord blood harvesting</td>
</tr>
<tr class="odd">
<td>S2142</td>
<td>0010</td>
<td>3</td>
<td>Cord blood-derived stem-cell transplantation, allogeneic</td>
<td>Cord blood-derived stem-cell</td>
</tr>
<tr class="even">
<td>S2150</td>
<td>0010</td>
<td>3</td>
<td>Bone marrow or blood-derived stem cells (peripheral or umbilical), allogeneic or autologous, harvesting, transplantation, and related complications; including: pheresis and cell preparation/storage; marrow ablative therapy; drugs, supplies, hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services; and the number of days of pre-and post-transplant care in the global definition</td>
<td>Bmt harv/transpl 28d pkg</td>
</tr>
<tr class="odd">
<td>S2152</td>
<td>0010</td>
<td>3</td>
<td>Solid organ(s), complete or segmental, single organ or combination of organs; deceased or living donor(s), procurement, transplantation, and related complications; including: drugs; supplies; hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services, and the number of days of pre- and post-transplant care in the global definition</td>
<td>Solid organ transpl pkg</td>
</tr>
<tr class="even">
<td>S2202</td>
<td>0010</td>
<td>3</td>
<td>Echosclerotherapy</td>
<td>Echosclerotherapy</td>
</tr>
<tr class="odd">
<td>S2205</td>
<td>0010</td>
<td>3</td>
<td>Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), single coronary arterial graft</td>
<td>Minimally invasive direct co</td>
</tr>
<tr class="even">
<td>S2206</td>
<td>0010</td>
<td>3</td>
<td>Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), two coronary arterial grafts</td>
<td>Minimally invasive direct co</td>
</tr>
<tr class="odd">
<td>S2207</td>
<td>0010</td>
<td>3</td>
<td>Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using venous graft only, single coronary venous graft</td>
<td>Minimally invasive direct co</td>
</tr>
<tr class="even">
<td>S2208</td>
<td>0010</td>
<td>3</td>
<td>Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using single arterial and venous graft(s), single venous graft</td>
<td>Minimally invasive direct co</td>
</tr>
<tr class="odd">
<td>S2209</td>
<td>0010</td>
<td>3</td>
<td>Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using two arterial grafts and single venous graft</td>
<td>Minimally invasive direct co</td>
</tr>
<tr class="even">
<td>S2225</td>
<td>0010</td>
<td>3</td>
<td>Myringotomy, laser-assisted</td>
<td>Myringotomy laser-assist</td>
</tr>
<tr class="odd">
<td>S2230</td>
<td>0010</td>
<td>3</td>
<td>Implantation of magnetic component of semi-implantable hearing device on ossicles in middle ear</td>
<td>Implant semi-imp hear</td>
</tr>
<tr class="even">
<td>S2235</td>
<td>0010</td>
<td>3</td>
<td>Implantation of auditory brain stem implant</td>
<td>Implant auditory brain imp</td>
</tr>
<tr class="odd">
<td>S2260</td>
<td>0010</td>
<td>3</td>
<td>Induced abortion, 17 to 24 weeks</td>
<td>Induced abortion 17-24 weeks</td>
</tr>
<tr class="even">
<td>S2265</td>
<td>0010</td>
<td>3</td>
<td>Induced abortion, 25 to 28 weeks</td>
<td>Induced abortion 25-28 wks</td>
</tr>
<tr class="odd">
<td>S2266</td>
<td>0010</td>
<td>3</td>
<td>Induced abortion, 29 to 31 weeks</td>
<td>Induced abortion 29-31 wks</td>
</tr>
<tr class="even">
<td>S2267</td>
<td>0010</td>
<td>3</td>
<td>Induced abortion, 32 weeks or greater</td>
<td>Induced abortion 32 or more</td>
</tr>
<tr class="odd">
<td>S2300</td>
<td>0010</td>
<td>3</td>
<td>Arthroscopy, shoulder, surgical; with thermally-induced capsulorrhaphy</td>
<td>Arthroscopy, shoulder, surgi</td>
</tr>
<tr class="even">
<td>S2325</td>
<td>0010</td>
<td>3</td>
<td>Hip core decompression</td>
<td>Hip core decompression</td>
</tr>
<tr class="odd">
<td>S2340</td>
<td>0010</td>
<td>3</td>
<td>Chemodenervation of abductor muscle(s) of vocal cord</td>
<td>Chemodenervation of abductor</td>
</tr>
<tr class="even">
<td>S2341</td>
<td>0010</td>
<td>3</td>
<td>Chemodenervation of adductor muscle(s) of vocal cord</td>
<td>Chemodenerv adduct vocal</td>
</tr>
<tr class="odd">
<td>S2342</td>
<td>0010</td>
<td>3</td>
<td>Nasal endoscopy for post-operative debridement following functional endoscopic sinus surgery, nasal and/or sinus cavity(s), unilateral or bilateral</td>
<td>Nasal endoscop po debrid</td>
</tr>
<tr class="even">
<td>S2348</td>
<td>0010</td>
<td>3</td>
<td>Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, using radiofrequency energy, single or multiple levels, lumbar</td>
<td>Decompress disc rf lumbar</td>
</tr>
<tr class="odd">
<td>S2350</td>
<td>0010</td>
<td>3</td>
<td>Diskectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; lumbar, single interspace</td>
<td>Diskectomy, anterior, with d</td>
</tr>
<tr class="even">
<td>S2351</td>
<td>0010</td>
<td>3</td>
<td>Diskectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; lumbar, each additional interspace (list separately in addition to code for primary procedure)</td>
<td>Diskectomy, anterior, with d</td>
</tr>
<tr class="odd">
<td>S2360</td>
<td>0010</td>
<td>3</td>
<td>Percutaneous vertebroplasty, one vertebral body, unilateral or bilateral injection; cervical</td>
<td>Vertebroplast cerv 1st</td>
</tr>
<tr class="even">
<td>S2361</td>
<td>0010</td>
<td>3</td>
<td>Each additional cervical vertebral body (list separately in addition to code for primary procedure)</td>
<td>Vertebroplast cerv addl</td>
</tr>
<tr class="odd">
<td>S2400</td>
<td>0010</td>
<td>3</td>
<td>Repair, congenital diaphragmatic hernia in the fetus using temporary tracheal occlusion, procedure performed in utero</td>
<td>Fetal surg congen hernia</td>
</tr>
<tr class="even">
<td>S2401</td>
<td>0010</td>
<td>3</td>
<td>Repair, urinary tract obstruction in the fetus, procedure performed in utero</td>
<td>Fetal surg urin trac obstr</td>
</tr>
<tr class="odd">
<td>S2402</td>
<td>0010</td>
<td>3</td>
<td>Repair, congenital cystic adenomatoid malformation in the fetus, procedure performed in utero</td>
<td>Fetal surg cong cyst malf</td>
</tr>
<tr class="even">
<td>S2403</td>
<td>0010</td>
<td>3</td>
<td>Repair, extralobar pulmonary sequestration in the fetus, procedure performed in utero</td>
<td>Fetal surg pulmon sequest</td>
</tr>
<tr class="odd">
<td>S2404</td>
<td>0010</td>
<td>3</td>
<td>Repair, myelomeningocele in the fetus, procedure performed in utero</td>
<td>Fetal surg myelomeningo</td>
</tr>
<tr class="even">
<td>S2405</td>
<td>0010</td>
<td>3</td>
<td>Repair of sacrococcygeal teratoma in the fetus, procedure performed in utero</td>
<td>Fetal surg sacrococ teratoma</td>
</tr>
<tr class="odd">
<td>S2409</td>
<td>0010</td>
<td>3</td>
<td>Repair, congenital malformation of fetus, procedure performed in utero, not otherwise classified</td>
<td>Fetal surg noc</td>
</tr>
<tr class="even">
<td>S2411</td>
<td>0010</td>
<td>3</td>
<td>Fetoscopic laser therapy for treatment of twin-to-twin transfusion syndrome</td>
<td>Fetoscop laser ther ttts</td>
</tr>
<tr class="odd">
<td>S2900</td>
<td>0010</td>
<td>3</td>
<td>Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)</td>
<td>Robotic surgical system</td>
</tr>
<tr class="even">
<td>S3000</td>
<td>0010</td>
<td>3</td>
<td>Diabetic indicator; retinal eye exam, dilated, bilateral</td>
<td>Bilat dil retinal exam</td>
</tr>
<tr class="odd">
<td>S3005</td>
<td>0010</td>
<td>3</td>
<td>Performance measurement, evaluation of patient self assessment, depression</td>
<td>Eval self-assess depression</td>
</tr>
<tr class="even">
<td>S3600</td>
<td>0010</td>
<td>3</td>
<td>Stat laboratory request (situations other than s3601)</td>
<td>Stat lab</td>
</tr>
<tr class="odd">
<td>S3601</td>
<td>0010</td>
<td>3</td>
<td>Emergency stat laboratory charge for patient who is homebound or residing in a nursing facility</td>
<td>Stat lab home/nf</td>
</tr>
<tr class="even">
<td>S3620</td>
<td>0010</td>
<td>3</td>
<td>Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total)</td>
<td>Newborn metabolic screening</td>
</tr>
<tr class="odd">
<td>S3630</td>
<td>0010</td>
<td>3</td>
<td>Eosinophil count, blood, direct</td>
<td>Eosinophil blood count</td>
</tr>
<tr class="even">
<td>S3645</td>
<td>0010</td>
<td>3</td>
<td>Hiv-1 antibody testing of oral mucosal transudate</td>
<td>Hiv-1 antibody testing of or</td>
</tr>
<tr class="odd">
<td>S3650</td>
<td>0010</td>
<td>3</td>
<td>Saliva test, hormone level; during menopause</td>
<td>Saliva test, hormone level;</td>
</tr>
<tr class="even">
<td>S3652</td>
<td>0010</td>
<td>3</td>
<td>Saliva test, hormone level; to assess preterm labor risk</td>
<td>Saliva test, hormone level;</td>
</tr>
<tr class="odd">
<td>S3655</td>
<td>0010</td>
<td>3</td>
<td>Antisperm antibodies test (immunobead)</td>
<td>Antisperm antibodies test</td>
</tr>
<tr class="even">
<td>S3708</td>
<td>0010</td>
<td>3</td>
<td>Gastrointestinal fat absorption study</td>
<td>Gastrointestinal fat absorpt</td>
</tr>
<tr class="odd">
<td>S3721</td>
<td>0010</td>
<td>3</td>
<td>Prostate cancer antigen 3 (pca3) testing</td>
<td>Pca3 testing</td>
</tr>
<tr class="even">
<td>S3722</td>
<td>0010</td>
<td>3</td>
<td>Dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil</td>
<td>Dose optimization auc - 5fu</td>
</tr>
<tr class="odd">
<td>S3800</td>
<td>0010</td>
<td>3</td>
<td>Genetic testing for amyotrophic lateral sclerosis (als)</td>
<td>Genetic testing als</td>
</tr>
<tr class="even">
<td>S3840</td>
<td>0010</td>
<td>3</td>
<td>Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2</td>
<td>Dna analysis ret-oncogene</td>
</tr>
<tr class="odd">
<td>S3841</td>
<td>0010</td>
<td>3</td>
<td>Genetic testing for retinoblastoma</td>
<td>Gene test retinoblastoma</td>
</tr>
<tr class="even">
<td>S3842</td>
<td>0010</td>
<td>3</td>
<td>Genetic testing for von hippel-lindau disease</td>
<td>Gene test hippel-lindau</td>
</tr>
<tr class="odd">
<td>S3844</td>
<td>0010</td>
<td>3</td>
<td>Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness</td>
<td>Dna analysis deafness</td>
</tr>
<tr class="even">
<td>S3845</td>
<td>0010</td>
<td>3</td>
<td>Genetic testing for alpha-thalassemia</td>
<td>Gene test alpha-thalassemia</td>
</tr>
<tr class="odd">
<td>S3846</td>
<td>0010</td>
<td>3</td>
<td>Genetic testing for hemoglobin e beta-thalassemia</td>
<td>Gene test beta-thalassemia</td>
</tr>
<tr class="even">
<td>S3849</td>
<td>0010</td>
<td>3</td>
<td>Genetic testing for niemann-pick disease</td>
<td>Gene test niemann-pick</td>
</tr>
<tr class="odd">
<td>S3850</td>
<td>0010</td>
<td>3</td>
<td>Genetic testing for sickle cell anemia</td>
<td>Gene test sickle cell</td>
</tr>
<tr class="even">
<td>S3852</td>
<td>0010</td>
<td>3</td>
<td>Dna analysis for apoe epsilon 4 allele for susceptibility to alzheimer’s disease</td>
<td>Dna analysis apoe alzheimer</td>
</tr>
<tr class="odd">
<td>S3853</td>
<td>0010</td>
<td>3</td>
<td>Genetic testing for myotonic muscular dystrophy</td>
<td>Gene test myo musclr dyst</td>
</tr>
<tr class="even">
<td>S3854</td>
<td>0010</td>
<td>3</td>
<td>Gene expression profiling panel for use in the management of breast cancer treatment</td>
<td>Gene profile panel breast</td>
</tr>
<tr class="odd">
<td>S3855</td>
<td>0010</td>
<td>3</td>
<td>Genetic testing for detection of mutations in the presenilin - 1 gene</td>
<td>Gene test presenilin-1 gene</td>
</tr>
<tr class="even">
<td>S3861</td>
<td>0010</td>
<td>3</td>
<td>Genetic testing, sodium channel, voltage-gated, type v, alpha subunit (scn5a) and variants for suspected brugada syndrome</td>
<td>Genetic test brugada</td>
</tr>
<tr class="odd">
<td>S3865</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive gene sequence analysis for hypertrophic cardiomyopathy</td>
<td>Comp genet test hyp cardiomy</td>
</tr>
<tr class="even">
<td>S3866</td>
<td>0010</td>
<td>3</td>
<td>Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the family</td>
<td>Spec gene test hyp cardiomy</td>
</tr>
<tr class="odd">
<td>S3870</td>
<td>0010</td>
<td>3</td>
<td>Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability</td>
<td>Cgh test developmental delay</td>
</tr>
<tr class="even">
<td>S3890</td>
<td>0010</td>
<td>3</td>
<td>Dna analysis, fecal, for colorectal cancer screening</td>
<td>Fecal dna analysis</td>
</tr>
<tr class="odd">
<td>S3900</td>
<td>0010</td>
<td>3</td>
<td>Surface electromyography (emg)</td>
<td>Surface emg</td>
</tr>
<tr class="even">
<td>S3902</td>
<td>0010</td>
<td>3</td>
<td>Ballistocardiogram</td>
<td>Ballistocardiogram</td>
</tr>
<tr class="odd">
<td>S3904</td>
<td>0010</td>
<td>3</td>
<td>Masters two step</td>
<td>Masters two step</td>
</tr>
<tr class="even">
<td>S4005</td>
<td>0010</td>
<td>3</td>
<td>Interim labor facility global (labor occurring but not resulting in delivery)</td>
<td>Interim labor facility globa</td>
</tr>
<tr class="odd">
<td>S4011</td>
<td>0010</td>
<td>3</td>
<td>In vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development</td>
<td>Ivf package</td>
</tr>
<tr class="even">
<td>S4013</td>
<td>0010</td>
<td>3</td>
<td>Complete cycle, gamete intrafallopian transfer (gift), case rate</td>
<td>Compl gift case rate</td>
</tr>
<tr class="odd">
<td>S4014</td>
<td>0010</td>
<td>3</td>
<td>Complete cycle, zygote intrafallopian transfer (zift), case rate</td>
<td>Compl zift case rate</td>
</tr>
<tr class="even">
<td>S4015</td>
<td>0010</td>
<td>3</td>
<td>Complete in vitro fertilization cycle, not otherwise specified, case rate</td>
<td>Complete ivf nos case rate</td>
</tr>
<tr class="odd">
<td>S4016</td>
<td>0010</td>
<td>3</td>
<td>Frozen in vitro fertilization cycle, case rate</td>
<td>Frozen ivf case rate</td>
</tr>
<tr class="even">
<td>S4017</td>
<td>0010</td>
<td>3</td>
<td>Incomplete cycle, treatment cancelled prior to stimulation, case rate</td>
<td>Ivf canc a stim case rate</td>
</tr>
<tr class="odd">
<td>S4018</td>
<td>0010</td>
<td>3</td>
<td>Frozen embryo transfer procedure cancelled before transfer, case rate</td>
<td>F emb trns canc case rate</td>
</tr>
<tr class="even">
<td>S4020</td>
<td>0010</td>
<td>3</td>
<td>In vitro fertilization procedure cancelled before aspiration, case rate</td>
<td>Ivf canc a aspir case rate</td>
</tr>
<tr class="odd">
<td>S4021</td>
<td>0010</td>
<td>3</td>
<td>In vitro fertilization procedure cancelled after aspiration, case rate</td>
<td>Ivf canc p aspir case rate</td>
</tr>
<tr class="even">
<td>S4022</td>
<td>0010</td>
<td>3</td>
<td>Assisted oocyte fertilization, case rate</td>
<td>Asst oocyte fert case rate</td>
</tr>
<tr class="odd">
<td>S4023</td>
<td>0010</td>
<td>3</td>
<td>Donor egg cycle, incomplete, case rate</td>
<td>Incompl donor egg case rate</td>
</tr>
<tr class="even">
<td>S4025</td>
<td>0010</td>
<td>3</td>
<td>Donor services for in vitro fertilization (sperm or embryo), case rate</td>
<td>Donor serv ivf case rate</td>
</tr>
<tr class="odd">
<td>S4026</td>
<td>0010</td>
<td>3</td>
<td>Procurement of donor sperm from sperm bank</td>
<td>Procure donor sperm</td>
</tr>
<tr class="even">
<td>S4027</td>
<td>0010</td>
<td>3</td>
<td>Storage of previously frozen embryos</td>
<td>Store prev froz embryos</td>
</tr>
<tr class="odd">
<td>S4028</td>
<td>0010</td>
<td>3</td>
<td>Microsurgical epididymal sperm aspiration (mesa)</td>
<td>Microsurg epi sperm asp</td>
</tr>
<tr class="even">
<td>S4030</td>
<td>0010</td>
<td>3</td>
<td>Sperm procurement and cryopreservation services; initial visit</td>
<td>Sperm procure init visit</td>
</tr>
<tr class="odd">
<td>S4031</td>
<td>0010</td>
<td>3</td>
<td>Sperm procurement and cryopreservation services; subsequent visit</td>
<td>Sperm procure subs visit</td>
</tr>
<tr class="even">
<td>S4035</td>
<td>0010</td>
<td>3</td>
<td>Stimulated intrauterine insemination (iui), case rate</td>
<td>Stimulated iui case rate</td>
</tr>
<tr class="odd">
<td>S4037</td>
<td>0010</td>
<td>3</td>
<td>Cryopreserved embryo transfer, case rate</td>
<td>Cryo embryo transf case rate</td>
</tr>
<tr class="even">
<td>S4040</td>
<td>0010</td>
<td>3</td>
<td>Monitoring and storage of cryopreserved embryos, per 30 days</td>
<td>Monit store cryo embryo 30 d</td>
</tr>
<tr class="odd">
<td>S4042</td>
<td>0010</td>
<td>3</td>
<td>Management of ovulation induction (interpretation of diagnostic tests and studies, non-face-to-face medical management of the patient), per cycle</td>
<td>Ovulation mgmt per cycle</td>
</tr>
<tr class="even">
<td>S4981</td>
<td>0010</td>
<td>3</td>
<td>Insertion of levonorgestrel-releasing intrauterine system</td>
<td>Insert levonorgestrel ius</td>
</tr>
<tr class="odd">
<td>S4989</td>
<td>0010</td>
<td>3</td>
<td>Contraceptive intrauterine device (e.g., progestacert iud), including implants and supplies</td>
<td>Contracept iud</td>
</tr>
<tr class="even">
<td>S4990</td>
<td>0010</td>
<td>3</td>
<td>Nicotine patches, legend</td>
<td>Nicotine patch legend</td>
</tr>
<tr class="odd">
<td>S4991</td>
<td>0010</td>
<td>3</td>
<td>Nicotine patches, non-legend</td>
<td>Nicotine patch nonlegend</td>
</tr>
<tr class="even">
<td>S4993</td>
<td>0010</td>
<td>3</td>
<td>Contraceptive pills for birth control</td>
<td>Contraceptive pills for bc</td>
</tr>
<tr class="odd">
<td>S4995</td>
<td>0010</td>
<td>3</td>
<td>Smoking cessation gum</td>
<td>Smoking cessation gum</td>
</tr>
<tr class="even">
<td>S5000</td>
<td>0010</td>
<td>3</td>
<td>Prescription drug, generic</td>
<td>Prescription drug, generic</td>
</tr>
<tr class="odd">
<td>S5001</td>
<td>0010</td>
<td>3</td>
<td>Prescription drug, brand name</td>
<td>Prescription drug,brand name</td>
</tr>
<tr class="even">
<td>S5010</td>
<td>0010</td>
<td>3</td>
<td>5% dextrose and 0.45% normal saline, 1000 ml</td>
<td>5% dextrose and 0.45% saline</td>
</tr>
<tr class="odd">
<td>S5011</td>
<td>0010</td>
<td>3</td>
<td>5% dextrose in lactated ringer’s, 1000 ml</td>
<td>5% dextrose in lactated ring</td>
</tr>
<tr class="even">
<td>S5012</td>
<td>0010</td>
<td>3</td>
<td>5% dextrose with potassium chloride, 1000 ml</td>
<td>5% dextrose with potassium</td>
</tr>
<tr class="odd">
<td>S5013</td>
<td>0010</td>
<td>3</td>
<td>5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1000 ml</td>
<td>5%dextrose/0.45%saline1000ml</td>
</tr>
<tr class="even">
<td>S5014</td>
<td>0010</td>
<td>3</td>
<td>5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1500 ml</td>
<td>D5w/0.45ns w kcl and mgs04</td>
</tr>
<tr class="odd">
<td>S5035</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, routine service of infusion device (e.g., pump maintenance)</td>
<td>Hit routine device maint</td>
</tr>
<tr class="even">
<td>S5036</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, repair of infusion device (e.g., pump repair)</td>
<td>Hit device repair</td>
</tr>
<tr class="odd">
<td>S5100</td>
<td>0010</td>
<td>3</td>
<td>Day care services, adult; per 15 minutes</td>
<td>Adult daycare services 15min</td>
</tr>
<tr class="even">
<td>S5101</td>
<td>0010</td>
<td>3</td>
<td>Day care services, adult; per half day</td>
<td>Adult day care per half day</td>
</tr>
<tr class="odd">
<td>S5102</td>
<td>0010</td>
<td>3</td>
<td>Day care services, adult; per diem</td>
<td>Adult day care per diem</td>
</tr>
<tr class="even">
<td>S5105</td>
<td>0010</td>
<td>3</td>
<td>Day care services, center-based; services not included in program fee, per diem</td>
<td>Centerbased day care perdiem</td>
</tr>
<tr class="odd">
<td>S5108</td>
<td>0010</td>
<td>3</td>
<td>Home care training to home care client, per 15 minutes</td>
<td>Homecare train pt 15 min</td>
</tr>
<tr class="even">
<td>S5109</td>
<td>0010</td>
<td>3</td>
<td>Home care training to home care client, per session</td>
<td>Homecare train pt session</td>
</tr>
<tr class="odd">
<td>S5110</td>
<td>0010</td>
<td>3</td>
<td>Home care training, family; per 15 minutes</td>
<td>Family homecare training 15m</td>
</tr>
<tr class="even">
<td>S5111</td>
<td>0010</td>
<td>3</td>
<td>Home care training, family; per session</td>
<td>Family homecare train/sessio</td>
</tr>
<tr class="odd">
<td>S5115</td>
<td>0010</td>
<td>3</td>
<td>Home care training, non-family; per 15 minutes</td>
<td>Nonfamily homecare train/15m</td>
</tr>
<tr class="even">
<td>S5116</td>
<td>0010</td>
<td>3</td>
<td>Home care training, non-family; per session</td>
<td>Nonfamily hc train/session</td>
</tr>
<tr class="odd">
<td>S5120</td>
<td>0010</td>
<td>3</td>
<td>Chore services; per 15 minutes</td>
<td>Chore services per 15 min</td>
</tr>
<tr class="even">
<td>S5121</td>
<td>0010</td>
<td>3</td>
<td>Chore services; per diem</td>
<td>Chore services per diem</td>
</tr>
<tr class="odd">
<td>S5125</td>
<td>0010</td>
<td>3</td>
<td>Attendant care services; per 15 minutes</td>
<td>Attendant care service /15m</td>
</tr>
<tr class="even">
<td>S5126</td>
<td>0010</td>
<td>3</td>
<td>Attendant care services; per diem</td>
<td>Attendant care service /diem</td>
</tr>
<tr class="odd">
<td>S5130</td>
<td>0010</td>
<td>3</td>
<td>Homemaker service, nos; per 15 minutes</td>
<td>Homaker service nos per 15m</td>
</tr>
<tr class="even">
<td>S5131</td>
<td>0010</td>
<td>3</td>
<td>Homemaker service, nos; per diem</td>
<td>Homemaker service nos /diem</td>
</tr>
<tr class="odd">
<td>S5135</td>
<td>0010</td>
<td>3</td>
<td>Companion care, adult (e.g., iadl/adl); per 15 minutes</td>
<td>Adult companioncare per 15m</td>
</tr>
<tr class="even">
<td>S5136</td>
<td>0010</td>
<td>3</td>
<td>Companion care, adult (e.g., iadl/adl); per diem</td>
<td>Adult companioncare per diem</td>
</tr>
<tr class="odd">
<td>S5140</td>
<td>0010</td>
<td>3</td>
<td>Foster care, adult; per diem</td>
<td>Adult foster care per diem</td>
</tr>
<tr class="even">
<td>S5141</td>
<td>0010</td>
<td>3</td>
<td>Foster care, adult; per month</td>
<td>Adult foster care per month</td>
</tr>
<tr class="odd">
<td>S5145</td>
<td>0010</td>
<td>3</td>
<td>Foster care, therapeutic, child; per diem</td>
<td>Child fostercare th per diem</td>
</tr>
<tr class="even">
<td>S5146</td>
<td>0010</td>
<td>3</td>
<td>Foster care, therapeutic, child; per month</td>
<td>Ther fostercare child /month</td>
</tr>
<tr class="odd">
<td>S5150</td>
<td>0010</td>
<td>3</td>
<td>Unskilled respite care, not hospice; per 15 minutes</td>
<td>Unskilled respite care /15m</td>
</tr>
<tr class="even">
<td>S5151</td>
<td>0010</td>
<td>3</td>
<td>Unskilled respite care, not hospice; per diem</td>
<td>Unskilled respitecare /diem</td>
</tr>
<tr class="odd">
<td>S5160</td>
<td>0010</td>
<td>3</td>
<td>Emergency response system; installation and testing</td>
<td>Emer response sys instal&amp;tst</td>
</tr>
<tr class="even">
<td>S5161</td>
<td>0010</td>
<td>3</td>
<td>Emergency response system; service fee, per month (excludes installation and testing)</td>
<td>Emer rspns sys serv permonth</td>
</tr>
<tr class="odd">
<td>S5162</td>
<td>0010</td>
<td>3</td>
<td>Emergency response system; purchase only</td>
<td>Emer rspns system purchase</td>
</tr>
<tr class="even">
<td>S5165</td>
<td>0010</td>
<td>3</td>
<td>Home modifications; per service</td>
<td>Home modifications per serv</td>
</tr>
<tr class="odd">
<td>S5170</td>
<td>0010</td>
<td>3</td>
<td>Home delivered meals, including preparation; per meal</td>
<td>Homedelivered prepared meal</td>
</tr>
<tr class="even">
<td>S5175</td>
<td>0010</td>
<td>3</td>
<td>Laundry service, external, professional; per order</td>
<td>Laundry serv,ext,prof,/order</td>
</tr>
<tr class="odd">
<td>S5180</td>
<td>0010</td>
<td>3</td>
<td>Home health respiratory therapy, initial evaluation</td>
<td>Hh respiratory thrpy in eval</td>
</tr>
<tr class="even">
<td>S5181</td>
<td>0010</td>
<td>3</td>
<td>Home health respiratory therapy, nos, per diem</td>
<td>Hh respiratory thrpy nos/day</td>
</tr>
<tr class="odd">
<td>S5185</td>
<td>0010</td>
<td>3</td>
<td>Medication reminder service, non-face-to-face; per month</td>
<td>Med reminder serv per month</td>
</tr>
<tr class="even">
<td>S5190</td>
<td>0010</td>
<td>3</td>
<td>Wellness assessment, performed by non-physician</td>
<td>Wellness assessment by nonph</td>
</tr>
<tr class="odd">
<td>S5199</td>
<td>0010</td>
<td>3</td>
<td>Personal care item, nos, each</td>
<td>Personal care item nos each</td>
</tr>
<tr class="even">
<td>S5497</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, catheter care / maintenance, not otherwise classified; includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit cath care noc</td>
</tr>
<tr class="odd">
<td>S5498</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, catheter care / maintenance, simple (single lumen), includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem</td>
<td>Hit simple cath care</td>
</tr>
<tr class="even">
<td>S5501</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, catheter care / maintenance, complex (more than one lumen), includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit complex cath care</td>
</tr>
<tr class="odd">
<td>S5502</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, catheter care / maintenance, implanted access device, includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem (use this code for interim maintenance of vascular access not currently in use)</td>
<td>Hit interim cath care</td>
</tr>
<tr class="even">
<td>S5517</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, all supplies necessary for restoration of catheter patency or declotting</td>
<td>Hit declotting kit</td>
</tr>
<tr class="odd">
<td>S5518</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, all supplies necessary for catheter repair</td>
<td>Hit cath repair kit</td>
</tr>
<tr class="even">
<td>S5520</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, all supplies (including catheter) necessary for a peripherally inserted central venous catheter (picc) line insertion</td>
<td>Hit picc insert kit</td>
</tr>
<tr class="odd">
<td>S5521</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, all supplies (including catheter) necessary for a midline catheter insertion</td>
<td>Hit midline cath insert kit</td>
</tr>
<tr class="even">
<td>S5522</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, insertion of peripherally inserted central venous catheter (picc), nursing services only (no supplies or catheter included)</td>
<td>Hit picc insert no supp</td>
</tr>
<tr class="odd">
<td>S5523</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, insertion of midline venous catheter, nursing services only (no supplies or catheter included)</td>
<td>Hip midline cath insert kit</td>
</tr>
<tr class="even">
<td>S5550</td>
<td>0010</td>
<td>3</td>
<td>Insulin, rapid onset, 5 units</td>
<td>Insulin rapid 5 u</td>
</tr>
<tr class="odd">
<td>S5551</td>
<td>0010</td>
<td>3</td>
<td>Insulin, most rapid onset (lispro or aspart); 5 units</td>
<td>Insulin most rapid 5 u</td>
</tr>
<tr class="even">
<td>S5552</td>
<td>0010</td>
<td>3</td>
<td>Insulin, intermediate acting (nph or lente); 5 units</td>
<td>Insulin intermed 5 u</td>
</tr>
<tr class="odd">
<td>S5553</td>
<td>0010</td>
<td>3</td>
<td>Insulin, long acting; 5 units</td>
<td>Insulin long acting 5 u</td>
</tr>
<tr class="even">
<td>S5560</td>
<td>0010</td>
<td>3</td>
<td>Insulin delivery device, reusable pen; 1.5 ml size</td>
<td>Insulin reuse pen 1.5 ml</td>
</tr>
<tr class="odd">
<td>S5561</td>
<td>0010</td>
<td>3</td>
<td>Insulin delivery device, reusable pen; 3 ml size</td>
<td>Insulin reuse pen 3 ml</td>
</tr>
<tr class="even">
<td>S5565</td>
<td>0010</td>
<td>3</td>
<td>Insulin cartridge for use in insulin delivery device other than pump; 150 units</td>
<td>Insulin cartridge 150 u</td>
</tr>
<tr class="odd">
<td>S5566</td>
<td>0010</td>
<td>3</td>
<td>Insulin cartridge for use in insulin delivery device other than pump; 300 units</td>
<td>Insulin cartridge 300 u</td>
</tr>
<tr class="even">
<td>S5570</td>
<td>0010</td>
<td>3</td>
<td>Insulin delivery device, disposable pen (including insulin); 1.5 ml size</td>
<td>Insulin dispos pen 1.5 ml</td>
</tr>
<tr class="odd">
<td>S5571</td>
<td>0010</td>
<td>3</td>
<td>Insulin delivery device, disposable pen (including insulin); 3 ml size</td>
<td>Insulin dispos pen 3 ml</td>
</tr>
<tr class="even">
<td>S8030</td>
<td>0010</td>
<td>3</td>
<td>Scleral application of tantalum ring(s) for localization of lesions for proton beam therapy</td>
<td>Tantalum ring application</td>
</tr>
<tr class="odd">
<td>S8032</td>
<td>0010</td>
<td>3</td>
<td>Low-dose computed tomography for lung cancer screening</td>
<td>Low dose ct lung screening</td>
</tr>
<tr class="even">
<td>S8035</td>
<td>0010</td>
<td>3</td>
<td>Magnetic source imaging</td>
<td>Magnetic source imaging</td>
</tr>
<tr class="odd">
<td>S8037</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance cholangiopancreatography (mrcp)</td>
<td>Mrcp</td>
</tr>
<tr class="even">
<td>S8040</td>
<td>0010</td>
<td>3</td>
<td>Topographic brain mapping</td>
<td>Topographic brain mapping</td>
</tr>
<tr class="odd">
<td>S8042</td>
<td>0010</td>
<td>3</td>
<td>Magnetic resonance imaging (mri), low-field</td>
<td>Mri low field</td>
</tr>
<tr class="even">
<td>S8055</td>
<td>0010</td>
<td>3</td>
<td>Ultrasound guidance for multifetal pregnancy reduction(s), technical component (only to be used when the physician doing the reduction procedure does not perform the ultrasound, guidance is included in the cpt code for multifetal pregnancy reduction - 59866)</td>
<td>Us guidance fetal reduct</td>
</tr>
<tr class="odd">
<td>S8080</td>
<td>0010</td>
<td>3</td>
<td>Scintimammography (radioimmunoscintigraphy of the breast), unilateral, including supply of radiopharmaceutical</td>
<td>Scintimammography</td>
</tr>
<tr class="even">
<td>S8085</td>
<td>0010</td>
<td>3</td>
<td>Fluorine-18 fluorodeoxyglucose (f-18 fdg) imaging using dual-head coincidence detection system (non-dedicated pet scan)</td>
<td>Fluorine-18 fluorodeoxygluco</td>
</tr>
<tr class="odd">
<td>S8092</td>
<td>0010</td>
<td>3</td>
<td>Electron beam computed tomography (also known as ultrafast ct, cine ct)</td>
<td>Electron beam computed tomog</td>
</tr>
<tr class="even">
<td>S8096</td>
<td>0010</td>
<td>3</td>
<td>Portable peak flow meter</td>
<td>Portable peak flow meter</td>
</tr>
<tr class="odd">
<td>S8097</td>
<td>0010</td>
<td>3</td>
<td>Asthma kit (including but not limited to portable peak expiratory flow meter, instructional video, brochure, and/or spacer)</td>
<td>Asthma kit</td>
</tr>
<tr class="even">
<td>S8100</td>
<td>0010</td>
<td>3</td>
<td>Holding chamber or spacer for use with an inhaler or nebulizer; without mask</td>
<td>Spacer without mask</td>
</tr>
<tr class="odd">
<td>S8101</td>
<td>0010</td>
<td>3</td>
<td>Holding chamber or spacer for use with an inhaler or nebulizer; with mask</td>
<td>Spacer with mask</td>
</tr>
<tr class="even">
<td>S8110</td>
<td>0010</td>
<td>3</td>
<td>Peak expiratory flow rate (physician services)</td>
<td>Peak expiratory flow rate (p</td>
</tr>
<tr class="odd">
<td>S8120</td>
<td>0010</td>
<td>3</td>
<td>Oxygen contents, gaseous, 1 unit equals 1 cubic foot</td>
<td>O2 contents gas cubic ft</td>
</tr>
<tr class="even">
<td>S8121</td>
<td>0010</td>
<td>3</td>
<td>Oxygen contents, liquid, 1 unit equals 1 pound</td>
<td>O2 contents liquid lb</td>
</tr>
<tr class="odd">
<td>S8130</td>
<td>0010</td>
<td>3</td>
<td>Interferential current stimulator, 2 channel</td>
<td>Interferential stim 2 chan</td>
</tr>
<tr class="even">
<td>S8131</td>
<td>0010</td>
<td>3</td>
<td>Interferential current stimulator, 4 channel</td>
<td>Interferential stim 4 chan</td>
</tr>
<tr class="odd">
<td>S8185</td>
<td>0010</td>
<td>3</td>
<td>Flutter device</td>
<td>Flutter device</td>
</tr>
<tr class="even">
<td>S8186</td>
<td>0010</td>
<td>3</td>
<td>Swivel adapter</td>
<td>Swivel adaptor</td>
</tr>
<tr class="odd">
<td>S8189</td>
<td>0010</td>
<td>3</td>
<td>Tracheostomy supply, not otherwise classified</td>
<td>Trach supply noc</td>
</tr>
<tr class="even">
<td>S8210</td>
<td>0010</td>
<td>3</td>
<td>Mucus trap</td>
<td>Mucus trap</td>
</tr>
<tr class="odd">
<td>S8262</td>
<td>0010</td>
<td>3</td>
<td>Mandibular orthopedic repositioning device, each</td>
<td>Mandib ortho repos device</td>
</tr>
<tr class="even">
<td>S8265</td>
<td>0010</td>
<td>3</td>
<td>Haberman feeder for cleft lip/palate</td>
<td>Haberman feeder</td>
</tr>
<tr class="odd">
<td>S8270</td>
<td>0010</td>
<td>3</td>
<td>Enuresis alarm, using auditory buzzer and/or vibration device</td>
<td>Enuresis alarm</td>
</tr>
<tr class="even">
<td>S8301</td>
<td>0010</td>
<td>3</td>
<td>Infection control supplies, not otherwise specified</td>
<td>Infect control supplies nos</td>
</tr>
<tr class="odd">
<td>S8415</td>
<td>0010</td>
<td>3</td>
<td>Supplies for home delivery of infant</td>
<td>Supplies for home delivery</td>
</tr>
<tr class="even">
<td>S8420</td>
<td>0010</td>
<td>3</td>
<td>Gradient pressure aid (sleeve and glove combination), custom made</td>
<td>Custom gradient sleev/glov</td>
</tr>
<tr class="odd">
<td>S8421</td>
<td>0010</td>
<td>3</td>
<td>Gradient pressure aid (sleeve and glove combination), ready made</td>
<td>Ready gradient sleev/glov</td>
</tr>
<tr class="even">
<td>S8422</td>
<td>0010</td>
<td>3</td>
<td>Gradient pressure aid (sleeve), custom made, medium weight</td>
<td>Custom grad sleeve med</td>
</tr>
<tr class="odd">
<td>S8423</td>
<td>0010</td>
<td>3</td>
<td>Gradient pressure aid (sleeve), custom made, heavy weight</td>
<td>Custom grad sleeve heavy</td>
</tr>
<tr class="even">
<td>S8424</td>
<td>0010</td>
<td>3</td>
<td>Gradient pressure aid (sleeve), ready made</td>
<td>Ready gradient sleeve</td>
</tr>
<tr class="odd">
<td>S8425</td>
<td>0010</td>
<td>3</td>
<td>Gradient pressure aid (glove), custom made, medium weight</td>
<td>Custom grad glove med</td>
</tr>
<tr class="even">
<td>S8426</td>
<td>0010</td>
<td>3</td>
<td>Gradient pressure aid (glove), custom made, heavy weight</td>
<td>Custom grad glove heavy</td>
</tr>
<tr class="odd">
<td>S8427</td>
<td>0010</td>
<td>3</td>
<td>Gradient pressure aid (glove), ready made</td>
<td>Ready gradient glove</td>
</tr>
<tr class="even">
<td>S8428</td>
<td>0010</td>
<td>3</td>
<td>Gradient pressure aid (gauntlet), ready made</td>
<td>Ready gradient gauntlet</td>
</tr>
<tr class="odd">
<td>S8429</td>
<td>0010</td>
<td>3</td>
<td>Gradient pressure exterior wrap</td>
<td>Gradient pressure wrap</td>
</tr>
<tr class="even">
<td>S8430</td>
<td>0010</td>
<td>3</td>
<td>Padding for compression bandage, roll</td>
<td>Padding for comprssn bdg</td>
</tr>
<tr class="odd">
<td>S8431</td>
<td>0010</td>
<td>3</td>
<td>Compression bandage, roll</td>
<td>Compression bandage</td>
</tr>
<tr class="even">
<td>S8450</td>
<td>0010</td>
<td>3</td>
<td>Splint, prefabricated, digit (specify digit by use of modifier)</td>
<td>Splint digit</td>
</tr>
<tr class="odd">
<td>S8451</td>
<td>0010</td>
<td>3</td>
<td>Splint, prefabricated, wrist or ankle</td>
<td>Splint wrist or ankle</td>
</tr>
<tr class="even">
<td>S8452</td>
<td>0010</td>
<td>3</td>
<td>Splint, prefabricated, elbow</td>
<td>Splint elbow</td>
</tr>
<tr class="odd">
<td>S8460</td>
<td>0010</td>
<td>3</td>
<td>Camisole, post-mastectomy</td>
<td>Camisole post-mast</td>
</tr>
<tr class="even">
<td>S8490</td>
<td>0010</td>
<td>3</td>
<td>Insulin syringes (100 syringes, any size)</td>
<td>100 insulin syringes</td>
</tr>
<tr class="odd">
<td>S8930</td>
<td>0010</td>
<td>3</td>
<td>Electrical stimulation of auricular acupuncture points; each 15 minutes of personal one-on-one contact with the patient</td>
<td>Auricular electrostimulation</td>
</tr>
<tr class="even">
<td>S8940</td>
<td>0010</td>
<td>3</td>
<td>Equestrian/hippotherapy, per session</td>
<td>Hippotherapy per session</td>
</tr>
<tr class="odd">
<td>S8948</td>
<td>0010</td>
<td>3</td>
<td>Application of a modality (requiring constant provider attendance) to one or more areas; low-level laser; each 15 minutes</td>
<td>Low-level laser trmt 15 min</td>
</tr>
<tr class="even">
<td>S8950</td>
<td>0010</td>
<td>3</td>
<td>Complex lymphedema therapy, each 15 minutes</td>
<td>Complex lymphedema therapy,</td>
</tr>
<tr class="odd">
<td>S8990</td>
<td>0010</td>
<td>3</td>
<td>Physical or manipulative therapy performed for maintenance rather than restoration</td>
<td>Pt or manip for maint</td>
</tr>
<tr class="even">
<td>S8999</td>
<td>0010</td>
<td>3</td>
<td>Resuscitation bag (for use by patient on artificial respiration during power failure or other catastrophic event)</td>
<td>Resuscitation bag</td>
</tr>
<tr class="odd">
<td>S9001</td>
<td>0010</td>
<td>3</td>
<td>Home uterine monitor with or without associated nursing services</td>
<td>Home uterine monitor with or</td>
</tr>
<tr class="even">
<td>S9007</td>
<td>0010</td>
<td>3</td>
<td>Ultrafiltration monitor</td>
<td>Ultrafiltration monitor</td>
</tr>
<tr class="odd">
<td>S9015</td>
<td>0010</td>
<td>3</td>
<td>Automated eeg monitoring</td>
<td>Automated eeg monitoring</td>
</tr>
<tr class="even">
<td>S9024</td>
<td>0010</td>
<td>3</td>
<td>Paranasal sinus ultrasound</td>
<td>Paranasal sinus ultrasound</td>
</tr>
<tr class="odd">
<td>S9025</td>
<td>0010</td>
<td>3</td>
<td>Omnicardiogram/cardiointegram</td>
<td>Omnicardiogram/cardiointegra</td>
</tr>
<tr class="even">
<td>S9034</td>
<td>0010</td>
<td>3</td>
<td>Extracorporeal shockwave lithotripsy for gall stones (if performed with ercp, use 43265)</td>
<td>Eswl for gallstones</td>
</tr>
<tr class="odd">
<td>S9055</td>
<td>0010</td>
<td>3</td>
<td>Procuren or other growth factor preparation to promote wound healing</td>
<td>Procuren or other growth fac</td>
</tr>
<tr class="even">
<td>S9056</td>
<td>0010</td>
<td>3</td>
<td>Coma stimulation per diem</td>
<td>Coma stimulation per diem</td>
</tr>
<tr class="odd">
<td>S9061</td>
<td>0010</td>
<td>3</td>
<td>Home administration of aerosolized drug therapy (e.g., pentamidine); administrative services, professional pharmacy services, care coordination, all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Medical supplies and equipme</td>
</tr>
<tr class="even">
<td>S9083</td>
<td>0010</td>
<td>3</td>
<td>Global fee urgent care centers</td>
<td>Urgent care center global</td>
</tr>
<tr class="odd">
<td>S9088</td>
<td>0010</td>
<td>3</td>
<td>Services provided in an urgent care center (list in addition to code for service)</td>
<td>Services provided in urgent</td>
</tr>
<tr class="even">
<td>S9090</td>
<td>0010</td>
<td>3</td>
<td>Vertebral axial decompression, per session</td>
<td>Vertebral axial decompressio</td>
</tr>
<tr class="odd">
<td>S9097</td>
<td>0010</td>
<td>3</td>
<td>Home visit for wound care</td>
<td>Home visit wound care</td>
</tr>
<tr class="even">
<td>S9098</td>
<td>0010</td>
<td>3</td>
<td>Home visit, phototherapy services (e.g., bili-lite), including equipment rental, nursing services, blood draw, supplies, and other services, per diem</td>
<td>Home phototherapy visit</td>
</tr>
<tr class="odd">
<td>S9110</td>
<td>0010</td>
<td>3</td>
<td>Telemonitoring of patient in their home, including all necessary equipment; computer system, connections, and software; maintenance; patient education and support; per month</td>
<td>Telemonitoring/home per mnth</td>
</tr>
<tr class="even">
<td>S9117</td>
<td>0010</td>
<td>3</td>
<td>Back school, per visit</td>
<td>Back school visit</td>
</tr>
<tr class="odd">
<td>S9122</td>
<td>0010</td>
<td>3</td>
<td>Home health aide or certified nurse assistant, providing care in the home; per hour</td>
<td>Home health aide or certifie</td>
</tr>
<tr class="even">
<td>S9123</td>
<td>0010</td>
<td>3</td>
<td>Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used)</td>
<td>Nursing care in home rn</td>
</tr>
<tr class="odd">
<td>S9124</td>
<td>0010</td>
<td>3</td>
<td>Nursing care, in the home; by licensed practical nurse, per hour</td>
<td>Nursing care, in the home; b</td>
</tr>
<tr class="even">
<td>S9125</td>
<td>0010</td>
<td>3</td>
<td>Respite care, in the home, per diem</td>
<td>Respite care, in the home, p</td>
</tr>
<tr class="odd">
<td>S9126</td>
<td>0010</td>
<td>3</td>
<td>Hospice care, in the home, per diem</td>
<td>Hospice care, in the home, p</td>
</tr>
<tr class="even">
<td>S9127</td>
<td>0010</td>
<td>3</td>
<td>Social work visit, in the home, per diem</td>
<td>Social work visit, in the ho</td>
</tr>
<tr class="odd">
<td>S9128</td>
<td>0010</td>
<td>3</td>
<td>Speech therapy, in the home, per diem</td>
<td>Speech therapy, in the home,</td>
</tr>
<tr class="even">
<td>S9129</td>
<td>0010</td>
<td>3</td>
<td>Occupational therapy, in the home, per diem</td>
<td>Occupational therapy, in the</td>
</tr>
<tr class="odd">
<td>S9131</td>
<td>0010</td>
<td>3</td>
<td>Physical therapy; in the home, per diem</td>
<td>Pt in the home per diem</td>
</tr>
<tr class="even">
<td>S9140</td>
<td>0010</td>
<td>3</td>
<td>Diabetic management program, follow-up visit to non-md provider</td>
<td>Diabetic management program,</td>
</tr>
<tr class="odd">
<td>S9141</td>
<td>0010</td>
<td>3</td>
<td>Diabetic management program, follow-up visit to md provider</td>
<td>Diabetic management program,</td>
</tr>
<tr class="even">
<td>S9145</td>
<td>0010</td>
<td>3</td>
<td>Insulin pump initiation, instruction in initial use of pump (pump not included)</td>
<td>Insulin pump initiation</td>
</tr>
<tr class="odd">
<td>S9150</td>
<td>0010</td>
<td>3</td>
<td>Evaluation by ocularist</td>
<td>Evaluation by ocularist</td>
</tr>
<tr class="even">
<td>S9152</td>
<td>0010</td>
<td>3</td>
<td>Speech therapy, re-evaluation</td>
<td>Speech therapy, re-eval</td>
</tr>
<tr class="odd">
<td>S9208</td>
<td>0010</td>
<td>3</td>
<td>Home management of preterm labor, including administrative services, professional pharmacy services, care coordination, and all necessary supplies or equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)</td>
<td>Home mgmt preterm labor</td>
</tr>
<tr class="even">
<td>S9209</td>
<td>0010</td>
<td>3</td>
<td>Home management of preterm premature rupture of membranes (pprom), including administrative services, professional pharmacy services, care coordination, and all necessary supplies or equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)</td>
<td>Home mgmt pprom</td>
</tr>
<tr class="odd">
<td>S9211</td>
<td>0010</td>
<td>3</td>
<td>Home management of gestational hypertension, includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately); per diem (do not use this code with any home infusion per diem code)</td>
<td>Home mgmt gest hypertension</td>
</tr>
<tr class="even">
<td>S9212</td>
<td>0010</td>
<td>3</td>
<td>Home management of postpartum hypertension, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)</td>
<td>Hm postpar hyper per diem</td>
</tr>
<tr class="odd">
<td>S9213</td>
<td>0010</td>
<td>3</td>
<td>Home management of preeclampsia, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing services coded separately); per diem (do not use this code with any home infusion per diem code)</td>
<td>Hm preeclamp per diem</td>
</tr>
<tr class="even">
<td>S9214</td>
<td>0010</td>
<td>3</td>
<td>Home management of gestational diabetes, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately); per diem (do not use this code with any home infusion per diem code)</td>
<td>Hm gest dm per diem</td>
</tr>
<tr class="odd">
<td>S9325</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem (do not use this code with s9326, s9327 or s9328)</td>
<td>Hit pain mgmt per diem</td>
</tr>
<tr class="even">
<td>S9326</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, continuous (twenty-four hours or more) pain management infusion; administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit cont pain per diem</td>
</tr>
<tr class="odd">
<td>S9327</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, intermittent (less than twenty-four hours) pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit int pain per diem</td>
</tr>
<tr class="even">
<td>S9328</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, implanted pump pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit pain imp pump diem</td>
</tr>
<tr class="odd">
<td>S9329</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with s9330 or s9331)</td>
<td>Hit chemo per diem</td>
</tr>
<tr class="even">
<td>S9330</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, continuous (twenty-four hours or more) chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit cont chem diem</td>
</tr>
<tr class="odd">
<td>S9331</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, intermittent (less than twenty-four hours) chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit intermit chemo diem</td>
</tr>
<tr class="even">
<td>S9335</td>
<td>0010</td>
<td>3</td>
<td>Home therapy, hemodialysis; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing services coded separately), per diem</td>
<td>Ht hemodialysis diem</td>
</tr>
<tr class="odd">
<td>S9336</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, continuous anticoagulant infusion therapy (e.g., heparin), administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit cont anticoag diem</td>
</tr>
<tr class="even">
<td>S9338</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, immunotherapy, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit immunotherapy diem</td>
</tr>
<tr class="odd">
<td>S9339</td>
<td>0010</td>
<td>3</td>
<td>Home therapy; peritoneal dialysis, administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit periton dialysis diem</td>
</tr>
<tr class="even">
<td>S9340</td>
<td>0010</td>
<td>3</td>
<td>Home therapy; enteral nutrition; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem</td>
<td>Hit enteral per diem</td>
</tr>
<tr class="odd">
<td>S9341</td>
<td>0010</td>
<td>3</td>
<td>Home therapy; enteral nutrition via gravity; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem</td>
<td>Hit enteral grav diem</td>
</tr>
<tr class="even">
<td>S9342</td>
<td>0010</td>
<td>3</td>
<td>Home therapy; enteral nutrition via pump; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem</td>
<td>Hit enteral pump diem</td>
</tr>
<tr class="odd">
<td>S9343</td>
<td>0010</td>
<td>3</td>
<td>Home therapy; enteral nutrition via bolus; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem</td>
<td>Hit enteral bolus nurs</td>
</tr>
<tr class="even">
<td>S9345</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, anti-hemophilic agent infusion therapy (e.g., factor viii); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit anti-hemophil diem</td>
</tr>
<tr class="odd">
<td>S9346</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, alpha-1-proteinase inhibitor (e.g., prolastin); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit alpha-1-proteinas diem</td>
</tr>
<tr class="even">
<td>S9347</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, uninterrupted, long-term, controlled rate intravenous or subcutaneous infusion therapy (e.g., epoprostenol); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit longterm infusion diem</td>
</tr>
<tr class="odd">
<td>S9348</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, sympathomimetic/inotropic agent infusion therapy (e.g., dobutamine); administrative services, professional pharmacy services, care coordination, all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit sympathomim diem</td>
</tr>
<tr class="even">
<td>S9349</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, tocolytic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit tocolysis diem</td>
</tr>
<tr class="odd">
<td>S9351</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, continuous or intermittent anti-emetic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and visits coded separately), per diem</td>
<td>Hit cont antiemetic diem</td>
</tr>
<tr class="even">
<td>S9353</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, continuous insulin infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit cont insulin diem</td>
</tr>
<tr class="odd">
<td>S9355</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, chelation therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit chelation diem</td>
</tr>
<tr class="even">
<td>S9357</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, enzyme replacement intravenous therapy; (e.g., imiglucerase); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit enzyme replace diem</td>
</tr>
<tr class="odd">
<td>S9359</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit anti-tnf per diem</td>
</tr>
<tr class="even">
<td>S9361</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, diuretic intravenous therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit diuretic infus diem</td>
</tr>
<tr class="odd">
<td>S9363</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, anti-spasmotic therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit anti-spasmotic diem</td>
</tr>
<tr class="even">
<td>S9364</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, total parenteral nutrition (tpn); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem (do not use with home infusion codes s9365-s9368 using daily volume scales)</td>
<td>Hit tpn total diem</td>
</tr>
<tr class="odd">
<td>S9365</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, total parenteral nutrition (tpn); one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem</td>
<td>Hit tpn 1 liter diem</td>
</tr>
<tr class="even">
<td>S9366</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, total parenteral nutrition (tpn); more than one liter but no more than two liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem</td>
<td>Hit tpn 2 liter diem</td>
</tr>
<tr class="odd">
<td>S9367</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, total parenteral nutrition (tpn); more than two liters but no more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem</td>
<td>Hit tpn 3 liter diem</td>
</tr>
<tr class="even">
<td>S9368</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, total parenteral nutrition (tpn); more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem</td>
<td>Hit tpn over 3l diem</td>
</tr>
<tr class="odd">
<td>S9370</td>
<td>0010</td>
<td>3</td>
<td>Home therapy, intermittent anti-emetic injection therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Ht inj antiemetic diem</td>
</tr>
<tr class="even">
<td>S9372</td>
<td>0010</td>
<td>3</td>
<td>Home therapy; intermittent anticoagulant injection therapy (e.g., heparin); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code for flushing of infusion devices with heparin to maintain patency)</td>
<td>Ht inj anticoag diem</td>
</tr>
<tr class="odd">
<td>S9373</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, hydration therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use with hydration therapy codes s9374-s9377 using daily volume scales)</td>
<td>Hit hydra total diem</td>
</tr>
<tr class="even">
<td>S9374</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, hydration therapy; one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit hydra 1 liter diem</td>
</tr>
<tr class="odd">
<td>S9375</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, hydration therapy; more than one liter but no more than two liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit hydra 2 liter diem</td>
</tr>
<tr class="even">
<td>S9376</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, hydration therapy; more than two liters but no more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit hydra 3 liter diem</td>
</tr>
<tr class="odd">
<td>S9377</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, hydration therapy; more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies (drugs and nursing visits coded separately), per diem</td>
<td>Hit hydra over 3l diem</td>
</tr>
<tr class="even">
<td>S9379</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit noc per diem</td>
</tr>
<tr class="odd">
<td>S9381</td>
<td>0010</td>
<td>3</td>
<td>Delivery or service to high risk areas requiring escort or extra protection, per visit</td>
<td>Hit high risk/escort</td>
</tr>
<tr class="even">
<td>S9401</td>
<td>0010</td>
<td>3</td>
<td>Anticoagulation clinic, inclusive of all services except laboratory tests, per session</td>
<td>Anticoag clinic per session</td>
</tr>
<tr class="odd">
<td>S9430</td>
<td>0010</td>
<td>3</td>
<td>Pharmacy compounding and dispensing services</td>
<td>Pharmacy comp/disp serv</td>
</tr>
<tr class="even">
<td>S9433</td>
<td>0010</td>
<td>3</td>
<td>Medical food nutritionally complete, administered orally, providing 100% of nutritional intake</td>
<td>Medical food oral 100% nutr</td>
</tr>
<tr class="odd">
<td>S9434</td>
<td>0010</td>
<td>3</td>
<td>Modified solid food supplements for inborn errors of metabolism</td>
<td>Mod solid food suppl</td>
</tr>
<tr class="even">
<td>S9435</td>
<td>0010</td>
<td>3</td>
<td>Medical foods for inborn errors of metabolism</td>
<td>Medical foods for inborn err</td>
</tr>
<tr class="odd">
<td>S9436</td>
<td>0010</td>
<td>3</td>
<td>Childbirth preparation/lamaze classes, non-physician provider, per session</td>
<td>Lamaze class</td>
</tr>
<tr class="even">
<td>S9437</td>
<td>0010</td>
<td>3</td>
<td>Childbirth refresher classes, non-physician provider, per session</td>
<td>Childbirth refresher class</td>
</tr>
<tr class="odd">
<td>S9438</td>
<td>0010</td>
<td>3</td>
<td>Cesarean birth classes, non-physician provider, per session</td>
<td>Cesarean birth class</td>
</tr>
<tr class="even">
<td>S9439</td>
<td>0010</td>
<td>3</td>
<td>Vbac (vaginal birth after cesarean) classes, non-physician provider, per session</td>
<td>Vbac class</td>
</tr>
<tr class="odd">
<td>S9441</td>
<td>0010</td>
<td>3</td>
<td>Asthma education, non-physician provider, per session</td>
<td>Asthma education</td>
</tr>
<tr class="even">
<td>S9442</td>
<td>0010</td>
<td>3</td>
<td>Birthing classes, non-physician provider, per session</td>
<td>Birthing class</td>
</tr>
<tr class="odd">
<td>S9443</td>
<td>0010</td>
<td>3</td>
<td>Lactation classes, non-physician provider, per session</td>
<td>Lactation class</td>
</tr>
<tr class="even">
<td>S9444</td>
<td>0010</td>
<td>3</td>
<td>Parenting classes, non-physician provider, per session</td>
<td>Parenting class</td>
</tr>
<tr class="odd">
<td>S9445</td>
<td>0010</td>
<td>3</td>
<td>Patient education, not otherwise classified, non-physician provider, individual, per session</td>
<td>Pt education noc individ</td>
</tr>
<tr class="even">
<td>S9446</td>
<td>0010</td>
<td>3</td>
<td>Patient education, not otherwise classified, non-physician provider, group, per session</td>
<td>Pt education noc group</td>
</tr>
<tr class="odd">
<td>S9447</td>
<td>0010</td>
<td>3</td>
<td>Infant safety (including cpr) classes, non-physician provider, per session</td>
<td>Infant safety class</td>
</tr>
<tr class="even">
<td>S9449</td>
<td>0010</td>
<td>3</td>
<td>Weight management classes, non-physician provider, per session</td>
<td>Weight mgmt class</td>
</tr>
<tr class="odd">
<td>S9451</td>
<td>0010</td>
<td>3</td>
<td>Exercise classes, non-physician provider, per session</td>
<td>Exercise class</td>
</tr>
<tr class="even">
<td>S9452</td>
<td>0010</td>
<td>3</td>
<td>Nutrition classes, non-physician provider, per session</td>
<td>Nutrition class</td>
</tr>
<tr class="odd">
<td>S9453</td>
<td>0010</td>
<td>3</td>
<td>Smoking cessation classes, non-physician provider, per session</td>
<td>Smoking cessation class</td>
</tr>
<tr class="even">
<td>S9454</td>
<td>0010</td>
<td>3</td>
<td>Stress management classes, non-physician provider, per session</td>
<td>Stress mgmt class</td>
</tr>
<tr class="odd">
<td>S9455</td>
<td>0010</td>
<td>3</td>
<td>Diabetic management program, group session</td>
<td>Diabetic management program,</td>
</tr>
<tr class="even">
<td>S9460</td>
<td>0010</td>
<td>3</td>
<td>Diabetic management program, nurse visit</td>
<td>Diabetic management program,</td>
</tr>
<tr class="odd">
<td>S9465</td>
<td>0010</td>
<td>3</td>
<td>Diabetic management program, dietitian visit</td>
<td>Diabetic management program,</td>
</tr>
<tr class="even">
<td>S9470</td>
<td>0010</td>
<td>3</td>
<td>Nutritional counseling, dietitian visit</td>
<td>Nutritional counseling, diet</td>
</tr>
<tr class="odd">
<td>S9472</td>
<td>0010</td>
<td>3</td>
<td>Cardiac rehabilitation program, non-physician provider, per diem</td>
<td>Cardiac rehabilitation progr</td>
</tr>
<tr class="even">
<td>S9473</td>
<td>0010</td>
<td>3</td>
<td>Pulmonary rehabilitation program, non-physician provider, per diem</td>
<td>Pulmonary rehabilitation pro</td>
</tr>
<tr class="odd">
<td>S9474</td>
<td>0010</td>
<td>3</td>
<td>Enterostomal therapy by a registered nurse certified in enterostomal therapy, per diem</td>
<td>Enterostomal therapy by a re</td>
</tr>
<tr class="even">
<td>S9475</td>
<td>0010</td>
<td>3</td>
<td>Ambulatory setting substance abuse treatment or detoxification services, per diem</td>
<td>Ambulatory setting substance</td>
</tr>
<tr class="odd">
<td>S9476</td>
<td>0010</td>
<td>3</td>
<td>Vestibular rehabilitation program, non-physician provider, per diem</td>
<td>Vestibular rehab per diem</td>
</tr>
<tr class="even">
<td>S9480</td>
<td>0010</td>
<td>3</td>
<td>Intensive outpatient psychiatric services, per diem</td>
<td>Intensive outpatient psychia</td>
</tr>
<tr class="odd">
<td>S9482</td>
<td>0010</td>
<td>3</td>
<td>Family stabilization services, per 15 minutes</td>
<td>Family stabilization 15 min</td>
</tr>
<tr class="even">
<td>S9484</td>
<td>0010</td>
<td>3</td>
<td>Crisis intervention mental health services, per hour</td>
<td>Crisis intervention per hour</td>
</tr>
<tr class="odd">
<td>S9485</td>
<td>0010</td>
<td>3</td>
<td>Crisis intervention mental health services, per diem</td>
<td>Crisis intervention mental h</td>
</tr>
<tr class="even">
<td>S9490</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, corticosteroid infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit corticosteroid/diem</td>
</tr>
<tr class="odd">
<td>S9494</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, antibiotic, antiviral, or antifungal therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with home infusion codes for hourly dosing schedules s9497-s9504)</td>
<td>Hit antibiotic total diem</td>
</tr>
<tr class="even">
<td>S9497</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 3 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit antibiotic q3h diem</td>
</tr>
<tr class="odd">
<td>S9500</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 24 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit antibiotic q24h diem</td>
</tr>
<tr class="even">
<td>S9501</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 12 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit antibiotic q12h diem</td>
</tr>
<tr class="odd">
<td>S9502</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 8 hours, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit antibiotic q8h diem</td>
</tr>
<tr class="even">
<td>S9503</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, antibiotic, antiviral, or antifungal; once every 6 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit antibiotic q6h diem</td>
</tr>
<tr class="odd">
<td>S9504</td>
<td>0010</td>
<td>3</td>
<td>Home infusion therapy, antibiotic, antiviral, or antifungal; once every 4 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit antibiotic q4h diem</td>
</tr>
<tr class="even">
<td>S9529</td>
<td>0010</td>
<td>3</td>
<td>Routine venipuncture for collection of specimen(s), single home bound, nursing home, or skilled nursing facility patient</td>
<td>Venipuncture home/snf</td>
</tr>
<tr class="odd">
<td>S9537</td>
<td>0010</td>
<td>3</td>
<td>Home therapy; hematopoietic hormone injection therapy (e.g., erythropoietin, g-csf, gm-csf); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Ht hem horm inj diem</td>
</tr>
<tr class="even">
<td>S9538</td>
<td>0010</td>
<td>3</td>
<td>Home transfusion of blood product(s); administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (blood products, drugs, and nursing visits coded separately), per diem</td>
<td>Hit blood products diem</td>
</tr>
<tr class="odd">
<td>S9542</td>
<td>0010</td>
<td>3</td>
<td>Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Ht inj noc per diem</td>
</tr>
<tr class="even">
<td>S9558</td>
<td>0010</td>
<td>3</td>
<td>Home injectable therapy; growth hormone, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Ht inj growth horm diem</td>
</tr>
<tr class="odd">
<td>S9559</td>
<td>0010</td>
<td>3</td>
<td>Home injectable therapy, interferon, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Hit inj interferon diem</td>
</tr>
<tr class="even">
<td>S9560</td>
<td>0010</td>
<td>3</td>
<td>Home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Ht inj hormone diem</td>
</tr>
<tr class="odd">
<td>S9562</td>
<td>0010</td>
<td>3</td>
<td>Home injectable therapy, palivizumab, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Ht inj palivizumab diem</td>
</tr>
<tr class="even">
<td>S9590</td>
<td>0010</td>
<td>3</td>
<td>Home therapy, irrigation therapy (e.g., sterile irrigation of an organ or anatomical cavity); including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem</td>
<td>Ht irrigation diem</td>
</tr>
<tr class="odd">
<td>S9810</td>
<td>0010</td>
<td>3</td>
<td>Home therapy; professional pharmacy services for provision of infusion, specialty drug administration, and/or disease state management, not otherwise classified, per hour (do not use this code with any per diem code)</td>
<td>Ht pharm per hour</td>
</tr>
<tr class="even">
<td>S9900</td>
<td>0010</td>
<td>3</td>
<td>Services by a journal-listed christian science practitioner for the purpose of healing, per diem</td>
<td>Christian sci pract visit</td>
</tr>
<tr class="odd">
<td>S9901</td>
<td>0010</td>
<td>3</td>
<td>Services by a journal-listed christian science nurse, per hour</td>
<td>Christian sci nurse visit</td>
</tr>
<tr class="even">
<td>S9960</td>
<td>0010</td>
<td>3</td>
<td>Ambulance service, conventional air service, nonemergency transport, one way (fixed wing)</td>
<td>Air ambulanc nonemerg fixed</td>
</tr>
<tr class="odd">
<td>S9961</td>
<td>0010</td>
<td>3</td>
<td>Ambulance service, conventional air service, nonemergency transport, one way (rotary wing)</td>
<td>Air ambulan nonemerg rotary</td>
</tr>
<tr class="even">
<td>S9970</td>
<td>0010</td>
<td>3</td>
<td>Health club membership, annual</td>
<td>Health club membership yr</td>
</tr>
<tr class="odd">
<td>S9975</td>
<td>0010</td>
<td>3</td>
<td>Transplant related lodging, meals and transportation, per diem</td>
<td>Transplant related per diem</td>
</tr>
<tr class="even">
<td>S9976</td>
<td>0010</td>
<td>3</td>
<td>Lodging, per diem, not otherwise classified</td>
<td>Lodging per diem</td>
</tr>
<tr class="odd">
<td>S9977</td>
<td>0010</td>
<td>3</td>
<td>Meals, per diem, not otherwise specified</td>
<td>Meals per diem</td>
</tr>
<tr class="even">
<td>S9981</td>
<td>0010</td>
<td>3</td>
<td>Medical records copying fee, administrative</td>
<td>Med record copy admin</td>
</tr>
<tr class="odd">
<td>S9982</td>
<td>0010</td>
<td>3</td>
<td>Medical records copying fee, per page</td>
<td>Med record copy per page</td>
</tr>
<tr class="even">
<td>S9986</td>
<td>0010</td>
<td>3</td>
<td>Not medically necessary service (patient is aware that service not medically necessary)</td>
<td>Not medically necessary svc</td>
</tr>
<tr class="odd">
<td>S9988</td>
<td>0010</td>
<td>3</td>
<td>Services provided as part of a phase i clinical trial</td>
<td>Serv part of phase i trial</td>
</tr>
<tr class="even">
<td>S9989</td>
<td>0010</td>
<td>3</td>
<td>Services provided outside of the united states of america (list in addition to code(s) for service(s))</td>
<td>Services outside us</td>
</tr>
<tr class="odd">
<td>S9990</td>
<td>0010</td>
<td>3</td>
<td>Services provided as part of a phase ii clinical trial</td>
<td>Services provided as part of</td>
</tr>
<tr class="even">
<td>S9991</td>
<td>0010</td>
<td>3</td>
<td>Services provided as part of a phase iii clinical trial</td>
<td>Services provided as part of</td>
</tr>
<tr class="odd">
<td>S9992</td>
<td>0010</td>
<td>3</td>
<td>Transportation costs to and from trial location and local transportation costs (e.g., fares for taxicab or bus) for clinical trial participant and one caregiver/companion</td>
<td>Transportation costs to and</td>
</tr>
<tr class="even">
<td>S9994</td>
<td>0010</td>
<td>3</td>
<td>Lodging costs (e.g., hotel charges) for clinical trial participant and one caregiver/companion</td>
<td>Lodging costs (e.g. hotel ch</td>
</tr>
<tr class="odd">
<td>S9996</td>
<td>0010</td>
<td>3</td>
<td>Meals for clinical trial participant and one caregiver/companion</td>
<td>Meals for clinical trial par</td>
</tr>
<tr class="even">
<td>S9999</td>
<td>0010</td>
<td>3</td>
<td>Sales tax</td>
<td>Sales tax</td>
</tr>
</tbody>
</table>
</div>
<div id="t-series-no-description" class="section level2">
<h2>T Series: No Description</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>T1000</td>
<td>0010</td>
<td>3</td>
<td>Private duty / independent nursing service(s) - licensed, up to 15 minutes</td>
<td>Private duty/independent nsg</td>
</tr>
<tr class="even">
<td>T1001</td>
<td>0010</td>
<td>3</td>
<td>Nursing assessment / evaluation</td>
<td>Nursing assessment/evaluatn</td>
</tr>
<tr class="odd">
<td>T1002</td>
<td>0010</td>
<td>3</td>
<td>Rn services, up to 15 minutes</td>
<td>Rn services up to 15 minutes</td>
</tr>
<tr class="even">
<td>T1003</td>
<td>0010</td>
<td>3</td>
<td>Lpn/lvn services, up to 15 minutes</td>
<td>Lpn/lvn services up to 15min</td>
</tr>
<tr class="odd">
<td>T1004</td>
<td>0010</td>
<td>3</td>
<td>Services of a qualified nursing aide, up to 15 minutes</td>
<td>Nsg aide service up to 15min</td>
</tr>
<tr class="even">
<td>T1005</td>
<td>0010</td>
<td>3</td>
<td>Respite care services, up to 15 minutes</td>
<td>Respite care service 15 min</td>
</tr>
<tr class="odd">
<td>T1006</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or substance abuse services, family/couple counseling</td>
<td>Family/couple counseling</td>
</tr>
<tr class="even">
<td>T1007</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or substance abuse services, treatment plan development and/or modification</td>
<td>Treatment plan development</td>
</tr>
<tr class="odd">
<td>T1009</td>
<td>0010</td>
<td>3</td>
<td>Child sitting services for children of the individual receiving alcohol and/or substance abuse services</td>
<td>Child sitting services</td>
</tr>
<tr class="even">
<td>T1010</td>
<td>0010</td>
<td>3</td>
<td>Meals for individuals receiving alcohol and/or substance abuse services (when meals not included in the program)</td>
<td>Meals when receive services</td>
</tr>
<tr class="odd">
<td>T1012</td>
<td>0010</td>
<td>3</td>
<td>Alcohol and/or substance abuse services, skills development</td>
<td>Alcohol/substance abuse skil</td>
</tr>
<tr class="even">
<td>T1013</td>
<td>0010</td>
<td>3</td>
<td>Sign language or oral interpretive services, per 15 minutes</td>
<td>Sign lang/oral interpreter</td>
</tr>
<tr class="odd">
<td>T1014</td>
<td>0010</td>
<td>3</td>
<td>Telehealth transmission, per minute, professional services bill separately</td>
<td>Telehealth transmit, per min</td>
</tr>
<tr class="even">
<td>T1015</td>
<td>0010</td>
<td>3</td>
<td>Clinic visit/encounter, all-inclusive</td>
<td>Clinic service</td>
</tr>
<tr class="odd">
<td>T1016</td>
<td>0010</td>
<td>3</td>
<td>Case management, each 15 minutes</td>
<td>Case management</td>
</tr>
<tr class="even">
<td>T1017</td>
<td>0010</td>
<td>3</td>
<td>Targeted case management, each 15 minutes</td>
<td>Targeted case management</td>
</tr>
<tr class="odd">
<td>T1018</td>
<td>0010</td>
<td>3</td>
<td>School-based individualized education program (iep) services, bundled</td>
<td>School-based iep ser bundled</td>
</tr>
<tr class="even">
<td>T1019</td>
<td>0010</td>
<td>3</td>
<td>Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)</td>
<td>Personal care ser per 15 min</td>
</tr>
<tr class="odd">
<td>T1020</td>
<td>0010</td>
<td>3</td>
<td>Personal care services, per diem, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)</td>
<td>Personal care ser per diem</td>
</tr>
<tr class="even">
<td>T1021</td>
<td>0010</td>
<td>3</td>
<td>Home health aide or certified nurse assistant, per visit</td>
<td>Hh aide or cn aide per visit</td>
</tr>
<tr class="odd">
<td>T1022</td>
<td>0010</td>
<td>3</td>
<td>Contracted home health agency services, all services provided under contract, per day</td>
<td>Contracted services per day</td>
</tr>
<tr class="even">
<td>T1023</td>
<td>0010</td>
<td>3</td>
<td>Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter</td>
<td>Program intake assessment</td>
</tr>
<tr class="odd">
<td>T1024</td>
<td>0010</td>
<td>3</td>
<td>Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter</td>
<td>Team evaluation &amp; management</td>
</tr>
<tr class="even">
<td>T1025</td>
<td>0010</td>
<td>3</td>
<td>Intensive, extended multidisciplinary services provided in a clinic setting to children with complex medical, physical, mental and psychosocial impairments, per diem</td>
<td>Ped compr care pkg, per diem</td>
</tr>
<tr class="odd">
<td>T1026</td>
<td>0010</td>
<td>3</td>
<td>Intensive, extended multidisciplinary services provided in a clinic setting to children with complex medical, physical, medical and psychosocial impairments, per hour</td>
<td>Ped compr care pkg, per hour</td>
</tr>
<tr class="even">
<td>T1027</td>
<td>0010</td>
<td>3</td>
<td>Family training and counseling for child development, per 15 minutes</td>
<td>Family training &amp; counseling</td>
</tr>
<tr class="odd">
<td>T1028</td>
<td>0010</td>
<td>3</td>
<td>Assessment of home, physical and family environment, to determine suitability to meet patient’s medical needs</td>
<td>Home environment assessment</td>
</tr>
<tr class="even">
<td>T1029</td>
<td>0010</td>
<td>3</td>
<td>Comprehensive environmental lead investigation, not including laboratory analysis, per dwelling</td>
<td>Dwelling lead investigation</td>
</tr>
<tr class="odd">
<td>T1030</td>
<td>0010</td>
<td>3</td>
<td>Nursing care, in the home, by registered nurse, per diem</td>
<td>Rn home care per diem</td>
</tr>
<tr class="even">
<td>T1031</td>
<td>0010</td>
<td>3</td>
<td>Nursing care, in the home, by licensed practical nurse, per diem</td>
<td>Lpn home care per diem</td>
</tr>
<tr class="odd">
<td>T1040</td>
<td>0010</td>
<td>3</td>
<td>Medicaid certified community behavioral health clinic services, per diem</td>
<td>Comm bh clinic svc per diem</td>
</tr>
<tr class="even">
<td>T1041</td>
<td>0010</td>
<td>3</td>
<td>Medicaid certified community behavioral health clinic services, per month</td>
<td>Comm bh clinic svc per month</td>
</tr>
<tr class="odd">
<td>T1502</td>
<td>0010</td>
<td>3</td>
<td>Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit</td>
<td>Medication admin visit</td>
</tr>
<tr class="even">
<td>T1503</td>
<td>0010</td>
<td>3</td>
<td>Administration of medication, other than oral and/or injectable, by a health care agency/professional, per visit</td>
<td>Med admin, not oral/inject</td>
</tr>
<tr class="odd">
<td>T1505</td>
<td>0010</td>
<td>3</td>
<td>Electronic medication compliance management device, includes all components and accessories, not otherwise classified</td>
<td>Elec med comp dev, noc</td>
</tr>
<tr class="even">
<td>T1999</td>
<td>0010</td>
<td>3</td>
<td>Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in “remarks”</td>
<td>Noc retail items andsupplies</td>
</tr>
<tr class="odd">
<td>T2001</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation; patient attendant/escort</td>
<td>N-et; patient attend/escort</td>
</tr>
<tr class="even">
<td>T2002</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation; per diem</td>
<td>N-et; per diem</td>
</tr>
<tr class="odd">
<td>T2003</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation; encounter/trip</td>
<td>N-et; encounter/trip</td>
</tr>
<tr class="even">
<td>T2004</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transport; commercial carrier, multi-pass</td>
<td>N-et; commerc carrier pass</td>
</tr>
<tr class="odd">
<td>T2005</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation; stretcher van</td>
<td>N-et; stretcher van</td>
</tr>
<tr class="even">
<td>T2007</td>
<td>0010</td>
<td>3</td>
<td>Transportation waiting time, air ambulance and non-emergency vehicle, one-half (1/2) hour increments</td>
<td>Non-emer transport wait time</td>
</tr>
<tr class="odd">
<td>T2010</td>
<td>0010</td>
<td>3</td>
<td>Preadmission screening and resident review (pasrr) level i identification screening, per screen</td>
<td>Pasrr level i</td>
</tr>
<tr class="even">
<td>T2011</td>
<td>0010</td>
<td>3</td>
<td>Preadmission screening and resident review (pasrr) level ii evaluation, per evaluation</td>
<td>Pasrr level ii</td>
</tr>
<tr class="odd">
<td>T2012</td>
<td>0010</td>
<td>3</td>
<td>Habilitation, educational; waiver, per diem</td>
<td>Habil ed waiver, per diem</td>
</tr>
<tr class="even">
<td>T2013</td>
<td>0010</td>
<td>3</td>
<td>Habilitation, educational, waiver; per hour</td>
<td>Habil ed waiver per hour</td>
</tr>
<tr class="odd">
<td>T2014</td>
<td>0010</td>
<td>3</td>
<td>Habilitation, prevocational, waiver; per diem</td>
<td>Habil prevoc waiver, per d</td>
</tr>
<tr class="even">
<td>T2015</td>
<td>0010</td>
<td>3</td>
<td>Habilitation, prevocational, waiver; per hour</td>
<td>Habil prevoc waiver per hr</td>
</tr>
<tr class="odd">
<td>T2016</td>
<td>0010</td>
<td>3</td>
<td>Habilitation, residential, waiver; per diem</td>
<td>Habil res waiver per diem</td>
</tr>
<tr class="even">
<td>T2017</td>
<td>0010</td>
<td>3</td>
<td>Habilitation, residential, waiver; 15 minutes</td>
<td>Habil res waiver 15 min</td>
</tr>
<tr class="odd">
<td>T2018</td>
<td>0010</td>
<td>3</td>
<td>Habilitation, supported employment, waiver; per diem</td>
<td>Habil sup empl waiver/diem</td>
</tr>
<tr class="even">
<td>T2019</td>
<td>0010</td>
<td>3</td>
<td>Habilitation, supported employment, waiver; per 15 minutes</td>
<td>Habil sup empl waiver 15min</td>
</tr>
<tr class="odd">
<td>T2020</td>
<td>0010</td>
<td>3</td>
<td>Day habilitation, waiver; per diem</td>
<td>Day habil waiver per diem</td>
</tr>
<tr class="even">
<td>T2021</td>
<td>0010</td>
<td>3</td>
<td>Day habilitation, waiver; per 15 minutes</td>
<td>Day habil waiver per 15 min</td>
</tr>
<tr class="odd">
<td>T2022</td>
<td>0010</td>
<td>3</td>
<td>Case management, per month</td>
<td>Case management, per month</td>
</tr>
<tr class="even">
<td>T2023</td>
<td>0010</td>
<td>3</td>
<td>Targeted case management; per month</td>
<td>Targeted case mgmt per month</td>
</tr>
<tr class="odd">
<td>T2024</td>
<td>0010</td>
<td>3</td>
<td>Service assessment/plan of care development, waiver</td>
<td>Serv asmnt/care plan waiver</td>
</tr>
<tr class="even">
<td>T2025</td>
<td>0010</td>
<td>3</td>
<td>Waiver services; not otherwise specified (nos)</td>
<td>Waiver service, nos</td>
</tr>
<tr class="odd">
<td>T2026</td>
<td>0010</td>
<td>3</td>
<td>Specialized childcare, waiver; per diem</td>
<td>Special childcare waiver/d</td>
</tr>
<tr class="even">
<td>T2027</td>
<td>0010</td>
<td>3</td>
<td>Specialized childcare, waiver; per 15 minutes</td>
<td>Spec childcare waiver 15 min</td>
</tr>
<tr class="odd">
<td>T2028</td>
<td>0010</td>
<td>3</td>
<td>Specialized supply, not otherwise specified, waiver</td>
<td>Special supply, nos waiver</td>
</tr>
<tr class="even">
<td>T2029</td>
<td>0010</td>
<td>3</td>
<td>Specialized medical equipment, not otherwise specified, waiver</td>
<td>Special med equip, noswaiver</td>
</tr>
<tr class="odd">
<td>T2030</td>
<td>0010</td>
<td>3</td>
<td>Assisted living, waiver; per month</td>
<td>Assist living waiver/month</td>
</tr>
<tr class="even">
<td>T2031</td>
<td>0010</td>
<td>3</td>
<td>Assisted living; waiver, per diem</td>
<td>Assist living waiver/diem</td>
</tr>
<tr class="odd">
<td>T2032</td>
<td>0010</td>
<td>3</td>
<td>Residential care, not otherwise specified (nos), waiver; per month</td>
<td>Res care, nos waiver/month</td>
</tr>
<tr class="even">
<td>T2033</td>
<td>0010</td>
<td>3</td>
<td>Residential care, not otherwise specified (nos), waiver; per diem</td>
<td>Res, nos waiver per diem</td>
</tr>
<tr class="odd">
<td>T2034</td>
<td>0010</td>
<td>3</td>
<td>Crisis intervention, waiver; per diem</td>
<td>Crisis interven waiver/diem</td>
</tr>
<tr class="even">
<td>T2035</td>
<td>0010</td>
<td>3</td>
<td>Utility services to support medical equipment and assistive technology/devices, waiver</td>
<td>Utility services waiver</td>
</tr>
<tr class="odd">
<td>T2036</td>
<td>0010</td>
<td>3</td>
<td>Therapeutic camping, overnight, waiver; each session</td>
<td>Camp overnite waiver/session</td>
</tr>
<tr class="even">
<td>T2037</td>
<td>0010</td>
<td>3</td>
<td>Therapeutic camping, day, waiver; each session</td>
<td>Camp day waiver/session</td>
</tr>
<tr class="odd">
<td>T2038</td>
<td>0010</td>
<td>3</td>
<td>Community transition, waiver; per service</td>
<td>Comm trans waiver/service</td>
</tr>
<tr class="even">
<td>T2039</td>
<td>0010</td>
<td>3</td>
<td>Vehicle modifications, waiver; per service</td>
<td>Vehicle mod waiver/service</td>
</tr>
<tr class="odd">
<td>T2040</td>
<td>0010</td>
<td>3</td>
<td>Financial management, self-directed, waiver; per 15 minutes</td>
<td>Financial mgt waiver/15min</td>
</tr>
<tr class="even">
<td>T2041</td>
<td>0010</td>
<td>3</td>
<td>Supports brokerage, self-directed, waiver; per 15 minutes</td>
<td>Support broker waiver/15 min</td>
</tr>
<tr class="odd">
<td>T2042</td>
<td>0010</td>
<td>3</td>
<td>Hospice routine home care; per diem</td>
<td>Hospice routine home care</td>
</tr>
<tr class="even">
<td>T2043</td>
<td>0010</td>
<td>3</td>
<td>Hospice continuous home care; per hour</td>
<td>Hospice continuous home care</td>
</tr>
<tr class="odd">
<td>T2044</td>
<td>0010</td>
<td>3</td>
<td>Hospice inpatient respite care; per diem</td>
<td>Hospice respite care</td>
</tr>
<tr class="even">
<td>T2045</td>
<td>0010</td>
<td>3</td>
<td>Hospice general inpatient care; per diem</td>
<td>Hospice general care</td>
</tr>
<tr class="odd">
<td>T2046</td>
<td>0010</td>
<td>3</td>
<td>Hospice long term care, room and board only; per diem</td>
<td>Hospice long term care, r&amp;b</td>
</tr>
<tr class="even">
<td>T2048</td>
<td>0010</td>
<td>3</td>
<td>Behavioral health; long-term care residential (non-acute care in a residential treatment program where stay is typically longer than 30 days), with room and board, per diem</td>
<td>Bh ltc res r&amp;b, per diem</td>
</tr>
<tr class="odd">
<td>T2049</td>
<td>0010</td>
<td>3</td>
<td>Non-emergency transportation; stretcher van, mileage; per mile</td>
<td>N-et; stretcher van, mileage</td>
</tr>
<tr class="even">
<td>T2101</td>
<td>0010</td>
<td>3</td>
<td>Human breast milk processing, storage and distribution only</td>
<td>Breast milk proc/store/dist</td>
</tr>
<tr class="odd">
<td>T4521</td>
<td>0010</td>
<td>3</td>
<td>Adult sized disposable incontinence product, brief/diaper, small, each</td>
<td>Adult size brief/diaper sm</td>
</tr>
<tr class="even">
<td>T4522</td>
<td>0010</td>
<td>3</td>
<td>Adult sized disposable incontinence product, brief/diaper, medium, each</td>
<td>Adult size brief/diaper med</td>
</tr>
<tr class="odd">
<td>T4523</td>
<td>0010</td>
<td>3</td>
<td>Adult sized disposable incontinence product, brief/diaper, large, each</td>
<td>Adult size brief/diaper lg</td>
</tr>
<tr class="even">
<td>T4524</td>
<td>0010</td>
<td>3</td>
<td>Adult sized disposable incontinence product, brief/diaper, extra large, each</td>
<td>Adult size brief/diaper xl</td>
</tr>
<tr class="odd">
<td>T4525</td>
<td>0010</td>
<td>3</td>
<td>Adult sized disposable incontinence product, protective underwear/pull-on, small size, each</td>
<td>Adult size pull-on sm</td>
</tr>
<tr class="even">
<td>T4526</td>
<td>0010</td>
<td>3</td>
<td>Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each</td>
<td>Adult size pull-on med</td>
</tr>
<tr class="odd">
<td>T4527</td>
<td>0010</td>
<td>3</td>
<td>Adult sized disposable incontinence product, protective underwear/pull-on, large size, each</td>
<td>Adult size pull-on lg</td>
</tr>
<tr class="even">
<td>T4528</td>
<td>0010</td>
<td>3</td>
<td>Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each</td>
<td>Adult size pull-on xl</td>
</tr>
<tr class="odd">
<td>T4529</td>
<td>0010</td>
<td>3</td>
<td>Pediatric sized disposable incontinence product, brief/diaper, small/medium size, each</td>
<td>Ped size brief/diaper sm/med</td>
</tr>
<tr class="even">
<td>T4530</td>
<td>0010</td>
<td>3</td>
<td>Pediatric sized disposable incontinence product, brief/diaper, large size, each</td>
<td>Ped size brief/diaper lg</td>
</tr>
<tr class="odd">
<td>T4531</td>
<td>0010</td>
<td>3</td>
<td>Pediatric sized disposable incontinence product, protective underwear/pull-on, small/medium size, each</td>
<td>Ped size pull-on sm/med</td>
</tr>
<tr class="even">
<td>T4532</td>
<td>0010</td>
<td>3</td>
<td>Pediatric sized disposable incontinence product, protective underwear/pull-on, large size, each</td>
<td>Ped size pull-on lg</td>
</tr>
<tr class="odd">
<td>T4533</td>
<td>0010</td>
<td>3</td>
<td>Youth sized disposable incontinence product, brief/diaper, each</td>
<td>Youth size brief/diaper</td>
</tr>
<tr class="even">
<td>T4534</td>
<td>0010</td>
<td>3</td>
<td>Youth sized disposable incontinence product, protective underwear/pull-on, each</td>
<td>Youth size pull-on</td>
</tr>
<tr class="odd">
<td>T4535</td>
<td>0010</td>
<td>3</td>
<td>Disposable liner/shield/guard/pad/undergarment, for incontinence, each</td>
<td>Disposable liner/shield/pad</td>
</tr>
<tr class="even">
<td>T4536</td>
<td>0010</td>
<td>3</td>
<td>Incontinence product, protective underwear/pull-on, reusable, any size, each</td>
<td>Reusable pull-on any size</td>
</tr>
<tr class="odd">
<td>T4537</td>
<td>0010</td>
<td>3</td>
<td>Incontinence product, protective underpad, reusable, bed size, each</td>
<td>Reusable underpad bed size</td>
</tr>
<tr class="even">
<td>T4538</td>
<td>0010</td>
<td>3</td>
<td>Diaper service, reusable diaper, each diaper</td>
<td>Diaper serv reusable diaper</td>
</tr>
<tr class="odd">
<td>T4539</td>
<td>0010</td>
<td>3</td>
<td>Incontinence product, diaper/brief, reusable, any size, each</td>
<td>Reuse diaper/brief any size</td>
</tr>
<tr class="even">
<td>T4540</td>
<td>0010</td>
<td>3</td>
<td>Incontinence product, protective underpad, reusable, chair size, each</td>
<td>Reusable underpad chair size</td>
</tr>
<tr class="odd">
<td>T4541</td>
<td>0010</td>
<td>3</td>
<td>Incontinence product, disposable underpad, large, each</td>
<td>Large disposable underpad</td>
</tr>
<tr class="even">
<td>T4542</td>
<td>0010</td>
<td>3</td>
<td>Incontinence product, disposable underpad, small size, each</td>
<td>Small disposable underpad</td>
</tr>
<tr class="odd">
<td>T4543</td>
<td>0010</td>
<td>3</td>
<td>Adult sized disposable incontinence product, protective brief/diaper, above extra large, each</td>
<td>Adult disp brief/diap abv xl</td>
</tr>
<tr class="even">
<td>T4544</td>
<td>0010</td>
<td>3</td>
<td>Adult sized disposable incontinence product, protective underwear/pull-on, above extra large, each</td>
<td>Adlt disp und/pull on abv xl</td>
</tr>
<tr class="odd">
<td>T4545</td>
<td>0010</td>
<td>3</td>
<td>Incontinence product, disposable, penile wrap, each</td>
<td>Incon disposable penile wrap</td>
</tr>
<tr class="even">
<td>T5001</td>
<td>0010</td>
<td>3</td>
<td>Positioning seat for persons with special orthopedic needs</td>
<td>Position seat spec orth need</td>
</tr>
<tr class="odd">
<td>T5999</td>
<td>0010</td>
<td>3</td>
<td>Supply, not otherwise specified</td>
<td>Supply, nos</td>
</tr>
</tbody>
</table>
</div>
<div id="v-series-no-description" class="section level2">
<h2>V Series: No Description</h2>
<table>
<colgroup>
<col width="10%"></col>
<col width="13%"></col>
<col width="12%"></col>
<col width="31%"></col>
<col width="32%"></col>
</colgroup>
<thead>
<tr class="header">
<th>HCPC</th>
<th>SEQNUM</th>
<th>RECID</th>
<th>LONG DESCRIPTION</th>
<th>SHORT DESCRIPTION</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>V2020</td>
<td>0010</td>
<td>3</td>
<td>Frames, purchases</td>
<td>Vision svcs frames purchases</td>
</tr>
<tr class="even">
<td>V2025</td>
<td>0010</td>
<td>3</td>
<td>Deluxe frame</td>
<td>Eyeglasses delux frames</td>
</tr>
<tr class="odd">
<td>V2100</td>
<td>0010</td>
<td>3</td>
<td>Sphere, single vision, plano to plus or minus 4.00, per lens</td>
<td>Lens spher single plano 4.00</td>
</tr>
<tr class="even">
<td>V2101</td>
<td>0010</td>
<td>3</td>
<td>Sphere, single vision, plus or minus 4.12 to plus or minus 7.00d, per lens</td>
<td>Single visn sphere 4.12-7.00</td>
</tr>
<tr class="odd">
<td>V2102</td>
<td>0010</td>
<td>3</td>
<td>Sphere, single vision, plus or minus 7.12 to plus or minus 20.00d, per lens</td>
<td>Singl visn sphere 7.12-20.00</td>
</tr>
<tr class="even">
<td>V2103</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens</td>
<td>Spherocylindr 4.00d/12-2.00d</td>
</tr>
<tr class="odd">
<td>V2104</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens</td>
<td>Spherocylindr 4.00d/2.12-4d</td>
</tr>
<tr class="even">
<td>V2105</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens</td>
<td>Spherocylinder 4.00d/4.25-6d</td>
</tr>
<tr class="odd">
<td>V2106</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, single vision, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens</td>
<td>Spherocylinder 4.00d/&gt;6.00d</td>
</tr>
<tr class="even">
<td>V2107</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00 sphere, .12 to 2.00d cylinder, per lens</td>
<td>Spherocylinder 4.25d/12-2d</td>
</tr>
<tr class="odd">
<td>V2108</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, single vision, plus or minus 4.25d to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens</td>
<td>Spherocylinder 4.25d/2.12-4d</td>
</tr>
<tr class="even">
<td>V2109</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens</td>
<td>Spherocylinder 4.25d/4.25-6d</td>
</tr>
<tr class="odd">
<td>V2110</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, single vision, plus or minus 4.25 to 7.00d sphere, over 6.00d cylinder, per lens</td>
<td>Spherocylinder 4.25d/over 6d</td>
</tr>
<tr class="even">
<td>V2111</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens</td>
<td>Spherocylindr 7.25d/.25-2.25</td>
</tr>
<tr class="odd">
<td>V2112</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25d to 4.00d cylinder, per lens</td>
<td>Spherocylindr 7.25d/2.25-4d</td>
</tr>
<tr class="even">
<td>V2113</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens</td>
<td>Spherocylindr 7.25d/4.25-6d</td>
</tr>
<tr class="odd">
<td>V2114</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, single vision, sphere over plus or minus 12.00d, per lens</td>
<td>Spherocylinder over 12.00d</td>
</tr>
<tr class="even">
<td>V2115</td>
<td>0010</td>
<td>3</td>
<td>Lenticular, (myodisc), per lens, single vision</td>
<td>Lens lenticular bifocal</td>
</tr>
<tr class="odd">
<td>V2118</td>
<td>0010</td>
<td>3</td>
<td>Aniseikonic lens, single vision</td>
<td>Lens aniseikonic single</td>
</tr>
<tr class="even">
<td>V2121</td>
<td>0010</td>
<td>3</td>
<td>Lenticular lens, per lens, single</td>
<td>Lenticular lens, single</td>
</tr>
<tr class="odd">
<td>V2199</td>
<td>0010</td>
<td>3</td>
<td>Not otherwise classified, single vision lens</td>
<td>Lens single vision not oth c</td>
</tr>
<tr class="even">
<td>V2200</td>
<td>0010</td>
<td>3</td>
<td>Sphere, bifocal, plano to plus or minus 4.00d, per lens</td>
<td>Lens spher bifoc plano 4.00d</td>
</tr>
<tr class="odd">
<td>V2201</td>
<td>0010</td>
<td>3</td>
<td>Sphere, bifocal, plus or minus 4.12 to plus or minus 7.00d, per lens</td>
<td>Lens sphere bifocal 4.12-7.0</td>
</tr>
<tr class="even">
<td>V2202</td>
<td>0010</td>
<td>3</td>
<td>Sphere, bifocal, plus or minus 7.12 to plus or minus 20.00d, per lens</td>
<td>Lens sphere bifocal 7.12-20.</td>
</tr>
<tr class="odd">
<td>V2203</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens</td>
<td>Lens sphcyl bifocal 4.00d/.1</td>
</tr>
<tr class="even">
<td>V2204</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens</td>
<td>Lens sphcy bifocal 4.00d/2.1</td>
</tr>
<tr class="odd">
<td>V2205</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens</td>
<td>Lens sphcy bifocal 4.00d/4.2</td>
</tr>
<tr class="even">
<td>V2206</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens</td>
<td>Lens sphcy bifocal 4.00d/ove</td>
</tr>
<tr class="odd">
<td>V2207</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere,.12 to 2.00d cylinder, per lens</td>
<td>Lens sphcy bifocal 4.25-7d/.</td>
</tr>
<tr class="even">
<td>V2208</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens</td>
<td>Lens sphcy bifocal 4.25-7/2.</td>
</tr>
<tr class="odd">
<td>V2209</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens</td>
<td>Lens sphcy bifocal 4.25-7/4.</td>
</tr>
<tr class="even">
<td>V2210</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over 6.00d cylinder, per lens</td>
<td>Lens sphcy bifocal 4.25-7/ov</td>
</tr>
<tr class="odd">
<td>V2211</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens</td>
<td>Lens sphcy bifo 7.25-12/.25-</td>
</tr>
<tr class="even">
<td>V2212</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25 to 4.00d cylinder, per lens</td>
<td>Lens sphcyl bifo 7.25-12/2.2</td>
</tr>
<tr class="odd">
<td>V2213</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens</td>
<td>Lens sphcyl bifo 7.25-12/4.2</td>
</tr>
<tr class="even">
<td>V2214</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, bifocal, sphere over plus or minus 12.00d, per lens</td>
<td>Lens sphcyl bifocal over 12.</td>
</tr>
<tr class="odd">
<td>V2215</td>
<td>0010</td>
<td>3</td>
<td>Lenticular (myodisc), per lens, bifocal</td>
<td>Lens lenticular bifocal</td>
</tr>
<tr class="even">
<td>V2218</td>
<td>0010</td>
<td>3</td>
<td>Aniseikonic, per lens, bifocal</td>
<td>Lens aniseikonic bifocal</td>
</tr>
<tr class="odd">
<td>V2219</td>
<td>0010</td>
<td>3</td>
<td>Bifocal seg width over 28 mm</td>
<td>Lens bifocal seg width over</td>
</tr>
<tr class="even">
<td>V2220</td>
<td>0010</td>
<td>3</td>
<td>Bifocal add over 3.25d</td>
<td>Lens bifocal add over 3.25d</td>
</tr>
<tr class="odd">
<td>V2221</td>
<td>0010</td>
<td>3</td>
<td>Lenticular lens, per lens, bifocal</td>
<td>Lenticular lens, bifocal</td>
</tr>
<tr class="even">
<td>V2299</td>
<td>0010</td>
<td>3</td>
<td>Specialty bifocal (by report)</td>
<td>Lens bifocal speciality</td>
</tr>
<tr class="odd">
<td>V2300</td>
<td>0010</td>
<td>3</td>
<td>Sphere, trifocal, plano to plus or minus 4.00d, per lens</td>
<td>Lens sphere trifocal 4.00d</td>
</tr>
<tr class="even">
<td>V2301</td>
<td>0010</td>
<td>3</td>
<td>Sphere, trifocal, plus or minus 4.12 to plus or minus 7.00d, per lens</td>
<td>Lens sphere trifocal 4.12-7.</td>
</tr>
<tr class="odd">
<td>V2302</td>
<td>0010</td>
<td>3</td>
<td>Sphere, trifocal, plus or minus 7.12 to plus or minus 20.00, per lens</td>
<td>Lens sphere trifocal 7.12-20</td>
</tr>
<tr class="even">
<td>V2303</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens</td>
<td>Lens sphcy trifocal 4.0/.12-</td>
</tr>
<tr class="odd">
<td>V2304</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 2.25-4.00d cylinder, per lens</td>
<td>Lens sphcy trifocal 4.0/2.25</td>
</tr>
<tr class="even">
<td>V2305</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 4.25 to 6.00 cylinder, per lens</td>
<td>Lens sphcy trifocal 4.0/4.25</td>
</tr>
<tr class="odd">
<td>V2306</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens</td>
<td>Lens sphcyl trifocal 4.00/&gt;6</td>
</tr>
<tr class="even">
<td>V2307</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, .12 to 2.00d cylinder, per lens</td>
<td>Lens sphcy trifocal 4.25-7/.</td>
</tr>
<tr class="odd">
<td>V2308</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens</td>
<td>Lens sphc trifocal 4.25-7/2.</td>
</tr>
<tr class="even">
<td>V2309</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens</td>
<td>Lens sphc trifocal 4.25-7/4.</td>
</tr>
<tr class="odd">
<td>V2310</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over 6.00d cylinder, per lens</td>
<td>Lens sphc trifocal 4.25-7/&gt;6</td>
</tr>
<tr class="even">
<td>V2311</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens</td>
<td>Lens sphc trifo 7.25-12/.25-</td>
</tr>
<tr class="odd">
<td>V2312</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25 to 4.00d cylinder, per lens</td>
<td>Lens sphc trifo 7.25-12/2.25</td>
</tr>
<tr class="even">
<td>V2313</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens</td>
<td>Lens sphc trifo 7.25-12/4.25</td>
</tr>
<tr class="odd">
<td>V2314</td>
<td>0010</td>
<td>3</td>
<td>Spherocylinder, trifocal, sphere over plus or minus 12.00d, per lens</td>
<td>Lens sphcyl trifocal over 12</td>
</tr>
<tr class="even">
<td>V2315</td>
<td>0010</td>
<td>3</td>
<td>Lenticular, (myodisc), per lens, trifocal</td>
<td>Lens lenticular trifocal</td>
</tr>
<tr class="odd">
<td>V2318</td>
<td>0010</td>
<td>3</td>
<td>Aniseikonic lens, trifocal</td>
<td>Lens aniseikonic trifocal</td>
</tr>
<tr class="even">
<td>V2319</td>
<td>0010</td>
<td>3</td>
<td>Trifocal seg width over 28 mm</td>
<td>Lens trifocal seg width &gt; 28</td>
</tr>
<tr class="odd">
<td>V2320</td>
<td>0010</td>
<td>3</td>
<td>Trifocal add over 3.25d</td>
<td>Lens trifocal add over 3.25d</td>
</tr>
<tr class="even">
<td>V2321</td>
<td>0010</td>
<td>3</td>
<td>Lenticular lens, per lens, trifocal</td>
<td>Lenticular lens, trifocal</td>
</tr>
<tr class="odd">
<td>V2399</td>
<td>0010</td>
<td>3</td>
<td>Specialty trifocal (by report)</td>
<td>Lens trifocal speciality</td>
</tr>
<tr class="even">
<td>V2410</td>
<td>0010</td>
<td>3</td>
<td>Variable asphericity lens, single vision, full field, glass or plastic, per lens</td>
<td>Lens variab asphericity sing</td>
</tr>
<tr class="odd">
<td>V2430</td>
<td>0010</td>
<td>3</td>
<td>Variable asphericity lens, bifocal, full field, glass or plastic, per lens</td>
<td>Lens variable asphericity bi</td>
</tr>
<tr class="even">
<td>V2499</td>
<td>0010</td>
<td>3</td>
<td>Variable sphericity lens, other type</td>
<td>Variable asphericity lens</td>
</tr>
<tr class="odd">
<td>V2500</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, pmma, spherical, per lens</td>
<td>Contact lens pmma spherical</td>
</tr>
<tr class="even">
<td>V2501</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, pmma, toric or prism ballast, per lens</td>
<td>Cntct lens pmma-toric/prism</td>
</tr>
<tr class="odd">
<td>V2502</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, pmma, bifocal, per lens</td>
<td>Contact lens pmma bifocal</td>
</tr>
<tr class="even">
<td>V2503</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, pmma, color vision deficiency, per lens</td>
<td>Cntct lens pmma color vision</td>
</tr>
<tr class="odd">
<td>V2510</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, gas permeable, spherical, per lens</td>
<td>Cntct gas permeable sphericl</td>
</tr>
<tr class="even">
<td>V2511</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, gas permeable, toric, prism ballast, per lens</td>
<td>Cntct toric prism ballast</td>
</tr>
<tr class="odd">
<td>V2512</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, gas permeable, bifocal, per lens</td>
<td>Cntct lens gas permbl bifocl</td>
</tr>
<tr class="even">
<td>V2513</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, gas permeable, extended wear, per lens</td>
<td>Contact lens extended wear</td>
</tr>
<tr class="odd">
<td>V2520</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, hydrophilic, spherical, per lens</td>
<td>Contact lens hydrophilic</td>
</tr>
<tr class="even">
<td>V2521</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, hydrophilic, toric, or prism ballast, per lens</td>
<td>Cntct lens hydrophilic toric</td>
</tr>
<tr class="odd">
<td>V2522</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, hydrophilic, bifocal, per lens</td>
<td>Cntct lens hydrophil bifocl</td>
</tr>
<tr class="even">
<td>V2523</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, hydrophilic, extended wear, per lens</td>
<td>Cntct lens hydrophil extend</td>
</tr>
<tr class="odd">
<td>V2530</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, scleral, gas impermeable, per lens (for contact lens modification, see 92325)</td>
<td>Contact lens gas impermeable</td>
</tr>
<tr class="even">
<td>V2531</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, scleral, gas permeable, per lens (for contact lens modification, see 92325)</td>
<td>Contact lens gas permeable</td>
</tr>
<tr class="odd">
<td>V2599</td>
<td>0010</td>
<td>3</td>
<td>Contact lens, other type</td>
<td>Contact lens/es other type</td>
</tr>
<tr class="even">
<td>V2600</td>
<td>0010</td>
<td>3</td>
<td>Hand held low vision aids and other nonspectacle mounted aids</td>
<td>Hand held low vision aids</td>
</tr>
<tr class="odd">
<td>V2610</td>
<td>0010</td>
<td>3</td>
<td>Single lens spectacle mounted low vision aids</td>
<td>Single lens spectacle mount</td>
</tr>
<tr class="even">
<td>V2615</td>
<td>0010</td>
<td>3</td>
<td>Telescopic and other compound lens system, including distance vision telescopic, near vision telescopes and compound microscopic lens system</td>
<td>Telescop/othr compound lens</td>
</tr>
<tr class="odd">
<td>V2623</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic eye, plastic, custom</td>
<td>Plastic eye prosth custom</td>
</tr>
<tr class="even">
<td>V2624</td>
<td>0010</td>
<td>3</td>
<td>Polishing/resurfacing of ocular prosthesis</td>
<td>Polishing artifical eye</td>
</tr>
<tr class="odd">
<td>V2625</td>
<td>0010</td>
<td>3</td>
<td>Enlargement of ocular prosthesis</td>
<td>Enlargemnt of eye prosthesis</td>
</tr>
<tr class="even">
<td>V2626</td>
<td>0010</td>
<td>3</td>
<td>Reduction of ocular prosthesis</td>
<td>Reduction of eye prosthesis</td>
</tr>
<tr class="odd">
<td>V2627</td>
<td>0010</td>
<td>3</td>
<td>Scleral cover shell</td>
<td>Scleral cover shell</td>
</tr>
<tr class="even">
<td>V2628</td>
<td>0010</td>
<td>3</td>
<td>Fabrication and fitting of ocular conformer</td>
<td>Fabrication &amp; fitting</td>
</tr>
<tr class="odd">
<td>V2629</td>
<td>0010</td>
<td>3</td>
<td>Prosthetic eye, other type</td>
<td>Prosthetic eye other type</td>
</tr>
<tr class="even">
<td>V2630</td>
<td>0010</td>
<td>3</td>
<td>Anterior chamber intraocular lens</td>
<td>Anter chamber intraocul lens</td>
</tr>
<tr class="odd">
<td>V2631</td>
<td>0010</td>
<td>3</td>
<td>Iris supported intraocular lens</td>
<td>Iris support intraoclr lens</td>
</tr>
<tr class="even">
<td>V2632</td>
<td>0010</td>
<td>3</td>
<td>Posterior chamber intraocular lens</td>
<td>Post chmbr intraocular lens</td>
</tr>
<tr class="odd">
<td>V2700</td>
<td>0010</td>
<td>3</td>
<td>Balance lens, per lens</td>
<td>Balance lens</td>
</tr>
<tr class="even">
<td>V2702</td>
<td>0010</td>
<td>3</td>
<td>Deluxe lens feature</td>
<td>Deluxe lens feature</td>
</tr>
<tr class="odd">
<td>V2710</td>
<td>0010</td>
<td>3</td>
<td>Slab off prism, glass or plastic, per lens</td>
<td>Glass/plastic slab off prism</td>
</tr>
<tr class="even">
<td>V2715</td>
<td>0010</td>
<td>3</td>
<td>Prism, per lens</td>
<td>Prism lens/es</td>
</tr>
<tr class="odd">
<td>V2718</td>
<td>0010</td>
<td>3</td>
<td>Press-on lens, fresnell prism, per lens</td>
<td>Fresnell prism press-on lens</td>
</tr>
<tr class="even">
<td>V2730</td>
<td>0010</td>
<td>3</td>
<td>Special base curve, glass or plastic, per lens</td>
<td>Special base curve</td>
</tr>
<tr class="odd">
<td>V2744</td>
<td>0010</td>
<td>3</td>
<td>Tint, photochromatic, per lens</td>
<td>Tint photochromatic lens/es</td>
</tr>
<tr class="even">
<td>V2745</td>
<td>0010</td>
<td>3</td>
<td>Addition to lens; tint, any color, solid, gradient or equal, excludes photochromatic, any lens material, per lens</td>
<td>Tint, any color/solid/grad</td>
</tr>
<tr class="odd">
<td>V2750</td>
<td>0010</td>
<td>3</td>
<td>Anti-reflective coating, per lens</td>
<td>Anti-reflective coating</td>
</tr>
<tr class="even">
<td>V2755</td>
<td>0010</td>
<td>3</td>
<td>U-v lens, per lens</td>
<td>Uv lens/es</td>
</tr>
<tr class="odd">
<td>V2756</td>
<td>0010</td>
<td>3</td>
<td>Eye glass case</td>
<td>Eye glass case</td>
</tr>
<tr class="even">
<td>V2760</td>
<td>0010</td>
<td>3</td>
<td>Scratch resistant coating, per lens</td>
<td>Scratch resistant coating</td>
</tr>
<tr class="odd">
<td>V2761</td>
<td>0010</td>
<td>3</td>
<td>Mirror coating, any type, solid, gradient or equal, any lens material, per lens</td>
<td>Mirror coating</td>
</tr>
<tr class="even">
<td>V2762</td>
<td>0010</td>
<td>3</td>
<td>Polarization, any lens material, per lens</td>
<td>Polarization, any lens</td>
</tr>
<tr class="odd">
<td>V2770</td>
<td>0010</td>
<td>3</td>
<td>Occluder lens, per lens</td>
<td>Occluder lens/es</td>
</tr>
<tr class="even">
<td>V2780</td>
<td>0010</td>
<td>3</td>
<td>Oversize lens, per lens</td>
<td>Oversize lens/es</td>
</tr>
<tr class="odd">
<td>V2781</td>
<td>0010</td>
<td>3</td>
<td>Progressive lens, per lens</td>
<td>Progressive lens per lens</td>
</tr>
<tr class="even">
<td>V2782</td>
<td>0010</td>
<td>3</td>
<td>Lens, index 1.54 to 1.65 plastic or 1.60 to 1.79 glass, excludes polycarbonate, per lens</td>
<td>Lens, 1.54-1.65 p/1.60-1.79g</td>
</tr>
<tr class="odd">
<td>V2783</td>
<td>0010</td>
<td>3</td>
<td>Lens, index greater than or equal to 1.66 plastic or greater than or equal to 1.80 glass, excludes polycarbonate, per lens</td>
<td>Lens, &gt;= 1.66 p/&gt;=1.80 g</td>
</tr>
<tr class="even">
<td>V2784</td>
<td>0010</td>
<td>3</td>
<td>Lens, polycarbonate or equal, any index, per lens</td>
<td>Lens polycarb or equal</td>
</tr>
<tr class="odd">
<td>V2785</td>
<td>0010</td>
<td>3</td>
<td>Processing, preserving and transporting corneal tissue</td>
<td>Corneal tissue processing</td>
</tr>
<tr class="even">
<td>V2786</td>
<td>0010</td>
<td>3</td>
<td>Specialty occupational multifocal lens, per lens</td>
<td>Occupational multifocal lens</td>
</tr>
<tr class="odd">
<td>V2787</td>
<td>0010</td>
<td>3</td>
<td>Astigmatism correcting function of intraocular lens</td>
<td>Astigmatism-correct function</td>
</tr>
<tr class="even">
<td>V2788</td>
<td>0010</td>
<td>3</td>
<td>Presbyopia correcting function of intraocular lens</td>
<td>Presbyopia-correct function</td>
</tr>
<tr class="odd">
<td>V2790</td>
<td>0010</td>
<td>3</td>
<td>Amniotic membrane for surgical reconstruction, per procedure</td>
<td>Amniotic membrane</td>
</tr>
<tr class="even">
<td>V2797</td>
<td>0010</td>
<td>3</td>
<td>Vision supply, accessory and/or service component of another hcpcs vision code</td>
<td>Vis item/svc in other code</td>
</tr>
<tr class="odd">
<td>V2799</td>
<td>0010</td>
<td>3</td>
<td>Vision item or service, miscellaneous</td>
<td>Misc vision item or service</td>
</tr>
<tr class="even">
<td>V5008</td>
<td>0010</td>
<td>3</td>
<td>Hearing screening</td>
<td>Hearing screening</td>
</tr>
<tr class="odd">
<td>V5010</td>
<td>0010</td>
<td>3</td>
<td>Assessment for hearing aid</td>
<td>Assessment for hearing aid</td>
</tr>
<tr class="even">
<td>V5011</td>
<td>0010</td>
<td>3</td>
<td>Fitting/orientation/checking of hearing aid</td>
<td>Hearing aid fitting/checking</td>
</tr>
<tr class="odd">
<td>V5014</td>
<td>0010</td>
<td>3</td>
<td>Repair/modification of a hearing aid</td>
<td>Hearing aid repair/modifying</td>
</tr>
<tr class="even">
<td>V5020</td>
<td>0010</td>
<td>3</td>
<td>Conformity evaluation</td>
<td>Conformity evaluation</td>
</tr>
<tr class="odd">
<td>V5030</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, monaural, body worn, air conduction</td>
<td>Body-worn hearing aid air</td>
</tr>
<tr class="even">
<td>V5040</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, monaural, body worn, bone conduction</td>
<td>Body-worn hearing aid bone</td>
</tr>
<tr class="odd">
<td>V5050</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, monaural, in the ear</td>
<td>Hearing aid monaural in ear</td>
</tr>
<tr class="even">
<td>V5060</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, monaural, behind the ear</td>
<td>Behind ear hearing aid</td>
</tr>
<tr class="odd">
<td>V5070</td>
<td>0010</td>
<td>3</td>
<td>Glasses, air conduction</td>
<td>Glasses air conduction</td>
</tr>
<tr class="even">
<td>V5080</td>
<td>0010</td>
<td>3</td>
<td>Glasses, bone conduction</td>
<td>Glasses bone conduction</td>
</tr>
<tr class="odd">
<td>V5090</td>
<td>0010</td>
<td>3</td>
<td>Dispensing fee, unspecified hearing aid</td>
<td>Hearing aid dispensing fee</td>
</tr>
<tr class="even">
<td>V5095</td>
<td>0010</td>
<td>3</td>
<td>Semi-implantable middle ear hearing prosthesis</td>
<td>Implant mid ear hearing pros</td>
</tr>
<tr class="odd">
<td>V5100</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, bilateral, body worn</td>
<td>Body-worn bilat hearing aid</td>
</tr>
<tr class="even">
<td>V5110</td>
<td>0010</td>
<td>3</td>
<td>Dispensing fee, bilateral</td>
<td>Hearing aid dispensing fee</td>
</tr>
<tr class="odd">
<td>V5120</td>
<td>0010</td>
<td>3</td>
<td>Binaural, body</td>
<td>Body-worn binaur hearing aid</td>
</tr>
<tr class="even">
<td>V5130</td>
<td>0010</td>
<td>3</td>
<td>Binaural, in the ear</td>
<td>In ear binaural hearing aid</td>
</tr>
<tr class="odd">
<td>V5140</td>
<td>0010</td>
<td>3</td>
<td>Binaural, behind the ear</td>
<td>Behind ear binaur hearing ai</td>
</tr>
<tr class="even">
<td>V5150</td>
<td>0010</td>
<td>3</td>
<td>Binaural, glasses</td>
<td>Glasses binaural hearing aid</td>
</tr>
<tr class="odd">
<td>V5160</td>
<td>0010</td>
<td>3</td>
<td>Dispensing fee, binaural</td>
<td>Dispensing fee binaural</td>
</tr>
<tr class="even">
<td>V5170</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, cros, in the ear</td>
<td>Within ear cros hearing aid</td>
</tr>
<tr class="odd">
<td>V5171</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, contralateral routing device, monaural, in the ear (ite)</td>
<td>Hearing aid monaural ite</td>
</tr>
<tr class="even">
<td>V5172</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, contralateral routing device, monaural, in the canal (itc)</td>
<td>Hearing aid monaural itc</td>
</tr>
<tr class="odd">
<td>V5180</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, cros, behind the ear</td>
<td>Behind ear cros hearing aid</td>
</tr>
<tr class="even">
<td>V5181</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, contralateral routing device, monaural, behind the ear (bte)</td>
<td>Hearing aid monaural bte</td>
</tr>
<tr class="odd">
<td>V5190</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, contralateral routing, monaural, glasses</td>
<td>Hearing aid monaural glasses</td>
</tr>
<tr class="even">
<td>V5200</td>
<td>0010</td>
<td>3</td>
<td>Dispensing fee, contralateral, monaural</td>
<td>Disp fee contralateral monau</td>
</tr>
<tr class="odd">
<td>V5210</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, bicros, in the ear</td>
<td>In ear bicros hearing aid</td>
</tr>
<tr class="even">
<td>V5211</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, contralateral routing system, binaural, ite/ite</td>
<td>Hearing aid binaural ite/ite</td>
</tr>
<tr class="odd">
<td>V5212</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, contralateral routing system, binaural, ite/itc</td>
<td>Hearing aid binaural ite/itc</td>
</tr>
<tr class="even">
<td>V5213</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, contralateral routing system, binaural, ite/bte</td>
<td>Hearing aid binaural ite/bte</td>
</tr>
<tr class="odd">
<td>V5214</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, contralateral routing system, binaural, itc/itc</td>
<td>Hearing aid binaural itc/itc</td>
</tr>
<tr class="even">
<td>V5215</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, contralateral routing system, binaural, itc/bte</td>
<td>Hearing aid binaural itc/bte</td>
</tr>
<tr class="odd">
<td>V5220</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, bicros, behind the ear</td>
<td>Behind ear bicros hearing ai</td>
</tr>
<tr class="even">
<td>V5221</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, contralateral routing system, binaural, bte/bte</td>
<td>Hearing aid binaural bte/bte</td>
</tr>
<tr class="odd">
<td>V5230</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, contralateral routing system, binaural, glasses</td>
<td>Hearing aid binaural glasses</td>
</tr>
<tr class="even">
<td>V5240</td>
<td>0010</td>
<td>3</td>
<td>Dispensing fee, contralateral routing system, binaural</td>
<td>Disp fee contralateral binau</td>
</tr>
<tr class="odd">
<td>V5241</td>
<td>0010</td>
<td>3</td>
<td>Dispensing fee, monaural hearing aid, any type</td>
<td>Dispensing fee, monaural</td>
</tr>
<tr class="even">
<td>V5242</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, analog, monaural, cic (completely in the ear canal)</td>
<td>Hearing aid, monaural, cic</td>
</tr>
<tr class="odd">
<td>V5243</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, analog, monaural, itc (in the canal)</td>
<td>Hearing aid, monaural, itc</td>
</tr>
<tr class="even">
<td>V5244</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digitally programmable analog, monaural, cic</td>
<td>Hearing aid, prog, mon, cic</td>
</tr>
<tr class="odd">
<td>V5245</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digitally programmable, analog, monaural, itc</td>
<td>Hearing aid, prog, mon, itc</td>
</tr>
<tr class="even">
<td>V5246</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digitally programmable analog, monaural, ite (in the ear)</td>
<td>Hearing aid, prog, mon, ite</td>
</tr>
<tr class="odd">
<td>V5247</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digitally programmable analog, monaural, bte (behind the ear)</td>
<td>Hearing aid, prog, mon, bte</td>
</tr>
<tr class="even">
<td>V5248</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, analog, binaural, cic</td>
<td>Hearing aid, binaural, cic</td>
</tr>
<tr class="odd">
<td>V5249</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, analog, binaural, itc</td>
<td>Hearing aid, binaural, itc</td>
</tr>
<tr class="even">
<td>V5250</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digitally programmable analog, binaural, cic</td>
<td>Hearing aid, prog, bin, cic</td>
</tr>
<tr class="odd">
<td>V5251</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digitally programmable analog, binaural, itc</td>
<td>Hearing aid, prog, bin, itc</td>
</tr>
<tr class="even">
<td>V5252</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digitally programmable, binaural, ite</td>
<td>Hearing aid, prog, bin, ite</td>
</tr>
<tr class="odd">
<td>V5253</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digitally programmable, binaural, bte</td>
<td>Hearing aid, prog, bin, bte</td>
</tr>
<tr class="even">
<td>V5254</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digital, monaural, cic</td>
<td>Hearing id, digit, mon, cic</td>
</tr>
<tr class="odd">
<td>V5255</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digital, monaural, itc</td>
<td>Hearing aid, digit, mon, itc</td>
</tr>
<tr class="even">
<td>V5256</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digital, monaural, ite</td>
<td>Hearing aid, digit, mon, ite</td>
</tr>
<tr class="odd">
<td>V5257</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digital, monaural, bte</td>
<td>Hearing aid, digit, mon, bte</td>
</tr>
<tr class="even">
<td>V5258</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digital, binaural, cic</td>
<td>Hearing aid, digit, bin, cic</td>
</tr>
<tr class="odd">
<td>V5259</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digital, binaural, itc</td>
<td>Hearing aid, digit, bin, itc</td>
</tr>
<tr class="even">
<td>V5260</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digital, binaural, ite</td>
<td>Hearing aid, digit, bin, ite</td>
</tr>
<tr class="odd">
<td>V5261</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, digital, binaural, bte</td>
<td>Hearing aid, digit, bin, bte</td>
</tr>
<tr class="even">
<td>V5262</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, disposable, any type, monaural</td>
<td>Hearing aid, disp, monaural</td>
</tr>
<tr class="odd">
<td>V5263</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, disposable, any type, binaural</td>
<td>Hearing aid, disp, binaural</td>
</tr>
<tr class="even">
<td>V5264</td>
<td>0010</td>
<td>3</td>
<td>Ear mold/insert, not disposable, any type</td>
<td>Ear mold/insert</td>
</tr>
<tr class="odd">
<td>V5265</td>
<td>0010</td>
<td>3</td>
<td>Ear mold/insert, disposable, any type</td>
<td>Ear mold/insert, disp</td>
</tr>
<tr class="even">
<td>V5266</td>
<td>0010</td>
<td>3</td>
<td>Battery for use in hearing device</td>
<td>Battery for hearing device</td>
</tr>
<tr class="odd">
<td>V5267</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid or assistive listening device/supplies/accessories, not otherwise specified</td>
<td>Hearing aid sup/access/dev</td>
</tr>
<tr class="even">
<td>V5268</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, telephone amplifier, any type</td>
<td>Ald telephone amplifier</td>
</tr>
<tr class="odd">
<td>V5269</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, alerting, any type</td>
<td>Alerting device, any type</td>
</tr>
<tr class="even">
<td>V5270</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, television amplifier, any type</td>
<td>Ald, tv amplifier, any type</td>
</tr>
<tr class="odd">
<td>V5271</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, television caption decoder</td>
<td>Ald, tv caption decoder</td>
</tr>
<tr class="even">
<td>V5272</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, tdd</td>
<td>Tdd</td>
</tr>
<tr class="odd">
<td>V5273</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, for use with cochlear implant</td>
<td>Ald for cochlear implant</td>
</tr>
<tr class="even">
<td>V5274</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, not otherwise specified</td>
<td>Ald unspecified</td>
</tr>
<tr class="odd">
<td>V5275</td>
<td>0010</td>
<td>3</td>
<td>Ear impression, each</td>
<td>Ear impression</td>
</tr>
<tr class="even">
<td>V5281</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, personal fm/dm system, monaural, (1 receiver, transmitter, microphone), any type</td>
<td>Ald fm/dm system, monaural</td>
</tr>
<tr class="odd">
<td>V5282</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, personal fm/dm system, binaural, (2 receivers, transmitter, microphone), any type</td>
<td>Ald fm/dm system binaural</td>
</tr>
<tr class="even">
<td>V5283</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, personal fm/dm neck, loop induction receiver</td>
<td>Ald neck, loop ind receiver</td>
</tr>
<tr class="odd">
<td>V5284</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, personal fm/dm, ear level receiver</td>
<td>Ald fm/dm ear level receiver</td>
</tr>
<tr class="even">
<td>V5285</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, personal fm/dm, direct audio input receiver</td>
<td>Ald fm/dm aud input receiver</td>
</tr>
<tr class="odd">
<td>V5286</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, personal blue tooth fm/dm receiver</td>
<td>Ald blu tooth fm/dm receiver</td>
</tr>
<tr class="even">
<td>V5287</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, personal fm/dm receiver, not otherwise specified</td>
<td>Ald fm/dm receiver, nos</td>
</tr>
<tr class="odd">
<td>V5288</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, personal fm/dm transmitter assistive listening device</td>
<td>Ald fm/dm transmitter ald</td>
</tr>
<tr class="even">
<td>V5289</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, personal fm/dm adapter/boot coupling device for receiver, any type</td>
<td>Ald fm/dm adapt/boot couplin</td>
</tr>
<tr class="odd">
<td>V5290</td>
<td>0010</td>
<td>3</td>
<td>Assistive listening device, transmitter microphone, any type</td>
<td>Ald transmitter microphone</td>
</tr>
<tr class="even">
<td>V5298</td>
<td>0010</td>
<td>3</td>
<td>Hearing aid, not otherwise classified</td>
<td>Hearing aid noc</td>
</tr>
<tr class="odd">
<td>V5299</td>
<td>0010</td>
<td>3</td>
<td>Hearing service, miscellaneous</td>
<td>Hearing service</td>
</tr>
<tr class="even">
<td>V5336</td>
<td>0010</td>
<td>3</td>
<td>Repair/modification of augmentative communicative system or device (excludes adaptive hearing aid)</td>
<td>Repair communication device</td>
</tr>
<tr class="odd">
<td>V5362</td>
<td>0010</td>
<td>3</td>
<td>Speech screening</td>
<td>Speech screening</td>
</tr>
<tr class="even">
<td>V5363</td>
<td>0010</td>
<td>3</td>
<td>Language screening</td>
<td>Language screening</td>
</tr>
<tr class="odd">
<td>V5364</td>
<td>0010</td>
<td>3</td>
<td>Dysphagia screening</td>
<td>Dysphagia screening</td>
</tr>
</tbody>
</table>
</div>
</div>



</div>
</div>

</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open')
  });
});
</script>

<!-- code folding -->

<script>
$(document).ready(function ()  {

    // move toc-ignore selectors from section div to header
    $('div.section.toc-ignore')
        .removeClass('toc-ignore')
        .children('h1,h2,h3,h4,h5').addClass('toc-ignore');

    // establish options
    var options = {
      selectors: "h1,h2",
      theme: "bootstrap3",
      context: '.toc-content',
      hashGenerator: function (text) {
        return text.replace(/[.\\/?&!#<>]/g, '').replace(/\s/g, '_').toLowerCase();
      },
      ignoreSelector: ".toc-ignore",
      scrollTo: 0
    };
    options.showAndHide = true;
    options.smoothScroll = true;

    // tocify
    var toc = $("#TOC").tocify(options).data("toc-tocify");
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
